
@article{ WOS:000223136700007,
Author = {Olausson, PO and Haglund, B and Weitoft, GR and Cnattingius, S},
Title = {Premature death among teenage mothers},
Journal = {BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY},
Year = {2004},
Volume = {111},
Number = {8},
Pages = {793-799},
Month = {AUG},
Abstract = {Objective Some data suggest an association between teenage childbearing
   and premature death. Whether this possible increase in risk is
   associated with social circumstances before or after childbirth is not
   known. We studied premature death in relation to age at first birth,
   social background and social situation after first birth.
   Design Population-based cohort study.
   Setting Women born in Sweden registered in the 1985 Swedish Population
   Census.
   Population Swedish women born 1950-1964 who had their first infant
   before the age of 30 years (N = 460,434).
   Methods Information on the women's social background and social
   situation after first birth was obtained from Population Censuses. The
   women were followed up with regard to cause of death from December 1,
   1990 to December 31, 1995. Mortality rate ratios and 95\% confidence
   intervals (CI) were calculated.
   Main outcome measures Mortality rates by cause of death.
   Results Independent of socio-economic background, teenage mothers faced
   an increased risk of premature death later in life compared with older
   mothers (rate ratio 1.6, 95\% CI 1.4-1.9). The increased risk was most
   evident for deaths from cervical cancer, lung cancer, ischaemic heart
   disease, suicide, inflicted violence and alcohol-related diseases. Some,
   but not all, of these increases in risk were associated with the poorer
   social position of teenagers mothers.
   Conclusions Teenage mothers, independent of socio-economic background,
   face an increased risk of premature death. Strategies to reduce teenage
   childbearing are likely to contribute to improved maternal and infant
   health.},
Publisher = {WILEY-BLACKWELL},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Olausson, PO (Corresponding Author), Natl Board Hlth \& Welf, Ctr Epidemiol, SE-10630 Stockholm, Sweden.
   Natl Board Hlth \& Welf, Ctr Epidemiol, SE-10630 Stockholm, Sweden.
   Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden.},
DOI = {10.1111/j.1471-0528.2004.00248.x},
ISSN = {1470-0328},
EISSN = {1471-0528},
Keywords-Plus = {REPORTED HEALTH-STATUS; RISK-FACTORS; REPRODUCTIVE HISTORY;
   CERVICAL-CANCER; WOMEN; CHILDBEARING; MORTALITY; SWEDEN; SUICIDE;
   SMOKING},
Research-Areas = {Obstetrics \& Gynecology},
Web-of-Science-Categories  = {Obstetrics \& Gynecology},
Cited-References = {ASGARD U, 1990, ACTA PSYCHIAT SCAND, V82, P115, DOI 10.1111/j.1600-0447.1990.tb01367.x.
   Bailey JE, 1997, ARCH INTERN MED, V157, P777, DOI 10.1001/archinte.157.7.777.
   BEARD CM, 1984, AM J EPIDEMIOL, V120, P108, DOI 10.1093/oxfordjournals.aje.a113859.
   Benzeval M, 1998, SOC SCI MED, V46, P1337, DOI 10.1016/S0277-9536(97)10083-1.
   Bjorge T, 1996, CANCER CAUSE CONTROL, V7, P351, DOI 10.1007/BF00052941.
   BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514.
   BURKMAN RT, 1988, AM J OBSTET GYNECOL, V158, P1592, DOI 10.1016/0002-9378(88)90195-0.
   Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641.
   ESTEVE J, 1993, FACTS FIGURES CANC E.
   FerradaNoli M, 1996, PSYCHOL REP, V79, P707, DOI 10.2466/pr0.1996.79.3.707.
   GERONIMUS AT, 1993, DEMOGRAPHY, V30, P281, DOI 10.2307/2061842.
   HOFFMAN SD, 1993, DEMOGRAPHY, V30, P1, DOI 10.2307/2061859.
   Johansson LM, 1997, SOC PSYCH PSYCH EPID, V32, P165.
   Kington R, 1997, AM J PUBLIC HEALTH, V87, P33, DOI 10.2105/AJPH.87.1.33.
   LUND E, 1990, J EPIDEMIOL COMMUN H, V44, P237, DOI 10.1136/jech.44.3.237.
   Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1.
   {*}NAT BOARD HLTH WE, 1998, CAUS DEATH 1996.
   {*}NAT BOARD HLTH WE, 1998, SWED PUBL HLTH REP 1.
   Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027.
   Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752.
   PALMER JR, 1992, AM J EPIDEMIOL, V136, P408, DOI 10.1093/oxfordjournals.aje.a116513.
   POPEY J, 1990, J SOC POLICY, V19, P499.
   SHERMAN CB, 1991, CLIN CHEST MED, V12, P643.
   SPIVAK H, 1987, JAMA-J AM MED ASSOC, V258, P1500, DOI 10.1001/jama.258.11.1500.
   {*}STAT SWED, 1984, SWED SOC CLASS REP S, V4.
   STEVENSSIMON C, 1995, ARCH PEDIAT ADOL MED, V149, P912, DOI 10.1001/archpedi.1995.02170210086015.
   Sundquist J, 1997, SOC SCI MED, V45, P1757, DOI 10.1016/S0277-9536(97)00107-X.
   TOMATIS L, 1990, IARCH SCI PUBL, V100.
   Weitoft GR, 2000, LANCET, V355, P1215, DOI 10.1016/S0140-6736(00)02087-0.
   WENGER NK, 1995, AM J HYPERTENS, V8, P94.},
Number-of-Cited-References = {30},
Times-Cited = {40},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {BJOG},
Doc-Delivery-Number = {844DE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000223136700007},
DA = {2022-03-29},
}

@article{ WOS:000486966400006,
Author = {Vienonen, Mikko A. and Jousilahti, Pekka J. and Mackiewicz, Karolina and
   Oganov, Rafael G. and Pisaryk, Vital M. and Denissov, Gleb R. and Nurm,
   Ulla-Karin and Pudule, Iveta and Gurevicius, Romualdas J. and Zablocki,
   Bartosz M. and Friberg, Marita I. and Krasilnikov, Igor A. and
   Koistinen, Veli O. and Vohlonen, Ilkka J.},
Title = {Preventable premature deaths (PYLL) in Northern Dimension partnership
   countries 2003-13},
Journal = {EUROPEAN JOURNAL OF PUBLIC HEALTH},
Year = {2019},
Volume = {29},
Number = {4},
Pages = {626-630},
Month = {AUG},
Abstract = {Background: Objective was to measure preventable premature loss of life
   in countries from same geographical area but with considerable
   differences in social and economic development. By comparing
   inter-country differences and similarities in premature mortality,
   acceleration of health-in-all-policies is enhanced. Methods: Preventable
   premature deaths were described by Potential Years of Life Lost (PYLL).
   Data consisted of death registers for 2003, 2009 and 2013. PYLL-rates
   were age-standardized by using standard OECD population from 1980 and
   expressed as sum of lost life years per 100 000 citizens. Results: In
   Northern Dimension area, PYLL-rates had declined from 2003 to 2013. In
   2013, worst PYLL-rate was in Belarus 9851 and best in Sweden 2511.
   PYLL-rates among men were twice as high as among women. Most premature
   losses (1023) were due to external causes. Malignant neoplasms came
   second (921) and vascular diseases third (816). Alcohol was also an
   important cause (270) and country differences were over 10-fold.
   Conclusions: In ND-area, the overall development of public health has
   been good during 2003-13. Nevertheless, for all countries foci for
   public health improvement and learning from each other could be
   identified. Examining the health of populations in countries from
   relatively similar geographical area with different social history and
   cultures can provide them with evidence-based tools for
   health-in-all-policies to advocate health promotion and disease
   prevention. Gender differences due to preventable premature deaths are
   striking. The higher the national PYLL-rate, the bigger the PYLL-rate
   difference between men and women and the loss of human capital.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Vohlonen, IJ (Corresponding Author), Univ Eastern Finland, Dept Publ Hlth, POB 1627, FI-70211 Kuopio, Finland.
   Vienonen, Mikko A.; Koistinen, Veli O., Finnish Consulting Grp, Management Consulting Grp, Helsinki, Finland.
   Jousilahti, Pekka J., Natl Inst Hlth \& Welf, Dept Publ Solut, Helsinki, Finland.
   Mackiewicz, Karolina, Balt Reg Hlth Cities Assoc, Turku, Finland.
   Oganov, Rafael G., Minist Hlth, Natl Res Ctr Prevent Med, Dept Comorbid Prevent, Moscow, Russia.
   Pisaryk, Vital M., Republican Sci \& Pract Ctr Med Technol, Minsk, BELARUS.
   Denissov, Gleb R., Estonian Registry Causes Death, Natl Inst Hlth Dev, Tallinn, Estonia.
   Nurm, Ulla-Karin, Northern Dimens Partnership Publ Hlth \& Social We, Stockholm, Sweden.
   Pudule, Iveta, Ctr Dis Prevent \& Control, Dept Hlth Stat, Riga, Latvia.
   Gurevicius, Romualdas J., Inst Hyg, Ctr Hlth Stat, Vilnius, Lithuania.
   Zablocki, Bartosz M., Minist Hlth, Dept Publ Hlth, Warsaw, Poland.
   Friberg, Marita I., Publ Hlth Agcy, Dept Hlth Stat, Solna, Sweden.
   Krasilnikov, Igor A., Strategic LLC, Soc Org Responsibil, St Petersburg, Russia.
   Vohlonen, Ilkka J., Univ Eastern Finland, Dept Publ Hlth \& Clin Nutr, Kuopio, Finland.},
DOI = {10.1093/eurpub/cky278},
ISSN = {1101-1262},
EISSN = {1464-360X},
Keywords-Plus = {LIFE EXPECTANCY; MORTALITY; TRENDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ilkka.vohlonen@uef.fi},
ResearcherID-Numbers = {Gurevicius, Romualdas/T-4406-2017},
Funding-Acknowledgement = {European UnionEuropean Commission {[}2013-Lot 8]},
Funding-Text = {This study was funded by the European Union (Framework Contract
   Beneficiaries 2013-Lot 8). (this is how EU wants to state it).},
Cited-References = {{[}Anonymous], 2018, GLOB STAT ALC HLTH.
   Armitage P., 1971, STAT METHODS MED RES.
   Becker GS., 1994, HUMAN CAPITAL THEORE.
   Friedman M., 1953, ESSAYS POSITIVE EC P, P3.
   Habicht T, 2018, HEALT SYST TRANSIT, V20, P1.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Jousilahti P, 2016, GLOB HEART, V11, P207, DOI 10.1016/j.gheart.2016.04.004.
   Jousilahti P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i721.
   Karlsson T, 2013, 13 FINN NAT I HLTH W.
   Koppel A, 2008, HLTH SYST TRANSIT, V10, P1.
   Lai Taavi, 2013, Health Syst Transit, V15, P1.
   Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061.
   MAUDSLEY G, 1994, J PUBLIC HEALTH MED, V16, P370.
   McDaid, 2013, PROMOTING HLTH PREVE.
   Minicozzi P, 2015, EUR J CANCER, V51, P2099.
   Minicuci N, 2004, Eur J Ageing, V1, P37, DOI 10.1007/s10433-004-0002-5.
   Mitenbergs U, 2012, HLTH SYSTEMS TRANSIT, V14, P1.
   Mladovsky P, 2009, OBSERVATORY STUDIES, V19.
   Murauskiene L, 2013, HEALT SYST TRANSIT, V15, P1.
   Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4.
   OECD, GLOSS STAT TERMS.
   Rampatige R, 2014, B WORLD HEALTH ORGAN, V92, P807, DOI 10.2471/BLT.14.137935.
   Richardson Erica, 2013, Health Syst Transit, V15, P1.
   Robine J-M, 2004, DISABILITY FREE LIFE, P1.
   Veillard Jeremy, 2010, Healthc Policy, V5, P49.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   World Health Organization, 2010, GLOBAL STATUS REPORT.},
Number-of-Cited-References = {27},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Eur. J. Public Health},
Doc-Delivery-Number = {IZ3EC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000486966400006},
DA = {2022-03-29},
}

@article{ WOS:A1985AWY8000011,
Author = {MCDONNELL, R and MAYNARD, A},
Title = {ESTIMATION OF LIFE YEARS LOST FROM ALCOHOL-RELATED PREMATURE DEATH},
Journal = {ALCOHOL AND ALCOHOLISM},
Year = {1985},
Volume = {20},
Number = {4},
Pages = {435-443},
Publisher = {OXFORD UNIV PRESS UNITED KINGDOM},
Address = {WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP},
Type = {Article},
Language = {English},
Affiliation = {MCDONNELL, R (Corresponding Author), UNIV YORK,CTR HLTH ECON,YORK YO1 5DD,N YORKSHIRE,ENGLAND.},
ISSN = {0735-0414},
Research-Areas = {Substance Abuse},
Web-of-Science-Categories  = {Substance Abuse},
Cited-References = {ADELSTEIN A, 1976, POPULATION TRENDS, P7.
   CULLIS JG, 1979, EC HLTH INTRO.
   CULYER AJ, 1971, SOCIAL TRENDS 1971.
   DEITCH R, 1980, LANCET, V1, P938.
   HOLTERMANN S, 1981, GES37 WORK PAP.
   Jones-Lee M, 1976, VALUE LIFE EC ANAL.
   JONES-LEE MW, 1985, ECON J, V95, P49, DOI 10.2307/2233468.
   KLARMAN HE, 1968, MED CARE, V6, P48, DOI 10.1097/00005650-196801000-00005.
   Mooney G.M, 1977, VALUATION HUMAN LIFE.
   MOONEY GH, 1984, NUFFIELD YORK PORTFO, V3.
   ROSSER R, 1978, INT J EPIDEMIOL, V7, P347, DOI 10.1093/ije/7.4.347.
   ROSSER R, 1983, HLTH INDICATORS INT.
   TORRANCE GW, 1984, UNPUB HLTH STATUS ME.
   {*}UK OPCS, 1984, GEN HOUS SURV ANN RE.
   {*}UK OPCS, 1984, MORT STAT CAUS 1983.
   WILLIAMS A, 1974, BRIT J PREV SOC MED, V28, P196.},
Number-of-Cited-References = {16},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Alcohol Alcohol.},
Doc-Delivery-Number = {AWY80},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1985AWY8000011},
DA = {2022-03-29},
}

@article{ WOS:000074026600018,
Author = {Ellis, PJ and Marshall, E and Windridge, C and Jones, S and Ellis, SJ},
Title = {Left-handedness and premature death},
Journal = {LANCET},
Year = {1998},
Volume = {351},
Number = {9116},
Pages = {1634},
Month = {MAY 30},
Publisher = {LANCET LTD},
Address = {42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Ellis, PJ (Corresponding Author), Keele Univ, N Staffordshire Royal Infirm, Dept Neurol, Stoke On Trent, Staffs, England.
   Keele Univ, N Staffordshire Royal Infirm, Dept Neurol, Stoke On Trent, Staffs, England.
   Univ Leeds, Comp Serv, Leeds, W Yorkshire, England.
   Klidonan House Grp Practice, Horwich, Lancs, England.},
DOI = {10.1016/S0140-6736(05)77690-X},
ISSN = {0140-6736},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {Ellis SJ, 1998, J EPIDEMIOL COMMUN H, V52, P41, DOI 10.1136/jech.52.1.41.
   HALPERN DF, 1991, NEW ENGL J MED, V324, P998.
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4.},
Number-of-Cited-References = {3},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {ZR900},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000074026600018},
DA = {2022-03-29},
}

@article{ WOS:000307140500045,
Author = {Johansson, Lars and Stenlund, Hans and Bylund, Per-Olof and Eriksson,
   Anders},
Title = {ER visits predict premature death among teenagers},
Journal = {ACCIDENT ANALYSIS AND PREVENTION},
Year = {2012},
Volume = {48},
Number = {SI},
Pages = {397-400},
Month = {SEP},
Abstract = {Background: The purpose of this study was to investigate if teenagers
   visiting an emergency room because of injury have an increased risk of
   premature death ahead and, if so, identify possible risk factors and
   suggest preventive measures.
   Methods: In January 2010, the personal identity numbers of 12,812
   teenagers who had visited the emergency room at the University Hospital
   in Umea. Sweden, during 1993 through 2006 because of injury were checked
   against the National Cause of Death Register in Sweden. Standardised
   mortality ratio and confidence intervals were calculated. For the
   unnatural deaths that took place in Sweden, the police report, autopsy
   protocol, and hospital records, if present, were studied.
   Results: Thirty-eight fatalities were included giving a standardised
   mortality ratio of 1.44 (95\% CI: 1.02-1.98). A majority of the
   decedents were males (n = 32, 84\%) and the median age at the time of
   death was 21 years. Twenty-three deaths were caused by unintentional
   injuries and ten by intentional injuries (all suicides), while five
   deaths were categorised as undetermined whether intentional or not.
   Seventy-four percent tested positive for either alcohol or drugs or a
   combination at the post mortem examination. Nine males and one female
   committed suicide, five tested positive for alcohol (one also for
   drugs), while four tested negative at the post mortem examination. One
   died abroad and in this case we lack information on alcohol and drugs.
   Conclusion: Teenagers visiting an emergency room due to injury
   experience an increased risk of premature death by unnatural cause and
   those at risk are especially males. The use of alcohol and drugs often
   seems to contribute to their untimely deaths. Identifying those at risk
   when they visit the emergency room for an injury and to take preventive
   actions at this stage could be a way to reduce the number of fatalities.
   (C) 2012 Elsevier Ltd. All rights reserved.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Johansson, L (Corresponding Author), Umea Univ, Dept Community Med \& Rehabil, Sect Forens Med, POB 7616, SE-90712 Umea, Sweden.
   Johansson, Lars; Eriksson, Anders, Umea Univ, Dept Community Med \& Rehabil, Sect Forens Med, SE-90712 Umea, Sweden.
   Stenlund, Hans, Umea Univ, Dept Publ Hlth \& Clin Med, Epidemiol Sect, SE-90185 Umea, Sweden.
   Bylund, Per-Olof, Umea Univ, Emergency \& Disaster Med Ctr, SE-90185 Umea, Sweden.},
DOI = {10.1016/j.aap.2012.02.012},
ISSN = {0001-4575},
Keywords = {ER; Premature death; Alcohol/drugs},
Keywords-Plus = {INJURY MORTALITY; TRAUMA PATIENTS; RISK-FACTORS; ALCOHOL-USE;
   ADOLESCENTS; SUICIDE; SWEDEN; TRENDS; INTERVENTION; DRUGS},
Research-Areas = {Engineering; Public, Environmental \& Occupational Health; Social
   Sciences - Other Topics; Transportation},
Web-of-Science-Categories  = {Ergonomics; Public, Environmental \& Occupational Health; Social
   Sciences, Interdisciplinary; Transportation},
Author-Email = {lars.a.johansson@vll.se
   hans.stenlund@epiph.umu.se
   perolof.bylund@vll.se
   anders.eriksson@rmv.se},
Cited-References = {Ahlm Kristin, 2006, Traffic Inj Prev, V7, P219, DOI 10.1080/15389580600727846.
   Bridge JA, 2008, JAMA-J AM MED ASSOC, V300, P1025, DOI 10.1001/jama.300.9.1025.
   Committee on Trauma Research, 1985, INJ AM.
   Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009.
   Dowd MD, 1996, AM J PUBLIC HEALTH, V86, P929, DOI 10.2105/AJPH.86.7.929.
   Draus JM, 2008, J PEDIATR SURG, V43, P208, DOI 10.1016/j.jpedsurg.2007.09.046.
   Drummer OH, 2003, FORENSIC SCI INT, V134, P154, DOI 10.1016/S0379-0738(03)00134-8.
   Ekman R, 2005, INJURY PREV, V11, P29, DOI 10.1136/ip.2003.005074.
   Gentilello LM, 2005, ANN SURG, V241, P541, DOI 10.1097/01.sla.0000157133.80396.1c.
   Grossman D, 2000, WESTERN J MED, V172, P151, DOI 10.1136/ewjm.172.3.151.
   GROSSMAN DC, 1993, EPIDEMIOLOGY, V4, P115, DOI 10.1097/00001648-199303000-00006.
   Grossman DC, 2000, FUTURE CHILD, V10, P23, DOI 10.2307/1602824.
   Holmgren P, 2005, FORENSIC SCI INT, V151, P11, DOI 10.1016/j.forsciint.2004.06.031.
   Hungerford DW, 2003, AM J EMERG MED, V21, P14, DOI 10.1053/ajem.2003.50004.
   Johansson L, 2001, Int J Circumpolar Health, V60, P380.
   Johansson L, 2005, ACCIDENT ANAL PREV, V37, P253, DOI 10.1016/j.aap.2004.09.002.
   Johansson Lars, 2006, BMC Fam Pract, V7, P32, DOI 10.1186/1471-2296-7-32.
   Lindqvist P, 2000, Inj Prev, V6, P115, DOI 10.1136/ip.6.2.115.
   Lindqvist P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-26.
   Mattila V, 2004, EUR J EPIDEMIOL, V19, P437, DOI 10.1023/B:EJEP.0000027355.85493.cb.
   Mattila VM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-90.
   Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989.
   Morrison A, 2000, J ADOLESCENT HEALTH, V27, P130, DOI 10.1016/S1054-139X(99)00112-3.
   Paavola M, 2004, J ADOLESCENT HEALTH, V35, P238, DOI 10.1016/j.jadohealth.2003.12.004.
   Rios A, 2006, ANN EMERG MED, V47, P361, DOI 10.1016/j.annemergmed.2006.01.007.
   Socialstyrelsen, 2009, CAUS DEATH.},
Number-of-Cited-References = {26},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Accid. Anal. Prev.},
Doc-Delivery-Number = {983TB},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000307140500045},
DA = {2022-03-29},
}

@incollection{ WOS:000327428200010,
Author = {Zittermann, A. and Prokop, S.},
Editor = {Watson, RR},
Title = {Vitamin D deficiency and premature death},
Booktitle = {HANDBOOK OF VITAMIN D IN HUMAN HEALTH: PREVENTION, TREATMENT AND
   TOXICITY},
Series = {Human Health Handbooks},
Year = {2013},
Number = {4},
Pages = {175-192},
Abstract = {This chapter gives an overview of the current knowledge about vitamin D
   deficiency and premature death and discusses possible life-prolonging
   mechanisms of vitamin D. Globally, vitamin D status is low and the
   prevalence of vitamin D deficiency is common. Historically, rickets was
   associated with a high mortality risk in Europe and Northern America. In
   frail elderly people, both mortality risk and the prevalence of vitamin
   D deficiency increase exponentially. Likewise, prospective cohort
   studies indicate an elevated mortality risk in vitamin D deficient
   people in the general population. Results from two meta-analyses that
   have summarized available data from randomized studies where all-cause
   mortality was a secondary endpoint indicate a 6-7\% reduction in
   all-cause mortality by vitamin D supplementation in frail elderly
   people. Studies with experimental animals lacking vitamin D action
   support the assumption that vitamin D deficiency results in premature
   death. Possible beneficial vitamin D actions include important
   regulatory properties of 1,25-dihydroxyvitamin D on a cellular level as
   well as higher telomerase activity, leading to maintained telomere
   length. Data from prospective cohort studies on cardiovascular mortality
   concur with those on all-cause mortality. For cancer mortality, data
   from epidemiological studies are less convincing and the evidence from
   randomized controlled trials is inconsistent. In conclusion, there is
   likely evidence that vitamin D reduces all-cause mortality in elderly
   people. However, adequately powered randomized controlled trials with
   all-cause mortality as primary endpoint are still needed.},
Publisher = {WAGENINGEN ACAD PUBL},
Address = {POSTBUS 220, 6700 AE WAGENINGEN, NETHERLANDS},
Type = {Article; Book Chapter},
Language = {English},
Affiliation = {Zittermann, A (Corresponding Author), Heart \& Diabet Ctr North Rhine Westphalia, Clin Thorac \& Cardiovasc Surg, Georgstr 11, D-32545 Bad Oeynhausen, Germany.
   Zittermann, A.; Prokop, S., Heart \& Diabet Ctr North Rhine Westphalia, Clin Thorac \& Cardiovasc Surg, D-32545 Bad Oeynhausen, Germany.},
ISSN = {2212-375X},
ISBN = {978-90-8686-765-3; 978-90-8686-210-8},
Keywords = {mortality; survival; premature death; cancer; cardiovascular disease;
   chronic kidney disease},
Keywords-Plus = {LOW 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE; D SUPPLEMENTATION;
   CANCER-MORTALITY; RISK; HEALTH; CALCIUM; METAANALYSIS; PREVENTION;
   PROSTATE},
Research-Areas = {Nutrition \& Dietetics},
Web-of-Science-Categories  = {Nutrition \& Dietetics},
Author-Email = {azittermann@hdz-nrw.de},
Cited-References = {Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152.
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730.
   Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309.
   Bjelakovic G.L., 2011, COCHRANE DATABASE SY, V207.
   Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032.
   Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264.
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004.
   Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf.
   Brunner RL, 2011, NUTR CANCER, V63, P827, DOI 10.1080/01635581.2011.594208.
   Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680.
   DGE (German Nutrition Society), 2012, VIT D PRAV AUSG CHRO.
   Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311.
   Freedman DM, 2007, JNCI-J NATL CANCER I, V99, P1594, DOI 10.1093/jnci/djm204.
   Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420.
   Freedman DM, 2002, OCCUP ENVIRON MED, V59, P257, DOI 10.1136/oem.59.4.257.
   Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439.
   Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021.
   GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227.
   Giovannucci E, 2006, CANCER EPIDEM BIOMAR, V15, P2467, DOI 10.1158/1055-9965.EPI-06-0357.
   Grandi NC, 2010, AM HEART J, V159, P1044, DOI 10.1016/j.ahj.2010.03.031.
   Grant WB, 2002, CANCER-AM CANCER SOC, V94, P272, DOI 10.1002/cncr.10196.
   Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014.
   Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y.
   Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119.
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553.
   Inaguma D, 2008, CLIN EXP NEPHROL, V12, P126, DOI 10.1007/s10157-007-0023-4.
   Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188.
   Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975.
   LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029.
   Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289.
   Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996.
   Looker Anne C, 2011, NCHS Data Brief, P1.
   Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6.
   Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002.
   Navaneethan SD, 2011, AM J KIDNEY DIS, V58, P536, DOI 10.1053/j.ajkd.2011.04.028.
   Pilz S, 2012, J CLIN ENDOCR METAB, V97, pE653, DOI 10.1210/jc.2011-3043.
   Pilz S, 2011, NEPHROL DIAL TRANSPL, V26, P3603, DOI 10.1093/ndt/gfr076.
   Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x.
   Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020.
   Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a.
   Rajakumar K, 2003, PEDIATRICS, V112, pE132, DOI 10.1542/peds.112.2.e132.
   Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420.
   Rodriguez M, 2011, KIDNEY BLOOD PRESS R, V34, P261, DOI 10.1159/000326903.
   Santillan GE, 1998, J MOL CELL CARDIOL, V30, P225, DOI 10.1006/jmcc.1997.0577.
   Santoro D, 2011, RENAL FAILURE, V33, P184, DOI 10.3109/0886022X.2011.553303.
   Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009.
   Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141.
   Tuohimaa P, 2009, J STEROID BIOCHEM, V114, P78, DOI 10.1016/j.jsbmb.2008.12.020.
   Vanoirbeek E, 2011, BEST PRACT RES CL EN, V25, P593, DOI 10.1016/j.beem.2011.05.001.
   VIETH R, 1987, J NUTR, V117, P914, DOI 10.1093/jn/117.5.914.
   Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010.
   Zhu H, 2012, INT J OBESITY, V36, P805, DOI 10.1038/ijo.2011.197.
   Zittermann A, 2010, MOL NUTR FOOD RES, V54, P1164, DOI 10.1002/mnfr.200900494.
   Zittermann A, 2008, CURR OPIN CLIN NUTR, V11, P752, DOI 10.1097/MCO.0b013e328312c33f.
   Zittermann A, 2009, DERM-ENDOCRINOL, V1, P301, DOI 10.4161/derm.1.6.10970.
   Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779.
   Zittermann A, 2010, J PHOTOCH PHOTOBIO B, V101, P124, DOI 10.1016/j.jphotobiol.2010.01.006.},
Number-of-Cited-References = {57},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {BIC84},
Web-of-Science-Index = {Book Citation Index – Science (BKCI-S)},
Unique-ID = {WOS:000327428200010},
DA = {2022-03-29},
}

@article{ WOS:000442351000026,
Author = {Richards, Kay L. and Milligan, Carol J. and Richardson, Robert J. and
   Jancovski, Nikola and Grunnet, Morten and Jacobson, Laura H. and
   Undheim, Eivind A. B. and Mobli, Mehdi and Chow, Chun Yuen and Herzig,
   Volker and Csoti, Agota and Panyi, Gyorgy and Reid, Christopher A. and
   King, Glenn F. and Petrou, Steven},
Title = {Selective Na(V)1.1 activation rescues Dravet syndrome mice from seizures
   and premature death},
Journal = {PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA},
Year = {2018},
Volume = {115},
Number = {34},
Pages = {E8077-E8085},
Month = {AUG 21},
Abstract = {Dravet syndrome is a catastrophic, pharmacoresistant epileptic
   encephalopathy. Disease onset occurs in the first year of life, followed
   by developmental delay with cognitive and behavioral dysfunction and
   substantially elevated risk of premature death. The majority of affected
   individuals harbor a loss-of-function mutation in one allele of SCN1A,
   which encodes the voltage-gated sodium channel NaV1.1. Brain Na(V)1.1 is
   primarily localized to fast-spiking inhibitory interneurons; thus the
   mechanism of epileptogenesis in Dravet syndrome is hypothesized to be
   reduced inhibitory neurotransmission leading to brain hyperexcitability.
   We show that selective activation of Na(V)1.1 by venom peptide Hm1a
   restores the function of inhibitory interneurons from Dravet syndrome
   mice without affecting the firing of excitatory neurons.
   Intracerebroventricular infusion of Hm1a rescues Dravet syndrome mice
   from seizures and premature death. This precision medicine approach,
   which specifically targets the molecular deficit in Dravet syndrome,
   presents an opportunity for treatment of this intractable epilepsy.},
Publisher = {NATL ACAD SCIENCES},
Address = {2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA},
Type = {Article},
Language = {English},
Affiliation = {Petrou, S (Corresponding Author), Florey Inst Neurosci \& Mental Hlth, Ion Channels \& Dis Grp, Parkville, Vic 3010, Australia.
   King, GF (Corresponding Author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.
   Petrou, S (Corresponding Author), Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia.
   Richards, Kay L.; Milligan, Carol J.; Richardson, Robert J.; Jancovski, Nikola; Reid, Christopher A.; Petrou, Steven, Florey Inst Neurosci \& Mental Hlth, Ion Channels \& Dis Grp, Parkville, Vic 3010, Australia.
   Grunnet, Morten, Neurosci Drug Discovery, H Lundbeck A-S, DK-2500 Valby, Denmark.
   Grunnet, Morten, Univ Copenhagen, Dept Drug Design \& Pharmacol, DK-2100 Copenhagen, Denmark.
   Jacobson, Laura H., Florey Insitute Neurosci \& Mental Hlth, Epilepsy Div, Sleep \& Cognit Grp, Parkville, Vic 3010, Australia.
   Jacobson, Laura H., Univ Melbourne, Dept Pharmacol \& Therapeut, Parkville, Vic 3010, Australia.
   Undheim, Eivind A. B.; Mobli, Mehdi, Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia.
   Chow, Chun Yuen; Herzig, Volker; King, Glenn F., Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.
   Csoti, Agota; Panyi, Gyorgy, Univ Debrecen, Fac Med, Dept Biophys \& Cell Biol, H-4032 Debrecen, Hungary.
   Petrou, Steven, Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia.},
DOI = {10.1073/pnas.1804764115},
ISSN = {0027-8424},
Keywords = {genetic epilepsy; targeted drug therapy; seizures; Dravet syndrome;
   spider venom},
Keywords-Plus = {SEVERE MYOCLONIC EPILEPSY; MOUSE MODEL; SODIUM-CHANNELS; INHIBITORY
   INTERNEURONS; ABSENCE EPILEPSY; NMR-SPECTROSCOPY; SUDDEN-DEATH;
   VARIANTS; HAPLOINSUFFICIENCY; PHARMACOLOGY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {glenn.king@imb.uq.edu.au
   spetrou@unimelb.edu.au},
ResearcherID-Numbers = {Chow, Chun Yuen/C-7941-2017
   Chow, Chun Yuen/AAS-2223-2020
   Herzig, Volker/A-7177-2008
   Panyi, Gyorgy/H-4406-2013
   Mobli, Mehdi/O-7244-2014
   },
ORCID-Numbers = {Chow, Chun Yuen/0000-0003-2861-5843
   Chow, Chun Yuen/0000-0003-2861-5843
   Herzig, Volker/0000-0003-2514-3983
   Panyi, Gyorgy/0000-0001-6227-3301
   Reid, Christopher/0000-0002-1457-8028
   Jacobson, Laura/0000-0003-2910-8659
   Mobli, Mehdi/0000-0003-2420-4262
   Undheim, Eivind/0000-0002-8667-3999
   King, Glenn/0000-0002-2308-2200
   Petrou, Steven/0000-0002-4960-6375},
Funding-Acknowledgement = {Citizen's United for Research in Epilepsy Pediatrics Award {[}353711];
   Australian National Health and Medical Research Council ProgramNational
   Health and Medical Research Council of Australia {[}10915693];
   Australian Research CouncilAustralian Research Council; Dowd Foundation;
   European UnionEuropean Commission {[}GINOP-2.3.2-15-2016-00044];
   European Regional Development FundEuropean Commission; Department of
   Health, State Government of Victoria},
Funding-Text = {We thank Prof. Kazuhiro Yamakawa (RIKEN Brain Science Institute) for
   donating Dravet syndrome mice and Prof. Gilles Guillemin (St Vincent's
   Centre for Applied Medical Research) for human CSF. This work was
   supported by Citizen's United for Research in Epilepsy Pediatrics Award
   353711, Australian National Health and Medical Research Council Program
   Grant 10915693 (to S.P. and C.A.R.), Principal Research Fellowships (to
   S.P. and G.F.K.), an Australian Research Council Discovery Early Career
   Researcher Award Fellowship (to E.A.B.U.), a Dowd Foundation Research
   Fellowship (to C.A.R.), and by the GINOP-2.3.2-15-2016-00044 Project
   cofinanced by the European Union and the European Regional Development
   Fund (G.P.). The Florey Institute of Neuroscience and Mental Health is
   supported by infrastructure funds from the Department of Health, State
   Government of Victoria.},
Cited-References = {Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029.
   Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108.
   Brigo F, 2017, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD010483.PUB4.
   Cao DZ, 2012, EPILEPSIA, V53, P1140, DOI 10.1111/j.1528-1167.2012.03497.x.
   Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232.
   Cheah CS, 2013, CHANNELS, V7, P468, DOI 10.4161/chan.26023.
   Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109.
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216.
   De Jonghe P, 2011, DEV MED CHILD NEUROL, V53, P7, DOI 10.1111/j.1469-8749.2011.03965.x.
   Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x.
   Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48.
   Gataullina S, 2017, SEIZURE-EUR J EPILEP, V44, P58, DOI 10.1016/j.seizure.2016.10.014.
   Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011.
   Guntert Peter, 2004, Methods Mol Biol, V278, P353.
   Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356.
   Higurashi N, 2013, J NEUROL NEUROPHYSIO, V4, P152.
   Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003.
   Jensen HS, 2014, TRENDS PHARMACOL SCI, V35, P113, DOI 10.1016/j.tips.2013.12.007.
   Kalume F, 2013, RESP PHYSIOL NEUROBI, V189, P324, DOI 10.1016/j.resp.2013.06.026.
   Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022.
   Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x.
   Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007.
   Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331.
   Oliva MK, 2014, NEUROBIOL DIS, V67, P180, DOI 10.1016/j.nbd.2014.03.007.
   Osteen JD, 2017, P NATL ACAD SCI USA, V114, P6836, DOI 10.1073/pnas.1621263114.
   Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976.
   PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022.
   Parihar R, 2013, J HUM GENET, V58, P573, DOI 10.1038/jhg.2013.77.
   Plosker GL, 2012, CNS DRUGS, V26, P993, DOI 10.1007/s40263-012-0004-3.
   Pope JE, 2015, NEUROMODULATION, V18, P414, DOI 10.1111/ner.12274.
   Sanford M, 2013, CNS DRUGS, V27, P989, DOI 10.1007/s40263-013-0107-5.
   Scheffer IE, 2012, EUR J PAEDIAT NEU S1, V16, P55.
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z.
   Shmuely S, 2016, EPILEPSY BEHAV, V64, P69, DOI 10.1016/j.yebeh.2016.09.007.
   Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104.
   Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046.
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449.
   Wallace A, 2016, PEDIATR DRUGS, V18, P197, DOI 10.1007/s40272-016-0171-7.
   Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754.
   Zhang MM, 2013, BRIT J PHARMACOL, V168, P1597, DOI 10.1111/bph.12051.},
Number-of-Cited-References = {40},
Times-Cited = {66},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Proc. Natl. Acad. Sci. U. S. A.},
Doc-Delivery-Number = {GR1YB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000442351000026},
OA = {Green Published, Green Submitted, hybrid},
DA = {2022-03-29},
}

@article{ WOS:A1986C929200002,
Author = {PALMER, CE and NOBLE, DN},
Title = {PREMATURE DEATH - DILEMMAS OF INFANT-MORTALITY},
Journal = {SOCIAL CASEWORK-JOURNAL OF CONTEMPORARY SOCIAL WORK},
Year = {1986},
Volume = {67},
Number = {6},
Pages = {332-339},
Month = {JUN},
Publisher = {FAMILY SERVICE AMER},
Address = {11700 WEST LAKE PARK DRIVE, MILWAUKEE, WI 53224},
Type = {Article},
Language = {English},
Affiliation = {PALMER, CE (Corresponding Author), UNIV SW LOUISIANA,DEPT SOCIOL \& ANTHROPOL,LAFAYETTE,LA 70504, USA.
   TEXAS TECH UNIV,DEPT SOCIOL,LUBBOCK,TX 79409.},
DOI = {10.1177/104438948606700602},
ISSN = {0037-7678},
Research-Areas = {Social Work},
Web-of-Science-Categories  = {Social Work},
Cited-References = {DOKA KJ, 1981, OMEGA, V12, P348.
   FAGERHAUGH SY, 1977, POLITICS PAIN MANAGE, P4.
   HAMILTON AK, 1983, SOC CASEWORK-JCSW, V64, P18, DOI 10.1177/104438948306400103.
   HARPER BC, 1977, DEATH COPING MECHANI, P21.
   HELLER DB, 1977, OMEGA, V8, P319.
   HOLDEN C, 1983, SCIENCE, V222, P908, DOI 10.1126/science.6227081.
   JONSEN A, 1976, ETHICS NEWBORN INTEN, P152.
   Kennel JH, 1978, CONTEMP OBSTET GYNEC, V12, P53.
   KIRKLEYBEST E, 1982, AM J ORTHOPSYCHIAT, V52, P420, DOI 10.1111/j.1939-0025.1982.tb01428.x.
   MAHAN CK, 1981, SOC WORK HEALTH CARE, V6, P69, DOI 10.1300/J010v06n03\_07.
   Noble D N, 1981, Health Soc Work, V6, P28.
   PALMER CE, 1983, J OCCUP PSYCHOL, V56, P83, DOI 10.1111/j.2044-8325.1983.tb00114.x.
   PAPPER S, 1978, DOMINANT ISSUES MED, P166.
   PEPPERS LG, 1980, PSYCHIATRY, V43, P155, DOI 10.1080/00332747.1980.11024061.
   RAPPAPORT C, 1981, SOC WORK HEALTH CARE, V6, P57, DOI 10.1300/J010v06n03\_06.
   SANDERS CM, 1979, OMEGA, V10, P303, DOI DOI 10.2190/X565-HW49-CHR0-FYB4.
   SOSNOWITZ BG, 1984, SOC PROBL, V31, P390, DOI 10.1525/sp.1984.31.4.03a00030.
   SUDNOW D, 1967, PASSING SOCIAL ORG D, P107.
   WESTMAN JC, 1979, CHILD ADVOCACY NEW P, P40.
   WILLIAMS WC, 1979, NORTON ANTHOLOGY AM, V2, P1450.},
Number-of-Cited-References = {20},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {C9292},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1986C929200002},
DA = {2022-03-29},
}

@article{ WOS:A1978FC79800002,
Author = {KLEIN, PA},
Title = {AMERICAN INSTITUTIONALISM - PREMATURE DEATH, PERMANENT RESURRECTION},
Journal = {JOURNAL OF ECONOMIC ISSUES},
Year = {1978},
Volume = {12},
Number = {2},
Pages = {251-276},
Publisher = {ASSOC EVOLUTIONARY ECONOMICS},
Address = {UNIV TENNESSEE, KNOXVILLE, DEPT OF ECONOMICS, KNOXVILLE, TN 37996-0550},
Type = {Article},
Language = {English},
Affiliation = {KLEIN, PA (Corresponding Author), PENN STATE UNIV,UNIVERSITY PK,PA 16801, USA.},
DOI = {10.1080/00213624.1978.11503527},
ISSN = {0021-3624},
Research-Areas = {Business \& Economics},
Web-of-Science-Categories  = {Economics},
Cited-References = {ADAMS W, 1966, ANTITRUST POLICY EC, P49.
   AYRES CE, 1967, J ECON ISSUES, V1, P3, DOI 10.1080/00213624.1967.11502735.
   AYRES CE, 1944, THEORY EC PROGR, P155.
   BOULDING K, 1948, EC ANALYSIS, P10.
   BOULDING KE, 1977, J ECON ISSUES, V11, P657.
   BRADY RA, 1943, BUSINESS SYSTEM POWE.
   CAMERON B, 1968, INPUT OUTPUT ANALYSI, P94.
   COPELAND MA, 1958, AM ECON REV, V48, P1.
   CYERT RM, 1972, J EC LITERATURE, V10, P407.
   Fellner W, 1949, COMPETITION FEW.
   FUSFELD DR, 1972, J ECON ISSUES, V6, P1.
   GALBRAITH JK, 1973, J EC ISSUES, V63, P1.
   GAMBS JS, 1968, J ECON ISSUES, V2, P69, DOI 10.1080/00213624.1968.11502817.
   GORDON RA, 1963, INSTITUTIONAL EC VEB.
   GRUCHY, ENCYCLOPEDIA SOCIAL, V4, P467.
   GRUCHY AG, 1969, J ECON ISSUES, V3, P11.
   GRUCHY AG, 1972, CONTEMPORARY EC THOU.
   HAMILTON D, 1973, J ECON ISSUES, V7, P197, DOI 10.1080/00213624.1973.11503104.
   HELLER WW, 1975, AM ECON REV, V65, P1.
   KLEIN PA, 1977, J ECON ISSUES, V11, P785, DOI 10.1080/00213624.1977.11503485.
   KLEIN PA, 1974, J ECON ISSUES, V8, P785, DOI 10.1080/00213624.1974.11503229.
   KLEIN PA, 1973, J ECON ISSUES, V7, P209, DOI 10.1080/00213624.1973.11503105.
   KLEIN PA, 1961, Q REV EC BUSINESS, V1, P77.
   LEWIS B, AM EC REV.
   MCCONNELL CR, 1975, ECONOMICS, P94.
   MELMAN S, 1976, J EC ISSUES, V10, P236.
   Mishan EJ, 1967, COSTS EC GROWTH.
   MITCHELL WC, 1927, BUSINESS CYCLES PROB, pR9.
   MUELLER WF, 1975, J ECON ISSUES, V9, P159, DOI 10.1080/00213624.1975.11503272.
   Nordhaus W. D., 1972, EC RES RETROSPECT PR, V5, P1.
   PETERSON W, 1977, J EC ISSUES, V11, P218.
   PRESTON LE, 1975, J EC LITERATURE, V13, P437.
   ROBINSON J, 1962, ECON PHILOS, P26.
   SAMUELSON P, 1972, BUSINESS CYCLE TODAY, V1, P167.
   SAMUELSON PA, 1976, ECONOMICS, P847.
   SCHLESINGER AM, 1963, PATTERNS AM THOUGHT.
   SCHULTZE CL, 1977, J GOVERNMENT SOC SEP, P14.
   SECKLER D, 1975, THORSTEIN VEBLEN INS, pR9.
   SELIGMAN BB, 1971, J EC ISSUES, V5, P21.
   TREBING HM, 1974, J ECON ISSUES, V8, P209, DOI 10.1080/00213624.1974.11503183.
   TUGWELL RG, TREND EC.
   COLLECTED SCI PAPERS, V2, P1729.
   {[}No title captured].},
Number-of-Cited-References = {43},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {J. Econ. Issues},
Doc-Delivery-Number = {FC798},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1978FC79800002},
DA = {2022-03-29},
}

@article{ WOS:000224041700007,
Author = {Li, W and Mital, S and Ojaimi, C and Csiszar, A and Kaley, G and Hintze,
   TH},
Title = {Premature death and age-related cardiac dysfunction in male
   eNOS-knockout mice},
Journal = {JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY},
Year = {2004},
Volume = {37},
Number = {3},
Pages = {671-680},
Month = {SEP},
Abstract = {The aims of our study were to determine mortality, and age- and
   genotype-related cardiac phenotype in endothelial nitric oxide synthase
   (NOS) knockout (-/-) and wild-type (+/+) mice. Male and female (-/-) and
   male and female (+/+) conscious mice were studied at different ages by
   echocardiography and tail-cuff blood pressure (BP) measurement. Only
   50\% male (-/-) mice lived longer than 21 months whereas 89\% (+/+) mice
   were still alive after 24 months (P < 0.005). There was little mortality
   in female mice of either genotype. Both (-/-) and (+/+) male mice have
   normal cardiac dimensions and function at 5.5 months. However, (-/-)
   mice developed cardiac dilation and dysfunction at 21 months as
   evidenced by a significant increase (P < 0.05) in left ventricular (LV)
   end-diastolic diameter from 2.69 +/- 0.13 to 3.13 +/- 0.09 mm, LV
   end-systolic diameter from 1.28 +/- 0.11 to 1.86 +/- 0.12 mm, LV
   end-diastolic cavity volume from 21 +/- 2.8 to 31 +/- 2.5 mul and LV
   mass from 19 +/- 2.5 to 27 +/- 1.9 mg/10 g and a significant decrease (P
   < 0.05) in ejection fraction (from 65 +/- 3.3\% to 41 +/- 4.6\%),
   shortening fraction (from 53 +/- 2.2\% to 41 +/- 3.4\%), LV posterior
   wall thickening (from 27 +/- 2\% to 12 +/- 4\%) and septum thickening
   (from 27 +/- 2\% to 12 +/- 4\%) compared with those at 5.5 months. There
   was a clear increase in cardiac weight and cardiac dilation by
   hematoxylin and eosin in male (-/-) mice at 21 months. BP in male (-/-)
   mice fell with the cardiac dysfunction, whereas female (-/-) mice were
   hypertensive even at 21 months. The level of mRNA for neuronal NOS and
   inducible NOS was greater in all females compared to males. These
   results indicate that male (-/-) mice have a significantly shorter
   lifespan than (+/+) or female mice, and male (-/-) mice develop cardiac
   dysfunction with age. (C) 2004 Elsevier Ltd. All rights reserved.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hintze, TH (Corresponding Author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.
   New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.
   Columbia Univ, Dept Pediat, Div Pediat Cardiol, New York, NY USA.},
DOI = {10.1016/j.yjmcc.2004.05.005},
ISSN = {0022-2828},
EISSN = {1095-8584},
Keywords = {aging; Kaplan-Meier analyses; knockout mice; cardiac dysfunction;
   female; iNOS; nNCS; mRNA},
Keywords-Plus = {NITRIC-OXIDE SYNTHASE; ARTERIOLAR DILATION; HEART-FAILURE; LIFE SPAN;
   LACKING; EXPRESSION; APOPTOSIS; CIRCULATION; PRESSURE; GENE},
Research-Areas = {Cardiovascular System \& Cardiology; Cell Biology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Cell Biology},
Author-Email = {thomas\_hintze@nymc.edu},
ResearcherID-Numbers = {Mital, Seema/G-7456-2011},
Funding-Acknowledgement = {NHLBI NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}HL P0-1-43023] Funding Source: Medline;
   PHS HHSUnited States Department of Health \& Human ServicesUnited States
   Public Health Service {[}61290, R0-1 50142] Funding Source: Medline},
Cited-References = {ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7.
   Barouch LA, 2003, J MOL CELL CARDIOL, V35, P637, DOI 10.1016/S0022-2828(03)00079-8.
   BATH PMW, 1993, EUR J CLIN PHARMACOL, V45, P53, DOI 10.1007/BF00315350.
   BING OHL, 1994, J MOL CELL CARDIOL, V26, P943, DOI 10.1006/jmcc.1994.1115.
   Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279.
   Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601.
   Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862.
   FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446.
   FINKEL MP, 1995, BRIT J CANCER, V9, P464.
   Fulton D, 2000, AM J PHYSIOL-HEART C, V278, pH658, DOI 10.1152/ajpheart.2000.278.2.H658.
   Gyurko R, 2000, AM J PHYSIOL-HEART C, V278, pH971, DOI 10.1152/ajpheart.2000.278.3.H971.
   Han XQ, 1998, P NATL ACAD SCI USA, V95, P6510, DOI 10.1073/pnas.95.11.6510.
   Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796.
   Huang A, 2000, AM J PHYSIOL-HEART C, V278, pH762, DOI 10.1152/ajpheart.2000.278.3.H762.
   Huang A, 2001, AM J PHYSIOL-HEART C, V280, pH2462, DOI 10.1152/ajpheart.2001.280.6.H2462.
   HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0.
   Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44.
   Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376.
   Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0.
   Lamping KG, 2000, AM J PHYSIOL-HEART C, V279, pH1906, DOI 10.1152/ajpheart.2000.279.4.H1906.
   Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345.
   Loke KE, 1999, CIRC RES, V84, P840.
   Loke KE, 2000, J MOL CELL CARDIOL, V32, P2299, DOI 10.1006/jmcc.2000.1258.
   Meng W, 1996, AM J PHYSIOL-HEART C, V271, pH1145, DOI 10.1152/ajpheart.1996.271.3.H1145.
   Mital S., 2001, Journal of Heart and Lung Transplantation, V20, P220, DOI 10.1016/S1053-2498(00)00482-4.
   Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293.
   MUHLBOCK O, 1968, GERONTOLOGIA, V3, P177.
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603.
   OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8.
   ONTKEAN M, 1991, CIRC RES, V69, P1088, DOI 10.1161/01.RES.69.4.1088.
   Pacher P, 2004, FASEB J, V18, pA274.
   Recchia FA, 1998, CIRC RES, V83, P969, DOI 10.1161/01.RES.83.10.969.
   Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699.
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072.
   Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176.
   SILBERBERG M, 1954, AM J PHYSIOL, V177, P23, DOI 10.1152/ajplegacy.1954.177.1.23.
   SILBERBERG R, 1961, AM J PHYSIOL, V200, P332, DOI 10.1152/ajplegacy.1961.200.2.332.
   SILBERBERG R, 1955, AM J PHYSIOL, V181, P128, DOI 10.1152/ajplegacy.1955.181.1.128.
   Smith CJ, 1996, CIRC RES, V78, P58, DOI 10.1161/01.RES.78.1.58.
   Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1.
   STRAUSS HM, 2000, ACTA PHYSL SCAND, V168, P155.
   Sun D, 1999, CIRC RES, V85, P288, DOI 10.1161/01.RES.85.3.288.
   Tada H, 2000, CIRC RES, V86, P270, DOI 10.1161/01.RES.86.3.270.
   ZHAO G, 1995, CIRCULATION, V91, P2655, DOI 10.1161/01.CIR.91.10.2655.},
Number-of-Cited-References = {44},
Times-Cited = {67},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Mol. Cell. Cardiol.},
Doc-Delivery-Number = {856JO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000224041700007},
DA = {2022-03-29},
}

@article{ WOS:000170971400001,
Author = {Genton, P and Gelisse, P},
Title = {Premature death in juvenile myoclonic epilepsy},
Journal = {ACTA NEUROLOGICA SCANDINAVICA},
Year = {2001},
Volume = {104},
Number = {3},
Pages = {125-129},
Month = {SEP},
Note = {52nd Annual Meeting of the American-Academy-of-Neurology, SAN DIEGO, CA,
   APR 29-MAY 06, 2000},
Organization = {Amer Acad Neurol},
Abstract = {Objectives-To report three cases of premature death in juvenile
   myoclonic epilepsy (JME), a benign form of idiopathic generalized
   epilepsy (IGE) in which no case of epilepsy-related death has been
   reported. Material and methods-We retrospectively analyzed all medical
   records of JME patients first referred to two epilepsy centers
   (Marseilles, Nice) between 1981 and 1998. Results-Among 170 consecutive
   JME cases, 3 female patients died prematurely. No autopsy was performed.
   The first had a history of severe anorexia nervosa (DSM IV: 307.1). She
   died at age 34 and 2 days, from severe inhalation pneumonia. The second
   is a woman with a history of infantile psychosis (DSM IV: 299.80) and
   with a case of IGE in her family. Her epilepsy was never controlled. At
   age 16, she was found cyanotic and unconscious one morning in the
   toilets. She died before resuscitation was undertaken. The third had a
   borderline personality (DSM IV: 301.83) and a history of alcoholism and
   low compliance. Her epilepsy was never well controlled. She also
   received neuroleptics. At age 42, she was found dead in her home.
   Conclusion-In the first case, death was apparently unrelated to
   epilepsy. In the second, an awakening seizure seems to be responsible.
   In the third, death is also possibly seizure-related. Cases two and
   three had persistent seizures and severe psychiatric disorders. Serious
   mental disorders seem to be risk factors for unexpected death. In JME,
   the overall death ratio was 1.4/1000 patient-years (or 0.9 if we exclude
   case 1).},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Genton, P (Corresponding Author), Ctr St Paul H Gastaut, 300 Bd St Marguerite, F-13258 Marseille 09, France.
   Ctr St Paul, Marseille, France.
   Gui de Chauliac Hosp, Epilepsy Unit, Montpellier, France.},
DOI = {10.1034/j.1600-0404.2001.00003.x},
ISSN = {0001-6314},
EISSN = {1600-0404},
Keywords = {juvenile myoclonic epilepsy; sudden unexplained death},
Keywords-Plus = {SUDDEN UNEXPLAINED DEATH; UNEXPECTED DEATH; MORTALITY; COHORT},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Author-Email = {piergen@aol.com},
ResearcherID-Numbers = {Gelisse, Philippe/AAK-7696-2021},
Cited-References = {{*}AM PSYCH ASS, 1994, DIAGN STAT MAN, V4.
   {[}Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x.
   Felker B, 1996, PSYCHIAT SERV, V47, P1356.
   Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270.
   Gelisse P, 2000, ACTA NEUROL SCAND, V102, P188, DOI 10.1034/j.1600-0404.2000.102003188.x.
   GENTON P, 1994, IDIOPATHIC GEN EPILE, P253.
   GENTON P, 2000, JUVENILE MYOCLONIC E, P11.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x.
   HIRSCH CS, 1971, NEUROLOGY, V21, P682, DOI 10.1212/WNL.21.7.682.
   Jallon P, 1999, PRESSE MED, V28, P605.
   JANZ D, 1969, EPILEPSIEN.
   Janz D, 1998, EPILEPSY COMPREHENSI, P2389.
   Leestma JE, 1997, EPILEPSIA, V38, P47, DOI 10.1111/j.1528-1157.1997.tb01076.x.
   Lhatoo SD, 1999, J NEUROL NEUROSUR PS, V66, P692, DOI 10.1136/jnnp.66.5.692.
   NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462.
   Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x.
   Shorvon S, 1997, EPILEPSIA, V38, pS20, DOI 10.1111/j.1528-1157.1997.tb06118.x.
   Wolf Peter, 1992, P313.},
Number-of-Cited-References = {19},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Acta Neurol. Scand.},
Doc-Delivery-Number = {472EW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000170971400001},
DA = {2022-03-29},
}

@article{ WOS:000172055900023,
Author = {McKee, M and Shkolnikov, V},
Title = {Understanding the toll of premature death among men in eastern Europe},
Journal = {BRITISH MEDICAL JOURNAL},
Year = {2001},
Volume = {323},
Number = {7320},
Pages = {1051-1055},
Month = {NOV 3},
Publisher = {BRITISH MED JOURNAL PUBL GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {McKee, M (Corresponding Author), Univ London London Sch Hyg \& Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.
   Univ London London Sch Hyg \& Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England.
   Max Planck Inst Demog Res, D-18057 Rostock, Germany.},
DOI = {10.1136/bmj.323.7320.1051},
ISSN = {0959-535X},
Keywords-Plus = {CORONARY HEART-DISEASE; LIFE EXPECTANCY; ADULT MORTALITY; ALCOHOL;
   RUSSIA; HEALTH; RATES; POPULATION; SMOKING; TRENDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ResearcherID-Numbers = {Mckee, Martin/E-6673-2018
   Shkolnikov, Vladimir/D-2986-2017
   McKee, Marc D/E-2187-2011},
ORCID-Numbers = {Mckee, Martin/0000-0002-0121-9683
   Shkolnikov, Vladimir/0000-0003-2259-5423
   McKee, Marc D/0000-0001-8349-965X},
Cited-References = {Bobak M, 1997, J EPIDEMIOL COMMUN H, V51, P272, DOI 10.1136/jech.51.3.272.
   Bobak M, 1998, SOC SCI MED, V47, P269, DOI 10.1016/S0277-9536(98)00095-1.
   Bobak M, 1996, BRIT MED J, V312, P421.
   Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x.
   Bobak M, 1998, EUR J CLIN NUTR, V52, P632, DOI 10.1038/sj.ejcn.1600616.
   Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328.
   Chambers JC, 2001, J ROY SOC MED, V94, P10, DOI 10.1177/014107680109400103.
   Chenet L, 1997, J EPIDEMIOL COMMUN H, V51, P510, DOI 10.1136/jech.51.5.510.
   Chenet L, 1998, EUR J POPUL, V14, P19, DOI 10.1023/A:1006012620847.
   Chenet L, 1998, J EPIDEMIOL COMMUN H, V52, P772, DOI 10.1136/jech.52.12.772.
   European Centre on Health of Societies in Transition (ECOHOST), 1998, CHILDH INJ PRIOR AR.
   Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218.
   FORSTER DP, 1990, LANCET, V335, P458, DOI 10.1016/0140-6736(90)90678-X.
   Hajdu P, 1995, EUR J PUBLIC HEALTH, V5, P259, DOI DOI 10.1093/EURPUB/5.4.259.
   JEDRYCHOWSKI W, 1985, SCAND J SOC MED, V13, P49, DOI 10.1177/140349488501300201.
   Kitange HM, 1996, BRIT MED J, V312, P216, DOI 10.1136/bmj.312.7025.216.
   Kristenson M, 1997, BRIT MED J, V314, P629, DOI 10.1136/bmj.314.7081.629.
   Laks T, 1999, J INTERN MED, V246, P53, DOI 10.1046/j.1365-2796.1999.00505.x.
   Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6.
   LEVIATAN U, 1985, SOC SCI MED, V21, P545, DOI 10.1016/0277-9536(85)90039-5.
   McKee M, 1998, TOB CONTROL, V7, P22, DOI 10.1136/tc.7.1.22.
   McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263.
   McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802.
   MCKEE M, 2001, POVERTY INEQUALITY H, P17.
   MCKEE M, IN PRESS HLTH CARE C.
   Ngongo KN, 1999, HEALTH POLICY, V48, P1, DOI 10.1016/S0168-8510(99)00029-9.
   Perova Natalia V., 1995, Annals of Epidemiology, V5, P179, DOI 10.1016/1047-2797(94)00104-2.
   PETO R, 1994, MORTALITY SMOKING.
   Pomerleau J, 2001, EUR J CLIN NUTR, V55, P200, DOI 10.1038/sj.ejcn.1601146.
   Rose R., 1995, E EUROPEAN CONSTITUT, V4, P34.
   SCHMIDT W, 1981, CANCER-AM CANCER SOC, V47, P1031, DOI 10.1002/1097-0142(19810301)47:5<1031::AID-CNCR2820470534>3.0.CO;2-C.
   SHAKHOV YA, 1993, ARTERIOSCLER THROMB, V13, P1770, DOI 10.1161/01.ATV.13.12.1770.
   Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4.
   Shkolnikov V, 1999, EUR J EPIDEMIOL, V15, P203, DOI 10.1023/A:1007546800982.
   Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3.
   SHKOLNIKOV VM, 2000, POLICIES CONTROL TRA.
   Sibai AM, 2001, J EPIDEMIOL COMMUN H, V55, P271, DOI 10.1136/jech.55.4.271.
   STERN V, 1999, SENTENCED DIE PROBLE.
   THUBRON C, 1999, SIBERIA, P29.
   VANGIJN J, 1993, HLTH ISSUES RELATED, P43.
   VIKHERT AM, 1986, J AM COLL CARDIOL, V8, pA3, DOI 10.1016/S0735-1097(86)80023-7.
   Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312.
   WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U.
   Walt, 2001, POVERTY INEQUALITY H, P58.
   WATSON P, 1995, SOC SCI MED, V41, P923, DOI 10.1016/0277-9536(94)00405-I.
   WATSON P, 1996, E W LIFE EXPECTANCY.
   {*}WHO, 2001, HLTH ALL DATABASE.
   Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047.},
Number-of-Cited-References = {48},
Times-Cited = {113},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Br. Med. J.},
Doc-Delivery-Number = {490MP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000172055900023},
OA = {Green Published, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:A1983QJ05100033,
Author = {CARLSON, KM and BRUMBACK, RA},
Title = {PSYCHOLOGICAL PROCESSES ASSOCIATED WITH PREMATURE DEATH IN DUCHENNE
   MUSCULAR-DYSTROPHY},
Journal = {PSYCHOLOGICAL REPORTS},
Year = {1983},
Volume = {52},
Number = {1},
Pages = {165-166},
Publisher = {PSYCHOLOGICAL REPORTS},
Address = {P O BOX 9229, MISSOULA, MT 59807},
Type = {Article},
Language = {English},
Affiliation = {UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642.
   UNIV N DAKOTA,GRAND FORKS,ND 58201.},
DOI = {10.2466/pr0.1983.52.1.165},
ISSN = {0033-2941},
Research-Areas = {Psychology},
Web-of-Science-Categories  = {Psychology, Multidisciplinary},
ResearcherID-Numbers = {Brumback, Roger A./A-2404-2008},
Cited-References = {ADLER SN, 1972, THESIS.
   BLACK FW, 1973, J PSYCHOL, V84, P333, DOI 10.1080/00223980.1973.9923848.
   MEARIG S, 1979, REHABILITATION LIT, V40, P262.
   MEARIG S, 1973, REHABILITATION LIT, V34, P226.
   POWER PW, 1980, ROLE FAMILY REHABILI, P173.
   TAFT LT, 1973, DEV MED CHILD NEUROL, V15, P510.
   TRAVIS G, 1976, CHRONIC ILLNESS CHIL.},
Number-of-Cited-References = {7},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Psychol. Rep.},
Doc-Delivery-Number = {QJ051},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1983QJ05100033},
DA = {2022-03-29},
}

@article{ WOS:000262045800007,
Author = {Princen, Frederic and Bard, Emilie and Sheikh, Farah and Zhang, Sharon
   S. and Wang, Jing and Zago, Wagner M. and Wu, Dongmei and Trelles, Ramon
   Diaz and Bailly-Maitre, Beatrice and Kahn, C. Ronald and Chen, Yan and
   Reed, John C. and Tong, Gary G. and Mercola, Mark and Chen, Ju and Feng,
   Gen-Sheng},
Title = {Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated
   Cardiomyopathy, Insulin Resistance, and Premature Death},
Journal = {MOLECULAR AND CELLULAR BIOLOGY},
Year = {2009},
Volume = {29},
Number = {2},
Pages = {378-388},
Month = {JAN 15},
Abstract = {The intracellular signaling mechanisms underlying the pathogenesis of
   cardiac diseases are not fully understood. We report here that selective
   deletion of Shp2, an SH2-containing cytoplasmic tyrosine phosphatase, in
   striated muscle results in severe dilated cardiomyopathy in mice,
   leading to heart failure and premature mortality. Development of
   cardiomyopathy in this mouse model is coupled with insulin resistance,
   glucose intolerance, and impaired glucose uptake in striated muscle
   cells. Shp2 deficiency leads to upregulation of leukemia inhibitory
   factor-stimulated phosphatidylinositol 3-kinase/Akt, Erk5, and Stat3
   pathways in cardiomyocytes. Insulin resistance and impaired glucose
   uptake in Shp2-deficient mice are at least in part due to impaired
   protein kinase C-zeta/lambda and AMP-kinase activities in striated
   muscle. Thus, we have generated a mouse line modeling human patients
   suffering from cardiomyopathy and insulin resistance. This study
   reinforces a concept that a compound disease with multiple
   cardiovascular and metabolic disturbances can be caused by a defect in a
   single molecule such as Shp2, which modulates multiple signaling
   pathways initiated by cytokines and hormones.},
Publisher = {AMER SOC MICROBIOLOGY},
Address = {1752 N ST NW, WASHINGTON, DC 20036-2904 USA},
Type = {Article},
Language = {English},
Affiliation = {Feng, GS (Corresponding Author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   Princen, Frederic; Bard, Emilie; Zhang, Sharon S.; Wang, Jing; Zago, Wagner M.; Wu, Dongmei; Trelles, Ramon Diaz; Bailly-Maitre, Beatrice; Reed, John C.; Tong, Gary G.; Mercola, Mark; Feng, Gen-Sheng, Burnham Inst Med Res, La Jolla, CA 92037 USA.
   Sheikh, Farah; Chen, Ju, Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   Tong, Gary G., Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   Kahn, C. Ronald, Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA.
   Chen, Yan, Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China.
   Feng, Gen-Sheng, Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China.},
DOI = {10.1128/MCB.01661-08},
ISSN = {0270-7306},
EISSN = {1098-5549},
Keywords-Plus = {ACTIVATED PROTEIN-KINASE; PTPN11 SHP2; HEART; RECEPTOR; CARDIOMYOCYTES;
   EXPRESSION; MOUSE; AKT; MUTATIONS; MECHANISM},
Research-Areas = {Biochemistry \& Molecular Biology; Cell Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Cell Biology},
Author-Email = {gfeng@burnham.org},
ResearcherID-Numbers = {Kahn, Ronald/AAY-2435-2021
   Bard-Chapeau, Emilie/H-6091-2011
   Tong, Gary/AAC-9426-2022
   Chen, Ju/E-5579-2011
   },
ORCID-Numbers = {Kahn, Ronald/0000-0002-7583-9228
   Diaz Trelles, Ramon/0000-0002-2666-9728
   Bailly-Maitre, Beatrice/0000-0002-8389-8498},
Funding-Acknowledgement = {NIHUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USA {[}R01DK73945, R01HL082902,
   R01HL059502]; American Heart AssociationAmerican Heart Association; AHA
   National Scientist DevelopmentAmerican Heart Association; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung \& Blood Institute (NHLBI) {[}R01HL082902, R01HL059502]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND
   DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}R01DK073945]
   Funding Source: NIH RePORTER},
Funding-Text = {This study was supported by NIH grants R01DK73945 to G.-S. F.,
   R01HL082902 to J. C., and R01HL059502 to M. M. R. D. T. is a recipient
   of a postdoctoral fellowship from American Heart Association. F. S. is a
   recipient of the AHA National Scientist Development Grant.},
Cited-References = {Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23.
   Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05.
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0.
   Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858.
   Carroll R, 2005, AM J PHYSIOL-ENDOC M, V288, pE900, DOI 10.1152/ajpendo.00491.2004.
   CASE RD, 1994, J BIOL CHEM, V269, P10467.
   CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945.
   Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8.
   Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200.
   Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397.
   Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200.
   Hagiwara Y, 2007, J MOL CELL CARDIOL, V43, P710, DOI 10.1016/j.yjmcc.2007.09.004.
   Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683.
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420.
   Hernandez R, 2001, FEBS LETT, V494, P225, DOI 10.1016/S0014-5793(01)02353-5.
   Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1.
   Johnatty SE, 2000, J MOL CELL CARDIOL, V32, P805, DOI 10.1006/jmcc.2000.1122.
   Jougasaki M, 2003, EUR J HEART FAIL, V5, P137, DOI 10.1016/S1388-9842(02)00236-2.
   Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC.
   Kemppainen J, 2003, J PHYSIOL-LONDON, V550, P305, DOI 10.1113/jphysiol.2003.042648.
   Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865.
   Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200.
   KUHNE MR, 1993, J BIOL CHEM, V268, P11479.
   Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315.
   Lai LA, 2004, TOP CURR GENET, V5, P275.
   Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236.
   Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200.
   MILARSKI KL, 1994, J BIOL CHEM, V269, P21239.
   Minamisawa S, 2004, EXP MOL MED, V36, P193, DOI 10.1038/emm.2004.27.
   Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921.
   Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908.
   Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4.
   Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757.
   Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299.
   Paternostro G, 1999, CARDIOVASC RES, V42, P246, DOI 10.1016/S0008-6363(98)00233-8.
   Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352.
   Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790.
   Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537.
   Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308.
   SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614.
   Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109.
   Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772.
   Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005.
   Wilkes JJ, 2003, DIABETES, V52, P1904, DOI 10.2337/diabetes.52.8.1904.
   Witteles RM, 2004, J AM COLL CARDIOL, V44, P78, DOI 10.1016/j.jacc.2004.03.037.
   Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101.
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505.
   Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693.},
Number-of-Cited-References = {48},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Mol. Cell. Biol.},
Doc-Delivery-Number = {388UW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000262045800007},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000074232000004,
Author = {Pulska, T and Pahkala, K and Laippalla, P and Kivela, SL},
Title = {Major depression as a predictor of premature deaths in elderly people in
   Finland: a community study},
Journal = {ACTA PSYCHIATRICA SCANDINAVICA},
Year = {1998},
Volume = {97},
Number = {6},
Pages = {408-411},
Month = {JUN},
Abstract = {In order to analyse the survival of elderly Finnish people with major
   depression, a total of 29 elderly (greater than or equal to 65 years)
   subjects suffering from major depression (DSM-III criteria) and 853
   non-depressed elderly subjects were followed up for 6 years. The
   Kaplan-Meier survival curves showed the survival of patients suffering
   from major depression to be poorer than that of non-depressed subjects.
   When age, sex, marital status, level of education, smoking habits,
   physical health, functional abilities and major depression were
   introduced into the Cox model, advanced age, male sex, smoking, poor
   physical health, reduced functional abilities and the occurrence of
   major depression were found to be related to higher levels of mortality.
   The results suggest that major depression in the elderly predicts higher
   mortality which is not explained by their poor baseline level of
   physical health alone.},
Publisher = {MUNKSGAARD INT PUBL LTD},
Address = {35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK},
Type = {Article},
Language = {English},
Affiliation = {Pulska, T (Corresponding Author), Univ Oulu, Dept Publ Hlth Sci \& Gen Practice, Aapistie 1, FIN-90220 Oulu, Finland.
   Univ Oulu, Dept Publ Hlth Sci \& Gen Practice, FIN-90220 Oulu, Finland.
   Reg Serv Unit, Prov State Off Western Finland, Hlth \& Social Serv, Vaasa, Finland.
   Tampere Univ, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland.
   Tampere Univ Hosp, Tampere, Finland.
   Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland.},
DOI = {10.1111/j.1600-0447.1998.tb10023.x},
ISSN = {0001-690X},
Keywords = {major depression; elderly; mortality; survival},
Keywords-Plus = {LATE-LIFE DEPRESSION; DSM-III; PREVALENCE; DISEASE; MORTALITY;
   DISORDERS; POPULATION; SYMPTOMS; RATES},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Cited-References = {American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rded..
   Beekman ATF, 1995, J AFFECT DISORDERS, V36, P65, DOI 10.1016/0165-0327(95)00061-5.
   BLAZER D, 1987, GERONTOLOGIST, V27, P281, DOI 10.1093/geront/27.3.281.
   BRUCE ML, 1989, AM J PUBLIC HEALTH, V79, P727, DOI 10.2105/AJPH.79.6.727.
   CARNEY RM, 1995, AM J CARDIOL, V76, P562, DOI 10.1016/S0002-9149(99)80155-6.
   Dixon WJ, 1985, BMDP STAT SOFTWARE.
   FUJIKAWA T, 1993, STROKE, V24, P1631, DOI 10.1161/01.STR.24.11.1631.
   GIRLING DM, 1995, J AFFECT DISORDERS, V34, P319, DOI 10.1016/0165-0327(95)00030-Q.
   HENDERSON AS, 1993, PSYCHOL MED, V23, P719, DOI 10.1017/S0033291700025496.
   HERBERT TB, 1993, PSYCHOL BULL, V113, P472, DOI 10.1037/0033-2909.113.3.472.
   JORM AF, 1991, INT J GERIATR PSYCH, V6, P5, DOI 10.1002/gps.930060103.
   KAY DWK, 1985, PSYCHOL MED, V15, P771, DOI 10.1017/S0033291700005006.
   KOENIG HG, 1989, J AM GERIATR SOC, V37, P599, DOI 10.1111/j.1532-5415.1989.tb01249.x.
   MADIANOS MG, 1992, ACTA PSYCHIAT SCAND, V86, P320, DOI 10.1111/j.1600-0447.1992.tb03273.x.
   MATTHEWS DE, 1988, USING UNDERSTANDING.
   MURPHY E, 1988, BRIT J PSYCHIAT, V152, P347, DOI 10.1192/bjp.152.3.347.
   PAHKALA K, 1995, SOC PSYCH PSYCH EPID, V30, P99, DOI 10.1007/BF00802037.
   PARMELEE PA, 1992, J GERONTOL, V47, P3.
   PEKKANEN J, 1992, INT J EPIDEMIOL, V21, P406, DOI 10.1093/ije/21.2.406.
   RABINS PV, 1985, J AFFECT DISORDERS, V9, P165, DOI 10.1016/0165-0327(85)90096-5.
   ROOSE SP, 1991, J CLIN PSYCHIAT, V52, P34.
   ROVNER BW, 1993, AM J MED S5A, V94, P19.
   SCHNEIDER LS, 1994, PRINCIPLES PRACTICE, P535.
   STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V154, P170, DOI 10.1192/bjp.154.2.170.
   WEISSMAN MM, 1985, ACTA PSYCHIAT SCAND, V71, P366, DOI 10.1111/j.1600-0447.1985.tb02536.x.},
Number-of-Cited-References = {25},
Times-Cited = {45},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Acta Psychiatr. Scand.},
Doc-Delivery-Number = {ZU762},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000074232000004},
DA = {2022-03-29},
}

@article{ WOS:A1989T186300002,
Author = {LYTLE, D},
Title = {UNITED-STATES PHOTONICS INDUSTRY - FACING PREMATURE DEATH},
Journal = {PHOTONICS SPECTRA},
Year = {1989},
Volume = {23},
Number = {2},
Pages = {36+},
Month = {FEB},
Publisher = {LAURIN PUBL CO INC},
Address = {BERKSHIRE COMMON PO BOX 1146, PITTSFIELD, MA 01202 USA},
Type = {Article},
Language = {English},
ISSN = {0731-1230},
Research-Areas = {Optics},
Web-of-Science-Categories  = {Optics},
Number-of-Cited-References = {0},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Photon. Spect.},
Doc-Delivery-Number = {T1863},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1989T186300002},
DA = {2022-03-29},
}

@article{ WOS:000269103500024,
Author = {Oyen, Nina and Boyd, Heather A. and Poulsen, Gry and Wohlfahrt, Jan and
   Melbye, Mads},
Title = {The Clustering of Premature Deaths in Families},
Journal = {EPIDEMIOLOGY},
Year = {2009},
Volume = {20},
Number = {5},
Pages = {757-765},
Month = {SEP},
Abstract = {Background: Infant deaths cluster in families, but beyond infancy,
   little is known about familial aggregation of premature deaths. We
   hypothesized that an individual's risk of premature death would be
   influenced by prior premature deaths of any age in family members.
   Methods: For all Danish residents registered in the Civil Registration
   System, 1968-2005, information was linked to the Causes of Death
   Register and the Danish Family Relation Database, yielding a cohort of
   4,870,821 persons linked to one or more relatives (93 million
   persons-years and 73,278 deaths). We used log-linear Poisson regression
   to estimate mortality rate ratios (relative risks) for premature death
   (before age 40 years) in persons with a family history of premature
   death, compared with persons without such a history.
   Results: Persons with a family history of premature death were 46\% more
   likely themselves to die prematurely than persons without such a family
   history (relative risk {[}RR] = 1.46 {[}95\% confidence interval =
   1.42-1.50]). Relative risks were higher for concordant age at death, a
   close kinship relation, and similar causes of death. As expected,
   certain natural causes clustered among first-degree relatives (RRs
   ranged from 1.81-618), but unnatural causes of death, such as
   nonsimultaneous motor vehicle injuries, other injuries, and suicides,
   also clustered (RRs = 1.80, 3.53, and 4.23, respectively). Previous
   family history of premature death in a first-degree relative also
   increased the risk of dying from another cause (overall RR = 2.08 in
   infancy and 1.33 between ages 1 and 39).
   Conclusion: Premature deaths cluster in families, for both similar and
   dissimilar causes.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Oyen, N (Corresponding Author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.
   Oyen, Nina; Boyd, Heather A.; Poulsen, Gry; Wohlfahrt, Jan; Melbye, Mads, Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.
   Oyen, Nina, Univ Bergen, Dept Publ Hlth \& Primary Hlth Care, Bergen, Norway.
   Oyen, Nina, Haukeland Hosp, Ctr Med Genet \& Mol Med, N-5021 Bergen, Norway.},
DOI = {10.1097/EDE.0b013e3181ad5444},
ISSN = {1044-3983},
EISSN = {1531-5487},
Keywords-Plus = {RECURRENCE RISK; INFANT-DEATH; HISTORY; DISEASE; COHORT; AGGREGATION;
   SUICIDE; MORTALITY; SWEDEN; SYSTEM},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {noy@ssi.dk},
ORCID-Numbers = {melbye, mads/0000-0001-8264-6785
   Boyd, Heather/0000-0001-6849-9985},
Funding-Acknowledgement = {Danish Heart Association {[}06-4-B571-A1059-22307]; Lundbeck
   foundationLundbeckfonden {[}287/06]; Regional Health Authority-Western
   Norway {[}911280]; Research Council NorwayResearch Council of Norway
   {[}176659/V00]},
Funding-Text = {Supported by the Danish Heart Association (06-4-B571-A1059-22307); The
   Lundbeck foundation (287/06); The Regional Health Authority-Western
   Norway (911280); and The Research Council Norway (176659/V00).},
Cited-References = {Andersen EW, 2002, STAT MED, V21, P3595, DOI 10.1002/sim.1319.
   Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2.
   BIRCH JM, 2004, GENETIC PREDISPOSITI, P63.
   Breslow N. E., 1987, STAT METHODS CANC RE, VII.
   Guo SW, 2000, AM J EPIDEMIOL, V151, P1121, DOI 10.1093/oxfordjournals.aje.a010156.
   Hemminki K, 2006, TWIN RES HUM GENET, V9, P580, DOI 10.1375/twin.9.4.580.
   Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y.
   Hougaard P., 2000, ANAL MULTIVARIATE SU.
   KAREGARD M, 1986, OBSTET GYNECOL, V67, P523.
   Kendler KS, 2006, AM J PSYCHIAT, V163, P109, DOI 10.1176/appi.ajp.163.1.109.
   LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101.
   Melchior M, 2006, J EPIDEMIOL COMMUN H, V60, P937, DOI 10.1136/jech.2005.042440.
   Mishara BL, 1999, CAN J PSYCHIAT, V44, P690, DOI 10.1177/070674379904400707.
   Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2.
   Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925.
   Pedersen CB, 2006, DAN MED BULL, V53, P441.
   Pell JP, 2003, HEART, V89, P1249, DOI 10.1136/heart.89.10.1249.
   Petersen L, 2008, EPIDEMIOLOGY, V19, P472, DOI 10.1097/EDE.0b013e3181692769.
   Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4.
   RIMOIN DL, 2002, EMERY RIMOINS PRINCI.
   Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N.
   Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317.
   Stoltenberg C, 1999, AM J PUBLIC HEALTH, V89, P517, DOI 10.2105/AJPH.89.4.517.
   Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581.
   Torgersen Svenn, 2005, Curr Psychiatry Rep, V7, P51, DOI 10.1007/s11920-005-0025-4.
   Vaez M, 2005, ACCIDENT ANAL PREV, V37, P605, DOI 10.1016/j.aap.2005.03.001.
   Vollset SE, 2006, ANN INTERN MED, V144, P381, DOI 10.7326/0003-4819-144-6-200603210-00004.
   WESTERGAARD T, 1997, BIRTH ORDER CANC RIS.
   Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009.
   Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488.},
Number-of-Cited-References = {30},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Epidemiology},
Doc-Delivery-Number = {485EJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000269103500024},
DA = {2022-03-29},
}

@article{ WOS:000071177500013,
Author = {Fournier, S and Dobscha, S and Mick, DG},
Title = {Preventing the premature death of relationship marketing},
Journal = {HARVARD BUSINESS REVIEW},
Year = {1998},
Volume = {76},
Number = {1},
Pages = {42+},
Month = {JAN-FEB},
Abstract = {Relationship marketing is in vogue. And why not? The new increasingly
   efficient ways that companies have of understanding and responding to
   customers' needs and preferences seemingly allow them to build more
   meaningful connections with consumers than ever before. These
   connections promise to benefit the bottom line by reducing costs and
   increasing revenue.
   Unfortunately, a close look suggests that the relationships between
   companies and customers are troubled ones, at best. Companies may
   delight in learning more about their customers and in being able to
   provide features and services to please every possible palate. But
   customers delight in neither. In fact, customer satisfaction rates in
   the United States are at an all-time low, while complaints, boycotts,
   and other expressions of consumer discontent are on the rise. This
   mounting wave of unhappiness has yet to reach the bottom line. Sooner or
   later, however, corporate performance will suffer unless relationship
   marketing becomes what it is supposed to be - the epitome of customer
   orientation.
   Ironically, the very things that marketers are doing to build
   relationships with customers are often the. things that are destroying
   those relationships. Relationship marketing is powerful in theory but
   troubled in practice. To prevent its premature death, marketers need to
   take the time to figure out how and why they are undermining their own
   best efforts, as well as how they can get things back on track.},
Publisher = {HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION},
Address = {60 HARVARD WAY, BOSTON, MA 02163 USA},
Type = {Article},
Language = {English},
Affiliation = {Fournier, S (Corresponding Author), Harvard Univ, Sch Business, Boston, MA 02163 USA.
   Harvard Univ, Sch Business, Boston, MA 02163 USA.
   Bentley Coll, Waltham, MA USA.
   Dublin City Univ, Dublin 9, Ireland.},
ISSN = {0017-8012},
Research-Areas = {Business \& Economics},
Web-of-Science-Categories  = {Business; Management},
Number-of-Cited-References = {0},
Times-Cited = {282},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {23},
Journal-ISO = {Harv. Bus. Rev.},
Doc-Delivery-Number = {YN527},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000071177500013},
DA = {2022-03-29},
}

@article{ WOS:000672090900001,
Author = {Zuberi, Anita and Teixeira, Samantha},
Title = {Death and taxes: Examining the racial inequality in premature death
   across neighborhoods},
Journal = {JOURNAL OF COMMUNITY PSYCHOLOGY},
Year = {2021},
Volume = {49},
Number = {7},
Pages = {2348-2365},
Month = {SEP},
Abstract = {Legacies of residential segregation have led to deep inequities felt in
   communities of color across the nation and have been established as a
   fundamental cause of health disparities. Historical practices such as
   the redlining of majority Black neighborhoods in cities have led to long
   term consequences on these communities, including concentrated poverty
   and disadvantage. Research shows a strong connection between living in a
   poor neighborhood and poorer health outcomes, including early death, but
   questions remain about what characteristics of poor neighborhoods drive
   these disparities. We combined data from the American Community Survey
   with administrative data from Pittsburgh, Pennsylvania to examine the
   difference in premature death in Black and white neighborhoods (N = 87)
   using measures of socioeconomic disadvantage and less commonly studied
   neighborhood features including vacancy, tax delinquency, and property
   sales and conditions. Results suggest that features of abandonment,
   particularly the percent of tax delinquent properties in a neighborhood,
   may capture an important structural difference between majority Black
   and majority white neighborhoods with impacts beyond socioeconomic
   disadvantage on community health. We discuss implications of these
   findings for research and practice.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Zuberi, A (Corresponding Author), Duquesne Univ, Dept Sociol, 600 Forbes Ave, Pittsburgh, PA 15282 USA.
   Zuberi, Anita, Duquesne Univ, Dept Sociol, 600 Forbes Ave, Pittsburgh, PA 15282 USA.
   Teixeira, Samantha, Boston Coll, Sch Social Work, Chestnut Hill, MA 02167 USA.},
DOI = {10.1002/jcop.22658},
EarlyAccessDate = {JUL 2021},
ISSN = {0090-4392},
EISSN = {1520-6629},
Keywords = {abandonment; death; health; housing; neighborhoods; poverty; race; tax
   delinquency},
Keywords-Plus = {NEW-YORK-CITY; PHYSICAL CONDITIONS; SOCIAL PROCESSES; MORTALITY; HEALTH;
   DISPARITIES; POVERTY},
Research-Areas = {Public, Environmental \& Occupational Health; Psychology; Social Work},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Psychology,
   Multidisciplinary; Social Work},
Author-Email = {zuberia@duq.edu},
ResearcherID-Numbers = {Zuberi, Anita/AAU-3532-2021
   },
ORCID-Numbers = {Zuberi, Anita/0000-0003-3897-580X},
Funding-Acknowledgement = {Center on Race and Social Problems at the University of Pittsburgh;
   Wimmer Family Foundation through Duquesne University},
Funding-Text = {The authors wish to thank Waverly Duck, Bob Gradeck, and Rick Hopkinson
   for contributions to the early stages of the project. We are also
   grateful to Jessica Hardie, Kristin Turney, and the anonymous reviewers
   for their feedback on earlier versions of the manuscript. Partial
   funding was provided by the Center on Race and Social Problems at the
   University of Pittsburgh as well as the Wimmer Family Foundation through
   Duquesne University.},
Cited-References = {Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007.
   Annie E. Casey Foundation, 2012, KIDS COUNT DATA SNAP.
   Boston Planning and Development Agency, 2016, BOST CONT NEIGHB 201.
   Browning CR, 2006, AM SOCIOL REV, V71, P661, DOI 10.1177/000312240607100407.
   Chen JT, 2006, J URBAN HEALTH, V83, P1063, DOI 10.1007/s11524-006-9089-7.
   Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467.
   Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517.
   DeLuca Stefanie, 2020, CONFRONTING INEQUALI, P187.
   Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158.
   Fullilove M. T., 2004, ROOT SHOCK TEARING C.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Garvin EC, 2013, INJURY PREV, V19, P198, DOI 10.1136/injuryprev-2012-040439.
   Geronimus AT, 2000, AM J PUBLIC HEALTH, V90, P867, DOI 10.2105/AJPH.90.6.867.
   Greenman E, 2011, SOC SCI RES, V40, P1434, DOI 10.1016/j.ssresearch.2011.04.007.
   Hackworth J, 2001, ENVIRON PLANN A, V33, P863, DOI 10.1068/a33160.
   Hannon L, 2006, AM J DRUG ALCOHOL AB, V32, P453, DOI 10.1080/00952990600753966.
   Jargowsky Paul., 2015, ARCHITECTURE SEGREGA.
   Johnson Sarah R Lindstrom, 2014, Int J Adolesc Med Health, V26, P459, DOI 10.1515/ijamh-2013-0333.
   Klinenberg E, 2002, HEAT WAVE SOCIAL AUT.
   Klinenberg Eric, 2018, PALACES PEOPLE SOCIA.
   Kondo M, 2016, URBAN STUD, V53, P3279, DOI 10.1177/0042098015608058.
   Kutner MH, 2004, APPL LINEAR REGRESSI, V4th.
   Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133.
   Mallach A., 2006, BRINGING BUILDINGS B.
   Massey DS, 1993, AM APARTHEID SEGREGA.
   McClure E, 2019, HEALTH PLACE, V55, P9, DOI 10.1016/j.healthplace.2018.10.004.
   Nardone A, 2020, LANCET PLANET HEALTH, V4, pE24, DOI 10.1016/S2542-5196(19)30241-4.
   Pittsburgh Land Bank, 2018, PITTSB LAND BANK 201.
   Robert Wood Johnson Foundation (RWJF), 2019, YOU LIV AFF LNG YOU.
   Rothstein R., 2017, COLOR LAW FORGOTTEN.
   Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x.
   Rutan DQ, 2018, PROF GEOGR, V70, P339, DOI 10.1080/00330124.2017.1371610.
   Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114.
   Sampson Robert J., 1995, CRIME INEQUALITY, P37, DOI DOI 10.1016/J.CITIES.2004.07.008.
   Schulz AJ, 2002, MILBANK Q, V80, P677, DOI 10.1111/1468-0009.00028.
   Sealy-Jefferson S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060904.
   Sharkey Patrick., 2013, STUCK PLACE URBAN NE.
   Sofer, 2019, RACIAL ETHNIC PATTER.
   SPELMAN W, 1993, J CRIM JUST, V21, P481, DOI 10.1016/0047-2352(93)90033-J.
   Teixeira S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090844.
   United Health Foundation, 2018, AM HLTH RANK PREM DE.
   Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P973, DOI 10.2105/AJPH.88.6.973.
   WALLACE R, 1990, B NEW YORK ACAD MED, V66, P391.
   Williams DR, 2010, J HEALTH SOC BEHAV, V51, pS15, DOI 10.1177/0022146510383838.
   Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7.
   Wilson W.J., 2018, DONT IGNORE CLASS AD.
   Wilson W.J., 1987, TRULY DISADVANTAGED.
   Yen IH, 1999, AM J EPIDEMIOL, V149, P898.
   Zuberi A, 2016, J URBAN AFF, V38, P546, DOI 10.1111/juaf.12261.},
Number-of-Cited-References = {49},
Times-Cited = {1},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Community Psychol.},
Doc-Delivery-Number = {UC5VM},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000672090900001},
DA = {2022-03-29},
}

@article{ WOS:000087110600004,
Author = {Hoy, WE and Baker, PR and Kelly, AM and Wang, ZQ},
Title = {Reducing premature death acid renal failure in Australian Aboriginals -
   A community-based cardiovascular and renal protective program},
Journal = {MEDICAL JOURNAL OF AUSTRALIA},
Year = {2000},
Volume = {172},
Number = {10},
Pages = {473-478},
Month = {MAY 15},
Abstract = {Objective: To describe results of a systematic treatment program to
   modify renal and cardiovascular disease in an Aboriginal community whose
   rates of renal failure and cardiovascular deaths are among the highest
   in Australia.
   Design: Longitudinal survey of people during treatment, and comparison
   of rates of natural death and renal failure with those in a historical
   control group.
   Setting: Tiwi Islands (population, about 1800), November 1995 to
   December 1998.
   Participants: All adults with blood pressure greater than or equal to
   140/90, with diabetes and urinary albumin/creatinine ratio (ACR) greater
   than or equal to 3.4 g/mol (microalbuminuria threshold), or with
   progressive overt albuminuria (ACR greater than or equal to 34 g/mol)
   were eligible for treatment. The historical control group comprised 229
   people who satisfied these criteria in the pretreatment period
   1992-1995.
   Interventions: Perindopril, combined with calcium-channel blockers and
   diuretics if needed to achieve blood pressure goals; attempts to improve
   control of blood glucose and lipid levels; health education.
   Main outcome measures: Blood pressure, ACR, serum creatinine level and
   glomerular filtration rate (GFR) over two years of treatment; rates of
   renal failure and natural death compared with control group (analysed on
   intention-to-treat basis).
   Results: 258 people enrolled in the program, and 118 had complete data
   for two years of treatment. in these 118, blood pressures fell
   significantly, while ACR and GFR stabilised. Rates of the combined
   endpoints of renal failure and natural death per 100 person-years were
   2.9 for the treatment group (95\% CI, 1.7-4.6) and 4.8 for the control
   group (95\% CI, 3.3-7.0). After adjustment for baseline ACR category,
   the relative risk of the treatment group versus the control group for
   these combined endpoints was 0.47 (95\% CI, 0.25-0.86; P=0.013).
   Treatment benefit was especially marked in people with overt albuminuria
   or hypertension and in non-diabetic people. The estimates of benefit
   were supported by a fall in community rates of death and renal failure.
   Conclusions: Aboriginal people can participate enthusiastically in
   chronic disease management, with rapid, dramatic improvement in clinical
   profiles and mortality Similar programs should be introduced urgently
   into other Aboriginal communities nationwide.},
Publisher = {AUSTRALASIAN MED PUBL CO LTD},
Address = {LEVEL 1, 76 BERRY ST, SYDNEY, NSW 2060, AUSTRALIA},
Type = {Article},
Language = {English},
Affiliation = {Hoy, WE (Corresponding Author), Menzies Sch Hlth Res, POB 41096, Casuarina, NT 0811, Australia.
   Menzies Sch Hlth Res, Casuarina, NT 0811, Australia.
   Univ Queensland, Dept Prevent \& Social Med, Brisbane, Qld, Australia.},
DOI = {10.5694/j.1326-5377.2000.tb124070.x},
ISSN = {0025-729X},
Keywords-Plus = {CONVERTING ENZYME-INHIBITION; LONG-TERM BENEFITS; DIABETIC NEPHROPATHY;
   NORTHERN-TERRITORY; BLOOD-PRESSURE; DISEASE; PROTEINURIA; CREATININE;
   ADULTS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ResearcherID-Numbers = {Hoy, Wendy E/A-7325-2010
   Wang, Zhiqiang/A-5835-2010},
ORCID-Numbers = {Hoy, Wendy E/0000-0002-8405-1539
   Wang, Zhiqiang/0000-0002-5839-743X},
Cited-References = {BAKER PRA, 1999, 35 ANN SCI M AUSTR N.
   BEDOGNA V, 1990, KIDNEY INT, V38, P101, DOI 10.1038/ki.1990.173.
   Black HR, 1997, ARCH INTERN MED, V157, P2413.
   CATTRAN DC, 1994, AM J KIDNEY DIS, V23, P247, DOI 10.1016/S0272-6386(12)80980-2.
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580.
   COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z.
   Cunningham J, 1996, MED J AUSTRALIA, V165, P309, DOI 10.5694/j.1326-5377.1996.tb124987.x.
   GANSEVOORT RT, 1993, AM J KIDNEY DIS, V22, P202, DOI 10.1016/S0272-6386(12)70187-7.
   Hoy W, 1998, NEPHROLOGY, V4, pS90, DOI 10.1111/j.1440-1797.1998.tb00481.x.
   Hoy WE, 1998, KIDNEY INT, V54, P1296, DOI 10.1046/j.1523-1755.1998.00099.x.
   Hoy WE, 1997, AUST NZ J PUBL HEAL, V21, P121, DOI 10.1111/j.1467-842X.1997.tb01670.x.
   HOY WE, 1999, 35 ANN SCI M AUSTR N.
   JAIN SK, 1994, 33130 ABS.
   LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004.
   LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056.
   Mackenzie HS, 1999, J AM SOC NEPHROL, V10, pS283.
   Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502.
   McDonald SP, 1999, CLIN EXP PHARMACOL P, V26, P618, DOI 10.1046/j.1440-1681.1999.03104.x.
   Mimran A, 1999, J AM SOC NEPHROL, V10, pS273.
   MOGENSEN CE, 1995, LANCET, V346, P1080, DOI 10.1016/S0140-6736(95)91747-0.
   MOGENSEN CE, 1992, BRIT MED J, V304, P327, DOI 10.1136/bmj.304.6823.327.
   RAVID M, 1992, ARCH INTERN MED, V152, P1225, DOI 10.1001/archinte.152.6.1225.
   RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001.
   Ruggenenti P, 1997, LANCET, V349, P1857.
   Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X.
   Spencer JL, 1998, MED J AUSTRALIA, V168, P537, DOI 10.5694/j.1326-5377.1998.tb139080.x.
   {*}STATC, 1999, STATSTAT SOFTW REL 6.
   YOU J, 1999, 35 ANN SCI M AUSTR N.},
Number-of-Cited-References = {28},
Times-Cited = {69},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Med. J. Aust.},
Doc-Delivery-Number = {315JM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000087110600004},
DA = {2022-03-29},
}

@article{ WOS:000256166000002,
Author = {Woody, George E. and Kane, Vince and Lewis, Kimberly and Thompson,
   Richard},
Title = {Premature deaths after discharge from methadone maintenance: A
   replication},
Journal = {JOURNAL OF ADDICTION MEDICINE},
Year = {2007},
Volume = {1},
Number = {4},
Pages = {180-185},
Month = {DEC},
Abstract = {Objective: Examine rate and causes of death among patients discharged
   from methadone maintenance, relate them to reasons for discharge, and
   discuss treatment implications.
   Method: Naturalistic study of deaths and causes of death among 636
   opioid-dependent veterans treated with methadone maintenance between
   January 1, 2000 and August 31, 2002.
   Results: Among 456 patients who remained on methadone, 31 (6.8\%) died
   (overdose, 1 accident, 13 liver problems, 16 other medical). Among 180
   discharged patients, 34 (18.8\%) died. Reasons for discharge and causes
   of death were: continuing drug use IN 52), 11 deaths (4 overdoses, 4
   liver problems, 3 other medical); other disciplinary problems (N = 31),
   8 deaths (2 suicides, 2 overdoses, 3 other medical, 1 unknown); other
   reasons (N = 97), 15 deaths (2 suicides, 1 overdose, 1 accident, 7 liver
   problems, 3 other medical, 1 unknown). Deaths were significantly less (P
   < 0.05) among patients who remained on methadone than in each category
   of those discharged. Follow-up interviews of 99 of 146 discharged
   patients showed problems in drug use, medical, employment, and
   psychiatric areas, and that only 21\% were in treatment.
   Conclusions: These findings are consistent with a previous study from
   the same program, and also from other studies, showing that
   participating in methadone maintenance reduces mortality. Considered in
   light of the increased mortality among patients discharged for
   continuing drug use or behavioral problems, these data suggest that
   premature mortality can be reduced by keeping patients in treatment
   and/or taking steps to ensure that discharged patients are promptly
   enrolled in another program.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA},
Type = {Article},
Language = {English},
Affiliation = {Woody, GE (Corresponding Author), Treatment Res Inst, 600 Publ Ledger Bldg,150 S Independence Mall W, Philadelphia, PA USA.
   Woody, George E.; Kane, Vince; Lewis, Kimberly; Thompson, Richard, Dept Vet Affairs Med Ctr, Res Educ \& Clin Ctr MIRECC, VISN Mental Illness 4, Philadelphia, PA 19104 USA.
   Woody, George E., Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
   Woody, George E., Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.
   Thompson, Richard, Univ Illinois, Dept Psychol, Chicago, IL 60612 USA.},
DOI = {10.1097/ADM.0b013e318155980e},
ISSN = {1932-0620},
Keywords = {methadone maintenance; mortality; treatment discharge},
Keywords-Plus = {RANDOMIZED CONTROLLED-TRIAL; DRUG-USE; OPIOID DEPENDENCE;
   HEROIN-ADDICTION; MORTALITY; IMPACT; REINFORCEMENT; ABSTINENCE; ABUSE;
   USERS},
Research-Areas = {Substance Abuse},
Web-of-Science-Categories  = {Substance Abuse},
Author-Email = {woody@tresearch.org},
ResearcherID-Numbers = {Thompson, Richard/G-5408-2011},
ORCID-Numbers = {Thompson, Richard/0000-0003-0127-513X},
Cited-References = {Ball JC., 1991, EFFECTIVENESS METHAD.
   BELDING MA, 1995, DRUG ALCOHOL DEPEN, V39, P45, DOI 10.1016/0376-8716(95)01135-L.
   Brooner Robert K, 2002, Sci Pract Perspect, V1, P38.
   CALSYN DA, 1991, J NERV MENT DIS, V179, P222, DOI 10.1097/00005053-199104000-00008.
   Calsyn DA, 2003, AM J PUBLIC HEALTH, V93, P1086, DOI 10.2105/AJPH.93.7.1086.
   CALSYN DA, 1994, J ADDICT DIS, V13, P47.
   Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806.
   CAPLEHORN JRM, 1994, ADDICTION, V89, P203, DOI 10.1111/j.1360-0443.1994.tb00879.x.
   CAPLEHORN JRM, 1991, MED J AUSTRALIA, V154, P195, DOI 10.5694/j.1326-5377.1991.tb121030.x.
   Darke S, 2000, DRUG ALCOHOL DEPEN, V60, P141, DOI 10.1016/S0376-8716(99)00147-7.
   Digiusto E, 2004, ADDICTION, V99, P450, DOI 10.1111/j.1360-0443.2004.00654.x.
   DOLAN MP, 1985, J CONSULT CLIN PSYCH, V53, P549, DOI 10.1037/0022-006X.53.4.549.
   DOLE VP, 1968, J AMER MED ASSOC, V206, P2708, DOI 10.1001/jama.206.12.2708.
   DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002.
   Esteban J, 2003, DRUG ALCOHOL DEPEN, V70, P193, DOI 10.1016/S0376-8716(03)00002-4.
   Fugelstad A, 1997, ACTA PSYCHIAT SCAND, V96, P169, DOI 10.1111/j.1600-0447.1997.tb10147.x.
   GEARING FR, 1974, AM J EPIDEMIOL, V100, P102.
   Gottheil Edward, 1993, Journal of Addictive Diseases, V12, P45, DOI 10.1300/J069v12n04\_04.
   GRONBLADH L, 1990, ACTA PSYCHIAT SCAND, V82, P223, DOI 10.1111/j.1600-0447.1990.tb03057.x.
   IGUCHI MY, 1993, DRUG ALCOHOL DEPEN, V32, P257, DOI 10.1016/0376-8716(93)90090-D.
   Iguchi MY, 1996, EXP CLIN PSYCHOPHARM, V4, P315, DOI 10.1037/1064-1297.4.3.315.
   Iguchi MY, 1997, J CONSULT CLIN PSYCH, V65, P421, DOI 10.1037/0022-006X.65.3.421.
   Kidorf M, 2004, SUBST USE MISUSE, V39, P2215, DOI 10.1081/JA-200034591.
   Kidorf M, 1997, J SUBST ABUSE TREAT, V14, P23, DOI 10.1016/S0740-5472(96)00121-3.
   Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774.
   McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689.
   MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006.
   MCLELLAN AT, 1992, J NERV MENT DIS, V180, P100.
   NIH Consensus Statement, 1997, EFF MED TREATM OP AD, V15, P6.
   Nunes EV, 1998, ARCH GEN PSYCHIAT, V55, P153, DOI 10.1001/archpsyc.55.2.153.
   Schwartz RP, 2006, ARCH GEN PSYCHIAT, V63, P102, DOI 10.1001/archpsyc.63.1.102.
   Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303.
   Silverman K, 1996, DRUG ALCOHOL DEPEN, V41, P157, DOI 10.1016/0376-8716(96)01246-X.
   STITZER ML, 1992, J CONSULT CLIN PSYCH, V60, P927, DOI 10.1037/0022-006X.60.6.927.
   Tyndall MW, 2001, J ACQ IMMUN DEF SYND, V28, P351, DOI 10.1097/00126334-200112010-00008.
   van Ameijden EJC, 1999, ADDICT BEHAV, V24, P559, DOI 10.1016/S0306-4603(98)00083-5.
   WEINSTEIN SP, 1993, J SUBST ABUSE TREAT, V10, P277, DOI 10.1016/0740-5472(93)90075-D.
   WOODY GE, 1995, AM J PSYCHIAT, V152, P1302.
   WOODY GE, 1983, ARCH GEN PSYCHIAT, V40, P639.
   WOODY GE, 2001, ANN M COLL PROBL DRU.
   Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0.},
Number-of-Cited-References = {41},
Times-Cited = {31},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Addict. Med.},
Doc-Delivery-Number = {305GM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000256166000002},
DA = {2022-03-29},
}

@article{ WOS:000208181300003,
Author = {Watson, James D. E.},
Title = {The Harm of Premature Death: Immortality - The Transhumanist Challenge},
Journal = {ETHICAL PERSPECTIVES},
Year = {2009},
Volume = {16},
Number = {4},
Pages = {435-458},
Month = {DEC},
Abstract = {Although an age-old problem, the debate over immortality has become
   reanimated in light of recent advances in life extension technologies,
   accompanied by an ever-growing body of enthusiasts, both within academic
   circles as well as the public in general. For these people, death is no
   longer a natural process, but a disease, and one that might be
   prevented. It seems that the desire for immortality is a result, in
   part, of a profound sense of incompleteness and frustration that death
   will rob us of our future goals and achievements. Consequently, this
   paper takes as its main focus an individual who affirms life and does
   not wish it to end, at least prematurely. `Prematurely' is understood as
   occurring before the individual desires life to end, no matter what age
   or condition they are in. If premature death is a harm, however, does
   this imply that `more life' is always better? Ultimately this paper
   questions whether the desire for immortality (or at least
   life-extension) would rectify the problems it was originally intended to
   solve.},
Publisher = {PEETERS},
Address = {BONDGENOTENLAAN 153, B-3000 LEUVEN, BELGIUM},
Type = {Article},
Language = {English},
Affiliation = {Watson, JDE (Corresponding Author), Kings Coll London, Dept Philosophy, London WC2R 2LS, England.
   Kings Coll London, Dept Philosophy, London WC2R 2LS, England.},
DOI = {10.2143/EP.16.4.2045851},
ISSN = {1370-0049},
EISSN = {1783-1431},
Keywords = {Death; immortality; life-extension; transhumanism},
Research-Areas = {Social Sciences - Other Topics; Philosophy},
Web-of-Science-Categories  = {Ethics; Philosophy},
Author-Email = {james.watson@kcl.ac.uk},
Cited-References = {Aries Philippe, 1991, HOUR OUR DEATH.
   Aristotle, 2002, NICOMACHEAN ETHICS.
   Bauman Z., 1992, MORTALITY IMMORTALIT.
   Bostrom N, 2005, J MED ETHICS, V31, P273, DOI 10.1136/jme.2004.009035.
   BURNET M, 1978, ENDURANCE LIFE IMPLI.
   Camus A., 2000, MYTH SISYPHUS.
   CARSE JP, 1980, DEATH EXISTENCE CONC.
   Critchley Simon, 1997, VERY LITTLE ALMOST N.
   DECONDORCET AN, 1955, SKETCH HIST PICTURE.
   Ettinger RCW, 2005, PROSPECT IMMORTALITY.
   Ewin R.E., 2002, REASONS FEAR DEATH.
   Foucault M., 1995, DISCIPLINE PUNISH BI.
   Harrington Alan, 1973, IMMORTALIST.
   Harris J, 2007, ENHANCING EVOLUTION.
   Kass Leon, 2002, LIFE LIBERTY DEFENSE, P257.
   Kirkwood T.B.L., 1999, TIME OUR LIVES SCI H.
   Lamb David., 1985, DEATH BRAIN DEATH ET.
   Lamont J, 1998, AUSTRALAS J PHILOS, V76, P198, DOI 10.1080/00048409812348351.
   Lewis C.S., 1961, GRIEF OBSERVED.
   McMahan J., 2002, ETHICS KILLING PROBL.
   Moore G. E., 1929, PRINCIPIA ETHICA.
   More Max, 1996, TRANSHUMANISM FUTURI.
   Nagel T., 1979, MORTAL QUESTIONS, P1.
   Nagel Thomas, 1979, MORTAL QUESTIONS, P11.
   Nagel Thomas, 1986, VIEW NOWHERE, P208.
   Nussbaum M., 1994, THERAPY DESIRE THEOR.
   PLATO, 1993, PHAEDO.
   Schlick M., 1987, LIFE MEANING, P60.
   Schopenhauer A., 1844, WORLD WILL REPRESENT, V2.
   Tsanoff Radoslav A., 1920, PHILOS REV, V29, P547.
   Walter T., 1994, REVIVAL DEATH.
   Warren J, 2001, J HELLENIC STUD, V121, P91, DOI 10.2307/631830.
   Williams, 1973, PROBLEMS SELF, P82, DOI DOI 10.1017/CBO9780511621253.008.
   Wittgenstein Ludwig, 2007, TRACTATUS LOGICOPBIL.
   Young J., 2003, DEATH GOD MEANING LI.
   {[}No title captured].},
Number-of-Cited-References = {36},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Ethical Perspect.},
Doc-Delivery-Number = {V21AU},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:000208181300003},
DA = {2022-03-29},
}

@article{ WOS:000650195600004,
Author = {Lee, Yongjin and Yang, Jiyeon and Lim, Youngwook and Kim, Changsoo},
Title = {Economic damage cost of premature death due to fine particulate matter
   in Seoul, Korea},
Journal = {ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH},
Year = {2021},
Volume = {28},
Number = {37},
Pages = {51702-51713},
Month = {OCT},
Abstract = {Analyzing the economic value of the damage to human health caused by
   environmental risks has become an essential research focus, given the
   increasing necessity for effective decision-making. Since logical and
   rational analyses such as cost-benefit and cost-utility analyses will
   likely gain importance in future policymaking, the evaluation of
   economic costs becomes necessary. Among the various types of air
   pollutants, fine particulate matter (PM) is reported as closely related
   to mortality. To reduce result uncertainty by improving the methodology
   of risk assessment or the economic evaluation of fine PM, risk control
   measures are required for high-priority areas. This study addresses this
   issue by estimating the relative risk of PM2.5 while calculating the
   economic loss cost arising from acute death due to fine PM exposure in
   Seoul, Korea. The value of statistical life of one person's willingness
   to pay for mortality risk reduction is calculated to estimate the
   economic loss cost at each current level of exposure. The estimated
   economic loss cost due to all-cause mortality during 2016-2018 totaled
   approximately USD 1307.9 million per year; the costs of loss from
   respiratory and cardiovascular mortalities were USD 128.1 million per
   year and USD 426.9 million, respectively. Based on these results, this
   study concludes that the standards for PM2.5 are more effective than the
   ones established for PM10 in terms of economic value.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Lee, Y (Corresponding Author), Yonsei Univ, Inst Environm Res, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   Lee, Yongjin; Yang, Jiyeon; Lim, Youngwook; Kim, Changsoo, Yonsei Univ, Inst Environm Res, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.},
DOI = {10.1007/s11356-021-14362-y},
EarlyAccessDate = {MAY 2021},
ISSN = {0944-1344},
EISSN = {1614-7499},
Keywords = {Air pollution; Particulate matter; Willingness to pay; Value of
   statistical life; Premature death},
Keywords-Plus = {AIR-POLLUTION; MORTALITY; HEALTH},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {yjlee75@yuhs.ac},
ORCID-Numbers = {Kim, Changsoo/0000-0002-5940-5649
   LEE, Yong Jin/0000-0002-2868-2221
   Lim, Young-Wook/0000-0001-8845-2850},
Funding-Acknowledgement = {Korea Ministry of Science and ICT; Ministry of Education and School
   Particulate Matter Center for Energy \& Environment Harmonization
   {[}2019M3E7A1113082]},
Funding-Text = {This work was supported by the Korea Ministry of Science and ICT and
   Ministry of Education and School Particulate Matter Center for Energy \&
   Environment Harmonization (No. 2019M3E7A1113082).},
Cited-References = {Alberini A, 1997, J ENVIRON ECON MANAG, V34, P107, DOI 10.1006/jeem.1997.1007.
   Albertsen PC, 1997, UROLOGY, V49, P207, DOI 10.1016/S0090-4295(96)00485-2.
   Arrow K.J., 1993, FED REGISTER, V58, P4602.
   BISHOP RC, 1990, AM J AGR ECON, V72, P249, DOI 10.2307/1243175.
   Brethour C, 2001, AGR ECON-BLACKWELL, V25, P219, DOI 10.1111/j.1574-0862.2001.tb00202.x.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Hanemann W. M., 1985, NE J AGR EC, V14, P1, DOI {[}10.1017/S0899367X00000702, DOI 10.1017/S0899367X00000702].
   JONES-LEE MW, 1985, ECON J, V95, P49, DOI 10.2307/2233468.
   Krupnick A, 2002, J RISK UNCERTAINTY, V24, P161, DOI 10.1023/A:1014020027011.
   Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4.
   Rabl A, 1999, ENVIRON INT, V25, P29, DOI 10.1016/S0160-4120(98)00089-0.
   Samet J M, 2000, Res Rep Health Eff Inst, V94, P5.
   SCHWARTZ J, 1990, AM J EPIDEMIOL, V131, P185, DOI 10.1093/oxfordjournals.aje.a115473.
   STYER P, 1995, ENVIRON HEALTH PERSP, V103, P490, DOI 10.2307/3432588.
   US EPA US EPA, 2001, 600P99002BB US EPA.
   US EPA US EPA, 1993, GUID COMP RISKS SETT.
   US EPA US EPA, 2000, EPA240R00003 US EPA.},
Number-of-Cited-References = {19},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Environ. Sci. Pollut. Res.},
Doc-Delivery-Number = {UW6KD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000650195600004},
DA = {2022-03-29},
}

@article{ WOS:000345813000018,
Author = {Peto, Richard},
Title = {Harveian Oration 2012: Halving premature death},
Journal = {CLINICAL MEDICINE},
Year = {2014},
Volume = {14},
Number = {6},
Pages = {643-657},
Month = {DEC},
Publisher = {ROY COLL PHYS LONDON EDITORIAL OFFICE},
Address = {11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Peto, R (Corresponding Author), Univ Oxford, Oxford, England.
   Univ Oxford, Oxford, England.},
DOI = {10.7861/clinmedicine.14-6-643},
ISSN = {1470-2118},
EISSN = {1473-4893},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; SMOKING;
   ALCOHOL; RUSSIA; CANCER; METAANALYSIS; COUNTRIES; EPIDEMIC},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5.
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5.
   Colgrove J, 2002, AM J PUBLIC HEALTH, V92, P725, DOI 10.2105/AJPH.92.5.725.
   Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271.
   DOLL R, 1964, BMJ-BRIT MED J, V1, P1460, DOI 10.1136/bmj.1.5396.1460.
   DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399.
   DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739.
   DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071.
   Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   Doll R, 1994, MORTALITY SMOKING DE.
   Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2.
   Editorial Committee, 1979, ATL CANC MORT PEOPL.
   IARC, 2007, IARC HDB CANC PREV, V11, P15.
   Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719.
   Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6.
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   McKeown Thomas, 1976, MODERN RISE POPULATI.
   McKeown Thomas., 1976, ROLE MED DREAM MIRAG.
   New York City Department of Health, HIST AIDS EP NEW YOR.
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731.
   Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   Peto R, 2010, BIOGR MEMS FELL R SO, V56, P63, DOI DOI 10.1098/RSBM.2010.0019.
   Peto R, 2010, NEW ENGL J MED, V362, P855, DOI 10.1056/NEJMc1000079.
   Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6.
   Royal College of Physicians, 1962, SMOK HLTH.
   Sargant WL, 1866, J STAT SOC LONDON, V29, P92.
   Szreter Simon, 1988, SOC HIST MED, V1, P1, DOI DOI 10.1093/SHM/1.1.1.
   Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294.
   {*}US PHS, 1964, PHS PUBL, V1103.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.
   Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160.
   Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5.
   {[}No title captured].},
Number-of-Cited-References = {40},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Clin. Med.},
Doc-Delivery-Number = {AU7YA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000345813000018},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1983QS17100011,
Author = {WARNER, KE and MURT, HA},
Title = {PREMATURE DEATHS AVOIDED BY THE ANTI-SMOKING CAMPAIGN},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {1983},
Volume = {73},
Number = {6},
Pages = {672-677},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {1015 FIFTEENTH ST NW, WASHINGTON, DC 20005},
Type = {Article},
Language = {English},
Affiliation = {WARNER, KE (Corresponding Author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT HLTH PLANNING \& ADM,ANN ARBOR,MI 48109, USA.},
DOI = {10.2105/AJPH.73.6.672},
ISSN = {0090-0036},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
ORCID-Numbers = {Warner, Kenneth/0000-0002-8214-1776},
Funding-Acknowledgement = {AHRQ HHSUnited States Department of Health \& Human ServicesAgency for
   Healthcare Research \& Quality {[}HS 03634] Funding Source: Medline},
Cited-References = {COWELL MJ, 1980, SOC ACTUARIES T, V32, P185.
   {*}CTR DIS CONTR, 1976, 1975 AD US TAB.
   {*}CTR DIS CONTR, 1973, DHEW HSM738727 PUBL.
   DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525.
   FRIEDMAN GD, 1981, NEW ENGL J MED, V304, P1407, DOI 10.1056/NEJM198106043042308.
   HADDON W, 1981, PREVENTIVE COMMUNITY.
   HARRIS JE, 1980, HLTH CONSEQUENCES SM.
   MYERS ML, 1981, STAFF REPORT CIGARET.
   {*}NAT INED, 1979, TEEN SMOK IMM LONGT.
   ROBERTSON LS, 1981, AM J PUBLIC HEALTH, V71, P818, DOI 10.2105/AJPH.71.8.818.
   ROGOT E, 1974, J CHRON DIS, V27, P189, DOI 10.1016/0021-9681(74)90045-9.
   TOFANY VL, 1981, TRAFFIC QUART, V35, P5.
   {*}US DEP HLTH HUM S, 1980, HLTH CONS SMOK WOM R.
   {*}US DHEW, 1979, PHS79500 PUBL.
   {*}US DHEW, 1975, HRA7511 SO PUBL.
   {*}US DHEW, 1981, PHS8150156 PUBL.
   {*}US DHEW, 1969, US TAB PRACT ATT KNO.
   {*}US EC RES SERV, 1981, TOB OUTL SIT DEC.
   WARNER KE, 1981, SCIENCE, V211, P729, DOI 10.1126/science.7455711.
   WARNER KE, J PUB HLTH POLICY.
   {[}No title captured].},
Number-of-Cited-References = {21},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {QS171},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1983QS17100011},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@incollection{ WOS:000293761400008,
Author = {DasMahapatra, Pronabesh and Alonso, Camilo Fernandez},
Editor = {Berenson, GS},
Title = {Morbid Obesity and Premature Death in the Young},
Booktitle = {EVOLUTION OF CARDIO-METABOLIC RISK FROM BIRTH TO MIDDLE AGE: THE
   BOGALUSA HEART STUDY},
Year = {2011},
Pages = {93-97},
Abstract = {Morbid obesity and related ectopic lipid accumulation play an important
   role in the pathogenesis of multi-organ damage. This autopsy report of a
   25 year old Caucasian male with history of sleep apnea but non-compliant
   to continuous positive airway pressure illustrates the consequences of
   chronic fatty organ changes in a morbidly obese young male.
   Fat, especially central obesity, plays an important role in the
   dysregulation of hemodynamic, metabolic, and inflammatory processes
   through mechanisms that include activation of release of free fatty
   acids, macrophage infiltration into adipose tissue, hepatic lipogenesis,
   adipose renin-angiotensin-aldosterone system, sympathetic activation,
   insulin resistance, oxidative and inflammatory stress. Lipid
   accumulation in the heart, skeletal muscle, pancreas, liver, and kidney
   play an important role in the pathogenesis of heart failure, potential
   arrhythmias and diabetes. Excess free fatty acids also impair normal
   cell signaling through central nervous system-acting signaling proteins
   (adipokines) which affect airway neuromuscular control. This coupled
   with mechanical compression within pharyngeal tissues and lungs lead to
   pharyngeal collapsibility and sleep apnea. Hypoxic status sets up the
   potential of arrhythmias and sudden death.},
Publisher = {SPRINGER},
Address = {PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS},
Type = {Article; Book Chapter},
Language = {English},
Affiliation = {DasMahapatra, P (Corresponding Author), Tulane Univ, Sch Publ Hlth \& Trop Med, Dept Epidemiol, Ctr Cardiovasc Hlth, New Orleans, LA USA.
   DasMahapatra, Pronabesh; Alonso, Camilo Fernandez, Tulane Univ, Sch Publ Hlth \& Trop Med, Dept Epidemiol, Ctr Cardiovasc Hlth, New Orleans, LA USA.},
DOI = {10.1007/978-94-007-1451-9\_8},
ISBN = {978-94-007-1450-2},
Keywords = {Morbid obesity; Lipotoxicity; Obstructive sleep apnea; Cardiovascular
   disease; Multi-organ damage},
Keywords-Plus = {SLEEP-APNEA; LIPOTOXICITY; PREVALENCE},
Research-Areas = {Cardiovascular System \& Cardiology; Public, Environmental \&
   Occupational Health},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Public, Environmental \& Occupational
   Health},
Author-Email = {pdasmaha@tulane.edu
   cfernan1@tulane.edu},
Cited-References = {Almaguel FG, 2010, BRAIN RES, V1318, P133, DOI 10.1016/j.brainres.2009.12.038.
   Berenson Gerald S, 2010, Prev Cardiol, V13, P23, DOI 10.1111/j.1751-7141.2009.00049.x.
   Broyles S, 2010, PEDIATRICS, V125, P900, DOI 10.1542/peds.2009-2748.
   Carpagnano GE, 2010, TRANSL RES, V155, P35, DOI 10.1016/j.trsl.2009.09.004.
   Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6.
   DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1.
   DOWNEY AM, 1987, J SCHOOL HEALTH, V57, P98, DOI 10.1111/j.1746-1561.1987.tb05378.x.
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014.
   Freedman DS, 2005, OBES RES, V13, P928, DOI 10.1038/oby.2005.107.
   Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018.
   McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011.
   Ogden Cynthia L, 2004, Adv Data, P1.
   Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012.
   Rial E, 2010, BBA-BIOENERGETICS, V1797, P800, DOI 10.1016/j.bbabio.2010.04.001.
   Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008.
   Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG.
   THOMPSON D, 2001, Obes Rev, V2, P197.
   Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006.
   Wolk R, 2003, HYPERTENSION, V42, P1067, DOI 10.1161/01.HYP.0000101686.98973.A3.},
Number-of-Cited-References = {19},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Doc-Delivery-Number = {BWE58},
Web-of-Science-Index = {Book Citation Index – Science (BKCI-S)},
Unique-ID = {WOS:000293761400008},
DA = {2022-03-29},
}

@article{ WOS:000230683300003,
Author = {Ozanne, SE and Hales, CN},
Title = {Poor fetal growth followed by rapid postnatal catch-up growth leads to
   premature death},
Journal = {MECHANISMS OF AGEING AND DEVELOPMENT},
Year = {2005},
Volume = {126},
Number = {8},
Pages = {852-854},
Month = {AUG},
Abstract = {It is widely accepted that individuals with a low birth weight are at
   increased risk of developing type 2 diabetes, insulin resistance and
   cardiovascular disease. This risk is amplified if the poor fetal growth
   is followed by rapid postnatal catch-up growth. We have shown recently
   that poor fetal growth, resulting from maternal protein restriction,
   followed by postnatal catch-up growth is associated with reduced average
   longevity in mice. Here, we show that in addition to reduced average
   longevity, mice which have been growth restricted in utero and then
   grown rapidly during the lactation period have a reduced maximum
   longevity. Maximum longevity of these mice was, further, reduced when
   the animals were weaned onto an obesity-inducing cafeteria-style diet.
   This reduced maximum longevity was associated with early age-related
   weight loss. These results demonstrate that maternal nutrition during
   critical periods of development has a major impact on quantity as well
   as quality of life. (c) 2005 Elsevier Ireland Ltd. All rights reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Ozanne, SE (Corresponding Author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Box 232,Level 4,Hills Rd, Cambridge CB2 2QR, England.
   Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England.},
DOI = {10.1016/j.mad.2005.03.005},
ISSN = {0047-6374},
Keywords = {fetal programming; early nutrition; lifespan; catch-up growth},
Keywords-Plus = {OBESITY; INSULIN; DIET; MICE},
Research-Areas = {Cell Biology; Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Cell Biology; Geriatrics \& Gerontology},
Author-Email = {seo10@cam.ac.uk},
ORCID-Numbers = {Ozanne, Susan/0000-0001-8753-5144},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline},
Cited-References = {Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008.
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5.
   Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341.
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b.
   Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278.
   Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46.
   Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5.
   Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753.
   Petry CJ, 1997, CLIN SCI, V93, P147, DOI 10.1042/cs0930147.
   Prentice AM, 2001, BRIT MED BULL, V60, P51, DOI 10.1093/bmb/60.1.51.
   Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9.
   Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9.
   SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170.
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447.
   von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147.},
Number-of-Cited-References = {15},
Times-Cited = {87},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Mech. Ageing Dev.},
Doc-Delivery-Number = {947YN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000230683300003},
DA = {2022-03-29},
}

@article{ WOS:000221173900016,
Author = {Cozen, AE and Moriwaki, H and Kremen, M and DeYoung, MB and Dichek, HL
   and Slezicki, KI and Young, SG and Veniant, M and Dichek, DA},
Title = {Macrophage-targeted overexpression of urokinase causes accelerated
   atherosclerosis, coronary artery occlusions, and premature death},
Journal = {CIRCULATION},
Year = {2004},
Volume = {109},
Number = {17},
Pages = {2129-2135},
Month = {MAY 4},
Abstract = {Background - Human atherosclerotic lesions contain elevated levels of
   urokinase plasminogen activator (uPA), expressed predominantly by
   macrophages.
   Methods and Results - To test the hypothesis that macrophage-expressed
   uPA contributes to the progression and complications of atherosclerosis,
   we generated transgenic mice with macrophage-targeted overexpression of
   uPA. The uPA transgene was bred into the apolipoprotein E - null
   background, and transgenic mice and nontransgenic littermate controls
   were fed an atherogenic diet. uPA-transgenic mice had significantly
   elevated uPA activity in the atherosclerotic artery wall, of a magnitude
   similar to elevations reported in atherosclerotic human arteries.
   Compared with littermate controls, uPA-transgenic mice had accelerated
   atherosclerosis, dilated aortic roots, occlusive proximal coronary
   artery disease, myocardial infarcts, and early mortality.
   Conclusions - These data support the hypothesis that overexpression of
   uPA by artery wall macrophages is atherogenic and suggest that uPA
   inhibitors might be therapeutically useful.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Dichek, DA (Corresponding Author), Univ Washington, Sch Med, Dept Med, 1959 NE Pacific St,Box 357710, Seattle, WA 98195 USA.
   Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
   Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA.},
DOI = {10.1161/01.CIR.0000127369.24127.03},
ISSN = {0009-7322},
EISSN = {1524-4539},
Keywords = {urokinase; atherosclerosis; coronary disease},
Keywords-Plus = {PLASMINOGEN-ACTIVATOR INHIBITOR-1; LDL RECEPTOR-DEFICIENT; MATRIX
   METALLOPROTEINASES; POSSIBLE MECHANISM; TRANSGENIC MICE; VESSEL WALL;
   EXPRESSION; GROWTH; LESIONS; CELLS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {ddichek@u.washington.edu},
ORCID-Numbers = {Young, Stephen/0000-0001-7270-3176
   Cozen, Aaron/0000-0003-2409-0023},
Funding-Acknowledgement = {NHLBI NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}F32-HL-10022, HL-61860, K08-HL-04031,
   HL-69063] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}K08HL004031, R01HL069063, R01HL061860, F32HL010022]
   Funding Source: NIH RePORTER},
Cited-References = {Agah R, 2000, CIRC RES, V86, P1024, DOI 10.1161/01.RES.86.10.1024.
   ANICHINI E, 1994, EXP CELL RES, V213, P438, DOI 10.1006/excr.1994.1221.
   Bendeck MP, 2002, CIRC RES, V90, P836, DOI 10.1161/01.RES.0000018141.73992.41.
   BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794.
   BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259.
   Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439.
   DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P8270, DOI 10.1021/bi00399a038.
   DICHEK DA, 1994, BLOOD, V84, P504.
   Dichek HL, 2001, J LIPID RES, V42, P201.
   Eitzman DT, 2000, BLOOD, V96, P4212.
   FALCONE DJ, 1993, J BIOL CHEM, V268, P11951.
   Falkenberg M, 1998, CARDIOVASC PATHOL, V7, P223, DOI 10.1016/S1054-8807(97)00114-2.
   Falkenberg M, 2002, P NATL ACAD SCI USA, V99, P10665, DOI 10.1073/pnas.162236599.
   Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670.
   FRIBERGER P, 1982, SCAND J CLIN LAB INV, V42, P1.
   Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624.
   HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C.
   HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391.
   Kienast J, 1998, THROMB HAEMOSTASIS, V79, P579.
   Lemaitre V, 2001, J CLIN INVEST, V107, P1227, DOI 10.1172/JCI9626.
   Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324.
   LUPU F, 1995, ARTERIOSCL THROM VAS, V15, P1444, DOI 10.1161/01.ATV.15.9.1444.
   Luttun A, 2002, ARTERIOSCL THROM VAS, V22, P499, DOI 10.1161/hq0302.104529.
   LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361.
   PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893.
   PITAS RE, 1987, J BIOL CHEM, V262, P14352.
   SANDGREN EP, 1992, P NATL ACAD SCI USA, V89, P11523, DOI 10.1073/pnas.89.23.11523.
   SCHNEIDERMAN J, 1995, J CLIN INVEST, V96, P639, DOI 10.1172/JCI118079.
   Sjoland H, 2000, ARTERIOSCL THROM VAS, V20, P846, DOI 10.1161/01.ATV.20.3.846.
   Smith P., 2002, ANAL FAILURE SURVIVA.
   Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503.
   Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697.
   Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511.
   WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551.
   Xiao Q, 1997, P NATL ACAD SCI USA, V94, P10335, DOI 10.1073/pnas.94.19.10335.
   Zar J.H., 1999, BIOSTAT ANAL.},
Number-of-Cited-References = {36},
Times-Cited = {74},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Circulation},
Doc-Delivery-Number = {817JN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000221173900016},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000078894000003,
Author = {Contamine, V and Picard, M},
Title = {Escape from premature death due to nuclear mutations in Podospora
   anserina: Repeal versus respite},
Journal = {FUNGAL GENETICS AND BIOLOGY},
Year = {1998},
Volume = {23},
Number = {3},
Pages = {223-236},
Month = {APR},
Abstract = {Premature death has been defined as a growth stoppage linked to the
   accumulation of specific deletions of the mitochondrial genome (mtDNA)
   in Podospora anserina, This occurs only in strains carrying the AS1-4
   mutation which lies in a gene encoding a cytosolic ribosomal protein,
   Here we describe the isolation and genetic characterization of 10
   nuclear mutations which either delay the appearance of this syndrome
   (respite from premature death) or cause a switch to the classical
   senescence process (repeal of premature death), These mutations lie in
   at least six genes. Some cause defects at the levels of ascospore
   germination, growth rates, and/or sensitivity toward inhibitors of
   protein syntheses. AII modify the onset of senescence in wild-type
   (AS1(+)) strains. The role played by these genes is discussed with
   respect to the control of diseases due to mtDNA rearrangements in
   filamentous fungi, (C) 1998 academic Press.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Contamine, V (Corresponding Author), Univ Paris 11, Inst Genet \& Microbiol, CNRS URA 2225, F-91405 Orsay, France.
   Univ Paris 11, Inst Genet \& Microbiol, CNRS URA 2225, F-91405 Orsay, France.},
DOI = {10.1006/fgbi.1998.1040},
ISSN = {1087-1845},
EISSN = {1096-0937},
Keywords = {mitochondrial genome; mtDNA deletions; nuclear suppressors; senescence;
   filamentous fungi; Podospora anserina},
Keywords-Plus = {MITOCHONDRIAL OUTER-MEMBRANE; PHENOTYPIC SUPPRESSION;
   SACCHAROMYCES-CEREVISIAE; ANTI-SUPPRESSORS; SENESCENCE; GENES; PROTEIN;
   MUTANTS; DNA; MUTAGENESIS},
Research-Areas = {Genetics \& Heredity; Mycology},
Web-of-Science-Categories  = {Genetics \& Heredity; Mycology},
Cited-References = {ALMASAN A, 1988, GENETICS, V120, P935.
   BELCOUR L, 1977, MOL GEN GENET, V153, P11, DOI 10.1007/BF01035991.
   BELCOUR L, 1991, P NATL ACAD SCI USA, V88, P3579, DOI 10.1073/pnas.88.9.3579.
   BELCOUR L, 1980, J GEN MICROBIOL, V119, P505.
   BERTRAND H, 1995, CAN J BOT, V73, pS198.
   BERTRAND H, 1969, GENETICS, V61, P643.
   Contamine V, 1996, GENETICS, V144, P541.
   COPPINRAYNAL E, 1981, BIOCHEM GENET, V19, P729, DOI 10.1007/BF00484005.
   COPPINRAYNAL E, 1989, MOL GEN GENET, V219, P270, DOI 10.1007/BF00261187.
   DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951.
   Dujon B., 1989, MOBILE DNA, P861.
   Esser K, 1974, HDB GENETICS, V1, P531.
   GORINI L, 1966, ANNU REV MICROBIOL, V20, P401, DOI 10.1146/annurev.mi.20.100166.002153.
   GRIFFITHS AJF, 1992, CURR GENET, V21, P479, DOI 10.1007/BF00351658.
   GRIFFITHS AJF, 1992, ANNU REV GENET, V26, P351, DOI 10.1146/annurev.ge.26.120192.002031.
   JametVierny C, 1997, MOL CELL BIOL, V17, P6359, DOI 10.1128/MCB.17.11.6359.
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055.
   LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536.
   LECELLIER G, 1995, THESIS U PARIS 11 OR.
   Marcou D., 1961, ANN SCI BIOL BOT VEG, V12, P653.
   Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625.
   Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211.
   PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0.
   Pfanner N, 1996, TRENDS BIOCHEM SCI, V21, P51, DOI 10.1016/0968-0004(96)80864-4.
   PICARD M, 1973, GENET RES, V21, P1, DOI 10.1017/S0016672300013173.
   PICARD M, 1971, MOL GEN GENET, V111, P35, DOI 10.1007/BF00286552.
   PICARDBENNOUN M, 1976, MOL GEN GENET, V147, P299, DOI 10.1007/BF00582881.
   RINE J, 1991, METHOD ENZYMOL, V194, P239.
   RIZET G, 1953, CR HEBD ACAD SCI, V237, P1106.
   RIZET GEORGES, 1949, REV CYTOL ET BIOL VEG, V11, P201.
   RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51.
   ROSSIGNOL M, 1996, MECH AGEING DEV, V90, P193.
   SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4.
   SILAR P, 1997, GENETICS, V145, P231.
   SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0.
   Slupska MM, 1996, P NATL ACAD SCI USA, V93, P4380, DOI 10.1073/pnas.93.9.4380.
   SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361.
   TUDZYNSKI P, 1982, CURR GENET, V6, P219, DOI 10.1007/BF00390341.
   TUDZYNSKI P, 1979, MOL GEN GENET, V173, P71, DOI 10.1007/BF00267692.},
Number-of-Cited-References = {39},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Fungal Genet. Biol.},
Doc-Delivery-Number = {171ZC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000078894000003},
DA = {2022-03-29},
}

@article{ WOS:000274397200005,
Author = {Franks, Paul W. and Hanson, Robert L. and Knowler, William C. and
   Sievers, Maurice L. and Bennett, Peter H. and Looker, Helen C.},
Title = {Childhood Obesity, Other Cardiovascular Risk Factors, and Premature
   Death},
Journal = {NEW ENGLAND JOURNAL OF MEDICINE},
Year = {2010},
Volume = {362},
Number = {6},
Pages = {485-493},
Month = {FEB 11},
Abstract = {BACKGROUND
   The effect of childhood risk factors for cardiovascular disease on adult
   mortality is poorly understood.
   METHODS
   In a cohort of 4857 American Indian children without diabetes (mean age,
   11.3 years; 12,659 examinations) who were born between 1945 and 1984, we
   assessed whether body-mass index (BMI), glucose tolerance, and blood
   pressure and cholesterol levels predicted premature death. Risk factors
   were standardized according to sex and age. Proportional-hazards models
   were used to assess whether each risk factor was associated with time to
   death occurring before 55 years of age. Models were adjusted for
   baseline age, sex, birth cohort, and Pima or Tohono O'odham Indian
   heritage.
   RESULTS
   There were 166 deaths from endogenous causes (3.4\% of the cohort)
   during a median follow-up period of 23.9 years. Rates of death from
   endogenous causes among children in the highest quartile of BMI were
   more than double those among children in the lowest BMI quartile
   (incidence-rate ratio, 2.30; 95\% confidence interval {[}CI], 1.46 to
   3.62). Rates of death from endogenous causes among children in the
   highest quartile of glucose intolerance were 73\% higher than those
   among children in the lowest quartile (incidence-rate ratio, 1.73; 95\%
   CI, 1.09 to 2.74). No significant associations were seen between rates
   of death from endogenous or external causes and childhood cholesterol
   levels or systolic or diastolic blood-pressure levels on a continuous
   scale, although childhood hypertension was significantly associated with
   premature death from endogenous causes (incidence-rate ratio, 1.57; 95\%
   CI, 1.10 to 2.24).
   CONCLUSIONS
   Obesity, glucose intolerance, and hypertension in childhood were
   strongly associated with increased rates of premature death from
   endogenous causes in this population. In contrast, childhood
   hypercholesterolemia was not a major predictor of premature death from
   endogenous causes.},
Publisher = {MASSACHUSETTS MEDICAL SOC},
Address = {WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA},
Type = {Article},
Language = {English},
Affiliation = {Franks, PW (Corresponding Author), Umea Univ Hosp, Genet Epidemiol \& Clin Res Grp, Dept Publ Hlth \& Clin Med, Med Sect, S-90187 Umea, Sweden.
   Franks, Paul W., Umea Univ Hosp, Genet Epidemiol \& Clin Res Grp, Dept Publ Hlth \& Clin Med, Med Sect, S-90187 Umea, Sweden.
   Franks, Paul W.; Hanson, Robert L.; Knowler, William C.; Sievers, Maurice L.; Bennett, Peter H.; Looker, Helen C., NIDDK, Diabet Epidemiol \& Clin Res Sect, NIH, Phoenix, AZ USA.
   Franks, Paul W., Univ Cambridge, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England.
   Looker, Helen C., Mt Sinai Sch Med, New York, NY USA.},
DOI = {10.1056/NEJMoa0904130},
ISSN = {0028-4793},
EISSN = {1533-4406},
Keywords-Plus = {BODY-MASS INDEX; UNITED-STATES; METABOLIC SYNDROME; DIABETES-MELLITUS;
   PIMA-INDIANS; US CHILDREN; FOLLOW-UP; MORTALITY; ADOLESCENTS; OVERWEIGHT},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {paul.franks@medicin.umu.se},
ResearcherID-Numbers = {Bennett, Peter/AAH-9605-2021
   Hrafnkelsson, Hannes/C-8490-2011
   Franks, Paul/AAA-3300-2020
   Hanson, Robert/O-3238-2015
   },
ORCID-Numbers = {Hanson, Robert/0000-0002-4252-7068
   Franks, Paul/0000-0002-0520-7604},
Funding-Acknowledgement = {National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK)United States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes \&
   Digestive \& Kidney Diseases (NIDDK); Swedish Diabetes Association;
   Swedish Heart Lung FoundationSwedish Heart-Lung Foundation; Swedish
   Research Council, Umea UniversitySwedish Research Council; Vasterbotten
   regional health authority; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE
   AND KIDNEY DISEASESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}ZIADK069000,
   ZIADK069097] Funding Source: NIH RePORTER},
Funding-Text = {Supported by the National Institute of Diabetes and Digestive and Kidney
   Diseases (NIDDK) intramural research program. Dr. Franks was supported
   in part by grants from the Swedish Diabetes Association, the Swedish
   Heart Lung Foundation, the Swedish Research Council, Umea University
   (Career Development Award), and the Vasterbotten regional health
   authority (Strategic Appointment 2006-09).},
Cited-References = {American Diabetes Association, 1999, DIABETES CARE S1, V22, pS1.
   Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2.
   BENNETT PH, 1971, LANCET, V2, P125.
   {*}CDCP, 2000, PUBL CDCP, V314.
   {*}DEP HLTH HUM SERV, 2004, CHILD HLTH US 2004.
   Department of Health Chief Medical Officer, 2002, ANN REP CHIEF MED OF.
   DIPIETRO L, 1994, INT J OBESITY, V18, P585.
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905.
   Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834.
   Franks PW, 2007, DIABETES, V56, P2964, DOI 10.2337/db06-1639.
   Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823.
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143.
   Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111.
   HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E.
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847.
   HOWARD BV, 1983, CIRCULATION, V68, P714, DOI 10.1161/01.CIR.68.4.714.
   KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648.
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709.
   Lindsay RS, 2001, J CLIN ENDOCR METAB, V86, P4061, DOI 10.1210/jc.86.9.4061.
   Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E.
   McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79.
   MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904.
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555.
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549.
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401.
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743.
   Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421.
   PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502.
   PRENTICE RL, 1979, BIOMETRICS, V35, P25, DOI 10.2307/2529934.
   SIEVERS ML, 1990, J CLIN EPIDEMIOL, V43, P1231, DOI 10.1016/0895-4356(90)90024-J.
   {*}WHO DEP NONC DIS, 1999, REP WHO CONS DEF D 1.},
Number-of-Cited-References = {31},
Times-Cited = {825},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {86},
Journal-ISO = {N. Engl. J. Med.},
Doc-Delivery-Number = {553WJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000274397200005},
OA = {Green Published, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000403823600009,
Author = {Ibrahim, Joseph E. and Bugeja, Lyndal and Willoughby, Melissa and Bevan,
   Marde and Kipsaina, Chebiwot and Young, Carmel and Pham, Tony and
   Ranson, David L.},
Title = {Premature deaths of nursing home residents: an epidemiological analysis},
Journal = {MEDICAL JOURNAL OF AUSTRALIA},
Year = {2017},
Volume = {206},
Number = {10},
Month = {JUN 5},
Abstract = {Objectives: To conduct a descriptive epidemiological analysis of
   external cause deaths (premature, usually injury-related, and
   potentially preventable) of nursing home residents in Australia.
   Design: Retrospective study of a cohort of nursing home residents, using
   coronial data routinely recorded by the National Coronial Information
   System.
   Setting and participants: Residents of accredited Australian nursing
   homes, whose deaths were reported to coroners between 1 July 2000 and 30
   June 2013, and determined to have resulted from external causes.
   Main outcome measures: Causes of death, analysed by sex and age group,
   and by location of incidents leading to death and location of death.
   Rates of death were estimated on the basis of Australian Bureau of
   Statistics population and Australian Institute of Health and Welfare
   nursing home data.
   Results: Of 21 672 deaths of nursing home residents, 3289 (15.2\%)
   resulted from external causes. The most frequent mechanisms of death
   were falls (2679 cases, 81.5\%), choking (261 cases, 7.9\%) and suicide
   (146 cases, 4.4\%). The incidents leading to death usually occurred in
   the nursing home (95.8\%), but the deaths more frequently occurred
   outside the nursing home (67.1\%). The annual number of external cause
   deaths in nursing homes increased during the study period (from 1.2 per
   1000 admissions in 2001-02 to 5.3 per 1000 admissions in 2011-12).
   Conclusion: The incidence of premature and potentially preventable
   deaths of nursing home residents has increased over the past decade. A
   national policy framework is needed to reduce the incidence of premature
   deaths among Australians living in nursing homes.},
Publisher = {AUSTRALASIAN MED PUBL CO LTD},
Address = {LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA},
Type = {Article},
Language = {English},
Affiliation = {Ibrahim, JE (Corresponding Author), Monash Univ, Melbourne, Vic, Australia.
   Ibrahim, Joseph E.; Bugeja, Lyndal; Willoughby, Melissa; Bevan, Marde; Kipsaina, Chebiwot; Young, Carmel; Pham, Tony, Monash Univ, Melbourne, Vic, Australia.
   Ranson, David L., Victorian Inst Forens Med, Melbourne, Vic, Australia.},
DOI = {10.5694/mja16.00873},
ISSN = {0025-729X},
EISSN = {1326-5377},
Keywords-Plus = {SYSTEM; HEALTH},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {Joseph.Ibrahim@monash.edu},
ORCID-Numbers = {Willoughby, Melissa/0000-0002-4360-2605
   Pham, Tony/0000-0001-5448-3288
   Bugeja, Lyndal/0000-0003-0547-710X
   Ibrahim, Joseph/0000-0003-2828-9160},
Funding-Acknowledgement = {federal Department of Social Services; Victorian Department of Health
   and Human Services (Ageing and Aged Care Branch); Department of Forensic
   Medicine, Monash University},
Funding-Text = {This work was supported by the federal Department of Social Services,
   the Victorian Department of Health and Human Services (Ageing and Aged
   Care Branch), and the Department of Forensic Medicine, Monash
   University. None of the funders influenced the design, methods, subject
   recruitment, data collection, analysis or preparation of the paper.},
Cited-References = {Australian Bureau of Statistics, 2016, AUSTR DEM STAT JUN 2.
   Australian Government, 2011, CAR OLD AUSTR.
   Australian Government Productivity Commission, REP GOV SERV 2015.
   Australian Institute of Health and Welfare, 2012, RES AG CAR AUSTR 201.
   Berry C, 2005, CLIN MED, V5, P455, DOI 10.7861/clinmedicine.5-5-455.
   Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5.
   Bugeja L, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0096-1.
   Gjertsen F, 2011, J CLIN EPIDEMIOL, V64, P1102, DOI 10.1016/j.jclinepi.2010.12.015.
   Hallberg D, 2009, EUR J AGEING, V6, P137, DOI 10.1007/s10433-009-0111-2.
   Hitchen T, 2017, AGEING SOC, V37, P1531, DOI 10.1017/S0144686X16000428.
   Ibrahim JE, 2015, J AM GERIATR SOC, V63, P954, DOI 10.1111/jgs.13377.
   Kalisch BJ, 2009, NURS OUTLOOK, V57, P3, DOI 10.1016/j.outlook.2008.05.007.
   McClure RJ, 2010, INJURY, V41, P16, DOI 10.1016/j.injury.2010.05.001.
   National Coroners Information System, 2014, DAT DICT NAT COR INF.
   Saito T, 2007, ARCH GERONTOL GERIAT, V45, P217, DOI 10.1016/j.archger.2006.11.001.
   Stoeckel KJ, 2010, J APPL GERONTOL, V29, P231, DOI 10.1177/0733464809335595.
   Swerissen H, 2014, 201410 GRATT I.
   WHO, 2010, IMPR QUAL US BIRTH D.
   World Health Organisation, 2006, INT STAT CLASS DIS R.
   World Health Organization, 2009, MOR WORDS CONC FRAM.},
Number-of-Cited-References = {20},
Times-Cited = {42},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Med. J. Aust.},
Doc-Delivery-Number = {EY2TF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000403823600009},
DA = {2022-03-29},
}

@article{ WOS:000167049100013,
Author = {Rutz, W},
Title = {Preventing suicide and premature death by education and treatment},
Journal = {JOURNAL OF AFFECTIVE DISORDERS},
Year = {2001},
Volume = {62},
Number = {1-2},
Pages = {123-129},
Month = {JAN},
Abstract = {Suicide is a leading cause of mortality. It is, in principle,
   preventable - given the fact that we possess effective treatments for
   depressive illness, the major contributor to such mortality.
   Nonetheless, complex logistic problems have prevented the institution of
   Successful suicide prevention programs. The present review summarizes
   the author's work on the island of Gotland in Sweden, where the small
   size of the population permitted the institution of an educational and
   treatment program aimed at the general medical practitioners. The
   program was successful in reducing suicide rates by 60\%. This was
   accompanied by reduction of different indices measuring depressive
   morbidity. Prevention was successful for as long as the program was
   instituted. The author provides his reflections on the public health
   implications of his data - particularly for Eastern Europe which is
   experiencing widespread stress in the workplace and in economic
   situations. More hypothetically, he presents his views on a
   serotonin-mediated `male suicide syndrome'. (C) 2001 Published by
   Elsevier Science B.V.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Rutz, W (Corresponding Author), Visby Hosp, Dept Psychiat, S-62100 Visby, Gotland, Sweden.
   Visby Hosp, Dept Psychiat, S-62100 Visby, Gotland, Sweden.},
DOI = {10.1016/S0165-0327(00)00356-6},
ISSN = {0165-0327},
EISSN = {1573-2517},
Keywords = {suicide prevention; premature death; education; treatment},
Keywords-Plus = {GENERAL-PRACTITIONERS; ANTIDEPRESSANTS; DEPRESSION},
Research-Areas = {Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Clinical Neurology; Psychiatry},
Author-Email = {wolfgang.rutz@gotland.se},
Cited-References = {BODLUND O, 1998, IMPROVEMENT GP ABILI.
   GOODWIL FK, 1990, BASIC DEPRESSIVE ILL.
   HAGNELL O, 1982, PSYCHOL MED, V12, P279, DOI 10.1017/S0033291700046614.
   HAGNELL O, 1990, INCIDENCE MENTAL ILL.
   ISACSSON G, 1994, BRIT MED J, V308, P506, DOI 10.1136/bmj.308.6927.506.
   Isacsson G, 1996, J AFFECT DISORDERS, V41, P1, DOI 10.1016/0165-0327(96)00050-X.
   JAKUBASCHK J, 1994, NERVENARZT, V65, P590.
   KHURI R, 1983, PSYCHIAT CLIN N AM, V6, P193.
   LAAKMAN G, 1996, REDUCED CSF 5 HAT ST.
   Martensson B, 1996, NORD J PSYCHIAT, V50, P443, DOI 10.3109/08039489609082512.
   PRIEST RG, 1944, BRIT MED J, V164, P265.
   Rihmer Z, 1998, PSYCHIAT RES, V81, P233, DOI 10.1016/S0165-1781(98)00106-1.
   RIHMER Z, 1990, J AFFECT DISORDERS, V20, P87, DOI 10.1016/0165-0327(90)90121-N.
   RIHMER Z, 1996, STRATEGIES SUICIDE P.
   RIHMER Z, 1996, 8 C AEP LOND.
   ROBINS E, 1986, FINAL MONTHS STUDY L.
   RUTZ W, 1995, LANCET, V345, P524, DOI 10.1016/S0140-6736(95)90622-3.
   Rutz W, 1997, Int J Psychiatry Clin Pract, V1, P39, DOI 10.3109/13651509709069204.
   Rutz W, 1996, NORD J PSYCHIAT, V50, P61, DOI 10.3109/08039489609099732.
   Rutz W, 1999, INT CLIN PSYCHOPHARM, V14, pS27, DOI 10.1097/00004850-199906003-00005.
   RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P457, DOI 10.1111/j.1600-0447.1992.tb03212.x.
   Rutz W., 1995, PRIMARY CARE PSYCHIA, V1, P59.
   RUTZ W, 1992, THESIS LINKONING U M.
   RUTZ W, 1999, STRESSUTLOST KONTISA.
   RUTZ W, 1998, INT J METHODS PSYCH, V6.
   TRASKMANBENDZ L, 1998, CHOLESTEROL BIOL SUI.
   TYLEE AT, 1993, BRIT J GEN PRACT, V43, P327.
   VANPRAAG HM, 1991, PSYCHOL MED, V21, P15, DOI 10.1017/S0033291700014604.
   {*}WHO REP FOR EUR, 1999, STAT DAT.
   {*}WHO REP OFF EUR, 1998, HLTH 21 HLTH ALL 21.},
Number-of-Cited-References = {30},
Times-Cited = {93},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Affect. Disord.},
Doc-Delivery-Number = {403NJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000167049100013},
DA = {2022-03-29},
}

@article{ WOS:A1996UA74200018,
Author = {Sagot, Y and Tan, SA and Hammang, JP and Aebischer, P and Kato, AC},
Title = {GDNF slows loss of motoneurons but not axonal degeneration or premature
   death of pmn/pmn mice},
Journal = {JOURNAL OF NEUROSCIENCE},
Year = {1996},
Volume = {16},
Number = {7},
Pages = {2335-2341},
Month = {APR 1},
Abstract = {Glial cell line-derived neurotrophic factor (GDNF), a member of the
   TGF-beta superfamily, has been shown to be a highly potent neurotrophic
   factor that enhances survival of various neuronal cell types including
   motoneurons. To assess its therapeutic potential in treating
   neurodegenerative diseases such as amyotrophic lateral sclerosis, we
   treated mutant mice displaying motoneuron degeneration (progressive
   motor neuropathy; pmn) with encapsulated GDNF-secreting cells. Effects
   of GDNF treatment on pmn/pmn mice were compared with previous results
   obtained with ciliary neurotrophic factor (CNTF) {[}Sagot Y, Tan SA,
   Baetge E, Schmalbruch H, Kato AC, Aebischer P (1995) Eur J Neurosci
   7:1313-1322].
   In contrast to CNTF, GDNF did not increase the lifespan of pmn/pmn mice.
   However, GDNF significantly reduced the loss of facial motoneurons by
   50\%, a value similar to what was observed when CNTF was administered to
   the pmn/pmn mice. Surprisingly, myelinated axon counts revealed that
   GDNF had no effect on nerve degeneration. Therefore, despite its
   potential in rescuing motoneuron cell bodies, the inability of GDNF to
   prevent nerve degeneration in pmn/pmn mice suggests that its usefulness
   in the treatment of motor neuron diseases may be restricted to
   cotreatment with other factors that act on the nerve process.},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513},
Type = {Article},
Language = {English},
Affiliation = {UNIV GENEVA,DIV CLIN NEUROMUSCULAR RES,CH-1211 GENEVA 4,SWITZERLAND.
   UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND.
   UNIV LAUSANNE,GENE THERAPY CTR,CH-1011 LAUSANNE,SWITZERLAND.
   UNIV LAUSANNE,DIV SURG RES,CH-1011 LAUSANNE,SWITZERLAND.
   CYTOTHERAPEUT INC,PROVIDENCE,RI 02906.},
ISSN = {0270-6474},
Keywords = {pmn/pmn mice; progressive motor neuronopathy; GDNF; motor neurons;
   neurodegenerative disease; encapsulated cell line},
Keywords-Plus = {PROGRESSIVE MOTOR NEURONOPATHY; CILIARY NEUROTROPHIC FACTOR; MOUSE
   MUTANT; NEURONS; CELLS},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
ResearcherID-Numbers = {Aebischer, Patrick/E-1387-2013},
Cited-References = {AEBISCHER P, 1991, EXP NEUROL, V111, P269, DOI 10.1016/0014-4886(91)90093-R.
   AEBISCHER P, 1994, TRANSPLANTATION, V58, P1275, DOI 10.1097/00007890-199412150-00025.
   ALLSOPP TE, 1995, EUR J NEUROSCI, V7, P1266, DOI 10.1111/j.1460-9568.1995.tb01116.x.
   ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N.
   BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331.
   CHU G, 1981, GENE, V13, P197, DOI 10.1016/0378-1119(81)90008-1.
   EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217.
   FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776.
   GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992.
   HAYES V, 1991, DEV BRAIN RES, V62, P159, DOI 10.1016/0165-3806(91)90163-D.
   HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109.
   HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9.
   HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664.
   HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O.
   KATO AC, 1994, EXP NEUROL, V130, P196, DOI 10.1006/exnr.1994.1198.
   KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P.
   KWON YW, 1994, NEUROREPORT, V5, P789, DOI 10.1097/00001756-199403000-00013.
   LEWIS ME, 1993, EXP NEUROL, V124, P73, DOI 10.1006/exnr.1993.1177.
   LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771.
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557.
   LIN LFH, 1994, J NEUROCHEM, V63, P758.
   LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X.
   MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T.
   MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451.
   OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0.
   PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599.
   SAGEN J, 1993, J NEUROSCI, V13, P2415, DOI 10.1523/JNEUROSCI.13-06-02415.1993.
   SAGOT Y, 1995, EUR J NEUROSCI, V7, P1313, DOI 10.1111/j.1460-9568.1995.tb01122.x.
   SAGOT Y, 1995, J NEUROSCI, V15, P7727.
   SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002.
   SEARLE PF, 1985, MOL CELL BIOL, V5, P1480, DOI 10.1128/MCB.5.6.1480.
   SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0.
   TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0.
   TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137.
   WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x.
   YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0.
   ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030.
   ZURN AD, 1996, IN PRESS J NEUROSCI.},
Number-of-Cited-References = {38},
Times-Cited = {121},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Neurosci.},
Doc-Delivery-Number = {UA742},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1996UA74200018},
DA = {2022-03-29},
}

@article{ WOS:000532015400001,
Author = {Gilderbloom, John Hans and Meares, Wesley L. and Squires, Gregory D.},
Title = {Pollution, place, and premature death: evidence from a mid-sized city},
Journal = {LOCAL ENVIRONMENT},
Year = {2020},
Volume = {25},
Number = {6},
Pages = {419-432},
Month = {JUN 2},
Abstract = {Neighborhood life expectancy varies by as much as 10 years across the
   City of Louisville. In 2013, the Greater Louisville Project funded by
   local government, businesses, and foundations, argued these differences
   had little to do with environmental factors. The Greater Louisville
   Project (2013) study argued that these neighborhood differences could be
   attributed 40\% to socio-economic factors (with a major emphasis on
   education), 10\% to physical environment, 30\% to health behaviors, and
   20\% to access to medical care. To test these claims, we construct our
   own model of neighborhood variation in years of potential life lost
   (YPLL) by adding two variables testing environmental degradation. We
   operationalise two separate measures of environmental contamination:
   proximity to EPA designated brownfield sites and proximity to chemical
   factories in an industrial park in the neighborhood known as
   ``Rubbertown{''}. We conduct several regression analyses, which show a
   relationship between proximity to environmental contaminants and an
   increase in neighborhood YPLL. Our beta weights challenge the claims
   made by the Greater Louisville Project, which minimize the impact
   nearness to environmental contaminants has on reductions in life
   expectancy in Louisville neighborhoods.},
Publisher = {ROUTLEDGE JOURNALS, TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Gilderbloom, JH (Corresponding Author), Univ Louisville, Washington DC Urban \& Publ Affairs, Neighborhood Associates Corp, 426 West Bloom St, Louisville, KY 40208 USA.
   Gilderbloom, John Hans, Neighborhood Associates Corp, Washington, DC USA.
   Gilderbloom, John Hans, Univ Louisville, Urban \& Publ Affairs, Louisville, KY 40208 USA.
   Meares, Wesley L., Augusta Univ, Polit Sci \& Publ Adm, Augusta, GA USA.
   Squires, Gregory D., George Washington Univ, Sociol \& Publ Policy \& Publ Adm, Washington, DC USA.},
DOI = {10.1080/13549839.2020.1754776},
EarlyAccessDate = {APR 2020},
ISSN = {1354-9839},
EISSN = {1469-6711},
Keywords = {Environmental justice; lifespan; Inequality},
Keywords-Plus = {FUTURE; INCOME},
Research-Areas = {Science \& Technology - Other Topics; Environmental Sciences \& Ecology;
   Geography; Public Administration; Urban Studies},
Web-of-Science-Categories  = {Green \& Sustainable Science \& Technology; Environmental Studies;
   Geography; Regional \& Urban Planning; Urban Studies},
Author-Email = {jigild01@louisville.edu},
Cited-References = {Agyeman J., 2013, INTRO JUST SUSTAINAB.
   {[}Anonymous], 2013, LANCET, V382, P1000, DOI 10.1016/S0140-6736(13)61960-1.
   Appelbaum R. P., 1978, SIZE GROWTH US CITIE.
   Banzhaf S., 2012, SUPERFUND TAINT MARK.
   Barnett R., 2011, ENV ISSUES LOUISVILL.
   Beck-Lewis M. S., 1993, INT HDB QUANTITATIVE.
   Beck-Lewis M. S., 1980, APPL REGRESSION.
   Been V, 1995, J LAND USE ENV L, V11, P1.
   Bullard R. D., 1990, DUMPING DIXIE RACE C, V3.
   Bullard R. D., 2000, DUMPING DIXIE RACE C.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Dannenberg A. L., 2011, MARKING HLTH PLACES.
   Environmental Protection Agency, 2013, SUP SIT REG 4.
   Environmental Protection Agency, 2012, FAC REG SYST STAT CS.
   Environmental Protection Agency, 2011, THIS IS SUP COMM GUI.
   Frederick C, 2019, SOC SCI MED, V232, P148, DOI 10.1016/j.socscimed.2019.04.047.
   Frederick C, 2018, LOCAL ENVIRON, V23, P54, DOI 10.1080/13549839.2017.1385001.
   Gilderbloom JI, 2019, J URBAN HIST, V45, P630, DOI 10.1177/0096144218764406.
   Gilderbloom J. I., 2008, INVISIBLE CITY HOUSI.
   Gilderbloom J. I., 2016, NY TIMES.
   Gilderbloom J. I., 1988, RETHINKING RENTAL HO.
   Gilderbloom J, 2016, LOCAL ENVIRON, V21, P653, DOI 10.1080/13549839.2015.1005467.
   Gilderbloom John, 2020, WHAT CITIES ARE MOST.
   Gilderbloom JI, 2015, CITIES, V42, P13, DOI 10.1016/j.cities.2014.08.001.
   Gilderbloom JI, 2012, J URBAN AFF, V34, P559, DOI 10.1111/j.1467-9906.2012.00619.x.
   Gilderbloom JI, 2009, LOCAL ENVIRON, V14, P473, DOI 10.1080/13549830902903799.
   Gilderbloom JI, 2017, LOCAL ENVIRON, V22, P894, DOI 10.1080/13549839.2017.1278751.
   Gilderblooom J.I., 2014, J URBANISM INT RES P, V9, P1, DOI DOI 10.1080/17549175.2014.905488.
   Greater Louisville Project, 2013, BUILD HLTH LOUISV.
   HAMILTON JT, 1995, J POLICY ANAL MANAG, V14, P107, DOI 10.2307/3325435.
   Hipp JR, 2010, HEALTH PLACE, V16, P674, DOI 10.1016/j.healthplace.2010.02.005.
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V311, P1486, DOI 10.1001/jama.2014.4031.
   Massey D., 2004, DU BOIS REV, V1, P7, DOI DOI 10.1017/S1742058X04040032.
   McMeekin I. M., 1946, LOUISVILLE GATEWAY C.
   Moyer B., 2001, TRADE SECRETS MOYERS.
   Organisation for Economic Co-operation and Development, 2012, ENV OUTL 2050 CONS I.
   Pahl R.E, 1975, WHOSE CITY.
   Pastor M, 2001, J URBAN AFF, V23, P1, DOI 10.1111/0735-2166.00072.
   Physicians for Social Responsibility, WEBS SLOG.
   Richardson T., 1998, THESIS.
   Schmid T.L., 2003, HLTH COMMUNITY DESIG.
   Smith CL, 2009, SOC SCI RES, V38, P681, DOI 10.1016/j.ssresearch.2009.03.005.
   Smith P., 2011, LOUISVILLE METROHEAL.
   Swanston S. F., 2012, J CIVIL RIGHTS EC DE, V9, P18.
   United States Census Bureau, 2012, AM COMMUNITY SURVEY.
   Wong Edward., 2013, NEW YORK TIMES.
   {[}No title captured].
   {[}No title captured].},
Number-of-Cited-References = {48},
Times-Cited = {5},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Local Environ.},
Doc-Delivery-Number = {LT4AJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000532015400001},
DA = {2022-03-29},
}

@article{ WOS:000354547200007,
Author = {Tyner, James A.},
Title = {Population geography II: Mortality, premature death, and the ordering of
   life},
Journal = {PROGRESS IN HUMAN GEOGRAPHY},
Year = {2015},
Volume = {39},
Number = {3},
Pages = {360-373},
Month = {JUN},
Abstract = {The geographic study of mortality is enjoying a renaissance. This is
   indicated by the growing number of studies on necropolitics,
   thanatopolitics, deathscapes', and the inequalities of premature death.
   Population geographers, however, have contributed little to the broader
   theoretical conceptualization - and spatiality - of mortality.
   Previously, I encouraged population geographers to reflect on the
   survivability of vulnerable populations. In this second progress report,
   I extend this focus through a reconsideration of mortality from the
   standpoint of survivability. As a discipline, population geography has
   long engaged with the concept of premature' death; here it is indicated
   how this concept is intimately bound to the modernist ordering of life
   that dominates our contemporary understanding of bodies and populations.
   First, I reflect on the embodiment of mortality, and this is followed by
   a critical engagement with the bio-logics' of life and death. I maintain
   that population geography is well positioned to contribute to ongoing
   debates regarding who lives, who dies, and who decides.},
Publisher = {SAGE PUBLICATIONS LTD},
Address = {1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Tyner, JA (Corresponding Author), Kent State Univ, Dept Geog, Kent, OH 44242 USA.
   Tyner, James A., Kent State Univ, Kent, OH 44242 USA.},
DOI = {10.1177/0309132514527037},
ISSN = {0309-1325},
EISSN = {1477-0288},
Keywords = {body; mortality; necropolitics; premature death},
Keywords-Plus = {CHINESE BURIAL GROUNDS; POLITICS; BODY; BIOPOLITICS; SPACE;
   PERSPECTIVES; BIOPOWER; FUTURE},
Research-Areas = {Geography},
Web-of-Science-Categories  = {Geography},
Author-Email = {jtyner@kent.edu},
Cited-References = {Ailio J, 2013, ALTERNATIVES, V38, P256, DOI 10.1177/0304375413497847.
   ALEXANDER M, 1980, HASTINGS CENT REP, V10, P25, DOI 10.2307/3560926.
   Anderson B, 2012, T I BRIT GEOGR, V37, P28, DOI 10.1111/j.1475-5661.2011.00441.x.
   Badmington N, 2004, ENVIRON PLANN A, V36, P1344.
   Bayatrizi Zohreh, 2008, LIFE SENTENCES MODER.
   Billingsley S, 2011, POPUL SPACE PLACE, V17, P267, DOI 10.1002/psp.660.
   Blackman Lisa., 2008, BODY KEY CONCEPTS.
   Boyle P, 2004, PROG HUM GEOG, V28, P767, DOI 10.1191/0309132504ph518pr.
   Braun B, 2007, CULT GEOGR, V14, P6, DOI 10.1177/1474474007072817.
   Cadman L, 2009, ANTIPODE, V41, P133, DOI 10.1111/j.1467-8330.2008.00659.x.
   Caldwell JC, 2001, ANN NY ACAD SCI, V954, P19, DOI 10.1111/j.1749-6632.2001.tb02744.x.
   Castree N, 2005, ANTIPODE, V37, P1, DOI 10.1111/j.0066-4812.2005.00469.x.
   Castree N, 2006, SOC CULT GEOGR, V7, P501, DOI 10.1080/14649360600825620.
   Coleman M, 2009, ENVIRON PLANN D, V27, P489, DOI 10.1068/d3508.
   Colls R, 2014, PROG HUM GEOG, V38, P733, DOI 10.1177/0309132513500373.
   Crampton JW, 2006, SOC CULT GEOGR, V7, P681, DOI 10.1080/14649360600971168.
   Crippen, 2008, END OF LIFE COMMUNIC, P65.
   de Sherbinin A, 2011, POPUL SPACE PLACE, V17, P27, DOI 10.1002/psp.599.
   Dorling D, 2010, GEOGR J, V176, P186, DOI 10.1111/j.1475-4959.2010.00373.x.
   Fassin D, 2009, THEOR CULT SOC, V26, P44, DOI 10.1177/0263276409106349.
   FINDLAY AM, 1993, PROG HUM GEOG, V17, P73, DOI 10.1177/030913259301700105.
   FOUCAULT, 1994, ORDER THINGS ARCHAEO.
   Foucault M., 2007, SECURITY TERRITORY P.
   Foucault M., 1990, HIST SEXUALITY.
   Foucault Michel, 1995, DISCIPLINE PUNISH BI.
   FRANCAVIGLIA RV, 1971, ANN ASSOC AM GEOGR, V61, P501, DOI 10.1111/j.1467-8306.1971.tb00802.x.
   Frank AW, 2004, HASTINGS CENT REP, V34, P18, DOI 10.2307/3527682.
   Fregonese S, 2009, POLIT GEOGR, V28, P309, DOI 10.1016/j.polgeo.2009.07.005.
   Fry-Revere Sigrid, 2010, J Contemp Health Law Policy, V27, P1.
   Ghosn W, 2013, EUR J PUBLIC HEALTH, V23, P834, DOI 10.1093/eurpub/cks078.
   Giacomini M, 1997, SOC SCI MED, V44, P1465, DOI 10.1016/S0277-9536(96)00266-3.
   Gilmore RW, 2002, PROF GEOGR, V54, P15, DOI 10.1111/0033-0124.00310.
   GOBER P, 1994, ANN ASSOC AM GEOGR, V84, P230, DOI 10.1111/j.1467-8306.1994.tb01736.x.
   Graham S., 2004, CITIES WAR TERRORISM.
   Graham S., 2008, CITY, V12, P25.
   Hannah MG, 2011, ANTIPODE, V43, P1034, DOI 10.1111/j.1467-8330.2010.00840.x.
   Harrison P, 2008, ENVIRON PLANN A, V40, P423, DOI 10.1068/a391.
   Hewitt K, 2009, ACME, V8, P340.
   Hoeyer K, 2009, BIOSOCIETIES, V4, P239, DOI 10.1017/S1745855209990159.
   Hyndman J, 2007, PROF GEOGR, V59, P35, DOI 10.1111/j.1467-9272.2007.00589.x.
   Kaufman SR, 2005, ANNU REV ANTHROPOL, V34, P317, DOI 10.1146/annurev.anthro.34.081804.120452.
   KNIFFEN F, 1967, GEOGR REV, V57, P426.
   Kong L., 1999, AUSTR GEOGRAPHICAL S, V37, P1, DOI DOI 10.1111/1467-8470.00061.
   Law J., 2004, BODY SOC, V10, P43, DOI {[}10.1177/1357034X04042932, DOI 10.1177/1357034X04042932].
   Legg S, 2005, POPUL SPACE PLACE, V11, P137, DOI 10.1002/psp.357.
   Lock M, 2004, BODY SOC, V10, P135, DOI DOI 10.1177/1357034X04042940.
   Maddrell A, 2010, DEATHSCAPES: SPACES FOR DEATH, DYING, MOURNING AND REMEMBRANCE, P1.
   McIntyre M, 2011, ANTIPODE, V43, P1465, DOI 10.1111/j.1467-8330.2011.00906.x.
   McMahan J., 2002, ETHICS KILLING PROBL.
   Murray S. J, 2008, COMMUNICATION CRITIC, V5, P203, DOI DOI 10.1080/14791420802024350.
   Norman P, 2011, SOC SCI MED, V73, P1575, DOI 10.1016/j.socscimed.2011.09.034.
   Orbach S., 2009, BODIES.
   Philo C, 2005, POPUL SPACE PLACE, V11, P325, DOI 10.1002/psp.369.
   Philo C, 2000, AREA, V32, P11, DOI 10.1111/j.1475-4762.2000.tb00110.x.
   PHILO C, 2001, INT J POPULATION GEO, V7, P473, DOI DOI 10.1002/IJPG.243.
   Philo C, 2012, T I BRIT GEOGR, V37, P496, DOI 10.1111/j.1475-5661.2011.00484.x.
   Philo C, 2012, HIST PSYCHIATR, V23, P91, DOI 10.1177/0957154X11428931.
   Pile Steve., 1998, PLACES BODY, P42.
   Popham F, 2011, HEALTH PLACE, V17, P1212, DOI 10.1016/j.healthplace.2011.08.004.
   Powner DJ, 1996, LANCET, V348, P1219, DOI 10.1016/S0140-6736(96)04015-9.
   Ramadan A, 2009, POLIT GEOGR, V28, P153, DOI 10.1016/j.polgeo.2009.02.004.
   Roberts EFS, 2011, BODY SOC, V17, P1, DOI 10.1177/1357034X11400925.
   Romanillos JL, 2011, ENVIRON PLANN A, V43, P2533, DOI 10.1068/a4474.
   Rose, 1993, FEMINISM GEOGRAPHY L.
   Rose, 2007, POLITICS LIFE ITSELF.
   Rose G., 2003, USING SOCIAL THEORY, P47.
   Rutherford P, 2013, GEOGR COMPASS, V7, P412, DOI 10.1111/gec3.12046.
   Rutherford S, 2013, GEOGR COMPASS, V7, P423, DOI 10.1111/gec3.12047.
   Scheper-Hughe N, 2008, GLOBAL ASSEMBLAGES T, P145.
   Scheper-Hughes Nancy, 2003, J HUMAN RIGHTS, V2, P197, DOI DOI 10.1080/1475483032000078189.
   Schlosser K, 2008, GEOGR COMPASS, V2, P1621, DOI 10.1111/j.1749-8198.2008.00163.x.
   Sharp L, 2006, STRANGE HARVEST ORGA.
   Sharp LA, 2000, ANNU REV ANTHROPOL, V29, P287, DOI 10.1146/annurev.anthro.29.1.287.
   Storeygard A, 2008, POPUL SPACE PLACE, V14, P209, DOI 10.1002/psp.484.
   Teather EK, 2001, SOC CULT GEOGR, V2, P185, DOI DOI 10.1080/14649360120047805.
   Tyner JA, 2014, GEOFORUM, V52, P70, DOI 10.1016/j.geoforum.2013.12.011.
   Tyner JA, 2013, PROG HUM GEOG, V37, P701, DOI 10.1177/0309132512473924.
   Whittaker A., 2008, Global Public Health, V3, P271, DOI 10.1080/17441690701463936.
   Widdows H, 2011, BIOETHICS, V25, P83, DOI 10.1111/j.1467-8519.2010.01868.x.
   Wylie J, 2009, T I BRIT GEOGR, V34, P275, DOI 10.1111/j.1475-5661.2009.00351.x.
   YEOH BSA, 1991, J SOUTHE ASIAN STUD, V22, P282, DOI 10.1017/S0022463400003891.
   YEOH BSA, 1995, J HIST GEOGR, V21, P184, DOI 10.1016/0305-7488(95)90035-7.
   Young C, 2013, T I BRIT GEOGR, V38, P135, DOI 10.1111/j.1475-5661.2012.00502.x.
   ZELINSKY W, 1994, PROF GEOGR, V46, P29, DOI 10.1111/j.0033-0124.1994.00029.x.},
Number-of-Cited-References = {84},
Times-Cited = {18},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {24},
Journal-ISO = {Prog. Hum. Geogr.},
Doc-Delivery-Number = {CI2AQ},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000354547200007},
DA = {2022-03-29},
}

@article{ WOS:000330244500216,
Author = {Albanese, Emiliano and Strand, Bjorn Heine and Guralnik, Jack M. and
   Patel, Kushang V. and Kuh, Diana and Hardy, Rebecca},
Title = {Weight Loss and Premature Death: The 1946 British Birth Cohort Study},
Journal = {PLOS ONE},
Year = {2014},
Volume = {9},
Number = {1},
Month = {JAN 21},
Abstract = {Objective: The relationship between weight loss and mortality has
   important clinical and public health significance but has proved to be
   complex. Evidence is mixed and particularly limited on the association
   between weight loss in mid-life and premature death (i.e. before 65
   years of age), a small albeit important segment of total mortality. We
   aimed to study the association between midlife weight change and
   mortality accounting for health and lifestyle characteristics, and also
   considering potential bias due to preexisting chronic diseases and
   smoking status.
   Design: Longitudinal, population-based, `the 1946 British' birth cohort
   study.
   Subjects and Measures: In 2750 men and women, mortality from age 53
   through 65 years was analyzed according to categories of measured 10
   year weight change between 43 and 53 years. Cox's hazard ratios (HR)
   were progressively adjusted for socio-demographic, lifestyle and health
   characteristics.
   Results: Nearly 20\% of participants lost weight and over 50\% gained 5
   kg or more in midlife. There were 164 deaths. Compared to those who
   gained between 2 and 5 kg, those who lost 5 kg or more had an increased
   risk of premature death independently of midlife physical activity,
   socio-economic circumstances and educational attainment. This
   association was unaltered when highest weight loss (lost more than 15
   Kg) (p = 0.04) and early deaths were excluded (p<0.001), but was no
   longer significant after adjustment for cardiovascular risk factors and
   health status (HR = 1.8; 95\% CI: 0.9 to 3.5).
   Conclusion: The inverse association between weight loss in midlife and
   higher risk of premature death may be explained by vascular risk factors
   and ill health. In consideration of the burden of premature death,
   closer monitoring of weight loss in mid-life is warranted.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Albanese, E (Corresponding Author), NIA, Lab Populat Sci, Bethesda, MD 20892 USA.
   Albanese, Emiliano, NIA, Lab Populat Sci, Bethesda, MD 20892 USA.
   Strand, Bjorn Heine, Norwegian Inst Publ Hlth, Oslo, Norway.
   Guralnik, Jack M., Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   Patel, Kushang V., Univ Washington, Dept Anesthesiol \& Pain Med, Seattle, WA 98195 USA.
   Kuh, Diana; Hardy, Rebecca, UCL, MRC Unit Lifelong Hlth \& Ageing, London, England.},
DOI = {10.1371/journal.pone.0086282},
Article-Number = {e86282},
ISSN = {1932-6203},
Keywords-Plus = {ALL-CAUSE MORTALITY; BODY-MASS INDEX; OLDER-ADULTS; ASSOCIATION; AGE;
   DISEASE; RISK; OVERWEIGHT; WOMEN; MEN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {emiliano.albanese@gmail.com},
ResearcherID-Numbers = {Kuh, Diana/L-6019-2014
   Hardy, Rebecca/AFR-1989-2022
   Strand, Bjørn/AAV-7948-2021
   },
ORCID-Numbers = {Kuh, Diana/0000-0001-7386-2857
   Strand, Bjørn/0000-0003-4385-8886
   Hardy, Rebecca/0000-0001-9949-0799},
Funding-Acknowledgement = {MRC Unit for Lifelong Health and Ageing, UK; National Institute on
   Aging, National Institutes of HealthUnited States Department of Health
   \& Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA); Medical Research CouncilUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC)European Commission
   {[}MC\_UU\_12019/1, MC\_UU\_12019/2] Funding Source: researchfish; MRCUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MC\_UU\_12019/2, MC\_UU\_12019/1] Funding Source: UKRI},
Funding-Text = {The NSHD study is funded by the MRC Unit for Lifelong Health and Ageing,
   UK and was supported in part by the Intramural Research Program of the
   National Institute on Aging, National Institutes of Health. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.},
Cited-References = {Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875.
   Arnold AM, 2010, J GERONTOL A-BIOL, V65, P63, DOI 10.1093/gerona/glp050.
   Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212.
   Committee E, 1972, BURNH FURTH ED COMM.
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367.
   Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623.
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5.
   Flegal KM, 2010, AM J EPIDEMIOLOGY.
   Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035.
   Harris TB, 1997, BMJ-BRIT MED J, V314, P1791, DOI 10.1136/bmj.314.7097.1791.
   HMSO, 1970, SURV OOPCA CLASS OCC.
   IRIBARREN C, 1995, NEW ENGL J MED, V333, P686, DOI 10.1056/NEJM199509143331102.
   Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594.
   Knudtson MD, 2005, ANN EPIDEMIOL, V15, P483, DOI 10.1016/j.annepidem.2004.12.003.
   Kolata G, 2007, NY TIMES.
   Kuh D, 2009, SOC SCI MED, V68, P1565, DOI 10.1016/j.socscimed.2009.02.006.
   LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602.
   LOSONCZY KG, 1995, AM J EPIDEMIOL, V141, P312, DOI 10.1093/aje/141.4.312.
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101.
   Maru S, 2004, AM J CLIN NUTR, V80, P231.
   Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325.
   Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710.
   Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x.
   Nilsson G, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000012.
   Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x.
   Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9.
   Sorensen T I A, 2003, Obes Rev, V4, P3, DOI 10.1046/j.1467-789X.2003.00090.x.
   Stampfer M, 2005, PLOS MED, V2, P476, DOI 10.1371/journal.pmed.0020181.
   Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.
   Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035.
   Wedick NM, 2002, J AM GERIATR SOC, V50, P1810, DOI 10.1046/j.1532-5415.2002.50509.x.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.
   Wilsgaard T, 2009, GENDER MED, V6, P575, DOI 10.1016/j.genm.2009.12.003.
   Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680.},
Number-of-Cited-References = {35},
Times-Cited = {7},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {297GT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000330244500216},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000753597600001,
Author = {Goffe, Rachel},
Title = {Reproducing the Plot: Making Life in the Shadow of Premature Death},
Journal = {ANTIPODE},
Abstract = {A protracted process of policy development has been underway in Jamaica
   to curtail the widespread incidence of informal settlements. Against the
   logic of emerging policy, this article aims to reconnect present-time
   unauthorised use of space to ancestral refusals of plantation land
   monopoly. Through ethnographic research and a reconsideration of
   historical texts, the article situates insecure tenure in a long history
   of conflict over land and livelihood-conflict that produces a boundary
   around the authorised use of space. That boundary is porous and mobile,
   the outcome of a palimpsest of colonial violence and its negation. This
   argument interrogates the gap between ``landless{''} and
   ``ownershipless{''}, revealing both the role of incomplete dispossession
   in racialised social reproduction and the spatial practices through
   which Jamaicans ``make life{''} even in the shadow of premature death.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Goffe, R (Corresponding Author), Univ Toronto, Dept Geog \& Planning, Toronto, ON, Canada.
   Goffe, R (Corresponding Author), Univ Toronto Scarborough, Dept Human Geog, Toronto, ON, Canada.
   Goffe, Rachel, Univ Toronto, Dept Geog \& Planning, Toronto, ON, Canada.
   Goffe, Rachel, Univ Toronto Scarborough, Dept Human Geog, Toronto, ON, Canada.},
DOI = {10.1111/anti.12812},
EarlyAccessDate = {FEB 2022},
ISSN = {0066-4812},
EISSN = {1467-8330},
Keywords = {social reproduction; insecure land tenure; Black geographies; Caribbean
   Studies; dispossession},
Keywords-Plus = {SOCIAL REPRODUCTION; PLANTATIONS},
Research-Areas = {Geography},
Web-of-Science-Categories  = {Geography},
Author-Email = {rachel.goffe@utoronto.ca},
Cited-References = {Alexander M.J., 2006, PEDAGOGIES CROSSING.
   Anderson CM, 2021, ANTIPODE, DOI 10.1111/anti.12788.
   Besson J., 2002, M BRAES 2 HIST EUROP.
   Brereton B., 1999, COLONIAL CARIBBEAN T, P77.
   Brooks S., 2009, THESIS LONDON UNPUB.
   Carney J, 2008, FOOD FOODWAYS, V16, P127, DOI 10.1080/07409710802085999.
   Crichlow MA., 2005, NEGOTIATING CARIBBEA.
   Crichlow MA, 1988, THESIS STATE U UNPUB.
   Cummings R, 2018, SMALL AXE, V22, P47, DOI 10.1215/07990537-7249126.
   Davis G., 2001, JAMAICA GLEANER.
   Dunkley A., 2008, JAMAICA OBSERVER.
   Edwards B., 1793, HIST CIVIL COMMERCIA.
   Gidwani V., 2014, ECON POLIT WEEKLY, V49, P40.
   Gilmore R.W., 2007, GOLDEN GULAG PRISONS.
   Gilmore RW, 2008, GLOB AREA INT ARCH, V6, P31.
   Giusti-Cordero J., 1994, LABOR ECOLOGY HIST C.
   Goffe R, 2017, THESIS GRADUAT UNPUB.
   GoJ, 2008, RAP SQUATT ASS.
   GoJ, 2004, NAT SQUATT SURV.
   GoJ (Government of Jamaica), GUID DEAL INF SETTL.
   Goodison L, 2004, CONTROLLING SILVER.
   Hall Catherine, 2002, CIVILISING SUBJECTS.
   Hall Douglas, 1959, FREE JAMAICA 1838 18.
   Higman BW., 2005, PLANTATION JAMAICA 1.
   Holt Thomas C, 1992, PROBLEM FREEDOM RACE.
   J amaica Information Service, 2008, GOVT AD ZER TOL APPR.
   Katz C, 2001, ANTIPODE, V33, P709, DOI 10.1111/1467-8330.00207.
   Katz C, 2001, SIGNS, V26, P1213, DOI 10.1086/495653.
   Lee M., 2007, POLICY PLAN MANAGING.
   Lewis Jovan., 2020, SCAMMERS YARD CRIME.
   Lubin A., 2017, FUTURES BLACK RADICA, P225.
   Luthra A, 2021, ANTIPODE, DOI 10.1111/anti.12784.
   Marshall W., 1972, Caribbean Quarterly, V18, P30.
   McKittrick K., 2006, DEMONIC GROUNDS BLAC.
   Mckittrick K, 2014, BLACK SCHOLAR, V44, P16, DOI 10.1080/00064246.2014.11413684.
   McKittrick K, 2013, SMALL AXE, V17, P1, DOI 10.1215/07990537-2378892.
   McKittrick K, 2011, SOC CULT GEOGR, V12, P947, DOI 10.1080/14649365.2011.624280.
   Mintz Sidney W., 1985, SWEETNESS POWER PLAC.
   Mintz SW., 1960, YALE U PUBLICATIONS, V57.
   Mintz SW., 1958, W INDISCHE GIDS, V38, P46.
   Mitchell K, 2003, ANTIPODE, V35, P415, DOI 10.1111/1467-8330.00333.
   Mullings B, 2021, GEOFORUM, V118, P150, DOI 10.1016/j.geoforum.2020.11.007.
   Mullings B, 2009, SINGAPORE J TROP GEO, V30, P174, DOI 10.1111/j.1467-9493.2009.00363.x.
   Newton MJ, 2013, SMALL AXE, V17, P108, DOI 10.1215/07990537-2323346.
   Paton D., 2001, RECLAIMING POLITICAL, P175.
   Paton Diana, 2004, NO BOND LAW PUNISHME.
   Posmentier S, 2017, CALLAL AFR DIASP SER, P1.
   Post K., 1978, ARISE YE STARVELINGS.
   Robotham D., 1981, 28 I SOC EC RES U W.
   Rodney W., 1981, HIST GUYANESE WORKIN.
   Roy A, 2005, J AM PLANN ASSOC, V71, P147, DOI 10.1080/01944360508976689.
   Satchell V., 1990, PLOTS PLANTATIONS LA.
   Scott J.C., 1998, SEEING STATE CERTAIN.
   Sheridan R., 1995, STRATEGIES SLAVE SUB.
   Stephens EH., 1986, DEMOCRATIC SOCIALISM.
   Thomas DA, 2016, ANTHROPOL THEOR, V16, P177, DOI 10.1177/1463499616636269.
   Tindigarukayo J, 2004, ENVIRON URBAN, V16, P199, DOI 10.1177/095624780401600116.
   Tomich D, 2015, CAMB IMP POST-COL ST, P184.
   Trotz A., 2020, POINT IS CHANGE WORL, P152.
   Trotz DA, 2010, INTERVENTIONS-UK, V12, P112, DOI 10.1080/13698010903553385.
   Weis T, 2006, J PEASANT STUD, V33, P61, DOI 10.1080/03066150600624496.
   Werner M, 2016, ANTIPODE BOOK SER, P1.
   Williams Eric, 1944, CAPITALISM SLAVERY.
   Woods C.A., 1998, DEV ARRESTED BLUES P.
   Wynter, 1971, SAVACOU, V5, P95.
   Wynter, 1970, JAMAICA J, V4, P34.
   Wynter Sylvia, 2000, SMALL AXE, V4, P119.},
Number-of-Cited-References = {67},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Antipode},
Doc-Delivery-Number = {YW7LX},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000753597600001},
DA = {2022-03-29},
}

@article{ WOS:000634376100071,
Author = {Wang, Zhuo and Luo, Yu and Yang, Shujuan and Zou, Kun and Pei, Rong and
   He, Jun and Deng, Ying and Zhou, Maigeng and Zhao, Li and Guo, Hui},
Title = {Premature deaths caused by smoking in Sichuan, Southwest China,
   2015-2030},
Journal = {SCIENTIFIC REPORTS},
Year = {2021},
Volume = {11},
Number = {1},
Month = {JAN 8},
Abstract = {Smoking has a substantial impact on deaths from non-communicable chronic
   diseases (NCDs). Quantitatively measuring the impact of tobacco control
   on population health is of great theoretical and practical importance,
   for governments to make health policy decisions. Focusing on premature
   deaths, we predicted the deaths by 2030 from major NCDs caused by
   smoking among people aged 30-69 years in Sichuan Province, Southwest
   China. We extracted data for 1990-2015 from the Global Burden of Disease
   Study 2015 and calculated the population attributable fraction, to
   estimate the proportion of deaths caused by smoking. Four different
   tobacco control standards were used to estimate 2030 projections for the
   prevalence of smoking and premature mortality. If smoking prevalence
   were reduced by 30\% from 2015 levels, premature mortality could be
   expected to decline by 24.4\% in 2030, achieving 81.3\% of the World
   Health Organization target for reducing premature mortality by 30\%.
   Compared with the continuation of historical trends, the strongest
   tobacco control policy scenario would reduce premature mortality by
   6.6\%, prevent 23,600 deaths, reduce mortality by 7.8\%, and increase
   life expectancy at birth by 0.3 years. Smoking bans represent an
   important action toward achieving national health goals.},
Publisher = {NATURE RESEARCH},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Guo, H (Corresponding Author), Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects \& Related Dis Women \& Child, Minist Educ, Chengdu 610041, Peoples R China.
   Zhao, L (Corresponding Author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China.
   Zhao, L (Corresponding Author), Sichuan Univ, West China Hosp 4, Chengdu 610041, Peoples R China.
   Wang, Zhuo; He, Jun; Deng, Ying, Sichuan Ctr Dis Control \& Prevent, Dept Chron \& Noncommunicable Dis Control \& Preven, Chengdu 610041, Peoples R China.
   Luo, Yu; Guo, Hui, Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects \& Related Dis Women \& Child, Minist Educ, Chengdu 610041, Peoples R China.
   Yang, Shujuan; Zou, Kun; Zhao, Li, Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China.
   Yang, Shujuan; Zou, Kun; Zhao, Li, Sichuan Univ, West China Hosp 4, Chengdu 610041, Peoples R China.
   Pei, Rong, Sichuan Univ Arts \& Sci, Sch Hlth Caring Ind, Dazhou 635000, Sichuan, Peoples R China.
   Zhou, Maigeng, Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing 100050, Peoples R China.},
DOI = {10.1038/s41598-020-79606-2},
Article-Number = {171},
ISSN = {2045-2322},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {zhaoli@scu.edu.cn
   491162470@qq.com},
Funding-Acknowledgement = {Science and Technology Bureau of Sichuan province {[}21ZDYF1329]},
Funding-Text = {This publication was supported by the Grants from Science and Technology
   Bureau of Sichuan province (No.21ZDYF1329).},
Cited-References = {Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1.
   Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P769.
   Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2.
   China Media Group, 2019, EC TOBACCO CONTROL.
   China's Ministry of Health, 2012, J HLTH POLICY, V6, P59.
   Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628.
   Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4.
   Foreman KJ, 2018, LANCET, V392, P2052, DOI {[}10.1016/s0140-6736(18)31694-5, 10.1016/S0140-6736(18)31694-5].
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Hu TW, 2013, GLOB HEALTH PROMOT, V20, P13, DOI 10.1177/1757975913501910.
   Li SS, 2016, LANCET, V387, P1375, DOI 10.1016/S0140-6736(16)30080-0.
   Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5.
   Liu P.P., 2019, PUBLICATION 2018 SIC.
   Lozano R, 2018, LANCET, V392, P2091, DOI {[}10.1016/S0140-6736(18)32281-5, 10.1016/s0140-6736(18)32281-5].
   Mackay J, 2016, BRIT MED BULL, V120, P15, DOI 10.1093/bmb/ldw043.
   Malone RE, 2017, TOB CONTROL, V26, P241, DOI 10.1136/tobaccocontrol-2017-053773.
   National Bureau of Statistics, 2019, CHINA STAT YB 2019.
   Nikogosian H, 2010, B WORLD HEALTH ORGAN, V88, P83, DOI 10.2471/BLT.10.075895.
   Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   Samet JM, 2013, THORAC SURG CLIN, V23, P103, DOI 10.1016/j.thorsurg.2013.01.009.
   The State Council, 2016, HLTH CHINA 2030 PLAN.
   United Nations, 2018, POL DECL 2018 HIGH L.
   Warner KE, 2000, TOB CONTROL, V9, P78, DOI 10.1136/tc.9.1.78.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   World Health Organisation, 2010, TOBACCO CONTROL EC.
   World Health Organisation, 2015, GOALS GOAL HLTH TARG.
   World Health Organisation, 2012, 65 WORLD HLTH ASSEMB.
   World Health Organisation, 2013, WHO REPORT GLOBAL TO.
   World Health Organisation, 2010, 9 VOLUNTARY GLOBAL T.
   World Health Organisation, 2018, TOP 10 CAUS DEATH.
   World Health Organisation, 2018, NONCOMMUNICABLE DIS.
   World Health Organisation, 2011, HIGH LEVEL M PREVENT.
   World Health Organisation, 2012, WHO GLOBAL REPORT.
   World Health Organisation, 2012, WHA65 8 PREVENTION C.
   Zeng X Y, 2017, Zhonghua Yu Fang Yi Xue Za Zhi, V51, P1079, DOI 10.3760/cma.j.issn.0253-9624.2017.12.006.
   Zheng R S, 2019, Zhonghua Zhong Liu Za Zhi, V41, P19, DOI 10.3760/cma.j.issn.0253-3766.2019.01.005.
   Zhou MG, 2019, LANCET, V394, P1145, DOI 10.1016/S0140-6736(19)30427-1.
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6.},
Number-of-Cited-References = {39},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {RE8CY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000634376100071},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000431880100002,
Author = {Behrens, Doris A. and Koland, Olivia and Leopold-Wildburger, Ulrike},
Title = {Why local air pollution is more than daily peaks: modelling policies in
   a city in order to avoid premature deaths},
Journal = {CENTRAL EUROPEAN JOURNAL OF OPERATIONS RESEARCH},
Year = {2018},
Volume = {26},
Number = {2, SI},
Pages = {265-286},
Month = {JUN},
Abstract = {We use a predator-prey representation of an urban system to analyse how
   policy interventions can prevent the adverse effects of air pollution on
   people's health. The number of residents is treated as prey variable,
   and particulate matter that consists of particles with a diameter of up
   to 10 micrometres (PM10) as predator variable. This representation
   allows integration of population trends and the effects of environmental
   interventions on the average level of PM10 concentration (which
   establishes a baseline for the potential health burden for residents).
   For the case of Graz, Austria, we illustrate the insights generated
   regarding the interdependency of market-based and technological
   pollution controls, and propose an indicator that assesses the cost of
   delayed interventions by counting additional premature deaths caused by
   polluted environments.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {Leopold-Wildburger, U (Corresponding Author), Karl Franzens Univ Graz, Dept Stat \& Operat Res, Univ Str 15-E3, A-8010 Graz, Austria.
   Behrens, Doris A., Cardiff Univ, Sch Math, Senghennydd Rd, Cardiff CF24 4AG, S Glam, Wales.
   Koland, Olivia; Leopold-Wildburger, Ulrike, Karl Franzens Univ Graz, Dept Stat \& Operat Res, Univ Str 15-E3, A-8010 Graz, Austria.},
DOI = {10.1007/s10100-018-0534-y},
ISSN = {1435-246X},
EISSN = {1613-9178},
Keywords = {Predator-prey model; Air pollution; Environmental policy interventions},
Keywords-Plus = {CARBON-DIOXIDE EMISSIONS; PARTICULATE-MATTER; LIFE SATISFACTION;
   EPIDEMIOLOGIC EVIDENCE; RESIDENTIAL PROXIMITY; NUMBER CONCENTRATION;
   POPULATION EXPOSURE; CHILDHOOD ASTHMA; QUALITY; HAPPINESS},
Research-Areas = {Operations Research \& Management Science},
Web-of-Science-Categories  = {Operations Research \& Management Science},
Author-Email = {behrensd1@cf.ac.uk
   olivia.koland@uni-graz.at
   ulrike.leopold@uni-graz.at},
ORCID-Numbers = {Leopold-Wildburger, Ulrike/0000-0002-3246-2109},
Funding-Acknowledgement = {University of Graz; Funds of the Austria National Bank (OeNB) {[}15483]},
Funding-Text = {Open access funding provided by University of Graz. This work was
   supported by Funds of the Austria National Bank (OeNB) under Grant
   Number 15483. The authors wish to express gratitude to Birgit
   Bednar-Friedl for fruitful and enlightening discussions.},
Cited-References = {Aleksandropoulou V, 2017, SCI TOTAL ENVIRON, V581, P399, DOI 10.1016/j.scitotenv.2016.12.148.
   Andersen ZJ, 2008, OCCUP ENVIRON MED, V65, P458, DOI 10.1136/oem.2007.033290.
   Baldauf R, 2008, J AIR WASTE MANAGE, V58, P865, DOI 10.3155/1047-3289.58.7.865.
   Bamberg S, 2011, TRANSPORT POLICY, V18, P228, DOI 10.1016/j.tranpol.2010.08.006.
   Banister D, 2008, TRANSPORT POLICY, V15, P73, DOI 10.1016/j.tranpol.2007.10.005.
   Bednar-Friedl B, 2016, DYNAM MOD ECON ECON, V22, P127, DOI 10.1007/978-3-319-39120-5\_8.
   Bednar-Friedl B, 2011, J ENVIRON PLANN MAN, V54, P145, DOI 10.1080/09640568.2010.502766.
   Brander JA, 1998, AM ECON REV, V88, P119.
   Bravo MA, 2012, ENVIRON RES, V116, P1, DOI 10.1016/j.envres.2012.04.008.
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805.
   Camagni R., 1992, EC URBANA.
   Capello R, 2002, ECOL ECON, V40, P181, DOI 10.1016/S0921-8009(01)00252-X.
   Cervero R, 2001, URBAN STUD, V38, P1651, DOI 10.1080/00420980120084804.
   Davis LW, 2008, J POLIT ECON, V116, P38, DOI 10.1086/529398.
   de Sherbinin A, 2007, ANNU REV ENV RESOUR, V32, P345, DOI 10.1146/annurev.energy.32.041306.100243.
   DENDRINOS DS, 1983, ENVIRON PLANN A, V15, P543, DOI 10.1068/a150543.
   Dockery DW, 2007, NEW ENGL J MED, V356, P511, DOI 10.1056/NEJMe068274.
   EEA-European Environment Agency, 2016, 282016 EEA.
   Ferreira S, 2013, ECOL ECON, V88, P1, DOI 10.1016/j.ecolecon.2012.12.027.
   Ferreira S, 2010, ENVIRON RESOUR ECON, V46, P249, DOI 10.1007/s10640-009-9339-8.
   Finkelstein MM, 2004, AM J EPIDEMIOL, V160, P173, DOI 10.1093/aje/kwh181.
   Friedl B, 2007, BIODIVERSITY ECONOMICS, P531.
   Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75.
   Georgopoulos PG, 2005, J EXPO ANAL ENV EPID, V15, P439, DOI 10.1038/sj.jea.7500422.
   Goodwin RM, 1951, ECONOMETRICA, V19, P1, DOI 10.2307/1907905.
   Goodwin R.M., 1967, SOCIALISM CAPITALISM, P54.
   Heiden B, 2008, ENDBERICHT EMISSIONS.
   Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC.
   Krzyzanowski M., 2005, HLTH EFFECTS TRAVEL.
   Kumar P, 2011, J AEROSOL SCI, V42, P580, DOI 10.1016/j.jaerosci.2011.06.001.
   Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2.
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0.
   Lee CJ, 2015, ENVIRON SCI TECHNOL, V49, P4335, DOI 10.1021/acs.est.5b00873.
   Levinson A, 1992, POLICY RES WORKING P, V942.
   Lotka A., 1925, ELEMENTS PHYS BIOL.
   MacKerron G, 2009, ECOL ECON, V68, P1441, DOI 10.1016/j.ecolecon.2008.10.004.
   Magistrat Graz, 2012, BEVOLKERUNGSPROGNOSE.
   Mathur M, 2016, MODELLING URBAN CARR.
   McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594.
   Miranda AI, 2016, ENVIRON SCI POLICY, V65, P29, DOI 10.1016/j.envsci.2016.04.010.
   Murr LE, 2009, ATMOS ENVIRON, V43, P2683, DOI 10.1016/j.atmosenv.2009.03.002.
   Neumayer E, 2004, AREA, V36, P33, DOI 10.1111/j.0004-0894.2004.00317.x.
   Neumayer E, 2002, ENERG POLICY, V30, P7, DOI 10.1016/S0301-4215(01)00045-3.
   ORISHIMO I, 1987, GEOGR ANAL, V19, P200.
   Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998.
   Pey J, 2009, ATMOS ENVIRON, V43, P4407, DOI 10.1016/j.atmosenv.2009.05.024.
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F.
   Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015.
   ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272.
   Salam MT, 2008, CURR OPIN PULM MED, V14, P3, DOI 10.1097/MCP.0b013e3282f1987a.
   Samet JM, 2007, INHAL TOXICOL, V19, P1021, DOI 10.1080/08958370701533541.
   Soares J, 2014, GEOSCI MODEL DEV, V7, P1855, DOI 10.5194/gmd-7-1855-2014.
   Steiermark Land, 2003, STATUSERHEBUNG GEMAB.
   Sterman J.D., 2000, BUSINESS DYNAMICS.
   Thorpe A, 2008, SCI TOTAL ENVIRON, V400, P270, DOI 10.1016/j.scitotenv.2008.06.007.
   Tracy, 1999, HDB REGIONAL URBAN E, V3, P1413.
   Tribby CP, 2013, TRANSPORT POLICY, V30, P173, DOI 10.1016/j.tranpol.2013.09.012.
   UNEP, 2011, GREEN EC PATHW SUST.
   United Nations, 2016, VAST MAJ WORLD 6 76.
   United Nations, 2011, WORLD URB PROSP 2011.
   UTELL MJ, 2005, DETERMINANTS SUSCEPT, P111.
   van Praag BMS, 2005, ECON J, V115, P224, DOI 10.1111/j.1468-0297.2004.00967.x.
   Vazquez Francisco J., 2011, Journal of Bioeconomics, V13, P31, DOI 10.1007/s10818-010-9098-1.
   Volterra V., 1926, VARIATIONS FLUCTUATI.
   Watkiss P, 2005, CAFE CBA BASELINE AN.
   Welsch H, 2007, ECOL ECON, V62, P544, DOI 10.1016/j.ecolecon.2006.07.017.
   Welsch H, 2006, ECOL ECON, V58, P801, DOI 10.1016/j.ecolecon.2005.09.006.
   Welsch H, 2009, ECOL ECON, V68, P2735, DOI 10.1016/j.ecolecon.2009.06.003.
   Wilhelm M, 2003, ENVIRON HEALTH PERSP, V111, P207, DOI 10.1289/ehp.5688.
   World Health Organization (WHO), 2006, AIR QUAL GUID GLOB U.
   Zhu YF, 2002, ATMOS ENVIRON, V36, P4323, DOI 10.1016/S1352-2310(02)00354-0.
   Zivin JG, 2009, J ENVIRON ECON MANAG, V58, P119, DOI 10.1016/j.jeem.2009.03.001.},
Number-of-Cited-References = {72},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Cent. Europ. J. Oper. Res.},
Doc-Delivery-Number = {GF3TW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000431880100002},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000380308800008,
Author = {Lallukka, Tea and Ervasti, Jenni and Mittendorfer-Rutz, Ellenor and
   Tinghog, Petter and Kjeldgard, Linnea and Pentti, Jaana and Virtanen,
   Marianna and Alexanderson, Kristina},
Title = {The joint contribution of diabetes and work disability to premature
   death during working age: a population-based study in Sweden},
Journal = {SCANDINAVIAN JOURNAL OF PUBLIC HEALTH},
Year = {2016},
Volume = {44},
Number = {6},
Pages = {580-586},
Month = {AUG},
Abstract = {Aims: We aimed to examine how newly diagnosed diabetes and work
   disability jointly predict death during working age. Methods: We used
   prospective population-based register data of 25-59-year-old adults who
   had lived in Sweden since 2002. All those with onset of diabetes
   recorded in 2006 were included (n=14266). A 2\% random sample (n=78598)
   was drawn from the general population, comprising people with no
   indication of diabetes during 2003-2010. Net days of sickness absence
   and disability pension in 2005-2006 were examined; the follow-up time
   for mortality was 2007-2010. Cox regression models were fitted (hazard
   ratios, HR, 95\% confidence interval, CI) adjusting for
   sociodemographics and time-dependent health conditions. Results:
   Individuals with diabetes and work disability for over 6 months were at
   a higher risk of premature death (HR=14.2, 95\% CI 12.0-16.8) than their
   counterparts without diabetes and work disability. A high risk was also
   observed among people without diabetes but equally prolonged work
   disability (HR=6.4, 95\% CI 5.4-7.6). Diabetes was associated with
   premature death even without work disability (HR=3.5, 95\% CI 2.8-4.4).
   The associations were particularly attenuated after adjustment for
   health conditions assessed over the follow-up. Conclusions: Diabetes and
   work disability jointly increase the risk of death during working age.
   Diabetes with long-term work disability is associated with the highest
   risk of premature death, which highlights the importance of their
   prevention and early detection.},
Publisher = {SAGE PUBLICATIONS LTD},
Address = {1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Lallukka, T (Corresponding Author), Finnish Inst Occupat Hlth, POB 40, FIN-00251 Helsinki, Finland.
   Lallukka, Tea; Ervasti, Jenni; Pentti, Jaana; Virtanen, Marianna, Finnish Inst Occupat Hlth, POB 40, FIN-00251 Helsinki, Finland.
   Lallukka, Tea, Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland.
   Mittendorfer-Rutz, Ellenor; Tinghog, Petter; Kjeldgard, Linnea; Alexanderson, Kristina, Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, SE-17177 Stockholm, Sweden.
   Tinghog, Petter, Red Cross Univ Coll, Stockholm, Sweden.},
DOI = {10.1177/1403494816655059},
ISSN = {1403-4948},
EISSN = {1651-1905},
Keywords = {Diabetes; mortality; sick-leave; disability pension; population-based;
   register data; chronic conditions; time-dependent; socioeconomic;
   insurance medicine},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; SICKNESS ABSENCE; ALL-CAUSE;
   PHYSICAL-ACTIVITY; DIAGNOSIS; REGISTER; RISK; INSOMNIA; MELLITUS; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {tea.lallukka@ttl.fi},
ResearcherID-Numbers = {Ervasti, Jenni/AAN-1856-2021
   },
ORCID-Numbers = {Ervasti, Jenni/0000-0001-9113-2428
   Kjeldgard, Linnea/0000-0002-4575-7483},
Funding-Acknowledgement = {Academy of FinlandAcademy of Finland {[}287488, 265174, 258598, 292824];
   Finnish Work Environment Fund {[}114260]; Swedish Research Council of
   Health, Working Life and Welfare {[}2007-1762]; Swedish Research
   CouncilSwedish Research CouncilEuropean Commission {[}522-2010-2683];
   Association for Promotion of Occupational Health},
Funding-Text = {This work was supported by the Academy of Finland (grant numbers 287488,
   265174, 258598, 292824); the Finnish Work Environment Fund (grant number
   114260); the Swedish Research Council of Health, Working Life and
   Welfare (grant number 2007-1762); the Swedish Research Council (grant
   number 522-2010-2683); and the Association for Promotion of Occupational
   Health to T.L. The reported funders did not participate in any parts of
   the study, design, data collection, the analyses or the preparation of
   the manuscript.},
Cited-References = {Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x.
   Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056.
   Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116.
   Bergmark E, 2009, HALSO OCH SJUKVARDSR, P366.
   Bjorkenstam C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1247.
   Bjorkenstam E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-733.
   Breton MC, 2013, DIABETES CARE, V36, P740, DOI 10.2337/dc12-0354.
   Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002.
   Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155.
   Ervasti J, 2015, AM J PUBLIC HEALTH, V105, pE22, DOI 10.2105/AJPH.2015.302646.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214.
   Lallukka T, 2014, EUR J PAIN, V18, P883, DOI 10.1002/j.1532-2149.2013.00432.x.
   Lallukka T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006988.
   Lallukka T, 2014, SLEEP, V37, P1413, DOI 10.5665/sleep.3986.
   Lallukka T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-565.
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450.
   Mittendorfer-Rutz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045788.
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Olsson D, 2015, J EPIDEMIOL COMMUN H, V69, P1052, DOI 10.1136/jech-2015-205886.
   Oortwijn W., 2011, SOCIAL DETERMINANTS.
   Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P233, DOI 10.5271/sjweh.3354.
   Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112.
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862.
   Shavelle Robert M, 2008, J Insur Med, V40, P170.
   Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347.
   Virtanen M, 2015, DIABETES CARE, V38, P1883, DOI 10.2337/dc15-0247.
   WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A.
   World Health Organization, 2004, INT STAT CLASS DIS H, V1.},
Number-of-Cited-References = {30},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Scand. J. Public Health},
Doc-Delivery-Number = {DS0TE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000380308800008},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000177586200012,
Author = {Enders, J},
Title = {Serving many masters: The PhD on the labour market, the everlasting need
   of inequality, and the premature death of humboldt},
Journal = {HIGHER EDUCATION},
Year = {2002},
Volume = {44},
Number = {3-4},
Pages = {493-517},
Month = {OCT-DEC},
Note = {Annual Conference on Consortium of Higher Education Research (CHER),
   DIJON, FRANCE, SEP, 2001},
Abstract = {The paper addresses the processes and outcomes of doctoral training and
   their impact on the subsequent careers and work affiliations of doctoral
   degree holders on the bases of the results of the first large scale
   survey among this target group in Germany. It assesses the German
   experience with the doctoral degree as a ticket to multiple journeys on
   the labour market inside and - quantitatively more important - outside
   academe. Links between `traditional' inequalities in the framework of
   the equality of opportunity discourse, `non-traditional' inequalities in
   the framework of the life-cycle discourse, transition to employment and
   advanced career stages, are addressed. The overall picture that derives
   from the survey results shows a quite positive outcome of the PhD on the
   labour market. By and large, PhD matters if we compare doctoral degree
   holders and graduates. Selection for doctoral training is biased by
   social origin while later career attainment among PhD-holders is not.
   Thus, the `need of inequality' is mainly satisfied by respective
   selection processes within the educational system. In contrast, the
   analysis supports the `entry-job hypotheses' that suggests a significant
   impact of early career stages on later stages. The analysis shows as
   well that a deviation from continuous full-time employment is a clear
   career hindrance.},
Publisher = {KLUWER ACADEMIC PUBL},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Enders, J (Corresponding Author), Univ Twente, CHEPS, POB 217, NL-7500 AE Enschede, Netherlands.
   Univ Twente, CHEPS, NL-7500 AE Enschede, Netherlands.},
DOI = {10.1023/A:1019850524330},
ISSN = {0018-1560},
Keywords = {career trajectories; Doctoral Training; PhD job markets; social
   inequality and career outcomes},
Research-Areas = {Education \& Educational Research},
Web-of-Science-Categories  = {Education \& Educational Research},
Cited-References = {BAETHGE M, 1996, FUHRUNGSKRAFTE DILEM.
   Baldauf B., 1998, EUROPEAN J ED, V33, P161.
   BARTELSE JA, 1999, CONCENTRATING MINDS.
   Becher T., 1994, GRADUATE ED BRITAIN.
   Blume S., 1995, RES TRAINING PRESENT, P9.
   BOCHOW M, 1987, WISSENSCHAFT KARRIER.
   BRUGGESTRAT M, 1988, WEG KARRIERE PROMOVI.
   CLARK BR, 1993, RES FDN GRADUATE ED.
   Enders J, 1999, EUROPEAN MODEL POSTG, P17.
   ENDERS J, 2002, IN PRESS MITTEILUNGE.
   Enders J., 1996, WISSENSCHAFTLICHEN M.
   Enders J., 2001, KARRIERE DOKTORTITEL.
   Enders J., 1995, BERUFSBILD LEHRENDEN.
   ENDERS J, 2001, BILDUNG BERUF AUSBIL, P159.
   Gibbons M., 1994, NEW PRODUCTION KNOWL.
   GRATZ F, 1985, FORUM, V1, P29.
   Hartmann M, 1996, TOPMANAGER REKRUTIER.
   HOLTKAMP R, 1986, JUNGE WISSENSCHAFTLE.
   Huber L., 1986, EUROPEAN J ED, V21, P287.
   KIVINEN O, 1999, EUROPEAN MODEL POSTG, P50.
   Mangematin V, 2000, RES POLICY, V29, P741, DOI 10.1016/S0048-7333(99)00047-5.
   Nerad M, 1999, SCIENCE, V285, P1533, DOI 10.1126/science.285.5433.1533.
   NERAD M, 2002, IN PRESS PHD PASSPOR.
   Paul J., 1999, EUROPEAN MODEL POSTG, P157.
   PREISSNER A, 1994, WIRTSCHAFTLWISSENSCH, V8, P427.
   Rhoades G., 1991, INT HIGHER ED ENCY, P127.
   RUHMANN P, 1995, WIRTSCHAFTLWISSENSCH, V11, P601.
   SCHEUCH U, 1995, MANAGER MAGAZIN, V25, P191.
   WEBER J, 1995, Z BETRIEBSWIRT, V7, P708.},
Number-of-Cited-References = {29},
Times-Cited = {67},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {30},
Journal-ISO = {High. Educ.},
Doc-Delivery-Number = {586LV},
Web-of-Science-Index = {Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000177586200012},
DA = {2022-03-29},
}

@article{ WOS:000382641500001,
Author = {Nuno-Lambarri, Natalia and Dominguez-Perez, Mayra and Baulies-Domenech,
   Anna and Monte, Maria J. and Marin, Jose J. G. and Rosales-Cruz,
   Patricia and Souza, Veronica and Miranda, Roxana U. and Bucio, Leticia
   and Montalvo-Jave, Eduardo E. and Concepcion Gutierrez-Ruiz, Maria and
   Garcia-Ruiz, Carmen and Fernandez-Checa, Jose C. and Enrique
   Gomez-Quiroz, Luis},
Title = {Liver Cholesterol Overload Aggravates Obstructive Cholestasis by
   Inducing Oxidative Stress and Premature Death in Mice},
Journal = {OXIDATIVE MEDICINE AND CELLULAR LONGEVITY},
Year = {2016},
Volume = {2016},
Abstract = {Nonalcoholic steatohepatitis is one of the leading causes of liver
   disease. Dietary factors determine the clinical presentation of
   steatohepatitis and can influence the progression of related diseases.
   Cholesterol has emerged as a critical player in the disease and hence
   consumption of cholesterol-enriched diets can lead to a progressive form
   of the disease. The aim was to investigate the impact of liver
   cholesterol overload on the progression of the obstructive cholestasis
   in mice subjected to bile duct ligation surgery. Mice were fed with a
   high cholesterol diet for two days and then were subjected to surgery
   procedure; histological, biochemical, and molecular analyses were
   conducted to address the effect of cholesterol in liver damage. Mice
   under the diet were more susceptible to damage. Results show that
   cholesterol fed mice exhibited increased apoptosis and oxidative stress
   as well as reduction in cell proliferation. Mortality following surgery
   was higher in HC fed mice. Liver cholesterol impairs the repair of liver
   during obstructive cholestasis and aggravates the disease with early
   fatal consequences; these effects were strongly associated with
   oxidative stress.},
Publisher = {HINDAWI LTD},
Address = {ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Gomez-Quiroz, LE (Corresponding Author), Univ Autonoma Metropolitana Iztapalapa, Dept Hlth Sci, Mexico City 09340, DF, Mexico.
   Fernandez-Checa, JC (Corresponding Author), Hosp Clin Barcelona, IDIBAPS, Inst Invest Biomed Barcelona, Dept Cell Death \& Proliferat,CSIC,Barcelona \& Liv, Barcelona 08036, Spain.
   Fernandez-Checa, JC (Corresponding Author), Ctr Invest Biomed Red CIBERehd, Barcelona 08036, Spain.
   Gomez-Quiroz, LE (Corresponding Author), Red Fisiopatol Enfermedades Hepaticas PRODEP SEP, Mexico City 09340, DF, Mexico.
   Fernandez-Checa, JC (Corresponding Author), Univ Sourthern Calif, Keck Sch Med, Res Ctr Alcohol Liver \& Pancreat Dis \& Cirrhosis, Los Angeles, CA 90033 USA.
   Nuno-Lambarri, Natalia; Dominguez-Perez, Mayra; Rosales-Cruz, Patricia, Univ Autonoma Metropolitana Iztapalapa, DCBS, Postgrad Program Expt Biol, Mexico City 09340, DF, Mexico.
   Nuno-Lambarri, Natalia; Dominguez-Perez, Mayra; Rosales-Cruz, Patricia; Souza, Veronica; Miranda, Roxana U.; Bucio, Leticia; Concepcion Gutierrez-Ruiz, Maria; Enrique Gomez-Quiroz, Luis, Univ Autonoma Metropolitana Iztapalapa, Dept Hlth Sci, Mexico City 09340, DF, Mexico.
   Nuno-Lambarri, Natalia, Med Clin \& Fdn, Translat Res Unit, Mexico City 14050, DF, Mexico.
   Baulies-Domenech, Anna; Garcia-Ruiz, Carmen; Fernandez-Checa, Jose C., Hosp Clin Barcelona, IDIBAPS, Inst Invest Biomed Barcelona, Dept Cell Death \& Proliferat,CSIC,Barcelona \& Liv, Barcelona 08036, Spain.
   Baulies-Domenech, Anna; Garcia-Ruiz, Carmen; Fernandez-Checa, Jose C., Ctr Invest Biomed Red CIBERehd, Barcelona 08036, Spain.
   Monte, Maria J.; Marin, Jose J. G., Univ Salamanca, Lab Expt Hepatol \& Drug Targeting HEVEFARM, Ctr Invest Biomed Red CIBERehd, Inst Invest Biomed Salamanaca IBSAL, Salamanca 37007, Spain.
   Souza, Veronica; Miranda, Roxana U.; Bucio, Leticia; Concepcion Gutierrez-Ruiz, Maria; Enrique Gomez-Quiroz, Luis, Red Fisiopatol Enfermedades Hepaticas PRODEP SEP, Mexico City 09340, DF, Mexico.
   Montalvo-Jave, Eduardo E., Univ Nacl Autonoma Mexico, Sch Med, Gen Hosp Mexico, Gen Surg Serv 304, Mexico City 06726, DF, Mexico.
   Fernandez-Checa, Jose C., Univ Sourthern Calif, Keck Sch Med, Res Ctr Alcohol Liver \& Pancreat Dis \& Cirrhosis, Los Angeles, CA 90033 USA.},
DOI = {10.1155/2016/9895176},
Article-Number = {9895176},
ISSN = {1942-0900},
EISSN = {1942-0994},
Keywords-Plus = {GROWTH-FACTOR PROTECTS; DIETARY HABITS; BILE-ACIDS; HEPATOCYTES;
   DISEASE; PATHOGENESIS; ACCUMULATION; GLUTATHIONE; MECHANISM; APOPTOSIS},
Research-Areas = {Cell Biology},
Web-of-Science-Categories  = {Cell Biology},
Author-Email = {checa229@yahoo.com
   legq@xanum.uam.mx},
ResearcherID-Numbers = {Domínguez-Pérez, Mayra/AAB-3264-2020
   Marin, Jose J. G./D-5017-2011
   Monte, Maria J/A-9529-2017
   Fernandez-Checa, Jose Carlos/L-8342-2014
   , Carmen/L-8211-2014},
ORCID-Numbers = {Domínguez-Pérez, Mayra/0000-0002-6049-0430
   Marin, Jose J. G./0000-0003-1186-6849
   Monte, Maria J/0000-0003-1844-7428
   Fernandez-Checa, Jose Carlos/0000-0003-3422-2990
   Nuno Lambarri, Natalia/0000-0001-7616-2661
   Gutierrez-Ruiz, Maria Concepcion/0000-0003-0501-7226
   Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985
   , Carmen/0000-0002-2652-6102},
Funding-Acknowledgement = {CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) {[}252942,
   236558, 166042]; CONACYT Fronteras de la Ciencia {[}1320]; Asociacion
   Mexicana de Hepatologia; Plan Nacional de I+D, Spain {[}SAF-2011-23031,
   SAF-2012-34831]; Fundacio la Marato de TV3; Instituto Salud Carlos
   IIIInstituto de Salud Carlos III {[}PI11/0325 (META)]; CIBEREHD;
   Research Center for Liver and Pancreatic Diseases - NIAAA/NIH
   {[}P50-AA-11999]; La Mutua Madrilena; Universidad Autonoma Metropolitana
   Iztapalapa;  {[}SEP-PRODEP-913026-1461211]; NATIONAL INSTITUTE ON
   ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Alcohol Abuse \& Alcoholism (NIAAA) {[}P50AA011999] Funding Source:
   NIH RePORTER},
Funding-Text = {This work was supported by grants of the CONACYT 252942, 236558, and
   166042, CONACYT Fronteras de la Ciencia 1320, Asociacion Mexicana de
   Hepatologia, and SEP-PRODEP-913026-1461211, Universidad Autonoma
   Metropolitana Iztapalapa, by grants SAF-2011-23031 and SAF-2012-34831
   from Plan Nacional de I+D, Spain, Fundacio la Marato de TV3, La Mutua
   Madrilena, PI11/0325 (META) Grant from the Instituto Salud Carlos III,
   by the support of CIBEREHD, and by the Center Grant P50-AA-11999 from
   Research Center for Liver and Pancreatic Diseases funded by NIAAA/NIH.},
Cited-References = {Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026.
   Arguello G, 2015, BBA-MOL BASIS DIS, V1852, P1765, DOI 10.1016/j.bbadis.2015.05.015.
   Bashiri A, 2013, CURR OPIN LIPIDOL, V24, P275, DOI 10.1097/MOL.0b013e328361633e.
   Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016.
   Chatterjee S, 2014, TOXICOL IN VITRO, V28, P218, DOI 10.1016/j.tiv.2013.10.020.
   Chen YS, 2015, LAB INVEST, V95, P124, DOI 10.1038/labinvest.2014.140.
   Cheng QQ, 2015, MOL ENDOCRINOL, V29, P571, DOI 10.1210/me.2014-1337.
   Clavijo-Cornejo D, 2014, FOOD CHEM TOXICOL, V69, P102, DOI 10.1016/j.fct.2014.04.002.
   Cole-Ezea P, 2012, FREE RADICAL BIO MED, V53, P488, DOI 10.1016/j.freeradbiomed.2012.05.029.
   Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228.
   Dominguez-Perez M., 2016, OXIDATIVE MED CELLUL, V2016, DOI {[}10.1155/2016/7960386, DOI 10.1155/2016/7960386].
   Enriquez-Cortina C, 2013, TOXICOL SCI, V135, P26, DOI 10.1093/toxsci/kft134.
   Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8.
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5.
   Geerts AM, 2008, INT J EXP PATHOL, V89, P251, DOI 10.1111/j.1365-2613.2008.00597.x.
   Ruiz MCG, 2012, GAC MED MEX, V148, P236.
   Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x.
   Kallwitz ER, 2015, CLIN GASTROENTEROL H, V13, P569, DOI 10.1016/j.cgh.2014.08.037.
   KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305.
   Lin CJ, 2015, BIOMEDICINE-TAIWAN, V5, P1, DOI 10.7603/s40681-015-0007-8.
   Lomonaco R, 2013, DRUGS, V73, P1, DOI 10.1007/s40265-012-0004-0.
   Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006.
   Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132.
   Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002.
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763.
   Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023.
   Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151.
   Roma MG, 2008, ANN HEPATOL, V7, P16, DOI 10.1016/S1665-2681(19)31884-8.
   Tomita K, 2014, HEPATOLOGY, V59, P154, DOI 10.1002/hep.26604.
   Valdes-Arzate A, 2009, FREE RADICAL BIO MED, V47, P424, DOI 10.1016/j.freeradbiomed.2009.05.014.
   Webster CRL, 2014, AM J PHYSIOL-GASTR L, V307, pG1207, DOI 10.1152/ajpgi.00165.2014.
   Woolbright BL, 2015, TOXICOL APPL PHARM, V283, P168, DOI 10.1016/j.taap.2015.01.015.
   Yasutake K, 2014, WORLD J GASTROENTERO, V20, P1756, DOI 10.3748/wjg.v20.i7.1756.},
Number-of-Cited-References = {33},
Times-Cited = {14},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Oxidative Med. Cell. Longev.},
Doc-Delivery-Number = {DV0WO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000382641500001},
OA = {Green Submitted, Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000367341500007,
Author = {Boitsov, S. A. and Samorodskaya, I. V. and Tret'yakov, V. V. and
   Vatolina, M. A.},
Title = {Losses related to premature death at an economically active age},
Journal = {HERALD OF THE RUSSIAN ACADEMY OF SCIENCES},
Year = {2015},
Volume = {85},
Number = {6},
Pages = {510-514},
Month = {NOV},
Abstract = {In the modern world, human life and health are the most important values
   and the basis for the formation of human capital-the backbone of a
   country's sustainable development. Early death at an active working age
   both from diseases and as a result of other factors is fraught with
   economic losses because of GDP shortfalls.},
Publisher = {MAIK NAUKA/INTERPERIODICA/SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013-1578 USA},
Type = {Article},
Language = {English},
Affiliation = {Vatolina, M. A., Minist Healthcare Russian Federat, Natl Res Ctr Prevent Med, Lab Demog Aspects Publ Hlth, Moscow, Russia.},
DOI = {10.1134/S1019331615060064},
ISSN = {1019-3316},
EISSN = {1555-6492},
Research-Areas = {History \& Philosophy of Science; Science \& Technology - Other Topics},
Web-of-Science-Categories  = {History \& Philosophy Of Science; Multidisciplinary Sciences},
Author-Email = {prof.boytsov@gmail.com
   samor2000@yandex.ru
   v.tretyakov@rian.ru
   maryvatolina@yandex.ru},
ResearcherID-Numbers = {Boytsov, Sergey A/M-4486-2014
   Boytsov, Sergey/AAK-5354-2021
   Samorodskaya, Irina/I-3490-2017},
ORCID-Numbers = {Boytsov, Sergey A/0000-0001-6998-8406
   Boytsov, Sergey/0000-0001-6998-8406
   },
Cited-References = {US Burden of Disease Collaborators, JAMA.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.},
Number-of-Cited-References = {2},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Her. Russ. Acad. Sci.},
Doc-Delivery-Number = {CZ8HT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000367341500007},
DA = {2022-03-29},
}

@article{ WOS:000507060000001,
Author = {Jones-Eversley, Sharon D. and Rice, II, Johnny and Adedoyin, A.
   Christson and James-Townes, Lori},
Title = {Premature Deaths of Young Black Males in the United States},
Journal = {JOURNAL OF BLACK STUDIES},
Year = {2020},
Volume = {51},
Number = {3},
Pages = {251-272},
Month = {APR},
Abstract = {It is undeniably a disturbing public health crisis that requires an
   urgent national response to reverse and ultimately eradicate the
   premature deaths of young Black males. In the United States, generations
   of young Black males, ages 15 to 24 years, are prematurely dying from
   homicide and suicide. Between 1950 and 2010, the average death rate for
   young Black males due to homicide was 81.7 per 100,000 and suicide was
   11.8 per 100,000. Ages 15 to 24 years are the intersecting developmental
   stages of adolescence and young adulthood when premature death should
   not be expected. The trauma and ceased procreation prospects stemming
   from Black males' premature deaths represent a public health crisis in
   America. Heightened public health approaches are needed to bring
   attention to a young racial-gender group that is dying five to six
   decades prior to their life expectancy. The mass suicide-homicide
   killings, premature deaths, and death disparities among young Black
   males, ages 15 to 24, in the United States is not a paranoid propaganda.
   It is undeniably a disturbing public health crisis that requires an
   urgent national response to reverse and ultimately eradicate the
   premature death of young Black males.},
Publisher = {SAGE PUBLICATIONS INC},
Address = {2455 TELLER RD, THOUSAND OAKS, CA 91320 USA},
Type = {Article},
Language = {English},
Affiliation = {Jones-Eversley, SD (Corresponding Author), Towson Univ, Dept Family Studies \& Community Dev, 8000 York Rd, Towson, MD 21252 USA.
   Jones-Eversley, Sharon D.; James-Townes, Lori, Towson Univ, Dept Family Studies \& Community Dev, 8000 York Rd, Towson, MD 21252 USA.
   Rice, Johnny, II, Coppin State Univ, Dept Criminal Justice \& Enforcement, Baltimore, MD USA.
   Adedoyin, A. Christson, Samford Univ, Sch Publ Hlth, Dept Social Work, Birmingham, AL USA.},
DOI = {10.1177/0021934719895999},
EarlyAccessDate = {JAN 2020},
Article-Number = {0021934719895999},
ISSN = {0021-9347},
EISSN = {1552-4566},
Keywords = {death disparities; determinants of premature death; homicide; premature
   death; suicide; young Black males},
Keywords-Plus = {AFRICAN-AMERICAN MALES; CRITICAL RACE THEORY; ALL-CAUSE MORTALITY;
   MENTAL-HEALTH; LIFE EXPECTANCY; RACIAL DISPARITIES; VIOLENT DEATHS;
   SUICIDE; HOMICIDE; BEHAVIORS},
Research-Areas = {Ethnic Studies; Social Sciences - Other Topics},
Web-of-Science-Categories  = {Ethnic Studies; Social Sciences, Interdisciplinary},
Author-Email = {sjoneseversley@towson.edu},
ORCID-Numbers = {Jones-Eversley, Sharon/0000-0002-0681-2267
   Rice II, Johnny/0000-0002-8275-4978},
Cited-References = {Adedoyin AC, 2019, J TEACH SOC WORK, V39, P111, DOI 10.1080/08841233.2019.1586807.
   Adedoyin C, 2018, J HUM BEHAV SOC ENVI, V28, P1078, DOI 10.1080/10911359.2018.1513886.
   Agar M, 2003, QUAL HEALTH RES, V13, P974, DOI 10.1177/1049732303256886.
   Al-Mateen C. S., 2017, SUICIDE DIVERSE YOUT, P31, DOI {[}10.1007/978-3-319-66203-9\_3, DOI 10.1007/978-3-319-66203-9\_3].
   Alang S, 2017, AM J PUBLIC HEALTH, V107, P662, DOI 10.2105/AJPH.2017.303691.
   {[}Anonymous], 1986, SOCIAL EC STUDIES, V35, P1.
   Assari S, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00078.
   Aymer SR, 2016, J HUM BEHAV SOC ENVI, V26, P367, DOI 10.1080/10911359.2015.1132828.
   Bittker B., 2007, REDRESS HIST INJUSTI, P143.
   Black Demographics, 2019, AFR AM LIF EXP.
   Bond MJ, 2016, AM J PUBLIC HEALTH, V106, P1167, DOI 10.2105/AJPH.2016.303251.
   Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485.
   Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062.
   Bridge JA, 2015, JAMA PEDIATR, V169, P673, DOI 10.1001/jamapediatrics.2015.0465.
   BROWN TN, 2000, RACE SOC, V0002.
   Bunney W. E., REDUCING SUICIDE NAT.
   CAIRNS RB, 1988, J CLIN CHILD PSYCHOL, V17, P298, DOI 10.1207/s15374424jccp1704\_1.
   Carter RT, 2011, CULT DIVERS ETHN MIN, V17, P156, DOI 10.1037/a0023358.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Center for Disease Control and Prevention, 2015, DEATH RAT SUIC SEX R.
   Center for Disease Control and Prevention, 2015, DEATH RAT HOM SEX RA.
   Chaney C., 2015, J PAN AFRICAN STUDIE, V8, P45.
   Chapman-Hilliard C, 2016, J BLACK PSYCHOL, V42, P479, DOI 10.1177/0095798415597840.
   Cheatham CT, 2008, J AM ACAD NURSE PRAC, V20, P555, DOI 10.1111/j.1745-7599.2008.00359.x.
   Child Trends, 2018, DAT LIF EXP.
   Coale AJ, 1965, ASPECTS ANAL FAMILY.
   Condic ML, 2016, J MED PHILOS, V41, P257, DOI 10.1093/jmp/jhw004.
   Crosby AE, 2006, J BLACK PSYCHOL, V32, P253, DOI 10.1177/0095798406290552.
   Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97.
   Davenport C, 2011, AM SOCIOL REV, V76, P152, DOI 10.1177/0003122410395370.
   DeGruy J., 2017, POST TRAUMATIC SLAVE.
   DeGruy J, 2012, J BLACK PSYCHOL, V38, P395, DOI 10.1177/0095798411429744.
   DeGruy-Leary J., 2001, THESIS, DOI {[}10.15760/etd.5808, DOI 10.15760/ETD.5808].
   DeGruy-Leary J.A, 2005, POST TRAUMATIC SLAVE.
   Diehr AJ, 2018, PREV MED, V112, P179, DOI 10.1016/j.ypmed.2018.04.032.
   Diversi M., 2016, BETWEENER TALK DECOL.
   Diversi M, 2016, CULT STUD-CRIT METHO, V16, P245, DOI 10.1177/1532708616634769.
   Dixon TL, 2000, COMMUN RES, V27, P547, DOI 10.1177/009365000027005001.
   Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105.
   Eitle D, 2009, J CRIM JUST, V37, P28, DOI 10.1016/j.jcrimjus.2008.12.005.
   Ellawala TI, 2016, SCHOLARLY UNDERGRADU, V2, P1.
   Escobar S., 2019, UNDERGRADUATE HIST J, V5, P42.
   Eyerman R, 2001, CULTURAL TRAUMA SLAV.
   FRILOUX CA, 1975, BAYLOR LAW REV, V27, P10.
   Fuchs VR, 2018, LIFE EXPECTANCY INEQ.
   Gill C, 2014, J EXP CRIMINOL, V10, P399, DOI 10.1007/s11292-014-9210-y.
   GREENBERG M, 1992, PUBLIC HEALTH REP, V107, P264.
   Gump J., 2017, TRANSGENERATIONAL TR, P102.
   Hagan J, 2010, WHO ARE THE CRIMINALS: THE POLITICS OF CRIME POLICY FROM THE AGE OF ROOSEVELT TO THE AGE OF REAGAN, P10.
   Hanzlick R., 2002, GUIDE MANNER DEATH C.
   Harmon, 2018, URBAN SOCIAL WORK, V2, P33, DOI {[}10.1891/2474-8684.2.1.33, DOI 10.1891/2474-8684.2.1.33].
   Hazekamp C, 2021, J INTERPERS VIOLENCE, V36, P5761, DOI 10.1177/0886260518807216.
   Hoelter J.W., 1981, OMEGA, V11, P241, DOI {[}10.2190/TY4E-KV6Q-WE9D-7DAT, DOI 10.2190/TY4E-KV6Q-WE9D-7DAT].
   HOLINGER PC, 1982, SOC SCI MED, V16, P1929, DOI 10.1016/0277-9536(82)90392-6.
   Hooper LM., 2017, J MENT HLTH COUNS, V39, P242.
   Howard TC, 2008, TEACH COLL REC, V110, P954.
   Hui D, 2014, J PAIN SYMPTOM MANAG, V47, P77, DOI 10.1016/j.jpainsymman.2013.02.021.
   Hutchinson E. O., 2019, BETRAYED HIST PRESID, DOI {[}10.4324/9780429039850, DOI 10.4324/9780429039850].
   JEFF MFX, 1981, URBAN LEAGUE REV, V6, P25.
   Joe S, 2018, RES SOCIAL WORK PRAC, V28, P340, DOI 10.1177/1049731517702745.
   Jones S., 2018, THESIS.
   Jones-Eversley S, 2018, J HUM BEHAV SOC ENVI, V28, P90, DOI 10.1080/10911359.2017.1355767.
   Khan A, 2019, LOS ANGELES TIMES.
   Kuehn BM, 2006, JAMA-J AM MED ASSOC, V296, P2303, DOI 10.1001/jama.296.19.2303.
   Lee BX, 2016, AGGRESS VIOLENT BEH, V28, P109, DOI 10.1016/j.avb.2016.05.003.
   Lee BX, 2014, AGGRESS VIOLENT BEH, V19, P721, DOI 10.1016/j.avb.2014.09.017.
   Levine RS, 2001, PUBLIC HEALTH REP, V116, P474, DOI 10.1093/phr/116.5.474.
   Liem M, 2011, FORENSIC SCI INT, V207, P70, DOI 10.1016/j.forsciint.2010.09.003.
   Lindsey MA, 2017, AM J ORTHOPSYCHIAT, V87, P377, DOI 10.1037/ort0000198.
   Lipscomb A. E., 2019, J SOCIOL, V7, P11.
   Malebranche DJ, 2009, MEN MASC, V12, P90, DOI 10.1177/1097184X07309504.
   Mannix D. P., 1962, BLACK CARGOES HIST A.
   May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243.
   McCann C., 2019, THESIS.
   McGee EO, 2015, EDUC THEORY, V65, P491, DOI 10.1111/edth.12129.
   MILLER JG, 1996, SEARCH DESTROY AFRIC.
   Montgomery L, 2019, CURR HIV-AIDS REP, V16, P17, DOI 10.1007/s11904-019-00422-z.
   NEIGHBORS HW, 1985, COMMUNITY MENT HLT J, V21, P156, DOI 10.1007/BF00754731.
   Nelson A, 2002, J NATL MED ASSOC, V94, P666.
   Noonan AS, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0025-4.
   Nordberg A, 2016, CHILD ADOLESC SOC WO, V33, P137, DOI 10.1007/s10560-015-0415-3.
   Ntloedibe F. N., 2018, AFRICAN IDENTITIES, V16, P349.
   Ogle M., 2019, THESIS.
   Olfson M, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3517.
   Oliver MB African, 2003, J AFRICAN AM STUDIES, V7, P3, DOI 10.1007/s12111-003-1006-5.
   Oliver WillardM., 2002, CRIMINAL JUSTICE POL, V13, P139, DOI DOI 10.1177/0887403402132003.
   Park MJ, 2006, J ADOLESCENT HEALTH, V39, P305, DOI 10.1016/j.jadohealth.2006.04.017.
   Pathak EB, 2018, J RACIAL ETHN HEALTH, V5, P50, DOI 10.1007/s40615-017-0341-5.
   Patterson GT, 2016, J HUM BEHAV SOC ENVI, V26, P267, DOI 10.1080/10911359.2015.1125204.
   Persson I, 2002, BIOETHICS, V16, P20, DOI 10.1111/1467-8519.00265.
   Pinetta, 2019, HDB CHILDREN PREJUDI, P23, DOI {[}10.1007/978-3-030-12228-7\_2, DOI 10.1007/978-3-030-12228-7\_2].
   Price JH, 2019, J COMMUN HEALTH, V44, P756, DOI 10.1007/s10900-019-00678-x.
   RANGE LM, 1987, J PSYCHOL, V121, P193, DOI 10.1080/00223980.1987.9712657.
   Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463.
   Regoli R. M., 2017, DELINQUENCY SOC.
   Rehkopf DH, 2006, AM J PUBLIC HEALTH, V96, P2135, DOI 10.2105/AJPH.2005.075408.
   Rich JA, 2005, AM J PUBLIC HEALTH, V95, P816, DOI 10.2105/AJPH.2004.044560.
   Rios VM, 2007, CRIT BLACK STUD SER, P17.
   Roche SP, 2016, J QUANT CRIMINOL, V32, P215, DOI 10.1007/s10940-015-9261-x.
   Rogers R. G., 2018, LOW FERTILITY REGIME, P49.
   ROGERS RG, 1992, DEMOGRAPHY, V29, P287, DOI 10.2307/2061732.
   Senior Living, 2018, 1900 2000 CHANG LIF.
   Sered Danielle, 2014, YOUNG MEN COLOR OTHE.
   SHAFFER D, 1994, AM J PSYCHIAT, V151, P1810.
   Sharkey P, 2019, DEMOGRAPHY, V56, P645, DOI 10.1007/s13524-019-00768-4.
   Singh GK, 2014, J URBAN HEALTH, V91, P272, DOI 10.1007/s11524-013-9847-2.
   Skogan W., 2006, POLICE COMMUNITY CHI.
   SKOGAN WG, 1995, ANN AM ACAD POLIT SS, V539, P59, DOI 10.1177/0002716295539001005.
   Smiley C, 2016, J HUM BEHAV SOC ENVI, V26, P350, DOI 10.1080/10911359.2015.1129256.
   Smith JR, 2015, AM J PUBLIC HEALTH, V105, pS483, DOI 10.2105/AJPH.2014.302535.
   Stewart E., 2007, CRIMINOL PUBLIC POL, V6, P123, DOI DOI 10.1111/J.1745-9133.2007.00425.X.
   Stillion J., 1995, MENS HLTH ILLNESS GE, P46.
   Terry Sr C. L., 2012, ED FDN, V26, P85.
   Thomas R, 1991, OUT ORDER POLICING B, P65.
   Thorpe RJ, 2013, AM J MENS HEALTH, V7, p8S, DOI 10.1177/1557988313487552.
   Trisel B. A., 2007, MINERVA, V11, P54.
   Umberson D, 2017, P NATL ACAD SCI USA, V114, P915, DOI 10.1073/pnas.1605599114.
   Violence Policy Center, 2019, BLACK HOM VICT.
   Voigt R, 2017, P NATL ACAD SCI USA, V114, P6521, DOI 10.1073/pnas.1702413114.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   Whittle EL, 2015, PSYCHOL MEN MASCULIN, V16, P426, DOI 10.1037/a0039024.
   WILBANKS W, 1985, CRIME DELINQUENCY, V31, P117, DOI 10.1177/0011128785031001007.
   Wilkins EJ, 2013, CONTEMP FAM THER, V35, P14, DOI 10.1007/s10591-012-9219-1.
   Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325.
   Wilson JP, 2017, J PERS SOC PSYCHOL, V113, P59, DOI 10.1037/pspi0000092.
   Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535.
   World Health Organization, 2019, GLOBAL HLTH AGING.
   {[}No title captured].},
Number-of-Cited-References = {128},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Black Stud.},
Doc-Delivery-Number = {KQ0OH},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000507060000001},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000329397300013,
Author = {Remington, Patrick L. and Catlin, Bridget B. and Kindig, David A.},
Title = {Monitoring Progress in Population Health: Trends in Premature Death
   Rates},
Journal = {PREVENTING CHRONIC DISEASE},
Year = {2013},
Volume = {10},
Month = {DEC},
Abstract = {Introduction
   Trends in population health outcomes can be monitored to evaluate the
   performance of population health systems at the national, state, and
   local levels. The objective of this study was to compare and contrast 4
   measures for assessing progress in population health improvement by
   using age-adjusted premature death rates as a summary measure of the
   overall health outcomes in the United States and in all 50 states.
   Methods
   To evaluate the performance of statewide population health systems
   during the past 20 years, we used 4 measures of age-adjusted premature
   (<75 years of age) death rates: current rates (2009), baseline trends
   (1990s), follow-up trends (2000s), and changes in trends from baseline
   to the follow-up periods (ie, ``bending the curve{''}).
   Results
   Current premature death rates varied by approximately twofold, with the
   lowest rate in Minnesota (268 deaths per 100,000) and the highest rate
   in Mississippi (482 deaths per 100,000). Rates improved the most in New
   York during the baseline period (-3.05\% per year) and in New Jersey
   during the follow-up period (-2.87\% per year), whereas Oklahoma ranked
   last in trends during both periods (-0.30\%/y, baseline; +0.18\%/y,
   follow-up). Trends improved the most in Connecticut, bending the curve
   downward by 1.03\%; trends worsened the most in New Mexico, bending the
   curve upward by 1.21\%.
   Discussion
   Current premature death rates, recent trends, and changes in trends vary
   by state in the United States. Policy makers can use these measures to
   evaluate the long-term population health impact of broad health care,
   behavioral, social, and economic investments in population health.},
Publisher = {CENTERS  DISEASE CONTROL \& PREVENTION},
Address = {1600 CLIFTON RD, ATLANTA, GA 30333 USA},
Type = {Article},
Language = {English},
Affiliation = {Remington, PL (Corresponding Author), Univ Wisconsin, Sch Med \& Publ Hlth, Dept Populat Hlth Sci, Populat Hlth Inst,Hlth Sci Learning Ctr 4263, 750 Highland Ave, Madison, WI 53705 USA.
   Remington, Patrick L., Univ Wisconsin, Sch Med \& Publ Hlth, Dept Populat Hlth Sci, Populat Hlth Inst,Hlth Sci Learning Ctr 4263, Madison, WI 53705 USA.
   Catlin, Bridget B.; Kindig, David A., Univ Wisconsin, Sch Med \& Publ Hlth, Dept Populat Hlth Sci, Populat Hlth Inst, Madison, WI 53705 USA.},
DOI = {10.5888/pcd10.130210},
Article-Number = {130210},
ISSN = {1545-1151},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {plreming@wisc.edu},
Funding-Acknowledgement = {Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF)
   {[}65017, 69835]},
Funding-Text = {This research was supported by grants (nos. 65017 and 69835) from the
   Robert Wood Johnson Foundation.},
Cited-References = {{[}Anonymous], 2012, HLTH IND 2012.
   Antos J, 2009, AM J MANAG CARE, V15, P676.
   Centers for Disease Control and Prevention National Center for Health Statistics, COMPR MORT FIL CDC W.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255.
   Kelley ET, 2006, INT J QUAL HEALTH C, V18, P45, DOI 10.1093/intqhc/mzl027.
   Keppel Kenneth, 2005, Vital Health Stat 2, P1.
   Kindig DA, 2010, PREV CHRONIC DIS, V7.
   Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046.
   Mokdad AH, 2010, PREV CHRONIC DIS, V7.
   Newburn VH, 2003, TOB CONTROL, V12, P161, DOI 10.1136/tc.12.2.161.
   Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129.
   Parrish RG, 2010, PREV CHRONIC DIS, V7.
   Peppard PE, 2008, AM J PUBLIC HEALTH, V98, P209, DOI 10.2105/AJPH.2006.092981.
   Remington PL, 2011, J PUBLIC HEALTH MAN, V17, P397, DOI 10.1097/PHH.0b013e318222b897.
   Rohan AMK, 2009, J PUBLIC HEALTH MAN, V15, P24, DOI 10.1097/PHH.0b013e3181903bf8.
   {*}UN HLTH FDN, AM HLTH STAT HLTH RA.
   University of Wisconsin Population Health Institute, COUNT HLTH RANK.
   WHO, 2000, WORLD HLTH REP 2000.},
Number-of-Cited-References = {19},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Prev. Chronic Dis.},
Doc-Delivery-Number = {285ME},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000329397300013},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000289450900002,
Author = {Savidan, Anita and Junker, Christoph and Cerny, Thomas and Ess, Silvia},
Title = {Premature deaths in Switzerland from 1995-2006: causes and trends},
Journal = {SWISS MEDICAL WEEKLY},
Year = {2010},
Volume = {140},
Month = {AUG 24},
Abstract = {Purpose: Mortality expressed as potential years of life lost (PYLL)
   underscores premature and preventable mortality. We analysed causes of
   and trends in premature death in Switzerland to highlight the areas
   which provide the greatest potential outcome for preventive measures.
   Methods: Premature mortality rates and trends from 1995-2006 were
   examined by reviewing potential years of life lost between age 1 and 70,
   as the upper age limit, considering 4 main categories: circulatory
   diseases, cancer, external causes of mortality and other causes, and 19
   specific causes of death. Trends were assessed using join point analysis
   with PYLL expressed as age-standardised rate. The analysis was based on
   the official death certification files provided by the Swiss Federal
   Statistical Office.
   Results: Age adjusted PYLL rates decreased for all categories of causes,
   but the decline in cancers was modest compared to circulatory diseases
   and external causes. The strongest downward trends were observed for
   AIDS, traffic accidents and ischaemic heart disease. In women breast
   cancer contributed most to the decline of premature mortality but
   remains the first cause of early death. Lung cancer in women is the only
   cause of premature mortality with rising trends.
   Conclusions: Past efforts in prevention, early detection and treatment,
   but also a healthier lifestyle and other factors, have very probably
   contributed to the considerable reduction in the rate of potential years
   of life lost, but the rising rate of premature mortality caused by lung
   cancer in women is of concern. Persistent efforts in prevention and
   early detection are required to further reduce premature death and its
   burden on society.},
Publisher = {E M H SWISS MEDICAL PUBLISHERS LTD},
Address = {FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Savidan, A (Corresponding Author), Krebsliga St Gallen Appenzell, Canc Registry, Flurhofstr 7, CH-9000 St Gallen, Switzerland.
   Savidan, Anita; Ess, Silvia, Canc Registry St Gallen Appenzell, St Gallen, Switzerland.
   Junker, Christoph, Fed Stat Off FSO, Sect Populat Hlth, Neuchatel, Switzerland.
   Cerny, Thomas, Kantonsspital St Gallen, Dept Internal Med Oncol, St Gallen, Switzerland.},
DOI = {10.4414/smw.2010.13077},
Article-Number = {w13077},
ISSN = {1424-7860},
EISSN = {1424-3997},
Keywords = {premature mortality; causes of death; time trends; Switzerland},
Keywords-Plus = {POTENTIAL LIFE LOST; MORTALITY TRENDS; CANCER-MORTALITY; RISK-FACTORS;
   LUNG-CANCER; IMPACT; PREVENTION; STATISTICS; REGRESSION; COUNTRIES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {anitasavidan@yahoo.com},
Funding-Acknowledgement = {Krebsliga St. Gallen - Appenzell},
Funding-Text = {This study was supported by an unrestricted grant from the Krebsliga St.
   Gallen - Appenzell.},
Cited-References = {BERRUT S, 2008, STAT SCHWEIZ.
   BLANE D, 1990, BRIT MED J, V301, P429, DOI 10.1136/bmj.301.6749.429.
   Blane D, 1998, BRIT MED J, V317, P255, DOI 10.1136/bmj.317.7153.255.
   Bulliard JL, 2006, ANN ONCOL, V17, P57, DOI 10.1093/annonc/mdj035.
   Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   GUBERAN E, 1979, SCHWEIZ MED WSCHR, V109, P1465.
   IARC, 1976, IARC SCI PUBL, P1.
   Kim HJ, 2004, BIOMETRICS, V60, P1005, DOI 10.1111/j.0006-341X.2004.00256.x.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Kuntsche S, 2005, SOZ PRAVENTIV MED, V50, P344, DOI 10.1007/s00038-005-4110-6.
   Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894.
   LAVECCHIA C, 2009, ANN ONCOL.
   Levi F, 2004, CANCER-AM CANCER SOC, V101, P2843, DOI 10.1002/cncr.20666.
   Levi F, 2007, INT J CANCER, V121, P462, DOI 10.1002/ijc.22694.
   Lutz JM, 2004, EUR J CANCER PREV, V13, P77, DOI 10.1097/00008469-200402000-00012.
   Meyer K, 2008, SWISS MED WKLY, V138, P506, DOI 2008/35/smw-12304.
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2.
   {*}NAT CANC I STAT R, 2009, JOINP REGR PROGR VER.
   {*}NCI, 2008, JOIN POINT REGR PROG.
   NIEMANN S, 2008, UNFALLGESCHEHEN SCHW.
   Parkin DM, 1994, 19 IARC.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   Rask K, 2009, J PUBLIC HEALTH-UK, V31, P231, DOI 10.1093/pubmed/fdp015.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   StataCorp, 2007, STAT STAT SOFTW REL.
   Steiger VS, 2009, SWISS MED WKLY, V139, P453.
   Tyczynski JE, 2003, LANCET ONCOL, V4, P45, DOI 10.1016/S1470-2045(03)00960-4.
   Wheller Levin, 2006, Health Stat Q, P34.
   Wiesner G, 1993, Gesundheitswesen, V55, P367.
   WIGLE DT, 1990, CAN J PUBLIC HEALTH, V81, P376.
   World Health Organization, 1994, INT STAT CLASS DIS R.},
Number-of-Cited-References = {32},
Times-Cited = {13},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Swiss Med. Wkly.},
Doc-Delivery-Number = {749GB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000289450900002},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:A1991GT16100012,
Author = {CORTEN, P and RIBOURDOUILLE, M and DRAMAIX, M},
Title = {PREMATURE DEATH AMONG OUTPATIENTS AT A COMMUNITY MENTAL-HEALTH-CENTER},
Journal = {HOSPITAL AND COMMUNITY PSYCHIATRY},
Year = {1991},
Volume = {42},
Number = {12},
Pages = {1248-1251},
Month = {DEC},
Abstract = {In a ten-year prospective study, mortality among psychiatric
   out-patients under age 40 was investigated in a sample of 322 Belgian
   patients who first visited a community mental health center in a
   district of Brussels between 1970 and 1973.  Fifteen of the patients
   died before age 40.  Compared with 15 matched controls from the group of
   living patients, the deceased patients had a higher incidence of
   concurrent physical illness and changed residence less frequently.  The
   standardized mortality ratio for male patients in the study was 5.05
   times greater than expected for a sample of the general population of
   Belgium, and for women it was 5.63 times greater.  Not all of the excess
   mortality could be attributed to suicide.  Results confirmed previous
   findings of excess mortality due to natural causes in this population
   and of the greater incidence of mortality during the first years of
   treatment.},
Publisher = {AMER PSYCHIATRIC ASSOCIATION},
Address = {1400 K ST NW, WASHINGTON, DC 20005},
Type = {Article},
Language = {English},
Affiliation = {CORTEN, P (Corresponding Author), FREE UNIV BRUSSELS,MED PSYCHOL LAB,4 PL VAN GEHUCHTEN,B-1050 BRUSSELS,BELGIUM.
   FREE UNIV BRUSSELS,SCH PUBL HLTH,EPIDEMIOL \& SOCIAL MED LAB,B-1050 BRUSSELS,BELGIUM.},
ISSN = {0022-1597},
Keywords-Plus = {MORTALITY},
Research-Areas = {Public, Environmental \& Occupational Health; Psychiatry},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Psychiatry},
Cited-References = {Corten P, 1986, Acta Psychiatr Belg, V86, P394.
   Corten P, 1987, Rev Med Suisse Romande, V107, P653.
   CORTEN PF, 1989, INTERACTION MENTAL P.
   CRAIG TJ, 1981, ARCH GEN PSYCHIAT, V38, P935.
   Cullerre A., 1890, TRAITE PRATIQUE MALA.
   ELLMAN JP, 1982, J PSYCHIATRY, V27, P331.
   Esquirol Jean-EtienneDominique., 1838, MALADIES MENTALES CO.
   FARR W, 1841, J STAT SOC, V4, P17.
   Griesinger W., 1865, TRAITE MALADIES MENT.
   HAFNER H, 1989, INTERACTIN MENTAL PH.
   HOENIG J, 1966, ACTA PSYCHIAT SCAND, V42, P349, DOI 10.1111/j.1600-0447.1966.tb06175.x.
   HOLLISTER LE, 1965, J AMER MED ASSOC, V192, P1035, DOI 10.1001/jama.1965.03080250013003.
   HUSSAR AE, 1966, J NERV MENT DIS, V142, P45, DOI 10.1097/00005053-196601000-00007.
   Innes G, 1970, Scott Med J, V15, P143.
   Malzberg B, 1953, MENT HYG, V37, P619.
   ODEGARD O, 1967, ACTA GENET STAT MED, V17, P137.
   ODEGARD O, 1951, ACTA GENETICA BASEL, V11, P141.
   RICHARDSON HL, 1966, J AMER MED ASSOC, V195, P254, DOI 10.1001/jama.195.4.254.
   RORSMAN B, 1974, ACTA PSYCHIAT SCAND, V50, P354, DOI 10.1111/j.1600-0447.1974.tb08221.x.
   SHEPHERD M, 1957, STUDY MAJOR PSYCHOSI.
   Siegel S, 1988, NONPARAMETRIC STATIS.
   SIMS ACP, 1982, PHYSICAL ILLNESS PSY.
   Thom Rene, 1983, PARABOLES CATASTROPH.
   von Krafft-Ebing R., 1897, TRAITE CLIN PSYCHIAT.
   {[}No title captured].},
Number-of-Cited-References = {25},
Times-Cited = {22},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Doc-Delivery-Number = {GT161},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991GT16100012},
DA = {2022-03-29},
}

@article{ WOS:A1978FJ09700015,
Author = {BOWERMAN, DL and LEVISKY, JA and URICH, RW and WITTENBERG, PH},
Title = {PREMATURE DEATHS IN PERSONS WITH SEIZURE DISORDERS - SUB-THERAPEUTIC
   LEVELS OF ANTICONVULSANT DRUGS IN POSTMORTEM BLOOD SPECIMENS},
Journal = {JOURNAL OF FORENSIC SCIENCES},
Year = {1978},
Volume = {23},
Number = {3},
Pages = {522-526},
Publisher = {AMER SOC TESTING MATERIALS},
Address = {100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959},
Type = {Article},
Language = {English},
Affiliation = {BOWERMAN, DL (Corresponding Author), ST FRANCIS HOSP,DEPT PATHOL,COLORADO SPRINGS,CO 80903, USA.},
ISSN = {0022-1198},
Research-Areas = {Legal Medicine},
Web-of-Science-Categories  = {Medicine, Legal},
Number-of-Cited-References = {0},
Times-Cited = {25},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Forensic Sci.},
Doc-Delivery-Number = {FJ097},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1978FJ09700015},
DA = {2022-03-29},
}

@article{ WOS:A1988M602200002,
Author = {SORENSEN, TIA and NIELSEN, GG and ANDERSEN, PK and TEASDALE, TW},
Title = {GENETIC AND ENVIRONMENTAL-INFLUENCES ON PREMATURE DEATH IN ADULT
   ADOPTEES},
Journal = {NEW ENGLAND JOURNAL OF MEDICINE},
Year = {1988},
Volume = {318},
Number = {12},
Pages = {727-732},
Month = {MAR 24},
Publisher = {MASS MEDICAL SOC},
Address = {10 SHATTUCK, BOSTON, MA 02115},
Type = {Article},
Language = {English},
Affiliation = {SORENSEN, TIA (Corresponding Author), HVIDOVRE UNIV HOSP,DEPT MED B259,DK-2650 COPENHAGEN,DENMARK.
   UNIV COPENHAGEN,PANUM INST,STAT RES UNIT,DK-2200 COPENHAGEN N,DENMARK.
   KOMMUNE HOSP,INST PSYCHOL,DK-1399 COPENHAGEN,DENMARK.},
DOI = {10.1056/NEJM198803243181202},
ISSN = {0028-4793},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {AALEN O, 1978, ANN STAT, V6, P534, DOI 10.1214/aos/1176344198.
   ABBOTT MH, 1974, JOHNS HOPKINS MED J, V134, P1.
   ABBOTT MH, 1978, AM J MED GENET, V2, P105, DOI 10.1002/ajmg.1320020202.
   ANDERSEN PK, 1982, BIOMETRICS, V38, P67, DOI 10.2307/2530289.
   ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976.
   BERG K, 1985, MED GENETICS PAST PR, P351.
   BIOZZI G, 1984, ADV IMMUNOL, V36, P189, DOI 10.1016/S0065-2776(08)60902-5.
   BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204.
   CARMELLI D, 1982, HUM BIOL, V54, P525.
   CLONINGER CR, 1979, AM J HUM GENET, V31, P366.
   COHEN BH, 1964, Q REV BIOL, V39, P130, DOI 10.1086/404164.
   COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408.
   COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   ELDRED CA, 1976, AM J ORTHOPSYCHIAT, V46, P279, DOI 10.1111/j.1939-0025.1976.tb00928.x.
   FABSITZ RR, 1978, BEHAV GENET, V8, P15, DOI 10.1007/BF01067701.
   FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464.
   FELDMAN MW, 1975, SCIENCE, V190, P1163, DOI 10.1126/science.1198102.
   GARN SM, 1979, HUM BIOL, V51, P565.
   GLASSER M, 1981, J CHRON DIS, V34, P439, DOI 10.1016/0021-9681(81)90003-5.
   GOLDBOURT U, 1986, ARTERIOSCLEROSIS, V6, P357, DOI 10.1161/01.ATV.6.4.357.
   GONWA TA, 1983, ADV IMMUNOL, V34, P71, DOI 10.1016/S0065-2776(08)60377-6.
   HAUGE M, 1963, GENETICS TODAY, P280.
   HAWKINS MR, 1965, B JOHNS HOPKINS HOSP, V117, P24.
   HOLM NV, 1982, CANCER SURV, V1, P1.
   HRUBEC Z, 1984, ACTA GENET MED GEMEL, V33, P403, DOI 10.1017/S0001566000005857.
   JACOBSEN B, 1981, PROSPECTIVE LONGITUD, P225.
   JARVIK LF, 1960, AM J HUM GENET, V12, P170.
   Juel K, 1981, Ugeskr Laeger, V143, P2669.
   KENDLER KS, 1986, AM J PSYCHIAT, V143, P279.
   KHOURY MJ, 1986, J CHRON DIS, V39, P963, DOI 10.1016/0021-9681(86)90134-7.
   KNUDSON AG, 1984, CANCER DETECT PREV, V7, P1.
   PEARL R., 1931, HUMAN BIOL, V3, P245.
   PHILIPPE P, 1978, AM J MED GENET, V2, P121, DOI 10.1002/ajmg.1320020203.
   PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374.
   SCHOTTENFELD D, 1986, J CHRON DIS, V39, P1021, DOI 10.1016/0021-9681(86)90137-2.
   Schull W J, 1980, Epidemiol Rev, V2, P1.
   STRONG LC, 1977, CANCER-AM CANCER SOC, V40, P438, DOI 10.1002/1097-0142(197707)40:1+<438::AID-CNCR2820400705>3.0.CO;2-I.
   STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401.
   SWEDLUND AC, 1983, HUM BIOL, V55, P115.
   TEASDALE TW, 1979, BEHAV GENET, V9, P103, DOI 10.1007/BF01074329.
   TSIATIS AA, 1981, ANN STAT, V9, P93, DOI 10.1214/aos/1176345335.
   VANDENBROUCKE JP, 1984, AM J EPIDEMIOL, V119, P742, DOI 10.1093/oxfordjournals.aje.a113795.
   WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X.
   WILLETT WC, 1984, NEW ENGL J MED, V310, P633, DOI 10.1056/NEJM198403083101006.
   WILLETT WC, 1984, NEW ENGL J MED, V310, P697, DOI 10.1056/NEJM198403153101106.
   WILLIAMS DL, 1985, ARTERIOSCLEROSIS, V5, P213, DOI 10.1161/01.ATV.5.3.213.
   WYSHAK G, 1978, SOC BIOL, V25, P315, DOI 10.1080/19485565.1978.9988353.
   {[}No title captured], DOI DOI 10.1016/0022-3956(68)90026-5.},
Number-of-Cited-References = {50},
Times-Cited = {568},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {N. Engl. J. Med.},
Doc-Delivery-Number = {M6022},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1988M602200002},
DA = {2022-03-29},
}

@article{ WOS:000344729700002,
Author = {Selassie, Anbesaw W. and Wilson, Dulaney A. and Malek, Angela M. and
   Wagner, Janelle L. and Smith, Gigi and Martz, Gabriel and Edwards,
   Jonathan and Wannamaker, Braxton and Zack, Matthew M. and Kobau,
   Rosemarie},
Title = {Premature Deaths Among Children with Epilepsy - South Carolina,
   2000-2011},
Journal = {MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT},
Year = {2014},
Volume = {63},
Number = {44},
Month = {NOV 7},
Publisher = {CENTER DISEASE CONTROL \& PREVENTION},
Address = {MAILSTOP E-90, ATLANTA, GA 30333 USA},
Type = {Article},
Language = {English},
Affiliation = {Kobau, R (Corresponding Author), CDC, Div Populat Hlth, Natl Ctr Chron Dis Prevent \& Hlth Promot, Atlanta, GA 30333 USA.
   Selassie, Anbesaw W.; Wilson, Dulaney A.; Malek, Angela M., Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC USA.
   Wagner, Janelle L.; Smith, Gigi, Med Univ S Carolina, Coll Nursing, Charleston, SC USA.
   Martz, Gabriel; Edwards, Jonathan; Wannamaker, Braxton, Med Univ S Carolina, Coll Med, Dept Neurol, Charleston, SC USA.
   Zack, Matthew M.; Kobau, Rosemarie, CDC, Div Populat Hlth, Natl Ctr Chron Dis Prevent \& Hlth Promot, Atlanta, GA 30333 USA.},
ISSN = {0149-2195},
EISSN = {1545-861X},
Keywords-Plus = {CHILDHOOD EPILEPSY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {rkobau@cdc.gov},
Cited-References = {Berg AT, 2013, NEUROLOGY, V81, P1166, DOI 10.1212/WNL.0b013e3182a55fb9.
   Berg AT, 2013, PEDIATRICS, V132, P124, DOI 10.1542/peds.2012-3998.
   Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x.
   Kenney MK, 2013, EPILEPSY RES TR 1021.
   MORGENSTERN H, 1980, INT J EPIDEMIOL, V9, P97, DOI 10.1093/ije/9.1.97.
   Pastor PN, 2014, DISABIL HLTH J.
   Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371.
   Turchi R, 2014, PEDIATRICS, V133, pE1451, DOI 10.1542/peds.2014-0318.
   Weis MA, 2006, INJURY PREV, V12, P17, DOI 10.1136/ip.2006.012427.},
Number-of-Cited-References = {9},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {MMWR-Morb. Mortal. Wkly. Rep.},
Doc-Delivery-Number = {AT1ZM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000344729700002},
DA = {2022-03-29},
}

@article{ WOS:000650821700002,
Author = {Pala, Kayihan and Aykac, Nilufer and Yasin, Yesim},
Title = {Premature deaths attributable to long-term exposure to PM2.5 in Turkey},
Journal = {ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH},
Year = {2021},
Volume = {28},
Number = {37},
Pages = {51940-51947},
Month = {OCT},
Abstract = {This research aims to reveal the premature deaths caused by long-term
   exposure to PM2.5 in 2018 in Turkey utilizing the AirQ+ program
   developed by the World Health Organization. Calculation of yearly
   average PM2.5 concentration in provinces, acreage of provinces, and the
   mortality rate of the at-risk population was the data required for the
   operation of the AirQ+ program. With the help of the AirQ+ program, the
   results revealed that a total of 44,617 people (95\% CI 29.882-57.709)
   died prematurely due to sustained exposure to PM2.5 in Turkey in 2018.
   The highest estimated mortality proportion attributable to PM2.5
   pollution was in the provinces of Igdir and Kahramanmaras. The highest
   estimated number of mortality cases per 100,000 population attributable
   to PM2.5 pollution was in the provinces of Manisa and Afyonkarahisar.
   This research points out that reaching the PM2.5 limits specified by the
   WHO could have prevented 44,617 premature deaths in the year 2018 in
   Turkey.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Yasin, Y (Corresponding Author), Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Publ Hlth, Icerenkoy Mah Kayisdagi Cad 32, TR-34684 Istanbul, Turkey.
   Pala, Kayihan, Bursa Uludag Univ, Fac Med, Dept Publ Hlth, Bursa, Turkey.
   Aykac, Nilufer, Gayrettepe Florence Nightingale Hosp, Dept Pulm Med, Istanbul, Turkey.
   Yasin, Yesim, Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Publ Hlth, Icerenkoy Mah Kayisdagi Cad 32, TR-34684 Istanbul, Turkey.},
DOI = {10.1007/s11356-021-13923-5},
EarlyAccessDate = {MAY 2021},
ISSN = {0944-1344},
EISSN = {1614-7499},
Keywords = {Air pollution; Premature deaths; AirQ plus; Particulate matter; Turkey},
Keywords-Plus = {OUTDOOR AIR-POLLUTION; HUMAN HEALTH; MORTALITY; IMPACT; QUALITY; DISEASE},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {kpala@uludag.edu.tr
   nilufer.aykac@florence.com.tr
   yesim.yasin@acibadem.edu.tr},
ORCID-Numbers = {Pala, Kayihan/0000-0002-0983-4904
   Yasin, Yesim/0000-0002-3188-3999},
Cited-References = {{[}Anonymous], TURKISH OFFICIAL GAZ.
   Badyda AJ, 2017, ADV EXP MED BIOL, V944, P9, DOI 10.1007/5584\_2016\_55.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Daryanoosh M, 2018, TOXIN REV, V37, P313, DOI 10.1080/15569543.2017.1370602.
   Fattore E, 2011, ENVIRON RES, V111, P1321, DOI 10.1016/j.envres.2011.06.012.
   Garcia CA, 2016, INT J ENVIRON HEAL R, V26, P145, DOI 10.1080/09603123.2015.1061113.
   Goudarzi G., 2012, ARCH HYG SCI, V1, P59.
   Gumusel D, 2015, REPORT HLTH ENV ALLI.
   Hadei M, 2020, ATMOS ENVIRON, V224, DOI 10.1016/j.atmosenv.2020.117365.
   Hamanaka RB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00680.
   Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43.
   {[}IARC] International Agency for Research on Cancer, 2013, OUTDOOR AIR POLLUTIO.
   Jimenez E, 2011, INT J ENVIRON HEAL R, V21, P372, DOI 10.1080/09603123.2011.560251.
   JIN JEONG SANG, 2013, Asian Journal of Atmospheric Environment, V7, P227, DOI 10.5572/ajae.2013.7.4.227.
   Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1.
   Lee BJ, 2014, TOXICOL RES-GER, V30, P71, DOI {[}10.5487/TR.2014.30.2.071, 10.5487/TR.2014.30.2.71].
   Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC.
   Liu Jingyi, 2019, Wei Sheng Yan Jiu, V48, P993.
   Maheswaran R, 2010, STROKE, V41, P869, DOI 10.1161/STROKEAHA.109.567743.
   Manojkumar N, 2021, INT J ENVIRON HEAL R, V31, P258, DOI 10.1080/09603123.2019.1651257.
   Marc M, 2018, ENVIRON SCI POLLUT R, V25, P2065, DOI 10.1007/s11356-017-0839-8.
   Miri M, 2017, ENVIRON SCI POLLUT R, V24, P16513, DOI 10.1007/s11356-017-9189-9.
   Miri M, 2016, ENVIRON RES, V151, P451, DOI 10.1016/j.envres.2016.07.039.
   Mudu P, 2018, AIRQ EXAMPLE CALCULA.
   Naddafi K, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-28.
   National Mapping Institution, GEN DIRECTORATE MAPP.
   Ozdemir TU, 2019, HLTH STAT YB 2018.
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Pope CA., 2006, ASSOC, V56, DOI {[}10.1080/10473289.2006.10464485, DOI 10.1080/10473289.2006.10464485].
   Rovira J, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135538.
   Sacks JD, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11050516.
   Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6.
   Shahsavani A, 2012, J ARID ENVIRON, V77, P72, DOI 10.1016/j.jaridenv.2011.09.007.
   Shahsavani A, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105299.
   Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518.
   Turkish Statistical Institute, 2018, POPULATION AGE GROUP.
   Turkish Statistical Institute, 2018, ADDRESS BASED POPULA.
   Turkish Statistical Institute, CENTRAL DISTRIBUTION.
   Turner MC, 2011, AM J RESP CRIT CARE, V184, P1374, DOI 10.1164/rccm.201106-1011OC.
   WHO, 2018, GLOBAL AMBIENT AIR Q.
   WHO, 2010, WHO REGIONAL OFFICE.
   WHO, 2020, HLTH IMPACT ASSESSME.
   WHO Regional Office for Europe European Centre for Environment and Health, 2019, AIRQ SOFTWARE TOOL H.
   World Health Organization (WHO), 2020, AMBIENT AIR POLLUTIO.
   Yu BF, 2009, INT J REFRIG, V32, P3, DOI 10.1016/j.ijrefrig.2008.05.004.},
Number-of-Cited-References = {46},
Times-Cited = {2},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Environ. Sci. Pollut. Res.},
Doc-Delivery-Number = {UW6KD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000650821700002},
DA = {2022-03-29},
}

@article{ WOS:000402477900009,
Author = {Carr, Matthew J. and Ashcroft, Darren M. and Kontopantelis, Evangelos
   and While, David and Awenat, Yvonne and Cooper, Jayne and Chew-Graham,
   Carolyn and Kapur, Nav and Webb, Roger T.},
Title = {Premature Death Among Primary Care Patients With a History of Self-Harm},
Journal = {ANNALS OF FAMILY MEDICINE},
Year = {2017},
Volume = {15},
Number = {3},
Pages = {246-254},
Month = {MAY-JUN},
Abstract = {PURPOSE Self-harm is a public health problem that requires a better
   understanding of mortality risk. We undertook a study to examine
   premature mortality in a nationally representative cohort of primary
   care patients who had harmed themselves.
   METHODS During 2001-2013, a total of 385 general practices in England
   contributed data to the Clinical Practice Research Datalink with linkage
   to Office for National Statistics mortality records. We identified
   30,017 persons aged 15 to 64 years with a recorded episode of self-harm.
   We estimated the relative risks of all-cause and cause-specific natural
   and unnatural mortality using a comparison cohort of 600,258 individuals
   matched on age, sex, and general practice.
   RESULTS We found an elevated risk of dying prematurely from any cause
   among the self-harm cohort, especially in the first year of follow-up
   (adjusted hazard ratio for that year, 3.6; 95\% CI, 3.1-4.2). In
   particular, suicide risk was especially high during the first year
   (adjusted hazard ratio, 54.4; 95\% CI, 34.3-86.3); although it declined
   sharply, it remained much higher than that in the comparison cohort.
   Large elevations of risk throughout the follow-up period were also
   observed for accidental, alcohol-related, and drug poisoning deaths. At
   10 years of follow-up, cumulative incidence values were 6.5\% (95\% CI,
   6.0\%-7.1\%) for all-cause mortality and 1.3\% (95\% CI, 1.2\%-1.5\%)
   for suicide.
   CONCLUSIONS Primary care patients who have harmed themselves are at
   greatly increased risk of dying prematurely by natural and unnatural
   causes, and especially within a year of a first episode. These
   individuals visit clinicians at a relatively high frequency, which
   presents a clear opportunity for preventive action. Primary care
   patients with myriad comorbidities, including self-harming behavior,
   mental disorder, addictions, and physical illnesses, will require
   concerted, multipronged, multidisciplinary collaborative care
   approaches.},
Publisher = {ANNALS FAMILY MEDICINE},
Address = {11400 TOMAHAWK CREEK PARKWAY, LEAWOOD, KS 66211-2672 USA},
Type = {Article},
Language = {English},
Affiliation = {Carr, MJ (Corresponding Author), Univ Manchester, Div Psychol \& Mental Hlth, Fac Biol Med \& Hlth, Manchester Acad Hlth Sci Ctr, Room 2-309,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
   Carr, Matthew J.; While, David; Awenat, Yvonne; Cooper, Jayne; Kapur, Nav; Webb, Roger T., Univ Manchester, Div Psychol \& Mental Hlth, Fac Biol Med \& Hlth, Manchester Acad Hlth Sci Ctr, Room 2-309,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
   Ashcroft, Darren M., Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Pharm \& Optometry, Fac Biol Med \& Hlth, Manchester M13 9PL, Lancs, England.
   Ashcroft, Darren M., NIHR Greater Manchester Primary Care Patient Safe, Manchester M13 9PL, Lancs, England.
   Kontopantelis, Evangelos, Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Informat Imaging \& Data Sci, Fac Biol Med \& Hlth, Manchester M13 9PL, Lancs, England.
   Chew-Graham, Carolyn, Keele Univ, Res Inst Primary Care \& Hlth Sci, Keele ST5 5BG, Staffs, England.
   Chew-Graham, Carolyn, West Midlands NIHR Collaborat Leadership Appl Hlt, Birmingham, W Midlands, England.},
DOI = {10.1370/afm.2054},
ISSN = {1544-1709},
EISSN = {1544-1717},
Keywords = {self-harm; general practice; mortality; suicide; primary care;
   practice-based research},
Keywords-Plus = {SUICIDE MORTALITY; RISK-FACTORS; MULTICENTER; COHORT; BEHAVIOR},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Primary Health Care; Medicine, General \& Internal},
Author-Email = {matthew.carr@manchester.ac.uk},
ResearcherID-Numbers = {Kontopantelis, Evangelos/H-2966-2019
   Ashcroft, Darren/G-3244-2015},
ORCID-Numbers = {Kontopantelis, Evangelos/0000-0001-6450-5815
   Webb, Roger/0000-0001-8532-2647
   Awenat, Yvonne/0000-0002-0767-4994
   Kapur, Nav/0000-0002-3100-3234
   Ashcroft, Darren/0000-0002-2958-915X},
Funding-Acknowledgement = {Department of Health Policy Research Programme Suicide Prevention {[}RDD
   023/0166]; Manchester Mental Health and Social Care Trust; National
   Institute for Health Research (NIHR) Collaborations for Leadership in
   Applied Health Research and Care West MidlandsNational Institute for
   Health Research (NIHR); MRC Health eResearch Centre (HeRC) grant
   {[}MR/K006665/1]; MRCUK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC) {[}MR/K006665/1] Funding Source: UKRI},
Funding-Text = {This work was supported by the Department of Health Policy Research
   Programme Suicide Prevention call (Self-harm in Primary Care Patients: A
   Nationally Representative Cohort Study Examining Patterns of Attendance,
   Treatment and Referral, and Risk of Selfharm Repetition, Suicide and
   Other Causes of Premature Death; RDD 023/0166). N.K. is funded in part
   by the Manchester Mental Health and Social Care Trust, and C.C.-G. is
   funded in part by the National Institute for Health Research (NIHR)
   Collaborations for Leadership in Applied Health Research and Care West
   Midlands. E.K.'s time and facilities were also supported by MRC Health
   eResearch Centre (HeRC) grant no. MR/K006665/1.},
Cited-References = {{[}Anonymous], 1992, MAN INT CLASS DIS.
   Bergen H, 2012, PSYCHOL MED, V42, P727, DOI 10.1017/S0033291711001747.
   Bergen H, 2014, JRSM OPEN, V5.
   Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6.
   Bjornaas MA, 2009, CLIN TOXICOL, V47, P116, DOI 10.1080/15563650701771981.
   Breakwell Claudia, 2007, Health Stat Q, P6.
   BROOKMEYER R, 1987, BIOMETRICS, V43, P739, DOI 10.2307/2531529.
   Carr MJ, 2016, J AFFECT DISORDERS, V197, P182, DOI 10.1016/j.jad.2016.03.013.
   Carr MJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0753-5.
   Carter G, 2005, AUST NZ J PSYCHIAT, V39, P101, DOI 10.1111/j.1440-1614.2005.01515.x.
   Chen VCH, 2011, BRIT J PSYCHIAT, V198, P31, DOI 10.1192/bjp.bp.110.080952.
   CHISHOLM J, 1990, BRIT MED J, V300, P1092, DOI 10.1136/bmj.300.6732.1092.
   Christiansen E, 2007, AUST NZ J PSYCHIAT, V41, P257, DOI 10.1080/00048670601172749.
   Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297.
   Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   De Leo D, 2001, INT J GERIATR PSYCH, V16, P300, DOI 10.1002/gps.337.
   Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 T.
   Druss BG, 2011, 21 RW JOHNS FDN.
   Fazel S, 2007, J CLIN PSYCHOPHARM, V27, P503, DOI 10.1097/jcp.0b013e31814ce3ef.
   Finkelstein Y, 2015, JAMA PSYCHIAT, V72, P570, DOI 10.1001/jamapsychiatry.2014.3188.
   Gibb SJ, 2005, AUST NZ J PSYCHIAT, V39, P95, DOI 10.1111/j.1440-1614.2005.01514.x.
   Hawton K, 2008, J CHILD PSYCHOL PSYC, V49, P441, DOI 10.1111/j.1469-7610.2007.01852.x.
   Heaton B, 2014, ANN EPIDEMIOL, V24, P741, DOI 10.1016/j.annepidem.2014.07.006.
   Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098.
   Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562.
   Kuo CJ, 2012, BRIT J PSYCHIAT, V200, P405, DOI 10.1192/bjp.bp.111.099366.
   Lebret S, 2006, INT J GERIATR PSYCH, V21, P1052, DOI 10.1002/gps.1605.
   Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465.
   McMahon EM, 2013, SUICIDE LIFE-THREAT, V43, P634, DOI 10.1111/sltb.12045.
   National Institute for Health and Clinical Excellence (NICE), 2011, SELFH LONG TERM MAN.
   Ness J, 2015, EMERG MED J, V32, P793, DOI 10.1136/emermed-2013-202753.
   NICE, 2004, SELF HARM SHORT TERM.
   NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637.
   ONS, DEATHS REL DRUG POIS.
   Owens D, 2005, BRIT J PSYCHIAT, V187, P470, DOI 10.1192/bjp.187.5.470.
   Reith DM, 2004, AUST NZ J PSYCHIAT, V38, P520, DOI 10.1111/j.1440-1614.2004.01405.x.
   Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419.
   Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825.
   Suominen K, 2004, SOC PSYCH PSYCH EPID, V39, P720, DOI 10.1007/s00127-004-0796-7.
   Tidemalm D, 2015, PSYCHOL MED, V45, P1699, DOI 10.1017/S0033291714002827.},
Number-of-Cited-References = {41},
Times-Cited = {18},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Ann. Fam. Med.},
Doc-Delivery-Number = {EW4NJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000402477900009},
OA = {Green Accepted, Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000714189200015,
Author = {Nansai, Keisuke and Tohno, Susumu and Chatani, Satoru and Kanemoto,
   Keiichiro and Kagawa, Shigemi and Kondo, Yasushi and Takayanagi, Wataru
   and Lenzen, Manfred},
Title = {Consumption in the G20 nations causes particulate air pollution
   resulting in two million premature deaths annually},
Journal = {NATURE COMMUNICATIONS},
Year = {2021},
Volume = {12},
Number = {1},
Month = {NOV 2},
Abstract = {Worldwide exposure to ambient PM2.5 causes millions of premature deaths
   annually. Here the authors quantify the global footprint of PM2.5-driven
   premature deaths for the G20 countries, which are in a position to lead
   internationally coordinated mitigation efforts.
   Worldwide exposure to ambient PM2.5 causes over 4 million premature
   deaths annually. As most of these deaths are in developing countries,
   without internationally coordinated efforts this polarized situation
   will continue. As yet, however, no studies have quantified
   nation-to-nation consumer responsibility for global mortality due to
   both primary and secondary PM2.5 particles. Here we quantify the global
   footprint of PM2.5-driven premature deaths for the 19 G20 nations in a
   position to lead such efforts. G20 consumption in 2010 was responsible
   for 1.983 {[}95\% Confidence Interval: 1.685-2.285] million premature
   deaths, at an average age of 67, including 78.6 {[}71.5-84.8] thousand
   infant deaths, implying that the G20 lifetime consumption of about 28
   {[}24-33] people claims one life. Our results indicate that G20 nations
   should take responsibility for their footprint rather than focusing
   solely on transboundary air pollution, as this would expand
   opportunities for reducing PM2.5-driven premature mortality. Given the
   infant mortality footprint identified, it would moreover contribute to
   ensuring infant lives are not unfairly left behind in countries like
   South Africa, which have a weak relationship with G20 nations.},
Publisher = {NATURE PORTFOLIO},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Nansai, K (Corresponding Author), Natl Inst Environm Studies, Mat Cycles Div, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   Nansai, K (Corresponding Author), Univ Sydney, Fac Sci, Sch Phys, ISA, Camperdown, NSW 2006, Australia.
   Nansai, Keisuke; Takayanagi, Wataru, Natl Inst Environm Studies, Mat Cycles Div, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   Nansai, Keisuke; Lenzen, Manfred, Univ Sydney, Fac Sci, Sch Phys, ISA, Camperdown, NSW 2006, Australia.
   Tohno, Susumu, Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.
   Chatani, Satoru, Natl Inst Environm Studies, Reg Environm Conservat Div, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   Kanemoto, Keiichiro, Res Inst Humanity \& Nat, Kita Ku, 457-4 Motoyama, Kyoto 6038047, Japan.
   Kagawa, Shigemi, Kyushu Univ, Fac Econ, Higashi Ku, 6-19-1 Hakozaki, Fukuoka 8128581, Japan.
   Kondo, Yasushi, Waseda Univ, Fac Polit Sci \& Econ, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.},
DOI = {10.1038/s41467-021-26348-y},
Article-Number = {6286},
EISSN = {2041-1723},
Keywords-Plus = {HEALTH IMPACTS; PM2.5 EXPOSURE; CONTROL POLICIES; MORTALITY; EMISSIONS;
   MATTER; CHINA; TRANSPORT; AEROSOLS; PRODUCER},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {nansai.keisuke@nies.go.jp},
ResearcherID-Numbers = {Kanemoto, Keiichiro/O-9633-2016
   Nansai, Keisuke/C-2516-2008
   Chatani, Satoru/B-3697-2014},
ORCID-Numbers = {Kanemoto, Keiichiro/0000-0003-0230-9020
   Nansai, Keisuke/0000-0002-2449-1874
   Tohno, Susumu/0000-0002-3936-5600
   Lenzen, Manfred/0000-0002-0828-5288
   Chatani, Satoru/0000-0002-6272-574X},
Funding-Acknowledgement = {Japanese Ministry of Education, Culture, Sports, Science and
   TechnologyMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) {[}16H01797]; Japan Society for the Promotion
   of ScienceMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science
   {[}18KK0322]},
Funding-Text = {This research was supported in part by a Grant-in-Aid for Research (No.
   16H01797) from the Japanese Ministry of Education, Culture, Sports,
   Science and Technology, and by a Fund for the Promotion of Joint
   International Research (Fostering Joint International Research (A)) of
   the Japan Society for the Promotion of Science (No. 18KK0322). We are
   also grateful to Nigel Harle of Gronsveld, the Netherlands, for his
   conscientious improvement of our English.},
Cited-References = {{[}Anonymous], 2020, G20 SAUD ARB 2020.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636.
   Center for International Earth Science Information Network-CIESIN-Columbia University, 2018, GRIDDED POPULATION W.
   Conibear L, 2018, GEOHEALTH, V2, P196, DOI 10.1029/2018GH000139.
   Crippa M, 2018, EARTH SYST SCI DATA, V10, P1987, DOI 10.5194/essd-10-1987-2018.
   Emmons LK, 2010, GEOSCI MODEL DEV, V3, P43, DOI 10.5194/gmd-3-43-2010.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Gasso S, 2010, ATMOS CHEM PHYS, V10, P8287, DOI 10.5194/acp-10-8287-2010.
   Ginoux P, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000388.
   Gomez-Losada A, 2021, ATMOSPHERE-BASEL, V12, P5, DOI 10.3390/atmos12010005.
   Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012.
   He GJ, 2020, NAT SUSTAIN, V3, DOI 10.1038/s41893-020-0581-y.
   Health Effects Institute, 2018, SPECIAL REPORT.
   Hu JL, 2017, ENVIRON SCI TECHNOL, V51, P9950, DOI 10.1021/acs.est.7b03193.
   Institute for Health Metrics and Evaluation (IHME), 2018, GLOB HLTH DAT EXCH.
   Joint Research Center, 2018, EM DAT GLOB ATM RES.
   Kanemoto K, 2016, ENVIRON SCI TECHNOL, V50, P10512, DOI 10.1021/acs.est.6b03227.
   Kim E, 2019, ANN REGIONAL SCI, V63, P255, DOI 10.1007/s00168-019-00925-y.
   Kutralam-Muniasamy G, 2021, ENVIRON SCI POLLUT R, V28, P49989, DOI 10.1007/s11356-021-14168-y.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018.
   Lenzen M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235654.
   Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x.
   Lestari P, 2009, ATMOS ENVIRON, V43, P1760, DOI 10.1016/j.atmosenv.2008.12.044.
   Levy R, 2015, NASA MODIS ADAPTIVE, DOI {[}10.5067/MODIS/MYD04\_ L2.006, DOI 10.5067/MODIS/MYD04\_L2.006, 10.5067/MODIS/MOD04\_L2.061, DOI 10.5067/MODIS/MOD04\_L2.061].
   Liang S, 2017, J CLEAN PROD, V167, P133, DOI 10.1016/j.jclepro.2017.08.139.
   Liu J, 2020, ATMOS CHEM PHYS, V20, P7783, DOI 10.5194/acp-20-7783-2020.
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Maji KJ, 2018, SCI TOTAL ENVIRON, V612, P683, DOI 10.1016/j.scitotenv.2017.08.254.
   Moran D, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094017.
   Munksgaard J, 2001, ENERG POLICY, V29, P327, DOI 10.1016/S0301-4215(00)00120-8.
   Nagashima F, 2018, ENERG ECON, V70, P465, DOI 10.1016/j.eneco.2018.01.033.
   Nagashima F, 2017, ECON SYST RES, V29, P105, DOI 10.1080/09535314.2016.1266992.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Nansai K, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105238.
   Permadi DA, 2018, ATMOS CHEM PHYS, V18, P2725, DOI 10.5194/acp-18-2725-2018.
   Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014.
   Shaddick G, 2018, ENVIRON SCI TECHNOL, V52, P9069, DOI 10.1021/acs.est.8b02864.
   Silver B, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/aba3a2.
   Skamarock W.C., 2008, NCARTN475STR, DOI DOI 10.5065/D6DZ069T.
   Snider G, 2016, ATMOS CHEM PHYS, V16, P9629, DOI 10.5194/acp-16-9629-2016.
   Takahashi K, 2014, ATMOS ENVIRON, V97, P406, DOI 10.1016/j.atmosenv.2014.04.028.
   Tessum CW, 2019, P NATL ACAD SCI USA, V116, P6001, DOI 10.1073/pnas.1818859116.
   Thornhill GD, 2018, ATMOS CHEM PHYS, V18, P5321, DOI 10.5194/acp-18-5321-2018.
   Trasande L, 2016, ENVIRON HEALTH PERSP, V124, P1913, DOI 10.1289/ehp.1510810.
   United Nations, 2015, SUSTAINABLE DEV GOAL.
   van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010.
   Wakamatsu S., 2017, COMP STUDY URBAN AIR.
   Wang HK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00918-5.
   Wang PF, 2020, RESOUR CONSERV RECY, V158, DOI 10.1016/j.resconrec.2020.104814.
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1.
   WHO, 2018, AMB OUTD AIR POLL.
   WHO, 2017, EV WHO AIR QUAL GUID.
   {*}WHO, 2016, AMB OUTD AIR POLL DA.
   Wiedmann T, 2018, NAT GEOSCI, V11, P314, DOI 10.1038/s41561-018-0113-9.
   World Bank \& Institute for Health Metrics and Evaluation, 2016, COST AIR POLL STRENG.
   Wu R, 2017, ENVIRON SCI TECHNOL, V51, P5035, DOI 10.1021/acs.est.7b00026.
   Wu ZT, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2020.137274.
   Xia Y, 2018, ATMOS CHEM PHYS, V18, P14433, DOI 10.5194/acp-18-14433-2018.
   Xiao YY, 2018, RESOUR CONSERV RECY, V129, P1, DOI 10.1016/j.resconrec.2017.10.002.
   Yang SY, 2019, APPL ENERG, V249, P316, DOI 10.1016/j.apenergy.2019.04.173.
   Zhang HR, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.104996.
   Zhang Q, 2017, NATURE, V543, P705, DOI 10.1038/nature21712.
   Zhang YX, 2018, ENVIRON INT, V112, P100, DOI 10.1016/j.envint.2017.12.021.
   Zhao HY, 2017, ATMOS CHEM PHYS, V17, P10367, DOI 10.5194/acp-17-10367-2017.},
Number-of-Cited-References = {68},
Times-Cited = {1},
Usage-Count-Last-180-days = {17},
Usage-Count-Since-2013 = {17},
Journal-ISO = {Nat. Commun.},
Doc-Delivery-Number = {WR0GZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000714189200015},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000294257900008,
Author = {Webb, R. T. and Marshall, C. E. and Abel, K. M.},
Title = {Teenage motherhood and risk of premature death: long-term follow-up in
   the ONS Longitudinal Study},
Journal = {PSYCHOLOGICAL MEDICINE},
Year = {2011},
Volume = {41},
Number = {9},
Pages = {1867-1877},
Month = {SEP},
Abstract = {Background. Teenage motherhood is relatively common in the UK, but
   little is known about related health inequalities in this population. We
   estimated cause-specific mortality risks over three decades in a
   nationally representative cohort.
   Method. We examined premature mortality in a 1.1\% sample of all women
   who were teenagers in England and Wales during the 1970s, 1980s and
   1990s using data from the Office for National Statistics Longitudinal
   Study (ONS LS). Our primary outcome was suicide. Long-term follow-up to
   31 December 2006, to a potential maximum age of 49 years, was achieved
   through near-complete routine linkage to national mortality records. We
   created a time-dependent exposure variable, with relative risks
   estimated according to age when women first experienced motherhood
   versus a reference group of those currently without children.
   Results. Women who were teenage mothers were around 30\% more likely to
   die prematurely by any cause and almost 60\% more likely to die
   unnaturally, whereas first-time motherhood at mature age conferred lower
   risk compared to women without children. Teenage motherhood was
   associated with a more than doubled risk of suicide {[} mortality rate
   ratio (MRR) 2.23, 95\% confidence interval (CI) 1.30-3.83], and elevated
   risks of fatal cancer of the cervix and lung were also found. Changing
   the reference category to first-time mothers at 20 years and above also
   revealed a significant elevation in risk of accidental death.
   Conclusions. The complex psychosocial needs of these women require
   greater attention from clinicians, public health professionals, social
   services and policymakers. Their elevated risk of poor health outcomes
   may persist well beyond the actual teenage motherhood years.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA},
Type = {Article},
Language = {English},
Affiliation = {Webb, RT (Corresponding Author), Univ Manchester, Mental Hlth \& Neurodegenerat Res Grp, Manchester Acad Hlth Sci Ctr, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
   Webb, R. T., Univ Manchester, Mental Hlth \& Neurodegenerat Res Grp, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.
   Marshall, C. E., London Sch Hyg \& Trop Med, CeLSIUS Ctr Longitudinal Study Informat \& User Su, London, England.
   Abel, K. M., Univ Manchester, Ctr Womens Mental Hlth, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.},
DOI = {10.1017/S0033291711000055},
ISSN = {0033-2917},
EISSN = {1469-8978},
Keywords = {Epidemiology; mothers; pregnancy in adolescence; psychosocial
   deprivation; suicide},
Keywords-Plus = {PSYCHIATRIC-DISORDERS; PREGNANCY; HEALTH; AGE; DEPRIVATION; MORTALITY;
   SUICIDE; CHILDREN; AREAS; WOMEN},
Research-Areas = {Psychology; Psychiatry},
Web-of-Science-Categories  = {Psychology, Clinical; Psychiatry; Psychology},
Author-Email = {roger.webb@manchester.ac.uk},
ORCID-Numbers = {Webb, Roger/0000-0001-8532-2647
   Abel, Kathryn M/0000-0003-3538-8896},
Funding-Acknowledgement = {Economic and Social Research Council (ESRC)UK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC) {[}RES-348-25-0004];
   Economic and Social Research CouncilUK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC) {[}ES/D000076/1]
   Funding Source: researchfish; ESRCUK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC) {[}ES/D000076/1]
   Funding Source: UKRI},
Funding-Text = {The permission of the Office for National Statistics to use the
   Longitudinal Study is gratefully acknowledged, as is the help provided
   by staff of the Centre for Longitudinal Study Information and User
   Support (CeLSIUS). CeLSIUS is supported by the Economic and Social
   Research Council (ESRC) Census of Population Programme (Award Ref. :
   RES-348-25-0004). The authors alone are responsible for the
   interpretation of the data. Census output is Crown copyright and is
   reproduced with the permission of the Controller of Her Majesty's
   Stationery Office (HMSO) and the Queen's Printer for Scotland. We are
   grateful to Dr P. Norman, School of Geography, University of Leeds, UK,
   who gave us useful advice to help in revising the manuscript,
   specifically in relation to interpreting our adjustments for area-level
   deprivation effects.},
Cited-References = {APPLEBY L, 1991, BRIT MED J, V302, P137, DOI 10.1136/bmj.302.6769.137.
   Bjorge T, 1996, CANCER CAUSE CONTROL, V7, P351, DOI 10.1007/BF00052941.
   Breakwell Claudia, 2007, Health Stat Q, P6.
   Butterworth P, 2004, BRIT J PSYCHIAT, V184, P21, DOI 10.1192/bjp.184.1.21.
   Clayton D., 1993, STAT MODELS EPIDEMIO.
   COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408.
   {*}DEP CHILDR SCH FA, 2010, TEEN PREGN STRAT.
   {*}DEP HTLH, 2010, HLTH PROF ENGL 2009.
   Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641.
   DOLHAMMER G, 2000, POPULATION STUDIES, V54, P169.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392.
   GERONIMUS AT, 1994, POPUL DEV REV, V20, P585, DOI 10.2307/2137602.
   Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046.
   Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X.
   Hobcraft J, 2001, BRIT J SOCIOL, V52, P495.
   Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006.
   Kessler RC, 1997, AM J PSYCHIAT, V154, P1405.
   Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138.
   KOVACS M, 1994, J AM ACAD CHILD PSY, V33, P106, DOI 10.1097/00004583-199401000-00014.
   LINEHAN MM, 1983, J CONSULT CLIN PSYCH, V51, P276, DOI 10.1037/0022-006X.51.2.276.
   Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465.
   Maughan B, 1997, PSYCHOL MED, V27, P1129, DOI 10.1017/S0033291797005576.
   MCGHEE R, 1996, ADDICT BEHAV, V31, P1711.
   McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199.
   Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082.
   MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318.
   Norman, 2010, APPL SPAT ANAL POLIC, V3, P107, DOI {[}10.1007/s12061-009-9036-6, DOI 10.1007/S12061-009-9036-6].
   Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008.
   Olausson PO, 2004, BJOG-INT J OBSTET GY, V111, P793, DOI 10.1111/j.1471-0528.2004.00248.x.
   OTTERBLADOLAUSS.P, 2001, FAMILY PLANNING PERS, V33, P70.
   Quinlivan JA, 2004, AUST NZ J PSYCHIAT, V38, P197, DOI 10.1111/j.1440-1614.2004.01336.x.
   Robson K, 2003, EUR SOCIOL REV, V19, P451, DOI 10.1093/esr/19.5.451.
   Sarfati D, 2001, NEW ZEAL MED J, V114, P257.
   Sloggett A, 1998, J EPIDEMIOL COMMUN H, V52, P228, DOI 10.1136/jech.52.4.228.
   SLOGGETT A, 1994, BRIT MED J, V309, P1470, DOI 10.1136/bmj.309.6967.1470.
   StataCorp, 2008, STAT STAT SOFTW REL.
   Targosz S, 2003, PSYCHOL MED, V33, P715, DOI 10.1017/S0033291703007347.
   Turley RNL, 2003, CHILD DEV, V74, P465.
   Weitoft GR, 2002, INT J EPIDEMIOL, V31, P573, DOI 10.1093/ije/31.3.573.
   {*}WHO, 1967, MAN INT CLASS DIS IC.
   WHO, 1977, INT CLASS DIS 9 REV.
   Williams S, 1997, SOC SCI MED, V45, P827, DOI 10.1016/S0277-9536(96)00423-6.
   World Health Organization, 1992, ICD 10 CLASS MENT BE.},
Number-of-Cited-References = {44},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {17},
Journal-ISO = {Psychol. Med.},
Doc-Delivery-Number = {811ZQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000294257900008},
DA = {2022-03-29},
}

@article{ WOS:A1984SR34900012,
Author = {BRUSTEIN, R},
Title = {THE PREMATURE DEATH OF MODERNISM},
Journal = {NEW REPUBLIC},
Year = {1984},
Volume = {190},
Number = {21},
Pages = {25-27},
Publisher = {NEW REPUBLIC INC},
Address = {1331 H STREET, NW STE 700, WASHINGTON, DC 20005 USA},
Type = {Article},
Language = {English},
ISSN = {0028-6583},
Research-Areas = {Government \& Law},
Web-of-Science-Categories  = {Political Science},
Number-of-Cited-References = {0},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {New Repub.},
Doc-Delivery-Number = {SR349},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:A1984SR34900012},
DA = {2022-03-29},
}

@article{ WOS:000393106700002,
Author = {Harker, Katy and Cheeseman, Hazel},
Title = {Shifting culture and taking action to reduce smoking and premature death
   among people with a mental health condition},
Journal = {JOURNAL OF PUBLIC MENTAL HEALTH},
Year = {2016},
Volume = {15},
Number = {4},
Pages = {184-187},
Abstract = {Purpose - Mental health conditions affect almost a quarter of the
   population who die on average 10-20 years earlier than the general
   population. Smoking is the single largest cause of this gap in life
   expectancy. Smoking rates among people with mental health conditions
   have barely changed over the last 20 years during a time when rates have
   been steadily falling in the general population. Action is needed to
   address the growing difference in smoking rates among those with a
   mental health condition compared to the general population. The paper
   aims to discuss these issues.
   Design/methodology/approach - This work has been informed by the input
   of a wide range of experts and professionals from across public health,
   mental health and the wider NHS.
   Findings - People with a mental health condition are just as likely to
   want to stop smoking as other smokers but they face more barriers to
   quitting and are more likely to be dependant and therefore need more
   support. Quitting smoking does not exacerbate poor mental health; in
   fact the positive impact of smoking cessation on anxiety and depression
   appears to be at least as large as antidepressants.
   Originality/value - The full report outlines the high-level ambitions
   and the specific actions that must be realised to drive down smoking
   rates among those with a mental health condition.},
Publisher = {EMERALD GROUP PUBLISHING LTD},
Address = {HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Harker, K (Corresponding Author), Publ Hlth Act Smoking \& Hlth, London, England.
   Harker, Katy, Publ Hlth Act Smoking \& Hlth, London, England.
   Cheeseman, Hazel, Act Smoking \& Hlth, Policy, London, England.},
DOI = {10.1108/JPMH-09-2016-0046},
ISSN = {1746-5729},
EISSN = {2042-8731},
Keywords = {Tobacco; Mental health; Health policy},
Keywords-Plus = {PEER-SUPPORT; CESSATION; ILLNESS; METAANALYSIS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {APMS, 2007, ADULT PSYCHIAT MORBI.
   Banham L, 2010, ADDICTION, V105, P1176, DOI 10.1111/j.1360-0443.2010.02946.x.
   Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590.
   Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128.
   Davidson L, 2012, WORLD PSYCHIATRY, V11, P123, DOI 10.1016/j.wpsyc.2012.05.009.
   Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e.
   Ford P, 2013, INT J ENV RES PUB HE, V10, P5507, DOI 10.3390/ijerph10115507.
   Health and Social Care Information Centre, 2007, AD PSYCH MORB ENGL.
   Health and Social Care Information Centre (HSCIC), 2010, HLTH SURV ENGL.
   HM Government Department of Health, 2011, NO HLTH MENTAL HLTH.
   HSCIC Health and Social Care Information Centre, 2015, STAT SMOK.
   Kerr S., 2013, BMC PUBLIC HLTH, V13.
   Lawn S, 2006, INT J MENT HEALTH NU, V15, P111, DOI 10.1111/j.1447-0349.2006.00410.x.
   McDermott MS, 2013, BRIT J PSYCHIAT, V202, P62, DOI 10.1192/bjp.bp.112.114389.
   Mcmanus S., 2010, CIGARETTE SMOKING ME.
   National Institute for Health Care and Clinical Excellence, 2013, PUBL HLTH GUID PH45, V45.
   NHS England, 2016, IMPL 5 YEAR FORW VIE.
   ODEGARD ORNULF, 1951, ACTA GENET ET STATIST MED, V2, P141.
   Office for National Statistics, 2016, OP LIF SURV AD SMOK.
   Public Health England, 2015, GUID COMM.
   Royal College of Physicians Royal College of Psychiatrists, 2013, SMOK MENT HLTH.
   Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4.
   Szatkowski L, 2013, ADDICTION, V108, P1487, DOI 10.1111/add.12163.
   Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151.
   Thornicroft G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2969.
   Tsoi DTY, 2010, BRIT J PSYCHIAT, V196, P346, DOI 10.1192/bjp.bp.109.066019.},
Number-of-Cited-References = {26},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Public Ment. Health},
Doc-Delivery-Number = {EJ3IV},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000393106700002},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000266318600009,
Author = {Weerasinghe, Daminda P. and Yusuf, Farhat and Parr, Nicholas J.},
Title = {Life Lost Due to Premature Deaths in New South Wales, Australia},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2009},
Volume = {6},
Number = {1},
Pages = {108-120},
Month = {JAN},
Abstract = {This study attempts to measure premature mortality, in addition to
   overall death rates, in order to provide more information that can be
   used to develop and monitor health programmes that are aimed at reducing
   premature (often preventable) mortality in New South Wales (NSW),
   Australia. Premature years of potential life lost (PYPLL) and valued
   years of potential life lost methods are applied for mortality data in
   NSW from 1990 to 2002. Variations in these measures for 2001 are studied
   further in terms of age, sex, urban/rural residence, and socio-economic
   status. PYPLL rates for all leading causes of death have declined. It is
   shown that the average male to female ratio of PYPLLs is highest for
   accidents, injury and poisoning (3.4:1) followed by mental disorders
   (2.7:1) and cardiovascular diseases (2.6:1). Although fewer women than
   men die of cardiovascular diseases, there is a greater proportionate
   importance of cerebrovascular mortality among women. In order to further
   reduce premature deaths, programs are required to improve the health of
   people living in lower socio-economic status areas, especially in rural
   NSW. Targeted regional or community level programs are required to
   reduce avoidable deaths due to accidents, injury and poisoning
   occasioned by motor vehicle accidents, poisoning and suicide among young
   adults.},
Publisher = {MOLECULAR DIVERSITY PRESERVATION INTERNATIONAL-MDPI},
Address = {KANDERERSTRASSE 25, CH-4057 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Weerasinghe, DP (Corresponding Author), Prince Wales Hosp, Dept Cardio Thorac Surg, Randwick, NSW 2031, Australia.
   Weerasinghe, Daminda P., Prince Wales Hosp, Dept Cardio Thorac Surg, Randwick, NSW 2031, Australia.
   Yusuf, Farhat; Parr, Nicholas J., Macquarie Univ, Fac Business \& Econ, N Ryde, NSW, Australia.},
DOI = {10.3390/ijerph6010108},
ISSN = {1660-4601},
Keywords = {Potential life lost; premature mortality; Australia},
Keywords-Plus = {MORTALITY},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {daminda.weerasinghe@sesiahs.health.nsw.gov.au
   f.yusuf@efs.mq.edu.au
   nparr@efs.mq.edu.au},
ResearcherID-Numbers = {Parr, Nicholas J/G-3985-2012},
ORCID-Numbers = {Parr, Nicholas J/0000-0002-7539-912X},
Cited-References = {{*}ABS CENS POP HOUS, 2003, 20390 ABS CENS POP H.
   {*}ABS CENS POP HOUS, 2001, 2039055001 ABS CENS.
   ANDERSON RN, 2001, NATL VITAL STAT REPO, V49.
   {*}AUSTR BUR STAT, 2004, 13700 AUSTR BUR STAT.
   Burnley IH, 1999, AUST NZ J PUBL HEAL, V23, P343, DOI 10.1111/j.1467-842X.1999.tb01273.x.
   BUSTAMANTEMONTES LP, 1994, REV SAUDE PUBL, V28, P198, DOI 10.1590/S0034-89101994000300006.
   {*}CDC, 1986, MMWR-MORBID MORTAL W, V35, pS1.
   {*}DET HLTH OUTC IND, 2000, 302001I OECD.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   GREVILLE TNE, 1948, AM REV TUBERC PULM, V57, P417.
   Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289.
   KJELLSTROM T, 2002, NZ EVIDENCE HLTH IMP.
   Lam LT, 2004, AUST NZ J PUBL HEAL, V28, P555, DOI 10.1111/j.1467-842X.2004.tb00046.x.
   MATHERS CD, 1933, 54 GPE WHO.
   McElduff P, 2000, AUST NZ J PUBL HEAL, V24, P465, DOI 10.1111/j.1467-842X.2000.tb00495.x.
   {*}NSW DEP HLTH INP, 2002, HLTH OUTC INF STAT T.
   Struttmann T W, 1998, J Ky Med Assoc, V96, P369.
   Yu XQ, 2000, AUST NZ J PUBL HEAL, V24, P365, DOI 10.1111/j.1467-842X.2000.tb01594.x.
   Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124.},
Number-of-Cited-References = {19},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {449GK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000266318600009},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:A1993NH51500015,
Author = {TAYLOR, R},
Title = {RISKS OF PREMATURE DEATH FROM SMOKING IN 15-YEAR-OLD AUSTRALIANS},
Journal = {AUSTRALIAN JOURNAL OF PUBLIC HEALTH},
Year = {1993},
Volume = {17},
Number = {4},
Pages = {358-364},
Month = {DEC},
Abstract = {This cross-sectional actuarial analysis of 1990 mortality data aimed to
   estimate absolute risk of premature death from all causes, and from lung
   cancer, ischaemic heart disease and chronic bronchitis/emphysema due to
   tobacco smoking in the Australian population, and to estimate the number
   of current 15-year-old smokers in the 1990 Australian population who
   will die prematurely due to smoking. Competing risks were allowed for in
   the calculations. In males, conditional life expectancy for 15-year-olds
   was 78.0 years in nonsmokers, 73.3 years in ever-smokers, and 71.5 years
   in smokers of more than one packet a day. For 15-year-old females, life
   expectancy was 82.0 years in nonsmokers, 78.4 years in ever-smokers, and
   76.9 years in smokers of more than one packet a day. The risk of
   premature death due to smoking in ever-smokers was estimated as 14.6 per
   cent in males (before 75 years) and 11.9 per cent in females (before 80
   years), with lung cancer (male: 4.2 per cent; female: 3.4 per cent),
   ischaemic heart disease (male: 3.7 per cent; female: 1.7 per cent) and
   chronic bronchitis/emphysema (male: 2.4 per cent; female: 2.5 per cent)
   as the major contributors. From one year of 15-year-old male smokers (26
   713), 3 916 premature deaths due to tobacco can be expected; this
   includes 1 106 lung cancer deaths, 991 ischaemic heart disease deaths
   and 641 chronic bronchitis/emphysema deaths. From one year of
   15-year-old female smokers (32 355), 3 861 premature deaths can be
   expected; this includes 1 086 lung cancer deaths, 559 ischaemic heart
   disease deaths and 798 chronic bronchitis/emphysema deaths.},
Publisher = {PUBLIC HEALTH ASSOC AUSTRALIA INC},
Address = {GPO BOX 2204 ATTN:FIONA BRAY, CANBERRA 2601, AUSTRALIA},
Type = {Article},
Language = {English},
Affiliation = {TAYLOR, R (Corresponding Author), NEW S WALES CANC COUNCIL,LOCKED MAIL BAG 1,KINGS CROSS,NSW 2011,AUSTRALIA.},
ISSN = {1035-7319},
Keywords-Plus = {UNITED-STATES; CANCER; MORTALITY; TOBACCO; PROBABILITIES; VETERANS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {ARMITAGE P, 1987, STATISTICAL METHODS.
   {*}AUSTR BUR STAT, 1991, 32010 CAT.
   {*}AUSTR BUR STAT, 1992, 1990 MORT TAB.
   BENDER AP, 1992, CANCER CAUSE CONTROL, V3, P69, DOI 10.1007/BF00051915.
   CORNFIELD J, 1957, AM J PUBLIC HEALTH N, V47, P601, DOI 10.2105/AJPH.47.5.601.
   CUTLER SJ, 1954, JNCI-J NATL CANCER I, V15, P201.
   CUTLER SJ, 1954, PUBLIC HEALTH REP, V69, P333, DOI 10.2307/4588761.
   DAY N, 1987, CANC INCIDENCE 5 CON, V5, pCH10.
   DOLL R, 1972, Journal of the Royal College of Physicians of London, V6, P216.
   DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399.
   DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525.
   DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967.
   Doll R., 1981, J NATL CANCER I, V66, P1192.
   EDWARDS K, 1990, CIGARETTE ALCOHOL CO.
   GILES GG, 1991, AUST J PUBLIC HEALTH, V15, P245.
   GOLDBERG ID, 1956, J NATL CANCER I, V17, P155.
   HAMMOND E C, 1958, J Am Med Assoc, V166, P1159.
   HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007.
   HILL DJ, 1991, MED J AUSTRALIA, V154, P797, DOI 10.5694/j.1326-5377.1991.tb121367.x.
   HOLMAN CDJ, 1986, MED J AUSTRALIA, V145, P7, DOI 10.5694/j.1326-5377.1986.tb113730.x.
   HOLMAN CDJ, 1988, QUANTIFICATION DRUG.
   MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   POLLARD AH, 1990, DEMOGRAPHIC TECHNIQU.
   ROGOT E, 1974, J CHRON DIS, V27, P189, DOI 10.1016/0021-9681(74)90045-9.
   ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213.
   SEIDMAN H, 1978, CA-CANCER J CLIN, V28, P33, DOI 10.3322/canjclin.28.1.33.
   SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36.
   TAYLOR R, 1992, 192 NSW CANC COUNC N.
   TAYLOR R, 1992, JUN REG ANN M OTT.
   Taylor R, 1993, TOB CONTROL, V2, P18.
   {*}US DEP HLTH HUM S, 1982, CHSS PHS8250179 PUBL.
   ZDEB MS, 1977, AM J EPIDEMIOL, V106, P6, DOI 10.1093/oxfordjournals.aje.a112432.},
Number-of-Cited-References = {33},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Aust. J. Public Health},
Doc-Delivery-Number = {NH515},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1993NH51500015},
DA = {2022-03-29},
}

@article{ WOS:000182795200004,
Author = {Qiao, Q and Tuomilehto, J and Borch-Johnsen, K},
Title = {Post-challenge hyperglycaemia is associated with premature death and
   macrovascular complications},
Journal = {DIABETOLOGIA},
Year = {2003},
Volume = {46},
Number = {1},
Pages = {M17-M21},
Month = {MAR},
Abstract = {Unravelling the precise association between cardiovascular disease and
   Type 2 (non-insulin-dependent) diabetes mellitus has proved problematic,
   largely as a result of the confusing variety of diagnostic criteria and
   methodologies used in previous studies of disease-associated risk. More
   recently, improved standardization and continuing refinements to risk
   analyses have beaun to clarify the relative importance of individual
   risk factors for macrovascular complications and progression to
   cardiovascular disease. The evidence accumulated from several
   large-scale epidemiological and intervention studies strongly indicates
   that hyperglycaemia and specifically the post-load hyperglycaemia
   resulting from postprandial glucose excursions is the main factor
   associated with increasing the risks of morbidity and mortality in Type
   2 diabetes. The DECODE study has, de-emphasized the importance of
   fasting glucose, in contrast to post-load hyperalycaemia, as the
   principal measurable determinant of exposure to the risk of
   cardiovascular disease in Type 2 diabetes. Similarly, the Diabetes
   Intervention Study identified mealtime hyperglycaemia as an independent
   risk factor for myocardial infarction and all-cause mortality, while
   several other studies have also shown that such mortality is better
   predicted from post-challenge measurement criteria rather than from
   fasting-glucose criteria. It is likely that postprandial hyperglycaemia
   is an independent risk factor for atherosclerosis and is also exerting
   an atherogenic effect indirectly through the clustering of a number of
   risk factors for atherosclerosis. Whether the relation between post-load
   hyperglycaemia and the risk of cardiovascular events is causal is still
   not known.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Article},
Language = {English},
Affiliation = {Qiao, Q (Corresponding Author), Mannerheimintie 166, Helsinki 00300, Finland.
   Natl Publ Hlth Inst, Diabet \& Genet Epidemiol Unit, Helsinki, Finland.
   Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland.
   Steno Diabet Ctr, DK-2820 Gentofte, Denmark.},
DOI = {10.1007/s00125-002-0932-4},
ISSN = {0012-186X},
EISSN = {1432-0428},
Keywords = {Type 2 diabetes; post-challenge hyperglycaemia; coronary heart disease;
   cardiovascular disease; impaired glucose tolerance; impaired fasting
   glycaemia; 2-hour glucose concentration},
Keywords-Plus = {IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; RISK-FACTOR;
   CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; FASTING GLUCOSE;
   PLASMA-GLUCOSE; PREVENTION; MORTALITY; NIDDM},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {qing.qiao@ktl.fi},
Cited-References = {Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360.
   Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236.
   Borch-Johnsen K, 1999, LANCET, V354, P617.
   Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397.
   Ceriello A, 1998, DIABETIC MED, V15, P188.
   Chalmers J, 1999, J HYPERTENS, V17, P151.
   Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233.
   CREPALDI G, 1995, DIABETES RES CLIN PR, V28, pS159, DOI 10.1016/0168-8227(95)01069-P.
   de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249.
   DELPRATO S, 1999, CURR OPIN ENDOCRINOL, V6, pS1.
   Epstein F H, 1985, Monogr Atheroscler, V13, P92.
   Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229.
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196.
   Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3.
   Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617.
   HARRIS M, 1979, DIABETES, V28, P1039.
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512.
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537.
   Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557.
   QIAO Q, 2000, 17 INT DIAB FED ABST, pS129.
   Rodriguez BL, 1999, DIABETES CARE, V22, P1262, DOI 10.2337/diacare.22.8.1262.
   Shaw JE, 1999, DIABETOLOGIA, V42, P1050, DOI 10.1007/s001250051269.
   STAMLER R, 1979, J CHRON DIS, V32, P683, DOI 10.1016/0021-9681(79)90047-X.
   Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830.
   Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920.
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801.
   W. H. O, 1985, WHO TECHN REP SER, V727.
   {*}WHO, 1980, WHO TECHN REP SER, V646.
   Zimmet P, 1979, Diabetes Care, V2, P144, DOI 10.2337/diacare.2.2.144.},
Number-of-Cited-References = {29},
Times-Cited = {63},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Diabetologia},
Doc-Delivery-Number = {677FA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000182795200004},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1990EJ02400015,
Author = {HEDBACK, G and TISELL, LE and BENGTSSON, BA and HEDMAN, I and ODEN, A},
Title = {PREMATURE DEATH IN PATIENTS OPERATED ON FOR PRIMARY HYPERPARATHYROIDISM},
Journal = {WORLD JOURNAL OF SURGERY},
Year = {1990},
Volume = {14},
Number = {6},
Pages = {829-836},
Month = {NOV-DEC},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {SAHLGRENS UNIV HOSP, DEPT SURG, S-41345 GOTHENBURG, SWEDEN.
   SAHLGRENS UNIV HOSP, DEPT MED, S-41345 GOTHENBURG, SWEDEN.
   GOTHENBURG UNIV, DEPT MATH \& STAT, S-41124 GOTHENBURG, SWEDEN.},
DOI = {10.1007/BF01670531},
ISSN = {0364-2313},
EISSN = {1432-2323},
Research-Areas = {Surgery},
Web-of-Science-Categories  = {Surgery},
Cited-References = {ATTIE JN, 1976, AM J SURG, V132, P449, DOI 10.1016/0002-9610(76)90317-2.
   BLOTH B, 1976, ACTA MED SCAND, V200, P281.
   Bruining H A, 1981, World J Surg, V5, P85.
   CHRISTENSSON T, 1977, EUR J CLIN INVEST, V7, P109, DOI 10.1111/j.1365-2362.1977.tb01581.x.
   CHRISTENSSON T, 1976, ACTA MED SCAND, V200, P361.
   COFFEY RJ, 1977, ANN SURG, V185, P518, DOI 10.1097/00000658-197705000-00003.
   DANIELS J, 1983, AM J MED, V75, P17, DOI 10.1016/0002-9343(83)91162-2.
   ELIAS AN, 1982, ACTA ENDOCRINOL-COP, V101, P47, DOI 10.1530/acta.0.1010047.
   GAZ RD, 1984, AM J SURG, V147, P498, DOI 10.1016/0002-9610(84)90012-6.
   HEDMAN I, 1982, AM J SURG, V143, P614, DOI 10.1016/0002-9610(82)90177-5.
   JANSSON S, 1987, SURGERY, V101, P549.
   KAPLAN L, 1971, CANCER-AM CANCER SOC, V28, P401, DOI 10.1002/1097-0142(197108)28:2<401::AID-CNCR2820280221>3.0.CO;2-H.
   LAFFERTY FW, 1981, ARCH INTERN MED, V141, P1761, DOI 10.1001/archinte.141.13.1761.
   LJUNGHALL S, 1978, ACTA ENDOCRINOL-COP, V89, P580.
   MCCARRON DA, 1980, HYPERTENSION, V2, P162, DOI 10.1161/01.HYP.2.2.162.
   MCCARRON DA, 1982, NEW ENGL J MED, V307, P226, DOI 10.1056/NEJM198207223070405.
   PALMER M, 1987, SURGERY, V102, P1.
   PALMER M, 1987, J CHRON DIS, V40, P121, DOI 10.1016/0021-9681(87)90063-4.
   PALMER M, 1988, AM J EPIDEMIOL, V127, P1031, DOI 10.1093/oxfordjournals.aje.a114879.
   PERRIS AD, 1971, AM J PHYSIOL, V220, P773, DOI 10.1152/ajplegacy.1971.220.3.773.
   RONNISIVULA H, 1985, ANN CHIR GYNAECOL FE, V74, P13.
   RUSSELL CF, 1982, BRIT J SURG, V69, P244, DOI 10.1002/bjs.1800690503.
   STRAZZULLO P, 1983, CLIN SCI, V65, P137, DOI 10.1042/cs0650137.
   SYMONS C, 1985, BRIT HEART J, V54, P539.
   TRIGONIS C, 1983, ACTA CHIR SCAND, V149, P675.
   WAJNGOT A, 1980, SURG GYNECOL OBSTET, V151, P401.
   1987, SCB1961 1985 NAT CEN.
   DEP STATISTICS CAUSE.
   1987, CLASSIFICATION DEATH.},
Number-of-Cited-References = {29},
Times-Cited = {164},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {World J.Surg.},
Doc-Delivery-Number = {EJ024},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1990EJ02400015},
DA = {2022-03-29},
}

@article{ WOS:000466833500003,
Author = {Ullrich, Melanie and Assmus, Benjamin and Augustin, Anne Marie and
   Haebich, Hannes and Abesser, Marco and Machado, Jorge Martin and Werner,
   Franziska and Erkens, Ralf and Arias-Loza, Anahi-Paula and Umbenhauer,
   Sandra and Wagner, Helga and Benz, Peter M. and Unger, Andreas and
   Linke, Wolfgang A. and Frantz, Stefan and Baba, Hideo A. and Kuhn,
   Michaela and Schuh, Kai},
Title = {SPRED2 deficiency elicits cardiac arrhythmias and premature death via
   impaired autophagy},
Journal = {JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY},
Year = {2019},
Volume = {129},
Pages = {13-26},
Month = {APR},
Abstract = {Cardiac functionality is dependent on a balanced protein turnover.
   Accordingly, regulated protein decay is critical to maintain cardiac
   function. Here we demonstrate that deficiency of SPRED2, an
   intracellular repressor of ERK-MAPK signaling markedly expressed in
   human heart, resulted in impaired autophagy, heart failure, and
   shortened lifespan. SPRED2(-/-) mice showed cardiomyocyte hypertrophy,
   cardiac fibrosis, impaired electrical excitability, and severe
   arrhythmias. Mechanistically, cardiomyocyte dysfunction resulted from
   ERK hyper-activation and dysregulated autophagy, observed as
   accumulation of vesicles, vacuolar structures, and de- generated
   mitochondria. The diminished autophagic flux in SPRED2(-/-) hearts was
   reflected by a reduced LC3- II/LC3-I ratio and by decreased Atg7, Atg4B
   and Atg16L expression. Furthermore, the autophagosomal adaptors
   p62/SQSTM1 and NBR1 and lysosomal Cathepsin D accumulated in SPRED2(-/-
   )hearts. In wild-type hearts, SPRED2 interacted physically with
   p62/SQSTM1, NBR1, and Cathepsin D, indicating that SPRED2 is required
   for autophagolysosome formation in regular autophagy. Restored
   inhibition of MAPK signaling by selumetinib led to an increase in
   autophagic flux in vivo. Therefore, our study identifies SPRED2 as a
   novel, indispensable regulator of cardiac autophagy. Vice versa, SPRED2
   deficiency impairs autophagy, leading to cardiac dysfunction and
   life-threatening arrhythmias.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Schuh, K (Corresponding Author), Univ Wurzburg, Inst Physiol 1, Roentgenring 9, D-97070 Wurzburg, Germany.
   Ullrich, Melanie; Assmus, Benjamin; Augustin, Anne Marie; Haebich, Hannes; Abesser, Marco; Machado, Jorge Martin; Werner, Franziska; Kuhn, Michaela; Schuh, Kai, Univ Wurzburg, Inst Physiol, Wurzburg, Germany.
   Erkens, Ralf, Univ Clin, Dusseldorf, Germany.
   Arias-Loza, Anahi-Paula; Umbenhauer, Sandra; Wagner, Helga; Frantz, Stefan, Comprehens Heart Failure Ctr, Wurzburg, Germany.
   Benz, Peter M., Vasc Res Ctr, Frankfurt, Germany.
   Unger, Andreas; Linke, Wolfgang A., Univ Munster, Inst Physiol 2, Munster, Germany.
   Baba, Hideo A., Univ Essen Gesamthsch, Inst Pathol, Essen, Germany.},
DOI = {10.1016/j.yjmcc.2019.01.023},
ISSN = {0022-2828},
EISSN = {1095-8584},
Keywords = {SPRED2; Arrhythmias; Autophagy; p62; Autophagic flux},
Keywords-Plus = {UBIQUITIN-PROTEASOME SYSTEM; CELL-DEATH; SIGNALING PATHWAYS;
   CALCINEURIN-NFAT; SPROUTY DOMAIN; MAPK-ERK; PROTEIN; EXPRESSION; MOUSE;
   MITOCHONDRIA},
Research-Areas = {Cardiovascular System \& Cardiology; Cell Biology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Cell Biology},
Author-Email = {kai.schuh@uni-wuerzburg.de},
ResearcherID-Numbers = {Frantz, Stefan/G-1723-2012
   },
ORCID-Numbers = {Linke, Wolfgang/0000-0003-0801-3773
   Arias-Loza, Anahi-Paula/0000-0003-4048-4719},
Funding-Acknowledgement = {Comprehensive Heart Failure Centre Wuerzburg {[}BMBF01 E01004]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) {[}DFG
   SCHU1600/3-1]; Deutsche Herzstiftung e.V.},
Funding-Text = {We thank Jessica Grein for kindly providing reagents and Pfizer Inc.,
   Peapack, NJ, USA for providing eplerenone in the framework of the
   Compound Transfer Program. This work was initiated by a start-up grant
   from the Comprehensive Heart Failure Centre Wuerzburg, project B.10
   (BMBF01 E01004) to M.U. and K.S. and was supported by the Deutsche
   Forschungsgemeinschaft to K.S. (DFG SCHU1600/3-1). A.M.A. obtained a
   Kaltenbach scholarship from the Deutsche Herzstiftung e.V.},
Cited-References = {Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011.
   Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181.
   Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113.
   Brems H, 2012, HUM MUTAT, V33, P1538, DOI 10.1002/humu.22152.
   Bundschu K, 2005, J BIOL CHEM, V280, P28572, DOI 10.1074/jbc.M503640200.
   Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003.
   Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632.
   Bundschu K, 2006, J BIOL CHEM, V281, P36477, DOI 10.1074/jbc.R600023200.
   Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424.
   D'Agostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3.
   Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147.
   Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6.
   Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445.
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012.
   Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399.
   Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787.
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910.
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002.
   Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008.
   Jhang WK, 2016, PEDIATR CARDIOL, V37, P1539, DOI 10.1007/s00246-016-1468-6.
   Jiang K, 2016, ONCOTARGET, V7, P25652, DOI 10.18632/oncotarget.8357.
   Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005.
   Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6.
   King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284.
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496.
   Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X.
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819.
   Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696.
   Linton PJ, 2015, J MOL CELL CARDIOL, V83, P44, DOI 10.1016/j.yjmcc.2014.12.017.
   Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893.
   Lyon RC, 2013, TRENDS MOL MED, V19, P239, DOI 10.1016/j.molmed.2013.01.005.
   Mardakheh FK, 2010, MOL CELL BIOL, V30, P5672, DOI 10.1128/MCB.00878-10.
   Mardakheh FK, 2009, J CELL BIOL, V187, P265, DOI 10.1083/jcb.200905118.
   Martinez-Lopez N, 2014, AUTOPHAGY, V10, P535, DOI 10.4161/auto.27642.
   Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759.
   Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021.
   Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023.
   Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505.
   Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830.
   Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200.
   Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312.
   Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431.
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138.
   Perera S, 2011, DEV BIOL, V351, P46, DOI 10.1016/j.ydbio.2010.12.024.
   Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510.
   Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006.
   Rougier JS, 2010, J CARDIOVASC PHARM, V56, P22, DOI 10.1097/FJC.0b013e3181daaff9.
   Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110.
   Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512.
   Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005.
   Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe.
   Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748.
   Spach MS, 2004, HEART RHYTHM, V1, P500, DOI 10.1016/j.hrthm.2004.06.010.
   Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112.
   Tuduce IL, 2010, DEV DYNAM, V239, P3072, DOI 10.1002/dvdy.22432.
   Ullrich M, 2018, MOL PSYCHIATR, V23, P444, DOI 10.1038/mp.2016.232.
   Ullrich M, 2011, J BIOL CHEM, V286, P9477, DOI 10.1074/jbc.M110.171306.
   Ullrich Melanie, 2009, Methods Mol Biol, V561, P145, DOI 10.1007/978-1-60327-019-9\_10.
   van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89.
   Van den Bergh A, 2008, PFLUG ARCH EUR J PHY, V455, P987, DOI 10.1007/s00424-007-0362-8.
   Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007.
   Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082.
   Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2.
   Waters S, 2009, FEBS LETT, V583, P1846, DOI 10.1016/j.febslet.2009.04.049.
   Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010.
   Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801.
   Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7.
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014.
   Zaglia T, 2014, J CLIN INVEST, V124, P2410, DOI 10.1172/JCI66339.
   EMBO J, V19, P6341.},
Number-of-Cited-References = {70},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {J. Mol. Cell. Cardiol.},
Doc-Delivery-Number = {HW6XG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000466833500003},
DA = {2022-03-29},
}

@article{ WOS:000482708400008,
Author = {Naimi, Timothy S. and Stadtmueller, Lyndsey A. and Chikritzhs, Tanya and
   Stockwell, Tim and Zhao, Jinhui and Britton, Annie and Saitz, Richard
   and Sherk, Adam},
Title = {Alcohol, Age, and Mortality: Estimating Selection Bias Due to Premature
   Death},
Journal = {JOURNAL OF STUDIES ON ALCOHOL AND DRUGS},
Year = {2019},
Volume = {80},
Number = {1},
Pages = {63-68},
Month = {JAN},
Abstract = {Objective: Alcohol use causes approximately 10\% of deaths among adults
   ages 20-65 in the United States. Although previous research has
   demonstrated differential age-related risk relationships. it is
   difficult to estimate the magnitude of selection bias attributable to
   premature mortality based on existing cohort studies, the average age of
   which is greater than 50 years. The objective of our study was to assess
   the distribution of mortality-related harms and benefits from alcohol
   among adults ages 20 and older in comparison with the distribution among
   those older than age 50. Method: Data from the Centers for DicPAce
   Control and Prevention's Alcohol-Related Disease Impact software
   application from 2006-10 were used to determine the distribution of
   alcohol-attributable deaths (AADs) and the years of potential life lost
   (YPLLs) that was caused or prevented by alcohol for 54 conditions by
   15-year age groupings (20-34, 35-49, 50-64, 65+) in the United States.
   We also determined the proportion of net deaths and YPLLs occurring in
   each age group, overall and by cause of death. Results: Adults ages
   20-49 years experienced 35.8\% of the deaths and 58.4\% of the YPLLs
   caused by alcohol, whereas the same group accrued only 4.5\% of AADs and
   14.2\% of YPLLs gained. Overall. 46.3\% of the total net deaths and
   64.7\% of the net YPLLs occurred among those ages 20-49; adding net
   deaths occurring among those ages 20-49 to those occurring after age 50
   would result in an 86.3\% relative increase in net deaths. Conclusions:
   Because of premature mortality, alcohol-mortality associations based on
   cohort studies may underestimate negative health consequences compared
   with those observed among the general population.},
Publisher = {ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV},
Address = {C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA},
Type = {Article},
Language = {English},
Affiliation = {Naimi, TS (Corresponding Author), Boston Med Ctr, Clin Addict Res \& Educ Unit, 801 Massachusetts Ave,Room 2046, Boston, MA 02118 USA.
   Naimi, Timothy S.; Saitz, Richard, Boston Med Ctr, Clin Addict Res \& Educ Unit, Sect Gen Internal Med, Boston, MA 02118 USA.
   Naimi, Timothy S.; Stadtmueller, Lyndsey A.; Saitz, Richard, Boston Univ, Dept Community Hlth Sci, Sch Publ Hlth, Boston, MA USA.
   Naimi, Timothy S.; Stockwell, Tim; Zhao, Jinhui, Canadian Inst Subst Use Res, Victoria, BC, Canada.
   Chikritzhs, Tanya, Curtin Univ, Natl Drug Res Inst, Perth, WA, Australia.
   Britton, Annie; Sherk, Adam, UCL, London, England.},
DOI = {10.15288/jsad.2019.80.63},
ISSN = {1937-1888},
EISSN = {1938-4114},
Keywords-Plus = {CORONARY-HEART-DISEASE; UPDATED METAANALYSIS; REDUCED MORTALITY; RISK;
   HEALTH; CONSUMPTION; MEN; DRINKERS},
Research-Areas = {Substance Abuse; Psychology},
Web-of-Science-Categories  = {Substance Abuse; Psychology},
Author-Email = {tim.naimi@bmc.org},
ORCID-Numbers = {Chikritzhs, Tanya/0000-0001-8871-3205
   Naimi, Timothy/0000-0001-9849-4413},
Funding-Acknowledgement = {MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MR/R024227/1, MR/M006638/1] Funding Source: UKRI; Medical Research
   CouncilUK Research \& Innovation (UKRI)Medical Research Council UK
   (MRC)European Commission {[}MR/M006638/1, MR/R024227/1] Funding Source:
   researchfish},
Cited-References = {Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607.
   Britton A, 2001, J EPIDEMIOL COMMUN H, V55, P383, DOI 10.1136/jech.55.6.383.
   Centers for Disease Control and Prevention, 2015, ALC REL DIS IMP ARDI.
   Chikritzhs T, 2009, DRUG ALCOHOL REV, V28, P441, DOI 10.1111/j.1465-3362.2009.00052.x.
   Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141.
   Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437.
   Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005.
   Gmel G, 2003, EUR J EPIDEMIOL, V18, P631, DOI 10.1023/A:1024805021504.
   Griswold MG, 2018, LANCET, V392, P1015, DOI {[}10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2].
   Haber JR, 2016, J STUD ALCOHOL DRUGS, V77, P859, DOI 10.15288/jsad.2016.77.859.
   Holmes Michael V, 2014, BMJ, V349, pg4164, DOI 10.1136/bmj.g4164.
   Jousilahti P, 2005, J EPIDEMIOL COMMUN H, V59, P310, DOI 10.1136/jech.2004.024349.
   Makela P, 1998, EUR J PUBLIC HEALTH, V8, P43, DOI 10.1093/eurpub/8.1.43.
   Marmet S, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13947.
   Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451.
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7.
   SHAPER AG, 1988, LANCET, V2, P1267.
   Shield Kevin D, 2015, BMC Res Notes, V8, P231, DOI 10.1186/s13104-015-1207-8.
   Staff J, 2017, J STUD ALCOHOL DRUGS, V78, P394, DOI 10.15288/jsad.2017.78.394.
   Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185.
   Wannamethee SG, 1998, NEUROEPIDEMIOLOGY, V17, P288, DOI 10.1159/000026182.
   Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X.
   Zhao J, 2017, J STUD ALCOHOL DRUGS, V78, P375, DOI 10.15288/jsad.2017.78.375.
   2014, GLOB STAT REP VIOL, P00001.},
Number-of-Cited-References = {24},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Stud. Alcohol Drugs},
Doc-Delivery-Number = {IT2UG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000482708400008},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000474590200010,
Author = {Habibzadeh, Farrokh and Yadollahie, Mahboobeh and Simi, Ashraf and
   Saeidimehr, Saeid and Nasihatkon, Ali-Asghar and Shamsollahi, Mohammad
   Sadegh and Javidi, Hojjatollah and Kucheki, Maryam and Hashemiasl,
   Kourosh and Jamali, Heidarali and Rafiei, Mohammad and Mahmoudi,
   Hamidreza and Kalantari, Farhad and Azadi, Safdar and Maleki, Vahid and
   Asnaashari, Abbas and Hosseinzadeh, Mehrdad and Sami, Habibollah},
Title = {Accessing free quality health care services and premature death},
Journal = {INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT},
Year = {2019},
Volume = {34},
Number = {2},
Pages = {594-603},
Month = {APR},
Abstract = {Background The type of health insurance may affect the likelihood of
   mortality of insured people. We conducted this study to determine if
   accessing free quality health care services could decrease the premature
   mortality of people in a developing country. Methods In a multicenter
   cross sectional study, ``years-life-lost{''} (YLL) due to premature
   death was evaluated in 202 671 insured people residing in six large
   regions in Iran. The participants had access to free quality health care
   services. The number of insured people that died in the six regions
   during March 20, 2014, to March 20, 2015, as well as their sex, age, and
   cause of the death, were collected, and the YLL was calculated based on
   assumptions made in Global Burden of Disease Study 2010 (GBD2010).
   Results The crude mortality rate was 2.3 per 1000, significantly lower
   than the overall rate of 4.6 per 1000 people in general population of
   Iran. The average YLL was 47 years per 1000 persons, significantly lower
   than that in general population of Iran and many industrialized
   countries. The most common causes of death (and YLL) were cardiovascular
   diseases and malignancies. Conclusion Having access to free quality
   health care services is associated with a significant decrease in
   premature death.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Habibzadeh, F (Corresponding Author), Petr Ind Hlth Org, R\&D Headquarters, Eram Blvd, Shiraz 71438, Iran.
   Habibzadeh, Farrokh; Yadollahie, Mahboobeh; Simi, Ashraf, Petr Ind Hlth Org, R\&D Headquarters, Eram Blvd, Shiraz 71438, Iran.
   Saeidimehr, Saeid; Kalantari, Farhad, Petr Ind Hlth Org, Ahvaz, Iran.
   Nasihatkon, Ali-Asghar; Javidi, Hojjatollah; Kucheki, Maryam; Azadi, Safdar, Petr Ind Hlth Org, Shiraz, Iran.
   Shamsollahi, Mohammad Sadegh; Jamali, Heidarali, Petr Ind Hlth Org, Karaj, Iran.
   Javidi, Hojjatollah, Islamic Azad Univ, Dept Psychol, Marvdasht, Iran.
   Hashemiasl, Kourosh; Rafiei, Mohammad; Mahmoudi, Hamidreza; Sami, Habibollah, Petr Ind Hlth Org Headquarters, Tehran, Iran.
   Maleki, Vahid, Petr Ind Hlth Org, Mashhad, Razavi Khorasan, Iran.
   Asnaashari, Abbas, Petr Ind Hlth Org, Esfahan, Iran.
   Hosseinzadeh, Mehrdad, Petr Ind Hlth Org, Bushehr, Iran.},
DOI = {10.1002/hpm.2720},
ISSN = {0749-6753},
EISSN = {1099-1751},
Keywords = {cause of death; health insurance; life expectancy; premature mortality},
Keywords-Plus = {INSURANCE STATUS; GLOBAL BURDEN; RISK-FACTORS; DISABILITY; MORTALITY;
   OUTCOMES; ADULTS},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Policy \& Services; Public, Environmental \& Occupational Health},
Author-Email = {farrokh.habibzadeh@theijoem.com},
ResearcherID-Numbers = {Mahmoudi, Hamidreza/AAA-2594-2019
   Habibzadeh, Farrokh/ABA-5286-2021
   },
ORCID-Numbers = {Mahmoudi, Hamidreza/0000-0002-1890-1005
   saeidimehr, saeid/0000-0001-5702-5709
   Habibzadeh, Farrokh/0000-0001-5360-2900},
Cited-References = {Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa.
   Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004.
   Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004.
   Goudarzi G, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4674-4.
   Institute for Health Metrics and Evaluation, GBD PROF.
   Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6.
   Master S, 2016, ANTICANCER RES, V36, P4915, DOI 10.21873/anticanres.11057.
   Montgomery AE, 2016, PUBLIC HEALTH REP, V131, P765, DOI 10.1177/0033354916667501.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   National Institute of Population and Social Security Research, ALL JAP LIF TABL DAT.
   Nguyen KH, 2016, AM J PUBLIC HEALTH, V106, P1409, DOI 10.2105/AJPH.2016.303156.
   Ortiz-Ortiz KJ, 2014, P R HEALTH SCI J, V33, P132.
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8.
   United Nations Department of Economic and Social Affairs and Population Division, POP PYR WORLD 1950 2.
   World Bank and World Development Indicators, DEATH RAT.},
Number-of-Cited-References = {15},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Int. J. Health Plan. Manag.},
Doc-Delivery-Number = {IH6FU},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000474590200010},
DA = {2022-03-29},
}

@article{ WOS:A1980JV48900008,
Author = {PETERSON, B and KRISTENSON, H and STERNBY, NH and TRELL, E and FEX, G
   and HOOD, B},
Title = {ALCOHOL-CONSUMPTION AND PREMATURE DEATH IN MIDDLE-AGED MEN},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {1980},
Volume = {280},
Number = {6229},
Pages = {1403-1406},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {PETERSON, B (Corresponding Author), UNIV LUND, MALMO GEN HOSP, DEPT INTERNAL MED, PREVENT MED SECT, S-21401 MALMO, SWEDEN.
   UNIV LUND, MALMO GEN HOSP, DEPT PATHOL, S-21401 MALMO, SWEDEN.
   UNIV LUND, MALMO GEN HOSP, DEPT ALCOHOL DIS, S-21401 MALMO, SWEDEN.
   UNIV LUND, MALMO GEN HOSP, DEPT CLIN CHEM, S-21401 MALMO, SWEDEN.},
DOI = {10.1136/bmj.280.6229.1403},
ISSN = {1756-1833},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {BAGREL A, 1979, CLIN CHEM, V25, P1242.
   BEAGELHOLE R, 1980, LANCET, V1, P285.
   DYER AR, 1977, CIRCULATION, V56, P1067, DOI 10.1161/01.CIR.56.6.1067.
   KONDO H, 1976, SANGYO IGAKU, V1, P95.
   KRISTENSON H, 1980, PREV MED, V9, P108, DOI 10.1016/0091-7435(80)90062-6.
   LANNERSTAD O, 1978, THESIS LUND.
   LIEBER CS, 1978, AM J MED, V65, P722, DOI 10.1016/0002-9343(78)90788-X.
   ROLLASON JG, 1972, CLIN CHIM ACTA, V39, P75, DOI 10.1016/0009-8981(72)90301-4.
   ROSALKI SB, 1972, CLIN CHIM ACTA, V39, P41, DOI 10.1016/0009-8981(72)90297-5.
   SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653.
   STRAUS R, 1977, ARCH INTERN MED, V137, P1513, DOI 10.1001/archinte.137.11.1513.
   TIBBLIN G, 1975, AM J CARDIOL, V35, P514, DOI 10.1016/0002-9149(75)90834-6.
   Tibblin G, 1974, Lakartidningen, V71, P2053.
   TIBBLIN G, 1967, ACTA MED SCAND     S, V470.
   WHITEHEAD TP, 1978, LANCET, V1, P978.
   WHITFIELD JB, 1978, ANN CLIN BIOCHEM, V15, P297, DOI 10.1177/000456327801500171.
   WU A, 1976, AM J GASTROENTEROL, V65, P318.
   1974, 2ND SPECIAL REPORT U.},
Number-of-Cited-References = {18},
Times-Cited = {51},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ-British Medical Journal},
Doc-Delivery-Number = {JV489},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1980JV48900008},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1997YC76300005,
Author = {Kantha, SS},
Title = {Could nitroglycerine poisoning be the cause of Alfred Nobel's anginal
   pains and premature death?},
Journal = {MEDICAL HYPOTHESES},
Year = {1997},
Volume = {49},
Number = {4},
Pages = {303-306},
Month = {OCT},
Abstract = {The life of 19th century Swedish chemist cum inventor Alfred Nobel can
   be conveniently divided into two equal phases: pre-nitroglycerine phase
   (1833-1863) and nitroglycerine phase (1864-1896). According to the
   records of Ragnar Sohlman, his assistant during his last year of life,
   Nobel's physical condition began to decline towards the end of the
   1870s, and for the last 16 years he suffered from deep depression and
   anginal pains. Based on Nobel's descriptions of his condition, on his
   prolonged experimentation with explosives, his strenuous work habit and
   some recent knowledge about nitroglycerine poisoning, I hypothesize that
   nitroglycerine poisoning was an aggravating factor which contributed to
   Nobel's deteriorating health and premature death at the age of 63.},
Publisher = {CHURCHILL LIVINGSTONE},
Address = {JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND},
Type = {Article},
Language = {English},
ISSN = {0306-9877},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
ResearcherID-Numbers = {Kantha, Sachi Sri/O-5641-2019
   },
ORCID-Numbers = {Sri Kantha, Sachi/0000-0001-6693-0110},
Cited-References = {ALTHIN T, 1974, DICT SCI BIOGRAPHY, V10, P132.
   DAY L, 1996, BIOGRAPHICAL DICT HI, P522.
   EVLANOFF M, 1969, A NOBEL LONELIEST MI.
   FANT K, 1993, A NOBEL BIOGRAPHY.
   HASCHEK WM, 1993, OCCUPATIONAL TOXICOL, P65.
   HOFBERG H, 1906, SVENSL BIOGRAFISKT H, VL, P183.
   LEWIS RJ, 1992, SAXS DANGEROUS PROPE, V3, P2539.
   REYNOLDS JEF, 1996, MARTINDALE EXTRA PHA, P874.
   SOHLMAN R, 1950, LEGACY A NOBEL.},
Number-of-Cited-References = {9},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Med. Hypotheses},
Doc-Delivery-Number = {YC763},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1997YC76300005},
DA = {2022-03-29},
}

@article{ WOS:000597421700001,
Author = {Leone, Marica and Kuja-Halkola, Ralf and Leval, Amy and D'Onofrio, Brian
   M. and Larsson, Henrik and Lichtenstein, Paul and Bergen, Sarah E.},
Title = {Association of Youth Depression With Subsequent Somatic Diseases and
   Premature Death},
Journal = {JAMA PSYCHIATRY},
Year = {2021},
Volume = {78},
Number = {3},
Pages = {302-310},
Month = {MAR},
Abstract = {This cohort study examines the outcomes of depression diagnosed during
   youth after follow-up of 12 years.
   Question Is depression during youth associated with higher risks of
   subsequent morbidity and mortality? Findings In this Swedish
   population-based cohort study of nearly 1.5 million individuals, 2.5\%
   were diagnosed with depression between ages 5 and 19 years, and there
   were increased relative and absolute risks of being diagnosed with a
   wide range of medical conditions and of early death among individuals
   with prior youth depression compared with the general population. When
   adjusted for psychiatric comorbidity, particularly for substance use
   disorders and anxiety disorders, relative risks decreased but persisted.
   Meaning This study presents evidence suggesting an association between
   youth depression, medical conditions across numerous diagnostic domains,
   and mortality, providing a foundation for future research.
   Importance Early-onset depression has been linked to poor health
   outcomes. However, it is unclear the extent to which this disorder is
   associated with specific diseases and premature death and whether these
   associations remain after controlling for psychiatric comorbidity.
   Objective To quantify the association of youth depression with
   subsequent diagnoses of numerous somatic diseases and mortality. Design,
   Setting, and Participants A population-based cohort study was conducted
   using Swedish national registers containing data on all individuals born
   in Sweden between 1982 and 1996. A total of 1 487 964 participants were
   followed up from age 5 years through 2013 if no censoring occurred. Data
   analysis was performed from January 15, 2019, to August 10, 2020.
   Exposures Youth depression was defined as having received at least 1
   diagnosis of depression from inpatient or outpatient care between ages 5
   and 19 years. Main Outcomes and Measures This study examined 69 somatic
   conditions diagnosed after youth depression, as well as all-cause and
   cause-specific mortalities. Overall and sex-specific hazard ratios
   (HRs), together with 95\% CIs, were estimated using Cox proportional
   hazards regression with attained age as underlying timescale and
   time-varying exposure, and adjusted for birth year and sex. All analyses
   were repeated controlling for psychiatric comorbidities. Absolute risk
   differences were calculated using standardization with Cox proportional
   hazards regression. Results Of 1 487 964 individuals included in the
   analysis, 51.2\% were male. A total of 37 185 patients (2.5\%; 67.4\%
   female) had an inpatient or outpatient contact for depression between
   ages 5 and 19 years (mean {[}SD] age at first recorded diagnosis of
   depression, 16.7 {[}2.1] years for males and 16.7 {[}1.8] years for
   females). Age at the end of follow-up ranged between 17 and 31 years.
   Individuals with youth depression had higher relative risks for 66 of
   the 69 somatic diagnoses. Strong associations were observed for certain
   injuries, especially self-harm in females (HR, 14.4; 95\% CI,
   13.8-15.1), sleep disorders (HR, 8.1; 95\% CI, 7.6-8.7), viral hepatitis
   (HR, 6.1; 95\% CI, 5.4-6.8), all-cause mortality (HR, 5.9; 95\% CI,
   5.3-6.6), and cause-specific mortalities, especially death by
   intentional self-harm (HR, 14.6; 95\% CI, 12.6-16.9). Most associations
   were attenuated but persisted after adjusting for psychiatric
   comorbidity. The absolute risk difference of a specific disease within
   12 years from the first diagnosis of depression during youth ranged from
   -0.2\% (95\% CI, -1.0\% to 0.6\%) for arthropathies among males to
   23.9\% (95\% CI, 22.7\%-25.0\%) for the broader category of injuries
   among females. Conclusions and Relevance In this Swedish population
   cohort study, patients with depression diagnosed during their youth
   appeared to have increased risks for many somatic diseases as well as
   for mortality, even after controlling for other psychiatric disorders.
   These findings suggest that several medical conditions should be
   considered when investigating youth depression.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Bergen, SE (Corresponding Author), Karolinska Inst, Dept Med Epidemiol \& Biostat, POB 281, SE-17177 Solna, Sweden.
   Leone, Marica; Leval, Amy, Janssen Pharmaceut Co Johnson \& Johnson, Solna, Sweden.
   Leone, Marica; Kuja-Halkola, Ralf; D'Onofrio, Brian M.; Larsson, Henrik; Lichtenstein, Paul; Bergen, Sarah E., Karolinska Inst, Dept Med Epidemiol \& Biostat, POB 281, SE-17177 Solna, Sweden.
   D'Onofrio, Brian M., Indiana Univ, Dept Psychol \& Brain Sci, Bloomington, IN USA.
   Larsson, Henrik, Orebro Univ, Sch Med Sci, Orebro, Sweden.},
DOI = {10.1001/jamapsychiatry.2020.3786},
EarlyAccessDate = {DEC 2020},
ISSN = {2168-622X},
EISSN = {2168-6238},
Keywords-Plus = {CHILDHOOD TRAUMA; SWEDISH; DISORDERS; SLEEP; RISK},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {sbergen@gmail.com},
ResearcherID-Numbers = {Bergen, Sarah/I-8313-2012
   Kuja-Halkola, Ralf/ABA-5061-2020
   Leone, Marica/ABB-3408-2021},
ORCID-Numbers = {Bergen, Sarah/0000-0002-5888-0034
   Kuja-Halkola, Ralf/0000-0002-3765-2067
   Leone, Marica/0000-0003-1252-7806},
Funding-Acknowledgement = {European Union's Horizon 2020 Research and Innovation Programme under
   the Marie Sklodowska-Curie {[}721567]},
Funding-Text = {This study was funded by the European Union's Horizon 2020 Research and
   Innovation Programme under the Marie Sklodowska-Curie grant agreement
   No. 721567.},
Cited-References = {Amare AT, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.261.
   Ashina S, 2012, J HEADACHE PAIN, V13, P615, DOI 10.1007/s10194-012-0479-9.
   Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x.
   Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1.
   Butwicka A, 2019, JAMA PEDIATR, V173, P969, DOI 10.1001/jamapediatrics.2019.2662.
   Clarke G, 2012, CHILD ADOL PSYCH CL, V21, P385, DOI 10.1016/j.chc.2012.01.006.
   Dantas-Duarte A, 2016, PSYCHIAT RES, V243, P75, DOI 10.1016/j.psychres.2016.04.114.
   Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x.
   Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0\_10.
   Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0.
   Goldstein BI, 2015, CIRCULATION, V132, P965, DOI 10.1161/CIR.0000000000000229.
   Groenman AP, 2017, J AM ACAD CHILD PSY, V56, P556, DOI 10.1016/j.jaac.2017.05.004.
   Gronlund O, 2016, J Intern Med, V280, P618, DOI 10.1111/joim.12535.
   Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648.
   Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7.
   Khandaker GM, 2018, JAMA PSYCHIAT, V75, P356, DOI 10.1001/jamapsychiatry.2017.4491.
   Lack Caleb W, 2009, J Pediatr Nurs, V24, P13, DOI 10.1016/j.pedn.2008.04.007.
   Lane JM, 2017, NAT GENET, V49, P274, DOI 10.1038/ng.3749.
   Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y.
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450.
   Momen NC, 2020, NEW ENGL J MED, V382, P1721, DOI 10.1056/NEJMoa1915784.
   Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5.
   Barreto FJN, 2017, WORLD J PSYCHIATR, V7, P106, DOI 10.5498/wjp.v7.i2.106.
   Nemiary D, 2012, PSYCHIAT ANN, V42, P305, DOI 10.3928/00485713-20120806-09.
   Otte C, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.65.
   Postolache TT, 2019, AM J MED GENET B, V180, P186, DOI 10.1002/ajmg.b.32712.
   Rutz EM, 2004, EUR CHILD ADOLES PSY, V13, P321, DOI 10.1007/s00787-004-0406-y.
   Sanders Richard D, 2012, Innov Clin Neurosci, V9, P10.
   Sjolander A, 2016, EUR J EPIDEMIOL, V31, P563, DOI 10.1007/s10654-016-0157-3.
   Souza LDD, 2016, PSYCHIAT RES, V246, P612, DOI 10.1016/j.psychres.2016.11.002.
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001.
   Sun SH, 2019, JAMA PSYCHIAT, V76, P1141, DOI 10.1001/jamapsychiatry.2019.1944.
   Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4.
   Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2.
   Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2.
   Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001.
   WHO, 2017, DEPRESSION OTHER COM.},
Number-of-Cited-References = {37},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {JAMA Psychiatry},
Doc-Delivery-Number = {QT9QK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000597421700001},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000273501200008,
Author = {Fitzhugh, Courtney D. and Lauder, Naudia and Jonassaint, Jude C. and
   Telen, Marilyn J. and Zhao, Xiongce and Wright, Elizabeth C. and
   Gilliam, Francis R. and De Castro, Laura M.},
Title = {Cardiopulmonary complications leading to premature deaths in adult
   patients with sickle cell disease},
Journal = {AMERICAN JOURNAL OF HEMATOLOGY},
Year = {2010},
Volume = {85},
Number = {1},
Pages = {36-40},
Month = {JAN},
Abstract = {Sickle cell disease (SCD) is associated with early mortality. We sought
   to determine the incidence, cause, and risk factors for death in an
   adult population of patients with SCD. All patients aged >= 18 years
   seen at the Adult Sickle Cell Center at Duke University Medical Center
   between January 2000 and April 2005 were enrolled. Forty-three patients
   (21 males and 22 females) died during the study period. The median age
   of survival was 39 years for females (95\% CI: 34-56), 40 years for
   males (95\% CI: 34-48), and 40 years overall (95\% CI: 35-48). Cardiac
   causes of death accounted for 25.6\% (11/43 patients); pulmonary, 14.0\%
   (six patients); other SCD related, 32.6\% (14 patients); unknown, 14.0\%
   (six patients); and others, 14.0\% (six patients). Pulseless electrical
   activity arrest, pulmonary emboli, multiorgan failure, and stroke were
   the most frequent causes of death. Among the deceased patients, the most
   common premorbid conditions were cardiopulmonary: acute chest
   syndrome/pneumonia (58.1\%), Pulmonary hypertension (pHTN; 41.9\%),
   systemic HTN (25.6\%), congestive heart failure (25.6\%), myocardial
   infarction (20.9\%), and arrhythmias (14.0\%). Tricuspid regurgitant jet
   velocity was significantly higher (3.1 m/sec vs. 2.6 misec, P < 0.001)
   and hemoglobin significantly lower (8.3 g/dL vs. 9.2 g/dL, P < 0.05) in
   deceased patients when compared with patients who lived, respectively.
   With improved preventive and therapeutic advances, including hydroxyurea
   therapy, acute complications such as infection are no longer the leading
   cause of death; instead, causes of death and premorbid conditions are
   shifting to chronic cardiopulmonary complications. Further, arrhythmia
   leading to premature death is under-recognized in SCD and warrants
   further investigation. Am. J. Hematol. 85:36-40, 2010. (C) 2009
   Wiley-Liss, Inc.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Fitzhugh, CD (Corresponding Author), NHLBI, Mol \& Clin Hematol Branch, NIDDK, NIH, 9000 Rockville Pike,Bldg 10,Room 9N-116, Bethesda, MD 20892 USA.
   Fitzhugh, Courtney D., NHLBI, Mol \& Clin Hematol Branch, NIDDK, NIH, Bethesda, MD 20892 USA.
   Lauder, Naudia, Johns Hopkins Univ Hosp, Dept Internal Med, Baltimore, MD 21287 USA.
   Jonassaint, Jude C.; Telen, Marilyn J.; De Castro, Laura M., Duke Univ, Med Ctr, Div Hematol, Durham, NC USA.
   Jonassaint, Jude C.; Telen, Marilyn J.; De Castro, Laura M., Duke Univ, Med Ctr, Duke Comprehens Sickle Cell Ctr, Durham, NC USA.
   Wright, Elizabeth C., NIDDK, Off Director, NIH, Bethesda, MD USA.
   Gilliam, Francis R., Cardiol Associates N Arkansas, Electrophysiol Div, Jonesboro, AR USA.},
DOI = {10.1002/ajh.21569},
ISSN = {0361-8609},
EISSN = {1096-8652},
Keywords-Plus = {PULMONARY-HYPERTENSION; IRON OVERLOAD; MYOCARDIAL-PERFUSION;
   RISK-FACTOR; MORTALITY; CHILDREN; ANEMIA; DEFIBRILLATOR; HYDROXYUREA;
   THALASSEMIA},
Research-Areas = {Hematology},
Web-of-Science-Categories  = {Hematology},
Author-Email = {fitzhughc@nhlbi.nih.gov},
ORCID-Numbers = {Telen, Marilyn/0000-0003-3809-1780},
Funding-Acknowledgement = {National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}R01HL68959,
   R01HL79915, U54HL070769]; Duke-UNC Comprehensive Sickle Cell Center
   {[}U54HL070769]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Heart Lung \& Blood Institute (NHLBI)
   {[}U54HL070769, R01HL068959, R01HL079915] Funding Source: NIH RePORTER},
Funding-Text = {Contract grant sponsor: National Institutes of Health (Intramural
   Research Program of the National Institute of Diabetes, Digestive, and
   Kidney Diseases and the National Heart, Lung, and Blood Institute);
   Contract grant numbers: R01HL68959, R01HL79915, U54HL070769. Contract
   grant sponsor: Duke-UNC Comprehensive Sickle Cell Center; Contract grant
   number: U54HL070769.},
Cited-References = {Acar P, 2000, PEDIATR RADIOL, V30, P352, DOI 10.1007/s002470050759.
   Aessopos A, 2001, AM J MED, V111, P355, DOI 10.1016/S0002-9343(01)00835-X.
   Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x.
   ATTAH EB, 1975, JAMA-J AM MED ASSOC, V233, P889, DOI 10.1001/jama.1975.03260080051021.
   Bakanay SM, 2005, BLOOD, V105, P545, DOI 10.1182/blood-2004-01-0322.
   Ballas SK, 2001, SEMIN HEMATOL, V38, P30, DOI 10.1053/shem.2001.20142.
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399.
   Boyd JH, 2007, HAEMATOLOGICA, V92, P1115, DOI 10.3324/haematol.11213.
   BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902.
   BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3.
   Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948.
   CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001.
   Davis H, 1997, AM J PUBLIC HEALTH, V87, P1317, DOI 10.2105/AJPH.87.8.1317.
   De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058.
   Diggs LMAH., 1973, SICKLE CELL DIS DIAG.
   Escoffery CT, 2002, FORENSIC SCI INT, V129, P116, DOI 10.1016/S0379-0738(02)00268-2.
   Fung EB, 2007, AM J HEMATOL, V82, P255, DOI 10.1002/ajh.20809.
   Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477.
   Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016.
   Graham JK, 2007, AM J FOREN MED PATH, V28, P168, DOI 10.1097/01.paf.0000257397.92466.50.
   GRAY A, 1991, J CLIN PATHOL, V44, P459, DOI 10.1136/jcp.44.6.459.
   Hagar RW, 2008, BRIT J HAEMATOL, V140, P104, DOI 10.1111/j.1365-2141.2007.06822.x.
   Harmatz P, 2000, BLOOD, V96, P76, DOI 10.1182/blood.V96.1.76.013k22\_76\_79.
   Kato GJ, 2008, JAMA-J AM MED ASSOC, V300, P2638, DOI 10.1001/jama.2008.598.
   Klings ES, 2008, AM J HEMATOL, V83, P4, DOI 10.1002/ajh.21083.
   Knight J, 1999, PEDIATR PULM, V28, P205, DOI 10.1002/(SICI)1099-0496(199909)28:3<205::AID-PPUL8>3.0.CO;2-Z.
   LEIKIN SL, 1989, PEDIATRICS, V84, P500.
   Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310.
   MAISEL A, 1983, CLIN CARDIOL, V6, P339, DOI 10.1002/clc.4960060707.
   Manci EA, 2003, BRIT J HAEMATOL, V123, P359, DOI 10.1046/j.1365-2141.2003.04594.x.
   Mansi IA, 2002, J NATL MED ASSOC, V94, P448.
   Maunoury C, 2003, AM J CARDIOL, V91, P374, DOI 10.1016/S0002-9149(02)03177-6.
   Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601.
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474.
   NORRIS S, 1991, J NATL MED ASSOC, V83, P209.
   Olivieri NF, 2001, SEMIN HEMATOL, V38, P57, DOI 10.1016/S0037-1963(01)90060-5.
   PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303.
   Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52.
   Prasad R, 2003, AM J MED SCI, V325, P107, DOI 10.1097/00000441-200303000-00001.
   Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758.
   Raman SV, 2006, HAEMATOLOGICA, V91, P1329.
   Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038.
   Schultz WH, 2003, AM J HEMATOL, V74, P249, DOI 10.1002/ajh.10427.
   Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921.
   Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485.
   Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645.
   Taylor JG, 2008, AM J HEMATOL, V83, P71, DOI 10.1002/ajh.21039.
   THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633.
   1998, JAMA, V279, P1059.},
Number-of-Cited-References = {49},
Times-Cited = {135},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Am. J. Hematol.},
Doc-Delivery-Number = {542NO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000273501200008},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000269554100002,
Author = {Heitmann, Berit L. and Frederiksen, Peder},
Title = {Thigh circumference and risk of heart disease and premature death:
   prospective cohort study},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {2009},
Volume = {339},
Month = {SEP 3},
Abstract = {Objective To examine associations between thigh circumference and
   incident cardiovascular disease and coronary heart disease and total
   mortality.
   Design Prospective observational cohort study with Cox proportional
   hazards model and restricted cubic splines.
   Setting Random subset of adults in Denmark.
   Participants 1436 men and 1380 women participating in the Danish MONICA
   project, examined in 1987-8 for height, weight, and thigh, hip, and
   waist circumference, and body composition by impedance.
   Main outcome measures 10 year incidence of cardiovascular and coronary
   heart disease and 12.5 years of follow-up for total death.
   Results A small thigh circumference was associated with an increased
   risk of cardiovascular and coronary heart diseases and total mortality
   in both men and women. A threshold effect for thigh circumference was
   evident, with greatly increased risk of premature death below around 60
   cm. Above the threshold there seemed to be no additional benefit of
   having larger thighs in either sex. These findings were independent of
   abdominal and general obesity, lifestyle, and cardiovascular risk
   factors such as blood pressure and lipid concentration. Conclusion A low
   thigh circumference seems to be associated with an increased risk of
   developing heart disease or premature death. The adverse effects of
   small thighs might be related to too little muscle mass in the region.
   The measure of thigh circumference might be a relevant anthropometric
   measure to help general practitioners in early identification of
   individuals at an increased risk of premature morbidity and mortality.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Heitmann, BL (Corresponding Author), Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, Ostre Sogade 20, DK-1357 Copenhagen K, Denmark.
   Heitmann, Berit L.; Frederiksen, Peder, Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1357 Copenhagen K, Denmark.
   Heitmann, Berit L., Glostrup Univ Hosp, Res Ctr Prevent \& Hlth, DK-2600 Glostrup, Denmark.},
DOI = {10.1136/bmj.b3292},
Article-Number = {b3292},
ISSN = {1756-1833},
Keywords-Plus = {ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT-FREE MASS; FOLLOW-UP; DANISH
   POPULATION; HIP CIRCUMFERENCE; PHYSICAL-ACTIVITY; STRENGTH; MUSCLE;
   ASSOCIATIONS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {blh@ipm.regionh.dk},
ORCID-Numbers = {Heitmann, Berit Lilienthal/0000-0002-6809-4504},
Funding-Acknowledgement = {Danish Medical Research CouncilDanish Medical Research CouncilUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)},
Funding-Text = {The study was funded by the Danish Medical Research Council. Both
   researchers were independent of the funding agency.},
Cited-References = {Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621.
   Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635.
   Brotman DJ, 2003, CIRCULATION, V108, pE61, DOI 10.1161/01.CIR.0000086784.14560.C3.
   Evans WJ, 1996, GERIATRICS, V51, P46.
   Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008.
   GRIMBY G, 1979, MUSCLE METABOLISM EX, P469.
   Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54.
   HEITMANN BL, 1991, INT J OBESITY, V15, P535.
   HEITMANN BL, 1990, INT J OBESITY, V14, P789.
   Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082.
   Hippe M, 1999, J EPIDEMIOL COMMUN H, V53, P269, DOI 10.1136/jech.53.5.269.
   JENSEN KH, 1991, GASTROENTEROLOGY, V100, P790, DOI 10.1016/0016-5085(91)80027-7.
   Korn EL, 1997, AM J EPIDEMIOL, V145, P72.
   Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85.
   Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031.
   MCCARTNEY N, 1995, J GERONTOL A-BIOL, V50, pB97, DOI 10.1093/gerona/50A.2.B97.
   McCarty MF, 2003, MED HYPOTHESES, V61, P173, DOI 10.1016/S0306-9877(02)00238-4.
   MILLER JP, 1994, J APPL PHYSIOL, V77, P1122, DOI 10.1152/jappl.1994.77.3.1122.
   Olsen DB, 2005, J PHYSIOL-LONDON, V565, P555, DOI 10.1113/jphysiol.2004.081356.
   {*}R DEV COR TEAM, 2005, R LANG ENV STAT COMP.
   Sacchetti M, 2005, DIABETOLOGIA, V48, P938, DOI 10.1007/s00125-005-1727-1.
   Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372.
   Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7.
   Tanko LB, 2004, CIRCULATION, V110, P2246, DOI 10.1161/01.CIR.0000144470.55149.E5.
   Therneau T. M., 2000, STAT BIOL HEALTH.
   WAALER HT, 1988, ACTA MED SCAND, V713, P17.
   World Health Organization, 1989, 123 EURICPNUT WHO.
   Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9.},
Number-of-Cited-References = {28},
Times-Cited = {114},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {10},
Journal-ISO = {BMJ-British Medical Journal},
Doc-Delivery-Number = {491CI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000269554100002},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000381214100013,
Author = {Stenvinkel, Peter and Carrero, Juan Jesus and von Walden, Ferdinand and
   Ikizler, T. Alp and Nader, Gustavo A.},
Title = {Muscle wasting in end-stage renal disease promulgates premature death:
   established, emerging and potential novel treatment strategies},
Journal = {NEPHROLOGY DIALYSIS TRANSPLANTATION},
Year = {2016},
Volume = {31},
Number = {7},
Pages = {1070-1077},
Month = {JUL},
Abstract = {Muscle wasting (or sarcopenia) is a common feature of the uremic
   phenotype and predisposes this vulnerable patient population to
   increased risk of comorbid complications, poor quality of life, frailty
   and premature death. The old age of dialysis patients is in addition a
   likely contributor to loss of muscle mass. As recent evidence suggests
   that assessment of muscle strength (i.e. function) is a better predictor
   of outcome and comorbidities than muscle mass, this opens new screening,
   assessment and therapeutic opportunities. Among established treatment
   strategies, the benefit of resistance exercise and endurance training
   are increasingly recognized among nephrologists as being effective and
   should be promoted in sedentary chronic kidney disease patients.
   Testosterone and growth hormone replacement appear as the most promising
   among emerging treatments strategies for muscle wasting. As treatment of
   muscle wasting is difficult and seldom successful in this often old,
   frail, sedentary and exercise-hesitant patient group, novel treatment
   strategies are urgently needed. In this review, we summarize recent
   studies on stimulation of mitochondrial biogenesis, myogenic stem
   (satellite) cells and manipulation of transforming growth factor family
   members, all of which hold promise for more effective therapies to
   target muscle mass loss and function in the future.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Stenvinkel, P (Corresponding Author), Karolinska Inst, CLINTEC, Dept Renal Med, Stockholm, Sweden.
   Stenvinkel, Peter; Carrero, Juan Jesus, Karolinska Inst, CLINTEC, Dept Renal Med, Stockholm, Sweden.
   von Walden, Ferdinand, Karolinska Inst, Dept Womens \& Childrens Hlth, Stockholm, Sweden.
   Ikizler, T. Alp, Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN USA.
   Nader, Gustavo A., Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.},
DOI = {10.1093/ndt/gfv122},
ISSN = {0931-0509},
EISSN = {1460-2385},
Keywords = {dialysis; exercise; growth hormone; inflammation; muscle wasting;
   sarcopenia},
Keywords-Plus = {CHRONIC KIDNEY-DISEASE; HUMAN GROWTH-HORMONE; PATIENTS RECEIVING
   DIALYSIS; SKELETAL-MUSCLE; RESISTANCE EXERCISE; TESTOSTERONE DEFICIENCY;
   INTERNATIONAL SOCIETY; NANDROLONE DECANOATE; CONSENSUS STATEMENT;
   BODY-COMPOSITION},
Research-Areas = {Transplantation; Urology \& Nephrology},
Web-of-Science-Categories  = {Transplantation; Urology \& Nephrology},
Author-Email = {peter.stenvinkel@ki.se},
ORCID-Numbers = {Ikizler, Talat/0000-0002-5717-4218
   Stenvinkel, Peter/0000-0002-8785-4820},
Funding-Acknowledgement = {Swedish Medical Research Council (VR)Swedish Medical Research Council
   (SMRC)Swedish Research Council},
Funding-Text = {Swedish Medical Research Council (VR) supported Peter Stenvinkel's and
   Juan Jesus Carrero's research.},
Cited-References = {Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051.
   Batsis JA, 2013, J AM GERIATR SOC, V61, P974, DOI 10.1111/jgs.12260.
   Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4.
   Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631.
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777.
   Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x.
   Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001.
   Carrero JJ, 2012, NEPHROL DIAL TRANSPL, V27, P4030, DOI 10.1093/ndt/gfs383.
   Carrero JJ, 2012, NEPHROL DIAL TRANSPL, V27, P709, DOI 10.1093/ndt/gfr288.
   CHAN W, 1993, KIDNEY INT, V43, P790, DOI 10.1038/ki.1993.112.
   Chang C-I, 2014, OBES RES CLIN PRACT.
   Cheema B, 2007, AM J KIDNEY DIS, V50, P574, DOI 10.1053/j.ajkd.2007.07.005.
   Chen F, 2011, J CACHEXIA SARCOPENI, V2, P45, DOI 10.1007/s13539-011-0021-y.
   Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011.
   Cigarran S, 2013, J RENAL NUTR, V23, pE89, DOI 10.1053/j.jrn.2012.08.007.
   de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205.
   Denham J, 2014, SPORTS MED, V44, P189, DOI 10.1007/s40279-013-0114-1.
   Dong J, 2011, J RENAL NUTR, V21, P149, DOI 10.1053/j.jrn.2010.03.004.
   Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053.
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082.
   Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082.
   Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258.
   Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585.
   Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159.
   Garibotto G, 1997, J CLIN INVEST, V99, P97, DOI 10.1172/JCI119139.
   Garibotto G, 2008, KIDNEY INT, V74, P937, DOI 10.1038/ki.2008.345.
   Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9.
   Goldsmith DJA, 2014, SEMIN NEPHROL, V34, P660, DOI 10.1016/j.semnephrol.2014.10.002.
   Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4.
   Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019.
   Howden EJ, 2015, AM J KIDNEY DIS, V65, P583, DOI 10.1053/j.ajkd.2014.09.017.
   Iglesias P, 1998, AM J KIDNEY DIS, V32, P454, DOI 10.1053/ajkd.1998.v32.pm9740162.
   Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147.
   Ikizler TA, 1996, KIDNEY INT, V50, P343, DOI 10.1038/ki.1996.323.
   Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013.
   Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652.
   Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034.
   Johansen KL, 1999, JAMA-J AM MED ASSOC, V281, P1275, DOI 10.1001/jama.281.14.1275.
   Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x.
   Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185.
   Kopple JD, 2011, NEPHROL DIAL TRANSPL, V26, P4095, DOI 10.1093/ndt/gfr363.
   Kotzmann H, 2001, KIDNEY INT, V60, P1578, DOI 10.1046/j.1523-1755.2001.00971.x.
   Lanza D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116468.
   Lee DY, 2015, J BONE MINER RES, V30, P563.
   Lee D, 2013, J BIOL CHEM, V288, P30515, DOI 10.1074/jbc.M113.489716.
   Liu G, 2014, J ACAD NUTR DIET, V114, P1544, DOI 10.1016/j.jand.2014.05.012.
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015.
   Majchrzak KM, 2008, NEPHROL DIAL TRANSPL, V23, P1362, DOI 10.1093/ndt/gfm773.
   Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5.
   Martinson M, 2014, CLIN J AM SOC NEPHRO, V9, P1082, DOI 10.2215/CJN.09200913.
   McGregor RA, 2014, AGEING RES REV, V17, P25, DOI 10.1016/j.arr.2014.05.001.
   MEHLS O, 1990, ACTA PAEDIATR SCAND, P28.
   Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220.
   Mitch WE, 2004, SEMIN NEPHROL, V24, P484, DOI 10.1016/j.semnephrol.2004.06.014.
   Miyamoto T, 2011, CLIN J AM SOC NEPHRO, V6, P1001, DOI 10.2215/CJN.10511110.
   Mori A, 2013, CLIN DRUG INVEST, V33, P837, DOI 10.1007/s40261-013-0132-7.
   Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014.
   Negroni E, 2015, NEUROPATH APPL NEURO, V41, P270, DOI 10.1111/nan.12198.
   Niemczyk S, 2010, KIDNEY INT, V77, P450, DOI 10.1038/ki.2009.480.
   Noh H, 2012, NEPHROL DIAL TRANSPL, V27, P218, DOI 10.1093/ndt/gfr267.
   Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619.
   Palmer SC, 2013, AM J KIDNEY DIS, V62, P493, DOI 10.1053/j.ajkd.2013.02.369.
   Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011.
   PRICE SR, 1994, AM J PHYSIOL-CELL PH, V267, pC955, DOI 10.1152/ajpcell.1994.267.4.C955.
   Pupim LB, 2005, AM J CLIN NUTR, V82, P1235, DOI 10.1093/ajcn/82.6.1235.
   Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x.
   Rossi AP, 2014, CLIN J AM SOC NEPHRO, V9, P2052, DOI 10.2215/CJN.11791113.
   Sakkas GK, 2006, AM J KIDNEY DIS, V47, P862, DOI 10.1053/j.ajkd.2006.01.013.
   Sanders KM, 2014, CURR OSTEOPOROS REP, V12, P74, DOI 10.1007/s11914-014-0193-4.
   Sharma D, 2014, CLIN J AM SOC NEPHRO, V9, P2079, DOI 10.2215/CJN.02140214.
   Shimokata H, 2014, GERIATR GERONTOL INT, V14, P85, DOI 10.1111/ggi.12219.
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152.
   Stenvinkel P, 2013, SEMIN DIALYSIS, V26, P16, DOI 10.1111/sdi.12020.
   Storer TW, 2005, NEPHROL DIAL TRANSPL, V20, P1429, DOI 10.1093/ndt/gfh784.
   Stratton RJ, 2005, AM J KIDNEY DIS, V46, P387, DOI 10.1053/j.ajkd.2005.04.036.
   Sun DF, 2004, J AM SOC NEPHROL, V15, P2630, DOI 10.1097/01.ASN.0000139492.36400.6C.
   Supasyndh O, 2013, CLIN J AM SOC NEPHRO, V8, P271, DOI 10.2215/CJN.00380112.
   Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364.
   Tonkin J, 2012, CURR OPIN PHARMACOL, V12, P372, DOI 10.1016/j.coph.2012.02.010.
   Trobec K, 2011, J CACHEXIA SARCOPENI, V2, P191, DOI 10.1007/s13539-011-0043-5.
   Van Craenenbroeck AH, 2014, CLIN J AM SOC NEPHRO, V9, P1305, DOI 10.2215/CJN.13031213.
   Viana JL, 2014, J AM SOC NEPHROL, V25, P2121, DOI 10.1681/ASN.2013070702.
   Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112.
   Watson EL, 2014, AM J KIDNEY IN PRESS.
   Yuen DA, 2011, CLIN J AM SOC NEPHRO, V6, P1345, DOI 10.2215/CJN.10911210.
   Zaza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077847.
   Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012.
   Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917.
   Zykovich A, 2014, AGING CELL, V13, P360, DOI 10.1111/acel.12180.},
Number-of-Cited-References = {89},
Times-Cited = {92},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Nephrol. Dial. Transplant.},
Doc-Delivery-Number = {DT1AM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000381214100013},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000228573700008,
Author = {Petersen, L and Andersen, PK and Sorensen, TIA},
Title = {Premature death of adult adoptees: Analyses of a case-cohort sample},
Journal = {GENETIC EPIDEMIOLOGY},
Year = {2005},
Volume = {28},
Number = {4},
Pages = {376-382},
Month = {MAY},
Abstract = {Genetic and environmental influence on risk of premature death in
   adulthood was investigated by estimating the associations in total and
   cause-specific mortality of adult Danish adoptees and their biological
   and adoptive parents. Among all 14,425 non-familial adoptions formally
   granted in Denmark during the period 1924 through 1947, we selected the
   study population according to a case-cohort sampling design. As the
   case-control design, the case-cohort design has the advantage of
   economic data collection and little loss in statistical efficiency, but
   the case-cohort sample has the additional advantages that rate ratio
   estimates may be obtained, and re-use of the cohort sample in future
   studies of other outcomes is possible. Analyses were performed using
   Kalbfleisch and Lawless's estimator for hazard ratio, and robust
   estimation for variances. In the main analyses the sample was restricted
   to birth years of the acloptees 1924 and after, and age of transfer to
   the adoptive parents before 7 years, and age at death was restricted to
   16 to 70 years. The results showed a higher mortality among acloptees,
   whose biological parents died in the age range of 16 to 70 years; this
   was significant for deaths from natural causes, vascular causes and all
   causes. No influence was seen from early death of adoptive parents,
   regardless of cause of death. (c) 2005 Wiley-Liss, Inc.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Petersen, L (Corresponding Author), Kommune Hosp Copenhagen, Inst Prevent Med, DK-1399 Copenhagen, Denmark.
   Copenhagen Univ Hosp, Danish Epidemiol Sci Ctr, Inst Prevent Med, Copenhagen K, Denmark.
   Statens Serum Inst, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen, Denmark.
   Univ Copenhagen, Dept Biostat, Copenhagen, Denmark.},
DOI = {10.1002/gepi.20071},
ISSN = {0741-0395},
EISSN = {1098-2272},
Keywords = {survival analysis; Cox proportional hazard; Kalbfleisch and Lawless
   estimator; cause-specific deaths},
Keywords-Plus = {LONGEVITY; DISEASE; DESIGN; TWINS; SUSCEPTIBILITY; RESIDUALS; CANCER;
   MODEL},
Research-Areas = {Genetics \& Heredity; Mathematical \& Computational Biology},
Web-of-Science-Categories  = {Genetics \& Heredity; Mathematical \& Computational Biology},
Author-Email = {lp@ipm.hosp.dk},
ORCID-Numbers = {Petersen, Liselotte Vogdrup/0000-0002-0479-5379},
Cited-References = {BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444.
   BORCHJOHNSEN K, 1993, ACTA PSYCHIAT SCAND, V87, P73, DOI 10.1111/j.1600-0447.1993.tb05364.x.
   Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674.
   Christensen K, 1996, J INTERN MED, V240, P333, DOI 10.1046/j.1365-2796.1996.d01-2853.x.
   COHEN BH, 1964, Q REV BIOL, V39, P130, DOI 10.1086/404164.
   ELDRED CA, 1976, AM J ORTHOPSYCHIAT, V46, P279, DOI 10.1111/j.1939-0025.1976.tb00928.x.
   GLASSER M, 1981, J CHRON DIS, V34, P439, DOI 10.1016/0021-9681(81)90003-5.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   HAYAKAWA K, 1992, ACTA GENET MED GEMEL, V41, P177, DOI 10.1017/S0001566000002385.
   Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042.
   Iachine I A, 1998, Twin Res, V1, P196.
   JACOBSEN S, 1981, PROSPECTIVE LONGITUD, P225.
   KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116.
   Keiding N., 1993, STAT MODELS BASED CO.
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201.
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085.
   MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503.
   MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237.
   Neale MC., 1992, METHODOLOGY GENETIC.
   Petersen L, 2003, STAT MED, V22, P3795, DOI 10.1002/sim.1672.
   Petersen L, 2002, GENET EPIDEMIOL, V23, P123, DOI 10.1002/gepi.1122.
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1.
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876.
   Sorensen P, 2000, BIOMETRIKA, V87, P49, DOI 10.1093/biomet/87.1.49.
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202.
   SORENSEN TIA, 1995, NEW ENGL J MED, V333, P1633, DOI 10.1056/NEJM199512143332411.
   {[}No title captured], DOI DOI 10.1016/0022-3956(68)90026-5.},
Number-of-Cited-References = {29},
Times-Cited = {17},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Genet. Epidemiol.},
Doc-Delivery-Number = {918US},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000228573700008},
DA = {2022-03-29},
}

@article{ WOS:000085292400005,
Author = {Kjelsberg, E},
Title = {Adolescent psychiatric in-patients - A high-risk group for premature
   death},
Journal = {BRITISH JOURNAL OF PSYCHIATRY},
Year = {2000},
Volume = {176},
Pages = {121-125},
Month = {FEB},
Abstract = {Background Research has demonstrated increased mortality rates in
   adolescent psychiatric in-patients.
   Aims To investigate this excess mortality by calculating standardised
   mortality ratios (SMRs) relative to cause of death, diagnosis, cohort
   and age.
   Method A nationwide Norwegian sample of 1095 former adolescent
   psychiatric in-patients were followed up 15-33 years after first
   hospitalisation by record linkage to the National Death Cause Registry
   Results The SMR was significantly increased for almost all causes of
   death investigated. In males, all psychiatric diagnoses had
   significantly increased SMRs, whereas in females, organic mental
   disorder, anxiety disorder and affective disorder had non-significantly
   increased SMRs. The SMR was significantly elevated for all age-spans and
   cohorts investigated.
   Conclusions Abroad prevention strategy is needed to combat the increased
   mortality rates found in adolescent psychiatric in-patients.
   Declaration of interest Funded by a grant from the Foundation for Health
   and Rehabilitation through the Norwegian Council for Mental Health.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Kjelsberg, E (Corresponding Author), Ctr Child \& Adolescent Psychiat, POB 26, N-0319 Oslo, Norway.
   Ctr Child \& Adolescent Psychiat, N-0319 Oslo, Norway.},
DOI = {10.1192/bjp.176.2.121},
ISSN = {0007-1250},
EISSN = {1472-1465},
Keywords-Plus = {FOLLOW-UP; EXCESS MORTALITY; CHILD; INPATIENTS; REGISTER},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Cited-References = {AMADDEO F, 1995, BRIT J PSYCHIAT, V166, P783, DOI 10.1192/bjp.166.6.783.
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT.
   BLACK DW, 1985, ARCH GEN PSYCHIAT, V42, P71.
   BUKSTEIN OG, 1989, AM J PSYCHIAT, V146, P1131.
   CASADEBAIG F, 1989, ACTA PSYCHIAT SCAND, V79, P257, DOI 10.1111/j.1600-0447.1989.tb10255.x.
   DECHATEAU P, 1990, ACTA PSYCHIAT SCAND, V81, P472, DOI 10.1111/j.1600-0447.1990.tb05484.x.
   EDERER F, 1974, AM J EPIDEMIOL, V100, P165, DOI 10.1093/oxfordjournals.aje.a112024.
   GARDNER MJ, 1989, CONFIDENCE INTERVAL.
   Gardner MJ, 1989, STAT CONFIDENCE.
   GOLDACRE M, 1985, BRIT J PSYCHIAT, V146, P395, DOI 10.1192/bjp.146.4.395.
   Hansen V, 1997, BRIT J PSYCHIAT, V170, P186, DOI 10.1192/bjp.170.2.186.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   Kjelsberg E, 1999, ACTA PSYCHIAT SCAND, V99, P237, DOI 10.1111/j.1600-0447.1999.tb07218.x.
   Kjelsberg E, 1998, ACTA PSYCHIAT SCAND, V98, P34, DOI 10.1111/j.1600-0447.1998.tb10039.x.
   KUPERMAN S, 1988, ARCH GEN PSYCHIAT, V45, P277.
   LARSEN FW, 1990, ACTA PSYCHIAT SCAND, V81, P39, DOI 10.1111/j.1600-0447.1990.tb06446.x.
   LEWINSOHN PM, 1995, J AM ACAD CHILD PSY, V34, P510, DOI 10.1097/00004583-199504000-00018.
   MARTIN RL, 1985, ARCH GEN PSYCHIAT, V42, P58.
   OSTMAN O, 1991, ACTA PSYCHIAT SCAND, V84, P40, DOI 10.1111/j.1600-0447.1991.tb01419.x.
   REITER K, 1974, SCAND J SOC MED, V2, P1.
   RYDELIUS PA, 1988, ACTA PSYCHIAT SCAND, V77, P398, DOI 10.1111/j.1600-0447.1988.tb05141.x.
   {*}WHO, 1977, 9 REVISION INT CLASS.
   ZILBER N, 1989, ACTA PSYCHIAT SCAND, V79, P248, DOI 10.1111/j.1600-0447.1989.tb10254.x.},
Number-of-Cited-References = {23},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Br. J. Psychiatry},
Doc-Delivery-Number = {283TT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000085292400005},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000254374600011,
Author = {Vlajinac, Hristina and Marinkovic, Jelena and Kocev, Nikola and Sipetic,
   Sandra and Bjegovic, Vesna and Jankovic, Slavenka and Stanisavljevic,
   Dejana and Markovic-Denic, Ljijana and Maksimovic, Jadranka},
Title = {Years of life lost due to premature death in Serbia (excluding Kosovo
   and Metohia)},
Journal = {PUBLIC HEALTH},
Year = {2008},
Volume = {122},
Number = {3},
Pages = {277-284},
Month = {MAR},
Abstract = {Objective: To provide an assessment of the mortality burden in Serbia
   (excluding Kosovo and Metohia).
   Methods: The study was undertaken using data for Serbia, excluding
   Kosovo and Metohia, for the year 2000. Years of life lost (YLL), the
   mortality component of disabitity-adjusted life years, was determined
   from the average life expectancy at each age of death while discounting
   future years by 3\% per annum. YLL was calculated using life expectancy
   at that age based on standard life tables, with life expectancy at birth
   fixed at 82.5 years for females and 80.0 years for mates.
   Results: Premature mortality was responsible for 814,022 YLL, after
   discounting future years at 3\% per annum and weighting for age. Mates
   lost 462,050 years and females lost 351,972 years. Cardiovascular
   diseases and cancers dominated the burden of premature mortality.
   Ischaemic heart disease was the leading single cause of YLL for mates,
   followed by stroke, lung cancer, inflammatory heart disease,
   self-inflicted injuries, road traffic accidents, colorectal. and stomach
   cancers, and chronic obstructive pulmonary disease. Each contributed
   over 10,000 YLL. For females, cerebrovascular disease was the leading
   cause of YLL, followed by ischaemic heart disease, breast and lung
   cancer, and diabetes mellitus. YLL due to premature death gives greater
   weight to those conditions that affect younger people. Consequently, a
   ranking of diseases by YLL differs from a ranking based on unadjusted
   numbers of deaths. In comparison with data from the Global Burden of
   Disease study (2000) for the world population and the EURO-A region, the
   mortality burden in Serbia is closer to that in developed than
   developing countries. Standardization was performed using the direct
   method, with the world population used as the standard.},
Publisher = {W B SAUNDERS CO LTD},
Address = {32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Vlajinac, H (Corresponding Author), Univ Belgrade, Sch Med, Inst Epidemiol, Visegradska 26, Belgrade 11000, Serbia.
   Vlajinac, Hristina; Sipetic, Sandra; Jankovic, Slavenka; Markovic-Denic, Ljijana; Maksimovic, Jadranka, Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade 11000, Serbia.
   Marinkovic, Jelena; Kocev, Nikola; Bjegovic, Vesna; Stanisavljevic, Dejana, Univ Belgrade, Sch Med, Inst Social Med Stat \& Hlth Res, Belgrade 11000, Serbia.},
DOI = {10.1016/j.puhe.2007.06.010},
ISSN = {0033-3506},
EISSN = {1476-5616},
Keywords = {years of life lost; mortality; epidemiotogy},
Keywords-Plus = {GLOBAL BURDEN; MORTALITY; DISEASE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {kristiv@eunet.yu},
ResearcherID-Numbers = {Bjegovic-Mikanovic, Vesna/AAD-9847-2019
   },
ORCID-Numbers = {Bjegovic-Mikanovic, Vesna/0000-0002-8299-6555
   Vlajinac, Hristina/0000-0002-8239-2989
   Jankovic, Slavenka/0000-0001-6791-3056},
Cited-References = {AHMAD OB, 2000, GLOBAL PROGRAMME EVI, V31, P3.
   Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   COALE AJ, 1983, REGIONAL MODEL LIFE, P1.
   {*}DEP HUM SERV, 1999, VICT BURD DIS STUD M, P20.
   Indrayan A, 2002, NATL MED J INDIA, V15, P7.
   LOZANO R, 2001, 1I GPE WHO.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Mathers C., 1999, BURDEN DIS INJURY AU.
   MATHERS C, 2001, NATL BURDEN DIS STUD, P43.
   Mathers CD, 2002, 50 GPE WHO.
   Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535.
   MURRAY CJ, 1996, GLOBAL BURDEN DIS IN, V1, P125.
   Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981.
   Murray CJL, 2000, HEALTH ECON, V9, P69, DOI 10.1002/(SICI)1099-1050(200001)9:1<69::AID-HEC493>3.0.CO;2-I.
   Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0.
   MURRAY CJL, 2001, GLOBAL BURDEN DIS 20.
   PEJINSTOKIC L, 1996, IMPROVEMENT PLANNING.
   Vlajinac HD, 1997, J EPIDEMIOL COMMUN H, V51, P172, DOI 10.1136/jech.51.2.172.
   VLAJINAC HD, 1994, J EPIDEMIOL COMMUN H, V48, P254, DOI 10.1136/jech.48.3.254.
   Williams A, 1999, HEALTH ECON, V8, P1.},
Number-of-Cited-References = {21},
Times-Cited = {18},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Public Health},
Doc-Delivery-Number = {279SJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000254374600011},
DA = {2022-03-29},
}

@article{ WOS:000501721300001,
Author = {Hammitt, James K. and Morfeld, Peter and Tuomisto, Jouni T. and Erren,
   Thomas C.},
Title = {Premature Deaths, Statistical Lives, and Years of Life Lost:
   Identification, Quantification, and Valuation of Mortality Risks},
Journal = {RISK ANALYSIS},
Year = {2020},
Volume = {40},
Number = {4},
Pages = {674-695},
Month = {APR},
Abstract = {Mortality effects of exposure to air pollution and other environmental
   hazards are often described by the estimated number of ``premature{''}
   or ``attributable{''} deaths and the economic value of a reduction in
   exposure as the product of an estimate of ``statistical lives saved{''}
   and a ``value per statistical life.{''} These terms can be misleading
   because the number of deaths advanced by exposure cannot be determined
   from mortality data alone, whether from epidemiology or randomized
   trials (it is not statistically identified). The fraction of deaths
   ``attributed{''} to exposure is conventionally derived as the hazard
   fraction (R - 1)/R, where R is the relative risk of mortality between
   high and low exposure levels. The fraction of deaths advanced by
   exposure (the ``etiologic{''} fraction) can be substantially larger or
   smaller: it can be as large as one and as small as 1/e (approximate to
   0.37) times the hazard fraction (if the association is causal and zero
   otherwise). Recent literature reveals misunderstanding about these
   concepts. Total life years lost in a population due to exposure can be
   estimated but cannot be disaggregated by age or cause of death. Economic
   valuation of a change in exposure-related mortality risk to a population
   is not affected by inability to know the fraction of deaths that are
   etiologic. When individuals facing larger or smaller changes in
   mortality risk cannot be identified, the mean change in population
   hazard is sufficient for valuation; otherwise, the economic value can
   depend on the distribution of risk reductions.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Hammitt, JK (Corresponding Author), Harvard Univ, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.
   Hammitt, JK (Corresponding Author), Harvard Univ, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.
   Hammitt, James K., Harvard Univ, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.
   Hammitt, James K., Harvard Univ, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.
   Hammitt, James K., Univ Toulouse Capitole, Toulouse Sch Econ, Toulouse, France.
   Morfeld, Peter, Univ Cologne, Ruhr Univ Bochum, Inst \& Policlin Occupat Med Environm Med \& Preven, Cologne, Germany.
   Tuomisto, Jouni T., Natl Inst Hlth \& Welf, Kuopio, Finland.
   Erren, Thomas C., Univ Cologne, Inst \& Policlin Occupat Med Environm Med \& Preven, Cologne, Germany.},
DOI = {10.1111/risa.13427},
EarlyAccessDate = {DEC 2019},
ISSN = {0272-4332},
EISSN = {1539-6924},
Keywords = {Attributable death; disability-adjusted life year; environmental burden
   of disease; hazard fraction; premature death; value per statistical
   life; years of live lost},
Keywords-Plus = {AMBIENT AIR-POLLUTANTS; STATED-PREFERENCE; ATTRIBUTABLE FRACTIONS;
   INCOME ELASTICITY; GLOBAL VALUES; POLLUTION; PROBABILITY; CAUSATION;
   DISEASE; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods},
Author-Email = {jkh@harvard.edu},
ORCID-Numbers = {Tuomisto, Jouni/0000-0002-9988-1762},
Cited-References = {Aldy JE, 2008, REV ECON STAT, V90, P573, DOI 10.1162/rest.90.3.573.
   Alolayan MA, 2017, ENVIRON RESOUR ECON, V66, P629, DOI 10.1007/s10640-015-9958-1.
   Anenberg S, 2019, GLOBAL SNAPSHOT AIR.
   Anenberg SC, 2017, NATURE, V545, P467, DOI 10.1038/nature22086.
   Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x.
   Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492.
   Beyea J, 1999, HEALTH PHYS, V76, P269, DOI 10.1097/00004032-199903000-00008.
   Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115.
   Cameron TA, 2010, REV ENV ECON POLICY, V4, P161, DOI 10.1093/reep/req010.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   COMEAP, 2010, COMEAP MORT EFF LONG.
   Dikensoy O, 2008, CURR OPIN PULM MED, V14, P322, DOI 10.1097/MCP.0b013e3282fcea65.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Dominici F, 2005, J TOXICOL ENV HEAL A, V68, P1071, DOI 10.1080/15287390590935932.
   Dreze J., 1962, REVUE FRANCAISE DE R, V23, P93.
   Eeckhoudt LR, 2001, J RISK UNCERTAINTY, V23, P261, DOI 10.1023/A:1011825824296.
   Environmental Protection Agency, 1996, EPA452R96013 OAQPS.
   Goodkind AL, 2019, P NATL ACAD SCI USA, V116, P8775, DOI 10.1073/pnas.1816102116.
   Greenland S, 1999, AM J PUBLIC HEALTH, V89, P1166, DOI 10.2105/AJPH.89.8.1166.
   GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073.
   Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003.
   Greenland S, 2015, ANN EPIDEMIOL, V25, P155, DOI 10.1016/j.annepidem.2014.11.005.
   Greenland S, 2012, B ATOM SCI, V68, P76, DOI 10.1177/0096340212444873.
   Greenland Sander, 2000, JURIMETRICS, V40, P321.
   Hammitt JK, 2007, REV ENV ECON POLICY, V1, P228, DOI 10.1093/reep/rem015.
   Hammitt JK, 2007, J RISK UNCERTAINTY, V35, P45, DOI 10.1007/s11166-007-9015-8.
   Hammitt JK, 2019, J RISK UNCERTAINTY, V58, P167, DOI 10.1007/s11166-019-09305-5.
   Hammitt JK, 2015, J RISK UNCERTAINTY, V51, P79, DOI 10.1007/s11166-015-9217-4.
   Hammitt JK, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1009.
   HANEMANN WM, 1991, AM ECON REV, V81, P635.
   Heroux ME, 2017, INT J PUBLIC HEALTH, V62, P339, DOI 10.1007/s00038-017-0956-7.
   Heroux ME, 2015, INT J PUBLIC HEALTH, V60, P619, DOI 10.1007/s00038-015-0690-y.
   HM Treasury, 2003, GREEN BOOK APPR EV C.
   Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43.
   HOWARD RA, 1984, MANAGE SCI, V30, P407, DOI 10.1287/mnsc.30.4.407.
   HRAPIE, 2013, HLTH RISKS AIR POLL.
   International Agency For Research On Cancer, 1987, IARC MON EV CARC S7, V7, P1.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Jasani B, 2012, ARCH PATHOL LAB MED, V136, P262, DOI 10.5858/arpa.2011-0039-RA.
   JONESLEE M, 1974, J POLIT ECON, V82, P835, DOI 10.1086/260238.
   Jonson JE, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8850.
   Krupnick A, 2007, REV ENV ECON POLICY, V1, P261, DOI 10.1093/reep/rem016.
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0.
   Lash TL., 2008, MODERN EPIDEMIOLOGY.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Masterman CJ, 2018, J BENEFIT-COST ANAL, V9, P407, DOI 10.1017/bca.2018.20.
   MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617.
   Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Ostro B., 2004, ENV BURDEN DIS SERIE.
   Poole C, 2015, ANN EPIDEMIOL, V25, P147, DOI 10.1016/j.annepidem.2014.11.015.
   POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351.
   Pruss-ustun A., 2003, ENV BURDEN DIS SERIE, V1.
   Rabl A, 2003, J AIR WASTE MANAGE, V53, P41, DOI 10.1080/10473289.2003.10466118.
   ROBINS J, 1989, BIOMETRICS, V45, P1125, DOI 10.2307/2531765.
   ROBINS J, 1991, STAT MED, V10, P79, DOI 10.1002/sim.4780100113.
   ROBINS JM, 1989, STAT MED, V8, P845, DOI 10.1002/sim.4780080709.
   Robinson LA, 2016, HEALTH ECON, V25, P1039, DOI 10.1002/hec.3214.
   Rowe AK, 2004, AM J PREV MED, V26, P243, DOI 10.1016/j.amepre.2003.12.007.
   Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034.
   Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6.
   Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333.
   Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912.
   TSIATIS A, 1975, P NATL ACAD SCI USA, V72, P20, DOI 10.1073/pnas.72.1.20.
   Viscusi WK, 2017, J BENEFIT-COST ANAL, V8, P226, DOI 10.1017/bca.2017.12.
   Wang JD, 2017, ENVIRON HEALTH PERSP, V125, P400, DOI 10.1289/EHP298.
   WEINSTEIN MC, 1980, Q J ECON, V94, P373, DOI 10.2307/1884546.
   World Health Organization, 2016, AMBIENT AIR POLLUTIO.},
Number-of-Cited-References = {69},
Times-Cited = {18},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Risk Anal.},
Doc-Delivery-Number = {LP9MY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000501721300001},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000374240200004,
Author = {Sierksma, Annerieke S. R. and de Nijs, Laurence and Hoogland, Govert and
   Vanmierlo, Tim and van Leeuwen, Fred W. and Rutten, Bart P. F. and
   Steinbusch, Harry W. M. and Prickaerts, Jos and van den Hove, Daniel L.
   A.},
Title = {Fluoxetine Treatment Induces Seizure Behavior and Premature Death in
   APPswe/PS1dE9 Mice},
Journal = {JOURNAL OF ALZHEIMERS DISEASE},
Year = {2016},
Volume = {51},
Number = {3},
Pages = {677-682},
Abstract = {Treatment of Alzheimer's disease (AD) patients with the antidepressant
   fluoxetine is known to improve memory and cognitive function. However,
   the mechanisms underlying these effects are largely unknown. To unravel
   these mechanisms, we aimed to treat APPswe/PS1dE9 mice with fluoxetine.
   Unexpectedly, with time, an increased number of animals displayed
   seizure behavior and died. Although spontaneous behavioral seizures have
   been reported previously in this mouse model, the observation of
   seizures and death consequential to fluoxetine treatment is new. Our
   results warrant further research on the underlying mechanisms as this
   may refine the treatment of AD patients.},
Publisher = {IOS PRESS},
Address = {NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {van den Hove, DLA (Corresponding Author), Maastricht Univ, Med Ctr, Sch Mental Hlth \& Neurosci MHeNS, Dept Psychiat \& Neuropsychol,Fac Hlth Med \& Life, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.
   Sierksma, Annerieke S. R.; de Nijs, Laurence; Hoogland, Govert; Vanmierlo, Tim; van Leeuwen, Fred W.; Rutten, Bart P. F.; Steinbusch, Harry W. M.; Prickaerts, Jos; van den Hove, Daniel L. A., Maastricht Univ, Fac Hlth Med \& Life Sci, Dept Psychiat \& Neuropsychol, Sch Mental Hlth \& Neurosci MHeNS, NL-6200 MD Maastricht, Netherlands.
   Hoogland, Govert, Maastricht Univ, Med Ctr, Dept Neurosurg, NL-6200 MD Maastricht, Netherlands.
   van den Hove, Daniel L. A., Univ Wurzburg, Dept Psychiat Psychosomat \& Psychotherapy, D-97070 Wurzburg, Germany.},
DOI = {10.3233/JAD-151066},
ISSN = {1387-2877},
EISSN = {1875-8908},
Keywords = {Alzheimer's disease; APPswe/PS1dE9; epilepsy; fluoxetine; premature
   death; seizure},
Keywords-Plus = {CLINICAL-TRIAL; ALZHEIMERS-DISEASE; TRANSGENIC MICE; DOUBLE-BLIND;
   ANTIDEPRESSANTS; DEMENTIA; RATS; COGNITION; EPILEPSY; STRESS},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Author-Email = {d.vandenhove@maastrichtuniversity.nl},
ResearcherID-Numbers = {Vanmierlo, Tim/C-7773-2013
   Sierksma, Annerieke/L-7990-2016
   Steinbusch, Heinrich/L-6950-2017
   },
ORCID-Numbers = {Vanmierlo, Tim/0000-0003-2912-0578
   van den Hove, Daniel/0000-0003-4047-3198
   Rutten, Bart/0000-0002-9834-6346},
Funding-Acknowledgement = {Internationale Stichting Alzheimer Onderzoek (ISAO) {[}07551, 11532]},
Funding-Text = {This study has been funded in part by the Internationale Stichting
   Alzheimer Onderzoek (ISAO) grant numbers 07551 and 11532 to D.L.A. van
   den Hove.},
Cited-References = {BENDELE RA, 1992, CANCER RES, V52, P6931.
   Bianchi Matt T., 2010, BMC Pharmacology, V10, P3, DOI 10.1186/1471-2210-10-3.
   Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0.
   Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051.
   BRAITBERG G, 1995, ANN EMERG MED, V26, P234, DOI 10.1016/S0196-0644(95)70157-5.
   Cardamone L, 2014, NEUROBIOL DIS, V63, P194, DOI 10.1016/j.nbd.2013.11.020.
   Chan JX, 2015, EPILEPSIA, V56, pe73, DOI 10.1111/epi.12993.
   Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108.
   Dailey JW, 1996, BIOCHEM PHARMACOL, V52, P1323, DOI 10.1016/S0006-2952(96)00509-6.
   Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040.
   Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015.
   Erenmemisoglu A, 1999, J PHARM PHARMACOL, V51, P741, DOI 10.1211/0022357991772899.
   Ferrero AJ, 2005, PROG NEURO-PSYCHOPH, V29, P678, DOI 10.1016/j.pnpbp.2005.04.013.
   Gomes KS, 2009, BRAIN RES BULL, V78, P323, DOI 10.1016/j.brainresbull.2008.11.003.
   Gross R, 1998, AM J EMERG MED, V16, P328, DOI 10.1016/S0735-6757(98)90118-8.
   Henry G, 2011, AM J ALZHEIMERS DIS, V26, P169, DOI 10.1177/1533317511402051.
   Igelstrom KM, 2012, EPILEPSIA, V53, P596, DOI 10.1111/j.1528-1167.2012.03427.x.
   Ivkovic Maja, 2004, Psychiatr Danub, V16, P15.
   KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322.
   Keowkase R, 2010, NEUROPHARMACOLOGY, V59, P358, DOI 10.1016/j.neuropharm.2010.04.008.
   Kessing LV, 2011, INT CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/YIC.0b013e32834ace0f.
   LANGE SC, 1976, EPILEPSIA, V17, P183, DOI 10.1111/j.1528-1157.1976.tb03396.x.
   Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005.
   Maguire J, 2013, EPILEPSY BEHAV, V26, P352, DOI 10.1016/j.yebeh.2012.09.040.
   Marlatt Michael W, 2013, Curr Top Behav Neurosci, V15, P313, DOI 10.1007/7854\_2012\_237.
   Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009.
   Montgomery SA, 2005, INT J CLIN PRACT, V59, P1435, DOI 10.1111/j.1368-5031.2005.00731.x.
   Mossello E, 2008, DEMENT GERIATR COGN, V25, P372, DOI 10.1159/000121334.
   Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P484, DOI 10.1097/jcp.0b013e31814b98c1.
   Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P67, DOI 10.1097/jcp.0b013e31802e0002.
   Neely J L, 1998, W V Med J, V94, P283.
   Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037.
   Oke A, 2001, QJM-MON J ASSOC PHYS, V94, P113, DOI 10.1093/qjmed/94.2.113.
   Parnetti L, 2001, MECH AGEING DEV, V122, P2063, DOI 10.1016/S0047-6374(01)00316-5.
   PRESKORN SH, 1992, J CLIN PSYCHIAT, V53, P160.
   Puzerey PA, 2014, J NEUROPHYSIOL, V112, P2357, DOI 10.1152/jn.00031.2014.
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0.
   Sheline YI, 2014, SCI TRANSL MED, V6.
   Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015.
   Velasco A, 1997, GEN PHARMACOL, V28, P509, DOI 10.1016/S0306-3623(96)00274-1.
   Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136.
   Wang JH, 2014, CURR ALZHEIMER RES, V11, P672, DOI 10.2174/1567205011666140812114715.
   Yang C, 2014, BRAZ J MED BIOL RES, V47, P237, DOI 10.1590/1414-431X20133275.
   Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003.},
Number-of-Cited-References = {44},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {J. Alzheimers Dis.},
Doc-Delivery-Number = {DJ5IL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000374240200004},
DA = {2022-03-29},
}

@article{ WOS:000187352900008,
Author = {Petersen, L and Sorensen, TIA and Andersen, PK},
Title = {Comparison of case-cohort estimators based on data on premature death of
   adult adoptees},
Journal = {STATISTICS IN MEDICINE},
Year = {2003},
Volume = {22},
Number = {24},
Pages = {3795-3803},
Month = {DEC 30},
Note = {23rd Scientific Meeting of the
   International-Society-for-Clinical-Biostatistics, PARIS, FRANCE, 2002},
Organization = {Int Soc Clin Biostatist},
Abstract = {A case-cohort sample of adoptees was collected to investigate genetic
   and environmental influences on premature death, which motivated us to
   supplement existing simulation results to explore the performance of
   various estimators proposed for case-cohort samples of survival data. We
   studied six regression coefficients estimators, which differ with regard
   to the weighting scheme used in a pseudo-likelihood function, and two
   different estimators of their variances. Compared to earlier simulation
   studies, we changed the following conditions: type of explanatory
   variable, the distribution of lifetimes, and the percentage of deaths in
   the full cohort. The latter condition affected the performance of the
   estimated variances of the regression coefficients, where we found a
   systematic bias of the estimator, proposed by Self and Prentice,
   dependent on the percentages of deaths. This dependence of percentages
   of death was different for different sizes of case-cohort studies. A
   robust variance estimator showed a better overall performance. The
   estimators of regression coefficients compared did not differ much, the
   estimators proposed by Kalbfleisch and Lawless and by Prentice
   performing very well. Results of the case-cohort data of adoptees were
   not in conflict with earlier findings of a moderate genetic influence on
   premature death in adulthood. Copyright (C) 2003 John Wiley Sons, Ltd.},
Publisher = {JOHN WILEY \& SONS LTD},
Address = {THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Petersen, L (Corresponding Author), Kommune Hosp Copenhagen, Inst Prevent Med, DK-1399 Copenhagen K, Denmark.
   Copenhagen Univ Hosp, Danish Epidemiol Sci Ctr, DK-1399 Copenhagen K, Denmark.
   Copenhagen Univ Hosp, Inst Prevent Med, DK-1399 Copenhagen, Denmark.
   Statens Serum Inst, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark.
   Univ Copenhagen, Dept Biostat, DK-2200 Copenhagen N, Denmark.},
DOI = {10.1002/sim.1672},
ISSN = {0277-6715},
Keywords = {case-cohort sampling; adoption; mortality; life span; survival analysis;
   Cox proportional hazard},
Keywords-Plus = {PROPORTIONAL HAZARDS MODEL; DESIGNS; REGRESSION; RESIDUALS},
Research-Areas = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Research \& Experimental
   Medicine; Mathematics},
Web-of-Science-Categories  = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Medicine, Research \&
   Experimental; Statistics \& Probability},
ORCID-Numbers = {Petersen, Liselotte Vogdrup/0000-0002-0479-5379},
Cited-References = {BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444.
   Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X.
   Borgan O, 2000, LIFETIME DATA ANAL, V6, P39, DOI 10.1023/A:1009661900674.
   Chen K, 1999, BIOMETRIKA, V86, P755, DOI 10.1093/biomet/86.4.755.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116.
   Khoury M.J., 1993, FUNDAMENTALS GENETIC.
   Kim S, 1999, LIFETIME DATA ANAL, V5, P149, DOI 10.1023/A:1009601512314.
   LIN DY, 1993, J AM STAT ASSOC, V88, P1341, DOI 10.2307/2291275.
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085.
   Neale MC., 1992, METHODOLOGY GENETIC.
   Petersen L, 2002, GENET EPIDEMIOL, V23, P123, DOI 10.1002/gepi.1122.
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1.
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876.
   SELF SG, 1988, ANN STAT, V16, P64, DOI 10.1214/aos/1176350691.
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202.
   Therneau TM, 1999, LIFETIME DATA ANAL, V5, P99, DOI 10.1023/A:1009691327335.},
Number-of-Cited-References = {17},
Times-Cited = {20},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Stat. Med.},
Doc-Delivery-Number = {754VM},
Web-of-Science-Index = {Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000187352900008},
DA = {2022-03-29},
}

@article{ WOS:A1995QW60200041,
Author = {BARKER, JE},
Title = {MURINE HERTWIGS ANEMIA - PREMATURE DEATH AFTER NORMAL BONE-MARROW
   TRANSPLANTATION IS RADIATION DOSE-DEPENDENT},
Journal = {BLOOD},
Year = {1995},
Volume = {85},
Number = {9},
Pages = {2627-2631},
Month = {MAY 1},
Abstract = {Marrow transplantation therapy in mice with heritable blood disorders
   usually leads to rapid blood cell normalization, but is sometimes
   followed by pancytopenia and premature death, This is especially true in
   mice with Hertwig's anemia (an/an). Unlike the +/+ recipients, 100\% of
   whom survive for over a year, 66\% of the mutant mice die by 6 months
   posttransplantation, and the rest die soon thereafter. It is not clear
   whether premature death is due to the radiation dose (10 Gy) or to the
   fact that the F1 mutant mice receive parental-type cells known to induce
   hybrid resistance, In the present report, experiments were designed to
   determine whether the F1-an/an host is more sensitive to radiation
   and/or resistant to continued expansion of the parental-type +/+ cells,
   The mutant mice are, indeed, more sensitive to irradiation, with an
   LD(100/30) of 7 Gy as compared with an LD(100/30) of 10 Gy for the +/+
   mice. The times of anemia onset and death for mutant mice implanted with
   +/+ cells postirradiation is also radiation dose-dependent. Further
   evidence that death is due to host radiation damage rather than F1
   hybrid resistance was provided by transplanting cells from three morbid
   10 Gy-irradiation recipients into unirradiated, anemic, stem
   cell-deficient, F1-W/W-v secondary hosts, All recipients were
   repopulated by the original parental cells, were cured of their anemia,
   and survived for 52 weeks posttransplantation. The an/an mouse's
   heightened susceptibility to radiation damage appears to be the major
   factor in early death after transplantation therapy, (C) 1995 by The
   American Society of Hematology.},
Publisher = {W B SAUNDERS CO},
Address = {INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399},
Type = {Article},
Language = {English},
Affiliation = {BARKER, JE (Corresponding Author), JACKSON LAB,BOX 258,600 MAIN ST,BAR HARBOR,ME 04609, USA.},
DOI = {10.1182/blood.V85.9.2627.bloodjournal8592627},
ISSN = {0006-4971},
Keywords-Plus = {HEMOLYTIC-DISEASE; MICE; MOUSE; REPOPULATION; REPLACEMENT; IRRADIATION;
   GENES},
Research-Areas = {Hematology},
Web-of-Science-Categories  = {Hematology},
Funding-Acknowledgement = {NCI NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}CA34196] Funding Source: Medline; NIDDK NIH HHSUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Diabetes \& Digestive \& Kidney
   Diseases (NIDDK) {[}DK27726] Funding Source: Medline; NATIONAL CANCER
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes \& Digestive \& Kidney Diseases (NIDDK)
   {[}R01DK027726] Funding Source: NIH RePORTER},
Cited-References = {BARKER JE, 1989, BLOOD, V73, P2014.
   BARKER JE, 1982, J CELL PHYSIOL, V113, P257, DOI 10.1002/jcp.1041130212.
   BARKER JE, 1988, P NATL ACAD SCI USA, V85, P7332, DOI 10.1073/pnas.85.19.7332.
   BARKER JE, 1983, BLOOD, V61, P765.
   BERNSTEIN S, 1962, SCIENCE, V137, P428, DOI 10.1126/science.137.3528.428.
   BERNSTEIN SE, 1989, EXP HEMATOL, V17, P1004.
   BERNSTEIN SE, 1980, LAB ANIM SCI, V30, P197.
   EICHER EM, 1978, P NATL ACAD SCI USA, V75, P946, DOI 10.1073/pnas.75.2.946.
   EPPIG JT, 1984, BLOOD, V64, P727.
   EPPIG JT, 1989, BLOOD, V73, P1373.
   FANCONI G., 1967, SEMINARS HAMATOL, V4, P233.
   HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x.
   HARRISON DE, 1972, BLOOD-J HEMATOL, V40, P893, DOI 10.1182/blood.V40.6.893.893.
   HARRISON DE, 1981, IMMUNOGENETICS, V13, P177, DOI 10.1007/BF00350784.
   HARRISON DE, 1980, BLOOD, V55, P77.
   Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0.
   RUSSELL ES, 1985, DEV BIOL, V110, P331, DOI 10.1016/0012-1606(85)90092-2.
   RUSSELL ES, 1956, SCIENCE, V124, P1067.
   SHULTZ LD, 1983, EXP HEMATOL, V11, P667.
   VANZANT G, 1983, CELL, V35, P639, DOI 10.1016/0092-8674(83)90096-X.
   WEVRICK R, 1993, MAMM GENOME, V4, P440, DOI 10.1007/BF00296818.
   WHITNEY JB, 1978, BIOCHEM GENET, V16, P667, DOI 10.1007/BF00484723.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Blood},
Doc-Delivery-Number = {QW602},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1995QW60200041},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000167587300039,
Author = {Neeleman, J},
Title = {A continuum of premature death. Meta-analysis of competing mortality in
   the psychosocially vulnerable},
Journal = {INTERNATIONAL JOURNAL OF EPIDEMIOLOGY},
Year = {2001},
Volume = {30},
Number = {1},
Pages = {154-162},
Month = {FEB},
Abstract = {Background Suicide may be an extreme expression of liability to death of
   any type. If true, suicide risk factors should also increase other
   mortality, and, given exposure, excess risk should be higher for suicide
   than for other mortality.
   Methods Of 304 publications identified in Index Medicus (1966-June 1988)
   by the string (suicide) and (mortality or death) and (accidental or
   natural), 24 reported total and cause-specific mortality associated with
   exposure to 16 established suicide risk factors: reference scanning
   yielded 122 more. These 146 publications reported on 163 cohorts (total
   subjects = 1179 126) mortality Meta-analysis gave random effects
   standardized mortality ratios (SMR) for natural, accidental and suicidal
   death, stratified over the 16 risk groups.
   Results Overall, SMR were 8.6 (95\% CI : 7.1-10.4) for suicide, 3.4
   (95\% CI : 2.9-4.0) for accidental and 2.1 (95\% CI: 1.9-2.3) for
   natural death. Compatible with the first hypothesis, in most groups,
   mortality of any type was raised. Supporting the second hypothesis,
   excesses increased from lowest for natural death to highest for suicide.
   This trend was most pronounced following deliberate self-harm,
   intermediate in substance abusers, and weakest, but present, in bereaved
   and low social class cohorts and reversed in smokers and epileptic
   people.
   Conclusions Many suicide risks apply to any type of premature death,
   whilst also retaining some specificity for suicide. Primary prevention,
   targeting such generic risk factors, will not only reduce rates of
   suicide but also of other types of death. Conversely when prevention
   focuses on specific outcomes-such as suicide-only, other types of
   mortality may increase.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Neeleman, J (Corresponding Author), Univ Groningen, Dept Social Psychiat, POB 30001, NL-9700 RB Groningen, Netherlands.
   Univ Groningen, Dept Social Psychiat, NL-9700 RB Groningen, Netherlands.},
DOI = {10.1093/ije/30.1.154},
ISSN = {0300-5771},
EISSN = {1464-3685},
Keywords = {suicide; accidental death; natural death; meta-analysis},
Keywords-Plus = {10-YEAR FOLLOW-UP; MANIC-DEPRESSIVE PATIENTS; RECURRENT MOOD DISORDERS;
   MAJOR AFFECTIVE-DISORDER; DUTCH MENTAL-HOSPITALS;
   INTRAVENOUS-DRUG-USERS; LONG-STAY POPULATION; PSYCHIATRIC-PATIENTS;
   EXCESS MORTALITY; ATTEMPTED-SUICIDE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {j.neeleman@med.rug.nl},
Cited-References = {ADAMS MJ, 1991, ACTA PHYTOPATHOL HUN, V26, P91.
   Adelstein A, 1976, POPULATION TRENDS, V6, P7.
   ALLEBECK P, 1991, PSYCHOL MED, V21, P979, DOI 10.1017/S0033291700029962.
   ALLGULANDER C, 1987, ACTA PSYCHIAT SCAND, V75, P521, DOI 10.1111/j.1600-0447.1987.tb02828.x.
   ALLGULANDER C, 1994, ARCH GEN PSYCHIAT, V51, P708.
   ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021.
   {[}Anonymous], 1987, JAMA, V257, P790.
   APPLEBY L, 1992, BRIT J PSYCHIAT, V161, P749, DOI 10.1192/bjp.161.6.749.
   ASTRUP C, 1959, ACTA PSYCHIAT ET NEUROL SCAND, V34, P7.
   BABIGIAN HM, 1969, AM J PSYCHIAT, V126, P470, DOI 10.1176/ajp.126.4.470.
   BADEN MM, 1972, HUM PATHOL, V3, P91, DOI 10.1016/S0046-8177(72)80058-3.
   BARR HL, 1984, J STUD ALCOHOL, V45, P440, DOI 10.15288/jsa.1984.45.440.
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446.
   BENSON G, 1984, ACTA PSYCHIAT SCAND, V70, P525, DOI 10.1111/j.1600-0447.1984.tb01244.x.
   BERGLUND M, 1987, ACTA PSYCHIAT SCAND, V76, P372, DOI 10.1111/j.1600-0447.1987.tb05621.x.
   BERGLUND M, 1984, ACTA PSYCHIAT SCAND, V70, P407, DOI 10.1111/j.1600-0447.1984.tb01228.x.
   BERGLUND M, 1985, ACTA PSYCHIAT SCAND, V71, P141, DOI 10.1111/j.1600-0447.1985.tb01264.x.
   BERREN MR, 1994, HOSP COMMUNITY PSYCH, V45, P604.
   BESKOW J, 1996, EUR PSYCHIAT, V11, P203.
   Blaauw E, 1997, SUICIDE LIFE-THREAT, V27, P153.
   BLACK DW, 1985, ARCH GEN PSYCHIAT, V42, P82.
   BLACK DW, 1985, ARCH GEN PSYCHIAT, V42, P71.
   BLACK DW, 1987, J NERV MENT DIS, V175, P674, DOI 10.1097/00005053-198711000-00005.
   Black DW, 1996, PSYCHOSOMATICS, V37, P131, DOI 10.1016/S0033-3182(96)71579-7.
   BLACK DW, 1992, SCHIZOPHR RES, V7, P109, DOI 10.1016/0920-9964(92)90040-C.
   BLAND RC, 1978, ACTA PSYCHIAT SCAND, V58, P327, DOI 10.1111/j.1600-0447.1978.tb00239.x.
   Boffetta P, 1990, Epidemiology, V1, P342, DOI 10.1097/00001648-199009000-00003.
   BRATFOS O, 1971, ACTA PSYCHIAT SCAND, V47, P38, DOI 10.1111/j.1600-0447.1971.tb02193.x.
   BRENNER B, 1967, Q J STUD ALCOHOL, V28, P517.
   BROOK OH, 1985, ACTA PSYCHIAT SCAND, V71, P626, DOI 10.1111/j.1600-0447.1985.tb02558.x.
   Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502.
   BUCHHOLTZHANSEN PE, 1993, ACTA PSYCHIAT SCAND, V87, P329, DOI 10.1111/j.1600-0447.1993.tb03381.x.
   BUCKNALL ABV, 1986, J ROY COLL GEN PRACT, V36, P120.
   BUDA M, 1988, ARCH GEN PSYCHIAT, V45, P283.
   BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002.
   CASADEBAIG F, 1989, ACTA PSYCHIAT SCAND, V79, P257, DOI 10.1111/j.1600-0447.1989.tb10255.x.
   COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5.
   COPPEN A, 1991, J AFFECT DISORDERS, V23, P1, DOI 10.1016/0165-0327(91)90030-V.
   CORYELL W, 1982, ARCH GEN PSYCHIAT, V39, P701.
   CORYELL W, 1984, J CLIN PSYCHIAT, V45, P252.
   COSTELLO RM, 1978, AM J DRUG ALCOHOL AB, V5, P199, DOI 10.3109/00952997809027998.
   Cox D.R., 1989, ANAL BINARY DATA, V2nd ed..
   CRISP AH, 1992, BRIT J PSYCHIAT, V161, P104, DOI 10.1192/bjp.161.1.104.
   DAHLGREN KG, 1951, ACTA PSYCH NEUROL, V26, P297, DOI 10.1111/j.1600-0447.1951.tb09676.x.
   DAHLGREN L, 1977, ACTA PSYCHIAT SCAND, V56, P81, DOI 10.1111/j.1600-0447.1977.tb06668.x.
   DAHLGREN L, 1979, ACTA PSYCHIAT SCAND, V59, P59, DOI 10.1111/j.1600-0447.1979.tb06947.x.
   de Lint J, 1975, Can Med Assoc J, V113, P385.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399.
   DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525.
   ECKERT ED, 1995, PSYCHOL MED, V25, P143, DOI 10.1017/S0033291700028166.
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629.
   EGGER M, 1999, BRIT MED J, V316, P61.
   EKEBERG O, 1994, SUICIDE LIFE-THREAT, V24, P398.
   ENGBERG M, 1994, ACTA PSYCHIAT SCAND, V89, P35, DOI 10.1111/j.1600-0447.1994.tb01482.x.
   ENGEL HO, 1991, J ROY SOC MED, V84, P163, DOI 10.1177/014107689108400316.
   ENZELL K, 1984, ACTA PSYCHIAT SCAND, V69, P89, DOI 10.1111/j.1600-0447.1984.tb02471.x.
   ESKILD A, 1993, INT J EPIDEMIOL, V22, P315, DOI 10.1093/ije/22.2.315.
   EVANS NJR, 1974, BRIT J PSYCHIAT, V124, P518, DOI 10.1192/bjp.124.6.518.
   EVANS NJR, 1983, J AFFECT DISORDERS, V5, P297, DOI 10.1016/0165-0327(83)90019-8.
   FRIBERG L, 1973, ARCH ENVIRON HEALTH, V27, P294, DOI 10.1080/00039896.1973.10666384.
   GIEL R, 1978, ACTA PSYCHIAT SCAND, V57, P361, DOI 10.1111/j.1600-0447.1978.tb06904.x.
   GILLIS LS, 1969, S AFR MED J     0301, P230.
   GLASSMAN AH, 1993, AM J PSYCHIAT, V150, P546.
   GOLDACRE M, 1985, BRIT J PSYCHIAT, V146, P395, DOI 10.1192/bjp.146.4.395.
   GOLDSTEIN JM, 1993, PSYCHOL MED, V23, P941, DOI 10.1017/S0033291700026404.
   Grabbe L, 1997, AM J PUBLIC HEALTH, V87, P434, DOI 10.2105/AJPH.87.3.434.
   GRANBOULAN V, 1995, ACTA PSYCHIAT SCAND, V91, P265, DOI 10.1111/j.1600-0447.1995.tb09780.x.
   GROOTENHUIS M, 1994, BRIT J PSYCHIAT, V165, P73, DOI 10.1192/bjp.165.1.73.
   GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227.
   HAASTRUP S, 1984, ACTA PSYCHIAT SCAND, V70, P503, DOI 10.1111/j.1600-0447.1984.tb01239.x.
   Hall DJ, 1998, BRIT J PSYCHIAT, V172, P239, DOI 10.1192/bjp.172.3.239.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x.
   HAWTON K, 1988, BRIT J PSYCHIAT, V152, P359, DOI 10.1192/bjp.152.3.359.
   HEARST N, 1986, NEW ENGL J MED, V314, P620, DOI 10.1056/NEJM198603063141005.
   HEGARTY JD, 1994, AM J PSYCHIAT, V151, P1409.
   HELGASON I, 1977, ACTA PSYCHIAT SCAND, V268, P1.
   HELSING KJ, 1982, AM J EPIDEMIOL, V116, P524, DOI 10.1093/oxfordjournals.aje.a113436.
   HEMENWAY D, 1993, AM J PUBLIC HEALTH, V83, P249, DOI 10.2105/AJPH.83.2.249.
   HIGUCHI S, 1987, Japanese Journal of Alcohol Studies and Drug Dependence, V22, P211.
   HUMPHREY JA, 1977, DIS NERV SYST, V38, P157.
   HUPPERT FA, 1995, PSYCHOL MED, V25, P1073, DOI 10.1017/S0033291700037569.
   Innes G, 1970, Scott Med J, V15, P143.
   IVERSEN L, 1987, BMJ-BRIT MED J, V295, P879, DOI 10.1136/bmj.295.6603.879.
   JORGENSEN P, 1992, ACTA PSYCHIAT SCAND, V85, P351, DOI 10.1111/j.1600-0447.1992.tb10317.x.
   KAPLAN HI, 1995, COMPREHENSIVE TXB PS, P4.
   KAPRIO J, 1987, AM J PUBLIC HEALTH, V77, P283, DOI 10.2105/AJPH.77.3.283.
   KEEHN RJ, 1974, PSYCHOSOM MED, V36, P27, DOI 10.1097/00006842-197401000-00003.
   KENDELL RE, 1966, Q J STUD ALCOHOL, V27, P30.
   KENDLER KS, 1986, ARCH GEN PSYCHIAT, V43, P643.
   KJELSBERG E, 1995, ACTA PSYCHIAT SCAND, V91, P236, DOI 10.1111/j.1600-0447.1995.tb09775.x.
   KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x.
   KLENERMAN P, 1993, J NEUROL NEUROSUR PS, V56, P149, DOI 10.1136/jnnp.56.2.149.
   KORANYI EK, 1977, ARCH GEN PSYCHIAT, V34, P1137.
   KUPERMAN S, 1988, ARCH GEN PSYCHIAT, V45, P277.
   LARSEN FW, 1990, ACTA PSYCHIAT SCAND, V81, P39, DOI 10.1111/j.1600-0447.1990.tb06446.x.
   Lewis G, 1998, LANCET, V351, P81, DOI 10.1016/S0140-6736(05)78154-X.
   Lewis G, 1997, BRIT J PSYCHIAT, V171, P351, DOI 10.1192/bjp.171.4.351.
   LICHT RW, 1993, ACTA PSYCHIAT SCAND, V87, P336, DOI 10.1111/j.1600-0447.1993.tb03382.x.
   LIM L C C, 1991, SMJ Singapore Medical Journal, V32, P130.
   LINDBERG S, 1998, BR J ADDICT, V83, P1193.
   LINDELIUS R, 1973, ACTA PSYCHIAT SCAND, V49, P315, DOI 10.1111/j.1600-0447.1973.tb04425.x.
   LINDELIUS R, 1974, ACTA PSYCHIAT SCAND, V50, P612, DOI 10.1111/j.1600-0447.1974.tb07524.x.
   LONNQVIST J, 1975, SUICIDE, V5, P39.
   MACKENZIE A, 1986, INT J ADDICT, V21, P865, DOI 10.3109/10826088609027400.
   MARSHALL EJ, 1994, ADDICTION, V89, P1293, DOI 10.1111/j.1360-0443.1994.tb03308.x.
   MEDHUS A, 1975, SCAND J SOC MED, V3, P111, DOI 10.1177/140349487500300302.
   MEHLUM L, 1994, MIL MED, V159, P138, DOI 10.1093/milmed/159.2.138.
   MollerMadsen S, 1996, ACTA PSYCHIAT SCAND, V94, P454, DOI 10.1111/j.1600-0447.1996.tb09890.x.
   MOSER KA, 1986, LANCET, V1, P365.
   MURPHY JM, 1989, SOC PSYCH PSYCH EPID, V24, P134, DOI 10.1007/BF01788022.
   MUSTO DF, 1981, NEW ENGL J MED, V304, P1071, DOI 10.1056/NEJM198104303041804.
   Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2.
   Neeleman J, 1997, BRIT J PSYCHIAT, V171, P303, DOI 10.1192/bjp.171.4.303.
   Neeleman J, 1996, ACTA PSYCHIAT SCAND, V94, P252, DOI 10.1111/j.1600-0447.1996.tb09857.x.
   Neeleman J, 1999, PSYCHOL MED, V29, P429, DOI 10.1017/S003329179800806X.
   Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631.
   NEELEMAN J, 1999, SOCIAL EPIDEMIOLOGIC.
   NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401.
   NEWMAN SC, 1991, ACTA PSYCHIAT SCAND, V83, P420, DOI 10.1111/j.1600-0447.1991.tb05568.x.
   NICHOLLS P, 1974, Q J STUD ALCOHOL, V35, P841.
   NILSSON A, 1995, PHARMACOPSYCHIATRY, V28, P8, DOI 10.1055/s-2007-979581.
   NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637.
   NORTON B, 1984, BRIT J PSYCHIAT, V145, P277, DOI 10.1192/bjp.145.3.277.
   NYMAN AK, 1986, ACTA PSYCHIAT SCAND, V73, P252, DOI 10.1111/j.1600-0447.1986.tb02682.x.
   ODONNELL I, 1994, SOC SCI MED, V38, P437, DOI 10.1016/0277-9536(94)90444-8.
   ODONNELL JA, 1964, AM J ORTHOPSYCHIAT, V34, P948, DOI 10.1111/j.1939-0025.1964.tb02251.x.
   OHARA K, 1989, BRIT J ADDICT, V84, P287.
   OLeary DA, 1996, BRIT J PSYCHIAT, V169, P423, DOI 10.1192/bjp.169.4.423.
   OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x.
   ORHOLM M, 1985, LIVER, V5, P253.
   OSTMAN O, 1991, ACTA PSYCHIAT SCAND, V84, P40, DOI 10.1111/j.1600-0447.1991.tb01419.x.
   PAFFENBA.RS, 1966, AM J EPIDEMIOL, V83, P314, DOI 10.1093/oxfordjournals.aje.a120587.
   PAFFENBA.RS, 1969, AM J PUBLIC HEALTH N, V59, P900, DOI 10.2105/AJPH.59.6.900.
   PAFFENBARGER RS, 1969, AM J EPIDEMIOL, V90, P527, DOI 10.1093/oxfordjournals.aje.a121099.
   Palsson SP, 1996, NORD J PSYCHIAT, V50, P207, DOI 10.3109/08039489609081410.
   PEDERSON AM, 1975, SUICIDE, V5, P145.
   Pell S, 1973, J Occup Med, V15, P120.
   PERUCCI CA, 1991, AM J PUBLIC HEALTH, V81, P1307, DOI 10.2105/AJPH.81.10.1307.
   POCOCK SJ, 1999, APPL STAT, V30, P286.
   POSER W, 1992, DRUG ALCOHOL DEPEN, V30, P49, DOI 10.1016/0376-8716(92)90035-B.
   RANTAKALLIO P, 1995, BMJ-BRIT MED J, V311, P477, DOI 10.1136/bmj.311.7003.477.
   RAVENSBO.MR, 1969, J CONSULT CLIN PSYCH, V33, P466, DOI 10.1037/h0027822.
   REITER K, 1974, SCAND J SOC MED, V2, P1.
   ROBERTSON G, 1987, BRIT MED J, V295, P632, DOI 10.1136/bmj.295.6599.632.
   ROBINETTE CD, 1979, AM J EPIDEMIOL, V109, P687, DOI 10.1093/oxfordjournals.aje.a112732.
   RORSMAN B, 1974, ACTA PSYCHIAT SCAND, V50, P354, DOI 10.1111/j.1600-0447.1974.tb08221.x.
   RORSMAN B, 1982, NEUROPSYCHOBIOLOGY, V8, P233, DOI 10.1159/000117904.
   RORSMAN B, 1982, NEUROPSYCHOBIOLOGY, V8, P188, DOI 10.1159/000117898.
   SAKU M, 1995, INT J EPIDEMIOL, V24, P366, DOI 10.1093/ije/24.2.366.
   SCHMIDT W, 1969, Q J STUD ALCOHOL, V30, P112.
   SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171.
   SEGAL SP, 1991, HOSP COMMUNITY PSYCH, V42, P708.
   SELLAR C, 1990, BRIT J PSYCHIAT, V156, P866, DOI 10.1192/bjp.156.6.866.
   SHAFFER D, 1993, AM J PUBLIC HEALTH, V83, P171, DOI 10.2105/AJPH.83.2.171.
   Sharp S, 1997, STATA TECH B, V38, P9.
   SIMS A, 1978, BRIT J PSYCHIAT, V133, P299, DOI 10.1192/bjp.133.4.299.
   SMITH EM, 1983, ALCOHOL CLIN EXP RES, V7, P237, DOI 10.1111/j.1530-0277.1983.tb05449.x.
   SMITH GD, 1992, LANCET, V340, P709.
   STEPTOE A, 1991, J PSYCHOSOM RES, V35, P633, DOI 10.1016/0022-3999(91)90113-3.
   STROM J, 1986, ACTA ANAESTH SCAND, V30, P148, DOI 10.1111/j.1399-6576.1986.tb02386.x.
   SURTEES PG, 1994, BRIT J PSYCHIAT, V164, P327, DOI 10.1192/bjp.164.3.327.
   THORARINSSON AA, 1979, J STUD ALCOHOL, V40, P704, DOI 10.15288/jsa.1979.40.704.
   TSIATIS A, 1975, P NATL ACAD SCI USA, V72, P20, DOI 10.1073/pnas.72.1.20.
   TSUAN MT, 1980, BRIT J PSYCHIAT, V132, P239.
   TSUANG MT, 1978, ARCH GEN PSYCHIAT, V35, P1181.
   Tuma TA, 1996, BRIT J PSYCHIAT, V168, P76, DOI 10.1192/bjp.168.1.76.
   TUNVING K, 1988, ACTA PSYCHIAT SCAND, V77, P551, DOI 10.1111/j.1600-0447.1988.tb05168.x.
   TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V.
   VAILLANT GE, 1966, NEW ENGL J MED, V275, P1282, DOI 10.1056/NEJM196612082752305.
   VESTERGAARD P, 1991, J AFFECT DISORDERS, V21, P33, DOI 10.1016/0165-0327(91)90016-L.
   WEEKE A, 1986, J AFFECT DISORDERS, V11, P227, DOI 10.1016/0165-0327(86)90074-1.
   WEINER BP, 1977, BRIT J PSYCHIAT, V131, P497, DOI 10.1192/bjp.131.5.497.
   WELLS JE, 1990, NEW ZEAL MED J, V103, P1.
   WHEELER EO, 1950, JAMA-J AM MED ASSOC, V142, P878, DOI 10.1001/jama.1950.02910300016005.
   WHITE SJ, 1979, LANCET, V2, P458.
   WHITLOCK FA, 1979, PSYCHOL MED, V9, P747, DOI 10.1017/S0033291700034061.
   {*}WHO, 1992, HLTH STAT DAT COLL.
   WILHELMSEN L, 1983, ACTA MED SCAND, V213, P263.
   WINOKUR G, 1987, AM J PSYCHIAT, V144, P208.
   WOOD JB, 1985, ACTA PSYCHIAT SCAND, V72, P218, DOI 10.1111/j.1600-0447.1985.tb02598.x.
   ZACCARELLI M, 1994, AIDS, V8, P345, DOI 10.1097/00002030-199403000-00008.
   Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8.
   ZILBER N, 1989, ACTA PSYCHIAT SCAND, V79, P248, DOI 10.1111/j.1600-0447.1989.tb10254.x.
   Zubenko GS, 1997, AM J PSYCHIAT, V154, P1360.
   1987, LANCET, V2, P897.
   1985, ARCH GEN PSYCHIAT, V42, P78.},
Number-of-Cited-References = {188},
Times-Cited = {57},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Int. J. Epidemiol.},
Doc-Delivery-Number = {413AG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000167587300039},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000280612700058,
Author = {Singh-Manoux, Archana and Kivimaki, Mika and Sjosten, Noora and Ferrie,
   Jane E. and Nabi, Hermann and Pentti, Jaana and Virtanen, Marianna and
   Oksanen, Tuula and Vahtera, Jussi},
Title = {Lost work days in the 6 years leading to premature death from
   cardiovascular disease in men and women},
Journal = {ATHEROSCLEROSIS},
Year = {2010},
Volume = {211},
Number = {2},
Pages = {689-693},
Month = {AUG},
Abstract = {Background: It is unclear whether individuals experience specific
   patterns of morbidity prior to premature death from cardiovascular
   disease (CVD).
   Methods: We examined morbidity levels in the 6 years leading up to death
   from CVD in 37,397 men and 113,198 women under 65 years of age from the
   Finnish Public Sector study, with a particular focus on gender
   differences. Morbidity was assessed using lost days from work, extracted
   from register data on sickness leave and disability pension. Data on
   cause-specific mortality were obtained from national health registers.
   Results: During a median follow-up of 8.5 years, there were 361 CVD
   deaths (174 from ischaemic heart disease (ICD9 410-414, 427.5; ICD10
   I21-I25, I46), 91 from stroke (ICD9 430, 431, 434; ICD10 I60-I60, I61,
   I63), and 96 from other diseases of circulatory system (ICD9 390-459;
   ICD10 I00-I99)). Women had lower morbidity than men over the 6 years
   preceding stroke deaths (RR for mean annual days = 0.33 (95\% CI
   0.14-0.78)). For other causes of CVD mortality, there were no gender
   differences in morbidity rates prior to death. In men, those who died
   from CVD had substantially greater morbidity levels than matched
   controls through the entire 6-year period preceding death (rate ratio =
   3.59; 95\% confidence interval 2.62-4.93). Among women, morbidity days
   were greater particularly in the year preceding death from stroke.
   Conclusion: Our results on working age men and women suggest no gender
   differences in morbidity prior to death from heart disease and lower
   morbidity in women prior to death from stroke. These findings challenge
   the widespread belief that women experience more morbidity symptoms than
   men. (C) 2010 Elsevier Ireland Ltd. All rights reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Singh-Manoux, A (Corresponding Author), Hop Paul Brousse, INSERM, U1018, Bat 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.
   Singh-Manoux, Archana; Nabi, Hermann, Hop Paul Brousse, INSERM, U1018, F-94807 Villejuif, France.
   Singh-Manoux, Archana; Kivimaki, Mika; Ferrie, Jane E., UCL, Dept Epidemiol \& Publ Hlth, London WC1E 6BT, England.
   Singh-Manoux, Archana, Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France.
   Sjosten, Noora; Pentti, Jaana; Virtanen, Marianna; Oksanen, Tuula; Vahtera, Jussi, Finnish Inst Occupat Hlth, Helsinki, Finland.
   Vahtera, Jussi, Univ Turku, Dept Publ Hlth, SF-20500 Turku, Finland.
   Vahtera, Jussi, Turku Univ Hosp, Turku, Finland.},
DOI = {10.1016/j.atherosclerosis.2010.04.013},
ISSN = {0021-9150},
EISSN = {1879-1484},
Keywords = {Cardiovascular disease; Stroke; Mortality; Gender},
Keywords-Plus = {SEX-DIFFERENCES; MYOCARDIAL-INFARCTION; RISK-FACTORS; SICKNESS ABSENCE;
   MEDICAL-CARE; MORTALITY; OUTCOMES; ILLNESS; HEALTH; AGE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {Archana.Singh-Manoux@inserm.fr},
ResearcherID-Numbers = {Singh-Manoux, Archana/F-6804-2013
   Ferrie, Jane/AAZ-2009-2020
   Kivimaki, Mika/B-3607-2012
   Vahtera, Jussi/J-3271-2013
   Oksanen, Tuula/AAK-5599-2021
   },
ORCID-Numbers = {Singh-Manoux, Archana/0000-0002-1244-5037
   Kivimaki, Mika/0000-0002-4699-5627
   Nabi, Hermann/0000-0002-7832-0413},
Funding-Acknowledgement = {European Science FoundationEuropean Science Foundation (ESF)European
   Commission; BUPA Foundation; Medical Research CouncilUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC)European Commission
   {[}G8802774]; Academy of FinlandAcademy of Finland {[}117604, 124271,
   124322, 129262]; Social Insurance Institution of Finland; ESRCUK
   Research \& Innovation (UKRI)Economic \& Social Research Council (ESRC)
   {[}RES-451-26-0491]; Economic and Social Research CouncilUK Research \&
   Innovation (UKRI)Economic \& Social Research Council (ESRC)
   {[}RES-451-26-0491] Funding Source: researchfish; NATIONAL HEART, LUNG,
   AND BLOOD INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}R01HL036310] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE ON AGINGUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}R01AG034454, R01AG013196] Funding Source: NIH RePORTER},
Funding-Text = {A.S.M. is supported by a ``European Young Investigator Award{''} from
   the European Science Foundation. M.K. is supported by the BUPA
   Foundation Specialist Research Grant. J.E.F. is supported by the Medical
   Research Council (Grant No. G8802774). The Finnish Public Sector study
   is supported by the Academy of Finland (projects 117604, 124271, 124322
   and 129262), the Social Insurance Institution of Finland and the
   participating organisations. Collaboration was facilitated by funding
   from the ESRC (RES-451-26-0491).},
Cited-References = {Allender S., 2008, EUROPEAN CARDIOVASCU.
   Andrikopoulos GK, 2006, INT J CARDIOL, V108, P320, DOI 10.1016/j.ijcard.2005.05.016.
   Arslanian-Engoren C, 2006, AM J CARDIOL, V98, P1177, DOI 10.1016/j.amjcard.2006.05.049.
   Barrett-Connor E, 2007, CAN MED ASSOC J, V176, P791, DOI 10.1503/cmaj.061677.
   Blankstein R, 2005, CIRCULATION, V112, pI323, DOI 10.1161/CIRCULATIONAHA.104.525139.
   DI CA, 2003, STROKE, V34, P1114.
   Fetters JK, 1996, AM HEART J, V131, P796, DOI 10.1016/S0002-8703(96)90289-6.
   Guru V, 2004, J THORAC CARDIOV SUR, V127, P1158, DOI 10.1016/j.jtcvs.2003.12.008.
   HIBBARD JH, 1986, WOMEN HEALTH, V11, P21, DOI 10.1300/J013v11n02\_03.
   Hogue CW, 2001, CIRCULATION, V103, P2133.
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359.
   Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165.
   Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364.
   Koch CG, 2003, J THORAC CARDIOV SUR, V126, P2032, DOI 10.1016/S0022-5223(03)00950-4.
   Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067.
   Lansky AJ, 2005, CIRCULATION, V111, P1611, DOI 10.1161/01.CIR.0000160362.55803.40.
   Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8.
   Medin J, 2007, BRAIN INJURY, V21, P457, DOI 10.1080/02699050701317643.
   NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3.
   Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813.
   Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5.
   Sjosten N, 2009, CHEST, V136, P130, DOI 10.1378/chest.08-2201.
   Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054.
   Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817.
   Verbrugge L M, 1987, Health Matrix, V5, P3.
   WALDRON I, 1983, SOC SCI MED, V17, P1107, DOI 10.1016/0277-9536(83)90004-7.
   {*}WHO, 2006, WORLD HLTH STAT 2006.
   World Health Organization, 2004, ATL HEART DIS STROK.
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9.},
Number-of-Cited-References = {29},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Atherosclerosis},
Doc-Delivery-Number = {634VC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000280612700058},
OA = {Green Submitted, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000493564400005,
Author = {Machado de Rezende, Leandro Fornias and Garcia, Leandro Martin Totaro
   and Mielke, Gregore Iven and Lee, Dong Hoon and Giovannucci, Edward and
   Eluf-Neto, Jose},
Title = {Physical activity and preventable premature deaths from non-communicable
   diseases in Brazil},
Journal = {JOURNAL OF PUBLIC HEALTH},
Year = {2019},
Volume = {41},
Number = {3},
Pages = {E253-E260},
Month = {SEP},
Abstract = {Background Studies on the impact of counterfactual scenarios of physical
   activity on premature deaths from non-communicable diseases (NCDs) are
   sparse in the literature. We estimated preventable premature deaths from
   NCDs (diabetes, ischemic heart disease, stroke, and breast and colon
   cancers) in Brazil by increasing population-wide physical activity (i)
   to theoretical minimum risk exposure levels; (ii) reaching the physical
   activity recommendation; (iii) reducing insufficient physical activity
   by 10\%; and (iv) eliminating the gender differences in physical
   activity.
   Methods Preventable fractions were estimated using data from a
   nationally representative survey, relative risks from a meta-analysis
   and number of premature deaths (30-69 years) from the Brazilian
   Mortality Information System.
   Results Physical activity could potentially avoid up to 16 700 premature
   deaths from NCDs in Brazil, corresponding to 5.75 and 3.23\% of
   premature deaths from major NCDs and of all-causes, respectively. Other
   scenarios suggested the following impact on premature deaths: reaching
   physical activity recommendation (5000 or 1.74\% of major NCDs); 10\%
   reduction in insufficient physical activity (500 or 0.17\% of major
   NCDs); eliminating gender differences in physical activity (1000 or
   0.33\% of major NCDs).
   Conclusions Physical activity may play an important role to reduce
   premature deaths from NCD in Brazil.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {de Rezende, LFM (Corresponding Author), Univ Sao Paulo, Dept Prevent Med, Fac Med FMUSP, Sao Paulo, SP, Brazil.
   Machado de Rezende, Leandro Fornias; Eluf-Neto, Jose, Univ Sao Paulo, Dept Prevent Med, Fac Med FMUSP, Sao Paulo, SP, Brazil.
   Garcia, Leandro Martin Totaro, Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, UKCRC Ctr Diet \& Act Res, Cambridge, England.
   Mielke, Gregore Iven, Univ Queensland, Sch Human Movement \& Nutr Sci, Brisbane, Qld, Australia.
   Mielke, Gregore Iven, Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.
   Lee, Dong Hoon; Giovannucci, Edward, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   Giovannucci, Edward, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Giovannucci, Edward, Brigham \& Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   Giovannucci, Edward, Harvard Med Sch, Boston, MA 02115 USA.},
DOI = {10.1093/pubmed/fdy183},
ISSN = {1741-3842},
EISSN = {1741-3850},
Keywords = {epidemiology; non-communicable diseases; physical activity; population
   attributable fraction; premature mortality},
Keywords-Plus = {COMPARATIVE RISK-ASSESSMENT; SYSTEMATIC ANALYSIS; GLOBAL BURDEN;
   INACTIVITY; WORLDWIDE; CLUSTERS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {lerezende@usp.br},
ResearcherID-Numbers = {Mielke, Gregore I/E-2141-2014
   Garcia, Leandro MT/I-7520-2013
   Eluf-Neto, Jose/B-2522-2009
   Rezende, Leandro F. M./C-1724-2012
   },
ORCID-Numbers = {Mielke, Gregore I/0000-0002-3043-2715
   Garcia, Leandro MT/0000-0001-5947-2617
   Eluf-Neto, Jose/0000-0001-7504-2115
   Rezende, Leandro F. M./0000-0002-7469-1399
   Lee, Dong Hoon/0000-0003-1329-4637},
Funding-Acknowledgement = {Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) {[}2014/25614-4, 2016/21390-0]; Centre for
   Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre
   of Excellence - British Heart Foundation; Cancer Research UKCancer
   Research UK; Economic and Social Research CouncilUK Research \&
   Innovation (UKRI)Economic \& Social Research Council (ESRC); Medical
   Research CouncilUK Research \& Innovation (UKRI)Medical Research Council
   UK (MRC)European Commission; National Institute for Health
   ResearchNational Institute for Health Research (NIHR); Wellcome
   TrustWellcome TrustEuropean Commission; MRCUK Research \& Innovation
   (UKRI)Medical Research Council UK (MRC) {[}MR/K023187/1] Funding Source:
   UKRI},
Funding-Text = {LFMR receives a doctoral scholarship from Sao Paulo Research Foundation
   (FAPESP) (Grants 2014/25614-4 and 2016/21390-0). LMTG undertook this
   work under the auspices of the Centre for Diet and Activity Research
   (CEDAR), a UKCRC Public Health Research Centre of Excellence which is
   funded by the British Heart Foundation, Cancer Research UK, Economic and
   Social Research Council, Medical Research Council, the National
   Institute for Health Research, and the Wellcome Trust.},
Cited-References = {Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12.
   Allen L, 2017, J PUBLIC HEALTH-UK, V39, P698, DOI 10.1093/pubmed/fdx008.
   Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018.
   Barreto PD, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h23.
   Barreto PD, 2013, B WORLD HEALTH ORGAN, V91, P390, DOI 10.2471/BLT.13.120790.
   Brasil. Ministerio da Saude, 2017, SIST INF MORT SIM 19.
   Brown WJ, 2016, LANCET, V388, P1257, DOI 10.1016/S0140-6736(16)30881-9.
   Doll R, 1994, MORTALITY SMOKING DE.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Hallman DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177042.
   Instituto Brasileiro de Geografia e Estatistica, 2013, PESQ NAC SAUID 2013.
   Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857.
   Lee IM, 2013, LANCET, V381, P992, DOI 10.1016/S0140-6736(13)60705-9.
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9.
   Lim SS, 2013, LANCET, V381, P993, DOI 10.1016/S0140-6736(13)60706-0.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   de Rezende LFM, 2018, BRIT J SPORT MED, V52, P826, DOI 10.1136/bjsports-2017-098391.
   Mielke GI, 2018, SPORTS MED, V48, P481, DOI 10.1007/s40279-017-0754-7.
   Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971.
   Poole C, 2015, ANN EPIDEMIOL, V25, P147, DOI 10.1016/j.annepidem.2014.11.015.
   Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024.
   Salkever DS, 2008, ADM POLICY MENT HLTH, V35, P261, DOI 10.1007/s10488-008-0168-9.
   Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5.
   Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112.
   Silva KS, 2017, PREV MED, V96, P160, DOI 10.1016/j.ypmed.2016.11.004.
   Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012.
   Wade KH, 2018, BRIT J SPORT MED, V52, P890, DOI 10.1136/bjsports-2017-098995.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1.},
Number-of-Cited-References = {31},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Public Health},
Doc-Delivery-Number = {JI6FY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000493564400005},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000165269100025,
Author = {Dean, PG and van Heerden, JA and Farley, DR and Thompson, GB and Grant,
   CS and Harmsen, WS and Ilstrup, DM},
Title = {Are patients with multiple endocrine neoplasia type I prone to premature
   death?},
Journal = {WORLD JOURNAL OF SURGERY},
Year = {2000},
Volume = {24},
Number = {11},
Pages = {1437-1441},
Month = {NOV},
Note = {38th World Congress of the
   International-Society-of-Surgery/Societe-Internationale-de-Chirurgie
   (ISS/SIC), VIENNA, AUSTRIA, AUG 15-20, 1999},
Organization = {Int Soc Surg; Soc Int Chirurg},
Abstract = {Multiple endocrine neoplasia type I (MEN-I) is an autosomal dominant
   disorder characterized by endocrinopathies involving the anterior
   pituitary gland, parathyroid glands, and pancreas. The long-term
   prognosis for patients affected with this disorder is uncertain. To
   better characterize this prognosis, we performed a retrospective review
   of all patients with MEN-I treated at a single institution during the
   period 1951-1997, A group of 233 patients served as the study
   population. Their records were analyzed for confirmation of diagnosis,
   treatments received, long-term survival, and cause of death. Altogether,
   108 eight male patients (46\%) and 125 female patients (54\%) were
   identified. At the conclusion of the study, 164 (70\%) were alive and 69
   (30\%) were deceased, with a median follow-up for patients alive at last
   contact of 13.4 years (range < 1 month to 54.3 years). The cause of
   death was reliably obtained in 60 patients. Of these patients, 17 (28\%)
   died of causes related to MEN-I, most commonly metastatic islet cell
   tumors (10 patients). The remaining patients died of causes unrelated to
   MEN-I, most commonly coronary artery disease and nonendocrine
   malignancies (14\% each). The overall 20-year survival of MEN-I patients
   was 64\% (95\% CI was 56-72\%), and that of an age- and gender-matched
   upper Midwest population was 81\% (p < 0.001). Patients with MEN-I
   appear to be at increased risk of premature death. Earlier diagnosis and
   treatment of potentially malignant pancreatic islet cell neoplasms may
   result in a decrease of this premature mortality.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {van Heerden, JA (Corresponding Author), Mayo Clin \& Mayo Fdn, Dept Surg, 200 1St St Sw, Rochester, MN 55905 USA.
   Mayo Clin \& Mayo Fdn, Dept Surg, Rochester, MN 55905 USA.
   Mayo Clin \& Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA.},
DOI = {10.1007/s002680010237},
ISSN = {0364-2313},
EISSN = {1432-2323},
Keywords-Plus = {ZOLLINGER-ELLISON SYNDROME; PRIMARY HYPERPARATHYROIDISM; ENDOSCOPIC
   ULTRASONOGRAPHY; SURGICAL-MANAGEMENT; INSULINOMAS; GASTRINOMAS;
   LOCALIZATION; SURVIVAL; PANCREAS; SURGERY},
Research-Areas = {Surgery},
Web-of-Science-Categories  = {Surgery},
Cited-References = {BERGSTRALH EJ, 1988, TECHNICAL REPORT SER, V37.
   Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404.
   DELCORE R, 1992, SURGERY, V112, P1016.
   DEMEURE MJ, 1991, SURGERY, V110, P998.
   Doherty GM, 1998, WORLD J SURG, V22, P581, DOI 10.1007/s002689900438.
   HEDBACK G, 1990, WORLD J SURG, V14, P829, DOI 10.1007/BF01670531.
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868.
   LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0.
   Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177.
   Lo CY, 1998, AM J SURG, V175, P305, DOI 10.1016/S0002-9610(98)00012-9.
   MACFARLANE MP, 1995, SURGERY, V118, P973, DOI 10.1016/S0039-6060(05)80102-3.
   OBERG K, 1989, ACTA ONCOL, V28, P383.
   OBrien T, 1996, NEUROSURGERY, V39, P273, DOI 10.1097/00006123-199608000-00008.
   ORIORDAIN DS, 1994, WORLD J SURG, V18, P488, DOI 10.1007/BF00353743.
   ORIORDAIN DS, 1993, SURGERY, V114, P1031.
   PALMER M, 1987, SURGERY, V102, P1.
   PETO R, 1972, J R STAT SOC A, V185.
   PIPELEERSMARICHAL M, 1993, WORLD J SURG, V17, P481, DOI 10.1007/BF01655107.
   ROBERTS WC, 1981, AM J MED, V71, P371, DOI 10.1016/0002-9343(81)90163-7.
   Schluter KD, 1998, CARDIOVASC RES, V37, P34, DOI 10.1016/S0008-6363(97)00194-6.
   Shelburne Samuel A., 1945, JOUR DIN ENDOCRINOL, V5, P232.
   SHEPHERD JJ, 1991, ARCH SURG-CHICAGO, V126, P935.
   Skogseid B, 1996, WORLD J SURG, V20, P872, DOI 10.1007/s002689900133.
   SKOGSEID B, 1994, ENDOCRIN METAB CLIN, V23, P1.
   SOLCIA E, 1990, AM J SURG PATHOL, V14, P503, DOI 10.1097/00000478-199006000-00001.
   Soreide JA, 1997, SURGERY, V122, P1117, DOI 10.1016/S0039-6060(97)90216-6.
   Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106.
   THOMPSON NW, 1984, WORLD J SURG, V8, P561, DOI 10.1007/BF01654938.
   THOMPSON NW, 1995, J INTERN MED, V238, P269, DOI 10.1111/j.1365-2796.1995.tb00934.x.
   THOMPSON NW, 1994, SURGERY, V116, P1131.
   THOMPSON NW, 1992, ACTA CHIR AUSTRIACA, V24, P82.
   VANHEERDEN JA, 1983, ARCH SURG-CHICAGO, V118, P533.
   WELLS SA, 1980, ANN SURG, V192, P451, DOI 10.1097/00000658-198010000-00003.
   WERMER P, 1963, AM J MED, V35, P205, DOI 10.1016/0002-9343(63)90212-2.
   Wermers RA, 1998, AM J MED, V104, P115, DOI 10.1016/S0002-9343(97)00270-2.
   WILKINSON S, 1993, ARCH SURG-CHICAGO, V128, P683.
   Zimmer T, 1996, GUT, V39, P562, DOI 10.1136/gut.39.4.562.},
Number-of-Cited-References = {37},
Times-Cited = {129},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {World J.Surg.},
Doc-Delivery-Number = {373BT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000165269100025},
DA = {2022-03-29},
}

@article{ WOS:000490155700005,
Author = {Cleveland, R. J. and Nelson, A. E. and Callahan, L. F.},
Title = {Knee and hip osteoarthritis as predictors of premature death: a review
   of the evidence},
Journal = {CLINICAL AND EXPERIMENTAL RHEUMATOLOGY},
Year = {2019},
Volume = {37},
Number = {5, 120},
Pages = {24-30},
Abstract = {Rheumatic and musculoskeletal diseases (RMDs) are common, with
   osteoarthritis (OA) being the most prevalent. RMDs, including OA, are
   associated with significant pain and functional limitations, as well as
   mortality rates up to 1.6-fold higher than in the general population.
   Most studies of OA and mortality have focused on knee and hip OA. Some,
   but not all, of these studies suggest an increased risk of death,
   however risks may differ by region. Reasons for discordant findings may
   be due to methodological considerations including definition of OA,
   study design, length of follow-up, and whether variables that can change
   and develop over time, such as measures of OA, body mass index (BMI) and
   comorbidities, were re-assessed during the follow-up period. Research
   has shown that the prognosis of OA is similar to that seen in rheumatoid
   arthritis (RA) patients, in many respects. In RA, disability and
   comorbidities are the most important predictors of mortality, although
   pain may be more prominent in the prognosis of OA mortality. The data
   suggest that addressing functional limitations and pain seen with OA
   could potentially reduce the increased mortality that has been observed
   in these individuals. Further study is needed concerning the potential
   excess mortality attributable to lower body OA, as well as associated
   disability, pain and comorbidities.},
Publisher = {CLINICAL \& EXPER RHEUMATOLOGY},
Address = {VIA SANTA MARIA 31, 56126 PISA, ITALY},
Type = {Review},
Language = {English},
Affiliation = {Cleveland, RJ (Corresponding Author), Univ North Carolina Chapel Hill, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB 7280, Chapel Hill, NC 27599 USA.
   Cleveland, R. J.; Nelson, A. E.; Callahan, L. F., Univ N Carolina, Thurston Arthrit Res Ctr, Div Rheumatol Immunol \& Allergy, Dept Med, Chapel Hill, NC 27515 USA.
   Callahan, L. F., Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27515 USA.
   Callahan, L. F., Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA.},
ISSN = {0392-856X},
EISSN = {1593-098X},
Keywords = {osteoarthritis; hip OA; knee OA; mortality; premature mortality},
Keywords-Plus = {LONG-TERM MORTALITY; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE;
   RHEUMATOID-ARTHRITIS; MUSCULOSKELETAL PAIN; BURDEN; RISK; INTERVENTIONS;
   DISABILITY; WOMEN},
Research-Areas = {Rheumatology},
Web-of-Science-Categories  = {Rheumatology},
Author-Email = {becki@unc.edu},
Funding-Acknowledgement = {Multidisciplinary Clinical Research Center (MCRC) of the UNC Thurston
   Arthritis Research Center, National Institute of Arthritis and
   Musculoskeletal and Skin Diseases (NIAMS) {[}5P60AR064166]; Centers for
   Disease Control and Prevention (CDC)United States Department of Health
   \& Human ServicesCenters for Disease Control \& Prevention - USA
   {[}U01DP006266]; NIAMSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Arthritis \& Musculoskeletal \& Skin Diseases (NIAMS)
   {[}1R01AR065937]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH
   PROMOUnited States Department of Health \& Human ServicesCenters for
   Disease Control \& Prevention - USA {[}U01DP006266] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN
   DISEASESUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Arthritis \&
   Musculoskeletal \& Skin Diseases (NIAMS) {[}P60AR064166] Funding Source:
   NIH RePORTER},
Funding-Text = {support for this manuscript was provided in part by the
   Multidisciplinary Clinical Research Center (MCRC) of the UNC Thurston
   Arthritis Research Center, National Institute of Arthritis and
   Musculoskeletal and Skin Diseases (NIAMS) 5P60AR064166; NIAMS
   1R01AR065937; and Centers for Disease Control and Prevention (CDC)
   U01DP006266.},
Cited-References = {Abhishek A, 2013, RHEUM DIS CLIN N AM, V39, P45, DOI 10.1016/j.rdc.2012.10.007.
   Barbour KE, 2015, ARTHRITIS RHEUMATOL, V67, P1798, DOI 10.1002/art.39113.
   Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116.
   Brooks PM, 2006, CLIN RHEUMATOL, V25, P778, DOI 10.1007/s10067-006-0240-3.
   Cacciatore F, 2014, RHEUMATOLOGY, V53, P293, DOI 10.1093/rheumatology/ket348.
   Callahan LF, 2011, ARTHRIT CARE RES, V63, P1098, DOI 10.1002/acr.20490.
   Callahan LF, 1995, ARTHRIT CARE RES, V8, P28, DOI 10.1002/art.1790080108.
   Chua JR, 2019, ARTHRITIS RHEUMATOL, V71, P1276, DOI 10.1002/art.40869.
   Cleveland RJ, 2019, OSTEOARTHR CARTILAGE, V27, P593, DOI 10.1016/j.joca.2018.12.008.
   Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763.
   El-Haddad C, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000391.
   Filc D, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0115-1.
   Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669.
   GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351.
   Han XZ, 2017, INT J CLIN EXP MED, V10, P1094.
   Hannan MT, 2000, J RHEUMATOL, V27, P1513.
   Haugen IK, 2015, ANN RHEUM DIS, V74, P74, DOI 10.1136/annrheumdis-2013-203789.
   Hawker GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091286.
   Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120.
   Hoeven TA, 2015, ANN RHEUM DIS, V74, P752, DOI 10.1136/annrheumdis-2013-204388.
   Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639.
   Iversen MD, 2012, ORTHOP NURS, V31, P103, DOI 10.1097/NOR.0b013e31824fce07.
   Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043.
   Kendzerska T, 2017, OSTEOARTHR CARTILAGE, V25, P1771, DOI 10.1016/j.joca.2017.07.024.
   Kluzek S, 2016, ANN RHEUM DIS, V75, P1749, DOI 10.1136/annrheumdis-2015-208056.
   Kluzek S, 2015, BRIT MED BULL, V115, P111, DOI 10.1093/bmb/ldv028.
   Liu Q, 2015, OSTEOARTHR CARTILAGE, V23, P1154, DOI 10.1016/j.joca.2015.03.021.
   Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03110-3.
   Liu R, 2015, Scand J Rheumatol, V44, P70, DOI 10.3109/03009742.2014.922213.
   Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001.
   McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424.
   Mendy A, 2018, INT J EPIDEMIOL, V47, P1821, DOI 10.1093/ije/dyy187.
   National Research Council (US) Institute of Medicine (US), 2013, US HLTH INT PERSP SH.
   Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002.
   Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165.
   Paskins Z, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-195.
   PCCOA, 2016, OST SER DIS OARSI PR.
   PINCUS T, 1994, ANN INTERN MED, V120, P26, DOI 10.7326/0003-4819-120-1-199401010-00005.
   Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092.
   Rosenberg EF, 1944, ANN INTERN MED, V20, P903, DOI 10.7326/0003-4819-20-6-903.
   Smith D, 2018, PAIN, V159, P1112, DOI 10.1097/j.pain.0000000000001193.
   Smith D, 2018, ARTHRIT CARE RES, V70, P236, DOI 10.1002/acr.23268.
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644.
   Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006.
   Tsuboi M, 2011, J BONE MINER METAB, V29, P217, DOI 10.1007/s00774-010-0214-z.
   Turkiewicz A, 2019, OSTEOARTHR CARTILAGE, V27, P848, DOI 10.1016/j.joca.2019.02.793.
   Turkiewicz A, 2016, EPIDEMIOLOGY, V27, P479, DOI 10.1097/EDE.0000000000000477.
   Veronese N, 2016, SEMIN ARTHRITIS RHEU, V46, P160, DOI 10.1016/j.semarthrit.2016.04.002.
   Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep39672.
   YANG Z, 2019, CLIN RHEUMATOL.},
Number-of-Cited-References = {50},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Clin. Exp. Rheumatol.},
Doc-Delivery-Number = {JD7IZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000490155700005},
DA = {2022-03-29},
}

@article{ WOS:000635021400043,
Author = {Hongli, Zhang and Bi, Xueyuan and Zheng, Nanbo and Li, Chao and Yan,
   Kangkang},
Title = {Joint effect of alcohol drinking and tobacco smoking on all-cause
   mortality and premature death in China: A cohort study},
Journal = {PLOS ONE},
Year = {2021},
Volume = {16},
Number = {1},
Month = {JAN 28},
Abstract = {Background
   Tobacco smoking and alcohol drinking are associated with several
   diseases, and studies on the joint effects of smoking and drinking are
   rare.
   Objective
   This study investigates the joint effects of tobacco smoking and alcohol
   drinking on all-cause and premature mortality in a contemporary cohort.
   Methods
   The China Health and Retirement Longitudinal Study (CHARLS) is an
   ongoing nationally representative survey of subjects aged over 45 years
   in China that was performed every two years for a total of three waves
   from 2011 to 2015 in China. We used weighted logistic regression models
   to estimate the joint effects of tobacco smoking and alcohol drinking on
   all-cause and premature mortality.
   Results
   After adjusting for prespecified confounders, the odds ratios (ORs) of
   all-cause mortality were 1.51 (95\% CI: 1.09-2.10) and 1.47 (95\% CI:
   1.03-2.08) in smokers and smokers/drinkers, respectively. Compared with
   nonsmokers/nondrinkers, the OR of smokers/drinkers for premature death
   was 3.14 (95\% CI: 1.56-6.34). In the female subgroup, there was an
   approximately 5-fold (OR = 4.95; 95\% CI: 2.00-12.27) odds of premature
   mortality for smokers/drinkers compared to nonsmokers/nondrinkers.
   Conclusion
   This study found a joint effect of tobacco smoking and alcohol drinking
   on all-cause and premature mortality among a contemporary and nationally
   representative cohort in China. Our results suggested that the joint
   effects were more pronounced in women, but further research is needed.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Yan, KK (Corresponding Author), Northwest Univ, Xian Hosp 3, Affiliated Hosp, Dept Pharm, Xian, Peoples R China.
   Hongli, Zhang; Li, Chao, Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Peoples R China.
   Hongli, Zhang; Zheng, Nanbo, Xian Cent Hosp, Dept Pharm, Xian, Peoples R China.
   Bi, Xueyuan, Xian Honghui Hosp, Dept Pharm, Xian, Peoples R China.
   Yan, Kangkang, Northwest Univ, Xian Hosp 3, Affiliated Hosp, Dept Pharm, Xian, Peoples R China.},
DOI = {10.1371/journal.pone.0245670},
Article-Number = {e0245670},
ISSN = {1932-6203},
Keywords-Plus = {CONSUMPTION; RISK; METAANALYSIS; DRINKERS; WOMEN; MEN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {kky\_hospital@163.com},
Cited-References = {Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   Ebbert JO, 2005, J GEN INTERN MED, V20, P14, DOI 10.1111/j.1525-1497.2005.40129.x.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   GBD 2016 Alcohol Collaborators, 2018, LANCET, V392, P1015, DOI DOI 10.1016/S0140-6736(16)31679-8.
   Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI {[}10.1136/bmj.k1611, 10.1136/bmj.j5855].
   He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467.
   Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164.
   Hurley MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-95.
   Khera R, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2357.
   Knott CS, 2015, BMJ-BRIT MED J, V350, DOI {[}10.1136/BMJ.h384, 10.1136/bmj.h384].
   Martelin T, 2004, EUR J PUBLIC HEALTH, V14, P422, DOI 10.1093/eurpub/14.4.422.
   Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971.
   Qin R, 2013, INT J CARDIOL, V167, P342, DOI 10.1016/j.ijcard.2011.12.100.
   Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X.
   Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185.
   Taghizadeh N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153310.
   Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127.
   Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X.
   Xi B, 2017, J AM COLL CARDIOL, V70, P913, DOI 10.1016/j.jacc.2017.06.054.
   Xu WH, 2007, PREV MED, V45, P313, DOI 10.1016/j.ypmed.2007.05.015.
   Zhang X, 2016, PERS INDIV DIFFER, V97, P229, DOI 10.1016/j.paid.2016.03.062.
   Zhao Y., 2013, CHINA HLTH RETIREMEN, P1.
   Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203.
   Zheng W, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001631.},
Number-of-Cited-References = {24},
Times-Cited = {4},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {5},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {RF7LJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000635021400043},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000175742500007,
Author = {Lingfors, H and Persson, LG and Lindstrom, K and Ljungquist, B and
   Bengtsson, C},
Title = {Time for a ``vision zero{''} concerning premature death from ischaemic
   heart disease?},
Journal = {SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE},
Year = {2002},
Volume = {20},
Number = {1},
Pages = {28-32},
Month = {MAR},
Abstract = {Objective - To study the trend in premature mortality (before 75 years
   of age) from ischaemic heart disease (IHD) in a Swedish primary health
   care district compared to communities of similar demographic situation
   and all Sweden.
   Design - Mortality from IHD in men and women was compared between the
   community of Habo and other Swedish communities of similar size and all
   Sweden for the period 1984-96.
   Setting - The community of Habo in Sweden with about 9600 inhabitants.
   Intervention - Intensified efforts by the local primary health care
   organisation, in co-operation with the community, in respect of primary
   and secondary cardiovascular prevention since the beginning of the
   1980s.
   Results - Mortality from IHD has decreased significantly both in Habo
   and in Sweden during these years. The decrease has been more prominent
   in Habo than in Sweden as a whole and other Swedish communities of
   similar demographic situation.
   Conclusion - With increased and purposeful efforts in primary and
   secondary prevention, in co-operation between the community and primary
   health care, it is possible to substantially decrease mortality from IHD
   in the community.},
Publisher = {TAYLOR \& FRANCIS AS},
Address = {CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY},
Type = {Article},
Language = {English},
Affiliation = {Lingfors, H (Corresponding Author), Habo Primary Hlth Care Ctr, POB 204, SE-56624 Habo, Sweden.
   Habo Primary Hlth Care Ctr, SE-56624 Habo, Sweden.
   Univ Gothenburg, Dept Res \& Dev Primary Hlth Care Jonkoping, SE-56624 Habo, Sweden.
   Univ Gothenburg, Dept Primary Hlth Care, SE-56624 Habo, Sweden.},
DOI = {10.1080/028134302317282707},
ISSN = {0281-3432},
Keywords = {ischaemic heart disease; mortality; primary health care; primary
   prevention; secondary prevention},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; MORTALITY; PROGRAM; SWEDEN;
   RISK; HYPERTENSION; MORBIDITY; TRIAL; LIFE},
Research-Areas = {Health Care Sciences \& Services; General \& Internal Medicine},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Primary Health Care; Medicine, General
   \& Internal},
Cited-References = {Bjorntorp P, 1993, Obes Res, V1, P206.
   CORSON J, 1990, World Health Forum, V11, P405.
   DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T.
   La Vecchia C, 1998, EUR J EPIDEMIOL, V14, P1, DOI 10.1023/A:1007440201137.
   LINDEBERG S, 1993, J INTERN MED, V233, P269, DOI 10.1111/j.1365-2796.1993.tb00986.x.
   LINDSTROM K, 1997, EUR WORK PART QUAL F, P96.
   Lingfors H., 1994, Scandinavian Journal of Nutrition/Naringsforskning, V38, P106.
   Luepker RV, 1996, AM J EPIDEMIOL, V144, P351, DOI 10.1093/oxfordjournals.aje.a008936.
   {*}NAT BOARD HLTH WE, 1998, STAT HLTH MED CAR YB.
   {*}NAT BOARD HLTH WE, 1997, HUM MAR SVER HOW ARE.
   Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001.
   Persson LG, 1998, J EPIDEMIOL COMMUN H, V52, P425, DOI 10.1136/jech.52.7.425.
   PERSSON LG, 1994, SCAND J SOC MED, V22, P264, DOI 10.1177/140349489402200405.
   Persson LG, 2000, SCAND J PRIM HEALTH, V18, P252, DOI 10.1080/028134300448841.
   {*}SWED NAT ROAD ADM, 1998, PUBL SWED NAT ROAD A, P20.
   TUOMILEHTO J, 1986, BRIT MED J, V293, P1068, DOI 10.1136/bmj.293.6554.1068.
   Weinehall L, 1999, J EPIDEMIOL COMMUN H, V53, P243, DOI 10.1136/jech.53.4.243.
   WIKSTRAND J, 1988, JAMA-J AM MED ASSOC, V259, P1976, DOI 10.1001/jama.259.13.1976.
   WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009.
   Wilhelmsen L, 1999, J INTERN MED, V245, P185, DOI 10.1046/j.1365-2796.1999.0435e.x.},
Number-of-Cited-References = {20},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Prim. Health Care},
Doc-Delivery-Number = {554NQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000175742500007},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1987K987500002,
Author = {LEADBEATTER, S and WILLIAMS, DW and STANSBIE, D},
Title = {INCIDENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN PREMATURE DEATHS DUE TO
   CORONARY HEART-DISEASE},
Journal = {AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY},
Year = {1987},
Volume = {8},
Number = {4},
Pages = {280-282},
Month = {DEC},
Publisher = {LIPPINCOTT-RAVEN PUBL},
Address = {227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106},
Type = {Article},
Language = {English},
Affiliation = {LEADBEATTER, S (Corresponding Author), UNIV WALES COLL MED,DEPT PATHOL,CARDIFF CF4 4XN,S GLAM,WALES.},
DOI = {10.1097/00000433-198712000-00002},
ISSN = {0195-7910},
Research-Areas = {Legal Medicine; Pathology},
Web-of-Science-Categories  = {Medicine, Legal; Pathology},
Number-of-Cited-References = {0},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Am. J. Forensic Med. Pathol.},
Doc-Delivery-Number = {K9875},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1987K987500002},
DA = {2022-03-29},
}

@article{ WOS:000293598400005,
Author = {Hakko, Helina and Wahlberg, Karl-Erik and Tienari, Pekka and Rasanen,
   Sami},
Title = {Genetic vulnerability and premature death in schizophrenia spectrum
   disorders: A 28-year follow-up of adoptees in the Finnish Adoptive
   Family Study of Schizophrenia},
Journal = {NORDIC JOURNAL OF PSYCHIATRY},
Year = {2011},
Volume = {65},
Number = {4},
Pages = {259-265},
Month = {SEP},
Abstract = {Background: Excess mortality is widely reported among schizophrenia
   patients, but rarely examined in adoption study settings. Aim: We
   investigated whether genetic background plays a role in the premature
   death of adoptees with schizophrenia. Methods: Mortality among 382
   adoptees in the Finnish Adoptive Family Study of Schizophrenia was
   monitored from 1977 to 2005 through the national causes-of-death
   register. The sample covered 190 adoptees with a high genetic risk of
   schizophrenia (HR) and 192 with a low risk (LR). Results: Overall
   mortality among the adoptees did not differ between the HR and LR
   groups, as 10\% and 9\% respectively had died during the follow-up, at
   mean ages of 45 and 46 years. Schizophrenia spectrum disorder was the
   most significant predictor of premature death in both groups, with
   dysfunction in the rearing family environment associated with mortality,
   unnatural deaths and suicides in the HR but not in the LR group. All the
   suicides involved HR cases. Conclusions: Mortality among the adoptees
   was not related to genetic factors but to environmental ones. The
   association of unnatural deaths and suicides with dysfunction in the
   rearing environment among the HR adoptees may indicate that they had a
   greater genetically determined vulnerability to environmental effects
   than their LR counterparts. The genetic and rearing environments can be
   disentangled in this setting because the biological parents give the
   offspring their genes and the adoptive parents give them their rearing
   environment. Our findings add to knowledge of the factors associated
   with the premature death of adoptees in mid-life.},
Publisher = {INFORMA HEALTHCARE},
Address = {TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hakko, H (Corresponding Author), Oulu Univ Hosp, Dept Psychiat, POB 26, Oys 90029, Finland.
   Hakko, Helina; Rasanen, Sami, Oulu Univ Hosp, Dept Psychiat, Oulu 90029, Finland.
   Wahlberg, Karl-Erik; Tienari, Pekka, Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu 90014, Finland.},
DOI = {10.3109/08039488.2010.540039},
ISSN = {0803-9488},
Keywords = {Adoption study Environmental risk; Genetic risk; Mortality;
   Schizophrenia spectrum disorders},
Keywords-Plus = {GENOTYPE-ENVIRONMENT INTERACTION; STAY PSYCHIATRIC-PATIENTS; EXCESS
   MORTALITY; ASSOCIATION; ILLNESS; LINKAGE; HEALTH; SAMPLE; RISK},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {helina.hakko@oulu.fi},
Cited-References = {American Psychiatric Association, 1994, DIAGN STAT MAN MENT.
   Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186.
   Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502.
   {*}CENTR STAT OFF FI, 1983, HDB CENTR STAT OFF F, V17.
   Dixon L, 1999, J NERV MENT DIS, V187, P496, DOI 10.1097/00005053-199908000-00006.
   Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   Iachine I A, 1998, Twin Res, V1, P196.
   Jones DR, 2004, PSYCHIAT SERV, V55, P1250, DOI 10.1176/appi.ps.55.11.1250.
   Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498.
   KENDLER KS, 1986, ARCH GEN PSYCHIAT, V43, P643.
   Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N.
   KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559.
   Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5.
   Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x.
   Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7.
   Petersen L, 2005, GENET EPIDEMIOL, V28, P376, DOI 10.1002/gepi.20071.
   Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765.
   Rasanen S, 2003, SOC PSYCH PSYCH EPID, V38, P297, DOI 10.1007/s00127-003-0635-2.
   Rasanen S, 2007, EUR PSYCHIAT, V22, P211, DOI 10.1016/j.eurpsy.2006.09.005.
   Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123.
   SPIZER RL, 1989, STRUCTURED CLIN INTE.
   {*}STAT FINL, 2000, CAUS DEATH 2000.
   Tienari P, 2005, NORD J PSYCHIAT, V59, P253, DOI 10.1080/08039480500227683.
   Tienari P, 2000, ACTA PSYCHIAT SCAND, V101, P433, DOI 10.1034/j.1600-0447.2000.101006433.x.
   Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216.
   Tienari P, 2003, AM J PSYCHIAT, V160, P1587, DOI 10.1176/appi.ajp.160.9.1587.
   TIENARI P, 1987, UNDERSTANDING MAJOR, P33.
   Wahlberg KE, 2004, PSYCHOL MED, V34, P1531, DOI 10.1017/S0033291704002661.
   Wahlberg KE, 1997, AM J PSYCHIAT, V154, P355.
   Webb RT, 2007, ARCH GEN PSYCHIAT, V64, P345, DOI 10.1001/archpsyc.64.3.345.
   Wing J, 1974, MEASUREMENT CLASSIFI.
   Wynne LC, 2006, FAM PROCESS, V45, P419, DOI 10.1111/j.1545-5300.2006.00180.x.},
Number-of-Cited-References = {33},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Nord. J. Psychiatr.},
Doc-Delivery-Number = {803RM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000293598400005},
DA = {2022-03-29},
}

@article{ WOS:000353688400003,
Author = {Oliva-Moreno, Juan and Pena-Longobardo, Luz M. and Alonso, Sonia and
   Fernandez-Bolanos, Antonio and Luisa Gutierrez, Maria and Hidalgo-Vega,
   Alvaro and de la Fuente, Elsa and Fernandez-Rodriguez, Conrado M.},
Title = {Labour productivity losses caused by premature death associated with
   hepatitis C in Spain},
Journal = {EUROPEAN JOURNAL OF GASTROENTEROLOGY \& HEPATOLOGY},
Year = {2015},
Volume = {27},
Number = {6},
Pages = {631-637},
Month = {JUN},
Abstract = {Background and aims Hepatitis C virus (HCV) infection places a huge
   burden on healthcare systems. There is no study assessing the impact of
   HCV infection on premature deaths in Spain. The aim of this study was to
   estimate productivity losses because of premature deaths attributable to
   hepatitis C occurring in Spain during 2007-2011.
   Materials and methods We use data from several sources (Registry of
   Deaths, Labour Force Survey and Wage Structure Survey) to develop a
   simulation model based on the human capital approach and to estimate the
   flows in labour productivity losses in the period considered. The
   attributable fraction method was used to estimate the numbers of deaths
   associated with HCV infection. Two sensitivity analyses were developed
   to test the robustness of the results.
   Results Our model shows total productivity losses attributable to HCV
   infection of 1054.7 million euros over the period analysed. The trend in
   productivity losses is decreasing over the period. This result is
   because of improvements in health outcomes, reflected in the reduction
   of the number of years of potential productive life lost. Of the total
   estimated losses, 18.6\% were because of hepatitis C, 24.6\% because of
   hepatocellular carcinoma, 30.1\% because of cirrhosis, 15.9\% because of
   other liver diseases and 10.7\% because of HIV-HCV coinfection.
   Conclusion The results show that premature mortality attributable to
   hepatitis C involves significant productivity losses. This highlights
   the need to extend the analysis to consider other social costs and
   obtain a more complete picture of the actual economic impact of
   hepatitis C infection. Copyright (c) 2015 Wolters Kluwer Health, Inc.
   All rights reserved.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Fernandez-Rodriguez, CM (Corresponding Author), Univ Rey Juan Carlos, Fdn Alcorcon Univ Hosp, Ave Valdelaguna 1, Madrid 28922, Spain.
   Oliva-Moreno, Juan; Pena-Longobardo, Luz M.; Fernandez-Bolanos, Antonio; Hidalgo-Vega, Alvaro, Univ Castilla La Mancha, Seminar Res Econ \& Hlth, Madrid, Spain.
   Alonso, Sonia; Luisa Gutierrez, Maria; de la Fuente, Elsa; Fernandez-Rodriguez, Conrado M., Univ Rey Juan Carlos, Fdn Alcorcon Univ Hosp, Serv Gastroenterol, Madrid 28922, Spain.},
DOI = {10.1097/MEG.0000000000000336},
ISSN = {0954-691X},
EISSN = {1473-5687},
Keywords = {hepatitis C; human capital approach; productivity losses; social costs},
Keywords-Plus = {DACLATASVIR PLUS SOFOSBUVIR; GENOTYPE 1 INFECTION; FRICTION COST METHOD;
   QUALITY-OF-LIFE; VIRUS-INFECTION; ECONOMIC BURDEN; EUROPEAN-UNION; HCV
   INFECTION; HEPATOCELLULAR-CARCINOMA; MENTAL-ILLNESS},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {cfernandez@fhalcorcon.es},
ResearcherID-Numbers = {Gutiérrez García, María Luisa/B-4311-2018
   Hidalgo, Alvaro/B-6768-2009
   Peña Longobardo, Luz María/K-6413-2017
   Oliva, Juan/A-1299-2011
   },
ORCID-Numbers = {Gutiérrez García, María Luisa/0000-0002-0035-9211
   Hidalgo, Alvaro/0000-0003-1031-2051
   Peña Longobardo, Luz María/0000-0001-7224-2189
   Oliva, Juan/0000-0002-8997-0307
   Fernandez Rodriguez, Conrado M/0000-0002-1915-2157},
Funding-Acknowledgement = {AbbvieAbbVie},
Funding-Text = {This study was funded by a research grant from Abbvie.},
Cited-References = {Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454.
   Akobundu E, 2006, PHARMACOECONOMICS, V24, P869, DOI 10.2165/00019053-200624090-00005.
   Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247.
   BRUIX J, 1989, LANCET, V2, P1004.
   Buti M, 2007, ALIMENT PHARM THER, V26, P705, DOI 10.1111/j.1365-2036.2007.03419.x.
   Casado Gomez M A, 2006, Farm Hosp, V30, P291.
   Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI 10.1590/s1135-57272009000100011.
   de Bruijne J, 2009, VOX SANG, V97, P1, DOI 10.1111/j.1423-0410.2009.01187.x.
   Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131.
   Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054.
   Dhaliwal HS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726.
   DiBonaventura MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086070.
   DiBonaventura MD, 2012, EUR J GASTROEN HEPAT, V24, P869, DOI 10.1097/MEG.0b013e3283551dee.
   Dominguez A, 2001, J MED VIROL, V65, P688, DOI 10.1002/jmv.2091.
   Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722.
   Garcia-Fulgueiras A, 2011, J VIRAL HEPATITIS, V18, pE453, DOI 10.1111/j.1365-2893.2011.01467.x.
   Garcia-Fulgueiras A, 2009, REV ESP SALUD PUBLIC, V83, P587, DOI 10.1590/s1135-57272009000400010.
   Garcia-Fulgueiras A, 2009, EUR J GASTROEN HEPAT, V21, P895, DOI 10.1097/MEG.0b013e328313139d.
   Grossman M., 1972, DEMAND HLTH THEORETI.
   Grossman M., 2000, HDB HLTH EC.
   Saflo OHA, 2009, GASTROENT HEPAT-BARC, V32, P472, DOI 10.1016/j.gastrohep.2009.01.181.
   Hu J, 2005, HEART LUNG, V34, P415, DOI 10.1016/j.hrtlng.2005.03.008.
   Hutchinson SJ, 2005, HEPATOLOGY, V42, P711, DOI 10.1002/hep.20836.
   Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669.
   Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854.
   Johannesson M, 1997, J HEALTH ECON, V16, P249, DOI 10.1016/S0167-6296(97)00006-4.
   Johannesson M, 1997, J HLTH EC, V16, P257.
   Knapp M, 2003, BRIT J PSYCHIAT, V183, P477, DOI 10.1192/bjp.183.6.477.
   KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5.
   Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355.
   Krol M, 2013, PHARMACOECONOMICS, V31, P537, DOI 10.1007/s40273-013-0056-3.
   Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2.
   Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853.
   Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733.
   Leigh JP, 2001, ARCH INTERN MED, V161, P2231, DOI 10.1001/archinte.161.18.2231.
   Levine Beverly, 2007, Prev Chronic Dis, V4, pA14.
   Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001.
   Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X.
   Luengo-Fernandez R, 2011, J ALZHEIMERS DIS, V27, P187, DOI 10.3233/JAD-2011-102019.
   Mahajan R, 2014, CLIN INFECT DIS, V58, P1055, DOI 10.1093/cid/ciu077.
   Manne V, 2014, J CLIN GASTROENTEROL, V48, P595, DOI 10.1097/MCG.0000000000000080.
   MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617.
   Mohammad A, 2012, J CLIN GASTROENTEROL, V46, P407, DOI 10.1097/MCG.0b013e3182485528.
   Muhlberger Nikolai, 2009, BMC Public Health, V9, P34, DOI 10.1186/1471-2458-9-34.
   Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000.
   Nyman JA, 2012, HEALTH ECON, V21, P1387, DOI 10.1002/hec.1795.
   Oliva-Moreno J, 2012, EUR J HEALTH ECON, V13, P605, DOI 10.1007/s10198-011-0344-9.
   Oliva-Moreno J, 2009, EUR J HEALTH ECON, V10, P361, DOI 10.1007/s10198-008-0135-0.
   Patruni B, 2013, HEPATITIS C PROJECTI, P58.
   Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003.
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013.
   Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869.
   Rodriguez AE, 2012, THESIS FLORIDA INT U.
   Sachs JD, 2001, MACROECONOMICS HLTH.
   Sacristan B, 1996, MED CLIN-BARCELONA, V107, P331.
   Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423.
   Shiell A, 2001, HEALTH POLICY, V58, P121, DOI 10.1016/S0168-8510(01)00159-2.
   Shurcke M, 2005, CONTRIBUTION HLTH EC.
   Spanish National Statistics Institute, 2014, EC ACT POP SURV.
   Spanish National Statistics Institute, 2012, ANN WAG STRUCT SURV.
   Spanish National Statistics Institute, 2014, CONS PRIC IND.
   Spanish National Statistics Institute, 2012, DEATH STAT ACC CAUS.
   Stahmeyer JT, 2014, EUR J GASTROEN HEPAT, V26, P1278, DOI 10.1097/MEG.0000000000000181.
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   Su J, 2010, HEPATOLOGY, V52, P436, DOI 10.1002/hep.23726.
   Vietri J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-16.
   Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562.
   Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145.
   Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561.
   Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557.
   Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026.},
Number-of-Cited-References = {71},
Times-Cited = {13},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Eur. J. Gastroenterol. Hepatol.},
Doc-Delivery-Number = {CH0DE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000353688400003},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1991GP22100007,
Author = {HALLBERG, H and MATTSSON, B},
Title = {PREMATURE DEATHS AMONG MEN IN A SWEDISH MUNICIPALITY - SOCIAL
   CHARACTERISTICS PRIOR TO DEATH},
Journal = {SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE},
Year = {1991},
Volume = {19},
Number = {3},
Pages = {181-186},
Abstract = {Premature deaths among 91 men in a Swedish municipality were analyzed
   regarding social class, immigrant status and their contacts with the
   Social Services because of alcohol abuse.  Unskilled manual workers were
   overrepresented (54\% versus 28\% in an age-adjusted male reference
   group) and self-employed (other than professionals) were
   underrepresented (4\% versus 15\%).  The job situation was, however,
   rather stable and low unemployment (1\%) was at hand.  The proportion of
   men born in Finland was high (20\%).  All men in this group belonged to
   the lowest social class.  Single men (ummarried or divorced) were
   overrepresented compared to the Swedish group (72\% versus 40\%). 
   Cardio-vascular disease was a common cause of death among the Finnish
   men (56\% versus 36\%).
   Combining medical and social data revealed alcohol abuse among 40\% of
   the 91 men (50\% among the Finnish and 37\% among the Swedish men).  The
   most complete information was given by the primary health care records
   where 89\% with alcohol abuse were identified, which is a high
   proportion compared to other studies.  Only 28\% were considered to have
   alcohol abuse according to the Social Services.},
Publisher = {SCANDINAVIAN UNIVERSITY PRESS},
Address = {PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY},
Type = {Article},
Language = {English},
Affiliation = {HALLBERG, H (Corresponding Author), CTY COUNCIL DALARNA,DEV UNIT,KOPPARVAGEN 29F,S-79142 FALUN,SWEDEN.
   MARIEHEMS PRIMARY HLTH CARE CTR,S-90187 UMEA,SWEDEN.},
DOI = {10.1177/140349489101900307},
ISSN = {0300-8037},
Keywords = {PREMATURE DEATHS; ALCOHOLISM; SOCIAL CLASS; IMMIGRANT STATUS},
Keywords-Plus = {MIDDLE-AGED MEN; EASTERN FINLAND; MARITAL-STATUS; MORTALITY; ALCOHOL;
   INDICATORS; POPULATION; RISK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {Agren G, 1986, Lakartidningen, V83, P3984.
   Alfredsson L, 1981, Nord Med, V96, P80.
   ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021.
   BERGSTRAND R, 1982, EUR HEART J, V3, P130, DOI 10.1093/oxfordjournals.eurheartj.a061274.
   Black D., 1980, INEQUALITIES HLTH.
   CAHALAN D, 1972, AM J PUBLIC HEALTH N, V62, P1473, DOI 10.2105/AJPH.62.11.1473.
   GOVE WR, 1973, AM J SOCIOL, V79, P45, DOI 10.1086/225505.
   GRANVIK M, 1982, COMMUNITY DIAGNOSES.
   HALLBERG H, 1990, SCAND J SOC MED, V18, P101.
   HJORTZBERGNORDL.H, 1968, ACTA PSYCHIATR SCA S, V199.
   HOLME I, 1980, J EPIDEMIOL COMMUN H, V34, P48, DOI 10.1136/jech.34.1.48.
   KNUPFER G, 1967, AM J PUBLIC HEALTH N, V57, P973, DOI 10.2105/AJPH.57.6.973.
   MARMOT MG, 1984, LANCET, V1, P1003.
   MORGAN M, 1980, SOC SCI MED-MED SOC, V14, P633, DOI 10.1016/0160-7979(80)90068-5.
   NAGI MH, 1973, HEALTH SERV REP, V88, P449, DOI 10.2307/4594817.
   {*}NAT BOARD HLTH WE, 1987, 15 REP.
   {*}NAT CENT BUR STAT, 1984, SWED SOC EC CLASS RE.
   NICHOLLS P, 1974, Q J STUD ALCOHOL, V35, P841.
   OJESJO L, 1980, SOC PSYCHIATR, V15, P81, DOI 10.1007/BF00578072.
   PETERSON B, 1980, BMJ-BRIT MED J, V280, P1403, DOI 10.1136/bmj.280.6229.1403.
   PETERSSON B, 1982, LANCET, V2, P1088.
   Poikolainen K, 1979, Nord Med, V94, P90.
   Romelsjo A, 1987, Scand J Prim Health Care, V5, P101, DOI 10.3109/02813438709013984.
   ROSENGREN A, 1988, BRIT MED J, V297, P1497, DOI 10.1136/bmj.297.6662.1497.
   ROSENGREN A, 1989, AM J EPIDEMIOL, V129, P54, DOI 10.1093/oxfordjournals.aje.a115124.
   SCHMIDT W, 1975, DRUG ALCOHOL DEPEN, V76, P27.
   SUNDBY P, 1967, PUBLICATION NATIONAL, V6.
   SYME SL, 1976, AM J EPIDEMIOL, V104, P1.
   TUOMILEHTO J, 1987, BRIT MED J, V295, P623, DOI 10.1136/bmj.295.6599.623.
   TUOMILEHTO J, 1979, ACTA CARDIOL, V34, P359.
   1987, DEMOGRAFIC YB 1985.},
Number-of-Cited-References = {31},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Scand. J. Soc. Med.},
Doc-Delivery-Number = {GP221},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991GP22100007},
DA = {2022-03-29},
}

@article{ WOS:000310598700032,
Author = {Bergen, Helen and Hawton, Keith and Waters, Keith and Ness, Jennifer and
   Cooper, Jayne and Steeg, Sarah and Kapur, Navneet},
Title = {Premature death after self-harm: a multicentre cohort study},
Journal = {LANCET},
Year = {2012},
Volume = {380},
Number = {9853},
Pages = {1568-1574},
Month = {NOV 3},
Abstract = {Background People who self-harm have an increased risk of premature
   death. The aim of this study was to investigate cause-specific premature
   death in individuals who self-harm, including associations with
   socioeconomic deprivation.
   Methods We undertook a cohort study of patients of all ages presenting
   to emergency departments in Oxford, Manchester, and Derby, UK, after
   self-poisoning or self-injury between Jan 1, 2000, and Dec 31, 2007.
   Postcodes of individuals' place of residence were linked to the Index of
   Multiple Deprivation 2007 in England. Mortality information was supplied
   by the Medical Research Information Service of the National Health
   Service. Patients were followed up to the end of 2009. We calculated
   age-standardised mortality ratios (SMRs) and years of life lost (YLL),
   and we tested for associations with socioeconomic deprivation.
   Findings 30 950 individuals presented with self-harm and were followed
   up for a median of 6.0 years (IQR 3.9-7.9). 1832 (6.1\%) patients died
   before the end of follow-up. Death was more likely in patients than in
   the general population (SMR 3.6, 95\% CI 3.5-3.8), and occurred more in
   males (4.1, 3.8-4.3) than females (3.2, 2.9-3.4). Deaths due to natural
   causes were 2-7.5 times more frequent than was expected. For individuals
   who died of any cause, mean YLL was 31.4 years (95\% CI 30.5-32.2) for
   male patients and 30.7 years (29.5-31.9) for female patients. Mean YLL
   for natural-cause deaths was 25.9 years (25.7-26.0) for male patients
   and 25.5 years (25.2-25.8) for female patients, and for external-cause
   deaths was 40.2 years (40.0-40.3) and 40.0 years (39.7-40.5),
   respectively. Disease of the circulatory (13.1\% in males; 13.0\% in
   females) and digestive (11.7\% in males; 17.8\% in females) systems were
   major contributors to YLL from natural causes. All-cause mortality
   increased with each quartile of socioeconomic deprivation in male
   patients (chi(2) trend 39.6; p<0.0001), female patients (13.9;
   p=0.0002), and both sexes combined (55.4; p<0.0001). Socioeconomic
   deprivation was related to mortality in both sexes combined from natural
   causes (51.0; p<0.0001) but not from external causes (0.30; p=0.58).
   Alcohol problems were associated with death from digestive-system
   disease, drug misuse with mental and behavioural disorders, and physical
   health problems with circulatory-system disease.
   Interpretation Physical health and life expectancy are severely
   compromised in individuals who self-harm compared with the general
   population. In the management of self-harm, clinicians assessing
   patients' psychosocial problems should also consider their physical
   needs.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Hawton, K (Corresponding Author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.
   Bergen, Helen; Hawton, Keith, Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.
   Waters, Keith; Ness, Jennifer, Derbyshire Healthcare NHS Fdn Trust, Mental Hlth Liaison Team, Royal Derby Hosp, Derby, England.
   Cooper, Jayne; Steeg, Sarah; Kapur, Navneet, Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England.},
DOI = {10.1016/S0140-6736(12)61141-6},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {FOLLOW-UP; SUICIDE; MORTALITY; ENGLAND; TRENDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {keith.hawton@psych.ox.ac.uk},
ResearcherID-Numbers = {Waters, Keith/AAH-5503-2019
   },
ORCID-Numbers = {Waters, Keith/0000-0002-5031-0870
   Steeg, Sarah/0000-0002-7935-1414
   Kapur, Nav/0000-0002-3100-3234},
Funding-Acknowledgement = {Department of Health Policy Research Programme},
Funding-Text = {This study was funded by the Department of Health Policy Research
   Programme. KH is a National Institute for Health Research Senior
   Investigator. From Oxford, we thank Deborah Casey, Elizabeth Bale, and
   members of the general hospital psychiatric services for their
   assistance with data collection, and statisticians from the Centre for
   Statistics in Medicine, University of Oxford, for statistical advice;
   from Manchester, the clinicians completing assessment forms, the
   research team for data collection, Elizabeth Murphy, Iain Donaldson,
   Victoria Matthews, and Stella Dickson; and from Derby, clinicians, and
   clerical and administrative staff in the Emergency Department and Mental
   Health Liaison Team.},
Cited-References = {Bergen H, 2012, PSYCHOL MED, V42, P727, DOI 10.1017/S0033291711001747.
   Bergen H, 2012, J AFFECT DISORDERS, V136, P526, DOI 10.1016/j.jad.2011.10.036.
   Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651.
   Breakwell C, 2009, HLTH STAT Q, V33, P6.
   Carter G, 2005, AUST NZ J PSYCHIAT, V39, P101, DOI 10.1111/j.1440-1614.2005.01515.x.
   Department of Health, MULT STUD SELF HARM.
   Gunnell D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6030.
   GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226.
   Hall DJ, 1998, BRIT J PSYCHIAT, V172, P239, DOI 10.1192/bjp.172.3.239.
   Haw C, 2005, SOC PSYCH PSYCH EPID, V40, P964, DOI 10.1007/s00127-005-0981-3.
   Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48.
   Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914.
   Hawton K, 2001, SOC PSYCH PSYCH EPID, V36, P437, DOI 10.1007/s001270170021.
   Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943.
   HAWTON K, 1988, BRIT J PSYCHIAT, V152, P359, DOI 10.1192/bjp.152.3.359.
   Karasouli E, 2011, SOC PSYCH PSYCH EPID, V46, P455, DOI 10.1007/s00127-010-0213-3.
   Mok PLH, 2012, BRIT J PSYCHIAT, V200, P245, DOI 10.1192/bjp.bp.111.092908.
   Naylor C, 2012, LONG TERM CONDITION.
   Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2.
   Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154.
   NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637.
   Office for National Statistics, 2010, IND MULT DEPR IMD 20.
   Office for National Statistics, HIGHL.
   Office for National Statistics, 2010, ENGL INT LIF TABL 19.
   Ostamo A, 2001, SOC PSYCH PSYCH EPID, V36, P29, DOI 10.1007/s001270050287.
   Reith DM, 2004, AUST NZ J PSYCHIAT, V38, P520, DOI 10.1111/j.1440-1614.2004.01405.x.
   Ridsdale B, 2010, MORTALITY CAUSE DEAT.
   Romeri Ester, 2006, Health Stat Q, P19.
   Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7.
   Skegg K, 2004, SUICIDE LIFE-THREAT, V34, P187, DOI 10.1521/suli.34.2.187.32790.
   Thomas B, 2010, BMJ-BRIT MED J, V341, P291.
   Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718.
   Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100.},
Number-of-Cited-References = {33},
Times-Cited = {155},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {41},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {030VR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000310598700032},
DA = {2022-03-29},
}

@article{ WOS:A1971J740800007,
Author = {KASTENBAUM, R and MISHARA, BL},
Title = {PREMATURE DEATH AND SELF-INJURIOUS BEHAVIOR IN OLD AGE},
Journal = {GERIATRICS},
Year = {1971},
Volume = {26},
Number = {7},
Pages = {70+},
Publisher = {ADVANSTAR COMMUNICATIONS INC},
Address = {131 W 1ST STREET, DULUTH, MN 55802 USA},
Type = {Article},
Language = {English},
ISSN = {0016-867X},
EISSN = {1936-5764},
Research-Areas = {Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Geriatrics \& Gerontology},
Cited-References = {CLARK M, 1969, DEPENDENCIES OLD PEO, P59.
   FARBEROW NL, 1967, CLUES SUICIDE.
   GLASER BG, 1965, AWARNESS DYING.
   GOLDFARB AI, 1970, GERONTOLOGIST, V10, P45, DOI 10.1093/geront/10.1\_Part\_2.45.
   KALISH RA, 1965, J SOC ISSUES, V21, P87, DOI 10.1111/j.1540-4560.1965.tb00516.x.
   KASTENBAUM R, RESEARCH ACTION PLAN.
   KASTENBAUM R, 1964, THOUGHTS OLD AGE, P316.
   KASTENBAUM R, 1965, J HUM RELAT, V13, P538.
   KASTENBAUM R, 1964, 17 ANN SCIENT M GER.
   LIPSITT DR, 1969, DEPENDENCIES OLD PEO, P17.
   LITMAN RE, 1963, JAMA-J AM MED ASSOC, V184, P924, DOI 10.1001/jama.1963.03700250060008.
   SHNEIDMAN E, 1965, CRY HELP.
   Shneidman E. S, 1966, INT J PSYCHIAT, V2, P167.
   SHNEIDMAN ES, 1967, APR NORTH NEW ENGL C.
   Sudnow, 1967, PASSING.
   WEISMAN AD, 1968, PSYCHOLOGICAL AUTOPS.
   WEISMAN AD, 1970, SUICIDE PREVENTION S, P1.
   WEISMAN AD, 1962, FOREST HOSP PUBL, V1, P16.
   1968, VITAL STATISTICS U B, V2.},
Number-of-Cited-References = {19},
Times-Cited = {22},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Geriatrics},
Doc-Delivery-Number = {J7408},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1971J740800007},
DA = {2022-03-29},
}

@article{ WOS:000083168900009,
Author = {Cherington, M and Smith, R and Nielsen, PJ},
Title = {The life, legacy, and premature death of Felix Mendelssohn},
Journal = {SEMINARS IN NEUROLOGY},
Year = {1999},
Volume = {19},
Number = {1},
Pages = {47-52},
Abstract = {Felix Mendelssohn is one of the great classical composers of all time.
   During his short lifetime in the first half of the nineteenth century,
   he reached enormous heights as a composer, conductor, and leader in the
   world of music. Nearly one hundred years after his death, the Nazi
   regime attempted, unsuccessfully, to erase his music and his memory from
   history. Since the end of World War II, there has been a resurgence in
   interest in the life and music of Felix Mendelssohn and that of his
   sister, Fanny, Felix Mendelssohn died in 1947 at the age of 38, Both of
   his sisters died suddenly at the ages of 42 and 45, There is
   insufficient laboratory or post-mortem data to make a medical diagnosis
   with certainty. However, based on the information available to us, we
   speculate that Mendelssohn suffered a subarachnoid or intracerebral
   hemorrhage. The differential diagnosis of familial stroke syndrome is
   discussed.},
Publisher = {THIEME MEDICAL PUBL INC},
Address = {333 SEVENTH AVE, NEW YORK, NY 10001 USA},
Type = {Article},
Language = {English},
Affiliation = {Cherington, M (Corresponding Author), Centura Hlth St Anthony Hosp, 4231 W 16th Ave, Denver, CO 80204 USA.
   Centura Hlth St Anthony Hosp, Denver, CO 80204 USA.},
ISSN = {0271-8235},
Keywords = {Felix and Fanny Mendelssohn; composer; subarachnoid hemorrhage},
Keywords-Plus = {ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTRACRANIAL HEMORRHAGE; FAMILIAL
   OCCURRENCE; CEREBRAL ANEURYSMS; STROKE; MANAGEMENT; DEFICIENCY; YOUNG;
   BRAIN; ABUSE},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Cited-References = {AMMER C, 1973, HARPERS DICT MUSIC, P302.
   Bennett Robert Sterndale, 1955, MUSIC LETT, V36, p{[}374, 376].
   BLUNT W, 1974, WINGS SONG, P273.
   Deruty R, 1996, NEUROL RES, V18, P39, DOI 10.1080/01616412.1996.11740375.
   Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6.
   Feigin VL, 1998, NEUROLOGY, V50, P876, DOI 10.1212/WNL.50.4.876.
   FRANKEN FH, 1979, KRANKHEIT TOD GROSSE, P192.
   GITTINGS, 1910, ARCH INTERN MED, V6, P196.
   GOULDING PG, 1992, CLASSICAL MUSIC, P220.
   GREEN D, 1992, NEUROLOGY, V42, P1029, DOI 10.1212/WNL.42.5.1029.
   Hamet P, 1998, J HYPERTENS, V16, P397, DOI 10.1097/00004872-199816040-00001.
   Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798.
   JACOB HE, 1963, F MENDELSSOHN HIS TI, P98.
   Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413.
   KAMEN G, 1996, HIDDEN MUSIC LIFE F, P35.
   Kerner D, 1968, Dtsch Med J, V19, P454.
   KOCH HW, 1989, NAME VOLK, P219.
   KUPFERBERG H, 1972, F MENDELSSOHN HIS LI, P31.
   Leblanc R, 1997, CAN J NEUROL SCI, V24, P191, DOI 10.1017/S031716710002179X.
   LEWIS WH, 1941, B NY ACAD MED, V17, P781.
   MACHLIS J, 1984, ENJOYMENT MUSIC, P59.
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331.
   MAREK GR, 1972, GENTLE GENIUS, P309.
   Marini C, 1997, ARCH NEUROL-CHICAGO, V54, P351, DOI 10.1001/archneur.1997.00550160007004.
   MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315.
   McEvoy AW, 1998, LANCET, V351, P1029, DOI 10.1016/S0140-6736(98)24014-1.
   MOSHANSKY M, 1981, MENDELSSOHN HIS LIFE.
   NEUMAYR A, 1995, MUSIC MED, V2, P143.
   Nolte KB, 1996, NEUROLOGY, V46, P1291, DOI 10.1212/WNL.46.5.1291.
   Nyholt DR, 1998, NEUROLOGY, V50, P1428, DOI 10.1212/WNL.50.5.1428.
   Re RN, 1997, MED CLIN N AM, V81, P1099, DOI 10.1016/S0025-7125(05)70569-1.
   RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605.
   Ronkainen A, 1998, STROKE, V29, P359, DOI 10.1161/01.STR.29.2.359.
   Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8.
   Roubey RAS, 1997, LANCET, V350, P1491, DOI 10.1016/S0140-6736(05)63936-0.
   Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001.
   STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823.
   TILLARD F, 1992, F MENDELSSOHN, P13.
   WADIA RS, 1992, J NEUROL NEUROSUR PS, V55, P227, DOI 10.1136/jnnp.55.3.227.
   YOKOYAMA K, 1991, J NEUROSURG, V74, P585, DOI 10.3171/jns.1991.74.4.0585.},
Number-of-Cited-References = {40},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Semin. Neurol.},
Doc-Delivery-Number = {246NB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000083168900009},
DA = {2022-03-29},
}

@article{ WOS:000223732000029,
Author = {Ivanov, SV and Ward, JM and Tessarollo, L and McAreavey, D and Sachdev,
   V and Fananapazir, L and Banks, MK and Morris, N and Djurickovic, D and
   Devor-Henneman, DE and Wei, MH and Alvord, GW and Gao, BN and
   Richardson, JA and Minna, JD and Rogawski, MA and Lerman, MI},
Title = {Animal model - Cerebellar ataxia, seizures, premature death, and cardiac
   abnormalities in mice with targeted disruption of the Cacna2d2 gene},
Journal = {AMERICAN JOURNAL OF PATHOLOGY},
Year = {2004},
Volume = {165},
Number = {3},
Pages = {1007-1018},
Month = {SEP},
Abstract = {CACNA2D2 is a putative tumor suppressor gene located in the human
   chromosome 3p21.3 region that shows frequent allelic imbalances in lung,
   breast, and other cancers. The alpha2delta-2 protein encoded by the gene
   is a regulatory subunit of voltage-dependent calcium channels and is
   expressed in brain, heart, and other tissues. Here we report that mice
   homozygous for targeted disruption of the Cacna2d2 gene exhibit growth
   retardation, reduced life span, ataxic gait with apoptosis of cerebellar
   granule cells followed by Purkinje cell depletion, enhanced
   susceptibility to seizures, and cardiac abnormalities. The
   Cacna2d2(tm1NCIF) null phenotype has much in common with that of Cacna1a
   mutants, such as cerebellar neuro-degeneration associated with ataxia,
   seizures, and premature death. A tendency to bradycardia and limited
   response of null mutants to isoflurane implicate alpha2delta-2 in
   sympathetic regulation of cardiac function. in summary, our findings
   provide genetic evidence that the alpha2delta-2 subunit serves in vivo
   as a component of P/Q-type calcium channels, is indispensable for the
   central nervous system function, and may be involved in hereditary
   cerebellar ataxias and epileptic disorders in humans.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Ivanov, SV (Corresponding Author), NCI, Basic Res Program, Bldg 560,POB B, Frederick, MD 21702 USA.
   NCI, Basic Res Program, Frederick, MD 21702 USA.
   NCI, Lab Anim Sci Program, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA.
   NCI, Immunobiol Lab, Ctr Canc Res, Frederick, MD 21702 USA.
   NCI, Vet \& Tumor Pathol Sect, Ctr Canc Res, Frederick, MD 21702 USA.
   NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA.
   NCI, Neural Dev Sect, Comp \& Stat Serv, Ctr Canc Res, Frederick, MD 21702 USA.
   NHLBI, Ctr Clin, NIH, Bethesda, MD 20892 USA.
   NHLBI, Clin Electrophysiol \& Inherited Heart Dis Sect, Cardiol Branch, NIH, Bethesda, MD 20892 USA.
   NINDS, Epilepsy Res Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA.
   Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA.
   Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX USA.},
DOI = {10.1016/S0002-9440(10)63362-7},
ISSN = {0002-9440},
EISSN = {1525-2191},
Keywords-Plus = {CALCIUM-CHANNELS; CA2+ CHANNELS; MOUSE; SUBUNIT; EXPRESSION; EPILEPSY;
   MUTATIONS; MUTANT; DUCKY; DIVERSITY},
Research-Areas = {Pathology},
Web-of-Science-Categories  = {Pathology},
Author-Email = {ivanov@mail.ncifcrf.gov},
ResearcherID-Numbers = {Rogawski, Michael A/B-6353-2009
   },
ORCID-Numbers = {Rogawski, Michael A/0000-0002-3296-8193
   Ivanov, Sergey/0000-0001-9770-7237},
Funding-Acknowledgement = {NATIONAL CANCER INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) {[}Z01BC008579] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders \& Stroke (NINDS)
   {[}Z01NS002877] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Cancer Institute (NCI) {[}N01CO12400,
   N01-CO-12400] Funding Source: Medline},
Cited-References = {Atiga WL, 2000, CIRCULATION, V101, P1237, DOI 10.1161/01.CIR.101.11.1237.
   Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001.
   Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094.
   Bonin A, 2000, METH MOL B, V158, P121.
   Breningstall GN, 2001, PEDIATR NEUROL, V25, P9, DOI 10.1016/S0887-8994(01)00252-1.
   Brill J, 2004, J BIOL CHEM, V279, P7322, DOI 10.1074/jbc.M308778200.
   Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200.
   Burgess DL, 1999, EPILEPSY RES, V36, P111, DOI 10.1016/S0920-1211(99)00045-5.
   Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066.
   Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521.
   Chu PJ, 2003, J MOL CELL CARDIOL, V35, P207, DOI 10.1016/S0022-2828(02)00313-9.
   Chu V, 2002, MUSCLE NERVE, V26, P513, DOI 10.1002/mus.10223.
   COUGHENOUR LL, 1977, PHARMACOL BIOCHEM BE, V6, P351, DOI 10.1016/0091-3057(77)90036-3.
   CRAWLEY JN, 1999, WHATS WRONG MY MOUSE, P56.
   De Waard M, 1996, Ion Channels, V4, P41.
   DEJONGH KS, 1990, J BIOL CHEM, V265, P14738.
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X.
   FANANAPAZIR L, 1991, AM J CARDIOL, V67, P280, DOI 10.1016/0002-9149(91)90560-8.
   Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje.
   Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1.
   Gao BN, 2000, J BIOL CHEM, V275, P12237, DOI 10.1074/jbc.275.16.12237.
   Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7.
   Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7.
   Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6.
   Hirose H, 2003, INT J MOL MED, V11, P187.
   Hobom M, 2000, EUR J NEUROSCI, V12, P1217, DOI 10.1046/j.1460-9568.2000.01009.x.
   HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.ne.17.030194.002151.
   Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9.
   Klugbauer N, 1999, J NEUROSCI, V19, P684.
   Lerman MI, 2000, CANCER RES, V60, P6116.
   Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4.
   Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243.
   MEIER H, 1968, ACTA NEUROPATHOL, V11, P15, DOI 10.1007/BF00692792.
   Mori Y, 2000, J NEUROSCI, V20, P5654, DOI 10.1523/JNEUROSCI.20-15-05654.2000.
   NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084.
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2.
   Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000.
   Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795.
   Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5.
   ROGAWSKI MA, 2002, ANTIEPILEPTIC DRUGS, P3.
   Santella L, 1997, FASEB J, V11, P1091, DOI 10.1096/fasebj.11.13.9367344.
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358.
   Shelton JM, 2000, J LIPID RES, V41, P532.
   STUDY RE, 1994, ANESTHESIOLOGY, V81, P104, DOI 10.1097/00000542-199407000-00016.
   Tessarollo L, 2000, METH MOL B, V158, P47.
   Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9.
   WETTS R, 2002, NEUROSCIENCE, V112, P509.
   Yusaf SP, 2001, NEUROSCI LETT, V311, P137, DOI 10.1016/S0304-3940(01)02038-9.
   Zhang Y, 2002, J NEUROSCI, V22, P6362.
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62.},
Number-of-Cited-References = {50},
Times-Cited = {58},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Am. J. Pathol.},
Doc-Delivery-Number = {852CE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000223732000029},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000362243200006,
Author = {Prometti, P. and Bellini, G. and Amaddeo, P.},
Title = {Premature death in professional wrestlers: cardiovascular and
   neuropsychiatric effects of anabolic-androgenic steroids},
Journal = {MEDICINA DELLO SPORT},
Year = {2015},
Volume = {68},
Number = {2},
Pages = {231-241},
Month = {JUN},
Abstract = {Aim. The modality and prematurity of death among professional wrestlers
   defy logic, insinuating a causal relationship between cause of death and
   use of anabolic steroids (AAS). This article proposes to conduct a
   retrospective study from 1985 to today to collect instances of premature
   death drawn from data published by World Wrestling Entertainment.
   Methods. We re-evaluated the pharmacological data of AAS, analyzing the
   reason of use and adverse effects on cardiovascular and cognitive
   functions.
   Results. Both experimental data and clinical autopsies have demonstrated
   that abuse of AAS causes the development of myocardial hypertrophy,
   similar to dilated cardiomyopathy in the presence of myocardial fibrosis
   and inflammation associated with changed lipid profiles, which acts on
   the arrhythmogenic substrate in the triggering of fatal arrhythmias. Not
   only are the dose and duration of consumption harmful, but the results
   are irreversible. It has been proven that pathological alterations of
   affective disorders vary greatly from depressive syndrome to paranoid
   psychosis, from reverse anorexia to drug and alcohol abuse. It has been
   hypothesized that neurotoxicity directed from the encephalic region is
   associated with visual-spatial memory. The retrospective study of
   approximately 600 professional wrestlers confirmed a significant
   reduction in life expectancy: more than 50\% of wrestlers die before the
   age of 50. The age segments that represent the greatest mortality are
   the fourth and fifth decades of life. Among causes of death, those that
   stand out most are sudden cardiac arrest and drug abuse (52\%) and
   violent death (10\% suicide, 7\% accident) dramatic events probably
   related to the abuse of AAS.
   Conclusion. The message of the study is clear: it is necessary to
   implement training programs that are respectful of health and
   simultaneously monitor cases so that in everyday primary prevention
   practices we can diagnose and correct the first signs of suspected AAS
   abuse.},
Publisher = {EDIZIONI MINERVA MEDICA},
Address = {CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY},
Type = {Article},
Language = {English},
Affiliation = {Amaddeo, P (Corresponding Author), Ctr Med Sport, Bgo Palazzo 130, I-24125 Bergamo, Italy.
   Prometti, P., FSM Ist Lumezzane, Brescia, Italy.
   Prometti, P.; Bellini, G., Univ Brescia, Scuola Specializzaz Med Sport, Brescia, Italy.
   Amaddeo, P., Azienda Osped Papa Giovanni XXIII, Ctr Med Sport, Bergamo, Italy.},
ISSN = {0025-7826},
EISSN = {1827-1863},
Keywords = {Wrestling; Anabolic agents; Mortality, premature},
Keywords-Plus = {TOXICOLOGICAL FINDINGS; SUBSTANCE USE; ABUSE; USERS; PERSPECTIVE;
   MANNER; RATS},
Research-Areas = {General \& Internal Medicine; Sport Sciences},
Web-of-Science-Categories  = {Medicine, General \& Internal; Sport Sciences},
Author-Email = {pamaddeo@hpg23.it},
ResearcherID-Numbers = {Prometti, Paola/AAC-2039-2020},
ORCID-Numbers = {Prometti, Paola/0000-0002-4846-4395},
Cited-References = {Basaria S, 2001, J CLIN ENDOCR METAB, V86, P5108, DOI 10.1210/jc.86.11.5108.
   Brower Kirk J, 2002, Curr Psychiatry Rep, V4, P377, DOI 10.1007/s11920-002-0086-6.
   BROWER KJ, 1989, AM J PSYCHIAT, V146, P1075.
   Far HRM, 2012, CARDIOVASC PATHOL, V21, P312, DOI 10.1016/j.carpath.2011.10.002.
   Furlanello Francesco, 2003, Ital Heart J, V4, P829.
   GLAZER G, 1991, ARCH INTERN MED, V151, P1925, DOI 10.1001/archinte.151.10.1925.
   Green GA, 2001, CLIN J SPORT MED, V11, P51, DOI 10.1097/00042752-200101000-00009.
   Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003.
   Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1.
   JANNE OA, 1993, ANN MED, V25, P83, DOI 10.3109/07853899309147863.
   Kanayama G, 2001, PSYCHOTHER PSYCHOSOM, V70, P137, DOI 10.1159/000056238.
   Kouvelas D, 2007, INT J NEUROPSYCHOPH, V10, P291, DOI 10.1017/S1461145706007243.
   McCredie RJ, 1998, J AM COLL CARDIOL, V32, P1331, DOI 10.1016/S0735-1097(98)00416-1.
   McCrohon JA, 1999, CIRCULATION, V99, P2317, DOI 10.1161/01.CIR.99.17.2317.
   McDuff DR, 2005, CLIN SPORT MED, V24, P885, DOI 10.1016/j.csm.2005.06.004.
   McKillop G, 1986, Br J Sports Med, V20, P151.
   MCNUTT RA, 1988, AM J CARDIOL, V62, P164, DOI 10.1016/0002-9149(88)91390-2.
   MELCHERT RB, 1995, MED SCI SPORT EXER, V27, P1252.
   Montisci M, 2012, FORENSIC SCI INT, V217, pE13, DOI 10.1016/j.forsciint.2011.10.032.
   National Institute on Drug Abuse, 2000, AN STER AB.
   Pagonis TA, 2006, EUR PSYCHIAT, V21, P563, DOI 10.1016/j.eurpsy.2005.11.002.
   Parssinen M, 2000, INT J SPORTS MED, V21, P225, DOI 10.1055/s-2000-304.
   Parssinen M, 2002, SPORTS MED, V32, P83, DOI 10.2165/00007256-200232020-00001.
   Pereira-Junior PP, 2006, EUR J APPL PHYSIOL, V96, P487, DOI 10.1007/s00421-005-0111-7.
   Petersson A, 2006, DRUG ALCOHOL DEPEN, V81, P241, DOI 10.1016/j.drugalcdep.2005.07.003.
   Phillis BD, 2007, TOXICOL SCI, V99, P605, DOI 10.1093/toxsci/kfm186.
   POPE HG, 1988, AM J PSYCHIAT, V145, P487.
   Pope HG, 2003, PSYCHONEUROENDOCRINOLOGY: SCIENTIFIC BASIS OF CLINICAL PRACTICE, P331.
   POPE HG, 1987, LANCET, V1, P863.
   Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006.
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0.
   Ruiz, 2009, COMPREHENSIVE TXB PS, P1419.
   Sader MA, 2003, CLIN ENDOCRINOL, V59, P62, DOI 10.1046/j.1365-2265.2003.01796.x.
   Santora Lawrence J, 2006, Prev Cardiol, V9, P198, DOI 10.1111/j.1559-4564.2006.05210.x.
   SCARPINO V, 1990, LANCET, V336, P1048, DOI 10.1016/0140-6736(90)92502-9.
   Sullivan ML, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80019-4.
   Thiblin I, 2000, J FORENSIC SCI, V45, P16.
   Vanberg Paul, 2010, Handb Exp Pharmacol, P411, DOI 10.1007/978-3-540-79088-4\_18.
   Vetere C, 1997, B FARMACODIPENDENZE, VXX, P111.},
Number-of-Cited-References = {39},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {16},
Journal-ISO = {Med. Sport},
Doc-Delivery-Number = {CS7DB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000362243200006},
DA = {2022-03-29},
}

@article{ WOS:000336868800018,
Author = {Zaglia, Tania and Milan, Giulia and Ruhs, Aaron and Franzoso, Mauro and
   Bertaggia, Enrico and Pianca, Nicola and Carpi, Andrea and Carullo,
   Pierluigi and Pesce, Paola and Sacerdoti, David and Sarais, Cristiano
   and Catalucci, Daniele and Krueger, Marcus and Mongillo, Marco and
   Sandri, Marco},
Title = {Atrogin-1 deficiency promotes cardiomyopathy and premature death via
   impaired autophagy},
Journal = {JOURNAL OF CLINICAL INVESTIGATION},
Year = {2014},
Volume = {124},
Number = {6},
Pages = {2410-2424},
Month = {JUN},
Abstract = {Cardiomyocyte proteostasis is mediated by the ubiquitin/proteasome
   system (UPS) and autophagy/lysosome system and is fundamental for
   cardiac adaptation to both physiologic (e.g., exercise) and pathologic
   (e.g., pressure overload) stresses. Both the UPS and autophagy/lysosome
   system exhibit reduced efficiency as a consequence of aging, and
   dysfunction in these systems is associated with cardiomyopathies. The
   muscle-specific ubiquitin ligase atrogin-1 targets signaling proteins
   involved in cardiac hypertrophy for degradation. Here, using atrogin-1
   KO mice in combination with in vivo pulsed stable isotope labeling of
   amino acids in cell culture proteomics and biochemical and cellular
   analyses, we identified charged multivesicular body protein 2B (CHMP2B),
   which is part of an endosomal sorting complex (ESCRT) required for
   autophagy, as a target of atrogin-1-mediated degradation. Mice lacking
   atrogin-1 failed to degrade CHMP2B, resulting in autophagy impairment,
   intracellular protein aggregate accumulation, unfolded protein response
   activation, and subsequent cardiomyocyte apoptosis, all of which
   increased progressively with age. Cellular proteostasis alterations
   resulted in cardiomyopathy characterized by myocardial remodeling with
   interstitial fibrosis, with reduced diastolic function and arrhythmias.
   CHMP2B downregulation in atrogin-1 KO mice restored autophagy and
   decreased proteotoxicity, thereby preventing cell death. These data
   indicate that atrogin-1 promotes cardiomyocyte health through mediating
   the interplay between UPS and autophagy/lysosome system and its
   alteration promotes development of cardiomyopathies.},
Publisher = {AMER SOC CLINICAL INVESTIGATION INC},
Address = {2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA},
Type = {Article},
Language = {English},
Affiliation = {Sandri, M (Corresponding Author), Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.
   Zaglia, Tania; Franzoso, Mauro; Pianca, Nicola; Mongillo, Marco; Sandri, Marco, Univ Padua, Dept Biomed Sci, Padua, Italy.
   Zaglia, Tania; Franzoso, Mauro; Pianca, Nicola; Mongillo, Marco; Sandri, Marco, Venetian Inst Mol Med, I-35129 Padua, Italy.
   Milan, Giulia; Bertaggia, Enrico; Sandri, Marco, Venetian Inst Mol Med, Muscle Signaling Lab, I-35129 Padua, Italy.
   Ruhs, Aaron; Krueger, Marcus, Max Planck Inst Heart \& Lung Res, Bad Nauheim, Germany.
   Carpi, Andrea, European Inst Oncol, Milan, Italy.
   Carullo, Pierluigi; Catalucci, Daniele, CNR, Inst Genet \& Biomed Res UOS Milan, I-20133 Milan, Italy.
   Carullo, Pierluigi; Catalucci, Daniele, Humanitas Clin \& Res Ctr, Milan, Italy.
   Pesce, Paola; Sacerdoti, David, Univ Padua, Dept Clin \& Expt Med, Padua, Italy.
   Sarais, Cristiano, Univ Padua, Dept Cardiac Thorac \& Vasc Sci, Padua, Italy.
   Mongillo, Marco; Sandri, Marco, CNR, Inst Neurosci, Padua, Italy.
   Sandri, Marco, Telethon Inst Genet \& Med TIGEM, Naples, Italy.},
DOI = {10.1172/JCI66339},
ISSN = {0021-9738},
EISSN = {1558-8238},
Keywords-Plus = {UBIQUITIN-PROTEASOME SYSTEM; DEPENDENT CARDIAC-HYPERTROPHY; MURINE
   MODEL; HEART; ESCRT; PRESSURE; FAILURE; LIGASES; IDENTIFICATION;
   DYSFUNCTION},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {marco.mongillo@unipd.it
   marco.sandri@unipd.it},
ResearcherID-Numbers = {Sacerdoti, David/G-3997-2012
   Catalucci, Daniele/AAA-6056-2022
   carullo, pierluigi/K-7492-2016
   Catalucci, Daniele/B-6745-2015
   Pianca, Nicola/AAA-7948-2019},
ORCID-Numbers = {Sacerdoti, David/0000-0002-4933-7718
   Catalucci, Daniele/0000-0001-7041-6114
   carullo, pierluigi/0000-0003-0812-7770
   Catalucci, Daniele/0000-0001-7041-6114
   Pianca, Nicola/0000-0001-7374-5626},
Funding-Acknowledgement = {Foundation LeducqLeducq Foundation; European Community (MYOAGE)
   {[}223576]; European Research Council (MyoPHAGY) {[}282310]; Italian
   Ministry of Education; University of Padova {[}CPDA0977, GRIC101133];
   European CommunityEuropean Commission {[}HEALTH-F2-2009-241526,];
   EUTrigTreat; Telethon-ItalyFondazione Telethon {[}TCPO4009, GGP11224]},
Funding-Text = {This work was supported by the Foundation Leducq, Telethon-Italy
   (TCPO4009); the European Community Seventh Framework Program of FP7
   (MYOAGE, contract 223576); the European Research Council (MyoPHAGY,
   contract 282310); the Italian Ministry of Education to M. Sandri;
   University of Padova (Progetto Ateneo 2010, contract CPDA0977); the
   European Community Seventh Framework Program FP7/2007-2013 under grant
   agreement HEALTH-F2-2009-241526, EUTrigTreat, and Telethon-Italy
   (GGP11224) to M. Mongillo; and University of Padova (Progetto Giovani
   Studiosi 2010, contract: GRIC101133) to T. Zaglia. We thank David J.
   Glass for providing atrogin-1 KO mice; Stefano Schiaffino for critical
   reading; Domenico Corrado for interpretation of ECG data; Giulia Borile,
   Emilio Bigon, Eleonora Piasentini, and Silvia Gaiani for technical
   assistance.},
Cited-References = {Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015.
   Baskin KK, 2011, CARDIOVASC RES, V90, P243, DOI 10.1093/cvr/cvr060.
   Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877.
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874.
   Caleshu C, 2011, AM J MED GENET A, V155A, P2229, DOI 10.1002/ajmg.a.34097.
   Cecarini V, 2012, BBA-MOL BASIS DIS, V1822, P1741, DOI 10.1016/j.bbadis.2012.07.015.
   Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827.
   Fang YP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-314.
   Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115.
   Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB.
   Gomes AV, 2006, ANTIOXID REDOX SIGN, V8, P1677, DOI 10.1089/ars.2006.8.1677.
   Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198.
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247.
   Hacihanefioglu A, 2008, INT J HEMATOL, V88, P219, DOI 10.1007/s12185-008-0139-7.
   Heineke J, 2010, J MOL CELL CARDIOL, V48, P1080, DOI 10.1016/j.yjmcc.2009.10.012.
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156.
   Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268.
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496.
   Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047.
   Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840.
   Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407.
   Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510.
   Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384.
   Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029.
   Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823.
   Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220.
   Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757.
   Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010.
   MARON BJ, 1975, AM J PATHOL, V79, P387.
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008.
   Metcalf D, 2010, BIOCHEM SOC T, V38, P1469, DOI 10.1042/BST0381469.
   Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958.
   Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com.
   Nowis D, 2010, AM J PATHOL, V176, P2658, DOI 10.2353/ajpath.2010.090690.
   Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x.
   Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339.
   Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571.
   Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006.
   Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557.
   Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961.
   Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032.
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3.
   Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe.
   Schlossarek S, 2011, J MOL CELL CARDIOL, V50, P613, DOI 10.1016/j.yjmcc.2011.01.014.
   Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200.
   Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049.
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4.
   Sugimoto S, 2007, AUTOPHAGY, V3, P638, DOI 10.4161/auto.4931.
   Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947.
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014.
   Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717.
   Voortman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-129.
   Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2.
   Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010.
   Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015.
   Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801.
   Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321.
   Zaglia T, 2013, CARDIOVASC RES, V97, P240, DOI 10.1093/cvr/cvs320.
   Zheng Qingwen, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P127.},
Number-of-Cited-References = {59},
Times-Cited = {96},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {26},
Journal-ISO = {J. Clin. Invest.},
Doc-Delivery-Number = {AI4XC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000336868800018},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000742170700001,
Author = {Gunta, Satya Preetham and Ul-Ejaz, Ain and Murphy, Abigail May and Gunn,
   Kaylea May and Bhatnagar, Ambika and Angraal, Vanika and Lopez-Candales,
   Angel and Angraal, Suveen},
Title = {Association of number of primary care physicians with preventable
   hospitalizations and premature deaths},
Journal = {POSTGRADUATE MEDICINE},
Abstract = {Background Primary care physicians (PCPs) may be the first providers for
   patients in a healthcare interaction, putting them in a unique position
   that may determine the health trajectory of a patient. Assessing whether
   PCPs improve the overall health of a community through reducing
   preventable hospital stays and premature deaths may provide necessary
   information towards improving the health outcomes at grassroots. Methods
   County-level data on the number of primary care physicians, preventable
   hospital stays and `years of potential life lost' (YPLL) were obtained
   from the Physician Master File data of the American Medical Association,
   Centers for Medicare \& Medicaid Services Office of Minority Health's
   Mapping Medicare Disparities data, and Center for Disease Control and
   Prevention's WONDER database, respectively. We employed linear
   regression model to assess the association of PCP rate with preventable
   hospital stays and YPLL. Results Preventable hospitalization rate in the
   United States was 6303.4 (95\% CI, 6212.5-6394.3) hospitalizations per
   100,00 population, while the average YPLL across the counties in the
   United States was 7792.9 (95\% CI, 7697.6-7888.3) years per 100,000
   population. For an increase of 1 PCP in a county, around 16
   hospitalizations were prevented per 100,000 population (P = 0.001) each
   year. Furthermore, around 14 years of life were saved per 100,000
   population for every additional PCP in a county across the United States
   (P < 0.001). Conclusion Higher number of PCPs in a county was associated
   with lower hospitalizations for preventable causes and lower premature
   deaths. Increasing PCPs may be an important metric to improve overall
   health in a community.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Angraal, S (Corresponding Author), Univ Missouri, Dept Internal Med, Kansas City, MO 64110 USA.
   Gunta, Satya Preetham; Ul-Ejaz, Ain; Murphy, Abigail May; Gunn, Kaylea May; Angraal, Suveen, Univ Missouri, Dept Internal Med, Kansas City, MO 64110 USA.
   Bhatnagar, Ambika, Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.
   Angraal, Vanika, Adesh Inst Med Sci \& Res, Bathinda, India.
   Lopez-Candales, Angel, Univ Missouri, Dept Cardiovasc Dis, Kansas City, MO 64110 USA.},
DOI = {10.1080/00325481.2021.2021038},
EarlyAccessDate = {JAN 2022},
ISSN = {0032-5481},
EISSN = {1941-9260},
Keywords = {Premature mortality; years of potential life lost; preventable
   hospitalization; primary care practitioner},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {suveen.angraal@umkc.edu},
ORCID-Numbers = {Gunta, Satya Preetham/0000-0003-2383-4342},
Cited-References = {{[}Anonymous], AMA PHYS MAST.
   Basu S, 2019, JAMA INTERN MED, V179, P506, DOI 10.1001/jamainternmed.2018.7624.
   Kronman AC, 2008, J GEN INTERN MED, V23, P1330, DOI 10.1007/s11606-008-0638-5.
   Levine DM, 2019, JAMA INTERN MED, V179, P363, DOI 10.1001/jamainternmed.2018.6716.
   Machado SR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33994.
   Mercier G, 2015, HEALTH AFFAIR, V34, P836, DOI 10.1377/hlthaff.2014.1065.
   Rizza P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-134.
   Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356.},
Number-of-Cited-References = {8},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Postgrad. Med.},
Doc-Delivery-Number = {YG0EE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000742170700001},
DA = {2022-03-29},
}

@article{ WOS:000572685500005,
Author = {Yoon, Young-Hee and Chen, Chiung M. and Slater, Megan E. and Jung, M.
   Katherine and White, Aaron M.},
Title = {Trends in Premature Deaths From Alcoholic Liver Disease in the US,
   1999-2018},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {2020},
Volume = {59},
Number = {4},
Pages = {E176-480},
Month = {OCT},
Abstract = {Introduction: So-called deaths of despair-those involving drug
   overdoses, alcohol-related liver disease, and suicide-have been rising
   in the U.S. among middle-aged white, non-Hispanic adults without a
   college degree. Premature deaths (ages 25-69) from alcoholic liver
   disease were examined specifically in this study from 1999 to 2018, by
   sex, race/Hispanic origin, and age group.
   Methods: Data were drawn from the 1999-2018 Multiple Cause of Death
   database and bridgedrace estimates of the U.S. resident population,
   including 281,243 alcoholic liver disease deaths or an average of 8
   deaths per 100,000 population. Analyses examined alcoholic liver disease
   death rates for sex differences among 3 age groups (25-49, 50-59, and
   60-69 years), by race and Hispanic origin, from 1999 to 2018;
   age-adjusted and age-specific annual percentage changes (accounted for
   cohorts); years of potential life lost; and age of death for
   sociodemographic backgrounds, alcoholic liver disease clinical courses,
   and comortalities.
   Results: White non-Hispanics increasingly experienced greater alcoholic
   liver disease mortality than black non-Hispanics and Hispanics,
   confirming the racial and ethnic crossover observed in previous studies.
   Although men consistently had higher rates of mortality, male-to-female
   ratios decreased in the past 2 decades and were the lowest among ages
   25-49 years and especially among ages 25-34 years. Although women
   generally had longer life expectancies, women died of alcoholic liver
   disease on average about 2-3 years earlier than men.
   Conclusions: Prevention and intervention efforts are imperative to
   address the narrowing sex gap and widening racial disparities in
   alcoholic liver disease premature deaths. (C) 2020 American Journal of
   Preventive Medicine. Published by Elsevier Inc. All rights reserved.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Chen, CM (Corresponding Author), CSR Inc, 901 N Stuart St,Suite 904-A, Arlington, VA 22203 USA.
   Yoon, Young-Hee; Chen, Chiung M.; Slater, Megan E., CSR Inc, 901 N Stuart St,Suite 904-A, Arlington, VA 22203 USA.
   Jung, M. Katherine; White, Aaron M., NIAAA, NIH, Bethesda, MD USA.},
DOI = {10.1016/j.amepre.2020.04.024},
ISSN = {0749-3797},
EISSN = {1873-2607},
Keywords-Plus = {EXTREME BINGE DRINKING; UNITED-STATES; CIRRHOSIS MORTALITY;
   GENDER-DIFFERENCES; LIFE EXPECTANCY; CONSUMPTION; RISK; PREVALENCE;
   AMERICANS; PATTERNS},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {cchen@csrincorporated.com},
Funding-Acknowledgement = {National Institute on Alcohol Abuse and Alcoholism, NIHUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}HHSN275201800004C]},
Funding-Text = {This article is based on a study conducted for the Alcohol Epidemiologic
   Data System project funded by the National Institute on Alcohol Abuse
   and Alcoholism, NIH, through Contract No. HHSN275201800004C to CSR, Inc.
   The views and opinions expressed in this article are those of the
   authors and should not be construed to represent the views of the
   sponsoring agency or the federal government.},
Cited-References = {{[}Anonymous], CPS HIST TIM SER TAB.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Balandin S, 2014, PROC CONF OPEN INNOV, P9, DOI 10.1109/FRUCT.2014.7000925.
   Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513.
   Becker U, 2002, HEPATOLOGY, V35, P868, DOI 10.1053/jhep.2002.32101.
   Bellis MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2766-x.
   Berkman LF, 2004, AM J EPIDEMIOL, V159, P167, DOI 10.1093/aje/kwh020.
   BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674.
   Best AF, 2018, LANCET PUBLIC HEALTH, V3, pE374, DOI 10.1016/S2468-2667(18)30114-2.
   Breslow RA, 2017, ALCOHOL CLIN EXP RES, V41, P976, DOI 10.1111/acer.13365.
   Brown L, 2018, ETHNIC DIS, V28, P123, DOI 10.18865/ed.28.2.123.
   CAETANO R, 1984, ALCOHOL ALCOHOLISM, V19, P31.
   CAETANO R, 1988, AM J DRUG ALCOHOL AB, V14, P293, DOI 10.3109/00952998809001552.
   Caetano R, 1996, SUBST USE MISUSE, V31, P1547, DOI 10.3109/10826089609063991.
   CANINO G, 1994, INT J ADDICT, V29, P1083, DOI 10.3109/10826089409047930.
   Case A, 2017, BROOKINGS PAP ECO AC, P397.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   {[}Centers for Disease Control and Prevention Centers for Disease Control and Prevention], MULT CAUS DEATH DAT.
   Chartier KG, 2013, ALCOHOL RES-CURR REV, V35, P229.
   Chen CM, 2014, 106 NAT I ALC AB ALC.
   Cholankeril G, 2019, TRANSPLANTATION, V103, P131, DOI 10.1097/TP.0000000000002471.
   CORRAO G, 1993, J CLIN EPIDEMIOL, V46, P601, DOI 10.1016/0895-4356(93)90032-V.
   Day CP, 2006, LIVER INT, V26, P1021, DOI 10.1111/j.1478-3231.2006.01323.x.
   Ding Wen-Xing, 2019, Liver Res, V3, P129, DOI 10.1016/j.livres.2019.11.006.
   DIPADOVA C, 1987, GASTROENTEROLOGY, V92, P1169, DOI 10.1016/S0016-5085(87)91073-0.
   Dwyer-Lindgren L, 2015, AM J PUBLIC HEALTH, V105, P1120, DOI 10.2105/AJPH.2014.302313.
   FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205.
   Fryar CD, 2019, PREVALENCE OVERWEIGH.
   Gaydosh L, 2019, AM J PUBLIC HEALTH, V109, P774, DOI 10.2105/AJPH.2019.305002.
   GILBERT MJ, 1986, HISPANIC J BEHAV SCI, V8, P1, DOI 10.1177/07399863860081001.
   Glei DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214947.
   GORDON T, 1984, AM J EPIDEMIOL, V120, P97, DOI 10.1093/oxfordjournals.aje.a113879.
   Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161.
   Grucza RA, 2018, ALCOHOL CLIN EXP RES, V42, P1939, DOI 10.1111/acer.13859.
   Han BH, 2019, J AM GERIATR SOC, V67, P2139, DOI 10.1111/jgs.16071.
   HANZLICK R, 1988, AM J FOREN MED PATH, V9, P149, DOI 10.1097/00000433-198806000-00011.
   HERD D, 1985, BRIT J ADDICT, V80, P397.
   Hingson R, 2014, J PEDIATR-US, V164, P675, DOI 10.1016/j.jpeds.2013.12.023.
   Hingson RW, 2013, JAMA PEDIATR, V167, P996, DOI 10.1001/jamapediatrics.2013.3083.
   Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669, DOI 10.1152/ajpgi.1998.274.4.G669.
   Imtiaz S, 2018, DRUG ALCOHOL REV, V37, pS263, DOI 10.1111/dar.12616.
   Jang JB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4023.
   Jepsen P, 2016, LIVER INT, V36, P1696, DOI 10.1111/liv.13151.
   Kemmer N, 2008, DIGEST DIS SCI, V53, P1339, DOI 10.1007/s10620-007-9992-0.
   Kerr WC, 2007, ALCOHOL CLIN EXP RES, V31, P1714, DOI 10.1111/j.1530-0277.2007.00467.x.
   Kerr WC, 2017, AM J PREV MED, V52, P469, DOI 10.1016/j.amepre.2016.09.021.
   Kerr WC, 2014, ALCOHOL CLIN EXP RES, V38, P2496, DOI 10.1111/acer.12521.
   Kerr WC, 2013, ALCOHOL ALCOHOLISM, V48, P605, DOI 10.1093/alcalc/agt031.
   Kerr WC, 2013, ADDICTION, V108, P1038, DOI 10.1111/j.1360-0443.2012.04055.x.
   Keyes KM, 2008, DRUG ALCOHOL DEPEN, V93, P21, DOI 10.1016/j.drugalcdep.2007.08.017.
   Keyes KM, 2019, ALCOHOL CLIN EXP RES, V43, P1344, DOI 10.1111/acer.14082.
   KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005.
   Kirpich IA, 2017, ALCOHOL CLIN EXP RES, V41, P747, DOI 10.1111/acer.13346.
   Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184.
   Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1.
   Kochanek Kenneth D, 2016, NCHS Data Brief, P1.
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107.
   Li TK, 2000, ALCOHOL CLIN EXP RES, V24, P415, DOI 10.1097/00000374-200004000-00009.
   Mandayam S, 2004, SEMIN LIVER DIS, V24, P217, DOI 10.1055/s-2004-832936.
   McCaul ME, 2019, ALCOHOL CLIN EXP RES, V43, P774, DOI 10.1111/acer.13985.
   Moon AM, 2020, AM J GASTROENTEROL, V115, P79, DOI 10.14309/ajg.0000000000000442.
   Mulia N, 2014, ALCOHOL CLIN EXP RES, V38, P1026, DOI 10.1111/acer.12301.
   Mumenthaler MS, 1999, ALCOHOL RES HEALTH, V23, P55.
   Murphy Sherry L, 2017, Natl Vital Stat Rep, V66, P1.
   NASHOLD RD, 1981, AM J PUBLIC HEALTH, V71, P1237, DOI 10.2105/AJPH.71.11.1237.
   National Center for Health Statistics, 2016, INSTR CLASS UND CAUS.
   National Center for Health Statistics, MED EX COR HDB DEATH.
   National Research Council (US) Institute of Medicine (US), 2013, US HLTH INT PERSP SH.
   Nelson David E., 1993, Morbidity and Mortality Weekly Report, V42, P29.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Office of Applied Studies, 1998, PREV SUBST US RAC ET.
   Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1.
   Patrick ME, 2019, SUBST ABUS-RES TREAT, V13, DOI 10.1177/1178221818822976.
   Patrick ME, 2018, ALCOHOL RES-CURR REV, V39, P49.
   Patrick ME, 2017, ALCOHOL CLIN EXP RES, V41, P1319, DOI 10.1111/acer.13413.
   Patrick ME, 2013, JAMA PEDIATR, V167, P1019, DOI 10.1001/jamapediatrics.2013.2392.
   PETERSSON B, 1982, LANCET, V2, P1088.
   POLLOCK DA, 1987, JAMA-J AM MED ASSOC, V258, P345, DOI 10.1001/jama.258.3.345.
   Probst C, 2018, CAN MED ASSOC J, V190, pE1294, DOI 10.1503/cmaj.180806.
   Probst C, 2014, INT J EPIDEMIOL, V43, P1314, DOI 10.1093/ije/dyu043.
   Raubenheimer PJ, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0487-5.
   Rehm J, 2018, EUR ADDICT RES, V24, P53, DOI 10.1159/000488328.
   Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007.
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x.
   Rehm J, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002477.
   Reuben A, 2008, CURR OPIN GASTROEN, V24, P328, DOI 10.1097/MOG.0b013e3282fbceca.
   ROMELSJO A, 1993, AM J PUBLIC HEALTH, V83, P838, DOI 10.2105/AJPH.83.6.838.
   ROSENBERG D, 1999, VITAL HLTH STAT, P1.
   Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300.
   Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x.
   SAUNDERS JB, 1981, BMJ-BRIT MED J, V282, P1140, DOI 10.1136/bmj.282.6270.1140.
   Schenker S, 1997, ALCOHOL CLIN EXP RES, V21, P179, DOI 10.1111/j.1530-0277.1997.tb03746.x.
   Shanahan L, 2019, AM J PUBLIC HEALTH, V109, P854, DOI 10.2105/AJPH.2019.305016.
   Shiels MS, 2017, LANCET, V389, P1043, DOI {[}10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3].
   Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469.
   Singal Ashwani K, 2013, Clin Liver Dis (Hoboken), V2, P53, DOI 10.1002/cld.168.
   Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549.
   Slade T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011827.
   Stein EM, 2017, AM J PUBLIC HEALTH, V107, P1541, DOI {[}10.2105/AJPH.2017.303941, 10.2105/ajph.2017.303941].
   Streba LAM, 2014, WORLD J GASTROENTERO, V20, P8040, DOI 10.3748/wjg.v20.i25.8040.
   Szabo G, 2018, NAT REV GASTRO HEPAT, V15, P253, DOI 10.1038/nrgastro.2018.8.
   Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042.
   Tapper EB, 2018, BMJ-BRIT MED J, V362, DOI {[}10.1136/bmj.k2817, 10.1136/bm1k2817].
   Taylor JL, 1996, AVIAT SPACE ENVIR MD, V67, P407.
   Thomasson H R, 1995, Recent Dev Alcohol, V12, P163.
   Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401.
   United Health Foundation, 2017, UN HLTH FDN ANN REP.
   Vaeth PAC, 2012, ADDICT BEHAV, V37, P1029, DOI 10.1016/j.addbeh.2012.04.015.
   White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815.
   White AM, 2020, ALCOHOL CLIN EXP RES, V44, P178, DOI 10.1111/acer.14239.
   White AM, 2018, ALCOHOL CLIN EXP RES, V42, P352, DOI 10.1111/acer.13559.
   White TJ, 2017, THEORIES OF INTERNATIONAL RELATIONS AND NORTHERN IRELAND, P201.
   Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209.
   Wood S. N., 2017, GEN ADDITIVE MODELS, V2nd.
   Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932.
   World Health Organization, 1992, ICD 10 CLASS MENT BE.
   Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1.
   Yoon Y- H, 114 NAT I ALC AB ALC.
   Yoon Y-H, 2005, 133 ANN M AM PUBL HL.
   Yoon YH, 2011, ALCOHOL CLIN EXP RES, V35, P240, DOI 10.1111/j.1530-0277.2010.01340.x.
   Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010.},
Number-of-Cited-References = {121},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Am. J. Prev. Med.},
Doc-Delivery-Number = {NT1BO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000572685500005},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000488203700004,
Author = {Wang, Xueying},
Title = {John Chrysostom on the Premature Death of Children and Parental Grief},
Journal = {JOURNAL OF EARLY CHRISTIAN STUDIES},
Year = {2019},
Volume = {27},
Number = {3},
Pages = {443-463},
Month = {FAL},
Abstract = {Premature death of children was a tragic, yet all too common phenomenon
   in antiquity. Modern scholars noticed a shift of focus in literature
   that addresses the loss of children: whereas authors in the
   pre-Christian era focused on the sorrow of bereaved parents, Christian
   writers paid more attention to the moral and eschatological status of
   deceased children. This article examines John Chrysostom's understanding
   of the premature death of children and the counsel he offers to bereaved
   parents. In comparison with Augustine and Gregory of Nyssa, who
   exclusively commented on deceased children, Chrysostom retains a focus
   on helping bereaved parents cope with their sorrow. His homilies provide
   us with a profound glimpse of the feelings and thoughts of parents
   dealing with their loss and the kind of counseling they were likely to
   receive from the church. This article will also suggest that
   Chrysostom's optimistic assessment of the destiny of deceased
   children-their guaranteed entry into heaven due to moral
   innocence-contributes significantly to his counseling of bereaved
   parents.},
Publisher = {JOHNS HOPKINS UNIV PRESS},
Address = {JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD
   21218-4363 USA},
Type = {Article},
Language = {English},
Affiliation = {Wang, XY (Corresponding Author), Loyola Univ Chicago, Theol, Chicago, IL 60660 USA.
   Wang, Xueying, Loyola Univ Chicago, Theol, Chicago, IL 60660 USA.},
DOI = {10.1353/earl.2019.0039},
ISSN = {1067-6341},
EISSN = {1086-3184},
Research-Areas = {History; Religion},
Web-of-Science-Categories  = {History; Religion},
Cited-References = {{[}Anonymous], 1983, HOMER LIFE DEATH, P108.
   {[}Anonymous], 1990, SOURCES CHRETIENNES, V358, P232.
   {[}Anonymous], 2009, AM J PHILOS, P130.
   Augustine, 1913, CORPUS SCRIPTORUM EC, V60, P33.
   Baltussen Han, 2013, GREEK ROMAN CONSOLAT, P20.
   Bradley Keith, 1991, DISCOVERING ROMAN FA, P117.
   Broadus John, 1995, NPNF, V13, P299.
   Brown Peter, 2012, EYE NEEDLE WEALTH FA, P69.
   Brown Peter, 1988, BODY SOC MEN WOMEN S, P120.
   Clapsis Emmanuel, 2011, GREEK ORTHODOX THEOL, V56, P55.
   DOERFLER ME, 2011, MUSEON, V124, P243, DOI DOI 10.2143/MUS.124.3.2141853.
   Frier B, 1982, Harv Stud Classic Philol, V86, P213, DOI 10.2307/311195.
   FRIER B, 1983, PHOENIX-J CLASS ASSN, V37, P328, DOI 10.2307/1088154.
   Garnsey Peter, 1996, ROMAN EMPIRE EC SOC, P112.
   Gebhardt E., 1967, GNO, V9, P461.
   Grubbs J. Evans, 2013, OXFORD HDB CHILDHOOD, P47.
   Horn Cornelia, 2009, LET LITTLE CHILDREN, P301.
   Hunter David, 1988, COMP KING MONK OPPON, P99.
   Kenny A., 1973, ANATOMY SOUL HIST ES, P1.
   Konstan David, 2013, GREEK ROMAN CONSOLAT, P145.
   Kostan David, 2006, EMOTIONS ANCIENT GRE, P250.
   Laes Christian, 2004, VIRTUTIS IMAGO IDEAL, P50.
   Laird Raymond, 2012, MINDSET MORAL CHOICE, P221.
   Langerbeck Hermanus, 1952, GNO, V6, P302.
   LEYERLE B, 1994, HARVARD THEOL REV, V87, P29, DOI 10.1017/S001781600003162X.
   Leyerle B, 2015, J LATE ANTIQUITY, V8, P368, DOI 10.1353/jla.2015.0031.
   Leyerle Blake, 1997, JECS, V5, P246.
   Malingrey A. M., 1980, SC, V272, P68.
   McDonough Jocobus A., 1987, DE INFANTIBUS PRAE 2, P67.
   Moss Candida R., 2010, WOMEN GENDER ANCIENT, P183.
   Musurillo H., 1964, GREGORII NYSSENI OPE, V7, P2.
   Neville Graham, 1984, SJ CHRYSOSTOM 6 BOOK, P39.
   O'Roark D, 1999, GREEK ROMAN BYZANTIN, V40, P53.
   Papageorgiou Panayiotis, 1995, STVLADIMIRS THEOLOGI, V39, P361.
   Parkin Tim, 2003, OLD AGE ROMAN WORLD, P206.
   Samellas A, 2015, Z ANTIKES CHRIST-J A, V19, P260, DOI 10.1515/zac-2015-0022.
   Schaff P., 1994, NPNF, V10, P209.
   Schenkl Karl, 1896, CSEL, V32, P304.
   Tuilier Andre, 2004, GREGOIRE NAZIANZE OE, V1, P18.
   Van Eijk Ton, 2006, MELANGES PATRISTIQUE, P227.
   Vuolanto Ville, 2015, CHILDREN ASCETICISM, P88.
   Wood Diana, 1994, CHURCH CHILDHOOD, P39.
   Zycha Joseph, 1900, CSEL, V41, P199.},
Number-of-Cited-References = {43},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Early Christ. Stud.},
Doc-Delivery-Number = {JA9XH},
Web-of-Science-Index = {Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:000488203700004},
DA = {2022-03-29},
}

@article{ WOS:000261128800052,
Author = {Sanchez Lazaro, I. J. and Almenar Bonet, L. and Martinez-Dolz, L. and
   Moro Lopez, J. and Rueda Soriano, J. and Arnau Vives, M. A. and Buendia
   Fuentes, F. and Ortiz Martinez, V. and Cano Perez, O. and Sanchez
   Soriano, R. and Salvador Sanz, A.},
Title = {Effect of Circulatory Assistance on Premature Death and Long-term
   Prognosis},
Journal = {TRANSPLANTATION PROCEEDINGS},
Year = {2008},
Volume = {40},
Number = {9},
Pages = {3025-3026},
Month = {NOV},
Note = {5th Congress of the
   Andalusian-Society-of-Organ-and-Tissue-Transplantation, Malaga, SPAIN,
   MAR 05-07, 2008},
Organization = {Andalusian Soc Organ \& Tissue Transplantat; ASTELLAS; NOVARTIS; ROCHE},
Abstract = {Background. Patients undergoing urgent heart transplantation (HT) have a
   poorer prognosis and more long-term complications. The objective of this
   study was to compare the preoperative course in patients undergoing
   urgent HT according to the need for preoperative intra-aortic balloon
   counterpulsation (IABP).
   Materials and Methods. We studied 102 consecutive patients including 23
   patients with IABP who underwent urgent HT between January 2000 and
   September 2006. We excluded patients who received combination
   transplants, those who underwent repeat HT, and pediatric patients who
   underwent HT. The statistical methods used were the t test for
   quantitative variables and the chi(2) test for qualitative variables. A
   logistic regression model was constructed to assess the possible
   relationship between IABP and other variables on premature death within
   30 days after HT.
   Results. Mean (SD) patient-age was 50 (10) years. No significant
   differences were observed in baseline characteristics between the IABP
   and the non-IAPB groups. The IABP patient group had higher rates of
   acute graft failure (45.5\% vs 35.4\%; P = .46) and premature death
   (18.8\% vs 14.8\%; P = .67) and shorter long-term survival (40.6
   {[}34.9] vs 54.5 {[}43.7] mo; P = .30). Multivariate analysis
   demonstrated no association between the need for IABP and increased
   frequency of premature death.
   Conclusions. Use of IABP is not associated with premature or late death.
   We recommend use of IABP in patients with acute decompensated heart
   failure to stabilize them before HT.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Lazaro, IJS (Corresponding Author), Hosp Univ La Fe, Dept Cardiol, Heart Failure \& Transplantat Unit, Avda,Campanar 21, Valencia 46009, Spain.
   Moro Lopez, J., La Fe Univ Hosp, Fdn Investigat, Valencia, Spain.
   Sanchez Lazaro, I. J.; Almenar Bonet, L.; Martinez-Dolz, L.; Rueda Soriano, J.; Arnau Vives, M. A.; Buendia Fuentes, F.; Ortiz Martinez, V.; Cano Perez, O.; Sanchez Soriano, R.; Salvador Sanz, A., Hosp Univ La Fe, Dept Cardiol, Heart Failure \& Transplantat Unit, Valencia 46009, Spain.},
DOI = {10.1016/j.transproceed.2008.08.114},
ISSN = {0041-1345},
EISSN = {1873-2623},
Research-Areas = {Immunology; Surgery; Transplantation},
Web-of-Science-Categories  = {Immunology; Surgery; Transplantation},
Author-Email = {igsanla@comv.es},
ResearcherID-Numbers = {Dolz, Luis Martinez/X-4627-2018
   },
ORCID-Numbers = {Dolz, Luis Martinez/0000-0001-5145-8191
   Sanchez-Lazaro, Ignacio J./0000-0003-2851-4153
   Cano, Oscar/0000-0001-6783-0138},
Cited-References = {Boehmer JP, 2006, CRIT CARE MED, V34, pS268, DOI 10.1097/01.CCM.0000232490.69771.28.
   Idelchik GM, 2008, J HEART LUNG TRANSPL, V27, P106, DOI 10.1016/j.healun.2007.10.013.},
Number-of-Cited-References = {2},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Transplant. Proc.},
Doc-Delivery-Number = {375QQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000261128800052},
DA = {2022-03-29},
}

@article{ WOS:000256215100001,
Author = {Aragon, Tomas J. and Lichtensztajn, Daphne Y. and Katcher, Brian S. and
   Reiter, Randy and Katz, Mitchell H.},
Title = {Calculating expected years of life lost for assessing local ethnic
   disparities in causes of premature death},
Journal = {BMC PUBLIC HEALTH},
Year = {2008},
Volume = {8},
Month = {APR 10},
Abstract = {Background: A core function of local health departments is to conduct
   health assessments. The analysis of death certificates provides
   information on diseases, conditions, and injuries that are likely to
   cause death -an important outcome indicator of population health. The
   expected years of life lost (YLL) measure is a valid, stand-alone
   measure for identifying and ranking the underlying causes of premature
   death. The purpose of this study was to rank the leading causes of
   premature death among San Francisco residents, and to share detailed
   methods so that these analyses can be used in other local health
   jurisdictions.
   Methods: Using death registry data and population estimates for San
   Francisco deaths in 2003 2004, we calculated the number of deaths, YLL,
   and age-standardized YLL rates (ASYRs). The results were stratified by
   sex, ethnicity, and underlying cause of death. The YLL values were used
   to rank the leading causes of premature death for men and women, and by
   ethnicity.
   Results: In the years 2003 -2004, 6312 men died (73,627 years of life
   lost), and 5726 women died (51,194 years of life lost). The ASYR for men
   was 65\% higher compared to the ASYR for women (8971.1 vs. 5438.6 per
   100,000 persons per year). The leading causes of premature deaths are
   those with the largest average YLLs and are largely preventable. Among
   men, these were HIV/AIDS, suicide, drug overdose, homicide, and alcohol
   use disorder; and among women, these were lung cancer, breast cancer,
   hypertensive heart disease, colon cancer, and diabetes mellitus. A large
   health disparity exists between African Americans and other ethnic
   groups: African American age-adjusted overall and cause-specific YLL
   rates were higher, especially for homicide among men. Except for
   homicide among Latino men, Latinos and Asians have comparable or lower
   YLL rates among the leading causes of death compared to whites.
   Conclusion: Local death registry data can be used to measure, rank, and
   monitor the leading causes of premature death, and to measure and
   monitor ethnic health disparities.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Aragon, TJ (Corresponding Author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.
   Aragon, Tomas J., Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.
   Aragon, Tomas J.; Lichtensztajn, Daphne Y.; Katcher, Brian S.; Reiter, Randy; Katz, Mitchell H., San Francisco Dept Publ Hlth, San Francisco, CA USA.
   Aragon, Tomas J.; Katz, Mitchell H., Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA 94143 USA.},
DOI = {10.1186/1471-2458-8-116},
Article-Number = {116},
EISSN = {1471-2458},
Keywords-Plus = {8 AMERICA; MORTALITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {aragon@berkeley.edu
   daphne@stanfordalumni.org
   brian.katcher@sfdph.org
   randy.reiter@sfdph.org
   mitch.katz@sfdph.org},
ORCID-Numbers = {Lichtensztajn, Daphne/0000-0003-2906-3868
   Aragon, Tomas/0000-0002-2058-0423},
Cited-References = {Anderson R N, 1998, Natl Vital Stat Rep, V47, P1.
   {[}Anonymous], 2001, MMWR Recomm Rep, V50, P1.
   ARAGON TJ, 1998, SAN FRANCISCO BURDEN.
   {*}CDCP, 1993, MMWR-MORBID MORTAL W, V42, P251.
   {*}CDCP CTR HLTH STA, 2002, ICD FRAM EXT CAUS IN.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224.
   Institute of Medicine. Committee for the Study of the Future of Public Health, 1988, FUT PUBL HLTH.
   Institute of Medicine (US) Committee on Assuring the Health of the Public in the 21st Century, 2003, FUT PUBL HLTH 21 CEN.
   KATZENELLENBOGE.J, 2003, SSPS W AUSTR BURDEN.
   Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463.
   Michalski C, 2006, EJC SUPPL, V4, P11, DOI 10.1016/j.ejcsup.2006.04.022.
   Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260.
   Murray CJL, 2005, AM J PREV MED, V29, P4, DOI 10.1016/j.amepre.2005.07.031.
   Murray CJL, 1996, COMPREHENSIVE ASSESS.
   R Development Team, R LANG ENV STAT COMP.
   Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6.
   {*}STAT CA DEP FIN, 2004, SAN FRANC RAC ETHN P.
   VANDOMMELEN L, 2007, LINEAR INTERPOLATION.
   {*}WHO, 2007, INT CLASS DIS ICD.
   Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979.},
Number-of-Cited-References = {25},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {305ZA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000256215100001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000455718600008,
Author = {Kim, Young-Eun and Lee, Ye-Rin and Yoon, Seok-Jun and Kim, Young-Ae and
   Oh, In-Hwan},
Title = {Years of Life Lost due to Premature Death in People with Disabilities in
   Korea: the Korean National Burden of Disease Study Framework},
Journal = {JOURNAL OF KOREAN MEDICAL SCIENCE},
Year = {2019},
Volume = {34},
Number = {2},
Month = {JAN 14},
Abstract = {Background: Several studies have been conducted regarding people with
   disabilities, however no studies have estimated the disease burden due
   to premature death. As such, we aimed to compare the years of life lost
   (YLLs) due to premature death between a population with disabilities and
   the total population of Korea.
   Methods: To calculate the YLLs in people with disabilities, we combined
   disability registration data from the 2002-2011 Ministry of Health and
   Welfare of Korea and the causes of mortality data by Statistics Korea
   for 3,158,231 people.
   Results: YLLs of people with disabilities were 517,337, which accounted
   for 23.4\% of YLLs of the total population. YLLs per 100,000 people with
   disabilities were approximately 3.8 times higher than those in the total
   Korean population. Ischemic stroke was associated with the highest YLLs
   per 100,000 people, followed by ischemic heart disease, hemorrhagic, and
   other non-ischemic stroke, diabetes mellitus, and self-harm. Among
   individuals with physical disabilities, ischemic heart disease was
   associated with the highest YLLs. For intellectual disability, epilepsy
   contributed to the most YLLs. For individuals with mental disability,
   self-harm was the largest contributor to YLLs.
   Conclusion: The burden of disease was higher in the population with
   disabilities than that in the general population. Cardiovascular
   diseases and cancer had a higher burden of disease than did other
   diseases in the population with disabilities; thus, overall,
   non-communicable diseases have a higher burden of disease than
   communicable diseases or injuries in the population with disabilities
   than in the general population.},
Publisher = {KOREAN ACAD MEDICAL SCIENCES},
Address = {302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA},
Type = {Article},
Language = {English},
Affiliation = {Oh, IH (Corresponding Author), Kyung Hee Univ, Dept Prevent Med, Sch Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   Kim, Young-Eun; Yoon, Seok-Jun, Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
   Lee, Ye-Rin; Oh, In-Hwan, Kyung Hee Univ, Dept Prevent Med, Sch Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.
   Kim, Young-Ae, Natl Canc Ctr, Natl Canc Control Inst, Canc Policy Branch, Goyang, South Korea.},
DOI = {10.3346/jkms.2019.34.e22},
Article-Number = {e22},
ISSN = {1011-8934},
EISSN = {1598-6357},
Keywords = {Mortality; Disability-Adjusted Life Years; Burden of Disease; Years of
   Life Lost; People with Disabilities},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; INTELLECTUAL DISABILITY; MENTAL-DISORDERS;
   SUICIDE; ADULTS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {parenchyme@gmail.com},
ResearcherID-Numbers = {Oh, In Hwan/AAI-9070-2020
   },
ORCID-Numbers = {Oh, In Hwan/0000-0002-5450-9887
   Lee, Rugyeom/0000-0002-4507-4877
   Yoon, Seok-Jun/0000-0003-3297-0071
   Kim, Young Ae/0000-0002-3819-0028
   Kim, Young-Eun/0000-0003-0694-6844},
Funding-Acknowledgement = {Korea National Rehabilitation Center Research Institute, Ministry of
   Health \& Welfare, Republic of Korea {[}2016008]},
Funding-Text = {This research was supported by the R\&D grant (No. 2016008) on
   rehabilitation by Korea National Rehabilitation Center Research
   Institute, Ministry of Health \& Welfare, Republic of Korea.},
Cited-References = {DEWILDE EJ, 1993, J AM ACAD CHILD PSY, V32, P51, DOI 10.1097/00004583-199301000-00008.
   Forsgren L, 1996, EPILEPSIA, V37, P956, DOI 10.1111/j.1528-1157.1996.tb00533.x.
   Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205.
   Hosking FJ, 2016, AM J PUBLIC HEALTH, V106, P1483, DOI 10.2105/AJPH.2016.303240.
   Kim SH, 2014, 2014 DISABILITY SURV.
   Kim W, 2017, J KOREAN MED SCI, V32, P835, DOI 10.3346/jkms.2017.32.5.835.
   Kinne S, 2008, DISABIL HEALTH J, V1, P42, DOI 10.1016/j.dhjo.2007.11.006.
   Lauer E, 2015, J APPL RES INTELLECT, V28, P394, DOI 10.1111/jar.12191.
   Lee YR, 2016, J KOREAN MED SCI, V31, pS121, DOI 10.3346/jkms.2016.31.S2.S121.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   McCarron M, 2015, J APPL RES INTELLECT, V28, P406, DOI 10.1111/jar.12194.
   Ministry of Health and Welfare, 2016, HLTH WELF WHIT PAP.
   MiYoung Kim, 2015, {[}Journal of Korean Academy of Psychiatric and Mental Health Nursing, 정신간호학회지], V24, P217.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Oquendo M A, 1997, Depress Anxiety, V5, P202, DOI 10.1002/(SICI)1520-6394(1997)5:4<202::AID-DA6>3.0.CO;2-E.
   Park S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5387-8.
   Patja K, 2001, J INTELL DISABIL RES, V45, P30, DOI 10.1046/j.1365-2788.2001.00290.x.
   Qin P, 2000, BRIT J PSYCHIAT, V177, P546, DOI 10.1192/bjp.177.6.546.
   Sadock B. J., 2003, KAPLAN SADOCKS SYNOP.
   Tyrer F, 2007, J INTELL DISABIL RES, V51, P520, DOI 10.1111/j.1365-2788.2006.00918.x.
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502.
   World Health Organization (WHO), WORLD REP DIS.
   Yoon J, 2016, J KOREAN MED SCI, V31, pS146, DOI 10.3346/jkms.2016.31.S2.S146.},
Number-of-Cited-References = {23},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {J. Korean Med. Sci.},
Doc-Delivery-Number = {HH4TN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000455718600008},
OA = {Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000594479000012,
Author = {Oduguwa, Emmanuella and Dongarwar, Deepa and Salihu, Hamisu M.},
Title = {Trends in Premature Deaths among Women Living with HIV/AIDS and Cervical
   Cancer},
Journal = {SOUTHERN MEDICAL JOURNAL},
Year = {2020},
Volume = {113},
Number = {12},
Pages = {651-658},
Month = {DEC},
Abstract = {Objectives: There is a lack of updated information on premature death
   and years of potential life lost (YPLL) among human immunodeficiency
   (HIV)-positive women with cervical cancer. We hypothesize that increased
   access to preventive resources such as antiretroviral therapy,
   preexposure prophylaxis, and human papillomavirus vaccines has reduced
   premature mortality and YPLL in these women in the previous decades.
   Methods: We used data from the National Inpatient Sample database from
   2003 to the third quarter of 2015, and restricted the analysis to
   HIV-positive women with or without cervical cancer. Joinpoint regression
   models were run to identify trends in the rates of HIV and cervical
   cancer. Overall and age-stratified YPLL were calculated for HIV-positive
   women with cervical cancer. Adjusted survey logistic regression models
   were built to determine the predictive factors of in-hospital mortality
   among women living with HIV.
   Results: Among hospitalized women, low-income, non-Hispanic Blacks, and
   patients aged 40 to 59 years experienced greater frequencies of
   HIV/cervical cancer comorbidity. The prevalence of HIV hospitalizations
   increased by an average annual percentage of 0.9\% (95\% confidence
   interval 0.3-1.6). YPLL decreased in HIV-positive women living with and
   without cervical cancer by 4.9\% and 4.3\%, respectively. The trajectory
   for YPLL was not uniform across age groups. YPLL decreased substantially
   in women aged 20 to 29 years with HIV/cervical cancer comorbidity.
   Cervical cancer remained a significant predictor of mortality among
   HIV-positive women when adjusted for age, race, and insurance coverage.
   Conclusions: Within a large, national sample from 2003 to 2015, we found
   an overall declining trend in YPLL in women living with HIV/cervical
   cancer comorbidity. In-hospital mortality among HIV-positive women was
   associated with cervical cancer, age, race, and insurance coverage. We
   recommend further investigation into the quality of HIV and cervical
   cancer treatment and prevention services for the sociodemographic groups
   described.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Salihu, HM (Corresponding Author), Baylor Coll Med, Dept Family \& Community Med, 3701 Kirby Dr, Houston, TX 77098 USA.
   Oduguwa, Emmanuella; Dongarwar, Deepa; Salihu, Hamisu M., Baylor Coll Med, Ctr Excellence Hlth Equ Training \& Res, Houston, TX 77030 USA.},
DOI = {10.14423/SMJ.0000000000001184},
ISSN = {0038-4348},
EISSN = {1541-8243},
Keywords = {cervical cancer; comorbidity; human immunodeficiency virus (HIV);
   temporal trends; years of potential life lost},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {ellaoduguwa@gmail.com
   Deepa.Dongarwar@bcm.edu
   salihu@bcm.edu},
ResearcherID-Numbers = {Dongarwar, Deepa/AAN-1159-2020
   },
ORCID-Numbers = {Dongarwar, Deepa/0000-0002-7338-0636
   Oduguwa, Emmanuella/0000-0002-6878-2075},
Funding-Acknowledgement = {US Department of Health and Human Services and Health Resources and
   Services Administration for the Baylor College of Medicine Center of
   Excellence in Health Equity, Training, and Research {[}D34HP31024]},
Funding-Text = {Research funding support was provided by the US Department of Health and
   Human Services and Health Resources and Services Administration for the
   Baylor College of Medicine Center of Excellence in Health Equity,
   Training, and Research (grant no. D34HP31024).},
Cited-References = {Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242.
   Andersen I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1387-0.
   Anis AH, 2002, CAN MED ASSOC J, V167, P633.
   Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6.
   Bahadori Mohammadkarim, 2013, Glob J Health Sci, V5, P179, DOI 10.5539/gjhs.v5n6p179.
   Belglaiaa E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020343.
   Benard VB, 2012, OBSTET GYNECOL, V120, P1117, DOI {[}10.1097/AOG.0b013e31826e4609, http://10.1097/AOG.0b013e31826e4609].
   Bhatti AB, 2016, CUREUS, V8, DOI 10.7759/cureus.515.
   Blondell SJ, 2015, AIDS BEHAV, V19, P2012, DOI 10.1007/s10461-015-1095-x.
   Boyd Andrew D, 2018, AMIA Jt Summits Transl Sci Proc, V2017, P35.
   Centers for Disease Control and Prevention, 2019, WHAT AR RISK FACT CE.
   Centers for Disease Control and Prevention, GEN HPV INF CDC FACT.
   Centers for Disease Control and Prevention, 1988, MMWR MORB MORTAL WKL, V37, P551.
   Centers of Disease Control and Prevention (CDC), 2019, HUMAN PAPILLOMAVIRUS.
   Coghill AE, 2015, J CLIN ONCOL, V33, P2376, DOI 10.1200/JCO.2014.59.5967.
   Corma S., 2019, J CLIN ONCOL, V37.
   Faizi Nafis, 2017, J Family Med Prim Care, V6, P169, DOI 10.4103/jfmpc.jfmpc\_13\_17.
   Feder J, 2001, HEALTH AFFAIR, V20, P27, DOI 10.1377/hlthaff.20.1.27.
   French AL., 2010, J ACQUIR IMMUNE DEFI, V51, P399.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gauri A, 2020, ETHNIC HEALTH, V25, P995, DOI 10.1080/13557858.2018.1471669.
   Ghebre RG, 2017, GYNECOL ONCOL REP, V21, P101, DOI 10.1016/j.gore.2017.07.009.
   Gross JJ., 2016, CURR EPIDEMIOL REP, V34, P352.
   Healthcare Cost and Utilization Project, NIS DESCR DAT EL DXN.
   Joint United Nations Programme on HIV/AIDS (UNAIDS), 2019, GO FURTH PARTN REACH.
   Keller MJ, 2012, JAMA-J AM MED ASSOC, V308, P362, DOI 10.1001/jama.2012.5664.
   Kim SC, 2018, RHEUMATOLOGY, V57, pV26, DOI 10.1093/rheumatology/kex523.
   Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894.
   Landy R, 2016, BRIT J CANCER, V115, P1140, DOI 10.1038/bjc.2016.290.
   Leece P, 2010, CAN FAM PHYSICIAN, V56, pE425.
   Liu G, 2018, AIDS, V32, P795, DOI {[}10.1097/QAD.0000000000001765, 10.1097/qad.0000000000001765].
   Lobao WM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206726.
   McGraw SL, 2014, WORLD J CLIN ONCOL, V5, P744, DOI 10.5306/wjco.v5.i4.744.
   Mogtomo Martin Luther Koanga, 2009, Infect Agent Cancer, V4, P9, DOI 10.1186/1750-9378-4-9.
   Monestime JP., 2019, PERSPECT HLTH INF MA, V1a, P16.
   Moore RD, 2011, CLIN INFECT DIS, V52, pS208, DOI 10.1093/cid/ciq044.
   Nkambule BB, 2015, J THROMB THROMBOLYS, V40, P458, DOI 10.1007/s11239-015-1212-8.
   Ogunmola OJ, 2014, HIV AIDS-RES PALLIAT, V6, P61, DOI 10.2147/HIV.S59061.
   Ononogbu U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-582.
   Rubinstein PG, 2014, AIDS, V28, P453, DOI 10.1097/QAD.0000000000000071.
   SCHWARTZ E, 1990, INT J EPIDEMIOL, V19, P591, DOI 10.1093/ije/19.3.591.
   Selik RM, 1997, AIDS, V11, P1635, DOI 10.1097/00002030-199713000-00013.
   Serraino D, 2002, AIDS, V16, P781, DOI 10.1097/00002030-200203290-00014.
   Shin JY, 2017, J NEURO-ONCOL, V132, P89, DOI 10.1007/s11060-016-2339-y.
   Siddiqi AEA, 2015, MMWR-MORBID MORTAL W, V64, P81.
   Social Security Administration, ACT LIF TABL.
   Song D, 2015, ONCOL LETT, V10, P600, DOI 10.3892/ol.2015.3295.
   Valdiserri Ronald O, 2013, Public Health Rep, V128, P354.
   Weinstein M, 2017, AIDS, V31, P2303, DOI 10.1097/QAD.0000000000001626.
   World Health Organization, 2013, HIV AD GUID HIV TEST.
   Yuan Sharleen, 2018, S D Med, V71, P214.},
Number-of-Cited-References = {51},
Times-Cited = {1},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {South.Med.J.},
Doc-Delivery-Number = {OY8GG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000594479000012},
DA = {2022-03-29},
}

@article{ WOS:000488255600006,
Author = {Debski, Maciej and Maniecka-Bryla, Irena and Dziankowska-Zaborszczyk,
   Elzbieta and Ulman, Mateusz and Zabek, Andrzej and Boczar, Krzysztof and
   Haberka, Kazimierz and Kuniewicz, Marcin and Lelakowski, Jacek and
   Malecka, Barbara},
Title = {Years of life lost as a measure of premature death among dual-chamber
   pacemaker recipients from Malopolska Province},
Journal = {KARDIOLOGIA POLSKA},
Year = {2019},
Volume = {77},
Number = {7-8},
Pages = {683-687},
Abstract = {BACKGROUND Pacemakers have become the standard of care in patients with
   severe bradycardia and conduction abnormalities. The survival and
   premature mortality can be assessed using the years of life lost (YLLs).
   AIMS The aim of the study was to analyze mortality trends over the
   period from 1999 to 2015 among patients implanted with a dual-chamber
   (DDD) pacemaker who were inhabitants of Malopolska Province.
   METHODS This was a retrospective study of records collected from
   consecutive patients who underwent de novo DDD pacemaker implantation at
   a single center between 1984 and 2014. Inclusion criteria were residence
   status in Malopolska Province at the latest follow-up visit and death
   between 1999 and 2015. The standard expected years of life lost per
   death was used to calculate YLLs. Time trends were evaluated with
   joinpoint models and presented as an average annual percentage change
   (AAPC).
   RESULTS Among a total of 3932 consecutive patients implanted with a DDD
   pacemaker, 1211 patients met the inclusion criteria. We noted an
   increase in the mean age at implant from 70 years in 1999 to 75.5 years
   in 2015 (AAPC, 0.6\%; P < 0.05), the number of years lived after DDD
   pacemaker implantation from 2.6 years to 8.2 years (AAPC, 7.4\%; P <
   0.05), and the mean age at death from 72.6 years to 83.8 years (AAPC,
   0.89\%; P < 0.05). Finally, we observed a reduction of the YLLs per
   death from 17.4 years in 1999 to 9 years in 2015 (AAPC, -4\%; P < 0.05).
   All trends were significant for both men and women.
   CONCLUSIONS In the 17-year follow-up, we showed significant changes in
   analyzed trends, in particular a reduction in the YLLs per death.},
Publisher = {POLISH CARDIAC SOC-POLSKIE TOWARZYSTWO KARDIOLOGICZNE},
Address = {UL STAWKI 3 A LOK 1-2, WARSZAWA, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Zabek, A (Corresponding Author), John Paul 2 Hosp, Dept Electrocardiol, Ul Pradnicka 80, PL-31202 Krakow, Poland.
   Debski, Maciej; Ulman, Mateusz; Zabek, Andrzej; Boczar, Krzysztof; Haberka, Kazimierz; Kuniewicz, Marcin; Lelakowski, Jacek; Malecka, Barbara, John Paul 2 Hosp, Dept Electrocardiol, Ul Pradnicka 80, PL-31202 Krakow, Poland.
   Maniecka-Bryla, Irena; Dziankowska-Zaborszczyk, Elzbieta, Med Univ Lodz, Dept Epidemiol \& Biostat, Div Social \& Prevent Med, Lodz, Poland.
   Kuniewicz, Marcin, Jagiellonian Univ, Coll Med, Dept Anat, Krakow, Poland.
   Lelakowski, Jacek; Malecka, Barbara, Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland.},
DOI = {10.33963/KP.14839},
ISSN = {0022-9032},
EISSN = {1897-4279},
Keywords = {average annual; percentage change; pacemaker; premature mortality; years
   of life lost},
Keywords-Plus = {LONG-TERM SURVIVAL; IMPLANTATION; TRENDS; MORTALITY; GENDER},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {andrzej\_j\_z@poczta.onet.pl},
ResearcherID-Numbers = {Dębski, Maciej/A-2785-2019
   Ząbek, Andrzej/V-1829-2019
   Maniecka-Bryla, Irena/AAW-5779-2021
   Kuniewicz, Marcin/ABC-6513-2021
   },
ORCID-Numbers = {Dębski, Maciej/0000-0002-3669-3916
   Ząbek, Andrzej/0000-0001-8331-3210
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606},
Cited-References = {Bradshaw PJ, 2015, INT J CARDIOL, V190, P42, DOI 10.1016/j.ijcard.2015.04.099.
   Brunner M, 2004, EUR HEART J, V25, P88, DOI 10.1016/j.ehj.2003.10.022.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   Debski M, 2019, CARDIOL J, V26, P717, DOI 10.5603/CJ.a2018.0093.
   Debski M, 2018, KARDIOL POL, V76, P1224, DOI 10.5603/KP.a2018.0089.
   Greenspon AJ, 2012, J AM COLL CARDIOL, V60, P1540, DOI 10.1016/j.jacc.2012.07.017.
   JELIC V, 1992, PACE, V15, P141, DOI 10.1111/j.1540-8159.1992.tb03057.x.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Mayosi BM, 1999, PACE, V22, P407, DOI 10.1111/j.1540-8159.1999.tb00468.x.
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Nowak B, 2010, EUROPACE, V12, P210, DOI 10.1093/europace/eup312.
   Pikala M, 2017, KARDIOL POL, V75, P1033, DOI 10.5603/KP.a2017.0124.
   Pikala M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09441-5.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Udo EO, 2013, HEART, V99, P1573, DOI 10.1136/heartjnl-2013-304445.
   Uslan DZ, 2008, AM HEART J, V155, P896, DOI 10.1016/j.ahj.2007.12.022.},
Number-of-Cited-References = {17},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Kardiol. Pol.},
Doc-Delivery-Number = {JB0OR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000488255600006},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:A1981MG71700019,
Author = {WYNDHAM, CH},
Title = {THE LOSS FROM PREMATURE DEATHS OF ECONOMICALLY ACTIVE MANPOWER IN THE
   VARIOUS POPULATIONS OF THE RSA .2. MAN-YEARS OF ECONOMICALLY ACTIVE LIFE
   LOST FROM PREMATURE DEATH},
Journal = {SOUTH AFRICAN MEDICAL JOURNAL},
Year = {1981},
Volume = {60},
Number = {12},
Pages = {458-462},
Publisher = {MED ASSOC S AFRICA},
Address = {MED HOUSE CENTRAL SQ 7430 PINELANDS JOHANNESBURG, SOUTH AFRICA},
Type = {Article},
Language = {English},
Affiliation = {WYNDHAM, CH (Corresponding Author), UNIV WITWATERSRAND,DEPT PHYSIOL,JOHANNESBURG 2001,SOUTH AFRICA.
   S AFRICAN MRC,INST BIOSTAT,JOHANNESBURG 2000,SOUTH AFRICA.},
ISSN = {0038-2469},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {DEMPSEY M, 1947, AM REV TUBERCULOSIS, V86, P157.
   LALONDE M, 1975, NEW PERSPECTIVE HLTH.
   MANON KG, 1980, INT J EPIDEM, V9, P111.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   WYNDHAM CH, 1980, S AFR MED J, V57, P729.
   1980, SALUS, V4, P8.},
Number-of-Cited-References = {6},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {S. Afr. Med. J.},
Doc-Delivery-Number = {MG717},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1981MG71700019},
DA = {2022-03-29},
}

@article{ WOS:000559469500001,
Author = {Robertson, Janet and Heslop, Pauline and Lauer, Emily and Taggart,
   Laurence and Hatton, Chris},
Title = {Gender and the Premature Deaths of People with Intellectual
   Disabilities: An International Expert Consultation},
Journal = {JOURNAL OF POLICY AND PRACTICE IN INTELLECTUAL DISABILITIES},
Year = {2021},
Volume = {18},
Number = {2},
Pages = {89-103},
Month = {JUN},
Abstract = {People with intellectual disabilities die at much younger ages than the
   general population, with this gap in life expectancy greater for females
   than males. This study aimed to seek the views of international experts
   concerning evidence relating to gender and the premature deaths of
   people with intellectual disabilities, their views on priorities for
   future research, and recommendations for future research and policy.
   Twenty international experts on the health and/or mortality of people
   with intellectual disabilities were invited to complete an online
   questionnaire. The questionnaire was based on summary statements from a
   literature review on gender and premature death among people with
   intellectual disabilities compared to the general population. Summary
   statements included general topics such as mortality and specific major
   causes of death (e.g., cancer). For each summary statement, respondents
   rated on 5-point scales: their agreement with the statement; the
   importance of the topic; and the adequacy of the evidence. Participants
   then indicated their top three priorities for future research, and gave
   recommendations for future research and policy. Eighteen (90\% response
   rate) respondents from nine countries participated. There was consensus
   among respondents regarding the greater inequality in intellectual
   disability vs. general population mortality rates for women compared to
   men. Evidence was considered inadequate for most topics. Evidence on
   cause-specific death rates was the most frequently mentioned main
   research priority, followed by age trends in mortality compared to the
   general population. Recommendations ranged from the need to use
   consistent methodology and case definition in future research, to the
   need for governments to be called to account on the issue. Further
   evidence on gender and mortality is urgently needed; an international
   consensus on recommendations for future research pertaining to gender
   and the premature deaths of people with intellectual disabilities would
   greatly assist the development of evidence-based policy and practice.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Hatton, C (Corresponding Author), Univ Lancaster, Fac Hlth \& Med, Ctr Disabil Res, Div Hlth Res, Lancaster LA1 4YT, Lancs, England.
   Robertson, Janet; Hatton, Chris, Univ Lancaster, Fac Hlth \& Med, Ctr Disabil Res, Div Hlth Res, Lancaster LA1 4YT, Lancs, England.
   Heslop, Pauline, Univ Bristol, Norah Fry Ctr Disabil Studies, Sch Policy Studies, Bristol, Avon, England.
   Lauer, Emily, Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr, Ctr Dev Disabil Evaluat \& Res CDDER, Worcester, MA USA.
   Taggart, Laurence, Univ Ulster, Sch Nursing, Inst Nursing Res, Coleraine, Londonderry, North Ireland.},
DOI = {10.1111/jppi.12360},
EarlyAccessDate = {AUG 2020},
ISSN = {1741-1122},
EISSN = {1741-1130},
Keywords = {expert consultation; gender; intellectual disabilities; mortality;
   review},
Keywords-Plus = {MORTALITY},
Research-Areas = {Health Care Sciences \& Services; Rehabilitation},
Web-of-Science-Categories  = {Health Policy \& Services; Rehabilitation},
Author-Email = {chris.hatton@lancaster.ac.uk},
ResearcherID-Numbers = {Heslop, Pauline/AAW-9538-2021
   Hatton, Chris/C-1924-2013
   },
ORCID-Numbers = {Hatton, Chris/0000-0001-8781-8486
   Robertson, Janet Margaret/0000-0002-0519-9077
   Taggart, Laurence/0000-0002-0954-2127},
Funding-Acknowledgement = {Public Health England},
Funding-Text = {This work was supported by Public Health England. However, the findings
   and views reported in this paper are those of the authors and should not
   be attributed to Public Health England. We would like to thank the
   international experts who took part in this study.},
Cited-References = {Arvio M, 2017, J APPL RES INTELLECT, V30, P782, DOI 10.1111/jar.12269.
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI {[}DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa].
   Glover G, 2017, J INTELL DISABIL RES, V61, P62, DOI 10.1111/jir.12314.
   Heslop P, 2014, LANCET, V383, P889, DOI 10.1016/S0140-6736(13)62026-7.
   O'Leary L, 2018, J APPL RES INTELLECT, V31, P325, DOI 10.1111/jar.12417.
   Robertson J, 2017, INTELLECT DEV DISAB, V55, P377, DOI 10.1352/1934-9556-55.6.377.
   Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P123, DOI 10.1016/j.seizure.2015.04.004.
   Trollor J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013489.},
Number-of-Cited-References = {8},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Policy Pract. Intellect. Disabil.},
Doc-Delivery-Number = {SV6DI},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000559469500001},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000231662800007,
Author = {Mokyr, J},
Title = {Hockey-stick economics - Robert Fogel, the escape from hunger and
   premature death, 1700-2100},
Journal = {TECHNOLOGY AND CULTURE},
Year = {2005},
Volume = {46},
Number = {3},
Pages = {613-617},
Month = {JUL},
Publisher = {JOHNS HOPKINS UNIV PRESS},
Address = {JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD
   21218-4363 USA},
Type = {Review},
Language = {English},
Affiliation = {Mokyr, J (Corresponding Author), Northwestern Univ, Evanston, IL 60208 USA.
   Northwestern Univ, Evanston, IL 60208 USA.},
DOI = {10.1353/tech.2005.0137},
ISSN = {0040-165X},
EISSN = {1097-3729},
Research-Areas = {History \& Philosophy of Science},
Web-of-Science-Categories  = {History \& Philosophy Of Science},
Cited-References = {{[}Anonymous], {[}No title captured].
   Basalla G., 1988, EVOLUTION TECHNOLOGY.
   Chesnais J.-C., 1992, DEMOGRAPHIC TRANSITI.
   Easterlin R.A., 1996, GROWTH TRIUMPHANT.
   Easterlin RA, 1995, J EVOLUT EC, V5, P393, DOI {[}10.1007/BF01194368, DOI 10.1007/BF01194368].
   McKeown Thomas, 1976, MODERN RISE POPULATI.
   WEIDNERWILLIAMS M, 1988, THESIS NW U.
   2005, SCI AM           MAR, P34.},
Number-of-Cited-References = {8},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Technol. Cult.},
Doc-Delivery-Number = {961LB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:000231662800007},
DA = {2022-03-29},
}

@article{ WOS:000076500200002,
Author = {Helweg-Larsen, K and Knudsen, LB and Petersson, B},
Title = {Women in Denmark - why do they die so young? Risk factors for premature
   death},
Journal = {SCANDINAVIAN JOURNAL OF SOCIAL WELFARE},
Year = {1998},
Volume = {7},
Number = {4},
Pages = {266-276},
Month = {OCT},
Abstract = {In Denmark the life expectancy of women has been declining since 1980,
   and is now the lowest of all OECD countries. Based upon analyses of the
   different trends in mortality of 35-64-year-old women in Denmark
   compared to women in Norway and Sweden, national differentials in
   external determinants of morbidity and premature mortality are
   described. The excess mortality of women in Denmark is linked to
   lifestyle factors: tobacco smoking, alcohol and drug consumption. We
   discuss the possible impact of other external factors: full-time
   employment, work load, job insecurity, unemployment, single motherhood,
   and social isolation. The main hypothesis is that the daily life of
   women in Denmark has deteriorated over the years, and that changes in
   lifestyle and behaviour in part can be explained by evolved strategies
   in order to cope with anxiety and strain. Contrary to conditions in
   Sweden, the welfare system in Denmark has not facilitated the
   combination of child-bearing and paid work. The analysis points to the
   importance of including data of external stressors in discussions of
   national variances in lifestyle factors linked to premature mortality.},
Publisher = {BLACKWELL PUBL LTD},
Address = {108 COWLEY RD, OXFORD OX4 1JF, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Helweg-Larsen, K (Corresponding Author), Danish Inst Clin Epidemiol, Svanemollevej 25, DK-2100 Copenhagen 0, Denmark.
   Danish Inst Clin Epidemiol, DK-2100 Copenhagen 0, Denmark.
   Univ Copenhagen, Inst Publ Hlth, DK-1168 Copenhagen, Denmark.},
DOI = {10.1111/j.1468-2397.1998.tb00247.x},
ISSN = {0907-2055},
Keywords = {life expectancy; premature mortality; lifestyle; drug consumption;
   single motherhood; unemployment},
Keywords-Plus = {CORONARY HEART-DISEASE; EMPLOYMENT STATUS; HEALTH BEHAVIORS;
   INEQUALITIES; NETHERLANDS; COMMUNITY; MORTALITY; SMOKING; WORK},
Research-Areas = {Social Work},
Web-of-Science-Categories  = {Social Work},
Cited-References = {ANDERSEN BH, 1994, 4 MIDD MIN HLTH.
   ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z.
   BERTELSEN O, 1980, NATL I SOCIAL RES PU, V99.
   BJERREGAARD P, 1993, LIFE EXPECTANCY MORT.
   BJERREGAARD P, 1994, LIFETIME DENMARK.
   BOJE TP, 1993, SCANDINAVIA NEW EURO.
   BONKE J, 1995, NATL I SOCIAL RES PU, V4.
   CHRISTOFFERSEN MN, 1996, NATL I SOCIAL RES PU, V14.
   CHRISTOFFERSEN MN, 1990, NATL I SOCIAL RES PU, V18.
   CHRISTOFFERSEN MN, 1987, NATL I SOCIAL RES PU, V168.
   COHEN S, 1991, PREV MED, V20, P306, DOI 10.1016/0091-7435(91)90029-4.
   DAHL E, 1993, SOC SCI MED, V36, P1077, DOI 10.1016/0277-9536(93)90126-O.
   ELSTAD JI, 1995, ACTA SOCIOL, V38, P231, DOI 10.1177/000169939503800302.
   Elstad JI, 1996, SOC SCI MED, V42, P75, DOI 10.1016/0277-9536(95)00078-X.
   FERRIE JE, 1995, BRIT MED J, V311, P264.
   Frankenhaeuser M., 1991, WOMEN WORK HLTH STRE.
   Freidl W, 1997, SOC SCI MED, V44, P1357, DOI 10.1016/S0277-9536(96)00301-2.
   Fridberg T., 1993, SOCIAL ASSISTANCE NO.
   GRONHOJ B, 1981, NATL I SOCIAL RES PU, V103.
   HAAVIOMANNILA E, 1986, SOC SCI MED, V22, P141, DOI 10.1016/0277-9536(86)90063-8.
   HAAVIOMANNILA E, 1977, FAMILY LIFECYCLE EUR.
   Hansen E. J., 1988, GENERATIONER LIVSFOR.
   HASKEY JC, 1993, EUROPEAN POPULATION, V2.
   HAYNES SG, 1980, AM J PUBLIC HEALTH, V70, P133, DOI 10.2105/AJPH.70.2.133.
   INGERSLEV O, 1994, SOCIAL DIFFERENCES M.
   IVERSEN L, 1987, BMJ-BRIT MED J, V295, P879, DOI 10.1136/bmj.295.6603.879.
   JOUNG IMA, 1995, J EPIDEMIOL COMMUN H, V49, P482, DOI 10.1136/jech.49.5.482.
   KAMPMANN JM, 1996, SOVEMEDICIN NERVEMED.
   KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178.
   KjOller M, 1995, SUNDHED SYGELIGHED D.
   Kristensen T S, 1996, J Occup Health Psychol, V1, P246, DOI 10.1037/1076-8998.1.3.246.
   Lazarus R.S., 1984, STRESS APPRAISAL COP.
   LOPEZ AD, 1984, EUROPEAN SERIES, V17.
   LUNDBERG O, 1991, SOC SCI MED, V32, P385, DOI 10.1016/0277-9536(91)90339-E.
   MAERKEDAHL I, 1994, 7 MIN HLTH.
   MAERKEDAHL I, 1989, NATL I SOCIAL SCI PU, V10.
   MOLLER L, 1991, SCAND J SOC MED, V19, P116, DOI 10.1177/140349489101900207.
   MORCK HI, 1982, NORD MED, V97, P134.
   {*}NORD COUNC MIN, 1994, PUBL NORD COUNC MIN, V58.
   {*}NORD STAT SECR, 1966, SOC TRYGH NORD LAND.
   {*}NOSOSCO, 1993, 59 NOSOSCO.
   OSLER M, 1992, SMOKING DANISH POPUL.
   RASMUSSEN NK, 1997, EQUITY HLTH PUBLIC P.
   RASMUSSEN NK, 1984, PREGNANCY DELIVERY C.
   REVELL AD, 1985, ADDICT BEHAV, V10, P209, DOI 10.1016/0306-4603(85)90002-4.
   Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27.
   SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373.
   SORENSEN A, 1991, NATL I SOCIAL RES PU, V7.
   Sundstrom M, 1996, SCAND J SOC WELFARE, V5, P76, DOI 10.1111/j.1468-2397.1996.tb00239.x.
   Theorell, 1990, HLTH WORK.
   Tuchsen F, 1996, AM J IND MED, V30, P407, DOI 10.1002/(SICI)1097-0274(199610)30:4<407::AID-AJIM5>3.0.CO;2-S.
   Valkonen T, 1997, EUR J PUBLIC HEALTH, V7, P302, DOI 10.1093/eurpub/7.3.302.
   VALKONEN T, 1990, SOCIOECONOMIC MORTAL.
   VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1.
   VOGEL J, 1990, LEVA NORDEN LEVNADSN.
   WEATHERALL R, 1994, SOC SCI MED, V38, P285, DOI 10.1016/0277-9536(94)90398-0.},
Number-of-Cited-References = {56},
Times-Cited = {8},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Scand. J. Soc. Welf.},
Doc-Delivery-Number = {130BW},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000076500200002},
DA = {2022-03-29},
}

@article{ WOS:000564549000022,
Author = {Lyn, Rodney and Heath, Erica and Torres, Andrea and Andrews, Christine},
Title = {Investigating improvements in premature death in two rural,
   majority-minority counties in the south},
Journal = {SSM-POPULATION HEALTH},
Year = {2020},
Volume = {11},
Month = {AUG},
Abstract = {This exploratory study investigates counties in the southeast United
   States with mortality outcomes that were better than might be expected
   given their sociodemographic profiles (i.e., positive deviance). This
   study seeks to understand the community characteristics with the
   potential to moderate the negative health outcomes typically associated
   with social, geographic, or economic disadvantages. This article
   describes the process used to identify positive deviants and reports on
   the findings from key informant interviews in positive deviant counties
   to identify community factors or practices that might contribute to
   positive deviance in the observed outcomes. County Health Rankings and
   Roadmaps 2015 data and mortality trends were examined to identify
   positive deviant counties. The inclusion criteria were median household
   incomes in the lowest tertile of their state, >= 33\% African American,
   and premature mortality rankings (as measured by Years of Potential Life
   Lost-YPLL) in the top quartile within their state. After benchmarking
   county rates against national figures and retaining counties with
   significant improvement trends, two counties emerged as positive
   deviants, Dooly County, Georgia and Washington County, North Carolina.
   Key informant interviews (n = 11) were conducted with community
   stakeholders in the study counties to better understand the community
   characteristics that could lead to the observed outcomes. Interview data
   were analyzed using qualitative methods. Key informant interviews
   revealed three emergent themes: 1. accessibility and availability of
   healthcare, 2. the provision of a robust EMS system, and 3. coordination
   of county-funded services targeting vulnerable populations. The positive
   deviance framework provides a foundation for the identification of
   community factors or practices with the potential to create a `culture
   of health' in communities at the greatest risk for adverse health
   outcomes. Our findings suggest that healthcare supported by the
   coordination of non-emergency transportation and health and social
   services across numerous stakeholders may have contributed to observed
   outcomes in the study counties.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Lyn, R (Corresponding Author), Georgia State Univ, Sch Publ Hlth, POB 3995, Atlanta, GA 30302 USA.
   Lyn, Rodney; Heath, Erica; Andrews, Christine, Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.
   Torres, Andrea, ICF, Fairfax, VA 22031 USA.},
DOI = {10.1016/j.ssmph.2020.100618},
Article-Number = {100618},
ISSN = {2352-8273},
Keywords = {Positive deviance; Premature mortality; Determinants of health; County
   health rankings; Qualitative research; Community health},
Keywords-Plus = {UNITED-STATES; HEALTH; MORTALITY; DISPARITIES; INCOME},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {RLyn1@gsu.edu},
Funding-Acknowledgement = {Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF)
   {[}336423]},
Funding-Text = {This work was supported by the Robert Wood Johnson Foundation {[}grant
   number 336423].},
Cited-References = {American Hospital Association, 2017, TRANSP ROL HOSP SOC.
   Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007.
   Backlund E, 1999, SOC SCI MED, V49, P1373, DOI 10.1016/S0277-9536(99)00209-9.
   Baxter R, 2019, BMJ QUAL SAF, V28, P618, DOI 10.1136/bmjqs-2018-008023.
   Berenson J., 2012, ACHIEVING BETTER QUA.
   Braveman P., 1974, SOCIAL DETERMIN S219, V129, P219.
   Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218.
   Centers for Disease Control and Prevention, 2015, COMM HLTH STAT IND C.
   Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62.
   Centers for Medicare and Medicaid Services, 2013, CRIT ACC HOSP DEF.
   Chan KS, 2014, AM J PUBLIC HEALTH, V104, P1751, DOI 10.2105/AJPH.2014.301944.
   Cunningham TJ, 2017, MMWR-MORBID MORTAL W, V66, P444, DOI 10.15585/mmwr.mm6617e1.
   Derose KP, 2011, HEALTH AFFAIR, V30, P1844, DOI 10.1377/hlthaff.2011.0644.
   Drake SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212026.
   Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151.
   Gindi R. M., 2016, 90 NAT CTR HLTH STAT, V90.
   Grant Roy, 2016, Adv Pediatr, V63, P389, DOI 10.1016/j.yapd.2016.04.003.
   Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187.
   Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491.
   Klaiman T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3259-7.
   KREUTER MW, 2002, EMERGING THEORIES HL.
   Liao Youlian, 2011, Morbidity and Mortality Weekly Report, V60, P1.
   Marsh DR, 2004, BMJ-BRIT MED J, V329, P1177, DOI 10.1136/bmj.329.7475.1177.
   Minkler M, 2012, COMMUNITY ORG COMMUN.
   Minnesota Department of Health, 2019, ISS BRIEF DISP PREM.
   Mohan J, 2005, SOC SCI MED, V60, P1267, DOI 10.1016/j.socscimed.2004.06.050.
   National Cancer Institute, 2015, STAT CANC PROF INC.
   Nc Commerce Labor and Economic Analysis Division, 2015, CENS EMPL WAG QCEW L.
   PUTNAM RD, 1995, J DEMOCRACY, V0006.
   QSR International Pty Ltd, 2018, NVIVO QUAL DAT AN SO.
   Rochlin DH, 2019, AM J PUBLIC HEALTH, V109, P472, DOI 10.2105/AJPH.2018.304857.
   Rodgers J, 2019, SOC SCI MED, V236, DOI 10.1016/j.socscimed.2019.112360.
   Shiell A., 2018, SOC SCI MED, DOI {[}10.1016/j.socscimed.2018.09.006., DOI 10.1016/J.SOCSCIMED.2018.09.006.].
   Stuckey HL, 2011, QUAL HEALTH RES, V21, P563, DOI 10.1177/1049732310386623.
   Thomson K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5677-1.
   United States Census Bureau, 2012, AM COMM SURV 2008 20.
   United States Department of Health and Human Services, HLTH RES COMP TOOL H.
   United States Department of Health and Human Services, 2015, COMM HLTH STAT IND C.
   University of Wisconsin Population Health Institute and Robert Wood Johnson Foundation, 2015, COUNT HLTH RANK.
   US Institute for Health Metrics and Evaluation, 2014, PREV POV DOOL COUNT.
   US Institute for Health Metrics and Evaluation, 2014, PREV POV WASH COUNT.
   Vergara-Duarte M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5456074.
   Vyncke V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-65.
   Wen M, 2005, HEALTH SERV RES, V40, P1108, DOI 10.1111/j.1475-6773.2005.00398.x.
   WHO, 2008, CLOS GAP GEN HLTH EQ.
   Ziller E., 2018, HUM RIGHTS, V43, P10.
   2018, EDUC POLICY PRACT CR, P1.},
Number-of-Cited-References = {47},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {SSM-Popul. Health},
Doc-Delivery-Number = {NH3BL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000564549000022},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000426811000014,
Author = {Willoughby, Melissa and Kipsaina, Chebi and Ferrah, Noha and Bugeja,
   Lyndal and Winbolt, Margaret and Ibrahim, Joseph Elias},
Title = {A greater risk of premature death in residential respite care: a
   national cohort study},
Journal = {AGE AND AGEING},
Year = {2018},
Volume = {47},
Number = {2},
Pages = {226-233},
Month = {MAR},
Abstract = {Background: the demand for residential respite care for older persons is
   high yet little is known about the occurrence of harm, including death
   in this care setting.
   Objective: to compare the prevalence and nature of deaths among
   residential respite to permanent nursing home residents.
   Design: retrospective cohort study. Setting: australian accredited
   nursing homes between 1 July 2000 and 30 June 2013.
   Subjects: respite and permanent residents of Australian accredited
   nursing homes, whose deaths were investigated by Australian coroners.
   Methods: prevalence of deaths of nursing home residents were calculated
   using routinely generated coronial data stored in the National Coronial
   Information System. Odds ratios (OR) were calculated to examine
   residency (respite or permanent) by cause of death.
   Results: of the 21,672 residents who died during the study period, 172
   (0.8\%) were in respite care. The majority of deaths were due to natural
   causes. A lower proportion occurred in respite (n = 119, 69.2\%) than
   permanent (n = 18,264, 84.9\%) residents. Falls-related deaths in
   respite as a proportion (n = 41, 23.8\%) was almost double that in
   permanent care (n = 2,638, 12.3\%). Deaths from other injury-related
   causes (such as suicide and choking) were significantly more likely in
   respite residents (OR = 2.0; 95\% confidence interval: 1.1-3.6; P =
   0.026).
   Conclusions: this is the first national cohort study examining mortality
   among respite residents. It established that premature, injury-related
   deaths do occur during respite care. This is the first step towards
   better understanding and reducing the risk of harm in respite care.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Ibrahim, JE (Corresponding Author), Monash Univ, Dept Forens Med, 65 Kavanagh St, Southbank, Vic 3006, Australia.
   Willoughby, Melissa; Kipsaina, Chebi; Ferrah, Noha; Bugeja, Lyndal; Ibrahim, Joseph Elias, Monash Univ, Dept Forens Med, Hlth Law \& Ageing Res Unit, 65 Kavanagh St, Southbank, Vic 3006, Australia.
   Winbolt, Margaret, La Trobe Univ, Fac Hlth Sci, Melbourne, Vic, Australia.},
DOI = {10.1093/ageing/afx177},
ISSN = {0002-0729},
EISSN = {1468-2834},
Keywords = {respite; mortality; transition; transfer; adverse events; older people},
Keywords-Plus = {NURSING-HOME RESIDENTS; OLDER-PEOPLE; TRANSITIONAL CARE},
Research-Areas = {Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Geriatrics \& Gerontology},
Author-Email = {joseph.ibrahim@monash.ed},
ORCID-Numbers = {Willoughby, Melissa/0000-0002-4360-2605
   Ibrahim, Joseph/0000-0003-2828-9160},
Funding-Acknowledgement = {Department of Health and Human Services, Aged Care Branch, Victoria,
   Australia; Department of Forensic Medicine, Monash University;
   Commonwealth Department of Social Services},
Funding-Text = {This work was supported by Commonwealth Department of Social Services;
   Department of Health and Human Services, Aged Care Branch, Victoria,
   Australia; and the Department of Forensic Medicine, Monash University.
   None of the funders influenced the design, methods, subject recruitment,
   data collections, analysis and preparation of article.},
Cited-References = {Access to Respite Care and Help National Respite Network and Resource Center, 2015, RES AG RESP CAR DEL.
   Aged Care Financing Authority, 2016, 4 REP FUND FIN AG CA.
   {[}Anonymous], 2016, REP GOV SERV.
   Australian Institute of Health and Welfare, 2015, RES AG CAR HOM CAR 2.
   Australian Institute of Health and Welfare, 2017, AG CAR.
   Australian Institute of Health and Welfare, 2013, RES AG CAR AG CAR PA.
   Bugeja L, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0096-1.
   Choi CY, 1998, AUST J AGEING, V17, P76, DOI 10.1111/j.1741-6612.1998.tb00038.x.
   de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622.
   Ferrah N, 2017, J AGING HEALTH, V2, P1.
   Ferrah N, 2017, J AM GERIATR SOC, V65, P433, DOI 10.1111/jgs.14683.
   Ibrahim JE, 2017, MED J AUSTRALIA, V206, DOI 10.5694/mja16.00873.
   Ibrahim JE, 2013, J LAW MED, V21, P255.
   International Alliance of Carer Organizations, 2015, GLOB CAR FACTS.
   Jeffcott SA, 2009, QUAL SAF HEALTH CARE, V18, P272, DOI 10.1136/qshc.2007.024570.
   LaMantia MA, 2010, J AM GERIATR SOC, V58, P777, DOI 10.1111/j.1532-5415.2010.02776.x.
   McCusker J, 2001, J AM GERIATR SOC, V49, P1327, DOI 10.1046/j.1532-5415.2001.49260.x.
   National Alliance for caregiving, 2015, CAR OLD AD FOC LOOK.
   National Coroners Information System, AB NCIS.
   Naylor Mary D, 2002, Annu Rev Nurs Res, V20, P127.
   Neville C, 2015, HEALTH SOC CARE COMM, V23, P51, DOI 10.1111/hsc.12095.
   Oakes SL, 2011, CLIN GERIATR MED, V27, P259, DOI 10.1016/j.cger.2011.02.004.
   Productivity Commission, 2011, CAR OLD AUSTR.
   Productivity Commission, 2008, TRENDS AG CAR SERV S.
   Shaw C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13200.
   StataCorp, 2015, STAT STAT SOFTW REL.
   Steering Committee for the Review of Government Service Provision, 2013, REP GOV SERV.
   Steering Committee for the Review of Government Service Provision, 2000, REP GOV SERV.
   The Joint Commission, 2015, COMPR ACCR MAN HOSP.
   Wiles JL, 2012, GERONTOLOGIST, V52, P357, DOI 10.1093/geront/gnr098.
   World Health Organisation, 2006, INT STAT CLASS DIS R.
   World Health Organization, 2007, COMM BAS MAN SEV AC.
   World Health Organization, 2015, AG AND HLTH.},
Number-of-Cited-References = {33},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Age Ageing},
Doc-Delivery-Number = {FY4QW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000426811000014},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1978FD00200002,
Author = {MARON, BJ and LIPSON, LC and ROBERTS, WC and SAVAGE, DD and EPSTEIN, SE},
Title = {MALIGNANT HYPERTROPHIC CARDIOMYOPATHY - IDENTIFICATION OF A SUBGROUP OF
   FAMILIES WITH UNUSUALLY FREQUENT PREMATURE DEATH},
Journal = {AMERICAN JOURNAL OF CARDIOLOGY},
Year = {1978},
Volume = {41},
Number = {7},
Pages = {1133-1140},
Publisher = {EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC},
Address = {685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA},
Type = {Article},
Language = {English},
Affiliation = {MARON, BJ (Corresponding Author), NHLBI, CARDIOL BRANCH, BETHESDA, MD 20014 USA.
   NHLBI, PATHOL BRANCH, BETHESDA, MD 20014 USA.},
DOI = {10.1016/0002-9149(78)90870-6},
ISSN = {0002-9149},
EISSN = {1879-1913},
Keywords-Plus = {ASYMMETRIC SEPTAL HYPERTROPHY; SUBAORTIC STENOSIS; VENTRICULAR OUTFLOW;
   PROGNOSIS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Cited-References = {ADELMAN AG, 1972, ANN INTERN MED, V77, P515, DOI 10.7326/0003-4819-77-4-515.
   EPSTEIN SE, 1974, ANN INTERN MED, V81, P650, DOI 10.7326/0003-4819-81-5-650.
   FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769.
   FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759.
   GOULD SE, 1968, PATHOLOGY HEART BLOO, P1139.
   HARDARSON T, 1973, LANCET, V2, P1462.
   HENRY WL, 1973, CIRCULATION, V47, P225, DOI 10.1161/01.CIR.47.2.225.
   MARON BJ, 1977, CIRCULATION, V55, P341, DOI 10.1161/01.CIR.55.2.341.
   MARON BJ, 1974, CIRCULATION, V50, P436, DOI 10.1161/01.CIR.50.3.436.
   MARON BJ, 1976, CIRCULATION, V53, P9, DOI 10.1161/01.CIR.53.1.9.
   MARON BJ, 1978, AM J CARDIOL, V41, P803, DOI 10.1016/0002-9149(78)90717-8.
   MORROW AG, 1969, AM HEART J, V77, P814, DOI 10.1016/0002-8703(69)90417-7.
   ROBERTS WC, 1973, CARDIOVASC CLIN, V5, P104.
   SHAH PM, 1974, CIRC RES, V35, P179.
   SWAN DA, 1971, BRIT HEART J, V33, P671.
   TEARE D, 1958, BRIT HEART J, V20, P1.
   1973, DISEASES HEART BLOOD, P286.},
Number-of-Cited-References = {17},
Times-Cited = {177},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Am. J. Cardiol.},
Doc-Delivery-Number = {FD002},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1978FD00200002},
DA = {2022-03-29},
}

@article{ WOS:000073055800007,
Author = {Dowd, MD},
Title = {Consequences of violence - Premature death, violence recidivism, and
   violent criminality},
Journal = {PEDIATRIC CLINICS OF NORTH AMERICA},
Year = {1998},
Volume = {45},
Number = {2},
Pages = {333+},
Month = {APR},
Abstract = {The burden of violence is born disproportionately by the youngest of our
   country. In this article, three important aspects of violence are
   discussed: premature death, violence recidivism, and violent
   criminality. The author emphasizes the role of the pediatrician in
   preventing these consequences.},
Publisher = {W B SAUNDERS CO-ELSEVIER INC},
Address = {1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA},
Type = {Article},
Language = {English},
Affiliation = {Dowd, MD (Corresponding Author), Univ Missouri, Childrens Mercy Hosp, Div Emergency Med, Dept Pediat,Sch Med, 2401 Gillham Rd, Kansas City, MO 64108 USA.
   Univ Missouri, Childrens Mercy Hosp, Div Emergency Med, Dept Pediat,Sch Med, Kansas City, MO 64108 USA.},
DOI = {10.1016/S0031-3955(05)70009-2},
ISSN = {0031-3955},
EISSN = {1557-8240},
Keywords-Plus = {INTERPERSONAL VIOLENCE; HOMICIDE VICTIMS; TRAUMA; BEHAVIOR; INJURY;
   CRIME},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Cited-References = {ALLENHAGEN B, 1993, JUVENILES VIOLENCE J.
   {*}AM SCH HLTH ASS A, 1989, NAT AD STUD HLTH SUR.
   Blendon RJ, 1996, JAMA-J AM MED ASSOC, V275, P1719, DOI 10.1001/jama.275.22.1719.
   BUKA S, 1993, HEALTH AFFAIR, V12, P46, DOI 10.1377/hlthaff.12.4.46.
   CALLAHAN CM, 1992, JAMA-J AM MED ASSOC, V267, P30.
   CARMEN E, 1984, AM J PSYCHIAT, V141, P378.
   {*}CDCP, 1996, MMWR-MORBID MORTAL W, V45, P460.
   {*}CDCP, 1993, MONTHLY VITAL STAT R, V42.
   {*}CDCP, 1994, MMWR-MORBID MORTAL W, V43, P725.
   Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P101.
   CENTERWALL BS, 1984, AM J PUBLIC HEALTH, V74, P813, DOI 10.2105/AJPH.74.8.813.
   Christoffel KK, 1996, PEDIATRICS, V98, P991.
   COHEN E, 1991, J ADOLESCENT HEALTH, V12, P539, DOI 10.1016/0197-0070(91)90084-Y.
   Dowd MD, 1996, AM J PUBLIC HEALTH, V86, P929, DOI 10.2105/AJPH.86.7.929.
   Farrington D P, 1989, Violence Vict, V4, P79.
   Farrington D. P., 1978, AGGRESSION ANTISOCIA, P73.
   FARRINGTON DP, 1993, CRIMINAL BEHAV MENTA, V0003.
   FARRINGTON DP, 1991, DEVELOPMENT AND TREATMENT OF CHILDHOOD AGGRESSION, P5.
   FARRINGTON DP, 1990, KRIMINALITAT PERSONL, P115.
   {*}FED BUR INV, 1992, CRIM US 1991.
   FINGERHUT LA, 1990, JAMA-J AM MED ASSOC, V263, P3292, DOI 10.1001/jama.263.24.3292.
   GOINS WA, 1992, J NATL MED ASSOC, V84, P431.
   GOODMAN RA, 1986, AM J PUBLIC HEALTH, V76, P144, DOI 10.2105/AJPH.76.2.144.
   GOODMAN RA, 1986, AM J EPIDEMIOL, V124, P851, DOI 10.1093/oxfordjournals.aje.a114462.
   HAUSMAN A J, 1989, Pediatric Emergency Care, V5, P275, DOI 10.1097/00006565-198912000-00022.
   JONES MA, 1994, IMAGES REALITY JUVEN.
   KAGAN J, 1989, AM PSYCHOL, V44, P668, DOI 10.1037/0003-066X.44.4.668.
   KLINGBEIL KS, 1976, NURS PRACT, V6, P21.
   Lauritsen J L, 1992, Violence Vict, V7, P91.
   MCCORD J, 1979, J PERS SOC PSYCHOL, V37, P1477, DOI 10.1037/0022-3514.37.9.1477.
   MORRISSEY TB, 1991, J TRAUMA, V31, P1536, DOI 10.1097/00005373-199111000-00013.
   {*}NAT CTR HLTH STAT, 1997, ADV REP FIN MORT STA.
   {*}NIH, 1992, NICHD MAY 1989.
   OCARROLL PW, 1986, HOMICIDE BLACK AM, P29.
   PATTERSON GR, 1991, DEVELOPMENT AND TREATMENT OF CHILDHOOD AGGRESSION, P139.
   POOLE GV, 1993, SURGERY, V113, P608.
   REINER DS, 1990, AM SURGEON, V56, P556.
   REISS AJ, 1993, UNDERSTANDING PREVEN, P372.
   RIVARA FP, 1995, ARCH PEDIAT ADOL MED, V149, P421, DOI 10.1001/archpedi.1995.02170160075011.
   ROBINS LN, 1986, PSYCHIATRIC EPIDEMIO, P73.
   Rosenberg M., 1991, VIOLENCE AM PUBLIC H, P14.
   Roth J. A., 1994, UNDERSTANDING PREVEN, V4.
   SAMPSON RJ, 1990, J RES CRIME DELINQ, V27, P110, DOI 10.1177/0022427890027002002.
   SINGH GK, 1996, MONTHLY VITAL STAT, V45.
   SLOAN JH, 1988, NEW ENGL J MED, V319, P1256, DOI 10.1056/NEJM198811103191905.
   STARK E, 1979, INT J HLTH SERV, V9, P224.
   {*}US DEP JUST, 1987, SURV YOUTH CUST 1987, P1.
   {*}US DEP JUST, 1993, CRIM VICT US 1991.
   {*}US FED BUR INV, 1991, UN CRIM REP US 1990.
   WEISBESKI D, 1989, J TRAUMA, V29, P940, DOI 10.1097/00005373-198907000-00006.
   WERNER E, 1982, VULNERABLE BUT INVIN.
   WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995.
   WILLIAMS KR, 1984, AM SOCIOL REV, V49, P283, DOI 10.2307/2095577.},
Number-of-Cited-References = {53},
Times-Cited = {18},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Pediatr. Clin. N. Am.},
Doc-Delivery-Number = {ZG945},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000073055800007},
DA = {2022-03-29},
}

@article{ WOS:000177707800003,
Author = {Petersen, L and Nielsen, GG and Andersen, PK and Sorensen, TIA},
Title = {Case-control study and environmental of genetic influences on premature
   death of adult adoptees},
Journal = {GENETIC EPIDEMIOLOGY},
Year = {2002},
Volume = {23},
Number = {2},
Pages = {123-132},
Month = {AUG},
Abstract = {Genetic and environmental influence on risk of premature death in
   adulthood was investigated by estimating the associations in total and
   cause-specific mortality of adult Danish adoptees and their biological
   and adoptive parents. Among all 14,427 nonfamilial adoptions formally
   granted in Denmark during the period 1923 through 1947, we identified
   976 case families in which the adoptee died before a fixed date. As
   control families, we selected 976 families where the adoptees were alive
   on that date, and matched to the case adoptees with regard to gender and
   year and month of birth. The data were viewed as a cohort of case
   parents and a cohort of control parents, and lifetime distributions in
   the two cohorts were compared using a Cox regression, stratified with
   regard to the matching variables: gender and year of birth. In the main
   analyses, the sample was restricted with regard to birth year of the
   adoptees, and age of transfer to the adoptive parents, and age at death
   was restricted to the same range for parents and offspring (25-64 years)
   in order to consider a symmetric lifetime distribution. This reduces the
   sample to 459 case families and 738 control families. Various
   truncations, restrictions, and stratifications were used in order to
   examine the robustness of the results. The results showed a higher
   mortality among biological parents who had children dying in the age
   range 25 through 64 years, and this was significant for death from
   natural causes, infectious causes, vascular causes, and from all causes
   combined. There were no significant effects for the adoptive parents.
   This study supports that there are moderate genetic influences on the
   risk of dying prematurely in adulthood, and only a small, if any, effect
   of the family environment. Genet. Epidemiol. 23:123-132, 2002. (C) 2002
   Wiley-Liss, Inc.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Sorensen, TIA (Corresponding Author), Kommuniehosp, Inst Prevent Med, DK-1399 Copenhagen K, Denmark.
   Univ Copenhagen Hosp, Danish Epidemiol Sci Ctr, Inst Prevent Med, DK-2100 Copenhagen K, Denmark.
   Univ Copenhagen, Dept Biostat, Copenhagen, Denmark.
   Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark.
   Danish Epidemiol Sci Ctr, Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.},
DOI = {10.1002/gepi.1122},
ISSN = {0741-0395},
EISSN = {1098-2272},
Keywords = {adoption; mortality; life span; causes of death; infection; vascular
   disease; cancer},
Keywords-Plus = {LONGEVITY; TWINS},
Research-Areas = {Genetics \& Heredity; Mathematical \& Computational Biology},
Web-of-Science-Categories  = {Genetics \& Heredity; Mathematical \& Computational Biology},
Author-Email = {tias@ipm.hosp.dk},
ORCID-Numbers = {Petersen, Liselotte Vogdrup/0000-0002-0479-5379},
Cited-References = {Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X.
   Christensen K, 1996, J INTERN MED, V240, P333, DOI 10.1046/j.1365-2796.1996.d01-2853.x.
   COHEN BH, 1964, REV BIOL, V39, P132.
   GLASSER M, 1981, J CHRON DIS, V34, P439, DOI 10.1016/0021-9681(81)90003-5.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   HAYAKAWA K, 1992, ACTA GENET MED GEMEL, V41, P177, DOI 10.1017/S0001566000002385.
   Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042.
   Hosmer DW, 2000, APPL LOGISTIC REGRES, P223.
   Iachine I A, 1998, Twin Res, V1, P196.
   JACOBSEN S, 1981, PROSPECTIVE LONGITUD, P225.
   Keiding N., 1993, STAT MODELS BASED CO.
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201.
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085.
   LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744.
   MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503.
   MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237.
   Neale MC., 1992, METHODOLOGY GENETIC.
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876.
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202.
   {[}No title captured], DOI DOI 10.1016/0022-3956(68)90026-5.},
Number-of-Cited-References = {20},
Times-Cited = {21},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Genet. Epidemiol.},
Doc-Delivery-Number = {588NP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000177707800003},
DA = {2022-03-29},
}

@article{ WOS:A1991FW61200008,
Author = {ROE, FJC and LEE, PN and CONYBEARE, G and TOBIN, G and KELLY, D and
   PRENTICE, D and MATTER, B},
Title = {RISKS OF PREMATURE DEATH AND CANCER PREDICTED BY BODY-WEIGHT IN EARLY
   ADULT LIFE},
Journal = {HUMAN \& EXPERIMENTAL TOXICOLOGY},
Year = {1991},
Volume = {10},
Number = {4},
Pages = {285-288},
Month = {JUL},
Abstract = {In a study of 30 months duration, involving 600 male and 600 female
   Wistar rats fed on 12 different diets/dietary regimes, none of which
   involved deliberate exposure to any known genotoxic carcinogen, highly
   significant between-group differences were observed in survival and
   incidence of various neoplastic and non-neoplastic diseases.  A full
   report of the findings is being prepared.  Here we report that,
   irrespective of diet or dietary regime, there were highly significant
   correlations of body weight at 29 weeks of age with premature death (P <
   0.0001 in both males and females), with development of benign or
   malignant neoplasm of any site (P < 0.0001 in males and P < 0.01 in
   females) and with development of malignant neoplasm at any site (P <
   0.0001 for sexes combined).  Numerous kinds of neoplasm contributed to
   these overall correlations.  The most significant were pituitary tumour
   (P < 0.0001), mammary gland tumour (P < 0.0001), squamous or anaplastic
   carcinoma of the jaw (P < 0.001), and subcutaneous mesodermal tumours (P
   < 0.05).  The 20\% of rats that were heaviest at 29 weeks were more than
   twice as likely to die prematurely than the lightest 20\% (2.56 times -
   males, and 2.11 times - females), and almost twice as likely to develop
   a malignant tumour (1.87 times for the sexes combined).  These findings
   have important implications for the design and interpretation of
   carcinogenicity tests in rodents and of laboratory and human studies of
   relationships between diet, ageing-related degenerative diseases, and
   cancer.},
Publisher = {STOCKTON PRESS},
Address = {HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS},
Type = {Article},
Language = {English},
Affiliation = {MICROBIOL LABS,HARROW HA2 7RE,MIDDX,ENGLAND.
   UNIV LEEDS,DEPT PHYSIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND.
   SANDOZ LTD,TOXICOL UNIT,CH-4002 BASEL,SWITZERLAND.},
DOI = {10.1177/096032719101000408},
ISSN = {0144-5952},
Keywords-Plus = {LONG-TERM; FOOD RESTRICTION; MICE; RATS; LONGEVITY; TUMORS; AGE},
Research-Areas = {Toxicology},
Web-of-Science-Categories  = {Toxicology},
ORCID-Numbers = {Lee, Peter/0000-0002-8244-1904},
Cited-References = {AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249.
   BERG BN, 1960, J NUTR, V71, P255.
   CONYBEARE G, 1980, FOOD COSMET TOXICOL, V18, P65, DOI 10.1016/0015-6264(80)90013-9.
   CONYBEARE G, 1988, ILSI MONOGRAPHS, P149.
   HELLER TD, 1990, GASTROENTEROLOGY, V98, P387, DOI 10.1016/0016-5085(90)90829-P.
   LOK E, 1990, CANCER LETT, V51, P67, DOI 10.1016/0304-3835(90)90232-M.
   RAO GN, 1990, FUND APPL TOXICOL, V15, P33, DOI 10.1016/0272-0590(90)90160-L.
   RAO GN, 1987, AM J CLIN NUTR, V45, P252, DOI 10.1093/ajcn/45.1.252.
   Roe F J, 1991, Fundam Appl Toxicol, V16, P616, DOI 10.1016/0272-0590(91)90100-I.
   ROE FJC, 1990, IN PRESS MAR P INT L.
   SALMON GK, 1990, FOOD CHEM TOXICOL, V28, P39, DOI 10.1016/0278-6915(90)90134-9.
   TUCKER MJ, 1979, INT J CANCER, V23, P803, DOI 10.1002/ijc.2910230611.
   TURNBULL GJ, 1985, FOOD CHEM TOXICOL, V23, P355, DOI 10.1016/0278-6915(85)90071-7.
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854.
   1980, IARC MONOGRAPHS S, V2, P311.},
Number-of-Cited-References = {15},
Times-Cited = {25},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Hum. Exp. Toxicol.},
Doc-Delivery-Number = {FW612},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991FW61200008},
DA = {2022-03-29},
}

@article{ WOS:000374693200020,
Author = {Salgado-Galvez, Mario A. and Bernal, Gabriel A. and Barbat, Alex H. and
   Carreno, Martha L. and Cardona, Omar-Dario},
Title = {Probabilistic estimation of annual lost economic production due to
   premature deaths because of earthquakes},
Journal = {HUMAN AND ECOLOGICAL RISK ASSESSMENT},
Year = {2016},
Volume = {22},
Number = {2},
Pages = {543-557},
Abstract = {A methodology to estimate, in a probabilistic way, the annual cost to
   society of premature deaths because of earthquakes is proposed in this
   article. The methodology makes use of results obtained by means of
   prospective and probabilistic seismic risk assessments where expected
   deaths caused by the collapse of buildings are obtained. Those results,
   combined with demographic and macroeconomic indicators such as the age
   distribution, life expectancy at birth, and per capita gross domestic
   product, are used to estimate the cost to society in terms of lost
   productivity due to premature mortality because of earthquakes. The
   proposed methodology does not attempt to estimate nor assign a cost to
   human lives at any stage, but the one associated to lost productivity at
   the societal level. One of the descriptors of the methodology is part of
   the components of the disability adjusted life year, a widely used
   metric in the public health field that estimates the burden of diseases
   based mostly on historical data. As an example, the methodology is
   applied to Medellin, the second largest city of Colombia, finding that
   the cost of lost productivity due to premature mortality because of
   earthquakes has a similar order of magnitude to the direct physical
   losses in the public and private building stock calculated in a previous
   probabilistic seismic risk assessment.},
Publisher = {TAYLOR \& FRANCIS INC},
Address = {530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA},
Type = {Article},
Language = {English},
Affiliation = {Salgado-Galvez, MA (Corresponding Author), Univ Politecn Cataluna, Ctr Int Metodes Numer Engn, Edifici C-1,Despatx C-111 Carrer Gran Capita S-N, Barcelona, Spain.
   Salgado-Galvez, Mario A.; Bernal, Gabriel A.; Barbat, Alex H.; Carreno, Martha L., Univ Politecn Cataluna, Ctr Int Metodes Numer Engn, Edifici C-1,Despatx C-111 Carrer Gran Capita S-N, Barcelona, Spain.
   Cardona, Omar-Dario, Univ Nacl Colombia, Inst Estudios Ambientales IDEA, Manizales, Colombia.},
DOI = {10.1080/10807039.2015.1095072},
ISSN = {1080-7039},
EISSN = {1549-7860},
Keywords = {probabilistic seismic risk assessment; average annual deaths; earthquake
   casualties; disability adjusted life year; CAPRA},
Keywords-Plus = {RISK-ASSESSMENT; MODEL},
Research-Areas = {Biodiversity \& Conservation; Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Biodiversity Conservation; Environmental Sciences},
Author-Email = {mario.sal.gal@gmail.com},
ResearcherID-Numbers = {Barbat, Alex H/M-6206-2013
   Carreno, Martha Liliana/C-8837-2015},
ORCID-Numbers = {Barbat, Alex H/0000-0002-3649-8053
   Carreno, Martha Liliana/0000-0003-1914-2992},
Funding-Acknowledgement = {Ministry of Education and Science of Spain ``Enfoque integral y
   probabilista para la evaluacion del riesgo sismico en Espana{''}-
   CoPASRE {[}CGL2011-29063]},
Funding-Text = {The authors are grateful for the support of the Ministry of Education
   and Science of Spain ``Enfoque integral y probabilista para la
   evaluacion del riesgo sismico en Espana{''}- CoPASRE (CGL2011-29063).
   They are also grateful to Spain's Ministry of Economy and
   Competitiveness in the framework of the researcher's formation program
   (FPI).},
Cited-References = {Algermissen ST, 1972, STUDY EARTHQUAKE LOS.
   Barbat AH, 2012, P 15 WORLD C EARTHQ.
   Brookings Institution, 2015, 2014 GLOB METR MON M.
   Cardona O. D., 2010, P 14 EUR C EARTHQ EN.
   Coburn A., 2002, EARTHQUAKE PROTECTIO.
   DANE (Departamento Administrativo Nacional de Estadistica) and Alcaldia de Medellin, 2010, PROYECC POBL MUN MED.
   Enarson E., 2007, HDB DISASTER RES, P130, DOI {[}10.1007/978.387.32353, DOI 10.1007/978-0-387-32353-4\_8].
   Evaluacion de Riesgos Naturales America Latina-ERN-AL, 2011, CAPRA GIS V2 0 PROGR.
   Federal Emergency Management Agency (FEMA), 2003, MULT LOSS EST METH E.
   Ferreira MA, 2011, HUMAN CASUALTIES EAR, P255.
   Grossi P, 2004, P 13 WORLD C EARTHQ.
   Guha-Sapir D, 2015, EM DAT INT DISASTER.
   Jaimes MA, 2015, J EARTHQ ENG, V19, P297, DOI 10.1080/13632469.2014.962673.
   Jaiswal K, 2010, EARTHQ SPECTRA, V26, P1017, DOI 10.1193/1.3480331.
   Krishnamoorthy K, 2005, CURR SCI INDIA, V89, P739.
   Liel AB, 2012, EARTHQ SPECTRA, V28, P1495, DOI 10.1193/1.4000090.
   Luco N, 2007, EARTHQ SPECTRA, V23, P357, DOI 10.1193/1.2723158.
   Marulanda MC, 2013, NAT HAZARDS, V69, P59, DOI 10.1007/s11069-013-0685-z.
   Marulanda MC, 2013, THESIS TU CATALONIA.
   McClure FE, 1979, EVALUATING SEISMIC H.
   Murphy C, 2011, SCI ENG ETHICS, V17, P553, DOI 10.1007/s11948-010-9242-2.
   Noy I, 2014, NONMONETARY GLOBAL M.
   Noy I, 2015, INT J DISAST RISK RE, V13, P61, DOI 10.1016/j.ijdrr.2015.03.009.
   Olson DL, 2010, HUM ECOL RISK ASSESS, V16, P478, DOI 10.1080/10807031003779898.
   Ordaz M, 2013, SEISMOL RES LETT, V84, P495, DOI 10.1785/0220120067.
   Ordaz M, 2000, METODOLOGIA EVALUACI.
   Ordaz M, 2015, NAT HAZARDS, V76, P389, DOI 10.1007/s11069-014-1495-7.
   Organisation for Economic Cooperation and Development (OECD), 2014, OECD EMPL OUTL 2014, DOI {[}10.1787/empl\_outlook-2014-en, DOI 10.1787/EMPL\_OUTLOOK-2014-EN].
   References AIS (Asociacion Colombiana de Ingenieria Sismica), 2010, AIS300.
   Reitherman R, 1982, COMPUTER AIDED EARTH.
   ROSENBLUETH E, 1976, J STRUCT DIV-ASCE, V102, P591.
   Salgado Mario A., 2010, rev.ing., P28.
   Salgado-Galvez MA, 2016, REV INT METOD NUMER, V32, P70, DOI 10.1016/j.rimni.2014.12.001.
   Salgado-Galvez MA, 2015, REV INT MET IN PRESS, DOI 10.1016/j.rimni.2015.07.001.
   Salgado-Galvez MA, 2016, NAT HAZARDS, V80, P1995, DOI 10.1007/s11069-015-2056-4.
   Salgado-Galvez MA, 2014, B EARTHQ ENG, V12, P671, DOI 10.1007/s10518-013-9550-4.
   Scawthorn C, 2011, HUMAN CASUALTIES EAR, P51, DOI DOI 10.1007/978-90-481-9455-1\_4.
   Spence R., 2009, 08HQGR0102 NEHRP.
   UNISDR, 2015, GLOB ASS REP DIS RIS.
   Velasquez CA, 2014, NAT HAZARDS, V72, P455, DOI 10.1007/s11069-013-1017-z.
   Wald DJ., 2011, HUMAN CASUALTIES EAR, P83, DOI DOI 10.1007/978-90-481-9455-1\_6.
   Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7.
   WHO, 2000, METH DAT SOURC GLOB.
   World Health Organization, 2004, GLOB BURD DIS 2004 U.},
Number-of-Cited-References = {44},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Hum. Ecol. Risk Assess.},
Doc-Delivery-Number = {DK1SB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000374693200020},
OA = {Green Accepted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1979HN48700001,
Author = {TSUANG, MT and DEMPSEY, GM and FLEMING, JA},
Title = {CAN ECT PREVENT PREMATURE DEATH AND SUICIDE IN SCHIZOAFFECTIVE PATIENTS},
Journal = {JOURNAL OF AFFECTIVE DISORDERS},
Year = {1979},
Volume = {1},
Number = {3},
Pages = {167-171},
Publisher = {ELSEVIER SCIENCE BV},
Address = {PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {TSUANG, MT (Corresponding Author), UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242, USA.},
DOI = {10.1016/0165-0327(79)90001-6},
ISSN = {0165-0327},
Research-Areas = {Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Clinical Neurology; Psychiatry},
Funding-Acknowledgement = {NIMH NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) {[}MH-31673, MH-24189] Funding Source: Medline},
Cited-References = {AVERY D, 1976, ARCH GEN PSYCHIAT, V33, P1029.
   DEMPSEY GM, 1975, COMPR PSYCHIAT, V16, P55, DOI 10.1016/0010-440X(75)90021-8.
   FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011.
   TSUANG MT, 1978, ARCH GEN PSYCHIAT, V35, P1181.
   TSUANG MT, 1978, ARCH GEN PSYCHIAT, V35, P153.
   TSUANG MT, 1976, ARCH GEN PSYCHIAT, V33, P1157.
   TSUANG MT, ARCH GEN PSYCHIAT.
   1940, VITAL STATISTICS US, V1, P186.},
Number-of-Cited-References = {8},
Times-Cited = {23},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Affect. Disord.},
Doc-Delivery-Number = {HN487},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1979HN48700001},
DA = {2022-03-29},
}

@article{ WOS:000262719900010,
Author = {Zheng, Ming and Cheng, Hongqiang and Li, Xiaodong and Zhang, Jianlin and
   Cui, Li and Ouyang, Kunfu and Han, Liang and Zhao, Ting and Gu, Yusu and
   Dalton, Nancy D. and Bang, Marie-Louise and Peterson, Kirk L. and Chen,
   Ju},
Title = {Cardiac-specific ablation of Cypher leads to a severe form of dilated
   cardiomyopathy with premature death},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2009},
Volume = {18},
Number = {4},
Pages = {701-713},
Month = {FEB 15},
Abstract = {Accumulating data suggest a link between alterations/deficiencies in
   cytoskeletal proteins and the progression of cardiomyopathy and heart
   failure, although the molecular basis for this link remains unclear.
   Cypher/ZASP is a cytoskeletal protein localized in the sarcomeric
   Z-line. Mutations in its encoding gene have been identified in patients
   with isolated non-compaction of the left ventricular myocardium, dilated
   cardiomyopathy (DCM) and hypertrophic cardiomyopathy. To explore the
   role of Cypher in myocardium and to better understand molecular
   mechanisms by which mutations in cypher cause cardiomyopathy, we
   utilized a conditional approach to knockout Cypher, specially in either
   developing or adult myocardium. Cardiac-specific Cypher knockout (CKO)
   mice developed a severe form of DCM with disrupted cardiomyocyte
   ultrastructure and decreased cardiac function, which eventually led to
   death before 23 weeks of age. A similar phenotype was observed in
   inducible cardiac-specific CKO mice in which Cypher was specifically
   ablated in adult myocardium. In both cardiac-specific CKO models, ERK
   and Stat3 signaling pathways were augmented. Finally, we demonstrate the
   specific binding of Cypher's PDZ domain to the C-terminal region of both
   calsarcin-1 and myotilin within the Z-line. In conclusion, our studies
   suggest that (i) Cypher plays a pivotal role in maintaining adult
   cardiac structure and cardiac function through protein-protein
   interactions with other Z-line proteins, (ii) myocardial ablation of
   Cypher results in DCM with premature death and (iii) specific signaling
   pathways participate in Cypher mutant-mediated dysfunction of the heart,
   and may in concert facilitate the progression to heart failure.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Chen, J (Corresponding Author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   Zheng, Ming; Cheng, Hongqiang; Li, Xiaodong; Zhang, Jianlin; Cui, Li; Ouyang, Kunfu; Gu, Yusu; Dalton, Nancy D.; Peterson, Kirk L.; Chen, Ju, Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   Zheng, Ming; Han, Liang; Zhao, Ting, Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
   Bang, Marie-Louise, CNR, ITB, Dulbecco Telethon Inst, I-20090 Milan, Italy.
   Bang, Marie-Louise, IRCCS Multimedia Sci \& Technol Pole, I-20138 Milan, Italy.},
DOI = {10.1093/hmg/ddn400},
ISSN = {0964-6906},
EISSN = {1460-2083},
Keywords-Plus = {DYSTROPHIN-GLYCOPROTEIN COMPLEX; ACTIVATED PROTEIN-KINASE;
   MUSCULAR-DYSTROPHY; HEART-FAILURE; SARCOMERIC PROTEIN; TROPONIN-T;
   MUTATIONS; MYOTILIN; GENE; PDZ},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {juchen@ucsd.edu},
ResearcherID-Numbers = {Bang, Marie-Louise/B-5683-2015
   Chen, Ju/E-5579-2011
   ouyang, kunfu/B-3073-2011
   },
ORCID-Numbers = {Bang, Marie-Louise/0000-0001-8859-5034
   ouyang, kunfu/0000-0003-0292-375X
   Cheng, Hongqiang/0000-0001-9662-1570},
Funding-Acknowledgement = {NIHUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USA; MDAMuscular Dystrophy Association;
   Children's Cardiomyopathy Foundation; National Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) {[}30770870,
   30500182]; National Key Basic Research Program of ChinaNational Basic
   Research Program of China {[}2007CB512100]; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}R01HL066100] Funding Source: NIH RePORTER;
   Fondazione TelethonFondazione Telethon Funding Source: Custom},
Funding-Text = {Grants from NIH, MDA and Children's Cardiomyopathy Foundation to J. C.,
   partially by National Science Foundation of China (30770870 and
   30500182) and National Key Basic Research Program of China
   (2007CB512100) to M. Z.},
Cited-References = {Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398.
   Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200.
   Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6.
   Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297.
   Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252.
   Dellefave L, 2008, CIRCULATION, V117, P2847, DOI 10.1161/CIRCULATIONAHA.108.781518.
   Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465.
   Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132.
   Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200.
   Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815.
   Gontier Y, 2005, J CELL SCI, V118, P3739, DOI 10.1242/jcs.02484.
   Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141.
   Hernandez-Torres F, 2008, FEBS LETT, V582, P1025, DOI 10.1016/j.febslet.2008.02.050.
   Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200.
   Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100.
   Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992.
   Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304.
   Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6.
   Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315.
   Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25.
   Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370.
   Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461.
   Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c.
   Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200.
   Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899.
   Moza M, 2007, MOL CELL BIOL, V27, P244, DOI 10.1128/MCB.00561-06.
   Nourry Claire, 2003, Sci STKE, V2003, pRE7.
   Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750.
   Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930.
   OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434.
   Petrich BG, 2004, TRENDS CARDIOVAS MED, V14, P50, DOI 10.1016/j.tcm.2003.11.002.
   Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF.
   Ravingerova T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033.
   Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200.
   Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329.
   Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37.
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2.
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376.
   Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75.
   Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002.
   Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687.
   Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200.
   Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109.
   Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119.
   Towbin JA, 2006, J CARDIOVASC ELECTR, V17, P919, DOI 10.1111/j.1540-8167.2006.00530.x.
   Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777.
   van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235.
   Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021.
   Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193.
   Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009.
   Zheng M, 2004, FASEB J, V18, P109, DOI 10.1096/fj.04-2604fje.
   Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807.
   Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092.},
Number-of-Cited-References = {53},
Times-Cited = {70},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Hum. Mol. Genet.},
Doc-Delivery-Number = {398GF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000262719900010},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1993MR91600002,
Author = {KNIGHT, J and SONG, L},
Title = {THE LENGTH OF LIFE AND THE STANDARD-OF-LIVING - ECONOMIC INFLUENCES ON
   PREMATURE DEATH IN CHINA},
Journal = {JOURNAL OF DEVELOPMENT STUDIES},
Year = {1993},
Volume = {30},
Number = {1},
Pages = {58-91},
Month = {OCT},
Abstract = {A detailed survey of mortality is used to analyse the determinants of
   premature death in rural China. Premature death is found to be inversely
   related to income: higher income in a county reduces its mortality rate,
   ceteris paribus. The inverse relationship is found for most major
   illnesses, and might be explained by the large element of self-reliance
   in the funding of health care expenditures in China, both at the
   household and the local levels. These and other results are used to
   address the basic question: why has there been a remarkable decline in
   premature mortality in China since the early 1950s? The contributions of
   income, of deliberate health care policies and of collective
   organisation are examined.},
Publisher = {FRANK CASS CO LTD},
Address = {11 GAINSBOROUGH ROAD, LONDON, ENGLAND E11 1RS},
Type = {Article},
Language = {English},
Affiliation = {KNIGHT, J (Corresponding Author), INST ECON \& STAT,OXFORD,OXON,ENGLAND.},
DOI = {10.1080/00220389308422305},
ISSN = {0022-0388},
Keywords-Plus = {MORTALITY},
Research-Areas = {Development Studies; Business \& Economics},
Web-of-Science-Categories  = {Development Studies; Economics},
Cited-References = {AHMAD E, 1989, 4 LOND SCH EC DEV EC.
   AORONG Z, 1987, HLTH POLICY MANAGEME.
   BANISTER J, 1981, POPUL DEV REV, V7, P98, DOI 10.2307/1972767.
   Banister Judith, 1987, CHINAS CHANGING POPU.
   BEHRMAN JR, 1988, HDB DEV EC, P631.
   Chen J, 1990, DIET LIFE STYLE MORT.
   CORNIA GA, 1989, J DEV PLANNING, V19, P159.
   Greene W. H., 1991, ECONOMETRIC ANAL.
   HUSSAIN A, 1990, 8 LOND SCH EC DEV EC.
   {*}INT MON FUND, 1982, INT FIN STAT.
   KNIGHT J, 1993, CAMBRIDGE J ECON, V17, P195, DOI 10.1093/oxfordjournals.cje.a035230.
   MARTORELL R, 1985, GOOD HLTH LOW COST, P199.
   MOSK C, 1986, POPUL DEV REV, V12, P415, DOI 10.2307/1973217.
   NOLAN P, 1992, WORLD DEV, V20, P1279, DOI 10.1016/0305-750X(92)90078-A.
   Parish W. L, 1978, VILLAGE FAMILY CONT.
   Preston S., 1976, MORTALITY PATTERNS N.
   Schultz TP, 1984, POPUL DEV REV, V10, P215, DOI 10.2307/2807962.
   SEN A, 1989, WORLD DEV, V17, P769, DOI 10.1016/0305-750X(89)90001-6.
   Sen A., 1989, J DEV PLANNING, V19, P41.
   SHAO YN, 1988, HLTH CAR CHIN.
   {*}STAT STAT BUR, 1989, STAT YB CHIN 1989.
   {*}STAT STAT BUR, 1986, STAT YB CHIN 1986.
   {*}UN, 1960, STAT YB 1960.
   {*}UN, 1969, YB NAT ACC STAT 1968, V2.
   VINES G, 1990, NEW SCI         1208, P37.
   {*}WORLD BANK, 1983, CHIN SOC EC DEV.
   {*}WORLD BANK, 1990, 1990 WORLD DEV REP.
   World Bank, 1989, CHIN LONG TERM ISS O.
   {*}WORLD BANK, 1988, 1988 WORLD DEV REP.
   YOUNG ME, 1986, 767 WORLD BANK STAFF.},
Number-of-Cited-References = {30},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {J. Dev. Stud.},
Doc-Delivery-Number = {MR916},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1993MR91600002},
DA = {2022-03-29},
}

@article{ WOS:A1987G508400024,
Author = {MOORE, D and HUNT, DJ},
Title = {THE ROLE OF PARASITIC NEMATODES AND HYMENOPTEROUS PARASITOIDS IN CAUSING
   PREMATURE DEATH OF OSCINELLA SPP LARVAE},
Journal = {ANNALS OF APPLIED BIOLOGY},
Year = {1987},
Volume = {110},
Number = {1},
Pages = {209-211},
Month = {FEB},
Publisher = {ASSN APPLIED BIOLOGISTS},
Address = {NATL VEGETABLE RES STATION WELLSBOURNE, WARWICK, ENGLAND CV35 9EF},
Type = {Article},
Language = {English},
Affiliation = {ANIM \& GRASSLAND RES INST,MAIDENHEAD SL6 5LR,BERKS,ENGLAND.
   CAB INT INST PARASITOL,ST ALBANS AL4 0XQ,ENGLAND.},
DOI = {10.1111/j.1744-7348.1987.tb03249.x},
ISSN = {0003-4746},
Research-Areas = {Agriculture},
Web-of-Science-Categories  = {Agriculture, Multidisciplinary},
Cited-References = {HENDERSON IF, 1977, J BRIT GRASSLAND SOC, V32, P89.
   MOORE D, 1984, ANN APPL BIOL, V104, P291, DOI 10.1111/j.1744-7348.1984.tb05613.x.
   MOORE D, 1983, B ENTOMOL RES, V73, P601, DOI 10.1017/S0007485300009202.
   MOORE D, 1986, IN PRESS J APPLIED E, V23.},
Number-of-Cited-References = {4},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Ann. Appl. Biol.},
Doc-Delivery-Number = {G5084},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1987G508400024},
DA = {2022-03-29},
}

@article{ WOS:000485515000001,
Author = {Karunarathne, Ayanthi and Gunnell, David and Konradsen, Flemming and
   Eddleston, Michael},
Title = {How many premature deaths from pesticide suicide have occurred since the
   agricultural Green Revolution?},
Journal = {CLINICAL TOXICOLOGY},
Year = {2020},
Volume = {58},
Number = {4},
Pages = {227-232},
Month = {APR 2},
Abstract = {Introduction: The agricultural Green Revolution in the 1950s and 60s is
   thought to have averted many deaths from famine. However, it also
   introduced highly hazardous pesticides such as parathion and endrin into
   poor rural communities that were totally unequipped to store or use them
   safely. Pesticide self-poisoning rapidly became one of the two most
   common global means of suicide. Thus far, no attempt has been made to
   enumerate the total number of deaths that have occurred subsequent to
   the Green Revolution. Objective: To calculate plausible estimates for
   the total global number of pesticide suicides that have occurred since
   1960. Methods: We performed a literature review on Medline and Embase
   databases to July 2019 to find papers that reported national or global
   numbers of pesticide suicides. We restricted our search to papers
   published in English. We used the search terms: pesticide) OR
   insecticide) OR paraquat) OR organophosphate) OR organophosphorus) OR
   agrochemical) AND suicide) OR ``{''}) OR deliberate) AND poison in all
   fields. These searches identified 2,144 papers; a further 8 citations
   were added through the searching of reference lists and our own paper
   collections. 2,136 papers were excluded as they contained no data on
   pesticide suicide, or were case reports, case series, or related to
   specific socio-demographic groups, or were non-human studies. This left
   16 papers giving country specific or global pesticide suicide data.
   Long-term national trend in pesticide suicides: We found studies from
   one low- and middle-income country (Sri Lanka) that recorded long-term
   trends in suicide throughout the Green Revolution. These data showed a
   steady increase in suicides from 1960 to the early 1970s, with a more
   rapid increase from 1979 to 1984. The number of suicides plateaued until
   1995, when they started a steady almost linear decrease that has
   continued at least until 2015. We used the Sri Lankan epidemiology as a
   model of the incidence of pesticide suicides in other low- and
   middle-income countries. Data from Bangladesh suggested that the
   decrease might have started in 2002. Estimating global numbers since
   1960: Starting from a conservative estimate of zero deaths in 1960, the
   best estimate of the total global burden of pesticide suicides from 1960
   to 2018 is 14,272,105 or 14,936,000 (depending on whether a fall in
   incidence began in 1995 or 2002), with a plausible range of 9,859,667 to
   17,303,333 deaths. These are likely underestimates because suicide is
   illegal in many countries, and most pesticide suicides occur in poor
   rural areas without effective death registration systems. Conclusions:
   Pesticide self-poisoning has been a major clinical and public health
   problem in rural Asia for decades, while being long ignored. Most
   pesticide suicides are relatively impulsive with little planning: in the
   absence of highly hazardous pesticides, many people would have survived
   their suicidal impulse, gone on to find support amongst family,
   community, and health services, and lived a full life. Pesticide
   suicides must therefore be considered a category 4 occupation condition
   following Schilling's classification - if they had not been brought into
   rural communities for agricultural use, pesticide suicides would not
   have occurred. Preventing these deaths should be a global public health
   priority.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Eddleston, M (Corresponding Author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Ctr Pesticide Suicide Prevent \& Pharmacol, Toxicol \& Therapeut, QMRI E3-22a,47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.
   Karunarathne, Ayanthi; Eddleston, Michael, Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Ctr Pesticide Suicide Prevent \& Pharmacol, Toxicol \& Therapeut, QMRI E3-22a,47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.
   Gunnell, David, Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.
   Konradsen, Flemming, Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, Copenhagen, Denmark.},
DOI = {10.1080/15563650.2019.1662433},
EarlyAccessDate = {SEP 2019},
ISSN = {1556-3650},
EISSN = {1556-9519},
Keywords = {Pesticide poisoning; suicide; mortality; Green Revolution},
Keywords-Plus = {POISONING DEATHS; CHINA; RATES; INDIA; MORTALITY; TRAGEDY; TRENDS;
   IMPACT},
Research-Areas = {Toxicology},
Web-of-Science-Categories  = {Toxicology},
Author-Email = {m.eddleston@ed.ac.uk},
ResearcherID-Numbers = {Gunnell, David/ABE-6653-2020
   },
ORCID-Numbers = {Gunnell, David/0000-0002-0829-6470
   Eddleston, Michael/0000-0002-6857-3441
   Konradsen, Flemming/0000-0003-1036-6949},
Funding-Acknowledgement = {Open Philanthropy Project Fund, an advised fund of Silicon Valley
   Community Foundation; NIHR Biomedical Research Centre at University
   Hospitals Bristol NHS Foundation Trust; University of Bristol, England;
   MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MR/M024075/1] Funding Source: UKRI},
Funding-Text = {We thank Dr Odin Chang and Dr Tse Man-Li for their help with reviewing
   the early Chinese language literature on pesticide poisoning. The Centre
   for Pesticide Suicide Prevention is funded by an Incubator Grant from
   the Open Philanthropy Project Fund, an advised fund of Silicon Valley
   Community Foundation, on the recommendation of GiveWell, USA. DG is
   supported by the NIHR Biomedical Research Centre at University Hospitals
   Bristol NHS Foundation Trust and the University of Bristol, England. The
   views expressed in this publication are those of the author(s) and not
   necessarily those of the NHS, the National Institute for Health Research
   or the Department of Health and Social Care.},
Cited-References = {Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0.
   Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304.
   Chowdhury FR, 2018, INT J EPIDEMIOL, V47, P175, DOI 10.1093/ije/dyx157.
   Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X.
   DAVIES GM, 1956, BMJ-BRIT MED J, V2, P393, DOI 10.1136/bmj.2.4989.393.
   Davies WP, 2003, NUTR REV, V61, pS124, DOI 10.1301/nr.2003.jun.S124-S134.
   Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715.
   Eddleston M, 2006, CLIN TOXICOL, V44, P283, DOI 10.1080/15563650600584444.
   Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42.
   Eddleston M, 1998, BRIT MED J, V317, P133, DOI 10.1136/bmj.317.7151.133.
   Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9.
   Elver H, 2017, AHRC3448 UN NAT GEN.
   ESHCHAR Y., 1961, ISRAEL MED JOUR, V20, P85.
   Food and Agriculture Organization of the United Nations, 2016, INT COD COND PEST MA.
   FROST J, 1964, Dan Med Bull, V11, P169.
   Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164.
   Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307.
   Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357.
   HOSSAIN K, 1946, Ind Med Gaz, V81, P418.
   Indian Council of Agricultural Research, 1967, REP SPEC COMM HARMF.
   Jayewardene C H, 1966, Ceylon Med J, V11, P143.
   JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139.
   JEYARATNAM J, 1982, B WORLD HEALTH ORGAN, V60, P615.
   JEYARATNAM J, 1987, B WORLD HEALTH ORGAN, V65, P521.
   Joseph A, 2003, BRIT MED J, V326, P1121, DOI 10.1136/bmj.326.7399.1121.
   Jupp J, 1977, PAC AFF, V50, P625.
   KARUNAKARAN C O, 1958, J Indian Med Assoc, V31, P204.
   Knipe DW, 2017, LANCET GLOB HEALTH, V5, pE651, DOI 10.1016/S2214-109X(17)30208-5.
   Knipe DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172893.
   Knipe DW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-839.
   Konradsen F, 2005, B WORLD HEALTH ORGAN, V83, P157.
   Liang BX, 1959, MED PHARM YUNNAN, V3, P37.
   Liu JZ, 1957, INTER MED J, V5, P37.
   London L, 2019, ENVIRON HEALTH INSIG, V13, DOI 10.1177/1178630218825243.
   Manuweera G, 2008, ENVIRON HEALTH PERSP, V116, P492, DOI 10.1289/ehp.11029.
   Mars B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-606.
   Mew EJ, 2017, J AFFECT DISORDERS, V219, P93, DOI 10.1016/j.jad.2017.05.002.
   OHBERG A, 1995, BRIT J PSYCHIAT, V166, P35, DOI 10.1192/bjp.166.1.35.
   Page A, 2017, J AFFECT DISORDERS, V208, P418, DOI 10.1016/j.jad.2016.10.047.
   Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0.
   Pearson M, 2017, LANCET, V390, P1863, DOI 10.1016/S0140-6736(17)31961-X.
   Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3.
   Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0.
   Pimentel D, 1996, SCI TOTAL ENVIRON, V188, pS86, DOI 10.1016/0048-9697(96)05280-1.
   Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109.
   Popp J, 2013, AGRON SUSTAIN DEV, V33, P243, DOI 10.1007/s13593-012-0105-x.
   Prasad J, 2006, INT J SOC PSYCHIATR, V52, P65, DOI 10.1177/0020764006061253.
   Reddy D B, 1966, J Indian Med Assoc, V46, P121.
   Roberts DM, 2003, B WORLD HEALTH ORGAN, V81, P789.
   SCHILLING RSF, 1989, BRIT J IND MED, V46, P683.
   The Lancet, 2017, Lancet, V389, P1076, DOI 10.1016/S0140-6736(17)30766-3.
   The Lancet Public H, 2018, LANCET PUBLIC HEALTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7.
   VETHANAY.AV, 1962, BRIT MED J, P986.
   VETHANAYAGAM A. V. A., 1962, CEYLON MED J, V7, P209.
   Wang LJ, 2018, B WORLD HEALTH ORGAN, V96, P314, DOI 10.2471/BLT.17.203943.
   Wesseling C, 1997, INT J HEALTH SERV, V27, P273, DOI 10.2190/E259-N3AH-TA1Y-H591.
   WHO, 2014, PREVENTING SUICIDE A.
   WHO (World Health Organization), 1990, PUBL HLTH IMP PEST U.
   World Health Organization, 2004, THE IMPACT OF PESTIC.
   ZHANG WJ, 2018, PROC INT ACAD ECOL E, V8, P1.
   Zinyemba C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196901.},
Number-of-Cited-References = {61},
Times-Cited = {31},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Clin. Toxicol.},
Doc-Delivery-Number = {KO4RI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000485515000001},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000282789700005,
Author = {Feigelman, William and Gorman, Bernard S.},
Title = {Prospective Predictors of Premature Death: Evidence from the National
   Longitudinal Study of Adolescent Health},
Journal = {JOURNAL OF PSYCHOACTIVE DRUGS},
Year = {2010},
Volume = {42},
Number = {3},
Pages = {353-361},
Month = {SEP},
Abstract = {This study was based on data from the National Longitudinal Study of
   Adolescent Health (Add Health), which revealed that 96 of its original
   Wave I respondents died prior to the collection of the Wave III survey.
   We compared psychosocial and behavioral characteristics reported at Wave
   I among those who died and those who lived (n = 16,719) using chi-square
   tests, t-tests, and logistic regression analyses to determine the most
   important risk factors for premature death among adolescents and young
   adults. Results suggested that driving while drunk was the most
   important risk factor for premature death (adjusted odds ratio = 2.48;
   95\% confidence interval: 1.12-5.50). The prevalence of driving while
   drunk was 17.7\% among decedents compared with 6.4\% among the
   survivors. Decedents were also significantly more likely to report
   multiple risk behaviors than survivors. As the current study
   demonstrates the importance of alcohol use as a contributing factor to
   the three leading causes of youth deaths, renewed efforts are needed to
   prevent and reduce alcohol consumption and abuse among this vulnerable
   population.},
Publisher = {ROUTLEDGE JOURNALS, TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Feigelman, W (Corresponding Author), Nassau Community Coll, Garden City, NY 11530 USA.
   Feigelman, William; Gorman, Bernard S., Nassau Community Coll, Garden City, NY 11530 USA.},
DOI = {10.1080/02791072.2010.10400698},
ISSN = {0279-1072},
EISSN = {2159-9777},
Keywords = {alcohol abuse; at-risk youth; risk behaviors; young adult mortality;
   youth mortality},
Keywords-Plus = {REDUCING DRINKING; ADULT MORTALITY; ALCOHOL; DIFFERENTIALS; DEPRESSION;
   CHILDHOOD; VIOLENCE; ISSUES; TRENDS},
Research-Areas = {Psychology; Substance Abuse},
Web-of-Science-Categories  = {Psychology, Clinical; Substance Abuse},
Author-Email = {feigelw@ncc.edu},
ResearcherID-Numbers = {Feigelman, William/R-9736-2019},
Funding-Acknowledgement = {NICHD NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health \& Human Development (NICHD)
   {[}P01-HD31921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH \& HUMAN DEVELOPMENTUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health \& Human
   Development (NICHD) {[}P01HD031921] Funding Source: NIH RePORTER},
Cited-References = {Badawi MA, 1999, SOC PSYCH PSYCH EPID, V34, P91, DOI 10.1007/s001270050117.
   BARRIOS LC, 2003, AM J HLTH ED S, V34, pS18.
   Barry R., 2004, Morbidity and Mortality Weekly Report, V53, P452.
   Bearman P., 1997, NATL LONGITUDINAL ST.
   Beyth-Marom R., 1997, HLTH RISKS DEV TRANS.
   BOONE DE, 1994, PSYCHOL REP, V74, P159, DOI 10.2466/pr0.1994.74.1.159.
   Brewer RD, 2005, JAMA-J AM MED ASSOC, V294, P616, DOI 10.1001/jama.294.5.616.
   CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1.
   Centers for Disease Control and Prevention, 2010, WEB BAS INJ STAT QU.
   Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22.
   CHANTALA K, 1999, STRATEGIES PER UNPUB.
   Dixey RA, 1999, HEALTH EDUC RES, V14, P197, DOI 10.1093/her/14.2.197.
   Elder RW, 2005, AM J PREV MED, V28, P288, DOI 10.1016/j.amepre.2005.02.015.
   Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002.
   FAN X, 2002, ADOPTION Q, V0006.
   Fan XT, 2006, FIELD METHOD, V18, P223, DOI 10.1177/152822X06289161.
   Glueck E. T., 1950, UNRAVELING JUVENILE.
   HINGSON R, 2006, HDB INJURY VIOLENCE.
   Hummer RA, 2000, SOC SCI QUART, V81, P459.
   JAMISON K, 1999, NIGHT FALLS FAST UND.
   Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076.
   Lattimore PK, 1997, J RES CRIME DELINQ, V34, P187, DOI 10.1177/0022427897034002002.
   Loeber R, 2005, J CONSULT CLIN PSYCH, V73, P1074, DOI 10.1037/0022-006X.73.6.1074.
   Loeber R, 1999, Violence Vict, V14, P339.
   Loeber R, 1997, ANNU REV PSYCHOL, V48, P371, DOI 10.1146/annurev.psych.48.1.371.
   MARZUK PM, 1995, NEW ENGL J MED, V332, P1753, DOI 10.1056/NEJM199506293322606.
   MULLENHARRIS K, 2002, SOC FORCES, V80, P1005.
   {*}NHTSA, 2002, YOUTH FAT CRASH ALC.
   Price DM, 2001, J THERM ANAL CALORIM, V64, P309, DOI 10.1023/A:1011569904070.
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306.
   Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6.
   SIMS ACP, 1988, INT CLIN PSYCHOPHARM, V3, P1.
   Singh GK, 1996, AM J PUBLIC HEALTH, V86, P560, DOI 10.2105/AJPH.86.4.560.
   Solomon Andrew., 2001, NOONDAY DEMON ATLAS.
   Spirito A, 2004, J PEDIATR-US, V145, P396, DOI 10.1016/j.jpeds.2004.04.057.
   {*}STAT CORP, 2001, STAT REF MAN REL 7.
   Swift W, 1996, ADDICTION, V91, P1141, DOI 10.1046/j.1360-0443.1996.91811416.x.
   Teplin LA, 2005, PEDIATRICS, V115, P1586, DOI 10.1542/peds.2004-1459.
   Thomson W, 1996, PERS INDIV DIFFER, V21, P613, DOI 10.1016/0191-8869(96)00104-3.
   TOURANGEAU R, 1999, GRAND SAMPLE W UNPUB.
   Unwin E, 1999, AUST NZ J PUBL HEAL, V23, P352, DOI 10.1111/j.1467-842X.1999.tb01274.x.
   {*}US DHHS, 2001, YOUTH VIOL REP SURG.
   Wagenaar AC, 2000, J STUD ALCOHOL, V61, P85, DOI 10.15288/jsa.2000.61.85.
   Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440.
   YEAGER CA, 1990, AM J PSYCHIAT, V147, P612.},
Number-of-Cited-References = {45},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Psychoact. Drugs},
Doc-Delivery-Number = {662EI},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000282789700005},
DA = {2022-03-29},
}

@article{ WOS:000247135700012,
Author = {Soder, B. and Jin, L. J. and Klinge, B. and Soder, P.-O.},
Title = {Periodontitis and premature death: a 16-year longitudinal study in a
   Swedish urban population},
Journal = {JOURNAL OF PERIODONTAL RESEARCH},
Year = {2007},
Volume = {42},
Number = {4},
Pages = {361-366},
Month = {AUG},
Abstract = {Background and Objective: Growing experimental evidence implicates
   chronic inflammation/infection due to periodontal diseases as a risk
   factor for death. The objective was to evaluate the role of
   periodontitis in premature death in a prospective study.
   Methods: The causes of death in 3273 randomly-selected subjects, aged
   30-40 years, from 1985 to 2001 were registered. At baseline, 1676
   individuals underwent a clinical oral examination (Group A) and 1597 did
   not (Group B). Mortality and causes of death from 1985 to 2001 were
   recorded according to ICD-9-10.
   Results: In Groups A (clinically examined group) and B, a total of 110
   subjects had died: 40 subjects in Group A, and 70 in Group B. In Group A
   significant differences were present at baseline between survivors and
   persons who later died, with respect to dental plaque, calculus,
   gingival inflammation and number of missing molars in subjects with
   periodontitis (p < 0.001). The multiple logistic regression analysis
   results of the relationship between being dead (dependent variable) and
   several independent variables identified periodontitis with any missing
   molars as a principal independent predictor of death.
   Conclusions: Young individuals with periodontitis and missing molars
   seem to be at increased risk for premature death by life-threatening
   diseases, such as neoplasms, and diseases of the circulatory and
   digestive systems.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Soder, B (Corresponding Author), Karolinska Inst, Inst Odontol, Box 4064, S-14104 Huddinge, Sweden.
   Karolinska Inst, Inst Odontol, S-14104 Huddinge, Sweden.
   Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.},
DOI = {10.1111/j.1600-0765.2006.00957.x},
ISSN = {0022-3484},
EISSN = {1600-0765},
Keywords = {missing molars; periodontitis; premature death},
Keywords-Plus = {CORONARY-HEART-DISEASE; SERUM ANTIBODY-LEVELS; CARDIOVASCULAR-DISEASE;
   DENTAL DISEASE; RISK; INFECTIONS; ATHEROSCLEROSIS; EPIDEMIOLOGY; PREDICT},
Research-Areas = {Dentistry, Oral Surgery \& Medicine},
Web-of-Science-Categories  = {Dentistry, Oral Surgery \& Medicine},
Author-Email = {birgitta.soder@ki.se},
ResearcherID-Numbers = {Klinge, Bjorn/ABA-7045-2021
   },
ORCID-Numbers = {Jin, Lijian/0000-0003-4305-1337
   Klinge, Bjorn/0000-0003-2100-2446},
Cited-References = {Airila-Mansson S, 2005, J CLIN PERIODONTOL, V32, P822, DOI 10.1111/j.1600-051X.2005.00744.x.
   ALBANDAR JM, 1990, J CLIN PERIODONTOL, V17, P467, DOI 10.1111/j.1600-051X.1990.tb02346.x.
   Albandar JM, 2002, PERIODONTOL 2000, V29, P31, DOI 10.1034/j.1600-0757.2002.290103.x.
   Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089.
   Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803.
   BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474.
   Bostrom G, 2001, SCAND J PUBLIC HEALT, P17.
   Buhlin K, 2003, EUR HEART J, V24, P2099, DOI 10.1016/j.ehj.2003.09.016.
   Danesh J, 1999, AM HEART J, V138, pS434, DOI 10.1016/S0002-8703(99)70270-X.
   DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688.
   Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22.
   Frisk F, 2003, ACTA ODONTOL SCAND, V61, P257, DOI 10.1080/00016350310005510.
   Gjermo P, 2002, PERIODONTOL 2000, V29, P70, DOI 10.1034/j.1600-0757.2001.290104.x.
   Greene JC, 1960, J AM DENT ASSOC, V61, P172, DOI DOI 10.14219/JADA.ARCHIVE.1960.0177.
   Howell TH, 2001, J AM COLL CARDIOL, V37, P445, DOI 10.1016/S0735-1097(00)01130-X.
   Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406.
   Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107.
   LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240.
   MATTILA KJ, 1989, J INTERN MED, V225, P293, DOI 10.1111/j.1365-2796.1989.tb00084.x.
   MATTILA KJ, 1993, EUR HEART J, V14, P51.
   Morrison HI, 1999, J CARDIOVASC RISK, V6, P7.
   Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x.
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8.
   Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59.
   Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008.
   Pussinen PJ, 2004, CURR OPIN LIPIDOL, V15, P583, DOI 10.1097/00041433-200410000-00013.
   Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe.
   Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38.
   Sheiham A, 2002, PERIODONTOL 2000, V29, P104, DOI 10.1034/j.1600-0757.2002.290106.x.
   SILNESS J, 1964, ACTA ODONTOL SCAND, V11, P19.
   Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x.
   Soder PO, 2005, STROKE, V36, P1195, DOI 10.1161/01.STR.0000165916.90593.cb.
   SYRJANEN J, 1989, J INTERN MED, V225, P179, DOI 10.1111/j.1365-2796.1989.tb00060.x.
   Wickholm S, 2004, ACTA ODONTOL SCAND, V62, P333, DOI 10.1080/00016350410001801.
   WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606.
   Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749.},
Number-of-Cited-References = {36},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Periodont. Res.},
Doc-Delivery-Number = {177EF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000247135700012},
DA = {2022-03-29},
}

@article{ WOS:A1973O855500013,
Author = {DEUTSCHER, S},
Title = {SOME FACTORS INFLUENCING DISTRIBUTION OF PREMATURE DEATH FROM CORONARY
   HEART-DISEASE IN NOVA-SCOTIA},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {1973},
Volume = {63},
Number = {2},
Pages = {150-157},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT EPIDEMIOL \& MICROBIOL, PITTSBURGH, PA 15213 USA.},
DOI = {10.2105/AJPH.63.2.150},
ISSN = {0090-0036},
EISSN = {1541-0048},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {ARMITAGE P, 1971, STATISTICAL METHODS, P310.
   BRENNER MH, 1971, AM J PUBLIC HEALTH N, V61, P606, DOI 10.2105/AJPH.61.3.606.
   CHASE HC, 1963, PUBL HLTH REP WASH, V78, P527.
   COMSTOCK GW, 1971, AM J EPIDEMIOL, V94, P1.
   CRAWFORD MD, 1971, BRIT MED BULL, V27, P21, DOI 10.1093/oxfordjournals.bmb.a070808.
   DUDLEY EF, 1969, J CHRON DIS, V22, P25, DOI 10.1016/0021-9681(69)90084-8.
   EPSTEIN FH, 1965, J CHRON DIS, V18, P735, DOI 10.1016/0021-9681(65)90017-2.
   GARDNER MJ, 1969, BRIT J PREV SOC MED, V23, P133.
   Geary R.C., 1954, INC STAT, V5, P115, DOI {[}10.2307/2986645, DOI 10.2307/2986645].
   HECHTER HH, 1965, PUBLIC HEALTH REP, V80, P11, DOI 10.2307/4592347.
   SAUER H I, 1959, J Chronic Dis, V10, P513, DOI 10.1016/0021-9681(59)90041-4.
   SAUER HI, 1966, PUBLIC HEALTH REP, V81, P455, DOI 10.2307/4592745.},
Number-of-Cited-References = {12},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {O8555},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1973O855500013},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000657771800001,
Author = {Bray, Freddie and Laversanne, Mathieu and Weiderpass, Elisabete and
   Soerjomataram, Isabelle},
Title = {The ever-increasing importance of cancer as a leading cause of premature
   death worldwide},
Journal = {CANCER},
Year = {2021},
Volume = {127},
Number = {16},
Pages = {3029-3030},
Month = {AUG 15},
Abstract = {The relative importance of cardiovascular disease (CVD) and cancer as
   leading causes of premature death are examined in this communication.
   CVD and cancer are now the leading causes in 127 countries, with CVD
   leading in 70 countries (including Brazil and India) and cancer leading
   in 57 countries (including China). Such observations can be seen as part
   of a late phase of an epidemiologic transition, taking place in the
   second half of the 20th century and the first half of the present one,
   in which the dominance of infectious diseases is progressively
   superseded by noncommunicable diseases. According to present ranks and
   recent trends, cancer may surpass CVD as the leading cause of premature
   death in most countries over the course of this century. Clearly,
   governments must factor in these transitions in developing cancer
   policies for the local disease profile.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Bray, F (Corresponding Author), Int Agcy Res Canc, Canc Surveillance Branch, 150 Cours Albert Thomas, F-69372 Lyon 08, France.
   Bray, Freddie; Laversanne, Mathieu; Weiderpass, Elisabete; Soerjomataram, Isabelle, Int Agcy Res Canc, Lyon, France.},
DOI = {10.1002/cncr.33587},
EarlyAccessDate = {JUN 2021},
ISSN = {0008-543X},
EISSN = {1097-0142},
Keywords = {cancer control; cardiovascular disease (CVD); epidemiologic transition;
   noncommunicable diseases (NCDs); premature mortality},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {brayf@iarc.fr},
ResearcherID-Numbers = {Weiderpass, Elisabete/M-4029-2016},
ORCID-Numbers = {Bray, Freddie/0000-0002-3248-7787
   Weiderpass, Elisabete/0000-0003-2237-0128},
Cited-References = {Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X.
   Bray F, 2015, CANC DIS CONTROL PRI, V3rd, P23.
   Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2.
   Levi F, 1999, EUR J CANCER, V35, P1477, DOI 10.1016/S0959-8049(99)00154-9.
   Oar A, 2019, LANCET ONCOL, V20, pE645, DOI 10.1016/S1470-2045(19)30404-8.
   Romero Y, 2018, LANCET ONCOL, V19, pE546, DOI 10.1016/S1470-2045(18)30681-8.
   United Nations, 2019, WORLD POPULATION PRO, VII.
   World Health Organization, BEST BUYSOTHER RECOM.
   World Health Organization (WHO), 2020, GLOBAL HLTH ESTIMATE.},
Number-of-Cited-References = {9},
Times-Cited = {47},
Usage-Count-Last-180-days = {86},
Usage-Count-Since-2013 = {117},
Journal-ISO = {Cancer},
Doc-Delivery-Number = {TM8WY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000657771800001},
DA = {2022-03-29},
}

@article{ WOS:A1988M506200005,
Author = {FERREIRA, CL and GILLILAND, SE},
Title = {BACTERIOCIN INVOLVED IN PREMATURE DEATH OF LACTOBACILLUS-ACIDOPHILUS
   NCFM DURING GROWTH AT PH-6},
Journal = {JOURNAL OF DAIRY SCIENCE},
Year = {1988},
Volume = {71},
Number = {2},
Pages = {306-315},
Month = {FEB},
Publisher = {AMER DAIRY SCIENCE ASSOC},
Address = {309 W CLARK ST, CHAMPAIGN, IL 61820},
Type = {Article},
Language = {English},
Affiliation = {OKLAHOMA STATE UNIV,DEPT ANIM SCI,STILLWATER,OK 74078.},
DOI = {10.3168/jds.S0022-0302(88)79559-4},
ISSN = {0022-0302},
Research-Areas = {Agriculture; Food Science \& Technology},
Web-of-Science-Categories  = {Agriculture, Dairy \& Animal Science; Food Science \& Technology},
Cited-References = {BAREFOOT SF, 1983, APPL ENVIRON MICROB, V45, P1808, DOI 10.1128/AEM.45.6.1808-1815.1983.
   Bergere J. -L., 1968, Lait, V48, P13, DOI 10.1051/lait:1968471-4722.
   COLLINS EB, 1980, J DAIRY SCI, V63, P353, DOI 10.3168/jds.S0022-0302(80)82938-9.
   DAHYA RS, 1968, J DAIRY SCI, V51, P1568.
   DEKLERK HC, 1967, NATURE, V214, P609, DOI 10.1038/214609a0.
   DEKLERK HC, 1967, J GEN MICROBIOL, V48, P309, DOI 10.1099/00221287-48-2-309.
   ELLISON JS, 1970, J BACTERIOL, V104, P19, DOI 10.1128/JB.104.1.19-26.1970.
   Genus Rogosa M., 1974, BERGEYS MANUAL DETER, P576.
   GILLILAN.SE, 1968, J DAIRY SCI, V51, P1573, DOI 10.3168/jds.S0022-0302(68)87233-9.
   Gilliland S E., 1985, BACTERIAL STARTER CU, P145.
   GILLILAND SE, 1974, J MILK FOOD TECHNOL, V37, P107, DOI 10.4315/0022-2747-37.2.107.
   GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P1289, DOI 10.1128/AEM.33.6.1289-1292.1977.
   IRIE R, 1974, J AGR CHEM SOC JPN, V48, P343, DOI 10.1271/nogeikagaku1924.48.343.
   IVANOVICS G, 1954, Nature, V174, P465, DOI 10.1038/174465a0.
   Jonas L. L., 1977, Cultured Dairy Products Journal, V12, P12.
   KEEN AR, 1972, J DAIRY RES, V39, P151, DOI 10.1017/S0022029900013947.
   KONISKY J, 1978, BACTERIA, V6, P71.
   Lloyd G. T., 1971, Dairy Science Abstracts, V33, P411.
   Marth E.H., 1978, STANDARD METHODS EXA, V4th.
   Mayr-Harting A., 1972, METHODS MICROBIOLO A, P315, DOI DOI 10.1016/S0580-9517(08)70618-4.
   MISTRY VV, 1986, J DAIRY SCI, V69, P945, DOI 10.3168/jds.S0022-0302(86)80485-4.
   MITCHELL SL, 1983, J DAIRY SCI, V66, P712, DOI 10.3168/jds.S0022-0302(83)81849-9.
   NOMURA M, 1967, ANNU REV MICROBIOL, V21, P257, DOI 10.1146/annurev.mi.21.100167.001353.
   PONT EG, 1968, AUST J DAIRY TECHNOL, V23, P22.
   STANLEY G, 1977, J SOC DAIRY TECHNOL, V30, P36, DOI 10.1111/j.1471-0307.1977.tb01165.x.
   Steel R.G.D, 1980, PRINCIPLES PROCEDURE.
   TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976.
   TAGG JR, 1981, CAN J MICROBIOL, V27, P918, DOI 10.1139/m81-144.
   UPRETI GC, 1973, ANTIMICROB AGENTS CH, V4, P487, DOI 10.1128/AAC.4.4.487.
   VINCENT JG, 1959, J BACTERIOL, V78, P477, DOI 10.1128/JB.78.4.477-484.1959.},
Number-of-Cited-References = {30},
Times-Cited = {15},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Dairy Sci.},
Doc-Delivery-Number = {M5062},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1988M506200005},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000172189200002,
Author = {Rosefielde, S},
Title = {Premature deaths: Russia's radical economic transition in Soviet
   perspective},
Journal = {EUROPE-ASIA STUDIES},
Year = {2001},
Volume = {53},
Number = {8},
Pages = {1159-1176},
Month = {DEC},
Publisher = {ROUTLEDGE JOURNALS, TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Rosefielde, S (Corresponding Author), Univ N Carolina, CB 3305,Gardner Hall, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Chapel Hill, NC 27599 USA.},
DOI = {10.1080/09668130120093174},
ISSN = {0966-8136},
EISSN = {1465-3427},
Keywords-Plus = {MARKET; PROPERTY},
Research-Areas = {Area Studies; Business \& Economics; Government \& Law},
Web-of-Science-Categories  = {Area Studies; Economics; Political Science},
Author-Email = {stevenr@email.unc.edu},
ResearcherID-Numbers = {Corkish, Richard/G-9441-2017},
ORCID-Numbers = {Corkish, Richard/0000-0001-7730-6284},
Cited-References = {ANDERSON B, PREMATURE DEATHS NEW, P120.
   ANDREEV EM, 1993, NASELENIE SOVETSKOG.
   Becker C, 1998, WORLD DEV, V26, P1913, DOI 10.1016/S0305-750X(98)00097-7.
   Bobadilla JL, 1997, PREMATURE DEATH NEW.
   BRESLAUER G, 2000, 32 NAT CONV AM ASS A.
   Bukharin N., 1969, ABC COMMUNISM.
   CHEN L, 1996, POPULATION DEV REV, V22.
   COMMANDER S, 1996, UNEMPLOYMENT RESTRUC.
   COMMANDER S, 1997, LESSONS EC TRANSITIO, P331.
   CONQUEST R, 1994, AM HIST REV      JUN, P1039.
   CONQUEST R, 1999, REFLECTIONS RAVAGED.
   CONQUEST R, 1986, HARVEST SORROW.
   Cornia G. A., 1996, MOST, V6, P95, DOI DOI 10.1007/BF02430940.
   CORNIA GA, 1995, TRANSITION MORTALITY.
   CORNIA GA, 1996, MOST, V6.
   COURTOIS S, 1998, BLACK BOOK COMMUNISM.
   DAVIS, EC TRANSFORMATION SO, P291.
   DAVIS RW, 1994, EC TRANSFORMATION SO, P62.
   EBERSTADT, 1999, POLICY REV       JUL.
   EBERSTADT, 1999, POLICY REV       JUN.
   Eberstadt N, 1990, Communist Econ, V2, P347.
   EBERSTADT N, 1994, EUROPE-ASIA STUD, V46, P519, DOI 10.1080/09668139408412176.
   EBERSTADT N, 1994, NATL INTEREST    SUM, P53.
   EBERSTADT N, 1994, EUROPE ASIA STUDIES, V46.
   ELLMAN M, 1994, J COMP ECON, V19, P1, DOI 10.1006/jcec.1994.1060.
   Ellman M, 2000, EUROPE-ASIA STUD, V52, P1417, DOI 10.1080/713663143.
   ELLMAN M, 1994, CAMBRIDGE J ECON, V18, P329, DOI 10.1093/oxfordjournals.cje.a035279.
   ELLMAN M, 1997, LESSONS EC TRANSITIO, P351.
   ELLMAN M, 2000, IN PRESS EC SURVEY E.
   ELLMAN M, 6 ICCEES WORLD C TAM.
   FESHBACH M, 1995, ECOLOGICAL DISASTER.
   FESHBACH M, 1993, FORMER SOVIET UNION, V2, P847.
   FESHBACH M, 1994, ENV HLTH ATLAS RUSSI.
   FESHBACH M, 1999, WASHINGTON POST 1024, pB7.
   FESHBACH M, 1994, ECOCIDE USSR HLTH NA.
   FESHBACH M, 1999, 31 NAT CONV AAASS ST.
   FESHBACK M, 1992, ECOCIDE USSR.
   FIELD M, 2000, TORN SAFETY NETS.
   Fischer S, 1996, J ECON PERSPECT, V10, P45, DOI 10.1257/jep.10.2.45.
   FISCHER S, 1991, J ECON PERSPECT, V5, P91, DOI 10.1257/jep.5.4.91.
   FURET F, 1999, PASSING ILLUSION IDE.
   GERSCHENKRON A, 1966, EC BACKWARDNESS HIST, P119.
   GETTY JA, 2000, ATLANTIC MONTHLY MAR, V285, P113.
   GLAZEV SY, 1998, GENOTSID OKTYABR 199.
   Gomulka S., 1991, COMP EC STUDIES, VXXXIII, P71.
   GOSKOMSTAT, 1997, DEMOGRAPHIC YB RUSSI, P549.
   GUTTENPLAN D, 2000, ATLANTIC MONTHLY, V285, P45.
   Hedlund S, 2001, EUROPE-ASIA STUD, V53, P213, DOI 10.1080/09668130020032271.
   Hedlund S, 1999, RUSSIAS MARKET EC BA.
   Ivanova Galina Mikhailovna, 2000, LABOR CAMP SOCIALISM.
   JACKMAN R, LESSONS EC TRANSITIO, P273.
   Khanin G, 1999, EUROPE-ASIA STUD, V51, P1433, DOI 10.1080/09668139998408.
   KINGKADE WW, 1993, FORMER SOVIET UNION, V2, P807.
   KINGKADE WW, PREMATURE DEATH NEW, P156.
   KINGKADE WW, 1993, FORMER SOVIET UNION, V2, P809.
   KONTOROVICH V, 2000, 6 ICCEES WORLD C TAM.
   KORNAI J, 1994, J COMP ECON, V19, P39, DOI 10.1006/jcec.1994.1062.
   KRIVOSHEEV GF, 1997, SOVIET CASUALTIES CO, P35.
   KUBONIWA M, DEV CAPITALISM RUSSI, pCH3.
   Lenin V. I., 1918, STATE REVOLUTION.
   Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6.
   Lorimer Frank, 1946, POPULATION SOVIET UN.
   MACURA M, 1995, STUDIA DEMOGRAFICZNE, V4.
   MALIA M, 2000, RUSSIA W EYES.
   MEDE F, 1996, TENDANCES RECENTES M, P65.
   MESLE F, 1996, TENDANCES RECENTES M.
   MURPHY KM, 1992, Q J ECON, V107, P889, DOI 10.2307/2118367.
   NOVE A, 1969, EC HIST USSR, P66.
   POWELL D, 2000, ROUNDT HLTH COND FOR.
   Rapaczynski A, 1996, J ECON PERSPECT, V10, P87, DOI 10.1257/jep.10.2.87.
   RIMASHEVSKAYA NM, 1999, ROSSIYA 1998, P95.
   Rosefielde S, 1996, EUROPE-ASIA STUD, V48, P959, DOI 10.1080/09668139608412393.
   Rosefielde S, 2001, PROBL POST-COMMUNISM, V48, P4.
   Rosefielde S, 2000, EUROPE-ASIA STUD, V52, P1433, DOI 10.1080/713663146.
   ROSEFIELDE S, 1983, SOV STUD, V35, P400.
   ROSEFIELDE S, 2002, COMP EC SYSTEMS, pCH14.
   ROSTOWSKI J, 1997, LESSONS EC TRANSITIO, P225.
   SHAPIRO J, 1995, RUSSIAN EC REFORM JE, P00149.
   SHKOLNIKOV V, PREMATURE DEATH NEW, P34.
   SOLNICK S, 1999, STEALING STATE.
   Stiglitz J.E., 1999, ANN WORLD BANK C DEV.
   TAYLOR L, 1994, J COMP ECON, V19, P64, DOI 10.1006/jcec.1994.1063.
   {*}UN, 1999, EC SURV EUR, P135.
   {*}UN EC COMM EUR, 1999, EC SURVEY EUROPE, pCH4.
   {*}UNICEFICDC, 1993, 1 UNICEFICDC.
   VANDYCKE N, THESIS LSE.
   VISHNEVSKY A, POPULATION DURESS, P59.
   VISHNEVSKY A, 1997, 19 MOSC CARN CTR.
   Volkov EZ, 1930, DINAMIKA NASELENIYA.
   WEDEL J, 2000, NATL INTEREST    SPR.
   WEDEL J, 2000, NATL INTEREST    FAL, P117.
   WEDEL J, 2000, NATL INTEREST    SUM.
   {*}WORLD BANK, 1995, RUSS FED REP NAT ACC.
   Yavlinsky G, 1998, FOREIGN AFF, V77, P67, DOI 10.2307/20048877.
   Zayonchkovskaya Zhanna, 1999, POPULATION DURESS GE.
   {[}No title captured].
   {[}No title captured].},
Number-of-Cited-References = {97},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Eur.-Asia Stud.},
Doc-Delivery-Number = {492VX},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000172189200002},
DA = {2022-03-29},
}

@article{ WOS:A1990EG26100008,
Author = {WIGLE, DT and MAO, Y and SEMENCIW, R and MCCANN, C and DAVIES, JW},
Title = {PREMATURE DEATHS IN CANADA - IMPACT, TRENDS AND OPPORTUNITIES FOR
   PREVENTION},
Journal = {CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE},
Year = {1990},
Volume = {81},
Number = {5},
Pages = {376-381},
Month = {SEP-OCT},
Publisher = {CANADIAN PUBL HEALTH ASSN},
Address = {1565 CARLING AVE, SUITE 400, OTTAWA ON K1Z 8R1, CANADA},
Type = {Article},
Language = {English},
Affiliation = {WIGLE, DT (Corresponding Author), HLTH \& WELF CANADA,HLTH PROTECT BRANCH,LAB CTR DIS CONTROL,BUR CHRON DIS EPIDEMIOL,OTTAWA K1A 0L2,ONTARIO,CANADA.},
ISSN = {0008-4263},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {CHARLTON JRH, 1986, BRIT MED J, V292, P295, DOI 10.1136/bmj.292.6516.295.
   CHARLTON JRH, 1983, LANCET, V1, P691.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   JOHANSEN H, 1987, CAN MED ASSOC J, V136, P823.
   LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X.
   MILLER AB, 1986, GENETIC TOXICOLOGY D, P275.
   ROBERTSON LS, 1986, ANNU REV PUBL HEALTH, V7, P13, DOI 10.1146/annurev.publhealth.7.1.13.
   SCHMIDT W, 1977, ALCOHOL LIVER, P1.
   SEMENCIW R, 1985, UNPUB TABULATIONS 14.
   SEMENCIW RM, 1988, INT J EPIDEMIOL, V17, P317, DOI 10.1093/ije/17.2.317.
   {*}US DEP HLTH HUM S, 1985, 852616 NIH PUBL.
   {*}US DEP HLTH HUM S, 1983, PHS831676 PUBL.
   {*}US DEP HLTH HUM S, 1983, PHS831677 PUBL.
   WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007.
   WILKINS R, 1983, AM J PUBLIC HEALTH, V73, P1073, DOI 10.2105/AJPH.73.9.1073.},
Number-of-Cited-References = {15},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Can. J. Public Health-Rev. Can. Sante Publ.},
Doc-Delivery-Number = {EG261},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1990EG26100008},
DA = {2022-03-29},
}

@incollection{ WOS:000630373600003,
Author = {Suits, David B.},
Book-Author = {Suits, DB},
Title = {Premature Death and the Complete Life},
Booktitle = {EPICURUS AND THE SINGULARITY OF DEATH: DEFENDING RADICAL EPICUREANISM},
Year = {2020},
Pages = {37-65},
Publisher = {BLOOMSBURY ACADEMIC},
Address = {1385 BROADWAY, NEW YORK, NY 10018 USA},
Type = {Article; Book Chapter},
Language = {English},
ISBN = {978-1-3501-3405-8; 978-1-3501-3404-1},
Research-Areas = {Classics; Philosophy},
Web-of-Science-Categories  = {Classics; Philosophy},
Number-of-Cited-References = {0},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {BR0SK},
Web-of-Science-Index = {Book Citation Index – Social Sciences & Humanities (BKCI-SSH)},
Unique-ID = {WOS:000630373600003},
DA = {2022-03-29},
}

@incollection{ WOS:000270417200012,
Author = {Purdy, Laura},
Editor = {Boylan, M},
Title = {THE POLITICS OF PREVENTING PREMATURE DEATH},
Booktitle = {PUBLIC HEALTH POLICY AND ETHICS},
Series = {International Library of Ethics Law and the New Medicine},
Year = {2005},
Volume = {19},
Pages = {167-185},
Abstract = {This paper argues that bioethics needs to focus more centrally on
   political and social practices that contribute to death, disease, or
   disability. A broader vision would help bioethicists show why attacking
   the root causes of premature death and physical suffering should have
   priority over contemplating the pros and cons of expensive, risky,
   high-tech solutions that often address problems after they have
   developed. Only this approach is consistent with bioethicists' professed
   values, such as the wrongness of hastening patients' deaths without
   their consent. This approach puts corporate and governmental
   decision-making at the center of moral inquiry, as they determine
   economic, environmental, and occupational conditions that are a major
   source of death, disease, and disability. However, there are significant
   cultural and institutional obstacles to this kind of bioethics.},
Publisher = {SPRINGER},
Address = {PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS},
Type = {Article; Book Chapter},
Language = {English},
Affiliation = {Purdy, Laura, Cornell Univ, Hamilton Coll, Ithaca, NY 14853 USA.
   Purdy, Laura, Univ Toronto, Toronto, ON M5S 1A1, Canada.},
ISSN = {1567-8008},
EISSN = {2351-955X},
ISBN = {978-1-4020-2207-4},
Keywords = {Death; premature death; physical suffering and ethics; informed consent;
   moral decision-making in bioethics},
Keywords-Plus = {CANCER},
Research-Areas = {Social Sciences - Other Topics; Public, Environmental \& Occupational
   Health; Government \& Law; Medical Ethics},
Web-of-Science-Categories  = {Ethics; Public, Environmental \& Occupational Health; Law; Medical
   Ethics},
Cited-References = {Beauchamp D. E., 1999, NEW ETHICS PUBLICS H.
   Butler D, 1998, NATURE, V391, P325.
   Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563.
   CHOPRA S, 1998, RBST NUTRILAC GAPS A.
   CLIFFORD WK, 1999, ETHICS BELIEF OTHER.
   CLINARD M, 1980, CORPORATE CRIME, P9.
   COOK RJ, 2002, DEV WORLD BIOETH, V7, P64.
   {*}CORN U, 1996, REPR PERS, P9.
   DUENWALD M, 2002, NY TIMES        0219.
   EVANS RG, 1993, WHY ARE SOME PEOPLE.
   French, 1995, CORPORATE ETHICS.
   GORDON W, 1983, HOW LJ, V26, P781.
   Gostin LO, 2000, JAMA-J AM MED ASSOC, V283, P2837, DOI 10.1001/jama.283.21.2837.
   GROSSMAN RL, 2001, DEFYING CORPORATIONS.
   Hacking I., 1999, SOCIAL CONSTRUCTION.
   Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1.
   Holmes Helen, 1999, EMBODYING BIOETHICS.
   ISAACS SL, 2002, AM PROSPECT     0704, P26.
   JUDGE K, 1999, BRIT MED J, V309, P1454.
   Judis John, 2002, AM PROSPECT     0603, P10.
   Kairys David, 1998, POLITICS LAW PROGR C.
   Kassirer JP, 2001, AM J LAW MED, V27, P149.
   KLEINMAN A, 1990, SOCIAL SCI PERSPECTI.
   Kleinman A, 1995, WRITING MARGIN DISCO.
   LaFollette H., 1977, WORLD HUNGER MORAL O.
   Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557.
   Macklin R, 2001, BIOETHICS, V15, P373, DOI 10.1111/1467-8519.00248.
   MAYER CJ, 1990, HASTINGS LAW J, V41, P577.
   McCumber John, 2001, TIME DITCH AM PHILOS.
   Michael Boylan, 2000, BASIC ETHICS.
   MIESTER DJ, 1990, TULANE LAW REV, V64, P919.
   MILES S, 1997, BIOETHICS EXAMINER, V1, P1.
   MILES S, 2002, BIOETHICS EXAMINER, V6, P1.
   MOKHIBER R, 2002, ZNET COMMENTARY 0408.
   MONTAGUE P, 1999, RACHELS ENV HLT 0527.
   MONTAGUE P, 1998, RACHELS ENV HLT 0827.
   MONTAGUE P, 1998, RACHELS ENV HLT 0205.
   NADIS S, 1993, CAR TROUBLE, P54.
   Norcross A, 1997, PHILOS PUBLIC AFF, V26, P135, DOI 10.1111/j.1088-4963.1997.tb00079.x.
   Norcross A, 1998, PHILOS PUBLIC AFF, V27, P59, DOI 10.1111/j.1088-4963.1998.tb00060.x.
   OLSON E, 2002, NY TIMES        0314.
   PIMENTEL D, 1998, BIOSCIENCE       OCT.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   PRESS E, 2000, ATLANTIC MONTHLY MAR.
   RAMPTON S, 2001, TRUST US WERE EXPERT, pCH1.
   REVKIN AC, 2002, NY TIMES        0302.
   Ridge M, 1998, PHILOS PUBLIC AFF, V27, P50, DOI 10.1111/j.1088-4963.1998.tb00059.x.
   SCHLOSSER E, 2002, FAST FOOD NATION DAR, P239.
   SCHLOSSER E, 2001, MOTHER JONES     JUL, P86.
   SCHLOSSER E, 2001, MOTHER JONES     JUL, P38.
   SHAW MH, 2001, MORAL ISSUES BUSINES.
   SHENK D, 1999, NATION          0322.
   Sherwin S., 1992, NO LONGER PATIENT FE.
   SILVERSTEIN K, 2002, MOTHER JONES     MAY, P69.
   SILVERSTEIN K, 2002, MOTHER JONES     MAY, P86.
   Simon R. L., 1994, NEUTRALITY ACAD ETHI.
   Small R, 2002, BIOETHICS, V16, P307, DOI 10.1111/1467-8519.00291.
   STRANAHAN SQ, 2002, MOTHER JONES     JUL, P15.
   Subedi Janardan, 1998, BIOETHICS SOC CONSTR.
   Tuana N, 1993, LESS NOBLE SEX.
   Unger P., 1996, LIVING HIGH LETTING.
   {*}US BUR LAB STAT, INJ ILLN FAT HOM.
   VAGO S, 2000, LAW SOC, P241.
   2002, DEATH JOB TOLL NEGLE.
   1997, RACHELS ENV HLT 1225.
   POLITICS LI IN PRESS.
   1996, REPROD PERSONS ISSUE, P132.},
Number-of-Cited-References = {67},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {BLL03},
Web-of-Science-Index = {Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)},
Unique-ID = {WOS:000270417200012},
DA = {2022-03-29},
}

@article{ WOS:A1987H255200024,
Author = {DONALD, PA and VENETTE, JR and GULYA, TJ},
Title = {RELATIONSHIP BETWEEN PHOMA-MACDONALDII AND PREMATURE DEATH OF SUNFLOWER
   IN NORTH-DAKOTA},
Journal = {PLANT DISEASE},
Year = {1987},
Volume = {71},
Number = {5},
Pages = {466-468},
Month = {MAY},
Publisher = {AMER PHYTOPATHOLOGICAL SOC},
Address = {3340 PILOT KNOB ROAD, ST PAUL, MN 55121},
Type = {Article},
Language = {English},
Affiliation = {DONALD, PA (Corresponding Author), N DAKOTA STATE UNIV,DEPT PLANT PATHOL,USDA ARS,FARGO,ND 58105, USA.},
DOI = {10.1094/PD-71-0466},
ISSN = {0191-2917},
Research-Areas = {Plant Sciences},
Web-of-Science-Categories  = {Plant Sciences},
Cited-References = {DONALD PA, 1984, P SUNFLOWER RES WORK, P6.
   FARKAS GL, 1978, PLANT DISEASE ADV TR, V3, P391.
   GAUDET MD, 1981, J ECON ENTOMOL, V74, P486, DOI 10.1093/jee/74.4.486.
   GULYA T, 1984, SUNFLOWER        DEC, P20.
   MUNTANOLACVETKOVIC M, 1985, T BRIT MYCOL SOC, V85, P477, DOI 10.1016/S0007-1536(85)80043-7.
   NYVALL RF, 1979, FIELD CROP DISEASES.
   ORELLANA RG, 1973, PLANT DIS REP, V/057, P318.
   RIDDELL RW, 1950, MYCOLOGIA, V42, P265, DOI 10.2307/3755439.
   ROWE RC, 1985, AM POTATO J, V62, P157, DOI 10.1007/BF02852972.
   SACKSTON WE, 1949, 29TH ANN REP CAN PLA, P35.
   SCHNEITER AA, 1981, CROP SCI, V21, P901, DOI 10.2135/cropsci1981.0011183X002100060024x.
   Tuite J., 1967, PLANT PATHOLOGICAL M.
   YANG SM, 1982, PHYTOPATHOLOGY, V72, P819, DOI 10.1094/Phyto-72-819.
   YOUNG H. C. jun., 1943, Phytopathology, V33, pp.},
Number-of-Cited-References = {14},
Times-Cited = {30},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {PLANT DIS.},
Doc-Delivery-Number = {H2552},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1987H255200024},
DA = {2022-03-29},
}

@article{ WOS:000281515000014,
Author = {Grant, William B. and Schwalfenberg, Gerry K. and Genuis, Stephen J. and
   Whiting, Susan J.},
Title = {An estimate of the economic burden and premature deaths due to vitamin D
   deficiency in Canada},
Journal = {MOLECULAR NUTRITION \& FOOD RESEARCH},
Year = {2010},
Volume = {54},
Number = {8},
Pages = {1172-1181},
Month = {AUG},
Abstract = {The objective of this work is to estimate the economic burden and
   premature death rate in Canada attributable to low serum
   25-hydroxyvitamin D (25(OH)D) levels. Vitamin D deficiency has been
   linked to many diseases and conditions in addition to bone diseases,
   including many types of cancer, several bacterial and viral infections,
   autoimmune diseases, cardiovascular diseases, and adverse pregnancy
   outcomes. Canadians have mean serum 25(OH)D levels averaging 67 nmol/L.
   The journal literature was searched for papers reporting dose response
   relationships for vitamin D indices and disease outcomes. The types of
   studies useful in this regard include randomized controlled trials,
   observational, cross-sectional, and ecological studies, and
   meta-analyses. The mortality rates for 2005 were obtained from
   Statistics Canada. The economic burden data were obtained from Health
   Canada. The estimated benefits in disease reduction were based on
   increasing the mean serum 25(OH)D level to 105 nmol/L. It is estimated
   that the death rate could fall by 37 000 deaths (22 300-52 300 deaths),
   representing 16.1\% (9.7-22.7\%) of annuals deaths and the economic
   burden by 6.9\% (3.8-10.0\%) or \$14.4 billion (\$8.0 billion \$20.1
   billion) less the cost of the program. It is recommended that Canadian
   health policy leaders consider measures to increase serum 25(OH)D levels
   for all Canadians.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Review},
Language = {English},
Affiliation = {Grant, WB (Corresponding Author), Sunlight Nutr \& Hlth Res Ctr SUNARC, POB 641603, San Francisco, CA 94164 USA.
   Grant, William B., Sunlight Nutr \& Hlth Res Ctr SUNARC, San Francisco, CA 94164 USA.
   Schwalfenberg, Gerry K., Univ Alberta, Dept Family Med, Edmonton, AB, Canada.
   Genuis, Stephen J., Univ Alberta, Dept Obstet \& Gynecol, Edmonton, AB, Canada.},
DOI = {10.1002/mnfr.200900420},
ISSN = {1613-4125},
EISSN = {1613-4133},
Keywords = {Cancer; Cardiovascular disease; Infectious disease; Pregnancy outcomes;
   Vitamin D},
Keywords-Plus = {PLASMA 25-HYDROXYVITAMIN D; SERUM 25-HYDROXYVITAMIN-D; BREAST-CANCER;
   MULTIPLE-SCLEROSIS; COLORECTAL-CANCER; D SUPPLEMENTATION;
   HYPOVITAMINOSIS-D; D INSUFFICIENCY; HUMAN-SKIN; ALL-CAUSE},
Research-Areas = {Food Science \& Technology},
Web-of-Science-Categories  = {Food Science \& Technology},
Author-Email = {wbgrant@infionline.net},
ResearcherID-Numbers = {Grant, William B./B-8311-2009
   },
ORCID-Numbers = {Grant, William B./0000-0002-1439-3285
   Schwalfenberg, Gerry/0000-0001-7874-2336},
Funding-Acknowledgement = {Vitamin D Society (Canada); UV Foundation (McLean, VA); Sunlight
   Research Forum (Veldhoven); Bio-Tech-Pharmacal (Fayetteville, AR); Dairy
   Farmers; Yoplait; IADSA},
Funding-Text = {This work was sponsored by the Vitamin D Society (Canada) (W B. G.). W
   B. G. also receives funding from the UV Foundation (McLean, VA), the
   Vitamin D Society (Canada), the Sunlight Research Forum (Veldhoven), and
   Bio-Tech-Pharmacal (Fayetteville, AR). S. J. W has received funding from
   the Dairy Farmers, Yoplait, and IADSA.},
Cited-References = {Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240.
   Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095, DOI 10.1017/S0950268807008308.
   Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117.
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730.
   Binkley Neil, 2008, Curr Osteoporos Rep, V6, P95, DOI 10.1007/s11914-008-0017-5.
   Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692.
   Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999.
   Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257.
   Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718.
   Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168.
   Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264.
   Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x.
   Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774.
   Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313.
   {*}CAN CANC SOC, 2009, LETS MAK CANC HIST.
   Cannell J, 2008, EXPERT OPIN PHARMACO, V9, P107, DOI 10.1517/14656566.9.1.107.
   Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175.
   Cannell JJ, 2008, ALTERN MED REV, V13, P6.
   Cherniack EP, 2008, J NUTR HEALTH AGING, V12, P366, DOI 10.1007/BF02982668.
   Chiu KC, 2004, AM J CLIN NUTR, V79, P820.
   Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138.
   Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340.
   FERLAY J, 2004, CANCERBASE, V5.
   Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007.
   Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260.
   Genuis SJ, 2010, J CHILD NEUROL, V25, P114, DOI 10.1177/0883073809336127.
   Genuis SJ, 2009, INT J ENV RES PUB HE, V6, P151, DOI 10.3390/ijerph6010151.
   Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x.
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174.
   Giovannucci E, 2006, CANCER EPIDEM BIOMAR, V15, P2467, DOI 10.1158/1055-9965.EPI-06-0357.
   GLASER G, 2009, SCI AM.
   Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583.
   Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004.
   Gozdzik A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-336.
   Grant WB, 2004, NUTR CANCER, V48, P115, DOI 10.1207/s15327914nc4802\_1.
   Grant WB, 2008, PHOTOCHEM PHOTOBIOL, V84, P356, DOI 10.1111/j.1751-1097.2007.00266.x.
   Grant WB, 2005, ALTERN MED REV, V10, P94.
   Grant WB, 2009, DERM-ENDOCRINOL, V1, P215, DOI 10.4161/derm.1.4.9063.
   Grant WB, 2009, PROG BIOPHYS MOL BIO, V99, P104, DOI 10.1016/j.pbiomolbio.2009.02.003.
   Grant WB, 2009, DERM-ENDOCRINOL, V1, P25, DOI 10.4161/derm.1.1.7729.
   Grant WB, 2009, DERM-ENDOCRINOL, V1, P17, DOI 10.4161/derm.1.1.7388.
   Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6.
   Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204.
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503.
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553.
   Hollis BW, 2007, J BONE MINER RES, V22, pV39, DOI 10.1359/JBMR.07S215.
   Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403.
   Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1.
   Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28.
   Karatekin G, 2009, EUR J CLIN NUTR, V63, P473, DOI 10.1038/sj.ejcn.1602960.
   Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227.
   Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x.
   Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad.
   Kostner K, 2009, ANTICANCER RES, V29, P3511.
   Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144.
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586.
   Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212.
   Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028.
   Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060.
   Lu Z, 2007, J STEROID BIOCHEM, V103, P642, DOI 10.1016/j.jsbmb.2006.12.010.
   MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134.
   Maiya S, 2008, HEART, V94, P581, DOI 10.1136/hrt.2007.119792.
   McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P1, DOI 10.1023/A:1022591007673.
   McNally JD, 2009, PEDIATR PULM, V44, P981, DOI 10.1002/ppul.21089.
   Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629.
   Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217.
   Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993.
   Natri AM, 2006, J NUTR, V136, P123, DOI 10.1093/jn/136.1.123.
   PATRA J, 2007, EC COSTS CHRONIC DIS.
   Peterlik M, 2009, EUR J CLIN NUTR, V63, P1377, DOI 10.1038/ejcn.2009.105.
   Pierrot-Deseilligny C, 2009, J NEUROL, V256, P1468, DOI 10.1007/s00415-009-5139-x.
   Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655.
   Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x.
   Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961.
   {*}POL RES DIV SPD P, 2002, EC BURD ILLN CAN.
   Porojnicu AC, 2008, J PHOTOCH PHOTOBIO B, V91, P125, DOI 10.1016/j.jphotobiol.2008.02.007.
   Rucker D, 2002, CAN MED ASSOC J, V166, P1517.
   Schwalfenberg G, 2007, CAN FAM PHYSICIAN, V53, P841.
   {*}STAT CAN, 2009, CAN HLTH MEAS SURV V.
   Statistics Canada, 2008, RANK NUMB DEATHS 10.
   Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275.
   von Hurst PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-267.
   Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788.
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127.
   Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670.
   WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373.
   White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08.
   Whiting SJ, 2005, J NUTR, V135, P304, DOI 10.1093/jn/135.2.304.
   Whiting SJ, 2007, J STEROID BIOCHEM, V103, P626, DOI 10.1016/j.jsbmb.2006.12.067.
   Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753.
   {[}No title captured].},
Number-of-Cited-References = {91},
Times-Cited = {41},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {22},
Journal-ISO = {Mol. Nutr. Food Res.},
Doc-Delivery-Number = {646DA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000281515000014},
DA = {2022-03-29},
}

@article{ WOS:000225981800010,
Author = {Lam, LT},
Title = {Different quantitative measures of the impact of premature deaths on the
   community in Australia},
Journal = {AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH},
Year = {2004},
Volume = {28},
Number = {6},
Pages = {555-558},
Month = {DEC},
Abstract = {Objective: Different quantitative measures based on the concept of years
   of potential life lost have been derived for assessing the burden of
   diseases and injuries. However, few studies have been conducted to
   compare the usefulness of these measures in terms of providing practical
   information. This study aims to examine the utility of different
   measures in assessing the impact of premature deaths on Australian
   society.
   Methods: This population-based study was conducted utilising data on the
   underlying causes of death officially reported by the Australian Bureau
   of Statistics. The mortality rates, potential years of life lost (PYLL),
   potentially productive years of life lost (PPYLL), and the valued
   potential years of life lost (VPYLL), are calculated and compared for
   deaths due to all known underlying causes.
   Results: In comparison with other causes of death, injury deaths had the
   second-highest annual rates of PYLL (1,206.7 years), the highest PPYLL
   (543.5 years), and VPYLL (489.7 years). Premature deaths due to injury
   were the only positively valued VPYLL among all major causes of death.
   Among injury deaths, intentional injury deaths caused the largest VPYLL
   (7,591.6 years), with a higher rate than unintentional injury deaths.
   Conclusion: As an indicator of the economic impact and burden of
   premature deaths to society, the VPYLL seems to be an advantageous
   utility. Injury poses the greatest public health problem to the
   Australian economy.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Lam, LT (Corresponding Author), Royal Alexandra Hosp Children, Locked Bag 4001, Westmead, NSW 2145, Australia.
   Royal Alexandra Hosp Children, Westmead, NSW 2145, Australia.},
DOI = {10.1111/j.1467-842X.2004.tb00046.x},
ISSN = {1326-0200},
EISSN = {1753-6405},
Keywords-Plus = {POTENTIAL LIFE LOST; INJURY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {lawrencl@chw.edu.au},
ORCID-Numbers = {Lam, Lawrence T./0000-0001-6183-6854},
Cited-References = {{*}ABS, 2001, DEM AUSTR 2001.
   {*}ABS, 2001, CAUS DEATHS AUSTR 20.
   {[}Anonymous], 1993, WORLD DEV REP 1993 I.
   BURROWS C, 1993, AUST J PUBLIC HEALTH, V7, P278.
   {*}CDC, 1982, MMWR-MORBID MORTAL W, V31, P117.
   {*}CDC, 1986, MMWR-MORBID MORTAL W, V35, P1.
   {*}CDC, 1982, MMWR-MORBID MORTAL W, V31, P109.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513.
   LINN S, 1993, EPIDEMIOLOGY, V4, P449, DOI 10.1097/00001648-199309000-00011.
   Lopez, 2002, SUMMARY MEASURES POP.
   MACKINNON A, 1994, NEW STATESMAN SOC, V7, P10.
   Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076.
   MURRAY CJL, 1996, SUMMARY GLOBAL BURDE, P553.
   RICE DP, 1966, PHS PUBLICATION, V947.
   ROTHMAN K, 1998, MODER EPIDEMIOLOGY.
   Semerl JS, 2002, CROAT MED J, V43, P439.
   Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124.},
Number-of-Cited-References = {18},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Aust. N. Z. Publ. Health},
Doc-Delivery-Number = {883AP},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000225981800010},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1978EZ51300005,
Author = {DAS, GD},
Title = {PREMATURE DEATH OF PURKINJE-CELLS FOLLOWING LOW-LEVEL X-RAY-IRRADIATION
   DURING EMBRYONIC-DEVELOPMENT},
Journal = {ACTA ANATOMICA},
Year = {1978},
Volume = {101},
Number = {3},
Pages = {225-233},
Publisher = {KARGER},
Address = {ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {DAS, GD (Corresponding Author), PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47907 USA.},
ISSN = {0001-5180},
Research-Areas = {Anatomy \& Morphology},
Web-of-Science-Categories  = {Anatomy \& Morphology},
Cited-References = {ANDREW WARREN, 1936, ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V25, P583, DOI 10.1007/BF00375620.
   BRIZZEE KR, 1967, J NEUROPATH EXP NEUR, V26, P584, DOI 10.1097/00005072-196710000-00006.
   BRIZZEE KR, 1962, ASPECTS INTERNAL IRR, P289.
   BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87.
   COWEN D, 1960, J NEUROPATH EXP NEUR, V19, P488, DOI 10.1097/00005072-196010000-00002.
   DAS GD, 1977, J COMP NEUROL, V176, P419, DOI 10.1002/cne.901760308.
   DAS GD, 1977, ACTA ANAT, V97, P435.
   DAS GD, 1977, J COMP NEUROL, V176, P435, DOI 10.1002/cne.901760309.
   DAS GD, 1971, VIRCHOWS ARCH B, V9, P58.
   DAS GD, 1972, Z ANAT ENTWICKLUNGS, V138, P155, DOI 10.1007/BF00519378.
   HICKS SP, 1958, PHYSIOL REV, V38, P337, DOI 10.1152/physrev.1958.38.3.337.
   HICKS SP, 1966, ADV TERATOL, P195.
   Inuka T, 1928, J COMP NEUROL, V45, P1, DOI 10.1002/cne.900450102.
   RUSSELL LB, 1957, P SOC EXP BIOL MED, V95, P174.
   SCHOLZ W, 1962, RESPONSE NERVOUS SYS, P211.
   SCHUMMELFEDER N, 1962, RESPONSE NERVOUS SYS, P191.
   SPIEGEL ARNOLD, 1928, ZOOL ANZ, V79, P173.
   VANHARREVELD A, 1962, J NEUROPATH EXP NEUR, V21, P410.},
Number-of-Cited-References = {18},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Acta Anat.},
Doc-Delivery-Number = {EZ513},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1978EZ51300005},
DA = {2022-03-29},
}

@article{ WOS:000538789800011,
Author = {Klofas, Lindsay K. and Short, Brittany P. and Zhou, Chengwen and Carson,
   Robert P.},
Title = {Prevention of premature death and seizures in a Depdc5 mouse epilepsy
   model through inhibition of mTORC1},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2020},
Volume = {29},
Number = {8},
Pages = {1365-1377},
Month = {APR 15},
Abstract = {Mutations in DEP domain containing 5 (DEPDC5) are increasingly
   appreciated as one of the most common causes of inherited focal
   epilepsy. Epilepsies due to DEPDC5 mutations are often associated with
   brain malformations, tend to be drug-resistant, and have been linked to
   an increased risk of sudden unexplained death in epilepsy (SUDEP).
   Generation of epilepsy models to define mechanisms of epileptogenesis
   remains vital for future therapies. Here, we describe a novel mouse
   model of Depdc5 deficiency with a severe epilepsy phenotype, generated
   by conditional deletion of Depdc5 in dorsal telencephalic
   neuroprogenitor cells. In contrast to control and heterozygous mice,
   Depdc5-Emx1-Cre conditional knockout (CKO) mice demonstrated
   macrocephaly, spontaneous seizures and premature death. Consistent with
   increased mTORC1 activation, targeted neurons were enlarged and both
   neurons and astrocytes demonstrated increased S6 phosphorylation.
   Electrophysiologic characterization of miniature inhibitory
   post-synaptic currents in excitatory neurons was consistent with
   impaired post-synaptic response to GABAergic input, suggesting a
   potential mechanism for neuronal hyperexcitability. mTORC1 inhibition
   with rapamycin significantly improved survival of CKO animals and
   prevented observed seizures, including for up to 40 days following
   rapamycin withdrawal. These data not only support a primary role for
   mTORC1 hyperactivation in epilepsy following homozygous loss of Depdc5,
   but also suggest a developmental window for treatment which may have a
   durable benefit for some time even after withdrawal.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Carson, RP (Corresponding Author), Vanderbilt Univ, Med Ctr, D-4105 MCN,1161 21st Ave South, Nashville, TN 37232 USA.
   Klofas, Lindsay K.; Carson, Robert P., Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA.
   Short, Brittany P.; Carson, Robert P., Vanderbilt Univ, Dept Pediat, Div Pediat Neurol, Med Ctr, Nashville, TN 37232 USA.
   Zhou, Chengwen, Vanderbilt Univ, Dept Neurol, Sch Med, Nashville, TN 37232 USA.
   Carson, Robert P., Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA.},
DOI = {10.1093/hmg/ddaa068},
ISSN = {0964-6906},
EISSN = {1460-2083},
Keywords-Plus = {FAMILIAL FOCAL EPILEPSY; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CORTICAL
   DYSPLASIA; MUTATIONS; NEURONS; PATHWAY; ABNORMALITIES; DELETION; COMPLEX},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {robert.carson@vumc.org},
ORCID-Numbers = {Klofas, Lindsay/0000-0002-3636-6149},
Funding-Acknowledgement = {National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}K08 NS083710];
   National Institute of General Medical SciencesUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) {[}T32GM007347,
   C57BL/6 N-Depdc5<SUP>tm1c, C57BL/6N-Depdc5<SUP>tm1c]},
Funding-Text = {This work was supported by the National Institutes of Health {[}K08
   NS083710 to R.P.C.] and National Institute of General Medical Sciences
   {[}T32GM007347 to L.K.K.]. The C57BL/6
   N-Depdc5<SUP>tm1c(EUCOMM)Hmgu</SUP> mice were obtained from the MRC
   Harwell Institute which distributes these mice on behalf of the European
   Mouse Mutant Archive (www.infrafrontier.eu).The MRC Harwell Institute is
   also a member of the International Mouse Phenotyping Consortium (IMPC)
   which funded the generation of the
   C57BL/6N-Depdc5<SUP>tm1c(EUCOMM)Hmgu</SUP> mice. Funding and associated
   primary phenotypic information may be found at www.mousephenotype.org.},
Cited-References = {Armour EA, 2012, AM J PHYSIOL-RENAL, V303, pF584, DOI 10.1152/ajprenal.00141.2012.
   Bagnall RD, 2016, ANN NEUROL, V79, P522, DOI 10.1002/ana.24596.
   Baldassari S, 2019, GENET MED, V21, P398, DOI 10.1038/s41436-018-0060-2.
   Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044.
   Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368.
   Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015.
   Carson RP, 2015, ANN CLIN TRANSL NEUR, V2, P1041, DOI 10.1002/acn3.254.
   Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414.
   Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024.
   Carvill GL, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000016.
   D'Gama AM, 2017, CELL REP, V21, P3754, DOI 10.1016/j.celrep.2017.11.106.
   D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357.
   Dawson RE, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104640.
   de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002.
   Dibbens LM, 2013, NAT GENET, V45, P546, DOI 10.1038/ng.2599.
   Ess KC, 2005, NEUROLOGY, V64, P1446, DOI 10.1212/01.WNL.0000158653.81008.49.
   Fu C, 2012, CEREB CORTEX, V22, P2111, DOI 10.1093/cercor/bhr300.
   Gorski JA, 2002, J NEUROSCI, V22, P6309.
   Grier MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188417.
   Hu ST, 2018, ANN NEUROL, V84, P140, DOI 10.1002/ana.25272.
   Hughes J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12574-2.
   Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601.
   Kang JQ, 2015, NAT NEUROSCI, V18, P988, DOI 10.1038/nn.4024.
   Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023.
   Lal D, 2014, ANN NEUROL, V75, P788, DOI 10.1002/ana.24127.
   Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008.
   Marsan E, 2016, NEUROBIOL DIS, V89, P180, DOI 10.1016/j.nbd.2016.02.010.
   McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815.
   Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008.
   Nascimento FA, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000028.
   O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324.
   Picard F, 2014, NEUROLOGY, V82, P2101, DOI 10.1212/WNL.0000000000000488.
   PINEL JPJ, 1978, EXP NEUROL, V58, P335, DOI 10.1016/0014-4886(78)90145-0.
   Ribierre T, 2018, J CLIN INVEST, V128, P2452, DOI 10.1172/JCI99384.
   Roy A, 2015, ELIFE, V4, DOI 10.7554/eLife.12703.
   Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013.
   Scerri T, 2015, ANN CLIN TRANSL NEUR, V2, P575, DOI 10.1002/acn3.191.
   Scheffer IE, 2014, ANN NEUROL, V75, P782, DOI 10.1002/ana.24126.
   Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106.
   Swaminathan A, 2018, CURR BIOL, V28, P1924, DOI 10.1016/j.cub.2018.04.061.
   VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750.
   Yuskaitis CJ, 2019, HUM MOL GENET, V28, P2952, DOI 10.1093/hmg/ddz123.
   Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010.
   Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491.
   Zhou CW, 2013, J BIOL CHEM, V288, P21458, DOI 10.1074/jbc.M112.444372.
   Zhou CW, 2011, J NEUROSCI, V31, P18211, DOI 10.1523/JNEUROSCI.4838-11.2011.
   Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009.},
Number-of-Cited-References = {47},
Times-Cited = {8},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Hum. Mol. Genet.},
Doc-Delivery-Number = {LV9TK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000538789800011},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000329339400022,
Author = {Holford, Theodore R. and Meza, Rafael and Warner, Kenneth E. and
   Meernik, Clare and Jeon, Jihyoun and Moolgavkar, Suresh H. and Levy,
   David T.},
Title = {Tobacco Control and the Reduction in Smoking-Related Premature Deaths in
   the United States, 1964-2012},
Journal = {JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
Year = {2014},
Volume = {311},
Number = {2},
Pages = {164-171},
Month = {JAN 8},
Abstract = {IMPORTANCE January 2014 marks the 50th anniversary of the first surgeon
   general's report on smoking and health. This seminal document inspired
   efforts by governments, nongovernmental organizations, and the private
   sector to reduce the toll of cigarette smoking through reduced
   initiation and increased cessation.
   OBJECTIVE To model reductions in smoking-related mortality associated
   with implementation of tobacco control since 1964.
   DESIGN, SETTING, AND PARTICIPANTS Smoking histories for individual birth
   cohorts that actually occurred and under likely scenarios had tobacco
   control never emerged were estimated. National mortality rates and
   mortality rate ratio estimates from analytical studies of the effect of
   smoking on mortality yielded death rates by smoking status. Actual
   smoking-related mortality from 1964 through 2012 was compared with
   estimated mortality under no tobacco control that included a likely
   scenario (primary counterfactual) and upper and lower bounds that would
   capture plausible alternatives.
   EXPOSURES National Health Interview Surveys yielded cigarette smoking
   histories for the US adult population in 1964-2012.
   MAIN OUTCOMES AND MEASURES Number of premature deaths avoided and years
   of life saved were primary outcomes. Change in life expectancy at age 40
   years associated with change in cigarette smoking exposure constituted
   another measure of overall health outcomes.
   RESULTS In 1964-2012, an estimated 17.7 million deaths were related to
   smoking, an estimated 8.0 million (credible range {[}CR], 7.4-8.3
   million, for the lower and upper tobacco control counterfactuals,
   respectively) fewer premature smoking-related deaths than what would
   have occurred under the alternatives and thus associated with tobacco
   control (5.3 million {[}CR, 4.8-5.5 million] men and 2.7 million {[}CR,
   2.5-2.7 million] women). This resulted in an estimated 157 million years
   (CR, 139-165 million) of life saved, a mean of 19.6 years for each
   beneficiary (111 million {[}CR, 97-117 million] for men, 46 million
   {[}CR, 42-48 million] for women). During this time, estimated life
   expectancy at age 40 years increased 7.8 years for men and 5.4 years for
   women, of which tobacco control is associated with 2.3 years (CR,
   1.8-2.5) (30\% {[}CR, 23\%-32\%]) of the increase for men and 1.6 years
   (CR, 1.4-1.7) (29\% {[}CR, 25\%-32\%]) for women.
   CONCLUSIONS AND RELEVANCE Tobacco control was estimated to be associated
   with avoidance of 8 million premature deaths and an estimated extended
   mean life span of 19 to 20 years. Although tobacco control represents an
   important public health achievement, efforts must continue to reduce the
   effect of smoking on the nation's death toll.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Holford, TR (Corresponding Author), Yale Univ, Sch Publ Hlth, Dept Biostat, 60 Coll St, New Haven, CT 06511 USA.
   Holford, Theodore R., Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06511 USA.
   Meza, Rafael; Meernik, Clare, Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   Warner, Kenneth E., Univ Michigan, Sch Publ Hlth, Dept Hlth Management \& Policy, Ann Arbor, MI 48109 USA.
   Jeon, Jihyoun; Moolgavkar, Suresh H., Fred Hutchinson Canc Res Ctr, Program Biostat \& Biomath, Seattle, WA 98104 USA.
   Levy, David T., Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.},
DOI = {10.1001/jama.2013.285112},
ISSN = {0098-7484},
EISSN = {1538-3598},
Keywords-Plus = {LUNG-CANCER; US MIDDLE; MORTALITY; TRENDS; IMPACT},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {theodore.holford@yale.edu},
ResearcherID-Numbers = {Meernik, Clare/O-2995-2016
   },
ORCID-Numbers = {Meernik, Clare/0000-0002-8564-1266
   Warner, Kenneth/0000-0002-8214-1776},
Funding-Acknowledgement = {National Cancer InstituteUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) {[}R01-CA-152956]; NATIONAL CANCER INSTITUTEUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) {[}U01CA152956,
   P30CA016359] Funding Source: NIH RePORTER},
Funding-Text = {This study was funded in part by the National Cancer Institute
   (R01-CA-152956).},
Cited-References = {Agaku IT, 2013, JAMA-J AM MED ASSOC, V309, P1992, DOI 10.1001/jama.2013.4412.
   Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x.
   {[}Anonymous], CANCER PREVENTION ST.
   {[}Anonymous], NATIONAL ESTIMATES B.
   {[}Anonymous], CURRENT CANCER PREVE.
   {[}Anonymous], NHANES EPIDEMIOLOGIC.
   {[}Anonymous], 2013, ANNUAL ESTIMATES OF.
   {[}Anonymous], 1989, REDUCING THE HEALTH.
   Arias E., 2010, UNITED STATES LIFE T.
   Centers for Disease Control and Prevention, SMOKING ATTRIBUTABLE.
   DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451.
   Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022.
   Holford TR, 2012, RISK ANAL, V32, pS39, DOI 10.1111/j.1539-6924.2011.01759.x.
   Jeon J, 2012, RISK ANAL, V32, pS51, DOI 10.1111/j.1539-6924.2011.01775.x.
   Levy DT, 2010, AM J PREV MED, V38, pS364, DOI 10.1016/j.amepre.2009.11.016.
   McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5543.
   Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136.
   Murphy SL, 2013, DEATHS FINAL DATA FO.
   Quinn VP, 2009, J GEN INTERN MED, V24, P149, DOI 10.1007/s11606-008-0865-9.
   Richardson A, 2013, NICOTINE TOB RES, V15, P1729, DOI 10.1093/ntr/ntt053.
   Rosenberg MA, 2012, RISK ANAL, V32, pS25, DOI 10.1111/j.1539-6924.2011.01662.x.
   Surgeon General's Advisory Committee on Smoking and Health, 1964, SMOKING AND HEALTH R.
   Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127.
   Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751.
   WARNER KE, 1989, AM J PUBLIC HEALTH, V79, P144, DOI 10.2105/AJPH.79.2.144.
   Warner KE, 2014, AM J PUBLIC HEALTH, V104, P83, DOI 10.2105/AJPH.2013.301591.
   WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001.},
Number-of-Cited-References = {27},
Times-Cited = {182},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {21},
Journal-ISO = {JAMA-J. Am. Med. Assoc.},
Doc-Delivery-Number = {284SA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000329339400022},
OA = {Green Accepted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000535510400011,
Author = {Carr, Matthew J. and Ashcroft, Darren M. and White, Peter D. and Kapur,
   Nav and Webb, Roger T.},
Title = {Prevalence of comorbid mental and physical illnesses and risks for
   self-harm and premature death among primary care patients diagnosed with
   fatigue syndromes},
Journal = {PSYCHOLOGICAL MEDICINE},
Year = {2020},
Volume = {50},
Number = {7},
Pages = {1156-1163},
Month = {MAY},
Abstract = {Background Fatigue syndromes (FSs) affect large numbers of individuals,
   yet evidence from epidemiological studies on adverse outcomes, such as
   premature death, is limited. Methods Cohort study involving 385 general
   practices in England that contributed to the Clinical Practice Research
   Datalink (CPRD) with linked inpatient Hospital Episode Statistics (HES)
   and Office for National Statistics (ONS) cause of death information. A
   total of 10 477 patients aged 15 years and above, diagnosed with a FS
   during 2000-2014, were individually matched with up to 20 comparator
   patients without a history of having a FS. Prevalence ratios (PRs) were
   estimated to compare the FS and comparison cohorts on clinical
   characteristics. Adjusted hazard ratios (HRs) for subsequent adverse
   outcomes were estimated from stratified Cox regression models. Results
   Among patients diagnosed with FSs, we found elevated baseline prevalence
   of: any psychiatric illness (PR 1.77; 95\% CI 1.72-1.82), anxiety
   disorders (PR 1.92; 1.85-1.99), depression (PR 1.89; 1.83-1.96),
   psychotropic prescriptions (PR 1.68; 1.64-1.72) and comorbid physical
   illness (PR 1.28; 1.23-1.32). We found no significant differences in
   risks for: all-cause mortality (HR 0.99; 0.91-1.09), natural death (HR
   0.99; 0.90-1.09), unnatural death (HR 1.00; 0.59-1.72) or suicide (HR
   1.68; 0.78-3.63). We did, however, observe a significantly elevated
   non-fatal self-harm risk: HR 1.83; 1.56-2.15. Conclusions The absence of
   elevated premature mortality risk is reassuring. The raised prevalence
   of mental illness and increased non-fatal self-harm risk indicate a need
   for enhanced assessment and management of psychopathology associated
   with fatigue syndromes.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA},
Type = {Article},
Language = {English},
Affiliation = {Webb, RT (Corresponding Author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med \& Hlth, Sch Hlth Sci,Div Psychol \& Mental Hlth, Manchester M13 9PL, Lancs, England.
   Webb, RT (Corresponding Author), NIHR Greater Manchester Patient Safety Translat R, Manchester M13 9PL, Lancs, England.
   Carr, Matthew J.; Kapur, Nav; Webb, Roger T., Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med \& Hlth, Sch Hlth Sci,Div Psychol \& Mental Hlth, Manchester M13 9PL, Lancs, England.
   Carr, Matthew J.; Ashcroft, Darren M.; Webb, Roger T., NIHR Greater Manchester Patient Safety Translat R, Manchester M13 9PL, Lancs, England.
   Ashcroft, Darren M., Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med \& Hlth,Div Pharm \& Optometry, Sch Hlth Sci,Ctr Pharmacoepidemiol \& Drug Safety, Manchester M13 9PT, Lancs, England.
   White, Peter D., Queen Mary Univ London, Barts \& London Sch Med \& Dent, Wolfson Inst, London, England.
   Kapur, Nav, Greater Manchester Mental Hlth \& Social Care Trus, Manchester, Lancs, England.},
DOI = {10.1017/S0033291719001065},
Article-Number = {PII S0033291719001065},
ISSN = {0033-2917},
EISSN = {1469-8978},
Keywords = {Co-morbidities; fatigue syndrome; premature mortality; self-harm;
   suicide},
Keywords-Plus = {MYALGIC ENCEPHALOMYELITIS; MORTALITY; SUICIDE; DEPRESSION; PEOPLE;
   COHORT},
Research-Areas = {Psychology; Psychiatry},
Web-of-Science-Categories  = {Psychology, Clinical; Psychiatry; Psychology},
Author-Email = {roger.webb@manchester.ac.uk},
ResearcherID-Numbers = {Ashcroft, Darren/G-3244-2015
   },
ORCID-Numbers = {Webb, Roger/0000-0001-8532-2647
   Ashcroft, Darren/0000-0002-2958-915X
   Kapur, Nav/0000-0002-3100-3234},
Funding-Acknowledgement = {National Institute for Health Research (NIHR) Greater Manchester Patient
   Safety Translational Research CentreNational Institute for Health
   Research (NIHR) {[}GMPSTRC-2012-1]},
Funding-Text = {This study was funded by the National Institute for Health Research
   (NIHR) Greater Manchester Patient Safety Translational Research Centre
   (grant No GMPSTRC-2012-1). The views expressed are those of the authors
   and not necessarily those of the NHS, the NIHR or the Department of
   Health and Social Care. The funders of the study had no role in study
   design or in data collection, analysis or interpretation. National
   Institute for Health Research (NIHR) Greater Manchester Patient Safety
   Translational Research Centre (grant No GMPSTRC-2012-1).},
Cited-References = {Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221.
   Baker R, 2007, BMJ-BRIT MED J, V335, P446, DOI 10.1136/bmj.39302.509005.AE.
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21.
   Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973.
   Cairns R, 2005, OCCUP MED-OXFORD, V55, P20, DOI 10.1093/occmed/kqi013.
   Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402.
   Cella M, 2013, PSYCHOL MED, V43, P375, DOI 10.1017/S0033291712000979.
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8.
   Daniels J, 2017, PSYCHOL PSYCHOTHER-T, V90, P502, DOI 10.1111/papt.12118.
   Department for Communities and Local Government, 2011, THE ENGLISH INDICES.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Hawton K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012189.
   Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098.
   Jason Leonard A, 2006, Health Care Women Int, V27, P615, DOI 10.1080/07399330600803766.
   Jason LA, 2011, J HEALTH PSYCHOL, V16, P445, DOI 10.1177/1359105310383603.
   Johnston Samantha, 2013, Clin Epidemiol, V5, P105, DOI 10.2147/CLEP.S39876.
   Kapur N, 2016, LANCET, V387, P1596, DOI 10.1016/S0140-6736(16)00270-1.
   Kapur N, 2013, BRIT J PSYCHIAT, V202, P326, DOI 10.1192/bjp.bp.112.116111.
   Larkin D, 2017, NEUROPHYSIOL CLIN, V47, P123, DOI 10.1016/j.neucli.2017.01.012.
   Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465.
   Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003.
   Mariman A, 2013, J PSYCHOSOM RES, V75, P491, DOI 10.1016/j.jpsychores.2013.07.010.
   McDonald L, 2018, EUR J EPIDEMIOL, V33, P601, DOI 10.1007/s10654-018-0389-5.
   McManimen SL, 2016, FATIGUE, V4, P195, DOI 10.1080/21641846.2016.1236588.
   Moss-Morris Rona, 2013, Handb Clin Neurol, V110, P303, DOI 10.1016/B978-0-444-52901-5.00025-3.
   National Institute for Health and Care Excellence, 2011, SELF HARM LONG MAN N.
   Ranjith G, 2005, OCCUP MED-OXFORD, V55, P13, DOI 10.1093/occmed/kqi012.
   Roberts E, 2016, LANCET, V387, P1638, DOI 10.1016/S0140-6736(15)01223-4.
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.2307/2335876.
   Skapinakis P, 2003, AM J PSYCHIAT, V160, P785, DOI 10.1176/appi.ajp.160.4.785.
   Smith WR, 2006, PSYCHOL MED, V36, P1301, DOI 10.1017/S0033291706007975.
   Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825.
   Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059.
   Williams TE, 2017, PSYCHOL MED, V47, P1454, DOI 10.1017/S0033291716003615.
   Woolley J, 2004, J PSYCHOSOM RES, V56, P203, DOI 10.1016/S0022-3999(03)00077-1.},
Number-of-Cited-References = {35},
Times-Cited = {9},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Psychol. Med.},
Doc-Delivery-Number = {LR2FD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000535510400011},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000563053400001,
Author = {Rosen, Mans and Stenbeck, Magnus},
Title = {Interventions to suppress the coronavirus pandemic will increase
   unemployment and lead to many premature deaths},
Journal = {SCANDINAVIAN JOURNAL OF PUBLIC HEALTH},
Year = {2021},
Volume = {49},
Number = {1, SI},
Pages = {64-68},
Month = {FEB},
Abstract = {Background and aims: Interventions to suppress the coronavirus pandemic
   have led to economic recession and higher unemployment, which will
   increase mortality and decrease quality of life. The aim of this article
   is to estimate the consequences on mortality and life expectancy of
   increased unemployment rates due to the coronavirus pandemic in Sweden
   and other countries. Methods: Based on recent increases and expected
   future unemployment rates due to the coronavirus pandemic, results from
   a systematic review and data from vital statistics in Sweden, the number
   of premature deaths due to unemployment in Sweden have been estimated.
   Results: Based on our assumptions, the calculations show that if the
   number of unemployed persons in Sweden increases by 100,000, one may
   expect some 1800 more premature deaths during the following 9 years. If
   the duration of the recession is limited to 4 years, excess deaths due
   to unemployment may be around 800. On average, the unemployed will lose
   2 years of their remaining life expectancy. In many other countries
   unemployment rates have or are estimated to rise more than in Sweden,
   sometimes two- or threefold, suggesting hundreds of thousands of excess
   deaths due to unemployment. Conclusions: Interventions to suppress the
   coronavirus pandemic include the shut-down of economic activities and
   lead to increased all-cause mortality. These public health effects must
   be considered in the decision-making process and should be added to
   overall estimates of the effects of the pandemic on public health.},
Publisher = {SAGE PUBLICATIONS LTD},
Address = {1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Rosen, M (Corresponding Author), Karolinska Inst, Kampementsgatan 30, S-11538 Stockholm, Sweden.
   Rosen, Mans, Karolinska Inst, Kampementsgatan 30, S-11538 Stockholm, Sweden.
   Stenbeck, Magnus, Karolinska Inst, Inst Environm Med, Stockholm, Sweden.},
DOI = {10.1177/1403494820947974},
EarlyAccessDate = {AUG 2020},
Article-Number = {1403494820947974},
ISSN = {1403-4948},
EISSN = {1651-1905},
Keywords = {Coronavirus; COVID-19; interventions; unemployment; mortality; economic
   recession},
Keywords-Plus = {ECONOMIC RECESSION; MORTALITY; HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mans.rosen@comhem.se},
ORCID-Numbers = {Rosen, Mans/0000-0001-5295-0014},
Cited-References = {Backhans MC, 2016, J STUD ALCOHOL DRUGS, V77, P936, DOI 10.15288/jsad.2016.77.936.
   Bayham J, 2020, LANCET PUBLIC HLTH.
   CIA, WORLD FACTB COUNTR C.
   Cox J., 2020, CNBC.
   Ferguson NM, 2020, REPORT 9 IMPACT NONP, DOI DOI 10.25561/77482.
   Folkhalsomyndigheten, 2020, VARDPERSONALENS FRAN, P1.
   Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034.
   Haw C, 2015, INT J SOC PSYCHIATR, V61, P73, DOI 10.1177/0020764014536545.
   Hogseth MH, 2020, 400000 HELT DELVIS L.
   Hone T, 2019, LANCET GLOB HEALTH, V7, pE1575, DOI 10.1016/S2214-109X(19)30409-7.
   Kerrache CA, 2020, T EMERG TELECOMMUN T, V31, DOI 10.1002/ett.3975.
   Montgomery S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003031.
   Norstrom F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6825-y.
   Oxfam, 2020, DIGN NOT DEST EC RES.
   Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005.
   Statista Research Department, 2020, UN UK STAT FACTS.
   Statistics Sweden, 2019, STAT MED EFT FOD EFT.
   Statistics Sweden, 2020, STAT BEF 15 74 AKU E.
   Vagero D, 2016, EUR J PUBLIC HEALTH, V26, P778, DOI 10.1093/eurpub/ckw053.
   Walker P., 2020, GLOBAL IMPACT COVID.
   Weisstein EW, MATH WORLD WOLFRAM W.},
Number-of-Cited-References = {21},
Times-Cited = {6},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Scand. J. Public Health},
Doc-Delivery-Number = {QC0QN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000563053400001},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000463594100001,
Author = {Baravelli, Carl Michael and Sandberg, Sverre and Aarsand, Aasne Karine
   and Tollanes, Mette Christophersen},
Title = {Porphyria cutanea tarda increases risk of hepatocellular carcinoma and
   premature death: a nationwide cohort study},
Journal = {ORPHANET JOURNAL OF RARE DISEASES},
Year = {2019},
Volume = {14},
Month = {APR 3},
Abstract = {BackgroundPorphyria cutanea tarda (PCT) is a skin disorder originating
   from a deficit of the liver enzyme uroporphyrinogen decarboxylase. PCT
   may be a risk factor for hepatocellular carcinoma (HCC) and other
   cancers, but the evidence is unclear. We aimed to investigate cancer and
   premature mortality risk in persons with PCT.MethodsThe cohort study
   consisted of all Norwegian residents from 18years between 2000 and 2016
   (n=5.4 million). 612 persons with PCT, and all cancer diagnoses and
   causes of death were identified through record linkage between national
   registries. Hazard ratios (HRs) and corresponding 95\% confidence
   intervals (CIs) were adjusted for age, sex, education and calendar
   years. We additionally compared persons with PCT to persons with a
   history of chronic alcohol abuse (n=30,468).ResultsPersons with PCT were
   more likely to be diagnosed with HCC {[}adjusted HR (aHR)=19.7,
   CI=8.8-44.0) and gallbladder and biliary tract cancer (aHR=6.8,
   CI=2.2-21.0) than the reference population. A moderate increased risk
   for HCC (aHR=3.1, CI=1.2-7.7) and gallbladder and biliary tract cancer
   (aHR=4.0, CI=1.1-14.4) remained when compared to persons with a history
   of chronic alcohol abuse. Additionally, compared to the reference
   population, persons with PCT had an increased risk of premature death
   (aHR=1.5, CI=1.2-1.7), due to the following causes of death: malignant
   neoplasms (aHR=1.4, CI=1.0-1.9), diseases of the liver (HR=5.5,
   CI=2.5-12.2), and drug and alcohol overdose (HR=9.9,
   CI=4.7-20.8).ConclusionsPersons with PCT had an increased risk of HCC
   and cancer of the gallbladder and biliary tract, as well as premature
   death. Although most of our findings can likely be explained by common
   lifestyle risk factors, something inherent in PCT may contribute to the
   development of HCC.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Baravelli, CM (Corresponding Author), Haukeland Hosp, Norwegian Porphyria Ctr NAPOS, Bergen, Norway.
   Baravelli, CM (Corresponding Author), Univ Bergen, Dept Global Publ Hlth \& Primary Care, Bergen, Norway.
   Baravelli, Carl Michael; Sandberg, Sverre; Aarsand, Aasne Karine, Haukeland Hosp, Norwegian Porphyria Ctr NAPOS, Bergen, Norway.
   Baravelli, Carl Michael; Sandberg, Sverre, Univ Bergen, Dept Global Publ Hlth \& Primary Care, Bergen, Norway.
   Sandberg, Sverre; Aarsand, Aasne Karine; Tollanes, Mette Christophersen, Haraldsplass Deaconess Hosp, Norwegian Qual Improvement Lab Examinat NOKLUS, Bergen, Norway.},
DOI = {10.1186/s13023-019-1051-3},
Article-Number = {77},
EISSN = {1750-1172},
Keywords = {Porphyria cutanea tarda; Neoplasms; Liver neoplasms; Hepatocellular
   carcinoma; Gallbladder and bile duct neoplasms; Cause of death},
Keywords-Plus = {LIVER-CANCER; DATA QUALITY; HEPATITIS-C; POPULATION; PREVALENCE;
   INFECTION; ALCOHOL; DISEASE},
Research-Areas = {Genetics \& Heredity; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Genetics \& Heredity; Medicine, Research \& Experimental},
Author-Email = {carl.michael.baravelli@helse-bergen.no},
ResearcherID-Numbers = {Sandberg, Sverre/T-9304-2019
   },
ORCID-Numbers = {Sandberg, Sverre/0000-0001-9521-5087
   Baravelli, Carl/0000-0001-7772-5315
   Aarsand, Aasne K./0000-0003-4167-8398},
Funding-Acknowledgement = {Norwegian National Advisory Unit on Rare Disorders (NKSD), Oslo
   University Hospital; Norwegian Porphyria Centre (NAPOS), Haukeland
   University Hospital; Western Norway Regional Health Authority},
Funding-Text = {The cost of acquiring and linking data from the Cancer Registry of
   Norway and Statistics Norway was funded by a grant awarded by the
   Norwegian National Advisory Unit on Rare Disorders (NKSD), Oslo
   University Hospital, and by the Norwegian Porphyria Centre (NAPOS),
   Haukeland University Hospital. The study was conducted as a part of a
   PhD, financed by Western Norway Regional Health Authority.},
Cited-References = {Aarsand AK, 2009, CLIN CHEM, V55, P795, DOI 10.1373/clinchem.2008.117432.
   {[}Anonymous], 2012, NASJ SERV MED KVAL.
   Badminton M., 2012, TIETZ TXB CLIN CHEM, P1031, DOI {[}10.1016/B978-1-4160-6164-9.00033-0, DOI 10.1016/B978-1-4160-6164-9.00033-0].
   Baravelli CM, 2017, J INTERN MED, V282, P229, DOI 10.1111/joim.12646.
   Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005.
   Dalgard O, 2003, SCAND J GASTROENTERO, V38, P864, DOI 10.1080/00365520310004542.
   El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061.
   Elder GH, 1999, CLIN DERMATOL, V17, P431, DOI 10.1016/S0738-081X(99)00029-2.
   European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021.
   Fargion S, 2003, J HEPATOL, V39, P635, DOI 10.1016/S0168-8278(03)00399-4.
   Fontanellas A, 2010, EXP DERMATOL, V19, pE326, DOI 10.1111/j.1600-0625.2009.01040.x.
   Fracanzani AL, 2001, J HEPATOL, V35, P498, DOI 10.1016/S0168-8278(01)00160-X.
   Frank J, 2010, BEST PRACT RES CL GA, V24, P735, DOI 10.1016/j.bpg.2010.07.002.
   Gage SH, 2018, INT J EPIDEMIOL, V47, P1131, DOI 10.1093/ije/dyy131.
   Gisbert JP, 2004, EUR J GASTROEN HEPAT, V16, P689, DOI 10.1097/01.meg.0000108318.52416.c9.
   Huckle T, 2018, DRUG ALCOHOL REV, V37, pS63, DOI 10.1111/dar.12810.
   Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037.
   Lim HW, 1997, PHOTODERMATOL PHOTO, V13, P75, DOI 10.1111/j.1600-0781.1997.tb00116.x.
   Linet MS, 1999, AM J EPIDEMIOL, V149, P1010.
   Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020.
   Munoz-Santos C, 2010, MEDICINE, V89, P69, DOI 10.1097/MD.0b013e3181d50928.
   Mykletun Mira, 2014, Tidsskr Nor Laegeforen, V134, P831, DOI 10.4045/tidsskr.13.0649.
   Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065.
   Rimseliene G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-153.
   Rossmann-Ringdahl I, 2005, ACTA DERM-VENEREOL, V85, P337, DOI 10.1080/00015550510033688.
   SIERSEMA PD, 1992, LIVER, V12, P56.
   Smith AG, 2018, TOXICOL RES-UK, V7, P647, DOI 10.1039/c8tx00019k.
   Sokmen M, 2007, TURK J GASTROENTEROL, V18, P201.
   VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607.},
Number-of-Cited-References = {29},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Orphanet J. Rare Dis.},
Doc-Delivery-Number = {HS1AX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000463594100001},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000380151100004,
Author = {Si, Yang and Chen, Deng and Tian, Linyu and Mu, Jie and Chen, Tao and
   Liu, Ling and Deng, Ying and He, Jun and Li, You and He, Li and Zhou,
   Dong},
Title = {Update on causes of premature death in people with convulsive epilepsy
   in rural West China},
Journal = {EPILEPSIA},
Year = {2016},
Volume = {57},
Number = {6},
Pages = {E117-E120},
Month = {JUN},
Abstract = {This longitudinal prospective study updated a previous report on
   premature mortality and focused on the risk factors among patients with
   convulsive epilepsy in resourcepoor settings. The present cohort size
   (7,231) and follow-up (mean 33.4 months) were expanded. The basic
   epidemiologic aspects of this cohort were similar to the original report
   (case fatality: 3.26\% vs. 2.97\%, respectively; injury contributed more
   than half of the deaths). Cox regression analysis suggested that male
   patients, late ages of onset (>45 years old), short duration of epilepsy
   (<10 years), and high convulsive seizure frequency (>2 per month) were
   independent risk factors for overall premature death. Male patients with
   late ages of onset and high seizure frequency had a higher risk of
   injury-specific death. This study emphasizes the preventable nature of
   injuries that are leading putative causes of death among people with
   convulsive epilepsy in rural West China. Education on specific
   populations and efficient seizure control are of paramount importance in
   reducing the risk of premature mortality.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Liu, L; Zhou, D (Corresponding Author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Wai Nan Guo Xue Lane, Chengdu 610041, Peoples R China.
   Si, Yang; Chen, Deng; Tian, Linyu; Mu, Jie; Chen, Tao; Liu, Ling; He, Li; Zhou, Dong, Sichuan Univ, West China Hosp, Dept Neurol, 37 Wai Nan Guo Xue Lane, Chengdu 610041, Peoples R China.
   Deng, Ying; He, Jun; Li, You, Sichuan Ctr Dis Control \& Prevent, Chengdu, Sichuan, Peoples R China.},
DOI = {10.1111/epi.13395},
ISSN = {0013-9580},
EISSN = {1528-1167},
Keywords = {Epilepsy; Preventable cause of death; Risk factor},
Keywords-Plus = {MORTALITY},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Author-Email = {zjllxx1968@163.com
   zhoudong66@yahoo.de},
Funding-Acknowledgement = {Chinese Ministry of Health; Sichuan Province Health Bureau; National
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China (NSFC) {[}81420108014, 81371529]},
Funding-Text = {We thank all the participants for their help and cooperation, the local
   physicians and health workers for their support, and the experts at the
   CDC of Sichuan Province for their assistance. This study was funded by
   the Chinese Ministry of Health and the Sichuan Province Health Bureau.
   And this study was supported by National Science Foundation of China
   (NSFC), No. 81420108014 \& 81371529.},
Cited-References = {Aspray TJ, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00402.x.
   Ding D, 2006, LANCET NEUROL, V5, P823, DOI 10.1016/S1474-4422(06)70528-2.
   Ding D, 2013, EPILEPSIA, V54, P512, DOI 10.1111/epi.12048.
   Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5.
   Liu L, 2010, EPILEPSY BEHAV, V17, P75, DOI 10.1016/j.yebeh.2009.10.013.
   Mu J, 2011, NEUROLOGY, V77, P132, DOI 10.1212/WNL.0b013e318223c784.
   Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6.
   Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005.
   Ridsdale L, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572463.
   Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4.},
Number-of-Cited-References = {10},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Epilepsia},
Doc-Delivery-Number = {DR8MD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000380151100004},
DA = {2022-03-29},
}

@article{ WOS:000344780300014,
Author = {Tuusov, Jana and Lang, Katrin and Vaeli, Marika and Paerna, Kersti and
   Tonisson, Mailis and Ringmets, Inge and McKee, Martin and Helander,
   Anders and Leon, David A.},
Title = {Prevalence of alcohol-related pathologies at autopsy: Estonian Forensic
   Study of Alcohol and Premature Death},
Journal = {ADDICTION},
Year = {2014},
Volume = {109},
Number = {12},
Pages = {2018-2026},
Month = {DEC},
Abstract = {AimsAlcohol can induce diverse serious pathologies, yet this complexity
   may be obscured when alcohol-related deaths are classified according to
   a single underlying cause. We sought to quantify this issue and its
   implications for analysing mortality data.
   Design, Setting and ParticipantsCross-sectional study included 554 men
   aged 25-54 in Estonia undergoing forensic autopsy in 2008-09.
   MeasurementsPotentially alcohol-related pathologies were identified
   following macroscopic and histological examination. Alcohol biomarkers
   levels were determined. For a subset (26\%), drinking behaviour was
   provided by next-of-kin. The Estonian Statistics Office provided
   underlying cause of death.
   FindingsMost deaths (75\%) showed evidence of potentially
   alcohol-related pathologies, and 32\% had pathologies in two or more
   organs. The liver was most commonly affected {[}60.5\%, 95\% confidence
   interval (CI)=56.3-64.6] followed by the lungs (18.6\%, 95\%
   CI=15.4-22.1), stomach (17.5\%, 95\% CI=14.4-20.9), pancreas (14.1\%,
   95\% CI=11.3-17.3), heart (4.9\%, 95\% CI=3.2-7.0) and oesophagus
   (1.4\%, 95\% CI=0.6-2.8). Only a minority with liver pathology had a
   second pathology. The number of pathologies correlated with alcohol
   biomarkers (phosphatidylethanol, gamma-glytamyl transpeptidase in blood,
   ethylglucuronide, ethylsulphate in urine). Despite the high prevalence
   of liver pathology, few deaths had alcoholic liver disease specified as
   the underlying cause.
   ConclusionThe majority of 554 men aged 25-54 undergoing forensic autopsy
   in Estonia in 2008-09 showed evidence of alcohol-related pathology.
   However, the recording of deaths by underlying cause failed to capture
   the scale and nature of alcohol-induced pathologies found.},
Publisher = {WILEY-BLACKWELL},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Tuusov, J (Corresponding Author), Estonian Forens Sci Inst, EE-50411 Tallinn, Estonia.
   Tuusov, Jana; Vaeli, Marika, Univ Tartu, Inst Pathol Anat \& Forens Med, EE-50090 Tartu, Estonia.
   Tuusov, Jana; Vaeli, Marika; Tonisson, Mailis, Estonian Forens Sci Inst, Tallinn, Estonia.
   Lang, Katrin; Paerna, Kersti; Ringmets, Inge, Univ Tartu, Dept Publ Hlth, EE-50090 Tartu, Estonia.
   Tonisson, Mailis; Leon, David A., Univ Tartu, Internal Med Clin, EE-50090 Tartu, Estonia.
   McKee, Martin, London Sch Hyg \& Trop Med, London WC1, England.
   Helander, Anders, Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
   Helander, Anders, Karolinska Univ Lab, Stockholm, Sweden.
   Leon, David A., Arctic Univ Norway, Tromso, Norway.},
DOI = {10.1111/add.12695},
ISSN = {0965-2140},
EISSN = {1360-0443},
Keywords = {Alcohol drinking; alcohol-related pathologies; epidemiology; Estonia;
   forensic autopsy; ICD codes; post-mortem alcohol biomarkers},
Keywords-Plus = {LIVER-DISEASE; ETHYL GLUCURONIDE; MORTALITY; RUSSIA; CONSUMPTION;
   BIOMARKERS; COUNTRIES; SYSTEM; INJURY; LUNG},
Research-Areas = {Substance Abuse; Psychiatry},
Web-of-Science-Categories  = {Substance Abuse; Psychiatry},
Author-Email = {jana.tuusov@ekei.ee},
ResearcherID-Numbers = {McKee, Marc D/E-2187-2011
   Leon, David A/G-2195-2010
   Lang, Katrin/J-9611-2012
   McKee, Martin/E-6673-2018},
ORCID-Numbers = {McKee, Marc D/0000-0001-8349-965X
   Leon, David A/0000-0001-9747-1762
   Helander, Anders/0000-0001-7480-8078
   McKee, Martin/0000-0002-0121-9683},
Funding-Acknowledgement = {Wellcome TrustWellcome TrustEuropean Commission {[}078557]; Estonian
   Science Foundation {[}8847]},
Funding-Text = {This study was funded by the Wellcome Trust (grant number 078557) and
   the Estonian Science Foundation (grant number 8847). We thank all the
   forensic doctors of the Estonian Forensic Science Institute who
   participated in the study.},
Cited-References = {Bogstrand ST, 2011, DRUG ALCOHOL DEPEN, V117, P132, DOI 10.1016/j.drugalcdep.2011.01.007.
   Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328.
   Centers for Disease Control and Prevention National Center for Health Statistics, 2013, INSTR CLASS UND CAUS.
   Darke S, 2013, ADDICTION, V108, P1411, DOI 10.1111/add.12191.
   Diehl AM, 2002, ALCOHOL, V27, P7, DOI 10.1016/S0741-8329(02)00204-5.
   Drummer O.H., 2001, FORENSIC PHARM DRUGS, V1st.
   Franke A, 2005, DIGEST DIS, V23, P204, DOI 10.1159/000090167.
   Gamble L, 2006, MED MALADIES INFECT, V36, P72, DOI 10.1016/j.medmal.2005.08.010.
   Hoek JB, 2004, SEMIN LIVER DIS, V24, P257, DOI 10.1055/s-2004-832939.
   Janssen F, 2004, B WORLD HEALTH ORGAN, V82, P904.
   Kaphalia L, 2013, TOXICOL LETT, V222, P171, DOI 10.1016/j.toxlet.2013.07.016.
   Lahti RA, 2011, FORENSIC SCI INT, V212, P121, DOI 10.1016/j.forsciint.2011.05.029.
   Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102.
   LIM RT, 1993, ALCOHOL CLIN EXP RES, V17, P1337, DOI 10.1111/j.1530-0277.1993.tb05250.x.
   Lu TH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-30.
   Lucas DL, 2005, J AM COLL CARDIOL, V45, P1916, DOI 10.1016/j.jacc.2005.02.075.
   MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605.
   Makela P, 1998, EUR J PUBLIC HEALTH, V8, P43, DOI 10.1093/eurpub/8.1.43.
   McDonald H, 2013, ADDICTION, V108, P1579, DOI 10.1111/add.12251.
   Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169.
   Rainio J, 2014, ALCOHOL ALCOHOLISM, V49, P55, DOI 10.1093/alcalc/agt159.
   Rainio J, 2013, FORENSIC SCI INT, V226, P261, DOI 10.1016/j.forsciint.2013.01.040.
   Ridley NJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt157.
   Ringmets I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-146.
   Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451.
   Saunders JB, 2012, ALCOHOL ALCOHOLISM, V47, P216, DOI 10.1093/alcalc/ags024.
   Stata Corporation, 2009, STAT STAT SOFTW REL.
   Tomkins S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-343.},
Number-of-Cited-References = {28},
Times-Cited = {13},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Addiction},
Doc-Delivery-Number = {AT2QY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000344780300014},
OA = {hybrid, Green Accepted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1991GB69100003,
Author = {SORENSEN, TIA},
Title = {GENETIC EPIDEMIOLOGY UTILIZING THE ADOPTION METHOD - STUDIES OF OBESITY
   AND OF PREMATURE DEATH IN ADULTS},
Journal = {SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE},
Year = {1991},
Volume = {19},
Number = {1},
Pages = {14-19},
Abstract = {Genetic epidemiology gives no priority to genes or environment in the
   search of disease causation.  However, a major problem in this field is
   the disentangling of the effects of environment and genes.  The study of
   subjects separated very early in life from their biologic parents and
   adopted by unrelated parents provide a strong tool for estimation of
   genetic and familial environmental influences.  The degree to which the
   trait or disease frequency of the adoptees is similar to that seen among
   the biologic relatives is an indication of the strength of the genetic
   influence.  Similarity to the adoptive relatives suggests influences of
   the family environment shared between them.  Adoption studies of adult
   obesity show that it is genes, and not the family environment, that is
   responsible for the familial aggregation of obesity.  A study of the
   mortality of adult adoptees and their biologic and adoptive parents
   indicates a genetic influence on the risk of premature death from all
   causes, from natural causes, infections, and cardio- and cerebrovascular
   conditions, and suggests familial environmental influences on death from
   the vascular causes and from cancer.},
Publisher = {SCANDINAVIAN UNIVERSITY PRESS},
Address = {PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY},
Type = {Article},
Language = {English},
Affiliation = {KOMMUNE HOSP COPENHAGEN,INST PSYKOL,DK-1399 COPENHAGEN,DENMARK.},
ISSN = {0300-8037},
Keywords = {ADOPTION; EPIDEMIOLOGY; GENETICS; MORTALITY; OBESITY},
Keywords-Plus = {BODY-MASS INDEX; DANISH YOUNG MEN; BIOLOGICAL INHERITANCE; HUMAN
   FATNESS; RISK-FACTORS; SOCIAL-CLASS; ADOPTEES; DISEASE; FAMILY;
   OVERWEIGHT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355.
   BRAY GA, 1971, PHYSIOL REV, V51, P598, DOI 10.1152/physrev.1971.51.3.598.
   CHILDS B, 1986, PERSPECT BIOL MED, V29, P437.
   CHRISTENSEN U, 1981, HUM BIOL, V53, P403.
   CLONINGER CR, 1979, AM J HUM GENET, V31, P366.
   COHEN BH, 1964, REV BIOL, V39, P130.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   FABSITZ RR, 1978, BEHAV GENET, V8, P15, DOI 10.1007/BF01067701.
   FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464.
   FELDMAN MW, 1975, SCIENCE, V190, P1163, DOI 10.1126/science.1198102.
   GARN SM, 1979, HUM BIOL, V51, P565.
   GOLDBOURT U, 1986, ARTERIOSCLEROSIS, V6, P357, DOI 10.1161/01.ATV.6.4.357.
   GONWA TA, 1983, ADV IMMUNOL, V34, P71, DOI 10.1016/S0065-2776(08)60377-6.
   HEATH AC, 1985, BEHAV GENET, V15, P439, DOI 10.1007/BF01066238.
   KENDLER KS, 1986, AM J PSYCHIAT, V143, P279.
   KETY SS, 1959, SCIENCE, V129, P1590, DOI 10.1126/science.129.3363.1590.
   KETY SS, 1967, J PSYCHIATR RES S1, V6, P345.
   KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842.
   KHOURY MJ, 1986, J CHRON DIS, V39, P963, DOI 10.1016/0021-9681(86)90134-7.
   KHOURY P, 1983, METABOLISM, V32, P82, DOI 10.1016/0026-0495(83)90161-0.
   MUELLER WH, 1983, YEARB PHYS ANTHROPOL, V26, P215.
   PRICE RA, 1987, AM J PSYCHIAT, V144, P1003.
   PRICE RA, 1989, INT J OBESITY, V3, P573.
   RAO DC, 1976, AM J HUM GENET, V28, P228.
   SCHOTTENFELD D, 1986, J CHRON DIS, V39, P1021, DOI 10.1016/0021-9681(86)90137-2.
   Schull W J, 1980, Epidemiol Rev, V2, P1.
   SCHULSINGER F, 1985, MED GEN, P461.
   SKEELS HM, 1939, P AM ASS MENTAL DEF, V63, P114.
   {*}SOC ACT, 1959, 1959 BUILD BLOOD PRE.
   SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7.
   SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87.
   SORENSEN TIA, 1990, INT J OBESITY, V14, P411.
   SORENSEN TIA, 1983, INT J OBESITY, V7, P115.
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202.
   SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3.
   STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593.
   STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401.
   STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102.
   TEASDALE TW, 1984, J BIOSOC SCI, V16, P521, DOI 10.1017/S0021932000015340.
   TEASDALE TW, 1979, BEHAV GENET, V9, P103, DOI 10.1007/BF01074329.
   WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X.
   WILLIAMS RR, 1988, NEW ENGL J MED, V318, P769, DOI 10.1056/NEJM198803243181208.},
Number-of-Cited-References = {42},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Scand. J. Soc. Med.},
Doc-Delivery-Number = {GB691},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991GB69100003},
DA = {2022-03-29},
}

@article{ WOS:000288800500015,
Author = {Tebbenkamp, Andrew T. N. and Swing, Debbie and Tessarollo, Lino and
   Borchelt, David R.},
Title = {Premature death and neurologic abnormalities in transgenic mice
   expressing a mutant huntingtin exon-2 fragment},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2011},
Volume = {20},
Number = {8},
Pages = {1633-1642},
Month = {APR 15},
Abstract = {Huntington's disease (HD) is a fatal neurodegenerative disease
   characterized pathologically by aggregates composed of N-terminal
   fragments of the mutant form of the protein huntingtin (htt). The role
   of these N-terminal fragments in disease pathogenesis has been
   questioned based in part on studies in transgenic mice. In one important
   example, mice that express an N-terminal fragment of mutant htt
   terminating at the C-terminus of exon 2 (termed the Shortstop mouse)
   were reported to develop robust inclusion pathology without developing
   phenotypic abnormalities seen in the R6/2 or N171-82Q models of HD,
   which are also based on expression of mutant N-terminal htt fragments.
   To further explore the capacity of mutant exon-2 htt fragments to
   produce neurologic abnormalities (N-terminal 118 amino acids; N118), we
   generated transgenic mice expressing cDNA that encodes htt N118-82Q with
   the mouse prion promoter vector. In mice generated in this manner, we
   demonstrate robust inclusion pathology accompanied by early death and
   failure to gain weight. These phenotypes are the most robust
   abnormalities identified in the R6/2 and N171-82Q models. We conclude
   that the lack of an overt phenotype in the initial Shortstop mice cannot
   be completely explained by the properties of mutant htt N118 fragments.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Borchelt, DR (Corresponding Author), Univ Florida, McKnight Brain Inst, Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, 100 Newell Dr,Rm L1-100, Gainesville, FL 32610 USA.
   Tebbenkamp, Andrew T. N.; Borchelt, David R., Univ Florida, McKnight Brain Inst, Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA.
   Swing, Debbie; Tessarollo, Lino, NCI, Mouse Canc Genet Program, Neural Dev Sect, Frederick, MD 21702 USA.},
DOI = {10.1093/hmg/ddr040},
ISSN = {0964-6906},
EISSN = {1460-2083},
Keywords-Plus = {YAC128 MOUSE MODEL; KNOCK-IN MICE; NEURONAL INTRANUCLEAR INCLUSIONS;
   N-TERMINAL FRAGMENTS; MOTOR DYSFUNCTION; NUCLEAR-LOCALIZATION;
   NERVOUS-SYSTEM; STRIATAL CELLS; HD MUTATION; CAG REPEAT},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {borchelt@mbi.ufl.edu},
ORCID-Numbers = {Tebbenkamp, Andrew/0000-0002-9015-3427},
Funding-Acknowledgement = {Huntington's Disease Society of America; CHDI Coalition for a Cure; NIH,
   Center for Cancer Research, National Cancer InstituteUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Cancer Institute (NCI); SantaFe HealthCare
   Alzheimer's Disease Research Center; NATIONAL CANCER INSTITUTEUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) {[}ZIABC010390,
   ZICBC010903] Funding Source: NIH RePORTER},
Funding-Text = {This work was supported by the Huntington's Disease Society of America
   and the CHDI Coalition for a Cure (A.T.N.T. and D. R. B.) and the
   Intramural Research Program of the NIH, Center for Cancer Research,
   National Cancer Institute (for D. S. and L. T.). Funding to pay the Open
   Access publication charges for this article was provided by SantaFe
   HealthCare Alzheimer's Disease Research Center.},
Cited-References = {Bhide PG, 1996, J NEUROSCI, V16, P5523.
   Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2.
   Carter RJ, 1999, J NEUROSCI, V19, P3248.
   Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783.
   Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9.
   DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003.
   DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990.
   FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372.
   Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008.
   Gutekunst CA, 1999, J NEUROSCI, V19, P2522.
   Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097.
   Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3.
   Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355.
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3.
   Kim M, 1999, J NEUROSCI, V19, P964.
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0.
   Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028.
   Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137.
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293.
   Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125.
   Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0.
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E.
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0.
   MANSON J, 1992, DEVELOPMENT, V115, P117.
   Menalled LB, 2002, J NEUROSCI, V22, P8266.
   MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341.
   Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992.
   Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200.
   Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397.
   Schilling G, 2001, NEUROBIOL DIS, V8, P405, DOI 10.1006/nbdi.2001.0385.
   Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8.
   Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102.
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169.
   Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680.
   Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799.
   Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010.
   Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147.
   Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1.
   Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175.
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004.
   Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503.
   Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004.
   Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037.
   Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6.
   ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155.
   Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012.},
Number-of-Cited-References = {46},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Hum. Mol. Genet.},
Doc-Delivery-Number = {740NC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000288800500015},
OA = {Green Published, hybrid, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000559317800019,
Author = {Maia-Elkhoury, Ana Nilce S. and Sierra Romero, Gustavo Adolfo and
   Valadas, Samantha Y. O. B. and Sousa-Gomes, Marcia L. and Lauletta
   Lindoso, Jose Angelo and Cupolillo, Elisa and Ruiz-Postigo, Jose Antonio
   and Argaw, Daniel and Sanchez-Vazquez, Manuel J.},
Title = {Premature deaths by visceral leishmaniasis in Brazil investigated
   through a cohort study: A challenging opportunity?},
Journal = {PLOS NEGLECTED TROPICAL DISEASES},
Year = {2019},
Volume = {13},
Number = {12},
Month = {DEC},
Abstract = {Background
   Visceral Leishmaniasis (VL) is the most severe form of leishmaniasis
   because it can lead to death. In the Americas, 96\% of cases are in
   Brazil, and despite efforts, the fatality rate has increased in the past
   years. We analyzed deaths associated to VL in Brazil and investigated
   the factors that could influence on the timeliness of fatal outcome with
   emphasis on time (tStoD).
   Methodology
   The registered deaths by VL were sourced from the Brazilian National
   Notification System from 2007-2014. Through a retrospective cohort
   study, univariate and multivariable Cox proportional hazards model
   analysis were performed and investigated the factors that could
   influence the time (tStoD). These factors were analyzed through survival
   models.
   Results
   Out of the 1,589 reported deaths, the median for onset of the symptoms
   and the case notification date (tStoN) is 25 days (10-61), and for date
   of case notification and death (tNotD) is 9 days (4-17). The time
   (tStoN) to event investigation for HIV non-infected individuals was 1.4
   (1.16-1.68) greater than the HIV positive group. At the same time
   peri-urban and urban area were 0.83 (0.47-1.44) and 1.33 (1.16-1.52),
   respectively. The explorations revealed apparent differences between the
   time to event investigation (both for tStoN and tNotD) and the age at
   the onset of the symptoms. According to the tStoN the rate of
   notification is 1.73 times greater in patients under 5 years old at the
   onset of the clinical symptoms compared to older patients.
   Conclusion
   VL patients under 5 years old were diagnosed earlier and had shorter
   survival. It could mean that in younger population, although properly
   diagnosed, the fatality pattern might be related to the severity of the
   disease. Main host characteristics were evaluated, and age and
   co-infections seem to have an impact in the disease progression.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Maia-Elkhoury, ANS (Corresponding Author), Pan Amer Hlth Org World Hlth Org PAHO WHO, Neglected Trop \& Vector Borne Dis VT, Communicable Dis \& Environm Determinants Hlth CDE, Duque De Caxias, RJ, Brazil.
   Maia-Elkhoury, Ana Nilce S.; Valadas, Samantha Y. O. B., Pan Amer Hlth Org World Hlth Org PAHO WHO, Neglected Trop \& Vector Borne Dis VT, Communicable Dis \& Environm Determinants Hlth CDE, Duque De Caxias, RJ, Brazil.
   Sierra Romero, Gustavo Adolfo, Univ Brasilia, Fac Med, Ctr Trop Med, Brasilia, DF, Brazil.
   Sousa-Gomes, Marcia L., Minist Hlth, Secretary Hlth Surveillance, Brasilia, DF, Brazil.
   Lauletta Lindoso, Jose Angelo, Univ Sao Paulo, Inst Infectol Emilio Ribas, Sao Paulo, Brazil.
   Lauletta Lindoso, Jose Angelo, Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   Cupolillo, Elisa, Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.
   Ruiz-Postigo, Jose Antonio; Argaw, Daniel, World Hlth Org WHO, Dept Neglected Trop Dis HTM NTD IDM, Geneva, Switzerland.
   Sanchez-Vazquez, Manuel J., Pan Amer Foot \& Mouth Dis Ctr PANAFTOSA PAHO, Duque De Caxias, RJ, Brazil.},
DOI = {10.1371/journal.pntd.0007841},
Article-Number = {e0007841},
ISSN = {1935-2735},
Keywords-Plus = {KALA-AZAR; OUTCOMES; TESTS},
Research-Areas = {Infectious Diseases; Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Infectious Diseases; Parasitology; Tropical Medicine},
Author-Email = {aelkhoury@paho.org},
ResearcherID-Numbers = {Lindoso, José Angelo Lauletta/E-9339-2012
   Romero, Gustavo A.S./F-7214-2012
   Cupolillo, Elisa/U-1667-2019
   Vazquez, Manuel J Sanchez/E-8628-2011
   },
ORCID-Numbers = {Lindoso, José Angelo Lauletta/0000-0002-4405-4401
   Romero, Gustavo A.S./0000-0003-1425-926X
   Cupolillo, Elisa/0000-0002-0620-3250
   Sanchez-Vazquez, Manuel Jose/0000-0001-6548-6425},
Funding-Acknowledgement = {World Health OrganizationWorld Health Organization {[}001] Funding
   Source: Medline},
Cited-References = {Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671.
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354.
   BARRAL A, 1986, AM J TROP MED HYG, V35, P732, DOI 10.4269/ajtmh.1986.35.732.
   Beachy SH, 2011, INT J HYPERTHER, V27, P344, DOI 10.3109/02656736.2011.562873.
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982.
   Brasil. Ministerio da Saude, 2016, COORD GER DES EP SER.
   Brasil. Ministerio da Saude, 2011, NORM MAN TECN A.
   Brasil. Ministerio da Saude, SIST INF SINAN CAS C.
   Brasil. Ministerio da Saude, 2000, SIST INF NOT SINAN L.
   Brasil. Ministerio da Saude, 2014, NOT INF CGDT DEVIT S.
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203.
   Costa DL, 2016, REV SOC BRAS MED TRO, V49, P728, DOI 10.1590/0037-8682-0258-2016.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   de Alvarenga DG, 2010, REV SOC BRAS MED TRO, V43, P194, DOI 10.1590/S0037-86822010000200017.
   de Sousa-Gomes ML, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005772.
   Driemeier M, 2015, PATHOG GLOB HEALTH, V109, P283, DOI 10.1179/2047773215Y.0000000029.
   Gardinassi LG, 2014, MBIO, V5, DOI 10.1128/mBio.01844-14.
   Góes Marco Aurélio de Oliveira, 2012, Rev. bras. epidemiol., V15, P298, DOI 10.1590/S1415-790X2012000200007.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Lindoso JAL, 2006, LEISHMANIOSE VISCERA, V3, P7.
   de Assis TSM, 2012, TROP MED INT HEALTH, V17, P1202, DOI 10.1111/j.1365-3156.2012.03064.x.
   Madalosso G, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/281572.
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024.
   Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242.
   Ministerio da Saude, 2014, MAN VIG CONTR LEISHM.
   de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511.
   Pan American Health Organization (PAHO), 2016, SER LEISHM REP, V4.
   Pastorino Antonio C., 2002, J. Pediatr. (Rio J.), V78, P120, DOI 10.1590/S0021-75572002000200010.
   Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012.
   Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI {[}10.1590/S0021-75572005000100014, 10.2223/JPED.1286].
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584.
   Santos Mácia A., 2002, Rev. Soc. Bras. Med. Trop., V35, P629, DOI 10.1590/S0037-86822002000600014.
   Santos PL, 2012, NITRIC OXIDE-BIOL CH, V27, P67, DOI 10.1016/j.niox.2012.04.004.
   Segatto M, 2012, MEM I OSWALDO CRUZ, V107, P39, DOI 10.1590/S0074-02762012000100006.
   Romero GAS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005706.
   de Carvalho IPSF, 2017, TROP MED INT HEALTH, V22, P1579, DOI 10.1111/tmi.12994.
   United Nations, 2015, UN C SUMM EC SOC REL.
   Weirather JL, 2017, ANN HUM GENET, V81, P41, DOI 10.1111/ahg.12180.
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9.
   WHO, 2016, WEEKLY EPIDEMIOLOGIC, V91, P285, DOI DOI 10.1186/1750-9378-2-15.VOIR.
   World Health Organization, 2002, WKLY EPIDEMIOL REC, V77, P365.
   World Health Organization (WHO) = Organisation mondiale de la Sante (OMS), 2017, GLOB LEISHM UPD 2006, V92, P557.
   Zacarias DA, 2017, TROP MED INT HEALTH, V22, P679, DOI 10.1111/tmi.12877.},
Number-of-Cited-References = {43},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Plos Neglect. Trop. Dis.},
Doc-Delivery-Number = {MZ7OY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000559317800019},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000446181900130,
Author = {Nalini, Mahdi and Oranuba, Ebele and Poustchi, Hossein and Sepanlou,
   Sadaf G. and Pourshams, Akram and Khoshnia, Masoud and Gharavi,
   Abdolsamad and Dawsey, Sanford M. and Abnet, Christian C. and Boffetta,
   Paolo and Brennan, Paul and Sotoudeh, Masoud and Nikmanesh, Arash and
   Merat, Shahin and Etemadi, Arash and Shakeri, Ramin and Sohrabpour, Amir
   Ali and Nasseri-Moghaddam, Siavosh and Kamangar, Farin and Malekzadeh,
   Reza},
Title = {Causes of premature death and their associated risk factors in the
   Golestan Cohort Study, Iran},
Journal = {BMJ OPEN},
Year = {2018},
Volume = {8},
Number = {7},
Month = {SEP},
Abstract = {Objectives To examine the causes of premature mortality (<70 years) and
   associated risk factors in the Golestan Cohort Study.
   Design Prospective.
   Setting The Golestan Cohort Study in northeastern Iran.
   Participants 50 045 people aged 40 or more participated in this
   population-based study from baseline (2004-2008) to August 2017, with
   over 99\% success follow-up rate.
   Main outcome measures The top causes of premature death, HR and their
   95\% CI and population attributable fraction (PAF) for risk factors.
   Results After 444 168 person-years of follow-up (median of 10 years),
   6347 deaths were reported, of which 4018 (63.3\%) occurred prematurely.
   Ischaemic heart disease (IHD) accounted for 33.9\% of premature death,
   followed by stroke (14.0\%), road injuries (4.7\%), stomach cancer
   (4.6\%) and oesophageal cancer (4.6\%). Significant risk/protective
   factors were: wealth score (HR for highest vs lowest quintile: 0.57, PAF
   for lowest four quintiles vs top quintile: 28\%), physical activity
   (highest vs lowest tertile: 0.67, lowest two tertiles vs top tertile:
   22\%), hypertension (1.50, 19\%), opium use (1.69, 14\%), education
   (middle school or higher vs illiterate: 0.84, illiterate or primary vs
   middle school or higher: 13\%), tobacco use (1.38, 11\%), diabetes
   (2.39, 8\%) and vegetable/fruit consumption (highest vs lowest tertile:
   0.87, lowest two tertiles vs top tertile: 8\%). Collectively, these
   factors accounted for 76\% of PAF in men and 69\% in women.
   Conclusion IHD and stroke are the leading causes of premature mortality
   in the Golestan Cohort Study. Enhancing socioeconomic status and
   physical activity, reducing opium and tobacco use, increasing
   vegetable/fruit consumption and controlling hypertension and diabetes
   are recommended to reduce premature deaths.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Malekzadeh, R (Corresponding Author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran.
   Kamangar, F; Malekzadeh, R (Corresponding Author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran.
   Malekzadeh, R (Corresponding Author), Univ Tehran Med Sci, Digest Dis Res Inst, Liver \& Pancreaticobiliary Dis Res Ctr, Tehran, Iran.
   Kamangar, F (Corresponding Author), Morgan State Univ, Sch Comp Math \& Nat Sci, Dept Biol, Baltimore, MD 21239 USA.
   Nalini, Mahdi; Poustchi, Hossein; Sepanlou, Sadaf G.; Pourshams, Akram; Sotoudeh, Masoud; Nikmanesh, Arash; Merat, Shahin; Etemadi, Arash; Shakeri, Ramin; Sohrabpour, Amir Ali; Nasseri-Moghaddam, Siavosh; Malekzadeh, Reza, Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran.
   Nalini, Mahdi, Kermanshah Univ Med Sci, Cardiovasc Dis Res Ctr, Kermanshah, Iran.
   Oranuba, Ebele, Morgan State Univ, Sch Community Hlth \& Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA.
   Poustchi, Hossein; Pourshams, Akram; Khoshnia, Masoud; Gharavi, Abdolsamad; Sotoudeh, Masoud; Nikmanesh, Arash; Shakeri, Ramin; Nasseri-Moghaddam, Siavosh; Kamangar, Farin; Malekzadeh, Reza, Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran.
   Pourshams, Akram; Merat, Shahin; Malekzadeh, Reza, Univ Tehran Med Sci, Digest Dis Res Inst, Liver \& Pancreaticobiliary Dis Res Ctr, Tehran, Iran.
   Khoshnia, Masoud; Gharavi, Abdolsamad, Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol \& Hepatol GRCGH, Gorgan, Iran.
   Dawsey, Sanford M.; Abnet, Christian C.; Etemadi, Arash, NCI, Metabol Epidemiol Branch, Div Canc Epidemiol \& Genet, NIH, Bethesda, MD 20892 USA.
   Boffetta, Paolo, Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.
   Boffetta, Paolo, Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA.
   Brennan, Paul, Int Agcy Res Cancel, Genet Sect, Genet Epidemiol Grp, Lyon, France.
   Kamangar, Farin, Morgan State Univ, Sch Comp Math \& Nat Sci, Dept Biol, Baltimore, MD 21239 USA.},
DOI = {10.1136/bmjopen-2018-021479},
Article-Number = {e021479},
ISSN = {2044-6055},
Keywords = {premature mortality; cause of death; risk factor; Iran},
Keywords-Plus = {REDUCING SALT INTAKE; ESOPHAGEAL CANCER; SOCIOECONOMIC-STATUS;
   MORTALITY; OPIUM; POLYPILLS; COUNTRIES; LESSONS; IMPACT},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {farin.kamangar@morgan.edu
   malek@tums.ac.ir},
ResearcherID-Numbers = {Etemadi, Arash/Y-7082-2018
   Nalini/AAY-1099-2020
   Abnet, Christian C/C-4111-2015
   Merat, Shahin/A-5478-2009
   Boffetta, Paolo/AAI-7767-2021
   Sepanlou, Sadaf/H-9343-2016
   },
ORCID-Numbers = {Etemadi, Arash/0000-0002-3458-1072
   Nalini/0000-0002-7464-9756
   Abnet, Christian C/0000-0002-3008-7843
   Boffetta, Paolo/0000-0002-3811-2791
   Sepanlou, Sadaf/0000-0002-3669-5129
   Pourshams, Akram/0000-0002-7950-3983},
Funding-Acknowledgement = {Tehran University of Medical SciencesTehran University of Medical
   Sciences {[}81/15]; Cancer Research UKCancer Research UK {[}C20/A5860];
   NGIMS/NIH {[}UL1 GM118973]; NCI/NIH Intramural Research Program; IARC;
   NATIONAL CANCER INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) {[}ZIACP000185] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   \& Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) {[}UL1GM118973] Funding
   Source: NIH RePORTER},
Funding-Text = {This study was supported by Tehran University of Medical Sciences (grant
   number: 81/15), Cancer Research UK (grant number: C20/A5860), the
   NGIMS/NIH (grant number: UL1 GM118973), the NCI/NIH Intramural Research
   Program, and through various collaborative research agreements with the
   IARC.},
Cited-References = {{[}Anonymous], 2017, WHO METH DAT SOURC C.
   Bazile J, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S1.
   Chen JT, 2006, J URBAN HEALTH, V83, P1063, DOI 10.1007/s11524-006-9089-7.
   Ellis J, 2013, J ROY SOC MED, V106, P57, DOI 10.1177/0141076812472623.
   Fahimi S, 2012, ARCH IRAN MED, V15, P110, DOI 012152/AIM.0014.
   Gholipour Mahin, 2016, Middle East J Dig Dis, V8, P249, DOI 10.15171/mejdd.2016.34.
   Huffman MD, 2017, LANCET, V389, P1055, DOI 10.1016/S0140-6736(17)30553-6.
   Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195.
   Kamangar F, 2014, LANCET ONCOL, V15, pE69, DOI 10.1016/S1470-2045(13)70550-3.
   Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502.
   Khademi H, 2012, ARCH IRAN MED, V15, P194, DOI 012154/AIM.003.
   Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183.
   Khorshidi A, 2016, J PAK MED ASSOC, V66, P517.
   Malekshah AF, 2006, EUR J CLIN NUTR, V60, P971, DOI 10.1038/sj.ejcn.1602407.
   Malekzadeh R, 2009, ARCH IRAN MED, V12, P576.
   Masoudkabir F, 2013, NAT REV CARDIOL, V10, P733, DOI 10.1038/nrcardio.2013.159.
   Mohammadifard N, 2012, ARCH IRAN MED, V15, P320, DOI 012155/AIM.0015.
   Montazeri A, 2004, PUBLIC HEALTH, V118, P110, DOI 10.1016/S0033-3506(03)00173-2.
   Moradi-Lakeh M, 2017, ARCH IRAN MED, V20, P419.
   Muller DC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0630-6.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369.
   O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2.
   Pande RP, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S2.
   Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971.
   Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161.
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0.
   Roshandel G, 2012, ARCH IRAN MED, V15, P196, DOI 012154/AIM.004.
   Sadeghian S, 2010, INT J CARDIOL, V141, P116, DOI 10.1016/j.ijcard.2008.11.063.
   Smith PC, 2008, PERFORMANCE MEASUREM.
   Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7.
   United Nations, 2019, SUSTAINABLE DEV GOAL.
   US Department of Health and Human Services Secretary Centers for Disease Control and Prevention National Center for Health Statistics, 2017, HLTH US 2016 CHARTB.
   Webster R, 2017, LANCET, V389, P1066, DOI 10.1016/S0140-6736(17)30558-5.
   WHO, 2017, TOP 10 CAUS DEATH FA.
   World Health Organization, 2017, HLTH STAT INF SYST E.
   World Health Organization, 2017, NONC DIS FACT SHEET.
   World Health Organization, 2017, CARD DIS CVDS FACT S.
   World Health Organization, 2017, WORLD HLTH STAT 2017.
   World Health Organization, 2016, REG OFF E MED ISL RE.
   World Health Organization. (WHO), 2013, GLOB ACT PLAN PREV C.},
Number-of-Cited-References = {41},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {GV5YI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000446181900130},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000230163800012,
Author = {Laing, SP and Jones, ME and Swerdlow, AJ and Burden, AC and Gatling, W},
Title = {Psychosocial and socioeconomic risk factors for premature death in young
   people with type 1 diabetes},
Journal = {DIABETES CARE},
Year = {2005},
Volume = {28},
Number = {7},
Pages = {1618-1623},
Month = {JUL},
Abstract = {OBJECTIVE - Mortality from acute diabetes-related events is greatly
   raised in young adults with type 1 diabetes. Psychosocial and
   socioeconomic risk factors are examined for deaths front acute events
   separately from deaths due to other causes.
   RESEARCH DESIGN AND METHODS - This study had a nested case-controlled
   design, The cases were patients from the Diabetes UK cohort who died
   before age 40 years, Deaths were categorized as acute events or chronic
   conditions related to diabetes. Where possible, two matched control
   subjects were selected for each case. Data relating to psychosocial and
   socioeconomic factors and variables related to diabetes complications
   were extracted from the case notes. Risks of death were estimated by
   calculation of odds ratios (ORs).
   RESULTS - Case notes were obtained for 98 case and 137 control subjects.
   Fifty-one deaths were attributed to acute causes, 34 to chronic
   conditions related to diabetes, and the remaining 13 were unrelated to
   diabetes. Living alone (OR 4.4), past drug abuse (5.7), and previous
   psychiatric referral (4.6) were all significantly associated with death
   from acute event, but not death from chronic conditions. There was no
   association between deaths from acute events and nephropathy,
   hypertension, neuropathy, or retinopathy, although all of these were
   associated with deaths from chronic conditions.
   CONCLUSIONS - The results indicate that psychosocial factors are
   powerful risk factors for mortality from acute events in patients with
   type 1 diabetes, although not for mortality from chronic conditions. The
   data enable the identification of a high-risk group suitable for
   targeting with preventive measures to reduce acute event mortality.},
Publisher = {AMER DIABETES ASSOC},
Address = {1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA},
Type = {Article},
Language = {English},
Affiliation = {Laing, SP (Corresponding Author), Inst Canc Res, Epidemiol Sect, Brookes Lawley Bldg,Cotswold Rd, Sutton SM2 5NG, Surrey, England.
   Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England.
   Poole Hosp NHS Trust, Poole, Dorset, England.
   Univ Leicester, Leicester, Leics, England.},
DOI = {10.2337/diacare.28.7.1618},
ISSN = {0149-5992},
Keywords-Plus = {QUALITY-OF-LIFE; ASSOCIATION COHORT; FOLLOW-UP; MORTALITY; MELLITUS;
   ADOLESCENTS; IDDM; SMOKING; REGIMEN},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {susan.laing@icr.ac.uk},
ResearcherID-Numbers = {Burden, Felix/AAE-9711-2020
   },
ORCID-Numbers = {Jones, Michael/0000-0001-7479-3451
   Swerdlow, Anthony/0000-0001-5550-4159},
Cited-References = {Breslow NE, 1980, STAT METHODS CANC RE, VI.
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536.
   DORMAN JS, 1986, PEDIATR ADOLESC ENDO, V15, P289.
   DORMAN JS, 1985, DIABETES CARE S1, V8, P53.
   Forsander GA, 2000, ACTA PAEDIATR, V89, P1462, DOI 10.1080/080352500456651.
   Gafvels C, 1997, SCAND J SOC MED, V25, P168, DOI 10.1177/140349489702500304.
   Goldston DB, 1997, J AM ACAD CHILD PSY, V36, P1528, DOI 10.1016/S0890-8567(09)66561-8.
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909.
   Guttmann-Bauman I, 1998, DIABETES CARE, V21, P915, DOI 10.2337/diacare.21.6.915.
   Jacobson AM, 1997, DIABETES CARE, V20, P811, DOI 10.2337/diacare.20.5.811.
   Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x.
   Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x.
   Matsushima M, 1996, DIABETOLOGIA, V39, P710.
   MOY CS, 1990, CIRCULATION, V82, P37, DOI 10.1161/01.CIR.82.1.37.
   Robinson N, 1998, DIABETIC MED, V15, P205, DOI 10.1002/(SICI)1096-9136(199803)15:3<205::AID-DIA519>3.0.CO;2-\#.
   Rossing P, 1996, BRIT MED J, V313, P779.
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401.
   TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x.},
Number-of-Cited-References = {18},
Times-Cited = {61},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Diabetes Care},
Doc-Delivery-Number = {940SG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000230163800012},
DA = {2022-03-29},
}

@article{ WOS:000297080500002,
Author = {Dong, Chuanhui and Yoon, Young-Hee and Chen, Chiung M. and Yi, Hsiao-Ye},
Title = {Heavy Alcohol Use and Premature Death from Hepatocellular Carcinoma in
   the United States, 1999-2006},
Journal = {JOURNAL OF STUDIES ON ALCOHOL AND DRUGS},
Year = {2011},
Volume = {72},
Number = {6},
Pages = {892-902},
Month = {NOV},
Abstract = {Objective: The incidence rate of hepatocellular carcinoma has been
   rising in the United States during the last 2 decades. Heavy alcohol use
   has been widely recognized as one of the major etiological factors of
   hepatocellular carcinoma. This study sought to assess the extent to
   which heavy alcohol use contributed to premature death from
   hepatocellular carcinoma on a population scale in the United States.
   Method: We analyzed the Multiple Cause of Death public-use data sets.
   Using codes from the International Classification of Diseases, 10th
   Revision, hepatocellular carcinoma death was defined based on the
   underlying cause of death, and heavy alcohol use was indicated by the
   presence of any alcohol-induced medical conditions among the
   contributing causes of death. During 1999-2006 in the United States,
   51,400 hepatocellular carcinoma deaths were identified from 17,727,245
   natural deaths of persons age 25 or older. We conducted Poisson
   regression, life table, and multiple linear regression analyses to
   compare prevalence ratios, cumulative probabilities, and mean ages of
   death, respectively, from hepatocellular carcinoma by heavy alcohol use
   status across sex and race/ethnicity. Results: Heavy alcohol use
   decedents had higher prevalence ratios of dying from hepatocellular
   carcinoma than from non chronic liver diseases compared with those
   decedents without heavy alcohol use. Heavy alcohol use was associated
   with decreased mean ages and increased cumulative probabilities of death
   among hepatocellular carcinoma decedents across racial/ethnic groups in
   both sexes. This association was stronger among women than men and
   stronger among non-Hispanic Whites than non-Hispanic Blacks.
   Conclusions: This study provides mortality-based empirical evidence to
   further establish heavy alcohol consumption as one of the key risk
   factors contributing to premature deaths from hepatocellular carcinoma
   in the United States, and its effect appears more prominent among women
   and non-Hispanic Whites. (J. Stud. Alcohol Drugs, 72, 892-902, 2011)},
Publisher = {ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV},
Address = {C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA},
Type = {Article},
Language = {English},
Affiliation = {Yoon, YH (Corresponding Author), CSR Inc, Alcohol Epidemiol Data Syst, 2107 Wilson Blvd,Suite 1000, Arlington, VA 22201 USA.
   Dong, Chuanhui; Yoon, Young-Hee; Chen, Chiung M., CSR Inc, Alcohol Epidemiol Data Syst, Arlington, VA 22201 USA.
   Dong, Chuanhui, Univ Miami, Miami, FL USA.},
DOI = {10.15288/jsad.2011.72.892},
ISSN = {1937-1888},
EISSN = {1938-4114},
Keywords-Plus = {HEPATITIS-C; GENDER-DIFFERENCES; LIVER-DISEASE; MORTALITY; METABOLISM;
   CANCER; RISK; PREVALENCE; TRENDS; CERTIFICATES},
Research-Areas = {Substance Abuse; Psychology},
Web-of-Science-Categories  = {Substance Abuse; Psychology},
Author-Email = {yhyoon@csrincorporated.com},
Funding-Acknowledgement = {National Institute on Alcohol Abuse and AlcoholismUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}HHSN267200800023C]},
Funding-Text = {This article is based on a study conducted for the Alcohol Epidemiologic
   Data System project funded by the National Institute on Alcohol Abuse
   and Alcoholism through Contract No. HHSN267200800023C to CSR
   Incorporated. The views and opinions expressed in this report are those
   of the authors and should not be construed to represent the views of the
   sponsoring agency or the federal government.},
Cited-References = {Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753.
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004.
   Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263.
   Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513.
   Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0.
   Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009.
   Chen CM, 2007, ALCOHOL CLIN EXP RES, V31, P285, DOI 10.1111/j.1530-0277.2006.00304.x.
   Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005.
   Davila JA, 2006, CLIN GASTROENTEROL H, V4, P104, DOI 10.1016/S1542-3565(05)00745-7.
   DIPADOVA C, 1987, GASTROENTEROLOGY, V92, P1169, DOI 10.1016/S0016-5085(87)91073-0.
   El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090.
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013.
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001.
   Freeman TL, 2005, ALCOHOL CLIN EXP RES, V29, P1310, DOI 10.1097/01.ALC.0000171484.52201.52.
   FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205.
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007.
   Garcia-Samaniego J, 2001, AM J GASTROENTEROL, V96, P179, DOI 10.1111/j.1572-0241.2001.03374.x.
   Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004.
   Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x.
   HANZLICK R, 1988, AM J FOREN MED PATH, V9, P149, DOI 10.1097/00000433-198806000-00011.
   Harrison LE, 2004, ARCH SURG-CHICAGO, V139, P992, DOI 10.1001/archsurg.139.9.992.
   Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780.
   Heron M. P, 2009, NATL VITAL STAT REPO, V57.
   Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669, DOI 10.1152/ajpgi.1998.274.4.G669.
   Ingram DD, 2003, VITAL HLTH STAT, V2.
   Kim WR, 2005, GASTROENTEROLOGY, V129, P486, DOI 10.1053/j.gastro.2005.05.001.
   Kwo PY, 1998, GASTROENTEROLOGY, V115, P1552, DOI 10.1016/S0016-5085(98)70035-6.
   Li TK, 2000, ALCOHOL CLIN EXP RES, V24, P415, DOI 10.1097/00000374-200004000-00009.
   Lieber CS, 2000, ALCOHOL CLIN EXP RES, V24, P417.
   Manos MM, 2008, HEPATOLOGY, V47, P1150, DOI 10.1002/hep.22181.
   Michielsen Peter P, 2005, World J Surg Oncol, V3, P27, DOI 10.1186/1477-7819-3-27.
   Muller C, 2006, WIEN MED WOCHENSCHR, V156, P523, DOI {[}10.1007/s10354-006-0348-8, 10.1007/s10354-006-0314-5].
   Mueller S, 2009, WORLD J GASTROENTERO, V15, P3462, DOI 10.3748/wjg.15.3462.
   National Center for Health Statistics, 2010, INSTR CLASS UND CAUS.
   National Center for Health Statistics, 2004, BRIDG RAC INT EST JU.
   National Center for Health Statistics, 2009, POSTC EST RES POP US.
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74.
   Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440.
   POLLOCK DA, 1987, JAMA-J AM MED ASSOC, V258, P345, DOI 10.1001/jama.258.3.345.
   Raoul JL, 2008, SEMIN NUCL MED, V38, pS13, DOI 10.1053/j.semnuclmed.2007.10.004.
   Redelings MD, 2007, AM J EPIDEMIOL, V166, P104, DOI 10.1093/aje/kwm037.
   {*}RES TRIANGL I, 2008, SUDAAN SOFTW STAT AN.
   Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X.
   Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38.
   Selvin S., 1996, STAT ANAL EPIDEMIOLO.
   Singal AK, 2007, J CLIN GASTROENTEROL, V41, P761, DOI 10.1097/MCG.0b013e3180381584.
   Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188.
   Sugimachi K, 2003, J CLIN PATHOL, V56, P854, DOI 10.1136/jcp.56.11.854.
   Taylor JL, 1996, AVIAT SPACE ENVIR MD, V67, P407.
   Thomasson H, 2000, ALCOHOL CLIN EXP RES, V24, P419, DOI 10.1097/00000374-200004000-00011.
   Thomasson H R, 1995, Recent Dev Alcohol, V12, P163.
   Tuma DJ, 2003, ALCOHOL RES HEALTH, V27, P285.
   Voigt Michael D, 2005, Clin Liver Dis, V9, P151, DOI 10.1016/j.cld.2004.10.003.
   Wong R, 2008, AM J MED, V121, P525, DOI 10.1016/j.amjmed.2008.03.005.
   World Health Organization, 1992, INT CLASS DIS REL HL.
   Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x.},
Number-of-Cited-References = {56},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {9},
Journal-ISO = {J. Stud. Alcohol Drugs},
Doc-Delivery-Number = {848UL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000297080500002},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000184976600013,
Author = {Ha, BM and Yoon, SJ and Lee, HY and Ahn, HS and Kim, CY and Shin, YS},
Title = {Measuring the burden of premature death due to smoking in Korea from
   1990 to 1999},
Journal = {PUBLIC HEALTH},
Year = {2003},
Volume = {117},
Number = {5},
Pages = {358-365},
Month = {SEP},
Abstract = {This study estimated the burden of premature death due to smoking in
   Korea between 1990 and 1999 using the years of life lost (YLL) due to
   premature death method. To implement this study, age-group-specific YLL
   due to premature death were calculated by employing the standard
   expected years of life lost method. YLL due to smoking were calculated
   based on assumptions and methods developed by the Global, Burden of
   Disease Study Group. The burden of premature death due to smoking was
   estimated by multiplying the population attributable risk by the YLL of
   smoking related diseases.
   In 1999, the burden of premature death due to smoking was 57.7\% in
   mates and 11.4\% in females in Korea. The burden of premature death due
   to smoking increased from 1643 person years per 100 000 in 1990 to 1888
   person years in 1999 for mates, and increased from 151 person years in
   1990 to 225 person years in 1999 for females in Korea. Our results
   suggest that the method employed in this study, generated in quantified
   terms, enabled the burden of premature death due to smoking to be
   obtained comparably with methods used by other international studies in
   this field, and thus can provide a rational basis for national health
   policy planning regarding premature death from smoking and the related
   risk factors in Korea. (C) 2003 The Royal Institute of Public Health.
   Published by Elsevier Ltd. All rights reserved.},
Publisher = {W B SAUNDERS CO LTD},
Address = {32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Yoon, SJ (Corresponding Author), Korea Univ, Coll Med, Dept Prevent Med, 126-1 5Ka, Seoul 136705, South Korea.
   Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.
   Seoul Natl Univ, Grad Sch Publ Hlth, Seoul 151, South Korea.
   Seoul Natl Univ, Coll Med, Dept Hlth Policy \& Management, Seoul 151, South Korea.},
DOI = {10.1016/S0033-3506(03)00142-2},
ISSN = {0033-3506},
Keywords = {cause of death; mortality rate; smoking},
Keywords-Plus = {CIGARETTE-SMOKING; CANCER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
ORCID-Numbers = {Kim, Chang-yup/0000-0002-4389-2454
   Yoon, Seok-Jun/0000-0003-3297-0071},
Cited-References = {{[}Anonymous], 1994, MMWR Recomm Rep, V43, P1.
   Boyle P, 1997, LUNG CANCER, V17, P1, DOI 10.1016/S0169-5002(97)00648-X.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908.
   Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980.
   HIRAYAMA T, 1989, CANCER CHEMOTH PHARM, V23, pS114, DOI 10.1007/BF00647254.
   Hirayama T., 1987, SMOKING HLTH, P76.
   International Agency for Research on Cancer (IARC), 1985, TOB HAB OTH SMOK BET.
   KEYS A, 1980, 7 COUNTRIES.
   {*}KOR ASS SMOK HLTH, 2000, TOB HLTH.
   MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   NAM HS, 1996, KOR J PREV MED, V29, P227.
   PARK J K, 1986, Yonsei Medical Journal, V27, P261.
   Pride NB, 1995, CHRONIC OBSTRUCTIVE, P69.
   {*}REP KOR NAT STAT, 1995, KOR STAND CLASS DIS, V3.
   RIJKEN B, 1998, EUR RESPIR J, V7, P41.
   STRACHAN DP, 1995, CHRONIC OBSTRUCTIVE, P47.
   US-DHHS, 1986, HLTH CONS INV SMOK R.
   WHO, 1997, TOB HLTH GLOB STAT R.
   Yoon SJ, 2000, KOR J PREV MED, V33, P231.},
Number-of-Cited-References = {21},
Times-Cited = {20},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Public Health},
Doc-Delivery-Number = {715MP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000184976600013},
DA = {2022-03-29},
}

@article{ WOS:000381508200022,
Author = {Saarela, Jan and Finnas, Fjalar},
Title = {The Ethno-linguistic Community and Premature Death: a Register-Based
   Study of Working-Aged Men in Finland},
Journal = {JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES},
Year = {2016},
Volume = {3},
Number = {2},
Pages = {373-380},
Month = {JUN},
Abstract = {One of the most striking features of premature death in Finland is the
   ethno-linguistic mortality gradient in working-aged men. Finnish
   speakers have a notably higher mortality risk than Swedish speakers. The
   underlying reasons are not fully clear, but one suggested explanation
   has been that the level of social integration is lower in the
   Finnish-speaking community than that in the Swedish-speaking one, as
   people in the former are geographically less rooted at the local level.
   In this paper, we derive a proxy for the influence of the
   ethnolinguistic community as a contextual factor on the Finnish-Swedish
   mortality gradient. The strategy is based on a unique setup that makes
   it possible to identify people not only by their ethno-linguistic
   background and ethno-linguistic affiliation, but we indirectly know also
   in which community a person has been raised. Results of multivariate
   regressions provide poor support for this contextual hypothesis,
   however, and rather suggest that some latent individual characteristics
   might be important, hence illuminating the complexity behind the excess
   mortality of Finnish speakers.},
Publisher = {SPRINGER INTERNATIONAL PUBLISHING AG},
Address = {GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Saarela, J (Corresponding Author), Abo Akad Univ, POB 311, FIN-65101 Vaasa, Finland.
   Saarela, Jan; Finnas, Fjalar, Abo Akad Univ, POB 311, FIN-65101 Vaasa, Finland.
   Saarela, Jan, Univ Helsinki, Helsinki, Finland.},
DOI = {10.1007/s40615-015-0163-2},
ISSN = {2197-3792},
EISSN = {2196-8837},
Keywords = {Premature death; Ethnic communities; Ethno-linguistic groups;
   Register-based data},
Keywords-Plus = {SELF-RATED HEALTH; CAUSE-SPECIFIC MORTALITY; GEOGRAPHIC ANCESTRY;
   POPULATION; DETERMINANTS; AFFILIATION; CHILDREN; LIFE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {jan.saarela@abo.fi},
Cited-References = {Auger N, 2012, EUR J EPIDEMIOL, V27, P27, DOI 10.1007/s10654-011-9644-8.
   Bandura A., 1986, SOCIAL FDN THOUGHT A, P1.
   Bauldry S, 2012, SOC SCI MED, V75, P1311, DOI 10.1016/j.socscimed.2012.05.017.
   Blomgren J, 2004, SOC SCI MED, V58, P2523, DOI 10.1016/j.socscimed.2003.09.027.
   Finnas F, 2003, EUR SOCIOL REV, V19, P483, DOI 10.1093/esr/19.5.483.
   Finnas F, 2000, 37 AB AK I FINL SAMH.
   Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106.
   Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522.
   Herian MN, 2014, SOC SCI MED, V105, P30, DOI 10.1016/j.socscimed.2014.01.003.
   Hyyppa MT, 2001, HEALTH PROMOT INT, V16, P55, DOI 10.1093/heapro/16.1.55.
   Hyyppa MT, 2001, PREV MED, V32, P148, DOI 10.1006/pmed.2000.0782.
   Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x.
   Kawachi I, 2013, GLOBAL PERSPECTIVES.
   Kawachi I., 2008, SOCIAL CAPITAL HLTH.
   Kawachi I, 2000, SOCIAL EPIDEMIOLOGY, P76, DOI DOI 10.1093/MED/9780195377903.003.0008.
   Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6.
   Lindstrom Martin, 2008, SOCIAL CAPITAL HLTH, P215, DOI DOI 10.1007/978-0-387-71311-3\_10.
   Lojander-Visapaa C, 2001, PUBLICATIONS, V630.
   Makinen T, 2006, SOC SCI MED, V62, P1831, DOI 10.1016/j.socscimed.2005.08.040.
   Nyqvist F, 2008, HEALTH PLACE, V14, P347, DOI 10.1016/j.healthplace.2007.09.001.
   O'Leary R, 2002, SOCIOLOGY, V36, P235, DOI 10.1177/0038038502036002001.
   Prins RG, 2014, SOC SCI MED, V105, P9, DOI 10.1016/j.socscimed.2013.12.031.
   Putnam R. D., 2000, BOWLING ALONE.
   Rostila M, 2013, SOCIAL CAPITAL AND HEALTH INEQUALITY IN EUROPEAN WELFARE STATES, P1.
   Saarela J, 2005, POP STUD-J DEMOG, V59, P313, DOI 10.1080/00324720500249372.
   Saarela J, 2003, TYOELAMAN TUTKIMUS, V1, P191.
   Saarela J, 2004, YB POPULATION REFI, V41, P61.
   Saarela Jan, 2006, Genus, V62, P169.
   Saarela J, 2008, HEALTH PLACE, V14, P265, DOI 10.1016/j.healthplace.2007.06.007.
   Saarela J, 2014, ACTA SOCIOL, V57, P77, DOI 10.1177/0001699313487533.
   Saarela J, 2013, J COMP FAM STUD, V44, P609.
   Saarela J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-385.
   Saarela J, 2008, ENVIRON HEALTH INSIG, V2, P1.
   Saarela J, 2009, POPUL REV, V48, P64, DOI 10.1353/prv.0.0015.
   Saarela J, 2010, HUM BIOL, V82, P1, DOI 10.3378/027.082.0102.
   Saarela J, 2009, POPUL RES POLICY REV, V28, P169, DOI 10.1007/s11113-008-9079-4.
   Sipila P, 2009, EUR J PUBLIC HEALTH, V19, P492, DOI 10.1093/eurpub/ckp074.
   Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl\_1.S21.
   Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013.
   Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70.},
Number-of-Cited-References = {40},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Racial Ethn. Health Disparities},
Doc-Delivery-Number = {DT5FY},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000381508200022},
DA = {2022-03-29},
}

@article{ WOS:000170949000070,
Author = {Wiekowski, MT and Leach, MW and Evans, EW and Sullivan, L and Chen, SC
   and Vassileva, G and Bazan, JF and Gorman, DM and Kastelein, RA and
   Narula, S and Lira, SA},
Title = {Ubiquitous transgenic expression of the IL-23 subunit p19 induces
   multiorgan inflammation, runting, infertility, and premature death},
Journal = {JOURNAL OF IMMUNOLOGY},
Year = {2001},
Volume = {166},
Number = {12},
Pages = {7563-7570},
Month = {JUN 15},
Abstract = {p19, a molecule structurally related to IL-6, G-CSF, and the p35 subunit
   of IL-12, is a subunit of the recently discovered cytokine IL-23. Here
   we show that expression of p19 in multiple tissues of transgenic mice
   induced a striking phenotype characterized by runting, systemic
   inflammation, infertility, and death before 3 mo of age. Founder animals
   had infiltrates of lymphocytes and macrophages in skin, lung, liver,
   pancreas, and the digestive tract and were anemic. The serum
   concentrations of the proinflammatory cytokines TNF-alpha and IL-1 were
   elevated, and the number of circulating neutrophils was increased. In
   addition, ubiquitous expression of p19 resulted in constitutive
   expression of acute phase proteins in the liver. Surprisingly,
   liver-specific expression of p19 failed to reproduce any of these
   abnormalities, suggesting specific requirements for production of
   biologically active p19. Bone marrow transfer experiments showed that
   expression of p19 by hemopoietic cells alone recapitulated the phenotype
   induced by its widespread expression, pointing to hemopoietic cells as
   the source of biologically active p19. These findings indicate that p19
   shares biological properties with IL-6, IL-12, and G-CSF and that
   cell-specific expression is required for its biological activity.},
Publisher = {AMER ASSOC IMMUNOLOGISTS},
Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
Type = {Article},
Language = {English},
Affiliation = {Lira, SA (Corresponding Author), Schering Plough Corp, Res Inst, Dept Immunol, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.
   Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA.
   Schering Plough Corp, Res Inst, Dept Drug Safety \& Metab, Lafayette, NJ 07848 USA.
   DNAX Res Inst Mol \& Cellular Biol Inc, Palo Alto, CA 94304 USA.},
DOI = {10.4049/jimmunol.166.12.7563},
ISSN = {0022-1767},
EISSN = {1550-6606},
Keywords-Plus = {NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING FACTOR; GROWTH-FACTOR-I;
   MONONUCLEAR-CELLS; POSTNATAL-GROWTH; BOWEL-DISEASE; MICE; INTERLEUKIN-6;
   RECEPTOR; IL-12},
Research-Areas = {Immunology},
Web-of-Science-Categories  = {Immunology},
Author-Email = {sergio.lira@spcorp.com},
ResearcherID-Numbers = {Bazan, J. Fernando/B-4562-2010
   Vassileva, Galya/A-6807-2009},
Cited-References = {AN E, 1994, EXP HEMATOL, V22, P149.
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O.
   BRANDT SJ, 1990, CURR TOP MICROBIOL, V166, P37.
   CAMPBELL P, 1993, PHYS WORLD, V6, P4, DOI 10.1088/2058-7058/6/7/2.
   DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537.
   DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207.
   DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206.
   DICOSMO BF, 1994, J CLIN INVEST, V94, P2028, DOI 10.1172/JCI117556.
   DUHRSEN U, 1988, BLOOD, V72, P2074.
   FATTORI E, 1994, BLOOD, V83, P2570.
   Fukada T, 1999, GROWTH FACTORS, V17, P81, DOI 10.3109/08977199909103518.
   Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127.
   GATELY MK, 1994, INT IMMUNOL, V6, P157, DOI 10.1093/intimm/6.1.157.
   Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937.
   HELLE M, 1988, EUR J IMMUNOL, V18, P957, DOI 10.1002/eji.1830180619.
   Hirano T, 1998, Int Rev Immunol, V16, P249.
   HOGAN B, 1994, MANIPULATION MOUSE E.
   KIRSCHNER BS, 1986, GASTROENTEROLOGY, V91, P830, DOI 10.1016/0016-5085(86)90683-9.
   LAURSEN EM, 1995, ARCH DIS CHILD, V72, P494, DOI 10.1136/adc.72.6.494.
   LEE GR, 1983, SEMIN HEMATOL, V20, P61.
   LEE GR, 1993, WINTROBES CLIN HEMAT, V1, P808.
   MALIK N, 1995, MOL CELL BIOL, V15, P2349.
   Manfra DJ, 2001, AM J PATHOL, V158, P41, DOI 10.1016/S0002-9440(10)63942-9.
   MANN JR, 1993, METHOD ENZYMOL, V225, P771.
   MURPHY C, 1995, J BIOL CHEM, V270, P704, DOI 10.1074/jbc.270.2.704.
   NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D.
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X.
   Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4.
   Pagenstecher A, 2000, J IMMUNOL, V164, P4481, DOI 10.4049/jimmunol.164.9.4481.
   Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47\_3495\_3504.
   REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174.
   SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433.
   STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378.
   SUEMATSU S, 1993, INT REV EXP PATHOL, V34, P91.
   SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547.
   Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9.
   TURKSEN K, 1992, P NATL ACAD SCI USA, V89, P5068, DOI 10.1073/pnas.89.11.5068.
   WOODROOFE C, 1992, DNA CELL BIOL, V11, P587, DOI 10.1089/dna.1992.11.587.
   Yamada T, 1996, LAB INVEST, V74, P384.
   Yang FC, 1999, BLOOD, V94, P950, DOI 10.1182/blood.V94.3.950.415a18\_950\_958.},
Number-of-Cited-References = {40},
Times-Cited = {223},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {J. Immunol.},
Doc-Delivery-Number = {471VH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000170949000070},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000263355100015,
Author = {Erichsen, Martina M. and Lovas, Kristian and Fougner, Kristian J. and
   Svartberg, Johan and Hauge, Erik R. and Bollerslev, Jens and Berg, Jens
   P. and Mella, Bjarne and Husebye, Eystein S.},
Title = {Normal overall mortality rate in Addison's disease, but young patients
   are at risk of premature death},
Journal = {EUROPEAN JOURNAL OF ENDOCRINOLOGY},
Year = {2009},
Volume = {160},
Number = {2},
Pages = {233-237},
Month = {FEB},
Abstract = {Context: Primary adrenal insufficiency (Addison's disease) is a rare
   autoimmune disease. Until recently, life expectancy in Addison's disease
   patients was considered normal.
   Objective: To determine the mortality rate in Addison's disease
   patients.
   Design and methods: i) Patients registered with Addison's disease in
   Norway during 1943-2005 were identified through search in hospital
   diagnosis registries. Scrutiny of the medical records provided
   diagnostic accuracy and age at diagnosis. ii) The patients who had died
   were identified from the National Directory of Residents. iii)
   Background mortality data were obtained from Statistics Norway, and
   standard mortality rate (SMR) calculated. iv) Death diagnoses were
   obtained from the Norwegian Death Cause Registry.
   Results: Totally 811. patients with Addison's disease were identified,
   of whom 147 were deceased. Overall SMR was 1.15 (95\%, confidence
   intervals (CI) 0.96-1.35), similar in females (1.18 (0.92-1.44)) and
   males (1.10 (0.80-1.39)). Patients diagnosed before the age of 40 had
   significantly elevated SMR at 1.50 (95\%, CI 1.09-2.01), most:
   pronounced in males (2.03 (1.19-2.86)). Acute adrenal failure was a
   major Cause of death: infection and Sudden death were more common than
   in the general Population. The mean ages at death for females (75.7
   years) and males (64.8 years) were 3.2 and 11.2 years less than the
   estimated life expectancy.
   Conclusion: Addison's disease is still a potentially lethal condition.
   with excess mortality in acute adrenal failure, infection, and sudden
   death in patients diagnosed at young age. Otherwise, the prognosis is
   excellent for patients with Addison's disease.},
Publisher = {BIOSCIENTIFICA LTD},
Address = {EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Erichsen, MM (Corresponding Author), Haukeland Hosp, Dept Med, Endocrinol Sect, N-5021 Bergen, Norway.
   Erichsen, Martina M.; Lovas, Kristian; Husebye, Eystein S., Haukeland Hosp, Dept Med, Endocrinol Sect, N-5021 Bergen, Norway.
   Lovas, Kristian; Husebye, Eystein S., Univ Bergen, Inst Med, N-5007 Bergen, Norway.
   Fougner, Kristian J., St Olavs Univ Hosp, N-7030 Trondheim, Norway.
   Svartberg, Johan, Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway.
   Svartberg, Johan, Univ Hosp N Norway, Dept Med, N-9038 Tromso, Norway.
   Hauge, Erik R., NKS Olaviken Hosp Old Age Psychiat, N-5009 Bergen, Norway.
   Bollerslev, Jens, Aker Univ Hosp, Radiumhosp, Rikshosp, N-0310 Oslo, Norway.
   Bollerslev, Jens; Berg, Jens P., Univ Oslo, Oslo, Norway.
   Berg, Jens P., Ullevaal Univ Hosp, N-0450 Oslo, Norway.
   Berg, Jens P., Aker Univ Hosp, N-0514 Oslo, Norway.
   Mella, Bjarne, Ostfold Hosp, N-1606 Fredrikstad, Norway.},
DOI = {10.1530/EJE-08-0550},
ISSN = {0804-4643},
EISSN = {1479-683X},
Keywords-Plus = {AUTOIMMUNE POLYENDOCRINE SYNDROMES; ADRENOCORTICAL INSUFFICIENCY;
   ADRENAL INSUFFICIENCY; AUTOANTIBODIES; NORWAY; PREVALENCE},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {mmer@helse-bergen.no},
ResearcherID-Numbers = {Berg, Jens P/G-1455-2012},
ORCID-Numbers = {Berg, Jens P/0000-0003-0157-5888},
Funding-Acknowledgement = {Western Norway Regional Health Authority},
Funding-Text = {This study was supported by grants from The Western Norway Regional
   Health Authority to MME. who is a doctoral fellow at the institution.},
Cited-References = {AlSabri AM, 1997, INT J LEGAL MED, V110, P278, DOI 10.1007/s004140050085.
   Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7.
   Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x.
   Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076.
   Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327.
   Brosnan CM, 1996, BRIT MED J, V312, P1085.
   Burke MP, 1999, AM J FOREN MED PATH, V20, P60, DOI 10.1097/00000433-199903000-00015.
   Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158.
   Filipsson H, 2006, J CLIN ENDOCR METAB, V91, P3954, DOI 10.1210/jc.2006-0524.
   Keljo DJ, 1996, NEW ENGL J MED, V334, P46, DOI 10.1056/NEJM199601043340111.
   KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x.
   Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762.
   Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x.
   MASON AS, 1968, LANCET, V2, P744.
   Myhre AG, 2002, J CLIN ENDOCR METAB, V87, P618, DOI 10.1210/jc.87.2.618.
   {*}NAT ASS INS, 2004, COMMRS MED MALPR INS, P21.
   NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127.
   Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611.
   Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X.
   Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873.},
Number-of-Cited-References = {20},
Times-Cited = {158},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Eur. J. Endocrinol.},
Doc-Delivery-Number = {407HV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000263355100015},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000265928900001,
Author = {Anda, Robert F. and Dong, Maxia and Brown, David W. and Felitti, Vincent
   J. and Giles, Wayne H. and Perry, Geraldine S. and Valerie, Edwards J.
   and Dube, Shanta R.},
Title = {The relationship of adverse childhood experiences to a history of
   premature death of family members},
Journal = {BMC PUBLIC HEALTH},
Year = {2009},
Volume = {9},
Month = {APR 16},
Abstract = {Background: To assess the association between adverse childhood
   experiences (ACEs), including childhood abuse and neglect, and serious
   household dysfunction, and premature death of a family member. Because
   ACEs increase the risk for many of the leading causes of death in adults
   and tend to be familial and intergenerational, we hypothesized that
   persons who report having more ACEs would be more likely to have family
   members at risk of premature death.
   Methods: We used data from 17,337 adult health plan members who
   completed a survey about 10 types of ACEs and whether a family member
   died before age 65. The prevalence of family member premature death and
   its association with ACEs were assessed.
   Results: Family members of respondents who experienced any type of ACEs
   were more likely to have elevated prevalence for premature death
   relative to those of respondents without such experience ( p < 0.01).
   The highest risk occurred among those who reported having been
   physically neglected and living with substance abusing or criminal
   family members during childhood. A powerful graded relationship between
   the number of ACEs and premature mortality in the family was observed
   for all age groups, and comparison between groups reporting 0 ACE and >=
   4 ACEs yielded an OR of 1.8 (95\% Cl, 1.6-2.0).
   Conclusion: Adverse childhood experiences may be an indicator of a
   chaotic family environment that results in an increased risk of
   premature death among family members.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Anda, RF (Corresponding Author), Ctr Dis Control \& Prevent, Natl Ctr Chron Dis Prevent \& Hlth Promot, ACE Study Group, Atlanta, GA 30333 USA.
   Anda, Robert F.; Dong, Maxia; Brown, David W.; Giles, Wayne H.; Perry, Geraldine S.; Valerie, Edwards J.; Dube, Shanta R., Ctr Dis Control \& Prevent, Natl Ctr Chron Dis Prevent \& Hlth Promot, ACE Study Group, Atlanta, GA 30333 USA.
   Felitti, Vincent J., So Calif Permanente Med Grp, Kaiser Permanente, Dept Prevent Med, San Diego, CA 92120 USA.},
DOI = {10.1186/1471-2458-9-106},
Article-Number = {106},
ISSN = {1471-2458},
Keywords-Plus = {NATIONAL LONGITUDINAL MORTALITY; HOUSEHOLD DYSFUNCTION; UNITED-STATES;
   MARITAL-STATUS; SEXUAL-ABUSE; SOCIAL SUPPORT; ALCOHOL-ABUSE; VIOLENT
   DEATH; RISK-FACTORS; DRUG-ABUSE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {rfa1@cdc.gov
   mfd7@cdc.gov
   zyi3@cdc.gov
   vjfmdsdca@msn.gov
   hwg0@cdc.gov
   gxp2@cdc.gov
   vae2@cdc.gov
   skd7@cdc.gov},
Funding-Acknowledgement = {CDC through the Association of Teachers of Preventive Medicine,United
   States Department of Health \& Human ServicesCenters for Disease Control
   \& Prevention - USA {[}TS-44-10/11]; Garfield Memorial Fund},
Funding-Text = {The ACE study was supported under cooperative agreement \# TS-44-10/11
   from the CDC through the Association of Teachers of Preventive Medicine,
   and a grant from the Garfield Memorial Fund Dr. Maxia Dong was supported
   by this cooperative agreement.},
Cited-References = {Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652.
   Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001.
   Anda RF, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.2.e19.
   Bailey JE, 1997, ARCH INTERN MED, V157, P777, DOI 10.1001/archinte.157.7.777.
   BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132.
   Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949.
   Dong MX, 2005, ARCH PEDIAT ADOL MED, V159, P1104, DOI 10.1001/archpedi.159.12.1104.
   Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F.
   Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564.
   Dube SR, 2002, ADDICT BEHAV, V27, P713, DOI 10.1016/S0306-4603(01)00204-0.
   Dube SR, 2001, CHILD ABUSE NEGLECT, V25, P1627, DOI 10.1016/S0145-2134(01)00293-9.
   Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089.
   EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723.
   Felitti VJ, 2003, PRAX KINDERPSYCHOL K, V52, P547.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   FINKELHOR D, 1990, CHILD ABUSE NEGLECT, V14, P19, DOI 10.1016/0145-2134(90)90077-7.
   Guyer B, 2000, PEDIATRICS, V106, P1307, DOI 10.1542/peds.106.6.1307.
   Hardy JB, 1998, DEV PSYCHOL, V34, P1220, DOI 10.1037/0012-1649.34.6.1220.
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676.
   Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6.
   KAUFMAN J, 1987, AM J ORTHOPSYCHIAT, V57, P186, DOI 10.1111/j.1939-0025.1987.tb03528.x.
   Kochanek K. D., 2004, NATL VITAL STAT REPO, V53, P1.
   KPOSOWA AJ, 1994, J QUANT CRIMINOL, V10, P277, DOI 10.1007/BF02221213.
   LYNCH J, 2000, SOCIAL EPIDEMIOLOGY.
   MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878.
   MacMillan HL, 1997, JAMA-J AM MED ASSOC, V278, P131, DOI 10.1001/jama.278.2.131.
   MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207.
   Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2.
   OLIVER JE, 1993, AM J PSYCHIAT, V150, P1315.
   Power C, 1997, BRIT MED BULL, V53, P210.
   Ritsher JEB, 2001, BRIT J PSYCHIAT, V178, pS84, DOI 10.1192/bjp.178.40.s84.
   Rivara FP, 1997, JAMA-J AM MED ASSOC, V278, P569, DOI 10.1001/jama.278.7.569.
   Rogers RG, 1996, J HEALTH SOC BEHAV, V37, P326, DOI 10.2307/2137260.
   ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319.
   Ross CE, 2002, J HEALTH SOC BEHAV, V43, P469, DOI 10.2307/3090238.
   RUTTER M, 1989, J CHILD PSYCHOL PSYC, V30, P23, DOI 10.1111/j.1469-7610.1989.tb00768.x.
   Selik RM, 1997, AIDS, V11, P1635, DOI 10.1097/00002030-199713000-00013.
   Sikora AG, 2002, AM J PUBLIC HEALTH, V92, P841, DOI 10.2105/AJPH.92.5.841.
   Singh GK, 1996, AM J PUBLIC HEALTH, V86, P505, DOI 10.2105/AJPH.86.4.505.
   STRAUS M, 1990, RISK FACTORS ADAPTAT.
   Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401.
   UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848.
   {*}US DEP HHS, 1993, VIT HLTH STAT 2, V118.
   US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND, V2.
   VAILLANT GE, 1992, ARCH GEN PSYCHIAT, V49, P709.
   Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932.
   Widom CS, 1999, J CONSULT CLIN PSYCH, V67, P867, DOI 10.1037/0022-006X.67.6.867.
   Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038.
   WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2.
   {[}No title captured].},
Number-of-Cited-References = {50},
Times-Cited = {110},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {4},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {443RU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000265928900001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1984TH82000009,
Author = {PETERSSON, B and TRELL, E and HOOD, B},
Title = {PREMATURE DEATH AND ASSOCIATED RISK-FACTORS IN URBAN MIDDLE-AGED MEN},
Journal = {AMERICAN JOURNAL OF MEDICINE},
Year = {1984},
Volume = {77},
Number = {3},
Pages = {418-426},
Publisher = {EXCERPTA MEDICA INC},
Address = {245 WEST 17TH STREET, NEW YORK, NY 10011},
Type = {Article},
Language = {English},
Affiliation = {UNIV LUND,MALMO GEN HOSP,DEPT INTERNAL MED,PREVENT MED SECT,S-21401 MALMO,SWEDEN.
   UNIV LUND,MALMO GEN HOSP,DEPT COMMUNITY HLTH SCI,S-21401 MALMO,SWEDEN.},
DOI = {10.1016/0002-9343(84)90096-2},
ISSN = {0002-9343},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {ARONSEN K F, 1970, Acta Chirurgica Scandinavica, V136, P17.
   BAGREL A, 1979, CLIN CHEM, V25, P1242.
   BELFRAGE P, 1977, EUR J CLIN INVEST, V7, P127, DOI 10.1111/j.1365-2362.1977.tb01584.x.
   BOTTIGER LE, 1982, ACTA MED SCAND, V211, P437.
   Bremner JM., 1972, STAT-US.
   CASTELLI WP, 1977, LANCET, V2, P153.
   CHAIT A, 1972, LANCET, V2, P62.
   CHANYEUNG M, 1981, AM J CLIN PATHOL, V75, P320.
   Dawber TR, 1980, FRAMINGHAM STUDY EPI.
   DOLL R, 1983, BMJ-BRIT MED J, V286, P445, DOI 10.1136/bmj.286.6363.445.
   EDWARDS G, 1979, LANCET, V2, P402.
   FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602.
   FOX AJ, 1983, 1982 P WHO M LYON.
   GILL GV, 1982, BR MED J, V2, P1770.
   GRANDE F, 1960, Minn Med, V43, P731.
   HENNINGSEN NC, 1983, HYPERTENSION, V5, P560, DOI 10.1161/01.HYP.5.4.560.
   HENNINGSEN NC, 1980, ACTA MED SCAND, V207, P245.
   HIGUCHI T, 1981, ISRAEL J MED SCI, V17, P1015.
   HORNER F, 1979, ENZYME, V24, P217, DOI 10.1159/000458662.
   HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503.
   JANZON L, 1983, DIABETOLOGIA, V25, P86.
   JANZON L, 1981, J EPIDEMIOL COMMUN H, V35, P271, DOI 10.1136/jech.35.4.271.
   JANZON L, 1981, SCAND J SOC MED, V9, P127, DOI 10.1177/140349488100900306.
   JONAS S, 1981, PREV MED, V10, P661.
   KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0.
   Keys A, 1980, 7 COUNTRIES MULTIVAR.
   KLATSKY AR, 1977, N ENGL J MED, V276, P1194.
   KRISTENSON H, 1983, ALCOHOL CLIN EXP RES, V7, P203, DOI 10.1111/j.1530-0277.1983.tb05441.x.
   KRISTENSON H, 1982, BRIT J ADDICT, V77, P297.
   KRISTENSON H, 1981, AM J EPIDEMIOL, V114, P862, DOI 10.1093/oxfordjournals.aje.a113256.
   KRISTENSON H, 1981, DRUG ALCOHOL DEPEN, V8, P43, DOI 10.1016/0376-8716(81)90085-5.
   LARBI EB, 1983, ARCH INTERN MED, V143, P28, DOI 10.1001/archinte.143.1.28.
   LARSSON L, 1983, SOCIALMEDICINSK TIDS, V60, P325.
   LIEBER CS, 1962, J CLIN INVEST, V41, P1863, DOI 10.1172/JCI104643.
   LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P171, DOI 10.1111/j.1530-0277.1982.tb04958.x.
   LINDBERG W, 1956, TIDSSKR NOR LAEGEFOR, V76, P231.
   MANTEL N, 1963, J AM STAT ASSOC, V58, P690.
   MATHEWS JD, 1976, CLIN SCI          S3, V51, P661.
   PENN R, 1983, BRIT MED J, V286, P531, DOI 10.1136/bmj.286.6364.531.
   PETERSON B, 1983, SCAND J CLIN LAB INV, V43, P141.
   PETERSON B, 1983, DRUG ALCOHOL DEPEN, V11, P279, DOI 10.1016/0376-8716(83)90019-4.
   PETERSON B, 1980, BMJ-BRIT MED J, V280, P1403, DOI 10.1136/bmj.280.6229.1403.
   PETERSSON B, 1982, LANCET, V2, P1088.
   PETERSSON B, 1983, KLIN WOCHENSCHR, V63, P795.
   PETERSSON B, 1983, BR MED J, V2, P7.
   PETERSSON B, 1982, BR MED J, V2, P1457.
   ROSALKI SB, 1971, LANCET, V2, P376.
   SHAW S, 1976, SCIENCE, V194, P1057, DOI 10.1126/science.824734.
   TESCHKE R, 1983, GUT, V24, P625, DOI 10.1136/gut.24.7.625.
   TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7.
   Trell E, 1983, Prax Klin Pneumol, V37 Suppl 1, P687.
   Trell E, 1983, Prax Klin Pneumol, V37 Suppl 1, P673.
   VANWAES L, 1977, BRIT MED J, V2, P1508, DOI 10.1136/bmj.2.6101.1508.
   WALIMAKI M, 1981, SCAND J CLIN LAB INV, V49, P99.
   WILHELMSEN L, 1973, CIRCULATION, V48, P950, DOI 10.1161/01.CIR.48.5.950.
   WU A, 1974, LANCET, V1, P829.
   {[}No title captured].
   {[}No title captured].},
Number-of-Cited-References = {58},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Am. J. Med.},
Doc-Delivery-Number = {TH820},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1984TH82000009},
DA = {2022-03-29},
}

@article{ WOS:000515613500010,
Author = {Chen, Yingxi and Freedman, Neal D. and Rodriquez, Erik J. and Shiels,
   Meredith S. and Napoles, Anna M. and Withrow, Diana R. and Spillane,
   Susan and Sigel, Byron and Perez-Stable, Eliseo J. and Berrington de
   Gonzalez, Amy},
Title = {Trends in Premature Deaths Among Adults in the United States and Latin
   America},
Journal = {JAMA NETWORK OPEN},
Year = {2020},
Volume = {3},
Number = {2},
Month = {FEB 12},
Abstract = {This cross-sectional study compares premature mortality rates among US
   Latino, white, and African American populations with those in Puerto
   Rico and 12 Latin American countries.
   Importance Premature death rates vary in the United States by
   race/ethnicity. Despite their socioeconomic disadvantages, US Latino
   populations have lower premature mortality rates than do US white
   populations, a phenomenon termed the ``Latino or Hispanic paradox.{''}
   Objective To investigate whether there is a broader Latin American
   paradox by comparing premature mortality rates in the United States
   according to race/ethnicity with rates in Latin America and Puerto Rico
   from 2001 to 2015. Design, Setting, and Participants This descriptive
   cross-sectional study used mortality data from the World Health
   Organization Mortality Database. All deaths occurring in individuals
   aged 20 to 64 years among US Latino, African American, white, and Puerto
   Rican and 12 other Latin American populations from January 2001 to
   December 2015 were selected. The data analysis began in October 2018.
   Exposures Age, sex, race/ethnicity, and country. Main Outcomes and
   Measures All-cause mortality, cause-specific mortality, age-standardized
   mortality rates (AMSRs), and average annual percentage change in
   mortality rates during 2001 to 2015. Results During 2001 to 2015, 22
   million deaths (8 million women and 14 million men) occurred among
   individuals aged 20 to 64 years in the selected populations. Among
   women, US Latina individuals had the lowest premature mortality rates
   (ASMR for 2015, 144 deaths per 100\& x202f;000 population) and US
   African American women had the highest premature mortality rate (ASMR
   for 2015, 340 deaths per 100\& x202f;000 population) of the 16
   populations studied. Rates among US white women shifted from the sixth
   lowest in 2001 (ASMR, 231 deaths per 100\& x202f;000 population) to the
   12th lowest in 2015 (ASMR, 235 deaths per 100\& x202f;000 population).
   Among men, Peru had the lowest premature mortality rates (ASMR for 2015,
   219 deaths per 100\& x202f;000 population), and Belize had the highest
   premature mortality rates (ASMR for 2015, 702 deaths per 100\& x202f;000
   population). White men in the United States shifted from the fifth
   lowest rates in 2001 (ASMR, 396 deaths per 100\& x202f;000 population)
   to the eighth lowest rates in 2015 (ASMR, 394 deaths per 100\& x202f;000
   population). Rates for both women and men decreased in all the
   populations studied from 2001 to 2015 (average annual percentage change
   range, 0.4\% to 3.8\% per year) except among US white populations, for
   which the rate plateaued (average annual percentage change, 0.02\% per
   year {[}95\% CI, -0.3\% to 0.2\% per year] for women; -0.2\% per year
   {[}95\% CI, -0.4\% to 0.0\% per year] for men) and among Nicaraguan men,
   for whom the rates increased (0.6\% per year {[}95\% CI, 0.2\% to 1.0\%
   per year]). The populations with the lowest mortality rates in 2015 had
   lower rates from all major causes, but rates were particularly lower for
   heart disease (21 deaths per 100\& x202f;000 population) and cancer (50
   deaths per 100\& x202f;000 population). Conclusions and Relevance
   Premature mortality rates are lower for US Latino populations and
   several Latin American countries than for US white populations,
   suggesting that there may be a broader Latin American paradox. This
   analysis also highlights the high premature mortality rates among US
   African American populations, especially women, compared with many Latin
   American populations.
   Question What are the premature mortality rates for US Latino
   populations compared with those of other US populations and Latin
   American countries? Findings In this descriptive cross-sectional study
   of 16 populations, premature mortality rates were lower among US Latino
   populations compared with US African American and white populations. The
   overall favorable mortality trends in 12 Latin American countries were
   comparable with those of US Latino populations and, in many cases,
   better than those of US white populations. Meaning Premature mortality
   rates are lower among US Latino populations and in several Latin
   American countries than among US white populations, which may be
   indicative of a broad ``Latino or Hispanic paradox.{''}},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Chen, YX (Corresponding Author), NCI, NIH, 9609 Med Ctr Dr,Room 6E-328, Rockville, MD 20850 USA.
   Chen, Yingxi; Freedman, Neal D.; Shiels, Meredith S.; Withrow, Diana R.; Spillane, Susan; Sigel, Byron; Berrington de Gonzalez, Amy, NCI, Div Canc Epidemiol \& Genet, NIH, Rockville, MD 20850 USA.
   Rodriquez, Erik J., NHLBI, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Napoles, Anna M.; Perez-Stable, Eliseo J., Natl Inst Minor Hlth \& Hlth Dispar, NIH, Bethesda, MD USA.},
DOI = {10.1001/jamanetworkopen.2019.21085},
Article-Number = {e1921085},
ISSN = {2574-3805},
Keywords-Plus = {RISK-FACTORS; MORTALITY; DISEASE; HEALTH; PREVALENCE; CANCER; BURDEN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {yingxi.chen@nih.gov},
ResearcherID-Numbers = {Chen, Yingxi/ABF-2593-2020
   Freedman, Neal David/AAA-5929-2022},
ORCID-Numbers = {Chen, Yingxi/0000-0002-3565-1052
   Freedman, Neal David/0000-0003-0074-1098},
Funding-Acknowledgement = {Intramural Research Programs of the National Cancer Institute, National
   Heart, Lung, and Blood Institute; National Institute on Minority Health
   and Health Disparities within the National Institutes of Health},
Funding-Text = {This work was supported by the Intramural Research Programs of the
   National Cancer Institute, National Heart, Lung, and Blood Institute,
   and National Institute on Minority Health and Health Disparities within
   the National Institutes of Health.},
Cited-References = {Aldridge RW, 2018, LANCET, V392, P2553, DOI 10.1016/S0140-6736(18)32781-8.
   Anderson I, 2016, LANCET, V388, P131, DOI 10.1016/S0140-6736(16)00345-7.
   Centers for Disease Control and Prevention, MULT CAUS DEATH 1999.
   Chen YX, 2019, ANN INTERN MED, V170, P352, DOI 10.7326/M18-2415.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   Cremonte M, 2018, INT J PSYCHOL, V53, P245, DOI 10.1002/ijop.12373.
   Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517.
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3.
   Herrero R, 2015, LANCET ONCOL, V16, pE206, DOI 10.1016/S1470-2045(14)70481-4.
   Jaitman L., 2017, COSTS CRIME VIOLENCE.
   Kontis V, 2015, LANCET GLOB HEALTH, V3, pE746, DOI 10.1016/S2214-109X(15)00179-5.
   Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171.
   McDonald JA, 2019, J IMMIGR MINOR HEALT, V21, P237, DOI 10.1007/s10903-018-0737-2.
   de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X.
   Monteiro MG, 2013, ADICCIONES, V25, P99.
   Morales LS, 2002, J HEALTH CARE POOR U, V13, P477, DOI 10.1177/104920802237532.
   Murillo R, 2016, CANCER EPIDEMIOL, V44, pS121, DOI 10.1016/j.canep.2016.07.015.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   National Cancer Institute, SEER STAT SOFTW.
   National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONSMOK 50 YE.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Ordunez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141685.
   Pan American Health Organization/, 2017, HLTH AM 2017 ED SUMM.
   Pineros M, 2016, CANCER EPIDEMIOL, V44, pS90, DOI 10.1016/j.canep.2016.03.002.
   Rocha-Brischiliari SC, 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0168950.
   Rubalcava LN, 2008, AM J PUBLIC HEALTH, V98, P78, DOI 10.2105/AJPH.2006.098418.
   Shiels MS, 2019, LANCET PUBLIC HEALTH, V4, pE97, DOI 10.1016/S2468-2667(18)30208-1.
   Shiels MS, 2017, LANCET, V389, P1043, DOI {[}10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3].
   The United Nations, WORLD POP PROSP 2017.
   U. S. Census Bureau, 2017, FACTS FEAT HISP HER.
   United States Census Bureau, 2018, HISP HER MONTH.
   Anauati MV, 2015, LAT AM ECON REV, V24, DOI 10.1007/s40503-015-0025-7.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   World Health Organization, CAUS DEATH QUER ONL.
   Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405.},
Number-of-Cited-References = {35},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {JAMA Netw. Open},
Doc-Delivery-Number = {KO5TZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000515613500010},
OA = {Green Accepted, gold},
DA = {2022-03-29},
}

@article{ WOS:A1979GW07900002,
Author = {MEHR, RI},
Title = {CHANGING RESPONSIBILITY FOR PERSONAL RISKS AND SOCIETAL CONSEQUENCES -
   PREMATURE DEATH AND OLD-AGE},
Journal = {ANNALS OF THE AMERICAN ACADEMY OF POLITICAL AND SOCIAL SCIENCE},
Year = {1979},
Volume = {443},
Number = {MAY},
Pages = {1-11},
Publisher = {SAGE PUBLICATIONS INC},
Address = {2455 TELLER RD, THOUSAND OAKS, CA 91320},
Type = {Article},
Language = {English},
Affiliation = {MEHR, RI (Corresponding Author), UNIV ILLINOIS,URBANA,IL 61801, USA.},
DOI = {10.1177/000271627944300102},
ISSN = {0002-7162},
Research-Areas = {Government \& Law; Social Sciences - Other Topics},
Web-of-Science-Categories  = {Political Science; Social Sciences, Interdisciplinary},
Cited-References = {{*}AM COUNC LIF INS, 1976, YOUTH 1976 ATT YOUNG, P18.
   ELDRED GW, 1977, J RISK INSUR, V44, P179, DOI 10.2307/252132.
   ELDRED WG, 1975, J RISK INSURANCE, V42, P433.
   HOFFLANDER AE, 1975, PACIFIC INSURANCE C, P201.
   {*}I LIF INS, 1974, TREND REP SPEC ISS, P10.
   LESNOY SD, 1975, SOC SECUR BULL, V38, P3.
   MEHR RI, 1975, PACIFIC INSURANCE C, P228.
   MILLER J, PACIFIC INSURANCE C, P124.
   OATES JF, 1968, BUSINESS SOCIAL CHAN, P72.
   REJDA GE, 1973, J RISK INSUR, V40, P313, DOI 10.2307/252220.
   ROSE TL, 1977, THESIS U ILLINOIS, P82.
   1978, BARRONS MAGAZIN 1106, P7.},
Number-of-Cited-References = {12},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Ann. Am. Acad. Polit. Soc. Sci.},
Doc-Delivery-Number = {GW079},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1979GW07900002},
DA = {2022-03-29},
}

@article{ WOS:000265665200006,
Author = {Bassett, A. S. and Chow, E. W. C. and Husted, J. and Hodgkinson, K. A.
   and Oechslin, E. and Harris, L. and Silversides, C.},
Title = {Premature death in adults with 22q11.2 deletion syndrome},
Journal = {JOURNAL OF MEDICAL GENETICS},
Year = {2009},
Volume = {46},
Number = {5},
Pages = {324-330},
Month = {MAY},
Abstract = {Background: 22q11.2 deletion syndrome (22q11.2DS) is a multisystem
   disease with a prevalence of 1/4000. Variable expression of congenital
   and later onset features contributes to its under-recognition. Longevity
   in those surviving childhood is believed to be normal but data are
   limited.
   Methods: We prospectively followed 264 subjects; 102 adults (> 17 years)
   with 22q11.2DS (44 male (M), 58 female (F); mean (SD) age 33.6 (10.9)
   years) and their 162 unaffected siblings (77 M, 85 F; mean age 36.1
   (12.2) years). We compared survival between groups using Kaplan-Meier
   estimates.
   Results: Twelve (11.8\%; 4 M, 8 F) individuals with 22q11.2DS and no
   siblings died (p < 0.0001). Survival to ages 40 and 50 years was 89.9\%
   and 73.9\%, respectively. Median age at death was 41.5 (range 18.1-68.6)
   years. Deaths included two (7.7\%) of 26 subjects with neither major
   congenital heart disease (CHD) nor schizophrenia. Four of six sudden and
   unexpected deaths occurred in individuals with no major CHD. There was
   no evidence of cancer or coronary artery disease or family history of
   sudden death in the 12 patients who died, six of whom had autopsies.
   Discussion: Individuals with 22q11.2DS who survive childhood have
   diminished life expectancy and increased risk of sudden death not
   attributable to any single factor. Some sudden and/or premature deaths
   observed in the general population may represent undiagnosed 22q11.2DS.
   Increased recognition of the syndrome by family doctors, specialists and
   coroners will be essential to facilitate the tissue studies needed to
   determine underlying mechanisms.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Bassett, AS (Corresponding Author), Ctr Addict \& Mental Hlth, Clin Genet Res Program, 1001 Queen St W, Toronto, ON M6J 1H4, Canada.
   Bassett, A. S.; Chow, E. W. C.; Husted, J.; Hodgkinson, K. A., Ctr Addict \& Mental Hlth, Clin Genet Res Program, Toronto, ON M6J 1H4, Canada.
   Bassett, A. S.; Chow, E. W. C., Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   Bassett, A. S.; Oechslin, E.; Harris, L.; Silversides, C., Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Peter Munk Cardiac Ctr,Toronto Congenital Cardiac, Toronto, ON M5G 1L7, Canada.
   Hodgkinson, K. A., Mem Univ Newfoundland, Dept Genet, St John, NF, Canada.
   Husted, J., Univ Waterloo, Dept Hlth Studies, Waterloo, ON N2L 3G1, Canada.},
DOI = {10.1136/jmg.2008.063800},
ISSN = {0022-2593},
EISSN = {1468-6244},
Keywords-Plus = {SUDDEN CARDIAC DEATH; CONGENITAL HEART-DISEASE; CLINICAL-FEATURES;
   SCHIZOPHRENIA; PHENOTYPE; SPECTRUM; RISK},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {anne.bassett@utoronto.ca},
ResearcherID-Numbers = {Silversides, Candice K/D-8967-2017},
Funding-Acknowledgement = {Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) {[}MOP-79518]; Medical Research Council of CanadaUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}MOP-38099]; W. Garfield Weston Foundation; Ontario Mental Health
   Foundation; National Alliance for Research on Schizophrenia and
   DepressionNARSAD; Canada Research Chair in Schizophrenia GeneticsCanada
   Research Chairs},
Funding-Text = {This research was supported by grants from the Canadian Institutes of
   Health Research (MOP-79518), Medical Research Council of Canada
   (MOP-38099), W. Garfield Weston Foundation and Ontario Mental Health
   Foundation, and by a Distinguished Investigator Award from the National
   Alliance for Research on Schizophrenia and Depression (ASB) and Canada
   Research Chair in Schizophrenia Genetics (ASB).},
Cited-References = {Anaclerio Silvia, 2004, Ital Heart J, V5, P624.
   Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148.
   Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307.
   Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984.
   Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6.
   Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580.
   Behr ER, 2007, HEART, V93, P601, DOI 10.1136/hrt.2006.099598.
   Billett J, 2008, HEART, V94, P1194, DOI 10.1136/hrt.2007.122671.
   BRAUNWALD E, 2007, BRAUNWALDS HEART DIS.
   Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007.
   DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813.
   Fabre A, 2006, HEART, V92, P316, DOI 10.1136/hrt.2004.045518.
   Fung WLA, 2008, INT J CARDIOL, V131, P51, DOI 10.1016/j.ijcard.2007.08.141.
   Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205.
   Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348.
   Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057.
   Greenhalgh KL, 2003, ARCH DIS CHILD, V88, P523, DOI 10.1136/adc.88.6.523.
   Kapadia RK, 2008, CAN MED ASSOC J, V178, P391, DOI 10.1503/cmaj.071300.
   Kiehl TR, 2009, CEREB CORTEX, V19, P153, DOI 10.1093/cercor/bhn066.
   Koponen H, 2008, NORD J PSYCHIAT, V62, P342, DOI 10.1080/08039480801959323.
   Lammers A, 2006, J THORAC CARDIOV SUR, V132, P647, DOI 10.1016/j.jtcvs.2006.03.057.
   Liling J, 1999, J MED GENET, V36, P794, DOI 10.1136/jmg.36.10.794.
   Mahle WT, 2003, ANN THORAC SURG, V76, P567, DOI 10.1016/S0003-4975(03)00516-2.
   McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006.
   Michielon G, 2006, ANN THORAC SURG, V81, P968, DOI 10.1016/j.athoracsur.2005.09.033.
   Oskarsdottir S, 2005, EUR J PEDIATR, V164, P146, DOI 10.1007/s00431-004-1577-8.
   Roos-Hesselink JW, 2003, EUR HEART J, V24, P190, DOI 10.1016/S0195-668X(02)00383-4.
   Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798.
   Scutt LE, 2001, AM J MED GENET, V105, P713, DOI 10.1002/ajmg.1612.
   Shashi V, 2003, AM J MED GENET A, V121A, P231, DOI 10.1002/ajmg.a.20219.
   Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2.
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9.
   {*}STAT CAN, 2005, LIF EXP BIRTH AG 65.
   Sullivan K E, 2001, Curr Allergy Asthma Rep, V1, P438, DOI 10.1007/s11882-001-0029-z.
   Swillen A, 2000, AM J MED GENET, V97, P128, DOI 10.1002/1096-8628(200022)97:2<128::AID-AJMG4>3.0.CO;2-Z.
   Weksberg R, 2007, HUM GENET, V120, P837, DOI 10.1007/s00439-006-0242-x.},
Number-of-Cited-References = {36},
Times-Cited = {59},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Med. Genet.},
Doc-Delivery-Number = {439YY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000265665200006},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000474414100005,
Author = {Hui, Yuanchi and Wang, Jinping and An, Yali and Gong, Qiuhong and Li,
   Hui and Zhang, Bo and Shuai, Ying and Chen, Yanyan and Hu, Yinghua and
   Li, Guangwei},
Title = {Premature death and risk of cardiovascular disease in young-onset
   diabetes: a 23-year follow-up of the Da Qing Diabetes Study},
Journal = {ENDOCRINE},
Year = {2019},
Volume = {65},
Number = {1},
Pages = {46-52},
Month = {JUL},
Abstract = {Objective: This study aimed to investigate premature mortality and the
   risk of cardiovascular disease (CVD) in Chinese adults with diabetes
   diagnosed before the age of 45 years.
   Methods A total of 519 participants with normal glucose tolerance (NGT)
   and 630 with newly diagnosed diabetes mellitus (DM) were recruited in
   1986 in the Da Qing Diabetes Study. In 2009, the participants were
   followed up to assess mortality and CVD events. The subjects were
   stratified into four subgroups according to age and diabetes status: age
   <45 years with NGT (NGT(<45y)), age <45 years with DM (DM<45y), age >=
   45 years with NGT (NGT(>= 45y)), and age >= 45 years with DM (DM >=
   45y). The risk of death and CVD events in patients with young-onset DM
   and elder subjects with NGT were compared to show the extent of
   premature death and CVD in the DM participants.
   Results During the 23-year follow-up, 26 (10.40\%) participants in
   NGT(<45y), 72 (34.12\%) in DM<45y, 74 (30.58\%) in NGT(>= 45y), and 266
   (68.73\%) in DM >= 45y died, including 13 (5.20\%), 36 (17.06\%), 24
   (9.92\%), and 128 (33.07\%) death attributed to CVD. The corresponding
   rates of CVD events were 56 (22.40\%), 90 (42.65\%), 89 (36.78), and 213
   (55.04\%). It also showed that the risk of all-cause death (HR 1.23,
   95\% CI 0.88-1.71) or CVD events (HR 1.25, 95\% CI 0.93-1.69) did not
   differ significantly between the DM<45y and NGT(>= 45y) groups after
   adjusting for sex, smoking, body mass index, systolic blood pressure,
   total cholesterol and previous history of CVD. Of note, participants in
   the DM<45y group had an higher risk of CVD mortality compared with that
   in the NGT(>= 45y) group (HR 1.76, 95\% CI 1.04-2.98), although the mean
   age in the former group was 12 years lesser than that in the latter
   group (39.015.00 vs 51.45 +/- 5.14).
   Conclusions Young-onset diabetes is a risk factor for the premature
   death and cardiovascular disease. Early prevention and intensive
   treatment are warrented in patients with young-onset diabetes.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Article},
Language = {English},
Affiliation = {Li, GW (Corresponding Author), Chinese Acad Med Sci, Fu Wai Hosp, Ctr Endocrinol \& Cardiol, Beijing, Peoples R China.
   Li, GW (Corresponding Author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.
   Hui, Yuanchi; An, Yali; Gong, Qiuhong; Chen, Yanyan; Li, Guangwei, Chinese Acad Med Sci, Fu Wai Hosp, Ctr Endocrinol \& Cardiol, Beijing, Peoples R China.
   Wang, Jinping; Li, Hui; Hu, Yinghua, Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China.
   Zhang, Bo; Shuai, Ying; Li, Guangwei, China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.},
DOI = {10.1007/s12020-019-01928-7},
ISSN = {1355-008X},
EISSN = {1559-0100},
Keywords = {Young-onset diabetes; Cardiovascular disease; Premature death; Follow-up},
Keywords-Plus = {IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; TYPE-2; MORTALITY; PEOPLE;
   COMPLICATIONS; PREVENTION; PREVALENCE; MELLITUS; CHINA},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {guangwei\_li45@126.com},
ResearcherID-Numbers = {wang, jinping/AAE-4392-2020},
Cited-References = {Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798.
   Amutha A, 2017, DIABETES RES CLIN PR, V123, P1, DOI 10.1016/j.diabres.2016.11.006.
   Aune D, 2018, NUTR METAB CARDIOVAS, V28, P543, DOI 10.1016/j.numecd.2018.02.011.
   Bansal V, 2018, DIABETOLOGIA, V61, P2180, DOI 10.1007/s00125-018-4690-3.
   Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016.
   Chow E, 2017, MED J AUSTRALIA, V207, P331, DOI 10.5694/mja17.00506.
   Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455.
   Duru OK, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0977-5.
   Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9.
   Hambling CE, 2017, DIABETIC MED, V34, P1219, DOI 10.1111/dme.13380.
   Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999.
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470.
   Huo XX, 2016, LANCET DIABETES ENDO, V4, P115, DOI 10.1016/S2213-8587(15)00508-2.
   Jacobs E, 2017, DIABETES CARE, V40, P1703, DOI 10.2337/dc17-0954.
   Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7.
   Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9.
   Ma RCW, 2018, DIABETOLOGIA, V61, P1249, DOI 10.1007/s00125-018-4557-7.
   Pan JM, 2018, FRONT MED-PRC, V12, P624, DOI 10.1007/s11684-018-0669-1.
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537.
   PAN XR, 1993, DIABETES CARE, V16, P150, DOI 10.2337/diacare.16.1.150.
   Rhodes ET, 2012, DIABETIC MED, V29, P453, DOI 10.1111/j.1464-5491.2011.03542.x.
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862.
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801.
   Waernbaum I, 2006, DIABETOLOGIA, V49, P653, DOI 10.1007/s00125-005-0135-x.
   Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596.
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292.
   Zhang D D, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P852, DOI 10.3760/cma.j.issn.0254-6450.2018.06.030.},
Number-of-Cited-References = {27},
Times-Cited = {5},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Endocrine},
Doc-Delivery-Number = {IH3TB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000474414100005},
DA = {2022-03-29},
}

@article{ WOS:000405299100041,
Author = {Ohkuma, Toshiaki and Woodward, Mark and Jun, Min and Muntner, Paul and
   Hata, Jun and Colagiuri, Stephen and Harrap, Stephen and Mancia,
   Giuseppe and Poulter, Neil and Williams, Bryan and Rothwell, Peter and
   Chalmers, John and ADVANCE Collaborative Grp},
Title = {Prognostic Value of Variability in Systolic Blood Pressure Related to
   Vascular Events and Premature Death in Type 2 Diabetes Mellitus The
   ADVANCE-ON Study},
Journal = {HYPERTENSION},
Year = {2017},
Volume = {70},
Number = {2},
Pages = {461+},
Month = {AUG},
Abstract = {Visit-to-visit variability in systolic blood pressure (SBP) is a risk
   factor for cardiovascular events. However, whether it provides
   additional predictive information beyond traditional risk factors,
   including mean SBP, in the long term is unclear. The ADVANCE trial
   (Action in Diabetes and Vascular Disease: Preterax and Diamicron
   Modified Release Controlled Evaluation) was a randomized controlled
   trial in patients with type 2 diabetes mellitus; ADVANCE-ON
   (ADVANCE-Observational) followed-up patients subsequently. In these
   analyses, 9114 patients without major macrovascular or renal events or
   death during the first 24 months were included. Data on SBP from 6
   visits during the first 24 months after randomization were used to
   estimate visit-to-visit variability in several ways: the primary measure
   was the standard deviation. Events accrued during the following 7.6
   years. The primary outcome was a composite of major macrovascular and
   renal events and all-cause mortality. Standard deviation of SBP was
   log-linearly associated with an increased risk of the primary outcome
   (P<0.001) after adjustment for mean SBP and other cardiovascular risk
   factors. The hazard ratio (HR; 95\% confidence interval {[}CI]) in the
   highest, compared with the lowest, tenth of the standard deviation was
   1.39 (1.15-1.69). Results were similar for major macrovascular events
   alone and all-cause mortality alone (both P<0.01). Addition of standard
   deviation of SBP significantly improved 8-year risk classification
   (continuous net reclassification improvement, 5.3\%). Results were
   similar for other measures of visit-to-visit variability, except maximum
   SBP. Visit-to-visit variability in SBP is an independent predictor of
   vascular complications and death, which improves risk prediction beyond
   that provided by traditional risk factors, including mean SBP.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Chalmers, J (Corresponding Author), Univ Sydney, George Inst Global Hlth, Royal Prince Alfred Hosp, Level 10,King George 5 Bldg,Missenden Rd, Camperdown, NSW 2050, Australia.
   Ohkuma, Toshiaki; Woodward, Mark; Jun, Min; Hata, Jun; Chalmers, John, Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.
   Colagiuri, Stephen, Univ Sydney, Sydney Med Sch, Boden Inst Obes Nutr Exercise \& Eating Disorders, Sydney, NSW, Australia.
   Woodward, Mark, Univ Oxford, George Inst Global Hlth, Oxford, England.
   Woodward, Mark, Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.
   Muntner, Paul, Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   Muntner, Paul, Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   Harrap, Stephen, Univ Melbourne, Royal Melbourne Hosp, Dept Physiol, Melbourne, Vic, Australia.
   Mancia, Giuseppe, Univ Milano Bicocca, Milan, Italy.
   Mancia, Giuseppe, Inst Auxol Italiano, Milan, Italy.
   Poulter, Neil, Imperial Coll, Int Ctr Circulatory Hlth, London, England.
   Williams, Bryan, UCL, Inst Cardiovasc Sci, London, England.
   Williams, Bryan, UCL Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England.
   Rothwell, Peter, Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford, England.},
DOI = {10.1161/HYPERTENSIONAHA.117.09359},
ISSN = {0194-911X},
EISSN = {1524-4563},
Keywords = {blood pressure variability; cardiovascular disease; diabetes mellitus;
   mortality; myocardial infarction; stroke},
Keywords-Plus = {TO-VISIT VARIABILITY; CARDIOVASCULAR-DISEASE; GLUCOSE CONTROL; RISK;
   ASSOCIATION; STROKE; MORTALITY; OUTCOMES; METRICS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Peripheral Vascular Disease},
Author-Email = {chalmers@georgeinstitute.org.au},
ResearcherID-Numbers = {Woodward, Mark/L-6817-2017
   Rothwell, Peter/ABE-5913-2020
   Jun, Min/AAK-5018-2021
   },
ORCID-Numbers = {Rothwell, Peter/0000-0001-9739-9211
   Colagiuri, Stephen/0000-0002-2398-4781
   Woodward, Mark/0000-0001-9800-5296
   Chalmers, John/0000-0002-9931-0580
   Jun, Min/0000-0003-1460-7535
   Williams, Bryan/0000-0002-8094-1841},
Funding-Acknowledgement = {National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia;
   ServierServier; MRCUK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC) {[}MC\_PC\_13090] Funding Source: UKRI; Medical
   Research CouncilUK Research \& Innovation (UKRI)Medical Research Council
   UK (MRC)European Commission {[}MC\_PC\_13090] Funding Source:
   researchfish; National Institute for Health ResearchNational Institute
   for Health Research (NIHR) {[}NF-SI-0514-10011, NF-SI-0509-10222]
   Funding Source: researchfish},
Funding-Text = {The ADVANCE trial was funded by grants from the National Health and
   Medical Research Council (NHMRC) of Australia and from Servier. T.
   Ohkuma holds the JSPS Postdoctoral Fellowships for Research Abroad. M.
   Woodward is a National Health and Medical Research Council of Australia
   Principal Research Fellow (1080206).},
Cited-References = {{[}Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001.
   Blacher J, 2015, J HUM HYPERTENS, V29, P122, DOI 10.1038/jhh.2014.44.
   Chalmers J, 2001, DIABETOLOGIA, V44, P1118.
   Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717.
   Hata J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055807.
   Hong K, 2016, J HUM HYPERTENS, V30, P73, DOI 10.1038/jhh.2015.26.
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427.
   KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8.
   Kim KI, 2008, CIRC J, V72, P293, DOI 10.1253/circj.72.293.
   Kronish IM, 2016, HYPERTENSION, V68, P39, DOI 10.1161/HYPERTENSIONAHA.115.06960.
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006.
   Levitan EB, 2013, J HUM HYPERTENS, V27, P589, DOI 10.1038/jhh.2013.19.
   Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803.
   Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001.
   Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303.
   Okada H, 2012, ATHEROSCLEROSIS, V220, P155, DOI 10.1016/j.atherosclerosis.2011.10.033.
   Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8.
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987.
   Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348.
   Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1.
   Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X.
   Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094.
   Su DF, 2006, CURR OPIN CARDIOL, V21, P486, DOI 10.1097/01.hco.0000240587.14463.58.
   Tatasciore A, 2008, HYPERTENS RES, V31, P2137, DOI 10.1291/hypres.31.2137.
   Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3.
   Wang JQ, 2017, J HYPERTENS, V35, P10, DOI 10.1097/HJH.0000000000001159.
   Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8.
   Woodward M, 2016, DIABETES OBES METAB, V18, P289, DOI 10.1111/dom.12614.
   Woodward M., 2014, EPIDEMIOLOGY STUDY D.
   Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963.},
Number-of-Cited-References = {30},
Times-Cited = {44},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Hypertension},
Doc-Delivery-Number = {FA2VM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000405299100041},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000470967500024,
Author = {Alm, Susanne and Laftman, Sara Brolin and Bohman, Hannes},
Title = {Poor Family Relationships in Adolescence and the Risk of Premature
   Death: Findings from the Stockholm Birth Cohort Study},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2019},
Volume = {16},
Number = {10},
Month = {MAY 2},
Abstract = {Poor family relationships during childhood have been shown to have
   long-term negative effects on an offspring's health. However, few
   studies have followed the offspring to retirement age, and relatedly,
   knowledge about the link between poor family relationships and premature
   death is scarce. The aim of this study was to examine the association
   between poor family relationships in adolescence and the risk of
   premature death, even when considering other adverse childhood
   conditions. Prospective data from the Stockholm Birth Cohort study were
   used, with 2636 individuals born in 1953 who were followed up until age
   65. Information on family relations was based on interviews with the
   participants' mothers in 1968. Information on mortality was retrieved
   from administrative register data from 1969-2018. Cox proportional
   hazards regressions showed that poor family relationships in adolescence
   were associated with an increased risk of premature death, even when
   adjusting for childhood conditions in terms of household social class,
   household economic poverty, contact with the child services, parental
   alcohol abuse, and parental mental illness (Hazard Ratio (HR), 2.08,
   95\% Confidence Interval (CI), 1.40-3.09). The findings show that poor
   family relationships in adolescence can have severe and long-lasting
   health consequences, highlighting the importance of early interventions.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Alm, S (Corresponding Author), Stockholm Univ, Swedish Inst Social Res, SE-10691 Stockholm, Sweden.
   Alm, Susanne, Stockholm Univ, Swedish Inst Social Res, SE-10691 Stockholm, Sweden.
   Laftman, Sara Brolin, Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equity Studies CHESS, SE-10691 Stockholm, Sweden.
   Bohman, Hannes, Uppsala Univ, Dept Neurosci Child \& Adolescent Psychiat, Box 593, SE-75124 Uppsala, Sweden.
   Bohman, Hannes, Akademiska Univ Hosp, Dept Womens \& Childrens Hlth, SE-75185 Uppsala, Sweden.
   Bohman, Hannes, Stockholm Cty Council, Stockholm Hlth Care Serv, S-10422 Stockholm, Sweden.},
DOI = {10.3390/ijerph16101690},
Article-Number = {1690},
ISSN = {1661-7827},
EISSN = {1660-4601},
Keywords = {adverse childhood experiences; family conflict; family discord; death;
   cohort; longitudinal; prospective},
Keywords-Plus = {ADVERSE CHILDHOOD EXPERIENCES; MENTAL-HEALTH; DEPRESSIVE DISORDER;
   MORTALITY; OUTCOMES; WELL; ASSOCIATIONS; EDUCATION; COHESION; SUPPORT},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {susanne.alm@sofi.su.se
   sara.brolin.laftman@su.se
   hannes.bohman@neuro.uu.se},
ResearcherID-Numbers = {Bohman, Hannes/R-6993-2019
   },
ORCID-Numbers = {Bohman, Hannes/0000-0001-9726-6478},
Funding-Acknowledgement = {Swedish Research Council for Health, Working Life, and Welfare (Forte)
   {[}2016-07148]},
Funding-Text = {This research was performed within the research program: Reproduction of
   Inequality through Linked Lives (RELINK), funded by the Swedish Research
   Council for Health, Working Life, and Welfare (Forte), grant number
   2016-07148.},
Cited-References = {Alaie I, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024939.
   Almquist YB, 2018, J EPIDEMIOL COMMUN H, V72, P997, DOI 10.1136/jech-2018-210487.
   Berg N, 2017, ADV LIFE COURSE RES, V32, P65, DOI 10.1016/j.alcr.2016.07.001.
   Berg N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178136.
   Bohman H, 2010, UPSALA J MED SCI, V115, P21, DOI 10.3109/03009730903572057.
   Bowlby John, 1969, ATTACHMENT LOSS VOL.
   Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013.
   Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225.
   Gao MH, 2017, INT J EPIDEMIOL, V46, P1010, DOI 10.1093/ije/dyw295.
   Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319.
   Haldorson L., 2008, FOKUS NARINGSLIV ARB.
   Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316.
   Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4.
   Janson C.-G., 1995, PROJECT METROPOLITAN.
   Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9.
   Landstedt E, 2015, SCAND J PUBLIC HEALT, V43, P460, DOI 10.1177/1403494815576360.
   Lewinsohn PM, 1999, J AM ACAD CHILD PSY, V38, P56, DOI 10.1097/00004583-199901000-00020.
   Manzi C, 2006, J MARRIAGE FAM, V68, P673, DOI 10.1111/j.1741-3737.2006.00282.x.
   Marmorstein NR, 2004, J CHILD PSYCHOL PSYC, V45, P377, DOI 10.1111/j.1469-7610.2004.00228.x.
   McEwen BS, 2017, CHRONIC STRESS, V1, DOI {[}10.1177/2470547017692328, DOI 10.1177/2470547017692328].
   McLeod GFH, 2016, PSYCHOL MED, V46, P1401, DOI 10.1017/S0033291715002950.
   Merz EM, 2013, ADV LIFE COURSE RES, V18, P212, DOI 10.1016/j.alcr.2013.05.002.
   Mood C, 2017, J MARRIAGE FAM, V79, P419, DOI 10.1111/jomf.12340.
   Morgan Z, 2012, SOC PSYCH PSYCH EPID, V47, P1707, DOI 10.1007/s00127-012-0481-1.
   Overbeek G, 2007, DEV PSYCHOL, V43, P429, DOI 10.1037/0012-1649.43.2.429.
   Repetti RL, 2011, DEV PSYCHOPATHOL, V23, P921, DOI 10.1017/S095457941100040X.
   Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330.
   Rothon C, 2012, SOC PSYCH PSYCH EPID, V47, P697, DOI 10.1007/s00127-011-0391-7.
   Sheeber LB, 2007, J ABNORM PSYCHOL, V116, P144, DOI 10.1037/0021-843X.116.1.144.
   Stenberg SA, 2006, INT J EPIDEMIOL, V35, P546, DOI 10.1093/ije/dyi310.
   Stenberg SA, 2007, SCAND J PUBLIC HEALT, V35, P104, DOI 10.1080/14034940600777385.
   Stewart-Brown SL, 2005, EUR J PUBLIC HEALTH, V15, P640, DOI 10.1093/eurpub/cki049.
   Su S, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0645-1.
   Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592.
   Torssander J, 2010, EUR SOCIOL REV, V26, P465, DOI 10.1093/esr/jcp034.
   Vandeleur CL, 2009, J MARRIAGE FAM, V71, P1205, DOI 10.1111/j.1741-3737.2009.00664.x.
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502.
   Weich S, 2009, BRIT J PSYCHIAT, V194, P392, DOI 10.1192/bjp.bp.107.042515.},
Number-of-Cited-References = {40},
Times-Cited = {5},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {IC4WF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000470967500024},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000364117600001,
Author = {Schwartz, Joel D. and Lee, Mihye and Kinney, Patrick L. and Yang, Suijia
   and Mills, David and Sarofim, Marcus C. and Jones, Russell and Streeter,
   Richard and St Juliana, Alexis and Peers, Jennifer and Horton, Radley M.},
Title = {Projections of temperature-attributable premature deaths in 209 US
   cities using a cluster-based Poisson approach},
Journal = {ENVIRONMENTAL HEALTH},
Year = {2015},
Volume = {14},
Month = {NOV 4},
Abstract = {Background: A warming climate will affect future
   temperature-attributable premature deaths. This analysis is the first to
   project these deaths at a near national scale for the United States
   using city and month-specific temperature-mortality relationships.
   Methods: We used Poisson regressions to model temperature-attributable
   premature mortality as a function of daily average temperature in 209
   U.S. cities by month. We used climate data to group cities into clusters
   and applied an Empirical Bayes adjustment to improve model stability and
   calculate cluster-based month-specific temperature-mortality functions.
   Using data from two climate models, we calculated future daily average
   temperatures in each city under Representative Concentration Pathway
   6.0. Holding population constant at 2010 levels, we combined the
   temperature data and cluster-based temperature-mortality functions to
   project city-specific temperature-attributable premature deaths for
   multiple future years which correspond to a single reporting year.
   Results within the reporting periods are then averaged to account for
   potential climate variability and reported as a change from a 1990
   baseline in the future reporting years of 2030, 2050 and 2100. Results:
   We found temperature-mortality relationships that vary by location and
   time of year. In general, the largest mortality response during hotter
   months (April -September) was in July in cities with cooler average
   conditions. The largest mortality response during colder months
   (October-March) was at the beginning (October) and end (March) of the
   period. Using data from two global climate models, we projected a net
   increase in premature deaths, aggregated across all 209 cities, in all
   future periods compared to 1990. However, the magnitude and sign of the
   change varied by cluster and city.
   Conclusions: We found increasing future premature deaths across the 209
   modeled U.S. cities using two climate model projections, based on
   constant temperature-mortality relationships from 1997 to 2006 without
   any future adaptation. However, results varied by location, with some
   locations showing net reductions in premature temperature-attributable
   deaths with climate change.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Mills, D (Corresponding Author), Abt Associates Inc, 1881 Ninth St,Suite 201, Boulder, CO 80302 USA.
   Schwartz, Joel D.; Lee, Mihye, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Schwartz, Joel D.; Lee, Mihye, Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA.
   Kinney, Patrick L.; Yang, Suijia, Columbia Univ, Mailman Sch Publ Hlth, Columbia Climate \& Hlth Program, New York, NY USA.
   Mills, David; Jones, Russell; Streeter, Richard; St Juliana, Alexis; Peers, Jennifer, Abt Associates Inc, Boulder, CO 80302 USA.
   Sarofim, Marcus C., US EPA, Climate Change Div, Washington, DC 20460 USA.
   Horton, Radley M., Columbia Univ, Ctr Climate Syst Res, New York, NY USA.},
DOI = {10.1186/s12940-015-0071-2},
Article-Number = {85},
EISSN = {1476-069X},
Keywords = {Temperature-attributable premature mortality; United States; Climate
   change},
Keywords-Plus = {HEAT-RELATED MORTALITY; CLIMATE-CHANGE; IMPACTS; UNCERTAINTY;
   ADAPTATION; EXPOSURE; WEATHER; WAVES; MODEL; TIME},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {dmills@stratusconsulting.com},
ORCID-Numbers = {Horton, Radley/0000-0002-5574-9962
   Sarofim, Marcus/0000-0001-7753-1676
   St. Juliana, Alexis/0000-0002-2135-3484},
Funding-Acknowledgement = {U.S. EPA Climate Change Division {[}EP-PA-12-H-0024, EP-B14-H00008];
   Stratus Consulting; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH
   SCIENCESUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) {[}P30ES000002, T32ES023770, P30ES009089]
   Funding Source: NIH RePORTER},
Funding-Text = {The authors thank Neal Fann and Philip Morefield of U.S. EPA for their
   contributions with the BenMAP model and ICLUS population data
   respectively. The U.S. EPA Climate Change Division provided funding for
   this research through contract EP-PA-12-H-0024 and order number
   EP-B14-H00008 with Stratus Consulting. The views expressed in this
   document are solely those of the authors and do not necessarily reflect
   those of their affiliated institutions, including the U.S. EPA.},
Cited-References = {Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313.
   Barreca AI, 2012, J ENVIRON ECON MANAG, V63, P19, DOI 10.1016/j.jeem.2011.07.004.
   Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392.
   Braga ALF, 2001, EPIDEMIOLOGY, V12, P662.
   Bureau of Reclamation, 2013, DOWNSC CMIP3 CMIP5 C, P47.
   Centers for Disease Control and Prevention, 2009, INT CLASS DIS 9 REV.
   Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80.
   Davis RE, 2003, INT J BIOMETEOROL, V47, P166, DOI 10.1007/s00484-003-0160-8.
   Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gosling SN, 2012, CLIMATIC CHANGE, V112, P217, DOI 10.1007/s10584-011-0211-9.
   Hayhoe K, 2010, J GREAT LAKES RES, V36, P65, DOI 10.1016/j.jglr.2009.12.009.
   Honda Y, 2014, ENVIRON HEALTH PREV, V19, P56, DOI 10.1007/s12199-013-0354-6.
   Hondula DM, 2015, CURR CLIM CHANGE REP, V1, P144, DOI 10.1007/s40641-015-0016-4.
   Houser T., 2014, AM CLIMATE PROSPECTU.
   Jones B, 2015, NAT CLIM CHANGE, V5, P652, DOI {[}10.1038/NCLIMATE2631, 10.1038/nclimate2631].
   Kaiser Reinhard, 2007, Am J Public Health, V97 Suppl 1, pS158, DOI 10.2105/AJPH.2006.100081.
   Kalkstein LS, 2011, NAT HAZARDS, V56, P113, DOI 10.1007/s11069-010-9552-3.
   Kinney PL, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064016.
   Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594.
   Le Tertre A, 2005, RISK ANAL, V25, P711, DOI 10.1111/j.1539-6924.2005.00606.x.
   Lee M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-89.
   Li TT, 2013, NAT CLIM CHANGE, V3, P717, DOI {[}10.1038/nclimate1902, 10.1038/NCLIMATE1902].
   Luber G., 2014, CLIMATE CHANGE IMPAC, DOI DOI 10.7930/J0PN93H5.
   Mills D, 2015, CLIMATIC CHANGE, V131, P83, DOI 10.1007/s10584-014-1154-8.
   Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823.
   National Oceanic and Atmospheric Administration, 2015, GLOB HIST CLIM NETW.
   National Oceanic and Atmospheric Administration, 2015, US CLIM REG.
   Petkova EP, 2014, EPIDEMIOLOGY, V25, P554, DOI 10.1097/EDE.0000000000000123.
   U.S. Energy Information Administration, 2015, COMM BUILD EN CONS S.
   U.S. Environmental Protection Agency, 2014, EPA600R09143F NAT CT.
   U.S. Environmental Protection Agency, 2014, ENV BEN MAPP AN PROG.
   U.S. Global Change Research Program, 2015, IMP CLIM CHANG HUM H.
   Wu JY, 2014, ENVIRON HEALTH PERSP, V122, P10, DOI {[}10.1289/ehp.1306670, 10.1289/ehp.1307701].},
Number-of-Cited-References = {34},
Times-Cited = {28},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Environ. Health},
Doc-Delivery-Number = {CV2WG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000364117600001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000311680600095,
Author = {Schildhaus, Sam and Dugoni, Bernard},
Title = {Premature Death as the Ultimate Failure: Predictors of Death in the US
   Drug User Treatment Population},
Journal = {SUBSTANCE USE \& MISUSE},
Year = {2012},
Volume = {47},
Number = {13-14},
Pages = {1666-1669},
Abstract = {Premature death is the ultimate failure in public health. Failure to
   complete substance user treatment increases the likelihood of death.
   Using the five-year follow-up (1990/91-1995/96) of a representative
   sample of 3,047 clients discharged from drug user treatment, this
   article documents that deaths after treatment were 4.7 times higher for
   substance user treatment clients than for the U. S. population matched
   by age, sex, and race; death rates ranged from 3.5 times as likely for
   Black males to nine times as likely for White females. Logistic
   regression models show that completion of treatment is associated with a
   three-fifths decreased likelihood of death.},
Publisher = {TAYLOR \& FRANCIS INC},
Address = {530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA},
Type = {Article},
Language = {English},
Affiliation = {Schildhaus, S (Corresponding Author), Thomson Reuters, 4301 Connecticut Ave NW, Washington, DC 20008 USA.
   Schildhaus, Sam, Thomson Reuters, Washington, DC 20008 USA.
   Schildhaus, Sam; Dugoni, Bernard, Univ Chicago, NORC, Chicago, IL 60637 USA.},
DOI = {10.3109/10826084.2012.706165},
ISSN = {1082-6084},
EISSN = {1532-2491},
Keywords = {premature death; public health; drug user treatment; death; treatment
   completion},
Keywords-Plus = {SERVICES RESEARCH OUTCOMES; FOLLOW-UP},
Research-Areas = {Substance Abuse; Psychiatry; Psychology},
Web-of-Science-Categories  = {Substance Abuse; Psychiatry; Psychology},
Author-Email = {schildhaus.sam@thomsonreuters.com},
Funding-Acknowledgement = {U.S. Department of Health and Human Services, Substance Abuse and Mental
   Health Services Administration, Office of Applied Studies
   {[}283-91-8321]},
Funding-Text = {This paper is a continuation of work originally carried out by the
   National Opinion Research Center (NORC) at The University of Chicago
   under contract 283-91-8321 from the U.S. Department of Health and Human
   Services, Substance Abuse and Mental Health Services Administration,
   Office of Applied Studies.},
Cited-References = {Adams B. F., 1991, NATL CTR HLTH STAT V, V10, P112.
   Garner P., 1996, ADV REPORT FINAL MOR.
   Gerstein D. R., 1997, NATL TREATMENT IMPRO.
   Gerstein D. R., 1994, EVALUATING RECOVERY.
   Harwood H., 2000, PUBLICATION NATL I A.
   Harwood H., 2004, PUBLICATION OFFICE N.
   Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503.
   Hubbard RL., 1989, DRUG ABUSE TREATMENT.
   Joe G. W., 1990, OPIOID ADDICTION TRE.
   Joe G. W., 1987, AM J PUBLIC HLTH.
   Magura S, 2002, SUBST USE MISUSE, V37, P1185, DOI 10.1081/JA-120004179.
   MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207.
   Philips DP, 1999, NEW ENGL J MED, V341, P93, DOI 10.1056/NEJM199907083410206.
   POLLOCK DA, 1991, JAMA-J AM MED ASSOC, V266, P2233, DOI 10.1001/jama.266.16.2233.
   Rivara FP, 1997, JAMA-J AM MED ASSOC, V278, P569, DOI 10.1001/jama.278.7.569.
   Schildhaus S, 2000, SUBST USE MISUSE, V35, P1849, DOI 10.3109/10826080009148243.
   Schildhaus S, 2000, SUBST USE MISUSE, V35, P1879, DOI 10.3109/10826080009148244.
   Simpson D. D., 1997, PSYCHOL ADDICT BEHAV, V11, P211.
   Vailiant G. E., 1996, AM J PSYCHIAT, V123, P573.
   VAILLANT GE, 1973, ARCH GEN PSYCHIAT, V29, P237.
   Vaillant GE, 2003, ADDICTION, V98, P1043, DOI 10.1046/j.1360-0443.2003.00422.x.
   VAILLANT GE, 1988, BRIT J ADDICT, V83, P1147.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Subst. Use Misuse},
Doc-Delivery-Number = {045FO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000311680600095},
DA = {2022-03-29},
}

@article{ WOS:000500745800010,
Author = {Henning-Smith, Carrie E. and Hernandez, Ashley M. and Hardeman, Rachel
   R. and Ramirez, Marizen R. and Kozhimannil, Katy Backes},
Title = {Rural Counties With Majority Black Or Indigenous Populations Suffer The
   Highest Rates Of Premature Death In The US},
Journal = {HEALTH AFFAIRS},
Year = {2019},
Volume = {38},
Number = {12},
Pages = {2019-2026},
Month = {DEC},
Abstract = {Despite well-documented health disparities by rurality and
   race/ethnicity, research investigating racial/ethnic health differences
   among US rural residents is limited. We used county-level data to
   measure and compare premature death rates in rural counties by each
   county's majority racial/ethnic group. Premature death rates were
   significantly higher in rural counties with a majority of non-Hispanic
   black or American Indian/Alaska Native (AI/AN) residents than in rural
   counties with a majority of non-Hispanic white residents. After we
   adjusted for community-level covariates, differences in premature death
   remained significant in counties with a majority of AI/AN residents but
   not those with a majority of non-Hispanic black residents. This study
   highlights the particular vulnerability of non-Hispanic black and AI/AN
   rural communities to high rates of premature mortality. Policies to
   improve rural health should focus on these racially diverse communities,
   addressing economic vitality and current and historical political
   context to mitigate health inequities and the harmful health effects of
   neglecting social determinants of health.},
Publisher = {PROJECT HOPE},
Address = {7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA},
Type = {Article},
Language = {English},
Affiliation = {Henning-Smith, CE (Corresponding Author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy \& Management, Minneapolis, MN 55455 USA.
   Henning-Smith, Carrie E.; Hardeman, Rachel R.; Kozhimannil, Katy Backes, Univ Minnesota, Sch Publ Hlth, Div Hlth Policy \& Management, Minneapolis, MN 55455 USA.
   Hernandez, Ashley M.; Ramirez, Marizen R., Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA.},
DOI = {10.1377/hlthaff.2019.00847},
ISSN = {0278-2715},
Keywords-Plus = {HEALTH DISPARITIES; UNITED-STATES; LEADING CAUSES; NONMETROPOLITAN;
   INEQUITIES; DIVERSITY; MORTALITY; RACISM; EQUITY; ACCESS},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Author-Email = {henn0329@umn.edu},
Funding-Acknowledgement = {Federal Office of Rural Health Policy (FORHP), Health Resources and
   Services Administration (HRSA), Department of Health and Human Services
   (HHS) {[}5U1CRH03717]},
Funding-Text = {Some of the results in this article have been presented previously, as
   an oral presentation at the National Rural Health Association Annual
   Rural Health Equity Conference in Atlanta, Georgia, May 7, 2019; and as
   a poster presentation at the AcademyHealth Annual Research Meeting in
   Washington, D. C., June 3, 2019. This study was supported by the Federal
   Office of Rural Health Policy (FORHP), Health Resources and Services
   Administration (HRSA), Department of Health and Human Services (HHS)
   (Public Health Service Grant No. 5U1CRH03717). The information,
   conclusions, and opinions expressed in this article are those of the
   authors, and no endorsement by FORHP, HRSA, or HHS is intended or should
   be inferred.},
Cited-References = {Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X.
   Beckwith D, COMMUNITY ORG PEOPLE.
   Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203.
   Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062.
   Centers for Disease Control and Prevention, 2019, PRINC EP PUBL HLTH P.
   Cosby AG, 2019, AM J PUBLIC HEALTH, V109, P155, DOI {[}10.2105/AJPH.2018.304787, 10.2105/ajph.2018.304787].
   Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001.
   Drolet A, 2010, MARKET CONSUM PSYCH, P51.
   Garcia MC, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6602a1.
   Henning-Smith C., 2019, DYING TOO SOON COUNT.
   Hood RG, 2001, J NATL MED ASSOC, V93, P1.
   Howard G, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140138.
   James CV, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6623a1.
   James W, 2017, J RURAL HEALTH, V33, P21, DOI 10.1111/jrh.12181.
   Jernigan VBB, 2017, J HUNGER ENVIRON NUT, V12, P1, DOI 10.1080/19320248.2016.1227750.
   Kozhimannil KB, 2016, AM J PERINAT, V33, P590, DOI 10.1055/s-0035-1570380.
   Kozhimannil KB, 2019, HLTH AFFAIRS BLOG, DOI {[}10.1377/hblog20190409.122546/full, DOI 10.1377/HBLOG20190409.122546/FULL].
   Lariscy JT, 2015, DEMOGRAPHY, V52, P1, DOI 10.1007/s13524-014-0357-y.
   Lichter DT, 2012, RURAL SOCIOL, V77, P3, DOI 10.1111/j.1549-0831.2012.00070.x.
   Moy E, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6601a1.
   Penman-Aguilar A, 2016, J PUBLIC HEALTH MAN, V22, pS33, DOI 10.1097/PHH.0000000000000373.
   Phelan JC, 2015, ANNU REV SOCIOL, V41, P311, DOI 10.1146/annurev-soc-073014-112305.
   Remington PL, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0044-2.
   Saha S, 2008, HEALTH AFFAIR, V27, P234, DOI 10.1377/hlthaff.27.1.234.
   Sawhill IV, 2016, CASE RACE CONSCIOUS.
   Shanks CB, 2016, PUBLIC HEALTH NUTR, V19, P1315, DOI 10.1017/S1368980015002359.
   Sharp G, 2017, RURAL SOCIOL, V82, P411, DOI 10.1111/ruso.12141.
   Treuhaft S, 2009, COMMUNITY MAPPING HL.
   United Health Foundation. America's Health Rankings, 2018, PREM DEATH.
   Warne D, 2014, AM J PUBLIC HEALTH, V104, pS263, DOI 10.2105/AJPH.2013.301682.
   Watts Rosalyn J, 2003, Online J Issues Nurs, V8, P4.},
Number-of-Cited-References = {31},
Times-Cited = {22},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Health Aff.},
Doc-Delivery-Number = {JT1GF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000500745800010},
DA = {2022-03-29},
}

@article{ WOS:000328730300070,
Author = {Falkstedt, Daniel and Sorjonen, Kimmo and Hemmingsson, Tomas and Deary,
   Ian J. and Melin, Bo},
Title = {Psychosocial Functioning and Intelligence Both Partly Explain
   Socioeconomic Inequalities in Premature Death. A Population-Based Male
   Cohort Study},
Journal = {PLOS ONE},
Year = {2013},
Volume = {8},
Number = {12},
Month = {DEC 11},
Abstract = {Objective: The possible contributions of psychosocial functioning and
   intelligence differences to socioeconomic status (SES)-related
   inequalities in premature death were investigated. None of the previous
   studies focusing on inequalities in mortality has included measures of
   both psychosocial functioning and intelligence.
   Methods: The study was based on a cohort of 49 321 men born 1949-1951
   from the general community in Sweden. Data on psychosocial functioning
   and intelligence from military conscription at similar to 18 years of
   age were linked with register data on education, occupational class, and
   income at 35-39 years of age. Psychosocial functioning was rated by
   psychologists as a summary measure of differences in level of activity,
   power of initiative, independence, and emotional stability. Intelligence
   was measured through a multidimensional test. Causes of death between 40
   and 57 years of age were followed in registers.
   Results: The estimated inequalities in all-cause mortality by education
   and occupational class were attenuated with 32\% (95\% confidence
   interval: 20-45\%) and 41\% (29-52\%) after adjustments for individual
   psychological differences; both psychosocial functioning and
   intelligence contributed to account for the inequalities. The
   inequalities in cardiovascular and injury mortality were attenuated by
   as much as 51\% (24-76\%) and 52\% (35-68\%) after the same adjustments,
   and the inequalities in alcohol-related mortality were attenuated by up
   to 33\% (8-59\%). Less of the inequalities were accounted for when those
   were measured by level of income, with which intelligence had a weaker
   correlation. The small SES-related inequalities in cancer mortality were
   not attenuated by adjustment for intelligence.
   Conclusions: Differences in psychosocial functioning and intelligence
   might both contribute to the explanation of observed SES-related
   inequalities in premature death, but the magnitude of their
   contributions likely varies with measure of socioeconomic status and
   cause of death. Both psychosocial functioning and intelligence should be
   considered in future studies.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Falkstedt, D (Corresponding Author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   Falkstedt, Daniel, Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   Falkstedt, Daniel; Sorjonen, Kimmo; Melin, Bo, Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden.
   Hemmingsson, Tomas, Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.
   Hemmingsson, Tomas, Stockholm Univ, Ctr Social Res Alcohol \& Drugs, S-10691 Stockholm, Sweden.
   Deary, Ian J., Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing \& Cognit Epidemiol, Edinburgh, Midlothian, Scotland.},
DOI = {10.1371/journal.pone.0082031},
Article-Number = {e82031},
ISSN = {1932-6203},
Keywords-Plus = {ALL-CAUSE-MORTALITY; COGNITIVE-ABILITY; HEALTH INEQUALITIES;
   SOCIAL-CLASS; MIDDLE-AGE; PERSONALITY; IQ; POSITION; RISK; ASSOCIATION},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {daniel.falkstedt@ki.se},
ResearcherID-Numbers = {Deary, Ian J/C-6297-2009
   },
ORCID-Numbers = {Deary, Ian J/0000-0002-1733-263X
   Melin, Bo Arthur/0000-0002-8008-2215
   Hemmingsson, Tomas/0000-0001-6156-3964
   Falkstedt, Daniel/0000-0003-4441-7003},
Funding-Acknowledgement = {Swedish Research CouncilSwedish Research CouncilEuropean Commission
   {[}2007-0992]; Swedish Council for Working Life and Social
   ResearchSwedish Research CouncilSwedish Research Council for Health
   Working Life \& Welfare (Forte) {[}2011-0634]; BBSRCUK Research \&
   Innovation (UKRI)Biotechnology and Biological Sciences Research Council
   (BBSRC); EPSRCUK Research \& Innovation (UKRI)Engineering \& Physical
   Sciences Research Council (EPSRC); ESRCUK Research \& Innovation
   (UKRI)Economic \& Social Research Council (ESRC); MRCUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC) {[}G0700704/84698];
   MRCUK Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}G0700704] Funding Source: UKRI; Medical Research CouncilUK Research
   \& Innovation (UKRI)Medical Research Council UK (MRC)European Commission
   {[}MR/K026992/1, G0700704] Funding Source: researchfish},
Funding-Text = {The study was funded by the Swedish Research Council
   (http://www.vr.se/), project no. 2007-0992, and the Swedish Council for
   Working Life and Social Research (http://www.fas.se/), project no.
   2011-0634. The funder had no role in the study design, in the
   collection, analysis, and interpretation of data, in the writing of the
   paper, or in the decision to submit the paper for publication. The
   researchers were independent from the funders and sponsors of the study.
   IJD is a member of The University of Edinburgh Centre for Cognitive
   Ageing and Cognitive Epidemiology, part of the cross council Life Long
   Health and Wellbeing Initiative. Funding from the BBSRC, EPSRC, ESRC and
   MRC is gratefully acknowledged (G0700704/84698).},
Cited-References = {Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254.
   Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381.
   Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE.
   Borghans L, 2011, PERS INDIV DIFFER, V51, P315, DOI 10.1016/j.paid.2011.03.029.
   Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190.
   Canty A., 2012, BOOT BOOTSTRAP R S P.
   Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323.
   Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801\_7.
   Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081.
   Gallacher J, 2008, INT J EPIDEMIOL, V37, P602, DOI 10.1093/ije/dyn062.
   Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001.
   Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x.
   Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174.
   Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86.
   Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762.
   Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104.
   Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321.
   Hemmingsson T, 2009, J EPIDEMIOL COMMUN H, V63, P697, DOI 10.1136/jech.2008.079160.
   Jokela M, 2009, PSYCHOSOM MED, V71, P322, DOI 10.1097/PSY.0b013e31819b69f6.
   Just C, 2011, PERS INDIV DIFFER, V50, P765, DOI 10.1016/j.paid.2011.01.008.
   Krueger RF, 2000, J PERS, V68, P967, DOI 10.1111/1467-6494.00123.
   Lager A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5282.
   Lilieblad B, 1977, C5501107 FOA ARM FOR.
   Lindqvist E, 2011, AM ECON J-APPL ECON, V3, P101, DOI 10.1257/app.3.1.101.
   Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031.
   Mackenbach JP, 2005, J EPIDEMIOL COMMUN H, V59, P268, DOI 10.1136/jech.2004.026807.
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1.
   Matthews G, 2003, PERSONALITY TRAITS.
   Nabi H, 2008, INT J EPIDEMIOL, V37, P591, DOI 10.1093/ije/dyn021.
   Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127.
   Pulkki L, 2003, INT J EPIDEMIOL, V32, P968, DOI 10.1093/ije/dyg097.
   Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x.
   Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109.
   Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x.
   Sorjonen K, 2012, INTELLIGENCE, V40, P269, DOI 10.1016/j.intell.2012.02.009.
   Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004.
   Weiss A, 2009, PSYCHOSOM MED, V71, P385, DOI 10.1097/PSY.0b013e318198de78.},
Number-of-Cited-References = {37},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {276EG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000328730300070},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000075543100005,
Author = {Hallam, DM and Maroun, LE},
Title = {Anti-gamma interferon can prevent the premature death of trisomy 16
   mouse cortical neurons in culture},
Journal = {NEUROSCIENCE LETTERS},
Year = {1998},
Volume = {252},
Number = {1},
Pages = {17-20},
Month = {AUG 7},
Abstract = {Previous reports have indicated that human trisomy 21 and mouse trisomy
   16 neurons exhibit decreased viability in culture when compared to
   euploid control cultures and that trisomic cells are significantly more
   sensitive to the anti-cellular effects of the interferons. In the study
   reported here, cortical neurons from euploid and trisomy 16 mouse
   fetuses were treated with either anti-gamma-interferon or non-specific
   IgG and neuron morphology and viability measured photographically. The
   addition of anti-gamma-interferon IgG to the culture media had no effect
   on euploid neurons, but significantly increased trisomy neuron viability
   throughout the 5-day culture period. Assay of both DNA fragmentation and
   phosphatidylserine externalization suggested that the trisomic neurons
   were undergoing apoptosis at a significantly higher rate than their
   euploid counterparts and that this increase in apoptosis could be almost
   completely prevented by addition of either ligand purified monoclonal or
   ligand purified polyclonal anti-gamma-interferon IgG. Taken together,
   these data suggest that endogenous interferon plays an important role in
   the premature death of the trisomy neuron. (C) 1998 Elsevier Science
   Ireland Ltd. Ail rights reserved.},
Publisher = {ELSEVIER SCI IRELAND LTD},
Address = {CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Maroun, LE (Corresponding Author), So Illinois Univ, Sch Med, Dept Med Microbiol \& Immunol, POB 19230, Springfield, IL 62794 USA.
   So Illinois Univ, Sch Med, Dept Med Microbiol \& Immunol, Springfield, IL 62794 USA.},
DOI = {10.1016/S0304-3940(98)00541-2},
ISSN = {0304-3940},
Keywords = {interferon; Down syndrome; anti-interferon immunoglobins; apoptosis;
   neuron culture; mouse trisomy 16; trisomy},
Keywords-Plus = {DOWNS-SYNDROME; GENERATION; SURVIVAL; BRAIN},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Cited-References = {BAMBRICK LL, 1995, P NATL ACAD SCI USA, V92, P9692, DOI 10.1073/pnas.92.21.9692.
   BERG JM, 1993, ALZHEIMER DIS DOWN S.
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749.
   Boersma AWM, 1996, CYTOMETRY, V24, P123, DOI 10.1002/(SICI)1097-0320(19960601)24:2<123::AID-CYTO4>3.0.CO;2-K.
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513.
   BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0.
   CALVET MC, 1979, NATURE, V278, P558, DOI 10.1038/278558a0.
   CASANOVA MF, 1985, ANN NEUROL, V18, P310, DOI 10.1002/ana.410180306.
   DARCANGELO G, 1991, BRAIN RES, V564, P245, DOI 10.1016/0006-8993(91)91459-E.
   GEARHART JD, 1986, BRAIN RES BULL, V16, P789, DOI 10.1016/0361-9230(86)90075-4.
   JONAKAIT GM, 1994, NEURON, V12, P1149.
   KISH S, 1989, J NEUROCHEM, V52, P1183, DOI 10.1111/j.1471-4159.1989.tb01864.x.
   Kola I, 1997, HUM MOL GENET, V6, P1713, DOI 10.1093/hmg/6.10.1713.
   MAROUN LE, 1995, TERATOLOGY, V51, P329, DOI 10.1002/tera.1420510509.
   MCGEER EG, 1985, EXP NEUROL, V87, P557, DOI 10.1016/0014-4886(85)90184-0.
   Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023.
   OLSSON T, 1994, EUR J IMMUNOL, V24, P308, DOI 10.1002/eji.1830240205.
   PEARCE R, 1995, BRAIN RES, V680, P108, DOI 10.1016/0006-8993(95)00251-K.
   TAN YH, 1976, NATURE, V260, P141, DOI 10.1038/260141a0.
   WISHART JG, 1995, ETIOLOGY PATHOGENESI, P57.
   WISNIEWSKI KE, 1986, NEUROBIOLOGY DOWN SY, P29.},
Number-of-Cited-References = {21},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Neurosci. Lett.},
Doc-Delivery-Number = {113GV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000075543100005},
DA = {2022-03-29},
}

@article{ WOS:000713354100023,
Author = {Hawkins, Nicole A. and Jurado, Manuel and Thaxton, Tyler T. and Duarte,
   Samantha E. and Barse, Levi and Tatsukawa, Tetsuya and Yamakawa,
   Kazuhiro and Nishi, Toshiya and Kondo, Shinichi and Miyamoto, Maki and
   Abrahams, Brett S. and During, Matthew J. and Kearney, Jennifer A.},
Title = {Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces
   seizures and premature death in Dravet syndrome mice},
Journal = {EPILEPSIA},
Year = {2021},
Volume = {62},
Number = {11},
Pages = {2845-2857},
Month = {NOV},
Abstract = {Objective Dravet syndrome is a severe developmental and epileptic
   encephalopathy (DEE) most often caused by de novo pathogenic variants in
   SCN1A. Individuals with Dravet syndrome rarely achieve seizure control
   and have significantly elevated risk for sudden unexplained death in
   epilepsy (SUDEP). Heterozygous deletion of Scn1a in mice (Scn1a(+/-))
   recapitulates several core phenotypes, including temperature-dependent
   and spontaneous seizures, SUDEP, and behavioral abnormalities.
   Furthermore, Scn1a(+/-) mice exhibit a similar clinical response to
   standard anticonvulsants. Cholesterol 24-hydroxlase (CH24H) is a
   brain-specific enzyme responsible for cholesterol catabolism. Recent
   research has indicated the therapeutic potential of CH24H inhibition for
   diseases associated with neural excitation, including seizures. Methods
   In this study, the novel compound soticlestat, a CH24H inhibitor, was
   administered to Scn1a(+/-) mice to investigate its ability to improve
   Dravet-like phenotypes in this preclinical model. Results Soticlestat
   treatment reduced seizure burden, protected against hyperthermia-induced
   seizures, and completely prevented SUDEP in Scn1a(+/-) mice.
   Video-electroencephalography (EEG) analysis confirmed the ability of
   soticlestat to reduce occurrence of electroclinical seizures.
   Significance This study demonstrates that soticlestat-mediated
   inhibition of CH24H provides therapeutic benefit for the treatment of
   Dravet syndrome in mice and has the potential for treatment of DEEs.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Kearney, JA (Corresponding Author), Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, 320 E Super St,Searle 8-520, Chicago, IL 60611 USA.
   Hawkins, Nicole A.; Jurado, Manuel; Thaxton, Tyler T.; Duarte, Samantha E.; Barse, Levi; Kearney, Jennifer A., Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, 320 E Super St,Searle 8-520, Chicago, IL 60611 USA.
   Tatsukawa, Tetsuya; Yamakawa, Kazuhiro, RIKEN, Lab Neurogenet, Brain Sci Inst, Wako, Saitama, Japan.
   Nishi, Toshiya; Kondo, Shinichi; Miyamoto, Maki, Takeda Pharmaceut Ltd, Neurosci Drug Discovery Unit, Fujisawa, Kanagawa, Japan.
   Abrahams, Brett S.; During, Matthew J., Ovid Therapeut, New York, NY USA.},
DOI = {10.1111/epi.17062},
ISSN = {0013-9580},
EISSN = {1528-1167},
Keywords = {anticonvulsants; cholesterol 24-hydroxylase; epilepsy; Nav1; 1
   voltage-gated sodium channel},
Keywords-Plus = {ELEVATED ZERO-MAZE; MOUSE MODEL; 24(S)-HYDROXYCHOLESTEROL; BEHAVIOR;
   GENE; HAPLOINSUFFICIENCY; INTERNEURONS; CANNABIDIOL; STIRIPENTOL;
   EXPRESSION},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology},
Author-Email = {jennifer.kearney@northwestern.edu},
ResearcherID-Numbers = {Yamakawa, Kazuhiro/N-5050-2015
   },
ORCID-Numbers = {Yamakawa, Kazuhiro/0000-0002-1478-4390
   Kondo, Shu/0000-0002-4625-8379},
Funding-Acknowledgement = {Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd Funding
   Source: Medline; Ovid Therapeutics Funding Source: Medline},
Cited-References = {Alexandrov P, 2005, NEUROREPORT, V16, P909, DOI 10.1097/00001756-200506210-00007.
   Anderson LL, 2019, EPILEPSIA, V60, P2224, DOI 10.1111/epi.16355.
   APPLEGATE CD, 1991, EPILEPSY RES, V10, P142, DOI 10.1016/0920-1211(91)90006-2.
   Bahceci D, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.106842.
   Berg AT, 2004, PEDIATRICS, V114, P645, DOI 10.1542/peds.2003-1151-L.
   Bialer M, 2017, EPILEPSIA, V58, P181, DOI {[}10.1111/epi.13634, 10.1111/epi.14557].
   Cao DZ, 2012, EPILEPSIA, V53, P1140, DOI 10.1111/j.1528-1167.2012.03497.x.
   Chever O., BIORXIV.
   Cook MN, 2002, BEHAV GENET, V32, P113, DOI 10.1023/A:1015249706579.
   Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618.
   Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x.
   Eschbach K, 2019, EXPERT REV CLIN PHAR, V12, P379, DOI 10.1080/17512433.2019.1605904.
   Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356.
   Hawkins NA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15609-w.
   Hawkins NA, 2017, ANN CLIN TRANSL NEUR, V4, P326, DOI 10.1002/acn3.413.
   Hawkins NA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006398.
   Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x.
   Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003.
   Kalume F, 2013, J CLIN INVEST, V123, P1798, DOI 10.1172/JCI66220.
   Kaplan JS, 2017, P NATL ACAD SCI USA, V114, P11229, DOI 10.1073/pnas.1711351114.
   Kulkarni SK, 2007, METHOD FIND EXP CLIN, V29, P343.
   Lagae L, 2019, LANCET, V394, P2243, DOI 10.1016/S0140-6736(19)32500-0.
   Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200.
   Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3.
   Miller AR, 2014, GENES BRAIN BEHAV, V13, P163, DOI 10.1111/gbb.12099.
   Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009.
   Mulligan MK, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00188.
   Nishi T., AES 2019 ANN M DAT.
   Nishi T., AES 2017 ANN M DAT.
   Nishi T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74036-6.
   Noguchi N, 2014, BIOCHEM BIOPH RES CO, V446, P692, DOI 10.1016/j.bbrc.2014.02.010.
   O'Reilly H, 2018, EPILEPSIA, V59, P2240, DOI 10.1111/epi.14589.
   Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007.
   Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331.
   Patra PH, 2020, BRIT J PHARMACOL, V177, P2779, DOI 10.1111/bph.15003.
   Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013.
   Ricobaraza A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50627-w.
   Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859.
   Samanta D, 2020, NEUROPEDIATRICS, V51, P135, DOI 10.1055/s-0040-1701694.
   Scheffer IE, 2020, EUR J PAEDIATR NEURO, V24, P11, DOI 10.1016/j.ejpn.2019.12.023.
   Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122.
   Sun MY, 2016, J NEUROPHYSIOL, V115, P1263, DOI 10.1152/jn.00890.2015.
   Tatsukawa T, 2018, NEUROBIOL DIS, V112, P24, DOI 10.1016/j.nbd.2018.01.009.
   Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641.
   Wang SN, 2021, BRIT J CLIN PHARMACO, V87, P4354, DOI 10.1111/bcp.14854.
   Wheless JW, 2020, PEDIATR NEUROL, V107, P28, DOI 10.1016/j.pediatrneurol.2020.01.005.
   Whitney R, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0547-4.
   Wirrell EC, 2016, CAN J NEUROL SCI, V43, pS13, DOI 10.1017/cjn.2016.249.
   Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754.
   Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003.},
Number-of-Cited-References = {50},
Times-Cited = {0},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Epilepsia},
Doc-Delivery-Number = {WP8CR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000713354100023},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000403469500014,
Author = {Lauseker, Michael and Hasford, Joerg and Saussele, Susanne and Kremers,
   Stephan and Kraemer, Doris and Lindemann, Walter and Hehlmann, Ruediger
   and Pfirrmann, Markus and German CML Study Grp},
Title = {Smokers With Chronic Myeloid Leukemia Are at a Higher Risk of Disease
   Progression and Premature Death},
Journal = {CANCER},
Year = {2017},
Volume = {123},
Number = {13},
Pages = {2467-2471},
Month = {JUL 1},
Abstract = {BACKGROUND: Smoking is suspected to not only be a risk factor for
   chronic myeloid leukemia but an adverse prognostic factor for the
   disease as well. The objective of the current study was to investigate
   the impact of smoking on survival and progression to advanced phases of
   disease. METHODS: Based on the data of the German CML Study IV, the
   authors analyzed the effect of smoking using a multivariate Cox model
   with the addition of the European Treatment and Outcome Study (EUTOS)
   long-term survival score variables of age, spleen size, thrombocytes,
   and peripheral blasts as well as sex, comorbidities, and type of
   treatment center. RESULTS: The 8-year survival probability was 87\% for
   a nonsmoking patient and 83\% for a patient who smoked. The authors
   noted a 2.08-times higher risk of death for smokers in comparison with
   nonsmokers and a 2.11-times higher cause-specific hazard of disease
   progression. An interaction between smoking and age was found in the
   model for survival. No significant difference with regard to molecular
   response was observed. CONCLUSIONS: Even when considering differences in
   socioeconomic status and lifestyle between patients who smoke and
   nonsmokers, the current analysis demonstrated that smoking also might
   affect disease biology. The results of the current study indicate that
   patients with chronic myeloid leukemia, in particular those aged <60
   years, should be encouraged to quit smoking. (C) 2017 American Cancer
   Society.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Lauseker, M (Corresponding Author), Ludwig Maximilians Univ Munchen, Inst Med Informat Sci Biometry \& Epidemiol, Marchioninistr 15, D-81377 Munich, Germany.
   Lauseker, Michael; Hasford, Joerg; Pfirrmann, Markus, Ludwig Maximilians Univ Munchen, Inst Med Informat Sci Biometry \& Epidemiol IBE, Munich, Germany.
   Saussele, Susanne; Hehlmann, Ruediger, Heidelberg Univ, Dept Med, Mannheim, Germany.
   Kremers, Stephan, Caritas Krankenhaus Lebach, Dept Hematol Oncol, Lebach, Germany.
   Kraemer, Doris, Oldenburg Clin, Dept Oncol \& Hematol, Oldenburg, Germany.
   Lindemann, Walter, Kathol Krankenhaus Hagen, St Marien Hosp, Hematol Oncol Clin, Hagen, Germany.},
DOI = {10.1002/cncr.30636},
ISSN = {0008-543X},
EISSN = {1097-0142},
Keywords = {chronic myeloid leukemia (CML); mortality; prognosis; progression;
   smoking},
Keywords-Plus = {CIGARETTE-SMOKING; RANDOMIZED CML; SURVIVAL; CANCER; MORTALITY;
   CESSATION; IMATINIB; IMPACT; BREAST},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {lauseker@ibe.med.uni-muenchen.de},
ResearcherID-Numbers = {Saussele, Susanne/M-3728-2019
   Pfirrmann, Markus/N-4328-2017
   },
ORCID-Numbers = {Lauseker, Michael/0000-0002-6662-7127},
Funding-Acknowledgement = {Deutsche KrebshilfeDeutsche Krebshilfe {[}106642]; Novartis (Nurnberg,
   Germany); Deutsches Kompetenznetz fur Akute und Chronische Leukamien
   {[}BMBF 01GI0270]; Deutsche Jose-Carreras Leukamiestiftung {[}DJCLS
   H09/01f, H06/04v, H03/01, R05/23]; European LeukemiaNet
   {[}LSHC-CT-2004-503216]; Roche (Grenzach-Wyhlen, Germany)Roche Holding;
   Essex Pharma (Munich, Germany)},
Funding-Text = {The CML Study IV was supported by the Deutsche Krebshilfe (grant
   106642), Novartis (Nurnberg, Germany), Deutsches Kompetenznetz fur Akute
   und Chronische Leukamien (BMBF 01GI0270), Deutsche Jose-Carreras
   Leukamiestiftung (DJCLS H09/01f, H06/04v, H03/01, and R05/23), European
   LeukemiaNet (LSHC-CT-2004-503216), Roche (Grenzach-Wyhlen, Germany), and
   Essex Pharma (Munich, Germany).},
Cited-References = {Aggarwal B, 2010, ANN BEHAV MED, V40, P228, DOI 10.1007/s12160-010-9212-6.
   ARCHIMBAUD E, 1989, CANCER-AM CANCER SOC, V63, P2060, DOI 10.1002/1097-0142(19890515)63:10<2060::AID-CNCR2820631031>3.0.CO;2-2.
   ARCHIMBAUD E, 1991, AM J HEMATOL, V36, P302, DOI 10.1002/ajh.2830360420.
   Blakely T, 2013, CANCER CAUSE CONTROL, V24, P1243, DOI 10.1007/s10552-013-0204-2.
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8.
   Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483.
   Cohen-Mansfield J, 2013, PREV MED, V56, P185, DOI 10.1016/j.ypmed.2012.12.009.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Gritz ER, 2006, CANCER-AM CANCER SOC, V106, P17, DOI 10.1002/cncr.21598.
   Hasselbalch HC, 2015, LEUKEMIA RES, V39, P1137, DOI 10.1016/j.leukres.2015.09.002.
   Hehlmann R, 2014, J CLIN ONCOL, V32, P415, DOI 10.1200/JCO.2013.49.9020.
   Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598.
   HERR R, 1990, AM J HEMATOL, V34, P1, DOI 10.1002/ajh.2830340102.
   Kabat GC, 2013, CANCER EPIDEM BIOMAR, V22, P848, DOI 10.1158/1055-9965.EPI-13-0093.
   Kalmanti L, 2015, LEUKEMIA, V29, P1123, DOI 10.1038/leu.2015.36.
   Lam TH, 2007, J AM GERIATR SOC, V55, P2090, DOI 10.1111/j.1532-5415.2007.01441.x.
   Land SR, 2011, CANCER PREV RES, V4, P1393, DOI 10.1158/1940-6207.CAPR-11-0172.
   Lauseker M, 2014, BLOOD, V123, P2494, DOI 10.1182/blood-2013-11-539742.
   Markkula A, 2012, CANCER PREV RES, V5, P735, DOI 10.1158/1940-6207.CAPR-11-0442.
   Marks DI, 2009, BIOL BLOOD MARROW TR, V15, P1277, DOI 10.1016/j.bbmt.2009.06.005.
   Musselman JRB, 2013, CANCER EPIDEMIOL, V37, P410, DOI 10.1016/j.canep.2013.03.012.
   Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803.
   Pfirrmann M, 2016, LEUKEMIA, V30, P48, DOI 10.1038/leu.2015.261.
   Ramaswamy AT, 2016, CANCER-AM CANCER SOC, V122, P1247, DOI 10.1002/cncr.29851.
   Reiter S., 2011, ALKOHOL UND TABAK.
   Saussele S, 2015, BLOOD, V126, P42, DOI 10.1182/blood-2015-01-617993.},
Number-of-Cited-References = {26},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Cancer},
Doc-Delivery-Number = {EX7ZY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000403469500014},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000171789200072,
Author = {Zhang, XM and Chai, JY and Azhar, G and Sheridan, P and Borras, AM and
   Furr, MC and Khrapko, K and Lawitts, J and Misra, RP and Wei, JY},
Title = {Early postnatal cardiac changes and premature death in transgenic mice
   overexpressing a mutant form of serum response factor},
Journal = {JOURNAL OF BIOLOGICAL CHEMISTRY},
Year = {2001},
Volume = {276},
Number = {43},
Pages = {40033-40040},
Month = {OCT 26},
Abstract = {Serum response factor (SRF) is a key regulator of a number of
   extracellular signal-regulated genes important for cell growth and
   differentiation. A form of the SRF gene with a double mutation (dmSRF)
   was generated. This mutation reduced the binding activity of SRF protein
   to the serum response element and reduced the capability of SRF to
   activate the atrial natriuretic factor promoter that contains the serum
   response element. Cardiac-specific overexpression of dmSRF attenuated
   the total SRF binding activity and resulted in remarkable morphologic
   changes in the heart of the transgenic mice. These mice had dilated
   atrial and ventricular chambers, and their ventricular wall thicknesses
   were only (1)/(2) to (1)/(3) the thickness of that of nontransgenic
   mice. Also these mice had smaller cardiac myocytes and had less
   myofibrils in their myocytes relative to nontransgenic mice. Altered
   gene expression and slight interstitial fibrosis were observed in the
   myocardium. of the transgenic mice. All the transgenic mice died within
   the first 12 days after birth, because of the early onset of severe,
   dilated cardiomyopathy. These results indicate that dmSRF overexpression
   in the heart apparently alters cardiac gene expression and blocks normal
   postnatal cardiac growth and development.},
Publisher = {AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC},
Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
Type = {Article},
Language = {English},
Affiliation = {Wei, JY (Corresponding Author), Beth Israel Deaconess Med Ctr, Dept Med, Gerontol Div, 330 Brookline Ave, Boston, MA 02215 USA.
   Beth Israel Deaconess Med Ctr, Dept Med, Gerontol Div, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Div Aging, Boston, MA 02215 USA.
   Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.},
DOI = {10.1074/jbc.M104934200},
ISSN = {0021-9258},
Keywords-Plus = {TERNARY COMPLEX FACTORS; MYOCARDIAL HYPERTROPHY; TRANSCRIPTION FACTORS;
   VENTRICULAR VOLUME; DNA-BINDING; GROWTH; CELL; SRF; ELEMENT;
   DIFFERENTIATION},
Research-Areas = {Biochemistry \& Molecular Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology},
ResearcherID-Numbers = {Chai, Jianyuan/AAJ-5892-2020
   Chai, Jianyuan/A-8300-2009
   Khrapko, Konstantin/A-3244-2009
   },
ORCID-Numbers = {Chai, Jianyuan/0000-0001-6975-6867},
Funding-Acknowledgement = {NIA NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   {[}AG 00294, AG 00251, AG 08812, AG 13314, AG 18388] Funding Source:
   Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health
   \& Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) {[}R01AG018388, P30AG013314, P60AG008812,
   P30AG008812] Funding Source: NIH RePORTER},
Cited-References = {Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289.
   BISHOP SP, 1990, TOXICOL PATHOL, V18, P438, DOI 10.1177/0192623390004Part\_102.
   Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619.
   Ding W, 1999, CANCER RES, V59, P3795.
   GAUTHIERROUVIERE C, 1995, MOL CELL BIOL, V15, P433, DOI 10.1128/MCB.15.1.433.
   Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434.
   HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0.
   JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920.
   KAYAR SR, 1992, J MOL CELL CARDIOL, V24, P1155, DOI 10.1016/0022-2828(92)93179-N.
   Kemp PR, 2000, BIOCHEM J, V345, P445, DOI 10.1042/0264-6021:3450445.
   KIM JH, 1994, J BIOL CHEM, V269, P13740.
   Kimpara T, 1997, HEART VESSELS, V12, P143, DOI 10.1007/BF02767132.
   Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001.
   NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076.
   OPARIL S, 1985, J AM COLL CARDIOL, V5, pB57, DOI 10.1016/S0735-1097(85)80528-3.
   Panitz F, 1998, EMBO J, V17, P4414, DOI 10.1093/emboj/17.15.4414.
   Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955.
   Robbins J, 1997, TRENDS CARDIOVAS MED, V7, P185, DOI 10.1016/S1050-1738(97)00048-0.
   Rudolph AM, 2000, ACTA PAEDIATR, V89, P129, DOI 10.1080/080352500750028681.
   SHARROCKS AD, 1993, MOL CELL BIOL, V13, P123, DOI 10.1128/MCB.13.1.123.
   Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537.
   SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x.
   Soh JW, 1999, MOL CELL BIOL, V19, P1313.
   Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121.
   SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613.
   Takahashi Y, 1996, EARLY HUM DEV, V44, P77, DOI 10.1016/0378-3782(95)01695-3.
   Tamura M, 1997, EARLY HUM DEV, V48, P1, DOI 10.1016/S0378-3782(96)01801-4.
   Treisman R, 1990, Semin Cancer Biol, V1, P47.
   TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x.
   TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3.
   Treisman R, 1992, CURR OPIN GENET DEV, V2, P221, DOI 10.1016/S0959-437X(05)80277-1.
   Tsou H, 1996, EXP CELL RES, V229, P432, DOI 10.1006/excr.1996.0388.
   Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835.
   WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106.
   Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782.},
Number-of-Cited-References = {35},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Biol. Chem.},
Doc-Delivery-Number = {485XR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000171789200072},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000375630500030,
Author = {Chowdhury, Sourangsu and Dey, Sagnik},
Title = {Cause-specific premature death from ambient PM2.5 exposure in India:
   Estimate adjusted for baseline mortality},
Journal = {ENVIRONMENT INTERNATIONAL},
Year = {2016},
Volume = {91},
Pages = {283-290},
Month = {MAY},
Abstract = {In India, more than a billion population is at risk of exposure to
   ambient fine particulate matter (PM2.5) concentration exceeding World
   Health Organization air quality guideline, posing a serious threat to
   health. Cause-specific premature death from ambient PM2.5 exposure is
   poorly known for India. Here we develop a non-linear power law (NLP)
   function to estimate the relative risk associated with ambient PM2.5
   exposure using satellite-based PM2.5 concentration (2001 - 2010) that is
   bias-corrected against coincident direct measurements. We show that
   estimate of annual premature death in India is lower by 14.7\% (192\%)
   using NLP (integrated exposure risk function, IER) for assumption of
   uniform baseline mortality across India (as considered in the global
   burden of disease study) relative to the estimate obtained by adjusting
   for state-specific baseline mortality using GDP as a proxy. 486,100
   (811,000) annual premature death in India is estimated using NLP (IER)
   risk functions after baseline mortality adjustment. 54.5\% of premature
   death estimated using NLP risk function is attributed to chronic
   obstructive pulmonary disease (COPD), 24.0\% to ischemic heart disease
   (IHD), 18.5\% to stroke and the remaining 3.0\% to lung cancer (LC).
   44,900 (5900-173,300) less premature death is expected annually, if
   India achieves its present annual air quality target of 40 mu g m(-3).
   Our results identify the worst affected districts in terms of ambient
   PM2.5 exposure and resulting annual premature death and call for
   initiation of long-term measures through a systematic framework of
   pollution and health data archive. (C) 2016 Elsevier Ltd. All rights
   reserved.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Dey, S (Corresponding Author), Indian Inst Technol Delhi, Ctr Atmospher Sci, New Delhi 110016, India.
   Chowdhury, Sourangsu; Dey, Sagnik, Indian Inst Technol Delhi, Ctr Atmospher Sci, New Delhi 110016, India.},
DOI = {10.1016/j.envint.2016.03.004},
ISSN = {0160-4120},
EISSN = {1873-6750},
Keywords = {Ambient PM2.5 exposure; India; Cause-specific premature death; Baseline
   mortality adjustment; District level statistics},
Keywords-Plus = {FINE PARTICULATE MATTER; COMPARATIVE RISK-ASSESSMENT; GLOBAL BURDEN;
   AIR-POLLUTION; DISEASE},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {sagnik@cas.iitd.ac.in},
ResearcherID-Numbers = {Dey, Sagnik/AAL-6285-2020
   Chowdhury, Sourangsu/AAJ-2733-2020
   },
ORCID-Numbers = {Chowdhury, Sourangsu/0000-0002-4600-2226
   Dey, Sagnik/0000-0002-0604-0869},
Funding-Acknowledgement = {Department of Science and Technology, Govt. of IndiaDepartment of
   Science \& Technology (India) {[}DST/CCP/(NET-2)/PR-36/2012(G), RP2726]},
Funding-Text = {We acknowledge financial support from the Department of Science and
   Technology, Govt. of India through a research grant
   (DST/CCP/(NET-2)/PR-36/2012(G)) under the network program of climate
   change and human health, currently operational at IIT Delhi (RP2726). We
   thank Prof. Kirk Smith (UC Berkeley) and Prof. Aaron Cohen (IHME,
   Washington University) for helpful discussion. We acknowledge the
   anonymous reviewers for comments that helped improving the earlier
   version of the manuscript},
Cited-References = {Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77.
   Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Chafe ZA, 2014, ENVIRON HEALTH PERSP, V122, P1314, DOI 10.1289/ehp.1206340.
   Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166.
   Dey N, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005609.
   Dey S, 2012, REMOTE SENS ENVIRON, V127, P153, DOI 10.1016/j.rse.2012.08.021.
   Dey S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048153.
   Health Effects Institute Research Report, 2011, HLTH SAN FRANCISCO, V157.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Murray C, 2015, LANCET, V386, P3, DOI 10.1016/S0140-6736(15)61171-0.
   Pope A., 2002, LUNG CANC, V287.
   Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639.
   Rich DQ, 2010, ENVIRON HEALTH PERSP, V118, P1229, DOI 10.1289/ehp.0901624.
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005.
   Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356.
   van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623.
   Venkataraman C, 2005, SCIENCE, V307, P1454, DOI 10.1126/science.1104359.
   Wellenius G. A., 2012, ARCH INTERN MED, V127, P358.
   World Health Organization, 2011, World health statistics 2011.},
Number-of-Cited-References = {22},
Times-Cited = {123},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {49},
Journal-ISO = {Environ. Int.},
Doc-Delivery-Number = {DL4TQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000375630500030},
DA = {2022-03-29},
}

@article{ WOS:000412230400015,
Author = {Jalanko, Eerika and Leppalahti, Suvi and Heikinheimo, Oskari and
   Gissler, Mika},
Title = {Increased risk of premature death following teenage abortion and
   childbirth-a longitudinal cohort study},
Journal = {EUROPEAN JOURNAL OF PUBLIC HEALTH},
Year = {2017},
Volume = {27},
Number = {5},
Pages = {845-849},
Month = {OCT},
Abstract = {Teenage pregnancy is associated with an increased risk of premature
   death. However, it is not known whether the outcome of pregnancy, i.e.
   induced abortion or childbirth, affects this risk.
   A Finnish population-based register study involving a cohort of 13 691
   nulliparous teenagers who conceived in 1987-89; 6652 of them underwent
   induced abortion and 7039 delivered. The control group consisted of 41
   012 coeval women without teenage pregnancy. Follow-up started at the end
   of pregnancy and lasted until 6th June 2013.
   Women with teenage pregnancy had a higher risk of overall mortality vs.
   controls (mortality rate ratio {[}MRR] 1.6, {[}95\% CI 1.4-1.8]) and
   were more likely to die prematurely as a result of suicide,
   alcohol-related causes, circulatory diseases and motor vehicle
   accidents. A low educational level appeared to explain these excess
   risks, except for suicide (adj. MRR 1.5, {[}95\% CI 1.1-2.0]). After
   adjusting for confounders, the childbirth group faced lower risks of
   suicide (adj. MRR 0.5, {[}95\% CI 0.3-0.9]) and dying from injury and
   poisoning (adj. MRR 0.6, {[}95\% CI 0.4-0.8]) compared with women who
   had undergone abortion.
   A low educational level is associated with the increased risk of
   premature death among women with a history of teenage pregnancy, except
   for suicide. Extra efforts should be made to encourage pregnant
   teenagers to continue education, and to provide psychosocial support to
   teenagers who undergo induced abortion.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Heikinheimo, O (Corresponding Author), Katiloopisto Hosp, Dept Obstet \& Gynaecol, POB 610, Helsinki 00029, Finland.
   Jalanko, Eerika; Leppalahti, Suvi; Heikinheimo, Oskari, Univ Helsinki, Dept Obstet \& Gynaecol, Helsinki, Finland.
   Jalanko, Eerika; Leppalahti, Suvi; Heikinheimo, Oskari, Helsinki Univ Hosp, Helsinki, Finland.
   Gissler, Mika, Natl Inst Hlth \& Welf, THL, Helsinki, Finland.
   Gissler, Mika, Univ Turku, Res Ctr Child Psychiat, Turku, Finland.
   Gissler, Mika, Karolinska Inst, Dept Neurobiol Care Sci \& Soc, Div Family Med, Stockholm, Sweden.},
DOI = {10.1093/eurpub/ckx065},
ISSN = {1101-1262},
EISSN = {1464-360X},
Keywords-Plus = {SOCIOECONOMIC INEQUALITIES; MORTALITY; MOTHERHOOD; COUNTRIES; PREGNANCY;
   HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {oskari.heikinheimo@helsinki.fi},
ResearcherID-Numbers = {Heikinheimo, Oskari/ABC-7792-2020
   },
ORCID-Numbers = {Gissler, Mika/0000-0001-8254-7525},
Cited-References = {{[}Anonymous], 2016, HUM REPROD, V31, P2142.
   Boden JM, 2008, J CHILD PSYCHOL PSYC, V49, P151, DOI 10.1111/j.1469-7610.2007.01830.x.
   Fergusson DM, 2007, PERSPECT SEX REPRO H, V39, P6, DOI 10.1363/3900607.
   Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013.
   Heino A, 2015, NORDIC PERINATAL STA.
   Heino A, 2015, INDUCED ABORTIONS 20.
   Imamura M, 2007, EUR J PUBLIC HEALTH, V17, P630, DOI 10.1093/eurpub/ckm014.
   Kongerslev L, 2016, HLTH STAT NORDIC COU.
   Kost K, 2014, US TEENAGE PREGNANCI.
   Kost K., 2016, US TEENAGE PREGNANCI.
   Lehti V, 2013, EUR J OBSTET GYN R B, V166, P190, DOI 10.1016/j.ejogrb.2012.10.017.
   Lehti V, 2012, ACTA OBSTET GYN SCAN, V91, P1319, DOI 10.1111/j.1600-0412.2012.01517.x.
   Leppalahti S, 2016, ACTA OBSTET GYN SCAN, V95, P572, DOI 10.1111/aogs.12879.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   Martinez Gladys, 2011, Vital Health Stat 23, P1.
   McLaren E., 2016, CONCEPTIONS ENGLAND.
   Menvielle G, 2009, M S-MED SCI, V25, P192, DOI 10.1051/medsci/2009252192.
   Olausson PO, 2004, BJOG-INT J OBSTET GY, V111, P793, DOI 10.1111/j.1471-0528.2004.00248.x.
   Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752.
   Overholser JC, 2012, J CLIN PSYCHOL, V68, DOI 10.1002/jclp.20859.
   PALMER JR, 1992, AM J EPIDEMIOL, V136, P408, DOI 10.1093/oxfordjournals.aje.a116513.
   Patel PH, 2012, MATERN CHILD HLTH J, V16, P1063, DOI 10.1007/s10995-011-0829-2.
   Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007.
   Stickley A, 2012, EUR J EPIDEMIOL, V27, P877, DOI 10.1007/s10654-012-9717-3.
   Vikat A, 2002, J EPIDEMIOL COMMUN H, V56, P659, DOI 10.1136/jech.56.9.659.
   Webb RT, 2011, PSYCHOL MED, V41, P1867, DOI 10.1017/S0033291711000055.
   Weitoft GR, 2000, LANCET, V355, P1215, DOI 10.1016/S0140-6736(00)02087-0.},
Number-of-Cited-References = {27},
Times-Cited = {6},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Eur. J. Public Health},
Doc-Delivery-Number = {FI8DD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000412230400015},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000317309200007,
Author = {Tennant, Peter W. G. and Parker, Louise and Thomas, Julian E. and Craft,
   Sir Alan W. and Pearce, Mark S.},
Title = {Childhood infectious disease and premature death from cancer: a
   prospective cohort study},
Journal = {EUROPEAN JOURNAL OF EPIDEMIOLOGY},
Year = {2013},
Volume = {28},
Number = {3},
Pages = {257-265},
Month = {MAR},
Abstract = {Studies of the association between early life infections and cancer have
   produced inconsistent findings, possibly due to limited adjustment for
   confounding and retrospective designs. This study utilised data from the
   Newcastle Thousand Families Study, a prospective cohort of 1,142
   individuals born in Newcastle-upon-Tyne in 1947, to assess the impact of
   various childhood infectious diseases on cancer mortality during ages
   15-60 years. Detailed information was collected prospectively on a
   number of early life factors. Deaths from cancer during ages 15-60 years
   were analysed in relation to childhood infections, adjusting for
   potential early-life confounders, using Cox proportional-hazards
   regression. In a subsample who returned questionnaires at aged 49-51
   years, additional adjustment was made for adult factors to predict death
   from cancer during ages 50-60 years. Childhood history of measles and
   influenza, were both independently associated with lower cancer
   mortality during ages 15-60 years (adjusted hazard ratios = 0.39, 95 \%
   CI 0.17-0.88 and 0.49, 95 \% CI 0.24-0.98 respectively). In contrast,
   childhood pertussis was associated with higher cancer mortality during
   ages 15-60 years (adjusted hazard ratio = 4.88, 95 \% CI 2.29-10.38). In
   the subsample with additional adjustment for adult variables, measles
   and pertussis remained significantly associated with cancer mortality
   during ages 50-60 years. In this pre-vaccination cohort, childhood
   infection with measles and influenza were associated with a reduced risk
   of death from cancer in adulthood, while pertussis was associated with
   an increased risk. While these results suggest some disease-specific
   associations between early-life infections and cancer, further studies
   are required to confirm the specific associations identified.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Pearce, MS (Corresponding Author), Newcastle Univ, Inst Hlth \& Soc, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.
   Tennant, Peter W. G., Newcastle Univ, Inst Hlth \& Soc, Newcastle Upon Tyne NE2 4AX, Tyne \& Wear, England.
   Parker, Louise, Populat Canc Res Program, Dept Med, Halifax, NS, Canada.
   Parker, Louise, Populat Canc Res Program, Dept Pediat, Halifax, NS, Canada.
   Thomas, Julian E., Royal Victoria Infirm, Sir James Spence Inst, Newcastle Upon Tyne NHS Fdn Trust, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.
   Craft, Sir Alan W., Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.
   Craft, Sir Alan W.; Pearce, Mark S., Royal Victoria Infirm, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.
   Pearce, Mark S., Newcastle Univ, Inst Hlth \& Soc, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.},
DOI = {10.1007/s10654-013-9775-1},
ISSN = {0393-2990},
EISSN = {1573-7284},
Keywords = {Epidemiology; Communicable diseases; Malignancy; Pertussis; Measles},
Keywords-Plus = {RISK; PREDICTORS; MELANOMA; HISTORY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mark.pearce@ncl.ac.uk},
ORCID-Numbers = {PARKER, LOUISE/0000-0002-5188-8113
   Pearce, Mark/0000-0002-0583-3779
   Tennant, Peter/0000-0003-1555-069X},
Cited-References = {ABEL U, 1991, J CANCER RES CLIN, V117, P339, DOI 10.1007/BF01630717.
   Albonico HU, 1998, MED HYPOTHESES, V51, P315, DOI 10.1016/S0306-9877(98)90055-X.
   {[}Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1.
   Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100.
   Blackwell DL, 2001, SOC SCI MED, V52, P1269, DOI 10.1016/S0277-9536(00)00230-6.
   Boffetta P, 2000, ENVIRON HEALTH PERSP, V108, P73, DOI 10.2307/3454298.
   Cramer DW, 2011, CURR OPIN IMMUNOL, V23, P265, DOI 10.1016/j.coi.2011.01.002.
   Engel P., 1934, WIEN KLIN WOCHENSCHR, V47, P1118.
   Engel P., 1935, WIEN KLIN WOCHENSCHR, V48, P112.
   FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17.
   Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1.
   Guiso Nicole, 2011, Hum Vaccin, V7, P481.
   Hoffmann C, 2002, FORSCH KOMPLEMENTMED, V9, P323.
   Hoption SA, 2006, CANCER DETECT PREV, V30, P83, DOI 10.1016/j.cdp.2005.11.001.
   Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5008.
   KOLMEL KF, 1992, MELANOMA RES, V2, P207.
   Krone B, 2005, EUR J CANCER, V41, P104, DOI 10.1016/j.ejca.2004.08.010.
   KUH DJL, 1992, J EPIDEMIOL COMMUN H, V46, P114, DOI 10.1136/jech.46.2.114.
   Kwiatkowski, 2009, J PRECLIN CLIN RES, V3, P31.
   Maynard M, 2003, J EPIDEMIOL COMMUN H, V57, P218, DOI 10.1136/jech.57.3.218.
   McDuffie HH, 2001, CANCER EPIDEM BIOMAR, V10, P1155.
   Mulholland EK, 2012, NEW ENGL J MED, V366, P1755, DOI 10.1056/NEJMp1202396.
   NEWHOUSE ML, 1977, BRIT J PREV SOC MED, V31, P148.
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731.
   Pearce MS, 2009, INT J EPIDEMIOL, V38, P932, DOI 10.1093/ije/dyn184.
   Pearl R, 1929, AM J HYG, V9, P97, DOI 10.1093/oxfordjournals.aje.a121646.
   SCHIFFMAN MH, 1985, AM J OBSTET GYNECOL, V152, P116, DOI 10.1016/S0002-9378(85)80198-8.
   SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986.
   Sinek F., 1936, J CANCER RES CLIN, V44, P492.
   Sorahan T, 1997, BRIT J CANCER, V76, P1525, DOI 10.1038/bjc.1997.589.
   Strachan DP, 1997, THORAX, V52, P905, DOI 10.1136/thx.52.10.905.
   Tennant PWG, 2008, THORAX, V63, P823, DOI 10.1136/thx.2008.096388.
   Tu SM, 2010, CANCER TREAT RES, V154, P129, DOI 10.1007/978-1-4419-5968-3\_12.
   WEST RO, 1966, CANCER, V19, P1001, DOI 10.1002/1097-0142(196607)19:7<1001::AID-CNCR2820190714>3.0.CO;2-S.},
Number-of-Cited-References = {34},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Eur. J. Epidemiol.},
Doc-Delivery-Number = {122HM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000317309200007},
DA = {2022-03-29},
}

@article{ WOS:000730228700017,
Author = {Zhang, Wenxiao and Yun, Xiao and Meng, Wenjun and Xu, Haoran and Zhong,
   Qirui and Yu, Xinyuan and Ren, Yu'ang and Shen, Huizhong and Chen, Yilin
   and Shen, Guofeng and Ma, Jianmin and Cheng, Hefa and Li, Bengang and
   Liu, Junfeng and Wang, Xuejun and Tao, Shu},
Title = {Urban residential energy switching in China between 1980 and 2014
   prevents 2.2 million premature deaths},
Journal = {ONE EARTH},
Year = {2021},
Volume = {4},
Number = {11},
Pages = {1602-1613},
Month = {NOV 19},
Abstract = {Exposure to air pollution by burning solid fuels (such as coal) for
   residential cooking and heating in China has caused significant health
   impacts in the past. The government has implemented measures to replace
   coal with relatively clean energy sources (e.g., natural gas). However,
   the scale and scope of health benefits associated with such energy
   switching in an urban context, when considering both ambient and indoor
   air quality, remain unclear. Here we used an atmospheric chemical
   transport model showing that relatively clean energy use increased from
   2\% to 71\% from 1980 to 2014, and although annual premature deaths
   attributed to particulate matter with an aerodynamic diameter less than
   2.5 mm (PM2.5) from urban residential sources increased from 136,000
   (87,000-194,000) to 202,000 (117,000-302,000) during the same period,
   this was primarily due to population growth, urbanization, aging, and
   backgroundmortality rate changes. In the absence of energy switching,
   there would have been 2.2 million additional premature deaths. The
   results provide solid evidence on health benefits of energy switching,
   suggesting further switching to cleaner energy for expanded
   health-climate co-benefits.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Tao, S (Corresponding Author), Peking Univ, Sino French Inst Earth Syst Sci, Coll Urban \& Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China.
   Tao, S (Corresponding Author), Southern Univ Sci \& Technol, Sch Environm Sci \& Engn, Shenzhen 518055, Peoples R China.
   Zhang, Wenxiao; Yun, Xiao; Meng, Wenjun; Xu, Haoran; Zhong, Qirui; Yu, Xinyuan; Ren, Yu'ang; Shen, Guofeng; Ma, Jianmin; Cheng, Hefa; Li, Bengang; Liu, Junfeng; Wang, Xuejun; Tao, Shu, Peking Univ, Sino French Inst Earth Syst Sci, Coll Urban \& Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China.
   Shen, Huizhong; Chen, Yilin; Tao, Shu, Southern Univ Sci \& Technol, Sch Environm Sci \& Engn, Shenzhen 518055, Peoples R China.},
DOI = {10.1016/j.oneear.2021.10.013},
EarlyAccessDate = {NOV 2021},
ISSN = {2590-3330},
EISSN = {2590-3322},
Keywords-Plus = {HOUSEHOLD AIR-POLLUTION; CARBON EMISSIONS; ECONOMIC-GROWTH; HEALTH
   IMPACTS; GLOBAL BURDEN; CONSUMPTION; COAL; PM2.5; COMBUSTION; TRANSITION},
Research-Areas = {Science \& Technology - Other Topics; Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Green \& Sustainable Science \& Technology; Environmental Sciences;
   Environmental Studies},
Author-Email = {taos@pku.edu.cn},
ResearcherID-Numbers = {Zhong, Qirui/AAD-7460-2022
   Shen, Huizhong/E-8152-2017
   Cheng, Hefa/A-1193-2007
   },
ORCID-Numbers = {Shen, Huizhong/0000-0003-1335-8477
   Cheng, Hefa/0000-0003-4911-6971
   Yun, Xiao/0000-0002-1062-1244
   Zhang, Wenxiao/0000-0002-0234-9295
   Zhong, Qirui/0000-0002-1397-6024},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}41991312, 41830641, 41922057, 41821005];
   Chinese Academy of ScienceChinese Academy of Sciences {[}2019QZKK0605,
   XDA23010100]; Undergraduate Student Research Training Program;
   High-performance Computing Platform of Peking University},
Funding-Text = {This work is funded by the National Natural Science Foundation of China
   (grants 41991312, 41830641, 41922057, and 41821005) , Chinese Academy of
   Science (2019QZKK0605, XDA23010100) , and Undergraduate Student Research
   Training Program, and supported by the High-performance Computing
   Platform of Peking University.},
Cited-References = {{[}Anonymous], 2020, US EMBASSY CONSULATE.
   {[}Anonymous], 2020, HIST CHINESE AIR QUA.
   {[}Anonymous], 2020, NCEP FNL OPERATIONAL.
   {[}Anonymous], 2020, IBM SPSS STAT MANUAL.
   {[}Anonymous], 2021, THE PEOPLES DAILY.
   {[}Anonymous], 2020, MATH WORKS DOCUMENTA.
   Beijing Municipal Commission of Development and Reform, 2019, GAS PRIC.
   Cai CJ, 2016, ATMOS ENVIRON, V124, P262, DOI 10.1016/j.atmosenv.2015.05.046.
   Cai H, 2007, ATMOS ENVIRON, V41, P8963, DOI 10.1016/j.atmosenv.2007.08.019.
   Chen YL, 2018, ENVIRON INT, V119, P117, DOI 10.1016/j.envint.2018.04.054.
   Chen YJ, 2005, ENVIRON SCI TECHNOL, V39, P1861, DOI 10.1021/es0493650.
   China Academy of Building Research, 1999, ENERGY CONSERVATION.
   China District Heating Association, 2019, REV ACH HEAT SUPPL I.
   China Petrochemical Industry Conference, CHIN PETR IND C.
   China State Council, 2014, STAT COUNC OP FURTH.
   China State Council, 1958, REG PEOPL REP CHIN H.
   China State Council, 2013, AIR POLL PREV CONTR.
   China State Council, 2018, STAT COUNC ISS 3 YEA.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Department of Energy Statistics and National Bureau of Statistics of People's Republic of China, 2020, CHINA ENERGY STAT YB.
   ESRI Data Management, 2020, ARCMAP DOC.
   European Commission Joint Research Centre/Netherlands Environmental Assessment Agency, EM DAT GLOB ATM RES.
   Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027.
   Hammer MS, 2020, ENVIRON SCI TECHNOL, V54, P7879, DOI 10.1021/acs.est.0c01764.
   Healthy China Initiative Promotion Committee, 2019, HLTH CHIN IN 2019 20.
   Hill LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186834.
   Huang Y, 2015, ATMOS ENVIRON, V122, P505, DOI 10.1016/j.atmosenv.2015.10.017.
   Huang Y, 2014, ENVIRON SCI TECHNOL, V48, P13834, DOI 10.1021/es503696k.
   Hung Anh L.D., 2021, J BUILD ENG, V44, P102604, DOI {[}DOI 10.1016/J.JOBE.2021.102604, 10.1016/j.jobe.2021.102604].
   Institute for Health Metrics and Evaluation, 2020, DAT GLOB BURD DIS GB.
   Institute for Health Metrics and Evaluation, 2017, GLOBAL BURDEN DIS CO.
   International Energy Agency, 2016, WORLD EN OUTL.
   Janssens-Maenhout G, 2015, ATMOS CHEM PHYS, V15, P11411, DOI 10.5194/acp-15-11411-2015.
   Langevin J, 2019, JOULE, V3, P2403, DOI 10.1016/j.joule.2019.07.013.
   Lei Y, 2011, ATMOS CHEM PHYS, V11, P931, DOI 10.5194/acp-11-931-2011.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Li GD, 2016, ENVIRON SCI TECHNOL, V50, P11452, DOI 10.1021/acs.est.6b02562.
   Li JL, 2019, ENERG POLICY, V127, P392, DOI 10.1016/j.enpol.2018.12.022.
   Li Q., 2015, SOC SCI CHINA, V36, P130.
   Lin WB, 2014, SUSTAINABILITY-BASEL, V6, P7710, DOI 10.3390/su6117710.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Madureira J, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114746.
   Malla S, 2014, WORLD BANK POLICY RE, V6903, DOI {[}10.1596/1813-9450-6903, DOI 10.1596/1813-9450-6903].
   Mao XQ, 2005, ENERG POLICY, V33, P307, DOI 10.1016/j.enpol.2003.08.002.
   McLean EV, 2019, WORLD DEV, V114, P267, DOI 10.1016/j.worlddev.2018.10.006.
   McNeil M.A., 2005, FORECASTING ELECT DE.
   Meng WJ, 2021, ENVIRON SCI TECHNOL, V55, P14567, DOI 10.1021/acs.est.1c04242.
   Meng WJ, 2020, ENVIRON SCI TECHNOL, V54, P13458, DOI 10.1021/acs.est.0c04019.
   Meng WJ, 2019, P NATL ACAD SCI USA, V116, P16773, DOI 10.1073/pnas.1904182116.
   Meng WJ, 2017, ENVIRON SCI TECHNOL, V51, P2821, DOI 10.1021/acs.est.6b03694.
   Mestl HES, 2007, SCI TOTAL ENVIRON, V377, P12, DOI 10.1016/j.scitotenv.2007.01.087.
   Microsoft Corporation, 2020, EXC HELP LEARN MICR.
   Ministry of Ecology and Environment of the People's Republic of China, 2021, B STAT CHIN EC ENV 2.
   Ministry of Ecology and Environment of the People's Republic of China, 2017, AIR POLLUTION PREVEN.
   Ministry of Environmental Protection, 2013, EXPOSURE FACTORS HDB.
   Ministry of Environmental Protection, 2016, EXPOSURE FACTORS HDB.
   Ministry of Housing and Urban-Rural Development of People's Republic of China, 2017, CHIN URB CONSTR STAT.
   Morawska L, 2013, INDOOR AIR, V23, P462, DOI 10.1111/ina.12044.
   National Bureau of Statistics, 2020, CHIN STAT YB TERT IN.
   National Bureau of Statistics of the People's Republic of China, 2017, CHIN STAT YB 1981 20.
   National Development and Reform Commission, 2007, PRIC YB CHIN 2007.
   National Development and Reform Commission, 2017, WINT CLEAN HEAT PLAN.
   National Energy Administration, 2016, 13 5 YEAR PLAN BIOM.
   National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN.
   National Meteorological Information Centre, 2020, CHIN EARTH INT EXCH.
   Ozturk I, 2010, ENERG POLICY, V38, P4422, DOI 10.1016/j.enpol.2010.03.071.
   Pang Jun, 2015, China Environmental Science, V35, P55.
   Peking University, PEK U EM INV.
   People's Government of Qilian County, 2018, GAS PRIC QINGH.
   Qi M, 2019, ENVIRON POLLUT, V244, P304, DOI 10.1016/j.envpol.2018.10.041.
   Ru MY, 2015, ENVIRON SCI TECHNOL, V49, P13708, DOI 10.1021/acs.est.5b03374.
   School of Public Health Tongji Medical University, 1990, ATL MORT MAIN DEATH.
   Shen GF, 2020, ENVIRON SCI TECH LET, V7, P128, DOI 10.1021/acs.estlett.0c00095.
   Shen GF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11453-w.
   Shen GF, 2015, RENEW SUST ENERG REV, V51, P741, DOI 10.1016/j.rser.2015.06.049.
   Shen HZ, 2021, SCI TOTAL ENVIRON, V770, DOI 10.1016/j.scitotenv.2021.145304.
   Shen HZ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700300.
   Sicard P, 2021, ATMOS ENVIRON, V244, DOI 10.1016/j.atmosenv.2020.118004.
   Tao S, 2018, NAT ENERGY, V3, P567, DOI 10.1038/s41560-018-0158-4.
   Trudinger C, 2005, CLIMATIC CHANGE, V68, P67, DOI 10.1007/s10584-005-6012-2.
   United Nations Framework Convention on Climate Change, 2002, METH ISS SCI METH AS.
   van der Kroon B, 2013, RENEW SUST ENERG REV, V20, P504, DOI 10.1016/j.rser.2012.11.045.
   van Donkelaar A, 2019, ENVIRON SCI TECHNOL, V53, P2595, DOI 10.1021/acs.est.8b06392.
   Wang R, 2014, ENVIRON SCI TECHNOL, V48, P6780, DOI 10.1021/es5021422.
   World Bank, MONG UL CLEAN AIR PR.
   World Health Organization, 2011, OUTDOOR AIR POLLUTIO.
   Xiang JB, 2019, ENVIRON SCI TECHNOL, V53, P3119, DOI 10.1021/acs.est.8b06878.
   Xinhua News Agency, 1998, PEOPLES REPUBLIC CHI.
   Yue H, 2021, APPL ENERG, V282, DOI 10.1016/j.apenergy.2020.116241.
   Yun X, 2021, ENVIRON SCI TECHNOL, V55, P7316, DOI 10.1021/acs.est.1c01148.
   Yun X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba7621.
   Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479.
   Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116.
   Zhao B, 2018, P NATL ACAD SCI USA, V115, P12401, DOI 10.1073/pnas.1812955115.
   Zhong QR, 2018, ENVIRON SCI TECHNOL, V52, P10416, DOI 10.1021/acs.est.8b02685.
   Zhong QR, 2017, ENVIRON SCI POLLUT R, V24, P864, DOI 10.1007/s11356-016-7896-2.
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6.
   Zhou Q, 2019, ENERG BUILDINGS, V190, P15, DOI 10.1016/j.enbuild.2019.02.015.
   Zhu D, 2013, APPL ENERG, V106, P17, DOI 10.1016/j.apenergy.2013.01.040.
   Zhu X, 2019, ENVIRON SCI TECHNOL, V53, P521, DOI 10.1021/acs.est.8b04280.},
Number-of-Cited-References = {100},
Times-Cited = {1},
Usage-Count-Last-180-days = {28},
Usage-Count-Since-2013 = {28},
Journal-ISO = {One Earth},
Doc-Delivery-Number = {XO5MF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000730228700017},
DA = {2022-03-29},
}

@article{ WOS:A1993LY83500011,
Author = {LAWSON, JS and BLACK, D},
Title = {SOCIOECONOMIC-STATUS - THE PRIME INDICATOR OF PREMATURE DEATH IN
   AUSTRALIA},
Journal = {JOURNAL OF BIOSOCIAL SCIENCE},
Year = {1993},
Volume = {25},
Number = {4},
Pages = {539-552},
Month = {OCT},
Abstract = {The link between socioeconomic status and health has long been
   recognised. This study of deaths among Australian men aged 15-59 years
   demonstrates that during the 20-year period, 1966-86 the number of
   premature deaths was dramatically reduced among all socioeconomic
   groups, primarily as a result of falls in death rates due to heart
   disease, stroke and trauma. However, the marked differences in death
   rates according to social class remain, to the extent that if men of all
   social classes had the same mortality experiences as professional and
   technical workers the overall death rates for Australian men would be
   reduced by 60\%. Socioeconomic status is the most important indicator of
   health status among Australians.},
Publisher = {GALTON FOUNDATION},
Address = {P O BOX 32 COMMERCE WAY, COLCHESTER, ESSEX, ENGLAND CO2 8HP},
Type = {Article},
Language = {English},
Affiliation = {LAWSON, JS (Corresponding Author), UNIV NEW S WALES,SCH HLTH SERV MANAGEMENT,SYDNEY,NSW,AUSTRALIA.},
DOI = {10.1017/S002193200002191X},
ISSN = {0021-9320},
Keywords-Plus = {ISCHEMIC-HEART-DISEASE; TOBACCO SMOKING; SOCIAL-CLASS; MORTALITY;
   INEQUALITIES; PATTERNS},
Research-Areas = {Demography; Public, Environmental \& Occupational Health; Biomedical
   Social Sciences},
Web-of-Science-Categories  = {Demography; Public, Environmental \& Occupational Health; Social
   Sciences, Biomedical},
ResearcherID-Numbers = {black, deborah/C-2829-2017},
ORCID-Numbers = {black, deborah/0000-0001-9174-1565},
Cited-References = {ACKERKNECHT EDWIN H., 1948, BULL HISTORY MED, V22, P117.
   ALROOMI KA, 1989, AM J EPIDEMIOL, V129, P503, DOI 10.1093/oxfordjournals.aje.a115161.
   {*}AUSTR BUR STAT, 1966, ABS0320 CAT.
   {*}AUSTR BUR STAT, 1986, ABS0720 CAT.
   {*}AUSTR BUR STAT, 1971, ABS0420 CAT.
   {*}AUSTR BUR STAT, 1986, ABS1220 CAT.
   {*}AUSTR BUR STAT, 1976, ABS0520 CAT.
   {*}AUSTR BUR STAT, 1981, ABS0620 CAT.
   BAGHURST KI, 1990, MED J AUSTRALIA, V153, P444, DOI 10.5694/j.1326-5377.1990.tb126148.x.
   CAPLAN GA, 1990, BRIT MED J, V301, P1121.
   Daniel A., 1983, POWER PRIVILEGE PRES.
   DOBSON AJ, 1988, AM J EPIDEMIOL, V128, P106, DOI 10.1093/oxfordjournals.aje.a114933.
   Fuchs, 1986, HLTH EC.
   GIBBERD RW, 1984, INT J EPIDEMIOL, V13, P25, DOI 10.1093/ije/13.1.25.
   HILL DJ, 1988, MED J AUSTRALIA, V149, P6, DOI 10.5694/j.1326-5377.1988.tb120474.x.
   HILL DJ, 1991, MED J AUSTRALIA, V154, P797, DOI 10.5694/j.1326-5377.1991.tb121367.x.
   HOGG J, 1985, LONDON IT IS SERIES.
   ILLSLEY R, 1991, SOC SCI MED, V32, P359, DOI 10.1016/0277-9536(91)90336-B.
   Jodice David A., 1983, WORLD HDB POLITICAL.
   Lawson J S, 1992, Drug Alcohol Rev, V11, P193, DOI 10.1080/09595239200185691.
   LAWSON JS, 1991, PUBLIC HLTH AUSTR IN.
   MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K.
   MARMOT MG, 1984, LANCET, V1, P1003.
   MCMICHAEL AJ, 1985, COMMUNITY HEALTH ST, V9, P220.
   QUINE S, 1991, J BIOSOC SCI, V23, P65, DOI 10.1017/S0021932000019088.
   QUINE S, 1989, COMMUNITY HEALTH ST, V13, P510.
   SAUNDERS P, 1991, 30 U NEW S WAL SOC P.
   SNOWDON DA, 1989, AM J EPIDEMIOL, V130, P999, DOI 10.1093/oxfordjournals.aje.a115433.
   THOM TJ, 1989, INT J EPIDEMIOL S1, V18, P520.},
Number-of-Cited-References = {29},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Biosoc. Sci.},
Doc-Delivery-Number = {LY835},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1993LY83500011},
DA = {2022-03-29},
}

@article{ WOS:000565636900005,
Author = {Nawaz, M. O. and Henze, D. K.},
Title = {Premature Deaths in Brazil Associated With Long-Term Exposure to PM2.5
   From Amazon Fires Between 2016 and 2019},
Journal = {GEOHEALTH},
Year = {2020},
Volume = {4},
Number = {8},
Month = {AUG},
Abstract = {Amazonian deforestation from slash-and-burn practices is a significant
   contributor to biomass burning within Brazil. Fires emit carbonaceous
   aerosols that negatively impact human health by increasing fine
   particulate matter (PM2.5) exposure. These negative effects on health
   compound the already detrimental climatological and ecological impacts.
   Despite high biomass burning emissions in Brazil and the international
   attention drawn by the relaxation of Amazon protections in 2019, little
   is known about the health impacts from PM(2.5)exposure attributable to
   these fires. We estimate PM2.5-related premature deaths in Brazil
   associated with biomass burning, focusing on temporal, interannual, and
   spatial trends. We find that during the fire season of 2019, 4,966
   (2,427, 8,340) premature deaths were attributable to fire emissions
   making up 10\% (5, 17) of all PM2.5-related premature deaths in Brazil.
   Between the 2019 and 2018 seasons, fire emissions increased by 1.37 Tg
   (1.00, 2.18) or 115\% (60, 201), which was responsible for an increase
   in health impacts of 2,109 (965, 3,623) premature deaths or 74\% (54,
   98). Biomass burning emissions throughout Brazil contribute
   significantly to premature deaths, with the largest burning events
   occurring in northwestern Brazil. The impact of fires on PM2.5-related
   premature deaths is highest in heavily populated regions despite their
   fires being 1 to 2 orders of magnitude smaller than the largest burning
   events. Results from this study characterize the extent to which
   elevated PM(2.5)exposure levels owing to fires affect public health in
   Brazil and present an additional, public health-focused, support for
   increased Amazon protections.},
Publisher = {AMER GEOPHYSICAL UNION},
Address = {2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA},
Type = {Article},
Language = {English},
Affiliation = {Nawaz, MO (Corresponding Author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   Nawaz, M. O.; Henze, D. K., Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.},
DOI = {10.1029/2020GH000268},
Article-Number = {e2020GH000268},
ISSN = {2471-1403},
Keywords = {adjoint; modeling; PM2.5; Amazon; fires; biomass},
Keywords-Plus = {FINE PARTICULATE MATTER; GLOBAL BURDEN; HEALTH IMPACTS; AIR-POLLUTION;
   SMOKE; DISEASE; MORTALITY; AEROSOL},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {muhammad.nawaz@colorado.edu},
ORCID-Numbers = {Nawaz, Muhammad/0000-0001-7706-7287},
Funding-Acknowledgement = {NASANational Aeronautics \& Space Administration (NASA) {[}NNX16AQ26G,
   80NSSC19K0193]; NOAA grantNational Oceanic Atmospheric Admin (NOAA) -
   USA {[}FIREX NA16OAR4310113]},
Funding-Text = {Thanks to Corey Trujillo for providing access to the biomass burning
   emissions and reviewing the manuscript. We thank the developers of the
   climate data toolbox for MATLAB (Greene et al., 2019). We recognize
   support from NASA grants NNX16AQ26G and 80NSSC19K0193 and NOAA grant
   FIREX NA16OAR4310113.},
Cited-References = {Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011.
   Andreoni M., 2019, NY TIMES.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   da Silva AMC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-309.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Darmenov A., 2015, NASA TECHNICAL REPOR, P38.
   Pereira EJDL, 2019, ENVIRON SCI POLICY, V100, P8, DOI 10.1016/j.envsci.2019.06.001.
   Ford B, 2018, GEOHEALTH, V2, P229, DOI 10.1029/2018GH000144.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016.
   Greene CA, 2019, GEOCHEM GEOPHY GEOSY, V20, P3774, DOI 10.1029/2019GC008392.
   Haikerwal A, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001653.
   Henze DK, 2007, ATMOS CHEM PHYS, V7, P2413, DOI 10.5194/acp-7-2413-2007.
   INPE, 2019, MONITORAMENTO DOS FO.
   INPE, 2019, SITUACAO ATUAL.
   Janssens-Maenhout G, 2015, ATMOS CHEM PHYS, V15, P11411, DOI 10.5194/acp-15-11411-2015.
   Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422.
   Kim PS, 2015, ATMOS ENVIRON, V102, P11, DOI 10.1016/j.atmosenv.2014.09.045.
   Kollanus V, 2017, ENVIRON HEALTH PERSP, V125, P30, DOI 10.1289/EHP194.
   Koplitz SN, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094023.
   Liu JC, 2015, ENVIRON RES, V136, P120, DOI 10.1016/j.envres.2014.10.015.
   Liu JC, 2016, CLIMATIC CHANGE, V138, P655, DOI 10.1007/s10584-016-1762-6.
   Liu TJ, 2020, REMOTE SENS ENVIRON, V237, DOI 10.1016/j.rse.2019.111557.
   Liu ZH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08237-z.
   Marlier ME, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085005.
   Marlier ME, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054010.
   Nawaz M. O., 2020, AMAZON FIRE HEALTH I.
   Pan XH, 2020, ATMOS CHEM PHYS, V20, P969, DOI 10.5194/acp-20-969-2020.
   Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075.
   Reddington CL, 2015, NAT GEOSCI, V8, P768, DOI {[}10.1038/ngeo2535, 10.1038/NGEO2535].
   Reddington CL, 2019, ATMOS CHEM PHYS, V19, P9125, DOI 10.5194/acp-19-9125-2019.
   Reid CE, 2016, ENVIRON HEALTH PERSP, V124, P1334, DOI 10.1289/ehp.1409277.
   Scovronick N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09499-x.
   Shaddick G, 2018, J R STAT SOC C-APPL, V67, P231, DOI 10.1111/rssc.12227.
   Tang W, 2017, J GEOPHYS RES-ATMOS, V122, P1224, DOI 10.1002/2016JD025216.
   Valderrama L, 2018, RESOURCES-BASEL, V7, DOI 10.3390/resources7020026.
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2.
   Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6.
   Wiedinmyer C., 2011, GEOSCI MODEL DEV, V4, P625, DOI {[}10.5194/gmd-4-625-2011, DOI 10.5194/gmd-4-625-2011].},
Number-of-Cited-References = {39},
Times-Cited = {11},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {11},
Journal-ISO = {GeoHealth},
Doc-Delivery-Number = {NI9AA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000565636900005},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000450079300007,
Author = {Oliva-Moreno, J. and Pena-Longobardo, L. M.},
Title = {Labour productivity loss caused by premature deaths associated with
   breast cancer: results from Spain over a 10-year period},
Journal = {BREAST CANCER RESEARCH AND TREATMENT},
Year = {2018},
Volume = {172},
Number = {3},
Pages = {571-576},
Month = {DEC},
Abstract = {BackgroundBreast cancer is one of the most common cancers among women
   worldwide, and is the most common cause of cancer deaths in them. Given
   that such disease has a significant impact on middle-aged women, it can
   result in considerable labour productivity losses. The main objective of
   this study is therefore to analyse labour productivity losses and years
   of potential working life lost as a result of premature deaths from
   breast cancer in Spain over a 10-year period (2005-2014).MethodTo this
   end, by combining data on average salary (Salary Structure Survey),
   occupation (Active Population Survey) and deaths (death registration
   according to cause of death), a simulation model based on the human
   capital approach was constructed to estimate productivity losses
   associated with premature deaths caused by this disease.ResultsThe
   results reveal that labour productivity losses in women are estimated to
   cost 2,137million euros, as a result of the 22,716 deaths occurring
   during working age and the 292,848years of potential productive life
   lost. This implies that breast cancer is responsible for 10.45\% of all
   estimated female labour productivity losses caused by premature deaths
   in the reference year.ConclusionThe article concludes by highlighting
   the major economic impact associated with breast cancer deaths and by
   pointing out future research areas.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {Pena-Longobardo, LM (Corresponding Author), Univ Castilla La Mancha, Dept Econ Anal \& Finance, Fac Law \& Social Sci Toledo, Cobertizo San Pedro Martir S-N, Toledo 45071, Spain.
   Oliva-Moreno, J.; Pena-Longobardo, L. M., Univ Castilla La Mancha, Dept Econ Anal \& Finance, Fac Law \& Social Sci Toledo, Cobertizo San Pedro Martir S-N, Toledo 45071, Spain.},
DOI = {10.1007/s10549-018-4963-z},
ISSN = {0167-6806},
EISSN = {1573-7217},
Keywords = {Breast cancer; Premature deaths; Labour productivity losses; Years of
   potential productive life lost; Economic impact; Human capital; J01;
   J24; I18},
Keywords-Plus = {ECONOMIC BURDEN; INDIRECT COSTS; MORTALITY; HEALTH; STATES; WORK},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {Juan.olivamoreno@uclm.es
   luzmaria.pena@uclm.es},
ResearcherID-Numbers = {Oliva, Juan/A-1299-2011
   Pena Longobardo, Luz Maria/K-6413-2017},
ORCID-Numbers = {Oliva, Juan/0000-0002-8997-0307
   Pena Longobardo, Luz Maria/0000-0001-7224-2189},
Funding-Acknowledgement = {PfizerPfizer},
Funding-Text = {This study has received a no-restricted grant from Pfizer, within the
   framework of a research project conducted by the University of
   Castilla-La Mancha.},
Cited-References = {{[}Anonymous], 2018, SEOM CIFRAS CANC ESP.
   Bank of Spain, GDP DEFL EC IND.
   Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384.
   Bradley CJ, 2002, J HEALTH ECON, V21, P757, DOI 10.1016/S0167-6296(02)00059-0.
   Broekx S, 2011, EUR J HEALTH ECON, V12, P311, DOI 10.1007/s10198-010-0237-3.
   Cabanes A, 2010, ANN ONCOL, V21, piii14, DOI 10.1093/annonc/mdq089.
   Carter HE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167521.
   Dahl FA, 2017, NORD J HLTH EC, V5, P70, DOI {[}10.5617/njhe.2981, DOI 10.5617/NJHE.2981].
   Drolet M, 2005, CAN MED ASSOC J, V173, P765, DOI 10.1503/cmaj.050178.
   Ekwueme DU, 2014, AM J PREV MED, V46, P71, DOI 10.1016/j.amepre.2013.08.016.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Grossman, 1972, DEMAND HLTH THEORETI.
   Grossman M., 2000, HDB HLTH EC.
   Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105.
   Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287.
   Hanly P, 2012, VALUE HEALTH, V15, P429, DOI 10.1016/j.jval.2011.12.012.
   Hanly Paul A, 2014, BMC Cancer, V14, P224, DOI 10.1186/1471-2407-14-224.
   http://ais. paho. org/classifications/Chapters/pdf/Volume3. pdf, CLASIFICACION ESTADI.
   Instituto Nacional de Estadistica (INEa), ENC ESTR SAL.
   Instituto Nacional de Estadistica (INEb), ENC POBL ACT.
   Instituto Nacional de Estadistica (INEc), REG DEF SEG CAUS MUE.
   KOOPMANSCHAP MA, 1992, SOC SCI MED, V34, P1005, DOI 10.1016/0277-9536(92)90131-9.
   Krol M, 2014, PHARMACOECONOMICS, V32, P335, DOI 10.1007/s40273-014-0132-3.
   Krol M, 2013, PHARMACOECONOMICS, V31, P537, DOI 10.1007/s40273-013-0056-3.
   Leal J, 2016, EUR UROL, V69, P438, DOI 10.1016/j.eururo.2015.10.024.
   Lidgren M, 2007, INT J TECHNOL ASSESS, V23, P223, DOI 10.1017/S0266462307070328.
   Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001.
   Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4.
   Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X.
   Lyszczarz B, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3669-7.
   Max W, 2009, BREAST CANCER RES TR, V116, P201, DOI 10.1007/s10549-008-0149-4.
   Mujahid MS, 2010, BREAST CANCER RES TR, V119, P213, DOI 10.1007/s10549-009-0389-y.
   Oliva Juan, 2005, Eur J Health Econ, V6, P309, DOI 10.1007/s10198-005-0303-4.
   Oliva-Moreno J, 2012, EUR J HEALTH ECON, V13, P605, DOI 10.1007/s10198-011-0344-9.
   Pearce A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2854-4.
   Longobardo LMP, 2015, REV ESP SALUD PUBLIC, V89, P39, DOI 10.4321/S1135-57272015000100005.
   Round J, 2015, PALLIATIVE MED, V29, P899, DOI 10.1177/0269216315595203.
   Vicente-Herrero MT, 2012, GAC MEX ONCOL, V11, P351.
   Yabroff KR, 2009, CANCER, V115, P4362, DOI 10.1002/cncr.24588.
   Zheng ZY, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv382.},
Number-of-Cited-References = {40},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Breast Cancer Res. Treat.},
Doc-Delivery-Number = {HA2OQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000450079300007},
DA = {2022-03-29},
}

@article{ WOS:000480735700034,
Author = {Sawano, Toyoaki and Nishikawa, Yoshitaka and Ozaki, Akihiko and Leppold,
   Claire and Takiguchi, Mai and Saito, Hiroaki and Shimada, Yuki and
   Morita, Tomohiro and Tsukada, Manabu and Ohira, Hiromichi and Tsubokura,
   Masaharu},
Title = {Premature death associated with long-term evacuation among a vulnerable
   population after the Fukushima nuclear disaster A case report},
Journal = {MEDICINE},
Year = {2019},
Volume = {98},
Number = {27},
Month = {JUL},
Abstract = {Rationale: The health vulnerability of certain populations such as
   children, the elderly and individuals with illnesses or physical
   disability can become significant in disasters. After the 2011 Fukushima
   Daiichi Nuclear Power Plant (FDNPP) accident, significant health impacts
   on vulnerable populations were observed during early or mid-term phase
   of the disaster, presumably associated with the evacuation. However,
   there is limited information available on the health impacts owing to
   long-term evacuation after disaster among them.
   Patient concerns: A 56-year-old physically challenged male with
   arteriovenous malformation on his right lower limb, diagnosed when he
   was 2 years' old, lived near the FDNPP. He and his family were forced to
   evacuate immediately after the accident.
   Diagnosis: Three months after evacuation following the FDNPP accident,
   he developed a refractory foot ulcer associated with atrial fibrillation
   and congestive cardiac failure because of deterioration of arteriovenous
   malformation, presumably led by repeated evacuations.
   Intervention: Although anticoagulation therapy and diuretic therapy
   improved his cardiac failure in the initial admission, he decided to
   only be treated with supportive care after revelation that his
   arteriovenous malformation was no longer eligible for aggressive
   intervention.
   Outcome: Three years after the long-term evacuation in temporary houses,
   the patient died of bleeding and infection of the ulcer.
   Lessons: This case suggests that long-term evacuation for individuals
   with physical disability may lead to significant health impacts, and
   even premature death, through the deterioration of daily life activities
   due to physical and psychological burdens. This case presents a need for
   further research on ways that disasters impact the health of individuals
   with physical disabilities, and greater disaster preparation for the
   needs of populations with physical disabilities.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Sawano, T (Corresponding Author), Minamisoma Municipal Gen Hosp, Dept Surg, 54-6 Takamicho 2 Chome,Haramachi, Fukushima 9750033, Japan.
   Sawano, Toyoaki; Tsukada, Manabu; Ohira, Hiromichi, Minamisoma Municipal Gen Hosp, Dept Surg, 54-6 Takamicho 2 Chome,Haramachi, Fukushima 9750033, Japan.
   Sawano, Toyoaki; Tsubokura, Masaharu, Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan.
   Nishikawa, Yoshitaka; Morita, Tomohiro, Soma Cent Hosp, Dept Internal Med, Fukushima, Japan.
   Nishikawa, Yoshitaka, Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan.
   Ozaki, Akihiko, Tokiwa Fdn, Jyoban Hosp, Dept Breast Surg, Fukushima, Japan.
   Ozaki, Akihiko; Tsubokura, Masaharu, Minamisoma Municipal Gen Hosp, Res Ctr Community Hlth, Fukushima, Japan.
   Leppold, Claire, Univ Edinburgh, Sch Social \& Polit Sci, Global Publ Hlth Unit, Edinburgh, Midlothian, Scotland.
   Takiguchi, Mai, Sukagawa Hosp, Dept Cardiol, Fukushima, Japan.
   Saito, Hiroaki, Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan.
   Shimada, Yuki, Minamisoma Municipal Gen Hosp, Dept Neurosurg, Fukushima, Japan.},
DOI = {10.1097/MD.0000000000016162},
Article-Number = {e16162},
ISSN = {0025-7974},
EISSN = {1536-5964},
Keywords = {fukushima daiichi nuclear power plant; fukushima nuclear disaster;
   individual with physical disability; long-term evacuation; temporary
   houses; the great east japan earthquake and tsunami; vulnerability},
Keywords-Plus = {ARTERIOVENOUS-MALFORMATIONS; PREPAREDNESS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {toyoakisawano@gmail.com},
ResearcherID-Numbers = {Tsubokura, Masaharu/AAV-4364-2021
   Ozaki, Akihiko/AAD-3889-2021
   },
ORCID-Numbers = {Tsubokura, Masaharu/0000-0001-8027-202X
   Saito, Hiroaki/0000-0002-0824-454X
   Ozaki, Akihiko/0000-0003-4415-9657
   Nishikawa, Yoshitaka/0000-0003-3313-1990},
Cited-References = {Anikeeva O, 2016, AUST J PRIM HEALTH, V22, P283, DOI 10.1071/PY15156.
   Balbus JM, 2009, J OCCUP ENVIRON MED, V51, P33, DOI 10.1097/JOM.0b013e318193e12e.
   Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019.
   Bethel JW, 2011, AM J PREV MED, V40, P139, DOI 10.1016/j.amepre.2010.10.020.
   Chou YJ, 2004, AM J EPIDEMIOL, V160, P688, DOI 10.1093/aje/kwh270.
   Hayakawa M., 2016, Annals of the ICRP, V45, P123, DOI 10.1177/0146645316666707.
   Igarashi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195684.
   Kohout MP, 1998, PLAST RECONSTR SURG, V102, P643, DOI 10.1097/00006534-199809030-00006.
   Liu AS, 2010, PLAST RECONSTR SURG, V125, P1185, DOI 10.1097/PRS.0b013e3181d18070.
   Nomura S, 2016, PREV MED, V82, P77, DOI 10.1016/j.ypmed.2015.11.014.
   Pakjouei S, 2018, J EDUC HEALTH PROMOT, V7, DOI 10.4103/jehp.jehp\_40\_18.
   Sawano T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013885.
   Todorovac Adnan, 2018, J Emerg Manag, V16, P113, DOI 10.5055/jem.2018.0360.
   World Health Organization (WHO), ENV HLTH EM VULN GRO.
   Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019.},
Number-of-Cited-References = {15},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Medicine (Baltimore)},
Doc-Delivery-Number = {IQ4QQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000480735700034},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000378046400001,
Author = {Muller, David C. and Murphy, Neil and Johansson, Mattias and Ferrari,
   Pietro and Tsilidis, Konstantinos K. and Boutron-Ruault, Marie-Christine
   and Clavel, Francoise and Dartois, Laureen and Li, Kuanrong and Kaaks,
   Rudolf and Weikert, Cornelia and Bergmann, Manuela and Boeing, Heiner
   and Tjonneland, Anne and Overvad, Kim and Luisa Redondo, M. and Agudo,
   Antonio and Molina-Portillo, Elena and Altzibar, Jone M. and Cirera,
   Lluis and Ardanaz, Eva and Khaw, Kay-Tee and Wareham, Nicholas J. and
   Key, Timothy J. and Travis, Ruth C. and Bamia, Christina and Orfanos,
   Philippos and Trichopoulou, Antonia and Palli, Domenico and Pala,
   Valeria and Tumino, Rosario and Vineis, Paolo and Panico, Salvatore and
   Bueno-de-Mesquita, H. Bas and Verschuren, W. M. Monique and Struijk,
   Ellen A. and Peeters, Petra H. and Engstrom, Gunnar and Melander, Olle
   and Sund, Malin and Weiderpass, Elisabete and Skeie, Guri and Lund,
   Eiliv and Norat, Teresa and Gunter, Marc and Riboli, Elio and Brennan,
   Paul},
Title = {Modifiable causes of premature death in middle-age in Western Europe:
   results from the EPIC cohort study},
Journal = {BMC MEDICINE},
Year = {2016},
Volume = {14},
Month = {JUN 14},
Abstract = {Background: Life expectancy is increasing in Europe, yet a substantial
   proportion of adults still die prematurely before the age of 70 years.
   We sought to estimate the joint and relative contributions of tobacco
   smoking, hypertension, obesity, physical inactivity, alcohol and poor
   diet towards risk of premature death.
   Methods: We analysed data from 264,906 European adults from the EPIC
   prospective cohort study, aged between 40 and 70 years at the time of
   recruitment. Flexible parametric survival models were used to model risk
   of death conditional on risk factors, and survival functions and
   attributable fractions (AF) for deaths prior to age 70 years were
   calculated based on the fitted models.
   Results: We identified 11,930 deaths which occurred before the age of
   70. The AF for premature mortality for smoking was 31 \% (95 \%
   confidence interval (CI), 31-32 \%) and 14 \% (95 \% CI, 12-16 \%) for
   poor diet. Important contributions were also observed for overweight and
   obesity measured by waist-hip ratio (10 \%; 95 \% CI, 8-12 \%) and high
   blood pressure (9 \%; 95 \% CI, 7-11 \%). AFs for physical inactivity
   and excessive alcohol intake were 7 \% and 4 \%, respectively.
   Collectively, the AF for all six risk factors was 57 \% (95 \% CI, 55-59
   \%), being 35 \% (95 \% CI, 32-37 \%) among never smokers and 74 \% (95
   \% CI, 73-75 \%) among current smokers.
   Conclusions: While smoking remains the predominant risk factor for
   premature death in Europe, poor diet, overweight and obesity,
   hypertension, physical inactivity, and excessive alcohol consumption
   also contribute substantially. Any attempt to minimise premature deaths
   will ultimately require all six factors to be addressed.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Brennan, P (Corresponding Author), Int Agcy Res Canc, F-69008 Lyon, France.
   Muller, David C.; Johansson, Mattias; Ferrari, Pietro; Brennan, Paul, Int Agcy Res Canc, F-69008 Lyon, France.
   Murphy, Neil; Vineis, Paolo; Bueno-de-Mesquita, H. Bas; Peeters, Petra H.; Norat, Teresa; Gunter, Marc; Riboli, Elio, Univ London Imperial Coll Sci Technol \& Med, Sch Publ Hlth, London SW7 2AZ, England.
   Tsilidis, Konstantinos K., Univ Ioannina, Sch Med, Dept Hyg \& Epidemiol, GR-45110 Ioannina, Greece.
   Tsilidis, Konstantinos K., Univ London Imperial Coll Sci Technol \& Med, Sch Publ Hlth, Dept Epidemiol \& Biostat, London SW7 2AZ, England.
   Boutron-Ruault, Marie-Christine, Ctr Res Epidemiol \& Populat Hlth CESP, F-94805 Villejuif, France.
   Boutron-Ruault, Marie-Christine; Clavel, Francoise; Dartois, Laureen, Univ Paris 11, Villejuif, France.
   Boutron-Ruault, Marie-Christine; Clavel, Francoise; Dartois, Laureen, Inst Gustave Roussy, Villejuif, France.
   Clavel, Francoise; Dartois, Laureen, INSERM, Ctr Res Epidemiol \& Populat Hlth CESP, F-94805 Villejuif, France.
   Li, Kuanrong; Kaaks, Rudolf, German Canc Res Ctr, Div Canc Epidemiol, DE-69120 Heidelberg, Germany.
   Weikert, Cornelia; Bergmann, Manuela; Boeing, Heiner, German Inst Human Nutr Potsdam Rehbrucke DifE, DE-14558 Nuthetal, Germany.
   Tjonneland, Anne, Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark.
   Overvad, Kim, Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus, Denmark.
   Luisa Redondo, M., Publ Hlth Directorate, Asturias 33006, Spain.
   Agudo, Antonio, Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm \& Canc, Barcelona 08908, Spain.
   Molina-Portillo, Elena, Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria GRANADA, Escuela Andaluza Salud Publ, Granada 18012, Spain.
   Molina-Portillo, Elena; Altzibar, Jone M.; Cirera, Lluis; Ardanaz, Eva, Consortium Biomed Res Epidemiol \& Publ Hlth CIBER, Madrid, Spain.
   Altzibar, Jone M., Basque Reg Hlth Dept, Publ Hlth Div Gipuzkoa BIODONOSTIA, San Sebastian 20014, Spain.
   Cirera, Lluis, IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia 30003, Spain.
   Cirera, Lluis, Univ Murcia, Dept Hlth \& Social Sci, Murcia, Spain.
   Ardanaz, Eva, Navarra Publ Hlth Inst, Pamplona 31003, Spain.
   Ardanaz, Eva, Navarra Inst Hlth Res IdiSNA Pamplona, Pamplona, Spain.
   Khaw, Kay-Tee, Univ Cambridge, Sch Clin Med, Cambridge CB2 2QQ, England.
   Wareham, Nicholas J., Univ Cambridge, Epidemiol Unit, MRC, Cambridge CB2 0SR, England.
   Key, Timothy J.; Travis, Ruth C., Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England.
   Bamia, Christina; Orfanos, Philippos; Trichopoulou, Antonia, Hellen Hlth Fdn, GR-11527 Athens, Greece.
   Bamia, Christina; Orfanos, Philippos; Trichopoulou, Antonia, Univ Athens, Sch Med, Dept Hyg Epidemiol \& Med Stat, GR-11527 Athens, Greece.
   Palli, Domenico, Canc Res \& Prevent Inst ISPO, Mol \& Nutr Epidemiol Unit, I-50134 Florence, Italy.
   Pala, Valeria, Ist Nazl Tumori, Fdn IRCCS, Epidemiol \& Prevent Unit, Via Venezian 1, I-20133 Milan, Italy.
   Tumino, Rosario, ASP Ragusa, Civ MP Arezzo Hosp, Canc Registry \& Histopathol Unit, I-97100 Ragusa, Italy.
   Vineis, Paolo, Human Genet Fdn HuGeF, Turin, Italy.
   Panico, Salvatore, Univ Naples Federico II, Dipartimento Med Clin \& Sperimentale, I-80138 Naples, Italy.
   Bueno-de-Mesquita, H. Bas; Verschuren, W. M. Monique, Natl Inst Publ Hlth \& Environm RIVM, Dept Determinants Chron Dis DCD, NL-3720 BA Bilthoven, Netherlands.
   Bueno-de-Mesquita, H. Bas, Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol \& Hepatol, Utrecht, Netherlands.
   Bueno-de-Mesquita, H. Bas, Univ Malaya, Fac Med, Dept Social \& Prevent Med, Kuala Lumpur, Malaysia.
   Verschuren, W. M. Monique; Struijk, Ellen A.; Peeters, Petra H., Univ Med Ctr Utrecht, Julius Ctr Hlth Sci \& Primary Care, Dept Epidemiol, Utrecht, Netherlands.
   Engstrom, Gunnar, Malmo Lund Univ, Dept Clin Sci, SE-20502 Lund, Sweden.
   Melander, Olle, Malmo Univ Hosp, Clin Res Ctr, Dept Clin Sci Hypertens \& Cardiovasc Dis, SE-20502 Malmo, Sweden.
   Sund, Malin, Umea Univ, Dept Surg \& Perioperat Sci, S-90185 Umea, Sweden.
   Weiderpass, Elisabete; Skeie, Guri; Lund, Eiliv, Univ Tromso, Dept Community Med, Fac Hlth Sci, Arctic Univ Norway, N-9037 Tromso, Norway.
   Weiderpass, Elisabete, Canc Registry Norway, Dept Res, Oslo, Norway.
   Weiderpass, Elisabete, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.
   Weiderpass, Elisabete, Samfundet Folkhalsan, Helsinki, Finland.
   Skeie, Guri; Lund, Eiliv, Arctic Univ Norway, Tromso, Norway.},
DOI = {10.1186/s12916-016-0630-6},
Article-Number = {87},
ISSN = {1741-7015},
Keywords = {Premature death; Mortality; Modifiable risk factors; Attributable
   fraction; Absolute risk},
Keywords-Plus = {ALL-CAUSE MORTALITY; BODY-MASS INDEX; RESEARCH FUND/AMERICAN INSTITUTE;
   CANCER-RESEARCH GUIDELINES; PHYSICAL-ACTIVITY; ABDOMINAL ADIPOSITY;
   GLYCATED HEMOGLOBIN; ALCOHOL-CONSUMPTION; RISK; NUTRITION},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {gep@iarc.fr},
ResearcherID-Numbers = {Orfanos, Philippos/AAL-2606-2021
   Pala, Valeria/K-4738-2016
   Johansson, Mattias/ABF-3365-2020
   TRICHOPOULOU, ANTONIA/ABF-8727-2021
   Agudo, Antonio/J-1805-2016
   Gunter, Marc/AAP-8621-2020
   Khaw, Kay-Tee/AAZ-3209-2021
   Boutron-Ruault, Marie-Christine/H-3936-2014
   Muller, David C/V-8207-2017
   Weiderpass, Elisabete/AAP-2747-2021
   MOLINA PORTILLO, ELENA/ABA-3364-2021
   Murphy, Neil/E-1189-2017
   Weiderpass, Elisabete/M-4029-2016
   },
ORCID-Numbers = {Pala, Valeria/0000-0001-5438-970X
   TRICHOPOULOU, ANTONIA/0000-0002-7204-6396
   Agudo, Antonio/0000-0001-9900-5677
   Boutron-Ruault, Marie-Christine/0000-0002-5956-5693
   Muller, David C/0000-0002-2350-0417
   Weiderpass, Elisabete/0000-0003-2237-0128
   MOLINA PORTILLO, ELENA/0000-0002-9955-3080
   Murphy, Neil/0000-0003-3347-8249
   Weiderpass, Elisabete/0000-0003-2237-0128
   tumino, rosario/0000-0003-2666-414X
   Struijk, Ellen/0000-0002-9302-9616
   ALTZIBAR, JONE MIREN/0000-0001-7037-7944
   Overvad, Kim/0000-0001-6429-7921
   Riboli, Elio/0000-0001-6795-6080
   Johansson, Mattias/0000-0002-3116-5081
   PALLI, Domenico/0000-0002-5558-2437
   Skeie, Guri/0000-0003-2476-4251
   Melander, Olle/0000-0002-2581-484X
   Tjonneland, Anne/0000-0003-4385-2097},
Funding-Acknowledgement = {French Social Affairs AMP; Health Ministry, Department of Health
   (Direction Generale de la Sante); IARC-Australia fellowship; Imperial
   College Biomedical Research Centre - National Institute of Health
   Research of UK; European Commission (DG-SANCO)European
   CommissionEuropean Commission Joint Research Centre; International
   Agency for Research on Cancer; Danish Cancer Society (Denmark)Danish
   Cancer Society; Ligue Contre le Cancer (France); Institut Gustave Roussy
   (France); Mutuelle Generale de l'Education Nationale (France); Institut
   National de la Sante et de la Recherche Medicale (INSERM)
   (France)Institut National de la Sante et de la Recherche Medicale
   (Inserm); Deutsche Krebshilfe (Germany)Deutsche Krebshilfe; Deutsches
   Krebsforschungszentrum (Germany); Federal Ministry of Education and
   Research (Germany)Federal Ministry of Education \& Research (BMBF);
   Hellenic Health Foundation (Greece); Associazione Italiana per la
   Ricerca sul Cancro-AIRC-Italy (Italy)Fondazione AIRC per la ricerca sul
   cancro; National Research Council (Italy)Consiglio Nazionale delle
   Ricerche (CNR); Dutch Ministry of Public Health (The Netherlands);
   Welfare and Sports (VWS) (The Netherlands)Netherlands Government;
   Netherlands Cancer Registry (NKR) (The Netherlands)Netherlands
   Government; LK Research Funds (The Netherlands)Netherlands Government;
   Dutch Prevention Funds (The Netherlands)Netherlands Government; Dutch
   ZON (Zorg Onderzoek Nederland) (The Netherlands)Netherlands Government;
   World Cancer Research Fund (WCRF) (The Netherlands)Netherlands
   GovernmentWorld Cancer Research Fund International (WCRF); Statistics
   Netherlands (The Netherlands)Netherlands Government; Nordic Centre of
   Excellence programme on Food, Nutrition and Health (Norway); Health
   Research Fund (FIS) (Spain)Instituto de Salud Carlos III {[}PI13/00061];
   Regional Governments of Andalucia (Spain); Asturias (Spain); Basque
   Country (Spain); Murcia (Spain) {[}6236]; Navarra (Spain); ISCIII RETIC
   (Spain)Instituto de Salud Carlos III {[}RD06/0020]; Swedish Cancer
   Society (Sweden)Swedish Cancer Society; Swedish Scientific Council
   (Sweden); County Councils of Skane and Vasterbotten (Sweden); Cancer
   Research UKCancer Research UK {[}14136, C570/A16491]; Medical Research
   Council (United Kingdom)UK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC) {[}1000143]; Cancer Council AustraliaCancer Council
   Australia; MRCUK Research \& Innovation (UKRI)Medical Research Council
   UK (MRC) {[}MR/N003284/1, MC\_UU\_12015/1] Funding Source: UKRI; Cancer
   Research UKCancer Research UK {[}16491] Funding Source: researchfish;
   Medical Research CouncilUK Research \& Innovation (UKRI)Medical Research
   Council UK (MRC)European Commission {[}MC\_PC\_13048, G0401527,
   MC\_U106179471, G1000143, MR/N003284/1, MC\_UU\_12015/1] Funding Source:
   researchfish; National Institute for Health ResearchNational Institute
   for Health Research (NIHR) {[}NF-SI-0512-10114] Funding Source:
   researchfish},
Funding-Text = {This work was supported by the French Social Affairs \& Health Ministry,
   Department of Health (Direction Generale de la Sante). The work
   undertaken by David C Muller for this project was performed during the
   tenure of an IARC-Australia fellowship supported by Cancer Council
   Australia. Elio Riboli was supported by the Imperial College Biomedical
   Research Centre funded by the National Institute of Health Research of
   UK. The coordination of EPIC is financially supported by the European
   Commission (DG-SANCO) and the International Agency for Research on
   Cancer. The national cohorts are supported by Danish Cancer Society
   (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle
   Generale de l'Education Nationale, Institut National de la Sante et de
   la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches
   Krebsforschungszentrum and Federal Ministry of Education and Research
   (Germany); the Hellenic Health Foundation (Greece); Associazione
   Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research
   Council (Italy); Dutch Ministry of Public Health, Welfare and Sports
   (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch
   Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer
   Research Fund (WCRF), Statistics Netherlands (The Netherlands); Nordic
   Centre of Excellence programme on Food, Nutrition and Health (Norway);
   Health Research Fund (FIS), PI13/00061 to Granada, Regional Governments
   of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra,
   ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish
   Scientific Council and County Councils of Skane and Vasterbotten
   (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 to
   EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk) (United
   Kingdom). The sponsors did not have any input into study design, study
   conduct, data collection, analysis, or interpretation nor did they
   influence the preparation, review, or approval of the manuscript.},
Cited-References = {Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154.
   Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688.
   Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027.
   Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058.
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367.
   Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437.
   Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   DUFFY JC, 1995, INT J EPIDEMIOL, V24, P100, DOI 10.1093/ije/24.1.100.
   Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065.
   Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245.
   Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005.
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881.
   Ikeda N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001160.
   Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x.
   Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15.
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8.
   Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   National High Blood Pressure Education Program, 2004, CLASS BLOOD PRESS 7.
   PEKKANEN J, 1987, LANCET, V1, P1473, DOI 10.1016/S0140-6736(87)92218-5.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6.
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891.
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X.
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394.
   Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl\_1.S6.
   Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674.
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203.
   Royston P., 2011, FLEXIBLE PARAMETRIC.
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9.
   Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359.
   Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311.
   Vergnaud AC, 2013, AM J CLIN NUTR, V97, P1107, DOI 10.3945/ajcn.112.049569.
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.},
Number-of-Cited-References = {37},
Times-Cited = {30},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {18},
Journal-ISO = {BMC Med.},
Doc-Delivery-Number = {DO8PT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000378046400001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000471001000006,
Author = {Eslami, Ali and Irvani, Seyed Sina Naghibi and Ramezankhani, Azra and
   Fekri, Nazanin and Asadi, Keyvan and Azizi, Fereidoun and Hadaegh,
   Farzad},
Title = {Incidence and associated risk factors for premature death in the Tehran
   Lipid and Glucose Study cohort, Iran},
Journal = {BMC PUBLIC HEALTH},
Year = {2019},
Volume = {19},
Month = {JUN 10},
Abstract = {BackgroundThe incidence and associated risk factors for premature death
   were investigated in a population-based cohort study in Iran.MethodsA
   total of 7245 participants (3216 men), aged 30-70years, were included.
   We conducted Cox proportional hazards models to identify the risk
   factors for premature death. For each risk factor, hazard ratio (HR),
   95\% confidence intervals (95\% CI) and population attributable fraction
   (PAF) were calculated.ResultsAfter a median follow-up of 13.8years, 262
   premature deaths (153 in men) occurred. Underlying causes of premature
   deaths were cardiovascular disease (CVD) (n=126), cancer (n=51), road
   injuries (n=15), sepsis and pneumonia (n=9) and miscellaneous reasons
   (n=61). The age-standardized incident rate of premature death was 2.35
   per 1000 person years based on WHO standard population. Hypertension
   {[}HR 1.40, 95\% CI (1.07-1.83)], diabetes (2.53, 1.94-3.29) and current
   smoking (1.58, 1.16-2.17) were significant risk factors for premature
   mortality; corresponding PAFs were 12.3, 22.4 and 9.2\%, respectively.
   Overweight (body mass index (BMI): 25-29.9kg/m(2)) (0.65, 0.49-0.87) and
   obesity (BMI 30kg/m(2)) (0.67, 0.48-0.94) were associated with decreased
   premature mortality. After replacing general adiposity with central
   adiposity, we found no significant risk for the latter (0.92,
   0.71-1.18). Moreover, when we excluded current smokers, those with
   prevalent cancer/cardiovascular disease and those with survival of less
   than 3years, the inverse association between overweight (0.59,
   0.39-0.88) and obesity (0.67, 0.43-1.04), generally remained unchanged;
   although, diabetes still showed a significant risk (2.62,
   1.84-3.72).ConclusionsControlling three modifiable risk factors
   including diabetes, hypertension and smoking might potentially reduce
   mortality events by over 40\%, and among these, prevention of diabetes
   should be prioritized to decrease burden of events. We didn't confirm a
   negative impact of overweight and obesity status on premature mortality
   events.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hadaegh, F (Corresponding Author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Floor 3th,24,Yemen St,POB 19395-4763, Tehran, Iran.
   Eslami, Ali; Irvani, Seyed Sina Naghibi; Ramezankhani, Azra; Fekri, Nazanin; Asadi, Keyvan; Hadaegh, Farzad, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Floor 3th,24,Yemen St,POB 19395-4763, Tehran, Iran.
   Fekri, Nazanin, Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol \& Biostat, Tehran, Iran.
   Azizi, Fereidoun, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.},
DOI = {10.1186/s12889-019-7056-y},
Article-Number = {719},
EISSN = {1471-2458},
Keywords = {Premature mortality; Risk factors; Cohort study; Population attributable
   fractions; Incidence},
Keywords-Plus = {FOLLOW-UP; MORTALITY; HYPERTENSION; OBESITY; POPULATION; PREVALENCE;
   DISEASES; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {fzhadaegh@endocrine.ac.ir},
ResearcherID-Numbers = {Eslami, Ali/N-3409-2017
   Irvani, Seyed Sina Naghibi/O-2413-2018
   Azizi, Fereidoun/ABD-4136-2021
   },
ORCID-Numbers = {Eslami, Ali/0000-0002-3755-7203
   Irvani, Seyed Sina Naghibi/0000-0002-4566-7402
   Azizi, Fereidoun/0000-0002-6470-2517
   Hadaegh, Farzad/0000-0002-8935-2744
   hadaegh, farzad/0000-0002-0352-8666},
Funding-Acknowledgement = {National Research Council of the Islamic Republic of Iran {[}121]},
Funding-Text = {This study was supported by grant No. 121 from the National Research
   Council of the Islamic Republic of Iran. This funding source had no role
   in the design of the study and collection, analysis, and interpretation
   of data and in writing the manuscript.},
Cited-References = {Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362.
   Ahmad OB, 2001, AGE STANDARDIZATION.
   Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5.
   Banack HR, 2014, PREV MED, V62, P96, DOI 10.1016/j.ypmed.2014.02.003.
   Bozorgmanesh M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-69.
   Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2.
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1.
   Eslami A, 2017, INT J CARDIOL, V227, P826, DOI 10.1016/j.ijcard.2016.10.037.
   Esteghamati A, 2008, AM J HYPERTENS, V21, P620, DOI 10.1038/ajh.2008.154.
   Esteghamati A, 2014, DIABETES RES CLIN PR, V103, P319, DOI 10.1016/j.diabres.2013.12.034.
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905.
   Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180.
   Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639.
   Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703.
   Kerr D, 2011, DIABETIC MED, V28, P1520, DOI 10.1111/j.1464-5491.2011.03443.x.
   Lotfaliany M, 2015, J HYPERTENS, V33, P1153, DOI 10.1097/HJH.0000000000000540.
   Mendis S., 2015, GLOBAL STATUS REPORT.
   Mendis S, 2017, CARDIOVASC DIAGN THE, V7, pS32, DOI 10.21037/cdt.2017.03.06.
   Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3.
   Muller DC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0630-6.
   Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x.
   Nwaneri C, 2013, DIABETES VASC DIS RE, V13, P192, DOI {[}10.1177/1474651413495703, DOI 10.1177/1474651413495703].
   Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699.
   Peto R, 2015, MORTALITY.
   Rafiefar S, 2016, ARCH IRAN MED, V19, P729.
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15.
   Tokuc B, 2016, BALK MED J, V33, P662, DOI 10.5152/balkanmedj.2016.151277.},
Number-of-Cited-References = {27},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {IC5IL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000471001000006},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000187503400008,
Author = {Leissring, MA and Farris, W and Chang, AY and Walsh, DM and Wu, XN and
   Sun, XY and Frosch, MP and Selkoe, DJ},
Title = {Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents
   plaque formation, secondary pathology, and premature death},
Journal = {NEURON},
Year = {2003},
Volume = {40},
Number = {6},
Pages = {1087-1093},
Month = {DEC 18},
Abstract = {Converging evidence suggests that the accumulation of cerebral amyloid
   p-protein (Abeta) in Alzheimer's disease (AD) reflects an imbalance
   between the production and degradation of this self-aggregating peptide.
   Upregulation of proteases that degrade Abeta thus represents a novel
   therapeutic approach to lowering steady-state Abeta levels, but the
   consequences of sustained upregulation in vivo have not been studied.
   Here we show that transgenic overexpression of insulin-degrading enzyme
   (IDE) or neprilysin (NEP) in neurons significantly reduces brain Abeta
   levels, retards or completely prevents amyloid plaque formation and its
   associated cytopathology, and rescues the premature lethality present in
   amyloid precursor protein (APP) transgenic mice. Our findings
   demonstrate that chronic upregulation of Abeta-degrading proteases
   represents an efficacious therapeutic approach to combating
   Alzheimer-type pathology in vivo.},
Publisher = {CELL PRESS},
Address = {1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA},
Type = {Article},
Language = {English},
Affiliation = {Selkoe, DJ (Corresponding Author), Harvard Univ, Brigham \& Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.
   Harvard Univ, Brigham \& Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Ctr Aging Genet \& Neurodegenerat, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.},
DOI = {10.1016/S0896-6273(03)00787-6},
ISSN = {0896-6273},
Keywords-Plus = {INSULIN-DEGRADING ENZYME; BRAIN A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL;
   PRECURSOR PROTEIN; IN-VIVO; PEPTIDE; DEGRADATION; EXPRESSION; ANTIBODIES},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
ResearcherID-Numbers = {Frosch, Matthew P/ABD-7456-2021
   LEISSRING, MALCOLM/AAW-5361-2021},
ORCID-Numbers = {Frosch, Matthew P/0000-0002-3940-9861
   LEISSRING, MALCOLM/0000-0001-7185-4255},
Funding-Acknowledgement = {NATIONAL INSTITUTE ON AGINGUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}R01AG012749] Funding Source: NIH RePORTER; NIA NIH
   HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   {[}AG12749] Funding Source: Medline},
Cited-References = {Ait-Ghezala G, 2002, NEUROSCI LETT, V325, P87, DOI 10.1016/S0304-3940(02)00243-4.
   Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682.
   Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302.
   Caughey B, 2003, ANNU REV NEUROSCI, V9, P9.
   DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398.
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608.
   Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200.
   Edland SD, 2003, NEUROSCI LETT, V345, P21, DOI 10.1016/S0304-3940(03)00488-9.
   Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100.
   FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1.
   GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0.
   Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100.
   Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0.
   Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783.
   Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228.
   HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8.
   Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946.
   JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550.
   KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2.
   LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45.
   Lazarov O, 2002, J NEUROSCI, V22, P9785.
   Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200.
   Marr RA, 2003, J NEUROSCI, V23, P1992.
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678.
   Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100.
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000.
   Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840.
   Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282.
   Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641.
   SAITO T, 2003, SCI AGING KNOWLEDGE, pPE1.
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124.
   Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248.
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069.
   Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5.
   Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066.
   TURNER AJ, 1998, HDB PROEOLYTIC ENZYM.
   Vekrellis K, 2000, J NEUROSCI, V20, P1657.
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a.
   Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552.
   Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s.
   Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.0.CO;2-W.},
Number-of-Cited-References = {41},
Times-Cited = {564},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {31},
Journal-ISO = {Neuron},
Doc-Delivery-Number = {756UZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000187503400008},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000354705000114,
Author = {Kato, Masayuki and Noda, Mitsuhiko and Mizoue, Tetsuya and Goto, Atsushi
   and Takahashi, Yoshihiko and Matsushita, Yumi and Nanri, Akiko and Iso,
   Hiroyasu and Inoue, Manami and Sawada, Norie and Tsugane, Shoichiro and
   JPHC Study Grp},
Title = {Diagnosed diabetes and premature death among middle-aged Japanese:
   results from a large-scale population-based cohort study in Japan (JPHC
   study)},
Journal = {BMJ OPEN},
Year = {2015},
Volume = {5},
Number = {4},
Abstract = {Objective: To examine the association between diabetes and premature
   death for Japanese general people.
   Design: Prospective cohort study.
   Setting: The Japan Public Health Center-based prospective study (JPHC
   study), data collected between 1990 and 2010.
   Population: A total of 46 017 men and 53 567 women, aged 40-69 years at
   the beginning of baseline survey.
   Main outcome measures: Overall and cause specific mortality. Cox
   proportional hazards models were used to calculate the HRs of all cause
   and cause specific mortality associated with diabetes.
   Results: The median follow-up period was 17.8 years. During the
   follow-up period, 8223 men and 4640 women have died. Diabetes was
   associated with increased risk of death (856 men and 345 women; HR 1.60,
   (95\% CI 1.49 to 1.71) for men and 1.98 (95\% CI 1.77 to 2.21) for
   women). As for the cause of death, diabetes was associated with
   increased risk of death by circulatory diseases (HR 1.76 (95\% CI 1.53
   to 2.02) for men and 2.49 (95\% CI 2.06 to 3.01) for women) while its
   association with the risk of cancer death was moderate (HR 1.25 (95\% CI
   1.11 to 1.42) for men and 1.04 (95\% CI 0.82 to 1.32) for women).
   Diabetes was also associated with increased risk of death for
   `non-cancer, non-circulatory system disease' (HR 1.91 (95\% CI 1.71 to
   2.14) for men and 2.67 (95\% CI 2.25 to 3.17) for women).
   Conclusions: Diabetes was associated with increased risk of death,
   especially the risk of death by circulatory diseases.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Noda, M (Corresponding Author), Natl Ctr Global Hlth \& Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.
   Kato, Masayuki; Noda, Mitsuhiko; Goto, Atsushi, Natl Ctr Global Hlth \& Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.
   Kato, Masayuki, Fiore Kenshin Clin, Tokyo, Japan.
   Mizoue, Tetsuya; Nanri, Akiko, Natl Ctr Global Hlth \& Med, Ctr Clin Sci, Dept Epidemiol \& Prevent, Tokyo, Japan.
   Goto, Atsushi, Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan.
   Takahashi, Yoshihiko, Iwate Med Univ, Sch Med, Div Diabet \& Metab, Morioka, Iwate 020, Japan.
   Matsushita, Yumi, Natl Ctr Global Hlth \& Med, Ctr Clin Sci, Dept Clin Res, Tokyo, Japan.
   Iso, Hiroyasu, Osaka Univ, Dept Publ Hlth, Dept Social \& Environm Med, Grad Sch Med, Suita, Osaka 565, Japan.
   Inoue, Manami; Sawada, Norie; Tsugane, Shoichiro, Natl Canc Ctr, Epidemiol \& Prevent Grp, Res Ctr Canc Prevent \& Screening, Tokyo 104, Japan.
   Inoue, Manami, Univ Tokyo, Grad Sch Med, Tokyo, Japan.},
DOI = {10.1136/bmjopen-2015-007736},
Article-Number = {e007736},
ISSN = {2044-6055},
Keywords-Plus = {CORONARY-HEART-DISEASE; RISK; MELLITUS; MORTALITY; CANCER; MEN;
   METAANALYSIS; WOMEN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {mnoda@hosp.ncgm.go.jp},
ResearcherID-Numbers = {Noda, Mitsuhiko/W-3905-2019
   Tsugane, Shoichiro/A-2424-2015},
ORCID-Numbers = {Noda, Mitsuhiko/0000-0003-0413-4631
   Tsugane, Shoichiro/0000-0003-4105-2774},
Funding-Acknowledgement = {National Cancer Center Research and Development FundNational Cancer
   Center - Japan {[}23-A-31, 26-A-2]; Ministry of Health, Labour and
   Welfare of JapanMinistry of Health, Labour and Welfare, Japan; Ministry
   of Health, Labour and Welfare of JapanMinistry of Health, Labour and
   Welfare, Japan {[}H19-016]},
Funding-Text = {The present study was supported by National Cancer Center Research and
   Development Fund (23-A-31(toku) and 26-A-2) (since 2011) and a
   Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and
   Welfare of Japan (from 1989 to 2010) and a Health Sciences Research
   Grant (Research on Comprehensive Research on Cardiovascular Diseases
   H19-016) from the Ministry of Health, Labour and Welfare of Japan.},
Cited-References = {Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C.
   Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871.
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003.
   Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15.
   Korn EL, 1997, AM J EPIDEMIOL, V145, P72.
   KUZUYA T, 1994, DIABETES RES CLIN PR, V24, pS15, DOI 10.1016/0168-8227(94)90222-4.
   National Institute of Health and Nutrition, 2007, OUTL NAT HLTH NUTR S.
   Nwaneri C, 2013, BR J DIABETES VASC D, V13, P192.
   Oba S, 2008, J EPIDEMIOL, V18, P197, DOI 10.2188/jea.JE2008004.
   Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6.
   Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008.
   Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117.
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862.
   Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405.
   Tsugane S, 2001, J Epidemiol, V11, pS24.
   Woodward M, 2003, DIABETES CARE, V26, P360.
   World Health Organization, 2011, WORLD HLTH STAT 2011.},
Number-of-Cited-References = {17},
Times-Cited = {16},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {CI4GB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000354705000114},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000083468600015,
Author = {Sherman, SE and D'Agostino, RB and Silbershatz, H and Kannel, WB},
Title = {Comparison of past versus recent physical activity in the prevention of
   premature death and coronary artery disease},
Journal = {AMERICAN HEART JOURNAL},
Year = {1999},
Volume = {138},
Number = {5, 1},
Pages = {900-907},
Month = {NOV},
Abstract = {Background People who are physically active live longer, but it is
   unclear whether this is because of physical activity in the distant or
   more recent post.
   Methods We assessed activity levels in 5209 men and women in the
   Framingham Heart Study from 1956 to 1958 and again from 1969 to 1973. We
   included individuals who were alive and without cardiovascular disease
   in the period 1969 to 1973. The primary outcome was death from all
   causes during the 16 years after the 1969 to 1973 assessment. Secondary
   outcomes were incidence and mortality rate of: cardiovascular disease.
   We used Cox proportional hazards regression to calculate the relative
   risk of being sedentary, both unadjusted and controlling for smoking,
   weight, systolic blood pressure, cholesterol, glucose intolerance, left
   ventricular hypertrophy, chronic obstructive pulmonary disease, and
   cancer.
   Results The overall 16-year mortality rate was 37\% for men and 27\% For
   women. When both distant and recent activity levels were included along
   with major cardiovascular disease risk Factors, for recent activity the
   most active tertile had lower overall mortality rate than the least
   active tertile for men (risk ratio 0.58, 95\% confidence interval,
   0.43-0.79) and women (risk ratio 0.61, 95\% confidence interval,
   0.45-0.82). For distant activity there was no difference in overall
   mortality rate between the most and least active tertiles either for men
   or for women. Adjusting for major cardiovascular disease risk factors
   had little effect on the results.
   Conclusions The reduction in overall mortality rates is more associated
   with recent activity than distant activity. These results suggest that
   for sedentary patients, it may never be tao late to begin exercising.},
Publisher = {MOSBY-ELSEVIER},
Address = {360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Sherman, SE (Corresponding Author), Vet Adm Med Ctr, PACE Ctr 00PG, 16111 Plummer St, Sepulveda, CA 91343 USA.
   Sepulveda Ambulatory Care \& Nursing Ctr, VA Greater Los Angeles Healthcare Syst, Primary Ambulatory Care \& Educ Ctr, Sepulveda, CA USA.
   Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.
   Boston Univ, Dept Math, Boston, MA 02215 USA.
   Boston Univ, Sch Med, Prevent Med \& Epidemiol Sect, Boston, MA 02118 USA.},
DOI = {10.1016/S0002-8703(99)70015-3},
ISSN = {0002-8703},
EISSN = {1097-5330},
Keywords-Plus = {EXERCISE; MORTALITY; HEALTH; WOMEN; MEN; DEPRESSION; STROKE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
ORCID-Numbers = {Sherman, Scott/0000-0003-1752-7303},
Funding-Acknowledgement = {NIA NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   {[}AG 10415-01] Funding Source: Medline; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   {[}P60AG010415] Funding Source: NIH RePORTER},
Cited-References = {Albanes D, 1990, Epidemiology, V1, P65, DOI 10.1097/00001648-199001000-00014.
   BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093.
   Bravo G, 1996, J AM GERIATR SOC, V44, P756, DOI 10.1111/j.1532-5415.1996.tb03730.x.
   CARNEY RM, 1987, NEPHRON, V47, P194, DOI 10.1159/000184490.
   Dawber TR, 1980, FRAMINGHAM STUDY EPI.
   DOYNE EJ, 1987, J CONSULT CLIN PSYCH, V55, P748, DOI 10.1037/0022-006X.55.5.748.
   {*}FRAM PHYS ACT IND, 1997, MED SCI SPORTS EX S, V29, P533.
   GARCIAPALMIERI MR, 1982, AM J CARDIOL, V50, P749, DOI 10.1016/0002-9149(82)91229-2.
   KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857.
   KIELY DK, 1994, AM J EPIDEMIOL, V140, P608, DOI 10.1093/oxfordjournals.aje.a117298.
   Lissner L, 1996, AM J EPIDEMIOL, V143, P54.
   MARCUS BH, 1992, HEALTH PSYCHOL, V11, P386, DOI 10.1037/0278-6133.11.6.386.
   PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804.
   PAFFENBARGER RS, 1984, JAMA-J AM MED ASSOC, V252, P491, DOI 10.1001/jama.252.4.491.
   PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x.
   Prior JC, 1996, CAN MED ASSOC J, V155, P940.
   PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102.
   SHERMAN SE, 1994, AM HEART J, V128, P879, DOI 10.1016/0002-8703(94)90583-5.
   SHERMAN SE, 1994, AM HEART J, V128, P965, DOI 10.1016/0002-8703(94)90596-7.
   SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402.
   STOKES J, 1987, CIRCULATION S5, V75.
   U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU.
   WANNAMETHEE G, 1992, BRIT MED J, V304, P597, DOI 10.1136/bmj.304.6827.597.
   Williams PT, 1997, ARCH INTERN MED, V157, P1774, DOI 10.1001/archinte.157.15.1774.},
Number-of-Cited-References = {24},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Am. Heart J.},
Doc-Delivery-Number = {251WD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000083468600015},
DA = {2022-03-29},
}

@article{ WOS:000518709300010,
Author = {Trosclair, Krystle and Dhaibar, Hemangini A. and Gautier, Nicole M. and
   Mishra, Vikas and Glasscock, Edward},
Title = {Neuron-specific Kv1.1 deficiency is sufficient to cause epilepsy,
   premature death, and cardiorespiratory dysregulation},
Journal = {NEUROBIOLOGY OF DISEASE},
Year = {2020},
Volume = {137},
Month = {APR},
Abstract = {Sudden unexpected death in epilepsy (SUDEP) is the leading cause of
   epilepsy-related mortality, but the precise cellular substrates involved
   remain elusive. Epilepsy-associated ion channel genes with co-expression
   in brain and heart have been proposed as SUDEP candidate genes since
   they provide a singular unifying link between seizures and lethal
   cardiac arrhythmias. Here, we generated a conditional knockout (cKO)
   mouse with neuron-specific deletion of Kenai, a SUDEP-associated gene
   with brain-heart co-expression, to test whether seizure-evoked cardiac
   arrhythmias and SUDEP require the absence of Kv1.1 in both brain and
   heart or whether ablation in neurons is sufficient. To obtain cKO mice,
   we developed a foxed Kcna1 mouse which we crossed to mice with the
   Synapsin1-Cre transgene, which selectively deletes Kcna1 in most
   neurons. Molecular analyses confirmed neuron-specific Kcna1 deletion in
   cKO mice and corresponding loss of Kv1.1 except in cerebellum where
   Synapsinl-Cre is not highly expressed. Survival studies and
   electroencephalography, electrocardiography, and plethysmography
   recordings showed that cK0 mice exhibit premature death, epilepsy, and
   cardiorespiratory dysregulation but to a lesser degree than global
   knockouts. Heart rate variability (HRV) was increased in cK0 mice with
   peaks during daytime suggesting disturbed diurnal HRV patterns as a
   SUDEP biomarker. Residual Kv1.1 expression in cKO cerebellum suggests it
   may play an unexpected role in regulating ictal cardiorespiratory
   dysfunction and SUDEP risk. This work demonstrates the principle that
   channelopathies with brain-heart expression patterns can increase death
   risk by brain-driven mechanisms alone without a functionally compromised
   heart, reinforcing seizure control as a primary clinical strategy for
   SUDEP prevention.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Glasscock, E (Corresponding Author), Southern Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.
   Trosclair, Krystle; Dhaibar, Hemangini A.; Gautier, Nicole M.; Mishra, Vikas; Glasscock, Edward, Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol \& Anat, Shreveport, LA 71103 USA.
   Glasscock, Edward, Southern Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.},
DOI = {10.1016/j.nbd.2020.104759},
Article-Number = {104759},
ISSN = {0969-9961},
EISSN = {1095-953X},
Keywords = {Kcna1; Kv1.1; Sudden unexpected death in epilepsy (SUDEP); Heart rate
   variability; Epilepsy; Apnea},
Keywords-Plus = {SUDDEN UNEXPECTED DEATH; HEART-RATE-VARIABILITY; POTASSIUM CHANNEL;
   MOUSE MODEL; MICE; MECHANISMS; EXPRESSION; DELETION; BRAIN; ACTIVATION},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Author-Email = {ktheri@lsuhsc.edu
   hdhaib@lsuhsc.edu
   ngauti@lsuhsc.edu
   vikasmishra12@gmail.com
   eglasscock@smu.edu},
ORCID-Numbers = {Mishra, Vikas/0000-0001-7162-5882},
Funding-Acknowledgement = {National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}R01NS100954,
   R01NS099188]; Malcolm Feist Predoctoral Fellowship from Louisiana State
   University Health Sciences Center-Shreveport (LSUHSC-S); Ike Muslow
   Predoctoral Fellowship from LSUHSC-S; Malcolm Feist Postdoctoral
   Fellowship from LSUHSC-S},
Funding-Text = {This work was supported by grants from the National Institutes of Health
   (R01NS100954 and R01NS099188 to E.G.); a Malcolm Feist Predoctoral
   Fellowship (to K.T.) from Louisiana State University Health Sciences
   Center-Shreveport (LSUHSC-S); an Ike Muslow Predoctoral Fellowship (to
   H.D.) from LSUHSC-S; and a Malcolm Feist Postdoctoral Fellowship (to
   V.M.) from LSUHSC-S. We would like to thank Oleg Chernyshev, M.D.
   (Department of Neurology at LSUHSC-S) for assistance with interpretation
   of EEG patterns. The address for Edward Glasscock is now the Department
   of Biological Sciences at Southern},
Cited-References = {Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050.
   Bagnall RD, 2016, ANN NEUROL, V79, P522, DOI 10.1002/ana.24596.
   Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2.
   CruzSanchez FF, 1997, J NEUROPATH EXP NEUR, V56, P340, DOI 10.1097/00005072-199704000-00002.
   DeGiorgio CM, 2010, EPILEPSY BEHAV, V19, P78, DOI 10.1016/j.yebeh.2010.06.011.
   Dhaibar H, 2019, NEUROBIOL DIS, V127, P502, DOI 10.1016/j.nbd.2019.04.006.
   Dlouhy BJ, 2016, J NEUROL NEUROSUR PS, V87, P402, DOI 10.1136/jnnp-2013-307442.
   Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179.
   Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153.
   Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999.
   Glasscock E, 2019, CHANNELS, V13, P299, DOI 10.1080/19336950.2019.1635864.
   Glasscock E, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0505-6.
   Glasscock E, 2014, EPILEPSY BEHAV, V38, P172, DOI 10.1016/j.yebeh.2013.09.019.
   Glasscock E, 2012, J PHYSIOL-LONDON, V590, P3913, DOI 10.1113/jphysiol.2012.235606.
   Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010.
   Goldman AM, 2016, EPILEPSIA, V57, P17, DOI 10.1111/epi.13232.
   Hallows JL, 1998, J NEUROSCI, V18, P5682.
   Jan LY, 2012, J PHYSIOL-LONDON, V590, P2591, DOI 10.1113/jphysiol.2011.224212.
   Jeppesen J, 2014, EPILEPSIA, V55, pE67, DOI 10.1111/epi.12614.
   Klassen TL, 2014, EPILEPSIA, V55, pE6, DOI 10.1111/epi.12489.
   Krook-Magnuson E, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0005-14.2014.
   Lavezzi AM, 2006, CURR MOL MED, V6, P429, DOI 10.2174/156652406777435381.
   Leu C, 2015, EBIOMEDICINE, V2, P1063, DOI 10.1016/j.ebiom.2015.07.005.
   Lhatoo SD, 2010, ANN NEUROL, V68, P787, DOI 10.1002/ana.22101.
   Loscher W, 2017, EPILEPSY BEHAV, V73, P214, DOI 10.1016/j.yebeh.2017.05.040.
   Massey CA, 2014, NAT REV NEUROL, V10, P271, DOI 10.1038/nrneurol.2014.64.
   May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004.
   Mishra V, 2018, J INSTRUM, V13, DOI 10.1088/1748-0221/13/11/T11003.
   Mishra V, 2017, HUM MOL GENET, V26, P2091, DOI 10.1093/hmg/ddx104.
   Moore BM, 2014, EPILEPSIA, V55, P1808, DOI 10.1111/epi.12793.
   Murphy TR, 2017, NEUROBIOL DIS, V104, P24, DOI 10.1016/j.nbd.2017.04.016.
   Myers KA, 2018, EPILEPSIA, V59, P1372, DOI 10.1111/epi.14438.
   Myers KA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2051.
   Peltola MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00148.
   Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183.
   Ren HX, 2013, DIABETES, V62, P3373, DOI 10.2337/db13-0597.
   Ruisu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074031.
   Ryvlin P, 2013, LANCET NEUROL, V12, P966, DOI 10.1016/S1474-4422(13)70214-X.
   Scorza FA, 2011, ARQ NEURO-PSIQUIAT, V69, P707, DOI 10.1590/S0004-282X2011000500024.
   Shields LBE, 2002, AM J FOREN MED PATH, V23, P307, DOI 10.1097/00000433-200212000-00001.
   Si M, 2019, AM J PHYSIOL-CELL PH, V316, pC154, DOI 10.1152/ajpcell.00335.2018.
   Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610.
   Simeone KA, 2016, EPILEPSIA, V57, pE178, DOI 10.1111/epi.13444.
   Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1.
   Smart SL, 1997, GLIA, V20, P127, DOI 10.1002/(SICI)1098-1136(199706)20:2<127::AID-GLIA4>3.0.CO;2-6.
   Thurman DJ, 2014, EPILEPSIA, V55, P1479, DOI 10.1111/epi.12666.
   Vanhoof-Villalba SL, 2018, EPILEPSIA, V59, P358, DOI 10.1111/epi.13978.
   WANG H, 1994, J NEUROSCI, V14, P4588.
   Xu Fadi, 2002, Cerebellum, V1, P35, DOI 10.1080/147342202753203078.
   Yang Z, 2018, EPILEPSY RES, V146, P151, DOI 10.1016/j.eplepsyres.2018.08.002.
   Yu T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003462.
   Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372.
   Yuskaitis CJ, 2019, HUM MOL GENET, V28, P2952, DOI 10.1093/hmg/ddz123.
   Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010.
   Zhou L, 1998, J NEUROSCI, V18, P7200.
   Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101.
   Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817.},
Number-of-Cited-References = {57},
Times-Cited = {11},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Neurobiol. Dis.},
Doc-Delivery-Number = {KT0OG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000518709300010},
OA = {hybrid, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000469879600004,
Author = {Fann, Neal and Coffman, Evan and Hajat, Anjum and Kim, Sun-Young},
Title = {Change in fine particle-related premature deaths among US population
   subgroups between 1980 and 2010},
Journal = {AIR QUALITY ATMOSPHERE AND HEALTH},
Year = {2019},
Volume = {12},
Number = {6},
Pages = {673-682},
Month = {JUN},
Abstract = {A multi-decade decline in the concentrations of fine particles (PM2.5)
   has benefited public health greatly by reducing the incidence of
   premature death and illnesses. A large body of literature has examined
   the change over time in this burden among the US population. However,
   less is known about these changes have affected subgroups most
   vulnerable and susceptible to poor air quality. In this study, we
   applied the results of an air quality prediction model that estimated
   changes in PM2.5 between 1980 and 2010 across all counties in the
   contiguous US. For the year 1980, we defined groups of vulnerable and
   susceptible populations according to attributes including county-level
   educational attainment, income, urbanicity, and all-cause death rate.
   Using a health impact function, we quantified PM2.5-attributable
   premature deaths for 1980 and 2010 among the overall US population as
   well as these subgroups. We then used the Atkinson index to explore the
   inequality in the absolute level and change in PM2.5 mortality among and
   between these subgroups. Between 1980 and 2010, total PM2.5 mortality
   risk declined for all groups. Risk inequality fell across all population
   groups and the risk experienced among each vulnerable and susceptible
   group became more equitably distributed. These results suggest that
   falling ambient PM2.5 concentrations over a 30-year period yield
   significant benefits among populations most susceptible and vulnerable
   to poor air quality. Furthermore, our results imply that policies
   including the Clean Air Act were effective at reducing health
   disparities.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Fann, N (Corresponding Author), US Environm Protect Agcy, Off Air Qual Planning \& Stand, Res Triangle Pk, NC 22207 USA.
   Fann, Neal, US Environm Protect Agcy, Off Air Qual Planning \& Stand, Res Triangle Pk, NC 22207 USA.
   Coffman, Evan, US Environm Protect Agcy, Off Res \& Dev, Res Triangle Pk, NC USA.
   Hajat, Anjum, Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   Kim, Sun-Young, Natl Canc Ctr, Grad Sch Canc Sci \& Policy, Dept Canc Control \& Populat Hlth, Goyang Si 10408, Gyeonggi Do, South Korea.},
DOI = {10.1007/s11869-019-00686-9},
ISSN = {1873-9318},
EISSN = {1873-9326},
Keywords = {Atkinson index; Gini coefficient; PM2.5; Mortality; Susceptible;
   Vulnerable},
Keywords-Plus = {AIR-POLLUTION EXPOSURE; GLOBAL BURDEN; HEALTH; INEQUALITY; DISEASE;
   TRENDS; RISK; STRATEGIES; MORTALITY; PM2.5},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {fann.neal@epa.gov},
ResearcherID-Numbers = {Fann, Neal/L-5446-2018},
ORCID-Numbers = {Fann, Neal/0000-0002-6724-8575},
Funding-Acknowledgement = {National Foundation of Korea (NRF) - Ministry of Education; Multi-Ethnic
   Study of Atherosclerosis and Air Pollution by the US Environmental
   Protection Agency (EPA) {[}RD 831697]; Ministry of Science and ICT in
   South Korea {[}2013R1A6A3A04059017, 2018R1A2B6004608];  {[}R00ES023498]},
Funding-Text = {AH was supported by R00ES023498. SYK was supported by the National
   Foundation of Korea (NRF) grants funded by the Ministry of Education and
   the Ministry of Science and ICT in South Korea (2013R1A6A3A04059017 and
   2018R1A2B6004608). Additional support was provided by the Multi-Ethnic
   Study of Atherosclerosis and Air Pollution by the US Environmental
   Protection Agency (EPA) (RD 831697). The EPA does not endorse any
   products or commercial services mentioned in this publication.},
Cited-References = {Bachmann J, 2007, J AIR WASTE MANAGE, V57, P652, DOI 10.3155/1047-3289.57.6.652.
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8.
   Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081.
   Chi GC, 2016, ENVIRON HEALTH PERSP, V124, P1840, DOI 10.1289/EHP199.
   Clark LP, 2017, ENVIRON HEALTH PERSP, V125, DOI {[}10.1289/EHP959, 10.1289/ehp959].
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166.
   De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969.
   Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747.
   Elbers C, 2005, RE INTERPRETING SUBG, DOI {[}10.1596/1813-9450-3687, DOI 10.1596/1813-9450-3687].
   Fann N, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP507.
   Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x.
   Fann N, 2011, RISK ANAL, V31, P908, DOI 10.1111/j.1539-6924.2011.01629.x.
   Hajat A, 2015, EPIDEMIOLOGY, V26, P310, DOI 10.1097/EDE.0000000000000267.
   Hand J, 2011, INTERAG MONIT PROT V.
   Hubbell BJ, 2009, AIR QUAL ATMOS HLTH, V2, P99, DOI 10.1007/s11869-009-0037-z.
   Hubbell BJ, 2010, REV ENV ECON POLICY, V4, P122, DOI 10.1093/reep/rep019.
   Jedrychowski W, 2009, ENVIRON INT, V35, P877, DOI 10.1016/j.envint.2009.03.004.
   Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x.
   Kim S-Y, 2015, UW BIOSTAT WORK PAP.
   Kim SY, 2017, ENVIRON HEALTH PERSP, V125, P38, DOI 10.1289/EHP131.
   Kim SY, 2015, ENVIRON HEALTH PERSP, V123, P651, DOI 10.1289/ehp.1307744.
   Kravitz-Wirtz N, 2016, DU BOIS REV, V13, P237, DOI 10.1017/S1742058X16000205.
   Krewski D., 2009, RES REP HLTH EFF I, V5, P115.
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5.
   Kunzli N, 2008, EPIDEMIOLOGY, V19, P179, DOI 10.1097/EDE.0b013e3181633c2f.
   Kunzli N, 2001, AM J EPIDEMIOL, V154, P974.
   Levy JL, 2002, ENVIRON HEALTH PERSP, V110, P1253, DOI 10.1289/ehp.021101253.
   Levy Jonathan I, 2006, Int J Equity Health, V5, P2, DOI 10.1186/1475-9276-5-2.
   Levy JI, 2007, ENVIRON HEALTH PERSP, V115, P743, DOI 10.1289/ehp.9712.
   Mahalingaiah S, 2015, REPROD SCI, V22, p214A.
   Martenies SE, 2018, AIR QUAL ATMOS HLTH, V11, P409, DOI 10.1007/s11869-017-0543-3.
   Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI {[}10.1146/annurev-environ-082508-094348, 10.1146/annurev.environ.082508-094348].
   Rosofsky A, 2018, ENVIRON RES, V161, P76, DOI 10.1016/j.envres.2017.10.028.
   Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255.
   Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313.
   Su JG, 2012, ENVIRON INT, V40, P79, DOI 10.1016/j.envint.2011.11.003.
   Su JG, 2009, ENVIRON SCI TECHNOL, V43, P7626, DOI 10.1021/es901041p.
   U.S. Environmental Protection Agency, 2018, OUR NAT AIR STAT TRE.
   U. S. EPA, 2009, EPA600R.
   U. S. EPA, 2012, REG IMP ASS PART MAT.
   Urrutia A. M., 2003, EC B, V4, P1.
   Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y.
   Wang JD, 2017, ENVIRON HEALTH PERSP, V125, P400, DOI 10.1289/EHP298.
   Zanobetti A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-48.},
Number-of-Cited-References = {45},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {Air Qual. Atmos. Health},
Doc-Delivery-Number = {IA9LV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000469879600004},
DA = {2022-03-29},
}

@article{ WOS:000355269300018,
Author = {Barquero-Calvo, Elias and Mora-Cartin, Ricardo and Arce-Gorvel, Vilma
   and de Diego, Juana L. and Chacon-Diaz, Carlos and Chaves-Olarte,
   Esteban and Guzman-Verri, Caterina and Buret, Andre G. and Gorvel,
   Jean-Pierre and Moreno, Edgardo},
Title = {Brucella abortus Induces the Premature Death of Human Neutrophils
   through the Action of Its Lipopolysaccharide},
Journal = {PLOS PATHOGENS},
Year = {2015},
Volume = {11},
Number = {5},
Month = {MAY},
Abstract = {Most bacterial infections induce the activation of polymorphonuclear
   neutrophils (PMNs), enhance their microbicidal function, and promote the
   survival of these leukocytes for protracted periods of time. Brucella
   abortus is a stealthy pathogen that evades innate immunity, barely
   activates PMNs, and resists the killing mechanisms of these phagocytes.
   Intriguing clinical signs observed during brucellosis are the low
   numbers of Brucella infected PMNs in the target organs and neutropenia
   in a proportion of the patients; features that deserve further
   attention. Here we demonstrate that B. abortus prematurely kills human
   PMNs in a dose-dependent and cell-specific manner. Death of PMNs is
   concomitant with the intracellular Brucella lipopolysaccharide (Br-LPS)
   release within vacuoles. This molecule and its lipid A reproduce the
   premature cell death of PMNs, a phenomenon associated to the low
   production of proinflammatory cytokines. Blocking of CD14 but not TLR4
   prevents the Br-LPS-induced cell death. The PMNs cell death departs from
   necrosis, NETosis and classical apoptosis. The mechanism of PMN cell
   death is linked to the activation of NADPH-oxidase and a modest but
   steadily increase of ROS mediators. These effectors generate DNA damage,
   recruitments of check point kinase 1, caspases 5 and to minor extent of
   caspase 4, RIP1 and Ca++ release. The production of IL-1 beta by PMNs
   was barely stimulated by B. abortus infection or Br-LPS treatment.
   Likewise, inhibition of caspase 1 did not hamper the Br-LPS induced PMN
   cell death, suggesting that the inflammasome pathway was not involved.
   Although activation of caspases 8 and 9 was observed, they did not seem
   to participate in the initial triggering mechanisms, since inhibition of
   these caspases scarcely blocked PMN cell death. These findings suggest a
   mechanism for neutropenia in chronic brucellosis and reveal a novel
   Brucella-host cross-talk through which B. abortus is able to hinder the
   innate function of PMN.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Barquero-Calvo, E (Corresponding Author), Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica.
   Barquero-Calvo, Elias; Mora-Cartin, Ricardo; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Moreno, Edgardo, Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica.
   Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Guzman-Verri, Caterina, Univ Costa Rica, Ctr Invest Enfermedades Trop, San Jose, Costa Rica.
   Arce-Gorvel, Vilma; Gorvel, Jean-Pierre, Aix Marseille Univ, UM2, CIML, Marseille, France.
   Arce-Gorvel, Vilma; Gorvel, Jean-Pierre, INSERM, U1104, F-13258 Marseille, France.
   Arce-Gorvel, Vilma; Gorvel, Jean-Pierre, CNRS, UMR7280, Marseille, France.
   de Diego, Juana L., Max Planck Inst Infect Biol, Dept Cell Microbiol, Berlin, Germany.
   Buret, Andre G., Univ Calgary, Biol Sci, Inflammat Res Network, Calgary, AB, Canada.
   Moreno, Edgardo, Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.},
DOI = {10.1371/journal.ppat.1004853},
Article-Number = {e1004853},
ISSN = {1553-7366},
EISSN = {1553-7374},
Keywords-Plus = {PROGRAMMED CELL-DEATH; TOLL-LIKE RECEPTOR-4; NADPH OXIDASE; TNF-ALPHA;
   IN-VITRO; BIOLOGICAL-ACTIVITIES; ROUGH STRAINS; III SECRETION;
   APOPTOSIS; PHAGOCYTOSIS},
Research-Areas = {Microbiology; Parasitology; Virology},
Web-of-Science-Categories  = {Microbiology; Parasitology; Virology},
Author-Email = {gorvel@ciml.univ-mrs.fr
   emoreno@racsa.co.cr},
ResearcherID-Numbers = {Gorvel, Jean-Pierre/O-1332-2018
   Guzman-Verri, Caterina/AAP-3074-2020
   },
ORCID-Numbers = {Gorvel, Jean-Pierre/0000-0002-2829-9804
   Guzman-Verri, Caterina/0000-0003-1036-920X
   BARQUERO-CALVO, ELIAS/0000-0003-4428-3340
   Arce-Gorvel, Vilma/0000-0003-0090-837X},
Funding-Acknowledgement = {grants Fondo Especial de la Educacion Superior (FEES-CONARE), Costa Rica
   {[}0500-13, 0504-13, 0505-13, 0248-13]; Fondation de la Recherche
   MedicaleFondation pour la Recherche Medicale; Fondation Mediterranee
   Infection; Centre National de la Recherche ScientifiqueCentre National
   de la Recherche Scientifique (CNRS); Institut National de la Sante et de
   la Recherche MedicaleInstitut National de la Sante et de la Recherche
   Medicale (Inserm); Aix-Marseille Universite; SEP-UCR; CONICIT-Costa Rica},
Funding-Text = {This work was partially supported by grants Fondo Especial de la
   Educacion Superior (FEES-CONARE) grant numbers 0500-13, 0504-13,
   0505-13, 0248-13, Costa Rica; the Fondation de la Recherche Medicale;
   The Fondation Mediterranee Infection; the Centre National de la
   Recherche Scientifique; the Institut National de la Sante et de la
   Recherche Medicale and the Aix-Marseille Universite. EB-C received a
   fellowship from SEP-UCR and CONICIT-Costa Rica. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.},
Cited-References = {ACKERMANN MR, 1988, VET PATHOL, V25, P28, DOI 10.1177/030098588802500104.
   Acorci MJ, 2009, SCAND J IMMUNOL, V69, P73, DOI 10.1111/j.1365-3083.2008.02199.x.
   AFFORD SC, 1992, J BIOL CHEM, V267, P21612.
   Aggarwal S, 2000, GENES IMMUN, V1, P271, DOI 10.1038/sj.gene.6363674.
   Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045.
   Altstaedt J, 1996, IMMUNOLOGY, V89, P563, DOI 10.1046/j.1365-2567.1996.d01-784.x.
   AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721.
   Anwar S, 2007, EXP LUNG RES, V33, P519, DOI 10.1080/01902140701756620.
   Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636.
   Baran J, 1996, INFECT IMMUN, V64, P4242, DOI 10.1128/IAI.64.10.4242-4248.1996.
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631.
   Barquero-Calvo E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003167.
   Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893.
   Bayraktutan U, 1998, CARDIOVASC RES, V38, P256, DOI 10.1016/S0008-6363(98)00003-0.
   BRAUDE AI, 1951, J INFECT DIS, V89, P87, DOI 10.1093/infdis/89.1.87.
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385.
   Brodsky IE, 2011, CURR BIOL, V21, pR72, DOI 10.1016/j.cub.2010.12.008.
   BUNDLE DR, 1989, INFECT IMMUN, V57, P2829, DOI 10.1128/IAI.57.9.2829-2836.1989.
   CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984.
   CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x.
   Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088.
   Chacon-Diaz C, 2011, VACCINE, V29, P577, DOI 10.1016/j.vaccine.2010.09.109.
   Chaves-Olarte E, 2014, METHODS MOL BIOL, V1197, P245, DOI 10.1007/978-1-4939-1261-2\_14.
   Chin AC, 2000, ANTIMICROB AGENTS CH, V44, P2465, DOI 10.1128/AAC.44.9.2465-2470.2000.
   COLOTTA F, 1992, BLOOD, V80, P2012.
   Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x.
   Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675.
   Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575.
   CROSBY E, 1984, J INFECT DIS, V150, P419, DOI 10.1093/infdis/150.3.419.
   Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000.
   DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa.
   Demir C, 2012, CHINESE MED J-PEKING, V125, P1871, DOI 10.3760/cma.j.issn.0366-6999.2012.11.006.
   DETEJADA GM, 1995, INFECT IMMUN, V63, P3054.
   Duenas AI, 2004, INT IMMUNOL, V16, P1467, DOI 10.1093/intimm/dxh148.
   El-Koumi MA, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.011.
   Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096.
   ESPINOZA AM, 1993, VIROLOGY, V195, P156, DOI 10.1006/viro.1993.1356.
   Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01\_4808\_4818.
   Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085.
   Forestier C, 1999, J IMMUNOL, V162, P6784.
   Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202.
   Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000.
   Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027.
   GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987.
   Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75.
   GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992.
   Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6.
   Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000.
   Iriarte M., 2004, Brucella: molecular and cellular biology, P159.
   JANEWAY CA, 1989, COLD SH Q B, V54, P1.
   Kamada S, 1997, CELL DEATH DIFFER, V4, P473, DOI 10.1038/sj.cdd.4400268.
   Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x.
   KOKKINI G, 1984, ARCH PATHOL LAB MED, V108, P213.
   KREUTZER DL, 1979, INFECT IMMUN, V23, P737, DOI 10.1128/IAI.23.3.737-742.1979.
   Kubler-Kielb J, 2013, CARBOHYD RES, V366, P33, DOI 10.1016/j.carres.2012.11.004.
   Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x.
   Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x.
   Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003.
   Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005.
   Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107.
   Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1.
   Lei M, 2012, VET MICROBIOL, V160, P362, DOI 10.1016/j.vetmic.2012.05.039.
   Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x.
   McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491.
   Meuth M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-21.
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x.
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960.
   Moreno E., 2004, Brucella: molecular and cellular biology, P287.
   MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990.
   MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981.
   Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772\_2772\_2783.
   Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x.
   Ocana MG, 2008, MOL IMMUNOL, V45, P2087, DOI 10.1016/j.molimm.2007.10.013.
   Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683.
   Olofsson Maria Haegg, 2008, BMC Chemical Biology, V8, P2, DOI 10.1186/1472-6769-8-2.
   ORDUNA A, 1991, Microbiologia (Madrid), V7, P113.
   PAYNE CM, 1994, MICROSC RES TECHNIQ, V28, P327, DOI 10.1002/jemt.1070280408.
   Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09.
   Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028.
   Prouty CC, 1934, J BACTERIOL, V27, P293, DOI 10.1128/JB.27.3.293-301.1934.
   RASOOL O, 1992, INFECT IMMUN, V60, P1699, DOI 10.1128/IAI.60.4.1699-1702.1992.
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208.
   RILEY LK, 1984, INFECT IMMUN, V46, P231, DOI 10.1128/IAI.46.1.231-236.1984.
   RILEY LK, 1984, INFECT IMMUN, V46, P224, DOI 10.1128/IAI.46.1.224-230.1984.
   Rodeberg DA, 1997, INFECT IMMUN, V65, P4747, DOI 10.1128/IAI.65.11.4747-4753.1997.
   ROJAS N, 1994, CLIN DIAGN LAB IMMUN, V1, P206, DOI 10.1128/CDLI.1.2.206-213.1994.
   Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8.
   ROOS D, 1980, J CLIN INVEST, V65, P1515, DOI 10.1172/JCI109817.
   Ruiz-Castaneda M., 1986, BRUCELOSIS.
   Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992.
   Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701.
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021.
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970.
   Scaife H, 2003, INFECT IMMUN, V71, P1995, DOI 10.1128/IAI.71.4.1995-2001.2003.
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304.
   Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011.
   STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341.
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126.
   Tumurkhuu G, 2006, MICROBIOL IMMUNOL, V50, P421, DOI 10.1111/j.1348-0421.2006.tb03810.x.
   Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861.
   van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768.
   Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000.
   Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309.
   Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005.
   Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118.
   Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593.
   Zwerdling A, 2009, MICROBES INFECT, V11, P689, DOI 10.1016/j.micinf.2009.04.010.},
Number-of-Cited-References = {107},
Times-Cited = {32},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {25},
Journal-ISO = {PLoS Pathog.},
Doc-Delivery-Number = {CJ1UF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000355269300018},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:A1983QE31900004,
Author = {VINNI, K},
Title = {PRODUCTIVITY LOSSES DUE TO ILLNESS, DISABILITY AND PREMATURE DEATH IN
   DIFFERENT OCCUPATIONAL GROUPS IN FINLAND},
Journal = {SOCIAL SCIENCE \& MEDICINE},
Year = {1983},
Volume = {17},
Number = {3},
Pages = {163-167},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB},
Type = {Article},
Language = {English},
Affiliation = {VINNI, K (Corresponding Author), UNIV TAMPERE,DEPT PUBL HLTH,SF-33101 TAMPERE 10,FINLAND.},
DOI = {10.1016/0277-9536(83)90249-6},
ISSN = {0277-9536},
Research-Areas = {Public, Environmental \& Occupational Health; Biomedical Social Sciences},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Social Sciences,
   Biomedical},
Cited-References = {Acton J., 1973, EVALUATING PUBLIC PR.
   {*}AS JA EL, 1978, SUOM VIR TIL.
   BAUMOL WJ, 1968, AM ECON REV, V58, P788.
   BERK A, 1978, MED CARE, V16, P785, DOI 10.1097/00005650-197809000-00009.
   Chiang C.L., 1968, INTRO STOCHASTIC PRO.
   COOPER BS, 1976, SOC SECUR BULL, V39, P21.
   CULLIS JG, 1977, EC HLTH INTRO.
   Dublin L. I., 1946, MONEY VALUE MAN.
   {*}FINL CENT STAT OF, 1979, 1978 STAT YB FINLAND.
   {*}FINL CENT STAT OF, 1979, 1975 POP HOUS CENS B, V1.
   FLESS JL, 1973, STATISTICAL METHODS.
   GUSTAFSSON F, 1979, KANSANELAKELAITOKSEN, V3, P31.
   HEMMINKI K, 1977, SOC SCI MED, V11, P827, DOI 10.1016/0037-7856(77)90122-6.
   Jones-Lee M, 1976, VALUE LIFE EC ANAL.
   KAITARANTA H, 1971, SOSIAALILAAKETIETEEL, V9, P79.
   {*}KANS, 1980, 1972 1976 UUD TYOK S.
   {*}KANS, 1977, 1974 1975 PAIV AMM V.
   LINDGREN B, 1981, COST ILLNESS SWEDEN.
   MISHAN EJ, 1971, J POLIT ECON, V79, P687, DOI 10.1086/259784.
   Mooney G.M, 1977, VALUATION HUMAN LIFE.
   NYMAN K, 1978, KANSANELAKELAITOKSEN.
   PAJULA J, 1979, INT SOC SEC REV, V32, P160.
   {*}POHJ AMM SUOM LAI, 1963, VALT KIRJ.
   RICE DP, 1967, JOM, V57, P424.
   RICE DP, 1967, JOM, V57, P1954.
   RINNE HJ, 1979, SOSIAALIVAKUUTUS, V6, P181.
   SAULI H, 1979, STUDIES CENTRAL STAT, V54.
   Titmuss R. M., 1971, GIFT RELATIONSHIP.},
Number-of-Cited-References = {28},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Soc. Sci. Med.},
Doc-Delivery-Number = {QE319},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1983QE31900004},
DA = {2022-03-29},
}

@article{ WOS:000579524400007,
Author = {Silvain, Johanne and Kerneis, Mathieu and Zeitouni, Michel and Lattuca,
   Benoit and Galier, Sophie and Brugier, Delphine and Mertens, Emilie and
   Procopi, Niki and Suc, Gaspard and Salloum, Tomy and Frisdal, Eric and
   Le Goff, Wilfried and Collet, Jean-Philippe and Vicaut, Eric and Lesnik,
   Philippe and Montalescot, Gilles and Guerin, Maryse},
Title = {Interleukin-1 beta and Risk of Premature Death in Patients With
   Myocardial Infarction},
Journal = {JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY},
Year = {2020},
Volume = {76},
Number = {15},
Pages = {1763-1773},
Month = {OCT 13},
Abstract = {BACKGROUND Inhibition of the interleukin (IL)-1 beta innate immunity
   pathway is associated with anti-inflammatory effects and a reduced risk
   of recurrent cardiovascular events in stable patients with previous
   myocardial infarction (MI) and elevated high-sensitivity C-reactive
   protein (hs-CRP).
   OBJECTIVES This study assessed the association between IL-1 beta level
   with all-cause mortality in patients with acute ST-segment elevation MI
   who underwent primary percutaneous coronary intervention and the
   interplay between IL-1 beta and hs-CRP concentrations on the risk of
   premature death.
   METHODS IL-1 beta concentration was measured in 1,398 patients with
   ST-segment elevation MI who enrolled in a prospective cohort. Crude and
   hazard ratios for all-cause and cardiovascular mortality were analyzed
   at 90 days and 1 year using multivariate Cox proportional regression
   analysis. Major adverse cardiovascular events (MACEs) were analyzed.
   RESULTS IL-1 beta concentration measured at admission was associated
   with all-cause mortality at 90 days (adjusted hazard ratio {[}adjHR]:
   1.47 per 1 SD increase; 95\% confidence interval {[}CI]: 1.16 to 1.87; p
   < 0.002). The relation was nonlinear, and the highest tertile of IL-1
   beta was associated with higher mortality rates at 90 days (adjHR: 2.78;
   95\% CI: 1.61 to 4.79; p = 0.0002) and at 1 year (adjHR: 1.93; 95\% CI:
   1.21 to 3.06; p = 0.005), regardless of the hs-CRP concentration.
   Significant relationships were equally observed when considering
   cardiovascular mortality and MACEs at 90 days (adjHR: 2.42; 95\% CI:
   1.36 to 4.28; p = 0.002, and adjHR: 2.29; 95\% CI: 1.31 to 4.01; p =
   0.004, respectively) and at 1 year (adjHR: 2.32; 95\% CI: 1.36 to 3.97;
   p = 0.002, and adjHR: 2.35; 95\% CI: 1.39 to 3.96; p = 0.001,
   respectively).
   CONCLUSIONS IL-1 beta measured at admission in patients with acute MI
   was independently associated with the risk of mortality and recurrent
   MACEs. (C) 2020 by the American College of Cardiology Foundation.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Montalescot, G (Corresponding Author), Sorbonne Univ, ACT Study Grp, ICAN Inst CardioMetab \& Nutr,Inst Cardiol, INSERM,UMRS1166,Hop Pitie Salpetriere,AP HP, Paris, France.
   Montalescot, G (Corresponding Author), Hop Pitie, INSERM, UMRSH66, Paris, France.
   Montalescot, G (Corresponding Author), Sorbonne Univ, Paris, France.
   Montalescot, G (Corresponding Author), Hop Pitie, ICAN Inst CardioMetab \& Nutr, Paris, France.
   Silvain, Johanne; Kerneis, Mathieu; Zeitouni, Michel; Lattuca, Benoit; Brugier, Delphine; Mertens, Emilie; Procopi, Niki; Suc, Gaspard; Salloum, Tomy; Collet, Jean-Philippe; Montalescot, Gilles, Sorbonne Univ, ACT Study Grp, ICAN Inst CardioMetab \& Nutr,Inst Cardiol, INSERM,UMRS1166,Hop Pitie Salpetriere,AP HP, Paris, France.
   Silvain, Johanne; Kerneis, Mathieu; Zeitouni, Michel; Lattuca, Benoit; Galier, Sophie; Brugier, Delphine; Frisdal, Eric; Le Goff, Wilfried; Collet, Jean-Philippe; Lesnik, Philippe; Montalescot, Gilles; Guerin, Maryse, Hop Pitie, INSERM, UMRSH66, Paris, France.
   Silvain, Johanne; Kerneis, Mathieu; Zeitouni, Michel; Lattuca, Benoit; Galier, Sophie; Brugier, Delphine; Frisdal, Eric; Le Goff, Wilfried; Collet, Jean-Philippe; Lesnik, Philippe; Montalescot, Gilles; Guerin, Maryse, Sorbonne Univ, Paris, France.
   Silvain, Johanne; Kerneis, Mathieu; Zeitouni, Michel; Lattuca, Benoit; Galier, Sophie; Brugier, Delphine; Frisdal, Eric; Le Goff, Wilfried; Collet, Jean-Philippe; Lesnik, Philippe; Montalescot, Gilles; Guerin, Maryse, Hop Pitie, ICAN Inst CardioMetab \& Nutr, Paris, France.
   Vicaut, Eric, Hop Fernand Widal, AP HP, ACT Study Grp, Unite Rech Clin, Paris, France.},
DOI = {10.1016/j.jacc.2020.08.026},
ISSN = {0735-1097},
EISSN = {1558-3597},
Keywords = {C-reactive protein; inflammation; interleukin-1 beta; mortality;
   myocardial infarction},
Keywords-Plus = {C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; HEART-FAILURE;
   INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION; REDUCTION; MORTALITY;
   MARKERS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {gilles.montalescot@aphp.fr},
ResearcherID-Numbers = {Guerin, Maryse/N-5794-2017
   Le Goff, Wilfried/N-6326-2017
   Lesnik, Philippe/AAD-7393-2020
   Zeitouni, Michel/AAE-1230-2021
   Le Goff, Wilfried/N-7593-2019
   },
ORCID-Numbers = {Le Goff, Wilfried/0000-0002-7611-9644
   Lesnik, Philippe/0000-0002-6909-7715
   Le Goff, Wilfried/0000-0002-7611-9644
   Kerneis, Mathieu/0000-0002-7141-5209
   GUERIN, Maryse/0000-0003-0150-1360
   Galier, Sophie/0000-0002-8094-3409},
Funding-Acknowledgement = {ACTION Coeur study group; Institut National de la Sante et de la
   Recherche Medicale (INSERM)Institut National de la Sante et de la
   Recherche Medicale (Inserm); Sorbonne University; Institute of
   CardioMetabolism and Nutrition (ICAN); French National Agency through
   the national program Investissements d'Avenir GrantFrench National
   Research Agency (ANR) {[}ANR-10-IAHU-05]; Institut Servier; Federation
   Francaise de Cardiologie; Sanofi; ServierServier; Daiichi-SankyoDaiichi
   Sankyo Company Limited},
Funding-Text = {This work was supported by the ACTION Coeur study group, the Institut
   National de la Sante et de la Recherche Medicale (INSERM), Sorbonne
   University, the Institute of CardioMetabolism and Nutrition (ICAN), and
   by the French National Agency through the national program
   Investissements d'Avenir Grant ANR-10-IAHU-05. Dr. Silvain has received
   consulting fees or lecture fees or travel support from AstraZeneca,
   Bayer HealthCare SAS, Boehringer Ingelheim France, CSL Behring SA,
   Gilead Science, Sanofi-Aventis France, Terumo France SAS, and Abbott
   Medical France SAS; and holds stock in Pharmaseeds. Dr. Kerneis has
   received research grants from Institut Servier, Federation Francaise de
   Cardiologie, and Sanofi; and has received consulting fees from Bayer,
   Sanofi, and Servier. Dr. Zeitouni has received research grants from
   Servier and the Federation Francaise de Cardiologie. Dr. Lattuca has
   received research grants from Daiichi-Sankyo and the Federation
   Francaise de Cardiologie; has received consultant fees from
   Daiichi-Sankyo and Eli Lilly; and has received lecture fees from
   AstraZeneca. Dr. Vicaut has received consulting or speaker fees from
   Abbott, Bristol Myers Squibb, Celgene, Edwards, Pfizer, Sanofi, and
   Novartis. Dr. Collet has received research grants or honorarium from
   AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi-Sankyo, Eli Lilly, the
   Federation Francaise de Cardiologie, Lead-Up, Medtronic, MSD, Sanofi,
   and WebMD, all outside of the submitted work. Dr. Montalescot has
   received research grants or honorarium from ADIR, Amgen, AstraZeneca,
   Bayer, Berlin Chimie AG, Boehringer Ingelheim, Bristol Myers Squibb,
   Beth Israel Deaconess Medical, Brigham Women's Hospital, Cardiovascular
   Research Foundation, Celladon, CME Resources, Daiichi-Sankyo, Eli Lilly,
   Europa, Elsevier, the Federation Francaise de Cardiologie, Fondazione
   Anna Maria Sechi per il Cuore, Gilead, ICAN, Janssen, Lead-Up, Menarini,
   Medtronic, MSD, Pfizer, Sanofi, Servier, The Medicines Company, TIMI
   Study Group, and WebMD, all outside of the submitted work. All other
   authors have reported that they have no relationships relevant to the
   contents of this paper to disclose. Paul M Ridker, MD, MPH, served as
   Guest Associate Editor for this paper. Deepak L. Bhatt, MD, MPH, served
   as Guest Editor-in-Chief for this paper.},
Cited-References = {Buckley LF, 2018, EUR HEART J, V39, P2063, DOI 10.1093/eurheartj/ehy128.
   Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800.
   Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417.
   Everett BM, 2019, J AM COLL CARDIOL, V73, P1026, DOI 10.1016/j.jacc.2019.01.005.
   Everett BM, 2019, CIRCULATION, V139, P1289, DOI 10.1161/CIRCULATIONAHA.118.038010.
   Fanola CL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005637.
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI {[}10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005].
   Guerin M, 2018, J AM COLL CARDIOL, V72, P3259, DOI 10.1016/j.jacc.2018.09.080.
   Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1.
   LIBBY P, 1986, AM J PATHOL, V124, P179.
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009.
   Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107.
   Morton AC, 2015, EUR HEART J, V36, P377, DOI 10.1093/eurheartj/ehu272.
   Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070.
   Pascual-Figal DA, 2019, J AM COLL CARDIOL, V73, P1016, DOI 10.1016/j.jacc.2018.11.054.
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914.
   Ridker PM, 2018, EUR HEART J, V39, P4109, DOI 10.1093/eurheartj/ehy723.
   Ridker PM, 2018, EUR HEART J, V39, P3499, DOI 10.1093/eurheartj/ehy310.
   Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3.
   Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202.
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207.
   Sager HB, 2015, CIRCULATION, V132, P1880, DOI 10.1161/CIRCULATIONAHA.115.016160.
   Suzuki K, 2001, CIRCULATION, V104, pI308.
   Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388.
   Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9.
   Van Tassell BW, 2018, CLIN CARDIOL, V41, P1004, DOI 10.1002/clc.22988.},
Number-of-Cited-References = {26},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Am. Coll. Cardiol.},
Doc-Delivery-Number = {OD0DF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000579524400007},
DA = {2022-03-29},
}

@article{ WOS:000076571900012,
Author = {Puska, P and Vartiainen, E and Tuomilehto, J and Salomaa, V and
   Nissinen, A},
Title = {Changes in premature deaths in Finland: successful long-term prevention
   of cardiovascular diseases},
Journal = {BULLETIN OF THE WORLD HEALTH ORGANIZATION},
Year = {1998},
Volume = {76},
Number = {4},
Pages = {419-425},
Abstract = {This article describes the long-term consequences of successful
   cardiovascular disease (CVD) prevention and its influence on premature
   mortality in Finland, with special reference to North Karelia. Active
   community-based CVD prevention began in 1972 in the province of North
   Karelia (population, 180 000). Since 1977, active preventive work has
   been carried out nationwide, taking advantage of the experience from
   North Karelia, which continued as a demonstration area for integrated
   prevention of noncommunicable diseases. Comprehensive community-based
   interventions as part of WHO Interhealth and CINDI programmes in North
   Karelia and nationwide aimed at changing the target risk factors and
   health behaviours (serum cholesterol, blood pressure, smoking, diet) at
   the population level. Age-adjusted mortality rates for CVD, coronary
   heart disease (CHD), cerebrovascular disease, all cancers, lung cancer
   accidents and violence, and all causes in the population aged 35-64
   years from the pre-programme period (1969-71) to 1995 were the main
   measures of the outcome.
   Among men there was a great reduction in deaths from CHD, CVD, cancer,
   and all causes in the whole country. From 1969-71 to 1995 the
   age-standardized CHD mortality (per 100 000) decreased in North Karelia
   by 73\% (from 672 to 185) and nationwide by 65\% (Prom 465 to 165). The
   reduction in CVD mortality was of the same magnitude. Among men, CHD
   mortality decreased in the 1970s, as did lung cancer mortality in the
   1980s and 1990s, significantly more in North Karelia than in all of
   Finland. Among women there was a great reduction in CVD (including CHD
   and stroke) mortality and all-causes mortality, but only a small
   reduction in cancer mortality. These results show that a major reduction
   in CVD mortality among the working-age population can take place in
   association with active reduction of major risk factors, with a
   favourable impact on cancer and all-causes mortality.},
Publisher = {WORLD HEALTH ORGANIZATION},
Address = {MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Puska, P (Corresponding Author), Natl Publ Hlth Inst, Div Hlth \& Chron Dis, Mannerheimintie 166, SF-00300 Helsinki, Finland.
   Natl Publ Hlth Inst, Div Hlth \& Chron Dis, SF-00300 Helsinki, Finland.
   Natl Publ Hlth Inst, Risk Factors \& Prevent Unit, SF-00300 Helsinki, Finland.
   Natl Publ Hlth Inst, Diabet \& Genet Epidemiol Unit, SF-00300 Helsinki, Finland.
   Natl Publ Hlth Inst, Cardiovasc Dis Unit, SF-00300 Helsinki, Finland.
   Univ Kuopio, Dept Community Hlth \& Gen Practice, FIN-70211 Kuopio, Finland.},
ISSN = {0042-9686},
EISSN = {1564-0604},
Keywords-Plus = {FACTORS EXPLAIN CHANGES; CORONARY HEART-DISEASE; RISK-FACTORS;
   MORTALITY; CHOLESTEROL; DECLINE; TRENDS; STROKE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {BOLANDER AM, 1971, STAT REPORTS BE, P9.
   MUSTANIEMI H, 1993, THESIS U KUOPIO.
   Ovcarov V K, 1978, World Health Stat Q, V31, P208.
   Puska P, 1996, CARDIOVASC RISK FACT, V6, P203.
   Puska P, 1993, Eur J Cancer Prev, V2, P457.
   PUSKA P, 1997, SMOKEFREE EUROPE FOR.
   PUSKA P, 1995, N KARELIA PROJECT 20.
   PUSKA P, 1981, COMMUNITY CONTROL CA.
   Salomaa V, 1996, CIRCULATION, V94, P3130, DOI 10.1161/01.CIR.94.12.3130.
   SALONEN JT, 1983, BRIT MED J, V286, P1857, DOI 10.1136/bmj.286.6381.1857.
   Tuomilehto J, 1996, STROKE, V27, P825, DOI 10.1161/01.STR.27.5.825.
   TUOMILEHTO J, 1989, INT J EPIDEMIOLOG S1, V3, pS109.
   VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495.
   VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23.
   VARTIAINEN E, 1994, BRIT MED J, V309, P445, DOI 10.1136/bmj.309.6952.445.
   VARTIAINEN E, 1995, BMJ-BRIT MED J, V310, P901, DOI 10.1136/bmj.310.6984.901.
   {[}No title captured].},
Number-of-Cited-References = {17},
Times-Cited = {124},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Bull. World Health Organ.},
Doc-Delivery-Number = {131JF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000076571900012},
DA = {2022-03-29},
}

@article{ WOS:000367249900018,
Author = {Turner, Matthew D. and Henze, Daven K. and Capps, Shannon L. and Hakami,
   Amir and Zhao, Shunliu and Resler, Jaroslav and Carmichael, Gregory R.
   and Stanier, Charles O. and Baek, Jaemeen and Sandu, Adrian and Russell,
   Armistead G. and Nenes, Athanasios and Pinder, Rob W. and Napelenok,
   Sergey L. and Bash, Jesse O. and Percell, Peter B. and Chai, Tianfeng},
Title = {Premature deaths attributed to source-specific BC emissions in six urban
   US regions},
Journal = {ENVIRONMENTAL RESEARCH LETTERS},
Year = {2015},
Volume = {10},
Number = {11},
Month = {NOV},
Abstract = {Recent studies have shown that exposure to particulate black carbon (BC)
   has significant adverse health effects and may be more detrimental to
   human health than exposure to PM2.5 as a whole. Mobile source BC
   emission controls, mostly on diesel-burning vehicles, have successfully
   decreased mobile source BC emissions to less than half of what they were
   30 years ago. Quantification of the benefits of previous emissions
   controls conveys the value of these regulatory actions and provides a
   method by which future control alternatives could be evaluated. In this
   study we use the adjoint of the Community Multiscale Air Quality (CMAQ)
   model to estimate highly-resolved spatial distributions of benefits
   related to emission reductions for six urban regions within the
   continental US. Emissions from outside each of the six chosen regions
   account for between 7\% and 27\% of the premature deaths attributed to
   exposure to BC within the region. While we estimate that nonroad mobile
   and onroad diesel emissions account for the largest number of premature
   deaths attributable to exposure to BC, onroad gasoline is shown to have
   more than double the benefit per unit emission relative to that of
   nonroad mobile and onroad diesel. Within the region encompassing New
   York City and Philadelphia, reductions in emissions from large
   industrial combustion sources that are not classified as EGUs (i.e.,
   non-EGU) are estimated to have up to triple the benefits per unit
   emission relative to reductions to onroad diesel sectors, and provide
   similar benefits per unit emission to that of onroad gasoline emissions
   in the region. While onroad mobile emissions have been decreasing in the
   past 30 years and a majority of vehicle emission controls that regulate
   PM focus on diesel emissions, our analysis shows the most efficient
   target for stricter controls is actually onroad gasoline emissions.},
Publisher = {IOP PUBLISHING LTD},
Address = {TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Turner, MD (Corresponding Author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   Turner, Matthew D.; Henze, Daven K.; Capps, Shannon L., Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   Hakami, Amir; Zhao, Shunliu, Carleton Univ, Dept Civil \& Environm Engn, Ottawa, ON K1S 5B6, Canada.
   Resler, Jaroslav, Inst Comp Sci, Nonlinear Modeling, Prague 18207, Czech Republic.
   Carmichael, Gregory R.; Stanier, Charles O.; Baek, Jaemeen, Univ Iowa, Dept Chem \& Biochem Engn, Iowa City, IA 52242 USA.
   Sandu, Adrian, Virginia Tech, Comp Sci, Blacksburg, VA 24061 USA.
   Russell, Armistead G., Georgia Tech, Sch Civil \& Environm Engn, Atlanta, GA 30331 USA.
   Nenes, Athanasios, Georgia Tech, Sch Earth \& Atmospher Sci, Atlanta, GA 30331 USA.
   Pinder, Rob W.; Napelenok, Sergey L.; Bash, Jesse O., US EPA, Atmospher Modeling \& Anal Div, Res Triangle Pk, NC 27711 USA.
   Percell, Peter B., Univ Houston, Dept Geosci, Houston, TX 77004 USA.
   Chai, Tianfeng, Univ Maryland, Coll Comp Math \& Nat Sci, College Pk, MD 20742 USA.},
DOI = {10.1088/1748-9326/10/11/114014},
Article-Number = {114014},
ISSN = {1748-9326},
Keywords = {source attribution; particulate matter; aerosols; air quality; human
   well-being},
Keywords-Plus = {MULTIMODEL ENSEMBLE SIMULATIONS; FINE PARTICULATE MATTER; LONG-TERM
   EXPOSURE; AIR-POLLUTION; BLACK CARBON; UNITED-STATES; BLOOD-PRESSURE;
   PUBLIC-HEALTH; GLOBAL BURDEN; MORTALITY},
Research-Areas = {Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences},
Web-of-Science-Categories  = {Environmental Sciences; Meteorology \& Atmospheric Sciences},
Author-Email = {matthew.d.turner@colorado.edu},
ResearcherID-Numbers = {Resler, Jaroslav/AAP-5726-2020
   Capps, Shannon/E-5602-2017
   Stanier, Charles O/D-4307-2016
   Resler, Jaroslav/E-6097-2014
   Chai, TF/I-5893-2019
   Chai, Tianfeng/E-5577-2010
   Capps, Shannon/H-7499-2013
   },
ORCID-Numbers = {Resler, Jaroslav/0000-0003-3847-7624
   Capps, Shannon/0000-0002-6872-6604
   Stanier, Charles O/0000-0001-9924-0853
   Chai, TF/0000-0003-3520-2641
   Chai, Tianfeng/0000-0003-3520-2641
   Capps, Shannon/0000-0002-6872-6604
   Hakami, Amir/0000-0003-3122-9548
   Bash, Jesse/0000-0001-8736-0102
   Zhao, Shunliu/0000-0003-0738-1048
   Turner, Matthew/0000-0001-8529-6709},
Funding-Acknowledgement = {NASA Applied Sciences ProgramNational Aeronautics \& Space
   Administration (NASA) {[}NNX09AN77G]; Research Participation Program at
   the Office of Research and Development, US EPA},
Funding-Text = {This research was supported by NASA Applied Sciences Program grant
   NNX09AN77G. This paper has been subjected to the United States
   Environmental Protection Agency's administrative review and approved for
   publication but solely reflects the views of the authors. Shannon L
   Capps was supported by an appointment to the Research Participation
   Program at the Office of Research and Development, US EPA, administered
   by ORISE.},
Cited-References = {Adar SD, 2007, EPIDEMIOLOGY, V18, P95, DOI 10.1097/01.ede.0000249409.81050.46.
   Anenberg SC, 2011, ATMOS CHEM PHYS, V11, P7253, DOI 10.5194/acp-11-7253-2011.
   Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   Bastien LAJ, 2015, ENVIRON SCI TECHNOL, V49, P7276, DOI 10.1021/acs.est.5b00686.
   Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767.
   Bell ML, 2008, AM J EPIDEMIOL, V167, P986, DOI 10.1093/aje/kwm396.
   Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC.
   Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752.
   Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636.
   Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081.
   {[}Cambridge Systematics and Arellano Associates AECOM], 2013, CAL STAT RAIL PLAN.
   Cohen A. J., 2004, COMP QUANTIFICATION, V2, P1353.
   Dallmann TR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013862.
   Dedoussi IC, 2014, ATMOS ENVIRON, V99, P610, DOI 10.1016/j.atmosenv.2014.10.033.
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b.
   {[}EPA US], 2012, 2 US EPA.
   {[}EPA US], 2001, CONTR AIR POLL NEW M.
   {[}EPA US], 2012, TECHNICAL REPORT.
   EPA U S, 2009, EPA600R08139F.
   Fann N, 2013, ENVIRON SCI TECHNOL, V47, P3580, DOI 10.1021/es304831q.
   Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x.
   Fann N, 2009, AIR QUAL ATMOS HLTH, V2, P169, DOI 10.1007/s11869-009-0044-0.
   Finkelstein MM, 2003, CAN MED ASSOC J, V169, P397.
   Flachs EM, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/760259.
   Flanagan JB, 2006, J AIR WASTE MANAGE, V56, P492, DOI 10.1080/10473289.2006.10464516.
   Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021.
   Grahame TJ, 2014, J AIR WASTE MANAGE, V64, P620, DOI 10.1080/10962247.2014.912692.
   Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667.
   Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369.
   Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098.
   Koch D, 2009, ATMOS CHEM PHYS, V9, P9001, DOI 10.5194/acp-9-9001-2009.
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5.
   Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC.
   Lee CJ, 2015, ENVIRON SCI TECHNOL, V49, P4335, DOI 10.1021/acs.est.5b00873.
   Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660.
   Li Y, 2016, AIR QUAL ATMOS HLTH, V9, P51, DOI 10.1007/s11869-015-0321-z.
   Malm WC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003739.
   McDonald BC, 2015, ENVIRON SCI TECHNOL, V49, P5178, DOI 10.1021/es505912b.
   Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04.
   Mesbah SM, 2013, ENVIRON SCI TECHNOL, V47, P13528, DOI 10.1021/es402531n.
   Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591.
   Murray, 2004, COMP QUANTIFICATION, V2.
   Neidell MJ, 2004, J HEALTH ECON, V23, P1209, DOI 10.1016/j.jhealeco.2004.05.002.
   Pappin AJ, 2013, ENVIRON SCI TECHNOL, V47, P13519, DOI 10.1021/es4024145.
   Pappin AJ, 2013, ENVIRON HEALTH PERSP, V121, P572, DOI 10.1289/ehp.1205561.
   Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767.
   Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572.
   Punger EM, 2013, AIR QUAL ATMOS HLTH, V6, P563, DOI 10.1007/s11869-013-0197-8.
   Qiao LP, 2014, ENVIRON SCI TECHNOL, V48, P10406, DOI 10.1021/es501305k.
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005.
   Sportisse B, 2006, J GEOPHYS RES-ATMOS, V11.
   Stevenson DS, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006338.
   Su JG, 2009, ENVIRON SCI TECHNOL, V43, P7626, DOI 10.1021/es901041p.
   Suh HH, 2010, J OCCUP ENVIRON MED, V52, P685, DOI 10.1097/JOM.0b013e3181e8071f.
   Thompson TM, 2012, ATMOS CHEM PHYS, V12, P9753, DOI 10.5194/acp-12-9753-2012.
   Turner MD, 2015, ENVIRON SCI TECHNOL, V49, P4362, DOI 10.1021/es505968b.
   van Noije TPC, 2006, ATMOS CHEM PHYS, V6, P2943, DOI 10.5194/acp-6-2943-2006.
   WHO, 2006, JOINT WHO CONV TASK, P169.
   Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002.
   Wilker EH, 2013, ENVIRON HEALTH PERSP, V121, P1061, DOI 10.1289/ehp.1104845.
   Wilker EH, 2010, ENVIRON HEALTH PERSP, V118, P943, DOI 10.1289/ehp.0901440.
   World Health Organization, 2012, TECHNICAL REPORT.
   Zhao SL, 2013, GEOPHYS RES LETT, V40, P5559, DOI 10.1002/2013GL057623.},
Number-of-Cited-References = {65},
Times-Cited = {12},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {42},
Journal-ISO = {Environ. Res. Lett.},
Doc-Delivery-Number = {CZ6ZO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000367249900018},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000251653900008,
Author = {Tolson, Gerald H. Jerry and Cuyjet, Michael J.},
Title = {Jazz and substance abuse: Road to creative genius or pathway to
   premature death},
Journal = {INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY},
Year = {2007},
Volume = {30},
Number = {6},
Pages = {530-538},
Month = {NOV-DEC},
Note = {29th International Conference of the
   International-Academy-of-Law-and-Mental-Health, Paris, FRANCE, JUL
   04-10, 2005},
Organization = {Int Acad Law \& Mental Hlth},
Abstract = {Jazz music and jazz musicians have often been linked for better or worse
   to the world of addictive substances. Many talented jazz musicians
   either had their careers sidetracked or prematurely ended due to their
   addiction to drugs and/or alcohol. The rigors of nightly performances,
   travel, and for many musicians a disapproving society exacted a toll
   that impacted the creativity of many artists of the genre. The fact that
   drug and alcohol use had a significant impact on the performance levels
   of numerous jazz musicians in the 1940's and 1950's has been much
   discussed, but more study of that impact is warranted. While recent
   research has provided new information regarding this challenging topic,
   there is still much to learn. Indeed, a number of questions for inquiry
   may be posed. Among those questions are the following: Was the work of
   these jazz artists truly inspired? Would their creative output have been
   enhanced had they not been addicted to substances? What was the impact
   of the addictive substances on their ability to function as creative
   artists and is there evidence to refute or verify that impact? Are there
   identifiable traits in certain artists that allowed them to be creative
   in spite of their addictions? This examination presents an evaluation of
   the evidence of the link between creativity and substance abuse
   especially as it relates to selected jazz artists during this time
   period and how they remained creative and actually prospered in their
   careers in spite of addictions to controlled substances. (c) 2007
   Published by Elsevier Inc.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Tolson, GHJ (Corresponding Author), Univ Louisville, Sch Mus, Jamey Aebersold Jazz Studies Program, Louisville, KY 40292 USA.
   Tolson, Gerald H. Jerry, Univ Louisville, Sch Mus, Jamey Aebersold Jazz Studies Program, Louisville, KY 40292 USA.
   Cuyjet, Michael J., Univ Louisville, Coll Educ \& Human Dev, Louisville, KY 40292 USA.},
DOI = {10.1016/j.ijlp.2007.09.004},
ISSN = {0160-2527},
Keywords-Plus = {MUSICIANS},
Research-Areas = {Government \& Law; Psychiatry},
Web-of-Science-Categories  = {Law; Psychiatry},
Author-Email = {jerry.tolson@louisville.edu
   Cuyjet@louisville.edu},
Cited-References = {ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288.
   BROWN L, 1961, ENIGMA DRUG ADDICTIO.
   Chesky KS, 1999, MED PROBL PERFORM AR, V14, P187.
   Collier James Lincoln, 1978, MAKING JAZZ COMPREHE.
   DAVIS Miles, 1989, MILES AUTOBIOGRAPHY.
   FITTERLING T, 1997, THELONIUS MONKS HIS.
   HAWES H., 1979, RAISE ME PORTRAIT HA.
   Hentoff Nat, 1961, JAZZ LIFE.
   Jung J., 2001, PSYCHOL ALCOHOL OTHE.
   KEEPNEWS O, 1988, VIEW JAZZ WRITING 19.
   KERR B, 1991, J CREATIVE BEHAV, V25, P145, DOI 10.1002/j.2162-6057.1991.tb01364.x.
   Krystal H, 1970, DRUG DEPENDENCE ASPE.
   LEES G, 1990, MEET ME JIM ANDYS JA.
   MAGGIN DL, 1996, STAN GETZ LIFE JAZZZ.
   MICHAEL B, LADY DAY MANY FACES.
   NICHOLSON S, 1995, BILLY HOLIDAY.
   OWENS T, 1995, BEBOP MUSIC ITS PLAY.
   Rauch L, 2000, J PSYCHOACTIVE DRUGS, V32, P343, DOI 10.1080/02791072.2000.10400459.
   Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x.
   Smale R, 2001, J Psychiatr Ment Health Nurs, V8, P459.
   Spencer Frederick J., 2002, JAZZ DEATH MED PROFI.
   Ten Berge J, 1999, J CREATIVE BEHAV, V33, P257.
   TODD J, 1968, PRACTITIONER, V201, P513.
   WARD GC, 2000, JAZZ HIST AM MUSIC.
   {*}WHO, 1957, WHO TECHNICAL REPORT, V116.
   Wills GI, 2003, BRIT J PSYCHIAT, V183, P255, DOI 10.1192/bjp.183.3.255.
   WINICK C, 1961, AM J ORTHOPSYCHIAT, V31, P622, DOI 10.1111/j.1939-0025.1961.tb02161.x.
   WINICK C, SOCIAL PROBLEMS, P7.
   YARDLEY J, 1990, ALL JIVE.
   {[}No title captured].},
Number-of-Cited-References = {30},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {19},
Journal-ISO = {Int. J. Law Psychiatr.},
Doc-Delivery-Number = {241JY},
Web-of-Science-Index = {Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000251653900008},
DA = {2022-03-29},
}

@article{ WOS:000639333200004,
Author = {Azarbakhsh, Habibollah and Mirahmadizadeh, Alireza and Rostami, Maryam
   and Vali, Mohebat},
Title = {Mortality Rate and Years of Life Lost, Due to Premature Death Caused by
   COVID-19 In Iran, Ahvaz Jundishapur University of Medical Sciences},
Journal = {MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS},
Year = {2021},
Volume = {10},
Abstract = {Introduction: The emerging and evolving situation of Coronavirus
   disaese-2019 (COVID-19) threatens the health of all human beings. This
   study aims to measure the mortality rate and years of life lost (YLL)
   due to premature death caused by COVID-19 in Iran, Ahvaz Jundishapur
   University of Medical Sciences.
   Materials and Methods: In this study, all definite deaths due to
   COVID-19 were used. First, descriptive analysis, including mean and
   standard deviation and the number, was performed. Then, raw and
   age-standardized mortality rates were calculated. The analysis of the
   number of YLL due to premature death caused by COVID-19 was performed
   using the YLL template of 2015, from the World Health Organization, in
   the Excel spreadsheet software version 2007.
   Results: During the study period (from March 2020 to June 2020), 629
   definite deaths due to COVID-19 occurred (men 59.14\% and women
   40.86\%). The mortality rate due to COVID-19 in men and women was 16.24
   and 17.17 per 100,000 persons, respectively. The total YLL during the
   study period was 4,722 (3.06 per thousand persons) in men, 3,691 (2.46
   per thousand persons) in women, and 8,413 (2.77 per thousand persons) in
   both sexes.
   Conclusion: This study is one of the first studies to measure YLL due to
   COVID-19 in Iran. The results of this study show that due to the high
   mortality of this disease, decision-makers should focus on reducing
   mortality to stop the potential next waves of COVID-19.},
Publisher = {GALENOS YAYINCILIK},
Address = {MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21, FINDIKZADE, ISTANBUL 34093,
   TURKEY},
Type = {Article},
Language = {English},
Affiliation = {Vali, M (Corresponding Author), Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   Azarbakhsh, Habibollah, Ahvaz Jundishapur Univ Med Sci, Infect \& Trop Dis Res Ctr, Hlth Res Inst, Ahvaz, Iran.
   Mirahmadizadeh, Alireza, Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran.
   Rostami, Maryam, Ahvaz Jundishapur Univ Med Sci, Dept Social Med, Ahvaz, Iran.
   Vali, Mohebat, Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.},
DOI = {10.4274/mjima.galenos.2021.2020.18},
Article-Number = {18},
ISSN = {2147-673X},
Keywords = {COVID-19; burden of disease; years of life lost; Iran},
Research-Areas = {Infectious Diseases},
Web-of-Science-Categories  = {Infectious Diseases},
Author-Email = {mohebatvali@gmail.com},
ResearcherID-Numbers = {vali, mohebat/AAU-5817-2021},
Funding-Acknowledgement = {Ahvaz Jundishapur University of Medical Sciences {[}330097286]},
Funding-Text = {This study was funded by Ahvaz Jundishapur University of Medical
   Sciences (grant No. 330097286).},
Cited-References = {Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008.
   CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI 10.15585/mmwr.mm6915e4.
   Chowell G, 2020, LANCET, V395, P1093, DOI 10.1016/S0140-6736(20)30743-1.
   Farnoosh G, 2020, NARRATIVE REV, V22, P1.
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032.
   Jo MW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e199.
   Kim YE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e75.
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012.
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924.
   Lee YR, 2016, J KOREAN MED SCI, V31, pS178, DOI 10.3346/jkms.2016.31.S2.S178.
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI {[}10.1002/jmv.25678, 10.1002/jmv.2567].
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683.
   Thompson R, 2020, LANCET INFECT DIS, V20, P280, DOI 10.1016/S1473-3099(20)30068-2.
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9.
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3.},
Number-of-Cited-References = {15},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Mediterr. J. Infect. Microbes Antimicrob.},
Doc-Delivery-Number = {RM0DQ},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000639333200004},
OA = {gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000292293400043,
Author = {Follo, Carlo and Ozzano, Matteo and Mugoni, Vera and Castino, Roberta
   and Santoro, Massimo and Isidoro, Ciro},
Title = {Knock-Down of Cathepsin D Affects the Retinal Pigment Epithelium,
   Impairs Swim-Bladder Ontogenesis and Causes Premature Death in Zebrafish},
Journal = {PLOS ONE},
Year = {2011},
Volume = {6},
Number = {7},
Month = {JUL 1},
Abstract = {The lysosomal aspartic protease Cathepsin D (CD) is ubiquitously
   expressed in eukaryotic organisms. CD activity is essential to
   accomplish the acid-dependent extensive or partial proteolysis of
   protein substrates within endosomal and lysosomal compartments therein
   delivered via endocytosis, phagocytosis or autophagocytosis. CD may also
   act at physiological pH on small-size substrates in the cytosol and in
   the extracellular milieu. Mouse and fruit fly CD knock-out models have
   highlighted the multi-pathophysiological roles of CD in tissue
   homeostasis and organ development. Here we report the first phenotypic
   description of the lack of CD expression during zebrafish (Danio rerio)
   development obtained by morpholino-mediated knock-down of CD mRNA. Since
   the un-fertilized eggs were shown to be supplied with maternal CD mRNA,
   only a morpholino targeting a sequence containing the starting ATG codon
   was effective. The main phenotypic alterations produced by CD knock-down
   in zebrafish were: 1. abnormal development of the eye and of retinal
   pigment epithelium; 2. absence of the swim-bladder; 3. skin
   hyper-pigmentation; 4. reduced growth and premature death. Rescue
   experiments confirmed the involvement of CD in the developmental
   processes leading to these phenotypic alterations. Our findings add to
   the list of CD functions in organ development and patho-physiology in
   vertebrates.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Follo, C (Corresponding Author), Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy.
   Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro, Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy.
   Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro, Univ Piemonte Orientale, Ctr Biotecnol Ric Med Applicata, Novara, Italy.
   Mugoni, Vera; Santoro, Massimo, Univ Turin, Ctr Mol Biotechnol, Turin, Italy.},
DOI = {10.1371/journal.pone.0021908},
Article-Number = {e21908},
ISSN = {1932-6203},
Keywords-Plus = {D-DEFICIENT MICE; GENE-EXPRESSION; CELL-DEATH; EMBRYONIC-DEVELOPMENT;
   PROTEOMIC ANALYSIS; LYSOSOMAL STORAGE; OVARIAN-FOLLICLE; YOLK FORMATION;
   PROCATHEPSIN-D; TNF-ALPHA},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {isidoro@med.unipmn.it},
ResearcherID-Numbers = {Isidoro, Ciro/J-6063-2016
   },
ORCID-Numbers = {Isidoro, Ciro/0000-0002-5494-3034
   Follo, Carlo/0000-0001-9711-2655
   SANTORO, Massimo Mattia/0000-0003-4605-5085},
Cited-References = {Abbott DE, 2010, CANCER BIOL THER, V9, P23, DOI 10.4161/cbt.9.1.10378.
   ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2.
   Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005.
   BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796.
   Barrett A.J, 1979, CIBA F SYMP, P37, DOI 10.1002/9780470720585.
   Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200.
   Capasso C, 1999, BBA-PROTEIN STRUCT M, V1431, P64, DOI 10.1016/S0167-4838(99)00039-4.
   Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007.
   Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140.
   Castino R, 2008, ENDOCRINOLOGY, V149, P4095, DOI 10.1210/en.2008-0249.
   Castino R, 2007, FREE RADICAL BIO MED, V42, P1305, DOI 10.1016/j.freeradbiomed.2006.12.030.
   Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850.
   Cheng AL, 2008, J PROTEOME RES, V7, P2415, DOI 10.1021/pr7008548.
   Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x.
   Demoz M, 2006, PROTEIN EXPRES PURIF, V45, P157, DOI 10.1016/j.pep.2005.07.024.
   Demoz M, 2002, BIOL CHEM, V383, P1237, DOI 10.1515/BC.2002.137.
   Erdmann S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1365, DOI 10.1152/ajpendo.00280.2007.
   Follo C, 2008, BIOTECHNOL APPL BIOC, V49, P175, DOI 10.1042/BA20070045.
   Follo C, 2007, INT J BIOCHEM CELL B, V39, P638, DOI 10.1016/j.biocel.2006.11.010.
   GEISLER R, 2008, DEVELOPMENT, V135, P387.
   GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1.
   Handley CJ, 2001, MATRIX BIOL, V20, P543, DOI 10.1016/S0945-053X(01)00168-8.
   Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138.
   Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276.
   Isidoro C, 1995, INT J CANCER, V63, P866, DOI 10.1002/ijc.2910630619.
   ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363.
   Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006.
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302.
   Knoll-Gellida A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-46.
   Kociok N, 2007, GRAEF ARCH CLIN EXP, V245, P101, DOI 10.1007/s00417-006-0266-x.
   Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6.
   Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000.
   Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014.
   Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701.
   Lee AY, 1998, NAT STRUCT BIOL, V5, P866, DOI 10.1038/2306.
   Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396.
   Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x.
   Margaryan NV, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12534.
   Minazaki CK, 2008, RES VET SCI, V84, P326, DOI 10.1016/j.rvsc.2007.06.013.
   MORRISON RL, 1991, J MORPHOL, V209, P229, DOI 10.1002/jmor.1052090209.
   Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019.
   Nakamura K, 1996, COMP BIOCHEM PHYS B, V113, P835, DOI 10.1016/0305-0491(95)02102-7.
   Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001.
   Nicotra G, 2010, CANCER BIOMARK, V7, P47, DOI 10.3233/CBM-2010-0143.
   Nielsen LB, 2001, COMP BIOCHEM PHYS B, V128, P351, DOI 10.1016/S1096-4959(00)00332-8.
   Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179.
   Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743.
   Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113.
   Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6.
   RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7.
   RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661.
   ROUGHLEY PJ, 1977, BIOCHEM J, V167, P639, DOI 10.1042/bj1670639.
   Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218.
   Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001.
   Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918.
   SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x.
   Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8.
   Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098.
   SCOTT PG, 1981, EUR J BIOCHEM, V114, P59.
   Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819.
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004.
   TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106.
   Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786.
   Tyynela J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P43, DOI 10.1053/ejpn.2000.0433.
   Vashishta Aruna, 2009, Endocrine Metabolic \& Immune Disorders-Drug Targets, V9, P385.
   Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127.
   Workman P, 1998, BRIT J CANCER, V77, P1.
   Yoshizaki N, 2004, DEV GROWTH DIFFER, V46, P229, DOI 10.1111/j.1440-169X.2004.00740.x.
   Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820.
   Zuzarte-Luis V, 2007, DEV DYNAM, V236, P880, DOI 10.1002/dvdy.21076.},
Number-of-Cited-References = {72},
Times-Cited = {26},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {9},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {786HC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000292293400043},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000371675400001,
Author = {Matsushita, Yuki and Sakai, Yasunari and Shimmura, Mitsunori and
   Shigeto, Hiroshi and Nishio, Miki and Akamine, Satoshi and Sanefuji,
   Masafumi and Ishizaki, Yoshito and Torisu, Hiroyuki and Nakabeppu,
   Yusaku and Suzuki, Akira and Takada, Hidetoshi and Hara, Toshiro},
Title = {Hyperactive mTOR signals in the proopiomelanocortin-expressing
   hippocampal neurons cause age-dependent epilepsy and premature death in
   mice},
Journal = {SCIENTIFIC REPORTS},
Year = {2016},
Volume = {6},
Month = {MAR 10},
Abstract = {Epilepsy is a frequent comorbidity in patients with focal cortical
   dysplasia (FCD). Recent studies utilizing massive sequencing data
   identified subsets of genes that are associated with epilepsy and FCD.
   AKT and mTOR-related signals have been recently implicated in the
   pathogenic processes of epilepsy and FCD. To clarify the functional
   roles of the AKT-mTOR pathway in the hippocampal neurons, we generated
   conditional knockout mice harboring the deletion of Pten (Pten-cKO) in
   Proopiomelanocortinexpressing neurons. The Pten-cKO mice developed
   normally until 8 weeks of age, then presented generalized seizures at
   8-10 weeks of age. Video-monitored electroencephalograms detected
   paroxysmal discharges emerging from the cerebral cortex and hippocampus.
   These mice showed progressive hypertrophy of the dentate gyrus (DG) with
   increased expressions of excitatory synaptic markers (Psd95, Shank3 and
   Homer). In contrast, the expression of inhibitory neurons (Gad67) was
   decreased at 6-8 weeks of age. Immunofluorescence studies revealed the
   abnormal sprouting of mossy fibers in the DG of the Pten-cKO mice prior
   to the onset of seizures. The treatment of these mice with an mTOR
   inhibitor rapamycin successfully prevented the development of seizures
   and reversed these molecular phenotypes. These data indicate that the
   mTOR pathway regulates hippocampal excitability in the postnatal brain.},
Publisher = {NATURE PUBLISHING GROUP},
Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Sakai, Y (Corresponding Author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan.
   Matsushita, Yuki; Sakai, Yasunari; Akamine, Satoshi; Sanefuji, Masafumi; Ishizaki, Yoshito; Torisu, Hiroyuki; Takada, Hidetoshi; Hara, Toshiro, Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan.
   Shimmura, Mitsunori; Shigeto, Hiroshi, Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Fukuoka 8128582, Japan.
   Nishio, Miki; Suzuki, Akira, Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 8128582, Japan.
   Nakabeppu, Yusaku, Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Fukuoka 8128582, Japan.
   Torisu, Hiroyuki, Fukuoka Dent Coll, Dept Pediat, Fukuoka 8140193, Japan.
   Hara, Toshiro, Fukuoka Childrens Hosp, Fukuoka 8130017, Japan.},
DOI = {10.1038/srep22991},
Article-Number = {22991},
ISSN = {2045-2322},
Keywords-Plus = {SOMATIC MUTATIONS; MAMMALIAN TARGET; MOUSE MODEL; CYTOMEGALIC NEURONS;
   CHILDHOOD EPILEPSY; INFANTILE SPASMS; BASIC MECHANISMS; POMC EXPRESSION;
   GRANULE CELLS; PTEN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {ysakai22q13@gmail.com},
ResearcherID-Numbers = {Sakai, Yasunari/S-7965-2018
   Nakabeppu, Yusaku/A-8902-2011},
ORCID-Numbers = {Sakai, Yasunari/0000-0002-5747-8692
   Nakabeppu, Yusaku/0000-0002-6739-242X},
Funding-Acknowledgement = {JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) {[}24650199,
   22221004, 26461547]; Japan Life Science Foundation; Takeda Science
   FoundationTakeda Science Foundation (TSF); Mother and Child Health
   FoundationMother and Child Health Foundation; Japan Epilepsy Research
   Foundation; Grants-in-Aid for Scientific ResearchMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   {[}16K08626, 15K09624] Funding Source: KAKEN},
Funding-Text = {We thank Christian P. Schaaf at the Neurological Research Institute,
   Texas Children's Hospital for the critical reading and helpful comments
   on this manuscript; Etsuro Ono and technical staffs for maintaining the
   mice at the Animal Core Facility of Kyushu University; Satoshi Tamura
   and Masako Ino (Nikon) for performing the morphological analyses; Junji
   Kishimoto (Kyushu University) for the statistical analysis; Setsuko
   Kitamura, Tamami Tanaka and Ayumi Tahara for their technical support
   (Kyushu University); Ryutaro Kira (Fukuoka Children's Hospital), and the
   laboratory members for their helpful discussions. This work was
   supported by JSPS KAKENHI Grant Numbers 24650199 (YS), 22221004 (YN) and
   26461547 (YI); Japan Life Science Foundation (YS); Takeda Science
   Foundation (YS); The Mother and Child Health Foundation (YS); and the
   Japan Epilepsy Research Foundation (YS).},
Cited-References = {Abdijadid S, 2015, CNS NEUROSCI THER, V21, P92, DOI 10.1111/cns.12345.
   Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030.
   Amiet C, 2013, BIOL PSYCHIAT, V74, pE3, DOI 10.1016/j.biopsych.2013.01.037.
   Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782.
   BARAM TZ, 1993, ANN NEUROL, V33, P231, DOI 10.1002/ana.410330302.
   Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x.
   Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124.
   Brunson KL, 2002, INT REV NEUROBIOL, V49, P185.
   Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011.
   Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036.
   Caruso V, 2014, NAT REV NEUROSCI, V15, P98, DOI 10.1038/nrn3657.
   Cepeda C, 2005, EPILEPSIA, V46, P82, DOI 10.1111/j.1528-1167.2005.01013.x.
   Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085.
   Crino PB, 2009, EPILEPSIA, V50, P3, DOI 10.1111/j.1528-1167.2009.02289.x.
   D'Alessio L, 2010, SEIZURE-EUR J EPILEP, V19, P567, DOI 10.1016/j.seizure.2010.09.004.
   D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357.
   Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023.
   Galanopoulou AS, 2013, BRAIN DEV-JPN, V35, P748, DOI 10.1016/j.braindev.2012.12.005.
   Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518.
   Hamano S, 2010, EPILEPSIA, V51, P1259, DOI 10.1111/j.1528-1167.2009.02495.x.
   Ito M, 2001, BRAIN DEV-JPN, V23, P635, DOI 10.1016/S0387-7604(01)00302-3.
   Jamuar SS, 2014, NEW ENGL J MED, V371, P2038, DOI 10.1056/NEJMc1411784.
   Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278.
   Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017.
   Kjeldsen MJ, 2001, EPILEPSY RES, V44, P167, DOI 10.1016/S0920-1211(01)00196-6.
   Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960.
   KWAK SP, 1993, NEUROENDOCRINOLOGY, V57, P96, DOI 10.1159/000126347.
   Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023.
   Kyrylenko S, 1999, MOL BRAIN RES, V73, P198, DOI 10.1016/S0169-328X(99)00259-4.
   Lachyankar MB, 2000, J NEUROSCI, V20, P1404.
   LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI {[}10.3389/fnmol.2014.00018, 10.3389/fnmo1.2014.00018].
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329.
   Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824.
   Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949.
   Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386.
   Mathern GW, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2009.02294.x.
   McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263.
   Nakashima M, 2015, ANN NEUROL, V78, P375, DOI 10.1002/ana.24444.
   Niikura K, 2013, NEUROSCIENCE, V236, P220, DOI 10.1016/j.neuroscience.2012.12.071.
   Oka E, 2006, EPILEPSIA, V47, P626, DOI 10.1111/j.1528-1167.2006.00477.x.
   Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004.
   Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665.
   Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002.
   Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371.
   Sakai Y, 2013, EUR J MED GENET, V56, P475, DOI 10.1016/j.ejmg.2013.06.009.
   Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166.
   Sisodiyo SM, 2009, LANCET NEUROL, V8, P830, DOI 10.1016/S1474-4422(09)70201-7.
   Sosunov AA, 2012, EPILEPSIA, V53, P78, DOI 10.1111/j.1528-1167.2012.03478.x.
   Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x.
   Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001.
   Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0.
   Takase K, 2008, EPILEPSIA, V49, P997, DOI 10.1111/j.1528-1167.2008.01558.x.
   Tye C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-55.
   Velez A, 2006, EPILEPSIA, V47, P193, DOI 10.1111/j.1528-1167.2006.00387.x.
   Wang W, 2004, PEDIATR RES, V55, P604, DOI 10.1203/01.PDR.0000112105.33521.DC.
   Williams MR, 2015, J NEUROSCI, V35, P943, DOI 10.1523/JNEUROSCI.3144-14.2015.
   Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260.
   Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331.
   Zucca I, 2016, ANN NEUROL, V79, P42, DOI 10.1002/ana.24541.},
Number-of-Cited-References = {59},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {DF9IW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000371675400001},
OA = {Green Published, Green Accepted, gold},
DA = {2022-03-29},
}

@article{ WOS:000331304100002,
Author = {Friberg, Emilie and Rosenhall, Ulf and Alexanderson, Kristina},
Title = {Sickness absence and disability pension due to otoaudiological
   diagnoses: risk of premature death - a nationwide prospective cohort
   study},
Journal = {BMC PUBLIC HEALTH},
Year = {2014},
Volume = {14},
Month = {FEB 8},
Abstract = {Background: It is estimated that hearing difficulties will be one of the
   top ten leading burdens of disease by 2030. Knowledge of mortality among
   individuals on sick leave or disability pension due to hearing diagnoses
   is virtually non-existent. We aimed prospectively to examine the
   associations of diagnosis-specific sick leave and disability pension due
   to different otoaudiological diagnoses with risks of all-cause and
   cause-specific mortality.
   Methods: A cohort, based on Swedish registry data, including all 5 248
   672 individuals living in Sweden in 2005, aged 20-64, and not on old-age
   pension, was followed through 2010. Otoaudiological diagnoses were
   placed in the following categories: otological, hearing, vertigo, and
   tinnitus. Hazard ratios (HRs) with 95\% confidence intervals (CIs) were
   estimated using Cox proportional hazard models; individuals on sick
   leave or disability pension due to different otoaudiological diagnoses
   during 2005 were compared with those not on sick leave or disability
   pension.
   Results: In multivariable models, individuals with sickness absence due
   to otoaudiological diagnoses showed a lower risk of mortality, while
   individuals on disability pension due to otoaudiological diagnoses
   showed a 14\% (95\% CI 1-29\%) increased risk of mortality, compared
   with individuals not on sick leave or disability pension. The risk
   increase among individuals on disability pension was largely
   attributable to otological (HR 1.56; 95\% CI = 1.04-2.33) and hearing
   diagnoses (HR 1.20; 95\% CI = 1.00-1.43).
   Conclusion: This large nationwide population-based cohort study suggests
   an increased risk of mortality among individuals on disability pension
   due to otoaudiological diagnoses.},
Publisher = {BIOMED CENTRAL LTD},
Address = {236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Friberg, E (Corresponding Author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, S-17177 Stockholm, Sweden.
   Friberg, Emilie; Alexanderson, Kristina, Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, S-17177 Stockholm, Sweden.
   Rosenhall, Ulf, Karolinska Inst, Dept Clin Neurosci, Ctr Hearing \& Commun Res, S-17177 Stockholm, Sweden.
   Rosenhall, Ulf, Karolinska Univ Hosp, Dept Audiol \& Neurotol, Stockholm, Sweden.},
DOI = {10.1186/1471-2458-14-137},
Article-Number = {137},
ISSN = {1471-2458},
Keywords = {Hearing diagnoses; Sick-leave; Mortality},
Keywords-Plus = {POPULATION-BASED COHORT; II PROSPECTIVE COHORT; WHITEHALL-II; FOLLOW-UP;
   MORTALITY; HEALTH; PREVALENCE; PREDICTOR; ASSOCIATION; RETIREMENT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Emilie.Friberg@ki.se},
ORCID-Numbers = {Alexanderson, Kristina/0000-0002-9313-3413
   Friberg, Emilie/0000-0001-7874-4243},
Funding-Acknowledgement = {Swedish Research Council for Health, Working Life and WelfareSwedish
   Research CouncilSwedish Research Council for Health Working Life \&
   Welfare (Forte) {[}2007-1762, 2006-1526]},
Funding-Text = {This work was supported by the Swedish Research Council for Health,
   Working Life and Welfare {[}grants 2007-1762, and 2006-1526].},
Cited-References = {Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522.
   Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P256, DOI 10.1080/14034950410021925.
   Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808.
   Alexanderson K, 1998, MEASURING HLTH INDIC, P121.
   Bambra C, 2006, HEALTH PLACE, V12, P728, DOI 10.1016/j.healthplace.2005.02.008.
   Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422.
   Friberg E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-772.
   Friberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029966.
   Friedland DR, 2009, LARYNGOSCOPE, V119, P473, DOI 10.1002/lary.20130.
   Giesdal S, 2008, SCAND J WORK ENV HEA, V34, P479, DOI 10.5271/sjweh.1286.
   Gjesdal S, 2008, EUR J PUBLIC HEALTH, V18, P517, DOI 10.1093/eurpub/ckn010.
   Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P168, DOI 10.1177/1403494808100937.
   Gustafsson K, 2011, SCAND J PUBLIC HEALT, V39, P501, DOI 10.1177/1403494811399652.
   Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430.
   Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130.
   Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469.
   Horselskadades Riksforbund, 2008, HORS RIKSF ARSR.
   Hull RH, 2010, AM J AUDIOL, V19, P9, DOI 10.1044/1059-0889(2010/08-0040).
   Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229.
   Kivimaki M, 2008, OCCUP ENVIRON MED, V65, P820, DOI 10.1136/oem.2007.038398.
   Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364.
   Lund T, 2009, OCCUP ENVIRON MED, V66, P150, DOI 10.1136/oem.2008.040154.
   MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124.
   Mathers C, 2000, GLOBAL BURDEN HEARIN, P2001.
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442.
   Quaade T, 2002, SCAND J PUBLIC HEALT, V30, P216, DOI 10.1080/14034940210134022.
   Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817.
   Wallhagen MI, 1997, AM J PUBLIC HEALTH, V87, P440, DOI 10.2105/AJPH.87.3.440.
   Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103.
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2.},
Number-of-Cited-References = {30},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {AA7VD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000331304100002},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000565877200013,
Author = {Lukacs, Marshall and Blizzard, Lauren E. and Stottmann, Rolf W.},
Title = {CNS glycosylphosphatidylinositol deficiency results in delayed white
   matter development, ataxia and premature death in a novel mouse model},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2020},
Volume = {29},
Number = {7},
Pages = {1205-1217},
Month = {APR 1},
Abstract = {The glycosylphosphatidylinositol (GPI) anchor is a post-translational
   modification added to approximately 150 different proteins to facilitate
   proper membrane anchoring and trafficking to lipid rafts. Biosynthesis
   and remodeling of the GPI anchor requires the activity of over 20
   distinct genes. Defects in the biosynthesis of GPI anchors in humans
   lead to inherited glycosylphosphatidylinositol deficiency (IGD). IGD
   patients display a wide range of phenotypes though the central nervous
   system (CNS) appears to be the most commonly affected tissue. A full
   understanding of the etiology of these phenotypes has been hampered by
   the lack of animal models due to embryonic lethality of GPI biosynthesis
   gene null mutants. Here we model IGD by genetically ablating GPI
   production in the CNS with a conditional mouse allele of
   phosphatidylinositol glycan anchor biosynthesis, class A (Piga) and
   Nestin-Cre. We find that the mutants do not have structural brain
   defects but do not survive past weaning. The mutants show progressive
   decline with severe ataxia consistent with defects in cerebellar
   development. We show that the mutants have reduced myelination and
   defective Purkinje cell development. Surprisingly, we found that Piga
   was expressed in a fairly restricted pattern in the early postnatal
   brain consistent with the defects we observed in our model. Thus, we
   have generated a novel mouse model of the neurological defects of IGD
   which demonstrates a critical role for GPI biosynthesis in cerebellar
   and white matter development.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Stottmann, RW (Corresponding Author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   Stottmann, RW (Corresponding Author), Cincinnati Childrens Hosp Med Ctr, Med Scientist Training Program, Cincinnati, OH 45229 USA.
   Stottmann, RW (Corresponding Author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
   Stottmann, RW (Corresponding Author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA.
   Lukacs, Marshall; Blizzard, Lauren E.; Stottmann, Rolf W., Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   Lukacs, Marshall; Stottmann, Rolf W., Cincinnati Childrens Hosp Med Ctr, Med Scientist Training Program, Cincinnati, OH 45229 USA.
   Stottmann, Rolf W., Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
   Stottmann, Rolf W., Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA.},
DOI = {10.1093/hmg/ddaa046},
ISSN = {0964-6906},
EISSN = {1460-2083},
Keywords-Plus = {TYROSINE-HYDROXYLASE IMMUNOREACTIVITY; PURKINJE-CELLS; ABNORMAL
   EXPRESSION; CEREBELLAR-ATAXIA; ANCHORED PROTEINS; GENE; MUTATION; PIGA;
   HYPERPHOSPHATASIA; BIOCHEMISTRY},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {Rolf.stottmann@cchmc.org},
Funding-Acknowledgement = {National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}R01NS085023]},
Funding-Text = {This work was supported by the National Institutes of Health {[}grant
   number R01NS085023 to R.W.S].},
Cited-References = {Ahrens MJ, 2009, DEVELOPMENT, V136, P3463, DOI 10.1242/dev.040592.
   Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106.
   Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425.
   Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5.
   Cendelin Jan, 2014, Cerebellum Ataxias, V1, P4, DOI 10.1186/2053-8871-1-4.
   CColakoglu G, 2014, P NATL ACAD SCI USA, V111, pE394, DOI 10.1073/pnas.1313769110.
   Duncan ID, 2016, EXP NEUROL, V283, P452, DOI 10.1016/j.expneurol.2016.04.002.
   Feather-Schussler DN, 2016, JOVE-J VIS EXP, DOI 10.3791/53569.
   Frappaolo A, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00436.
   Freeze HH, 2015, ANNU REV NEUROSCI, V38, P105, DOI 10.1146/annurev-neuro-071714-034019.
   Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274.
   Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002.
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9.
   Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648.
   Huang Y, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-015-0183-1.
   Jeong YG, 2001, DEV BRAIN RES, V129, P201, DOI 10.1016/S0165-3806(01)00212-7.
   Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031.
   Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389.
   Kinoshita Taroh, 2017, Rinsho Ketsueki, V58, P353, DOI 10.11406/rinketsu.58.353.
   Kinoshita T, 2016, J LIPID RES, V57, P4, DOI 10.1194/jlr.E065417.
   Kinoshita T, 2014, P JPN ACAD B-PHYS, V90, P130, DOI 10.2183/pjab.90.130.
   Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5.
   Knaus A, 2016, HUM MUTAT, V37, P737, DOI 10.1002/humu.23006.
   Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a.
   Lalonde R, 2011, BRAIN RES REV, V67, P252, DOI 10.1016/j.brainresrev.2011.02.005.
   Liang HX, 2012, BIOL OPEN, V1, P1200, DOI 10.1242/bio.20122287.
   Lukacs M, 2019, ELIFE, V8, DOI 10.7554/eLife.45248.
   McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3.
   Nozaki M, 1999, LAB INVEST, V79, P293.
   Pagnamenta AT, 2017, EUR J HUM GENET, V25, P669, DOI 10.1038/ejhg.2017.32.
   Sawada K, 1999, BRAIN RES, V829, P107, DOI 10.1016/S0006-8993(99)01347-5.
   Sawada K, 1999, BRAIN RES, V844, P188, DOI 10.1016/S0006-8993(99)01899-5.
   Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189.
   Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8.
   Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400.
   Nguyen TTM, 2018, AM J HUM GENET, V103, P602, DOI 10.1016/j.ajhg.2018.08.014.
   Thompson MD, 2006, PEDIATR NEUROL, V34, P303, DOI 10.1016/j.pediatrneurol.2005.08.020.
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703.
   Um JW, 2017, TRENDS CELL BIOL, V27, P931, DOI 10.1016/j.tcb.2017.06.007.
   Visconte V, 2010, HAEMATOL-HEMATOL J, V95, P214, DOI 10.3324/haematol.2009.011650.
   Wang JY, 2015, DIS MODEL MECH, V8, P957, DOI 10.1242/dmm.019240.
   Yuan X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174074.
   Zhang Y, 2015, J NEUROSCI, V35, P864, DOI 10.1523/JNEUROSCI.4506-14.2015.},
Number-of-Cited-References = {43},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Hum. Mol. Genet.},
Doc-Delivery-Number = {NJ2LI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000565877200013},
OA = {Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000295498500010,
Author = {Wang, Wanting and Kagaya, Yutaka and Asaumi, Yasuhide and Fukui,
   Shigefumi and Takeda, Morihiko and Shimokawa, Hiroaki},
Title = {Protective Effects of Recombinant Human Erythropoietin against Pressure
   Overload-Induced Left Ventricular Remodeling and Premature Death in Mice},
Journal = {TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE},
Year = {2011},
Volume = {225},
Number = {2},
Pages = {131-143},
Month = {OCT},
Abstract = {Chronic left ventricular (LV) pressure overload induced by hypertension
   is one of the most common causes of heart failure. Earlier reports have
   shown the cardioprotective effects of erythropoietin (EPO). In the
   present study, we tested the hypothesis that recombinant human EPO
   exerts a protective effect against pressure-overload induced LV
   remodeling. Mice subjected to transverse aortic constriction (TAC) (n =
   70) were randomly assigned to the treatment with phosphate buffer
   solution (PBS) (TAC-PBS) or EPO (2,000 U/kg twice a week) (TAC-EPO). At
   8 weeks after TAC, LV weight was comparably increased in both TAC groups
   compared with sham-operated mice (Sham) (both P < 0.001). The treatment
   with EPO improved the survival of TAC mice as compared with treatment
   with PBS (80 vs. 47\%, P < 0.01), which was associated with reductions
   in the extent of myocardial fibrosis and the number of TUNEL positive
   cardiomyocytes (both P < 0.05). Echocardiography revealed that TAC
   increased LV chamber diameter and decreased LV fractional shortening
   compared with Sham (P < 0.05), which was ameliorated by the treatment
   with EPO (P < 0.05). In TAC-EPO as compared to TAC-PBS, phosphorylation
   of STAT3, Akt and eNOS was all increased, while phosphorylation of p38
   was decreased (all P < 0.05). Importantly, the expression level of VEGF
   and the capillary density in LV myocardium were similar among the 3
   groups. These results suggest that recombinant human EPO ameliorates the
   cardiac remodeling and the premature death associated with chronic LV
   pressure overload through the mechanisms independent of angiogenesis.},
Publisher = {TOHOKU UNIV MEDICAL PRESS},
Address = {2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN},
Type = {Article},
Language = {English},
Affiliation = {Kagaya, Y (Corresponding Author), Tohoku Univ Hosp, Grad Med Educ Ctr, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.
   Kagaya, Yutaka, Tohoku Univ Hosp, Grad Med Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan.
   Wang, Wanting; Asaumi, Yasuhide; Fukui, Shigefumi; Takeda, Morihiko; Shimokawa, Hiroaki, Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.},
DOI = {10.1620/tjem.225.131},
ISSN = {0040-8727},
EISSN = {1349-3329},
Keywords = {cardioprotection; erythropoietin; left ventricular hypertrophy;
   pressure-overloaded hearts; ventricular remodeling},
Keywords-Plus = {ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE
   SYNTHASE; HEART-FAILURE; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY;
   SIGNALING PATHWAYS; HYPERTENSIVE-RATS; PROGENITOR CELLS; ANGIOTENSIN-II},
Research-Areas = {General \& Internal Medicine; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal; Medicine, Research \& Experimental},
Author-Email = {kagaya@med.tohoku.ac.jp},
ORCID-Numbers = {Shimokawa, Hiroaki/0000-0001-7534-4826
   Asaumi, Yasuhide/0000-0002-9009-7234},
Funding-Acknowledgement = {Japanese Ministry of Education, Culture, Sports, Science and Technology,
   Tokyo, JapanMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) {[}16209027, 20117009, 22590800]},
Funding-Text = {We thank Ms. Naomi Yamaki, Ms. Fumie Natsui and Ms. Fumie Tatebayashi
   for their excellent technical assistance. This study was supported in
   part by Grants-in-Aid for Science Research (Nos. 16209027, 20117009,
   22590800) from the Japanese Ministry of Education, Culture, Sports,
   Science and Technology, Tokyo, Japan},
Cited-References = {Asaumi Y, 2007, CIRCULATION, V115, P2022, DOI 10.1161/CIRCULATIONAHA.106.659037.
   Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004.
   Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003.
   Burger D, 2006, CARDIOVASC RES, V72, P51, DOI 10.1016/j.cardiores.2006.06.026.
   Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23.
   Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100.
   Cinar Y, 1999, AM J HYPERTENS, V12, P739, DOI 10.1016/S0895-7061(99)00011-4.
   DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231.
   DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717.
   Fukui S, 2009, HYPERTENS RES, V32, P472, DOI 10.1038/hr.2009.43.
   Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723.
   Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952.
   Hunt SA, 2005, J AM COLL CARDIOL, V46, P1.
   Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065.
   Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31.
   Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100.
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498.
   Kerkela R, 2006, J AM COLL CARDIOL, V48, P556, DOI 10.1016/j.jacc.2006.05.005.
   KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648.
   Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402.
   McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4.
   MELKUMYANTS AM, 1989, CARDIOVASC RES, V23, P741, DOI 10.1093/cvr/23.9.741.
   MIYATA S, 2006, CARDIOVASC RES, V71, P684.
   Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe.
   Namiuchi S, 2005, J AM COLL CARDIOL, V45, P1406, DOI 10.1016/j.jacc.2005.01.043.
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa.
   Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004.
   Nishiya D, 2006, J PHARMACOL SCI, V101, P31, DOI 10.1254/jphs.FP0050966.
   Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359.
   PANIDIS IP, 1984, J AM COLL CARDIOL, V3, P1309, DOI 10.1016/S0735-1097(84)80192-8.
   Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200.
   Rafiee P, 2005, BASIC RES CARDIOL, V100, P187, DOI 10.1007/s00395-004-0508-1.
   Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021.
   Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019.
   Satoh K, 2006, CIRCULATION, V113, P1442, DOI 10.1161/CIRCULATIONAHA.105.583732.
   Schultz JE, 1999, J CLIN INVEST, V104, P709, DOI 10.1172/JCI7315.
   Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190.
   Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F.
   SHOEMAKER CB, 1986, MOL CELL BIOL, V6, P849, DOI 10.1128/MCB.6.3.849.
   Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485.
   Smith KJ, 2003, CARDIOVASC RES, V59, P538, DOI 10.1016/S0008-6363(03)00468-1.
   Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010.
   Ueda K, 2010, J CLIN INVEST, V120, P2016, DOI 10.1172/JCI39896.
   van der Meer P, 2005, J AM COLL CARDIOL, V46, P125, DOI 10.1016/j.jacc.2005.03.044.
   WEN D, 1993, BLOOD, V82, P1507.
   Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje.},
Number-of-Cited-References = {46},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Tohoku J. Exp. Med.},
Doc-Delivery-Number = {828JY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000295498500010},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000366724000017,
Author = {Wang, Dong D. and Li, Yanping and Chiuve, Stephanie E. and Hu, Frank B.
   and Willett, Walter C.},
Title = {Improvements In US Diet Helped Reduce Disease Burden And Lower Premature
   Deaths, 1999-2012; Overall Diet Remains Poor},
Journal = {HEALTH AFFAIRS},
Year = {2015},
Volume = {34},
Number = {11},
Pages = {1916-1922},
Month = {NOV},
Abstract = {Evaluation of time trends in dietary quality and their relation to
   disease burden provides essential feedback for policy making. We used an
   index titled the Alternate Healthy Eating Index 2010 to evaluate trends
   in dietary quality among 33,885 US adults. From 1999 to 2012 the index
   increased from 39.9 to 48.2 ( perfect score = 110). Gaps in performance
   on the index across socioeconomic groups persisted or widened. Using
   data relating index scores to health outcomes in two large cohorts, we
   estimated that the improvements in dietary quality from 1999 to 2012
   prevented 1.1 million premature deaths. Also, this improvement in diet
   quality resulted in 8.6 percent fewer cardiovascular disease cases, 1.3
   percent fewer cancer cases, and 12.6 percent fewer type 2 diabetes
   cases. Although the steady improvement in dietary quality likely
   accounted for substantial reductions in disease burden from 1999 to
   2012, overall dietary quality in the United States remains poor. Policy
   initiatives are needed to ensure further improvements.},
Publisher = {PROJECT HOPE},
Address = {7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA},
Type = {Article},
Language = {English},
Affiliation = {Wang, DD (Corresponding Author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Wang, Dong D.; Li, Yanping; Chiuve, Stephanie E.; Hu, Frank B.; Willett, Walter C., Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Wang, Dong D.; Chiuve, Stephanie E.; Hu, Frank B.; Willett, Walter C., Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Chiuve, Stephanie E., Harvard Univ, Sch Med, Dept Med, Div Prevent Med, Boston, MA 02115 USA.
   Hu, Frank B.; Willett, Walter C., Brigham \& Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.
   Hu, Frank B.; Willett, Walter C., Harvard Univ, Sch Med, Boston, MA 02115 USA.},
DOI = {10.1377/hlthaff.2015.0640},
ISSN = {0278-2715},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; HEALTH; QUALITY; OBESITY; RISK},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Author-Email = {dow471@mail.harvard.edu},
ResearcherID-Numbers = {Li, Yanping/H-6437-2011},
ORCID-Numbers = {Wang, Dong/0000-0002-0897-3048
   Li, Yanping/0000-0002-0412-2748},
Funding-Acknowledgement = {National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA {[}UM1 CA186107, P01
   CA87969, R01 HL034594, R01 HL088521, UM1 CA167552, R01 HL35464];
   NATIONAL CANCER INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) {[}UM1CA186107, UM1CA167552, P01CA087969] Funding
   Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung \& Blood Institute (NHLBI)
   {[}R01HL035464, R01HL088521, R01HL034594] Funding Source: NIH RePORTER},
Funding-Text = {The authors thank the participants and staff of the National Health and
   Nutrition Examination Survey for their outstanding contributions. They
   also thank the participants and staff of the Nurses' Health Study and
   the Health Professionals Follow-up Study for their valuable
   contributions, as well as the following state cancer registries for
   their help: Alabama, Arizona, Arkansas, California, Colorado,
   Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa,
   Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Nebraska,
   New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio,
   Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee,
   Texas, Virginia, Washington, and Wyoming. The authors assume full
   responsibility for analyses and interpretation of these data. The
   Nurses' Health Study and the Health Professionals Follow-up Study were
   supported by research grants (Grant Nos. UM1 CA186107, P01 CA87969, R01
   HL034594, R01 HL088521, UM1 CA167552, and R01 HL35464) from the National
   Institutes of Health.},
Cited-References = {Belin RJ, 2011, AM J CLIN NUTR, V94, P49, DOI 10.3945/ajcn.110.011221.
   Bowman S., 2008, MYPYRAMID EQUIVALENT.
   Brownell KD, 2014, NEW ENGL J MED, V370, P1773, DOI 10.1056/NEJMp1314072.
   Brownell KD, 2010, HEALTH AFFAIR, V29, P379, DOI 10.1377/hlthaff.2009.0739.
   Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR.
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222.
   Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058.
   Department of Agriculture Agricultural Research Service, 2014, FOOD NUTR DATABASE D.
   Doell D, 2012, FOOD ADDIT CONTAM A, V29, P861, DOI 10.1080/19440049.2012.664570.
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303.
   Fung TT, 2005, AM J CLIN NUTR, V82, P163.
   Harvard, HLTH PROFESSIONALS F.
   Harvard Medical School, NURS HLTH STUD.
   HealthyPeople.gov, HLTH PEOPL 2020 TOP.
   Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1.
   Krebs-Smith SM, 2010, AM J PREV MED, V38, P472, DOI 10.1016/j.amepre.2010.01.016.
   Kumanyika SK, 2008, PHYSIOL BEHAV, V94, P61, DOI 10.1016/j.physbeh.2007.11.019.
   Liese AD, 2015, J NUTR, V145, P393, DOI 10.3945/jn.114.205336.
   Menino Thomas M., 2011, ORDER RELATIVE HLTHL.
   Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1.
   Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029.
   Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311.
   Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646.
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S.},
Number-of-Cited-References = {24},
Times-Cited = {56},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Health Aff.},
Doc-Delivery-Number = {CY9JU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000366724000017},
OA = {Green Accepted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000332399500029,
Author = {Heslop, Pauline and Blair, Peter S. and Fleming, Peter and Hoghton,
   Matthew and Marriott, Anna and Russ, Lesley},
Title = {The Confidential Inquiry into premature deaths of people with
   intellectual disabilities in the UK: a population-based study},
Journal = {LANCET},
Year = {2014},
Volume = {383},
Number = {9920},
Pages = {889-895},
Month = {MAR 8},
Abstract = {Background The Confidential Inquiry into premature deaths of people with
   intellectual disabilities in England was commissioned to provide
   evidence about contributory factors to avoidable and premature deaths in
   this population.
   Methods The population-based Confidential Inquiry reviewed the deaths of
   people with intellectual disabilities aged 4 years and older who had
   been registered with a general practitioner in one of five Primary Care
   Trust areas of southwest England, who died between June 1, 2010, and May
   31, 2012. A network of health, social-care, and voluntary-sector
   services; community contacts; and statutory agencies notified the
   Confidential Inquiry of all deaths of people with intellectual
   disabilities and provided core data. The Office for National Statistics
   provided data about the coding of individual cause of death
   certificates. Deaths were described as avoidable (preventable or
   amenable), according to Office for National Statistics definitions.
   Contributory factors to deaths were identified and quantified by the
   case investigator, verified by a local review panel meeting, and agreed
   by the Confidential Inquiry overview panel. Contributory factors were
   grouped into four domains: intrinsic to the individual, within the
   family and environment, care provision, and service provision. The
   deaths of a comparator group of people without intellectual disabilities
   but much the same in age, sex, and cause of death and registered at the
   same general practices as those with intellectual disabilities were also
   investigated.
   Findings The Confidential Inquiry reviewed the deaths of 247 people with
   intellectual disabilities. Nearly a quarter (22\%, 54) of people with
   intellectual disabilities were younger than 50 years when they died, and
   the median age at death was 64 years (IQR 52-75). The median age at
   death of male individuals with intellectual disabilities was 65 years
   (IQR 54-76), 13 years younger than the median age at death of male
   individuals in the general population of England and Wales (78 years).
   The median age at death of female individuals with intellectual
   disabilities was 63 years (IQR 54-75), 20 years younger than the median
   age at death for female individuals in the general population (83
   years). Avoidable deaths from causes amenable to change by good quality
   health care were more common in people with intellectual disabilities
   (37\%, 90 of 244) than in the general population of England and Wales
   (13\%). Contributory factors to premature deaths in a subset of people
   with intellectual disabilities compared with a comparator group of
   people without intellectual disabilities included problems in advanced
   care planning (p=0.0003), adherence to the Mental Capacity Act
   (p=0.0008), living in inappropriate accommodation (p<0.0001), adjusting
   care as needs changed (p=0.009), and carers not feeling listened to
   (p=0.006).
   Interpretation The Confidential Inquiry provides evidence of the
   substantial contribution of factors relating to the provision of care
   and health services to the health disparities between people with and
   without intellectual disabilities. It is imperative to examine care and
   service provision for this population as potentially contributory
   factors to their deaths-factors that can largely be ameliorated.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Heslop, P (Corresponding Author), Univ Bristol, Sch Policy Studies, Norah Fry Res Ctr, Bristol BS8 1TZ, Avon, England.
   Heslop, Pauline; Blair, Peter S.; Fleming, Peter; Marriott, Anna, Univ Bristol, Bristol BS8 1TZ, Avon, England.
   Hoghton, Matthew, Clevedon Med Ctr, Clevedon Riverside Grp, Clevedon, Somerset, England.
   Russ, Lesley, Bristol City Publ Hlth Team, Bristol, Avon, England.},
DOI = {10.1016/S0140-6736(13)62026-7},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {LIFE EXPECTANCY; MORTALITY; DISPARITIES; SURVIVAL; CHILDREN; ADULTS;
   HEALTH},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {pauline.heslop@bristol.ac.uk},
ResearcherID-Numbers = {Blair, Peter S/C-1213-2009
   Heslop, Pauline/AAW-9538-2021
   Fleming, Peter/O-3231-2019
   },
ORCID-Numbers = {Fleming, Peter/0000-0003-2521-5764
   Blair, Peter/0000-0002-7832-8087},
Funding-Acknowledgement = {Department of Health for England},
Funding-Text = {Department of Health for England.},
Cited-References = {Cohen A, 2008, J CHILD NEUROL, V23, P536, DOI 10.1177/0883073807309795.
   Department of Health, 6 LIV PROGR REP HEAL.
   Emerson E, WORKING DEFINITION L.
   Emerson E., 2012, HLTH INEQUALITIES PE.
   EYMAN RK, 1990, NEW ENGL J MED, V323, P584, DOI 10.1056/NEJM199008303230906.
   Forsgren L, 1996, EPILEPSIA, V37, P956, DOI 10.1111/j.1528-1157.1996.tb00533.x.
   FORSSMAN H, 1970, J MENT DEFIC RES, V14, P276.
   Glover G, PEOPLE LEARNING DIAS.
   Hatton C., 2011, ESTIMATING FUTURE NE.
   Heslop P, 2013, CONFIDENTIAL INQUIRY.
   Hollins S, 1998, DEV MED CHILD NEUROL, V40, P50.
   Kiani R, 2013, J INTELL DISABIL RES, DOI {[}10.1111/jidr10247, DOI 10.1111/JIDR10247].
   Krahn GL, 2006, MENT RETARD DEV D R, V12, P70, DOI 10.1002/mrdd.20098.
   Lavin KE, 2006, J INTELLECT DISABILI, V10, P155, DOI 10.1177/1744629506064011.
   McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029.
   Mencap, 2007, DEATH IND.
   Michael J., 2008, HEALTHCARE ALL.
   National Patient Safety Agency, ROOT CAUS AN TOOLK.
   Office for National Statistics, SEARCH KS201EW ENGL.
   Office for National Statistics, 2012, AV MORT ENGL WAL 201.
   Office for National Statistics, 2010, MOR UK.
   Ouellette-Kuntz H, 2005, J APPL RES INTELLECT, V18, P113, DOI 10.1111/j.1468-3148.2005.00240.x.
   Patja K, 2000, J INTELL DISABIL RES, V44, P591, DOI 10.1046/j.1365-2788.2000.00280.x.
   Patja K, 2001, J INTELL DISABIL RES, V45, P30, DOI 10.1046/j.1365-2788.2001.00290.x.
   Strauss D, 1997, J PEDIATR-US, V131, P712, DOI 10.1016/S0022-3476(97)70098-2.
   Tyrer F, 2007, J INTELL DISABIL RES, V51, P520, DOI 10.1111/j.1365-2788.2006.00918.x.
   Tyrer F, 2009, J INTELL DISABIL RES, V53, P898, DOI 10.1111/j.1365-2788.2009.01201.x.
   Tyrer F, 2007, J APPL RES INTELLECT, V20, P360, DOI 10.1111/j.1468-3148.2006.00343.x.
   World Health Assembly, 2013, RES DIS.},
Number-of-Cited-References = {29},
Times-Cited = {238},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {28},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {AC3FC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000332399500029},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000595719100022,
Author = {Rodriguez, Patricia Q. and Unnersjo-Jess, David and Zambrano, Sonia S.
   and Guo, Jing and Moller-Hackbarth, Katja and Blom, Hans and
   Jahnukainen, Timo and Ebarasi, Lwaki and Patrakka, Jaakko},
Title = {Inactivation of mediator complex protein 22 in podocytes results in
   intracellular vacuole formation, podocyte loss and premature death},
Journal = {SCIENTIFIC REPORTS},
Year = {2020},
Volume = {10},
Number = {1},
Month = {NOV 18},
Abstract = {Podocytes are critical for the maintenance of kidney ultrafiltration
   barrier and play a key role in the progression of glomerular diseases.
   Although mediator complex proteins have been shown to be important for
   many physiological and pathological processes, their role in kidney
   tissue has not been studied. In this study, we identified a mediator
   complex protein 22 (Med22) as a renal podocyte cell-enriched molecule.
   Podocyte-specific Med22 knockout mouse showed that Med22 was not needed
   for normal podocyte maturation. However, it was critical for the
   maintenance of podocyte health as the mice developed progressive
   glomerular disease and died due to renal failure. Detailed morphological
   analyses showed that Med22-deficiency in podocytes resulted in
   intracellular vacuole formation followed by podocyte loss. Moreover,
   Med22-deficiency in younger mice promoted the progression of glomerular
   disease, suggesting Med22-mediated processes may have a role in the
   development of glomerulopathies. This study shows for the first time
   that mediator complex has a critical role in kidney physiology.},
Publisher = {NATURE RESEARCH},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Patrakka, J (Corresponding Author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Pathol,Integrated Cardio Metab Ctr, Stockholm, Sweden.
   Rodriguez, Patricia Q.; Zambrano, Sonia S.; Moller-Hackbarth, Katja; Ebarasi, Lwaki; Patrakka, Jaakko, Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Pathol,Integrated Cardio Metab Ctr, Stockholm, Sweden.
   Unnersjo-Jess, David; Blom, Hans, Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Solna, Sweden.
   Guo, Jing, Karolinska Inst, Dept Med Biochem \& Biophys, Stockholm, Sweden.
   Guo, Jing, Duke NUS Med Sch, Cardiovasc \& Metab Disorders Program, Singapore, Singapore.
   Jahnukainen, Timo, Univ Helsinki, Helsinki Univ Hosp, New Childrens Hosp, Dept Pediat Nephrol \& Transplantat, Helsinki, Finland.},
DOI = {10.1038/s41598-020-76870-0},
Article-Number = {20037},
ISSN = {2045-2322},
Keywords-Plus = {KIDNEY; IDENTIFICATION; EXPRESSION; COMPONENTS; GLOMERULI; SUBUNITS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {jaakko.patrakka@ki.se},
Funding-Acknowledgement = {Karolinska InstituteKarolinska Institutet; AstraZenecaAstraZeneca;
   Swedish Diabetes Foundation; Swedish Kidney Foundation; Marianne and
   Marcus Wallenberg Foundation; Karolinska Research Foundation; Sigrid
   Juselius FoundationSigrid Juselius Foundation},
Funding-Text = {Open Access funding provided by Karolinska Institute. JP's research was
   supported by AstraZeneca, Swedish Diabetes Foundation, Swedish Kidney
   Foundation, Marianne and Marcus Wallenberg Foundation and Karolinska
   Research Foundation. TJ's research was supported by Sigrid Juselius
   Foundation.},
Cited-References = {Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951.
   Angiolillo A, 2002, GENE, V284, P169, DOI 10.1016/S0378-1119(02)00379-7.
   Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031.
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635.
   Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788.
   Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006.
   Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012.
   Lal MA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00409.
   Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065.
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8.
   Neal CR, 2005, J AM SOC NEPHROL, V16, P1223, DOI 10.1681/ASN.2004100822.
   Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108.
   Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X.
   Ruotsalainen V, 2000, AM J PATHOL, V157, P1905, DOI 10.1016/S0002-9440(10)64829-8.
   Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006.
   Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200.
   Sistani L, 2013, KIDNEY INT, V83, P63, DOI 10.1038/ki.2012.321.
   Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115.
   Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3.
   TOTH T, 1992, NEPHRON, V61, P16, DOI 10.1159/000186828.
   Unnersjo-Jess D, 2018, KIDNEY INT, V93, P1008, DOI 10.1016/j.kint.2017.09.019.
   Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055.
   Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110.
   WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527.
   Xu L, 2010, MODERN PATHOL, V23, P1241, DOI 10.1038/modpathol.2010.110.
   YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394.
   Zambrano S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23104-z.},
Number-of-Cited-References = {27},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {PA6BR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000595719100022},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000236890700008,
Author = {Deaton, A},
Title = {The great escape: A review of Robert Fogel's The escape from hunger and
   premature death, 1700-2100},
Journal = {JOURNAL OF ECONOMIC LITERATURE},
Year = {2006},
Volume = {44},
Number = {1},
Pages = {106-114},
Month = {MAR},
Abstract = {In this essay, I review Robert Fogel's The Escape from Hunger and
   Premature Death, 1700-2100, which is concerned with the past, present,
   and future of human health. Fogel's work places great emphasis on
   nutrition, not only for the history of health, but for explaining
   aspects Of current health, not only in comparing poor and rich
   countries, but in thinking about rich countries now and in the future. I
   discuss Fogel's analysis alongside alternative interpretations that
   place greater emphasis on the historical role of public health, and on
   the current and future role of improvements in medical technology.},
Publisher = {AMER ECONOMIC ASSOC},
Address = {2014 BROADWAY, STE 305, NASHVILLE, TN 37203 USA},
Type = {Review},
Language = {English},
Affiliation = {Deaton, A (Corresponding Author), Princeton Univ, Woodrow Wilson Sch, Res Program Dev Studies, Princeton, NJ 08544 USA.
   Princeton Univ, Woodrow Wilson Sch, Res Program Dev Studies, Princeton, NJ 08544 USA.
   Princeton Univ, Woodrow Wilson Sch, Ctr Hlth \& Wellbeing, Princeton, NJ 08544 USA.},
DOI = {10.1257/002205106776162672},
ISSN = {0022-0515},
EISSN = {2328-8175},
Keywords-Plus = {MORTALITY; HEALTH; LIFE},
Research-Areas = {Business \& Economics},
Web-of-Science-Categories  = {Economics},
ResearcherID-Numbers = {Deaton, Angus S/C-3334-2008},
Cited-References = {{[}Anonymous], {[}No title captured].
   Barker D.J.P., 1994, MOTHERS BABIES DIS L.
   Case A, 2005, AM ECON REV, V95, P229, DOI 10.1257/000282805774670310.
   Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883.
   Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E.
   Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002.
   Cutler D. M., 2004, YOUR MONEY YOUR LIFE.
   Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898.
   DOBLHAMMER G, 2002, 200219 M PLANCK I DE.
   Duffy John, 1990, SANITARIANS HIST AM.
   Easterlin R.A, 1996, GROWTH TRIUMPHANT 21.
   Easterly W, 1999, J ECON GROWTH, V4, P239, DOI 10.1023/A:1009882702130.
   Fogel Robert, 2000, 4 GREAT AWAKENING FU.
   Fogel RW, 1997, DEMOGRAPHY, V34, P49, DOI 10.2307/2061659.
   FOGEL RW, 1997, HDB POPULATION FAMIL, P00433.
   FOGEL RW, 2005, NBER WORKING PAPER.
   GWATKIN DR, 1980, POPUL DEV REV, V6, P615, DOI 10.2307/1972929.
   Komlos J, 2004, ECON HUM BIOL, V2, P57, DOI 10.1016/j.ehb.2003.12.006.
   McKeown Thomas, 1979, ROLE MED DREAM MIRAG.
   McKeown Thomas, 1976, MODERN RISE POPULATI.
   Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675.
   Preston Samuel H., 1996, AM LONGEVITY PRESENT.
   PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509.
   Preston SH, 1980, POPULATION EC CHANGE, P289.
   Sen A., 1999, DEV FREEDOM.
   Subramanian S, 1996, J POLIT ECON, V104, P133, DOI 10.1086/262020.
   Szreter Simon, 1988, SOC HIST MED, V1, P1, DOI DOI 10.1093/SHM/1.1.1.
   Tomes Nancy, 1998, GOSPEL GERMS MEN WOM.
   VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P430, DOI 10.2105/AJPH.76.4.430.
   WAALER HT, 1984, ACTA MED SCAND, P1.
   {[}No title captured].},
Number-of-Cited-References = {31},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {J. Econ. Lit.},
Doc-Delivery-Number = {033YK},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000236890700008},
DA = {2022-03-29},
}

@article{ WOS:000382361000001,
Author = {Giannadaki, Despina and Lelieveld, Jos and Pozzer, Andrea},
Title = {Implementing the US air quality standard for PM2.5 worldwide can prevent
   millions of premature deaths per year},
Journal = {ENVIRONMENTAL HEALTH},
Year = {2016},
Volume = {15},
Month = {AUG 23},
Abstract = {Background: Air pollution by fine aerosol particles is among the leading
   causes of poor health and premature mortality worldwide. The growing
   awareness of this issue has led several countries to implement air
   pollution legislation. However, populations in large parts of the world
   are still exposed to high levels of ambient particulate pollution. The
   main aim of this work is to evaluate the potential impact of
   implementing current air quality standards for fine particulate matter
   (PM2.5) in the European Union (EU), United States (US) and other
   countries where PM2.5 levels are high.
   Methods: We use a high-resolution global atmospheric chemistry model
   combined with epidemiological concentration response functions to
   investigate premature mortality attributable to PM2.5 in adults >= 30
   years and children <5 years. We perform sensitivity studies to estimate
   the reductions in mortality that could be achieved if the PM2.5 air
   quality standards of the EU and US and other national standards would be
   implemented worldwide.
   Results: We estimate the global premature mortality by PM2.5 at 3.15
   million/year in 2010. China is the leading country with about 1.33
   million, followed by India with 575 thousand and Pakistan with 105
   thousand per year. For the 28 EU member states we estimate 173 thousand
   and for the United States 52 thousand premature deaths in 2010. Based on
   sensitivity analysis, applying worldwide the EU annual mean standard of
   25 mu g/m(3) for PM2.5 could reduce global premature mortality due to
   PM2.5 exposure by 17 \%; while within the EU the effect is negligible.
   With the 2012 revised US standard of 12 mu g/m(3) premature mortality by
   PM2.5 could drop by 46 \% worldwide; 4 \% in the US and 20 \% in the EU,
   69 \% in China, 49 \% in India and 36 \% in Pakistan. These estimates
   take into consideration that about 22 \% of the global PM2.5 related
   mortality cannot be avoided due to the contribution of natural PM2.5
   sources, mainly airborne desert dust and PM2.5 from wild fires.
   Conclusions: Our results reflect the need to adopt stricter limits for
   annual mean PM2.5 levels globally, like the US standard of 12 mu g/m(3)
   or an even lower limit to substantially reduce premature mortality in
   most of the world.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Giannadaki, D (Corresponding Author), Cyprus Inst, POB 27456, CY-1645 Nicosia, Cyprus.
   Giannadaki, Despina; Lelieveld, Jos, Cyprus Inst, POB 27456, CY-1645 Nicosia, Cyprus.
   Lelieveld, Jos; Pozzer, Andrea, Max Planck Inst Chem, Hahn Meitnerweg 1, D-55128 Mainz, Germany.
   Lelieveld, Jos, King Saud Univ, Riyadh 11451, Saudi Arabia.},
DOI = {10.1186/s12940-016-0170-8},
Article-Number = {88},
EISSN = {1476-069X},
Keywords = {Air quality; Outdoor air pollution; Fine particulate matter; PM2.5
   standards; Premature mortality},
Keywords-Plus = {FINE PARTICULATE MATTER; GLOBAL BURDEN; RISK-FACTORS; HUMAN HEALTH;
   MORTALITY; POLLUTION; DISEASE; OZONE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {d.giannadaki@cyi.ac.cy},
ResearcherID-Numbers = {Lelieveld, Jos/A-1986-2013
   Pozzer, Andrea/L-4872-2013
   },
ORCID-Numbers = {Lelieveld, Jos/0000-0001-6307-3846
   Pozzer, Andrea/0000-0003-2440-6104
   Giannadaki, Despina/0000-0002-0314-6115},
Funding-Acknowledgement = {European Research Council under the European Union's Seventh Framework
   Programme (FP7)/ERCEuropean Research Council (ERC) {[}226 144]},
Funding-Text = {The research leading to these results has received funding from the
   European Research Council under the European Union's Seventh Framework
   Programme (FP7/2007-2013)/ERC grant agreement no. 226 144.},
Cited-References = {Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   {[}Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Australian Government, STAT AIR COMM SUMM 1.
   Bell ML, 2011, ENVIRON SCI POLICY, V14, P357, DOI 10.1016/j.envsci.2011.02.006.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   CAI - Asia (Clean Air Initiative for Asia), 2010, PART MATT STAND AS.
   Canadian Ambient Air Quality Standards, 2015, CANADIAN AMBIENT AIR.
   Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166.
   Cooke RM, 2007, ENVIRON SCI TECHNOL, V41, P6598, DOI 10.1021/es0714078.
   EPA (United States Environmental Protection Agency), 2015, REG ACT.
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6.
   Giannadaki D, 2014, ATMOS CHEM PHYS, V14, P957, DOI 10.5194/acp-14-957-2014.
   Green J, 2012, AIR QUALITY LATIN AM.
   Jockel P, 2006, ATMOS CHEM PHYS, V6, P5067.
   Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1.
   Kingdom of Saudi Arabia, NAT ENV STAND AMB AI.
   Kinney PL, 2010, ENVIRON SCI POLICY, V13, P434, DOI 10.1016/j.envsci.2010.05.002.
   Krewski D, 2009, EXTENDED FOLLOW UP S.
   Krzyzanowski M, 2008, AIR QUAL ATMOS HLTH, V1, P7, DOI 10.1007/s11869-008-0008-9.
   Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lelieveld J, 2013, ATMOS CHEM PHYS, V13, P7023, DOI 10.5194/acp-13-7023-2013.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lippmann Morton, 2013, Res Rep Health Eff Inst, P5.
   Pinault L, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0111-6.
   Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646.
   Pozzer A, 2015, ATMOS CHEM PHYS, V15, P5521, DOI 10.5194/acp-15-5521-2015.
   Pozzer A, 2012, ATMOS CHEM PHYS, V12, P6915, DOI 10.5194/acp-12-6915-2012.
   Pozzer A, 2012, ATMOS CHEM PHYS, V12, P961, DOI 10.5194/acp-12-961-2012.
   Roman HA, EXPERT JUDGEMENT ASS.
   Shi LH, 2016, ENVIRON HEALTH PERSP, V124, P46, DOI 10.1289/ehp.1409111.
   Tuomisto JT, 2008, RELIAB ENG SYST SAFE, V93, P732, DOI 10.1016/j.ress.2007.03.002.
   WHO Regional Office for Europe, 2015, EC COST HLTH IMP AIR.
   WHO Regional Office for Europe, 2013, HLTH EFF PART MATT P.
   WHO Regional Office for Europe, 2013, REV EV HLTH ASP AIR.
   WHO (World Health Organization), 2015, DET DAT FIL WHO MORT.
   WHO-World Health Organization, 2018, AMB OUTD AIR QUAL HL.
   Zheng S, 2015, ATMOS CHEM PHYS, V15, P5715, DOI 10.5194/acp-15-5715-2015.},
Number-of-Cited-References = {39},
Times-Cited = {53},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {49},
Journal-ISO = {Environ. Health},
Doc-Delivery-Number = {DU6YR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000382361000001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000385581200015,
Author = {Semb, Synne and Neermark, Soren and Dam-Larsen, Sanne and Franzmann,
   Maria Benedicte and Albrectsen, Jens and Kallemose, Thomas and Becker,
   Ulrik and Bendtsen, Flemming},
Title = {Presence of alcoholic steatohepatitis, but no selective histological
   feature, indicates an increased risk of cirrhosis and premature death},
Journal = {SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY},
Year = {2016},
Volume = {51},
Number = {11},
Pages = {1367-1374},
Abstract = {Objective: The prognostic impact of early stages of histologically
   confirmed alcoholic liver disease is uncertain. Our aim was to determine
   the risk of cirrhosis and premature death, and identify prognostic
   markers, in patients with biopsy-proven alcoholic steatohepatitis - and
   to compare prognosis in patients with alcoholic pure fatty liver and the
   general population.Material and methods: Patients with biopsy-proven
   alcoholic fatty liver disease diagnosed during 1976-1987 were
   identified. Data were collected from medical records, the Danish
   National Patient Registry and the Registry of Causes of Death. All
   biopsies were re-examined and morphological findings assessed. A
   reference cohort matched for age and gender was created. Cox
   proportional hazard models adjusted for age and gender were used to
   analyse differences in mortality and cirrhosis development, as well as
   the prognostic impact of histological and biochemical
   parameters.Results: Two hundred and twenty-five patients with fatty
   liver and 111 with steatohepatitis were followed for median 13 and 9.7
   years, respectively. There was a significantly higher risk of developing
   cirrhosis amongst patients with steatohepatitis compared to both
   patients with fatty liver (p<0.001) and the reference cohort (p<0.001).
   Mortality was significantly higher in patients with steatohepatitis
   compared to patients with fatty liver (p=0.046) and the general
   population (p<0.001). No histological or biochemical parameters with
   prognostic significance for mortality were identified.Conclusion:
   Presence of steatohepatitis indicates an increased risk of cirrhosis and
   premature death. However, none of the histological parameters defining
   steatohepatitis can independently identify patients at risk for
   premature death.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Semb, S (Corresponding Author), Hvidovre Univ Hosp, Gastro Unit, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.
   Semb, Synne; Neermark, Soren; Becker, Ulrik; Bendtsen, Flemming, Univ Copenhagen, Hvidovre Hosp, Gastro Unit, Copenhagen, Denmark.
   Neermark, Soren; Becker, Ulrik, Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   Dam-Larsen, Sanne, Zealand Univ Hosp, Dept Med, Koge, Denmark.
   Franzmann, Maria Benedicte; Albrectsen, Jens, Univ Copenhagen, Hvidovre Hosp, Dept Pathol, Copenhagen, Denmark.
   Kallemose, Thomas, Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, Copenhagen, Denmark.
   Kallemose, Thomas, Univ Copenhagen, Hvidovre Hosp, Dept Orthoped Surg, Copenhagen, Denmark.},
DOI = {10.1080/00365521.2016.1203016},
ISSN = {0036-5521},
EISSN = {1502-7708},
Keywords = {Alcoholic fatty liver; alcoholic liver disease; alcoholic
   steatohepatitis; cirrhosis; prognosis},
Keywords-Plus = {FATTY LIVER PATIENTS; CLINICAL FOLLOW-UP; LONG-TERM; NONALCOHOLIC
   STEATOHEPATITIS; DISEASE; FIBROSIS; REGISTER; PROGRESSION; VALIDATION;
   PROGNOSIS},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {synnesemb@hotmail.com},
ResearcherID-Numbers = {Becker, Ulrik/D-2657-2012
   },
ORCID-Numbers = {Becker, Ulrik/0000-0002-1678-7771
   Neermark, Soren/0000-0002-0677-0140},
Funding-Acknowledgement = {Research Council at Hvidovre Hospital; Hvidovre Hospital Foundation for
   the Study of Liver Disease},
Funding-Text = {The corresponding author has received funding from the Research Council
   at Hvidovre Hospital as well as from the `Hvidovre Hospital Foundation
   for the Study of Liver Disease'.},
Cited-References = {Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043.
   Askgaard G, 2015, J HEPATOL, V62, P1061, DOI 10.1016/j.jhep.2014.12.005.
   BAPTISTA A, 1981, Lancet, V1, P707.
   Bendtsen F, 2010, DIGEST DIS, V28, P709, DOI 10.1159/000324277.
   Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563.
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5.
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8.
   Christensen PB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-178.
   Dam-Larsen S, 2005, SCAND J GASTROENTERO, V40, P460, DOI 10.1080/00365520510012217.
   Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984.
   Dam-Larsen S, 2009, SCAND J GASTROENTERO, V44, P1236, DOI 10.1080/00365520903171284.
   Deleuran T, 2012, ALIMENT PHARM THER, V35, P1336, DOI 10.1111/j.1365-2036.2012.05091.x.
   Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368.
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Hansen N, 2013, EUROSURVEILLANCE, V18, DOI {[}10.2807/1560-7917.ES2013.18.47.20637, DOI 10.2807/1560-7917.ES2013.18.47.20637.].
   Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958.
   Kamper-Jorgensen M, 2004, J HEPATOL, V41, P25, DOI 10.1016/j.jhep.2004.03.002.
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701.
   Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001.
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482.
   MARBET UA, 1987, J HEPATOL, V4, P364, DOI 10.1016/S0168-8278(87)80547-0.
   Mathurin P, 2007, ALIMENT PHARM THER, V25, P1047, DOI 10.1111/j.1365-2036.2007.03302.x.
   Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004.
   Pohar M, 2007, COMPUT BIOL MED, V37, P1741, DOI 10.1016/j.compbiomed.2007.04.010.
   Pollard C., 2015, R LANGUAGE ENV STAT.
   Semb S, 2012, DAN MED J, V59.
   SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2.
   TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7.
   Vestberg K, 1997, J Med Syst, V21, P11, DOI 10.1023/A:1022835207287.},
Number-of-Cited-References = {30},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Gastroenterol.},
Doc-Delivery-Number = {DZ1EH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000385581200015},
DA = {2022-03-29},
}

@article{ WOS:A1980KL55600001,
Author = {TSUANG, MT and WOOLSON, RF and FLEMING, JA},
Title = {PREMATURE DEATHS IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS - AN ANALYSIS
   OF SURVIVAL CURVES AND VARIABLES AFFECTING THE SHORTENED SURVIVAL},
Journal = {ARCHIVES OF GENERAL PSYCHIATRY},
Year = {1980},
Volume = {37},
Number = {9},
Pages = {979-983},
Publisher = {AMER MEDICAL ASSOC},
Address = {515 N STATE ST, CHICAGO, IL 60610},
Type = {Article},
Language = {English},
Affiliation = {TSUANG, MT (Corresponding Author), UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242, USA.
   UNIV IOWA,COLL MED,DEPT PREVENT MED,IOWA CITY,IA 52242.
   UNIV IOWA,COLL MED,DEPT ENVIRONM HLTH,IOWA CITY,IA 52242.},
ISSN = {0003-990X},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Funding-Acknowledgement = {NIMH NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) {[}MH-24189, MH-31673] Funding Source: Medline},
Cited-References = {ALSTROM CH, 1942, ACTA PSYCHIATR NEU S, V24.
   BOOK J A, 1953, Acta Genet Stat Med, V4, P1.
   CHIANG CL, 1968, INTRO STOCHASTIC PRO, pCH9.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7.
   EVANS NJR, 1974, BRIT J PSYCHIAT, V124, P518, DOI 10.1192/bjp.124.6.518.
   FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011.
   FOX BH, 1978, SCIENCE, V201, P966, DOI 10.1126/science.684429.
   GROSS AJ, 1975, SURVIVAL DISTRIBUTIO, P23.
   KATZ J, 1967, CANCER, V20, P2194, DOI 10.1002/1097-0142(196712)20:12<2194::AID-CNCR2820201220>3.0.CO;2-M.
   KOZIOL JA, 1975, TECHNOMETRICS, V17, P507, DOI 10.2307/1268440.
   LEVI RN, 1975, LANCET, V2, P11.
   LINDELIUS R, 1973, ACTA PSYCHIATR SCAND, V59, P315.
   MODRZEWSKA K, 1979, LANCET, V1, P275.
   MORRISON J, 1972, ARCH GEN PSYCHIAT, V27, P457.
   TSUANG MT, 1977, BRIT J PSYCHIAT, V130, P162, DOI 10.1192/bjp.130.2.162.
   TSUANG MT, 1978, ARCH GEN PSYCHIAT, V35, P1181.
   TSUANG MT, 1978, ARCH GEN PSYCHIAT, V35, P153.
   TSUANG MT, 1980, BRIT J PSYCHIAT, V136, P239, DOI 10.1192/bjp.136.3.239.
   {*}US CENS BUR, 1940, VIT STAT US, V1, P186.
   {*}US DHEW, 1960, VIT STAT US, V2, P200.
   {*}US DHEW, 1970, VIT STAT US, V2, P258.
   {*}US DHEW, 1950, VIT STAT US, V3, P308.
   WOOLSON RF, 1980, J CHRON DIS, V33, P183, DOI 10.1016/0021-9681(80)90018-1.
   WOOLSON RF, 1978, METHOD INFORM MED, V17, P116.},
Number-of-Cited-References = {25},
Times-Cited = {147},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Arch. Gen. Psychiatry},
Doc-Delivery-Number = {KL556},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1980KL55600001},
DA = {2022-03-29},
}

@article{ WOS:000537434800013,
Author = {Maji, Kamal Jyoti},
Title = {Substantial changes in PM2.5 pollution and corresponding premature
   deaths across China during 2015-2019: A model prospective},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2020},
Volume = {729},
Month = {AUG 10},
Abstract = {Long-term exposure to the ambient fine particulatematter (PM2.5) is the
   major public health risk factor in China. Several past studies have
   assessed prematuremortalities associated with PM2.5 in China at varying
   levels of temporal and spatial scales using differentmethodological
   approaches. However, recently developed global exposure mortality model
   {[}GEMM NCD + LRI and GEMM 5-COD] provides a much more sophisticated
   methodology in capturing mortality due to PM2.5-exposure than the
   commonly accepted integrated exposure-response (IER) model, which this
   study applied to China. This study provides a comparative assessment of
   the excess longterm PM2.5-attributed nonaccidental deaths aswell as
   cause-specific deaths for 349 cities inmainland China during five years
   (from 2015 to 2019) and compares the results with the spatial resolution
   scale of 0.1 degrees x 0.1 degrees across overall China. The results
   demonstrate that the national annual average PM2.5 concentration
   declined from 51.9 +/- 18.2 mu g/m(3) in 2015 to 39.0 +/- 13.2 mu g/m(3)
   in 2019, and the overall annual negative trend was around -3.1 +/- 2.2
   mu g/m(3)/year {[}-5.6 +/- 3.4\%/year] across China. Consequently, the
   number of PM2.5-related deaths decreased by 383 thousand {[}95\% CI:
   331- 429] to 1755 thousand {[}95\% Confidence Interval: 1470-2025; GEMM
   NCD+ LRI]; 315 thousand {[}95\% CI: 227-370] to 1380 thousand {[}95\%
   CI: 948-1740; GEMM5-COD] and 125 thousand {[}95\% CI: 64-140] to 876
   thousand {[}95\% CI: 394-1262; IER] in 2019, derived fromthe
   pre-establishedmodels (GEMMand IER). The estimate PM2.5-attributed
   deathwith a spatial resolution of 0.1 degrees x 0.1 degrees was 2419
   thousand {[}95\% CI: 2041-2771; GEMMNCD+ LRI], 1918 thousand {[}95\% CI:
   1333-2377; GEMM5-COD] and 1162 thousand {[}95\% CI: 534-1611; IER] in
   2015, which is about 11-16\% higher value than the city-level health
   risk assessment study. The estimated deaths by GEMM NCD + LRI and GEMM
   5-COD were 104\% and 61\% higher than the estimated by IER, highlighting
   that total premature mortalities associated with PM2.5 were
   substantially left behind based on the pre-existing model. The ``other
   noncommunicable diseases{''} mortality, which IER method doesn't account
   for, was 375 thousand in 2019, 68 thousand less than in 2015. Such
   significant mortality was previously overlooked in estimation methods,
   which should now be considered for the air pollution-related policy
   development in China. The high number of premature deaths in central and
   northern parts of China, calls for the need for the Government to
   quickly impose even more stringent and effective pollution control
   measures. (C) 2020 Elsevier B.V. All rights reserved.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Maji, KJ (Corresponding Author), Indian Inst Technol, Environm Sci \& Engn Dept, Mumbai 400076, Maharashtra, India.
   Maji, Kamal Jyoti, Indian Inst Technol, Environm Sci \& Engn Dept, Mumbai 400076, Maharashtra, India.
   Maji, Kamal Jyoti, Newcastle Univ, Sch Engn, Environm Engn Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne \& Wear, England.},
DOI = {10.1016/j.scitotenv.2020.138838},
Article-Number = {138838},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {China; PM2.5; Trend; Long-term mortality; Methodological uncertainty;
   Unaccounted deaths},
Keywords-Plus = {FINE PARTICULATE MATTER; AIR-POLLUTION; GLOBAL BURDEN; ANTHROPOGENIC
   EMISSIONS; MORTALITY BURDEN; CONTROL POLICIES; EXPOSURE; HEALTH;
   DISEASE; TRENDS},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {kjmaji@gmail.com},
ORCID-Numbers = {Maji, Kamal Jyoti/0000-0001-7843-1204},
Cited-References = {An ZS, 2019, P NATL ACAD SCI USA, V116, P8657, DOI 10.1073/pnas.1900125116.
   Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   {[}Anonymous], 2019, LANCET PLANET HEALTH, DOI DOI 10.1016/S2542-5196(18)30261-4.
   Bowe B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15834.
   Bowe B, 2018, J AM SOC NEPHROL, V29, P218, DOI 10.1681/ASN.2017030253.
   Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Carslaw D., 2019, OPENAIR MANUAL OPEN.
   Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P52, DOI 10.1016/j.envsoft.2011.09.008.
   Chan TC, 2018, ENVIRON HEALTH PERSP, V126, DOI {[}10.1289/EHP3304, 10.1289/ehp3304].
   Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI {[}10.1164/rccm.201609-1862oc, 10.1164/rccm.201609-1862OC, 10.1164/rccm.201612-2427OC].
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Ding D, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4157.
   Feng LW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111321.
   Fleming ZL, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.273.
   Fu PF, 2019, SCI TOTAL ENVIRON, V655, P1240, DOI 10.1016/j.scitotenv.2018.11.218.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   GBD 2017 Risk Factor Collaborators, 2018, LANCET, V392, P1923, DOI 10.1016/S0140-6736(18)32225-6.
   Global Health Data Exchange (GHDx), 2019, GLOB HLTH DAT EXCH D.
   Guan Y, 2019, J CLEAN PROD, V217, P284, DOI 10.1016/j.jclepro.2019.01.284.
   Guo H, 2019, CHEMOSPHERE, V225, P27, DOI 10.1016/j.chemosphere.2019.02.154.
   He QQ, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105536.
   Huang J, 2018, LANCET PLANET HEALTH, V2, pE313, DOI 10.1016/S2542-5196(18)30141-4.
   IHME and HEI, 2019, STAT GLOB AIR 2019 S.
   Jiang L, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120631.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lelieveld J, 2020, CARDIOVASC RES, V116, P1910, DOI 10.1093/cvr/cvaa025.
   Lelieveld J, 2019, EUR HEART J, V40, P1590, DOI 10.1093/eurheartj/ehz135.
   Li J, 2018, ENVIRON POLLUT, V243, P1710, DOI 10.1016/j.envpol.2018.09.089.
   Li SX, 2018, INT ARCH PHOTOGRAMM, V42-3, P39, DOI 10.5194/isprs-archives-XLII-3-W5-39-2018d.
   Li TT, 2019, ENVIRON INT, V125, P245, DOI 10.1016/j.envint.2019.01.073.
   Li XY, 2019, ENVIRON POLLUT, V246, P11, DOI 10.1016/j.envpol.2018.11.103.
   Lin CQ, 2018, ATMOS ENVIRON, V180, P110, DOI 10.1016/j.atmosenv.2018.02.045.
   Liu J., 2019, ATMOS CHEM PHYS DISC, DOI {[}10.5194/acp-2019-895, DOI 10.5194/ACP-2019-895].
   Liu ZR, 2018, ATMOS CHEM PHYS, V18, P8849, DOI 10.5194/acp-18-8849-2018.
   Lu XC, 2019, SCI TOTAL ENVIRON, V652, P683, DOI 10.1016/j.scitotenv.2018.10.140.
   Ma ZW, 2019, ATMOS CHEM PHYS, V19, P6861, DOI 10.5194/acp-19-6861-2019.
   Maji KJ, 2018, ENVIRON INT, V121, P392, DOI 10.1016/j.envint.2018.09.024.
   Maji KJ, 2018, SCI TOTAL ENVIRON, V612, P683, DOI 10.1016/j.scitotenv.2017.08.254.
   Matus K, 2012, GLOBAL ENVIRON CHANG, V22, P55, DOI 10.1016/j.gloenvcha.2011.08.006.
   NBSC (National Bureau of Statistics of China), 2019, CHIN STAT YB 2018.
   Pope CA, 2018, CIRC RES, V122, P1645, DOI 10.1161/CIRCRESAHA.118.312956.
   Qi JL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003027.
   R Core Team, 2019, R LANG ENV STAT COMP.
   SEDAC, 2016, DAT CTR NASAS EARTH.
   Shaddick G, 2018, ENVIRON SCI TECHNOL, V52, P9069, DOI 10.1021/acs.est.8b02864.
   Shaddick G, 2018, J R STAT SOC C-APPL, V67, P231, DOI 10.1111/rssc.12227.
   Shen Y, 2019, SCI TOTAL ENVIRON, V655, P13, DOI 10.1016/j.scitotenv.2018.11.105.
   Silver B, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae718.
   Song CB, 2017, ENVIRON POLLUT, V223, P575, DOI 10.1016/j.envpol.2017.01.060.
   Symonds P, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134105.
   United Nations, 2017, WORLD POP PROSP 2017.
   Wang Q, 2019, LANCET PLANET HEALTH, V3, pE71, DOI 10.1016/S2542-5196(18)30277-8.
   Wang ZH, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2020.114076.
   Xiang JB, 2019, INDOOR AIR, V29, P604, DOI 10.1111/ina.12565.
   Xie Y, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.075.
   Xie Y, 2016, ENVIRON SCI TECHNOL, V50, P4836, DOI 10.1021/acs.est.5b05576.
   Xu W, 2018, ATMOS CHEM PHYS, V18, P10931, DOI 10.5194/acp-18-10931-2018.
   Xue T, 2019, ENVIRON INT, V129, P430, DOI 10.1016/j.envint.2019.05.067.
   Xue T, 2019, ENVIRON INT, V123, P345, DOI 10.1016/j.envint.2018.11.075.
   Xue WH, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.134577.
   Yan ML, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4464.
   Yin P, 2017, ENVIRON HEALTH PERSP, V125, DOI {[}10.1289/EHP1673, 10.1289/ehp1673].
   Yue HB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15319-4.
   Zhai SX, 2019, ATMOS CHEM PHYS, V19, P11031, DOI 10.5194/acp-19-11031-2019.
   Zhang FY, 2020, J ENVIRON MANAGE, V260, DOI 10.1016/j.jenvman.2019.110031.
   Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116.
   Zhang X, 2017, ENERG ECON, V68, P478, DOI 10.1016/j.eneco.2017.10.013.
   Zhao XL, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105145.
   Zheng B, 2018, ATMOS CHEM PHYS, V18, P14095, DOI 10.5194/acp-18-14095-2018.
   Zheng YX, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8a32.
   Zou B, 2019, ENVIRON INT, V125, P529, DOI 10.1016/j.envint.2018.10.045.},
Number-of-Cited-References = {72},
Times-Cited = {20},
Usage-Count-Last-180-days = {16},
Usage-Count-Since-2013 = {60},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {LU0DU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000537434800013},
DA = {2022-03-29},
}

@article{ WOS:000434827200002,
Author = {Gaglioti, Anne H. and Xu, Junjun and Rollins, Latrice and Baltrus, Peter
   and O'Connell, Laura Kathryn and Cooper, Dexter L. and Hopkins, Jammie
   and Botchwey, Nisha D. and Akintobi, Tabia Henry},
Title = {Neighborhood Environmental Health and Premature Death From
   Cardiovascular Disease},
Journal = {PREVENTING CHRONIC DISEASE},
Year = {2018},
Volume = {15},
Month = {FEB},
Abstract = {Introduction
   Cardiovascular disease (CVD) is the leading cause of death in the United
   States and disproportionately affects racial/ethnic minority groups.
   Healthy neighborhood conditions are associated with increased uptake of
   health behaviors that reduce CVD risk, but minority neighborhoods often
   have poor food access and poor walkability. This study tested the
   community-driven hypothesis that poor access to food at the neighborhood
   level and poor neighborhood walkability are associated with racial
   disparities in premature deaths from CVD.
   Methods
   We examined the relationship between neighborhood-level food access and
   walkability on premature CVD mortality rates at the census tract level
   for the city of Atlanta using multivariable logistic regression models.
   We produced maps to illustrate premature CVD mortality, food access, and
   walkability by census tract for the city.
   Results
   We found significant racial differences in premature CVD mortality rates
   and geographic disparities in food access and walkability among census
   tracts in Atlanta. Improved food access and walkability were associated
   with reduced overall premature CVD mortality in unadjusted models, but
   this association did not persist in models adjusted for census tract
   population composition and poverty. Census tracts with high
   concentrations of minority populations had higher levels of poor food
   access, poor walkability, and premature CVD mortality.
   Conclusion
   This study highlights disparities in premature CVD mortality and
   neighborhood food access and walkability at the census tract level in
   the city of Atlanta. Improving food access may have differential effects
   for subpopulations living in the same area. These results can be used to
   calibrate neighborhood-level interventions, and they highlight the need
   to examine race-specific health outcomes.},
Publisher = {CENTERS  DISEASE CONTROL},
Address = {1600 CLIFTON RD, ATLANTA, GA 30333 USA},
Type = {Article},
Language = {English},
Affiliation = {Gaglioti, AH (Corresponding Author), Morehouse Sch Med, Natl Ctr Primary Care, 720 Westview Dr SW, Atlanta, GA 30310 USA.
   Gaglioti, Anne H.; Xu, Junjun; Baltrus, Peter, Morehouse Sch Med, Natl Ctr Primary Care, 720 Westview Dr SW, Atlanta, GA 30310 USA.
   Rollins, Latrice; Cooper, Dexter L.; Akintobi, Tabia Henry, Morehouse Sch Med, Prevent Res Ctr, Atlanta, GA USA.
   O'Connell, Laura Kathryn; Botchwey, Nisha D., Georgia Inst Technol, Sch City \& Reg Planning, Ctr Geog Informat Syst, Atlanta, GA 30332 USA.
   Hopkins, Jammie, Morehouse Sch Med, Satcher Hlth Leadership Inst, Transdisciplinary Collaborat Ctr Hlth Dispar Res, Atlanta, GA 30310 USA.},
DOI = {10.5888/pcd15.170220},
Article-Number = {170220},
ISSN = {1545-1151},
Keywords-Plus = {BUILT ENVIRONMENT; COHORT; WALKABILITY; DISPARITIES; MORTALITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {agaglioti@msm.edu},
ORCID-Numbers = {Baltrus, Peter/0000-0001-9808-0501
   Gaglioti, Anne/0000-0001-5843-8476},
Funding-Acknowledgement = {CDC through the Racial and Ethnic Approaches to Community Health
   {[}1U58DP00594]; American Heart Association's Strategically Focused
   Research Network in Health Disparities (Morehouse-Emory Cardiovascular
   Study) {[}15SFDRNh26140001]; Deep South Resource Center for Minority
   Aging Research ({[}National Institute on Aging]) from the National
   Institutes of Health (NIH) {[}P30AG031054]; CDC's Health Promotion and
   Disease Prevention Research Center {[}1U58DP005946]; National Institutes
   on Minority Health and Health Disparities {[}S21MD000101]; National
   Institute of Diabetes and Digestive and Kidney DiseasesUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Diabetes \& Digestive \& Kidney
   Diseases (NIDDK) {[}P30DK111024]; NATIONAL CENTER FOR CHRONIC DISEASE
   PREV AND HEALTH PROMOUnited States Department of Health \& Human
   ServicesCenters for Disease Control \& Prevention - USA {[}U48DP005042,
   U58DP005945, U58DP005946] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Diabetes \& Digestive \& Kidney
   Diseases (NIDDK) {[}P30DK111024] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON AGINGUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}P30AG031054] Funding Source: NIH RePORTER; National
   Institute on Minority Health and Health DisparitiesUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Minority Health \& Health
   Disparities (NIMHD) {[}R25MD007589, S21MD000101] Funding Source: NIH
   RePORTER},
Funding-Text = {Funding for this project was provided by CDC through the Racial and
   Ethnic Approaches to Community Health Program and grant no. 1U58DP00594.
   The census-tract-level mortality data used in this analysis and Dr
   Baltrus and Mr Xu are partially funded by a grant from the American
   Heart Association's Strategically Focused Research Network in Health
   Disparities (Morehouse-Emory Cardiovascular Study, no.
   15SFDRNh26140001). Dr Baltrus was also supported by Deep South Resource
   Center for Minority Aging Research ({[}National Institute on Aging]:
   P30AG031054) from the National Institutes of Health (NIH). Drs Rollins
   and Henry Akintobi are supported through research infrastructure grants,
   including CDC's Health Promotion and Disease Prevention Research Center,
   grant no. 1U58DP005946; the National Institutes on Minority Health and
   Health Disparities, grant no. S21MD000101; and the National Institute of
   Diabetes and Digestive and Kidney Diseases, grant no. P30DK111024. The
   content of this article is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institute on Aging, CDC, or NIH.},
Cited-References = {Blumenthal D., 2011, CTS-CLIN TRANSL SCI, P134.
   Centers for Disease Control and Prevention, LEAD CAUS DEATH 2016.
   Chum A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1788-0.
   Dankwa-Mullan I, 2010, AM J PUBLIC HEALTH, V100, pS12, DOI 10.2105/AJPH.2010.191619.
   Ford MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146085.
   Georgia Department of Health, 2012, GDPH PROGR DAT SUMM.
   Goodin L, 2013, J MED ASS ATLANTA, V84, P14.
   Henry Akintobi T, 2017, HDB COMMUNITY BASED, P131.
   Israel BA., 2005, METHODS COMMUNITY BA.
   Kramer MR, 2015, AM J EPIDEMIOL, V182, P302, DOI 10.1093/aje/kwv050.
   Lee A, 2012, GEOR PLANN ASS M COL.
   Li FZ, 2009, PREV MED, V48, P237, DOI 10.1016/j.ypmed.2009.01.005.
   Li FZ, 2009, AM J HEALTH PROMOT, V23, P203, DOI 10.4278/ajhp.071214133.
   Manaugh K, 2011, TRANSPORT RES D-TR E, V16, P309, DOI 10.1016/j.trd.2011.01.009.
   {*}NAT CTR HLTH STAT, 1980, INT CLASS DIS.
   Paquet C, 2014, HEALTH PLACE, V28, P173, DOI 10.1016/j.healthplace.2014.05.001.
   Rollins L., 2017, J GA PUBLIC HLTH ASS, V6, P402.
   Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017.
   U.S. Census Bureau, 2010, AM FACTFINDER.
   Unger E, 2014, CIRC-CARDIOVASC QUAL, V7, P524, DOI 10.1161/CIRCOUTCOMES.113.000698.
   Van Dyck D, 2011, HEALTH PLACE, V17, P1011, DOI 10.1016/j.healthplace.2011.05.005.
   Ver Ploeg M, 2010, ACCESS AFFORDABLE NU.
   Walk Score, 2010, WALK SCOR METH.
   Weinfield NS, HUNGER AM 2014 NATIO.
   Wen M, 2005, HEALTH SERV RES, V40, P1108, DOI 10.1111/j.1475-6773.2005.00398.x.
   World Health Organization, 1992, ICD 10 INT STAT CLAS.
   {[}No title captured].},
Number-of-Cited-References = {27},
Times-Cited = {10},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Prev. Chronic Dis.},
Doc-Delivery-Number = {GI9EG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000434827200002},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1984SN80900008,
Author = {PETERSSON, B and TRELL, E and HENNINGSEN, NC and HOOD, B},
Title = {RISK-FACTORS FOR PREMATURE DEATH IN MIDDLE-AGED MEN},
Journal = {BRITISH MEDICAL JOURNAL},
Year = {1984},
Volume = {288},
Number = {6426},
Pages = {1264-1268},
Publisher = {BRITISH MED JOURNAL PUBL GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR},
Type = {Article},
Language = {English},
Affiliation = {UNIV LUND,MALMO GEN HOSP,DEPT INTERNAL MED,PREVENT MED SECT,S-21401 MALMO,SWEDEN.
   UNIV LUND,MALMO GEN HOSP,DEPT COMMUNITY HLTH SERV,PREVENT MED SECT,S-21401 MALMO,SWEDEN.},
DOI = {10.1136/bmj.288.6426.1264},
ISSN = {0959-8138},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {ARONSEN K F, 1970, Acta Chirurgica Scandinavica, V136, P17.
   BAGREL A, 1979, CLIN CHEM, V25, P1242.
   BELFRAGE P, 1977, EUR J CLIN INVEST, V7, P127, DOI 10.1111/j.1365-2362.1977.tb01584.x.
   BOTTIGER LE, 1982, ACTA MED SCAND, V211, P437.
   Bremner JM., 1972, STAT-US.
   CASTELLI WP, 1977, LANCET, V2, P153.
   CHAIT A, 1972, LANCET, V2, P62.
   CHANYEUNG M, 1981, AM J CLIN PATHOL, V75, P320.
   Dawber TR, 1980, FRAMINGHAM STUDY EPI.
   DOLL R, 1983, BMJ-BRIT MED J, V286, P445, DOI 10.1136/bmj.286.6363.445.
   EDWARDS G, 1979, LANCET, V2, P402.
   FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602.
   FOX AJ, 1983, 1982 M WHO LYONS.
   GILL GV, 1982, BRIT MED J, V285, P1770, DOI 10.1136/bmj.285.6357.1770.
   GRANDE F, 1960, Minn Med, V43, P731.
   HENNINGSEN NC, 1983, HYPERTENSION, V5, P560, DOI 10.1161/01.HYP.5.4.560.
   HENNINGSEN NC, 1980, ACTA MED SCAND, V207, P245.
   HIGUCHI T, 1981, ISRAEL J MED SCI, V17, P1015.
   HORNER F, 1979, ENZYME, V24, P217, DOI 10.1159/000458662.
   HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503.
   JANZON L, 1983, DIABETOLOGIA, V25, P86.
   JANZON L, 1981, J EPIDEMIOL COMMUN H, V35, P271, DOI 10.1136/jech.35.4.271.
   JANZON L, 1981, SCAND J SOC MED, V9, P127, DOI 10.1177/140349488100900306.
   JONAS S, 1981, PREV MED, V10, P661.
   KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0.
   Keys A, 1980, 7 COUNTRIES MULTIVAR.
   KLATSKY AR, 1977, N ENGL J MED, V276, P1194.
   KRISTENSON H, 1983, ALCOHOL CLIN EXP RES, V7, P203, DOI 10.1111/j.1530-0277.1983.tb05441.x.
   KRISTENSON H, 1982, BRIT J ADDICT, V77, P297.
   KRISTENSON H, 1981, AM J EPIDEMIOL, V114, P862, DOI 10.1093/oxfordjournals.aje.a113256.
   KRISTENSON H, 1981, DRUG ALCOHOL DEPEN, V8, P43, DOI 10.1016/0376-8716(81)90085-5.
   LARBI EB, 1983, ARCH INTERN MED, V143, P28, DOI 10.1001/archinte.143.1.28.
   LARSSON L, 1983, SOCIALMEDICINSK TIDS, V60, P325.
   LIEBER CS, 1962, J CLIN INVEST, V41, P1863, DOI 10.1172/JCI104643.
   LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P171, DOI 10.1111/j.1530-0277.1982.tb04958.x.
   LINDBERG W, 1956, TIDSSKR NOR LAEGEFOR, V76, P231.
   MANTEL N, 1963, J AM STAT ASSOC, V58, P690.
   MATHEWS JD, 1976, CLIN SCI          S3, V51, P661.
   PENN R, 1983, BRIT MED J, V286, P531, DOI 10.1136/bmj.286.6364.531.
   PETERSON B, 1983, SCAND J CLIN LAB INV, V43, P141.
   PETERSON B, 1983, DRUG ALCOHOL DEPEN, V11, P279, DOI 10.1016/0376-8716(83)90019-4.
   PETERSON B, 1980, BMJ-BRIT MED J, V280, P1403, DOI 10.1136/bmj.280.6229.1403.
   PETERSSON B, 1983, BMJ-BRIT MED J, V287, P7, DOI 10.1136/bmj.287.6384.7.
   PETERSSON B, 1982, BRIT MED J, V285, P1457, DOI 10.1136/bmj.285.6353.1457.
   PETERSSON B, 1982, LANCET, V2, P1088.
   PETERSSON B, 1983, KLIN WOCHENSCHR, V63, P795.
   ROSALKI SB, 1971, LANCET, V2, P376.
   SHAW S, 1976, SCIENCE, V194, P1057, DOI 10.1126/science.824734.
   TESCHKE R, 1983, GUT, V24, P625, DOI 10.1136/gut.24.7.625.
   TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7.
   Trell E, 1983, Prax Klin Pneumol, V37 Suppl 1, P687.
   Trell E, 1983, Prax Klin Pneumol, V37 Suppl 1, P673.
   VANWAES L, 1977, BRIT MED J, V2, P1508, DOI 10.1136/bmj.2.6101.1508.
   WALIMAKI M, 1981, SCAND J CLIN LAB INV, V49, P99.
   WILHELMSEN L, 1973, CIRCULATION, V48, P950, DOI 10.1161/01.CIR.48.5.950.
   WU A, 1974, LANCET, V1, P829.
   {[}No title captured].
   {[}No title captured].},
Number-of-Cited-References = {58},
Times-Cited = {44},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Br. Med. J.},
Doc-Delivery-Number = {SN809},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1984SN80900008},
OA = {Green Published, Bronze, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000381439000007,
Author = {Ma, Guoxia and Wang, Jinnan and Yu, Fang and Guo, Xiaomin and Zhang,
   Yanshen and Li, Chao},
Title = {Assessing the premature death due to ambient particulate matter in
   China's urban areas from 2004 to 2013},
Journal = {FRONTIERS OF ENVIRONMENTAL SCIENCE \& ENGINEERING},
Year = {2016},
Volume = {10},
Number = {5},
Month = {OCT},
Abstract = {The Environmental Burden of Disease (EBD) approach for outdoor air
   pollution has been used to calculate premature deaths and average
   potential years of life lost attributable to air pollution in China over
   the past 10 years with differences between the North and the South of
   the country being analyzed. The results indicate that: (1) Between 2004
   and 2013, annual premature deaths attributable to outdoor air pollution
   in China ranged from 350000 to 520000. In 2013, deaths resulting from
   air pollution in China represented 9.9\% of the country's total deaths.
   (2) In 2004, the average life expectancy of the Chinese population and
   the number of potential years of life lost (PYLL) attributable to air
   pollution was 69.6 and 1.85 years respectively as compared to 74.4 and
   0.67 years respectively in 2013. (3) The number of the PYLL attributable
   to air pollution in the northern regions of China is found to be larger
   than that of the southern regions. The PYLL figures of the northern and
   southern regions in 2004 were 2.3 and 1.8 years, respectively, with a
   difference of 0.5 years, as compared to 1.4 and 0.7 years respectively
   with a difference of 0.7 years in 2013. (C) Higher Education Press and
   Springer-Verlag Berlin Heidelberg 2016},
Publisher = {HIGHER EDUCATION PRESS},
Address = {CHAOYANG DIST, 4, HUIXINDONGJIE, FUSHENG BLDG, BEIJING 100029, PEOPLES R
   CHINA},
Type = {Article},
Language = {English},
Affiliation = {Wang, JN (Corresponding Author), Chinese Acad Environm Planning, Beijing 100012, Peoples R China.
   Ma, Guoxia; Wang, Jinnan; Yu, Fang; Zhang, Yanshen; Li, Chao, Chinese Acad Environm Planning, Beijing 100012, Peoples R China.
   Guo, Xiaomin, Minist Environm Protect Peoples Republ China, Beijing 100035, Peoples R China.},
DOI = {10.1007/s11783-016-0849-7},
Article-Number = {07},
ISSN = {2095-2201},
EISSN = {2095-221X},
Keywords = {Air pollution; Public health; Premature deaths; Health assessment},
Keywords-Plus = {AIR-POLLUTION; GLOBAL BURDEN; MORTALITY; EXPOSURE; DISEASE},
Research-Areas = {Engineering; Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Engineering, Environmental; Environmental Sciences},
Author-Email = {wangjn@caep.org.cn},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}41371533]; Chinese Ministry of
   Environmental Protection's Fiscal Program ``Research on the
   Establishment of China Environmental Economics Measurement System{''}
   {[}1441100040]; Public Utility Research Program of Ministry of
   Environmental Protection {[}201309043]},
Funding-Text = {This study was supported by the National Natural Science Foundation of
   China (Grant No. 41371533), the Chinese Ministry of Environmental
   Protection's Fiscal Program ``Research on the Establishment of China
   Environmental Economics Measurement System{''} (No. 1441100040), and
   Public Utility Research Program of Ministry of Environmental Protection
   (No. 201309043).},
Cited-References = {Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Cao J, 2011, J HAZARD MATER, V186, P1594, DOI 10.1016/j.jhazmat.2010.12.036.
   Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4934, DOI 10.1016/j.scitotenv.2011.08.058.
   Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110.
   Chen Z, 2012, HLTH CHINA 2002 STRA, P22.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6.
   HEI Public Health and Air Pollution in Asia Program, 2010, 154 HEI PUBL HLTH AI.
   Kan H D, 2003, THESIS, P2.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Ma GX, 2016, FRONT ENV SCI ENG, V10, P288, DOI 10.1007/s11783-014-0738-x.
   Ministry of Health, 2008, CHINA CANC, P344.
   Organization World Health, 2002, WORLD HLTH REPORT 20.
   Ostro B., 2004, WHO ENV BURDEN DIS S, V5.
   Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Qiu XZ, 2015, FRONT ENV SCI ENG, V9, P1056, DOI 10.1007/s11783-015-0796-8.
   WHO, 2000, WORLD HLTH REP 2000.
   WHO, 2010, BURD DIS ASS URB OUT.
   World Bank, 2007, COST POLL CHIN EC ES.
   World Bank, 1997, CLEAR WAT BLUE SKIES.
   World Health Organization, WORLD HLTH REPORT 20.
   World Health Organization, 1999, WORLD HLTH REP 1999.
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1.
   Yu F., 2009, GUIDELINE CHINESE EN.
   YU F, 2013, NATL MED J CHINA, V93, P2695, DOI DOI 10.2307/20066129.
   Yu F., 2007, J ENVIRON HEALTH, V24, P999, DOI {[}10.16241/j.cnki.1001-5914.2007.12.034, DOI 10.16241/J.CNKI.1001-5914.2007.12.034].
   Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015.
   Zhang DS, 2010, ENERG POLICY, V38, P491, DOI 10.1016/j.enpol.2009.09.039.
   洪传洁, 2005, {[}环境与健康杂志, Journal of Environment and Health], V22, P62.},
Number-of-Cited-References = {30},
Times-Cited = {10},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {32},
Journal-ISO = {Front. Env. Sci. Eng.},
Doc-Delivery-Number = {DT4GU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000381439000007},
DA = {2022-03-29},
}

@article{ WOS:000364995100007,
Author = {Olsson, Daniel and Alexanderson, Kristina and Bottai, Matteo},
Title = {Sickness absence and the time-varying excess risk of premature death: a
   Swedish population-based prospective cohort study},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2015},
Volume = {69},
Number = {11},
Pages = {1052-1057},
Month = {NOV},
Abstract = {Background Previous studies have found that sickness absentees have an
   excess risk of premature death. Most of the studies compared sickness
   absentees with non-sickness absentees, with 1 report including the total
   population. However, no study to date has investigated in detail how the
   risk of premature death varies over the time course of a sick-leave
   spell.
   Methods A population-based cohort of all 5.6 million people aged 16-64
   years was followed up for 6 years. Hazard rates with 95\% CI for
   mortality in the total population, sickness absentees with sick-leave
   spells exceeding 30 days and non-sickness absentees, were estimated over
   time and were standardised so that the distribution of background
   variables in all 3 groups was as close as possible to that in the total
   population.
   Results The standardised hazard rate of premature death at the first day
   under risk for the sickness absentees was 13.58 (95\% CI 13.26 to 13.95)
   deaths per 1000 person-years, 2.29 (2.24 to 2.35) in the total
   population and 0.90 (0.87 to 0.94) among non-sickness absentees. The
   standardised hazard rates of premature death at 6 years was 3.42 (3.22
   to 3.62) among sickness absentees, 3.48 (3.43 to 3.52) in the total
   population and 2.61 (2.57 to 2.66) among the non-sickness absentees. The
   hazard rates varied greatly across sick-leave diagnoses.
   Conclusions Right after start of a sick-leave spell exceeding 30 days,
   sickness absentees were at higher risk of premature death than the total
   population. The difference in risk, however, decreased over time and
   vanished completely after 6 years of follow-up.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Olsson, D (Corresponding Author), Karolinska Inst, Dept Environm Med IMM, Biostat Unit, SE-17177 Stockholm, Sweden.
   Olsson, Daniel; Bottai, Matteo, Karolinska Inst, Dept Environm Med IMM, Biostat Unit, SE-17177 Stockholm, Sweden.
   Alexanderson, Kristina, Karolinska Inst, Dept Clin Neurosci CNS, Div Insurance Med, SE-17177 Stockholm, Sweden.},
DOI = {10.1136/jech-2015-205886},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords-Plus = {ALL-CAUSE; MORTALITY; PREDICTOR},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {daniel.olsson@ki.se},
ORCID-Numbers = {Olsson, Daniel/0000-0003-0535-2729},
Funding-Acknowledgement = {Swedish Research Council of Health, Working Life and Welfare
   {[}2007-1762]},
Funding-Text = {This study was financially supported by the Swedish Research Council of
   Health, Working Life and Welfare (2007-1762).},
Cited-References = {Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808.
   Alexanderson Kristina, 2004, Scand J Public Health Suppl, V63, P256.
   Bjorkenstam E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-733.
   Ferrie JE, 2009, J EPIDEMIOL COMMUN H, V63, P50, DOI 10.1136/jech.2008.074369.
   Gjesdal S, 2008, EUR J PUBLIC HEALTH, V18, P517, DOI 10.1093/eurpub/ckn010.
   Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469.
   Jackson, 2014, FLEXSURV FLEXIBLE PA.
   Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229.
   Kivimaki M, 2008, OCCUP ENVIRON MED, V65, P820, DOI 10.1136/oem.2007.038398.
   Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207.
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203.
   Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817.
   Vingard E, 2004, SCAND J PUBLIC HEALT, V32, P207, DOI 10.1080/14034950410021899.
   World Health Organization, 2004, INT STAT CLASS DIS R.},
Number-of-Cited-References = {16},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {CW4VQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000364995100007},
DA = {2022-03-29},
}

@article{ WOS:000258869000026,
Author = {Maekinen, Ville-Petteri and Forsblom, Carol and Thorn, Lena M. and
   Waden, Johan and Gordin, Daniel and Heikkilae, Outi and Hietala, Kustaa
   and Kylloenen, Laura and Kytoe, Janne and Rosengard-Baerlund, Milla and
   Saraheimo, Markku and Tolonen, Nina and Parkkonen, Maija and Kaski,
   Kimmo and Ala-Korpela, Mika and Groop, Per-Henrik and Behalf FinnDiane
   Study Grp},
Title = {Metabolic phenotypes, vascular complications, and premature deaths in a
   population of 4,197 patients with type 1 diabetes},
Journal = {DIABETES},
Year = {2008},
Volume = {57},
Number = {9},
Pages = {2480-2487},
Month = {SEP},
Abstract = {OBJECTIEVE-Poor glycemic control, elevated triglycerides, and
   albuminuria are associated with vascular complications in diabetes.
   However, few studies have investigated combined associations between
   metabolic markers, diabetic kidney disease, retinopathy, hypertension,
   obesity, and mortality. Here, the goal was to reveal previously
   undetected association patterns between clinical diagnoses and
   biochemistry in the FinnDiane dataset.
   RESEARCH DESIGN AND METHODS-At baseline, clinical records, serum, and
   24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes
   were collected. The data were analyzed by the self-organizing map, which
   is an unsupervised pattern recognition algorithm that produces a
   two-dimensional layout of the patients based on their multivariate
   biochemical profiles. At follow-up, the results were compared against
   all-cause mortality during 6.5 years (295 deaths).
   RESULTS-The highest mortality was associated with advanced kidney
   disease. Other risk factors included 1) a profile of insulin resistance,
   abdominal obesity, high cholesterol, triglycerides, and low HDL2
   cholesterol, and 2) high adiponectin and high LDL cholesterol for older
   patients. The highest population-adjusted risk of death was 10.1-fold
   (95\% CI 7.3-13.1) for men and 10.7-fold (7.9-13.7) for women.
   Nonsignificant risk was observed for a profile with good glycemic
   control and high HDL, cholesterol and for a low cholesterol profile with
   a short diabetes duration.
   CONCLUSIONS-The self-organizing map analysis enabled detailed risk
   estimates, described the associations between known risk factors and
   complications, and uncovered statistical patterns difficult to detect by
   classical methods. The results also suggest that diabetes per se,
   without an adverse metabolic phenotype, does not contribute to increased
   mortality.},
Publisher = {AMER DIABETES ASSOC},
Address = {1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA},
Type = {Article},
Language = {English},
Affiliation = {Makinen, VP (Corresponding Author), Aalto Univ, Dept Biomed Engn \& Computat Sci, Helsinki, Finland.
   Maekinen, Ville-Petteri; Kaski, Kimmo; Ala-Korpela, Mika, Aalto Univ, Dept Biomed Engn \& Computat Sci, Helsinki, Finland.
   Maekinen, Ville-Petteri; Forsblom, Carol; Thorn, Lena M.; Waden, Johan; Gordin, Daniel; Heikkilae, Outi; Hietala, Kustaa; Kylloenen, Laura; Kytoe, Janne; Rosengard-Baerlund, Milla; Saraheimo, Markku; Tolonen, Nina; Parkkonen, Maija; Ala-Korpela, Mika; Groop, Per-Henrik, Biomed Helsinki, Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki, Finland.
   Maekinen, Ville-Petteri; Forsblom, Carol; Thorn, Lena M.; Waden, Johan; Gordin, Daniel; Heikkilae, Outi; Hietala, Kustaa; Kylloenen, Laura; Kytoe, Janne; Rosengard-Baerlund, Milla; Saraheimo, Markku; Tolonen, Nina; Parkkonen, Maija; Ala-Korpela, Mika; Groop, Per-Henrik, Helsinki Univ Hosp, Dept Med, Div Nephrol, Helsinki, Finland.},
DOI = {10.2337/db08-0332},
ISSN = {0012-1797},
EISSN = {1939-327X},
Keywords-Plus = {RISK-FACTORS; H-1-NMR METABONOMICS; SERUM ADIPONECTIN; MICROVASCULAR
   COMPLICATIONS; LIPOPROTEIN SUBCLASSES; INSULIN-RESISTANCE;
   HEART-DISEASE; NEPHROPATHY; INFLAMMATION; ASSOCIATION},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {ville-petteri.makinen@computationalmedicine.fi
   per-henrik.groop@helsinki.fi},
ResearcherID-Numbers = {Tolonen, Nina/F-2819-2012
   Kaski, Kimmo K K/G-8067-2012
   Kaski, Kimmo/AAO-4320-2021
   },
ORCID-Numbers = {Kaski, Kimmo/0000-0002-3805-9687
   THORN, LENA/0000-0003-3999-0390
   Lakka, Timo/0000-0002-9199-2871
   Gordin, Daniel/0000-0003-1494-8292
   Rosengard-Barlund, Milla/0000-0001-5469-3517
   Makinen, Ville-Petteri/0000-0002-7262-2656
   Ala-Korpela, Mika/0000-0001-5905-1206},
Funding-Acknowledgement = {Center of Excellence Program of the Academy of FinlandAcademy of
   Finland; Folkhalsan Research Foundation; Jenny and Antti Wihuri
   Foundation; Wilhelm and Else Stockmann Foundation; Liv och Halsa
   Foundation; European CommissionEuropean CommissionEuropean Commission
   Joint Research Centre {[}QLG2-CT-2001-01669, LSHB-CT-2006-037681]},
Funding-Text = {V.-P.M. has received support from the Center of Excellence Program of
   the Academy of Finland. K.K. has received support from the Center of
   Excellence Program of the Academy of Finland. M.A.-K. has received
   support from the Center of Excellence Program of the Academy of Finland.
   This study has received grants from the Folkhalsan Research Foundation,
   the Jenny and Antti Wihuri Foundation, the Wilhelm and Else Stockmann
   Foundation, the Liv och Halsa Foundation, and the European Commission
   (QLG2-CT-2001-01669, LSHB-CT-2006-037681).},
Cited-References = {Al-Kateb H, 2008, DIABETES, V57, P218, DOI 10.2337/db07-1059.
   Ala-Korpela M, 2006, ANN MED, V38, P322, DOI 10.1080/07853890600862418.
   Boright AP, 2005, DIABETES, V54, P1238, DOI 10.2337/diabetes.54.4.1238.
   Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399.
   Chaturvedi N, 2001, DIABETES CARE, V24, P2071, DOI 10.2337/diacare.24.12.2071.
   Colhoun HM, 2001, DIABETOLOGIA, V44, pS46, DOI 10.1007/PL00002939.
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180.
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7.
   Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782.
   Frystyk J, 2005, DIABETOLOGIA, V48, P1911, DOI 10.1007/s00125-005-1850-z.
   Groop PH, 2007, DIABETES CARE, V30, P2706, DOI 10.2337/dc07-0030.
   Groop PH, 2005, NAT CLIN PRACT ENDOC, V1, P100, DOI 10.1038/ncpendmet0046.
   Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164.
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143.
   Hadjadj S, 2005, DIABETOLOGIA, V48, P1088, DOI 10.1007/s00125-005-1747-x.
   Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773.
   Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101.
   Hyvonen MT, 2001, J AM CHEM SOC, V123, P810, DOI 10.1021/ja0025853.
   Kohonen T., 2000, SELF ORGANIZING MAPS.
   LAMPINEN J, 1999, NEURAL NETWORKS, V3, P1911.
   Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f.
   Lindstrom T, 2006, CLIN ENDOCRINOL, V65, P776, DOI 10.1111/j.1365-2265.2006.02666.x.
   Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163.
   Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648.
   Maahs DM, 2007, AM J EPIDEMIOL, V166, P731, DOI 10.1093/aje/kwm125.
   Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205.
   Makinen VP, 2006, MAGN RESON MATER PHY, V19, P281, DOI 10.1007/s10334-006-0054-y.
   Meier M, 2005, J DIABETES COMPLICAT, V19, P223, DOI 10.1016/j.jdiacomp.2004.10.002.
   Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934.
   Newman DJ, 2005, HEALTH TECHNOL ASSES, V9, P1.
   Osterholm AM, 2007, KIDNEY INT, V71, P140, DOI 10.1038/sj.ki.5001933.
   Pambianco G, 2007, DIABETES CARE, V30, P1248, DOI 10.2337/dc06-2053.
   Saraheimo M, 2005, DIABETES CARE, V28, P1410, DOI 10.2337/diacare.28.6.1410.
   Saraheimo M, 2005, DIABETOLOGIA, V48, P198, DOI 10.1007/s00125-004-1594-1.
   Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5.
   Shen BJ, 2003, AM J EPIDEMIOL, V157, P701, DOI 10.1093/aje/kwg045.
   Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530.
   Stadler M, 2006, J CLIN ENDOCR METAB, V91, P3814, DOI 10.1210/jc.2006-1058.
   Stimadel H, 2008, ATHEROSCLEROSIS, V197, P868, DOI 10.1016/j.atherosclerosis.2007.07.038.
   Suna T, 2007, NMR BIOMED, V20, P658, DOI 10.1002/nbm.1123.
   Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145.
   Thomas MC, 2008, NAT CLIN PRACT NEPHR, V4, P2, DOI 10.1038/ncpneph0679.
   Thorn LM, 2007, DIABETES CARE, V30, P1162, DOI 10.2337/dc06-2033.
   Thorn LM, 2005, DIABETES CARE, V28, P2019, DOI 10.2337/diacare.28.8.2019.
   Tolonen N, 2008, DIABETOLOGIA, V51, P12, DOI 10.1007/s00125-007-0858-y.
   Torffvit O, 2005, DIABETIC MED, V22, P723, DOI 10.1111/j.1464-5491.2005.01476.x.
   Valkonen VP, 2002, INT J EPIDEMIOL, V31, P864, DOI 10.1093/ije/31.4.864.
   Vehtari A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S8.
   Vionnet N, 2006, DIABETES, V55, P3166, DOI 10.2337/db06-0271.
   von Hertzen L, 2004, J INTERN MED, V255, P602, DOI 10.1111/j.1365-2796.2004.01330.x.},
Number-of-Cited-References = {50},
Times-Cited = {69},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Diabetes},
Doc-Delivery-Number = {343QP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000258869000026},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000225270600009,
Author = {Chen, SP},
Title = {Yuan Hong: A case of premature death by historians?},
Journal = {JOURNAL OF THE AMERICAN ORIENTAL SOCIETY},
Year = {2003},
Volume = {123},
Number = {4},
Pages = {841-846},
Month = {OCT-DEC},
Publisher = {AMER ORIENTAL SOCIETY},
Address = {HARLAN HATCHER GRADUATE LIB UNIV OF MICHIGAN, ANN ARBOR, MI 48109-1205
   USA},
Type = {Article},
Language = {English},
DOI = {10.2307/3589972},
ISSN = {0003-0279},
Research-Areas = {Asian Studies},
Web-of-Science-Categories  = {Asian Studies},
Cited-References = {{[}Anonymous], 1997, QINDING SIKU QUANSHU.
   BAZIN L, 1974, CALENDRIERS TURCS ME.
   BAZIN L, 1991, SYSTEMS CHRONOLOGIQU.
   CAO DH, 1996, ZHONGGUO WENXUEJIA C.
   Chavannes E, 1906, TOUNG PAO, VVII, P51.
   FLETCHER W, 1966, GEMS CHINESE VERSE, P34.
   Hao Zhai, 1937, TONGSU BIAN.
   Hucker Charles O., 1985, DICT OFFICIAL TITLES.
   LI H, 1963, TANG HUIYAO.
   QIAN DX, 1939, HENGYAN LU.
   RAO Zongyi, 1982, YUNMENG QINJIAN RISH.
   THURGOOD G, 1985, LINGUISTICS SINOTIBE, P85.
   Xu Zhene., 1984, SHISHUO XINYU JIAOJI.
   Yi Zhao, 1727, GAIYU CONGKAO.
   YU HL, 1981, YUNMENG QINJIAN YANJ, P315.
   ZHOU TY, 1987, HOU HAN JIAOZHU.
   1938, HARVARD J ASIATIC ST, V3, P223.},
Number-of-Cited-References = {17},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Am. Orient. Soc.},
Doc-Delivery-Number = {873HN},
Web-of-Science-Index = {Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:000225270600009},
DA = {2022-03-29},
}

@article{ WOS:000308222200004,
Author = {Lee, Chioun and White, Helene R.},
Title = {Effects of Childhood Maltreatment on Violent Injuries and Premature
   Death During Young Adulthood Among Urban High-Risk Men},
Journal = {ARCHIVES OF PEDIATRICS \& ADOLESCENT MEDICINE},
Year = {2012},
Volume = {166},
Number = {9},
Pages = {814-820},
Month = {SEP},
Abstract = {Objectives: To assess childhood maltreatment as a risk factor for
   violent injuries and premature death in young adulthood and whether
   these associations are mediated by adolescent heavy drinking, hard drug
   use, hard drug selling, and violent offending.
   Design: Prospective longitudinal study of boys followed from childhood
   into young adulthood.
   Setting: Pittsburgh, Pennsylvania.
   Participants: A total of 1009 men from the Pittsburgh Youth Study. Main
   Exposure: Childhood maltreatment.
   Main Outcome Measures: Premature deaths between ages 18 and 38 years
   from the Social Security Death Index and self-reports of violent
   injuries inflicted by gunshot or knife between ages 18 and 28 years.
   Results: Young men who experienced childhood maltreatment, compared with
   their counterparts who did not experience it, had a greater risk of
   violent injuries (relative risk = 1.61; 95\% CI, 1.10-2.35) and death (
   hazard ratio = 2.85; 95\% CI, 1.37-5.93) during young adulthood.
   Adolescent violent offending and hard drug selling explained the
   association between childhood maltreatment and violent injuries, and
   violent offending partially accounted for the association between
   childhood maltreatment and premature death. Although adolescent violent
   offending predicted both outcomes, maltreated boys still had an
   increased risk of premature death ( hazard ratio = 2.54; 95\% CI,
   1.21-5.34) after accounting for their adolescent violence.
   Conclusions: Childhood maltreatment significantly predicts premature
   death and violent injuries during young adulthood. These associations
   are partially explained by adolescent involvement in violence and drug
   dealing. Targeted interventions for maltreated boys to reduce their
   involvement in adolescent deviant behaviors may help decrease their
   risks for later serious injuries and premature death.},
Publisher = {AMER MEDICAL ASSOC},
Address = {515 N STATE ST, CHICAGO, IL 60654-0946 USA},
Type = {Article},
Language = {English},
Affiliation = {White, HR (Corresponding Author), Rutgers State Univ, Ctr Alcohol Studies, 607 Allison Rd, Piscataway, NJ 08854 USA.
   White, Helene R., Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Dept Sociol, Piscataway, NJ 08854 USA.},
DOI = {10.1001/archpediatrics.2012.244},
ISSN = {1072-4710},
Keywords-Plus = {ILLICIT DRUG-USE; UNITED-STATES; SUBSTANCE USE; MIDDLE ADULTHOOD;
   PHYSICAL ABUSE; ADOLESCENT; MORTALITY; NEGLECT; VICTIMIZATION;
   EXPERIENCES},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Author-Email = {hewhite@rci.rutgers.edu},
ORCID-Numbers = {Lee, Chioun/0000-0002-6886-8397},
Funding-Acknowledgement = {National Institute on Alcohol Abuse and AlcoholismUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}ARRA R01 AA 016798, R01 AA 019511]; National Institute on Drug
   AbuseUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA)European Commission {[}R01 DA411018]; National Institute of Mental
   HealthUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) {[}P30 MH079920, R01 MH73941]; Office of Juvenile Justice and
   Delinquency Prevention {[}96-MU-FX-0012, OJJDP 2005-JK-FX-0001];
   Department of Health of the Commonwealth of Pennsylvania; Centers for
   Disease Control and PreventionUnited States Department of Health \&
   Human ServicesCenters for Disease Control \& Prevention - USA; NATIONAL
   INSTITUTE OF MENTAL HEALTHUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Mental Health (NIMH) {[}P30MH079920] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}R01AA019511, R01AA016798] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON DRUG ABUSEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA)European Commission {[}R01DA011018] Funding Source:
   NIH RePORTER},
Funding-Text = {This work was supported in part by grants ARRA R01 AA 016798 and R01 AA
   019511 from the National Institute on Alcohol Abuse and Alcoholism, R01
   DA411018 from the National Institute on Drug Abuse, P30 MH079920 and R01
   MH73941 from the National Institute of Mental Health, and 96-MU-FX-0012
   and OJJDP 2005-JK-FX-0001 from the Office of Juvenile Justice and
   Delinquency Prevention and by the Department of Health of the
   Commonwealth of Pennsylvania and the Centers for Disease Control and
   Prevention.},
Cited-References = {Allison P.D., 2001, MISSING DATA.
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173.
   BILLMIRE ME, 1985, PEDIATRICS, V75, P340.
   BLACK MM, 1994, PEDIATRICS, V93, P1065.
   Blossfeld H. P., 2007, EVENT HIST ANAL STAT.
   Blumstein A, 2000, ANNU REV PUBL HEALTH, V21, P505, DOI 10.1146/annurev.publhealth.21.1.505.
   Borowsky IW, 2004, PEDIATRICS, V113, P530, DOI 10.1542/peds.113.3.530.
   Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021.
   Brown J, 1999, J AM ACAD CHILD PSY, V38, P1490, DOI 10.1097/00004583-199912000-00009.
   Children's Bureau Administration on Children Youth and Families Administration for Children and Families US Department of Health and Human Services, 2009, CHILD MALTR 2009.
   Clark DB, 2008, J ADOLESCENT HEALTH, V42, P637, DOI 10.1016/j.jadohealth.2007.11.147.
   Cross TP, 2009, CHILD MALTREATMENT, V14, P38, DOI 10.1177/1077559508318400.
   Dunn MG, 2002, CLIN PSYCHOL REV, V22, P1063, DOI 10.1016/S0272-7358(02)00132-0.
   Fabio A, 2006, AM J EPIDEMIOL, V164, P151, DOI 10.1093/aje/kwj172.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   Fluke JD, 2003, CHILD YOUTH SERV REV, V25, P359, DOI 10.1016/S0190-7409(03)00026-4.
   Goldstein PJ, 1989, CONTEMP DRUG PROBL, V16, P651.
   Goodwin RD, 2004, PSYCHOL MED, V34, P509, DOI 10.1017/S003329170300134X.
   Graham JW, 2002, EVALUATION REV, V26, P147, DOI 10.1177/0193841X02026002002.
   Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463.
   Hingson RW, 2002, J STUD ALCOHOL, V63, P136, DOI 10.15288/jsa.2002.63.136.
   Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA.
   Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177.
   Huang S, 2011, ADDICT BEHAV, V36, P95, DOI 10.1016/j.addbeh.2010.09.001.
   Ireland TO, 2002, CRIMINOLOGY, V40, P359, DOI 10.1111/j.1745-9125.2002.tb00960.x.
   Jessor R., 1994, ADOLESCENCE PROBLEM.
   Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603.
   Laskey AL, 2012, J PEDIATR-US, V160, P1003, DOI 10.1016/j.jpeds.2011.11.042.
   Lee C, J ADOLESC H IN PRESS.
   Lee Chioun, 2010, J Ethn Subst Abuse, V9, P301, DOI 10.1080/15332640.2010.522898.
   Loeber R, 2008, VIOLENCE AND SERIOUS THEFT: DEVELOPMENT AND PREDICTION FROM CHILDHOOD TO ADULTHOOD, P1.
   Loeber R, 1999, Violence Vict, V14, P339.
   Loeber R., 2001, JUVENILE JUSTICE B, P1.
   Lynch M, 1998, DEV PSYCHOPATHOL, V10, P235, DOI 10.1017/S095457949800159X.
   MacKinnon DP., 2008, INTRO STAT MEDIATION.
   Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753.
   Mulye TP, 2009, J ADOLESCENT HEALTH, V45, P8, DOI 10.1016/j.jadohealth.2009.03.013.
   National Center for Injury Prevention and Control, WISQARS LEAD CAUS DE.
   Rich JA, 2005, AM J PUBLIC HEALTH, V95, P816, DOI 10.2105/AJPH.2004.044560.
   SABOTTA EE, 1992, CHILD ABUSE NEGLECT, V16, P627, DOI 10.1016/0145-2134(92)90101-V.
   SEAGULL EAW, 1987, CHILD ABUSE NEGLECT, V11, P41, DOI 10.1016/0145-2134(87)90032-9.
   Sedlak A. J., 2010, REPORT C.
   Springer KW, 2009, SOC SCI MED, V69, P138, DOI 10.1016/j.socscimed.2009.04.011.
   Stouthamer-Loeber M, 2001, DEV PSYCHOPATHOL, V13, P941, DOI 10.1017/S0954579401004102.
   Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1.
   Thornberry TP, 2010, J ADOLESCENT HEALTH, V46, P359, DOI 10.1016/j.jadohealth.2009.09.011.
   White HR, 2003, CHILD ABUSE NEGLECT, V27, P841, DOI 10.1016/S0145-2134(03)00110-8.
   Widom C., 2001, UPDATE CYCLE VIOLENC.
   Widom CS, 2007, J STUD ALCOHOL DRUGS, V68, P317, DOI 10.15288/jsad.2007.68.317.
   Widom CS, 2006, PSYCHOL ADDICT BEHAV, V20, P394, DOI 10.1037/0893-164X.20.4.394.
   WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995.},
Number-of-Cited-References = {51},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Arch. Pediatr. Adolesc. Med.},
Doc-Delivery-Number = {998FG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000308222200004},
OA = {Bronze, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000754989500008,
Author = {Costa Nascimento, Luiz Fernando and Pompeo Ferreira Vieira, Luciana
   Cristina},
Title = {Years of life lost due to premature deaths associated with air
   pollution: an ecological time-series study},
Journal = {SAO PAULO MEDICAL JOURNAL},
Year = {2021},
Volume = {139},
Number = {6},
Pages = {591-597},
Abstract = {BACKGROUND: Exposure to air pollutants is associated with hospital
   admissions due to cardiovascular diseases and premature deaths.
   OBJECTIVE: To estimate years of life lost (YLL) due to premature deaths
   and their financial costs.
   DESIGN AND SETTING: Ecological time-series study carried out in Sao Jose
   dos Campos, Brazil, in 2016.
   METHODS: Data on deaths among residents of this city in 2016 were
   assessed to estimate the financial cost of premature deaths associated
   with air pollution. The diagnoses studied were ischemic heart disease,
   congestive heart failure and cerebrovascular disease, according to YLL.
   The fractions attributable to deaths associated with air pollutant
   exposure and to each potential year of life lost were calculated using
   negative binomial regression with lags of 0-7 days between exposure and
   outcome. Nitrogen dioxide, particulate matter (PM10) and ozone
   concentrations were included in the model and adjusted for temperature,
   humidity and seasonality.
   RESULTS: Exposure to particulate matter was significant at lag 3 days.
   There were 2177 hospitalizations over the study period, with 201 deaths
   (9.2\%). Premature deaths led to 2035.69 years of life lost. A 10 mu
   g/m(3) increase in PM10 concentrations was correlated with 8.0\% of the
   hospitalizations, which corresponded to 152.67 YLL (81.67 for males and
   71.00 for females). The cost generated was approximately US\$ 9.1
   million in 2016.
   CONCLUSION: In this first study conducted in a medium-sized Brazilian
   city, using the YLL methodology, we identified an excess expense
   attributable to air pollution.},
Publisher = {ASSOCIACAO PAULISTA MEDICINA},
Address = {AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Costa Nascimento, LF (Corresponding Author), Av Ariberto Pereira da Cunha 333, Guaratingueta, SP, Brazil.
   Costa Nascimento, Luiz Fernando; Pompeo Ferreira Vieira, Luciana Cristina, Sao Paulo State Univ UNESP, Dept Energy, Guaratingueta, Brazil.
   Costa Nascimento, Luiz Fernando; Pompeo Ferreira Vieira, Luciana Cristina, Univ Estadual Sao Paulo UNESP, Dept Energy, Postgrad Program Mech Engn, Guaratingueta, Brazil.},
DOI = {10.1590/1516-3180.2021.0129.090422021},
ISSN = {1516-3180},
Keywords = {Mortality, premature; Particulate matter; Air pollutants; Value of life},
Keywords-Plus = {FINE PARTICULATE MATTER; HOSPITAL ADMISSIONS; EXPOSURE; POLLUTANTS;
   MORTALITY; DISEASES; STROKE},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {fernando.nascimento@unesp.br},
ResearcherID-Numbers = {Nascimento, Luiz Fernando/D-7224-2018},
ORCID-Numbers = {Nascimento, Luiz Fernando/0000-0001-9793-750X},
Funding-Acknowledgement = {Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) {[}2019/12928-4]},
Funding-Text = {Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) -grant
   number: 2019/12928-4},
Cited-References = {Abe KC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070694.
   Achilleos S, 2017, ENVIRON INT, V109, P89, DOI 10.1016/j.envint.2017.09.010.
   Al-Hemoud A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112609.
   Amancio CT, 2014, SAO PAULO MED J, V132, P353, DOI 10.1590/1516-3180.2014.1326733.
   Bazyar J, 2019, ENVIRON SCI POLLUT R, V26, P12648, DOI 10.1007/s11356-019-04874-z.
   Brasil. Ministerio da Saude,, DATA SUS.
   Brazil. Ministry of Health, SUS DEP INF DATASUS.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190.
   Nascimento LFC, 2012, CAD SAUDE PUBLICA, V28, P1319, DOI 10.1590/S0102-311X2012000700010.
   Mantovani KCC, 2016, CIENC SAUDE COLETIVA, V21, P509, DOI 10.1590/1413-81232015212.16102014.
   Pestana PRD, 2017, REV SAUDE PUBL, V51, DOI {[}10.1590/S1518-8787.2017051006495, 10.1590/s1518-8787.2017051006495].
   Miraglia SGE, 2014, CIENC SAUDE COLETIVA, V19, P4141, DOI 10.1590/1413-812320141910.09232014.
   Gao TT, 2015, SCI TOTAL ENVIRON, V511, P268, DOI 10.1016/j.scitotenv.2014.11.048.
   Johnson JYM, 2010, STROKE, V41, P1319, DOI 10.1161/STROKEAHA.110.580571.
   Machin AB, 2019, BRAZ J MED BIOL RES, V52, DOI {[}10.1590/1414-431X20188130, 10.1590/1414-431x20188130].
   Machin AB, 2018, CAD SAUDE PUBLICA, V34, DOI {[}10.1590/0102-311X00006617, 10.1590/0102-311x00006617].
   Martinez GS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040626.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Patto NV, 2016, REV ASSOC MED BRAS, V62, P342, DOI 10.1590/1806-9282.62.04.342.
   Ribeiro PC, 2019, SAO PAULO MED J, V137, P60, DOI 10.1590/1516-3180.2018.0239040119.
   Sao Paulo, ENV AG SAO PAUL STAT.
   Tuan TS, 2016, ARQ BRAS CARDIOL, V107, P216, DOI 10.5935/abc.20160117.
   Yang J, 2016, SCI TOTAL ENVIRON, V573, P1566, DOI 10.1016/j.scitotenv.2016.09.014.},
Number-of-Cited-References = {24},
Times-Cited = {0},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Sao Paulo Med. J.},
Doc-Delivery-Number = {YY7TJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000754989500008},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000461330700001,
Author = {Wen, Jia and Yan, Hao and He, Meina and Zhang, Tuo and Mu, Xinyi and
   Wang, Haibin and Zhang, Hua and Xia, Guoliang and Wang, Chao},
Title = {GSK-3 protects fetal oocytes from premature death via modulating TAp63
   expression in mice},
Journal = {BMC BIOLOGY},
Year = {2019},
Volume = {17},
Month = {MAR 12},
Abstract = {BackgroundFemale mammals have a limited reproductive lifespan determined
   by the size of the primordial follicle pool established perinatally.
   Over two thirds of fetal oocytes are abolished via programmed cell death
   during early folliculogenesis. However, the underlying mechanisms
   governing fetal oocyte attrition remain largely elusive.ResultsHere, we
   demonstrate that glycogen synthase kinase-3 beta (GSK-3) is
   indispensable for fetal oocyte maintenance during meiotic prophase I in
   mice. In vitro inhibition of GSK-3 activity or in vivo conditional
   deletion of Gsk-3 in the germline led to a dramatic loss of fetal
   oocytes via apoptosis, which subsequently resulted in a reduced capacity
   of the primordial follicle pool. Inhibition of GSK-3 also impeded
   meiotic progression in fetal oocytes and led to a deficiency in DNA
   double-strand break (DSB) repair associated with premature upregulation
   of Tap63, the major genome guardian of the female germline, following
   GSK-3 inhibition in fetal ovaries. Mechanistically, we demonstrated that
   aberrant nuclear translocation of -catenin was responsible for the
   abnormal expression of TAp63 and global fetal oocyte attrition following
   GSK-3 inhibition.ConclusionsIn summary, GSK-3 was essential for
   sustaining fetal oocyte survival and folliculogenesis via fine-tuning
   the cytoplasmic-nuclear translocation of -catenin, which in turn
   modulates timely TAp63 expression during meiotic prophase I in mice. Our
   study provides a perspective on the physiological regulatory role of DNA
   damage checkpoint signaling in fetal oocyte guardianship and female
   fertility.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Wang, C (Corresponding Author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
   Wang, C (Corresponding Author), Ningxia Univ, Key Lab Minist Educ Conservat \& Utilizat Special, Coll Life Sci, 539 Helanshan Rd, Ningxia 750021, Peoples R China.
   Wen, Jia; Yan, Hao; He, Meina; Zhang, Tuo; Mu, Xinyi; Zhang, Hua; Xia, Guoliang; Wang, Chao, China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
   Wang, Haibin, Xiamen Univ, Med Coll, Fujian Prov Key Lab Reprod Hlth Res, Xiamen 361005, Fujian, Peoples R China.
   Xia, Guoliang; Wang, Chao, Ningxia Univ, Key Lab Minist Educ Conservat \& Utilizat Special, Coll Life Sci, 539 Helanshan Rd, Ningxia 750021, Peoples R China.},
DOI = {10.1186/s12915-019-0641-9},
Article-Number = {23},
EISSN = {1741-7007},
Keywords = {DNA damage checkpoint; GSK-3; Meiotic prophase I; Oocytes; Primordial
   follicle},
Keywords-Plus = {PRIMORDIAL GERM-CELL; GLYCOGEN-SYNTHASE KINASE-3-BETA; MEIOTIC PROPHASE
   I; BETA-CATENIN; MOUSE OOCYTES; DIFFERENTIATION; STABILIZATION;
   FOLLICLE; PROMOTES; MEIOSIS},
Research-Areas = {Life Sciences \& Biomedicine - Other Topics},
Web-of-Science-Categories  = {Biology},
Author-Email = {wangcam@126.com},
ORCID-Numbers = {Yan, Hao/0000-0003-1468-6165},
Funding-Acknowledgement = {National Key Research \& Developmental Program of China
   {[}2018YFC1003700, 2017YFC1001100, 2018YFC1003801]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) {[}31872792, 31371448, 31571540]; Beijing Natural Science
   FoundationBeijing Natural Science Foundation {[}5182015, 7182090]; State
   Key Laboratory of Agrobiotechnology grant {[}2015SKLAB4-1, 2016SKLAB-1];
   Institution of Higher Education Projects of Building First-class
   Discipline Construction in Ningxia Region (Biology) {[}NXYLXK2017B05];
   National Basic Research Program of ChinaNational Basic Research Program
   of China {[}2014CB943202, 2013CB945501, 2014CB138503]},
Funding-Text = {This study was supported by grants from the National Key Research \&
   Developmental Program of China grant number 2018YFC1003700 to G.X and C.
   W., 2017YFC1001100 to G.X and 2018YFC1003801 to C.W.; National Basic
   Research Program of China grant numbers 2014CB943202 to C.W.,
   2013CB945501 to G.X. and C. W., 2014CB138503 to B.Z.; the National
   Natural Science Foundation of China grant numbers 31872792 to C.W.,
   31371448, 31571540 to G.X.; the Beijing Natural Science Foundation grant
   numbers 5182015 to C.W., 7182090 to G.X.; Project of State Key
   Laboratory of Agrobiotechnology grant numbers 2015SKLAB4-1 to C.W.,
   2016SKLAB-1 to G. X. and Institution of Higher Education Projects of
   Building First-class Discipline Construction in Ningxia Region (Biology)
   grant number NXYLXK2017B05 to G. X..},
Cited-References = {Baluch DP, 2008, DEV BIOL, V317, P46, DOI 10.1016/j.ydbio.2008.01.044.
   Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671.
   Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691.
   Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105.
   Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881.
   Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016.
   Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017.
   Coutandin D, 2016, ELIFE, V5, DOI 10.7554/eLife.13909.
   da Rocha AM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128181.
   Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200.
   Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310.
   Gifford JAH, 2015, REPRODUCTION, V150, pR137, DOI 10.1530/REP-14-0685.
   Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280.
   Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033.
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9.
   Grive KJ, 2015, DEVELOPMENT, V142, P2554, DOI 10.1242/dev.125211.
   Grive KJ, 2014, DEV BIOL, V392, P42, DOI 10.1016/j.ydbio.2014.05.001.
   Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266.
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574.
   Holt JE, 2014, DEVELOPMENT, V141, P1354, DOI 10.1242/dev.104828.
   Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004.
   Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017.
   Kim DA, 2014, MOL CELL BIOL, V34, P1460, DOI 10.1128/MCB.01223-13.
   Kimura T, 2006, DEV BIOL, V300, P545, DOI 10.1016/j.ydbio.2006.06.038.
   Klinger FG, 2015, INT J DEV BIOL, V59, P51, DOI 10.1387/ijdb.150063fk.
   Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864.
   Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086.
   Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362.
   Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054.
   Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193.
   Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830.
   McMillan M, 2005, DRUG DISCOV TODAY, V10, P1467, DOI 10.1016/S1359-6446(05)03613-5.
   Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010.
   Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km.
   Monniaux D, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117077.
   Motta PM, 1997, HUM REPROD UPDATE, V3, P281, DOI 10.1093/humupd/3.3.281.
   Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965.
   Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269.
   Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258.
   Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036.
   Rinaldi VD, 2017, MOL CELL, V67, P1026, DOI 10.1016/j.molcel.2017.07.027.
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723.
   Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108.
   Sieber MH, 2016, CELL, V164, P420, DOI 10.1016/j.cell.2015.12.020.
   Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337.
   Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607.
   Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053.
   Tuppi M, 2018, NAT STRUCT MOL BIOL, V25, P261, DOI 10.1038/s41594-018-0035-7.
   Wang C, 2017, CELL MOL LIFE SCI, V74, P2547, DOI 10.1007/s00018-017-2480-6.
   Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755.
   Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200.},
Number-of-Cited-References = {51},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {BMC Biol.},
Doc-Delivery-Number = {HP0BT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000461330700001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000166388000029,
Author = {Wagner, KF and Katschinski, DM and Hasegawa, J and Schumacher, D and
   Meller, B and Gembruch, U and Schramm, U and Jelkmann, W and Gassmann, M
   and Fandrey, J},
Title = {Chronic inborn erythrocytosis leads to cardiac dysfunction and premature
   death in mice overexpressing erythropoietin},
Journal = {BLOOD},
Year = {2001},
Volume = {97},
Number = {2},
Pages = {536-542},
Month = {JAN 15},
Abstract = {The most common cause of an increase of the hematocrit is secondary to
   elevated erythropoietin levels. Erythrocytosis is assumed to cause
   higher blood viscosity that could put the cardiovascular system at
   hemodynamic and rheological risks. Secondary erythrocytosis results from
   tissue hypoxia, and one can hardly define what cardiovascular
   consequences are caused by chronic erythrocytosis or hypoxia, Herein, a
   novel transgenic (tg) mouse line is characterized that is erythrocytotic
   because of chronic over-expression of the human erythropoietin gene.
   These mice grow up well, reaching a hematocrit of about 0.80 in
   adulthood. Blood volume of adult tg mice was markedly increased by 75\%,
   Unexpectedly, blood pressure was not elevated and cardiac output was not
   decreased. Still, the adult tg mice showed features of cardiac
   dysfunction with increased heart weight. In vivo, high-frequency
   echocardiography revealed marked ventricular dilatation that was
   confirmed by histologic examination. Furthermore, by transmission
   electron microscopy, a prominent intracellular edema of the
   cardiomyocytes was seen. Exercise performance of the tg mice was
   dramatically reduced, unmasking the severity of their compromised
   cardiovascular function, in addition, life expectancy of the tg mice was
   significantly reduced to 7.4 months. Our findings suggest that severe
   erythrocytosis per se results in cardiac dysfunction and markedly
   reduced life span, (C) 2001 by The American Society of Hematology.},
Publisher = {AMER SOC HEMATOLOGY},
Address = {2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA},
Type = {Article},
Language = {English},
Affiliation = {Wagner, KF (Corresponding Author), Med Univ Lubeck, Dept Anesthesiol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Dept Anesthesiol, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Dept Radiotherapy \& Nucl Med, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Dept Gynecol \& Obstet, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany.
   Univ Zurich, Inst Physiol, CH-8006 Zurich, Switzerland.
   Univ Essen Gesamthsch, Inst Physiol, Essen, Germany.},
DOI = {10.1182/blood.V97.2.536},
ISSN = {0006-4971},
EISSN = {1528-0020},
Keywords-Plus = {HYPOXIC PULMONARY-HYPERTENSION; SMOOTH-MUSCLE CELLS; POLYCYTHEMIA},
Research-Areas = {Hematology},
Web-of-Science-Categories  = {Hematology},
Author-Email = {wagner@physio.mu-luebeck.de},
ResearcherID-Numbers = {Fandrey, Joachim/AAA-3524-2021
   Jelkmann, Wolfgang/AAF-8897-2019
   Gembruch, Ulrich/Q-8228-2017
   },
ORCID-Numbers = {Gembruch, Ulrich/0000-0001-8284-4669
   Fandrey, Joachim/0000-0001-9585-0531},
Cited-References = {{[}Anonymous], 1989, Lancet, V2, P20.
   Banerjee D, 2000, KIDNEY INT, V57, P1895, DOI 10.1046/j.1523-1755.2000.00039.x.
   BARBEE RW, 1992, AM J PHYSIOL, V263, pR728, DOI 10.1152/ajpregu.1992.263.3.R728.
   BILGRAMI S, 1995, SEMIN ONCOL, V22, P307.
   CIRILLO M, 1993, NEPHRON, V65, P505, DOI 10.1159/000187555.
   DEWARDENER HE, 1951, LANCET, V261, P204.
   Fewell JG, 1997, AM J PHYSIOL-HEART C, V273, pH1595, DOI 10.1152/ajpheart.1997.273.3.H1595.
   Fisher JW, 1997, P SOC EXP BIOL MED, V216, P358.
   Florea VG, 1999, INT J CARDIOL, V70, P51, DOI 10.1016/S0167-5273(99)00047-9.
   GOGUSEV J, 1994, BIOCHEM BIOPH RES CO, V199, P977, DOI 10.1006/bbrc.1994.1325.
   JANSSENS SP, 1991, J APPL PHYSIOL, V71, P2218, DOI 10.1152/jappl.1991.71.6.2218.
   JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449.
   LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164.
   Marshall JM, 1999, EXP PHYSIOL, V84, P449, DOI 10.1111/j.1469-445X.1999.01884.x.
   NAEYE RL, 1967, AM J PATHOL, V50, P1027.
   NEUSSER M, 1993, CARDIOVASC RES, V27, P1233, DOI 10.1093/cvr/27.7.1233.
   PETIT RD, 1995, J APPL PHYSIOL, V79, P229, DOI 10.1152/jappl.1995.79.1.229.
   PETIT RD, 1993, RESP PHYSIOL, V91, P271, DOI 10.1016/0034-5687(93)90105-J.
   RAINE AEG, 1990, SEMIN NEPHROL, V10, P40.
   REID LM, 1986, CHEST, V89, P279, DOI 10.1378/chest.89.2.279.
   RICHARDSON TQ, 1959, AM J PHYSIOL, V197, P1167, DOI 10.1152/ajplegacy.1959.197.6.1167.
   Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609.
   SEMENZA GL, 1989, P NATL ACAD SCI USA, V86, P2301, DOI 10.1073/pnas.86.7.2301.
   STANKEWYTSCH-JANUSCH B, 1981, Journal of Developmental Physiology (Eynsham), V3, P245.
   SWIGART RH, 1965, CIRC RES, V17, P30, DOI 10.1161/01.RES.17.1.30.
   TAN LB, 1991, POSTGRAD MED J, V67, pS10.
   VILLEVAL JL, 1992, LEUKEMIA, V6, P107.
   WISH L, 1950, P SOC EXP BIOL MED, V74, P644.
   Yamane Y, 1999, BIOMED RES-TOKYO, V20, P281, DOI 10.2220/biomedres.20.281.
   Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163.},
Number-of-Cited-References = {30},
Times-Cited = {91},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Blood},
Doc-Delivery-Number = {392AG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000166388000029},
DA = {2022-03-29},
}

@article{ WOS:000493152900001,
Author = {Ohkuma, Toshiaki and Zoungas, Sophia and Jun, Min and Liu Lisheng and
   Mancia, Giuseppe and Marre, Michel and Rodgers, Anthony and Williams,
   Bryan and Woodward, Mark and Chalmers, John and ADV Collaborative Grp},
Title = {Intensive glucose-lowering and the risk of vascular events and premature
   death in patients with decreased kidney function: The ADVANCE trial},
Journal = {DIABETES OBESITY \& METABOLISM},
Year = {2020},
Volume = {22},
Number = {3},
Pages = {452-457},
Month = {MAR},
Abstract = {To assess the effects of intensive glucose control on the risk of major
   clinical outcomes according to estimated glomerular filtration rate
   (eGFR) levels in people with type 2 diabetes. Of 11 140 ADVANCE trial
   participants, 11 096 with baseline eGFR measurements were included, and
   classified into three eGFR groups: >= 90 mL/min/1.73 m(2); 60 to 89
   mL/min/1.73 m(2); and < 60 mL/min/1.73 m(2). Relative risk reduction of
   randomized intensive glucose control with regard to the composite
   outcome of major macro- and microvascular events, all-cause death and
   cardiovascular death did not significantly vary by eGFR level (P for
   heterogeneity >= 0.49). The risk of severe hypoglycaemia increased with
   intensive glucose control; however, this risk did not vary across eGFR
   groups (P for heterogeneity = 0.83). The risk-benefit profile of
   intensive glucose control in patients with type 2 diabetes and impaired
   kidney function appears similar to that observed in those with preserved
   kidney function.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Chalmers, J (Corresponding Author), Royal Prince Alfred Hosp, Level 10,King George V Bldg,Missenden Rd, Camperdown, NSW 2050, Australia.
   Ohkuma, Toshiaki; Zoungas, Sophia; Jun, Min; Rodgers, Anthony; Woodward, Mark; Chalmers, John, Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia.
   Zoungas, Sophia, Monash Univ, Sch Publ Hlth \& Prevent Med, Melbourne, Vic, Australia.
   Liu Lisheng, Chinese Hypertens League Inst, Beijing, Peoples R China.
   Mancia, Giuseppe, Univ Milano Bicocca, Ist Auxol Italiano, Milan, Italy.
   Marre, Michel, Univ Paris, Hop Bichat Claude Bernard, Dept Endocrinol, Paris, France.
   Williams, Bryan, UCL, Inst Cardiovasc Sci, London, England.
   Williams, Bryan, UCL Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England.
   Woodward, Mark, Univ Oxford, George Inst Global Hlth, Oxford, England.
   Woodward, Mark, Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.},
DOI = {10.1111/dom.13878},
EarlyAccessDate = {OCT 2019},
ISSN = {1462-8902},
EISSN = {1463-1326},
Keywords = {cardiovascular disease; clinical trial; glycaemic control;
   hypoglycaemia; type 2 diabetes},
Keywords-Plus = {SEVERE HYPOGLYCEMIA; DISEASE},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {chalmers@georgeinstitute.org.au},
ResearcherID-Numbers = {Jun, Min/AAK-5018-2021
   },
ORCID-Numbers = {Rodgers, Anthony/0000-0003-1282-1896
   Woodward, Mark/0000-0001-9800-5296
   Chalmers, John/0000-0002-9931-0580
   Williams, Bryan/0000-0002-8094-1841},
Funding-Acknowledgement = {National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia;
   ServierServier; John Chalmers Clinical Research Fellowship of the George
   Institute; Scientia Fellowship from UNSW Sydney},
Funding-Text = {The ADVANCE trial was funded by the grants from the National Health and
   Medical Research Council (NHMRC) of Australia and Servier. T.O. is
   supported by the John Chalmers Clinical Research Fellowship of the
   George Institute. M.J. is supported by a Scientia Fellowship from UNSW
   Sydney. B.W. is a National Institute for Health Research (NIHR) Senior
   Investigator. M.W. is a NHMRC of Australia Principal Research Fellow
   (1080206).},
Cited-References = {{[}Anonymous], 2019, DIABETES CARE, V42, pS1, DOI {[}10.2337/dc19-SINT01, 10.2337/dc19-Sint01].
   Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909.
   Chalmers J, 2001, DIABETOLOGIA, V44, P1118.
   Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033.
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006.
   Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77.
   Papademetriou V, 2015, KIDNEY INT, V87, P649, DOI 10.1038/ki.2014.296.
   Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8.
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987.
   Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0.
   Wong MG, 2016, DIABETES CARE, V39, P694, DOI 10.2337/dc15-2322.
   Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795.},
Number-of-Cited-References = {12},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Diabetes Obes. Metab.},
Doc-Delivery-Number = {KL9WU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000493152900001},
OA = {Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000423171000007,
Author = {Wilbek, Therese E. and Jansen, Rasmus B. and Jorgensen, Bo and Svendsen,
   Ole Lander},
Title = {Risk Factors for Premature Death in Diabetes Patients who Undergo
   Amputations below Ankle Level},
Journal = {EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY \& DIABETES},
Year = {2018},
Volume = {126},
Number = {1},
Pages = {61-65},
Month = {JAN},
Abstract = {Aim To identify risk factors for early death in diabetes patients who
   undergo amputations below the ankle.
   Methods A retrospective study, where all hospital records of all
   diabetes patients who had undergone minimum one amputation below the
   ankle at the CWHC Bispebjerg Hospital, Denmark, in the period 1996-2013,
   were examined. The amputations were mainly trans-metatarsal amputations
   and partial amputations of toes. The participants were found via
   ICD10-codes. The included patients were followed from their first
   contact to the last registered contact. The statistical analysis in this
   article is performed on patients with a of minimum 5-year follow-up.
   Results The 5 year mortality was 42 \% for patients with type 2
   diabetes, and 29 \% for patients with type 1 diabetes. For patients with
   type 2 diabetes, multivariable analysis showed that high age, peripheral
   arterial insufficiency and short time from first admission to amputation
   were independently statistically significantly associated with increased
   5-years mortality. Use of statins was associated with decreased
   mortality. 35 \% died as a result of their diabetes, mostly due to
   cardiovascular -causes.
   Conclusion Short time from first admission to amputation is a risk
   factor for early death. Arterial insufficiency and high age is also
   associated with increased mortality, whereas use of statin is associated
   with decreased mortality, in patients with type 2 diabetes.},
Publisher = {JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH},
Address = {RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Wilbek, TE (Corresponding Author), Univ Copenhagen, Bispebjerg Hosp, Dept Endocrinol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
   Jorgensen, Bo; Svendsen, Ole Lander, Univ Copenhagen, Bispebjerg Hosp, Copenhagen Diabet Foot Ctr, Copenhagen, Denmark.
   Svendsen, Ole Lander, Univ Copenhagen, Bispebjerg Hosp, Copenhagen Wound Healing Ctr, Copenhagen, Denmark.
   Wilbek, Therese E.; Jansen, Rasmus B.; Svendsen, Ole Lander, Univ Copenhagen, Bispebjerg Hosp, Dept Endocrinol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.},
DOI = {10.1055/s-0043-109700},
ISSN = {0947-7349},
EISSN = {1439-3646},
Keywords = {diabetes; multidisciplinary foot care team; amputations; mortality; risk
   factors},
Keywords-Plus = {MULTIDISCIPLINARY TEAM; MORTALITY; FOOT; SURVIVAL; DISEASE; 5-YEAR},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {twilbek@gmail.com},
ResearcherID-Numbers = {Fabricius, Therese Wilbek/AAG-7974-2019
   },
ORCID-Numbers = {Fabricius, Therese Wilbek/0000-0002-6344-5408
   Svendsen, Ole Lander/0000-0003-2846-9532},
Cited-References = {Rubio JA, 2014, INT J LOW EXTR WOUND, V13, P22, DOI 10.1177/1534734614521234.
   Armstrong DG, 1997, SOUTHERN MED J, V90, P384, DOI 10.1097/00007611-199704000-00004.
   Ballotta E, 2014, J VASC SURG, V59, P708, DOI 10.1016/j.jvs.2013.08.103.
   Campbell WB, 2000, EUR J VASC ENDOVASC, V19, P174, DOI 10.1053/ejvs.1999.1006.
   Coppini DV, 2000, J CLIN EPIDEMIOL, V53, P519, DOI 10.1016/S0895-4356(99)00170-5.
   Hero C, 2016, DIABETES CARE, V39, P996, DOI 10.2337/dc15-2450.
   IBM, IBM SPSS STAT.
   Icks A, 2011, DIABETES CARE, V34, P1350, DOI 10.2337/dc10-2341.
   Inan B, 2013, ARCH MED SCI, V9, P1078, DOI 10.5114/aoms.2013.39630.
   Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X.
   Kelly PJ, 2014, DIABETIC MED, V31, P954, DOI 10.1111/dme.12468.
   Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491.
   Papazafiropoulou A, 2009, J DIABETES COMPLICAT, V23, P7, DOI 10.1016/j.jdiacomp.2007.11.008.
   Reiber GE, 1996, DIABETIC MED, V13, pS6, DOI 10.1002/dme.1996.13.s1.6.
   Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465.
   Sohn MW, 2013, J VASC SURG, V58, P1578, DOI 10.1016/j.jvs.2013.06.069.
   Tatoulis J, 2016, ANN THORAC SURG, V102, P1948, DOI 10.1016/j.athoracsur.2016.05.062.
   Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598.
   Uzzaman MM, 2011, ANGIOLOGY, V62, P365, DOI 10.1177/0003319710395558.
   WHO, 2015, DIABETES.
   Wilbek TE, 2016, EXP CLIN ENDOCR DIAB, V124, P535, DOI 10.1055/s-0042-109260.},
Number-of-Cited-References = {21},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Exp. Clin. Endocrinol. Diabet.},
Doc-Delivery-Number = {FT5CG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000423171000007},
DA = {2022-03-29},
}

@article{ WOS:000311608200003,
Author = {Ortega, Francisco B. and Silventoinen, Karri and Tynelius, Per and
   Rasmussen, Finn},
Title = {Muscular strength in male adolescents and premature death: cohort study
   of one million participants},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {2012},
Volume = {345},
Month = {NOV 20},
Abstract = {Objectives To explore the extent to which muscular strength in
   adolescence is associated with all cause and cause specific premature
   mortality (<55 years).
   Design Prospective cohort study.
   Setting Sweden.
   Participants 1 142 599 Swedish male adolescents aged 16-19 years were
   followed over a period of 24 years.
   Main outcome measures Baseline examinations included knee extension,
   handgrip, and elbow flexion strength tests, as well as measures of
   diastolic and systolic blood pressure and body mass index. Cox
   regression was used to estimate hazard ratios for mortality according to
   muscular strength categories (tenths).
   Results During a median follow-up period of 24 years, 26 145
   participants died. Suicide was a more frequent cause of death in young
   adulthood (22.3\%) than was cardiovascular diseases (7.8\%) or cancer
   (14.9\%). High muscular strength in adolescence, as assessed by knee
   extension and handgrip tests, was associated with a 20-35\% lower risk
   of premature mortality due to any cause or cardiovascular disease,
   independently of body mass index or blood pressure; no association was
   observed with mortality due to cancer. Stronger adolescents had a
   20-30\% lower risk of death from suicide and were 15-65\% less likely to
   have any psychiatric diagnosis (such as schizophrenia and mood
   disorders). Adolescents in the lowest tenth of muscular strength showed
   by far the highest risk of mortality for different causes. All cause
   mortality rates (per 100 000 person years) ranged between 122.3 and 86.9
   for the weakest and strongest adolescents; corresponding figures were
   9.5 and 5.6 for mortality due to cardiovascular diseases and 24.6 and
   16.9 for mortality due to suicide.
   Conclusions Low muscular strength in adolescents is an emerging risk
   factor for major causes of death in young adulthood, such as suicide and
   cardiovascular diseases. The effect size observed for all cause
   mortality was equivalent to that for well established risk factors such
   as elevated body mass index or blood pressure.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Rasmussen, F (Corresponding Author), Karolinska Inst, Dept Publ Hlth Sci, Child \& Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden.
   Tynelius, Per; Rasmussen, Finn, Karolinska Inst, Dept Publ Hlth Sci, Child \& Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden.
   Ortega, Francisco B., Univ Granada, Sch Sport Sci, Dept Phys Educ \& Sport, Granada, Spain.
   Ortega, Francisco B., Karolinska Inst, Novum, Dept Biosci \& Nutr, Stockholm, Sweden.
   Ortega, Francisco B., Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain.
   Silventoinen, Karri, Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland.},
DOI = {10.1136/bmj.e7279},
Article-Number = {e7279},
ISSN = {1756-1833},
Keywords-Plus = {ALL-CAUSE MORTALITY; BODY-MASS INDEX; ATTEMPTED-SUICIDE COHORT;
   CARDIORESPIRATORY FITNESS; MUSCLE STRENGTH; SELF-ESTEEM; DEPRESSIVE
   SYMPTOMS; PHYSICAL-ACTIVITY; EARLY ADULTHOOD; GRIP STRENGTH},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {Finn.Rasmussen@ki.se},
ResearcherID-Numbers = {Ortega, Francisco B/B-4002-2010
   Ortega, Francisco B./AAG-5195-2021
   },
ORCID-Numbers = {Ortega, Francisco B/0000-0003-2001-1121
   Ortega, Francisco B./0000-0003-2001-1121
   Silventoinen, Karri/0000-0003-1759-3079
   Tynelius, Per/0000-0001-8155-7406
   Rasmussen, Finn/0000-0001-7915-7809},
Funding-Acknowledgement = {Swedish Research CouncilSwedish Research CouncilEuropean Commission
   {[}2007-5942]; Spanish Ministry of Science and InnovationSpanish
   Government {[}RYC-2011-09011]; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission},
Funding-Text = {The study was supported by a grant to FR from the Swedish Research
   Council (grant 2007-5942). FBO was supported by grants from the Spanish
   Ministry of Science and Innovation (RYC-2011-09011). The funding bodies
   had no role in the preparation of this manuscript.; All authors have
   completed the ICMJE uniform disclosure form at
   www.icmje.org/coi\_disclosure.pdf (available on request from the
   corresponding author) and declare: the study was supported by a grant to
   FR from the Swedish Research Council, and FBO was supported by grants
   from the Spanish Ministry of Science and Innovation; no financial
   relationships with any organisations that might have an interest in the
   submitted work in the previous three years; no other relationships or
   activities that could appear to have influenced the submitted work.},
Cited-References = {Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x.
   ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021.
   Artero EG, 2011, J AM COLL CARDIOL, V57, P1831, DOI 10.1016/j.jacc.2010.12.025.
   Au ACY, 2009, ADOLESCENCE, V44, P851.
   Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659.
   Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274.
   Batty GD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2506.
   Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076.
   Beary M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1152.
   Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P685.
   De Leo D, 2004, INT SUICIDE RATES PR.
   Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396.
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130.
   FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1.
   Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224.
   Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000.
   Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28.
   Garaigordobil M, 2008, PSICOTHEMA, V20, P114.
   Greenleaf CA, 2010, RES Q EXERCISE SPORT, V81, pS65, DOI 10.1080/02701367.2010.10599695.
   Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002.
   Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681.
   Koivukangas J, 2010, SCHIZOPHR RES, V116, P152, DOI 10.1016/j.schres.2009.10.022.
   Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002.
   Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359.
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858.
   National Board of Health and Welfare, 2010, CAUS DEATH HIST BACK.
   Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496.
   Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679.
   Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1.
   Ortega FB, 2010, AM J PREV MED, V39, P440, DOI 10.1016/j.amepre.2010.07.015.
   Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168.
   Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y.
   Roberts JE, 1999, BRIT J CLIN PSYCHOL, V38, P425, DOI 10.1348/014466599162917.
   Romm KL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-136.
   Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439.
   Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341.
   Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018.
   Sato M, 2009, EPIDEMIOLOGY, V20, P463, DOI 10.1097/EDE.0b013e31819ed09f.
   Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231.
   Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308.
   Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043.
   Statistics Sweden, 2011, MULT REG 2010 DESCR.
   Sui XM, 2009, J PSYCHIATR RES, V43, P546, DOI 10.1016/j.jpsychires.2008.08.002.
   Sundstrom J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d643.
   VIITASALO JT, 1985, ERGONOMICS, V28, P1563, DOI 10.1080/00140138508963288.
   Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639.},
Number-of-Cited-References = {46},
Times-Cited = {282},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {41},
Journal-ISO = {BMJ-British Medical Journal},
Doc-Delivery-Number = {044GT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000311608200003},
OA = {Green Submitted, Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000182368700001,
Author = {Moller-Leimkuhler, AM},
Title = {The gender gap in suicide and premature death or: why are men so
   vulnerable?},
Journal = {EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE},
Year = {2003},
Volume = {253},
Number = {1},
Pages = {1-8},
Month = {FEB},
Abstract = {Suicide and premature death due to coronary heart disease, violence,
   accidents, drug or alcohol abuse are strikingly male phenomena,
   particularly in the young and middle-aged groups. Rates of offending
   behaviour, conduct disorders, suicide and depression are even rising,
   and give evidence to a high gender-related vulnerability of young men.
   In explaining this vulnerability, the gender perspective offers an
   analytical tool to integrate structural and cultural factors. It is
   shown that traditional masculinity is a key risk factor for male
   vulnerability promoting maladaptive coping strategies such as emotional
   unexpressiveness, reluctance to seek help, or alcohol abuse. This basic
   male disposition is shown to increase psychosocial stress due to
   different societal conditions: to changes in male gender-role, to
   postmodern individualism and to rapid social change in Eastern Europe
   and Russia. Relying on empirical data and theoretical explanations, a
   gender model of male vulnerability is proposed. It is concluded that the
   gender gap in suicide and premature death can most likely be explained
   by perceived reduction in social role opportunities leading to social
   exclusion.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Moller-Leimkuhler, AM (Corresponding Author), Univ Munich, Dept Psychiat, Nussbaumstr 7, D-80336 Munich, Germany.
   Univ Munich, Dept Psychiat, D-80336 Munich, Germany.},
DOI = {10.1007/s00406-003-0397-6},
ISSN = {0940-1334},
EISSN = {1433-8491},
Keywords = {suicide; premature death; masculinity; gender; coping - social change},
Keywords-Plus = {SEX-DIFFERENCES; INCREASING RATES; HELP-SEEKING; YOUNG MEN; DEPRESSION;
   EPIDEMIOLOGY; STEREOTYPES; MORTALITY; ENGLAND; DISEASE},
Research-Areas = {Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Clinical Neurology; Psychiatry},
Author-Email = {amoeller@psy.med.uni-muenchen.de},
Cited-References = {ANGST J, 1999, WEIBLICHE IDENTITAT, P69.
   Archer John, 1994, MALE VIOLENCE.
   AUGUSTIN R, 1992, SUICIDE LIFE-THREAT, V22, P197.
   BAUMANN Z, 1999, UNBEHAGEN POSTMODERN.
   Beck U., 1986, RISIKOGESELLSCHAFT A.
   Bobak M, 2000, SOC SCI MED, V51, P1343, DOI 10.1016/S0277-9536(00)00096-4.
   Canetto SS, 1997, SUICIDE LIFE-THREAT, V27, P339.
   Cantor C, 2000, AUST NZ J PSYCHIAT, V34, P370, DOI 10.1080/j.1440-1614.2000.00756.x.
   Cashdan E, 1998, BRIT J SOC PSYCHOL, V37, P213, DOI 10.1111/j.2044-8309.1998.tb01166.x.
   Chan KPM, 2001, CHILD ADOL PSYCH CL, V10, P777, DOI 10.1016/S1056-4993(18)30030-0.
   Crawford MJ, 1999, SOC SCI MED, V49, P1419, DOI 10.1016/S0277-9536(99)00213-0.
   Culbertson FM, 1997, AM PSYCHOL, V52, P25, DOI 10.1037/0003-066X.52.1.25.
   DELUTY RH, 1988, OMEGA, V19, P315, DOI DOI 10.2190/YX4X-YJBG-45WV-8VW0.
   Durkheim ?., 1897, SUICIDE STUDY SOCIOL.
   Eckersley R, 2002, SOC SCI MED, V55, P1891, DOI 10.1016/S0277-9536(01)00319-7.
   FOMBONNE E, 1994, ACTA PSYCHIAT SCAND, V90, P145, DOI 10.1111/j.1600-0447.1994.tb01571.x.
   GINTER I, 1995, NEW ENGL J MED, V336, P1915.
   GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010.
   Hawton K, 1998, Crisis, V19, P119, DOI 10.1027/0227-5910.19.3.119.
   Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484.
   Hosoda M, 2000, PERCEPT MOTOR SKILL, V90, P1283, DOI 10.2466/PMS.90.3.1283-1294.
   KLERMAN GL, 1989, JAMA-J AM MED ASSOC, V261, P2229, DOI 10.1001/jama.261.15.2229.
   Kopp MS, 2000, SOC SCI MED, V51, P1351, DOI 10.1016/S0277-9536(00)00097-6.
   Kristenson M, 1998, PSYCHOSOM MED, V60, P277, DOI 10.1097/00006842-199805000-00011.
   LEWIS RJ, 1992, SUICIDE LIFE-THREAT, V22, P187.
   Makinen IH, 2000, SOC SCI MED, V51, P1405, DOI 10.1016/S0277-9536(00)00105-2.
   McClure GMG, 2000, BRIT J PSYCHIAT, V176, P64, DOI 10.1192/bjp.176.1.64.
   McConatha JT, 1997, PSYCHOL REP, V80, P499, DOI 10.2466/pr0.1997.80.2.499.
   McQueen C, 2002, SOC SCI MED, V55, P1493, DOI 10.1016/S0277-9536(01)00186-1.
   Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2.
   Murphy GE, 1998, COMPR PSYCHIAT, V39, P165, DOI 10.1016/S0010-440X(98)90057-8.
   Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580.
   Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x.
   Nesbitt MN, 2000, PSYCHOL REP, V87, P493, DOI 10.2466/PR0.87.6.493-511.
   RICKWOOD DJ, 1994, SOC SCI MED, V39, P563, DOI 10.1016/0277-9536(94)90099-X.
   Rutter M, 1995, PSYCHOSOCIAL DISORDE.
   RUTZ W, 1995, LANCET, V345, P524, DOI 10.1016/S0140-6736(95)90622-3.
   Sennett R, 1998, FLEXIBLE MENSCH KULT.
   Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3.
   Siegrist J, 2000, SOC SCI MED, V51, P1283, DOI 10.1016/S0277-9536(00)00092-7.
   SMITH DJ, 1995, PSYCHOSOCIAL DISORDE.
   Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145.
   TRAUE H, 1998, EMOTION GESUNDHEIT P.
   VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1.
   WARREN LW, 1983, CLIN PSYCHOL REV, V3, P147, DOI 10.1016/0272-7358(83)90009-0.
   WATSON P, 1995, SOC SCI MED, V41, P923, DOI 10.1016/0277-9536(94)00405-I.
   Weidner G, 2000, J AM COLL HEALTH, V48, P291, DOI 10.1080/07448480009596270.
   West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002.
   WHITE H, 1988, PSYCHOL WOMEN QUART, V12, P357, DOI 10.1111/j.1471-6402.1988.tb00949.x.
   {*}WHO, 1996, WHO STAT ANN 1995.
   Williams J.E., 1990, SEX PSYCHE GENDER SE.
   WILLIAMS JE, 1982, EDUC PSYCHOL MEAS, V37, P101.
   Willis LA, 2002, SOC SCI MED, V55, P907, DOI 10.1016/S0277-9536(01)00235-0.
   Wittchen HU, 1999, NERVENHEILKUNDE, V18, P202.
   Wood W, 1997, J PERS SOC PSYCHOL, V73, P523, DOI 10.1037/0022-3514.73.3.523.
   ZIERAU F, 2002, IN PRESS NORDIC J PS.},
Number-of-Cited-References = {56},
Times-Cited = {279},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {55},
Journal-ISO = {Eur. Arch. Psych. Clin. Neurosci.},
Doc-Delivery-Number = {669UK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000182368700001},
DA = {2022-03-29},
}

@article{ WOS:000381514500097,
Author = {Steffens, Niklas K. and Cruwys, Tegan and Haslam, Catherine and Jetten,
   Jolanda and Haslam, S. Alexander},
Title = {Social group memberships in retirement are associated with reduced risk
   of premature death: evidence from a longitudinal cohort study},
Journal = {BMJ OPEN},
Year = {2016},
Volume = {6},
Number = {2},
Abstract = {Objectives: Retirement constitutes a major life transition that poses
   significant challenges to health, with many retirees experiencing a
   precipitous decline in health status following retirement. We examine
   the extent to which membership in social groups following retirement
   determines quality of life and mortality.
   Design: The longitudinal impact of the number of social group
   memberships before and after the transition to retirement was assessed
   on retirees' quality of life and risk of death 6 years later.
   Setting: Nationally representative cohort study of older adults living
   in England.
   Participants: Adults who underwent the transition to retirement (N=424).
   A matched control group (N=424) of participants who had comparable
   demographic and health characteristics at baseline but did not undergo
   the transition to retirement were also examined.
   Outcome measures: Analyses examined participants' quality of life and
   mortality during a period of 6 years.
   Results: Retirees who had two group memberships prior to retirement had
   a 2\% risk of death in the first 6 years of retirement if they
   maintained membership in two groups, a 5\% risk if they lost one group
   and a 12\% risk if they lost both groups. Furthermore, for every group
   membership that participants lost in the year following retirement,
   their experienced quality of life 6 years later was approximately 10\%
   lower. These relationships are robust when controlling for key
   sociodemographic variables (age, gender, relationship status and
   socioeconomic status prior to retirement). A comparison with a matched
   control group confirmed that these effects were specific to those
   undergoing the transition to retirement. The effect of social group
   memberships on mortality was comparable to that of physical exercise.
   Conclusions: Theoretical implications for our understanding of the
   determinants of retiree quality of life and health, and practical
   implications for the support of people transitioning from a life of work
   to retirement are discussed.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Steffens, NK (Corresponding Author), Univ Queensland, Brisbane, Qld, Australia.
   Steffens, Niklas K.; Cruwys, Tegan; Haslam, Catherine; Jetten, Jolanda; Haslam, S. Alexander, Univ Queensland, Brisbane, Qld, Australia.},
DOI = {10.1136/bmjopen-2015-010164},
ISSN = {2044-6055},
Keywords-Plus = {MULTIPLE GROUP MEMBERSHIPS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; BRIDGE
   EMPLOYMENT; HEALTH; IDENTITY; PREDICTORS; TRANSITION; SATISFACTION;
   LONELINESS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {n.steffens@uq.edu.au},
ResearcherID-Numbers = {Cruwys, Tegan/G-2956-2014
   Steffens, Niklas/D-3609-2016
   Haslam, Catherine/Y-5763-2018
   Haslam, Alex/AAA-2512-2019},
ORCID-Numbers = {Cruwys, Tegan/0000-0001-5296-3480
   Steffens, Niklas/0000-0002-3990-2592
   Haslam, Catherine/0000-0003-0124-9601
   Haslam, Alex/0000-0001-9523-7921},
Funding-Acknowledgement = {Australian Research CouncilAustralian Research Council {[}FT110100238,
   FL110100199]},
Funding-Text = {This research was supported by two grants from the Australian Research
   Council awarded to JJ (FT110100238) and SAH (FL110100199). The funding
   body did not play any role in the research design; in the collection,
   analysis, and interpretation of data; in the writing of the manuscript;
   or in the decision to submit the manuscript for publication.},
Cited-References = {Adams GA, 2011, AM PSYCHOL, V66, P180, DOI 10.1037/a0022131.
   Bailey M, 2005, AGING MENT HEALTH, V9, P82, DOI 10.1080/13607860512331334031.
   Banks J, 2011, LONGITUD LIFE COURSE, V2, P101, DOI 10.14301/llcs.v2i2.115.
   BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006.
   Boden-Albala B, 2005, NEUROLOGY, V64, P1888, DOI 10.1212/01.WNL.0000163510.79351.AF.
   Brook AT, 2008, PERS SOC PSYCHOL B, V34, P1588, DOI 10.1177/0146167208324629.
   Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005.
   Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140.
   Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154.
   Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839.
   Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013.
   Deller J, 2009, GENEVA PAP R I-ISS P, V34, P137, DOI 10.1057/gpp.2008.44.
   Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756.
   Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276.
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901\_13.
   Diener E, 2013, SOC INDIC RES, V112, P497, DOI 10.1007/s11205-012-0076-y.
   Dorfman LT, 2005, EDUC GERONTOL, V31, P343, DOI 10.1080/03601270590921645.
   Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987.
   Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654.
   Fasbender U, 2014, J VOCAT BEHAV, V84, P215, DOI 10.1016/j.jvb.2014.01.006.
   Feldman DC, 2011, AM PSYCHOL, V66, P193, DOI 10.1037/a0022153.
   Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449.
   Haslam C, 2014, SOC SCI MED, V120, P57, DOI 10.1016/j.socscimed.2014.08.037.
   Haslam S.A., 2009, PSYCHOL PROSOCIAL BE, DOI DOI 10.1002/9781444307948.CH7.
   Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x.
   Haslam SA, 2004, PSYCHOL ORG SOCIAL I.
   Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316.
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676.
   Howell JL, 2014, EUR J SOC PSYCHOL, V44, P612, DOI 10.1002/ejsp.2030.
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359.
   Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628.
   Jetten J, 2012, SOCIAL CURE IDENTITY.
   Jetten J., 2009, SCI AM MIND, V20, P26, DOI 10.1038/scientificamericanmind0909-26.
   Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003.
   Jetten N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102994.
   Jones JM, 2011, SOC PSYCHOL PERS SCI, V2, P239, DOI 10.1177/1948550610386806.
   Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699.
   Kim S, 2000, ACAD MANAGE J, V43, P1195, DOI 10.2307/1556345.
   Lord SR, 2003, J AM GERIATR SOC, V51, P1685, DOI 10.1046/j.1532-5415.2003.51551.x.
   Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI {[}10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650].
   Nimrod G., 2007, Leisure Studies, V26, P65, DOI 10.1080/02614360500333937.
   Nimrod G, 2009, LEISURE SCI, V31, P37, DOI 10.1080/01490400802558087.
   PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003.
   Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI {[}10.1080/17439760701756946, DOI 10.1080/17439760701756946].
   Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4\_5.
   Pinquart M, 2007, PSYCHOL AGING, V22, P442, DOI 10.1037/0882-7974.22.3.442.
   Putnam R., 2000, BOWLING ALONE COLLAP.
   Reitzes DC, 2004, INT J AGING HUM DEV, V59, P63, DOI 10.2190/NYPP-RFFP-5RFK-8EB8.
   ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x.
   Sani F, 2015, BRIT J HEALTH PSYCH, V20, P466, DOI 10.1111/bjhp.12119.
   Sani F, 2012, BRIT J SOC PSYCHOL, V51, P781, DOI 10.1111/j.2044-8309.2012.02101.x.
   SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944.
   Sjoersten N, 2012, BMJ OPEN, V2.
   Szinovacz ME, 2004, J GERONTOL B-PSYCHOL, V59, pP233, DOI 10.1093/geronb/59.5.P233.
   Tajfel H., 1979, SOCIAL PSYCHOL INTER, P255, DOI {[}DOI 10.1016/S0065-2601(05)37005-5, 10.1016/S0065-2601(05)37005-5].
   Thoits PA, 1991, SOC PSYCHOL QUART, V52, P22.
   Topa G, 2009, J VOCAT BEHAV, V75, P38, DOI 10.1016/j.jvb.2009.03.002.
   Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x.
   Wang M, 2007, J APPL PSYCHOL, V92, P455, DOI 10.1037/0021-9010.92.2.455.
   Wang M, 2014, ANNU REV PSYCHOL, V65, P209, DOI 10.1146/annurev-psych-010213-115131.
   Wang M, 2011, AM PSYCHOL, V66, P204, DOI 10.1037/a0022414.
   Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703.
   Zhan YJ, 2009, J OCCUP HEALTH PSYCH, V14, P374, DOI 10.1037/a0015285.},
Number-of-Cited-References = {63},
Times-Cited = {67},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {15},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {DT5HX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000381514500097},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000372681900026,
Author = {Sheron, Nick},
Title = {Alcohol and liver disease in Europe - Simple measures have the potential
   to prevent tens of thousands of premature deaths},
Journal = {JOURNAL OF HEPATOLOGY},
Year = {2016},
Volume = {64},
Number = {4},
Pages = {957-967},
Month = {APR},
Abstract = {In the World Health Organisation European Region, more than 2,370,000
   years of life are lost from liver disease before the age of 50; more
   than lung cancer, trachea, bronchus, oesophageal, stomach, colon, rectum
   and pancreatic cancer combined. Between 60-80\% of these deaths are
   alcohol related, a disease for which no pharmaceutical therapy has yet
   been shown to improve long-term survival.
   The toxicity of alcohol is dose related at an individual level; and is
   dose related at a population level; overall liver mortality is largely
   determined by population alcohol consumption. Trends in alcohol
   consumption correlate closely with trends in overall liver mortality,
   with 3-5-fold decreases or increases in liver mortality in different
   European countries over the last few decades.
   The evidence base for alcohol control measures aimed at reducing
   population alcohol consumption has been subjected to rigorous
   evaluation; most recently by the Organisation for Economic Co-Operation
   and Development (OECD). Effective alcohol policy measures reduce alcohol
   mortality, including mortality from liver disease. The most effective
   and cost effective measures have been summarised by the OECD and the
   World Health Organisation: regular incremental above inflation tax
   increases, a minimum price for alcohol, effective protection of children
   from alcohol marketing and low level interventions from clinicians.
   Simple, cheap and effective changes to alcohol policy by European
   Institutions and member states have the potential to dramatically reduce
   liver mortality in Europe. (C) 2016 Published by Elsevier B.V. on behalf
   of the European Association for the Study of the Liver.},
Publisher = {ELSEVIER SCIENCE BV},
Address = {PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Sheron, N (Corresponding Author), Royal Coll Physicians, European Union Alcohol Policies, London, England.
   Sheron, Nick, Royal Coll Physicians, European Union Alcohol Policies, London, England.},
DOI = {10.1016/j.jhep.2015.11.006},
ISSN = {0168-8278},
EISSN = {1600-0641},
Keywords = {Alcohol; Public health; Policy},
Keywords-Plus = {COMPARATIVE COST-EFFECTIVENESS; GLOBAL BURDEN; PRIMARY-CARE; DRINKING;
   CONSUMPTION; HEALTH; INTERVENTIONS; MORTALITY; CIRRHOSIS; PRICE},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {sheron@soton.ac.uk},
ORCID-Numbers = {Sheron, Nick/0000-0001-5232-8292
   Sheron, Nick/0000-0002-6156-8367},
Cited-References = {Academy of Medical Sciences, 2004, HOUS COMM HLTH COMM.
   Anderson P, 2004, J STUD ALCOHOL, V65, P191, DOI 10.15288/jsa.2004.65.191.
   Anderson P, 2009, ALCOHOL ALCOHOL.
   Anderson P, 2007, ALCOHOL EUROPE PUBLI.
   Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3.
   {[}Anonymous], 2015, MSPS URGED REJECT MI.
   Babor T., 2003, ALCOHOL NO ORDINARY.
   Ballesteros J, 2004, ADDICTION, V99, P103, DOI 10.1111/j.1360-0443.2004.00499.x.
   British Beer and Pub Association, 2013, BRIT BEER PUB ASS HD.
   British Beer and Pub Association, 2009, BRIT BEER PUB ASS HD.
   Bruun Kettil, 1975, ALCOHOL CONTROL POLI.
   Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003.
   Chaloupka FJ, 2015, TOB CONTROL, V24, P112, DOI 10.1136/tobaccocontrol-2014-052022.
   Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782.
   Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487.
   Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x.
   COLLIN M., 1997, ALTERED STATE STORY.
   Craplet M, 2004, THE GLOBE.
   Department of Health, 2008, SAF SENS SOC CONS FU.
   Duffy G J, 1971, J Ir Med Assoc, V64, P393.
   Edwards G, 1997, ADDICTION, V92, pS73, DOI 10.1111/j.1360-0443.1997.tb03399.x.
   European Commission, 2015, EUR.
   European Commission DS, 2015, EU ALC STRAT.
   European Commission Health and Consumers Directorate-General, 2015, ALC REL IND REP WORK.
   Foxcroft DR, 2012, PERSPECT PUBLIC HEAL, V132, P128, DOI 10.1177/1757913912443487.
   Gallet CA, 2015, AUSTR J AGR RESOURCE, V7, P121.
   Habel C, 2008, PARETO EFFECT 80 20.
   Harman DJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007516.
   Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039.
   Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x.
   Health and Social Care Information Centre LS, 2012, STAT ALC 2012.
   Hibell B, 2011, 2011 ESPAD REP SUBST.
   House of Commons, 2013, HOUS COMM HLTH COMM.
   Jenkins RJ, 2009, DRUG ALCOHOL DEPEN, V100, P107, DOI 10.1016/j.drugalcdep.2008.09.016.
   Kaner E, 2010, OXFORD TXB MED, P1334.
   Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501.
   Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x.
   Knai C, 2015, ADDICTION.
   KRISTENSON H, 1981, AM J EPIDEMIOL, V114, P862, DOI 10.1093/oxfordjournals.aje.a113256.
   Lhachimi SK, 2012, PREV MED, V55, P237, DOI 10.1016/j.ypmed.2012.06.006.
   Lhachimi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033317.
   Loring B., 2014, ALCOHOL INEQUITIES G.
   Meier P, 2008, INDEPENDENT REV EFFE.
   Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y.
   Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x.
   NICE, 2007, SCH BAS INT ALC INT.
   OECD, 2015, TACKL HARMF ALC US E.
   Office for National Statistics, 2013, MORT STAT DEATHS REG.
   Pinsky I, 2008, REV BRAS PSIQUIATR, V30, P362, DOI 10.1590/S1516-44462008000400012.
   Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X.
   Rand Europe, 2012, ASS YOUNG PEOPL EXP.
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x.
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7.
   Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0.
   Saffer H, 2015, 18180 NAT BUR EC RES.
   Schiff S, 2010, CLEOPATRA LIFE LITTL.
   Science Group of the European Alcohol and Health Forum, 2009, DOES MARK COMM IMP V.
   Sheron N, 2013, BRIT J GEN PRACT, V63, pE698, DOI 10.3399/bjgp13X673711.
   Sheron N, 2014, CLIN MED, V14, P396, DOI 10.7861/clinmedicine.14-4-396.
   Sheron N, 2012, LANCET, V379, P687, DOI 10.1016/S0140-6736(12)60244-X.
   Siegfried N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010704.pub2.
   Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7.
   Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51.
   Stockwell T, 2013, ADDICTION, V7.
   Stockwell T, 2013, ADDICTION, V108, P1172, DOI 10.1111/add.12178.
   UK House of Lords European Union Committee, 2015, NEW EU ALC STRAT.
   van den Berg M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-36.
   Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x.
   Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007.
   Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x.
   WHO, 2012, GLOB HLTH EST GHE 20.
   WHO, 2011, SCAL ACT NONC DIS MU.
   {*}WHO, 2004, WHO GLOB STAT REP AL.
   Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P426, DOI 10.1111/j.1465-3362.2009.00055.x.
   Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9.
   World Health Organization, 2015, WHO MORT DAT RAW DAT.
   World Health Organization regional office for Europe, 2014, EUR HLTH ALL DAT HFA.
   Zhao J, 2013, ADDICTION, V7.},
Number-of-Cited-References = {80},
Times-Cited = {66},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {J. Hepatol.},
Doc-Delivery-Number = {DH3IY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000372681900026},
DA = {2022-03-29},
}

@article{ WOS:000503200800010,
Author = {Sun, Shihua and Kuja-Halkola, Ralf and Faraone, Stephen V. and
   D'Onofrio, Brian M. and Dalsgaard, Soren and Chang, Zheng and Larsson,
   Henrik},
Title = {Association of Psychiatric Comorbidity With the Risk of Premature Death
   Among Children and Adults With Attention-Deficit/Hyperactivity Disorder},
Journal = {JAMA PSYCHIATRY},
Year = {2019},
Volume = {76},
Number = {11},
Pages = {1141-1149},
Month = {NOV},
Abstract = {IMPORTANCE A previous register-based study reported elevated all-cause
   mortality in attention-deficit/hyperactivity disorder (ADHD), but
   cause-specific risks and the potential associations of psychiatric
   comorbidities remain unknown.
   OBJECTIVES To investigate the all-cause and cause-specific mortality
   risks in ADHD and to explore the potential role of psychiatric
   comorbidities.
   DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study used
   Swedish national registers to identify 2 675 615 individuals born in
   Sweden from January 1, 1983, through December 31, 2009, as the study
   population, among whom 86 670 individuals (3.2\%) received a diagnosis
   of ADHD during follow-up. Follow-up was completed December 31, 2013, and
   data were analyzed from October 2018 through March 2019.
   EXPOSURES Attention-deficit/hyperactivity disorder identified by first
   clinical diagnosis or first prescription of ADHD medications as recorded
   in Swedish registers. Clinical diagnosis of psychiatric comorbidity was
   available in the National Patient Register.
   MAIN OUTCOMES AND MEASURES All-cause and cause-specific mortalities and
   hazard ratios (HRs) using Cox proportional hazards regression models.
   RESULTS In the overall cohort of 2 675 615 individuals, 1 374 790
   (51.4\%) were male (57 919 with an ADHD diagnosis) and 1 300 825
   (48.6\%) were female (28 751 with an ADHD diagnosis). Mean (SD) age at
   study entry was 6.4 (5.6) years. During follow-up, 424 individuals with
   ADHD and 6231 without ADHD died, resulting in mortality rates of 11.57
   and 2.16 per 10 000 person-years, respectively. The association was
   stronger in adulthood (HR, 4.64; 95\% CI, 4.11-5.25) compared with
   childhood (HR, 1.41; 95\% CI, 0.97-2.04) and increased substantially
   with the number of psychiatric comorbidities with ADHD (HR for
   individuals with only ADHD, 1.41 {[}95\% CI, 1.01-1.97]; HR for those
   with >= 4 comorbidities, 25.22 {[}95\% CI, 19.60-32.46]). In adulthood,
   when adjusting for early-onset psychiatric comorbidity, the association
   between ADHD and risk of death due to natural causes was attenuated
   substantially and was no longer statistically significant (HR, 1.32;
   95\% CI, 0.94-1.85). When adjusting for later-onset psychiatric
   disorders, the association was attenuated to statistical nonsignificance
   for death due to suicide (HR, 1.13; 95\% CI, 0.88-1.45) but remained
   statistically significant for death caused by unintentional injury (HR,
   2.14; 95\% CI, 1.71-2.68) or other external causes (HR, 1.75; 95\% CI,
   1.23-2.48).
   CONCLUSIONS AND RELEVANCE Psychiatric comorbidity appears to play an
   important role in all-cause and cause-specific mortality risks in ADHD.
   In adulthood, early-onset psychiatric comorbidity contributed primarily
   to the association with death due to natural causes, whereas later-onset
   psychiatric comorbidity mainly influenced death due to unnatural causes,
   including suicide and unintentional injury. These findings suggest that
   health care professionals should closely monitor specific psychiatric
   comorbidities in individuals with ADHD to identify high-risk groups for
   prevention efforts.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Sun, SH (Corresponding Author), Karolinska Inst, Dept Med Epidemiol \& Biostat, POB 281, S-17177 Stockholm, Sweden.
   Sun, Shihua; Kuja-Halkola, Ralf; D'Onofrio, Brian M.; Chang, Zheng; Larsson, Henrik, Karolinska Inst, Dept Med Epidemiol \& Biostat, POB 281, S-17177 Stockholm, Sweden.
   Faraone, Stephen V., SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA.
   Faraone, Stephen V., SUNY Upstate Med Univ, Dept Neurosci \& Physiol, Syracuse, NY 13210 USA.
   D'Onofrio, Brian M., Indiana Univ, Dept Psychol \& Brain Sci, Bloomington, IN USA.
   Dalsgaard, Soren, Aarhus Univ, Dept Econ \& Business Econ, Natl Ctr Register Based Res, Aarhus, Denmark.
   Dalsgaard, Soren, iPSYCH Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark.
   Dalsgaard, Soren, Hosp Telemark, Dept Child \& Adolescent Psychiat, Kragero, Norway.
   Larsson, Henrik, Orebro Univ, Sch Med Sci, Orebro, Sweden.},
DOI = {10.1001/jamapsychiatry.2019.1944},
ISSN = {2168-622X},
EISSN = {2168-6238},
Keywords-Plus = {DEFICIT-HYPERACTIVITY DISORDER; INTELLECTUAL DISABILITY; ADHD
   MEDICATION; DEPRESSION; SUICIDE; ACCIDENTS; MORTALITY},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {shihua.sun@ki.se},
ResearcherID-Numbers = {Kuja-Halkola, Ralf/ABA-5061-2020
   Dalsgaard, Søren/AAA-4475-2020},
ORCID-Numbers = {Kuja-Halkola, Ralf/0000-0002-3765-2067
   Dalsgaard, Søren/0000-0003-4659-0969},
Funding-Acknowledgement = {Shire International GmbH; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission {[}2018-02259]; Swedish Brain Foundation
   {[}F02018-0273]; Swedish Initiative for Research on Microdata in the
   Social and Medical Sciences framework (Swedish Research Council)
   {[}340-2013-5867]; National Institute of Mental HealthUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Mental Health (NIMH)
   {[}1R01MH102221]; European UnionEuropean Commission {[}667302]; American
   Foundation for Suicide Prevention; Aarhus University Research Foundation
   {[}AUFF-E-2015-FLS-8-61]; iPSYCH from the Lundbeck Foundation
   {[}R102-A9118, R155-2014-1724]; National Institutes of HealthUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USA {[}R01E5026993]; Novo Nordisk FoundationNovo Nordisk
   FoundationNovocure Limited {[}22018]; Chinese Scholarship CouncilChina
   Scholarship Council {[}201600160084]},
Funding-Text = {This work was supported by Shire International GmbH, the Swedish
   Research Council (2018-02259), and the Swedish Brain Foundation
   (F02018-0273). This work was also supported by grant 340-2013-5867
   through the Swedish Initiative for Research on Microdata in the Social
   and Medical Sciences framework (Swedish Research Council); grant
   1R01MH102221from the National Institute of Mental Health; grant
   agreement 667302 from the European Union's Horizon 2020 Research and
   Innovation Programme; the American Foundation for Suicide Prevention;
   grant AUFF-E-2015-FLS-8-61 from Aarhus University Research Foundation
   (Dr Dalsgaard); iPSYCH grants R102-A9118 and R155-2014-1724 from the
   Lundbeck Foundation (Dr Dalsgaard); grant R01E5026993 from the National
   Institutes of Health (Dr Dalsgaard); grant 22018 from the Novo Nordisk
   Foundation (Dr Dalsgaard); and grant 201600160084 from the Chinese
   Scholarship Council (Dr Sun).},
Cited-References = {American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th Edn, DOI 10.1176/appi.books.9780890425596.dsm05.
   BIEDERMAN J, 1993, AM J PSYCHIAT, V150, P1792.
   Biederman Joseph, 2006, MedGenMed, V8, P12.
   Capusan AJ, 2019, J ATTEN DISORD, V23, P1416, DOI 10.1177/1087054715626511.
   Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659.
   Chang Z, 2016, BIOL PSYCHIAT, V80, P916, DOI 10.1016/j.biopsych.2016.02.018.
   Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164.
   Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174.
   Chen YY, 2019, J AFFECT DISORDERS, V242, P96, DOI 10.1016/j.jad.2018.08.023.
   Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128.
   Chronis-Tuscano A, 2010, ARCH GEN PSYCHIAT, V67, P1044, DOI 10.1001/archgenpsychiatry.2010.127.
   Cortese S, 2007, NUTR REV, V65, P404, DOI 10.1111/j.1753-4887.2007.tb00318.x.
   Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4.
   Dalsgaard S, 2002, BRIT J PSYCHIAT, V181, P416, DOI 10.1192/bjp.181.5.416.
   Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0.
   Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6.
   Dalsgaard S, 2014, ADDICT BEHAV, V39, P325, DOI 10.1016/j.addbeh.2013.09.002.
   Danckaerts M, 2010, EUR CHILD ADOLES PSY, V19, P83, DOI 10.1007/s00787-009-0046-3.
   Daviss WB, 2008, J CHILD ADOL PSYCHOP, V18, P565, DOI 10.1089/cap.2008.032.
   Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016.
   Faraone SV, 2017, J AM ACAD CHILD PSY, V56, P167, DOI 10.1016/j.jaac.2016.11.011.
   Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20.
   Faraone SV, 2015, LANCET, V385, P2132, DOI 10.1016/S0140-6736(14)61822-5.
   Ghirardi L, 2018, MOL PSYCHIATR, V23, P257, DOI 10.1038/mp.2017.17.
   Groenman AP, 2013, ADDICTION, V108, P1503, DOI 10.1111/add.12188.
   Impey M, 2012, ACTA PSYCHIAT SCAND, V125, P93, DOI 10.1111/j.1600-0447.2011.01798.x.
   James A, 2004, ACTA PSYCHIAT SCAND, V110, P408, DOI 10.1111/j.1600-0447.2004.00384.x.
   Janicki MP, 1999, DISABIL REHABIL, V21, P284.
   Kaisari P, 2017, CLIN PSYCHOL REV, V53, P109, DOI 10.1016/j.cpr.2017.03.002.
   Larochette A, 2009, ARCH CLIN NEUROPSYCH, V24, P510.
   Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241.
   London AS, 2016, PREV MED, V90, P8, DOI 10.1016/j.ypmed.2016.06.021.
   Mayes SD, 2009, J PEDIATR PSYCHOL, V34, P328, DOI 10.1093/jpepsy/jsn083.
   Ottosen C, 2019, J AM ACAD CHILD PSY, V58, P412, DOI 10.1016/j.jaac.2018.07.910.
   Pridmore S, 2015, AUSTRALAS PSYCHIATRY, V23, P81, DOI 10.1177/1039856214562079.
   Quinn PD, 2017, AM J PSYCHIAT, V174, P877, DOI 10.1176/appi.ajp.2017.16060686.
   Tyrer F, 2009, J INTELL DISABIL RES, V53, P898, DOI 10.1111/j.1365-2788.2009.01201.x.
   Vaa T, 2014, ACCIDENT ANAL PREV, V62, P415, DOI 10.1016/j.aap.2013.10.003.},
Number-of-Cited-References = {38},
Times-Cited = {24},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {15},
Journal-ISO = {JAMA Psychiatry},
Doc-Delivery-Number = {JW7AO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000503200800010},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000522922300004,
Author = {Fernandez-Fernandez, Beatriz and Valino-Rivas, Lara and Sanchez-Nino,
   Maria D. and Ortiz, Alberto},
Title = {Albuminuria Downregulation of the Anti-Aging Factor Klotho: The Missing
   Link Potentially Explaining the Association of Pathological Albuminuria
   with Premature Death},
Journal = {ADVANCES IN THERAPY},
Year = {2020},
Volume = {37},
Number = {SUPPL 2, 2, SI},
Pages = {62-72},
Month = {MAY},
Abstract = {Ten percent of the adult population has chronic kidney disease (CKD),
   which is diagnosed when the glomerular filtration rate (GFR) is below 60
   mL/min per 1.73 m(2) or when albuminuria is above 30 mg/day. The
   numerical thresholds were chosen because they are associated with an
   increased risk of CKD progression or premature death within a wider
   scenario of accelerated aging. Indeed, CKD is one of the fastest growing
   causes of death worldwide. A decreased GFR is associated with the
   accumulation of uraemic toxins that may promote tissue and organ damage.
   However, CKD may be diagnosed when the GFR is completely normal, as long
   as there is pathological albuminuria. A key unanswered question to stem
   the rise of CKD-associated deaths is whether the association between
   isolated albuminuria (when the GFR is normal) and premature death is
   causal. The recent demonstration that albuminuria per se directly
   suppresses the production of the anti-aging factor Klotho by kidney
   tubular cells may be one of the first steps to address the causality of
   the albuminuria-premature death-accelerated aging association. This
   hypothesis should be tested in interventional studies that should draw
   from translational science advances. Thus, the observation that
   albuminuria decreases Klotho production through epigenetic mechanisms
   implies that Klotho downregulation may persist after the correction of
   albuminuria, and innovative therapeutic approaches are needed to restore
   Klotho production. On the basis of recent literature, these may include
   manipulation of NF-kappaB regulators such as B cell lymphoma 3 protein
   (BCL-3), and epigenetic regulators such as histone deacetylases, or the
   repurposing of drugs such as pentoxifylline.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Review},
Language = {English},
Affiliation = {Ortiz, A (Corresponding Author), Univ Autonoma Madrid, Fdn Renal Inigo Alvarez de Toledo IRSIN, IIS Fundacio Jimenez Diaz, Fac Med, Madrid, Spain.
   Ortiz, A (Corresponding Author), REDINREN, Madrid, Spain.
   Fernandez-Fernandez, Beatriz; Valino-Rivas, Lara; Sanchez-Nino, Maria D.; Ortiz, Alberto, Univ Autonoma Madrid, Fdn Renal Inigo Alvarez de Toledo IRSIN, IIS Fundacio Jimenez Diaz, Fac Med, Madrid, Spain.
   Fernandez-Fernandez, Beatriz; Valino-Rivas, Lara; Sanchez-Nino, Maria D.; Ortiz, Alberto, REDINREN, Madrid, Spain.},
DOI = {10.1007/s12325-019-01180-5},
EarlyAccessDate = {MAR 2020},
ISSN = {0741-238X},
EISSN = {1865-8652},
Keywords = {Aging; Albuminuria; Chronic kidney disease; Glomerular filtration rate;
   Klotho},
Keywords-Plus = {CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; GROWTH-FACTOR 23;
   ALL-CAUSE; PHOSPHATE; DIETARY; GENE; EXPRESSION; MORTALITY; RISK},
Research-Areas = {Research \& Experimental Medicine; Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Medicine, Research \& Experimental; Pharmacology \& Pharmacy},
Author-Email = {aortiz@fjd.es},
ResearcherID-Numbers = {Valiño, Lara/ABH-2425-2020
   Sanchez-Nino, Maria Dolores/B-7350-2019},
ORCID-Numbers = {Valiño, Lara/0000-0003-3340-0716
   Sanchez-Nino, Maria Dolores/0000-0001-7110-6409},
Funding-Acknowledgement = {Kyowa Kirin; ISCIIIInstituto de Salud Carlos III; FEDER fundsEuropean
   Commission {[}PI16/02057, PI15/00298, PI18/01366]; Sociedad Espanola de
   Nefrologia, ISCIII-RETIC REDinREN {[}RD016/009]; Comunidad de Madrid
   CIFRA2Comunidad de Madrid {[}B2017/BMD-3686]},
Funding-Text = {Kyowa Kirin organized the scientific meeting and contributed to the
   financing of the publication of the opinion of the speakers presented at
   that meeting (Madrid, November 2018). Research by the authors is
   supported by ISCIII and FEDER funds, PI16/02057, PI15/00298, PI18/01366,
   Sociedad Espanola de Nefrologia, ISCIII-RETIC REDinREN RD016/009,
   Comunidad de Madrid CIFRA2 B2017/BMD-3686.},
Cited-References = {Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155.
   Castillo-Rodriguez E, 2018, TOXINS, V10, DOI 10.3390/toxins10070300.
   Castillo-Rodriguez E, 2017, TOXINS, V9, DOI 10.3390/toxins9040114.
   Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148.
   Coresh J, 2019, LANCET DIABETES ENDO, V7, P115, DOI 10.1016/S2213-8587(18)30313-9.
   Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368.
   de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104.
   Dhayat NA, 2016, KIDNEY INT, V90, P648, DOI 10.1016/j.kint.2016.04.024.
   Sanchez-Nino MD, 2020, CLIN KIDNEY J, V13, P125, DOI 10.1093/ckj/sfz125.
   Sanchez-Nino MD, 2017, CLIN SCI, V131, P1617, DOI 10.1042/CS20160395.
   Sanchez-Nino MD, 2017, CLIN KIDNEY J, V10, P188, DOI 10.1093/ckj/sfx023.
   Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175.
   Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0.
   Fernandez-Fernandez B, 2019, LANCET DIABETES ENDO, V7, P80, DOI 10.1016/S2213-8587(18)30352-8.
   Fernandez-Fernandez B, 2018, NEPHROL DIAL TRANSPL, V33, P1712, DOI 10.1093/ndt/gfx376.
   Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016.
   Fukui T, 2011, YONAGO ACTA MED, V54, P49.
   Heerspink HL, 2019, LANCET DIABETES ENDO, V7, P128, DOI 10.1016/S2213-8587(18)30314-0.
   Hommos MS, 2017, J AM SOC NEPHROL, V28, P2838, DOI 10.1681/ASN.2017040421.
   Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160.
   Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311.
   Hum JM, 2017, J AM SOC NEPHROL, V28, P1162, DOI 10.1681/ASN.2015111266.
   Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826.
   Itkonen ST, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-94.
   Izquierdo MC, 2012, NEPHROL DIAL TRANSPL, V27, piv6, DOI 10.1093/ndt/gfs426.
   Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313.
   KDIGO, 2012, KIDNEY INT S, V3, P1, DOI DOI 10.1038/kisup.2012.73.
   Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224.
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285.
   Kurt B, 2015, AM J PHYSIOL-REG I, V308, pR455, DOI 10.1152/ajpregu.00568.2013.
   Liao HK, 2017, CELL, V171, P1495, DOI 10.1016/j.cell.2017.10.025.
   Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209.
   Liu YN, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4989847.
   Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6.
   Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5.
   McClelland R, 2016, AGING-US, V8, P1135, DOI 10.18632/aging.100948.
   Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Navarro-Gonzalez JF, 2018, DIABETES CARE, V41, P1817, DOI 10.2337/dc18-0078.
   Neyra JA, 2020, CLIN KIDNEY J, V13, P235, DOI 10.1093/ckj/sfz085.
   Neyra JA, 2017, BONE, V100, P41, DOI 10.1016/j.bone.2017.01.017.
   Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488.
   Ortiz A, 2014, LANCET, V383, P1831, DOI 10.1016/S0140-6736(14)60384-6.
   Ortiz A, 2019, NEFROLOGIA, V39, P29, DOI 10.1016/j.nefro.2018.09.002.
   Ortiz A, 2015, LANCET DIABETES ENDO, V3, P489, DOI 10.1016/S2213-8587(15)00092-3.
   Pena MJ, 2017, KIDNEY INT SUPPL, V7, P107, DOI 10.1016/j.kisu.2017.07.005.
   Poveda J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.89.
   Poveda J, 2016, BBA-MOL BASIS DIS, V1862, P635, DOI 10.1016/j.bbadis.2016.01.006.
   Rodriguez-Ortiz ME, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34386-8.
   Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914.
   Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562.
   Perez-Gomez MV, 2019, CLIN KIDNEY J, V12, P258, DOI 10.1093/ckj/sfz007.
   Vanholder R, 2016, LANCET DIABETES ENDO, V4, P360, DOI 10.1016/S2213-8587(16)00033-4.
   Yoon CY, 2017, AM J CLIN NUTR, V106, P311, DOI 10.3945/ajcn.116.151654.
   Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537.},
Number-of-Cited-References = {55},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Adv. Ther.},
Doc-Delivery-Number = {LI2ZO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000522922300004},
DA = {2022-03-29},
}

@article{ WOS:000750052000001,
Author = {Sancassiani, Federica and Massa, Elena and Pibia, Carla and Perda,
   Giulia and Boe, Laura and Fantozzi, Elena and Cossu, Giulia and Caocci,
   Giovanni and Mulas, Olga and Morelli, Emanuela and Lindert, Jutta and
   Lai, Eleonora and Nardi, Antonio Egidio and Scartozzi, Mario and La
   Nasa, Giorgio and Carta, Mauro Giovanni},
Title = {The association between Major Depressive Disorder and premature death
   risk in hematologic and solid cancer: A longitudinal cohort study},
Journal = {JOURNAL OF PUBLIC HEALTH RESEARCH},
Year = {2021},
Volume = {10},
Number = {3},
Abstract = {Background: the aim was to verify the association between Major
   Depressive Disorders (MDD) and the risk of premature death in people
   with oncological diseases, and to collect evidence about the causality
   of a possible association from a longitudinal perspective.
   Design and Method: it is a cohort study lasting 9 months, involving
   people with solid or hematologic cancers. The assessment was conducted
   by an ad hoc form to collect socio-demographic and clinical-oncological
   data, the PHQ-9 to screen MDD (cut-off >= 10) and the SF-12 to evaluate
   HRQoL. Relative Risk (RR) of early death between MDD exposed and
   not-exposed and Kaplan-Meier survival were carried out.
   Results: people exposed to MDD during the follow-up were 107/263
   (40.7\%). Among them, 36 deceased during the observation period.
   Overtime, having MDD and death' occurrence showed a strong association
   (RR=2.15; 95\% CI (1.10-4.20); chi(2)=5.224, p=0.0022), confirmed by
   Kaplan-Meier survival analysis (chi(2) =4.357, p=0.037). Among people
   who died, there was not any association between MDD, age, gender. HRQoL,
   cancer stage and site.
   Conclusions: the study confirms the association between MDD and early
   death in people with cancer. The absence of any association between the
   onset of MDD and advanced stage of cancer may suggest that it could be
   due to the consequences of MDD in worsening the clinical conditions
   related to cancer. The findings point out the relevance of MDD' early
   detention among people with cancer.},
Publisher = {PAGEPRESS PUBL},
Address = {MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY},
Type = {Article},
Language = {English},
Affiliation = {Massa, E (Corresponding Author), Univ Cagliari, Dept Med Sci \& Publ Hlth, Cittadella Univ Monserrato Asse Didatt E, I-09042 Monserrato, CA, Italy.
   Sancassiani, Federica; Massa, Elena; Pibia, Carla; Perda, Giulia; Boe, Laura; Fantozzi, Elena; Cossu, Giulia; Lai, Eleonora; Scartozzi, Mario; La Nasa, Giorgio; Carta, Mauro Giovanni, Univ Cagliari, Dept Med Sci \& Publ Hlth, Cittadella Univ Monserrato Asse Didatt E, I-09042 Monserrato, CA, Italy.
   Caocci, Giovanni; Mulas, Olga; Morelli, Emanuela; La Nasa, Giorgio, Businco Hosp, ARNAS G Brotzu, Hematol \& CTMO, Cagliari, Italy.
   Lindert, Jutta, Univ Appl Sci Emden Leer, Emden, Germany.
   Nardi, Antonio Egidio, Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil.},
DOI = {10.4081/jphr.2021.2247},
Article-Number = {2247},
ISSN = {2279-9028},
EISSN = {2279-9036},
Keywords = {depression; oncology; hematology; psychosocial health; death risk},
Keywords-Plus = {QUALITY-OF-LIFE; HEALTH QUESTIONNAIRE; IMMUNE-SYSTEM; MORTALITY;
   SYMPTOMS; ANXIETY; METAANALYSIS; INSTRUMENTS; PROGRESSION; PREVALENCE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {dinetto13112012@gmail.com},
ORCID-Numbers = {Lai, Eleonora/0000-0002-0275-8187
   Olga, Mulas/0000-0002-7487-3328
   Cossu, Giulia/0000-0002-1245-016X},
Funding-Acknowledgement = {P. O.R. SARDEGNA F.S.E. 2014-2020, Asse III-Istruzione e Formazione,
   Obiettivo Tematico: 10-Obiettivo Specifico, 10.5-Azione dell'accordo di
   Partenariato; 10.5.12-Avviso di chiamata per il finanziamento di
   Progetti di ricerca-Anno 2017},
Funding-Text = {the present study is supported by P. O.R. SARDEGNA F.S.E. 2014-2020,
   Asse III-Istruzione e Formazione, Obiettivo Tematico: 10-Obiettivo
   Specifico, 10.5-Azione dell'accordo di Partenariato; 10.5.12-Avviso di
   chiamata per il finanziamento di Progetti di ricerca-Anno 2017.},
Cited-References = {Andersen BL, 2015, J ONCOL PRACT, V11, P133, DOI 10.1200/JOP.2014.002311.
   Apolone G, 2001, QUESTIONARIO STATO S.
   Arrieta O, 2013, ANN SURG ONCOL, V20, P1941, DOI 10.1245/s10434-012-2793-5.
   Basch E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju244.
   Bortolato B, 2017, CANCER TREAT REV, V52, P58, DOI 10.1016/j.ctrv.2016.11.004.
   Carta Mauro Giovanni, 2010, Clin Pract Epidemiol Ment Health, V6, P94, DOI 10.2174/1745017901006010094.
   Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325.
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297.
   Galway K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007064.pub2.
   Global Burden of Disease Study 2013 Collaborators, 2015, LANCET, V386, P743, DOI {[}10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4].
   Hartung TJ, 2017, EUR J CANCER, V72, P46, DOI 10.1016/j.ejca.2016.11.017.
   Hartung TJ, 2017, CANCER-AM CANCER SOC, V123, P4236, DOI 10.1002/cncr.30846.
   Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409.
   Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409.
   Kuehner C, 2017, LANCET PSYCHIAT, V4, P146, DOI 10.1016/S2215-0366(16)30263-2.
   La Nasa Giorgio, 2020, Clin Pract Epidemiol Ment Health, V16, P174, DOI 10.2174/1745017902016010174.
   Lloyd-Williams M, 2009, J AFFECT DISORDERS, V113, P127, DOI 10.1016/j.jad.2008.04.002.
   Lutgendorf SK, 2015, AM PSYCHOL, V70, P186, DOI 10.1037/a0035730.
   Machado MO, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1101-z.
   Mantovani G, 1996, SUPPORT CARE CANCER, V4, P129, DOI 10.1007/BF01845762.
   Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768.
   Moylan S, 2013, MOL PSYCHIATR, V18, P595, DOI 10.1038/mp.2012.33.
   Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43.
   Ostuzzi G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011006.pub2.
   Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003.
   Rackley S, 2012, PSYCHIAT CLIN N AM, V35, P231, DOI 10.1016/j.psc.2011.11.001.
   Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9.
   Rizzo R, 2000, PSYCHOL MED, V30, P831, DOI 10.1017/S0033291799002512.
   Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561.
   Scocco P, 2020, DEATH STUD, DOI 10.1080/07481187.2020.1855608.
   Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507.
   Spencer JC, 2016, PATIENT EDUC COUNS, V99, P1099, DOI 10.1016/j.pec.2016.02.003.
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737.
   Thekkumpurath P, 2011, CANCER-AM CANCER SOC, V117, P218, DOI 10.1002/cncr.25514.
   van Dams R, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.19.00072.
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502.
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003.
   WHO, 2013, WORLD MALARIA REPORT 2013, P1.
   Zhang MF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000897.
   ZONDERMAN AB, 1989, JAMA-J AM MED ASSOC, V262, P1191, DOI 10.1001/jama.262.9.1191.},
Number-of-Cited-References = {40},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Public Health Res.},
Doc-Delivery-Number = {YR5RR},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000750052000001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000482993400004,
Author = {Reilly, Kathleen H. and Johns, Eileen and Noyan, Nebahat and Schretzman,
   Maryanne and Tsao, Tsu-Yu},
Title = {Potentially Avertable Premature Deaths Associated with Jail
   Incarceration in New York City},
Journal = {JOURNAL OF COMMUNITY HEALTH},
Year = {2019},
Volume = {44},
Number = {5},
Pages = {881-887},
Month = {OCT},
Abstract = {This study assessed neighborhood-level association between jail
   incarceration and premature mortality and estimated the number of
   potentially avertable premature deaths associated with jail
   incarceration in NYC. The study outcome was premature mortality rate and
   the main predictor of interest was jail incarceration rate. Variables
   associated with premature mortality in bivariate analysis were
   considered for inclusion in the multivariable ordinary least squares
   model and in the multivariable linear mixed effects model accounting for
   spatial correlation. Numbers of potentially avertable premature deaths
   were calculated by substituting the citywide incarceration rate for the
   neighborhoods with incarceration rates higher than the citywide rate in
   the final regression model. There were large disparities in both jail
   incarceration and premature mortality rates. Incarceration was strongly
   associated with premature mortality. The number of potentially avertable
   premature deaths associated with jail incarceration from 2011 to 2015
   was approximately 6000, representing 10\% of all predicted premature
   deaths in NYC. This study indicates that incarceration is closely
   correlated with premature mortality rates, which may contribute to
   health inequities among low-income NYC neighborhoods with predominantly
   black and Latino residents.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {Reilly, KH (Corresponding Author), New York City Dept Hlth \& Mental Hyg, Bur Epidemiol, 4209 28th St,CN 07-103, Long Isl City, NY 11101 USA.
   Reilly, Kathleen H., New York City Dept Hlth \& Mental Hyg, Bur Epidemiol, 4209 28th St,CN 07-103, Long Isl City, NY 11101 USA.
   Johns, Eileen; Noyan, Nebahat; Schretzman, Maryanne, New York City Ctr Innovat Data Intelligence, Off Mayor City New York, New York, NY 10007 USA.
   Tsao, Tsu-Yu, New York City Dept Hlth \& Mental Hyg, Off Policy Planning \& Strateg Data Use, Long Isl City, NY 11101 USA.},
DOI = {10.1007/s10900-018-00611-8},
ISSN = {0094-5145},
EISSN = {1573-3610},
Keywords = {Spatial analysis; Avoidable deaths; Inequalities; Neighborhood; place;
   Public health},
Keywords-Plus = {PARENTAL INCARCERATION; MASS INCARCERATION; HEALTH; MORTALITY;
   CONSEQUENCES; DISPARITIES; LEGITIMACY; PRISON; RISK},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Policy \& Services; Public, Environmental \& Occupational Health},
Author-Email = {kreilly3@health.nyc.gov},
Funding-Acknowledgement = {Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF)},
Funding-Text = {Funding was provided by Robert Wood Johnson Foundation (Grant No. Data
   Across Sectors for Health).},
Cited-References = {Arditti JA, 2003, FAM RELAT, V52, P195, DOI 10.1111/j.1741-3729.2003.00195.x.
   Austin J., 2016, MANY AM ARE UNNECESS.
   Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115.
   Bobo LD, 2006, SOC RES, V73, P445.
   Bureau of Justice Statistics, KEY STAT INC RAT.
   Chae DH, 2018, SOC SCI MED, V199, P49, DOI 10.1016/j.socscimed.2017.04.019.
   Chandola T, 2001, HEALTH PLACE, V7, P105, DOI 10.1016/S1353-8292(01)00002-8.
   Chauhan P., 2018, TRENDS ARRESTS MISDE.
   Cooper HLF, 2014, SUBST USE MISUSE, V49, P176, DOI 10.3109/10826084.2013.824474.
   Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1.
   Geronimus A T, 2001, J Am Med Womens Assoc (1972), V56, P133.
   Golembeski C, 2005, AM J PUBLIC HEALTH, V95, P1701, DOI 10.2105/AJPH.2005.063768.
   Hatzenbuehler ML, 2015, AM J PUBLIC HEALTH, V105, P138, DOI 10.2105/AJPH.2014.302184.
   James D. J., 2006, 213600 NCJ BUR JUST.
   Kulkarni SP, 2010, J COMMUN HEALTH, V35, P268, DOI 10.1007/s10900-010-9234-9.
   Lee H, 2014, AM J PUBLIC HEALTH, V104, P421, DOI 10.2105/AJPH.2013.301504.
   Lee H, 2014, ANN AM ACAD POLIT SS, V651, P44, DOI 10.1177/0002716213502920.
   Lukies J, 2011, INT J OFFENDER THER, V55, P460, DOI 10.1177/0306624X09359933.
   Massoglia M, 2008, LAW SOC REV, V42, P275, DOI 10.1111/j.1540-5893.2008.00342.x.
   Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105.
   Massoglia M, 2014, SOC SCI RES, V46, P142, DOI 10.1016/j.ssresearch.2014.03.002.
   New York City Department of Correction, 2011, NYC DEP CORR GLANC N.
   New York City Department of Health and Mental Hygiene, 2018, NEW YORK CIT NEIGHB.
   New York City Office of the Mayor, 2017, MAYOR BLAS ANN CIT J.
   Organisation for Economic Co-operation and Development, 2016, SOC GLANC 2016 SPOTL.
   Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740.
   Richardson AS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0611-y.
   Tefft N, 2014, HEALTH SERV RES, V49, P186, DOI 10.1111/1475-6773.12091.
   Thomas JC, 2005, J INFECT DIS, V191, pS55, DOI 10.1086/425278.
   Tsao TY, 2016, AM J PUBLIC HEALTH, V106, P1036, DOI 10.2105/AJPH.2016.303188.
   Tung Elizabeth L, 2018, Prev Med Rep, V9, P153, DOI 10.1016/j.pmedr.2018.01.017.
   Turney K, 2014, J HEALTH SOC BEHAV, V55, P302, DOI 10.1177/0022146514544173.
   Wildeman C, 2017, LANCET, V389, P1464, DOI 10.1016/S0140-6736(17)30259-3.
   Wildeman C, 2014, AM J PUBLIC HEALTH, V104, P428, DOI 10.2105/AJPH.2013.301590.
   Wildeman C, 2013, WOMEN HEALTH ISS, V23, pE335, DOI 10.1016/j.whi.2013.07.006.
   Wildeman C, 2012, AM SOCIOL REV, V77, P216, DOI 10.1177/0003122411436234.},
Number-of-Cited-References = {36},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Community Health},
Doc-Delivery-Number = {IT6OB},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000482993400004},
DA = {2022-03-29},
}

@article{ WOS:000308137600006,
Author = {Ranthe, Mattis Flyvholm and Carstensen, Lisbeth and Oyen, Nina and
   Tfelt-Hansen, Jacob and Christiansen, Michael and McKenna, William J.
   and Wohlfahrt, Jan and Melbye, Mads and Boyd, Heather A.},
Title = {Family History of Premature Death and Risk of Early Onset Cardiovascular
   Disease},
Journal = {JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY},
Year = {2012},
Volume = {60},
Number = {9},
Pages = {814-821},
Month = {AUG 28},
Abstract = {Objectives The purpose of this study was to examine the effect of a
   family history of premature death, cardiovascular death in particular,
   on the risk of early cardiovascular disease.
   Background Studies suggest that fatal cardiovascular events and less
   severe cardiovascular diseases may co-occur in families. Consequently, a
   family history of premature death may indicate a familial cardiac
   frailty that predisposes to early cardiovascular disease.
   Methods We ascertained family history of premature death (age <60 years)
   in all individuals born in Denmark from 1950 to 2008 and followed this
   cohort for early cardiovascular disease (age <50 years). Using Poisson
   regression, we estimated incidence rate ratios (IRRs) reflecting the
   effect of premature death in the family on early cardiovascular disease
   risk.
   Results Among 3,985,301 persons followed up for 89,294,258 person-years,
   129,825, 31,172, and 5,214 were diagnosed with any early cardiovascular
   disease, ischemic heart disease, and ventricular arrhythmia,
   respectively. IRRs for these conditions given a history of premature
   cardiovascular death in first-degree relatives were 1.72 (95\%
   confidence interval {[}CI]: 1.68 to 1.77), 2.21 (95\% CI: 2.11 to 2.31),
   and 1.94 (95\% CI: 1.70 to 2.20), respectively. With >= 2 cardiovascular
   deaths in a family, corresponding IRRs were 3.30 (95\% CI: 2.77 to
   3.94), 5.00 (95\% CI: 3.87 to 6.45), and 6.18 (95\% CI: 3.32 to 11.50).
   The IRR for any early cardiovascular disease given a family history of
   premature noncardiovascular death was significantly lower, 1.12 (95\%
   CI: 1.10 to 1.14) (p(cardiac vs. noncardiac) < 0.0001).
   Conclusions Family history of premature cardiovascular death was
   consistently and significantly associated with a risk of early
   cardiovascular disease, suggesting an inherited cardiac vulnerability.
   These results should be kept in mind when assessing cardiovascular
   disease risk in persons with a family history of premature
   cardiovascular death. (J Am Coll Cardiol 2012;60:814-21) (C) 2012 by the
   American College of Cardiology Foundation},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Ranthe, MF (Corresponding Author), Statens Serum Inst, Dept Epidemiol Res, Bldg 206,Artillerivej 5, DK-2300 Copenhagen S, Denmark.
   Ranthe, Mattis Flyvholm; Carstensen, Lisbeth; Oyen, Nina; Tfelt-Hansen, Jacob; Christiansen, Michael; McKenna, William J.; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A., Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.},
DOI = {10.1016/j.jacc.2012.06.018},
ISSN = {0735-1097},
EISSN = {1558-3597},
Keywords = {arrhythmia; cardiovascular diseases; epidemiology; ischemia; risk
   factors},
Keywords-Plus = {ACUTE MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; UNEXPLAINED DEATH;
   DIAGNOSIS; AUTOPSY},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {fly@ssi.dk},
ResearcherID-Numbers = {McKenna, William J/C-3243-2008
   Tfelt-Hansen, Jacob/AAU-8691-2020
   Ranthe, Mattis/C-8483-2013
   Tfelt-Hansen, Jacob/K-7700-2012
   Christiansen, Michael/B-4588-2009
   },
ORCID-Numbers = {McKenna, William J/0000-0001-7994-2460
   Tfelt-Hansen, Jacob/0000-0003-3895-9316
   Christiansen, Michael/0000-0003-4713-755X
   Boyd, Heather/0000-0001-6849-9985
   Ranthe, Mattis Flyvholm/0000-0002-6363-6386
   melbye, mads/0000-0001-8264-6785},
Funding-Acknowledgement = {Danish Heart Foundation {[}10-04-R78-A2799-22615,
   06-4-B571-A1059-22307]; Lundbeck FoundationLundbeckfonden {[}287/06]},
Funding-Text = {From the Department of Epidemiology Research, Statens Serum Institut,
   Copenhagen, Denmark. This work was supported by grants from the Danish
   Heart Foundation (10-04-R78-A2799-22615 and 06-4-B571-A1059-22307) and
   the Lundbeck Foundation (287/06). All authors have reported that they
   have no relationships relevant to the contents of this paper to
   disclose.},
Cited-References = {Ackerman MJ, 2009, PACE, V32, pS86, DOI 10.1111/j.1540-8159.2009.02393.x.
   Behr ER, 2008, EUR HEART J, V29, P1670, DOI 10.1093/eurheartj/ehn219.
   Bowker TJ, 2003, Q J MED, V96, P279.
   Brown David W, 2002, Community Genet, V5, P232, DOI 10.1159/000066684.
   Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278.
   Chow CK, 2007, BMJ-BRIT MED J, V335, P481, DOI 10.1136/bmj.39253.577859.BE.
   Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054.
   Cipriani V, 2010, EUR J INTERN MED, V21, P511, DOI 10.1016/j.ejim.2010.07.017.
   DAVIES MJ, 1992, BRIT MED J, V305, P538, DOI 10.1136/bmj.305.6853.538.
   Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145.
   Dent THS, 2010, ATHEROSCLEROSIS, V213, P352, DOI 10.1016/j.atherosclerosis.2010.06.021.
   Framingham Heart Study, RISK SCOR PROF FRAM.
   Friedlander Y, 2001, ATHEROSCLEROSIS, V156, P201, DOI 10.1016/S0021-9150(00)00635-3.
   Gjersoe P, 1998, Ugeskr Laeger, V160, P5030.
   Guo SW, 2000, AM J EPIDEMIOL, V151, P1121, DOI 10.1093/oxfordjournals.aje.a010156.
   Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958.
   Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650.
   Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978.
   Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717.
   Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006.
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482.
   Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7.
   Oyen N, 2009, EPIDEMIOLOGY, V20, P757, DOI 10.1097/EDE.0b013e3181ad5444.
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965.
   Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x.
   Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740.
   Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836.
   Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581.
   Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428.},
Number-of-Cited-References = {29},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Am. Coll. Cardiol.},
Doc-Delivery-Number = {997AY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000308137600006},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000229798800012,
Author = {Yang, MC and Fann, CY and Wen, CP and Cheng, TY},
Title = {Smoking attributable medical expenditures, years of potential life lost,
   and the cost of premature death in Taiwan},
Journal = {TOBACCO CONTROL},
Year = {2005},
Volume = {14},
Number = {1},
Pages = {I62-I70},
Month = {JUN},
Abstract = {Objective: To estimate the smoking attributable medical expenditures and
   productivity loss of people aged 35 and over in Taiwan in 2001 from a
   societal viewpoint.
   Methods: A prevalence based approach was used to estimate smoking
   attributable costs. Epidemiological parameters were obtained from two
   follow up studies and government statistics. Data on medical care
   utilisation and expenditure were extracted from the National Health
   Insurance claim data.
   Results: Total smoking attributable medical expenditures ( SAEs)
   amounted to US\$397.6 million, which accounted for 6.8\% of the total
   medical expenditures for people aged 35 and over. Mean annual medical
   expenditures per smoker was US\$70 more than that of each non-smoker.
   Smoking attributable years of potential life lost ( YPLL) totalled to
   217 761 years for males and 15 462 years for females, and the
   corresponding productivity loss was US\$1371 million for males and
   US\$18.7 million for females.
   Conclusion: Medical expenditures attributable to smoking accounted for
   6.8\% of the total medical expenditure of people aged 35 and over for
   the year 2001 in Taiwan. Corresponding YPLL and productivity loss also
   demand that actions be taken to fight cigarette smoking.},
Publisher = {B M J PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Yang, MC (Corresponding Author), Natl Taiwan Univ, Inst Hlth Care Org Adm, Taipei, Taiwan.
   Natl Taiwan Univ, Inst Hlth Care Org Adm, Taipei, Taiwan.},
DOI = {10.1136/tc.2004.007963},
ISSN = {0964-4563},
Keywords-Plus = {CIGARETTE-SMOKING; MORTALITY; TOBACCO; IMPACT},
Research-Areas = {Substance Abuse; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Substance Abuse; Public, Environmental \& Occupational Health},
Author-Email = {mcy@ha.mc.ntu.edu.tw},
ResearcherID-Numbers = {Wen, Chi-Pang/E-3851-2010},
Cited-References = {{*}CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300.
   Cutler DM, 2002, J POLICY ANAL MANAG, V21, P1, DOI 10.1002/pam.1037.
   Ho MS., 1993, LONG TERM FOLLOW UP.
   Izumi Y, 2001, INT J EPIDEMIOL, V30, P616, DOI 10.1093/ije/30.3.616.
   Kang HY, 2003, TOB CONTROL, V12, P37, DOI 10.1136/tc.12.1.37.
   Lam TH, 1997, JAMA-J AM MED ASSOC, V278, P1505, DOI 10.1001/jama.278.18.1505.
   Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361.
   Liaw KM, 1998, TOB CONTROL, V7, P141, DOI 10.1136/tc.7.2.141.
   LILIENFELD AM, 1994, FDN EPIDEMIOLOGY.
   Max W., 2000, VALUING HUMAN LIFE E.
   {*}NHIS, 2001, NAT HLTH INT SURV 20.
   RICE DP, 1986, MILBANK Q, V64, P489, DOI 10.2307/3349924.
   SHULTZ JM, 1991, PUBLIC HEALTH REP, V106, P326.
   Warner KE, 1999, TOB CONTROL, V8, P290, DOI 10.1136/tc.8.3.290.
   Warner KE, 2000, TOB CONTROL, V9, P78, DOI 10.1136/tc.9.1.78.
   Wen CP, 2004, PREV MED, V39, P528, DOI 10.1016/j.ypmed.2004.02.010.
   {*}WHO, 1999, WORLD HLTH REP 1999, P65.
   Zhang XL, 1999, HEALTH CARE FINANC R, V20, P179.},
Number-of-Cited-References = {18},
Times-Cited = {30},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Tob. Control},
Doc-Delivery-Number = {935RG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000229798800012},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000419237700016,
Author = {Stein, Elizabeth M. and Gennuso, Keith P. and Ugboaja, Donna C. and
   Remington, Patrick L.},
Title = {The Epidemic of Despair Among White Americans: Trends in the Leading
   Causes of Premature Death, 1999-2015},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2017},
Volume = {107},
Number = {10},
Pages = {1541-1547},
Month = {OCT},
Abstract = {Objectives. To evaluate trends in premature death rates by cause of
   death, age, race, and urbanization level in the United States.
   Methods. We calculated cause-specific death rates using the Compressed
   Mortality File, National Center for Health Statistics data for adults
   aged 25 to 64 years in 2 time periods: 1999 to 2001 and 2013 to 2015. We
   defined 48 subpopulations by 10-year age groups, race/ethnicity, and
   county urbanization level (large urban, suburban, small or medium
   metropolitan, and rural).
   Results. The age-adjusted premature death rates for all adults declined
   by8\% between 1999 to 2001 and 2013 to 2015, with decreases in 39 of the
   48 subpopulations. Most decreases in death rates were attributable to
   HIV, cardiovascular disease, and cancer. All 9 subpopulations with
   increased death rates were non-Hispanic Whites, largely outside large
   urban areas. Most increases in death rates were attributable to suicide,
   poisoning, and liver disease.
   Conclusions. The unfavorable recent trends in premature death rate among
   non-Hispanic Whites outside large urban areas were primarily caused by
   self-destructive health behaviors likely related to underlying social
   and economic factors in these communities.},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {Stein, EM (Corresponding Author), 1108 Coddington Rd, Ithaca, NY 14850 USA.
   Stein, Elizabeth M., Univ Wisconsin, Sch Med \& Publ Hlth, Prevent Med Residency Program, Madison, WI 53706 USA.
   Gennuso, Keith P., Univ Wisconsin, Populat Hlth Inst, Cty Hlth Rankings, Sch Med \& Publ Hlth, Madison, WI USA.
   Ugboaja, Donna C., Univ Wisconsin, Sch Med \& Publ Hlth, Madison, WI USA.
   Remington, Patrick L., Univ Wisconsin, Sch Med \& Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA.},
DOI = {10.2105/AJPH.2017.303941},
ISSN = {0090-0036},
EISSN = {1541-0048},
Keywords-Plus = {UNITED-STATES; MORTALITY; HEALTH; ACCURACY; CERTIFICATES; PERIOD;
   INCOME; US},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {elizabethstein@gmail.com},
Funding-Acknowledgement = {University of Wisconsin School of Medicine and Public Health from the
   Wisconsin Partnership Program; Robert Wood Johnson FoundationRobert Wood
   Johnson Foundation (RWJF) {[}71865]},
Funding-Text = {Funding for E. M. Stein's salary was provided by the University of
   Wisconsin School of Medicine and Public Health from the Wisconsin
   Partnership Program. P. L. Remington and K. P. Gennuso are supported by
   a grant from the Robert Wood Johnson Foundation, for the County Health
   Rankings (ID 71865).},
Cited-References = {Ahmad FB, 2017, Q PROVISIONAL ESTIMA.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Case A., 2017, MORTALITY MORBIDITY.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Cooke T, 2006, URBAN STUD, V43, P1971, DOI 10.1080/00420980600897818.
   Duncan CM, 1999, WORLDS APART WHY POV.
   Eschbach K, 2006, AM J PUBLIC HEALTH, V96, P2209, DOI 10.2105/AJPH.2005.080721.
   Garcia JJL, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302706.
   Glasmeir A, 2006, LOW SKILL WORKERS RU.
   Hartley D, 2004, AM J PUBLIC HEALTH, V94, P1675, DOI 10.2105/AJPH.94.10.1675.
   HASUO Y, 1989, J CLIN EPIDEMIOL, V42, P577, DOI 10.1016/0895-4356(89)90154-6.
   Holmes RVR, 2001, GUNS RACE DIFFERENT.
   Hoyt DR, 1997, AM J COMMUN PSYCHOL, V25, P449, DOI 10.1023/A:1024655521619.
   Jemal A, 2008, AM J PREV MED, V34, P1, DOI 10.1016/j.amepre.2007.09.017.
   Kneebone E., 2016, US CONCENTRATED POVE.
   Lichter D, 2011, GEOGRAPHY EXCLUSION.
   Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31.
   Masters RK, 2014, DEMOGRAPHY, V51, P2047, DOI 10.1007/s13524-014-0343-4.
   Moy E, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6601a1.
   Parisi, 2008, CONCENTRATED RURAL P.
   Parlapiano A, 2015, NY TIMES.
   Patel KV, 2004, AM J EPIDEMIOL, V159, P707, DOI 10.1093/aje/kwh089.
   Pew Research Center, 2015, AM MIDDL CLASS IS LO.
   Remington PL, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0044-2.
   Schaffar R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-609.
   Sidenius KE, 2000, RESP MED, V94, P373, DOI 10.1053/rmed.1999.0727.
   Teixeira R., 2008, DECLINE WHITE WORKIN.
   United States Department of Agriculture, 2016, RUR AM GLANC.
   University of Wisconsin Population Health Institute, 2016, 2016 COUNT HLTH RANK.
   WHO, 1992, INT CLASS DIS.},
Number-of-Cited-References = {31},
Times-Cited = {101},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {26},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {FR7HF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000419237700016},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000324121800014,
Author = {Ellis, Ryan N.},
Title = {The Premature Death of Electronic Mail: The United States Postal
   Service's E-COM Program, 1978-1985},
Journal = {INTERNATIONAL JOURNAL OF COMMUNICATION},
Year = {2013},
Volume = {7},
Pages = {1949-1967},
Abstract = {In the late-1970s, the United States Postal Service (USPS) launched an
   innovative electronic mail service, ``E-COM,{''} that sought to
   integrate networked computing and the postal system. Postal management
   envisioned E-COM as a path-breaking program that would carve out a key
   place for postal service in the coming information age. The following
   examination of the ultimate failure of E-COM contributes to the history
   of networked computing and communications, while additionally providing
   a unique perspective on the current precarious state of postal service
   in the United States. Typically, the decline of postal service is
   considered to be the result of the ``natural{''} obsolescence of an old
   medium in the face of new technologies, or it is linked to the failings
   of a public agency in the face of nimble competition. Yet revisiting
   E-COM challenges these dominate narratives: A consideration of E-COM
   highlights the role that private telecommunications companies played in
   preventing the expansion of postal service into new markets and,
   importantly, draws attention to the ways in which patterns of
   technological change are historically and politically situated.},
Publisher = {USC ANNENBERG PRESS},
Address = {UNIV SOUTHERN CALIFORNIA, KERCKHOFF HALL, 734 W ADAMS BLVD, MC7725, LOS
   ANGELES, CA 90089 USA},
Type = {Article},
Language = {English},
Affiliation = {Ellis, RN (Corresponding Author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.
   Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.},
ISSN = {1932-8036},
Research-Areas = {Communication},
Web-of-Science-Categories  = {Communication},
Author-Email = {ryan\_ellis@hks.harvard.edu},
ResearcherID-Numbers = {Ellis, Ryan/AAK-1448-2021},
Cited-References = {Abbate J., 1999, INVENTING INTERNET.
   Achiron M., 1984, NEWSWEEK, P64.
   {[}Anonymous], 2012, WASH POST, pA16.
   Associated Press, 2012, NY TIMES, pB3.
   Bruns J. H., 1979, WASH POST, pH13.
   Carroll P. B., 2010, WASH POST, pA19.
   Castells M., 2000, INFORM AGE EC SOC CU, V1.
   Ceruzzi PE., 2003, HIST MODERN COMPUTIN.
   Editorial, 2012, NY TIMES, pA18.
   Greenhouse Steven, 2011, NY TIMES, pA1.
   Horwitz R., 1989, IRONY REGULATORY REF.
   Hughes T.P., 1993, NETWORKS POWER ELECT.
   John Richard R., 1998, SPREADING NEWS AM PO.
   Jones W. H., 1978, WASH POST, pD7.
   Jones W. H., 1979, WASH POST, pE1.
   Kielbowicz Richard B., 1989, NEWS MAIL PRESS POST.
   MCI Corp. launches new bulk-mail service, 1984, WASH POST, pC1.
   Nixon R., 2012, NY TIMES, pB26.
   Pierson P, 2004, POLITICS TIME HIST I.
   President's Commission on Postal Organization, 1968, POST EXC REP PRES CO.
   President's Commission on Postal Service, 2003, EMBR FUT MAK TOUGH C.
   Rosenthal E., 2011, NY TIMES.
   Starr P., 2004, CREATION MEDIA POLIT.
   Stross R., 2011, NY TIMES, pBU4.
   U.S. Commission on Postal Service, 1977, REP COMM POST SERV, V1-2.
   U.S. Congressional Research Service (CRS), 2012, R41024 US CRS.
   U.S. Department of Commerce, 1977, POST CRIS POST FUNCT.
   U.S. Government Accountability Office, 2009, GAO09937SP.
   U.S. Office of Technology Assessment, 1982, IMPL EL MAIL MESS SY.
   United State Postal Service (USPS), 2010, FDN FUT 2010 ANN REP.
   United State Postal Service (USPS), 1973, PRIV EXPR STAT THEIR.
   United State Postal Service (USPS), 2011, DEL NEW REAL 2011 AN.
   United States Postal Service (USPS), 2011, WORKF OPT.
   United States Postal Service (USPS), 2007, US POST SERV USPS PU, V100.
   United States Postal Service (USPS), 2008, E COM EL COMP OR MAI.
   US Postal Service (USPS), 2010, ENS VIABL POST SERV.
   Williams Timothy, 2011, N Y TIMES, pA16.},
Number-of-Cited-References = {37},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Int. J. Commun.},
Doc-Delivery-Number = {214HD},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000324121800014},
DA = {2022-03-29},
}

@article{ WOS:A1983SD74500009,
Author = {MESTERHAZY, A},
Title = {RELATIONSHIP BETWEEN RESISTANCE TO STALK ROT AND EAR ROT OF CORN
   INFLUENCED BY RIND RESISTANCE, PREMATURE DEATH AND THE RATE OF DRYING OF
   THE EAR},
Journal = {MAYDICA},
Year = {1983},
Volume = {28},
Number = {4},
Pages = {425-437},
Publisher = {MAYDICA-IST SPER CEREALICOLTUR},
Address = {SEZ DI BERGAMO VIA STEZZANO, 24, 24100 BERGAMO, ITALY},
Type = {Article},
Language = {English},
Affiliation = {MESTERHAZY, A (Corresponding Author), CEREAL RES INST,SZEGED,HUNGARY.},
ISSN = {0025-6153},
Research-Areas = {Agriculture; Plant Sciences},
Web-of-Science-Categories  = {Agronomy; Plant Sciences},
ResearcherID-Numbers = {Mesterhazy, Akos/M-5149-2018},
Cited-References = {BAUSCH P, 1982, ANGEW BOT, V56, P9.
   BEKESI P., 1970, Novenyvedelem, V6, P13.
   BIRONE GM, 1975, THESIS U AGR GODOLLO.
   Christensen C. M., 1969, GRAIN STORAGE.
   CHRISTENSEN JJ, 1966, AM PHYTOPATH SOC MON, V3.
   COLBERT TR, 1978, CAN J PLANT SCI, V58, P319, DOI 10.4141/cjps78-051.
   Holbert JR, 1923, J AGRIC RES, V23, P0583.
   HOOKER AL, 1977, BREEDING DISEASE RES, P132.
   HRISTINA S, 1972, 3 ACT C UN FIT MED O, P529.
   MENSAH R A, 1975, Pflanzenschutzberichte, V44, P161.
   MESTERHAZY A, 1977, NOVENYTERMELES, V26, P367.
   MESTERHAZY A, 1981, NOVENYTERMELES, V30, P309.
   MESTERHAZY A, 1979, PLANT DIS REP, V63, P227.
   MESTERHAZY A, 1982, PHYTOPATHOL Z, V103, P218.
   PINTER L, 1976, NAGYITO ALATT SZEGED.
   PINTER L, 1980, INFORMATION 1979 LAR.
   PINTER L, 1979, INFORMATION 1978 LAR.
   PINTER L, 1978, INFORMATION 1977 LAR.
   PINTER L, 1977, INFORMATION 1976 LAR.
   THOMPSON DL, 1971, PLANT DIS REPTR, V61, P54.},
Number-of-Cited-References = {20},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Maydica},
Doc-Delivery-Number = {SD745},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1983SD74500009},
DA = {2022-03-29},
}

@article{ WOS:000234149000024,
Author = {Yu, H and Zhang, WW and Yancey, PG and Koury, MJ and Zhang, YM and
   Fazio, S and Linton, MF},
Title = {Macrophage apolipoprotein E reduces atherosclerosis and prevents
   premature death in apolipoprotein E and scavenger receptor-class BI
   double-knockout mice},
Journal = {ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY},
Year = {2006},
Volume = {26},
Number = {1},
Pages = {150-156},
Month = {JAN},
Abstract = {Objective: Mice null for both apolipoprotein (apo)E and scavenger
   receptor (SR)-BI (DKO) develop severe hypercholesterolemia, occlusive
   coronary atherosclerosis, myocardial infarction, and premature death.
   The current study examines the ability of macrophage apoE to improve the
   dyslipidemia, reduce atherosclerosis, and rescue the lethal phenotype of
   DKO mice.
   Methods and Results: Initially, bone marrow transplantation (BMT) was
   unsuccessful, because the DKO mice died from a rapidly fatal anemia 3 to
   5 days after lethal irradiation. Therefore, probucol was used to rescue
   the DKO mice during BMT and was discontinued 2-weeks after BMT, allowing
   successful reconstitution with donor marrow. Twelve male apoE(-/-)
   SR-BI-/- mice fed 0.5\% probucol in a chow diet were lethally irradiated
   and transplanted with either wild-type (WT) or DKO bone marrow.
   Two-weeks after BMT, apoE was detected in serum in WT -> DKO mice, and
   mean serum cholesterol levels were reduced by 70\% versus DKO -> DKO
   mice. Lipoprotein profiles and HDL subpopulations in WT -> DKO mice were
   similar to apoE(+/+) SR-BI-/--> DKO mice and resembled those of SR-BI-/-
   mice. In WT -> DKO mice, aortic atherosclerosis was reduced by 88\% to
   90\% versus DKO -> DKO mice. Furthermore, the DKO -> DKO mice died
   approximate to 8 weeks after BMT, whereas WT -> DKO mice exhibited a
   life span > 40 weeks after BMT.
   Conclusions: Macrophage apoE is able to rescue the lethal phenotype of
   apoE(-/-) SR-BI-/- mice by improving the dyslipidemia and dramatically
   reducing atherosclerotic lesion development.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Linton, MF (Corresponding Author), Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiovasc Med,Dept Med, 383 PRB,2220 Pierce Ave, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiovasc Med,Dept Med, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Dept Hematol, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.},
DOI = {10.1161/01.ATV.0000194096.89476.73},
ISSN = {1079-5642},
EISSN = {1524-4636},
Keywords = {macrophages; apolipoprotein E; SR-BI; cholesterol; atherosclerosis},
Keywords-Plus = {HIGH-DENSITY-LIPOPROTEIN; SR-BI; CORONARY ATHEROSCLEROSIS; CARDIAC
   DYSFUNCTION; CHOLESTEROL EFFLUX; HDL RECEPTOR; A-I; DEFICIENT;
   EXPRESSION; APOE},
Research-Areas = {Hematology; Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Hematology; Peripheral Vascular Disease},
Author-Email = {sergio.fazio@vanderbilt.edu
   macrae.linton@vanderbilt.edu},
ResearcherID-Numbers = {Yancey, Patricia/ABB-5856-2021},
Funding-Acknowledgement = {NHLBI NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}HL53989, HL65405, HL57986] Funding Source:
   Medline; NIDDK NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}DK59637] Funding
   Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Heart Lung \& Blood Institute (NHLBI)
   {[}R01HL057986, R01HL065405, R01HL053989] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes \& Digestive \&
   Kidney Diseases (NIDDK) {[}U24DK059637, U2CDK059637] Funding Source: NIH
   RePORTER},
Cited-References = {Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518.
   Arai T, 1999, P NATL ACAD SCI USA, V96, P12050, DOI 10.1073/pnas.96.21.12050.
   ASZTALOS BF, 1993, BIOCHIM BIOPHYS ACTA, V1169, P291, DOI 10.1016/0005-2760(93)90253-6.
   Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100.
   Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462.
   Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0.
   DavitSpraul A, 1996, GASTROENTEROLOGY, V111, P1023, DOI 10.1016/S0016-5085(96)70071-9.
   Fazio S, 2005, CIRCULATION, V111, P3349, DOI 10.1161/CIRCULATIONAHA.105.545996.
   Fazio S, 2002, J LIPID RES, V43, P1602, DOI 10.1194/jlr.M200108-JLR200.
   Fazio S, 2001, FRONT BIOSCI-LANDMRK, V6, pD515, DOI 10.2741/Fazio.
   Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647.
   Forte TM, 2002, J LIPID RES, V43, P477.
   Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200.
   Herz Joachim, 1995, Current Opinion in Lipidology, V6, P97, DOI 10.1097/00041433-199504000-00007.
   Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817.
   Huang ZH, 2002, J LIPID RES, V43, P375.
   Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982.
   Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI14011.
   Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181.
   LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332.
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507.
   Marathe S, 2000, ARTERIOSCL THROM VAS, V20, P2607, DOI 10.1161/01.ATV.20.12.2607.
   MAZZONE T, 1994, J LIPID RES, V35, P1345.
   Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200.
   Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200.
   PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4.
   Raffai RL, 2003, J BIOL CHEM, V278, P11670, DOI 10.1074/jbc.M212873200.
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610.
   Shah PK, 2001, CIRCULATION, V104, P2498, DOI 10.1161/hc4501.098468.
   Spangenberg J, 1997, BBA-LIPID LIPID MET, V1349, P109, DOI 10.1016/S0005-2760(97)00123-9.
   Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322.
   Van Eck M, 2000, ATHEROSCLEROSIS, V150, P71, DOI 10.1016/S0021-9150(99)00372-X.
   Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563.
   Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D.
   Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585.},
Number-of-Cited-References = {35},
Times-Cited = {31},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Arterioscler. Thromb. Vasc. Biol.},
Doc-Delivery-Number = {996BI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000234149000024},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000450417500006,
Author = {Almquist, Ylva B. and Jackisch, Josephine and Forsman, Hilma and
   Gauffin, Karl and Vinnerljung, Bo and Hjern, Anders and Braennstroem,
   Lars},
Title = {A decade lost: does educational success mitigate the increased risks of
   premature death among children with experience of out-of-home care?},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2018},
Volume = {72},
Number = {11},
Pages = {997-1002},
Month = {NOV},
Abstract = {Background Past research has consistently identified children with
   out-of-home care (OHC) experience as a high-risk group for premature
   mortality. While many have argued that educational success is a key
   factor in reducing these individuals' excessive death risks, empirical
   evidence has hitherto been limited. The aim of the current study was
   therefore to examine the potentially mitigating role of educational
   success in the association between OHC experience and premature
   mortality.
   Methods Drawing on a Stockholm cohort born in 1953 (n=15117), we
   analysed the associations among placement in OHC (ages 0-12), school
   performance (ages 13, 16 and 19) and premature all-cause mortality (ages
   20-56) by means of Cox and Laplace regression analyses.
   Results The Cox regression models confirmed the increased risk of
   premature mortality among individuals with OHC experience. Unadjusted
   Laplace regression models showed that, based on median survival time,
   these children died more than a decade before their majority population
   peers. However, among individuals who performed well at school, that is,
   those who scored above-average marks at the age of 16 (grade 9) and at
   the age of 19 (grade 12), the risks of premature mortality did not
   significantly differ between the two groups.
   Conclusion Educational success seems to mitigate the increased risks of
   premature death among children with OHC experience.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Almquist, YB (Corresponding Author), Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies CHESS, SE-10691 Stockholm, Sweden.
   Almquist, Ylva B.; Jackisch, Josephine; Gauffin, Karl; Hjern, Anders, Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies CHESS, SE-10691 Stockholm, Sweden.
   Forsman, Hilma; Vinnerljung, Bo; Braennstroem, Lars, Stockholm Univ, Dept Social Work, Stockholm, Sweden.},
DOI = {10.1136/jech-2018-210487},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords = {cohort studies; education; health inequalities; lifecourse; childhood
   circumstances; mortality},
Keywords-Plus = {FOSTER-CARE; PSYCHOSOCIAL PROBLEMS; LAPLACE REGRESSION; SCHOOL
   PERFORMANCE; MORTALITY; HEALTH; REGISTRY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ylva.almquist@su.se},
ResearcherID-Numbers = {Jackisch, Josephine/AAO-6161-2020
   },
ORCID-Numbers = {Jackisch, Josephine/0000-0002-5958-2303
   Gauffin, Karl/0000-0001-9349-9936
   Brannstrom, Lars/0000-0002-8526-9396},
Funding-Acknowledgement = {Swedish Research Council for Health, Working Life and WelfareSwedish
   Research CouncilSwedish Research Council for Health Working Life \&
   Welfare (Forte) {[}2012-0201]; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission {[}2017-01746]},
Funding-Text = {This study was financially supported by the Swedish Research Council for
   Health, Working Life and Welfare (grant no 2012-0201) and the Swedish
   Research Council (grant no 2017-01746).},
Cited-References = {Bambra C, 2011, J EPIDEMIOL COMMUN H, V65, P740, DOI 10.1136/jech.2011.136333.
   Barth RP, 1998, CHILD YOUTH SERV REV, V20, P577, DOI 10.1016/S0190-7409(98)00027-9.
   Bask M, 2017, LONGITUD LIFE COURSE, V8, P365, DOI 10.14301/llcs.v8i4.459.
   Bellavia A, 2018, AM J EPIDEMIOL, V187, P1311, DOI 10.1093/aje/kwx355.
   Bellavia A, 2015, AM J EPIDEMIOL, V182, P271, DOI 10.1093/aje/kwv033.
   Berlin M, 2011, CHILD YOUTH SERV REV, V33, P2489, DOI 10.1016/j.childyouth.2011.08.024.
   Bjorkenstam C, 2013, EUR CHILD ADOLES PSY, V22, P349, DOI 10.1007/s00787-012-0372-8.
   Bottai M, 2015, J STAT COMPUT SIM, V85, P1919, DOI 10.1080/00949655.2014.908879.
   Bottai M, 2013, STATA J, V13, P302, DOI 10.1177/1536867X1301300204.
   Bottai M, 2010, BIOMETRICAL J, V52, P487, DOI 10.1002/bimj.200900310.
   Brannstrom L, 2017, CHILD MALTREATMENT, V22, P205, DOI 10.1177/1077559517701855.
   Brannstrom L, 2017, CHILD ABUSE NEGLECT, V67, P408, DOI 10.1016/j.chiabu.2016.11.009.
   Breen R, 2010, SOC FORCES, V89, P365, DOI 10.1353/sof.2010.0076.
   Dregan A, 2012, SOC PSYCH PSYCH EPID, V47, P1517, DOI 10.1007/s00127-011-0458-5.
   Esping-Andersen G., 1986, INT J SOCIOLOGY, V16, P39, DOI DOI 10.1080/15579336.1986.11769910.
   Evans R, 2017, BRIT EDUC RES J, V43, P68, DOI 10.1002/berj.3252.
   Ferguson HB, 2012, CHILD YOUTH SERV REV, V34, P1143, DOI 10.1016/j.childyouth.2012.01.034.
   Ferraro KF, 2016, AM SOCIOL REV, V81, P107, DOI 10.1177/0003122415619617.
   Ferraro KF, 2009, GERONTOLOGIST, V49, P333, DOI 10.1093/geront/gnp034.
   Forsman H, 2016, CHILD ABUSE NEGLECT, V57, P61, DOI 10.1016/j.chiabu.2016.06.006.
   Gao MH, 2017, INT J EPIDEMIOL, V46, P1010, DOI 10.1093/ije/dyw295.
   Geraci M, 2007, BIOSTATISTICS, V8, P140, DOI 10.1093/biostatistics/kxj039.
   Hjern A, 2004, J EPIDEMIOL COMMUN H, V58, P412, DOI 10.1136/jech.2003.014282.
   Hummer RA, 2011, INT HANDB POPUL, V2, P241, DOI 10.1007/978-90-481-9996-9\_12.
   Kalland M, 2001, BRIT MED J, V323, P207, DOI 10.1136/bmj.323.7306.207.
   Lager ACJ, 2012, P NATL ACAD SCI USA, V109, P8461, DOI 10.1073/pnas.1105839109.
   Leslie LK, 2000, CHILD ABUSE NEGLECT, V24, P465, DOI 10.1016/S0145-2134(00)00116-2.
   O'Higgins A, 2017, CHILD YOUTH SERV REV, V79, P198, DOI 10.1016/j.childyouth.2017.06.004.
   Ostergren O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182526.
   Stenberg SA, 2006, INT J EPIDEMIOL, V35, P546, DOI 10.1093/ije/dyi310.
   Tideman E, 2011, ADOPT FOSTER, V35, P44, DOI 10.1177/030857591103500106.
   Trejos-Castillo E., 2018, HDB FOSTER YOUTH.
   VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121.
   Vinnerljung B, 2001, INT J SOC WELF, V10, P164, DOI 10.1111/1468-2397.00169.
   Vinnerljung B., 1996, FOSTERBARN SOM VUXNA.
   Vinnerljung B, 2008, INT J SOC WELF, V17, P301, DOI 10.1111/j.1468-2397.2008.00568.x.
   Vinnerljung B, 2015, CHILD YOUTH SERV REV, V56, P169, DOI 10.1016/j.childyouth.2015.07.001.
   Wildeman C, 2014, ANNU REV SOCIOL, V40, P599, DOI 10.1146/annurev-soc-071913-043358.
   Zlotnick C, 2012, AM J PUBLIC HEALTH, V102, P534, DOI 10.2105/AJPH.2011.300285.},
Number-of-Cited-References = {39},
Times-Cited = {8},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {8},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {HA6VA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000450417500006},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000248068200027,
Author = {Otabe, Shuichi and Yuan, Xiaohong and Fukutani, Tomoka and Wada,
   Nobuhiko and Hashinaga, Toshihiko and Nakayama, Hitomi and Hirota,
   Naotoshi and Kojima, Masayasu and Yamada, Kentaro},
Title = {Overexpression of human adiponectin in transgenic mice results in
   suppression of fat accumulation and prevention of premature death by
   high-calorie diet},
Journal = {AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM},
Year = {2007},
Volume = {293},
Number = {1},
Pages = {E210-E218},
Month = {JUL},
Abstract = {Adiponectin, a physiologically active polypeptide secreted by
   adipocytes, shows insulm- sensitizing, anti-inflammatory, and
   antiatherogenic, properties in rodents and humans. To assess the effects
   of chronic hyperadiponectinerma on metabolic phenotypes, we established
   three lines of transgenic mice expressing human adiponectin in the
   liver. When maintained on a high-fat/high-sucrose diet, mice of two
   lines that had persistent hyperadiponectinerma exhibited significantly
   decreased weight gain associated with less fat accumulation and smaller
   adipocytes in both visceral and subcutaneous adipose tissues. Macrophage
   infiltration in adipose tissue was markedly suppressed in the transgenic
   mice. Expression levels of adiponectin receptors were not altered in
   skeletal muscle or liver. Circulating levels of endogenous adiponectin
   were elevated, whereas fasting glucose, insulin, and leptin levels were
   reduced compared with control mice. In the hyperadiponectinemic mice
   daily food intake was not altered, but oxygen consumption was
   significantly greater, suggesting increased energy expenditure.
   Moreover, high-calorie diet-induced premature death was almost
   completely prevented in the hyperadiponectinemic, mice in association
   with attenuated oxidative DNA damage. The transgenic, mice also showed
   longer life span on a conventional low-fat chow. In conclusion,
   transgenic expression of human adiponectin blocked the excessive fat
   accumulation and reduced the morbidity and mortality in mice fed a
   high-calorie diet. These observations may provide new insights into the
   prevention and therapy of metabolic syndrome in humans.},
Publisher = {AMER PHYSIOLOGICAL SOC},
Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
Type = {Article},
Language = {English},
Affiliation = {Yamada, K (Corresponding Author), Kurume Univ, Sch Med, Dept Med, Div Endocrinol \& Metab, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.
   Kurume Univ, Sch Med, Dept Med, Div Endocrinol \& Metab, Kurume, Fukuoka 8300011, Japan.
   Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 8300011, Japan.},
DOI = {10.1152/ajpendo.00645.2006},
ISSN = {0193-1849},
Keywords = {adipocyte; macrophage; life span; 8-hyroxy-2-deoxyguanosine},
Keywords-Plus = {OXIDATIVE DNA-DAMAGE; BRAIN NATRIURETIC PEPTIDE; ADIPOSE-SPECIFIC
   PROTEIN; INSULIN-RESISTANCE; GLUCOSE-METABOLISM; FREE-RADICALS;
   WEIGHT-LOSS; OBESITY; DISEASE; STRESS},
Research-Areas = {Endocrinology \& Metabolism; Physiology},
Web-of-Science-Categories  = {Endocrinology \& Metabolism; Physiology},
Author-Email = {yamada@med.kurume-u.ac.jp},
Cited-References = {Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255.
   ARUOMA OI, 1991, J ROY SOC HEALTH, V111, P172, DOI 10.1177/146642409111100506.
   Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017.
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005.
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992.
   Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100.
   Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277.
   CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0.
   Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068.
   CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1.
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798.
   Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x.
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378.
   GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2.
   Halliwell B, 1996, FREE RADICAL RES, V25, P57, DOI 10.3109/10715769609145656.
   Hanna IR, 2005, AM FAM PHYSICIAN, V71, P2289.
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595.
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683.
   JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7.
   Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5.
   Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3.
   Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315.
   Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200.
   Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200.
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724.
   Mizoue T, 2006, CANCER EPIDEM BIOMAR, V15, P582, DOI 10.1158/1055-9965.EPI-05-0658.
   Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436.
   Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822.
   OGAWA Y, 1994, J CLIN INVEST, V93, P1911, DOI 10.1172/JCI117182.
   Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19.
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697.
   Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100.
   Streeper RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE388, DOI 10.1152/ajpendo.00621.2005.
   Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337.
   Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x.
   Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78.
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407.
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246.
   WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9.
   Wong RH, 2003, MUTAT RES-GEN TOX EN, V535, P181, DOI 10.1016/S1383-5718(02)00294-2.
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451.
   Yamauchi M, 2005, CHEST, V127, P1674, DOI 10.1378/chest.127.5.1674.
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984.
   Yoshida S, 1996, INT J OBESITY, V20, P909.},
Number-of-Cited-References = {44},
Times-Cited = {100},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Am. J. Physiol.-Endocrinol. Metab.},
Doc-Delivery-Number = {190OJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000248068200027},
DA = {2022-03-29},
}

@article{ WOS:000238531300004,
Author = {Razvi, Salman and Vaidya, Bijay and Perros, Petros and Pearce, Simon H.
   S.},
Title = {What is the evidence behind the evidence-base? The premature death of
   block-replace antithyroid drug regimens for Graves' disease},
Journal = {EUROPEAN JOURNAL OF ENDOCRINOLOGY},
Year = {2006},
Volume = {154},
Number = {6},
Pages = {783-786},
Month = {JUN},
Abstract = {Block-replace and titration antithyroid drug regimens both give similar
   rates of medium- to long-term remission of hyperthyroid Graves' disease.
   Recent meta-analysis. however, has suggested that titration regimens may
   be preferable owing to a higher rate of adverse events seen in the
   block-replace arms of published comparative studies. This article
   critically re-evaluates the evidence upon which these metaanalyses were
   based. We suggest that there is little objective evidence that is
   pertinent to current clinical practice to separate block-replace from
   titration antithyroid drug regimens and that both remain satisfactory
   approaches to the medical management of hyperthyroid Graves' disease.},
Publisher = {BIOSCIENTIFICA LTD},
Address = {EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Pearce, SHS (Corresponding Author), Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne \& Wear, England.
   Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne \& Wear, England.
   Royal Devon \& Exeter Hosp, Dept Endocrinol \& Diabet, Exeter EX2 5DW, Devon, England.
   Freeman Rd Hosp, Dept Endocrinol, Newcastle Upon Tyne NE7 7DN, Tyne \& Wear, England.
   Univ Newcastle, Sch Clin Med Sci, Newcastle Upon Tyne NE1 3BZ, Tyne \& Wear, England.},
DOI = {10.1530/eje.1.02169},
ISSN = {0804-4643},
EISSN = {1479-683X},
Keywords-Plus = {SHORT-TERM TREATMENT; RANDOMIZED-TRIAL; CARBIMAZOLE; METHIMAZOLE;
   THYROXINE; THERAPY; HYPERTHYROIDISM; REMISSION},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {s.h.s.pearcc@ncl.ac.uk},
ResearcherID-Numbers = {Vaidya, Bijay/AAF-1947-2020
   Pearce, Simon/AAB-3692-2019
   Razvi, Salman/H-6118-2019
   },
ORCID-Numbers = {Pearce, Simon/0000-0001-8384-8063
   Razvi, Salman/0000-0002-9047-1556
   Perros, Petros/0000-0001-7320-5574
   Vaidya, Bijay/0000-0002-2223-0494},
Cited-References = {Abraham P, 2005, EUR J ENDOCRINOL, V153, P489, DOI 10.1530/eje.1.01993.
   Abraham P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003420.pub3.
   Bartalena L, 1996, DRUG SAFETY, V15, P53, DOI 10.2165/00002018-199615010-00004.
   Benker G, 1998, CLIN ENDOCRINOL, V49, P451, DOI 10.1046/j.1365-2265.1998.00554.x.
   Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972.
   EDMONDS CJ, 1994, EUR J ENDOCRINOL, V131, P120, DOI 10.1530/eje.0.1310120.
   Franklyn JA, 2005, JAMA-J AM MED ASSOC, V294, P71, DOI 10.1001/jama.294.1.71.
   Grebe SKG, 1998, CLIN ENDOCRINOL, V48, P585, DOI 10.1046/j.1365-2265.1998.00446.x.
   {*}HLTH SOC CAR INF, 2004, PRESCR COST AN ENGL.
   JANSSON R, 1983, INT J CLIN PHARM TH, V21, P505.
   JORDE R, 1995, J INTERN MED, V238, P161, DOI 10.1111/j.1365-2796.1995.tb00914.x.
   Leandro G, 2005, META ANAL MED RES HD.
   LECLERE J, 1994, ANN ENDOCRINOL-PARIS, V55, P11.
   Nedrebo BG, 2002, EUR J ENDOCRINOL, V147, P583, DOI 10.1530/eje.0.1470583.
   Pearce SHS, 2004, CLIN ENDOCRINOL, V61, P589, DOI 10.1111/j.1365-2265.2004.02135.x.
   REINWEIN D, 1993, J CLIN ENDOCR METAB, V76, P1516.
   SOLOMON DH, 1953, JAMA-J AM MED ASSOC, V152, P201, DOI 10.1001/jama.1953.03690030001001.
   TAJIRI J, 1990, ARCH INTERN MED, V150, P621, DOI 10.1001/archinte.150.3.621.
   TALLSTEDT L, 1994, EUR J ENDOCRINOL, V130, P494, DOI 10.1530/eje.0.1300494.
   WEETMAN AP, 1986, Q J MED, V59, P409.
   WIBERG JJ, 1972, ANN INTERN MED, V77, P414, DOI 10.7326/0003-4819-77-3-414.
   Wilson R, 1996, QJM-INT J MED, V89, P381.},
Number-of-Cited-References = {22},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Eur. J. Endocrinol.},
Doc-Delivery-Number = {056NP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000238531300004},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000247968800102,
Author = {Flagg, Thomas P. and Patton, Brian and Masia, Ricard and Mansfield,
   Carrie and Lopatin, Anatoli N. and Yamada, Kathryn A. and Nichols, Colin
   G.},
Title = {Arrhythmia susceptibility and premature death in transgenic mice
   overexpressing both SUR1 and Kir6.2{[}Delta N30, K185Q] in the heart},
Journal = {AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY},
Year = {2007},
Volume = {293},
Number = {1},
Pages = {H836-H845},
Month = {JUL},
Abstract = {Sarcolemmal ATP-sensitive potassium (K-ATP) channels are activated after
   pathological depletion of intracellular ATP, unlike their pancreatic
   beta-cell counterparts, which dynamically regulate membrane excitability
   in response to changes in blood glucose. We recently engineered a series
   of transgenic (TG) mice overexpressing an ATP-insensitive inward
   rectifying K+ channel protein (Kir) 6.2 mutant (Kir6.2{[}Delta
   N30,K185Q]) or the accessory sulfonylurea receptor (SUR)2A (FLAG-SUR2A)
   or SUR1 (FLAG-SUR1) subunits of the K-ATP channel, under transcriptional
   control of the alpha-myosin heavy chain promoter. In the present study,
   we generated double transgenic (DTG) animals overexpressing both
   Kir6.2{[}Delta N30,K185Q] and FLAG-SUR1 or FLAG-SUR2A and examined the
   effects on cardiac excitability in vivo. No animals expressing both
   FLAG-SUR1 and Kir6.2{[}Delta N30,K185Q] transgenes at a high level were
   obtained. DTG mice expressing one transgene at a high level and the
   other at a lower level are born, but they die prematurely.
   Electrocardiographic analysis of both anesthetized and conscious animals
   revealed a constellation of arrhythmias in DTG animals, but not in
   wild-type or single TG littermates. The proarrhythmic effect of the
   transgene combination is intrinsic to the myocardium, since it persists
   in isolated hearts. Importantly, this effect is specific for
   SUR1-expressing DTG animals: DTG animals expressing both Kir6.2{[}Delta
   N30,K185Q] and FLAG-SUR2A at high levels exhibit neither impaired
   survival nor increased arrhythmia frequency, even with both subunits
   expressed at high levels. In demonstrating the profound arrhythmic
   consequences of K-ATP channels comprised of SUR1 and Kir6.2{[}Delta
   N30,K185Q] in the myocardium specifically, the results highlight the
   critical differential activation of SUR1 versus SUR2A, and indicate that
   expression of hyperactive K-ATP in the heart is likely to be
   proarrhythmic.},
Publisher = {AMER PHYSIOLOGICAL SOC},
Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA},
Type = {Article},
Language = {English},
Affiliation = {Flagg, TP (Corresponding Author), Washington Univ, Sch Med, Dept Cell Biol \& Physiol, 660 S Euclid Ave, Bos 8228, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Dept Cell Biol \& Physiol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Dept Med, St Louis, MO USA.
   Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI USA.},
DOI = {10.1152/ajpheart.00011.2007},
ISSN = {0363-6135},
EISSN = {1522-1539},
Keywords = {ATP-sensitive potassium channel; sulfonylurea receptor 2A},
Keywords-Plus = {K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; INSULIN-SECRETION;
   SULFONYLUREA RECEPTOR; VENTRICULAR MYOCYTES; ACTION-POTENTIALS; MOUSE
   HEART; SUBUNITS; CELLS; DIAZOXIDE},
Research-Areas = {Cardiovascular System \& Cardiology; Physiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease},
Author-Email = {tflagg@cellbiology.wust.edu},
ResearcherID-Numbers = {Nichols, Colin/D-6336-2012},
Cited-References = {Ashcroft FM, 2000, TRENDS PHARMACOL SCI, V21, P439.
   Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9.
   Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132.
   Baron A, 1999, CIRC RES, V85, P707, DOI 10.1161/01.RES.85.8.707.
   Chen MK, 2003, J NEUROSCI, V23, P8568.
   Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672.
   Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9.
   COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0.
   FAIVRE JF, 1989, BIOCHIM BIOPHYS ACTA, V984, P1, DOI 10.1016/0005-2736(89)90334-9.
   Fischbach PS, 2004, J PHARMACOL EXP THER, V309, P554, DOI 10.1124/jpet.103.060780.
   Flagg TP, 2005, J MOL CELL CARDIOL, V39, P647, DOI 10.1016/j.yjmcc.2005.06.003.
   Flagg TP, 2004, AM J PHYSIOL-HEART C, V286, pH1361, DOI 10.1152/ajpheart.00676.2003.
   Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922.
   Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145.
   Han X, 1996, J PHYSIOL-LONDON, V490, P337, DOI 10.1113/jphysiol.1996.sp021148.
   INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166.
   Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1.
   Koster JC, 2001, CIRC RES, V89, P1022, DOI 10.1161/hh2301.100342.
   LEDERER WJ, 1989, J PHYSIOL-LONDON, V413, P329, DOI 10.1113/jphysiol.1989.sp017657.
   Li JD, 2004, AM J PHYSIOL-HEART C, V287, pH2790, DOI 10.1152/ajpheart.00114.2004.
   Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837.
   Liu YG, 2001, MOL PHARMACOL, V59, P225, DOI 10.1124/mol.59.2.225.
   Lorenz E, 1999, J MOL CELL CARDIOL, V31, P425, DOI 10.1006/jmcc.1998.0876.
   Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009.
   Morrissey A, 2005, PEDIATR RES, V58, P185, DOI 10.1203/01.PDR.0000169967.83576.CB.
   Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1.
   Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785.
   NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0.
   SAWANOBORI T, 1995, J MOL CELL CARDIOL, V27, P647, DOI 10.1016/S0022-2828(08)80057-0.
   Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389.
   Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270.
   Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337.
   Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200.
   Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643.
   Singh H, 2003, J MOL CELL CARDIOL, V35, P445, DOI 10.1016/S0022-2828(03)00041-5.
   Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100.
   Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270.
   Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570.
   Van Cuong D, 2005, MITOCHONDRION, V5, P121, DOI 10.1016/j.mito.2004.12.001.
   Yokoshiki H, 1999, PFLUG ARCH EUR J PHY, V437, P400, DOI 10.1007/s004240050794.},
Number-of-Cited-References = {40},
Times-Cited = {21},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Am. J. Physiol.-Heart Circul. Physiol.},
Doc-Delivery-Number = {189DE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000247968800102},
DA = {2022-03-29},
}

@article{ WOS:000311140800026,
Author = {Cramb, Susanna M. and Mengersen, Kerrie L. and Turrell, Gavin and Baade,
   Peter D.},
Title = {Spatial inequalities in colorectal and breast cancer survival: Premature
   deaths and associated factors},
Journal = {HEALTH \& PLACE},
Year = {2012},
Volume = {18},
Number = {6},
Pages = {1412-1421},
Month = {NOV},
Abstract = {This study examines the influence of cancer stage, distance to treatment
   facilities and area disadvantage on breast and colorectal cancer spatial
   survival inequalities. We also estimate the number of premature deaths
   after adjusting for cancer stage to quantify the impact of spatial
   survival inequalities. Population-based descriptive study of residents
   aged < 90 years in Queensland, Australia diagnosed with primary invasive
   breast (25,202 females) or colorectal (14,690 males, 11,700 females)
   cancers during 1996-2007. Bayesian hierarchical models explored relative
   survival inequalities across 478 regions. Cancer stage and disadvantage
   explained the spatial inequalities in breast cancer survival, however
   spatial inequalities in colorectal cancer survival persisted after
   adjustment. Of the 6,019 colorectal cancer deaths within 5 years of
   diagnosis, 470 (8\%) were associated with spatial inequalities in
   non-diagnostic factors, i.e. factors beyond cancer stage at diagnosis.
   For breast cancers, of 2,412 deaths, 170 (7\%) were related to spatial
   inequalities in non-diagnostic factors. Quantifying premature deaths can
   increase incentive for action to reduce these spatial inequalities. (C)
   2012 Elsevier Ltd. All rights reserved.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Cramb, SM (Corresponding Author), Canc Council Queensland, Viertel Ctr Res Canc Control, POB 201, Spring Hill 4004, Australia.
   Cramb, Susanna M.; Baade, Peter D., Canc Council Queensland, Viertel Ctr Res Canc Control, Spring Hill 4004, Australia.
   Cramb, Susanna M.; Mengersen, Kerrie L., Queensland Univ Technol, Sch Math Sci, Ctr Data Anal Modelling \& Computat, Brisbane, Qld 4001, Australia.
   Turrell, Gavin; Baade, Peter D., Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.
   Baade, Peter D., Griffith Univ, Griffith Hlth Inst, Nathan, Qld 4111, Australia.},
DOI = {10.1016/j.healthplace.2012.07.006},
ISSN = {1353-8292},
EISSN = {1873-2054},
Keywords = {Cancer; Premature deaths; Relative survival; Spatial; Bayesian},
Keywords-Plus = {RELATIVE SURVIVAL; DISPARITIES; AUSTRALIA; DIAGNOSIS; STAGE; CARE;
   QUEENSLAND; MANAGEMENT; MORTALITY; MODELS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {susannacramb@cancerqld.org.au},
ResearcherID-Numbers = {Baade, Peter/C-4113-2009
   },
ORCID-Numbers = {Baade, Peter/0000-0001-8576-8868
   Turrell, Gavin/0000-0002-3576-8744
   Cramb, Susanna/0000-0001-9041-9531
   Mengersen, Kerrie/0000-0001-8625-9168},
Funding-Acknowledgement = {National Health and Medical Research Council (NHMRC) Career Development
   FellowshipNational Health and Medical Research Council of Australia
   {[}ID 1005334]; CRCAustralian GovernmentDepartment of Industry,
   Innovation and ScienceCooperative Research Centres (CRC) Programme;
   NHMRC Senior Research FellowshipNational Health and Medical Research
   Council of Australia {[}ID 1003710]; NHMRCNational Health and Medical
   Research Council of Australia {[}ID 561700]},
Funding-Text = {Peter Baade was supported by a National Health and Medical Research
   Council (NHMRC) Career Development Fellowship (ID 1005334). Kerrie
   Mengersen acknowledges support from the CRC for Spatial Information.
   Gavin Turrell was supported by an NHMRC Senior Research Fellowship (ID
   1003710). The extraction of colorectal cancer stage was supported by an
   NHMRC grant (ID 561700). The authors would like to thank Nicole White,
   Queensland University of Technology, for helpful methodological
   discussions, and Joanne Aitken, Cancer Council Queensland, for her
   review of a previous draft of this manuscript. The views expressed in
   this paper are those of the authors and not of any funding body.},
Cited-References = {Aitkin M, 2009, ANN APPL STAT, V3, P199, DOI 10.1214/08-AOAS205.
   Australia Bureau of Statistics, 2008, INFORM PAPER INTRO S.
   Australian Bureau of Statistics, 2008, POP AG SEX REG AUSTR.
   Australian Institute of Health and Welfare, 2009, NAT BOW CANC SCREEN.
   Australian Institute of Health and Welfare, 2010, AUSTR I HLTH WELF CA, V55.
   Australian Institute of Health and Welfare Cancer Australia \& Australasian Association of Cancer Registries, 2008, AUSTR I HLTH WELF CA, V42.
   Baade P, 2009, CURRENT STATUS FEMAL.
   Baade P.D., 2011, BR J CANC.
   Baade P.D., 2011, J EPIDEMIOLOGY COMMU.
   Baade PD, 2011, MED J AUSTRALIA, V195, P350, DOI 10.5694/mja10.11204.
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466.
   Brenner H, 2009, INT J CANCER, V124, P1384, DOI 10.1002/ijc.24021.
   Carlin BP, 1999, J EXPO ANAL ENV EPID, V9, P66, DOI 10.1038/sj.jea.7500027.
   Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3.
   Cramb SM, 2011, ATLAS CANC QUEENSLAN.
   Davies E A, 2010, Br J Cancer, V103, P1076, DOI 10.1038/sj.bjc.6605857.
   Dickman PW, 1997, J EPIDEMIOL COMMUN H, V51, P289, DOI 10.1136/jech.51.3.289.
   Du XLL, 2011, CANCER-AM CANCER SOC, V117, P3242, DOI 10.1002/cncr.25854.
   Eberly LE, 2000, STAT MED, V19, P2279, DOI 10.1002/1097-0258(20000915/30)19:17/18<2279::AID-SIM569>3.0.CO;2-R.
   Ederer F, 1959, 10 NAT CANC I END RE.
   Fairley L, 2008, BRIT J CANCER, V99, P1786, DOI 10.1038/sj.bjc.6604757.
   Ferlay J., 2010, GLOBOCAN 2008 CANC I.
   Frederiksen BL, 2009, SOC SCI MED, V69, P1107, DOI 10.1016/j.socscimed.2009.07.040.
   Fusco M, 2010, EUR J CANCER, V46, P142, DOI 10.1016/j.ejca.2009.07.005.
   Geweke J., 1996, BAYESIAN STAT, P169.
   Haas JS, 2011, CANCER-AM CANCER SOC, V117, P4267, DOI 10.1002/cncr.26034.
   Haq AI, 2009, LANCET ONCOL, V10, P1128, DOI 10.1016/S1470-2045(09)70157-3.
   Henry KA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-48.
   Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x.
   Krnjacki LJ, 2008, AUST NZ J PUBL HEAL, V32, P378, DOI 10.1111/j.1753-6405.2008.00259.x.
   Kulldorff M, 2006, AM J PREV MED, V30, pS37, DOI 10.1016/j.amepre.2005.09.009.
   Leroux B., 2000, STAT MODELS EPIDEMIO, P135.
   McKenzie F., 2011, ETHNICITY HLTH, P1.
   Mitchell KJ, 2006, BREAST, V15, P769, DOI 10.1016/j.breast.2006.04.001.
   Queensland Cancer Registry, 2010, CANC QUEENSL INC MOR.
   Richardson S, 2004, ENVIRON HEALTH PERSP, V112, P1016, DOI 10.1289/ehp.6740.
   Saez M, 2012, J R STAT SOC A STAT, V175, P107, DOI 10.1111/j.1467-985X.2011.00720.x.
   Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR.
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353.
   Tango T, 2000, STAT MED, V19, P191, DOI 10.1002/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q.
   Thompson J, 2006, STATA J, V6, P530, DOI 10.1177/1536867X0600600406.
   Tian N., 2012, WOMENS HLTH ISSUES.
   Tian N, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-24.
   Wakefield J, 1999, STAT MED, V18, P2377, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2377::AID-SIM263>3.0.CO;2-G.
   Wan N, 2012, HEALTH PLACE, V18, P321, DOI 10.1016/j.healthplace.2011.10.007.
   Yu XQ, 2005, EUR J CANCER, V41, P2715, DOI 10.1016/j.ejca.2005.05.018.
   Yu XQ, 2004, CANCER CAUSE CONTROL, V15, P611, DOI 10.1023/B:CACO.0000036165.13089.e8.
   Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364.},
Number-of-Cited-References = {48},
Times-Cited = {36},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Health Place},
Doc-Delivery-Number = {037XW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000311140800026},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000313723100101,
Author = {Esmaeili, Mohammad A. and Panahi, Marzieh and Yadav, Shilpi and
   Hennings, Leah and Kiaei, Mahmoud},
Title = {Premature death of TDP-43 (A315T) transgenic mice due to
   gastrointestinal complications prior to development of full neurological
   symptoms of amyotrophic lateral sclerosis},
Journal = {INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY},
Year = {2013},
Volume = {94},
Number = {1},
Pages = {56-64},
Month = {FEB},
Abstract = {Abnormal distribution, modification and aggregation of transactivation
   response DNA-binding protein 43 (TDP-43) are the hallmarks of multiple
   neurodegenerative diseases, especially frontotemporal lobar degeneration
   with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral
   sclerosis (ALS). Transgenic mouse lines overexpressing wild-type or
   mutant TDP-43 exhibit ALS-like symptom, motor abnormalities and early
   paralysis followed by death. Reports on lifespan and phenotypic
   behaviour in Prp-TDP-43 (A315T) vary, and these animals are not fully
   characterized. Although it has been proposed that the approximate 20\%
   loss of motor neurons at end stage is responsible for the severe
   weakness and death in TDP-43 mice, this degree of neurologic damage
   appears insufficient to cause death. Hence we studied these mice to
   further characterize and determine the reason for the death. Our
   characterization of TDP-43 transgenic mice showed that these mice
   develop ALS-like symptoms that later become compounded by
   gastrointestinal (GI) complications that resulted in death. This is the
   first report of a set of pathological evidence in the GI track that is
   strong indicator for the cause of death of Prp-hTDP-43 (A315T)
   transgenic mice.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Kiaei, M (Corresponding Author), Univ Arkansas Med Sci, Dept Neurobiol \& Dev Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA.
   Esmaeili, Mohammad A.; Panahi, Marzieh; Yadav, Shilpi; Kiaei, Mahmoud, Univ Arkansas Med Sci, Dept Neurobiol \& Dev Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA.
   Hennings, Leah, Univ Arkansas Med Sci, Dept Pathol, Coll Med, Little Rock, AR 72205 USA.},
DOI = {10.1111/iep.12006},
ISSN = {0959-9673},
EISSN = {1365-2613},
Keywords = {amyotrophic lateral sclerosis; gastrointestinal track; mouse model of
   ALS; TDP-43},
Keywords-Plus = {FRONTOTEMPORAL LOBAR DEGENERATION; ALS-LINKED SOD1; MOUSE MODEL; PROTEIN
   AGGREGATION; DISEASE; MUTATIONS; DYSFUNCTION; INCLUSIONS},
Research-Areas = {Pathology},
Web-of-Science-Categories  = {Pathology},
Author-Email = {mkiaei@uams.edu},
ResearcherID-Numbers = {Esmaeeli, Mohamad/Q-3074-2018},
ORCID-Numbers = {Esmaeeli, Mohamad/0000-0001-9990-2001},
Funding-Acknowledgement = {UAMS and Department of Neurobiology and Developmental Sciences, Center
   for translational Neurosciences start up fund, Paul Dunn Fund; National
   Center for Research ResourcesUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) {[}5P20RR020146-09]; National Institute of
   General Medical SciencesUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) {[}8 P20 GM103425-09]; NATIONAL
   CENTER FOR RESEARCH RESOURCESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) {[}P20RR020146] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) {[}P20GM103425]
   Funding Source: NIH RePORTER},
Funding-Text = {Funding provided by UAMS and Department of Neurobiology and
   Developmental Sciences, Center for translational Neurosciences start up
   fund, Paul Dunn Fund to MK. Authors acknowledge the support by grants
   from the National Center for Research Resources (5P20RR020146-09) and
   the National Institute of General Medical Sciences (8 P20 GM103425-09).
   We thank Kim Tarkington for helping to compile and edit the references.
   Authors acknowledge valuable technical supports by Jennifer Johnson and
   Yingni Che. Histology performed in the UAMS Translational Pathology
   Shared Resource.},
Cited-References = {Agar J, 2003, AMYOTROPH LATERAL SC, V4, P232, DOI 10.1080/14660820310011278.
   Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O.
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093.
   Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5.
   Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851.
   DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367.
   Gendron TF, 2011, J MOL NEUROSCI, V45, P486, DOI 10.1007/s12031-011-9610-7.
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344.
   Guo YS, 2012, BRAIN RES, V1460, P88, DOI 10.1016/j.brainres.2012.04.003.
   Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1.
   Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x.
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132.
   Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006.
   Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x.
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066.
   Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270.
   Maragakis NJ, 2001, ARCH NEUROL-CHICAGO, V58, P365, DOI 10.1001/archneur.58.3.365.
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108.
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971.
   Przedborski S, 2004, NEUROLOGIST, V10, P1, DOI 10.1097/01.nrl.0000106920.84668.37.
   Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4.
   Rothstein JD, 1996, CLIN NEUROSCI, V3, P348.
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107.
   Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75.
   Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017.
   Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313.
   Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3.
   Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x.
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942.
   Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005.
   Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106.
   Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107.
   Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x.
   Xu ZS, 2004, J BIOENERG BIOMEMBR, V36, P395, DOI 10.1023/B:JOBB.0000041774.12654.e1.
   Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392.},
Number-of-Cited-References = {35},
Times-Cited = {50},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Int. J. Exp. Pathol.},
Doc-Delivery-Number = {073DH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000313723100101},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000293370100003,
Author = {Ho, Jin-Nyoung and Kang, Eun-Ryung and Yoon, Ho-Geun and Jeon, Hyelin
   and Jun, Woojin and Watson, Ronald R. and Lee, Jeongmin},
Title = {Inhibition of Premature Death by Isothiocyanates through Immune
   Restoration in LP-BM5 Leukemia Retrovirus-Infected C57BL/6 Mice},
Journal = {BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY},
Year = {2011},
Volume = {75},
Number = {7},
Pages = {1234-1239},
Month = {JUL},
Abstract = {The purpose of this study was to determine the effect of isothiocyanates
   (ITCs) in delaying the progression of the murine immunodeficiency virus
   to murine AIDS, resulting in increased life span. Furthermore, we
   investigated the role of ITCs in modulating immune dysfunction caused by
   LP-BM5 retrovirus infection. Among the tested ITCs, oral administration
   of sulforaphane (SUL), benzyl isothiocyante (BITC), and phenethyl
   isothiocyanate (PEITC) showed the inhibition of premature death caused
   by LP-BM5 retrovirus infection, while indolo{[}3,2-b] carbazole (ICZ)
   and indole-3-carbinol (I3C) did not delay the progress of the LP-BM5
   retrovirus to murine AIDS. Inhibition of premature death by BITC, PEITC,
   and SUL could be explained by restoration of the immune system and down
   regulation of free radicals. Dysfunction of T and B cell mitogenesis
   caused by retrovirus infection in primary cultured splenocytes has been
   partially recovered with administration of BITC, PEITC, and SUL. There
   was a shift from imbalanced cytokine production (increased Th2 and
   decreased Th1 cell cytokine production) into balanced Th1/Th2 cell
   secretion of cytokines under administration of these ITCs during the
   development of murine AIDS. Hepatic vitamin E level was significantly
   restored by administration of these ITCs, in accordance with reduced
   hepatic lipid peroxidation levels. This study suggests that certain
   types of ITCs have beneficial effects in preventing premature death
   during progression to murine AIDS by restoration of immune dysfunction
   and removal of excessive free radicals, implying that selective usage of
   ITCs would be helpful in retarding the progression from HIV infection to
   AIDS.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Lee, J (Corresponding Author), Kyung Hee Univ, Grad Sch EW Sci, Dept Med Nutr, Yongin 446701, Gyeonggi, South Korea.
   Ho, Jin-Nyoung; Kang, Eun-Ryung; Jeon, Hyelin; Lee, Jeongmin, Kyung Hee Univ, Grad Sch EW Sci, Dept Med Nutr, Yongin 446701, Gyeonggi, South Korea.
   Yoon, Ho-Geun, Yonsei Univ, Coll Med, Dept Biochem \& Mol Biol, Seoul 120752, South Korea.
   Jun, Woojin, Chonnam Natl Univ, Dept Food \& Nutr, Human Ecol Res Inst, Kwangju 500757, South Korea.
   Watson, Ronald R., Univ Arizona, Div Hlth Promot Sci, Mel \& Enid Zuckermann Coll Publ Hlth, Tucson, AZ 85724 USA.
   Lee, Jeongmin, Kyung Hee Univ, Res Inst Clin Nutr, Seoul 130701, South Korea.},
DOI = {10.1271/bbb.100840},
ISSN = {0916-8451},
EISSN = {1347-6947},
Keywords = {isothiocyanates; murine AIDS; immune dysfunction; oxidative stress; Th1
   and Th2 cytokines},
Keywords-Plus = {INDUCED APOPTOSIS; DOWN-REGULATION; DYSFUNCTION; CELLS; ACTIVATION;
   PATHWAYS; PEITC; LUNG},
Research-Areas = {Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Chemistry; Food Science \& Technology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Chemistry, Applied; Food Science \& Technology},
Author-Email = {jlee2007@khu.ac.kr},
Funding-Acknowledgement = {Korean Government (MOEHRD)Ministry of Education \& Human Resources
   Development (MOEHRD), Republic of KoreaKorean Government
   {[}KRF-2006-003-F00060]},
Funding-Text = {This work was supported by Korean Research Foundation Grant funded by
   the Korean Government (MOEHRD, Basic Research Promotion Fund)
   (KRF-2006-003-F00060).},
Cited-References = {AMARAKOON AMT, 1995, INFLAMM RES, V44, P301, DOI 10.1007/BF02032573.
   {*}ANT THER COH COLL, 2008, LANCET, V37, P293.
   Brown KK, 2009, J BIOL CHEM, V284, P32425, DOI 10.1074/jbc.M109.047092.
   BURTON GW, 1985, LIPIDS, V20, P29, DOI 10.1007/BF02534359.
   CHOUAIB S, 1985, J IMMUNOL, V135, P1172.
   Crapo JD, 2003, EUR RESPIR J, V22, p4S, DOI 10.1183/09031936.03.00000203a.
   Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2.
   Hu R, 2003, CARCINOGENESIS, V24, P1361, DOI 10.1093/carcin/bgg092.
   KAMINSKA T, 2003, MED SCI MONITOR, V9, P71.
   KANAGAWA O, 1993, SCIENCE, V262, P240, DOI 10.1126/science.8211142.
   Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016.
   Lam TK, 2009, CANCER EPIDEM BIOMAR, V18, P184, DOI 10.1158/1055-9965.EPI-08-0710.
   Lee J, 2005, NUTR RES, V25, P401, DOI 10.1016/j.nutres.2004.12.010.
   Lee J, 1998, NUTR RES, V18, P327, DOI 10.1016/S0271-5317(98)00025-6.
   Lee JW, 2008, ARCH PHARM RES, V31, P1604, DOI 10.1007/s12272-001-2158-2.
   Liang BL, 2001, IMMUNOPHARM IMMUNOT, V23, P307, DOI 10.1081/IPH-100107332.
   MARCUS U, 2009, EPIDEMIOL B, V48, P491.
   MORSE MA, 1989, CANCER RES, V49, P549.
   OHISHI N, 1985, BIOCHEM INT, V10, P205.
   Papi A, 2008, J AGR FOOD CHEM, V56, P875, DOI 10.1021/jf073123c.
   Powolny AA, 2010, PHARM RES-DORDR, V27, P2766, DOI 10.1007/s11095-010-0278-4.
   Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916.
   SEPULVEDA T, 2002, CARDIOVASC TOXICOL, V2, P53.
   Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815.
   Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009.
   van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946.
   Vogel M, 2010, DTSCH ARZTEBL INT, V107, P507, DOI 10.3238/arztebl.2010.0507.
   WANG Y, 1994, IMMUNOLOGY, V83, P384.
   Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6.
   Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50.
   Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200.
   Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396.},
Number-of-Cited-References = {32},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Biosci. Biotechnol. Biochem.},
Doc-Delivery-Number = {800OF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000293370100003},
DA = {2022-03-29},
}

@article{ WOS:000076173200007,
Author = {Jackson, TA and McNeill, MR},
Title = {Premature death in parasitized Listronotus bonariensis adults can be
   caused by bacteria transmitted by the parasitoid Microctonus hyperodae},
Journal = {BIOCONTROL SCIENCE AND TECHNOLOGY},
Year = {1998},
Volume = {8},
Number = {3},
Pages = {389-396},
Month = {SEP},
Abstract = {During experiments to determine the impact of the introduced parasitoid
   Microctonus hyperodae Loan (Hymenoptera: Braconidae) on the Argentine
   stern weevil Listronotus bonariensis (Kuschel) (Col.. Curculionidae), it
   was discover ed that weevils frequently died prior to development of the
   parasitoid. It was postulated that this premature mortality could be
   caused by an ingress of pathogens in the puncture wounds created during
   parasitoid oviposition. This hypothesis was tested using the pathogenic
   bacterium Serratia marcescens Bizio as a model indicator of bacterial
   transmission by the parasitoid. Wizen the bacteria Mere injected with a
   pin, simulating parasitoid attack, 92\% of weevils died. Weevils exposed
   to parasitoids contaminated with bacteria suffered significantly higher
   mortality than those exposed to parasitoids untreated with bacteria.
   When parasitoids and weevils were confined in Petri dishes on filter
   paper contaminated with S. marcescens, there was significantly higher
   weevil mortality than in dishes without bacteria. The treatment of
   weevils, using the pin injection method, with bacteria isolated from
   weevils and soil (Serratia spp., Bacillus spp. and Pseudomonas
   fluorescens (Trevisan)), produced similar levels of weevil mortality to
   the test strain. These results strongly suggest that parasitoid-mediated
   transmission of bacteria causing rapid death of the host can act as a
   significant mortality factor in biological control programmes, and
   should be considered in their interpretation.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Jackson, TA (Corresponding Author), AgResearch, Canterbury Agr \& Sci Ctr, POB 60, Lincoln, New Zealand.
   AgResearch, Canterbury Agr \& Sci Ctr, Lincoln, New Zealand.},
DOI = {10.1080/09583159830199},
ISSN = {0958-3157},
EISSN = {1360-0478},
Keywords = {Listronotus bonariensis; Microctonus hyperodae; parasitoid bacteria
   transmission; bacteria; Serratia marcescens},
Keywords-Plus = {ARGENTINE STEM WEEVIL; NEW-ZEALAND; HYMENOPTERA; BRACONIDAE; SERRATIA},
Research-Areas = {Biotechnology \& Applied Microbiology; Entomology},
Web-of-Science-Categories  = {Biotechnology \& Applied Microbiology; Entomology},
Author-Email = {jacksont@agresearch.cri.nz},
ORCID-Numbers = {McNeill, Mark/0000-0001-9140-610X},
Cited-References = {BARLOW ND, 1994, BIOCONTROL SCI TECHN, V4, P375, DOI 10.1080/09583159409355347.
   BELL JV, 1974, ANN ENTOMOL SOC AM, V67, P712, DOI 10.1093/aesa/67.4.712.
   BUCHER GE, 1993, J INSECT PATHOL, V5, P227.
   BUCHER GE, 1963, J INSECT PATHOL, V2, P172.
   COULDRON TA, 1991, ACS SYM SER, V449, P41.
   Goldson S.L., 1990, Proceedings of New Zealand Weed and Pest Control Conference, V43, P334.
   GOLDSON SL, 1992, P NZ PLAN P, P210.
   GOLDSON SL, 1993, P 6 AUSTR C GRASSL I, P355.
   McNeill MR, 1996, BIOCONTROL SCI TECHN, V6, P77, DOI 10.1080/09583159650039548.
   OCALLAGHAN M, 1993, J APPL BACTERIOL, V75, P307, DOI 10.1111/j.1365-2672.1993.tb02781.x.
   PHILLIPS CB, 1995, THESIS LINCOLN U NZ.
   REARDON R C, 1976, Entomophaga, V21, P333, DOI 10.1007/BF02371630.
   SAMBROOK J, 1989, MOL CLONING.
   SAMSON-BOSHUIZEN M, 1974, Netherlands Journal of Zoology, V24, P67.
   STARR MP, 1976, J CLIN MICROBIOL, V4, P270.
   STOLTZ DB, 1986, J INSECT PHYSIOL, V32, P347, DOI 10.1016/0022-1910(86)90047-8.},
Number-of-Cited-References = {16},
Times-Cited = {13},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Biocontrol Sci. Technol.},
Doc-Delivery-Number = {124GC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000076173200007},
DA = {2022-03-29},
}

@article{ WOS:000730890700011,
Author = {Liu, Xueying and Tai, Amos P. K. and Chen, Youfan and Zhang, Lin and
   Shaddick, Gavin and Yan, Xiaoyu and Lam, Hon-Ming},
Title = {Dietary shifts can reduce premature deaths related to particulate matter
   pollution in China},
Journal = {NATURE FOOD},
Year = {2021},
Volume = {2},
Number = {12},
Pages = {997-1004},
Month = {DEC},
Abstract = {Shifting towards more meat-intensive diets may have indirect health
   consequences through environmental degradation. Here we examine how
   trends in dietary patterns in China over 1980-2010 have worsened fine
   particulate matter (PM2.5) pollution, thereby inducing indirect health
   impacts. We show that changes in dietary composition alone, mainly by
   driving the rising demands for meat and animal feed, have enhanced
   ammonia (NH3) emissions from Chinese agriculture by 63\% and increased
   annual PM2.5 by up to similar to 10 mu g m(-3) (similar to 20\% of total
   PM2.5 increase) over the period. Such effects are more than double that
   driven by increased food production solely due to population growth.
   Shifting the current diet towards a less meat-intensive recommended diet
   can decrease NH3 emission by similar to 17\% and PM2.5 by 2-6 mu g m(-3)
   , and avoid similar to 75,000 Chinese annual premature deaths related to
   PM2.5.},
Publisher = {NATURE PORTFOLIO},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Tai, APK (Corresponding Author), Chinese Univ Hong Kong, Fac Sci, Earth Syst Sci Programme, Hong Kong, Peoples R China.
   Tai, APK (Corresponding Author), Chinese Univ Hong Kong, Fac Sci, Grad Div Earth \& Atmospher Sci, Hong Kong, Peoples R China.
   Tai, APK (Corresponding Author), Chinese Univ Hong Kong, Inst Environm Energy \& Sustainabil, Hong Kong, Peoples R China.
   Tai, APK (Corresponding Author), Chinese Univ Hong Kong, Ctr Soybean Res, State Key Lab Agrobiotechnol, Hong Kong, Peoples R China.
   Liu, Xueying; Tai, Amos P. K., Chinese Univ Hong Kong, Fac Sci, Earth Syst Sci Programme, Hong Kong, Peoples R China.
   Liu, Xueying; Tai, Amos P. K., Chinese Univ Hong Kong, Fac Sci, Grad Div Earth \& Atmospher Sci, Hong Kong, Peoples R China.
   Tai, Amos P. K.; Lam, Hon-Ming, Chinese Univ Hong Kong, Inst Environm Energy \& Sustainabil, Hong Kong, Peoples R China.
   Tai, Amos P. K.; Lam, Hon-Ming, Chinese Univ Hong Kong, Ctr Soybean Res, State Key Lab Agrobiotechnol, Hong Kong, Peoples R China.
   Chen, Youfan; Zhang, Lin, Peking Univ, Sch Phys, Dept Atmospher \& Ocean Sci, Lab Climate \& Ocean Atmosphere Studies, Beijing, Peoples R China.
   Shaddick, Gavin, Univ Exeter, Dept Math, Exeter, Devon, England.
   Shaddick, Gavin, Univ Exeter, Joint Ctr Excellence Environm Intelligence, Met Off, Exeter, Devon, England.
   Yan, Xiaoyu, Univ Exeter, Environm \& Sustainabil Inst, Penryn, England.
   Lam, Hon-Ming, Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China.
   Liu, Xueying, Univ Houston, Dept Earth \& Atmospher Sci, Houston, TX USA.},
DOI = {10.1038/s43016-021-00430-6},
EarlyAccessDate = {DEC 2021},
EISSN = {2662-1355},
Keywords-Plus = {ENVIRONMENTAL IMPACTS; AMMONIA EMISSIONS; AIR-POLLUTION; HEALTH;
   QUALITY; NITRATE; PREVALENCE; EFFICIENCY; MORTALITY},
Research-Areas = {Food Science \& Technology},
Web-of-Science-Categories  = {Food Science \& Technology},
Author-Email = {amostai@cuhk.edu.hk},
ResearcherID-Numbers = {Lam, Hon-Ming/A-9866-2008
   Yan, Xiaoyu/C-4178-2008},
ORCID-Numbers = {Liu, Xueying/0000-0002-5582-5347
   Chen, Youfan/0000-0003-2916-3826
   Tai, Amos/0000-0001-5189-6263
   Lam, Hon-Ming/0000-0002-6673-8740
   Yan, Xiaoyu/0000-0003-3165-5870},
Funding-Acknowledgement = {CUHK-Exeter Joint Centre for Environmental Sustainability and Resilience
   (ENSURE) {[}MD18518]; Research Grants Council (RGC) General Research
   Fund {[}14323116]; RGC Area of Excellence Scheme;  {[}AoE/M-403/16]},
Funding-Text = {This work was supported by funding (MD18518) from the CUHK-Exeter Joint
   Centre for Environmental Sustainability and Resilience (ENSURE) awarded
   to the whole team, Research Grants Council (RGC) General Research Fund
   (14323116) awarded to A.P.K.T., and RGC Area of Excellence Scheme
   (AoE/M-403/16) awarded to H.-M.L.},
Cited-References = {Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8.
   {[}Anonymous], 2002, CHINA HLTH NUTR SURV.
   {[}Anonymous], 2021, R PROJECT STAT COMPU.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Aunan K, 2018, CHINA QUART, V234, P279, DOI 10.1017/S0305741017001369.
   Bajzelj B, 2014, NAT CLIM CHANGE, V4, P924, DOI {[}10.1038/nclimate2353, 10.1038/NCLIMATE2353].
   Bauer SE, 2016, GEOPHYS RES LETT, V43, P5394, DOI 10.1002/2016GL068354.
   Bruinsma, 2012, 1203 ESA, DOI 10.22004/ag.econ.288998.
   Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115.
   Cai WJ, 2018, LANCET PLANET HEALTH, V2, pE151, DOI {[}10.1016/S2542-5196(18)30050-0, 10.1016/s2542-5196(18)30050-0].
   Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609.
   Chinese Nutrition Society, 2012, CHIN DIET GUID.
   Clark MA, 2019, P NATL ACAD SCI USA, V116, P23357, DOI 10.1073/pnas.1906908116.
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X.
   Domingo NGG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013637118.
   Du YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06381-0.
   FAOSTAT, 2017, FAO STAT DAT.
   Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452.
   Fung KM, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aafc8b.
   Geng GN, 2015, REMOTE SENS ENVIRON, V166, P262, DOI 10.1016/j.rse.2015.05.016.
   Godfray HCJ, 2018, SCIENCE, V361, DOI 10.1126/science.aam5324.
   Guo YX, 2020, NAT FOOD, V1, P648, DOI 10.1038/s43016-020-00162-z.
   Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention.
   Hasegawa T, 2019, NAT SUSTAIN, V2, P826, DOI 10.1038/s41893-019-0371-6.
   He P, 2018, NAT SUSTAIN, V1, P122, DOI 10.1038/s41893-018-0035-y.
   Huang GR, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab3c10.
   Lam HM, 2013, LANCET, V381, P2044, DOI 10.1016/S0140-6736(13)60776-X.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Liang XY, 2019, NAT SUSTAIN, V2, P962, DOI 10.1038/s41893-019-0398-8.
   Liu MX, 2019, P NATL ACAD SCI USA, V116, P7760, DOI 10.1073/pnas.1814880116.
   Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947.
   Nenes A, 2020, ATMOS CHEM PHYS, V20, P3249, DOI 10.5194/acp-20-3249-2020.
   Paulot F, 2014, J GEOPHYS RES-ATMOS, V119, P4343, DOI 10.1002/2013JD021130.
   Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216.
   Rosenzweig C, 2020, NAT FOOD, V1, P94, DOI 10.1038/s43016-020-0031-z.
   Schiferl LD, 2014, J GEOPHYS RES-ATMOS, V119, P1883, DOI 10.1002/2013JD020765.
   Shaddick G, 2018, ENVIRON SCI TECHNOL, V52, P9069, DOI 10.1021/acs.est.8b02864.
   Shaddick G, 2018, J R STAT SOC C-APPL, V67, P231, DOI 10.1111/rssc.12227.
   Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0.
   Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855.
   Stocker T. F, 2013, IPCC CLIMATE CHANGE.
   Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959.
   van Donkelaar A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006996.
   Vasilakos P, 2018, ATMOS CHEM PHYS, V18, P12765, DOI 10.5194/acp-18-12765-2018.
   WANG YF, 1984, HUM GENET, V67, P103.
   Weber RJ, 2016, NAT GEOSCI, V9, P282, DOI 10.1038/NGEO2665.
   Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4.
   Xu ZY, 2019, ATMOS CHEM PHYS, V19, P5605, DOI 10.5194/acp-19-5605-2019.
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1.
   Yang YX, 2000, CHINESE MED J-PEKING, V113, P1129.
   Yano C. R, 2000, MORAL FOODS, P262.
   Zhang L, 2018, ATMOS CHEM PHYS, V18, P339, DOI 10.5194/acp-18-339-2018.
   Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116.
   Zhou MG, 2019, LANCET, V394, P1145, DOI 10.1016/S0140-6736(19)30427-1.},
Number-of-Cited-References = {54},
Times-Cited = {1},
Usage-Count-Last-180-days = {62},
Usage-Count-Since-2013 = {62},
Journal-ISO = {Nat. Food},
Doc-Delivery-Number = {XQ1DL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000730890700011},
DA = {2022-03-29},
}

@article{ WOS:000388202600003,
Author = {Berenson, Gerald S. and Srinivasan, Sathanur R. and Xu, Ji Hua and Chen,
   Wei},
Title = {Adiposity and Cardiovascular Risk Factor Variables in Childhood Are
   Associated With Premature Death From Coronary Heart Disease in Adults:
   The Bogalusa Heart Study},
Journal = {AMERICAN JOURNAL OF THE MEDICAL SCIENCES},
Year = {2016},
Volume = {352},
Number = {5},
Pages = {448-454},
Month = {NOV},
Abstract = {Background: More than 600 deaths of all causes have been documented over
   the 40-year duration of the Bogalusa Heart Study. Of these, 97 deaths
   have been related to cardiovascular events, based on obituaries
   published in local newspapers, death certificates obtained from the
   State Health Department, information from the coroner and word of mouth
   by nursing staff from the community.
   Methods: This study was a retrospective longitudinal cohort with several
   observations of each subject. It consisted of 6 cross-sectional surveys
   of children aged 5-7 years, conducted between 1973 and 1988, and 4
   cross-sectional surveys of previously examined subjects as young adults
   extending into middle age, conducted between 1988 and 2010.
   Results: Excluding pulmonary, congenital and noncoronary cardiovascular
   diseases, 46 deaths (average age at death = 44.7 years, range: 31-55)
   were considered to have been related to coronary artery disease, that
   is, myocardial infarction. Cardiovascular risk factor observations,
   gathered from multiple surveys (average of 4.4 surveys, range: 1-14)
   since childhood, indicated that body fatness and elevated blood pressure
   beginning in childhood were more common in subjects who later died of
   coronary artery disease than in living subjects.
   Conclusions: The present findings emphasize that sub-clinical
   cardiovascular disease begins early in life and that early prevention is
   vital.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Berenson, GS (Corresponding Author), Tulane Univ, Hlth Sci Ctr, Ctr Cardiovasc Hlth, 1440 Canal St,Suite 1829, New Orleans, LA 70112 USA.
   Berenson, Gerald S.; Srinivasan, Sathanur R.; Xu, Ji Hua; Chen, Wei, Tulane Univ, Hlth Sci Ctr, Ctr Cardiovasc Hlth, Dept Epidemiol, New Orleans, LA 70118 USA.
   Berenson, Gerald S., Tulane Univ, Dept Med, Hlth Sci Ctr, Cardiol Sect, New Orleans, LA 70118 USA.},
DOI = {10.1016/j.amjms.2016.08.006},
ISSN = {0002-9629},
EISSN = {1538-2990},
Keywords = {Coronary artery disease; Atherosclerosis; Premature mortality},
Keywords-Plus = {YOUNG ADULTHOOD; ATHEROSCLEROSIS; OBESITY; MORTALITY; CHILDREN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {berenson@tulane.edu},
Funding-Acknowledgement = {National Institutes of Health, United StatesUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USA
   {[}NHLBI 15103, HL 3219, NIA 5R01AG16592, HL 38844, HD 32914]; American
   Heart Association, United StatesAmerican Heart Association
   {[}13SDG14650068]},
Funding-Text = {Supported by funds from the National Institutes of Health, United
   States, Grant numbers NHLBI 15103, HL 3219, NIA 5R01AG16592, HL 38844
   and HD 32914 and from the American Heart Association, United States,
   Grant number 13SDG14650068.},
Cited-References = {Bao WH, 1997, JAMA-J AM MED ASSOC, V278, P1749, DOI 10.1001/jama.278.21.1749.
   Berenson G, 1980, CHILDHOOD PREVENTION, P75.
   Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302.
   BERENSON GS, 1980, CARDIOVASCULAR RISK.
   BERENSON GS, 1986, CAUSATION CARDIOVASC, P1.
   Berenson GS, 2011, EVOLUTION CARDIOMETA.
   Cannon Christopher P, 2007, Clin Cornerstone, V8, P11, DOI 10.1016/S1098-3597(07)80025-1.
   Downey A M, 1989, Health Values, V13, P31.
   ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002.
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861.
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130.
   Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302.
   Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111.
   Haji SA, 2006, AM J CARDIOL, V98, P1234, DOI 10.1016/j.amjcard.2006.05.054.
   Hetzel BS, CARDIOVASCULAR RISK, P1.
   HOLMAN RL, 1958, AM J PATHOL, V34, P209.
   IBM Corp, IBM SPSS STAT WIND V.
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019.
   Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767.
   Lewis L., 1983, CRC HDB ELECTROPHORE, P185.
   McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95.
   Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6.
   Morrison JA, 2009, METABOLISM, V58, P1277, DOI 10.1016/j.metabol.2009.04.009.
   NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302.
   Nguyen QM, 2009, EUR J EPIDEMIOL, V24, P537, DOI 10.1007/s10654-009-9372-5.
   Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x.
   Radhakrishnamurthy B, 1986, CAUSATION CARDIOVASC, P131.
   Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277.
   Salz Inbal, 2013, J La State Med Soc, V165, P194.
   Srinivasan SR, 1999, METABOLISM, V48, P928, DOI 10.1016/S0026-0495(99)90231-7.
   STRONG JP, 1969, J ATHEROSCLER RES, V9, P251, DOI 10.1016/S0368-1319(69)80020-7.
   Urbina EM, 2011, EVOLUTION OF CARDIO-METABOLIC RISK FROM BIRTH TO MIDDLE AGE: THE BOGALUSA HEART STUDY, P99, DOI 10.1007/978-94-007-1451-9\_9.
   US Department of Health Education and Welfare (NIH), 1974, LIP RES CLIN PROGR M, V1, P75.
   Webber BJ, 2012, JAMA-J AM MED ASSOC, V308, P2577, DOI 10.1001/jama.2012.70830.
   Webber LS, 1986, CAUSATION CARDIOVASC, P42.},
Number-of-Cited-References = {35},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Am. J. Med. Sci.},
Doc-Delivery-Number = {EC5UO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000388202600003},
DA = {2022-03-29},
}

@article{ WOS:000333414700033,
Author = {Kong, Alice P. S. and Yang, Xilin and Luk, Andrea and Ma, Ronald C. W.
   and So, Wing Yee and Ozaki, Risa and Ting, Rose and Cheung, Kitty and
   Ho, Chung Shun and Chan, Michael H. M. and Chow, Chun Chung and Chan,
   Juliana C. N.},
Title = {Severe Hypoglycemia Identifies Vulnerable Patients With Type 2 Diabetes
   at Risk for Premature Death and All-Site Cancer: The Hong Kong Diabetes
   Registry},
Journal = {DIABETES CARE},
Year = {2014},
Volume = {37},
Number = {4},
Pages = {1024-1031},
Month = {APR},
Abstract = {OBJECTIVE
   We examined the associations of clinical profiles in type 2 diabetic
   patients who developed severe hypoglycemia and their clinical outcomes,
   including death and all-site cancer.
   RESEARCH DESIGN AND METHODS
   A consecutive cohort of 8,767 type 2 diabetic patients with and without
   severe hypoglycemia in the 12 months before enrollment were recruited
   between 1995 and 2007, with follow-up until 2009. Severe hypoglycemia
   was defined by ICD-9 codes as hospitalizations resulting from
   hypoglycemia. Cox proportional hazards regression was used to calculate
   the hazard ratio (HR) and 95\% CIs of clinical factors collected at
   enrollment for severe hypoglycemia.
   RESULTS
   In this cohort, mean age was 57.4 (SD 13.2) years and median disease
   duration of diabetes was 5 (interquartile range {[}IQR] 1-11) years.
   During a median follow-up of 6.71 (IQR 3.47-10.38) years, 235 patients
   had severe hypoglycemia (incidence 3.96 {[}95\% CI 3.45-4.46] per 1,000
   patient-years). At enrollment, patients with and without severe
   hypoglycemia had similar cancer rates. During follow-up, patients with
   severe hypoglycemia had a higher incidence of all-site cancer (13.4 vs.
   6.4\%, P < 0.0001) and mortality (32.8 vs. 11.2\%, P < 0.0001) than
   those without severe hypoglycemia. After adjusting for confounders, old
   age, low BMI, high glycated hemoglobin, low triglyceride (TG), low LDL
   cholesterol (LDL-C), albuminuria, and chronic kidney disease were
   independent predictors for severe hypoglycemia.
   CONCLUSIONS
   In type 2 diabetes, severe hypoglycemia is associated with advanced age,
   renal dysfunction, poor glycemic control, and cancer subphenotypes (low
   BMI, low LDL-C, and low TG).},
Publisher = {AMER DIABETES ASSOC},
Address = {1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA},
Type = {Article},
Language = {English},
Affiliation = {Kong, APS (Corresponding Author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med \& Therapeut, Hong Kong, Hong Kong, Peoples R China.
   Kong, Alice P. S.; Yang, Xilin; Luk, Andrea; Ma, Ronald C. W.; So, Wing Yee; Ozaki, Risa; Ting, Rose; Cheung, Kitty; Chow, Chun Chung; Chan, Juliana C. N., Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med \& Therapeut, Hong Kong, Hong Kong, Peoples R China.
   Yang, Xilin, Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Tianjin, Peoples R China.
   Luk, Andrea; Chan, Juliana C. N., Chinese Univ Hong Kong, Prince Wales Hosp, Asia Diabet Fdn, Hong Kong, Hong Kong, Peoples R China.
   Ho, Chung Shun; Chan, Michael H. M., Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.
   Chan, Juliana C. N., Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China.
   Chan, Juliana C. N., Chinese Univ Hong Kong, Hong Kong Inst Diabet \& Obes, Prince Wales Hosp, Hong Kong, Peoples R China.},
DOI = {10.2337/dc13-2507},
ISSN = {0149-5992},
EISSN = {1935-5548},
Keywords-Plus = {CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; CHINESE PATIENTS; CAUSE
   MORTALITY; ASSOCIATIONS; MELLITUS; MANAGEMENT; HYPERGLYCEMIA; ACCURACY;
   OUTCOMES},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {alicekong@cuhk.edu.hk},
ResearcherID-Numbers = {Kong, Alice/P-3703-2015
   Luk, Andrea/B-5766-2016
   Chan, Juliana/B-7918-2016
   Ma, Ronald/C-2788-2009
   },
ORCID-Numbers = {Kong, Alice/0000-0001-8927-6764
   Chan, Juliana/0000-0003-1325-1194
   Ma, Ronald/0000-0002-1227-803X
   Chan, Michael/0000-0003-1949-1666},
Funding-Acknowledgement = {Li Ka Shing Institute of Health Science and Hong Kong Foundation for
   Research and Development in Diabetes under Chinese University of Hong
   Kong},
Funding-Text = {This study was supported by the Li Ka Shing Institute of Health Science
   and Hong Kong Foundation for Research and Development in Diabetes under
   the auspices of The Chinese University of Hong Kong.},
Cited-References = {Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9.
   Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909.
   Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485.
   Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082.
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743.
   Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858.
   Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533.
   Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413.
   Katon WJ, 2013, ANN FAM MED, V11, P245, DOI 10.1370/afm.1501.
   Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013.
   Kong APS, 2007, DIABETES CARE, V30, P953, DOI 10.2337/dc06-2443.
   Kong APS, 2012, CURR DIABETES REP, V12, P325, DOI 10.1007/s11892-012-0277-4.
   LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177.
   Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368.
   Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209.
   Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8.
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891.
   PIWERNETZ K, 1993, DIABETIC MED, V10, P371, DOI 10.1111/j.1464-5491.1993.tb00083.x.
   Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092.
   Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862.
   So WY, 2008, DIABETES-METAB RES, V24, P238, DOI 10.1002/dmrr.792.
   So WY, 2002, DIABETIC MED, V19, P966, DOI 10.1046/j.1464-5491.2002.00807\_1.x.
   Stengel B, 2010, J NEPHROL, V23, P253.
   Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865.
   Yang XL, 2012, DIABETES OBES METAB, V14, P579, DOI 10.1111/j.1463-1326.2011.01551.x.
   Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474.
   Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451.
   Yang XL, 2008, ENDOCR-RELAT CANCER, V15, P597, DOI 10.1677/ERC-07-0266.
   Yang XL, 2013, ENDOCR-RELAT CANCER, V20, P161, DOI 10.1530/ERC-12-0290.
   Yang XL, 2012, ACTA DIABETOL, V49, pS185, DOI 10.1007/s00592-012-0409-y.
   Yang XL, 2012, DIABETES-METAB RES, V28, P379, DOI 10.1002/dmrr.2287.
   Yang XL, 2011, CANCER-AM CANCER SOC, V117, P862, DOI 10.1002/cncr.25455.
   Yang XL, 2011, DIABETES CARE, V34, P375, DOI 10.2337/dc10-1509.
   Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371.
   Yang XL, 2009, DIABETES CARE, V32, P1826, DOI 10.2337/dc09-0725.
   Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795.},
Number-of-Cited-References = {36},
Times-Cited = {47},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Diabetes Care},
Doc-Delivery-Number = {AD7BB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000333414700033},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000432591100002,
Author = {Henning, Oliver and Nakken, Karl O. and Lossius, Morten I.},
Title = {People with epilepsy and their relatives want more information about
   risks of injuries and premature death},
Journal = {EPILEPSY \& BEHAVIOR},
Year = {2018},
Volume = {82},
Pages = {6-10},
Month = {MAY},
Abstract = {For most people with chronic diseases such as epilepsy, thorough
   knowledge of the disease is important in order to reduce feelings of
   insecurity and to enable better management of everyday life. Whether and
   when to inform patients and their families about all the risks
   associated with epilepsy is a matter of controversy.
   Using a web-based survey, patients with epilepsy (PWE) (n = 1183) and
   carers, family members, or guardians of PWE, who could either answer on
   behalf of the patients (CBP) (n = 676) or on their own behalf (CAR) (n =
   231) were asked whether they wanted information about the risk of
   epilepsy-related injuries and premature death and also whether they had
   received such information.
   Ninety percent or more of PWE, COP, and CAR reported that they wanted
   such information, and 50\% of CAR, 81\% of CBP, and 70\% of PWE had
   received some information about seizure-related injuries. Regarding risk
   of unexpected death, 31\% of PWE, 35\% of CBP, and 28\% of CAR had
   received information on this issue. Those with tonic-clonic seizures
   were most eager to obtain information on these matters, and those best
   informed about epilepsy-related risks were males and the youngest part
   of the cohort. The wish for more information or the likelihood of having
   already received information was independent of the individual's seizure
   situation.
   This study demonstrates that there is a considerable gap between what
   the patients want regarding information and what they are actually given
   by healthcare providers. (C) 2018 Elsevier Inc. All rights reserved.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Henning, O (Corresponding Author), Oslo Univ Hosp, Div Clin Neurosci, Natl Ctr Epilepsy, POB 4950, N-0424 Oslo, Norway.
   Henning, Oliver; Nakken, Karl O.; Lossius, Morten I., Oslo Univ Hosp, Div Clin Neurosci, Natl Ctr Epilepsy, POB 4950, N-0424 Oslo, Norway.},
DOI = {10.1016/j.yebeh.2018.02.023},
ISSN = {1525-5050},
EISSN = {1525-5069},
Keywords = {Epilepsy; Death; SUDEP; Injury; Information},
Keywords-Plus = {SUDDEN UNEXPECTED DEATH; SUDEP; TELL},
Research-Areas = {Behavioral Sciences; Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Behavioral Sciences; Clinical Neurology; Psychiatry},
Author-Email = {oliver.henning@ous-hf.no},
Cited-References = {Brodie MJ, 2008, EPILEPSIA, V49, P99, DOI 10.1111/j.1528-1167.2008.01933.x.
   Chen HF, 2010, EPILEPSY BEHAV, V19, P43, DOI 10.1016/j.yebeh.2010.06.007.
   Duncan S, 2011, EPILEPSY BEHAV, V21, P344, DOI 10.1016/j.yebeh.2011.04.056.
   Excellence NIoC, 2013, EP DIAGN MAN.
   Galli F, 2017, EPILEPSY BEHAV, V67, P33, DOI 10.1016/j.yebeh.2016.12.001.
   Keddie S, 2016, JRSM Open, V7, p2054270416654358, DOI 10.1177/2054270416654358.
   Kroner BL, 2014, EPILEPSIA, V55, P1486, DOI 10.1111/epi.12799.
   Mclean Brendan, 2017, Pract Neurol, V17, P13, DOI 10.1136/practneurol-2016-001392.
   Morton B, 2006, J NEUROL NEUROSUR PS, V77, P199, DOI 10.1136/jnnp.2005.066852.
   RamachandranNair R, 2016, EPILEPSY BEHAV, V64, P195, DOI 10.1016/j.yebeh.2016.09.022.
   RamachandranNair R, 2013, EPILEPSY BEHAV, V29, P560, DOI 10.1016/j.yebeh.2013.09.040.
   Shankar R, 2017, EPILEPTIC DISORD, V19, P1, DOI 10.1684/epd.2017.0891.
   Tomson T, 2016, EPILEPSIA, V57, P4, DOI 10.1111/epi.13234.
   Xu ZY, 2015, EPILEPSY BEHAV, V42, P29, DOI 10.1016/j.yebeh.2014.11.007.},
Number-of-Cited-References = {14},
Times-Cited = {17},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Epilepsy Behav.},
Doc-Delivery-Number = {GG3KQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000432591100002},
DA = {2022-03-29},
}

@article{ WOS:000226614400016,
Author = {McCarty, JH and Lacy-Hulbert, A and Charest, A and Bronson, RT and
   Crowley, D and Housman, D and Savill, J and Roes, J and Hynes, RO},
Title = {Selective ablation of alpha v integrins in the central nervous system
   leads to cerebral hemorrhage, seizures, axonal degeneration and
   premature death},
Journal = {DEVELOPMENT},
Year = {2005},
Volume = {132},
Number = {1},
Pages = {165-176},
Month = {JAN},
Abstract = {Mouse embryos genetically null for all alphav integrins develop
   intracerebral hemorrhage owing to defective interactions between blood
   vessels and brain parenchymal cells. Here, we have used conditional
   knockout technology to address whether the cerebral hemorrhage is due to
   primary defects in vascular or neural cell types. We show that ablating
   av expression in the vascular endothelium has no detectable effect on
   cerebral blood vessel development, whereas deletion of alphav expression
   in central nervous system glial cells leads to embryonic and neonatal
   cerebral hemorrhage. Conditional deletion of alphav integrin in both
   central nervous system glia and neurons also leads to cerebral
   hemorrhage, but additionally to severe neurological defects.
   Approximately 30\% of these mutants develop seizures and die by 4 weeks
   of age. The remaining mutants survive for several months, but develop
   axonal deterioration in the spinal cord and cerebellum. leading to
   ataxia and loss of hindlimb coordination. Collectively these data
   provide evidence that alphav integrins on embryonic central nervous
   system neural cells, particularly glia, are necessary for proper
   cerebral blood vessel development. and also reveal a novel function for
   alphav integrins expressed on axons in the postnatal central nervous
   system.},
Publisher = {COMPANY BIOLOGISTS LTD},
Address = {BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hynes, RO (Corresponding Author), Howard Hughes Med Inst, Boston, MA 02115 USA.
   MIT, Ctr Canc Res, Cambridge, MA 02139 USA.
   MRC, Edinburgh EH8 9AG, Midlothian, Scotland.
   Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   UCL, Windeyer Inst Med Sci, London W1T 4JF, England.},
DOI = {10.1242/dev.01551},
ISSN = {0950-1991},
EISSN = {1477-9129},
Keywords = {cerebral hemorrhage; spastic paraparesis; ataxia; mouse},
Keywords-Plus = {ASTROCYTE DIFFERENTIATION; VASCULAR MORPHOGENESIS; ENDOTHELIAL-CELLS;
   TRANSGENIC MICE; BLOOD-VESSELS; ALPHA-V-BETA-8; GENE; INACTIVATION;
   ANGIOGENESIS; MIGRATION},
Research-Areas = {Developmental Biology},
Web-of-Science-Categories  = {Developmental Biology},
Author-Email = {rohynes@mit.edu},
ORCID-Numbers = {Roes, Jurgen/0000-0003-3235-2345
   Lacy-Hulbert, Adam/0000-0003-2162-0156},
Funding-Acknowledgement = {NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung \& Blood Institute (NHLBI) {[}P01HL066105] Funding
   Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung \& Blood Institute (NHLBI) {[}P01 HL66105-03] Funding Source:
   Medline},
Cited-References = {Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460.
   Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0.
   Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2.
   Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9.
   Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002.
   Bosco G, 2003, CEREBELLUM, V2, P162, DOI 10.1080/14734220310016105.
   BOSSY B, 1990, BIOCHEMISTRY-US, V29, P10191, DOI 10.1021/bi00496a006.
   Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021.
   Gerety SS, 2002, DEVELOPMENT, V129, P1397.
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9.
   Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499.
   Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7.
   HARLOWE E, 1999, USING ANTIBODIES LAB, P437.
   HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203.
   Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921.
   Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106.
   Kobayashi H, 1996, J NEUROL SCI, V137, P131, DOI 10.1016/0022-510X(95)00349-7.
   Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815.
   Liao Y, 2001, P NATL ACAD SCI USA, V98, P9989, DOI 10.1073/pnas.171305298.
   Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5.
   Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8.
   Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103.
   Marino S, 2000, GENE DEV, V14, P994.
   McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002.
   McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150.
   Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001.
   Milner R, 1999, J CELL SCI, V112, P4271.
   Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100.
   NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708.
   Nishimura SL, 1998, BRAIN RES, V791, P271, DOI 10.1016/S0006-8993(98)00118-8.
   Ozduman K, 2004, PEDIATR NEUROL, V30, P151, DOI 10.1016/j.pediatrneurol.2003.08.004.
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3.
   Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790.
   Silverberg GD, 2004, BRAIN, V127, P947, DOI 10.1093/brain/awh178.
   Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a.
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007.
   Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002.
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703.
   VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419.
   Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7.
   Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3.
   Zhu JW, 2002, DEVELOPMENT, V129, P2891.
   Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008.
   Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813.},
Number-of-Cited-References = {44},
Times-Cited = {168},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Development},
Doc-Delivery-Number = {891XN},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000226614400016},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000627409700030,
Author = {Yamada, Hiroya and Suzuki, Koji and Fujii, Ryosuke and Kawado, Miyuki
   and Hashimoto, Shuji and Watanabe, Yoshiyuki and Iso, Hiroyasu and
   Fujino, Yoshihisa and Wakai, Kenji and Tamakoshi, Akiko},
Title = {Circulating miR-21, miR-29a, and miR-126 are associated with premature
   death risk due to cancer and cardiovascular disease: the JACC Study},
Journal = {SCIENTIFIC REPORTS},
Year = {2021},
Volume = {11},
Number = {1},
Month = {MAR 5},
Abstract = {Primary prevention of premature death is a public health concern
   worldwide. Circulating microRNAs (miRNAs) have been described as
   potential diagnostic biomarkers for diseases as cancer and
   cardiovascular disease (CVD). This case-cohort study aimed to
   investigate the potential relationship between circulating miRNAs and
   the risk of premature death. A total of 39,242 subjects provided
   baseline serum samples in 1988-1990. Of these, 345 subjects who died of
   intrinsic disease (<65 years old) and for which measurable samples were
   available were included in this study. We randomly selected a sub-cohort
   of 879 subjects. Circulatring miR-21, miR-29a, and miR-126 were
   determined using qRT-PCR. Conditional logistic regression models were
   used to analyse the data with respect to stratified miRNA levels.
   Multivariable logistic regression revealed that subjects with high
   circulating miR-21 and miR-29a individual levels had a significantly
   higher risk of total death, cancer death, and CVD death than those with
   medium miR-21 and miR-29a individual levels. Conversely, subjects with
   low circulating miR-126 levels had a significantly higher risk of total
   death than those with medium levels. This suggests that circulating
   miRNAs are associated with the risk of premature death from cancer and
   CVD, identifying them as potential biomarkers for early detection of
   high-risk individuals.},
Publisher = {NATURE RESEARCH},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Yamada, H (Corresponding Author), Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Kutsukake Cho, Toyoake, Aichi 4701192, Japan.
   Yamada, Hiroya; Kawado, Miyuki; Hashimoto, Shuji, Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Kutsukake Cho, Toyoake, Aichi 4701192, Japan.
   Suzuki, Koji; Fujii, Ryosuke, Fujita Hlth Univ, Sch Hlth Sci, Dept Prevent Med Sci, Toyoake, Aichi, Japan.
   Watanabe, Yoshiyuki, Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Epidemiol Community Hlth \& Med, Kyoto, Japan.
   Iso, Hiroyasu, Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Osaka, Japan.
   Fujino, Yoshihisa, Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan.
   Wakai, Kenji, Nagoya Univ, Dept Prevent Med, Grad Sch Med, Nagoya, Aichi, Japan.
   Tamakoshi, Akiko, Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Sapporo, Hokkaido, Japan.},
DOI = {10.1038/s41598-021-84707-7},
Article-Number = {5298},
ISSN = {2045-2322},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {hyamada@fujita-hu.ac.jp},
Funding-Acknowledgement = {Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT)Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); MEXTMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) {[}61010076, 62010074, 63010074, 1010068,
   2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022,
   18014011, 20014026, 20390156, 26293138, 16H06277]},
Funding-Text = {The JACC Study has been supported by Grants-in-Aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (MEXT); Grants-in-Aid for Scientific Research on
   Priority Areas of Cancer; Grants-in-Aid for Scientific Research on
   Priority Areas of Cancer Epidemiology from MEXT (Nos. 61010076,
   62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069,
   6279102, 11181101, 17015022, 18014011, 20014026, 20390156, 26293138 and
   16H06277).},
Cited-References = {Alizadeh M, 2019, J CELL PHYSIOL, V234, P19280, DOI 10.1002/jcp.28607.
   Ando Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55076-z.
   Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030.
   Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6.
   Cho HJ, 2017, CLIN RES HEPATOL GAS, V41, P181, DOI 10.1016/j.clinre.2016.09.011.
   Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452.
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021.
   Dufresne S, 2018, CANCER EPIDEM BIOMAR, V27, P11, DOI 10.1158/1055-9965.EPI-16-0969.
   Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308.
   Ferraro A, 2014, EPIGENETICS-US, V9, P129, DOI 10.4161/epi.26842.
   Fujii R, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1651-0.
   Fujii R, 2020, J EPIDEMIOL, V30, P177, DOI 10.2188/jea.JE20180233.
   Grimolizzi F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15475-6.
   Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105.
   He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190.
   Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062.
   Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112.
   Iso H, 2005, AM J EPIDEMIOL, V161, P170, DOI 10.1093/aje/kwi027.
   Jansen F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001249.
   Japanese Ministry of Education Culture Sports Science and Technology \& Ministry of Health Labor and Welfare, 2016, ETHICAL GUIDELINES M.
   Jiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05026.
   Jimenez-Lucena R, 2018, MOL THER-NUCL ACIDS, V12, P146, DOI 10.1016/j.omtn.2018.05.002.
   Jin FQ, 2018, NEUROL SCI, V39, P1757, DOI 10.1007/s10072-018-3499-7.
   Khalighfard S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36321-3.
   Khanaghaei M, 2016, HEART INT, V11, pE1, DOI 10.5301/heartint.5000226.
   Kikuchi N, 2017, SCI REP-UK, V7, DOI 10.1038/srep40363.
   Lin XJ, 2015, LANCET ONCOL, V16, P804, DOI 10.1016/S1470-2045(15)00048-0.
   Lyu GL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04994-z.
   Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319.
   Muller DC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0630-6.
   Munetsuna E, 2018, ANN CLIN BIOCHEM, V55, P437, DOI 10.1177/0004563217735124.
   Nakayama T, 2005, J EPIDEMIOL, V15, P107, DOI 10.2188/jea.15.107.
   Noda H, 2005, J AM COLL CARDIOL, V46, P1761, DOI 10.1016/j.jacc.2005.07.038.
   Pfeffer SR, 2015, DRUG DEVELOP RES, V76, P270, DOI 10.1002/ddr.21257.
   Pham TM, 2007, EUR J CANCER, V43, P1611, DOI 10.1016/j.ejca.2007.04.014.
   Pham TM, 2010, CANCER EPIDEMIOL, V34, P279, DOI 10.1016/j.canep.2010.03.017.
   R Core Team, 2019, LANG ENV STAT COMP R, DOI DOI 11/44679/INDEX.HTM.
   Rasky E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2502-y.
   Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720.
   Shan LQ, 2015, CANCER BIOMARK, V15, P47, DOI 10.3233/CBM-140437.
   Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019.
   Shiels MS, 2017, LANCET, V389, P1043, DOI {[}10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3].
   Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7.
   Tamakoshi A, 2004, J EPIDEMIOL, V14, P177, DOI 10.2188/jea.14.177.
   Tamakoshi A, 2013, J EPIDEMIOL, V23, P227, DOI 10.2188/jea.JE20120161.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   Watanabe Y, 2016, EBIOMEDICINE, V12, P68, DOI 10.1016/j.ebiom.2016.09.001.
   Willeit P, 2017, DIABETES, V66, P347, DOI 10.2337/db16-0731.
   Wu JH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/435656.
   Yamada A, 2015, CLIN CANCER RES, V21, P4234, DOI 10.1158/1078-0432.CCR-14-2793.
   Yamada H, 2015, CLIN CHIM ACTA, V446, P267, DOI 10.1016/j.cca.2015.05.002.
   Yamada H, 2014, J EPIDEMIOL, V24, P370, DOI 10.2188/jea.JE20130168.
   Yamada H, 2014, CLIN ENDOCRINOL, V81, P276, DOI 10.1111/cen.12432.
   Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021.
   Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056.
   Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357.
   Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3.
   Zhang L, 2017, ANN ONCOL, V28, P1124, DOI 10.1093/annonc/mdx046.
   Zhang T, 2015, BIOCHEM BIOPH RES CO, V463, P60, DOI 10.1016/j.bbrc.2015.05.017.},
Number-of-Cited-References = {59},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {QU6RY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000627409700030},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000726755300001,
Author = {Zhang, Ji and Jin, Yinzi and Jia, Peng and Li, Na and Zheng, Zhi-Jie},
Title = {Global Gender Disparities in Premature Death from Cardiovascular
   Disease, and Their Associations with Country Capacity for
   Noncommunicable Disease Prevention and Control},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2021},
Volume = {18},
Number = {19},
Month = {OCT},
Abstract = {This study aimed to describe the prevalence of gender disparity in
   cardiovascular disease and explore its association with a country's
   capacity for controlling noncommunicable diseases. Study data were
   extracted from the Global Health Estimates, and the Noncommunicable
   Disease Country Capacity Survey. Age-standardized premature death rates
   from cardiovascular disease, defined as any death occurring from ages 30
   to 70 years, were calculated. Univariate and multivariate general linear
   regression models were fitted to estimate the correlations between
   gender disparity and country capacity for noncommunicable disease
   control. Globally, the premature death rate from cardiovascular diseases
   was 35.6\% higher among men than women in 2000, and the figure hardly
   changed from 2000 to 2016. The highest gender differences were observed
   in Europe and high-income countries. The existence of dedicated and
   multisectoral noncommunicable disease governance bodies and the
   availability of cardiovascular disease stratification in primary
   healthcare facilities were positively correlated with gender
   differences. Conclusively, gender disparities in premature death rates
   from cardiovascular diseases differed with economic conditions and
   across geographic regions, with higher relative differences observed in
   more developed countries. The effects of existing control measures may
   have plateaued in men but are ongoing among women, especially in more
   developed countries, widening the gender disparity.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Zheng, ZJ (Corresponding Author), Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing 100191, Peoples R China.
   Zheng, ZJ (Corresponding Author), Peking Univ, Inst Global Hlth \& Dev, Beijing 100871, Peoples R China.
   Zhang, Ji; Jin, Yinzi; Li, Na; Zheng, Zhi-Jie, Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing 100191, Peoples R China.
   Zhang, Ji; Jin, Yinzi; Li, Na; Zheng, Zhi-Jie, Peking Univ, Inst Global Hlth \& Dev, Beijing 100871, Peoples R China.
   Jia, Peng, Wuhan Univ, Sch Resources \& Environm Sci, Wuhan 430072, Hubei, Peoples R China.
   Jia, Peng, Wuhan Univ, Int Inst Spatial Lifecourse Epidmiol, Wuhan 430072, Hubei, Peoples R China.},
DOI = {10.3390/ijerph181910389},
Article-Number = {10389},
EISSN = {1660-4601},
Keywords = {cardiovascular disease; premature death; gender disparity;
   noncommunicable disease control},
Keywords-Plus = {CORONARY-HEART-DISEASE; RISK-FACTORS; HEALTH; WOMEN; MORTALITY;
   EPIDEMIOLOGY; TRENDS; MEN},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {jizhang@bjmu.edu.cn
   yzjin@bjmu.edu.cn
   jiapengff@hotmail.com
   lina2021@bjmu.edu.cn
   zhengzj@bjmu.edu.cn},
ResearcherID-Numbers = {Jia, Peng/K-1446-2017},
ORCID-Numbers = {Jin, Yinzi/0000-0003-0634-3955
   Jia, Peng/0000-0003-0110-3637},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}71904004]; Beijing Natural Science
   FoundationBeijing Natural Science Foundation {[}9204025]},
Funding-Text = {FundingThis research was supported by the National Natural Science
   Foundation of China (No. 71904004) and the Beijing Natural Science
   Foundation (No. 9204025). The study sponsor had no role in the study
   design, data analysis and interpretation of data, the writing of the
   manuscript, or the decision to submit the paper for publication.},
Cited-References = {Ahmad OB, 2001, AGE STANDARDIZATION.
   {[}Anonymous], 2018, LANCET, V392, P1789, DOI {[}10.1016/S0140-6736(18)32279-7, DOI 10.1016/S0140-6736(18)32279-7].
   Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516.
   Chow CK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013817.
   Clemens KK, 2020, DIABETES CARE, V43, P1157, DOI 10.2337/dc19-2257.
   De Smedt D, 2016, INT J CARDIOL, V209, P284, DOI 10.1016/j.ijcard.2016.02.015.
   Domanski MJ, 2006, EUR HEART J, V27, P1416, DOI 10.1093/eurheartj/ehl022.
   Dorbala S, 2016, J NUCL CARDIOL, V23, P973, DOI 10.1007/s12350-016-0604-2.
   Dugani S, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-015-0679-4.
   Gheorghe A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5806-x.
   Gulati M, 2017, CIRCULATION, V135, P495, DOI 10.1161/CIRCULATIONAHA.116.025303.
   Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C.
   Hyun KK, 2017, HEART, V103, P500, DOI 10.1136/heartjnl-2016-310216.
   Joseph P, 2017, CIRC RES, V121, P677, DOI 10.1161/CIRCRESAHA.117.308903.
   Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4.
   Kontis V, 2015, LANCET GLOB HEALTH, V3, pE746, DOI 10.1016/S2214-109X(15)00179-5.
   Leal MTBC, 2019, REV SOC BRAS MED TRO, V52, DOI {[}DOI 10.1590/0037-8682-0041-2019, 10.1590/0037-8682-0041-2019].
   Lencucha R, 2018, HEALTH POLICY PLANN, V33, P420, DOI 10.1093/heapol/czy005.
   Lopez AD, 2019, INT J EPIDEMIOL, V48, P1815, DOI 10.1093/ije/dyz143.
   Martinez-Lacoba R, 2018, EUR J PUBLIC HEALTH, V28, P955, DOI 10.1093/eurpub/cky113.
   Montagnese C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061325.
   Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI {[}10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8].
   National Center for Cardiovascular Diseases China, 2019, REPORT CARDIOVASCULA.
   Ni H, 2009, AM HEART J, V157, P46, DOI 10.1016/j.ahj.2008.08.016.
   Pearson-Stuttard J, 2016, CIRCULATION, V133, P967, DOI 10.1161/CIRCULATIONAHA.115.019904.
   Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971.
   Prescott E, 1998, BMJ-BRIT MED J, V316, P1043.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7.
   Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720.
   Saliba M, 2010, WOMEN HEALTH ISS, V20, P171, DOI 10.1016/j.whi.2010.01.001.
   Sliwa K, 2014, CLIN RES CARDIOL, V103, P515, DOI 10.1007/s00392-014-0660-z.
   Stahl T, 2018, SCAND J PUBLIC HEALT, V46, P38, DOI 10.1177/1403494817743895.
   Tzoulaki I, 2016, CIRCULATION, V133, P2314, DOI 10.1161/CIRCULATIONAHA.115.008718.
   Vogel B, 2021, LANCET, V397, P2385, DOI 10.1016/S0140-6736(21)00684-X.
   WHO, 2018, WHO METH DAT SOURC C.
   WHO, 2013, NIN VOL GLOB TARG 25.
   World Health Organization, GLOB HLTH OBS DAT RE.
   World Health Organization, ASS NAT CAP PREV CON.
   World Health Organization (WHO), 2007, EV BUS STRENGTH HLTH.},
Number-of-Cited-References = {39},
Times-Cited = {0},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {XJ4JB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000726755300001},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1987J126200008,
Author = {GREEN, ST and GREEN, FAM},
Title = {THE GREAT COMPOSERS - THEIR PREMATURE DEATHS},
Journal = {JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON},
Year = {1987},
Volume = {21},
Number = {3},
Pages = {202-205},
Month = {JUL},
Publisher = {ROY COLL PHYS LONDON EDITORIAL OFFICE},
Address = {11 ST ANDREWS PLACE REGENTS PARK, LONDON, ENGLAND NW1 4LE},
Type = {Article},
Language = {English},
Affiliation = {UNIV GLASGOW,STOBHILL GEN HOSP,DEPT MAT MED,GLASGOW G21 3UW,SCOTLAND.},
ISSN = {0035-8819},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {BROWN DAVID, 1986, NEW GROVE RUSSIAN MA, V1.
   BROWN MEJ, 1982, NEW GROVE SCHUBERT.
   BROWN MJE, 1980, NEW GROVE SCHUBERT.
   BUTTERWORTH N, 1980, DVORAK HIS LIFE TIME.
   CALVOCORESSI MD, 1974, MASTER MUSICIANS MUS.
   DAVIES PJ, 1983, J ROY SOC MED, V76, P776, DOI 10.1177/014107688307600914.
   DEAN W, 1977, MASTER MUSICIANS BIZ.
   DOWN T, 1982, ILLUSTRATED LIVES GR.
   GARDNER E, 1973, MASTER MUSICIANS TSC.
   GRAMOND P, 1980, ILLUSTRATED GUIDE CO.
   Greene DM, 1986, GREENES BIOGRAPHICAL.
   HUGHES G, 1964, 50 FAMOUS COMPOSERS.
   IMRIE CW, 1984, EMERGENCIES MED, P113.
   KENNEDY M, 1981, MASTER MUSICIANS BRI.
   LAMPERT V, 1984, NEW GROVE MODERN MAS.
   LARKIN E, 1985, BEETHOVEN LAST DECAD.
   MAREK G, 1985, SCHUBERT BIOGRAPHY.
   MCDONALD H, 1982, MASTER MUSICIANS BER.
   MILNE H, 1982, ILLUSTRATED LIVES GR.
   MOSSHANSK N, 1982, ILLUSTRATED LIVES GR.
   NAIWEN US, 1971, ANN INTERNAL MED, V74, P995.
   NICHOLS R, 1977, MASTER MUSICIANS RAV.
   SADRE S, 1985, CAMBRIDGE MUSIC GUID.
   SCHOENTAL R, 1983, J ROY SOC MED, V76, P1079.
   Schonberg Harold C., 1980, LIVES GREAT COMPOSER.
   SCHONBERG HC, 1982, LIVES GREAT COMPOSER.
   SCHWARTZ C, 1979, GERSHWIN HIS LIFE MU.
   Schwartz Charles, 1973, GERSHWIN HIS LIFE MU.
   SITWELL S, 1934, LISZT.
   WARNACK J, 1985, NEW GROVE EARLY ROMA.},
Number-of-Cited-References = {30},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. R. Coll. Physicians Lond.},
Doc-Delivery-Number = {J1262},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:A1987J126200008},
DA = {2022-03-29},
}

@article{ WOS:000071964800003,
Author = {Galgali, G and Beaglehole, R and Scragg, R and Tobias, M},
Title = {Potential for prevention of premature death and disease in New Zealand},
Journal = {NEW ZEALAND MEDICAL JOURNAL},
Year = {1998},
Volume = {111},
Number = {1058},
Pages = {7-10},
Month = {JAN 23},
Abstract = {Aim. To assess the potential for preventing major causes of premature
   death, disease and injury in New Zealand.
   Methods, Population attributable risks for major modifiable risk factors
   for important causes of death and disease in New Zealand were calculated
   using available national and international data on the relative risk of
   disease and the prevalence of risk factors in the relevant New Zealand
   population. Attainable changes in risk factor prevalences were used to
   model population attributable risks over the next five years. These
   estimates were then used to estimate potential reductions in absolute
   numbers of deaths from major diseases.
   Results, High population attributable risks were found for several
   disease/risk factor combinations: smoking and lung cancer (81\% in
   Maori), smoking and coronary heart disease (44\% in Maori), smoking and
   sudden infant death syndrome (49\% in Maori); raised serum cholesterol
   and coronary heart disease (58\%); physical inactivity and coronary
   heart disease (35\%), physical inactivity and diabetes (30\%), physical
   inactivity and colorectal cancer (33\%), physical inactivity and
   fractured neck of femur (65\%); obesity and hypertension (66\%), obesity
   and diabetes (46\%); lack of fruits and vegetables and stomach cancer
   (46\%), and colorectal cancer (34\%). The estimated, readily attainable
   reduction in absolute numbers of annual deaths due to decrease in risk
   factor prevalence was greatest for smoking (457 deaths), followed by
   hypertension (326), physical inactivity (303) and raised serum
   cholesterol (142).
   Conclusion. There is significant scope for reducing mortality from major
   non-communicable diseases although for some diseases such as the
   cancers, there will be a time lag of many years before the full benefits
   are realised. Together, reducing the prevalence of smoking,
   hypertension, physical inactivity and raised serum cholesterol would
   result in 1228 fewer deaths per year.},
Publisher = {NEW ZEALAND MED ASSN},
Address = {PO BOX 156, WELLINGTON, NEW ZEALAND},
Type = {Article},
Language = {English},
Affiliation = {Galgali, G (Corresponding Author), Univ Auckland, Sch Med, Dept Community Hlth, Private Bag 92019, Auckland, New Zealand.
   Auckland Sch Med, Dept Community Hlth, Auckland, New Zealand.
   Minist Hlth, Wellington, New Zealand.},
ISSN = {0028-8446},
Keywords-Plus = {CORONARY HEART-DISEASE; RISK-FACTORS; SMOKING; MORTALITY; CANCER;
   STROKE; ALCOHOL; RANGE; WOMEN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ORCID-Numbers = {Scragg, Robert/0000-0003-0013-2620},
Cited-References = {BEAGLEHOLE R, 1985, NEW ZEAL MED J, V98, P131.
   BEAGLEHOLE R, 1988, NEW ZEAL MED J, V101, P480.
   BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704.
   BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201.
   BONITA R, 1986, BRIT MED J, V293, P5.
   BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106.
   CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202.
   GORELICK PB, 1994, STROKE, V25, P220, DOI 10.1161/01.STR.25.1.220.
   Holman C. D. J., 1990, QUANTIFICATION DRUG.
   JACKSON R, 1995, NEW ZEAL MED J, V108, P451.
   KANNEL WB, 1995, AM J CARDIOL, V76, pC69, DOI 10.1016/S0002-9149(99)80474-3.
   KAWACHI I, 1989, NEW ZEAL MED J, V102, P337.
   KING DR, 1983, NEW ZEAL MED J, V96, P195.
   LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367.
   Macfarlane G J, 1994, Eur J Cancer Prev, V3, P393, DOI 10.1097/00008469-199409000-00002.
   MCMAHON S, 1990, LANCET, V335, P765.
   MILSUM JH, 1988, CAN J PUBLIC HEALTH, V79, P181.
   MITCHELL EA, 1993, BMJ-BRIT MED J, V306, P13, DOI 10.1136/bmj.306.6869.13.
   {*}NZ HLTH INF SERV, 1994, MORT DEM DAT 1992.
   {*}NZ HLTH INF SERV, SHAP PROF NZ PATT SM.
   {*}OTR SPECTR RES, 1996, CIG SMOK PREV TRENDS.
   POWELL KE, 1994, MED SCI SPORT EXER, V26, P851.
   RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385.
   SCRAGG R, 1995, NEW ZEAL MED J, V108, P218.
   SCRAGG R, 1995, AUST NZ J MED, V25, P5, DOI 10.1111/j.1445-5994.1995.tb00571.x.
   SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789.
   SIMMONS G, 1996, NZ MED J, V1018, P90.
   VANDENBRANDT PA, 1995, AM J EPIDEMIOL, V141, P907, DOI 10.1093/oxfordjournals.aje.a117357.
   {*}WELL PUBL HLTH CO, 1993, OUR HLTH OUR FUT STA.
   WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186.
   WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461.},
Number-of-Cited-References = {31},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {N. Z. Med. J.},
Doc-Delivery-Number = {YW710},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000071964800003},
DA = {2022-03-29},
}

@article{ WOS:000456426700001,
Author = {Xian, Wei and Han, Bing and Xia, Leizhen and Ma, Yining and Xu, Haodi
   and Zhang, Lu and Li, Li and Liu, Hongbo},
Title = {Focusing on the premature death of redeployed miners in China: an
   analysis of cause-of-death information from non-communicable diseases},
Journal = {GLOBALIZATION AND HEALTH},
Year = {2019},
Volume = {15},
Month = {JAN 22},
Abstract = {BackgroundReducing premature deaths is an important step towards
   achieving the World Health Organization's sustainable development goal.
   Redeployed miners are more prone to disease or premature death due to
   the special occupational characteristics. Our aims were to describe the
   deaths of redeployed miners, assess the losses due to premature death
   and identify their main health problems. All the records of individuals
   were obtained from Fuxin Mining Area Social Security Administration
   Center. Year of life lost (YLL) and average year of life lost were used
   to assess the loss due to premature death. YLL rates per 1000
   individuals were considered to compare deaths from different
   populations.ResultsCirculatory system diseases contributed the most
   years of life lost in the causes of death, followed by neoplasms. But
   average year of life lost in neoplasms was 6.85, higher than circulatory
   system diseases, 5.63. Cerebrovascular disease and ischemic heart
   disease were the main causes of death in circulatory system diseases.
   And average years of life lost in cerebrovascular disease and ischemic
   heart disease were 5.85 and 5.62, higher than those in other circulatory
   system diseases. Lung cancer was the principal cause of death in
   neoplasms. Average year of life lost in liver cancer was 7.92, the
   highest in neoplasms.ConclusionsFor redeployed miners, YLL rates per
   1000 individuals in cerebrovascular disease, ischemic heart disease and
   lung cancer were higher than those in other populations, especially in
   men. It is important to attach importance to the health of redeployed
   miners, take appropriate measures to reduce premature death and achieve
   the sustainable development goal. Our findings also contribute to a
   certain theoretical reference for other countries that face or will face
   the same problem.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Liu, HB (Corresponding Author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.
   Xian, Wei; Han, Bing; Xia, Leizhen; Ma, Yining; Xu, Haodi; Zhang, Lu; Liu, Hongbo, China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.
   Li, Li, Natl Jewish Hlth, Div Environm \& Occupat Hlth Sci, Denver, CO USA.},
DOI = {10.1186/s12992-019-0450-5},
Article-Number = {7},
ISSN = {1744-8603},
Keywords = {Redeployed miners; Non-communicable diseases; Premature death; Year of
   life lost},
Keywords-Plus = {COAL-WORKERS; BLOOD-PRESSURE; MORTALITY; PNEUMOCONIOSIS; CANCER; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {hbliu@cmu.edu.cn},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}71073176]; National Natural Science
   Foundation of Liaoning Province {[}2014021099]},
Funding-Text = {This study was supported by the National Natural Science Foundation of
   China (no. 71073176 to Hongbo Liu) and the National Natural Science
   Foundation of Liaoning Province (no. 2014021099 to Hongbo Liu). None of
   the funders had any role in the design of the study and collection,
   analysis, and interpretation of data and in writing the manuscript.},
Cited-References = {{[}Anonymous], 2001, A PRACT GUID.
   Beer C, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1264711.
   Bian LQ, 2015, INT J OCCUP MED ENV, V28, P62, DOI 10.13075/ijomeh.1896.00330.
   Cai Le, 2006, Int J Equity Health, V5, P13, DOI 10.1186/1475-9276-5-13.
   Casey ML, 2017, J AM SOC HYPERTENS, V11, P541, DOI 10.1016/j.jash.2017.06.007.
   Chen H, 2013, SAFETY SCI, V51, P217, DOI 10.1016/j.ssci.2012.06.025.
   Cheng LW, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-713.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Hajizadeh Nastaran, 2016, Gastroenterol Hepatol Bed Bench, V9, P295.
   Han B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148179.
   Hung YP, 2014, INT J CANCER, V134, P2910, DOI 10.1002/ijc.28611.
   Landen DD, 2011, AM J IND MED, V54, P727, DOI 10.1002/ajim.20986.
   Cai L, 2008, PUBLIC HEALTH, V122, P478, DOI 10.1016/j.puhe.2007.08.017.
   Liu J, 2016, J THORAC DIS, V8, P422, DOI 10.21037/jtd.2016.02.59.
   McCunney RJ, 2009, J OCCUP ENVIRON MED, V51, P462, DOI 10.1097/JOM.0b013e3181a01ada.
   McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009.
   Mohner M, 2016, INT ARCH OCC ENV HEA, V89, P593, DOI 10.1007/s00420-015-1097-z.
   Pham TM, 2010, INT J CANCER, V127, P190, DOI 10.1002/ijc.25021.
   Qian QZ, 2016, KAOHSIUNG J MED SCI, V32, P44, DOI 10.1016/j.kjms.2015.11.003.
   Shen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082181.
   Stansbury RC, 2013, AM J IND MED, V56, P1107, DOI 10.1002/ajim.22211.
   Sun YF, 2010, HLJ FOREIGN EC RELAT, V187, P109, DOI DOI 10.3969/J.ISSN.2095-3283.2010.01.041.
   Rey CHT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/647878.
   Waldstein SR, 2012, J HYPERTENS, V30, P2352, DOI 10.1097/HJH.0b013e3283595651.
   Wang XL, 2004, CHIN MED REC, V5, P38, DOI {[}10.3969/j.issn.1672-2566.2004.03.027, DOI 10.3969/J.ISSN.1672-2566.2004.03.027].
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   Yeoman KM, 2016, ARCH ENVIRON OCCUP H, V71, P119, DOI 10.1080/19338244.2014.998330.
   Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188.},
Number-of-Cited-References = {28},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Global. Health},
Doc-Delivery-Number = {HI4NE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000456426700001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000442512600841,
Author = {Ohkuma, Toshiaki and Ninomiya, Toshiharu and Tomiyama, Hirofumi and
   Kario, Kazuomi and Hoshide, Satoshi and Kita, Yoshikuni and Inoguchi,
   Toyoshi and Maeda, Yasutaka and Kohara, Katsuhiko and Tabara, Yasuharu
   and Nakamura, Motoyuki and Ohkubo, Takayoshi and Watada, Hirotaka and
   Munakata, Masanori and Ohishi, Mitsuru and Ito, Norihisa and Nakamura,
   Michinari and Shoji, Tetsuo and Vlachopoulos, Charalambos and Aboyans,
   Victor and Yamashina, Akira and Collaborative Grp Japan Brachial-A},
Title = {Ankle-brachial index measured by oscillometry is predictive for
   cardiovascular disease and premature death in the Japanese population:
   An individual participant data meta-analysis},
Journal = {ATHEROSCLEROSIS},
Year = {2018},
Volume = {275},
Pages = {141-148},
Month = {AUG},
Abstract = {Background and aims: The ankle-brachial index (ABI) is a predictor of
   cardiovascular disease (CVD) and premature death. However, few studies
   on this marker are available in the general Asian populations. This
   study aimed to investigate the association between ABI measured with
   oscillometry and the risk of these outcomes.
   Methods: We conducted an individual participant data meta-analysis in
   10,679 community-dwelling Japanese individuals without a history of CVD.
   The primary outcome was a composite of CVD events and all-cause
   mortality.
   Results: During an average of 7.8 years of follow-up, 720 participants
   experienced the primary outcome. The multivariable-adjusted hazard
   ratios (HRs) of the primary outcome significantly increased with a lower
   ABI. The HRs were 1.07 (95\% confidence interval {[}CI] 0.91-1.27) for
   ABI of 1.00-1.09, HR 1.37 (95\% CI 1.04-1.81) for ABI of 0.91-0.99, and
   HR 1.60 (95\% CI 1.06-2.41) for ABI of <= 0.90, compared with ABI of
   1.10-1.19. Furthermore, a high ABI (>= 1.30) was associated with a
   greater risk of outcome (HR 2.42 {[}95\% CI 1.14-5.13]). Similar
   tendencies were observed for CVD events alone and all-cause mortality
   alone. Addition of ABI to a model with the Framingham risk score
   marginally improved the c-statistics (p = 0.08) and integrated
   discrimination improvement (p < 0.05) for the primary outcome.
   Conclusions: The present study suggests that lower and higher ABI are
   significantly associated with an increased risk of CVD and all-cause
   mortality in the Japanese population. The ABI, which is easily measured
   by oscillometry, may be incorporated into daily clinical practice to
   identify high-risk populations. (C) 2018 Elsevier B.V. All rights
   reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Tomiyama, H (Corresponding Author), Tokyo Med Univ, Dept Cardiol, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.
   Ohkuma, Toshiaki; Ninomiya, Toshiharu, Kyushu Univ, Grad Sch Med Sci, Dept Epidemiol \& Publ Hlth, Fukuoka, Fukuoka, Japan.
   Tomiyama, Hirofumi; Yamashina, Akira, Tokyo Med Univ, Dept Cardiol, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.
   Kario, Kazuomi; Hoshide, Satoshi, Jichi Med Univ, Dept Med, Div Cardiovasc Med, Sch Med, Shimotsuke, Japan.
   Kita, Yoshikuni, Tsuruga Nursing Univ, Fac Nursing Sci, Tsuruga, Fukui, Japan.
   Inoguchi, Toyoshi, Kyushu Univ, Japan Innovat Ctr Med Redox Nav, Fukuoka, Fukuoka, Japan.
   Maeda, Yasutaka, Kyushu Univ, Grad Sch Med Sci, Dept Med \& Bioregulatory Sci, Fukuoka, Fukuoka, Japan.
   Kohara, Katsuhiko, Ehime Univ, Dept Reg Resource Management, Fac Collaborat Reg Innovat, Matsuyama, Ehime, Japan.
   Tabara, Yasuharu, Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan.
   Nakamura, Motoyuki, Iwate Med Univ, Dept Internal Med, Morioka, Iwate, Japan.
   Ohkubo, Takayoshi, Teikyo Univ, Dept Hyg \& Publ Hlth, Sch Med, Tokyo, Japan.
   Watada, Hirotaka, Juntendo Univ, Grad Sch Med, Dept Metab, Tokyo, Japan.
   Watada, Hirotaka, Juntendo Univ, Grad Sch Med, Dept Endocrinol, Tokyo, Japan.
   Munakata, Masanori, Tohoku Rosai Hosp, Prevent Med Ctr, Sendai, Miyagi, Japan.
   Ohishi, Mitsuru, Kagoshima Univ, Grad Sch Med \& Dent Sci, Dept Cardiovasc Med \& Hypertens, Kagoshima, Japan.
   Ito, Norihisa, Osaka Univ, Dept Geriatr Med \& Nephrol, Grad Sch Med, Osaka, Japan.
   Nakamura, Michinari, Cardiovasc Inst Japan, Tokyo, Japan.
   Shoji, Tetsuo, Osaka City Univ, Dept Vasc Med, Grad Sch Med, Osaka, Japan.
   Vlachopoulos, Charalambos, Hippokrateion Hosp, Athens Med Sch, Dept Cardiol 1, Hypertens \& Cardiometab Unit, Athens, Greece.
   Aboyans, Victor, Dupuytren Univ Hosp, Dept Cardiol, Limoges, France.},
DOI = {10.1016/j.atherosclerosis.2018.05.048},
ISSN = {0021-9150},
EISSN = {1879-1484},
Keywords = {Ankle-brachial index; Individual participant data meta-analysis; Risk
   factors},
Keywords-Plus = {PULSE-WAVE VELOCITY; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY;
   ASSOCIATION TASK-FORCE; FRAMINGHAM RISK SCORE; HEART-ASSOCIATION;
   PROGNOSTIC-SIGNIFICANCE; NET RECLASSIFICATION; PRACTICE GUIDELINES;
   GENERAL-POPULATION},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {tomiyama@tokyo-med.ac.jp},
ResearcherID-Numbers = {Aboyans, Victor/AAN-8308-2020
   Nakamura, Michinari/ABA-6689-2021
   },
ORCID-Numbers = {Nakamura, Michinari/0000-0003-2005-3161
   Ohkubo, Takayoshi/0000-0002-3283-8196
   Inoguchi, Toyoshi/0000-0002-7344-6199},
Funding-Acknowledgement = {Omron Health Care Company (Kyoto, Japan)},
Funding-Text = {This study was supported by Omron Health Care Company (Kyoto, Japan),
   which awarded a grant to the baPWV IPD meta-analysis study group.},
Cited-References = {Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb.
   Chen HY, 2017, J NEPHROL, V30, P493, DOI 10.1007/s40620-017-0376-z.
   Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060.
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595.
   Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197.
   Fowkes FGR, 2014, EUR J PREV CARDIOL, V21, P310, DOI 10.1177/2047487313516564.
   Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c.
   Hajibandeh S, 2017, VASCULAR, V25, P208, DOI 10.1177/1708538116658392.
   Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599.
   Hoshide S, 2016, HYPERTENSION, V68, P54, DOI 10.1161/HYPERTENSIONAHA.116.07201.
   Ishisone T, 2013, INT HEART J, V54, P160, DOI 10.1536/ihj.54.160.
   Kawai T, 2013, J ATHEROSCLER THROMB, V20, P391, DOI 10.5551/jat.15040.
   Kerr KF, 2014, EPIDEMIOLOGY, V25, P114, DOI 10.1097/EDE.0000000000000018.
   Kohara K, 2014, ATHEROSCLEROSIS, V235, P424, DOI 10.1016/j.atherosclerosis.2014.05.940.
   Koji Y, 2004, AM J CARDIOL, V94, P868, DOI 10.1016/j.amjcard.2004.06.020.
   Maeda Y, 2014, DIABETES CARE, V37, P2383, DOI 10.2337/dc13-1886.
   Mohler ER, 2004, VASC MED, V9, P253, DOI 10.1191/1358863x04vm559oa.
   Munakata M, 2005, HYPERTENS RES, V28, P9, DOI 10.1291/hypres.28.9.
   Munakata M, 2012, HYPERTENS RES, V35, P839, DOI 10.1038/hr.2012.53.
   Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037.
   Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126.
   Ninomiya T, 2013, J HYPERTENS, V31, P477, DOI 10.1097/HJH.0b013e32835c5c23.
   Ohkuma T, 2017, HYPERTENSION, V69, P1045, DOI {[}10.1161/HYPERTENSIONAHA.117.09097, 10.1161/hypertensionaha.117.09097].
   Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348.
   Richart T, 2009, HYPERTENS RES, V32, P884, DOI 10.1038/hr.2009.125.
   Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023.
   Shoji T, 2010, ATHEROSCLEROSIS, V210, P145, DOI 10.1016/j.atherosclerosis.2009.11.013.
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008.
   Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815.
   Tomiyama H, 2012, INT HEART J, V53, P170, DOI 10.1536/ihj.53.170.
   Turin TC, 2010, HYPERTENS RES, V33, P922, DOI 10.1038/hr.2010.103.
   Velescu A, 2015, ATHEROSCLEROSIS, V241, P357, DOI 10.1016/j.atherosclerosis.2015.05.017.
   Vlachopoulos C, 2015, ATHEROSCLEROSIS, V241, P507, DOI 10.1016/j.atherosclerosis.2015.05.007.
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837.
   Yoshida M, 2012, DIABETES CARE, V35, P178, DOI 10.2337/dc11-1333.},
Number-of-Cited-References = {35},
Times-Cited = {15},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Atherosclerosis},
Doc-Delivery-Number = {GR3RP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000442512600841},
DA = {2022-03-29},
}

@article{ WOS:000398868300002,
Author = {Parker, Jason and Cuthbertson, Courtney and Loveridge, Scott and
   Skidmore, Mark and Dyar, Will},
Title = {Forecasting state-level premature deaths from alcohol, drugs, and
   suicides using Google Trends data},
Journal = {JOURNAL OF AFFECTIVE DISORDERS},
Year = {2017},
Volume = {213},
Pages = {9-15},
Month = {APR 15},
Abstract = {Background: Vital statistics on the number of, alcohol-induced death
   (AICD) drug-induced death (DICD), and suicides at the local-level are
   only available after a substantial lag of up to two years after the
   events occur. We (1) investigate how well Google Trends search data
   explain variation in state-level rates in the US, and (2) use this
   method to forecast these rates of death for 2015 as official data are
   not yet available.
   Methods: We tested the degree to which Google Trends data on 27 terms
   can be fit to CDC data using L-1-regularization on AICD, DICD, and
   suicide. Using Google Trends data, we forecast 2015 AICD, DICD, and
   suicide rates.
   Results: L-1-regularization fit the pre-2015 data much better than the
   alternative model using state-level unemployment and income variables.
   Google Trends data account for substantial variation in growth of state
   level rates of death: 30.9\% for AICD, 23.9\% for DICD, and 21.8\% for
   suicide rates. Every state except Hawaii is forecasted to increase in
   all three of these rates in 2015.
   Limitations: The model predicts state, not local or individual behavior,
   and is dependent on continued availability of Google Trends data.
   Conclusions: The method predicts state-level AICD, DICD, and suicide
   rates better than the alternative model. The study findings suggest that
   this methodology can be developed into a public health surveillance
   system for behavioral health-related causes of death. State-level
   predictions could be used to inform state interventions aimed at
   reducing AICD, DICD, and suicide.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Parker, J (Corresponding Author), Michigan State Univ, Agr Food \& Resource Econ, 446 W Circle Dr,Suite 66,Morrill Hall Agr, E Lansing, MI 48824 USA.
   Parker, Jason; Loveridge, Scott; Skidmore, Mark, Michigan State Univ, Agr Food \& Resource Econ, 446 W Circle Dr,Suite 66,Morrill Hall Agr, E Lansing, MI 48824 USA.
   Cuthbertson, Courtney, Michigan State Univ, 446 W Circle Dr,Suite 66,Morrill Hall Agr, E Lansing, MI 48824 USA.
   Dyar, Will, Michigan State Univ, Agr Food \& Resource Econ, 458 W Circle Dr,Suite 908,Cook Hall, E Lansing, MI 48824 USA.},
DOI = {10.1016/j.jad.2016.10.038},
ISSN = {0165-0327},
EISSN = {1573-2517},
Keywords = {Behavioral health; Forecasting; Suicide; Substance abuse; Google Trends;
   Regional analysis},
Keywords-Plus = {INTERNET; SEARCHES; OUTCOMES; ABUSE},
Research-Areas = {Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Clinical Neurology; Psychiatry},
Author-Email = {parke392@msu.edu
   cuthbe16@msu.edu
   loverid2@msu.edu
   mskidmor@msu.edu
   dyarwill@msu.edu},
Funding-Acknowledgement = {Substance Abuse and Mental Health Services Administration, United
   States; United States Department of Agriculture National Institute of
   Food and AgricultureUnited States Department of Agriculture (USDA)},
Funding-Text = {Partial support for this work from the Substance Abuse and Mental Health
   Services Administration, United States and the United States Department
   of Agriculture National Institute of Food and Agriculture. The funders
   had no role in the study design, implementation, writing of the report,
   decision to submit the paper for publication, or choice of journal. The
   corresponding author had full access to all the data and had final
   responsibility for the decision to submit for publication.},
Cited-References = {BEA, 2015, REG EC ACC.
   Bragazzi NL, 2014, PSYCHOL RES BEHAV MA, V7, P1, DOI 10.2147/PRBM.S44084.
   Cavazos-Rehg P.A., 2014, TOBACCOCONTROL201305.
   CDC, 2015, VIT SIGNS DEM SUBST.
   CDC, 2013, MULT CAUS DEATH DAT.
   CDC, 2015, WID RANG ONL DAT EP.
   Compton WM, 2014, DRUG ALCOHOL DEPEN, V142, P350, DOI 10.1016/j.drugalcdep.2014.06.012.
   Conner KR, 2014, AM J PUBLIC HEALTH, V104, P171, DOI 10.2105/AJPH.2013.301352.
   Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0.
   Deluca P, 2012, PROG NEURO-PSYCHOPH, V39, P221, DOI 10.1016/j.pnpbp.2012.07.011.
   Fox S., 2011, PEW INTERNET AM LIFE.
   Frijters P, 2013, SOC SCI MED, V84, P61, DOI 10.1016/j.socscimed.2013.01.028.
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634.
   Gunn JF, 2013, J AFFECT DISORDERS, V148, P411, DOI 10.1016/j.jad.2012.11.004.
   Hanson CL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2503.
   Hastie T., 2016, ELEMENTS STAT LEARNI.
   Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Luxton DD, 2012, AM J PUBLIC HEALTH, V102, pS195, DOI 10.2105/AJPH.2011.300608.
   Ma-Kellams C, 2016, CLIN PSYCHOL SCI, V4, P480, DOI 10.1177/2167702615593475.
   Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537.
   McCarthy MJ, 2010, J AFFECT DISORDERS, V122, P277, DOI 10.1016/j.jad.2009.08.015.
   MOOS RH, 1982, J STUD ALCOHOL, V43, P888, DOI 10.15288/jsa.1982.43.888.
   Newman C.F., 2001, COGNITIVE THERAPY SU.
   Nunez-Anton V, 2000, BIOMETRICS, V56, P699, DOI 10.1111/j.0006-341X.2000.00699.x.
   Perrin A, 2015, AM INTERNET ACCESS 2, P26.
   Recupero P.R., 2008, J CLIN PSYCHIAT.
   REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511.
   Shah A, 2010, SUICIDE LIFE-THREAT, V40, P146, DOI 10.1521/suli.2010.40.2.146.
   STEINGLASS P, 1981, J STUD ALCOHOL, V42, P288, DOI 10.15288/jsa.1981.42.288.
   Steppan M, 2013, INT J DRUG POLICY, V24, P23, DOI 10.1016/j.drugpo.2012.05.002.
   Sueki H, 2011, PSYCHIAT CLIN NEUROS, V65, P392, DOI 10.1111/j.1440-1819.2011.02216.x.
   Swensen ID, 2015, J PUBLIC ECON, V122, P13, DOI 10.1016/j.jpubeco.2014.12.008.
   Vayena E, 2012, AM J PUBLIC HEALTH, V102, P2225, DOI 10.2105/AJPH.2012.300813.
   WEISS RD, 1992, AM J DRUG ALCOHOL AB, V18, P121, DOI 10.3109/00952999208992825.
   {*}WHO, 2004, WHO GLOB STAT REP AL.
   Woo JM, 2012, INT J ENV RES PUB HE, V9, P531, DOI 10.3390/ijerph9020531.
   World Health Organization, 2014, PREVENTING SUICIDE G.
   Yang AC, 2011, J AFFECT DISORDERS, V132, P179, DOI 10.1016/j.jad.2011.01.019.
   Ybarra ML, 2006, INT J MED INFORM, V75, P29, DOI 10.1016/j.ijmedinf.2005.07.029.},
Number-of-Cited-References = {40},
Times-Cited = {26},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {15},
Journal-ISO = {J. Affect. Disord.},
Doc-Delivery-Number = {ER5UH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000398868300002},
DA = {2022-03-29},
}

@article{ WOS:000280647500004,
Author = {Hirschy, Alain and Croquelois, Adrien and Perriard, Evelyne and
   Schoenauer, Roman and Agarkova, Irina and Hoerstrup, Simon P. and
   Taketo, Makoto M. and Pedrazzini, Thierry and Perriard, Jean-Claude and
   Ehler, Elisabeth},
Title = {Stabilised beta-catenin in postnatal ventricular myocardium leads to
   dilated cardiomyopathy and premature death},
Journal = {BASIC RESEARCH IN CARDIOLOGY},
Year = {2010},
Volume = {105},
Number = {5},
Pages = {597-608},
Month = {SEP},
Abstract = {Beta-catenin is a component of the intercalated disc in cardiomyocytes,
   but can also be involved in signalling and activation of gene
   transcription. We wanted to determine how long-term changes in
   beta-catenin expression levels would affect mature cardiomyocytes.
   Conditional transgenic mice that either lacked beta-catenin or that
   expressed a non-degradable form of beta-catenin in the adult ventricle
   were created. While mice lacking beta-catenin in the ventricle do not
   have an overt phenotype, mice expressing a non-degradable form develop
   dilated cardiomyopathy and do not survive beyond 5 months. A detailed
   analysis could reveal that this phenotype is correlated with a distinct
   localisation of beta-catenin in adult cardiomyocytes, which cannot be
   detected in the nucleus, no matter how much protein is present. Our
   report is the first study that addresses long-term effects of either the
   absence of beta-catenin or its stabilisation on ventricular
   cardiomyocytes and it suggests that beta-catenin's role in the nucleus
   may be of little significance in the healthy adult heart.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Ehler, E (Corresponding Author), Kings Coll London, Randall Div Cell \& Mol Biophys, BHF Ctr Res Excellence, Room 3-26A,New Hunts House,Guys Campus, London SE1 1UL, England.
   Ehler, Elisabeth, Kings Coll London, Randall Div Cell \& Mol Biophys, BHF Ctr Res Excellence, London SE1 1UL, England.
   Ehler, Elisabeth, Kings Coll London, Div Cardiovasc, London SE1 1UL, England.
   Hirschy, Alain; Perriard, Evelyne; Perriard, Jean-Claude, ETH Zurich Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.
   Croquelois, Adrien; Pedrazzini, Thierry, Univ Lausanne, Sch Med, Div Hypertens, CH-1011 Lausanne, Switzerland.
   Schoenauer, Roman; Agarkova, Irina; Hoerstrup, Simon P., Univ Zurich Hosp, CH-8091 Zurich, Switzerland.
   Taketo, Makoto M., Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan.},
DOI = {10.1007/s00395-010-0101-8},
ISSN = {0300-8428},
EISSN = {1435-1803},
Keywords = {Beta-catenin; Hypertrophy; Intercalated disc; Canonical Wnt signalling;
   Dilated cardiomyopathy},
Keywords-Plus = {MYOCYTE-SPECIFIC EXCISION; CARDIAC-HYPERTROPHY; INTERCALATED DISC;
   SIGNALING PATHWAY; MOUSE DEVELOPMENT; NUCLEAR-MEMBRANE; PROGENITOR
   CELLS; PROTEIN EMERIN; CANCER CELLS; GENE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {Elisabeth.ehler@kcl.ac.uk},
ORCID-Numbers = {Ehler, Elisabeth/0000-0001-5646-5964},
Funding-Acknowledgement = {Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)European Commission {[}3100-063486.00]; Gebert Ruf Foundation
   {[}P038-01]; Swiss Cardiovascular Training and Research Network
   (SCARTNet); Swiss University Conference (SUK); MRCUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research \&
   Innovation (UKRI)Medical Research Council UK (MRC) {[}G0400153] Funding
   Source: UKRI; Medical Research CouncilUK Research \& Innovation
   (UKRI)Medical Research Council UK (MRC)European Commission {[}G0400153]
   Funding Source: researchfish},
Funding-Text = {This work was supported by a grant from the Swiss National Science
   Foundation (grant\#3100-063486.00), a grant from the Gebert Ruf
   Foundation (grant \# P038-01), by the Swiss Cardiovascular Training and
   Research Network (SCARTNet) and the Swiss University Conference (SUK).
   Work in the laboratory of Dr Ehler is supported by a Career
   Establishment Grant by the MRC. We are grateful for many helpful
   discussions with all members of the Perriard group, especially Dr Jaya
   Krishnan. In addition we thank Dr Stephan Lange (UCSD, San Diego, USA)
   and Dr Matthew Wheeler (King's College London, London, UK) for
   critically reading the manuscript. We thank Professors Rolf Kemler
   (Max-Planck Institute, Freiburg, Germany) and Ju Chen (UCSD, San Diego,
   USA) who provided us with beta-catenin floxed mice and MLC2v-Cre mice.
   We thank Dr Andrea Domenighetti (University Hospital, Lausanne,
   Switzerland) and Dr P. Jonsen (VisualSonics Inc., Toronto, Canada) for
   performing ECG studies on cKO and c Delta ex3 animals. The help of Dr
   Nicolas Lindegger (Department of Physiology, Bern, Switzerland) for the
   isolation of adult cardiomyocytes is also acknowledged. We are grateful
   to Dr Katja Gehmlich (University College London) for the donation of
   HL-1 cells.},
Cited-References = {Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88.
   Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a.
   Brault V, 2001, DEVELOPMENT, V128, P1253.
   Chen J, 1998, DEVELOPMENT, V125, P1943.
   Chen X, 2006, MOL CELL BIOL, V26, P4462, DOI 10.1128/MCB.02157-05.
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979.
   Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731.
   Ehler E, 2001, J CELL BIOL, V153, P763, DOI 10.1083/jcb.153.4.763.
   Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X.
   FORBES MS, 1985, TISSUE CELL, V17, P605, DOI 10.1016/0040-8166(85)90001-1.
   Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7.
   Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751.
   Gehmlich K, 2008, J MUSCLE RES CELL M, V29, P155, DOI 10.1007/s10974-008-9159-4.
   Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153.
   Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208.
   Gupta P, 2010, BASIC RES CARDIOL, V105, P365, DOI 10.1007/s00395-010-0085-4.
   HAEGEL H, 1995, DEVELOPMENT, V121, P3529.
   Hahn JY, 2006, J BIOL CHEM, V281, P30979, DOI 10.1074/jbc.M603916200.
   Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100.
   Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931.
   Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046.
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002.
   Kapiloff MS, 2001, J CELL SCI, V114, P3167.
   Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6.
   Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200.
   Leu M, 2001, ANAT EMBRYOL, V204, P217, DOI 10.1007/s004290100206.
   Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X.
   Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104.
   Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899.
   Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100.
   Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230.
   Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009.
   Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268.
   Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885.
   Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8.
   Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6.
   Qu JX, 2007, J MOL CELL CARDIOL, V43, P319, DOI 10.1016/j.yjmcc.2007.06.006.
   RHEE D, 1994, CELL MOTIL CYTOSKEL, V28, P1, DOI 10.1002/cm.970280102.
   Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026.
   Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790.
   Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469.
   Snabaitis AK, 2006, J BIOL CHEM, V281, P20252, DOI 10.1074/jbc.M600268200.
   Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023.
   Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511.
   Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040.
   van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0.
   Vincan E, 2000, ONCOL RES, V12, P193.
   Wheeler MA, 2010, CELL MOL LIFE SCI, V67, P781, DOI 10.1007/s00018-009-0219-8.
   Zelarayan L, 2007, CELL CYCLE, V6, P2120, DOI 10.4161/cc.6.17.4632.
   Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07.
   Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006.},
Number-of-Cited-References = {51},
Times-Cited = {32},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Basic Res. Cardiol.},
Doc-Delivery-Number = {635HZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000280647500004},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:A1980KX90700021,
Author = {MESHARTREE, M and ARMSTRONG, JB},
Title = {EVIDENCE THAT THE PREMATURE DEATH MUTATION (P) IN THE MEXICAN AXOLOTL
   (AMBYSTOMA-MEXICANUM) IS NOT AN AUTONOMOUS CELL LETHAL},
Journal = {JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY},
Year = {1980},
Volume = {60},
Number = {DEC},
Pages = {295-302},
Publisher = {COMPANY OF BIOLOGISTS LTD},
Address = {BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL},
Type = {Article},
Language = {English},
Affiliation = {MESHARTREE, M (Corresponding Author), UNIV OTTAWA,DEPT BIOL,OTTAWA K1N 6N5,ONTARIO,CANADA.},
ISSN = {0022-0752},
Research-Areas = {Anatomy \& Morphology; Developmental Biology},
Web-of-Science-Categories  = {Anatomy \& Morphology; Developmental Biology},
Cited-References = {BRIGGS R, 1973, S SOC DEVELOP BIOL, V31, P169.
   Humphrey R.R., 1975, HDB GENETICS, P3, DOI 10.1007/978-1-4613-4470-4\_1.
   HUMPHREY RR, 1972, DEV BIOL, V27, P365, DOI 10.1016/0012-1606(72)90175-3.
   HUMPHREY RR, 1977, J EXP ZOOL, V202, P195, DOI 10.1002/jez.1402020208.
   LEMANSKI LF, 1976, J SUPRAMOL STR CELL, V5, P221, DOI 10.1002/jss.400050209.
   MALACINSKI GM, 1978, AM ZOOL, V18, P195.
   MALACINSKI GM, 1974, SCIENCE, V184, P1142, DOI 10.1126/science.184.4142.1142.
   Rugh R., 1962, EXPT EMBRYOLOGY.
   SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7.
   SLACK JMW, 1977, J EMBRYOL EXP MORPH, V39, P151.
   TROTTIER TM, 1977, J EMBRYOL EXP MORPH, V39, P139.},
Number-of-Cited-References = {11},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {KX907},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1980KX90700021},
DA = {2022-03-29},
}

@article{ WOS:000272385800002,
Author = {Lee, Robert},
Title = {Early Death and Long Life in History: Establishing the Scale of
   Premature Death in Europe and its Cultural, Economic and Social
   Significance},
Journal = {HISTORICAL SOCIAL RESEARCH-HISTORISCHE SOZIALFORSCHUNG},
Year = {2009},
Volume = {34},
Number = {4, SI},
Pages = {23-60},
Abstract = {``Fruher Tod und langes Leben in historischer Perspektive. Der
   vorzeitige Tod in Europa und seine kulturelle, okonomische und soziale
   Bedeutung{''}. Up until the late-eighteenth century and beyond,
   premature death was a constant reality for individuals and their
   families irrespective of their social standing rather than an
   exceptional occurrence. Premature death is a theme which has given rise
   to wide-ranging discussions relating to its economic and social
   significance, its interpretation and commemoration, its cultural and
   political representation, and the role of medical practitioners and
   other professional groups in limiting its familial and societal impact.
   This paper will analyse the process by which the scale of premature
   death was scientifically established from the early eighteenth century
   onwards; examine the key factors which influenced the growing concern
   over the extent of truncated longevity; explore the ways in which
   private perceptions of premature death evolved over time; assess the
   role of human agency in responding to an avoidable loss of life; and
   discuss the cultural, economic and social significance of premature
   death.},
Publisher = {GESIS LEIBNIZ INST SOCIAL SCIENCES},
Address = {UNTER SACHSENHAUSEN 6-8, COLOGNE, D-50667, GERMANY},
Type = {Review},
Language = {English},
Affiliation = {Lee, R (Corresponding Author), Univ Liverpool, Sch Hist, 9 Abercromby Sq, Liverpool L69 7WZ, Merseyside, England.
   Univ Liverpool, Sch Hist, Liverpool L69 7WZ, Merseyside, England.},
ISSN = {0172-6404},
Keywords = {premature death; population science; political economy; private
   perceptions; commemoration; longvity},
Keywords-Plus = {MATERNAL MORTALITY; UNITED-STATES; LOST; HEALTH; TRENDS; TERM;
   EXPECTANCY; DISABILITY; ENGLAND; TABLES},
Research-Areas = {History; Social Sciences - Other Topics; Business \& Economics},
Web-of-Science-Categories  = {History; History Of Social Sciences; Industrial Relations \& Labor;
   Social Sciences, Interdisciplinary},
Author-Email = {W.R.Lee@liverpool.ac.uk},
Cited-References = {AINSWORTH M, 2000, POLICY RES WORKING P, P2266.
   ALBORN TL, 1994, SCI CONTEXT, V7, P433, DOI 10.1017/S0269889700001770.
   ANDERSON M, 1980, STUDIES EC SOCIAL HI.
   {[}Anonymous], 2009, GUARDIAN        0420.
   ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839.
   ARCA M, 1988, AM J PUBLIC HEALTH, V78, P1202, DOI 10.2105/AJPH.78.9.1202.
   Aries P., 1972, CENTURIES CHILDHOOD.
   Armstrong John, 1744, ART PRESERVING HLTH, VIII.
   Ballod, 1899, MITTLERE LEBENSDAUER.
   Banta J E, 1987, J Community Health, V12, P185, DOI 10.1007/BF01323480.
   BEDDOES T, 1802, HYGEIA ESSAYS MORAL.
   Behar L, 1976, Ann Demogr Hist (Paris), P173.
   BEJEAN S, 2005, EUR J HEALTH ECON, V1, P16.
   Bellhouse DR, 2007, STAT SCI, V22, P109, DOI 10.1214/088342306000000268.
   BENCHAN, 1998, CANADIAN MED ASS J S, V159, pS1.
   Berridge V., 2003, POOR HLTH SOCIAL INE.
   Bertillon J., 1892, J ROY STAT SOC, V55, P559.
   BIEDERMANN K, 1880, DTSCH POLITISCHE MAT.
   Birn AE, 2008, B HIST MED, V82, P311, DOI 10.1353/bhm.0.0015.
   BLACK M, 1987, AM FOLK PAINTING.
   BLACK MC, 1963, ART AM, V51, P82.
   BLACK MC, 1966, ART AM, V54, P49.
   BLYTH AW, 1890, MANUAL PUBLIC HLTH.
   BOBADILLA J, 2006, PREMATURE DEATH NEW.
   Bolovan Ioan, 2003, TRANSYLVANIA MODERN.
   BROWN M, 2009, GUARDIAN        0401.
   Brownlee J, 1911, J R STAT SOC, V74, P201, DOI 10.2307/2339836.
   BROWNLEE J, 1916, PUBLIC HLTH, V29, P228.
   Buchan William, 1769, DOMESTIC MED.
   BUCK P, 1977, ISIS, V68, P67, DOI 10.1086/351715.
   BURNET A, 1836, NEW MED ADVISER FAMI.
   Cadogan W, 1748, ESSAY NURSING MANAGE.
   CAMPBELL D, 2009, GUARDIAN        0430.
   CAREY JR, 1995, EXP GERONTOL, V30, P315, DOI 10.1016/0531-5565(94)00041-Z.
   Carr-Saunders A., 1964, WORLD POPULATION GRO.
   CARTER MR, 2007, EC IMPACT PREMATURE, P1.
   Charles Booth., 1886, J R STAT SOC, P314.
   Clark Geoffrey Wilson, 1999, BETTING LIVES CULTUR.
   COCK R, 2010, NETWORKS PO IN PRESS.
   COMBE A, 1836, PRINCIPLE PHYSL APPL.
   CORNARO L, 1821, SURE METHOD ATTAININ.
   Crimmins EM, 1997, POPUL DEV REV, V23, P555, DOI 10.2307/2137572.
   Curl J. S., 1972, VICTORIAN CELEBRATIO.
   CURTIS JH, 1838, SIMPLICITY LIVING OB.
   Daston L., 1988, CLASSICAL PROBABILIT.
   De Brouwere V, 2007, SOC HIST MED, V20, P541, DOI 10.1093/shm/hkm070.
   DEMONFERRAND JF, 1838, ESSAI LOIS MORTALITE.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   DENBUTLER FA, 2004, ECONOMIST, V153, P439.
   DEUCHAR JJ, 1882, T INSURANCE ACTUARIA, V3, P33.
   DICKINSON FG, 1948, J AM MED ASS, V64.
   Dimand RW, 2005, AM J ECON SOCIOL, V64, P393, DOI 10.1111/j.1536-7150.2005.00368.x.
   DUBLIN LI, 1936, LENGTH LIFE.
   Dudfield R, 1912, J R STAT SOC, V76, P1, DOI 10.2307/2340027.
   DUNN PM, 2003, ARCH DIS CHILD-FETAL, V83, pF71.
   DUPAQUIER M, 1984, POPULATION, V39, P339, DOI 10.1016/0167-5699(84)90072-0.
   EDIEV D, 2007, VIENNA YB POPULATION, P327, DOI DOI 10.1553/POPULATIONYEARBOOK2007S327.
   Elderton WP, 1943, J R STAT SOC, V106, P1, DOI 10.2307/2980239.
   ENGEL E, WERTH MENSCHEN 1 THE.
   Euler L., 1760, MEMOIRES ACAD ROYALE, V16, P144.
   Eyler JM, 2002, SOZ PRAVENTIV MED, V47, P6, DOI 10.1007/BF01318400.
   FARR W, 1865, J STAT SOC LONDON, V28, P125.
   FARR W, 1837, STAT ACCOUNT BRIT EM, P567.
   FINDL P, 1979, GESCH ERGEBNISSE ZEN, P425.
   FISHER I, 1917, AM LABOR LEGISLATION, V7, P9.
   Fissell Mary E., 1991, PATIENTS POWER POOR.
   Flandrin J-L., 1979, FAMILIES FORMER TIME.
   FOGEL RW, 2004, CAMBRIDGE STUDIES PO, V38.
   FREITAS RA, 2009, LONGEVITY MEME ACTIV.
   GILESM J, 1999, HUMAN CAPITAL THEORY.
   GILPIN J, 1812, MONUMENT PARENTAL AF.
   Glass D. V, 1959, INTRO MALTHUS.
   GLASS DV, 1973, 18 CENTURY POPULATIO.
   GOLDSCHEID R, 1911, HOHERENTWICKLUNG MEN.
   Gottstein Adolf, 1929, LEHRE EPIDEMIEN.
   {*}GOV DISTR COL, 2006, DEP HLTH VIT STAT LE.
   GRAUNT W, 1662, NATURAL POLITICAL OB.
   Greenwood M., 1948, MED STAT GRAUNT FARR.
   GUY WA, 1857, J STAT SOC LONDON, V20, P65.
   Haberman S., 1995, HIST ACTUARIAL SCI.
   Hacking, 1985, EMERGENCE PROBABILIT.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Haines MR, 1998, HIST METHOD, V31, P149, DOI 10.1080/01615449809601197.
   HAINES MR, 1980, J INTERDISCIPL HIST, V11, P73, DOI 10.2307/202987.
   Halling Thorsten, 2005, KONSTRUKT BEVOLKERUN, P388.
   HARKNESS J, 1989, CAN PUBLIC POL, V15, P405, DOI 10.2307/3550356.
   HARTWIG J, 1937, ARCH BEVOLKERUNGSWIS, V7, P234.
   Hayward TE, 1901, J R STAT SOC, V64, P636.
   HEIEN DM, 1989, J STUD ALCOHOL, V50, P567, DOI 10.15288/jsa.1989.50.567.
   HENRIKSSON GF, J INTERNAL MED, V244, P461.
   HIGGS E, 1990, HIST COMPUTING, P67.
   HOCKER PF, 1965, J I ACTUARIES, V91, P203.
   HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801.
   HOFFMANN JG, 1839, BEVOLKERUNG PREUSSIS.
   Hogberg U, 2004, AM J PUBLIC HEALTH, V94, P1312, DOI 10.2105/AJPH.94.8.1312.
   HOLLINGSWORTH TH, 1977, POPULATION, V32, P323, DOI 10.2307/1531814.
   HOOCK J, 1979, ANN DEMOGRAPHIE HIST, P145.
   Houlbrooke Ralph, 1998, DEATH RELIG FAMILY E.
   HOULT J, 1913, W DERBY OLD SWAN WAV.
   Houston R. A., 1992, CONTINUITY CHANGE, V7, P47, DOI 10.1017/S0268416000001454.
   HOUSTON RA, 1995, J INTERDISCIPL HIST, V26, P233, DOI 10.2307/206607.
   HUANG R, 2003, P 25 INT C AGR EC 16, P218.
   HUFELAND CW, 1796, KUNST MENSCHLICHE LE.
   Humblet PC, 2000, J EPIDEMIOL COMMUN H, V54, P687, DOI 10.1136/jech.54.9.687.
   HUMPHREYS N, 1883, J STAT SOC LONDON, V46, P189.
   HUMPHREYS NA, 1885, VITAL STAT MEMORIAL.
   Jalland Pat, 1996, DEATH VICTORIAN FAMI.
   Jensen NT, 2009, B HIST MED, V83, P95, DOI 10.1353/bhm.0.0179.
   JOHANSEN JD, 2000, SCANDINAVIAN J PUBLI, V33, P222.
   JOHANSSON SR, 1991, CONTINUITY CHANGE, V6, P135.
   KENT N, 1987, NORDISK KONST FRAN C.
   KERSSEBOOM W, 1748, ESSAYS POLITICAL ARI.
   KINGDOM GG, 2002, STUDIES BABI BAHAI R, V13.
   KNEIPP S, 1891, MY WATER CURE.
   KRAUSE RM, 2005, INDIAN J COMMUNITY M, V30, P104.
   LAMMERT G, 1869, VOLKSMEDIZIN MEDIZIN.
   Lawrence C J, 1975, Med Hist, V19, P20.
   LESKY E, 1976, SYSTEM COMPLETE ME 2.
   Lexis W, 1878, ANN DEMOGRAPHIE INT, V2, P447.
   Lindemann Mary, 1996, HLTH HEALING 18 CENT.
   LINN S, 1993, EPIDEMIOLOGY, V4, P449, DOI 10.1097/00001648-199309000-00011.
   Loudon I, 2000, AM J CLIN NUTR, V72, p241S, DOI 10.1093/ajcn/72.1.241S.
   Loudon Irvine, 1992, DEATH CHILDBIRTH INT.
   MADDOX RL, 2007, METHODIST HIST, V46, P4.
   MARLAND H, 1993, ART MIDWIFERY EARLY, P192.
   MOSS W, 1784, FAMILIAR MED SURVEY.
   MULLAHY J, 1989, INQUIRY-J HEALTH CAR, V26, P272.
   MULLER FW, 1891, URSACHEN NICHTSTILLE.
   NAKAJIMA H, 1995, WORLD HLTH REPORT 19.
   Neimeyer RA, 2004, DEATH STUD, V28, P309, DOI 10.1080/07481180490432324.
   Newsholme A., 1923, ELEMENTS VITAL STAT.
   NICOLAI CF, 1788, BESCHREIBUNGEN REISE.
   North Michael, 2008, MAT DELIGHT JOY LIVI.
   Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675.
   Ogle W, 1886, Med Chir Trans, V69, P217.
   OLIVARES N, 2008, VICTORIAN PHOTOS MIX.
   Orme Nicholas, 2001, MEDIEVAL CHILDREN.
   Overbeek J., 1974, HIST POPULATION THEO.
   PEARSON K, 1978, HIST STAT 17 18 CENT.
   Pearson R, 1997, ECON HIST REV, V50, P235, DOI 10.1111/1468-0289.00053.
   PERLOFF J D, 1984, Journal of Public Health Policy, V5, P167, DOI 10.2307/3342337.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.
   PICTON JA, 1873, MEMORIALS LIVERPOOL, V2.
   PIGLER A, 1957, ACTA HIST ARTIUM ACA, V4, P1.
   POLLOCK LA, 1983, FORGOTTEN CHILDREN P.
   PORTER R, 1989, GUT, V30, P75, DOI 10.1136/gut.30.Spec\_No.75.
   Ratcliffe H, 1850, OBSERVATIONS RATE MO.
   RENDLE-SHORT J, 1960, Bull Hist Med, V34, P97.
   RENN DF, 1998, LIFE DEATH MONEY ACT.
   RICE DP, EC COST ALCOHOL DRUG.
   RILEY JC, INTRO BIBLIOGRAPHY H.
   RILEY JC, 2000, POPUL DEV REV, V31, P537.
   RILEY JC, 2001, LIFE EXPECTANCY GLOB.
   ROBINSON LH, 1948, CANADIAN J PUBLIC HL, V39, P60.
   ROHRBASSER JM, 2009, HIST FAMILY, V9, P115.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Rosset E., 1964, AGING PROCESS POPULA.
   Rusnock A, 2002, CLIO MEDICA, V67, P37.
   Rusnock A, 2002, VITAL ACCOUNTS QUANT.
   Rutherford S., 2008, VICTORIAN CEMETERY.
   Sandifer Edward, 2007, EARLY MATH L EULER.
   Seguy I, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P83, DOI 10.1007/978-1-4020-6424-1\_4.
   Shorter E., 1976, MAKING MODERN FAMILY.
   SIBBETT T, 2007, SEM EXPL ACT HIST 14.
   SINGER RB, 1933, J INSURANCE MED, V33, P298.
   SKOLD P, 1996, 2 FACES SMALLPOX DIS.
   Smala, 1987, 18 CENTURY CAMPAIGN.
   SOEBORG K, 1902, CHRISTEN DALSGAARD K.
   STONE L, 1977, FAMILY SEX MARRIAGE.
   STRIXNER JM, 1768, ZUSTAND GEBURSTHULFE.
   Sussman G.D., 1982, SELLING MOTHERS MILK.
   Szreter Simon., 2005, HLTH WEALTH STUDIES.
   TEDEBRAND LG, 2000, LANDESGESCHICHTE HIS.
   THATCHER A, NOTE SOME HIST DAT O.
   Tomer A., 2000, DEATH ATTITUDES OLDE.
   TRENDHILL JM, LOST LANGUAGE.
   Tucker Holly, 2003, PREGNANT FICTIONS CH.
   Veron J, 2003, POPULATION, V58, P343, DOI 10.2307/3271331.
   VINOVSKIS MA, 1971, J ECON HIST, V31, P570, DOI 10.1017/S0022050700074337.
   VOGELE J, 2002, BEVOLKERUNGSLEHRE BE, P121.
   WALL R, 1974, MORTALITY 19 CENTURY.
   WATKINS K, 2009, GUARDIAN        0407.
   WEISZ B, 1880, EINFLUSS THEUEREN BI.
   WENDELSTADT GFC, 1797, PFLICHT GESUNDER MUT.
   WERNICKE J, 1896, VERHALTNIS ZWISCHEN.
   WIEDEMANN HR, 1995, EUR J PEDIATR, V154, P943, DOI 10.1007/BF01958634.
   WILKE J, 2004, HIST FAMILY, V9, P63.
   WITTSTEIN T, 1867, MATH STAT DEREN ANWE.
   Woods R, 1996, SOC HIST MED, V9, P1, DOI 10.1093/shm/9.1.1.
   WOODS R, 1995, CONTINUITY CHANGE, V10, P105, DOI 10.1017/S0268416000002514.
   Woods R, 2007, SOC HIST MED, V20, P483, DOI 10.1093/shm/hkm072.
   Woods Robert, 2006, CHILDREN REMEMBERED.
   Wootton D, 2006, BAD MED DOCTORS DOIN.
   Wrigley E. A., 1981, POPULATION HIST ENGL.
   WRIGLEY EA, 1968, DAEDALUS-US, V97, P546.
   Wrigley EA, 2004, CAMBRIDGE EC HIST MO, VI, P57.
   YALLOP H, 2000, C RECONSTR AG BOD W, P1600.
   Zhao ZW, 1997, POP STUD-J DEMOG, V51, P117, DOI 10.1080/0032472031000149856.
   1899, CONSULT ME PREFACED.
   MCQUIE FAMILY J, P1846.},
Number-of-Cited-References = {200},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Hist. Soc. Res.},
Doc-Delivery-Number = {527SC},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000272385800002},
DA = {2022-03-29},
}

@article{ WOS:000550988200045,
Author = {Wang, Kai and Li, Yanping and Liu, Gang and Rimm, Eric and Chan, Andrew
   T. and Giovannucci, Edward L. and Song, Mingyang},
Title = {Healthy Lifestyle for Prevention of Premature Death Among Users and
   Nonusers of Common Preventive Medications: A Prospective Study in 2 US
   Cohorts},
Journal = {JOURNAL OF THE AMERICAN HEART ASSOCIATION},
Year = {2020},
Volume = {9},
Number = {13},
Month = {JUL 7},
Abstract = {Background It remains unknown whether individuals who regularly use
   preventive medications receive the same benefit from healthy lifestyle
   as those who do not use medications. We aimed to examine the
   associations of healthy lifestyle with mortality according to use of
   major preventive medications, including aspirin, antihypertensives, and
   lipid-lowering medications.
   Methods and Results Among 79 043 women in the Nurses' Health Study
   (1988-2014) and 39 544 men in the Health Professionals Follow-up Study
   (1986-2014), we defined a healthy lifestyle score based on body mass
   index, smoking, physical activity, diet, and alcohol intake. We
   estimated multivariable hazard ratios (HRs) and population-attributable
   risks of death from any cause, cardiovascular disease, cancer, and other
   causes in relation to healthy lifestyle according to medication use. We
   documented 35 195 deaths. A similar association of healthy lifestyle
   score with lower all-cause mortality was observed among medication users
   (HR, 0.82 per unit increment; 95\% CI, 0.81-0.82) and nonusers (HR,
   0.81; 95\% CI, 0.79-0.83) (P interaction=0.54). The fraction of
   premature deaths that might be prevented by adherence to the 5 healthy
   lifestyle factors among medication users and nonusers was 38\% (95\% CI,
   32\%-42\%) and 40\% (95\% CI, 29\%-50\%) for all-cause mortality, 37\%
   (95\% CI, 27\%-46\%) and 45\% (95\% CI, 18\%-66\%) for cardiovascular
   disease mortality, and 38\% (95\% CI, 28\%-46\%) and 33\% (95\% CI,
   14\%-49\%) for cancer mortality, respectively.
   Conclusions Adherence to a healthy lifestyle confers substantial benefit
   for prevention of premature death among both regular users and nonusers
   of preventive medications. Adherence to a healthy lifestyle remains
   important even among individuals regularly using preventive medications.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Song, MY (Corresponding Author), 667 Huntington Ave,Kresge 906A, Boston, MA 02115 USA.
   Wang, Kai; Rimm, Eric; Giovannucci, Edward L.; Song, Mingyang, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Li, Yanping; Liu, Gang; Rimm, Eric; Giovannucci, Edward L.; Song, Mingyang, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   Liu, Gang, Tongji Med Coll, Sch Publ Hlth, Dept Nutr \& Food Hyg,Minist Educ, Hubei Key Lab Food Nutr \& Safety,Key Lab Environm, Wuhan, Peoples R China.
   Rimm, Eric; Chan, Andrew T.; Giovannucci, Edward L., Brigham \& Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   Rimm, Eric; Chan, Andrew T.; Giovannucci, Edward L., Harvard Med Sch, Boston, MA 02115 USA.
   Chan, Andrew T.; Song, Mingyang, Massachusetts Gen Hosp, Clin \& Translat Epidemiol Unit, Boston, MA 02114 USA.
   Chan, Andrew T.; Song, Mingyang, Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   Chan, Andrew T., Broad Inst MIT \& Harvard, Cambridge, MA 02142 USA.
   Harvard TH Chan Sch Publ Hlth, Dept Immunol \& Infect Dis, Dept Immunol \& Infect Dis, Boston, MA USA.},
DOI = {10.1161/JAHA.119.016692},
Article-Number = {e016692},
ISSN = {2047-9980},
Keywords = {lifestyle; mortality; nutrition; preventive medication; primary
   prevention},
Keywords-Plus = {PHYSICAL-ACTIVITY},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {mingyangsong@mail.harvard.edu},
ResearcherID-Numbers = {Liu, Gang/H-6420-2019
   Wang, Kai/O-7754-2019
   Song, Mingyang/M-6701-2013},
ORCID-Numbers = {Liu, Gang/0000-0002-1430-3016
   Wang, Kai/0000-0002-5614-5618
   Song, Mingyang/0000-0002-1324-0316},
Funding-Acknowledgement = {American Cancer Society Mentored Research Scholar GrantAmerican Cancer
   Society {[}MRSG-17-220-01 -NEC]; US National Institutes of HealthUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USA {[}P01 CA87969, U01 CA186107, P01 CA55075, UM1
   CA167552, K24 DK098311, R01 CA137178, R01 CA202704, R01 CA176726, K99
   CA215314, R00 CA215314]},
Funding-Text = {This work was supported by the American Cancer Society Mentored Research
   Scholar Grant (MRSG-17-220-01 -NEC to Song); by the US National
   Institutes of Health grants (P01 CA87969 to M. J. Stampfer; U01 CA186107
   to M. J. Stampfer; P01 CA55075, to W. C. Willett; UM1 CA167552 to W. C.
   Willett; K24 DK098311, R01 CA137178, R01 CA202704, R01 CA176726, to
   Chan; K99 CA215314 and R00 CA215314 to Song). Dr Chan is a Stuart and
   Suzanne Steele MGH Research Scholar. The funders had no role in the
   design and conduct of the study; collection, management, analysis, and
   interpretation of the data; and preparation, review, or approval of the
   article.},
Cited-References = {Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643.
   Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226.
   {[}Anonymous], 2020, J AM HEART ASSOC, V9, DOI {[}10.1161/JAHA.119.016692, DOI 10.1161/JAHA.119.016692].
   Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533.
   Aucott L, 2011, OBES REV, V12, pe412, DOI 10.1111/j.1467-789X.2010.00819.x.
   Batra D, 2009, PROC CVPR IEEE, P409.
   Bowles EJA, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5493-8.
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174.
   Cao Y, 2016, JAMA ONCOL, V2, P762, DOI 10.1001/jamaoncol.2015.6396.
   ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014.
   Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417.
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222.
   Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49.
   Colpani V, 2018, EUR J EPIDEMIOL, V33, P831, DOI 10.1007/s10654-018-0374-z.
   Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74.
   Deutekom M, 2011, J PUBLIC HEALTH-UK, V33, P71, DOI 10.1093/pubmed/fdq050.
   Fang J, 2005, AM J HYPERTENS, V18, P751, DOI 10.1016/j.amjhyper.2004.12.020.
   Fang J, 2018, MMWR-MORBID MORTAL W, V67, P219, DOI 10.15585/mmwr.mm6707a4.
   Fretheim A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-33.
   Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X.
   GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810.
   GIOVANNUCCI E, 1993, CANCER CAUSE CONTROL, V4, P441, DOI 10.1007/BF00050863.
   Gu Q, 2014, NCHS DATA BRIEF, P1.
   Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702.
   Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197.
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849.
   Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433.
   Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766.
   Kochanek Kenneth D, 2017, NCHS Data Brief, P1.
   Li T., 2008, BMJ-BRIT MED J, V337, DOI {[}DOI 10.1136/bmj.a1440, 10.1136/bmj.a1440].
   Li YP, 2018, CIRCULATION, V138, P345, DOI {[}10.1161/CIRCULATIONAHA.117.032047, 10.1161/circulationaha.117.032047].
   Lianov L, 2010, JAMA-J AM MED ASSOC, V304, P202, DOI 10.1001/jama.2010.903.
   O'Brien CW, 2019, ANN INTERN MED, V171, P596, DOI 10.7326/M19-0953.
   Pitkala KH, 2007, PATIENT EDUC COUNS, V67, P44, DOI 10.1016/j.pec.2007.01.016.
   Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442.
   Rebholz CM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003192.
   RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191.
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009.
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W.
   Roshandel G, 2019, LANCET, V394, P672, DOI 10.1016/S0140-6736(19)31791-X.
   Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8.
   Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7.
   Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8.
   Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141.
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059.
   Song MY, 2016, JAMA ONCOL, V2, P1154, DOI 10.1001/jamaoncol.2016.0843.
   Song MY, 2016, JAMA INTERN MED, V176, P1453, DOI 10.1001/jamainternmed.2016.4182.
   Sotos-Prieto M, 2017, NEW ENGL J MED, V377, P143, DOI {[}10.1056/NEJMoa1613502, 10.1056/nejmoa1613502].
   Stamatakis E, 2009, HEART, V95, P448, DOI 10.1136/hrt.2008.152041.
   STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804.
   Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250.
   Tramacere I, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1298-5.
   TROY LM, 1995, INT J OBESITY, V19, P570.
   Tsao AS, 2004, CA-CANCER J CLIN, V54, P150, DOI 10.3322/canjclin.54.3.150.
   Tunstall-Pedoe H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7809.
   Tuomilehto J, 2011, DIABETES CARE, DOI 10.1161/JAHA.116.003192.
   WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252.
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086.
   Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005.
   Xi B, 2017, J AM COLL CARDIOL, V70, P913, DOI 10.1016/j.jacc.2017.06.054.
   Yu E, 2017, ANN INTERN MED, V166, P613, DOI 10.7326/M16-1390.},
Number-of-Cited-References = {61},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Am. Heart Assoc.},
Doc-Delivery-Number = {MN6XT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000550988200045},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1997XE16900001,
Author = {Boyle, P},
Title = {Cancer, cigarette smoking and premature death in Europe: A review
   including the Recommendations of European Cancer Experts Consensus
   Meeting, Helsinki, October 1996},
Journal = {LUNG CANCER},
Year = {1997},
Volume = {17},
Number = {1},
Pages = {1-60},
Month = {MAY},
Abstract = {Cigarette smoking has been clearly and unambiguously identified as a
   direct cause of cancers of the oral cavity, oesophagus, stomach,
   pancreas. larynx, lung, bladder, kidney and leukaemia, especially acute
   myeloid leukaemia. Additionally, cigarette smoking is a direct cause of
   ischaemic heart disease (the commonest cause of death in western
   countries), respiratory heart disease, aortic aneurysm, chronic
   obstructive lung disease, stroke, pneumonia and cirrhosis and cancer of
   the liver. Cigarette smoking can kill in 24 different ways and, although
   smoking protects against several fatal and non-fatal conditions, the
   adverse effect of smoking on health is largely negative, In developed
   countries as a whole, tobacco is responsible for 24\% of all male deaths
   and 7\% of all female deaths: these figures rise to over 40\% in men in
   some countries of central and eastern Europe and to 17\% in women in the
   United States, The average loss of life of smokers is 8 years.
   Among United Kingdom doctors followed for 40 years, overall death rates
   in middle age were about three times higher among doctors who smoked
   cigarettes as among doctors who had never smoked regularly. About half
   of ail regular cigarette smokers will eventually be killed by their
   habit. The important information is that it is never too late to stop
   smoking: among United Kingdom doctors who slopped smoking. even in
   middle age, there eras a substantial improvement in life expectancy.
   World-wide, smoking is killing three million people each year and this
   figure is increasing. In most countries the worst is yet to come, since
   by the time the young smokers of today reach middle or old age there
   will be about IO million deaths/year from tobacco. Approximately 500
   million individuals alive today can expect to be killed by tobacco, 250
   million of these deaths will occur in middle age. Tobacco is already the
   biggest cause of adult death in developed countries. Over the next few
   decades tobacco could well become the biggest cause of adult death in
   the world. For men in developed countries, the full effects of smoking
   call already be seen. Tobacco now causes one-third of all male deaths in
   middle age (plus one fifth in old age). Tobacco is a cause of about half
   of: all male cancer deaths in middle age (plus one-third in old age). Of
   those who start smoking in their teenage years and keep on smoking,
   about half will be killed by tobacco. Waif of these deaths will be in
   middle age (35-69) and each will lose an average of 20-25 years of
   non-smoker life expectancy. In non-smokers in many countries, cancer
   mortality is decreasing slowly and total mortality rapidly. The war
   against cancer is being tron slowly: the effects of cigarette smoking
   are holding back this victory.
   Lung cancer now kills more women in the United States each year than
   breast cancer. For women in developed countries, the peak of the tobacco
   epidemic has not yet arrived. Tobacco now causes almost one-third of all
   deaths in women in middle age ill the United States. Although it has
   only 5\% of the world's female population. the United States has 50\% of
   the world's deaths from smoking in women.
   Tobacco smoking is a major cause of premature death. Throughout Europe,
   in 1990 tobacco smoking caused three quarters of a million deaths in
   middle age (between 35 and 69). In the Member States of the European
   Union in 1990 there were over one quarter of a million deaths in middle
   age directly caused by tobacco smoking: there were 219 700 in men and 31
   900 iu women. There were many more deaths caused by tobacco at older
   ages. In countries of central and eastern Europe. including the former
   USSR. there were 141 200 deaths in middle age in men and 42100 deaths in
   women. There is a need for urgent action to help contain this important
   and unnecessary loss of life. In formulating Recommendations,, the
   European Cancer Experts Consensus Committee recognised that Tobacco
   Control depends on various parts of society and not only on the
   individual. The individual, however, has actions which he or she can
   take. The important message is that cancer call be avoided and that
   three items with regard to cigarette smoking should be respected: (1)do
   not smoke; (2) smokers, stop as quickly as possible and do not smoke in
   the presence of others; and (3) if you do nut smoke, do not experiment
   with tobacco. (C) 1997 Elsevier Science Ireland Ltd.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Review},
Language = {English},
Affiliation = {Boyle, P (Corresponding Author), EUROPEAN INST ONCOL, DIV EPIDEMIOL \& BIOSTAT, VIA RIPAMONTI 435, I-20141 MILAN, ITALY.},
DOI = {10.1016/S0169-5002(97)00648-X},
ISSN = {0169-5002},
EISSN = {1872-8332},
Keywords = {cancer; cigarette smoking; premature death; review; recommendations;
   European Cancer Expert Consensus},
Keywords-Plus = {ENVIRONMENTAL TOBACCO-SMOKE; INVASIVE CERVICAL NEOPLASIA; UNITED-STATES
   VETERANS; ACUTE MYELOID-LEUKEMIA; SIMPLEX TYPE-2 VIRUS; MALE BRITISH
   DOCTORS; WOOD DUST EXPOSURE; RENAL-CELL CANCER; BLADDER-CANCER;
   STOMACH-CANCER},
Research-Areas = {Oncology; Respiratory System},
Web-of-Science-Categories  = {Oncology; Respiratory System},
ResearcherID-Numbers = {Boyle, Peter/A-4380-2014},
ORCID-Numbers = {Boyle, Peter/0000-0001-6251-0610},
Cited-References = {ACHESON ED, 1968, BRIT MED J, V2, P587, DOI 10.1136/bmj.2.5605.587.
   AUSTIN H, 1986, J CHRON DIS, V39, P417, DOI 10.1016/0021-9681(86)90108-6.
   BEGG CB, 1995, AM J EPIDEMIOL, V142, P653, DOI 10.1093/oxfordjournals.aje.a117689.
   BJARTVEIT K, 1986, TOBACCO MAJOR INT HL, P285.
   BLOT WJ, 1988, CANCER RES, V48, P3282.
   BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483.
   BLUM A, 1983, NY STATE J MED, V83, P1250.
   BOEING H, 1991, INT J CANCER, V47, P858, DOI 10.1002/ijc.2910470612.
   BOFFETTA P, 1993, EUR J CANCER, V29A, P1331, DOI 10.1016/0959-8049(93)90086-U.
   BOICE JD, 1985, J NATL CANCER I, V74, P955.
   BOUCHARDY C, 1990, INT J CANCER, V45, P842, DOI 10.1002/ijc.2910450509.
   BOUISSON J, 1959, MONPELLIER MED, V2, P539.
   BOYLE P, 1989, INT J PANCREATOL, V5, P327, DOI 10.1007/BF02924298.
   Boyle P, 1996, INT J CANCER, V67, P63, DOI 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-D.
   BOYLE P, 1987, AM J EPIDEMIOL, V125, P731, DOI 10.1093/oxfordjournals.aje.a114585.
   BOYLE P, 1992, Current Opinion in Oncology, V4, P471.
   BOYLE P, 1995, LUNG CANCER, V12, P167, DOI 10.1016/0169-5002(95)00443-5.
   BOYLE P, 1995, ORAL ONCOL, V31B, P1.
   BOYLE P, 1993, NEW ENGL J MED, V328, P1708, DOI 10.1056/NEJM199306103282311.
   BOYLE P, 1995, UR J CANC, V9, P1395.
   Boyle P, 1995, OXFORD TXB ONCOLOGY, P199.
   BRINTON LA, 1986, J CHRON DIS, V39, P1051, DOI 10.1016/0021-9681(86)90139-6.
   BRINTON LA, 1984, AM J EPIDEMIOL, V119, P896, DOI 10.1093/oxfordjournals.aje.a113812.
   BRINTON LA, 1987, J NATL CANCER I, V79, P23.
   BRINTON LA, 1989, AM J EPIDEMIOL, V130, P486, DOI 10.1093/oxfordjournals.aje.a115362.
   BRINTON LA, 1989, INT J CANCER, V44, P199, DOI 10.1002/ijc.2910440202.
   BRINTON LA, 1986, INT J CANCER, V38, P339, DOI 10.1002/ijc.2910380307.
   BRINTON LA, 1987, CANCER RES, V47, P1706.
   BROSS IDJ, 1968, AM J PUBLIC HEALTH N, V58, P1396, DOI 10.2105/AJPH.58.8.1396.
   BROWN LM, 1992, AM J EPIDEMIOL, V135, P763.
   BROWNSON RC, 1988, ARCH ENVIRON HEALTH, V43, P238, DOI 10.1080/00039896.1988.9934940.
   BROWNSON RC, 1989, J CLIN EPIDEMIOL, V42, P1025, DOI 10.1016/0895-4356(89)90169-8.
   BUIATTI E, 1990, INT J CANCER, V45, P896, DOI 10.1002/ijc.2910450520.
   BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409.
   BURNS DM, 1992, J NATL CANCER I, V84, P1387, DOI 10.1093/jnci/84.18.1387.
   CAPOCCIA R, 1994, INT J CANCER, V57, P154, DOI 10.1002/ijc.2910570204.
   CARTWRIGHT RA, 1988, LEUKEMIA, V2, P687.
   CARTWRIGHT RA, 1983, J EPIDEMIOL COMMUN H, V37, P256, DOI 10.1136/jech.37.4.256.
   Cattaruzza MS, 1996, ORAL ONCOL, V32B, P293, DOI 10.1016/0964-1955(96)00002-4.
   CEDERLOF R, 1975, RELATIONSHIP SMOKING.
   CHILMONCZYK BA, 1993, NEW ENGL J MED, V328, P1665, DOI 10.1056/NEJM199306103282303.
   CHOI SY, 1991, INT J CANCER, V49, P381, DOI 10.1002/ijc.2910490312.
   CHOLLATTRAQUET C, 1992, WOMEN TOBECCO.
   Chyou P H, 1993, Ann Epidemiol, V3, P211.
   Clemmesen J, 1965, STAT STUDIES MALIGNA.
   COLE P, 1971, NEW ENGL J MED, V284, P129, DOI 10.1056/NEJM197101212840304.
   COOKMOZAFFARI PJ, 1979, BRIT J CANCER, V39, P293, DOI 10.1038/bjc.1979.54.
   CORREA P, 1985, JNCI-J NATL CANCER I, V75, P645.
   {*}CTR DIS CONTR, 1991, MMWR-MORBID MORTAL W, V40, P62.
   CUCKLE HS, 1990, PRENATAL DIAG, V10, P561, DOI 10.1002/pd.1970100903.
   CULVER HA, 1993, ANN EPIDEMIOL, V3, P429.
   CUZICK J, 1989, INT J CANCER, V43, P415, DOI 10.1002/ijc.2910430312.
   DALLAVORGIA P, 1990, SCAND J SOC MED, V18, P81, DOI 10.1177/140349489001800201.
   DAVANZO B, 1990, EUR J CANCER, V26, P714, DOI 10.1016/0277-5379(90)90124-C.
   Davidson J, 1923, BRIT MED J, V1923, P733.
   DECARLI A, 1987, Nutrition and Cancer, V10, P29.
   DECARLI A, 1986, CANCER, V58, P2560, DOI 10.1002/1097-0142(19861201)58:11<2560::AID-CNCR2820581134>3.0.CO;2-U.
   DEMERS PA, 1995, SCAND J WORK ENV HEA, V21, P179, DOI 10.5271/sjweh.26.
   DESTEFANI E, 1990, REV EPIDEMIOL SANTE, V38, P297.
   DESTEFANI E, 1991, CANCER-AM CANCER SOC, V67, P536, DOI 10.1002/1097-0142(19910115)67:2<536::AID-CNCR2820670236>3.0.CO;2-8.
   {*}DHSS, 1988, 4 REP IND SCI COMM S.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271.
   DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525.
   DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739.
   Doll R, 1996, BRIT MED BULL, V52, P35, DOI 10.1093/oxfordjournals.bmb.a011531.
   Doll RPJ, 1985, EFFECTS HLTH EXPOSUR.
   DUNHAM LJ, 1968, J NATL CANCER I, V41, P683.
   {*}ENC BRITT, 1966, ENCY BRITT.
   EPA, 1992, RESP HLTH EFF PASS S.
   FELLS MJ, 1908, BMJ-BRIT MED J, V1, P1357.
   FITZPATRICK JM, 1993, WORLD J UROL, V11, P142.
   FLANDERS WD, 1982, AM J EPIDEMIOL, V115, P371, DOI 10.1093/oxfordjournals.aje.a113315.
   FLECKSEDER R, 1936, MUNCHEN MED WOCHEN, V36, P1585.
   FLODIN U, 1986, ARCH ENVIRON HEALTH, V41, P77, DOI 10.1080/00039896.1986.9937413.
   FONTHAM ETH, 1991, CANCER EPIDEM BIOMAR, V1, P35.
   FRANCESCHI S, 1990, J NATL CANCER I, V82, P1407, DOI 10.1093/jnci/82.17.1407.
   FRANCO EL, 1989, INT J CANCER, V43, P992, DOI 10.1002/ijc.2910430607.
   FUKUDA K, 1990, CANCER CAUSE CONTROL, V1, P165, DOI 10.1007/BF00053168.
   GARFINKEL L, 1990, CANCER, V65, P2356, DOI 10.1002/1097-0142(19900515)65:10<2356::AID-CNCR2820651033>3.0.CO;2-1.
   GARFINKEL L, 1985, J NATL CANCER I, V75, P463.
   GILBERT ES, 1979, RADIAT RES, V79, P122, DOI 10.2307/3575027.
   GOLD EB, 1993, AM J EPIDEMIOL, V137, P620, DOI 10.1093/oxfordjournals.aje.a116719.
   GRAHAM S, 1981, AM J EPIDEMIOL, V113, P675, DOI 10.1093/oxfordjournals.aje.a113147.
   GRAHAM S, 1977, J NATL CANCER I, V59, P1611, DOI 10.1093/jnci/59.6.1611.
   GUNTER W, 1954, ABTEIL ALLG KRANKENH, V41, P64.
   HABUCHI T, 1993, CANCER RES, V53, P3795.
   Hammond E. C., 1977, ORIGINS HUMAN CANCER, P101.
   HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127.
   HAMMOND SK, 1993, J NATL CANCER I, V85, P474, DOI 10.1093/jnci/85.6.474.
   HANIS NM, 1985, J OCCUP ENVIRON MED, V27, P283.
   HANSSON LE, 1994, INT J CANCER, V57, P26, DOI 10.1002/ijc.2910570106.
   HARTGE P, 1993, CANCER CAUSE CONTROL, V4, P391, DOI 10.1007/BF00051343.
   HAYES RB, 1993, CANCER CAUSE CONTROL, V4, P157, DOI 10.1007/BF00053157.
   HAYES RB, 1986, AM J EPIDEMIOL, V124, P569, DOI 10.1093/oxfordjournals.aje.a114429.
   HAYES RB, 1987, BRIT J CANCER, V56, P843, DOI 10.1038/bjc.1987.303.
   HIRAYAMA T, 1984, PREV MED, V13, P680, DOI 10.1016/S0091-7435(84)80017-1.
   HIRAYAMA T, 1990, LIFE STYLE MORTALITY, P28.
   HOSHIYAMA Y, 1992, CANCER CAUSE CONTROL, V3, P441, DOI 10.1007/BF00051357.
   HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306.
   HOWE GR, 1980, JNCI-J NATL CANCER I, V64, P701.
   HOWSON CP, 1986, EPIDEMIOL REV, V8, P1.
   HU JF, 1988, INT J CANCER, V41, P331, DOI 10.1002/ijc.2910410302.
   {*}IARC, 1988, MON EV CARC RISK HUM, V44, P44.
   {*}IARC, 1995, MON EV CARC MAN, V62.
   {*}IARC, 1990, MON EV CARC RISK HUM, P51.
   {*}IARC, 1986, INOUED J, V293, P659.
   {*}IARC, 1986, MON EV CARC RISK HUM, V38.
   {*}IARC, 1985, MON EV CARC MAN, V37.
   INOUE M, 1994, INT J CANCER, V56, P494, DOI 10.1002/ijc.2910560407.
   International Agency for Research on Cancer (IARC), 1987, MON EV CARC RISKS HU, P1.
   JEDRYCHOWSKI W, 1993, INT J EPIDEMIOL, V22, P606, DOI 10.1093/ije/22.4.606.
   JEDRYCHOWSKI W, 1986, INT J CANCER, V37, P837, DOI 10.1002/ijc.2910370607.
   JENSEN OM, 1987, J EPIDEMIOL COMMUN H, V41, P30, DOI 10.1136/jech.41.1.30.
   Jensen OM, 1980, CANC MORBIDITY CAUSE.
   Joint Iran-International Agency for Research on Cancer Study Group, 1977, Journal of the National Cancer Institute, V59, P1127.
   KABAT GC, 1993, CANCER CAUSE CONTROL, V4, P123, DOI 10.1007/BF00053153.
   KABAT GC, 1988, J CLIN EPIDEMIOL, V41, P907, DOI 10.1016/0895-4356(88)90108-4.
   KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1.
   KATO H, 1982, RADIAT RES, V90, P395, DOI 10.2307/3575716.
   KATO I, 1992, JPN J CANCER RES, V83, P568, DOI 10.1111/j.1349-7006.1992.tb00127.x.
   KATO I, 1990, CANCER RES, V50, P6559.
   KATO I, 1992, JPN J CANCER RES, V83, P1137, DOI 10.1111/j.1349-7006.1992.tb02736.x.
   KELLER AZ, 1970, AM J EPIDEMIOL, V91, P486, DOI 10.1093/oxfordjournals.aje.a121159.
   KENNAWAY EL, 1947, BRIT J CANCER, V1, P260, DOI 10.1038/bjc.1947.24.
   KINLEN LJ, 1988, BMJ-BRIT MED J, V297, P657, DOI 10.1136/bmj.297.6649.657.
   KNELLER RW, 1991, CANCER, V68, P672, DOI 10.1002/1097-0142(19910801)68:3<672::AID-CNCR2820680339>3.0.CO;2-T.
   KONO S, 1986, INT J EPIDEMIOL, V15, P527, DOI 10.1093/ije/15.4.527.
   KOPECKY KJ, 1987, 1386 RAD EFF RES F.
   KUNZE E, 1992, CANCER-AM CANCER SOC, V69, P1776, DOI 10.1002/1097-0142(19920401)69:7<1776::AID-CNCR2820690721>3.0.CO;2-P.
   Lamy L., 1910, ARCH MAL APPAR DIG, V4, P451.
   LAVECCHIA C, 1989, INT J CANCER, V43, P784, DOI 10.1002/ijc.2910430507.
   LAVECCHIA C, 1991, INT J EPIDEMIOL, V20, P39, DOI 10.1093/ije/20.1.39.
   LAVECCHIA C, 1990, CANCER RES, V50, P4497.
   LAVECCHIA C, 1992, EUR J CANCER, V28A, P514, DOI 10.1016/S0959-8049(05)80091-7.
   LAVECCHIA C, 1986, CANCER, V58, P935, DOI 10.1002/1097-0142(19860815)58:4<935::AID-CNCR2820580422>3.0.CO;2-O.
   LAVECCHIA C, 1987, INT J CANCER, V40, P484, DOI 10.1002/ijc.2910400409.
   LAVECCHIA C, 1984, LANCET, V1, P406.
   LAVECCHIA C, 1988, PREV MED, V17, P712, DOI 10.1016/0091-7435(88)90090-4.
   LAVECCHIA C, 1988, GYNECOL ONCOL, V30, P187, DOI 10.1016/0090-8258(88)90023-6.
   LAVECCHIA C, 1990, CANCER CAUSE CONTROL, V1, P69, DOI 10.1007/BF00053185.
   LAVECCHIA C, 1991, EUR J CANCER, V27, P94, DOI 10.1016/0277-5379(91)90071-K.
   LEVI F, 1990, INT J CANCER, V45, P852, DOI 10.1002/ijc.2910450511.
   LEVI F, 1989, SOZ PRAVENTIVMED S2, V34, P1.
   LEVIN ML, 1950, JAMA-J AM MED ASSOC, V143, P336, DOI 10.1001/jama.1950.02910390008002.
   LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X.
   LINDQVIST C, 1979, AM J EPIDEMIOL, V109, P521, DOI 10.1093/oxfordjournals.aje.a112710.
   LINET MS, 1991, CANCER CAUSE CONTROL, V2, P413, DOI 10.1007/BF00054302.
   LOCKWOOD K, 1961, ACTA PATHOL MIC S145, V51.
   LOPEZABENTE G, 1991, AM J EPIDEMIOL, V134, P830, DOI 10.1093/oxfordjournals.aje.a116158.
   LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001.
   LUCE D, 1993, INT J CANCER, V53, P224, DOI 10.1002/ijc.2910530209.
   MACFARLANE GJ, 1994, CANCER CAUSE CONTROL, V5, P259, DOI 10.1007/BF01830246.
   MACLURE M, 1987, ENVIRON RES, V42, P353, DOI 10.1016/S0013-9351(87)80200-1.
   Maclure M, 1990, Epidemiology, V1, P430, DOI 10.1097/00001648-199011000-00004.
   Marmot M, 1990, SMOKING HORMONE RELA.
   Marshall JR, 1996, CANCER CAUSE CONTROL, V7, P101, DOI 10.1007/BF00115642.
   Maxwell JL, 1924, BRIT MED J, V1924, P729.
   MCCREDIE M, 1983, BRIT J UROL, V55, P220, DOI 10.1111/j.1464-410X.1983.tb06561.x.
   MCCREDIE M, 1988, INT J CANCER, V42, P13, DOI 10.1002/ijc.2910420104.
   MCCREDIE M, 1983, J UROLOGY, V130, P28, DOI 10.1016/S0022-5347(17)50936-2.
   MCLAUGHLIN JK, 1985, J OCCUP ENVIRON MED, V27, P672.
   MCLAUGHLIN JK, 1983, J NATL CANCER I, V71, P287.
   MCLAUGHLIN JK, 1989, JNCI-J NATL CANCER I, V81, P1262, DOI 10.1093/jnci/81.16.1262.
   MCLAUGHLIN JK, 1988, J NATL CANCER I, V80, P1237, DOI 10.1093/jnci/80.15.1237.
   MELZER R, 1850, ANN MED UND PHYSL, V2, P480.
   MERLETTI F, 1989, CANCER RES, V49, P4919.
   MILHAM S, 1976, OCCUPATIONAL MORTALI, V1.
   MILLS CA, 1950, CANCER RES, V10, P539.
   MILLS PK, 1990, J NATL CANCER I, V82, P1832, DOI 10.1093/jnci/82.23.1832.
   MOHTASHAMIPUR E, 1989, J CANCER RES CLIN, V115, P503, DOI 10.1007/BF00391350.
   MOMAS I, 1994, EUR J EPIDEMIOL, V10, P599, DOI 10.1007/BF01719579.
   MOMMSEN S, 1983, CARCINOGENESIS, V4, P335, DOI 10.1093/carcin/4.3.335.
   MOMMSEN S, 1982, EUR J CANCER CLIN ON, V18, P1205, DOI 10.1016/0277-5379(82)90103-1.
   MORGAN RW, 1974, CAN MED ASSOC J, V111, P1067.
   MORRISON AS, 1984, J UROLOGY, V131, P650, DOI 10.1016/S0022-5347(17)50559-5.
   MULLER F. H., 1939, ZEITSCHR KREBSJORSCH, V49, P57.
   Mun \~{}oz N, 1989, IARC SCI PUBLICATION, V94.
   MUNOZ N, 1988, BRIT J CANCER, V57, P1, DOI 10.1038/bjc.1988.1.
   MUNOZ N, 1987, HERPES PAPILLOMA VIR, P97.
   MUNOZ N, 1989, IARC SCI PUBL, V94, P9.
   NAJEM GR, 1982, INT J EPIDEMIOL, V11, P212, DOI 10.1093/ije/11.3.212.
   NANDAKUMAR A, 1990, BRIT J CANCER, V62, P847, DOI 10.1038/bjc.1990.392.
   NOMURA A, 1990, CANCER RES, V50, P627.
   NOTANI P N, 1987, Nutrition and Cancer, V10, P103.
   NYLANDER LA, 1993, AM J IND MED, V24, P619, DOI 10.1002/ajim.4700240511.
   Ochsner A., 1939, SURG GYNECOL OBSTET, V68, P435.
   ORR IM, 1993, LANCET, V342, P575.
   PAFFENBARGER RS, 1978, J NATL CANCER I, V60, P89, DOI 10.1093/jnci/60.1.89.
   PALLI D, 1992, BRIT J CANCER, V65, P263, DOI 10.1038/bjc.1992.52.
   PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205.
   PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411.
   PARKIN DM, 1984, B WORLD HEALTH ORGAN, V62, P163, DOI 10.1139/b84-027.
   Parkin DM, 1992, IARC SCI PUBLICATION, V120.
   PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603.
   PETERSEN GR, 1980, 80104 US DHEW NIOSH.
   Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   PRESTON DL, 1986, 186 RAD EFF RES F.
   RAITANEN MP, 1995, BRIT J UROL, V76, P470, DOI 10.1111/j.1464-410X.1995.tb07748.x.
   RECHNITZ J, 1841, OEST MED WOCH, V23, P535.
   RISCH HA, 1985, AM J EPIDEMIOL, V122, P947, DOI 10.1093/oxfordjournals.aje.a114199.
   Roemer R., 1993, LEGISLATIVE ACTION C, V2nd.
   ROSS RK, 1989, CANCER RES, V49, P1045.
   ROSS RK, 1990, SMOKING HORMONE DIS.
   ROTHMAN K, 1972, J CHRON DIS, V25, P711, DOI 10.1016/0021-9681(72)90006-9.
   ROTHMAN KJ, 1989, AM J PUBLIC HEALTH, V79, P1516, DOI 10.2105/AJPH.79.11.1516.
   SALMINEN E, 1994, J UROLOGY, V152, P1420, DOI 10.1016/S0022-5347(17)32435-7.
   SANKARANARAYANAN R, 1989, BRIT J CANCER, V60, P638, DOI 10.1038/bjc.1989.330.
   Schairer E, 1943, Z KREBSFORSCH, V54, P261.
   SCHREK R, 1950, CANCER RES, V10, P49.
   SCHWARTZ D, 1961, J NATL CANCER I, V26, P1085.
   SEVERSON RK, 1987, CANCER-AM CANCER SOC, V60, P141, DOI 10.1002/1097-0142(19870715)60:2<141::AID-CNCR2820600202>3.0.CO;2-8.
   SHIMIZU Y, 1987, 1287 RAD EFF RES F.
   SIEGEL M, 1993, AM J EPIDEMIOL, V138, P1.
   SIEMIATYCKI J, 1995, INT J EPIDEMIOL, V24, P504, DOI 10.1093/ije/24.3.504.
   SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1.
   SKOV T, 1991, CANCER CAUSE CONTROL, V2, P365, DOI 10.1007/BF00054296.
   SMANS M, 1992, IARC PUBLICATION SER, V107.
   SMITH PG, 1982, BRIT MED J, V284, P449, DOI 10.1136/bmj.284.6314.449.
   Sommering ST, 1795, MORBIS VASORUM ABSOR.
   SORAHAN T, 1994, BRIT J UROL, V74, P753, DOI 10.1111/j.1464-410X.1994.tb07120.x.
   Spittel RL, 1924, BRIT MED J, V1924, P158, DOI 10.1136/bmj.1.3291.158.
   SPITZER WO, 1975, NEW ENGL J MED, V293, P419, DOI 10.1056/NEJM197508282930903.
   STASZEWSKI J, 1966, BRIT J CANCER, V20, P32, DOI 10.1038/bjc.1966.4.
   STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672.
   STOCKWELL HG, 1992, J NATL CANCER I, V84, P1417, DOI 10.1093/jnci/84.18.1417.
   STRADER CH, 1983, J EPIDEMIOL COMMUNIT, V42, P243.
   STURGEON SR, 1994, EPIDEMIOLOGY, V5, P218, DOI 10.1097/00001648-199403000-00012.
   TALAMINI R, 1990, CANCER CAUSE CONTROL, V1, P125, DOI 10.1007/BF00053163.
   TOLA S, 1980, INT ARCH OCC ENV HEA, V46, P43, DOI 10.1007/BF00377458.
   TOLLEY HD, 1983, RADIAT RES, V95, P211, DOI 10.2307/3576087.
   TOMATIS L, 1990, EUROPEAN SCH ONCOLOG.
   TOMINAGA K, 1991, JPN J CANCER RES, V82, P974, DOI 10.1111/j.1349-7006.1991.tb01930.x.
   TRICHOPOULOS D, 1985, INT J CANCER, V36, P291, DOI 10.1002/ijc.1985.36.3.291.
   TSO TC, 1986, HDB TOBACCO TOBACCO.
   TSO TC, 1972, PHYSL BIOCHEMISTRY T.
   TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403.
   TUYNS AJ, 1977, B CANCER, V64, P45.
   Tylecote FE, 1927, LANCET, V2, P256.
   Tyrrell A B, 1971, J Ir Med Assoc, V64, P213.
   UCHIDA T, 1995, J UROLOGY, V153, P1097, DOI 10.1016/S0022-5347(01)67517-7.
   {*}US PHS, 1964, DHEWS PUBL, V1103.
   {*}US SURG GEN, 1982, HLTH CONS SMOK CANC.
   {*}US SURG GEN SMOK, 1979, DHEW PUBL.
   {*}US SURG GEN SMOK, 1982, 7950066 DHEW.
   {*}USDHHS, 1989, RED HLTH CONS SMOK 2.
   {*}USDHHS, 1980, SMOK TOB HLTH FACT B.
   VAUGHAN TL, 1991, AM J EPIDEMIOL, V133, P560, DOI 10.1093/oxfordjournals.aje.a115927.
   VELEMA JP, 1986, EPIDEMIOL REV, V8, P28, DOI 10.1093/oxfordjournals.epirev.a036294.
   VINEIS P, 1984, INT J CANCER, V34, P165, DOI 10.1002/ijc.2910340205.
   VINEIS P, 1991, EUR J CANCER, V27, P1491, DOI 10.1016/0277-5379(91)90038-F.
   VINEIS P, 1991, ARCH ENV HLTH VOGL, V6, P6.
   VOGLER WR, 1962, CANCER-AM CANCER SOC, V15, P246, DOI 10.1002/1097-0142(196203/04)15:2<246::AID-CNCR2820150206>3.0.CO;2-5.
   VONKA V, 1984, INT J CANCER, V33, P49, DOI 10.1002/ijc.2910330110.
   VONKA V, 1987, ADV CANCER RES, V48, P149, DOI 10.1016/S0065-230X(08)60692-2.
   WALD N, 1990, SMOKING HORMONE RELA.
   Wald NJ, 1996, BRIT MED BULL, V52, P3, DOI 10.1093/oxfordjournals.bmb.a011530.
   WALD NJ, 1988, BRIT MED J, P297.
   WALKER R, 1984, FIRE HIST TOBACCO SM.
   WHITTEMORE AS, 1983, J NATL CANCER I, V71, P489.
   {*}WHO, 1985, BRIT MED J, V290, P9631.
   WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525.
   WINN DM, 1984, CANCER RES, V44, P1216.
   WINN DM, 1981, NEW ENGL J MED, V304, P745, DOI 10.1056/NEJM198103263041301.
   Winstanley M, 1995, TOBACCO AUSTR FACTS.
   WUWILLIAMS AH, 1990, CANCER RES, V50, P2569.
   WYNDER EL, 1977, CANCER-AM CANCER SOC, V40, P1246, DOI 10.1002/1097-0142(197709)40:3<1246::AID-CNCR2820400340>3.0.CO;2-5.
   WYNDER EL, 1976, CANCER-AM CANCER SOC, V38, P1591, DOI 10.1002/1097-0142(197610)38:4<1591::AID-CNCR2820380425>3.0.CO;2-R.
   WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001.
   WYNDER EL, 1957, CANCER, V10, P1300, DOI 10.1002/1097-0142(195711/12)10:6\&lt;1300::AID-CNCR2820100628\&gt;3.0.CO;2-2.
   WYNDER EL, 1963, DEUT MED WOCHENSCHR, V88, P623, DOI 10.1055/s-0028-1111989.
   YOU WC, 1989, J NATL CANCER I, V81, P162, DOI 10.1093/jnci/81.2.162.
   YOU WC, 1938, CANCER RES, V48, P48.
   YOUNG M, 1926, 99 MED RES COUNC.
   YU GP, 1991, CANCER CAUSE CONTROL, V2, P169, DOI 10.1007/BF00056210.
   ZAHM SH, 1992, CANCER CAUSE CONTROL, V3, P371, DOI 10.1007/BF00146891.
   ZATONSKI W, 1991, CANCER CAUSE CONTROL, V2, P3, DOI 10.1007/BF00052355.
   ZHANG ZF, 1994, CANCER EPIDEM BIOMAR, V3, P19.
   ZHENG W, 1992, INT J CANCER, V52, P557, DOI 10.1002/ijc.2910520410.
   ZHENG W, 1993, AM J EPIDEMIOL, V138, P965, DOI 10.1093/oxfordjournals.aje.a116816.
   1986, LANCET, V1, P198.},
Number-of-Cited-References = {283},
Times-Cited = {147},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Lung Cancer},
Doc-Delivery-Number = {XE169},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1997XE16900001},
DA = {2022-03-29},
}

@article{ WOS:000302709000007,
Author = {Otabe, S. and Wada, N. and Hashinaga, T. and Yuan, X. and Shimokawa, I.
   and Fukutani, T. and Tanaka, K. and Ohki, T. and Kakino, S. and Kurita,
   Y. and Nakayama, H. and Tajiri, Y. and Yamada, K.},
Title = {Hyperadiponectinemia protects against premature death in metabolic
   syndrome model mice by inhibiting AKT signaling and chronic inflammation},
Journal = {JOURNAL OF ENDOCRINOLOGY},
Year = {2012},
Volume = {213},
Number = {1},
Pages = {67-76},
Month = {APR},
Abstract = {We previously reported that transgenic (Tg) expression of adiponectin
   significantly prolonged the lifespan of normal mice. The aim of this
   study was to elucidate the mechanism involved in the longevity effects
   of adiponectin using KK/Ta mice, a murine model of metabolic syndrome.
   We established a Tg line of KK/Ta (Tg-KK/Ta) mice expressing human
   adiponectin in the liver, and assessed their lifespan. The cause of
   death was determined by macroscopic and microscopic examinations
   immediately after death. The expressions of SIRT1, C-reactive protein
   (CRP), inflammatory cytokines, AMPK, and AKT were measured by
   quantitative real-time PCR, ELISAs, and/or western blotting. KK/Ta mice
   had lower serum adiponectin levels and shorter lifespan (57.6 +/- 13.9
   vs 106.5 +/- 18.3 weeks, P<0.0001) than C57BL/6N mice. Tg adiponectin
   expression significantly extended the lifespan of KK/Ta mice (73.6 +/-
   16.6 weeks, P<0.001) without affecting body weight, daily food
   consumption, or plasma glucose levels. Neoplasms were observed in only
   three of 22KK/Ta mice that died spontaneously because of tumors.
   Atherosclerotic lesions were not detected in any mice. SIRT1 levels were
   not significantly different between KK/Ta and Tg-KK/Ta mice. Gene
   expressions of Crp, Tnf alpha, Il6, and Nf kappa b were increased in
   KK/Ta mice, but they were significantly attenuated in Tg-KK/Ta mice.
   Phosphorylated AMPK levels were increased and phosphorylated AKT levels
   were decreased in Tg-KK/Ta mice. The anti-inflammatory effects of
   adiponectin, achieved by inhibiting the AKT signaling pathway, may
   explain how adiponectin slows the accelerated aging process associated
   with the metabolic syndrome. Journal of Endocrinology (2012) 213, 67-76},
Publisher = {BIOSCIENTIFICA LTD},
Address = {EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Yamada, K (Corresponding Author), Kurume Univ, Sch Med, Dept Med, Div Endocrinol \& Metab, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.
   Otabe, S.; Wada, N.; Hashinaga, T.; Yuan, X.; Fukutani, T.; Tanaka, K.; Ohki, T.; Kakino, S.; Kurita, Y.; Nakayama, H.; Tajiri, Y.; Yamada, K., Kurume Univ, Sch Med, Dept Med, Div Endocrinol \& Metab, Kurume, Fukuoka 8300011, Japan.
   Shimokawa, I., Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Nagasaki 852, Japan.},
DOI = {10.1530/JOE-11-0329},
ISSN = {0022-0795},
Keywords-Plus = {ADIPOSE-SPECIFIC PROTEIN; C-REACTIVE PROTEIN; CALORIE RESTRICTION;
   INSULIN-RESISTANCE; KK/TA MICE; DIABETIC-NEPHROPATHY; HUMAN ADIPONECTIN;
   PLASMA-PROTEIN; KK MOUSE; BODY-FAT},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {yamada@med.kurume-u.ac.jp},
Funding-Acknowledgement = {Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science {[}21591154]},
Funding-Text = {This study was partially supported by a Grant-in-Aid for Scientific
   Research from the Japan Society for the Promotion of Science (grant
   number 21591154).},
Cited-References = {Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022.
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255.
   CAMERON TP, 1985, FUND APPL TOXICOL, V5, P526, DOI 10.1016/0272-0590(85)90100-9.
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608.
   Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004.
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196.
   Festa A, 2001, INT J OBESITY, V25, P1407, DOI 10.1038/sj.ijo.0801792.
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633.
   Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518.
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029.
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595.
   IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2.
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002.
   Lapice E, 2009, DIABETES CARE, V32, P1734, DOI 10.2337/dc09-0176.
   Liao J, 2003, J NEPHROL, V16, P841.
   Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2.
   MATSUO T, 1972, DIABETOLOGIA, V8, P391, DOI 10.1007/BF01212165.
   Murakoshi M, 2011, NEPHROL DIAL TRANSPL, V26, P2153, DOI 10.1093/ndt/gfq708.
   Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198.
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728.
   Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586.
   Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006.
   Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473.
   Ozes ON, 1999, NATURE, V401, P82.
   Pannacciulli N, 2001, INT J OBESITY, V25, P1416, DOI 10.1038/sj.ijo.0801719.
   Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008.
   Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553.
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354.
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182.
   TAKETOMI S, 1988, DIABETES RES CLIN PR, V5, P125, DOI 10.1016/S0168-8227(88)80051-2.
   TAKETOMI S, 1982, HORM METAB RES, V14, P14, DOI 10.1055/s-2007-1018909.
   Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016.
   Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200.
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984.
   Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245.},
Number-of-Cited-References = {35},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Endocrinol.},
Doc-Delivery-Number = {924RM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000302709000007},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000613514200001,
Author = {Xiang, Jianbang and Seto, Edmund and Mo, Jinhan and Zhang, Junfeng (Jim)
   and Zhang, Yinping},
Title = {Impacts of implementing Healthy Building guidelines for daily PM2.5
   limit on premature deaths and economic losses in urban China: A
   population-based modeling study},
Journal = {ENVIRONMENT INTERNATIONAL},
Year = {2021},
Volume = {147},
Month = {FEB},
Abstract = {Given a large fraction of people's exposure to urban PM2.5 occur
   indoors, reducing indoor PM2.5 levels may offer a more feasible and
   immediate way to save substantial lives and economic losses attributable
   to PM2.5 exposure. We aimed to estimate the premature mortality and
   economic loss reductions associated with achieving the newly established
   Chinese indoor air guideline and a few hypothetical indoor PM2.5
   guideline values. We used outdoor PM2.5 concentrations from 1497
   monitoring sites in 339 Chinese cities in 2015, coupled with a
   steady-state mass balance model, to estimate indoor concentrations of
   outdoor-infiltrated PM2.5. Using province-specific time -activity
   patterns for urban residents, we estimated outdoor and indoor exposures
   to PM2.5 of outdoor origin. We then proceeded to use localized
   census-based concentration-response models and the value of statistical
   life estimates to calculate premature deaths and economic losses
   attributable to PM2.5 exposure across urban China. Finally, we estimated
   potentially avoidable mortality and corresponding economic losses by
   meeting the current 24-hour based guideline and various hypothetical
   indoor limits for PM2.5. In 2015 in urban areas of mainland China, the
   city-specific annual mean outdoor and indoor PM2.5 concentrations ranged
   9-108 mu g/m(3) and 5-56 mu g/m(3), respectively. Indoor exposures
   contributed 62\%-91\% daily and 68\%-83\% annually to the total time
   weighted exposures. The potential reductions in total deaths and
   economic losses for the scenario in which daily indoor concentrations
   met the current guideline of 75 mu g/m(3), 37.5 mu g/m(3), and 25 mu
   g/m(3) were 16.9 (95\% CI: 0.7-62.1) thousand, 87.7 (95\% CI: 9.7-197.7)
   thousand, and 165.5 (95\% CI: 30.8-304.0) thousand, respectively. The
   corresponding reductions in economic losses were 5.7 (95\% CI: 0.2-34.8)
   billion, 29.4 (95\% CI: 2.4-109.6) billion, and 55.2 (95\% CI:
   7.7-168.0) billion US Dollars, respectively. Deaths and economic losses
   would be reduced exponentially within the range of 0-75 mu g/m(3) for
   hypothetical indoor PM2.5 limits. The findings demonstrate the
   effectiveness of reducing indoor concentrations of outdoor-originated
   PM2.5 in saving substantial lives and economic losses in China. The
   analysis provides quantitative evidence to support the implementation of
   an indoor air quality guideline or standard for PM2.5.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Zhang, YP (Corresponding Author), Dept Bldg Sci, Beijing 100084, Peoples R China.
   Xiang, Jianbang; Seto, Edmund, Univ Washington, Dept Environm \& Occupat Hlth Sci, Seattle, WA 98195 USA.
   Xiang, Jianbang; Mo, Jinhan; Zhang, Yinping, Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China.
   Mo, Jinhan; Zhang, Yinping, Beijing Key Lab Indoor Air Qual Evaluat \& Control, Beijing 100084, Peoples R China.
   Zhang, Junfeng (Jim), Duke Univ, Global Hlth Inst, Durham, NC 27708 USA.
   Zhang, Junfeng (Jim), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   Zhang, Junfeng (Jim), Duke Kunshan Univ, Global \& Environm Hlth, Kunshan 215316, Jiangsu, Peoples R China.},
DOI = {10.1016/j.envint.2020.106342},
EarlyAccessDate = {JAN 2021},
Article-Number = {106342},
ISSN = {0160-4120},
EISSN = {1873-6750},
Keywords = {PM2.5; Indoor air quality guideline; Healthy building; Burden of
   disease; Environmental health},
Keywords-Plus = {FINE PARTICULATE MATTER; AIR-POLLUTION; ULTRAFINE PARTICLES; MORTALITY;
   EXPOSURE; INDOOR; INFILTRATION; FILTRATION; RISK; BURDEN},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {zhangyp@tsinghua.edu.cn},
ResearcherID-Numbers = {Mo, Jinhan/A-7424-2008
   },
ORCID-Numbers = {Mo, Jinhan/0000-0002-3178-6507
   Zhang, Junfeng/0000-0003-3759-6672},
Funding-Acknowledgement = {National Key Research and Development Program of China
   {[}2017YFC0702700]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China (NSFC) {[}51420105010, 51521005]},
Funding-Text = {The authors wish to express special thanks to Dr. Charles J. Weschler
   for helpful discussions and suggestions and Louise Weschler for
   providing language help. This study was supported by the National Key
   Research and Development Program of China (2017YFC0702700) and the
   Natural Science Foundation of China (51420105010 and 51521005).},
Cited-References = {Architectural Society of China, 2017, 022016 TA SC ARCH SO.
   Azimi P, 2020, J EXPO SCI ENV EPID, V30, P271, DOI 10.1038/s41370-018-0103-4.
   Azimi P, 2014, ATMOS ENVIRON, V98, P337, DOI 10.1016/j.atmosenv.2014.09.007.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Chen C, 2011, ATMOS ENVIRON, V45, P275, DOI 10.1016/j.atmosenv.2010.09.048.
   Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI {[}10.1164/rccm.201609-1862oc, 10.1164/rccm.201609-1862OC, 10.1164/rccm.201612-2427OC].
   Cui XX, 2018, ENVIRON INT, V114, P27, DOI 10.1016/j.envint.2018.02.010.
   Day DB, 2017, JAMA INTERN MED, V177, P1344, DOI 10.1001/jamainternmed.2017.2842.
   Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035.
   Fisk WJ, 2017, INDOOR AIR, V27, P909, DOI 10.1111/ina.12371.
   Huang C, 2017, CIRCULATION, V136, P1575, DOI {[}10.1161/CIRCULATIONAHA.116.026487, 10.1161/circulationaha.116.026487].
   III CAP, 2007, BUILD ENVIRON, V19, P33, DOI DOI 10.1080/08958370701492961.
   Institute for Health Metrics and Evaluation, 2020, GLOB DIS BURD GBD CO.
   Ji WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124238.
   Jin Y., 2018, ASIAN DEV REV, V35, P58, DOI DOI 10.1162/ADEV\_A\_00114.
   Johns Hopkins University, 2020, COVID 19 DASHB.
   Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1.
   Lelieveld J, 2013, ATMOS CHEM PHYS, V13, P7023, DOI 10.5194/acp-13-7023-2013.
   Li TT, 2019, ENVIRON INT, V125, P245, DOI 10.1016/j.envint.2019.01.073.
   Li TT, 2018, LANCET PUBLIC HEALTH, V3, pE470, DOI 10.1016/S2468-2667(18)30144-0.
   Liang DH, 2020, INNOVATION-AMSTERDAM, V1, DOI {[}10.1016/j.xinn.2020.100047, 10.1101/2020.05.04.20090746].
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Ministry of Housing and Urban-Rural Development of China, 2018, JGJTX20XX MIN HOUS U.
   Montgomery JF, 2015, BUILD ENVIRON, V85, P17, DOI 10.1016/j.buildenv.2014.11.005.
   Olsen Y, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-112.
   Somers CM, 2004, SCIENCE, V304, P1008, DOI 10.1126/science.1095815.
   Soppa VJ, 2014, INT J ENV RES PUB HE, V11, P6871, DOI 10.3390/ijerph110706871.
   State Administration for Market Regulation of China; China National Standardization Management Committee, 2020, 188832020 GBT STAT A.
   Sun ZW, 2019, BUILD ENVIRON, V161, DOI 10.1016/j.buildenv.2019.106243.
   Tan Xiaodong, 2017, Value Health Reg Issues, V12, P112, DOI 10.1016/j.vhri.2017.04.001.
   Wang F, 2016, ENVIRON POLLUT, V215, P280, DOI 10.1016/j.envpol.2016.05.023.
   Wang YF, 2015, PROCEDIA ENGINEER, V121, P333, DOI 10.1016/j.proeng.2015.08.1076.
   Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987.
   Xiang J., 2017, HLTH BUILDING 2017.
   Xiang JB, 2019, INDOOR AIR, V29, P604, DOI 10.1111/ina.12565.
   Xiang JB, 2016, ENVIRON SCI TECHNOL, V50, P10236, DOI 10.1021/acs.est.6b03069.
   XIE R, 2016, INDOOR AIR, V97, P180.
   Xu CY, 2017, J AIR WASTE MANAGE, V67, P694, DOI 10.1080/10962247.2016.1272503.
   Xue T, 2019, ENVIRON INT, V129, P430, DOI 10.1016/j.envint.2019.05.067.
   Yang J, 2018, LANCET, V391, P2140, DOI 10.1016/S0140-6736(18)30486-0.
   Yin P, 2017, ENVIRON HEALTH PERSP, V125, DOI {[}10.1289/EHP1673, 10.1289/ehp1673].
   Zauli-Sajani S, 2018, SCI TOTAL ENVIRON, V627, P67, DOI 10.1016/j.scitotenv.2018.01.217.
   Zhao D, 2015, INT J ENV RES PUB HE, V12, P8448, DOI 10.3390/ijerph120708448.
   Zhiyan Consulting Group, 2017 23 CHIN RES FRE.
   Zhu SW, 2015, BUILD ENVIRON, V93, P41, DOI 10.1016/j.buildenv.2015.02.028.},
Number-of-Cited-References = {45},
Times-Cited = {6},
Usage-Count-Last-180-days = {8},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Environ. Int.},
Doc-Delivery-Number = {QA5VT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000613514200001},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000266414900010,
Author = {Fareed, Ayman and Casarella, Jennifer and Amar, Richard and Vayalapalli,
   Sreedevi and Drexler, Karen},
Title = {Benefits of Retention in Methadone Maintenance and Chronic Medical
   Conditions as Risk Factors for Premature Death Among Older Heroin
   Addicts},
Journal = {JOURNAL OF PSYCHIATRIC PRACTICE},
Year = {2009},
Volume = {15},
Number = {3},
Pages = {227-234},
Month = {MAY},
Abstract = {Background. Methadone maintenance treatment reduces rates of premature
   mortality in heroin addicts. However, few published studies have
   addressed the effectiveness of treatment, mortality rates, or causes of
   death in older (geriatric) patients maintained on methadone. Identifying
   risk factors for premature mortality and potential targets for early
   intervention may reduce rates of premature mortality in older patients
   maintained on methadone. Methods. We conducted a retrospective chart
   review for patients enrolled in the methadone maintenance program at the
   Atlanta Veterans Affairs Medical Center. We reviewed the charts of 91
   patients and collected the following information: demographics (age,
   gender, marital status, and race); composite score at admission on the
   Addiction Severity Index (ASI); most recent ASI score for alcohol use,
   drug use, and medical, psychiatric, family, legal, and employment
   problems; results of urine drug screens for opiates, cocaine, and
   benzodiazepines (first 4 screens after admission and last 4 screens);
   dose and duration of methadone treatment; HIV and hepatitis B and C
   status; tobacco smoking; presence of diabetes mellitus, hypertension,
   heart disease, chronic obstructive pulmonary disease, or cancer; history
   of intravenous drug use; and missed primary care appointments (last five
   appointments). Results. A statistically significant association was
   found between diabetes mellitus and between liver and gastrointestinal
   cancer and premature mortality in this sample of older patients
   maintained on methadone (OR = 30.79, p = 0.008 for diabetes mellitus; OR
   = 19.91, p = 0.017 for cancer). Patients who remained in treatment
   showed statistically significant improvement in ASI scores for problems
   related to drug use and for psychiatric, medical, and legal problems.
   They showed a nonsignificant trend toward reduction of problems
   associated with alcohol use. The group of patients who dropped out of
   methadone treatment did not show statistically significant improvement
   on any area of the ASI except family problems. The group who remained in
   treatment also showed a statistically significant reduction in drug use
   when results of the first four and last four urine drug screens for
   opiates, cocaine, and benzodiazepines were compared (p < 0.0001 for
   opiates and cocaine, p = 0.02 for benzodiazepines). On the other hand,
   the group who dropped out of methadone treatment did not show any
   statistically significant reduction in drug use based on urine screens
   (p = 0.05 for opiates, p = 0.38 for cocaine, and p = 0.53 for
   benzodiazepines). Conclusions. The results presented here suggest
   potential targets for intervention related to lifestyle risk factors and
   comorbid medical conditions, such as nicotine dependence and diabetes
   mellitus, that may have the potential to improve health outcomes for
   older patients with opioid dependence. (Journal of Psychiatric Practice
   2009;15:227-234)},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Fareed, A (Corresponding Author), Atlanta VA Med Ctr 116A, 1670 Clairmont Rd, Decatur, GA 30033 USA.
   Fareed, Ayman; Casarella, Jennifer; Amar, Richard; Vayalapalli, Sreedevi; Drexler, Karen, Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA.},
DOI = {10.1097/01.pra.0000351884.83377.e2},
ISSN = {1527-4160},
EISSN = {1538-1145},
Keywords = {premature death; methadone; comorbid medical conditions; opiate
   dependence; substance use},
Keywords-Plus = {DIABETES-MELLITUS; DRUG-USE; MORTALITY-RATES; SEVERITY INDEX;
   HEPATITIS-C; COHORT; USERS; PREVALENCE; DEPENDENCE; EFFICACY},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {ayman.fareed@va.gov},
ResearcherID-Numbers = {Stockwell, Tim/B-6662-2012},
Cited-References = {Alterman AI, 1998, DRUG ALCOHOL DEPEN, V49, P217, DOI 10.1016/S0376-8716(98)00015-5.
   Arao M, 2003, J GASTROENTEROL, V38, P355, DOI 10.1007/s005350300063.
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004.
   Ball JC., 1991, EFFECTIVENESS METHAD.
   BARR HL, 1984, J STUD ALCOHOL, V45, P440, DOI 10.15288/jsa.1984.45.440.
   BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121.
   Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x.
   Center for Disease Control and Prevention, 1980, PREV DIAGN DIAB AG U.
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P303.
   Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888.
   DAVILA DG, 1993, MAYO CLIN PROC, V68, P170, DOI 10.1016/S0025-6196(12)60166-9.
   De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306.
   {*}DEP HLTH HUM SERV, 1982, PUBL PHS.
   DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002.
   Eissenberg T, 1997, JAMA-J AM MED ASSOC, V277, P1945, DOI 10.1001/jama.277.24.1945.
   Firoz S, 2004, AM J GERIAT PSYCHIAT, V12, P539, DOI 10.1176/appi.ajgp.12.5.539.
   HAASTRUP S, 1988, ACTA PSYCHIAT SCAND, V77, P22, DOI 10.1111/j.1600-0447.1988.tb05071.x.
   JOE GW, 1982, AM J PUBLIC HEALTH, V72, P703, DOI 10.2105/AJPH.72.7.703.
   JOE GW, 1987, AM J PUBLIC HEALTH, V77, P347, DOI 10.2105/AJPH.77.3.347.
   Leonhard C, 2000, J SUBST ABUSE TREAT, V18, P129, DOI 10.1016/S0740-5472(99)00025-2.
   LING W, 1976, ARCH GEN PSYCHIAT, V33, P709.
   Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x.
   MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006.
   MCLELLAN AT, 1983, ARCH GEN PSYCHIAT, V40, P620.
   MCLELLAN AT, 1983, NIDA RES MONOGRAPH S.
   OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x.
   Petit JM, 2001, J HEPATOL, V35, P279, DOI 10.1016/S0168-8278(01)00143-X.
   Rathod NH, 2005, BRIT J PSYCHIAT, V187, P421, DOI 10.1192/bjp.187.5.421.
   Rosen D, 2004, GERONTOLOGIST, V44, P543, DOI 10.1093/geront/44.4.543.
   Smyth B, 2007, PREV MED, V44, P369, DOI 10.1016/j.ypmed.2006.10.003.
   Sorensen HJ, 2005, ACTA PSYCHIAT SCAND, V111, P244, DOI 10.1111/j.1600-0447.2004.00445.x.
   STRAIN EC, 1993, ANN INTERN MED, V119, P23, DOI 10.7326/0003-4819-119-1-199307010-00004.
   Tan A, 2008, LIVER INT, V28, P175, DOI 10.1111/j.1478-3231.2007.01652.x.
   Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035.
   Thuluvath PJ, 2003, AM J GASTROENTEROL, V98, P438, DOI 10.1016/S0002-9270(02)05924-5.
   Vlahov D, 2004, ADDICTION, V99, P946, DOI 10.1111/j.1360-0443.2004.00780.x.
   Woody GE, 2007, J ADDICT MED, V1, P180, DOI 10.1097/ADM.0b013e318155980e.
   Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0.
   ZANIS DA, 1994, J SUBST ABUSE TREAT, V11, P541, DOI 10.1016/0740-5472(94)90005-1.},
Number-of-Cited-References = {39},
Times-Cited = {64},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {9},
Journal-ISO = {J. Psychiatr. Pract.},
Doc-Delivery-Number = {450QC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000266414900010},
DA = {2022-03-29},
}

@article{ WOS:000667569600001,
Author = {Witteveen, Dirk},
Title = {Premature Death Risk from Young Adulthood Incarceration},
Journal = {SOCIOLOGICAL QUARTERLY},
Abstract = {Drawing the National Longitudinal Survey of Youth 1979 data, a
   comprehensive treatment model indicates a strong positive influence of
   incarceration on premature death risk. Models adjust for numerous
   covariates of mortality, including demographics, family background, and
   a range of health and behavioral indicators measured during childhood,
   as well as selection into incarceration ({''}treatment{''}). This study
   expands extant research by observing much longer panel data, closer to
   the mortality curve. The main treatment effect reveals risk of premature
   death by one's mid-fifties being increased by 13.9 percentage-points.
   Results also indicate that young adulthood incarceration shortens lives
   equally for Blacks and non-Blacks.},
Publisher = {TAYLOR \& FRANCIS INC},
Address = {530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Witteveen, D (Corresponding Author), Univ Oxford, Nuffield Coll, 1 New Rd, Oxford OX1 1NF, England.
   Witteveen, Dirk, Univ Oxford, Nuffield Coll, 1 New Rd, Oxford OX1 1NF, England.},
DOI = {10.1080/00380253.2021.1923379},
EarlyAccessDate = {JUN 2021},
ISSN = {0038-0253},
EISSN = {1533-8525},
Keywords = {Incarceration; premature death; race; prisoners; penal system},
Keywords-Plus = {RACIAL DISPARITIES; CORRECTIONAL FACILITIES; INFECTIOUS-DISEASE; HIV
   TRANSMISSION; MORTALITY; PRISON; BLACK; WHITE; LIFE; GENDER},
Research-Areas = {Sociology},
Web-of-Science-Categories  = {Sociology},
Author-Email = {dirk.witteveen@nuffield.ox.ac.uk},
Cited-References = {Abadie A, 2006, ECONOMETRICA, V74, P235, DOI 10.1111/j.1468-0262.2006.00655.x.
   Alexander M., 2010, NEW JIM CROW MASS IN.
   Ansell DA, 2017, DEATH GAP INEQUALITY.
   Beckett K, 2006, CRIMINOLOGY, V44, P105, DOI 10.1111/j.1745-9125.2006.00044.x.
   Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115.
   Blumstein Alfred., 1993, U COLORADO LAW REV, V64, P743.
   BonillaSilva E, 1997, AM SOCIOL REV, V62, P465, DOI 10.2307/2657316.
   Braman D., 2004, DOING TIME OUTSIDE I.
   Bridges GS, 1998, AM SOCIOL REV, V63, P554, DOI 10.2307/2657267.
   Bureau of Labor Statistics U. S. Department of Labor., 2019, NAT LONG SURV YOUTH.
   Campbell MC, 2015, CRIMINOLOGY, V53, P180, DOI 10.1111/1745-9125.12065.
   Carson E.A., 2018, PRISONERS 2016.
   Cattaneo MD, 2010, J ECONOMETRICS, V155, P138, DOI 10.1016/j.jeconom.2009.09.023.
   Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2.
   Daza S, 2020, DEMOGRAPHY, V57, P577, DOI 10.1007/s13524-020-00869-5.
   Delgado R., 2017, CRITICAL RACE THEORY.
   Dirkzwager A, 2012, J RES CRIME DELINQ, V49, P383, DOI 10.1177/0022427811415534.
   ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718.
   Elwert F, 2014, ANNU REV SOCIOL, V40, P31, DOI 10.1146/annurev-soc-071913-043455.
   Epstein AM, 2001, NEW ENGL J MED, V344, P1471, DOI 10.1056/NEJM200105103441911.
   Farmer P., 2002, INVISIBLE PUNISHMENT, P239.
   Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1.
   Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7.
   Ford JA, 2005, SOCIOL INQ, V75, P109, DOI 10.1111/j.1475-682X.2005.00114.x.
   Frank KA, 2013, EDUC EVAL POLICY AN, V35, P437, DOI 10.3102/0162373713493129.
   Freeman RB, 1996, J ECON PERSPECT, V10, P25, DOI 10.1257/jep.10.1.25.
   Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439.
   Furlong A., 2009, HDB YOUTH YOUNG ADUL.
   Gangl M, 2010, ANNU REV SOCIOL, V36, P21, DOI 10.1146/annurev.soc.012809.102702.
   Geruso M, 2012, DEMOGRAPHY, V49, P553, DOI 10.1007/s13524-011-0089-1.
   HAGAN J, 1990, AM J SOCIOL, V96, P265, DOI 10.1086/229530.
   Hagan J, 1999, CRIME JUSTICE, V26, P121, DOI DOI 10.1086/449296.
   Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993.
   Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789.
   Harris Casey T, 2009, Race Soc Probl, V1, P187.
   Hassine Victor., 2004, LIFE PAROLE LIVING P, V3.
   Hayes LM, 2012, J CORRECT HEALTH CAR, V18, P233, DOI 10.1177/1078345812445457.
   Hayward MD, 2000, AM SOCIOL REV, V65, P910, DOI 10.2307/2657519.
   Heimer Karen., 2005, GENDER CRIME PATTERN.
   Hilinski-Rosick CarlyM., 2017, ISSUES CORRECTIONS R.
   Huebner BM, 2005, JUSTICE Q, V22, P281, DOI 10.1080/07418820500089141.
   Imai K, 2014, J R STAT SOC B, V76, P243, DOI 10.1111/rssb.12027.
   Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751.
   Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651.
   Jiang SH, 2006, PRISON J, V86, P32, DOI 10.1177/0032885505283876.
   Johnson EI, 2012, J MARRIAGE FAM, V74, P342, DOI 10.1111/j.1741-3737.2012.00957.x.
   Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0.
   Keen B, 2009, CRIMINOLOGY, V47, P209, DOI 10.1111/j.1745-9125.2009.00143.x.
   Kjelsberg E, 2010, EUR J EPIDEMIOL, V25, P237, DOI 10.1007/s10654-010-9436-6.
   Krebs CP, 2002, AIDS EDUC PREV, V14, P53, DOI 10.1521/aeap.14.7.53.23865.
   Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370.
   Kutateladze BL, 2014, CRIMINOLOGY, V52, P514, DOI 10.1111/1745-9125.12047.
   Lopoo LM, 2005, J MARRIAGE FAM, V67, P721, DOI 10.1111/j.1741-3737.2005.00165.x.
   Macalino G. E., 2004, International Journal of Drug Policy, V15, P103, DOI 10.1016/j.drugpo.2003.10.006.
   Massey DS, 1993, AM APARTHEID SEGREGA.
   Massoglia M, 2008, LAW SOC REV, V42, P275, DOI 10.1111/j.1540-5893.2008.00342.x.
   Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105.
   Massoglia M, 2015, ANNU REV SOCIOL, V41, P291, DOI 10.1146/annurev-soc-073014-112326.
   Massoglia M, 2014, SOC SCI RES, V46, P142, DOI 10.1016/j.ssresearch.2014.03.002.
   Morenoff J. D., 2005, ETHNICITY CAUSAL MEC, P139, DOI DOI 10.1017/CBO9781139140348.
   Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564.
   Mumola, 2007, MED CAUSES DEATH STA.
   Mumola ChristopherJ., 2008, DEATHS CUSTODY STAT.
   Pager D, 2003, AM J SOCIOL, V108, P937, DOI 10.1086/374403.
   Pager D, 2009, ANN AM ACAD POLIT SS, V623, P195, DOI 10.1177/0002716208330793.
   Pastore A. L., 2007, SOURCEBOOK CRIMINAL.
   Patterson EJ, 2013, AM J PUBLIC HEALTH, V103, P523, DOI 10.2105/AJPH.2012.301148.
   Patterson EJ, 2010, DEMOGRAPHY, V47, P587, DOI 10.1353/dem.0.0123.
   Petersilia, 2003, PRISONERS COME HOME.
   Pettit B, 2004, AM SOCIOL REV, V69, P151, DOI 10.1177/000312240406900201.
   Pridemore WA, 2014, J HEALTH SOC BEHAV, V55, P215, DOI 10.1177/0022146514533119.
   Roeder O, 2015, WHAT CAUSED CRIME DE.
   Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007.
   Rucks-Ahidiana Z, 2021, SOC PROBL, V68, P438, DOI 10.1093/socpro/spaa018.
   Sampson RJ, 1997, CRIME JUSTICE, V21, P311, DOI 10.1086/449253.
   Schnittker J, 2007, J HEALTH SOC BEHAV, V48, P115, DOI 10.1177/002214650704800202.
   Steffensmeier D, 2000, AM SOCIOL REV, V65, P705, DOI 10.2307/2657543.
   Steffensmeier D, 2006, J QUANT CRIMINOL, V22, P241, DOI 10.1007/s10940-006-9010-2.
   Steffensmeier D, 2017, SOCIOL PERSPECT, V60, P810, DOI 10.1177/0731121416679371.
   Troesken Werner, 2004, WATER RACE DIS.
   Uggen C, 2006, ANN AM ACAD POLIT SS, V605, P281, DOI 10.1177/0002716206286898.
   Uggen C, 2002, AM SOCIOL REV, V67, P777, DOI 10.2307/3088970.
   Wacquant L, 2002, NEW LEFT REV, P41.
   Wacquant L, 2001, MASS IMPRISONMENT SO, P82, DOI DOI 10.4135/9781446221228.
   Wakefield S, 2010, ANNU REV SOCIOL, V36, P387, DOI 10.1146/annurev.soc.012809.102551.
   WELLS LE, 1991, SOC PROBL, V38, P71, DOI 10.1525/sp.1991.38.1.03a00050.
   Western B, 2005, AM J SOCIOL, V111, P553, DOI 10.1086/432780.
   Western B, 2002, AM SOCIOL REV, V67, P526, DOI 10.2307/3088944.
   Western B, 2015, AM J SOCIOL, V120, P1512, DOI 10.1086/681301.
   Western Bruce., 2006, PUNISHMENT INEQUALIT.
   Western Bruce., 2019, HOMEWARD LIFE YEAR P.
   Wheelock D., 2008, COLORS POVERTY WHY R, P261.
   Wildeman C, 2009, DEMOGRAPHY, V46, P265, DOI 10.1353/dem.0.0052.
   Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7.
   Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279.},
Number-of-Cited-References = {95},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Sociol. Q.},
Doc-Delivery-Number = {TA9MP},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000667569600001},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000508318100001,
Author = {Samuelsson, John and Samuelsson, Ulf and Hanberger, Lena and Bladh,
   Marie and Akesson, Karin},
Title = {Poor metabolic control in childhood strongly correlates to
   diabetes-related premature death in persons <30 years of age-A
   population-based cohort study},
Journal = {PEDIATRIC DIABETES},
Year = {2020},
Volume = {21},
Number = {3},
Pages = {479-485},
Month = {MAY},
Abstract = {Background/objective The importance of metabolic control in childhood
   regarding excess risk of death in young persons has not been well
   studied. This registry-based study aimed to investigate mortality rates
   and cause of death related to metabolic control in young persons (<= 29
   years) in Sweden with type 1 diabetes. Methods All 12 652 subjects
   registered in the Swedish pediatric diabetes quality register, from 2006
   to 2014, were included. Data were merged with the Swedish Cause of Death
   Register. Standardized mortality rates were calculated using the
   official Swedish population register. Results Of 68 deaths identified,
   38.2\% of the deaths were registered as being due to diabetes whereof
   the major cause of death was acute complications. Overall standardized
   mortality ratio was 2.7 (2.1-3.4, 95\% CI). Subjects who died from
   diabetes had a mean HbA1c of 74 +/- 19 mmol/mol (8.9 +/- 1.7\%) during
   childhood vs 62 +/- 12 mmol/mol (7.8 +/- 1.1\%) in those still alive (P
   < .001). Conclusions In this nationwide cohort of young subjects with
   type 1 diabetes, there was a high mortality rate compared to the general
   population. Mean HbA1c in childhood was significantly higher in those
   who died from diabetes, compared to subjects who were still alive. To
   decrease mortality in young persons with type 1 diabetes it is essential
   not only to achieve but also to maintain a good metabolic control during
   childhood and adolescence.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Samuelsson, J (Corresponding Author), Ryhov Cty Hosp, Dept Pediat, S-55185 Jonkoping, Sweden.
   Samuelsson, John; Akesson, Karin, Ryhov Cty Hosp, Dept Pediat, S-55185 Jonkoping, Sweden.
   Samuelsson, John; Samuelsson, Ulf; Bladh, Marie; Akesson, Karin, Linkoping Univ, Dept Clin \& Expt Med, Div Childrens \& Womens Hlth, Linkoping, Sweden.
   Hanberger, Lena, Linkoping Univ, Dept Med \& Hlth Sci, Div Nursing, Linkoping, Sweden.},
DOI = {10.1111/pedi.12980},
EarlyAccessDate = {JAN 2020},
ISSN = {1399-543X},
EISSN = {1399-5448},
Keywords = {adolescent; children; glycated hemoglobin a; mortality; type 1 diabetes
   mellitus},
Keywords-Plus = {EXCESS MORTALITY; GLYCEMIC CONTROL; MICROVASCULAR COMPLICATIONS; EARLY
   ADULTHOOD; YOUNG-ADULTS; TYPE-1; ONSET; NATIONWIDE; MELLITUS; RISK},
Research-Areas = {Endocrinology \& Metabolism; Pediatrics},
Web-of-Science-Categories  = {Endocrinology \& Metabolism; Pediatrics},
Author-Email = {john.samuelsson@rjl.se},
ORCID-Numbers = {Samuelsson, John/0000-0001-6010-3501},
Funding-Acknowledgement = {Futurum - academy for Health and Care, Region Jonkoping County, Sweden;
   Swedish Diabetes Foundation},
Funding-Text = {Futurum - academy for Health and Care, Region Jonkoping County, Sweden;
   The Swedish Diabetes Foundation},
Cited-References = {Anderzen J, 2016, J DIABETES COMPLICAT, V30, P533, DOI 10.1016/j.jdiacomp.2015.12.004.
   {[}Anonymous], 2016, DIABETES CARE, V39, P1378.
   Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813.
   Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x.
   Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1.
   Buschur EO, 2017, TRANSL PEDIATR, V6, P373, DOI 10.21037/tp.2017.09.06.
   Cooper MN, 2014, DIABETIC MED, V31, P1550, DOI 10.1111/dme.12522.
   Dahlquist G, 2005, DIABETES CARE, V28, P2384, DOI 10.2337/diacare.28.10.2384.
   Evans-Cheung TC, 2018, DIABETIC MED, V35, P112, DOI 10.1111/dme.13544.
   Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2.
   Gagnum V, 2017, DIABETIC MED, V34, P56, DOI 10.1111/dme.13114.
   Gagnum V, 2015, DIABETOLOGIA, V58, P1779, DOI 10.1007/s00125-015-3623-7.
   Hanas R, 2010, DIABETES CARE, V33, P1903, DOI 10.2337/dc10-0953.
   Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364.
   Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214.
   Morgan E, 2018, PEDIATR DIABETES, V19, P166, DOI 10.1111/pedi.12539.
   Morgan E, 2015, ACTA DIABETOL, V52, P801, DOI 10.1007/s00592-014-0702-z.
   Nordwall M, 2009, PEDIATR DIABETES, V10, P168, DOI 10.1111/j.1399-5448.2008.00472.x.
   Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8.
   Rawshani A, 2018, LANCET, V392, P477, DOI 10.1016/S0140-6736(18)31506-X.
   Samuelsson U, 2016, J DIABETES COMPLICAT, V30, P917, DOI 10.1016/j.jdiacomp.2016.02.007.
   Samuelsson U, 2014, PEDIATR DIABETES, V15, P229, DOI 10.1111/pedi.12085.
   Sandahl K, 2017, DIABETIC MED, V34, P380, DOI 10.1111/dme.13124.
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401.
   Svensson M, 2004, DIABETES CARE, V27, P955, DOI 10.2337/diacare.27.4.955.
   Swediabkids, 2016, ANN REP 2016.
   Swediabkids, 2013, ANN REP 2013.
   Swedish Association of Local Authorities and Regions, 2017, SWED ASS LOC AUTH RE.
   The National Board of Health and Welfare, 2017, SWED CAUS DEATH REG.},
Number-of-Cited-References = {29},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Pediatr. Diabetes},
Doc-Delivery-Number = {LH9LY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000508318100001},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000250800900017,
Author = {Wang, Xin and Nadarajah, Bagirathy and Robinson, Andrew C. and McColl,
   Barry W. and Jin, Jia-Wei and Dajas-Bailador, Federico and
   Boot-Handford, Raymond P. and Tournier, Cathy},
Title = {Targeted deletion of the mitogen-activated protein kinase kinase 4 gene
   in the nervous system causes severe brain developmental defects and
   premature death},
Journal = {MOLECULAR AND CELLULAR BIOLOGY},
Year = {2007},
Volume = {27},
Number = {22},
Pages = {7935-7946},
Month = {NOV},
Abstract = {The c-Jun NH2-terminal protein kinase (JNK) is a mitogen-activated
   protein kinase (MAPK) involved in the regulation of various
   physiological processes. Its activity is increased upon phosphorylation
   by the MAPK kinases MKK4 and MKK7. The early embryonic death of mice
   lacking an mkk4 or mkk7 gene has provided genetic evidence that MKK4 and
   MKK7 have nonredundant functions in vivo. To elucidate the physiological
   role of MKK4, we generated a novel mouse model in which the mkk4 gene
   could be specifically deleted in the brain. At birth, the mutant mice
   were indistinguishable from their control littermates, but they stopped
   growing a few days later and died prematurely, displaying severe
   neurological defects. Decreased JNK activity in the absence of MKK4
   correlated with impaired phosphorylation of a subset of physiologically
   relevant JNK substrates and with altered gene expression. These defects
   resulted in the misalignment of the Purkinje cells in the cerebellum and
   delayed radial migration in the cerebral cortex. Together, our data
   demonstrate for the first time that MKK4 is an essential activator of
   JNK required for the normal development of the brain.},
Publisher = {AMER SOC MICROBIOLOGY},
Address = {1752 N ST NW, WASHINGTON, DC 20036-2904 USA},
Type = {Article},
Language = {English},
Affiliation = {Tournier, C (Corresponding Author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.},
DOI = {10.1128/MCB.00226-07},
ISSN = {0270-7306},
Keywords-Plus = {N-TERMINAL KINASE; DOUBLECORTIN-LIKE-KINASE; NEURONAL MIGRATION;
   SYNERGISTIC ACTIVATION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS;
   CELL-MIGRATION; AXON OUTGROWTH; MICE LACKING; P190 RHOGAP},
Research-Areas = {Biochemistry \& Molecular Biology; Cell Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Cell Biology},
Author-Email = {cathy.tournier@manchester.ac.uk},
ResearcherID-Numbers = {jin, jiawei/AAJ-7378-2021
   },
ORCID-Numbers = {Tournier, Cathy/0000-0002-4618-2570
   Dajas-Bailador, Federico/0000-0002-2212-1482
   McColl, Barry W/0000-0002-0521-9656
   Boot-Handford, Raymond/0000-0002-6167-8419
   , Jiawei Jin/0000-0001-5598-6039
   Robinson, Andrew/0000-0003-2208-7728},
Funding-Acknowledgement = {Biotechnology and Biological Sciences Research CouncilUK Research \&
   Innovation (UKRI)Biotechnology and Biological Sciences Research Council
   (BBSRC) {[}BBS/B/0224X] Funding Source: Medline; Medical Research
   CouncilUK Research \& Innovation (UKRI)Medical Research Council UK
   (MRC)European Commission {[}G0001285] Funding Source: Medline; MRCUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC)
   {[}G0001285] Funding Source: UKRI},
Cited-References = {Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046.
   Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854.
   Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005.
   Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742.
   Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303.
   Brouns MR, 2000, DEVELOPMENT, V127, P4891.
   Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042.
   Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7.
   Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019.
   Coffey ET, 2000, J NEUROSCI, V20, P7602.
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1.
   Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038.
   Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963.
   Fernyhough P, 1999, DIABETES, V48, P881, DOI 10.2337/diabetes.48.4.881.
   Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145.
   Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079.
   Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213.
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9.
   Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006.
   Hunter AW, 2000, J CELL SCI, V113, P4379.
   Ito M., 1984, CEREBELLUM NEURAL CO.
   Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413.
   Kayahara M, 2005, MOL CELL BIOL, V25, P3784, DOI 10.1128/MCB.25.9.3784-3792.2005.
   Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100.
   Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040.
   Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8.
   Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270.
   Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0.
   Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895.
   Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711.
   Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169.
   Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0.
   Nishina H, 1999, DEVELOPMENT, V126, P505.
   Raingeaud J, 1996, MOL CELL BIOL, V16, P1247.
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105.
   RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380.
   Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037.
   Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0.
   Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005.
   Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374.
   Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0.
   Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024.
   Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593.
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7.
   Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615.
   Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025.
   Voogd J, 2003, J NEUROSCI, V23, P4645.
   Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016.
   Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143.
   Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899.
   Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3.
   Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378.
   Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257.},
Number-of-Cited-References = {55},
Times-Cited = {49},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Mol. Cell. Biol.},
Doc-Delivery-Number = {229KD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000250800900017},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000435649400012,
Author = {Kochovska, Slavica and Luckett, Tim and Agar, Meera and Phillips, Jane
   L.},
Title = {Impacts on employment, finances, and lifestyle for working age people
   facing an expected premature death: A systematic review},
Journal = {PALLIATIVE \& SUPPORTIVE CARE},
Year = {2018},
Volume = {16},
Number = {3},
Pages = {347-364},
Month = {JUN},
Abstract = {Objective:The working ages (25-65 years) are a period when most people
   have significant work, financial, and family responsibilities. A small
   proportion of working age people will face an expected premature death
   from cancer or other life-limiting illness. Understanding the impact an
   expected premature death has on this population is important for
   informing support. The current study set out to summarize research
   describing the effects that facing an expected premature death has on
   employment, financial, and lifestyle of working age people and their
   families.
   Method:A systematic review using narrative synthesis approach. Four
   electronic databases were searched in July 2016 for peer-reviewed,
   English language studies focusing on the financial, employment, and
   lifestyle concerns of working age adults living with an advanced
   life-limiting illness and/or their carers and/or children.
   Results:Fifteen quantitative and 12 qualitative studies were included.
   Two-thirds (n=18) were focused on cancer. All studies identified adverse
   effects on workforce participation, finances, and lifestyle. Many
   patients were forced to work less or give up work/retire early because
   of symptoms and reduced functioning. In addition to treatment costs,
   patients and families were also faced with child care, travel, and
   home/car modification costs. Being younger was associated with greater
   employment and financial burden, whereas having children was associated
   with lower functional well-being. Changes in family roles were
   identified as challenging regardless of diagnosis, whereas maintaining
   normalcy and creating stability was seen as a priority by parents with
   advanced cancer. This review is limited by the smaller number of studies
   focussing on the needs of working age people with nonmalignant disease.
   Significance of results:Working age people facing an expected premature
   death and their families have significant unmet financial, employment,
   and lifestyle needs. Comparing and contrasting their severity, timing,
   and priority for people with nonmalignant conditions is required to
   better understand their unique needs.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA},
Type = {Review},
Language = {English},
Affiliation = {Phillips, JL (Corresponding Author), Univ Technol Sydney, IMPACCT Improving Palliat Aged \& Chron Care Clin, Fac Hlth, Sydney, NSW, Australia.
   Phillips, JL (Corresponding Author), Univ Technol Sydney, IMPACCT Improving Palliat Aged \& Chron Care Clin, Fac Hlth, Nursing Palliat Care, Sydney, NSW, Australia.
   Kochovska, Slavica; Luckett, Tim; Agar, Meera; Phillips, Jane L., Univ Technol Sydney, IMPACCT Improving Palliat Aged \& Chron Care Clin, Fac Hlth, Sydney, NSW, Australia.},
DOI = {10.1017/S1478951517000979},
ISSN = {1478-9515},
EISSN = {1478-9523},
Keywords = {Palliative care; End of life; Employment; Financial concerns; Family},
Keywords-Plus = {QUALITY-OF-LIFE; SUPPORTIVE CARE NEEDS; PALLIATIVE CARE;
   MULTIPLE-SCLEROSIS; NEURODEGENERATIVE CONDITIONS; CANCER REHABILITATION;
   ECONOMIC BURDEN; LUNG-CANCER; UNMET NEEDS; TOXICITY},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Policy \& Services},
Author-Email = {jane.phillips@uts.edu.au},
ResearcherID-Numbers = {Agar, Meera/AAI-4002-2021
   Phillips, Jane/A-7780-2015
   Kochovska, Slavica/ABD-3905-2021
   },
ORCID-Numbers = {Agar, Meera/0000-0002-6756-6119
   Phillips, Jane/0000-0002-3691-8230
   Kochovska, Slavica/0000-0002-3531-0389
   Luckett, Tim/0000-0001-6121-5409},
Funding-Acknowledgement = {AMP Services Limited},
Funding-Text = {This research was undertaken, in part, with funding support from AMP
   Services Limited for consultancy work that was designed to provide
   insights into the characteristics and needs of working-age people faced
   with an expected premature death and their families and carers.},
Cited-References = {Amir Z, 2012, PSYCHO-ONCOLOGY, V21, P1167, DOI 10.1002/pon.2021.
   {[}Anonymous], 2017, LIFESTYLE, V2017.
   {[}Anonymous], 2017, NAT STAT, V2017.
   Australian Bureau of Statistics, 2010, 4102 0 AUSTR SOCIAL.
   Australian Department of Health and Ageing, 2006, GUID PALL APPR RES A.
   Australian Institute of Health and Welfare, 2016, LEAD CAUS DEATH, V2016.
   Boland EG, 2014, SUPPORT CARE CANCER, V22, P2615, DOI 10.1007/s00520-014-2231-2.
   Burns CM, 2011, PSYCHO-ONCOLOGY, V20, P203, DOI 10.1002/pon.1725.
   Catt S., 2016, J CANCER SURVIV, P1.
   Currow D, 2016, MED J AUSTRALIA, V204, P397, DOI 10.5694/mja16.00182.
   Currow DC, 2011, J PAIN SYMPTOM MANAG, V41, P661, DOI 10.1016/j.jpainsymman.2010.06.017.
   Elmberger E, 2005, NURS ETHICS, V12, P253, DOI 10.1191/0969733005ne787oa.
   Financial Services Council, 2005, FAST FACTS NAT EXP.
   Forbes A, 2007, J ADV NURS, V58, P11, DOI 10.1111/j.1365-2648.2007.04219.x.
   Galushko M, 2014, J PALLIAT MED, V17, P274, DOI 10.1089/jpm.2013.0497.
   Gardiner C, 2014, PALLIATIVE MED, V28, P375, DOI 10.1177/0269216313510588.
   Geyer S, 2009, CONGENIT HEART DIS, V4, P25, DOI 10.1111/j.1747-0803.2008.00239.x.
   Girgis A, 2013, J ONCOL PRACT, V9, P197, DOI 10.1200/JOP.2012.000690.
   Gordon L.G., 2015, EUR J CANCER CARE, P1.
   Halkett GKB, 2015, PATIENT EDUC COUNS, V98, P525, DOI 10.1016/j.pec.2015.01.002.
   Halkett GKB, 2010, PATIENT EDUC COUNS, V79, P112, DOI 10.1016/j.pec.2009.08.013.
   Halman M, 2014, AIDS CARE, V26, P320, DOI 10.1080/09540121.2013.819404.
   Hanratty B, 2007, PALLIATIVE MED, V21, P595, DOI 10.1177/0269216307082476.
   Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5.
   Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1.
   Higgins JP., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.
   Houldin AD, 2006, ONCOL NURS FORUM, V33, P719, DOI 10.1188/06.ONF.719-725.
   Huizinga GA, 2003, CANCER NURS, V26, P195, DOI 10.1097/00002820-200306000-00004.
   Huntington SF, 2015, LANCET HAEMATOL, V2, pE408, DOI 10.1016/S2352-3026(15)00151-9.
   Janda M, 2008, PATIENT EDUC COUNS, V71, P251, DOI 10.1016/j.pec.2008.01.020.
   Janda M, 2006, SUPPORT CARE CANCER, V14, P1094, DOI 10.1007/s00520-006-0074-1.
   Jassem J, 2015, QUAL LIFE RES, V24, P2843, DOI 10.1007/s11136-015-1028-1.
   Kastner M, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e25.
   Kennedy VL, 2009, PSYCHO-ONCOLOGY, V18, P886, DOI 10.1002/pon.1455.
   Kennedy VL, 2009, J AFFECT DISORDERS, V114, P149, DOI 10.1016/j.jad.2008.06.022.
   Kmet L., 2004, STANDARD QUALITY ASS.
   Koopman Wilma J, 2006, J Neurosci Nurs, V38, P369.
   Kristjanson LJ, 2006, INT J PALLIAT NURS, V12, P368, DOI 10.12968/ijpn.2006.12.8.368.
   Kristjanson LJ, 2006, J PALLIAT CARE, V22, P151, DOI 10.1177/082585970602200305.
   Lathan CS, 2016, J CLIN ONCOL, V34, P1732, DOI 10.1200/JCO.2015.63.2232.
   Mack JW, 2016, PSYCHO-ONCOLOGY, V25, P1085, DOI 10.1002/pon.3949.
   McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x.
   McPherson CJ, 2007, PALLIATIVE MED, V21, P115, DOI 10.1177/0269216307076345.
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097.
   Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa.
   National Health Medical Research Council, 1999, GUID DEV IMPL EV CLI.
   Neugut AI, 2011, J CLIN ONCOL, V29, P2534, DOI 10.1200/JCO.2010.33.3179.
   O'Connor M, 2007, MENT HEALTH RELIG CU, V10, P631, DOI 10.1080/13674670601078221.
   Office for National Statistics, 2013, WHAT AR TOP CAUS DEA, V2015.
   Organization WH, 2006, WHO CHILD GROWTH STA, P1.
   Osse BHP, 2005, SUPPORT CARE CANCER, V13, P722, DOI 10.1007/s00520-004-0771-6.
   Osse BHP, 2002, PATIENT EDUC COUNS, V47, P195, DOI 10.1016/S0738-3991(02)00019-8.
   Owens D., 2008, J HOSP PALLIAT NURS, V10, P14.
   Palliative Care Search, 2016, BER SEARCH FILT, V2016.
   Palliative Care Search, 2016, PALL CAR SEARCH FILT, V2016.
   Payne S., 2017, WILL CARING YOUR LOV.
   Popay J., 2006, GUIDANCE CONDUCT NAR, V1, pb92, DOI {[}DOI 10.13140/2.1.1018.4643, 10.13140/2.1.1018.4643].
   Rainbird K, 2009, BRIT J CANCER, V101, P759, DOI 10.1038/sj.bjc.6605235.
   Raynes NV, 2000, PALLIATIVE MED, V14, P159, DOI 10.1191/026921600668099835.
   Reed E, 2012, J PAIN SYMPTOM MANAG, V43, P747, DOI 10.1016/j.jpainsymman.2011.05.005.
   Silver JK, 2014, CANCER-AM CANCER SOC, V120, P2072, DOI 10.1002/cncr.28713.
   Silver JK, 2013, WORK, V46, P455, DOI 10.3233/WOR-131755.
   Silver JK, 2013, AM J PHYS MED REHAB, V92, P715, DOI 10.1097/PHM.0b013e31829b4afe.
   Stephen AI, 2015, DEATH STUD, V39, P151, DOI 10.1080/07481187.2014.920435.
   Tucker-Seeley RD, 2015, PSYCHO-ONCOLOGY, V24, P572, DOI 10.1002/pon.3624.
   Turner Jane, 2007, Palliat Support Care, V5, P135, DOI 10.1017/S1478951507070204.
   Ubel PA, 2013, NEW ENGL J MED, V369, P1484, DOI 10.1056/NEJMp1306826.
   US National Library of Medicine, 2016, MED SUBJ HEAD MESH D, V2016.
   Ventura AD, 2014, PALLIATIVE MED, V28, P391, DOI 10.1177/0269216313511141.
   Wollin JA, 2006, INT J PALLIAT NURS, V12, P20, DOI 10.12968/ijpn.2006.12.1.20392.
   Zafar SY, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv370.
   Zafar SY, 2013, ONCOLOGY-NY, V27, P253.
   Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279.
   Zafar SY, 2013, ONCOLOGY-NY, V27, P80.},
Number-of-Cited-References = {74},
Times-Cited = {7},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Palliat. Support Care},
Doc-Delivery-Number = {GJ8OM},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000435649400012},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000230691700014,
Author = {Leslie, DL and Zhang, Y and Holford, TR and Bogardus, ST and
   Leo-Summers, LS and Inouye, SK},
Title = {Premature death associated with delirium at 1-year follow-up},
Journal = {ARCHIVES OF INTERNAL MEDICINE},
Year = {2005},
Volume = {165},
Number = {14},
Pages = {1657-1662},
Month = {JUL 25},
Abstract = {Background: While previous studies have demonstrated the increased
   mortality risk associated with delirium, little is known about the
   mortality time course. The objective of this study is to estimate the
   fraction of a year of life lost associated with delirium at 1-year
   follow-up.
   Methods: Hospitalized patients 70 years and older who participated in a
   previous controlled clinical trial of a delirium prevention intervention
   at an academic medical center from March 25, 1995, through March 18,
   1998, were followed up for 1 year after discharge, and patients who died
   were identified, along with the date of death. The adjusted number of
   days survived were estimated using a 2-step regression model approach
   and compared across patients who developed delirium during
   hospitalization and those who did not develop delirium.
   Results: After adjusting for pertinent covariates (age, sex, functional
   status, and comorbidity), patients with delirium survived 274 days,
   compared with 321 days for patients without delirium, representing a
   difference of 13\% of a year (hazard ratio, 1.62; P < 001). Results were
   confirmed with a separate binomial regression analysis.
   Conclusions: Patients who experienced delirium during hospitalization
   had a 62\% increased risk of mortality and lost an average of 13\% of a
   year of life compared with patients without delirium. Although delirium
   is an acute condition, it is associated with multiple long-term sequelae
   that extend beyond the hospital setting, including premature mortality.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Leslie, DL (Corresponding Author), NE Program Evaluat Ctr, Mail Stop 182,950 Campbell Ave, West Haven, CT 06516 USA.
   NE Program Evaluat Ctr, West Haven, CT 06516 USA.
   Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.
   Yale Univ, Sch Med, Dept Epidemiol \& Publ Hlth, New Haven, CT USA.
   Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA.},
DOI = {10.1001/archinte.165.14.1657},
ISSN = {0003-9926},
EISSN = {1538-3679},
Keywords-Plus = {MINI-MENTAL STATE; PROGNOSTIC-SIGNIFICANCE; MEDICAL PATIENTS; OLDER
   PERSONS; DEMENTIA; OUTCOMES; ILLNESS; IMPACT; TIME; RISK},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {douglas.leslie@yale.edu},
ResearcherID-Numbers = {Inouye, Sharon/R-7216-2019
   },
ORCID-Numbers = {Leslie, Douglas/0000-0001-6145-4610},
Funding-Acknowledgement = {NATIONAL INSTITUTE ON AGINGUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}R01AG012551, K24AG000949, P30AG021342] Funding Source:
   NIH RePORTER; NIA NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}K24AG00949, P30AG21342, R01AG12551] Funding Source:
   Medline},
Cited-References = {BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797.
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8.
   Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x.
   COLE MG, 1993, CAN MED ASSOC J, V149, P41.
   Edelstein DM, 2004, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000128649.59959.0c.
   Efron B., 1993, INTRO BOOTSTRAP, V57.
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6.
   FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x.
   Franco K, 2001, PSYCHOSOMATICS, V42, P68, DOI 10.1176/appi.psy.42.1.68.
   Froehlich TE, 1998, J AM GERIATR SOC, V46, P1506, DOI 10.1111/j.1532-5415.1998.tb01534.x.
   Inouye SK, 1999, AM J MED, V106, P565, DOI 10.1016/S0002-9343(99)00070-4.
   Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901.
   INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005.
   INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941.
   Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x.
   Inouye SK, 1998, J GERONTOL A-BIOL, V53, pM281, DOI 10.1093/gerona/53A.4.M281.
   Inouye SK, 2003, MED CARE, V41, P70, DOI 10.1097/00005650-200301000-00010.
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016.
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009.
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3\_Part\_1.179.
   LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334.
   LEVKOFF SE, 1994, AM J GERIAT PSYCHIAT, V2, P230, DOI 10.1097/00019442-199400230-00007.
   Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB.
   Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x.
   Marcantonio ER, 1998, J GEN INTERN MED, V13, P621, DOI 10.1046/j.1525-1497.1998.00185.x.
   Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x.
   McCusker J, 2003, J GEN INTERN MED, V18, P696, DOI 10.1046/j.1525-1497.2003.20602.x.
   McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457.
   Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92.
   Murphy S L, 2000, Natl Vital Stat Rep, V48, P1.
   MURRAY AM, 1993, J GERONTOL, V48, pM181, DOI 10.1093/geronj/48.5.M181.
   OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x.
   POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x.
   RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149.
   Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551.
   ROCKWOOD K, 1993, J GERONTOL, V48, pM162, DOI 10.1093/geronj/48.4.M162.
   {*}SAS I INC, 2001, SAS VERS 8 2.
   UHLMANN RF, 1987, J GERONTOL, V42, P33, DOI 10.1093/geronj/42.1.33.
   VANHEMERT AM, 1994, J PSYCHOSOM RES, V38, P339, DOI 10.1016/0022-3999(94)90038-8.},
Number-of-Cited-References = {39},
Times-Cited = {147},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Arch. Intern. Med.},
Doc-Delivery-Number = {948BT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000230691700014},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000250135400005,
Author = {Young, R. P. and Hopkins, R. and Eaton, T. E.},
Title = {Forced expiratory volume in one second: not just a lung function test
   but a marker of premature death from all causes},
Journal = {EUROPEAN RESPIRATORY JOURNAL},
Year = {2007},
Volume = {30},
Number = {4},
Pages = {616-622},
Month = {OCT},
Abstract = {The clinical utility of spirometric screening of asymptomatic smokers
   for early signs of air flow limitation has recently come under review.
   The current authors propose that reduced forced expiratory volume in one
   second (FEV1) is more than a measure of airflow limitation, but a marker
   of premature death with broad utility in assessing baseline risk of
   chronic obstructive pulmonary disease (COPD), lung cancer, coronary
   artery disease and stroke, collectively accounting for 70-80\% of
   premature death in smokers.
   Reduced FEV1 identifies undiagnosed COPD, has comparable utility to that
   of serum cholesterol in assessing cardiovascular risk and defines those
   smokers at greatest risk of lung cancer. As such, reduced FEV1 should be
   considered a marker that identifies smokers at greatest need of medical
   intervention.
   Smoking cessation has been shown to attenuate FEV1 decline and, if
   achieved before the age of 45-50 yrs, may not only preserve FEV1 within
   normal values but substantially reduce cardiorespiratory complications
   of smoking.
   Recent findings suggest inhaled drugs (bronchodilators and
   corticosteroids), and possibly statins, may be effective in reducing
   morbidity and mortality in patients with chronic obstructive pulmonary
   disease. The current authors propose that spirometry has broad utility
   in identifying smokers who are at greatest risk of cardiorespiratory
   complications and greatest benefit from targeted preventive strategies,
   such as smoking cessation, prioritised screening and effective
   pharmacotherapy.},
Publisher = {EUROPEAN RESPIRATORY SOC JOURNALS LTD},
Address = {442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Young, RP (Corresponding Author), Auckland Hosp, Dept Med, Private Bag 92019, Auckland, New Zealand.
   Auckland Hosp, Dept Med, Auckland, New Zealand.
   Green Lane Hosp, Resp Serv, Auckland 3, New Zealand.},
DOI = {10.1183/09031936.00021707},
ISSN = {0903-1936},
EISSN = {1399-3003},
Keywords = {baseline risk; chronic obstructive pulmonary disease; epidemiology; lung
   function; premature death; spirometry},
Keywords-Plus = {OBSTRUCTIVE PULMONARY-DISEASE; NUTRITION EXAMINATION SURVEY;
   CORONARY-HEART-DISEASE; AIR-FLOW OBSTRUCTION; 1ST NATIONAL-HEALTH;
   SMOKING-CESSATION; FOLLOW-UP; PRIMARY-CARE; INHALED CORTICOSTEROIDS;
   CIGARETTE-SMOKING},
Research-Areas = {Respiratory System},
Web-of-Science-Categories  = {Respiratory System},
Author-Email = {robeny@adhb.govt.nz},
ORCID-Numbers = {Hopkins, Raewyn/0000-0003-2168-6235},
Cited-References = {Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096.
   Bechtel JJ, 2005, CHEST, V127, P1140, DOI 10.1378/chest.127.4.1140.
   Bednarek M, 2006, THORAX, V61, P869, DOI 10.1136/thx.2006.059071.
   Boushey H, 2005, AM J RESP CRIT CARE, V172, P1481, DOI 10.1164/rccm.2509009.
   BURROWS B, 1977, AM REV RESPIR DIS, V115, P195.
   DeJong Sandra R, 2004, Clin Nurse Spec, V18, P72, DOI 10.1097/00002800-200403000-00012.
   DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Donaldson GC, 2003, EUR RESPIR J, V22, P931, DOI 10.1183/09031936.03.00038303.
   Eaton T, 1999, CHEST, V116, P416, DOI 10.1378/chest.116.2.416.
   Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146.
   FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645.
   Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997.
   Gorecka D, 2003, CHEST, V123, P1916, DOI 10.1378/chest.123.6.1916.
   Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10.
   Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158.
   Hole DJ, 1996, BRIT MED J, V313, P711.
   Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976.
   Hunninghake Donald B, 2005, Proc Am Thorac Soc, V2, P44, DOI 10.1513/pats.200410-050SF.
   Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931.
   Kiri VA, 2005, AM J RESP CRIT CARE, V172, P460, DOI 10.1164/rccm.200502-210OC.
   KNOT UN, 2003, JAMA-J AM MED ASSOC, V290, P898.
   Krahn Murray, 2003, Can Respir J, V10, P320.
   Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC.
   Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802.
   Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039.
   Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605.
   Mannino DM, 2005, INT J TUBERC LUNG D, V9, P613.
   Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475.
   MAPEL DW, 2006, AM THORACIC SOC, pA110.
   OLOFSON J, 1987, EUR J RESPIR DIS, V71, P69.
   Pelkonen M, 2000, THORAX, V55, P746, DOI 10.1136/thorax.55.9.746.
   Pelkonen M, 2001, THORAX, V56, P703, DOI 10.1136/thorax.56.9.703.
   Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895.
   Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983.
   Rea TD, 2002, ANN INTERN MED, V137, P494, DOI 10.7326/0003-4819-137-6-200209170-00009.
   SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398.
   Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385.
   Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952.
   SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503.
   Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406.
   Stavem K, 2005, EUR RESPIR J, V25, P618, DOI 10.1183/09031936.05.00008504.
   TOCKMAN MS, 1989, AM REV RESPIR DIS, V140, pS56, DOI 10.1164/ajrccm/140.3\_Pt\_2.S56.
   TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512.
   Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045.
   Truelsen T, 2001, INT J EPIDEMIOL, V30, P145, DOI 10.1093/ije/30.1.145.
   Wagena EJ, 2004, RESP MED, V98, P805, DOI 10.1016/j.rmed.2004.06.001.
   Walker PP, 2006, EUR RESPIR J, V28, P945, DOI 10.1183/09031936.06.00019306.
   Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135.
   website GIfCOLD, 2006, GLOBAL INITIATIVE CH.
   Weinstein ND, 2005, TOB CONTROL, V14, P55, DOI 10.1136/tc.2004.008375.
   West R, 2006, BRIT MED J, V332, P458, DOI 10.1136/bmj.38723.573866.AE.
   Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179.
   Younis WG, 2006, CHEST, V130, p180S, DOI 10.1378/chest.130.4\_MeetingAbstracts.180S-c.},
Number-of-Cited-References = {55},
Times-Cited = {199},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Eur. Resp. J.},
Doc-Delivery-Number = {220CV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000250135400005},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000300699900030,
Author = {Friedbichler, Katrin and Themanns, Madeleine and Mueller, Kristina M.
   and Schlederer, Michaela and Kornfeld, Jan-Wilhelm and Terracciano,
   Luigi M. and Kozlov, Andrey V. and Haindl, Susanne and Kenner, Lukas and
   Kolbe, Thomas and Mueller, Mathias and Snibson, Kenneth J. and Heim,
   Markus H. and Moriggl, Richard},
Title = {Growth-hormone-induced signal transducer and activator of transcription
   5 signaling causes gigantism, inflammation, and premature death but
   protects mice from aggressive liver cancer},
Journal = {HEPATOLOGY},
Year = {2012},
Volume = {55},
Number = {3},
Pages = {941-952},
Month = {MAR},
Abstract = {Persistently high levels of growth hormone (GH) can cause liver cancer.
   GH activates multiple signal-transduction pathways, among them janus
   kinase (JAK) 2-signal transducer and activator of transcription (STAT) 5
   (signal transducer and activator of transcription 5). Both
   hyperactivation and deletion of STAT5 in hepatocytes have been
   implicated in the development of hepatocellular carcinoma (HCC);
   nevertheless, the role of STAT5 in the development of HCC as a result of
   high GH levels remains enigmatic. Thus, we crossed a mouse model of
   gigantism and inflammatory liver cancer caused by hyperactivated GH
   signaling (GHtg) to mice with hepatic deletion of STAT5 (STAT5?hep).
   Unlike GHtg mice, GHtgSTAT5?hep animals did not display gigantism.
   Moreover, the premature mortality, which was associated with chronic
   inflammation, as well as the pathologic alterations of hepatocytes
   observed in GHtg mice, were not observed in GHtg animals lacking STAT5.
   Strikingly, loss of hepatic STAT5 proteins led to enhanced HCC
   development in GHtg mice. Despite reduced chronic inflammation,
   GHtgSTAT5?hep mice displayed earlier and more advanced HCC than GHtg
   animals. This may be attributed to the combination of increased
   peripheral lipolysis, hepatic lipid synthesis, loss of hepatoprotective
   mediators accompanied by aberrant activation of tumor-promoting c-JUN
   and STAT3 signaling cascades, and accumulation of DNA damage secondary
   to loss of cell-cycle control. Thus, HCC was never observed in STAT5?hep
   mice. Conclusion: As a result of their hepatoprotective functions, STAT5
   proteins prevent progressive fatty liver disease and the formation of
   aggressive HCC in the setting of hyperactivated GH signaling. At the
   same time, they play a key role in controlling systemic inflammation and
   regulating organ and body size. (Hepatology 2012)},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Moriggl, R (Corresponding Author), Ludwig Boltzmann Inst Canc Res LBI CR, Wahringer Str 13A, A-1090 Vienna, Austria.
   Friedbichler, Katrin; Themanns, Madeleine; Mueller, Kristina M.; Schlederer, Michaela; Kenner, Lukas; Moriggl, Richard, Ludwig Boltzmann Inst Canc Res LBI CR, A-1090 Vienna, Austria.
   Kornfeld, Jan-Wilhelm, Univ Cologne, Inst Genet, Dept Mouse Genet \& Metab, Cologne, Germany.
   Terracciano, Luigi M., Univ Basel Hosp, Dept Mol Pathol, Inst Pathol, Basel, Switzerland.
   Kozlov, Andrey V.; Haindl, Susanne, Ludwig Boltzmann Inst Traumatol, Vienna, Austria.
   Kenner, Lukas, Med Univ Vienna, Inst Clin Pathol, Vienna, Austria.
   Kolbe, Thomas, Inst Lab Anim Sci, Vienna, Austria.
   Kolbe, Thomas, Univ Appl Life Sci \& Nat Ressources, IFA Tulln, Vienna, Austria.
   Mueller, Mathias, Inst Anim Breeding, Vienna, Austria.
   Mueller, Mathias, Inst Genet, Vienna, Austria.
   Mueller, Mathias, Inst Biomodels Austria, Vienna, Austria.
   Snibson, Kenneth J., Univ Melbourne, Ctr Anim Biotechnol, Melbourne, Vic, Australia.
   Heim, Markus H., Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.},
DOI = {10.1002/hep.24765},
ISSN = {0270-9139},
EISSN = {1527-3350},
Keywords-Plus = {HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; TGF-BETA; STAT5A; AXIS;
   PROLIFERATION; CIRRHOSIS; PATHWAYS; FIBROSIS; MODEL},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {richard.moriggl@lbicr.lbg.ac.at},
ResearcherID-Numbers = {Heim, Markus/A-7526-2008
   Kornfeld, Jan-Wilhelm/AAF-1170-2019
   Terracciano, Luigi M./AAB-5335-2022
   Moriggl, Richard/H-8118-2019
   },
ORCID-Numbers = {Heim, Markus/0000-0002-7523-4894
   Kornfeld, Jan-Wilhelm/0000-0002-6802-4442
   Terracciano, Luigi M./0000-0002-9393-9660
   Moriggl, Richard/0000-0003-0918-9463
   Snibson, Kenneth/0000-0003-4772-9408
   Kozlov, Andrey/0000-0002-0834-4997
   Kenner, Lukas/0000-0003-2184-1338},
Funding-Acknowledgement = {Austrian Science Fund (FWF)Austrian Science Fund (FWF) {[}F 2808, F
   2807] Funding Source: researchfish},
Cited-References = {Assy N, 2008, J HEPATOL, V49, P34, DOI 10.1016/j.jhep.2008.02.013.
   Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537.
   Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889.
   Bisgaard HC, 1996, CLIN LAB MED, V16, P325, DOI 10.1016/S0272-2712(18)30272-5.
   Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469.
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408.
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006.
   Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI {[}10.1586/eem.10.73, 10.1586/EEM.10.73].
   Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713.
   Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4.
   Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007.
   Fain JN, 1999, BIOCHEM BIOPH RES CO, V263, P201, DOI 10.1006/bbrc.1999.1302.
   Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308.
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014.
   Hardy CL, 1997, IMMUNOLOGY, V90, P412, DOI 10.1111/j.1365-2567.1997.00412.x.
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048.
   Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908.
   Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214.
   Hosui A, 2008, PHYSIOL GENOMICS, V34, P135, DOI 10.1152/physiolgenomics.00048.2008.
   Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003.
   Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5.
   Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092.
   Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429.
   Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509.
   Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005.
   ORIAN JM, 1990, JNCI-J NATL CANCER I, V82, P393, DOI 10.1093/jnci/82.5.393.
   Scharf JG, 2001, J CLIN PATHOL-MOL PA, V54, P138, DOI 10.1136/mp.54.3.138.
   SHEA BT, 1987, ENDOCRINOLOGY, V121, P1924, DOI 10.1210/endo-121-6-1924.
   Snibson KJ, 1999, LIVER, V19, P242, DOI 10.1111/j.1478-3231.1999.tb00042.x.
   Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894.
   Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3.
   Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077.
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694.
   WANKE R, 1991, PEDIATR NEPHROL, V5, P513, DOI 10.1007/BF01453693.
   Yu JH, 2010, HEPATOLOGY, V52, P1808, DOI 10.1002/hep.23882.},
Number-of-Cited-References = {35},
Times-Cited = {31},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Hepatology},
Doc-Delivery-Number = {897YS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000300699900030},
DA = {2022-03-29},
}

@article{ WOS:000496736000001,
Author = {Valdimarsdottir, Unnur A. and Lu, Donghao and Lund, Sigrun H. and Fall,
   Katja and Fang, Fang and Kristjansson, Thordur and Gudbjartsson, Daniel
   and Helgason, Agnar and Stefansson, Kari},
Title = {The mother's risk of premature death after child loss across two
   centuries},
Journal = {ELIFE},
Year = {2019},
Volume = {8},
Month = {NOV 12},
Abstract = {While the rare occurrence of child loss is accompanied by reduced life
   expectancy of parents in contemporary affluent populations, its impact
   in developing societies with high child mortality rates is unclear. We
   identified all parents in Iceland born 1800-1996 and compared the
   mortality rates of 47,711 parents who lost a child to those of their
   siblings (N = 126,342) who did not. The proportion of parents who
   experienced child loss decreased from 61.1\% of those born 1800-1880 to
   5.2\% of those born after 1930. Child loss was consistently associated
   with increased rate of maternal, but not paternal, death before the age
   of 50 across all parent birth cohorts; the relative increase in maternal
   mortality rate ranged from 35\% among mothers born 1800-1930 to 64\%
   among mothers born after 1930. The loss of a child poses a threat to the
   survival of young mothers, even during periods of high infant mortality
   rates.},
Publisher = {ELIFE SCIENCES PUBLICATIONS LTD},
Address = {SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Valdimarsdottir, UA (Corresponding Author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.
   Valdimarsdottir, UA (Corresponding Author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Valdimarsdottir, UA (Corresponding Author), Karolinska Inst, Dept Med Epidemiol \& Biostat, Solna, Sweden.
   Stefansson, K (Corresponding Author), deCODE Genet, Reykjavik, Iceland.
   Stefansson, K (Corresponding Author), Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.
   Valdimarsdottir, Unnur A.; Lu, Donghao, Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.
   Valdimarsdottir, Unnur A.; Lu, Donghao, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Valdimarsdottir, Unnur A.; Lu, Donghao; Fall, Katja; Fang, Fang, Karolinska Inst, Dept Med Epidemiol \& Biostat, Solna, Sweden.
   Lu, Donghao, Harvard Med Sch, Brigham \& Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA.
   Lund, Sigrun H.; Kristjansson, Thordur; Gudbjartsson, Daniel; Helgason, Agnar; Stefansson, Kari, deCODE Genet, Reykjavik, Iceland.
   Fall, Katja, Orebro Univ, Sch Med Sci, Clin Epidemiol \& Biostat, Orebro, Sweden.
   Gudbjartsson, Daniel, Univ Iceland, Sch Engn \& Nat Sci, Reykjavik, Iceland.
   Helgason, Agnar, Univ Iceland, Dept Anthropol, Reykjavik, Iceland.
   Stefansson, Kari, Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.},
DOI = {10.7554/eLife.43476},
Article-Number = {e43476},
ISSN = {2050-084X},
Keywords-Plus = {POSTTRAUMATIC-STRESS-DISORDER; CANCER INCIDENCE; PARENTS; NATIONWIDE;
   MORTALITY; BEREAVEMENT; SUICIDE; POPULATION; ILLNESS},
Research-Areas = {Life Sciences \& Biomedicine - Other Topics},
Web-of-Science-Categories  = {Biology},
Author-Email = {unnurav@hi.is
   kstefans@decode.is},
ResearcherID-Numbers = {Fall, Katja/AAE-1876-2021
   Lund, Sigrún Helga/AAG-6042-2019
   Lu, Donghao/AAH-6445-2019
   },
ORCID-Numbers = {Fall, Katja/0000-0002-3649-2639
   Lund, Sigrún Helga/0000-0002-3806-2296
   Lu, Donghao/0000-0002-4186-8661
   Valdimarsdottir, Unnur/0000-0001-5382-946X},
Funding-Acknowledgement = {RANNIS {[}163362-051]; European Research CouncilEuropean Research
   Council (ERC)European Commission {[}726413]},
Funding-Text = {RANNIS 163362-051 Unnur Valdimarsdottir; European Research Council
   726413 Unnur Valdimarsdottir},
Cited-References = {Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950.
   Bowlby J., 1980, ATTACHMENT LOSS.
   Boyden JY, 2014, DEATH STUD, V38, P374, DOI 10.1080/07481187.2013.766656.
   Chen CC, 2012, J EPIDEMIOL, V22, P532, DOI 10.2188/jea.JE20120060.
   Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031.
   Einarsdottir J, 2004, MOTHER LOVE CHILD DE.
   Espinosa J, 2013, ECON HUM BIOL, V11, P371, DOI 10.1016/j.ehb.2012.06.002.
   Fang F, 2011, CANCER RES, V71, P116, DOI 10.1158/0008-5472.CAN-10-0470.
   Garoarsdottir O, 2005, LJOSMAEORBLAOIO, V83, P19.
   Gradus JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009334.
   Gradus JL, 2010, AM J EPIDEMIOL, V171, P721, DOI 10.1093/aje/kwp456.
   Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247.
   Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043.
   Harper Mairi, 2011, BMJ Support Palliat Care, V1, P306, DOI 10.1136/bmjspcare-2011-000025.
   Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171.
   Huang JQ, 2013, AM J EPIDEMIOL, V178, P582, DOI 10.1093/aje/kwt045.
   Huerta MC, 2014, EUR J SOC SECUR, V16, P308, DOI 10.1177/138826271401600403.
   JONSSON G, 1997, HAGSKINNA ICELANDIC.
   Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740.
   LEVAV I, 1988, NEW ENGL J MED, V319, P457, DOI 10.1056/NEJM198808253190801.
   Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160.
   Li J, 2002, CANCER, V95, P2237, DOI 10.1002/cncr.10943.
   Li J, 2003, NEUROEPIDEMIOLOGY, V22, P211, DOI 10.1159/000069898.
   Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2.
   Li J, 2002, CIRCULATION, V106, P1634, DOI 10.1161/01.CIR.0000031569.45667.58.
   Lindemann E, 1944, AM J PSYCHIAT, V101, P141, DOI 10.1176/ajp.101.2.141.
   Magnusson SG., 2010, SOCIAL HIST ICELAND, P99.
   Moon JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023465.
   Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77.
   Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009.
   Parkes C. M., 2014, PRICE LOVE SELECTED.
   Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797.
   Rostila M, 2015, EUR J EPIDEMIOL, V30, P239, DOI 10.1007/s10654-015-9989-5.
   Rostila M, 2012, J EPIDEMIOL COMMUN H, V66, P927, DOI 10.1136/jech-2011-200339.
   Schorr L, 2016, ANN EPIDEMIOL, V26, P115, DOI 10.1016/j.annepidem.2015.12.008.
   Shor E, 2012, DEMOGRAPHY, V49, P575, DOI 10.1007/s13524-012-0096-x.
   Song H, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1255.
   Statistics Iceland, 2019, INF MORT LAT FET DEA.
   Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398.
   Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959.
   United Nations, 2015, STAT YB 2012 27 IEE.
   Wilcox HC, 2015, SOC PSYCH PSYCH EPID, V50, P1249, DOI 10.1007/s00127-014-0997-7.
   Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557.
   Woods R, 2003, J INTERDISCIPL HIST, V33, P421, DOI 10.1162/002219502320815181.},
Number-of-Cited-References = {44},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {eLife},
Doc-Delivery-Number = {JN2MV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000496736000001},
OA = {Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000469881600022,
Author = {Wang, Dong D. and Li, Yanping and Afshin, Ashkan and Springmann, Marco
   and Mozaffarian, Dariush and Stampfer, Meir J. and Hu, Frank B. and
   Murray, Christopher J. L. and Willett, Walter C.},
Title = {Global Improvement in Dietary Quality Could Lead to Substantial
   Reduction in Premature Death},
Journal = {JOURNAL OF NUTRITION},
Year = {2019},
Volume = {149},
Number = {6},
Pages = {1065-1074},
Month = {JUN},
Abstract = {Background: The preventable premature mortality achievable by
   improvement in dietary quality at a global level is unclear.
   Objective: The aim of this study was to assess dietary quality globally,
   and to quantify the potential global impact of improving dietary quality
   on population health.
   Methods: We applied the Alternate Healthy Eating Index (AHEI, potential
   range 0-100) to a global dietary database to assess dietary quality
   among adults in 190 countries/territories. The relation of AHEI score to
   risks of major chronic disease was estimated from 2 large cohorts of men
   and women for whom many repeated dietary assessments during up to 30
   years were available. We calculated the preventable premature deaths
   achievable by shifting from current national diets to a reference
   healthy diet.
   Results: The global mean AHEI score in 2017 was 49.5 for males and 50.5
   for females. Large differences between current and target intakes
   existed for whole grains, sodium, long-chain n-3 polyunsaturated fats,
   polyunsaturated fats, and fruits. From 1990 to 2017, the global mean
   AHEI score increased modestly from 45.4 to 50.0. Diet quality varied
   substantially across the world. Coastal Mediterranean nations, the
   Caribbean region, and Eastern Asia (except China and Mongolia) had a
   higher AHEI score, whereas Central Asia, the South Pacific, and Eastern
   and Northern Europe had a lower score. An improvement in dietary quality
   from the current global diet to the reference healthy diet could prevent
   >11 million premature deaths, similar to 24\% of total deaths in 2017.
   These included 1.6 million cancer deaths, 3.9 million coronary artery
   disease deaths, 1.0 million stroke deaths, 1.7 million respiratory
   disease deaths, 0.4 million neurodegenerative disease deaths, 0.5
   million kidney disease deaths, 0.6 million diabetes deaths, and 1.2
   million digestive disease deaths.
   Conclusions: Global dietary quality is slowly improving, but remains far
   from optimal and varies across countries. Improvements in dietary
   quality have the potential to reduce mortality rates substantially.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Willett, WC (Corresponding Author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   Willett, WC (Corresponding Author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Willett, WC (Corresponding Author), Brigham \& Womens Hosp, Channing Div Network Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.
   Willett, WC (Corresponding Author), Harvard Med Sch, Boston, MA 02115 USA.
   Wang, Dong D.; Li, Yanping; Stampfer, Meir J.; Hu, Frank B.; Willett, Walter C., Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   Afshin, Ashkan; Murray, Christopher J. L., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Springmann, Marco, Univ Oxford, Oxford Martin Program Future Food, Oxford, England.
   Springmann, Marco, Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   Mozaffarian, Dariush, Tufts Univ, Friedman Sch Nutr Sci \& Policy, Boston, MA 02111 USA.
   Stampfer, Meir J.; Hu, Frank B.; Willett, Walter C., Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   Stampfer, Meir J.; Hu, Frank B.; Willett, Walter C., Brigham \& Womens Hosp, Channing Div Network Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.
   Stampfer, Meir J.; Hu, Frank B.; Willett, Walter C., Harvard Med Sch, Boston, MA 02115 USA.},
DOI = {10.1093/jn/nxz010},
ISSN = {0022-3166},
EISSN = {1541-6100},
Keywords = {diet; chronic disease; global health; mortality; nutrition},
Keywords-Plus = {MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; NUTRITION EDUCATION;
   HEART-DISEASE; UNITED-STATES; RISK-FACTORS; LIFE-STYLE; ASSOCIATION;
   HEALTH; EPIDEMIOLOGY},
Research-Areas = {Nutrition \& Dietetics},
Web-of-Science-Categories  = {Nutrition \& Dietetics},
Author-Email = {wwillett@hsph.harvard.edu},
ResearcherID-Numbers = {Wang, Dong D./AAU-2951-2021
   Mozaffarian, Dariush/ABC-2822-2020
   Li, Yanping/H-6437-2011},
ORCID-Numbers = {Wang, Dong D./0000-0002-0897-3048
   Li, Yanping/0000-0002-0412-2748},
Funding-Acknowledgement = {NIHUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USA {[}UM1 CA167552, R01 HL35464, K99
   DK119412, R01 HL130735]; Wellcome Trust, Our Planet Our Health
   (Livestock, Environment and People-LEAP) {[}205212/Z/16/Z];  {[}UM1
   CA186107];  {[}P01 CA87969];  {[}R01 CA49449];  {[}R01 HL034594]; 
   {[}R01 HL60712];  {[}R01 HL088521]; NATIONAL INSTITUTE OF DIABETES AND
   DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}K99DK119412]
   Funding Source: NIH RePORTER},
Funding-Text = {The Nurses' Health Study was supported by research grants UM1 CA186107,
   P01 CA87969, R01 CA49449, R01 HL034594, R01 HL60712 and R01 HL088521 and
   the Health Professionals' Follow-Up Study was supported by research
   grants UM1 CA167552 and R01 HL35464 from the NIH. DDW was supported by
   research grant K99 DK119412 from the NIH. MS was supported by the
   Wellcome Trust, Our Planet Our Health (Livestock, Environment and
   People-LEAP), award 205212/Z/16/Z. DM was supported by research grant
   R01 HL130735 from the NIH.},
Cited-References = {Adachi M, 2008, ASIA PAC J CLIN NUTR, V17, P180.
   Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050.
   Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007.
   {[}Anonymous], 1985, HLTH PROF FOLL UP ST.
   Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057.
   Belin RJ, 2011, AM J CLIN NUTR, V94, P49, DOI 10.3945/ajcn.110.011221.
   Brandt EJ, 2017, JAMA CARDIOL, V2, P627, DOI 10.1001/jamacardio.2017.0491.
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222.
   COLCHERO MA, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.H6704.
   de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779.
   Denoth F, 2016, EAT WEIGHT DISORD-ST, V21, P257, DOI 10.1007/s40519-015-0225-9.
   Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121.
   Dugee O, 2009, ASIA PAC J CLIN NUTR, V18, P433.
   Estruch R, 2018, NEW ENGL J MED, V378, DOI {[}10.1056/NEJMoa1800389, 10.1056/nejmoa1800389].
   Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736.
   Fung TT, 2005, AM J CLIN NUTR, V82, P163.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Gao X, 2007, AM J CLIN NUTR, V86, P1486, DOI 10.1093/ajcn/86.5.1486.
   Gerald J, 2018, GLOBAL DIETARY DATAB.
   Ghebreyesus TA, 2018, LANCET, V391, P1978, DOI 10.1016/S0140-6736(18)31083-3.
   Global Burden of Disease, 2019, LANCET.
   Griswold MG, 2018, LANCET, V392, P1015, DOI {[}10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2].
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002.
   Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X.
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658.
   Keys A, 1980, 7 COUNTRIES MULTIVAR.
   Kim T, 2012, INT RELAT ASIA-PAC, V12, P41, DOI 10.1093/irap/lcr010.
   Li YP, 2016, J AM COLL CARDIOL, V68, P818, DOI 10.1016/j.jacc.2016.06.011.
   Liese AD, 2015, J NUTR, V145, P393, DOI 10.3945/jn.114.205336.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Messer E, 2015, WORLD MED HEALTH POL, V7, P211, DOI 10.1002/wmh3.147.
   Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149.
   Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947.
   Miyoshi M, 2012, ASIA PAC J CLIN NUTR, V21, P159.
   Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158.
   Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035.
   Mozaffarian D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2426.
   Mozaffarian D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2392.
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Naska A, 2010, PUBLIC HEALTH NUTR, V13, P1346, DOI 10.1017/S1368980010000613.
   Park HK, 2008, ASIA PAC J CLIN NUTR, V17, P343.
   Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694.
   Rhee JJ, 2015, DIABETES CARE, V38, P596, DOI 10.2337/dc14-1986.
   Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725.
   Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492.
   Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024.
   Singh GP, 2013, PLOS ONE, V8, DOI {[}10.1371/journal.pone.0065174, 10.1371/journal.pone.0064893].
   Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845.
   Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673.
   Sotos-Prieto M, 2017, NEW ENGL J MED, V377, P143, DOI {[}10.1056/NEJMoa1613502, 10.1056/nejmoa1613502].
   Springmann M, 2018, LANCET PLANET HEALTH, V2, pE451, DOI 10.1016/s2542-5196(18)30206-7.
   Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3.
   Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519.
   Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838.
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039.
   Tzeng MS, 2008, ASIA PAC J CLIN NUTR, V17, P59.
   Varraso R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h286.
   Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640.
   Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422.
   Willett W, 2013, SEE REF.
   Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4.
   Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646.
   WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S.
   Willett WC, 2006, PUBLIC HEALTH NUTR, V9, P105, DOI 10.1079/PHN2005931.
   World Health Organization, 2016, FISC POL DIET PREV N.
   World Health Organization. (WHO), 2013, GLOB ACT PLAN PREV C.
   Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151.},
Number-of-Cited-References = {68},
Times-Cited = {46},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {J. Nutr.},
Doc-Delivery-Number = {IA9MP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000469881600022},
OA = {Green Published, Green Submitted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000704612000017,
Author = {Kanazawa, Nobuo and Hara, Mariko and Hara, Tomoyuki and Kunimoto, Kayo
   and Mikita, Naoya and Furukawa, Fukumi},
Title = {CO2 narcosis as a notable cause of premature death in Nakajo-Nishimura
   syndrome},
Journal = {MODERN RHEUMATOLOGY CASE REPORTS},
Year = {2019},
Volume = {3},
Number = {1},
Pages = {74-78},
Month = {JAN 2},
Abstract = {Nakajo-Nishimura syndrome (NNS) is an inherited inflammatory and wasting
   disease caused by a distinct homozygous mutation of the PSMB8 gene,
   which encodes the beta 5i subunit of the immunoproteasome. Although NNS
   was originally reported in Japan more than 70 years ago, related
   diseases with an overlapping entity, namely joint contractures, muscular
   atrophy, microcytic anemia and panniculitis-associated lipodystrophy
   (JMP) syndrome and chronic atypical neutrophilic dermatosis with
   lipodystrophy and elevated temperature (CANDLE) syndrome, have recently
   been reported and these three diseases are now collectively referred to
   as proteasome-associated autoinflammatory syndromes (PRAAS). Although
   some distinct characteristics can be pointed out in each disease, most
   patients with these diseases commonly start to show inflammatory attacks
   in infancy and, after growing-up, clinically resemble progeria with
   marked emaciation especially in the upper body. Notably, some NNS cases
   with premature or sudden death have been reported and cardiac failure
   was considered to be a major cause of death. Here we report a Japanese
   male case with NNS, who had received no continuous medication and died
   of CO2 narcosis (respiratory acidosis) triggered by an acute septic
   infection in the absence of cardiac failure at 47 years of age. Due to a
   remarkable lipomuscular atrophy and contracture of the chest wall, CO2
   narcosis should be noted as an important complication of NNS/PRAAS,
   which can develop into premature death.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Kanazawa, N (Corresponding Author), Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama 6410012, Japan.
   Kanazawa, Nobuo; Hara, Mariko; Hara, Tomoyuki; Kunimoto, Kayo; Mikita, Naoya; Furukawa, Fukumi, Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama 6410012, Japan.},
DOI = {10.1080/24725625.2018.1524540},
EISSN = {2472-5625},
Keywords = {CO2 narcosis; Nakajo-Nishimura syndrome; proteasome-associated
   autoinflammatory syndromes; premature death},
Keywords-Plus = {PROTEASOME SUBUNIT; AUTOINFLAMMATORY DISORDER; JOINT CONTRACTURES;
   MICROCYTIC ANEMIA; MUSCULAR-ATROPHY; LIPODYSTROPHY},
Research-Areas = {Rheumatology},
Web-of-Science-Categories  = {Rheumatology},
Author-Email = {nkanazaw@wakayama-med.ac.jp},
Funding-Acknowledgement = {Japan Society for Promotion of ScienceMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of Science {[}15K09780]},
Funding-Text = {This work was supported by grants from the Japan Society for Promotion
   of Science for N.K. {[}15K09780] and K.K. {[}15K09780].},
Cited-References = {Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031.
   Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108.
   Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260.
   Garg A, 2010, J CLIN ENDOCR METAB, V95, pE58, DOI 10.1210/jc.2010-0488.
   Ichinose Y, 1994, Ryoikibetsu Shokogun Shirizu, P455.
   Kanazawa N, 2012, ALLERGOL INT, V61, P197, DOI 10.2332/allergolint.11-RAI-0416.
   Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368.
   McDermott A, 2015, INT J DERMATOL, V54, P121, DOI 10.1111/ijd.12695.
   MURAMATSU T, 1987, Hifu, V29, P727.
   OYANAGI K, 1987, ACTA NEUROPATHOL, V73, P313, DOI 10.1007/BF00688252.
   Torrelo A, 2010, J AM ACAD DERMATOL, V62, P489, DOI 10.1016/j.jaad.2009.04.046.},
Number-of-Cited-References = {11},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Mod. Rheumatol. Case Rep.},
Doc-Delivery-Number = {WD0AY},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000704612000017},
DA = {2022-03-29},
}

@article{ WOS:000294278000001,
Author = {Yoon, Young-Hee and Chen, Chiung M. and Yi, Hsiao-ye and Moss, Howard B.},
Title = {Effect of comorbid alcohol and drug use disorders on premature death
   among unipolar and bipolar disorder decedents in the United States, 1999
   to 2006},
Journal = {COMPREHENSIVE PSYCHIATRY},
Year = {2011},
Volume = {52},
Number = {5},
Pages = {453-464},
Month = {SEP-OCT},
Abstract = {Objective: The aim of this study was to quantify the effect of comorbid
   alcohol and drug use disorders on premature death, as reflected by the
   manner of death (suicide and other unnatural death versus natural death)
   and the age at death, among decedents with unipolar and bipolar
   disorders.
   Methods: This study is based on the US Multiple Cause of Death
   public-use data files for 1999 to 2006. Secondary data analysis was
   conducted comparing decedents with unipolar/bipolar disorders and
   decedents with all other causes of death, based on the death records of
   19 052 468 decedents in the Multiple Cause of Death data files who died
   at 15 years and older. Poisson regression models were used to derive
   prevalence ratios to assess the effect of comorbid substance use
   disorders (SUD) on the risks for being an unnatural death among mood
   disorder deaths. Multiple-cause life table analysis and mean age at
   death were used to quantify the effect of comorbid SUDs on premature
   mortality among mood disorder deaths.
   Results: Prevalence of comorbid SUDs was higher among unipolar and
   bipolar disorder deaths than that among all other deaths. Among unipolar
   and bipolar disorder deaths, comorbid SUDs were associated with elevated
   risks for suicide and other unnatural death in both men and women
   (prevalence ratios ranging 1.49-9.46, P < .05). They also were
   associated with reductions in mean ages at death (ranging 11.7-33.8
   years, P < .05). In general, these effects were much stronger for drug
   use disorders than for alcohol use disorders. Both SUDs had stronger
   effects on suicide among women, whereas their effects on other unnatural
   deaths were stronger among men.
   Conclusions: This study is among the first to provide population
   mortality-based evidence to further establish comorbid SUD as one of the
   key risk factors for premature death among individuals with unipolar or
   bipolar disorders in the United States. Clinicians need to be aware of
   the potentially lethal risk associated with these comorbid conditions.
   (C) 2011 Elsevier Inc. All rights reserved.},
Publisher = {W B SAUNDERS CO-ELSEVIER INC},
Address = {1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA},
Type = {Article},
Language = {English},
Affiliation = {Yoon, YH (Corresponding Author), CSR Inc, Alcohol Epidemiol Data Syst, Arlington, VA 22201 USA.
   Yoon, Young-Hee; Chen, Chiung M.; Yi, Hsiao-ye, CSR Inc, Alcohol Epidemiol Data Syst, Arlington, VA 22201 USA.
   Moss, Howard B., NIAAA, NIH, Bethesda, MD USA.},
DOI = {10.1016/j.comppsych.2010.10.005},
ISSN = {0010-440X},
Keywords-Plus = {SUBSTANCE USE DISORDERS; NATIONAL EPIDEMIOLOGIC SURVEY; CAUSE-SPECIFIC
   MORTALITY; EXCESS MORTALITY; MENTAL-DISORDERS; PSYCHIATRIC-DISORDERS;
   SURVEY REPLICATION; MAJOR DEPRESSION; ILLNESS; PREVALENCE},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {yhyoon@csrincorporated.com},
Funding-Acknowledgement = {National Institute on Alcohol Abuse and AlcoholismUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}HHSN267200800023C]},
Funding-Text = {This study was conducted for the Alcohol Epidemiologic Data System
   project funded by the National Institute on Alcohol Abuse and Alcoholism
   through Contract (Contract No. HHSN267200800023C) to CSR, Inc.},
Cited-References = {AMADDEO F, 1995, BRIT J PSYCHIAT, V166, P783, DOI 10.1192/bjp.166.6.783.
   Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003.
   BLACK DW, 1985, JAMA-J AM MED ASSOC, V253, P58, DOI 10.1001/jama.253.1.58.
   Brienza RS, 2002, J GEN INTERN MED, V17, P387, DOI 10.1007/s11606-002-0046-1.
   BROWN SA, 1995, AM J PSYCHIAT, V152, P45.
   BRUCE ML, 1994, AM J PSYCHIAT, V151, P716.
   Centers for Disease Control and Prevention, 2008, NAT VIOL DEATH REP S.
   Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211.
   Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X.
   Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058.
   Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408.
   Dickey B, 2004, J BEHAV HEALTH SER R, V31, P75, DOI 10.1007/BF02287340.
   Drake RE, 1998, RECENT DEV ALCOHOL, V14, P285, DOI 10.1007/0-306-47148-5\_12.
   Driessen M, 1998, ADDICTION, V93, P889, DOI 10.1046/j.1360-0443.1998.93688910.x.
   Flynn PM, 2008, J SUBST ABUSE TREAT, V34, P36, DOI 10.1016/j.jsat.2006.11.013.
   Gau SSF, 2004, BRIT J PSYCHIAT, V185, P422, DOI 10.1192/bjp.185.5.422.
   Goldacre MJ, 2006, SOC PSYCH PSYCH EPID, V41, P409, DOI 10.1007/s00127-006-0035-5.
   GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4.
   Grant BF, 2005, J CLIN PSYCHIAT, V66, P1205, DOI 10.4088/JCP.v66n1001.
   Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x.
   Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11.
   Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205.
   Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097.
   Heron M, 2009, DEATHS FINAL DATA 20.
   Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6.
   HIRSCHFELD RMA, 1989, J AFFECT DISORDERS, V16, P151, DOI 10.1016/0165-0327(89)90069-4.
   Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498.
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593.
   McIntosh C., 2001, ADV PSYCHIAT TREATME, V7, P357.
   Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18.
   Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543.
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238.
   Murphy JM, 2008, SOC PSYCH PSYCH EPID, V43, P594, DOI 10.1007/s00127-008-0323-3.
   Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862.
   {*}NCHS, BRIDG RAC INT EST JU.
   {*}NCHS, POSTC EST RES POP US.
   Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844.
   Quello Susan B, 2005, Sci Pract Perspect, V3, P13.
   RAMALHEIRA C, 2001, STATA TECH B, V59, P29.
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7.
   {*}RES TRIANGL I, 2008, SUDAAN LANG EX MAN R.
   Roberts RE, 2007, DRUG ALCOHOL DEPEN, V88, pS4, DOI 10.1016/j.drugalcdep.2006.12.010.
   Rockett IRH, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-10.
   Ruzicka LT, 2005, SOC SCI MED, V61, P333, DOI 10.1016/j.socscimed.2004.12.005.
   Selvin S., 1996, STAT ANAL EPIDEMIOLO.
   Stahl S.M., 2000, ESSENTIAL PSYCHOPHAR.
   Strakowski SM, 2005, ARCH GEN PSYCHIAT, V62, P851, DOI 10.1001/archpsyc.62.8.851.
   Swendsen JD, 2000, CLIN PSYCHOL REV, V20, P173, DOI 10.1016/S0272-7358(99)00026-4.
   Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003.
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2.
   World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U.
   Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003.},
Number-of-Cited-References = {52},
Times-Cited = {38},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Compr. Psychiat.},
Doc-Delivery-Number = {812GB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000294278000001},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000576980900003,
Author = {Luo, Zheng and He, Yuan and Ma, Guifen and Deng, Yang and Chen, Yichen
   and Zhou, Yi and Xu, Xiaoyun and Li, Xiaopan and Du, Yan},
Title = {Years of life lost due to premature death and their trends in people
   with malignant neoplasm of female genital organs in Shanghai, China
   during 1995-2018: a population based study},
Journal = {BMC PUBLIC HEALTH},
Year = {2020},
Volume = {20},
Number = {1},
Month = {OCT 1},
Abstract = {Background: The increasing aging population has been posing a
   significant challenge to disease burden in developing countries. In
   particular, the contribution of population aging to and long term
   changes of disease burden of malignant neoplasm of female genital organs
   (MNFGO) have not been quantitatively demonstrated.
   Methods: Data were collected from the Shanghai Vital Statistics System
   of Pudong New Area (PNA). Crude mortality rate (CMR), age-standardized
   mortality rate by Segi's world standard population (ASMRW), and years of
   life lost (YLL) of MNFGO as the underlying cause of death in age and
   pathology types from 1995 to 2018 were calculated. The joinpoint
   regression was used to estimate the trends of those rates by identifying
   the annual percent changes (APCs), and the decomposition method was used
   to calculate the increased rates and the contribution resulting from
   demographic and non-demographic factors.
   Results: From 1995 to 2018, a total of 2869 MNFGO-specific deaths were
   reported in PNA, accounting for 0.64\% of the total deaths. The CMR and
   ASMRW of MNFGO were 9.23/10(5) person-years and 4.80/10(5) person-years,
   respectively. Ovary cancer was the most common cause of MNFGO death,
   accounting for 43.9\% (1260/2869) of all MNFGO death. Other common
   causes of MNFGO death included cervix uteri cancer, uterus unspecified
   cancer, and corpus uteri cancer. With the increase of age, the mortality
   rate of MNFGO in residents had shown an upward trend ({[}APC (95\%CI) =
   3.46 (2.74, 4.18), P < 0.001)] for each five-year age group from 0 to 4
   to 85+ years. From 1995 to 2018, YLL of MNFGO in Shanghai PNA was
   42,152.82 years, and the rate of YLL was 135.56 /10(5). The top three
   MNFGO types in YLLs were ovary cancer, cervix uteri cancer and uterus
   unspecified cancer. Demographic factors contributed significantly to the
   upward trends of CMR, ASMRW, and YLL rates of MNFGO.
   Conclusion: With aggravated population aging in Shanghai, MNFGO is and
   will continue to be a serious threat to women's health. More precise and
   effective prevention strategies are needed to target high risk
   population, to achieve efficient health resource allocation and to
   improve women's health in particular.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Xu, XY (Corresponding Author), Shanghai Univ Med \& Hlth Sci, Affiliated Zhoupu Hosp, 1500 Zhouyuan Rd,Pudong New Area, Shanghai 201318, Peoples R China.
   Du, Y (Corresponding Author), Fudan Univ, Obstetr \& Gynecol Hosp, 419 Fangxie Rd, Shanghai 200011, Peoples R China.
   Li, XP (Corresponding Author), Ctr Dis Control \& Prevent, 3039 Zhangyang Rd,Pudong New Area, Shanghai 200136, Peoples R China.
   Luo, Zheng; Xu, Xiaoyun, Shanghai Univ Med \& Hlth Sci, Affiliated Zhoupu Hosp, 1500 Zhouyuan Rd,Pudong New Area, Shanghai 201318, Peoples R China.
   He, Yuan; Du, Yan, Fudan Univ, Obstetr \& Gynecol Hosp, 419 Fangxie Rd, Shanghai 200011, Peoples R China.
   Ma, Guifen, Fudan Univ, Zhongshan Hosp, Dept Radiotherapy, Shanghai 200032, Peoples R China.
   Deng, Yang, Shandong First Med Univ, Sch Publ Hlth, Tai An 271016, Shandong, Peoples R China.
   Deng, Yang, Shandong Acad Med Sci, Tai An 271016, Shandong, Peoples R China.
   Chen, Yichen; Zhou, Yi; Li, Xiaopan, Ctr Dis Control \& Prevent, 3039 Zhangyang Rd,Pudong New Area, Shanghai 200136, Peoples R China.
   Chen, Yichen; Zhou, Yi; Li, Xiaopan, Fudan Univ, Pudong Inst Prevent Med, Pudong New Area, Shanghai 200136, Peoples R China.},
DOI = {10.1186/s12889-020-09593-6},
Article-Number = {1489},
EISSN = {1471-2458},
Keywords = {Malignant neoplasm of female genital organs; Mortality; Years of life
   lost; Trend analysis; Decomposition method},
Keywords-Plus = {CANCER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {xxy195211@163.com
   xiaopanli0224@126.com
   sophiedu\_61@163.com},
ResearcherID-Numbers = {Du, Yan/AAD-5510-2020
   },
ORCID-Numbers = {Du, Yan/0000-0001-5413-7836
   Li, xiaopan/0000-0002-9625-478X},
Funding-Acknowledgement = {Shanghai Talent Development Fund {[}2017090]; Key Disciplines
   Construction Foundation of Health Commission of Shanghai Pudong New
   District of China {[}PWzxk2017-25]; Project of Hundred Talents Pool in
   Shanghai University of Medicine \& Health Sciences},
Funding-Text = {This study was funded by the Shanghai Talent Development Fund (Grant
   Number: 2017090 to YD), the Key Disciplines Construction Foundation of
   Health Commission of Shanghai Pudong New District of China (Grant
   Number: PWzxk2017-25 to KL), and the Project of Hundred Talents Pool in
   Shanghai University of Medicine \& Health Sciences (to ZL).},
Cited-References = {{[}Anonymous], 2016, ICD 10 VERS.
   {[}Anonymous], 2019, SHANGH STAT YB.
   {[}Anonymous], {*}{*}NON-TRADITIONAL{*}{*}.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526.
   Chen HY, 2018, BMC PUBLIC HEALTH, V18, DOI {[}10.1186/s12889-018-5112-7, 10.1186/s12889-018-5146-x].
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338.
   Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996.
   Gonzalez-Martin A, 2019, NEW ENGL J MED, V381, P2391, DOI 10.1056/NEJMoa1910962.
   Kim YE, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e22.
   Li XP, 2019, PREV MED, V118, P243, DOI 10.1016/j.ypmed.2018.11.002.
   Li XP, 2019, CHIN J GASTROENTEROL, V24, P279.
   Lortet-Tieulent J, 2018, JNCI-J NATL CANCER I, V110, P354, DOI 10.1093/jnci/djx214.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Tan XD, 2019, GLOB HEALTH PROMOT, V26, P96, DOI 10.1177/1757975917743533.
   Wang J, 2018, DRUG DISCOV THER, V12, P77, DOI 10.5582/ddt.2018.01009.
   Wong LP, 2019, HUM VACC IMMUNOTHER, V15, P1533, DOI 10.1080/21645515.2019.1611157.
   World Health Organization, CHIN COUNTR ASS REP.
   World Health Organization, HLTH STAT INF SYST D.
   Xi YF, 2019, CHINESE J CANCER RES, V31, P435, DOI 10.21147/j.issn.1000-9604.2019.03.05.
   Zheng Xiao-xing, 2006, Fudan Xuebao Zirankexueban, V45, P732.
   Zhou JY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00802.},
Number-of-Cited-References = {23},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {NZ3ER},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000576980900003},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000308912600071,
Author = {Cheah, Christine S. and Yu, Frank H. and Westenbroek, Ruth E. and
   Kalume, Franck K. and Oakley, John C. and Potter, Gregory B. and
   Rubenstein, John L. and Catterall, William A.},
Title = {Specific deletion of Na(V)1.1 sodium channels in inhibitory interneurons
   causes seizures and premature death in a mouse model of Dravet syndrome},
Journal = {PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA},
Year = {2012},
Volume = {109},
Number = {36},
Pages = {14646-14651},
Month = {SEP 4},
Abstract = {Heterozygous loss-of-function mutations in the brain sodium channel
   Na(V)1.1 cause Dravet syndrome (DS), a pharmacoresistant infantile-onset
   epilepsy syndrome with comorbidities of cognitive impairment and
   premature death. Previous studies using a mouse model of DS revealed
   reduced sodium currents and impaired excitability in GABAergic
   interneurons in the hippocampus, leading to the hypothesis that impaired
   excitability of GABAergic inhibitory neurons is the cause of epilepsy
   and premature death in DS. However, other classes of GABAergic
   interneurons are less impaired, so the direct cause of
   hyperexcitability, epilepsy, and premature death has remained
   unresolved. We generated a floxed Scn1a mouse line and used the Cre-Lox
   method driven by an enhancer from the Dlx1,2 locus for conditional
   deletion of Scn1a in forebrain GABAergic neurons. Immunocytochemical
   studies demonstrated selective loss of Na(V)1.1 channels in GABAergic
   interneurons in cerebral cortex and hippocampus. Mice with this deletion
   died prematurely following generalized tonic-clonic seizures, and they
   were equally susceptible to thermal induction of seizures as mice with
   global deletion of Scn1a. Evidently, loss of Na(v)1.1 channels in
   forebrain GABAergic neurons is both necessary and sufficient to cause
   epilepsy and premature death in DS.},
Publisher = {NATL ACAD SCIENCES},
Address = {2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA},
Type = {Article},
Language = {English},
Affiliation = {Yu, FH (Corresponding Author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Cheah, Christine S.; Yu, Frank H.; Westenbroek, Ruth E.; Kalume, Franck K.; Catterall, William A., Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Oakley, John C., Univ Washington, Dept Neurol, Seattle, WA 98195 USA.
   Yu, Frank H., Seoul Natl Univ, Sch Dent, Program Neurobiol, Seoul 110749, South Korea.
   Yu, Frank H., Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
   Potter, Gregory B.; Rubenstein, John L., Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.},
DOI = {10.1073/pnas.1211591109},
ISSN = {0027-8424},
Keywords-Plus = {SEVERE MYOCLONIC EPILEPSY; MUTATIONS; INFANCY; BRAIN; LOCALIZATION;
   NEURONS; MICE; AUXILIARY; SUBUNITS; SUBTYPES},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {frankyu@snu.ac.kr
   wcatt@uw.edu},
ResearcherID-Numbers = {Ritter, Stefanie L/D-9312-2012
   },
ORCID-Numbers = {Yu, Frank/0000-0001-9306-1731
   Potter, Gregory/0000-0002-0585-6575},
Funding-Acknowledgement = {National Institutes of Health Research GrantsUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USA {[}R01
   NS25704, R37 MH049428]; McKnight Foundation; National Research
   Foundation of KoreaNational Research Foundation of Korea
   {[}2010-009803]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Mental Health (NIMH)
   {[}R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders \& Stroke (NINDS) {[}R01NS025704]
   Funding Source: NIH RePORTER},
Funding-Text = {This research was supported by National Institutes of Health Research
   Grants R01 NS25704 (to W.A.C.) and R37 MH049428 (to J.L.R.),a research
   grant from the McKnight Foundation (to W.A.C.), and National Research
   Foundation of Korea Grant \#2010-009803 (to F.H.Y.).},
Cited-References = {Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x.
   Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2.
   Catterall WA, 2010, SOC NEUR ABS, V255, P15.
   Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008.
   Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484.
   Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609.
   Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499.
   Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x.
   Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x.
   Gong B, 1999, J COMP NEUROL, V412, P342.
   Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108.
   Kalume F, 2010, SOC NEUR ABS, V254, P5.
   Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007.
   Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854.
   Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100.
   Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699.
   Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482.
   Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106.
   Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007.
   Oguni H, 2001, BRAIN DEV-JPN, V23, P736, DOI 10.1016/S0387-7604(01)00276-5.
   Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003.
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0.
   Sakauchi M, 2011, EPILEPSIA, V52, P50, DOI 10.1111/j.1528-1167.2011.03002.x.
   Sugawara T, 2003, EPILEPSY RES, V54, P201, DOI 10.1016/S0920-1211(03)00084-6.
   Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328.
   WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9.
   Westenbroek RE, 1998, J NEUROSCI, V18, P6319.
   Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954.
   YU FH, 2004, SCI STKE.},
Number-of-Cited-References = {29},
Times-Cited = {177},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Proc. Natl. Acad. Sci. U. S. A.},
Doc-Delivery-Number = {007TZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000308912600071},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000637025500031,
Author = {Filgueiras-Rama, David and Vasilijevic, Jasmina and Jalife, Jose and
   Noujaim, Sami F. and Alfonso, Jose M. and Nicolas-Avila, Jose A. and
   Gutierrez, Celia and Zamarreno, Noelia and Hidalgo, Andres and Bernabe,
   Alejandro and Cop, Christopher Pablo and Ponce-Balbuena, Daniela and
   Guerrero-Serna, Guadalupe and Calle, Daniel and Desco, Manuel and
   Ruiz-Cabello, Jesus and Nieto, Amelia and Falcon, Ana},
Title = {Human influenza A virus causes myocardial and cardiac-specific
   conduction system infections associated with early inflammation and
   premature death},
Journal = {CARDIOVASCULAR RESEARCH},
Year = {2021},
Volume = {117},
Number = {3},
Pages = {876-889},
Month = {MAR 1},
Abstract = {Aims Human influenza A virus (hIAV) infection is associated with
   important cardiovascular complications, although cardiac infection
   pathophysiology is poorly understood. We aimed to study the ability of
   hIAV of different pathogenicity to infect the mouse heart, and establish
   the relationship between the infective capacity and the associated in
   vivo, cellular and molecular alterations.
   Methods and results We evaluated lung and heart viral titres in mice
   infected with either one of several hIAV strains inoculated
   intranasally. 3D reconstructions of infected cardiac tissue were used to
   identify viral proteins inside mouse cardiomyocytes, Purkinje cells, and
   cardiac vessels. Viral replication was measured in mouse cultured
   cardiomyocytes. Human-induced pluripotent stem cell-derived
   cardiomyocytes (hiPSC-CMs) were used to confirm infection and study
   underlying molecular alterations associated with the in vivo
   electrophysiological phenotype. Pathogenic and attenuated hIAV strains
   infected and replicated in cardiomyocytes, Purkinje cells, and
   hiPSC-CMs. The infection was also present in cardiac endothelial cells.
   Remarkably, lung viral titres did not statistically correlate with viral
   titres in the mouse heart. The highly pathogenic human recombinant virus
   PAmut showed faster replication, higher level of inflammatory cytokines
   in cardiac tissue and higher viral titres in cardiac HL-1 mouse cells
   and hiPSC-CMs compared with PB2mut-attenuated virus. Correspondingly,
   cardiac conduction alterations were especially pronounced in
   PAmut-infected mice, associated with high mortality rates, compared with
   PB2mutinfected animals. Consistently, connexin43 and Na(V)1.5 expression
   decreased acutely in hiPSC-CMs infected with PAmut virus. YEM1 L
   protease also decreased more rapidly and to lower levels in
   PAmut-infected hiPSC-CMs compared with PB2mut-infected cells, consistent
   with mitochondrial dysfunction. Human IAV infection did not increase
   myocardial fibrosis at 4-day post-infection, although PAmut-infected
   mice showed an early increase in mRNAs expression of lysyl oxidase.
   Conclusion Human IAV can infect the heart and cardiac-specific
   conduction system, which may contribute to cardiac complications and
   premature death.
   {[}GRAPHICS]
   .},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Falcon, A (Corresponding Author), Spanish Natl Res Council, Natl Ctr Biotechnol, Dept Mol \& Cellular Biol, Madrid, Spain.
   Falcon, A (Corresponding Author), Consortium CIBER Resp Dis, Madrid, Spain.
   Falcon, A (Corresponding Author), Algenex SL, Madrid, Spain.
   Filgueiras-Rama, David, Hosp Clin San Carlos, Cardiac Electrophysiol Unit, Madrid, Spain.
   Filgueiras-Rama, David; Jalife, Jose; Alfonso, Jose M.; Nicolas-Avila, Jose A.; Hidalgo, Andres; Bernabe, Alejandro; Cop, Christopher Pablo; Calle, Daniel; Desco, Manuel, Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.
   Filgueiras-Rama, David; Jalife, Jose, Consortium CIBER Cardiovasc Dis CIBERCV, Valladolid, Spain.
   Vasilijevic, Jasmina; Gutierrez, Celia; Zamarreno, Noelia; Nieto, Amelia; Falcon, Ana, Spanish Natl Res Council, Natl Ctr Biotechnol, Dept Mol \& Cellular Biol, Madrid, Spain.
   Vasilijevic, Jasmina; Ruiz-Cabello, Jesus; Nieto, Amelia; Falcon, Ana, Consortium CIBER Resp Dis, Madrid, Spain.
   Jalife, Jose; Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe, Univ Michigan, Ctr Arrhythmia Res, Hlth Syst, Ann Arbor, MI 48109 USA.
   Noujaim, Sami F., Univ S Florida, Morsani Coll Med Mol Pharmacol \& Physiol, Tampa, FL 33620 USA.
   Calle, Daniel; Desco, Manuel, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.
   Desco, Manuel, Univ Carlos III Madrid, Dept Bioengn \& Aerosp Engn, Madrid, Spain.
   Desco, Manuel, Consortium CIBER Mental Hlth CIBERSAM, Madrid, Spain.
   Ruiz-Cabello, Jesus, Basque Res \& Technol Alliance BRTA, Ctr Cooperat Res Biomat CIC BiomaGUNE, San Sebastian, Spain.
   Ruiz-Cabello, Jesus, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain.
   Ruiz-Cabello, Jesus, Univ Complutense Madrid, Madrid, Spain.
   Falcon, Ana, Algenex SL, Madrid, Spain.},
DOI = {10.1093/cvr/cvaa117},
ISSN = {0008-6363},
EISSN = {1755-3245},
Keywords = {Human influenza A virus; Heart infection; Viral replication; Premature
   death},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; FULMINANT MYOCARDITIS; INFARCTION; RISK;
   PREVENTION; SUBUNIT; VACCINE; NS1},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {anafalcon.af@gmail.com},
ResearcherID-Numbers = {Jalife, Jose/AAJ-9156-2021
   Ruiz-Cabello, Jesus/A-9570-2012
   Filgueiras-Rama, David/M-1860-2014
   Jalife, Jose/L-4833-2015
   Nicolás-Ávila, José Ángel/AAD-6550-2020
   Hidalgo, Andrés/L-5643-2014
   Calle, Daniel/K-3846-2014},
ORCID-Numbers = {Jalife, Jose/0000-0003-0080-3500
   Ruiz-Cabello, Jesus/0000-0001-8681-5056
   Filgueiras-Rama, David/0000-0001-5909-2454
   Jalife, Jose/0000-0003-0080-3500
   Nicolás-Ávila, José Ángel/0000-0002-8301-7216
   Hidalgo, Andrés/0000-0001-5513-555X
   Calle, Daniel/0000-0003-0436-0487},
Funding-Acknowledgement = {European Molecular Biology OrganizationEuropean Molecular Biology
   Organization (EMBO) {[}STF-7649]; Spanish Ministry of Science,
   Innovation and Universities (MCIU)Spanish Government {[}BFU2014-57797-R,
   BFU2017-83392-R]; network Ciber de Enfermedades Respiratorias (CIBERES);
   Maria de Maeztu Units of Excellence Program from the Spanish State
   Research AgencySpanish Government; Severo Ochoa Center of
   ExcellenceSpanish Government {[}SEV-2015-0505]; MCIU; Pro CNIC
   Foundation; Maria de Maeztu Units of Excellence Program from the Spanish
   State Research AgencySpanish Government {[}MDM-2017-0720]; Fondo Europeo
   de Desarrollo RegionalEuropean Commission {[}CB16/11/00458]; MCIU
   {[}SAF2015-65607-R, SAF2016-80324-R]; Frankel Cardiovascular Centre,
   Michigan Medicine {[}332475]; National Heart, Lung, and Blood
   InstituteUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}HL122352, R21HL138064, R01HL129136]; 
   {[}SVP-2014-068595]},
Funding-Text = {J.V. is a PhD fellow of the La Caixa Foundation International Fellowship
   Programme (La Caixa/CNB). This work was supported by the European
   Molecular Biology Organization (STF-7649 to A.F.), the Spanish Ministry
   of Science, Innovation and Universities (MCIU), (BFU2014-57797-R and
   BFU2017-83392-R to A.N.), and the network Ciber de Enfermedades
   Respiratorias (CIBERES) including the Improvement and Mobility
   Programme. CNB-CSIC is supported by the Maria de Maeztu Units of
   Excellence Program from the Spanish State Research Agency. CNIC is a
   Severo Ochoa Center of Excellence (SEV-2015-0505). CNIC is supported by
   MCIU and the Pro CNIC Foundation. CIC biomaGUNE is supported by the
   Maria de Maeztu Units of Excellence Program from the Spanish State
   Research Agency -Grant No. MDM-2017-0720. This study was supported by
   grants from Fondo Europeo de Desarrollo Regional (CB16/11/00458), grants
   SAF2015-65607-R and SAF2016-80324-R from MCIU (A.H. and D.F.R.) and
   fellowship SVP-2014-068595 to J.A.N.-A. This study was supported by
   Frankel Cardiovascular Centre, Michigan Medicine (Grant No. 332475).
   J.J. is supported in part by the National Heart, Lung, and Blood
   Institute (R01 Grant No. HL122352). S.F.N is supported in part by the
   National Heart, Lung, and Blood Institute (Grant Nos R21HL138064 and
   R01HL129136).},
Cited-References = {Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065.
   Baik SH, 2015, INFECT CHEMOTHER, V47, P272, DOI 10.3947/ic.2015.47.4.272.
   Beltran PMJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00268-17.
   Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X.
   Cesnekova J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123930.
   Chacko B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.016.
   Cioc AM, 2002, MODERN PATHOL, V15, P914, DOI 10.1097/01.MP.0000024291.37651.CD.
   Clayton TC, 2005, HEART, V91, P1601, DOI 10.1136/hrt.2004.046920.
   Cobas M, 2010, BMJ CASE REP, V17.
   COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606.
   Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7.
   Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004.
   Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534.
   Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004.
   Gdynia G, 2011, VIRCHOWS ARCH, V458, P371, DOI 10.1007/s00428-010-1035-0.
   Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4.
   Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767.
   Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3.
   Guo YZ, 2018, CARDIOVASC RES, V114, P979, DOI 10.1093/cvr/cvy052.
   Hou L, 2016, J CELL SCI, V129, P3084, DOI 10.1242/jcs.184374.
   Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9.
   Hsu SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002869.
   Ilyinskii PO, 2007, CELL CYCLE, V6, P2043, DOI 10.4161/cc.6.16.4564.
   Jeyanathan T, 2013, CAN MED ASSOC J, V185, P581, DOI 10.1503/cmaj.110807.
   Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462.
   Kenney AD, 2019, P NATL ACAD SCI USA, V116, P18607, DOI 10.1073/pnas.1900784116.
   Komai T, 2011, EUR HEART J, V32, P283, DOI 10.1093/eurheartj/ehq359.
   Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090.
   LAMB RA, 1980, P NATL ACAD SCI-BIOL, V77, P1857, DOI 10.1073/pnas.77.4.1857.
   MacIntyre CR, 2016, HEART, V102, P1953, DOI 10.1136/heartjnl-2016-309983.
   Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035.
   Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044.
   Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007.
   Miura M, 2001, TOHOKU J EXP MED, V195, P11, DOI 10.1620/tjem.195.11.
   Montcriol Ambroise, 2008, Cases J, V1, P46, DOI 10.1186/1757-1626-1-46.
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157.
   Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433.
   Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358.
   Ponce-Balbuena D, 2018, CIRC RES, V122, P1501, DOI 10.1161/CIRCRESAHA.117.311872.
   Puzelli S, 2010, J CLIN MICROBIOL, V48, P2298, DOI 10.1128/JCM.00418-10.
   Richter F, 2019, J CELL BIOL, V218, P598, DOI 10.1083/jcb.201806093.
   Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06.
   Rodriguez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053515.
   Ruan Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.414.
   Ukimura Akira, 2012, Influenza Res Treat, V2012, P351979, DOI 10.1155/2012/351979.
   Vasilijevic J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006650.
   Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597.
   Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6.},
Number-of-Cited-References = {48},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Cardiovasc. Res.},
Doc-Delivery-Number = {RI6OA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000637025500031},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000444825300003,
Author = {Liu, Chengdong and Xin, Yi and Bai, Yan and Lewin, Grant and He, Gen and
   Mai, Kangsen and Duan, Cunming},
Title = {Ca2+ concentration-dependent premature death of igfbp5a(-/-) fish
   reveals a critical role of IGF signaling in adaptive epithelial growth},
Journal = {SCIENCE SIGNALING},
Year = {2018},
Volume = {11},
Number = {548},
Month = {SEP 18},
Abstract = {The phenotype gap is a challenge for genetically dissecting redundant
   endocrine signaling pathways, such as the six isoforms in the
   insulin-like growth factor binding protein (IGFBP) family. Although
   overexpressed IGFBPs can inhibit or potentiate IGF actions or have
   IGF-independent actions, mutant mice lacking IGFBP-encoding genes do not
   exhibit major phenotypes. We found that although zebrafish deficient in
   igfbp5a did not show overt phenotypes when raised in Ca2+-rich
   solutions, they died prematurely in low Ca2+ conditions. A group of
   epithelial cells expressing igfbp5a take up Ca2+ and proliferate under
   low Ca2+ conditions because of activation of IGF signaling. Deletion of
   igfbp5a blunted low Ca2+ stress-induced IGF signaling and impaired
   adaptive proliferation. Reintroducing zebrafish Igfbp5a, but not its
   ligand binding-deficient mutant, restored adaptive proliferation.
   Similarly, adaptive proliferation was restored in zebrafish lacking
   igfbp5a by expression of human IGFBP5, but not two cancer-associated
   IGFBP5 mutants. Knockdown of IGFBP5 in human colon carcinoma cells
   resulted in reduced IGF-stimulated cell proliferation. These results
   reveal a conserved mechanism by which a locally expressed Igfbp
   regulates organismal Ca2+ homeostasis and survival by activating IGF
   signaling in epithelial cells and promoting their proliferation in
   Ca2+-deficient states. These findings underscore the importance of
   physiological context when analyzing loss-of-function phenotypes of
   endocrine factors.},
Publisher = {AMER ASSOC ADVANCEMENT SCIENCE},
Address = {1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA},
Type = {Article},
Language = {English},
Affiliation = {Duan, CM (Corresponding Author), Univ Michigan, Dept Mol Cellular \& Dev Biol, Ann Arbor, MI 48109 USA.
   Liu, Chengdong; Xin, Yi; Bai, Yan; Lewin, Grant; Duan, Cunming, Univ Michigan, Dept Mol Cellular \& Dev Biol, Ann Arbor, MI 48109 USA.
   Liu, Chengdong; He, Gen; Mai, Kangsen, Ocean Univ China, Key Lab Mariculture, Educ Minist China, Qingdao 266003, Peoples R China.
   Liu, Chengdong; He, Gen; Mai, Kangsen, Ocean Univ China, Coll Fisheries, Qingdao 266003, Peoples R China.
   He, Gen; Mai, Kangsen, Pilot Natl Lab Marine Sci \& Technol Qingdao, Qingdao 266237, Peoples R China.},
DOI = {10.1126/scisignal.aat2231},
Article-Number = {eaat2231},
ISSN = {1945-0877},
EISSN = {1937-9145},
Keywords-Plus = {FACTOR-BINDING PROTEIN-5; ZEBRAFISH EMBRYOS; VITAMIN-D; INSULIN;
   EXPRESSION; MUTATIONS; CALCIUM; MICE; BONE; RECEPTOR},
Research-Areas = {Biochemistry \& Molecular Biology; Cell Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Cell Biology},
Author-Email = {cduan@umich.edu},
ORCID-Numbers = {Liu, Chengdong/0000-0002-4080-8085
   Xin, Yi/0000-0002-4443-1342},
Funding-Acknowledgement = {NSFNational Science Foundation (NSF) {[}IOS-1557850]; MCube2.0 Project
   {[}U0496246]},
Funding-Text = {We thank J. Allard for critically reading and editing of the initial
   draft of the manuscript. This work was supported by NSF grant
   IOS-1557850 and MCube2.0 Project U0496246 to C.D.},
Cited-References = {Allard JB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00117.
   Anderson JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007105.
   ANDRESS DL, 1991, BIOCHEM BIOPH RES CO, V176, P213, DOI 10.1016/0006-291X(91)90911-P.
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O.
   BAUTISTA CM, 1991, BIOCHEM BIOPH RES CO, V176, P756, DOI 10.1016/S0006-291X(05)80249-9.
   Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720.
   BEATY MM, 1993, J NUTR, V123, P144, DOI 10.1093/jn/123.1.144.
   Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537.
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218.
   Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359.
   Clemmons DR, 1998, ENDOCR J, V45, pS1, DOI 10.1507/endocrj.45.Suppl\_S1.
   CONOVER CA, 1993, J CLIN ENDOCR METAB, V76, P1153, DOI 10.1210/jc.76.5.1153.
   Conover CA, 2017, AGING CELL, V16, P205, DOI 10.1111/acel.12564.
   Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177.
   Dai W, 2010, FASEB J, V24, P2020, DOI 10.1096/fj.09-149435.
   Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047.
   DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068.
   Ding M, 2016, NAT CELL BIOL, V18, P319, DOI 10.1038/ncb3311.
   Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390.
   Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022.
   Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836.
   El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780.
   Ewen-Campen B, 2017, DEV CELL, V43, P6, DOI 10.1016/j.devcel.2017.09.020.
   Flik Gert, 1995, V14, P317.
   Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054.
   Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853.
   KIEFER MC, 1992, J BIOL CHEM, V267, P12692.
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302.
   Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018.
   Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144.
   Liu CD, 2014, GEN COMP ENDOCR, V197, P82, DOI 10.1016/j.ygcen.2013.12.006.
   Liu C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01143-2.
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K.
   Liu Y, 2017, ENDOCRINOLOGY, V158, P604, DOI 10.1210/en.2016-1540.
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001.
   Massoner P, 2010, BRIT J CANCER, V103, P1479, DOI 10.1038/sj.bjc.6605932.
   Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722.
   MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424.
   Mokady E, 2000, NUTR CANCER, V38, P65, DOI 10.1207/S15327914NC381\_10.
   Ning Y, 2007, ENDOCRINOLOGY, V148, P2138, DOI 10.1210/en.2006-0041.
   Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196.
   Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110.
   Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580.
   Schmid C, 1996, AM J PHYSIOL-ENDOC M, V271, pE1029.
   Schneider MR, 2001, BIOCHEM BIOPH RES CO, V288, P435, DOI 10.1006/bbrc.2001.5785.
   Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171.
   Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001.
   Tang HP, 2015, ENDOCRINOLOGY, V156, P589, DOI 10.1210/en.2014-1204.
   Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019.
   Westerfield M, 2007, ZEBRAFISH BOOK GUIDE, V5th.
   Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472.
   Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF.
   Yin P, 2004, J BIOL CHEM, V279, P32660, DOI 10.1074/jbc.M401378200.
   Zhang CY, 2012, INT J CANCER, V130, P2003, DOI 10.1002/ijc.26201.
   Zhang P, 2016, ELIFE, V5, DOI 10.7554/eLife.08996.
   Zhao Y, 2006, J BIOL CHEM, V281, P14184, DOI 10.1074/jbc.M506941200.
   Zhong YB, 2011, J CELL SCI, V124, P1925, DOI 10.1242/jcs.082644.
   Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420.
   Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026.},
Number-of-Cited-References = {59},
Times-Cited = {9},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {20},
Journal-ISO = {Sci. Signal.},
Doc-Delivery-Number = {GT8YF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000444825300003},
DA = {2022-03-29},
}

@article{ WOS:000080248000003,
Author = {Moechars, D and Lorent, K and Van Leuven, F},
Title = {Premature death in transgenic mice that overexpress a mutant amyloid
   precursor protein is preceded by severe neurodegeneration and apoptosis},
Journal = {NEUROSCIENCE},
Year = {1999},
Volume = {91},
Number = {3},
Pages = {819-830},
Abstract = {A mutant amyloid precursor protein (APP/RK) designed to interfere with
   processing by alpha-secretase caused a severe phenotype in transgenic
   mice, including behavioural abnormalities, i.e. neophobia, aggression,
   hypersensitivity to kainic acid, hyposensitivity to
   N-methyl-D-aspartate, and premature death {[}Moechars D. et al. (1996)
   Eur. molec. Biol. Org. J. 15, 1265-1274]. We now demonstrated that the
   APP/RK transgene did not disturb the expression of several other genes,
   i.e. endogenous amyloid precursor protein and amyloid precursor
   protein-like proteins, members of the low density lipoprotein receptor
   lipoprotein receptor family and several of their ligands, including
   apolipoprotein E, but expression of alpha-2-macroglobulin was never
   detected. Neither amyloid deposits nor neurofibrillary tangles were
   detected in the brain of APP/RK transgenic mice, even when
   15-months-old. The tendency for seizures and hyposensitivity for
   N-methyl-D-aspartate was not due to or reflected in the distribution of
   the three major types of glutamate receptors.
   The major and consistent finding in transgenic APP/RK mice that died
   prematurely was extensive neurodegeneration and apoptosis, mainly in
   hippocampus and cortex, and accompanied by astrocytosis throughout the
   brain. Reduced synaptic density and dendritic damage was only observed
   in three transgenic mice that were killed shortly after positive
   observation of seizures. In addition, the distribution of cathepsin D
   and ubiquitin was abnormal in these mice. (C) 1999 IBRO. Published by
   Elsevier Science Ltd.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Van Leuven, F (Corresponding Author), Katholieke Univ Leuven VIB, Ctr Human Genet, Expt Genet Grp, Campus Gasthuisberg, B-3000 Louvain, Belgium.
   Katholieke Univ Leuven VIB, Ctr Human Genet, Expt Genet Grp, B-3000 Louvain, Belgium.},
DOI = {10.1016/S0306-4522(98)00599-5},
ISSN = {0306-4522},
EISSN = {1873-7544},
Keywords = {transgenic mice; amyloid precursor protein; Alzheimer's disease;
   apoptosis; neurodegeneration},
Keywords-Plus = {RECEPTOR-RELATED PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E
   RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; BETA-PROTEIN; NEUROFIBRILLARY
   TANGLES; SENILE PLAQUES; MOLECULAR-CLONING; BINDING-PROTEIN;
   MESSENGER-RNA},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Cited-References = {Blennow K, 1996, J NEURAL TRANSM, V103, P603, DOI 10.1007/BF01273157.
   Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5.
   Cataldo AM, 1996, J NEUROSCI, V16, P186.
   CHURUKIAN CJ, 1992, J HISTOTECHNOL, V15, P299, DOI 10.1179/his.1992.15.4.299.
   De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910.
   DESTROOPER B, 1991, BIOCHIM BIOPHYS ACTA, V1129, P141, DOI 10.1016/0167-4781(91)90231-A.
   DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295.
   FURUKAWA T, 1990, J BIOCHEM-TOKYO, V108, P297, DOI 10.1093/oxfordjournals.jbchem.a123197.
   GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387.
   GARVEY W, 1991, J HISTOTECHNOL, V14, P39, DOI 10.1179/his.1991.14.1.39.
   HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E.
   HILBICH C, 1993, J BIOL CHEM, V268, P26571.
   HOFFER MJV, 1993, BIOCHEM BIOPH RES CO, V191, P880, DOI 10.1006/bbrc.1993.1299.
   HORIUCHI K, 1989, J BIOCHEM-TOKYO, V106, P98, DOI 10.1093/oxfordjournals.jbchem.a122828.
   Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99.
   HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8.
   Kamboh MI, 1998, NEUROSCI LETT, V244, P65, DOI 10.1016/S0304-3940(98)00141-4.
   Kasper M, 1996, VIRCHOWS ARCH, V428, P207.
   KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420.
   LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21.
   LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536.
   LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J.
   LORENT K, 1994, DIFFERENTIATION, V55, P213, DOI 10.1046/j.1432-0436.1994.5530213.x.
   Moechars D, 1998, BEHAV BRAIN RES, V95, P55, DOI 10.1016/S0166-4328(97)00210-6.
   Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x.
   NAKAMOTO M, 1993, J BIOCHEM-TOKYO, V114, P344, DOI 10.1093/oxfordjournals.jbchem.a124179.
   NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F.
   OUIMET CC, 1994, J COMP NEUROL, V348, P244, DOI 10.1002/cne.903480207.
   PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033.
   REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212.
   RICKLES RJ, 1988, J BIOL CHEM, V263, P1563.
   Saftig P, 1996, J BIOL CHEM, V271, P27241, DOI 10.1074/jbc.271.44.27241.
   Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864.
   Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295.
   STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725.
   THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x.
   TOOYAMA I, 1993, MOL CHEM NEUROPATHOL, V18, P153, DOI 10.1007/BF03160029.
   VANGOOL D, 1993, NEUROBIOL AGING, V14, P233, DOI 10.1016/0197-4580(93)90006-W.
   VANLEUVEN F, 1992, EUR J BIOCHEM, V210, P319.
   VANLEUVEN F, 1993, BIOCHIM BIOPHYS ACTA, V1173, P71, DOI 10.1016/0167-4781(93)90244-8.
   VIDAL F, 1992, BIOCHEM BIOPH RES CO, V189, P1336, DOI 10.1016/0006-291X(92)90220-F.
   WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95.
   WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9.
   YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303.},
Number-of-Cited-References = {44},
Times-Cited = {61},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Neuroscience},
Doc-Delivery-Number = {195JV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000080248000003},
DA = {2022-03-29},
}

@article{ WOS:000428427800013,
Author = {Fajardo, Val Andrew and LeBlanc, Paul J. and Fajardo, Val Andrei},
Title = {Trace lithium in Texas tap water is negatively associated with all-cause
   mortality and premature death},
Journal = {APPLIED PHYSIOLOGY NUTRITION AND METABOLISM},
Year = {2018},
Volume = {43},
Number = {4},
Pages = {412-414},
Month = {APR},
Abstract = {Lithium in tap water was previously found to have life-extending effects
   across 18 Japanese municipalities. Using a larger dataset with several
   Texas counties, our study shows that lithium concentrations in tap water
   are negatively associated with all-cause mortality (r = -0.18, p =
   0.006, 232 counties) and years of potential life lost (r = -0.22, p =
   0.001, 214 counties). Thus, our present findings extend and reinforce
   lithium's purported life-prolonging effect in humans.},
Publisher = {CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS},
Address = {65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA},
Type = {Article},
Language = {English},
Affiliation = {Fajardo, VA (Corresponding Author), Univ Waterloo, Dept Actuarial Sci, Waterloo, ON N2L 3G1, Canada.
   Fajardo, Val Andrew; LeBlanc, Paul J., Brock Univ, Dept Hlth Sci, St Catharines, ON L2S 3A1, Canada.
   Fajardo, Val Andrew; LeBlanc, Paul J., Brock Univ, Ctr Bone \& Muscle Hlth, St Catharines, ON L2S 3A1, Canada.
   Fajardo, Val Andrei, Univ Waterloo, Dept Actuarial Sci, Waterloo, ON N2L 3G1, Canada.},
DOI = {10.1139/apnm-2017-0653},
ISSN = {1715-5312},
EISSN = {1715-5320},
Keywords = {lifespan; longevity; GSK3; lithium; healthspan},
Keywords-Plus = {CAENORHABDITIS-ELEGANS; RISK-FACTORS; SUICIDE},
Research-Areas = {Nutrition \& Dietetics; Physiology; Sport Sciences},
Web-of-Science-Categories  = {Nutrition \& Dietetics; Physiology; Sport Sciences},
Author-Email = {vfajardo@brocku.ca},
Funding-Acknowledgement = {Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada
   (NSERC)},
Funding-Text = {V.A.F. was funded by a Natural Sciences and Engineering Research Council
   of Canada (NSERC) postdoctoral fellowship.},
Cited-References = {Bluml V, 2013, J PSYCHIATR RES, V47, P407, DOI 10.1016/j.jpsychires.2012.12.002.
   Castillo-Quan JI, 2016, CELL REP, V15, P638, DOI 10.1016/j.celrep.2016.03.041.
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031.
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1068.
   Lutz J, 2018, J AFFECT DISORDERS, V227, P260, DOI 10.1016/j.jad.2017.10.043.
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946.
   Malhi GS, 2011, CNS DRUGS, V25, P289, DOI 10.2165/11586970-000000000-00000.
   Marshall T., 2015, J AM PHYS, V20, P104.
   McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200.
   Ohgami H, 2009, BRIT J PSYCHIAT, V194, P464, DOI 10.1192/bjp.bp.108.055798.
   Sozeri-Varma G, 2012, AGING DIS, V3, P465.
   Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7.
   Tam ZY, 2014, J GERONTOL A-BIOL, V69, P810, DOI 10.1093/gerona/glt210.
   Zarse K, 2011, EUR J NUTR, V50, P387, DOI 10.1007/s00394-011-0171-x.},
Number-of-Cited-References = {14},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Appl. Physiol. Nutr. Metab.},
Doc-Delivery-Number = {GA6FG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000428427800013},
DA = {2022-03-29},
}

@article{ WOS:000335230800004,
Author = {Schmidt, Morten and Botker, Hans Erik and Pedersen, Lars and Sorensen,
   Henrik Toft},
Title = {Adult height and risk of ischemic heart disease, atrial fibrillation,
   stroke, venous thromboembolism, and premature death: a population based
   36-year follow-up study},
Journal = {EUROPEAN JOURNAL OF EPIDEMIOLOGY},
Year = {2014},
Volume = {29},
Number = {2},
Pages = {111-118},
Month = {FEB},
Abstract = {Few studies have associated height with cardiovascular diseases other
   than myocardial infarction. We conducted a population-based 36-year
   cohort study of 12,859 men born in 1955 or 1965 whose fitness for
   military service was assessed by Draft Boards in Northern Denmark.
   Hospital diagnoses for ischemic heart diseases, atrial fibrillation,
   stroke, and venous thromboembolism were obtained from the Danish
   National Patient Registry, covering all Danish hospitals since 1977.
   Mortality data were obtained from the Danish Civil Registration System.
   We began follow-up on the 22nd birthday of each subject and continued
   until occurrence of an outcome, emigration, death, or 31 December 2012,
   whichever came first. We used Cox regression to compute hazard ratios
   (HRs) with 95 \% confidence intervals (CIs). Compared with short
   stature, the education-adjusted HR among tall men was 0.67 (95 \% CI
   0.54-0.84) for ischemic heart disease (similar for myocardial
   infarction, angina pectoris, and heart failure), 1.60 (95 \% CI
   1.11-2.33) for atrial fibrillation, 1.05 (95 \% CI 0.75-1.46) for
   stroke, 1.04 (95 \% CI 0.67-1.64) for venous thromboembolism, and 0.70
   (95 \% CI 0.58-0.86) for death. In conclusion, short stature was a risk
   factor for ischemic heart disease and premature death, but a protective
   factor for atrial fibrillation. Stature was not substantially associated
   with stroke or venous thromboembolism.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Schmidt, M (Corresponding Author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus, Denmark.
   Schmidt, Morten; Pedersen, Lars; Sorensen, Henrik Toft, Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus, Denmark.
   Schmidt, Morten; Botker, Hans Erik, Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark.},
DOI = {10.1007/s10654-013-9867-y},
ISSN = {0393-2990},
EISSN = {1573-7284},
Keywords = {Height; Myocardial infarction; Heart failure; Atrial fibrillation;
   Stroke; Venous thromboembolism},
Keywords-Plus = {MIDDLE-AGED MEN; BODY HEIGHT; CARDIOVASCULAR-DISEASE; SHORT STATURE;
   WOMEN; SIZE; PREVALENCE; THROMBOSIS; DIAGNOSES; OBESITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {morten.schmidt@dadlnet.dk},
ResearcherID-Numbers = {Sorensen, Henrik Toft/Z-6181-2019
   },
ORCID-Numbers = {Sorensen, Henrik Toft/0000-0003-4299-7040
   Botker, Hans Erik/0000-0001-6358-8962
   Schmidt, Morten/0000-0002-4935-4059},
Funding-Acknowledgement = {Aarhus University; Danish Research CouncilDet Frie Forskningsrad (DFF)
   {[}11-108354, 11-115818]; Augustinusfonden; Clinical Epidemiological
   Research Foundation, Denmark; Department of Clinical Epidemiology,
   Aarhus University Hospital; Novo Nordisk FondenNovo Nordisk Foundation
   {[}NNF13OC0007447] Funding Source: researchfish},
Funding-Text = {The study was supported by Aarhus University, the Danish Research
   Council (grants 11-108354 and 11-115818), ``Augustinusfonden{''}, and
   the Clinical Epidemiological Research Foundation, Denmark. These funding
   sources had no role in the design, conduct, analysis, or reporting of
   this study. The Department of Clinical Epidemiology, Aarhus University
   Hospital, receives funding for other studies from companies in the form
   of research grants to (and administered by) Aarhus University. None of
   the company-funded studies have any relation to the present study.},
Cited-References = {Akinkuolie AO, 2012, AM J CARDIOL, V109, P994, DOI 10.1016/j.amjcard.2011.11.032.
   BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148.
   BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A.
   Borch KH, 2011, ARTERIOSCL THROM VAS, V31, P1439, DOI 10.1161/ATVBAHA.110.218925.
   Braekkan SK, 2010, AM J EPIDEMIOL, V171, P1109, DOI 10.1093/aje/kwq066.
   Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049.
   Conen D, 2010, CIRCULATION, V122, P764, DOI 10.1161/CIRCULATIONAHA.110.947978.
   Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458.
   Ezekowitz MD, 1999, ANN INTERN MED, V131, P537, DOI 10.7326/0003-4819-131-7-199910050-00011.
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170.
   Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993.
   Gertler MM, 1951, JAMA-J AM MED ASSOC, V13, P621.
   Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309.
   Guglin M, 2011, AM J CARDIOL, V107, P579, DOI 10.1016/j.amjcard.2010.10.018.
   Hanna IR, 2006, J AM COLL CARDIOL, V47, P1683, DOI 10.1016/j.jacc.2005.11.068.
   Hart CL, 2000, STROKE, V31, P1893, DOI 10.1161/01.STR.31.8.1893.
   HEBERT PR, 1993, CIRCULATION, V88, P1437, DOI 10.1161/01.CIR.88.4.1437.
   Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504.
   Honjo K, 2011, EUR J EPIDEMIOL, V26, P13, DOI 10.1007/s10654-010-9515-8.
   Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005.
   Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143.
   KUH D, 1989, INT J EPIDEMIOL, V18, P663, DOI 10.1093/ije/18.3.663.
   Lemos PA, 2007, INT J CARDIOVAS IMAG, V23, P1, DOI 10.1007/s10554-006-9119-2.
   Lutsey PL, 2011, THROMB HAEMOSTASIS, V106, P113, DOI 10.1160/TH11-02-0100.
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482.
   Mard Shan, 2010, Clin Epidemiol, V2, P235, DOI 10.2147/CLEP.S12457.
   Martin-Du Pan RC, 2004, SWISS MED WKLY, V134, P543.
   McCarron P, 2000, J EPIDEMIOL COMMUN H, V54, P239, DOI 10.1136/jech.54.3.239.
   McCarron P, 2001, J EPIDEMIOL COMMUN H, V55, P404, DOI 10.1136/jech.55.6.404.
   Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263.
   Nielsen GL, 2007, DIABETES CARE, V30, P2827, DOI 10.2337/dc07-1225.
   Njolstad I, 1996, CIRCULATION, V94, P2877.
   Nwasokwa ON, 1997, AM HEART J, V133, P147, DOI 10.1016/S0002-8703(97)70202-3.
   Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155.
   Parker DR, 1998, INT J EPIDEMIOL, V27, P970, DOI 10.1093/ije/27.6.970.
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965.
   Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x.
   Psaty BM, 1997, CIRCULATION, V96, P2455.
   RICHEDWARDS JW, 1995, AM J EPIDEMIOL, V142, P909, DOI 10.1093/oxfordjournals.aje.a117738.
   Rosenberg MA, 2012, EUR HEART J, V33, P2709, DOI 10.1093/eurheartj/ehs301.
   Rosengren A, 2008, J THROMB HAEMOST, V6, P558, DOI 10.1111/j.1538-7836.2007.02857.x.
   Rosengren A, 2009, EUR HEART J, V30, P1113, DOI 10.1093/eurheartj/ehp076.
   Sankaranarayanan R, 2013, CARDIOL RES PRACT, V2013, DOI 10.1155/2013/976976.
   Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698.
   Schmidt M, 2013, EPIDEMIOLOGY, V24, P632, DOI 10.1097/EDE.0b013e31829e0ea2.
   Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8.
   Schotten U, 2003, PROG BIOPHYS MOL BIO, V82, P151, DOI 10.1016/S0079-6107(03)00012-9.
   Severinsen MT, 2010, J CLIN EPIDEMIOL, V63, P223, DOI 10.1016/j.jclinepi.2009.03.018.
   Suzuki S, 2010, CIRC J, V74, P66, DOI 10.1253/circj.CJ-09-0431.
   van Langevelde K, 2012, BLOOD, V120, P933, DOI 10.1182/blood-2012-02-407551.
   WALKER M, 1989, INT J EPIDEMIOL, V18, P602, DOI 10.1093/ije/18.3.602.
   Wannamethee SG, 1998, AM J EPIDEMIOL, V148, P1069.
   Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086.},
Number-of-Cited-References = {53},
Times-Cited = {48},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Eur. J. Epidemiol.},
Doc-Delivery-Number = {AG2FF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000335230800004},
DA = {2022-03-29},
}

@article{ WOS:A1979GQ71600006,
Author = {LANNERSTAD, O and ISACSSON, SO and LINDELL, SE},
Title = {RISK-FACTORS FOR PREMATURE DEATH IN MEN 56-60 YEARS OLD},
Journal = {SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE},
Year = {1979},
Volume = {7},
Number = {1},
Pages = {41-47},
Publisher = {SCANDINAVIAN UNIVERSITY PRESS},
Address = {PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY},
Type = {Article},
Language = {English},
Affiliation = {LANNERSTAD, O (Corresponding Author), UNIV LUND,ALLAMANNA SJUKHUSET,DEPT CLIN PHYSIOL,S-21401 MALMO,SWEDEN.
   UNIV LUND,ALLAMANNA SJUKHUSET,DEPT SURG,S-21401 MALMO,SWEDEN.
   UNIV LUND,ALLAMANNA SJUKHUSET,DEPT SOCIAL \& PREVENT MED,S-21401 MALMO,SWEDEN.},
DOI = {10.1177/140349487900700106},
ISSN = {0300-8037},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {CARLSON LA, 1972, LANCET, V1, P865.
   CEDERLOF R, 1975, RELATIONSHIP SMOKING.
   DOLL R, 1964, BMJ-BRIT MED J, V1, P1460, DOI 10.1136/bmj.1.5396.1460.
   DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399.
   DYER AR, 1975, LANCET, V1, P1051.
   FREIS ED, 1970, JAMA-J AM MED ASSOC, V213, P1143.
   Furberg C, 1975, Lakartidningen, V72, P2936.
   GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661.
   HAMMOND EC, 1966, 19 NAT CANC I MON, P127.
   ISACSSON SO, 1976, SCAND J SOC MED, V4, P25.
   ISACSSON SO, 1975, SCAND J SOC MED, V3, P93, DOI 10.1177/140349487500300208.
   ISACSSON SO, 1972, ACTA MED SCAND  S537.
   JANZON L, 1974, ACTA CHIR SCAND S451.
   KEYS A, 1972, CIRCULATION, V45, P815, DOI 10.1161/01.CIR.45.4.815.
   KEYS A, 1975, ATHEROSCLEROSIS, V22, P149, DOI 10.1016/0021-9150(75)90001-5.
   LANNERSTAD O, UNPUBLISHED.
   ROGOT R, 1974, NIH74 DHEW PUBL, P544.
   {*}ROY COLL PHYS, 1977, REP.
   TIBBLIN G, 1975, AM J CARDIOL, V35, P514, DOI 10.1016/0002-9149(75)90834-6.
   TRUETT J, 1967, J CHRON DIS, V20, P511, DOI 10.1016/0021-9681(67)90082-3.
   WERKO L, 1976, AM HEART J, V91, P87, DOI 10.1016/S0002-8703(76)80439-5.
   WILHELMSEN L, 1973, CIRCULATION, V48, P950, DOI 10.1161/01.CIR.48.5.950.
   WILHELMSEN L, 1969, PEHR DUBB JOURNALEN, V4, P43.},
Number-of-Cited-References = {23},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Soc. Med.},
Doc-Delivery-Number = {GQ716},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1979GQ71600006},
DA = {2022-03-29},
}

@article{ WOS:A1992JW73000021,
Author = {WALKER, SE and MCMURRAY, RW and BESCHWILLIFORD, CL and KEISLER, DH},
Title = {PREMATURE DEATH WITH BLADDER OUTLET OBSTRUCTION AND HYPERPROLACTINEMIA
   IN NEW-ZEALAND BLACK X NEW-ZEALAND WHITE MICE TREATED WITH ETHINYL
   ESTRADIOL AND 17-BETA-ESTRADIOL},
Journal = {ARTHRITIS AND RHEUMATISM},
Year = {1992},
Volume = {35},
Number = {11},
Pages = {1387-1392},
Month = {NOV},
Abstract = {Objective. To determine causes of death, estrogen toxicity, and
   hyperprolactinemia in a murine model of systemic lupus erythematosus
   (SLE).
   Methods. Female New Zealand Black x New Zealand White (NZB x NZW) mice
   were implanted with ethinyl estradiol, 17 beta-estradiol, or empty
   capsules (controls).
   Results. Estrogen-treated mice developed striking hyperprotactinemia and
   died prematurely with genitourinary complications.
   Conclusion. Implanted estrogens, including 17 beta-estradiol in a dose
   reported previously to stimulate SLE, contribute to premature death in
   NZB x NZW mice, through toxic effects. Estrogen therapy increases the
   level of prolactin, an immunostimulatory hormone.},
Publisher = {LIPPINCOTT-RAVEN PUBL},
Address = {227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106},
Type = {Article},
Language = {English},
Affiliation = {UNIV MISSOURI,DEPT INTERNAL MED,COLUMBIA,MO 65201.
   UNIV MISSOURI,DEPT ANIM SCI,COLUMBIA,MO 65201.
   UNIV MISSOURI,COLL VET MED,COLUMBIA,MO 65201.},
DOI = {10.1002/art.1780351123},
ISSN = {0004-3591},
Keywords-Plus = {AUTOIMMUNE-DISEASE; NZB/W MICE},
Research-Areas = {Rheumatology},
Web-of-Science-Categories  = {Rheumatology},
ResearcherID-Numbers = {Keisler, Duane H/C-2746-2011},
ORCID-Numbers = {Keisler, Duane H/0000-0002-8792-7030},
Cited-References = {AZAD N, 1989, Journal of Experimental Pathology (New York), V4, P237.
   FRANKS S, 1983, CLIN SCI, V65, P457, DOI 10.1042/cs0650457.
   Gardner WU, 1939, ARCH PATHOL, V27, P138.
   KEISLER LW, 1991, BIOL REPROD, V44, P707, DOI 10.1095/biolreprod44.4.707.
   KEISLER LW, 1991, AUTOIMMUNITY, V9, P21, DOI 10.3109/08916939108997120.
   MCMURRAY R, 1991, J IMMUNOL, V147, P3780.
   MELEZ KA, 1978, ANN INST PASTEUR IMM, VC129, P707.
   NOBLE RL, 1975, CANCER RES, V35, P766.
   Rothfield N. F., 1989, ARTHRITIS ALLIED CON.
   ROUBINIAN J, 1979, ARTHRITIS RHEUM, V22, P1162.
   ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568.
   Selye H, 1939, CAN MED ASSOC J, V41, P48.
   SIITERI PK, 1980, J STEROID BIOCHEM, V12, P425, DOI 10.1016/0022-4731(80)90303-9.
   SIMPSON W, 1976, LAB ANIM, V40, P413.
   THEOFILOPOULOS A, 1987, SYSTEMIC LUPUS ERYTH.
   YULEE L, 1990, MOL CELL ENDOCRINOL, V8, P21.},
Number-of-Cited-References = {16},
Times-Cited = {37},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Arthritis Rheum.},
Doc-Delivery-Number = {JW730},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1992JW73000021},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000078679300024,
Author = {Zureik, M and Touboul, PJ and Bonithon-Kopp, C and Courbon, D and
   Ruelland, I and Ducimetiere, P},
Title = {Differential association of common carotid intima-media thickness and
   carotid atherosclerotic plaques with parental history of premature death
   from coronary heart disease - The EVA study},
Journal = {ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY},
Year = {1999},
Volume = {19},
Number = {2},
Pages = {366-371},
Month = {FEB},
Abstract = {Familial aggregation of coronary heart disease (CHD) has been reported
   in several studies. The specific underlying mechanisms and the relative
   contribution of atherosclerosis to the subsequent CI-ID events in
   subjects with family history are not well established. This study
   examined the association of parental history of premature death from CHD
   with ultrasound carotid measurements of atherosclerosis in a population
   of 1040 subjects aged 59 to 71 years. Ultrasound examination included
   measurements of intima-media thickness at the common carotid arteries
   (at sites free of plaques) and assessment of atherosclerotic plaques in
   the extracranial carotid arteries. Subjects who reported that 1 or both
   parents had sudden death or died of myocardial infarction before the age
   of 65 years were considered positive for parental history of premature
   death from CHD (n = 53, 5.1\%). The prevalence of atheromatous plaques
   was higher in subjects with history of premature death from CHD compared
   with those without history (41.5\% versus 20.5\%, P < 0.001). Age- and
   sex-adjusted odds ratio of atheromatous plaques associated with parental
   history of premature death from CHD was 2.85 (95\% confidence interval,
   1.60 to 5.08; P < 0.001). Multivariate adjustment for major known
   cardiovascular risk factors did not markedly alter the results (odds
   ratio, 2.70; P < 0.002), In contrast, common carotid intima-media
   thickness was not associated with parental history of premature death
   from CND (0.66 +/- 0.11 versus 0.66 +/- 0.12 mm, P = 0.76). These
   findings were observed in both men and women. In conclusion, parental
   history of premature death from CHD is strongly associated with carotid
   plaques. Familial transmission of CHD risk does not seem to be
   specifically mediated by arterial wall thickening measured at sites free
   of plaques.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA},
Type = {Article},
Language = {English},
Affiliation = {Zureik, M (Corresponding Author), Hop Broussais, INSERM, U258, 96 Rue Didot, F-75674 Paris 14, France.
   Ctr Diagnost \& Prevent Neurovasc, Paris, France.
   INSERM, Ctr Examen EVA, Nantes, France.},
DOI = {10.1161/01.ATV.19.2.366},
ISSN = {1079-5642},
Keywords = {carotid arteries; atherosclerosis; coronary disease; ultrasonics;
   epidemiology},
Keywords-Plus = {INDEPENDENT RISK FACTOR; B-MODE ULTRASOUND; ARTERY DISEASE;
   MYOCARDIAL-INFARCTION; FAMILY HISTORY; CARDIOVASCULAR HEALTH; WALL
   THICKNESS; MEN; WOMEN; DETERMINANTS},
Research-Areas = {Hematology; Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Hematology; Peripheral Vascular Disease},
Author-Email = {zureik@hbroussais.fr},
ResearcherID-Numbers = {Zureik, Mahmoud/F-7855-2018},
ORCID-Numbers = {Touboul, Pierre-Jean Touboul/0000-0002-8872-9917
   Zureik, Mahmoud/0000-0002-8393-4217},
Cited-References = {ANDERSON AJ, 1979, PREV MED, V8, P419, DOI 10.1016/0091-7435(79)90019-7.
   BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065.
   BEATY TH, 1982, AM J EPIDEMIOL, V125, P979.
   BERG K, 1983, PROG MED GENET, V5, P35.
   BonithonKopp C, 1996, ARTERIOSCL THROM VAS, V16, P310, DOI 10.1161/01.ATV.16.2.310.
   BONITHONKOPP C, 1993, STROKE, V24, P1837, DOI 10.1161/01.STR.24.12.1837.
   BonithonKopp C, 1996, STROKE, V27, P654, DOI 10.1161/01.STR.27.4.654.
   BOTS ML, 1992, HYPERTENSION, V19, P717, DOI 10.1161/01.HYP.19.6.717.
   BOTS ML, 1993, ATHEROSCLEROSIS, V102, P99, DOI 10.1016/0021-9150(93)90088-C.
   Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432.
   Bots ML, 1997, STROKE, V28, P442.
   BURKE GL, 1991, CIRCULATION, V84, P1176, DOI 10.1161/01.CIR.84.3.1176.
   CAMBIEN F, 1987, CIRCULATION, V76, P266, DOI 10.1161/01.CIR.76.2.266.
   CLARKE WR, 1986, AM J EPIDEMIOL, V123, P67, DOI 10.1093/oxfordjournals.aje.a114225.
   COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223.
   COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F.
   Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155.
   GARIEPY J, 1995, ATHEROSCLEROSIS, V113, P141, DOI 10.1016/0021-9150(94)05436-M.
   GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018.
   GLAGOV S, 1989, Journal of Vascular Surgery, V10, P571.
   HAMSTEN A, 1987, AM J CARDIOL, V59, P14, DOI 10.1016/S0002-9149(87)80061-9.
   HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078.
   HELLER RF, 1983, J EPIDEMIOL COMMUN H, V37, P29, DOI 10.1136/jech.37.1.29.
   KAPRIO J, 1993, CIRCULATION, V87, P1960, DOI 10.1161/01.CIR.87.6.1960.
   KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528.
   KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963.
   MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503.
   Minamikawa J, 1998, DIABETES CARE, V21, P323, DOI 10.2337/diacare.21.2.323.
   MUKERJI V, 1989, ANGIOLOGY, V40, P88, DOI 10.1177/000331978904000202.
   MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K.
   NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503.
   OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155.
   OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752.
   PERKINS KA, 1986, AM J EPIDEMIOL, V124, P182, DOI 10.1093/oxfordjournals.aje.a114377.
   PESONEN E, 1990, EUR HEART J, V11, P53, DOI 10.1093/eurheartj/11.suppl\_E.53.
   PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399.
   ROSSENEU M, 1994, CIRCULATION, V89, P1967, DOI 10.1161/01.CIR.89.5.1967.
   SALONEN JT, 1989, ANN MED, V21, P227, DOI 10.3109/07853898909149939.
   SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245.
   SALONEN R, 1991, J INTERN MED, V229, P225, DOI 10.1111/j.1365-2796.1991.tb00336.x.
   SEGAL P, 1982, EPIDEMIOL REV, V4, P132.
   SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8.
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202.
   TOUBOUL PJ, 1992, J HYPERTENS, V10, pS37, DOI 10.1097/00004872-199207005-00006.
   VLODAVER Z, 1969, CIRCULATION, V39, P541, DOI 10.1161/01.CIR.39.4.541.
   WANG XL, 1994, CIRCULATION, V89, P1974, DOI 10.1161/01.CIR.89.5.1974.
   WENDELHAG I, 1992, ARTERIOSCLER THROMB, V12, P70, DOI 10.1161/01.ATV.12.1.70.
   WOFFORD JL, 1991, ARTERIOSCLER THROMB, V11, P1786, DOI 10.1161/01.ATV.11.6.1786.},
Number-of-Cited-References = {48},
Times-Cited = {75},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Arterioscler. Thromb. Vasc. Biol.},
Doc-Delivery-Number = {168EV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000078679300024},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000723003700008,
Author = {Hatman, Elif Altundas and Karagul, Duygu Acar and Oyman, Eliz Kuman and
   Tuzun, Bahar and Simsek, Kadir Onur and Kilicaslan, Zeki},
Title = {Premature Deaths Due to Silicosis in Turkey, 2006-2017: A Twelve-Year
   Longitudinal Study},
Journal = {BALKAN MEDICAL JOURNAL},
Year = {2021},
Volume = {38},
Number = {6},
Pages = {374-381},
Month = {NOV},
Abstract = {Background: Deaths due to epidemics of silicosis still continue to be
   reported both in developing and developed countries, and silica exposure
   from different sectors remains an important occupational health concern.
   Aims: To identify characteristics of silicosis cases by focusing on a
   developing country and evaluate the frequency of and factors related to
   premature deaths and also reveal preventable causes of premature deaths
   in silicosis.
   Study Design: Retrospective cohort.
   Methods: We reviewed the records of 9769 patients who were diagnosed
   with occupational diseases in Istanbul Occupational Diseases Hospital
   between 2006 and 2017. According to International Classification of
   Diseases (ICD)-10 codes, 1473 silicosis cases were detected. The
   sociodemographic characteristics, job characteristics, comorbidities,
   serological, functional, and radiological data, and follow-up time were
   obtained from the medical records. Mortality data were gathered from The
   National Death Notification System of Ministry of Health.
   Results: The study examined 9769 cases diagnosed with an occupational
   disease, and 15.0\% (n = 1473) of them were diagnosed with silicosis.
   The median age of silicosis patients was 40.0 years, and 26.9\% of them
   were child labor when they started to work in dusty industries. Child
   labor was mostly seen among dental technicians (57.7\%), denim
   sandblasters (46.4\%), and miners (37.0\%). In the follow-up period,
   26.3\% of Teflon sandblasters, 11.1\% of coal miners, 8.6\% of denim
   sandblasters had died before their average life expectancy, and the
   years of loss of life was 26.0 +/- 11.6 years all over the group.
   Premature death was associated with occupation {[}hazard ratio (Teflon
   sandblasting): 3.93, CI: 1.43-10.78; hazard ratio (marble production):
   4.4, CI: 1.02-19.21]; large opacities in posterior anterior chest X-ray
   {[}hazard ratio: 2.14, CI: 1.18-3.86]; tuberculosis {[}hazard ratio:
   2.60, CI: 1.42-4.76]; and reduction in forced vital capacity (forced
   vital capacity\% <= 80) during diagnosis {[}hazard ratio: 4.43, CI:
   2.22-8.83].
   Conclusion: More than a quarter of silicosis cases are those who start
   working in dusty industries at an early age. Factors associated with
   premature death in patients with silicosis are patient occupation, large
   opacities on chest X-ray, tuberculosis, and pulmonary function loss at
   diagnosis.},
Publisher = {GALENOS PUBL HOUSE},
Address = { MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21-1, ISTANBUL, TURKEY},
Type = {Article},
Language = {English},
Affiliation = {Hatman, EA (Corresponding Author), Istanbul Yedikule Chest Dis \& Thorac Surg Trainin, Dept Occupat Med, Istanbul, Turkey.
   Hatman, Elif Altundas, Istanbul Yedikule Chest Dis \& Thorac Surg Trainin, Dept Occupat Med, Istanbul, Turkey.
   Karagul, Duygu Acar; Oyman, Eliz Kuman; Simsek, Kadir Onur, Istanbul Univ, Istanbul Sch Med, Dept Publ Hlth, Istanbul, Turkey.
   Tuzun, Bahar, Sureyyapa Chest Dis \& Thorac Surg Training \& Res, Dept Pulmonol, Istanbul, Turkey.
   Kilicaslan, Zeki, Istanbul Univ, Istanbul Sch Med, Dept Pulmonol, Istanbul, Turkey.},
DOI = {10.5152/balkanmedj.2021.21208},
ISSN = {2146-3123},
EISSN = {2146-3131},
Keywords-Plus = {UNITED-STATES; MORTALITY; GENERATION; EXPOSURE; DUST},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {elifaltundashatman@istanbul.edu.tr},
Cited-References = {Akgun M, 2008, EUR RESPIR J, V32, P1295, DOI 10.1183/09031936.00093507.
   Akgun M, 2018, TURK THORAC J, V19, P89, DOI 10.5152/TurkThoracJ.2018.040189.
   Akgun M, 2015, CHEST, V148, P647, DOI 10.1378/chest.14-2848.
   Arrouays D, 2014, GLOBAL SOIL MAP BASI, V1st.
   Bakan ND, 2011, CHEST, V140, P1300, DOI 10.1378/chest.10-1856.
   Barnes H, 2019, RESPIROLOGY, V24, P1165, DOI 10.1111/resp.13695.
   Bilir N., 2016, OCCUPATIONAL SAFETY, V1st.
   Blackley DJ, 2018, AM J PUBLIC HEALTH, V108, P1220, DOI 10.2105/AJPH.2018.304517.
   Perez JJB, 2019, ARCH BRONCONEUMOL, V55, P88, DOI 10.1016/j.arbres.2018.07.004.
   Centers for Disease Control and Prevention (CDC), 2019, PREV SIL.
   Centers for Disease Control and Prevention (CDC), 2002, DHHS NIOSH PUBLICATI.
   Chiavegatto CV, 2010, INT J OCCUP ENV HEAL, V16, P147.
   De Matteis S, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0080-2017.
   De Vuyst P, 2000, Curr Opin Pulm Med, V6, P151, DOI 10.1097/00063198-200003000-00012.
   Farazi A, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.333.4993.
   Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7.
   Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020.
   Hoy RF, 2018, OCCUP ENVIRON MED, V75, P3, DOI 10.1136/oemed-2017-104428.
   ILO International Labour Office., 2017, GLOB EST CHILD LAB R.
   Jiang CQ, 2001, AM J IND MED, V40, P87, DOI 10.1002/ajim.1074.
   Jindal SK, 2013, CURR OPIN PULM MED, V19, P163, DOI 10.1097/MCP.0b013e32835bb19e.
   Koksal N, 2011, INT J OCCUP ENV HEAL, V17, P210.
   Liu J, 2019, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V37, P366, DOI 10.3760/cma.j.issn.1001-9391.2019.05.010.
   Liu YW, 2017, AM J EPIDEMIOL, V186, P481, DOI 10.1093/aje/kwx124.
   Mazurek J. M., 2008, Morbidity and Mortality Weekly Report, V57, P771.
   Nasrullah M, 2011, AM J EPIDEMIOL, V174, P839, DOI 10.1093/aje/kwr159.
   NG TP, 1992, RESP MED, V86, P115, DOI 10.1016/S0954-6111(06)80226-X.
   `t Mannetje A, 2002, OCCUP ENVIRON MED, V59, P723, DOI 10.1136/oem.59.11.723.
   Turkish National Statistical Office, 2017, LIF EXP BIRTH EUR CO.
   VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213.
   Wang W, 2018, DNA CELL BIOL, V37, P925, DOI 10.1089/dna.2018.4370.
   Xie L Z, 2019, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V37, P189, DOI 10.3760/cma.j.issn.1001-9391.2019.03.006.
   Zhong YN, 1995, SCAND J WORK ENV HEA, V21, P91.},
Number-of-Cited-References = {33},
Times-Cited = {0},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Balk. Med. J.},
Doc-Delivery-Number = {XD9ES},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000723003700008},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000257149400002,
Author = {Inoue, Manami and Iso, Hiroyasu and Yamamoto, Seiichiro and Kurahashi,
   Norie and Iwasaki, Motoki and Sasazuki, Shizuka and Tsugane, Shoichiro
   and Japan Public Hlth Centre-Based pro},
Title = {Daily total physical activity level and premature death in men and
   women: Results from a large-scale population-based cohort study in Japan
   (JPHC study)},
Journal = {ANNALS OF EPIDEMIOLOGY},
Year = {2008},
Volume = {18},
Number = {7},
Pages = {522-530},
Month = {JUL},
Abstract = {PURPOSE: The impact of daily total physical activity level on premature
   deaths has not been fully clarified in non-Western, relatively lean
   populations. We prospectively examined the association between daily
   total physical activity level (METs/day) and subsequent risk of
   all-cause mortality and mortalities from cancer, heart disease, and
   cerebrovascular disease.
   METHODS: A total of 83,034 general Japanese citizens ages 45-74 years
   who responded to the questionnaire in 1995-1999 were followed for any
   cause of death through December 2005. Mutlivariate-adjusted hazard
   ratios were calculated with a Cox proportional hazards model controlling
   for potential confounding factors.
   RESULTS: During follow-up, a total of 4564 deaths were recorded.
   Compared with subjects in the lowest quartile, increased daily total
   physical activity was associated with a significantly decreased risk of
   all-cause mortality in both sexes (hazard ratios for the second, third,
   and highest quartiles were: men, 0.79, 0.82, 0.73 and women, 0.75, 0.64,
   0.61, respectively). The decreased risk was observed regardless of age,
   frequency of leisure-time sports or physical exercise, or obesity
   status, albeit with a degree of risk attenuation among those with a high
   body mass index. A significantly decreased risk was similarly observed
   for death from cancer and heart disease in both sexes, and from
   cerebrovascular disease in women.
   CONCLUSION: Greater daily total physical activity level, either from
   occupation, daily life, or leisure time, may be of benefit in preventing
   premature death.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Inoue, M (Corresponding Author), Natl Canc Ctr, Res Ctr Canc Prevent \& Screening, Epidemiol \& Prevent Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.
   Inoue, Manami; Kurahashi, Norie; Iwasaki, Motoki; Sasazuki, Shizuka; Tsugane, Shoichiro, Natl Canc Ctr, Res Ctr Canc Prevent \& Screening, Epidemiol \& Prevent Div, Chuo Ku, Tokyo 1040045, Japan.
   Yamamoto, Seiichiro, Natl Canc Ctr, Ctr Canc Control \& Informat Services, Canc Informat Serv \& Surveillance Div, Tokyo 1040045, Japan.
   Iso, Hiroyasu, Osaka Univ, Grad Sch Med, Dept Social \& Environm Med, Osaka, Japan.},
DOI = {10.1016/j.annepidem.2008.03.008},
ISSN = {1047-2797},
EISSN = {1873-2585},
Keywords = {physical activity; population-based; cohort study; mortality},
Keywords-Plus = {ALL-CAUSE MORTALITY; ENERGY-EXPENDITURE; LIFE-STYLE; EXERCISE;
   INTENSITY; FITNESS; TIME; WALKING; CANCER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mnminoue@ncc.go.jp},
ResearcherID-Numbers = {Tsugane, Shoichiro/A-2424-2015
   },
ORCID-Numbers = {Tsugane, Shoichiro/0000-0003-4105-2774
   Iso, Hiroyasu/0000-0002-9241-7289},
Cited-References = {Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS457, DOI 10.1097/00005768-200009001-00004.
   Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335.
   {[}Anonymous], 2002, IARC HDB CANC PREV, V6.
   {[}Anonymous], 2004, GLOB STRAT DIET PHYS.
   Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007.
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327.
   Crespo CJ, 2002, ANN EPIDEMIOL, V12, P543, DOI 10.1016/S1047-2797(01)00296-4.
   Dorn JP, 1999, ANN EPIDEMIOL, V9, P366, DOI 10.1016/S1047-2797(99)00025-3.
   Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327.
   Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x.
   Fujita K, 2004, J EPIDEMIOL, V14, pS26, DOI 10.2188/jea.14.S26.
   Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085.
   Hardman A, 1995, J Cardiovasc Risk, V2, P285, DOI 10.1097/00043798-199508000-00001.
   Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870.
   Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x.
   KING AC, 1995, CIRCULATION, V91, P2596, DOI 10.1161/01.CIR.91.10.2596.
   Lam TH, 2004, ANN EPIDEMIOL, V14, P391, DOI 10.1016/j.annepidem.2003.09.005.
   Lee IM, 2003, MED SCI SPORT EXER, V35, P1823, DOI 10.1249/01.MSS.0000093620.27893.23.
   Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205.
   Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171.
   Marrugat J, 1996, AM J EPIDEMIOL, V143, P562.
   Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088.
   Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669.
   Menotti A, 2001, EUR J EPIDEMIOL, V17, P337, DOI 10.1023/A:1012757616119.
   Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162.
   Pedersen BK, 2000, BRIT J SPORT MED, V34, P246, DOI 10.1136/bjsm.34.4.246.
   Rauramaa R, 2001, MED SCI SPORT EXER, V33, pS516, DOI 10.1097/00005768-200106001-00022.
   Sesso HD, 2007, AM J EPIDEMIOL, V165, P1351, DOI 10.1093/aje/kwm093.
   SHERMAN SE, 1994, AM HEART J, V128, P879, DOI 10.1016/0002-8703(94)90583-5.
   {*}STAT CORP, 2007, STAT STAT SOFTW VERS.
   SZYMANSKI LM, 1994, MED SCI SPORT EXER, V26, P1102.
   Thune I, 1998, ARCH INTERN MED, V158, P1633, DOI 10.1001/archinte.158.15.1633.
   Tsubono Y, 1996, J Epidemiol, V6, P45.
   Tsugane S, 2001, J Epidemiol, V11, pS24.
   Wannamethee S Goya, 2002, Semin Vasc Med, V2, P257, DOI 10.1055/s-2002-35400.
   Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012.
   World Health Organization, 1990, INT CLASS DIS HLTH R.},
Number-of-Cited-References = {37},
Times-Cited = {103},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Ann. Epidemiol.},
Doc-Delivery-Number = {319FL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000257149400002},
DA = {2022-03-29},
}

@article{ WOS:000630333900001,
Author = {Luo, Zheng and Lv, Huihui and Chen, Yichen and Xu, Xiaoyun and Liu,
   Kangyong and Li, Xiaopan and Deng, Yang and Zhou, Yi},
Title = {Years of Life Lost Due to Premature Death and Their Trends in People
   With Selected Neurological Disorders in Shanghai, China, 1995-2018: A
   Population-Based Study},
Journal = {FRONTIERS IN NEUROLOGY},
Year = {2021},
Volume = {12},
Month = {MAR 5},
Abstract = {Background: Neurological disorders are the leading cause of long-term
   disability and the second leading cause of death in the world. We aimed
   to characterize the long-term trends in mortality and disease burden of
   selected neurological disorders and quantitatively analyze the
   contributions of demographic and non-demographic factors on the
   mortality of selected neurological disorders in Shanghai, China,
   1995-2018.
   Methods: Mortality data were derived from the Vital Statistics System of
   Pudong New Area, Shanghai, China, during 1995-2018. Temporal trends for
   the mortality rates and burden of selected neurological disorders were
   analyzed by Joinpoint Regression Program. Years of life lost (YLL) was
   used to analyze the burden of disease. The increasing mortality rates
   related to demographic and non-demographic factors were estimated by the
   decomposition method.
   Results: A total of 4432 deaths from selected neurological disorders
   occurred during 1995-2018, accounting for 0.98\% of total deaths. The
   crude mortality rates (CMR) and age-standardized mortality rates (ASMRW)
   of neurological disorders were 7.14/10(5) person-years and 4.08/10(5)
   person-years, respectively. Extrapyramidal and movement disorders, other
   degenerative diseases of the nervous system, and episodic and paroxysmal
   disorders were the three leading causes of mortality and YLL of selected
   neurological disorders. The CMR, ASMRW, and rate of YLL for deaths from
   selected neurological disorders showed significantly increasing trends
   in males, females, and the total population during 1995-2018 (all P <
   0.001). The contribution rates of increased values of CMR related to
   demographic factors were more evident than non-demographic factors.
   Conclusion: The mortality rate and rate of YLL for death from selected
   neurological disorders increased significantly during 1995-2018 in
   Pudong New Area, Shanghai. The demographic factors, particularly aging,
   might be related to an increase in the mortality of neurological
   disorders. More effective prevention strategies are needed to prevent
   the aging-related death and burden from neurological disorders in the
   future.},
Publisher = {FRONTIERS MEDIA SA},
Address = {AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Zhou, Y (Corresponding Author), Ctr Dis Control \& Prevent Pudong New Area, Shanghai, Peoples R China.
   Li, XP; Zhou, Y (Corresponding Author), Fudan Univ, Pudong Inst Prevent Med, Off Sci Res \& Informat Management, Shanghai, Peoples R China.
   Deng, Y (Corresponding Author), Shandong First Med Univ \& Shandong Acad Med Sci, Sch Publ Hlth, Tai An, Shandong, Peoples R China.
   Luo, Zheng; Xu, Xiaoyun; Liu, Kangyong, Shanghai Univ Med \& Hlth Sci, Affiliated Zhoupu Hosp, Dept Neurol, Shanghai, Peoples R China.
   Lv, Huihui, Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese \& Western, Dept Neurol, Shanghai, Peoples R China.
   Chen, Yichen; Zhou, Yi, Ctr Dis Control \& Prevent Pudong New Area, Shanghai, Peoples R China.
   Chen, Yichen; Li, Xiaopan; Zhou, Yi, Fudan Univ, Pudong Inst Prevent Med, Off Sci Res \& Informat Management, Shanghai, Peoples R China.
   Deng, Yang, Shandong First Med Univ \& Shandong Acad Med Sci, Sch Publ Hlth, Tai An, Shandong, Peoples R China.},
DOI = {10.3389/fneur.2021.625042},
Article-Number = {625042},
ISSN = {1664-2295},
Keywords = {neurological disorder; mortality; years of life lost; trend analysis;
   decomposition method},
Keywords-Plus = {MORTALITY},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology; Neurosciences},
Author-Email = {xiaopanli0224@126.com
   dengyang3417@126.com
   yzhou@pdcdc.sh.cn},
ORCID-Numbers = {Li, xiaopan/0000-0002-9625-478X},
Funding-Acknowledgement = {Academic Leaders Training Program of Pudong Health Bureau of Shanghai
   {[}PWRd2019-11]; Academic Leaders Training Program of Shanghai Health
   Bureau {[}GWV-10.2-XD24]; Project of Hundred Talents Pool in Shanghai
   University of Medicine \& Health Sciences; Zhoupu Hospital of Shanghai
   Health Medical College {[}ZPXM-2019B05]; Key Disciplines Construction
   Foundation of Health Commission of Shanghai Pudong New District of China
   {[}PWZxk2017-25]; Reserve Academic Leaders Training Program of Pudong
   New Area Center for Disease Control and Prevention {[}PDCDC-HBXD202005];
   National Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) {[}81904014]},
Funding-Text = {This study was funded by the Academic Leaders Training Program of Pudong
   Health Bureau of Shanghai (Grant No. PWRd2019-11 to YZ), the Academic
   Leaders Training Program of Shanghai Health Bureau (Grant No.
   GWV-10.2-XD24 to YZ), the Project of Hundred Talents Pool in Shanghai
   University of Medicine \& Health Sciences (to ZL), the Project of Zhoupu
   Hospital of Shanghai Health Medical College (ZPXM-2019B05 to ZL), the
   Key Disciplines Construction Foundation of Health Commission of Shanghai
   Pudong New District of China (Grant No: PWZxk2017-25 to KL), the Reserve
   Academic Leaders Training Program of Pudong New Area Center for Disease
   Control and Prevention (PDCDC-HBXD202005 to XL), and the National
   Science Foundation of China (81904014 to HL).},
Cited-References = {Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3.
   Baxter AJ, 2016, LANCET PSYCHIAT, V3, P832, DOI 10.1016/S2215-0366(16)30139-0.
   Bhatti GK, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00369.
   Chen HY, 2018, BMC PUBLIC HEALTH, V18, DOI {[}10.1186/s12889-018-5112-7, 10.1186/s12889-018-5146-x].
   Cheng XJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003138.
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3.
   Dumurgier J, 2020, REV NEUROL-FRANCE, V176, P642, DOI 10.1016/j.neurol.2020.01.356.
   Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5.
   Jimenez-Mejias E, 2014, INJURY PREV, V20, P416, DOI 10.1136/injuryprev-2013-041129.
   Li XP, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00579.
   Li XP, 2019, PREV MED, V118, P243, DOI 10.1016/j.ypmed.2018.11.002.
   Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331.
   Mir RH, 2020, ENVIRON SCI POLLUT R, V27, P44724, DOI 10.1007/s11356-020-09964-x.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Nag N, 2019, NEURODEGENER DIS, V19, P51, DOI 10.1159/000502292.
   Noble EE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00009.
   Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003.
   Robertson FC, 2019, J NEUROSURG, V130, P1107, DOI 10.3171/2017.10.JNS17359.
   Shi FD, 2011, NEUROLOGY, V77, P1986, DOI 10.1212/WNL.0b013e31823a0ed3.
   Vanni S, 2020, J NEUROSCI RES, V98, P299, DOI 10.1002/jnr.24379.
   Vlaar T, 2018, EUR J EPIDEMIOL, V33, P1101, DOI 10.1007/s10654-018-0399-3.
   Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5.
   Wang S, 2018, CAN MED ASSOC J, V190, pE1153, DOI 10.1503/cmaj.180272.
   World Health Organization, 2018, GLOB HLTH EST 2016 D.
   Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3.
   Yang W, 2012, BMC PUBLIC HEALTH, V12, DOI {[}10.1186/1471-2458-12-804, 10.1186/1471-2458-12-1127].},
Number-of-Cited-References = {26},
Times-Cited = {2},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Front. Neurol.},
Doc-Delivery-Number = {QY9CR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000630333900001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000435566600012,
Author = {Bush, Montika and Simpson, Jr., Ross J. and Kucharska-Newton, Anna and
   Fang, Gang and Sturmer, Til and Brookhart, M. Alan},
Title = {Approaches to Address Premature Death of Patients When Assessing
   Patterns of Use of Health Care Services After an Index Event},
Journal = {MEDICAL CARE},
Year = {2018},
Volume = {56},
Number = {7},
Pages = {619-625},
Month = {JUL},
Abstract = {Background:Studies of the use of health care after the onset of disease
   are important for assessing quality of care, treatment disparities, and
   guideline compliance. Cohort definition and analysis method are
   important considerations for the generalizability and validity of study
   results. We compared different approaches for cohort definition
   (restriction by survival time vs. comorbidity score) and analysis method
   {[}Kaplan-Meier (KM) vs. competing risk] when assessing patterns of
   guideline adoption in elderly patients.Methods:Medicare beneficiaries
   aged 65-95 years old who had an acute myocardial infarction (AMI) in
   2008 were eligible for this study. Beneficiaries with substantial
   frailty or an AMI in the prior year were excluded. We compared KM with
   competing risk estimates of guideline adoption during the first year
   post-AMI.Results:At 1-year post-AMI, 14.2\% {[}95\% confidence interval
   (CI), 14.0\%-14.5\%) of beneficiaries overall initiated cardiac
   rehabilitation when using competing risk analysis and 15.1\% (95\% CI,
   14.8\%-15.3\%) from the KM analysis. Guideline medication adoption was
   estimated as 52.3\% (95\% CI, 52.0\%-52.7\%) and 53.4\% (95\% CI,
   53.1\%-53.8\%) for competing risk and KM methods, respectively.
   Mortality was 17.0\% (95\%CI, 16.8\%-17.3\%) at 1 year post-AMI. The
   difference in cardiac rehabilitation initiation at 1-year post-AMI from
   the overall population was 0.1\%, 1.7\%, and 1.9\% compared with 30-day
   survivor, 1-year survivor, and comorbidity-score restricted populations,
   respectively.Conclusions:In this study, the KM method consistently
   overestimated the competing risk method. Competing risk approaches avoid
   unrealistic mortality assumptions and lead to interpretations of
   estimates that are more meaningful.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Bush, M (Corresponding Author), Univ N Carolina, 170 Manning Dr,CB 7594, Chapel Hill, NC 27599 USA.
   Bush, Montika; Kucharska-Newton, Anna; Sturmer, Til; Brookhart, M. Alan, Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   Simpson, Ross J., Jr., Univ N Carolina, Div Cardiol, Sch Med, Chapel Hill, NC 27515 USA.
   Fang, Gang, Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27515 USA.},
DOI = {10.1097/MLR.0000000000000923},
ISSN = {0025-7079},
EISSN = {1537-1948},
Keywords = {cardiac rehabilitation; guideline concordant care; Medicare
   administrative claims data; survival analysis method comparison;
   post-acute MI health care},
Keywords-Plus = {RESTRICTION; POPULATION},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services; Public,
   Environmental \& Occupational Health},
Author-Email = {mbush8@unc.edu},
ResearcherID-Numbers = {Stürmer, Til/AAB-5459-2022
   },
ORCID-Numbers = {Bush, Montika/0000-0002-7257-9512},
Funding-Acknowledgement = {National Service Research Award Pre-Doctoral/Post-Doctoral Traineeship
   from the Agency for Health Care Research and Quality - Cecil G. Sheps
   Center for Health Services Research, University of North Carolina at
   Chapel Hill {[}5T32 S000032]; National Institute on Aging (NIA)United
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Aging (NIA) {[}R01 AG023178,
   R01 AG056479]; National Institutes of Health (NIH)United States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USA {[}R01 CA174453, R01 HL118255, R21-HD080214]; Comparative
   Effectiveness Research (CER) Strategic Initiative, NC TraCS Institute,
   UNC Clinical and Translational Science Award {[}UL1TR001111];
   AmgenAmgen; AstraZenecaAstraZeneca; AGENCY FOR HEALTHCARE RESEARCH AND
   QUALITYUnited States Department of Health \& Human ServicesAgency for
   Healthcare Research \& Quality {[}T32HS000032] Funding Source: NIH
   RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH \&
   HUMAN DEVELOPMENTUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health \& Human Development (NICHD)
   {[}R21HD080214] Funding Source: NIH RePORTER; NATIONAL CANCER
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}R01CA174453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR
   ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) {[}UL1TR001111]
   Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}R01HL118255] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON AGINGUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) {[}R01AG056479, R01AG023178] Funding Source: NIH RePORTER},
Funding-Text = {Supported by a National Service Research Award
   Pre-Doctoral/Post-Doctoral Traineeship from the Agency for Health Care
   Research and Quality sponsored by the Cecil G. Sheps Center for Health
   Services Research, University of North Carolina at Chapel Hill, Grant
   No. 5T32 S000032.; T.S.: received investigator-initiated research
   funding and support as Principal Investigator (R01 AG023178; R01
   AG056479) from the National Institute on Aging (NIA), and as
   Co-Investigator (R01 CA174453; R01 HL118255, R21-HD080214) from the
   National Institutes of Health (NIH). He also received salary support as
   Director of the Comparative Effectiveness Research (CER) Strategic
   Initiative, NC TraCS Institute, UNC Clinical and Translational Science
   Award (UL1TR001111), and as Director of the Center for
   Pharmacoepidemiology and research support from pharmaceutical companies
   (Amgen, AstraZeneca) to the Department of Epidemiology, University of
   North Carolina at Chapel Hill. He does not accept personal compensation
   of any kind from any pharmaceutical company. He owns stock in Novartis,
   Roche, BASF, AstraZeneca, Johnson \& Johnson, and Novo Nordisk. The
   remaining authors declare no conflict of interest.},
Cited-References = {Austin PC, 2006, J EVAL CLIN PRACT, V12, P601, DOI 10.1111/j.1365-2753.2005.00624.x.
   Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572.
   Block AE, 2008, J GEN INTERN MED, V23, P1447, DOI 10.1007/s11606-008-0697-7.
   Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010.
   Faurot KR, 2015, PHARMACOEPIDEM DR S, V24, P59, DOI 10.1002/pds.3719.
   Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004.
   Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43.
   Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217.
   Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107.
   Lauffenburger JC, 2013, PHARMACOEPIDEM DR S, V22, P899, DOI 10.1002/pds.3458.
   Lee HY, 2008, J MANAGE CARE PHARM, V14, P271, DOI 10.18553/jmcp.2008.14.3.271.
   Li X, 2014, MED CARE, V52, P773, DOI 10.1097/MLR.0000000000000174.
   Lin G., 2012, ANAL SURVIVAL DATA C.
   MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4.
   McGrath LJ, 2015, AM J EPIDEMIOL, V182, P17, DOI 10.1093/aje/kwu485.
   Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385.
   Nichols GA, 2010, AM J CARDIOL, V105, P786, DOI 10.1016/j.amjcard.2009.11.008.
   Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e.
   Sisler JJ, 2012, J ONCOL PRACT, V8, pE69, DOI 10.1200/JOP.2011.000396.
   Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d.
   Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466.
   Wilk A, 2014, OSTEOPOROSIS INT, V25, P2777, DOI 10.1007/s00198-014-2827-x.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Med. Care},
Doc-Delivery-Number = {GJ7KT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000435566600012},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:A1996VK26100010,
Author = {Contamine, V and Lecellier, G and Belcour, L and Picard, M},
Title = {Premature death in Podospora anserina: Sporadic accumulation of the
   deleted mitochondrial genome, translational parameters and innocuity of
   the mating types},
Journal = {GENETICS},
Year = {1996},
Volume = {144},
Number = {2},
Pages = {541-555},
Month = {OCT},
Abstract = {The Podospora anserina premature death syndrome was described as early
   growth arrest caused by a site-specific deletion of the mitochondrial
   genome (mtDNA) and occurring in strains displaying the genotype AS1-4
   mat-. The AS1-4 mutation lies in a gene encoding a cytosolic ribosomal
   protein, while mat- is one of the two forms (mat- and mat+) of the
   mating-type locus. Here we show that, depending on culture conditions,
   death due to the accumulation of the deleted mtDNA molecule can occur in
   the AS1-4 mat+ context and can be delayed in the AS1-4 mat- background.
   Furthermore, we show that premature death and the classical senescence
   process are mutually exclusive. Several approaches permit the
   identification of the mat-linked gene involved in the appearance of
   premature death. The gene, rmp, exhibits two natural alleles, rmp-
   linked to mat- and rmp+ linked to mat+. The first is probably functional
   while the second probably carries a nonsense mutation and is sporadially
   expressed through natural suppression. A model is proposed that
   emphasizes the roles played by the AS1-4 mutation, the rmp gene, and
   environmental conditions in the accumulation of the deleted
   mitochondrial genome characteristic of this syndrome.},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA},
Type = {Article},
Language = {English},
Affiliation = {Contamine, V (Corresponding Author), UNIV PARIS 11, INST MICROBIOL \& GENET, CNRS URA 1354, BATIMENT 400, F-91405 ORSAY, FRANCE.
   CNRS, CTR GENET MOL, GIF SUR YVETTE, FRANCE.},
ISSN = {0016-6731},
EISSN = {1943-2631},
Keywords-Plus = {NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; PHENOTYPIC SUPPRESSION;
   KLUYVEROMYCES-LACTIS; ANTI-SUPPRESSORS; TRANSFER-RNA; DNA; YEAST;
   MUTATIONS; RECOMBINATION},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
ResearcherID-Numbers = {Lecellier, Gael/D-3782-2009},
ORCID-Numbers = {Lecellier, Gael/0000-0003-3331-6311},
Cited-References = {ALMASAN A, 1991, P NATL ACAD SCI USA, V88, P7684, DOI 10.1073/pnas.88.17.7684.
   ALTMANN M, 1993, TRENDS BIOCHEM SCI, V18, P429, DOI 10.1016/0968-0004(93)90143-B.
   ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2.
   Beadle GW, 1944, GENETICS, V29, P291.
   BELCOUR L, 1977, MOL GEN GENET, V153, P11, DOI 10.1007/BF01035991.
   BELCOUR L, 1991, P NATL ACAD SCI USA, V88, P3579, DOI 10.1073/pnas.88.9.3579.
   BELCOUR L, 1980, J GEN MICROBIOL, V119, P505.
   BERNET J., 1965, Ann. Sci. nat., V6, P611.
   BERNET J, 1988, EXP MYCOL, V12, P217, DOI 10.1016/0147-5975(88)90036-9.
   BERTRAND H, 1993, MOL CELL BIOL, V13, P6778, DOI 10.1128/MCB.13.11.6778.
   BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942.
   BRYGOO Y, 1985, MOL GEN GENET, V200, P128, DOI 10.1007/BF00383325.
   CAPLAN AB, 1984, MOL GEN GENET, V194, P534, DOI 10.1007/BF00425571.
   CHEN X, 1995, AM J HUM GENET, V57, P239.
   CHEN XJ, 1995, EMBO J, V14, P3277, DOI 10.1002/j.1460-2075.1995.tb07331.x.
   CHEN XJ, 1993, GENETICS, V133, P517.
   COPPIN E, 1993, MOL GEN GENET, V241, P409, DOI 10.1007/BF00284694.
   COPPINRAYNAL E, 1981, BIOCHEM GENET, V19, P729, DOI 10.1007/BF00484005.
   CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517.
   DEBUCHY R, 1985, EMBO J, V4, P3553, DOI 10.1002/j.1460-2075.1985.tb04116.x.
   DEBUCHY R, 1992, MOL GEN GENET, V233, P113, DOI 10.1007/BF00587568.
   DEBUCHY R, 1988, CURR GENET, V13, P105, DOI 10.1007/BF00365644.
   DEQUARDCHABLAT M, 1986, J MOL BIOL, V190, P167, DOI 10.1016/0022-2836(86)90290-1.
   DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951.
   DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0.
   DUJARDIN G, 1984, CURR GENET, V9, P21, DOI 10.1007/BF00396200.
   Dujon B., 1989, MOBILE DNA, P861.
   EPHRUSSI B, 1953, NUCLEOCYTOPLASMIC RE.
   Esser K., 1974, BACTERIA BACTERIOPHA, P531.
   FAYE G, 1973, BIOCHIMIE, V55, P779, DOI 10.1016/S0300-9084(73)80030-6.
   FEARON K, 1994, J BIOL CHEM, V269, P17802.
   GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912.
   GRIFFITHS AJF, 1992, ANNU REV GENET, V26, P351, DOI 10.1146/annurev.ge.26.120192.002031.
   HAFFTER P, 1992, GENETICS, V131, P255.
   KIEUNGOC A, 1988, GENET RES, V51, P179, DOI 10.1017/S0016672300024277.
   KOLL F, 1984, CURR GENET, V8, P127, DOI 10.1007/BF00420231.
   KOPCZYNSKI JB, 1992, MOL GEN GENET, V234, P369, DOI 10.1007/BF00538696.
   KOZAK M, 1991, J BIOL CHEM, V266, P19867.
   KUENEN R, 1962, Z VEREBUNGSL, V93, P66.
   KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333.
   LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536.
   LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4.
   MARCOU D, 1979, MOL GEN GENET, V176, P67, DOI 10.1007/BF00334297.
   MARCOU D, 1980, GENETICS MAPS, P151.
   Marcou D., 1961, ANN SCI BIOL BOT VEG, V12, P653.
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122.
   MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075.
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561.
   MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x.
   PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0.
   PICARD M, 1973, GENET RES, V21, P1, DOI 10.1017/S0016672300013173.
   PICARD M, 1991, GENETICS, V128, P539.
   PICARDBENNOUN M, 1976, MOL GEN GENET, V147, P299, DOI 10.1007/BF00582881.
   POULTON J, 1992, BIOESSAYS, V14, P763, DOI 10.1002/bies.950141108.
   RIZET G, 1953, CR HEBD ACAD SCI, V237, P760.
   RIZET G, 1953, CR HEBD ACAD SCI, V237, P1106.
   RIZET GEORGES, 1949, REV CYTOL ET BIOL VEG, V11, P201.
   RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51.
   SAINSARDCHANET A, 1993, J MOL BIOL, V234, P1, DOI 10.1006/jmbi.1993.1558.
   SCHAPIRA AHV, 1993, CURR OPIN GENET DEV, V3, P457, DOI 10.1016/0959-437X(93)90120-E.
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184.
   SEIDELROGOL BL, 1989, MOL CELL BIOL, V9, P4259, DOI 10.1128/MCB.9.10.4259.
   SELLEM CH, 1993, NATURE, V366, P176, DOI 10.1038/366176a0.
   SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4.
   SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0.
   SOKAL RR, 1969, BIOMETRY, P62.
   STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917.
   VANBUUL CPJJ, 1984, FEBS LETT, V177, P119, DOI 10.1016/0014-5793(84)80994-1.
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523.
   WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269.
   ZWEIFEL SG, 1991, GENETICS, V128, P241.},
Number-of-Cited-References = {71},
Times-Cited = {22},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Genetics},
Doc-Delivery-Number = {VK261},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1996VK26100010},
DA = {2022-03-29},
}

@article{ WOS:000444086400005,
Author = {Kim, Jong-Hun and Oh, In-Hwan and Park, Jae-Hyun and Cheong, Hae-Kwan},
Title = {Premature Deaths Attributable to Long-term Exposure to Ambient Fine
   Particulate Matter in the Republic of Korea},
Journal = {JOURNAL OF KOREAN MEDICAL SCIENCE},
Year = {2018},
Volume = {33},
Number = {37},
Month = {SEP 10},
Abstract = {Background: Ambient fine particulate matter (PM2.5) is the major
   environmental health risk factor in Korea. Exposure to PM2.5 has been a
   growing public concern nationwide. With the rapid aging of the Korean
   population, the health effects attributable to long-term exposure to
   PM2.5 were expected to increase further in the future. We aimed to
   estimate premature deaths attributable to long-term exposure to ambient
   PM2.5 in Korea.
   Methods: A modelled estimation of long-term exposure to PM2.5 was used
   to calculate the nationwide exposure level. Hazard ratios of long-term
   exposure to PM2.5 were obtained from a large prospective cohort study in
   North America. Modified cause of death (CoD) data, which applied the
   garbage code reclassification algorithm, were used to calculate
   premature deaths attributable to long-term exposure to PM2.5.
   Results: From 1990 to 2013, the average population-weighted PM2.5
   concentration in Korea was 30.2 mu g/m(3). The estimated number of
   premature deaths was 17,203 (95\% confidence interval {[}CI],
   11,056-22,772). The most common CoD was ischemic stroke (5,382;
   3,101-7,403), followed by cancer of trachea, bronchus, and lung (4,958;
   2,857-6,820), hemorrhagic stroke (3,452; 1,989-4,748), and ischemic
   heart disease (3,432; 1,383-5,358).
   Conclusion: Premature deaths due to long-term exposure to PM2.5
   accounted for 6.4\% of all deaths in Korea. However, individual efforts
   alone cannot prevent the effects of air pollution. This disease burden
   study can serve as a basis for the establishment of government policies
   and budgets and can be used to assess the effectiveness of environmental
   health policies.},
Publisher = {KOREAN ACAD MEDICAL SCIENCES},
Address = {302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA},
Type = {Article},
Language = {English},
Affiliation = {Cheong, HK (Corresponding Author), Sungkyunkwan Univ, Dept Social \& Prevent Med, Sch Med, 2066 Seobu Ro, Suwon 16419, South Korea.
   Kim, Jong-Hun; Park, Jae-Hyun; Cheong, Hae-Kwan, Sungkyunkwan Univ, Dept Social \& Prevent Med, Sch Med, 2066 Seobu Ro, Suwon 16419, South Korea.
   Oh, In-Hwan, Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.},
DOI = {10.3346/jkms.2018.33.e251},
Article-Number = {e251},
ISSN = {1011-8934},
EISSN = {1598-6357},
Keywords = {Particulate Matter; Premature Deaths; Mortality; Air Pollution; Air
   Quality},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; AIR-POLLUTION; GLOBAL BURDEN; DISEASE; PM2.5},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {hkcheong@skku.edu},
ResearcherID-Numbers = {Oh, In Hwan/AAI-9070-2020
   },
ORCID-Numbers = {Oh, In Hwan/0000-0002-5450-9887
   Cheong, Hae-Kwan/0000-0003-2758-9399
   Kim, Jong-Hun/0000-0002-4974-5180},
Funding-Acknowledgement = {Ministry of Environment, Republic of Korea, as ``The Environmental
   Health Action program{''} {[}2014001360001]},
Funding-Text = {This study was supported by Ministry of Environment, Republic of Korea,
   as ``The Environmental Health Action program{''} (2014001360001).},
Cited-References = {Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621.
   Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Eurostat, PROP POP AG 65 EU.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Health Effects Institute (US), STAT GLOB AIR 2018.
   Hoek Gerard, 2017, Curr Environ Health Rep, V4, P450, DOI 10.1007/s40572-017-0169-5.
   Korean Statistical Information Service, INT MIGR STAT.
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V311, P1486, DOI 10.1001/jama.2014.4031.
   Lee YR, 2016, J KOREAN MED SCI, V31, pS121, DOI 10.3346/jkms.2016.31.S2.S121.
   Leem JH, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0058-z.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Organization for Economic Cooperation and Development (OECD), ENV AIR QUAL HLTH OE.
   Organization for Economic Cooperation and Development (OECD), 2016, EC CONS OUTD POLL.
   Organization for Economic Cooperation and Development (OECD), DEM POP STAT OECD CO.
   Ostro B, 2007, ENVIRON HEALTH PERSP, V115, P13, DOI 10.1289/ehp.9281.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Prss-Ustn J., 2016, PREVENTING DIS HLTH.
   Solazzo E, 2013, GEOSCI MODEL DEV, V6, P791, DOI 10.5194/gmd-6-791-2013.
   Son JY, 2012, ENVIRON HEALTH PERSP, V120, P872, DOI 10.1289/ehp.1104316.
   Statistics Korea, HOUS TYP ADM DISTR K.
   Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC.
   van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833.
   van Donkelaar A, 2015, ENVIRON HEALTH PERSP, V123, P135, DOI 10.1289/ehp.1408646.
   World Health Organization, 2016, AMBIENT AIR POLLUTIO.
   World Health Organization (WHO), AMB OUTD AIR QUAL HL.
   Wu CF, 2014, ENVIRON RES, V133, P96, DOI 10.1016/j.envres.2014.04.038.
   Yoon J, 2016, J KOREAN MED SCI, V31, pS158, DOI 10.3346/jkms.2016.31.S2.S158.
   Zhang Q, 2017, NATURE, V543, P705, DOI 10.1038/nature21712.},
Number-of-Cited-References = {33},
Times-Cited = {12},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {7},
Journal-ISO = {J. Korean Med. Sci.},
Doc-Delivery-Number = {GS9ZF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000444086400005},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000390732600021,
Author = {Mok, Pearl L. H. and Antonsen, Sussie and Pedersen, Carsten Bocker and
   Webb, Roger T.},
Title = {Younger or older parental age and risk of suicidality, premature death,
   psychiatric illness, and criminality in offspring},
Journal = {JOURNAL OF AFFECTIVE DISORDERS},
Year = {2017},
Volume = {208},
Pages = {130-138},
Month = {JAN 15},
Abstract = {Background: Younger or older parental age has been linked with a range
   of adverse offspring endpoints. We investigated associations between
   parental age and nine adverse offspring outcomes in three correlated
   domains: (i) Premature death: suicide, unnatural death, natural death;
   (ii) Psychiatric morbidity: any mental illness, suicide attempt,
   substance misuse; (iii) Criminality: violent offending, imprisonment,
   driving whilst intoxicated.
   Methods: Persons born in Denmark 1966-1996 were followed from their 15th
   until 40th birthday or December 2011 (N=1,793,681). Incidence rate
   ratios were estimated.
   Results: Offspring of teenage mothers had the greatest risks for all
   nine adverse outcomes, especially for imprisonment, violent offending,
   substance misuse, and attempted suicide. Teenage fatherhood was also
   associated with elevated risks for offspring adverse psychiatric and
   criminality outcomes, but not premature mortality (at ages 15-39 years).
   For the psychiatric and criminality outcomes there was a U-shape trend
   linked with paternal age, but risks for premature mortality tended to
   increase with rising paternal age. On the contrary, maternal age 30
   years and over was not linked with raised risks for any of the outcomes
   examined. Limitations: Parental links are based on legal and not
   biological relationships.
   Conclusions: The substantially elevated risks linked with teenage
   motherhood for a variety of poor offspring outcomes is a concern for
   clinicians and policymakers. The associations observed across such a
   wide array of adverse outcomes also suggest that multiple causal
   mechanisms may be implicated.},
Publisher = {ELSEVIER SCIENCE BV},
Address = {PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Webb, RT (Corresponding Author), Univ Manchester, Ctr Mental Hlth \& Safety, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
   Mok, Pearl L. H.; Webb, Roger T., Univ Manchester, Ctr Mental Hlth \& Safety, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
   Antonsen, Sussie; Pedersen, Carsten Bocker, Aarhus Univ, Ctr Integrated Register Based Res, CIRRAU, Aarhus, Denmark.
   Antonsen, Sussie; Pedersen, Carsten Bocker, Aarhus Univ, Natl Ctr Register Based Res, Business \& Social Sci, Fuglesangs Alle 4, DK-8210 Aarhus V, Denmark.},
DOI = {10.1016/j.jad.2016.10.001},
ISSN = {0165-0327},
EISSN = {1573-2517},
Keywords = {Maternal age; Paternal age; Suicidality; Psychiatric disorder; Premature
   mortality; Criminality},
Keywords-Plus = {ADVANCING PATERNAL AGE; NATIONAL COHORT; MATERNAL AGE;
   GENERAL-POPULATION; ADVERSE OUTCOMES; CHILDREN BORN; ABSOLUTE RISK;
   BIRTH; SCHIZOPHRENIA; MOTHERHOOD},
Research-Areas = {Neurosciences \& Neurology; Psychiatry},
Web-of-Science-Categories  = {Clinical Neurology; Psychiatry},
Author-Email = {roger.webb@manchester.ac.uk},
ResearcherID-Numbers = {Pedersen, Carsten Bøcker/B-8441-2013
   },
ORCID-Numbers = {Pedersen, Carsten Bøcker/0000-0003-2077-8533
   Mok, Pearl/0000-0001-9983-6374
   Webb, Roger/0000-0001-8532-2647},
Funding-Acknowledgement = {European Research Council Starting GrantEuropean Research Council (ERC)
   {[}335905]},
Funding-Text = {This work was supported by a European Research Council Starting Grant
   (grant number 335905) awarded to Dr Webb.},
Cited-References = {Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708.
   Andersen AMN, 2004, AM J EPIDEMIOL, V160, P1214, DOI 10.1093/aje/kwh332.
   Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157.
   Bjorngaard JH, 2013, AM J EPIDEMIOL, V177, P638, DOI 10.1093/aje/kwt014.
   Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284.
   Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51.
   Coyne CA, 2013, TWIN RES HUM GENET, V16, P679, DOI 10.1017/thg.2013.23.
   D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525.
   Danmarks Statistik, 1991, IDA INT DAT ARB DANM.
   Ek M, 2015, SCHIZOPHRENIA BULL, V41, P708, DOI 10.1093/schbul/sbu154.
   Ekeus C, 2006, PSYCHOL MED, V36, P269, DOI 10.1017/S0033291705006549.
   Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464.
   Frisell T, 2011, PSYCHOL MED, V41, P97, DOI 10.1017/S0033291710000462.
   Harden KP, 2007, J ABNORM PSYCHOL, V116, P667, DOI 10.1037/0021-843X.116.4.667.
   Jaffee S, 2001, DEV PSYCHOPATHOL, V13, P377, DOI 10.1017/S0954579401002103.
   Juel K, 1999, DAN MED BULL, V46, P354.
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396.
   Kuja-Halkola R, 2012, DEV PSYCHOPATHOL, V24, P739, DOI 10.1017/S095457941200034X.
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482.
   McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081.
   Miller B, 2010, J NERV MENT DIS, V198, P404, DOI 10.1097/NMD.0b013e3181e07d79.
   Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026.
   Mok PLH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2249-5.
   Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825.
   Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2.
   Niederkrotenthaler T, 2012, EUR J EPIDEMIOL, V27, P729, DOI 10.1007/s10654-012-9724-4.
   Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113.
   O'Donnell O, 2015, J AFFECT DISORDERS, V175, P325, DOI 10.1016/j.jad.2014.12.051.
   Pedersen CB, 2014, MOL PSYCHIATR, V19, P530, DOI 10.1038/mp.2013.69.
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965.
   Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039.
   Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252.
   Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012.
   Sergentanis TN, 2015, EUR J EPIDEMIOL, V30, P1229, DOI 10.1007/s10654-015-0089-3.
   Sutcliffe AG, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5116.
   World Health Organization, 2014, AD PREGN FACT SHEET.},
Number-of-Cited-References = {36},
Times-Cited = {11},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {16},
Journal-ISO = {J. Affect. Disord.},
Doc-Delivery-Number = {EG0OR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000390732600021},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000275677000007,
Author = {Pehar, Mariana and O'Riordan, Kenneth J. and Burns-Cusato, Melissa and
   Andrzejewski, Matthew E. and del Alcazar, Carlos Gil and Burger, Corinna
   and Scrable, Heidi and Puglielli, Luigi},
Title = {Altered longevity-assurance activity of p53:p44 in the mouse causes
   memory loss, neurodegeneration and premature death},
Journal = {AGING CELL},
Year = {2010},
Volume = {9},
Number = {2},
Pages = {174-190},
Month = {APR},
Abstract = {The longevity-assurance activity of the tumor suppressor p53 depends on
   the levels of Delta 40p53 (p44), a short and naturally occurring isoform
   of the p53 gene. As such, increased dosage of p44 in the mouse leads to
   accelerated aging and short lifespan. Here we show that mice homozygous
   for a transgene encoding p44 (p44(+/+)) display cognitive decline and
   synaptic impairment early in life. The synaptic deficits are attributed
   to hyperactivation of insulin-like growth factor 1 receptor (IGF-1R)
   signaling and altered metabolism of the microtubule-binding protein tau.
   In fact, they were rescued by either Igf1r or Mapt haploinsufficiency.
   When expressing a human or a `humanized' form of the amyloid precursor
   protein (APP), p44(+/+) animals developed a selective degeneration of
   memory-forming and - retrieving areas of the brain, and died
   prematurely. Mechanistically, the neurodegeneration was caused by both
   paraptosis- and autophagy-like cell deaths. These results indicate that
   altered longevity-assurance activity of p53: p44 causes memory loss and
   neurodegeneration by affecting IGF-1R signaling. Importantly, Igf1r
   haploinsufficiency was also able to correct the synaptic deficits of
   APP695/swe mice, a model of Alzheimer's disease.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Puglielli, L (Corresponding Author), Univ Wisconsin, Dept Med, VAH GRECC 11G,2500 Overlook Terrace, Madison, WI 53705 USA.
   Pehar, Mariana; O'Riordan, Kenneth J.; Puglielli, Luigi, Univ Wisconsin, Dept Med, Madison, WI 53705 USA.
   O'Riordan, Kenneth J.; del Alcazar, Carlos Gil; Burger, Corinna, Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.
   Burns-Cusato, Melissa; Scrable, Heidi, Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA.
   Andrzejewski, Matthew E., Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.
   Puglielli, Luigi, VA Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA.},
DOI = {10.1111/j.1474-9726.2010.00547.x},
ISSN = {1474-9718},
EISSN = {1474-9726},
Keywords = {Alzheimer's disease; insulin-like growth factor 1 receptor; memory loss;
   neurodegeneration; p44; p53},
Keywords-Plus = {ALZHEIMERS-DISEASE; LIFE-SPAN; CORPUS-CALLOSUM; GROWTH-HORMONE;
   CELL-DEATH; AUTOPHAGY; MICE; BRAIN; IGF-1; HIPPOCAMPUS},
Research-Areas = {Cell Biology; Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Cell Biology; Geriatrics \& Gerontology},
Author-Email = {lp1@medicine.wisc.edu},
ResearcherID-Numbers = {O'Riordan, Kenneth J./H-6467-2019
   },
ORCID-Numbers = {O'Riordan, Kenneth J./0000-0003-0081-6010
   Burger, Corinna/0000-0002-9432-0114
   Andrzejewski, Matthew/0000-0002-3557-3453},
Funding-Acknowledgement = {NIH/NIAUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   {[}RO1 AG028569]; Department of Veterans AffairsUS Department of
   Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Aging (NIA) {[}R01AG028569] Funding Source: NIH
   RePORTER},
Funding-Text = {This research was supported by the NIH/NIA (RO1 AG028569 to L. P.), the
   Department of Veterans Affairs (Merit Review grant to L. P.) and the
   Wisconsin Comprehensive Memory Program of the University of Wisconsin
   School of Medicine and Public Health.},
Cited-References = {Auer T, 2008, EPILEPSIA, V49, P1562, DOI 10.1111/j.1528-1167.2008.01679.x.
   BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6.
   Bauer JH, 2006, AGING CELL, V5, P437, DOI 10.1111/j.1474-9726.2006.00228.x.
   Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5.
   Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905.
   Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223.
   Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793.
   Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200.
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372.
   Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474.
   Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646.
   Costantini C, 2005, BIOCHEM J, V391, P59, DOI 10.1042/BJ20050700.
   Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040.
   Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062.
   Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874.
   Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8.
   Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043.
   Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004.
   Hedden T, 2005, CURR OPIN NEUROL, V18, P740, DOI 10.1097/01.wco.0000189875.29852.48.
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298.
   Hongo A, 1998, CANCER RES, V58, P2477.
   HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172.
   Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132.
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002.
   Kinney HC, 2007, PEDIATR DEVEL PATHOL, V10, P208, DOI 10.2350/06-08-0144.1.
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5.
   Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200.
   Lanz TA, 2008, BIOCHEM PHARMACOL, V75, P1093, DOI 10.1016/j.bcp.2007.11.001.
   Lee JA, 2009, BMB REP, V42, P324, DOI 10.5483/BMBRep.2009.42.6.324.
   Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121.
   Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008.
   Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533.
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K.
   Liu YM, 1998, CANCER RES, V58, P570.
   Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975.
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404.
   Menendez M, 2005, BRAIN DEV-JPN, V27, P246, DOI 10.1016/j.braindev.2004.07.008.
   Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113.
   Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003.
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873.
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107.
   Plymate SSR, 1997, ENDOCRINE, V7, P119, DOI 10.1007/BF02778078.
   Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566.
   Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010.
   RISSE S C, 1990, Alzheimer Disease and Associated Disorders, V4, P217, DOI 10.1097/00002093-199040400-00003.
   Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744.
   SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694.
   Savonenko AV, 2003, NEUROBIOL DIS, V12, P194, DOI 10.1016/S0969-9961(02)00012-8.
   Sevigny JJ, 2008, NEUROLOGY, V71, P1702, DOI 10.1212/01.wnl.0000335163.88054.e7.
   SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6.
   Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465.
   Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376.
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105.
   Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010.
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179.
   Teipel SJ, 2003, NEUROBIOL AGING, V24, P85, DOI 10.1016/S0197-4580(02)00044-1.
   Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3.
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a.
   Ungewitter E, 2009, MECH AGEING DEV, V130, P10, DOI 10.1016/j.mad.2008.06.002.
   van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x.
   Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994.
   Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157.
   Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176.
   Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044.
   Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801.},
Number-of-Cited-References = {65},
Times-Cited = {51},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Aging Cell},
Doc-Delivery-Number = {570KU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000275677000007},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1981MF70700013,
Author = {WYNDHAM, CH},
Title = {THE LOSS FROM PREMATURE DEATHS OF ECONOMICALLY ACTIVE MANPOWER IN THE
   VARIOUS POPULATIONS OF THE RSA .1. LEADING CAUSES OF DEATH - HEALTH
   STRATEGIES FOR REDUCING MORTALITY},
Journal = {SOUTH AFRICAN MEDICAL JOURNAL},
Year = {1981},
Volume = {60},
Number = {11},
Pages = {411-419},
Publisher = {MED ASSOC S AFRICA},
Address = {MED HOUSE CENTRAL SQ 7430 PINELANDS JOHANNESBURG, SOUTH AFRICA},
Type = {Article},
Language = {English},
Affiliation = {WYNDHAM, CH (Corresponding Author), UNIV WITWATERSRAND,DEPT PHYSIOL,JOHANNESBURG 2001,SOUTH AFRICA.
   S AFRICAN MRC,INST BIOSTAT,JOHANNESBURG 2000,SOUTH AFRICA.},
ISSN = {0038-2469},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {LALONDE M, 1975, NEW PERSPECTIVE HLTH.
   LATHAM W, 1976, NEW ENGL J MED, V291, P18.
   MCKEOWN T, 1976, ROLE MED.
   MITCHELL D, 1980, S AFR J SCI, V76, P248.
   WYNDHAM CH, 1975, 1975 UN FUT RES.
   1975, HLTH SECTOR POLICY P.
   1979, DHEW PHS7055071 PUB.
   1980, SALUS, V4, P1.
   1974, 070303 DEP STAT REP.
   1980, SALUS, V4, P10.
   1974, 070304 DEP STAT REP.
   1976, 020508 DEP STAT REP.
   1970, WORLD HLTH STATISTIC, V1, P88.
   1972, WORLD HLTH STATISTIC, V1, P246.},
Number-of-Cited-References = {14},
Times-Cited = {37},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {S. Afr. Med. J.},
Doc-Delivery-Number = {MF707},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1981MF70700013},
DA = {2022-03-29},
}

@article{ WOS:000356055600008,
Author = {Jemal, Ahmedin and Siegel, Rebecca L. and Ma, Jiemin and Islami, Farhad
   and DeSantis, Carol and Sauer, Ann Goding and Simard, Edgar P. and Ward,
   Elizabeth M.},
Title = {Inequalities in Premature Death From Colorectal Cancer by State},
Journal = {JOURNAL OF CLINICAL ONCOLOGY},
Year = {2015},
Volume = {33},
Number = {8},
Pages = {829+},
Month = {MAR 10},
Abstract = {Purpose
   Although disparities in colorectal cancer (CRC) with regard to race,
   socioeconomic status, and geography are well documented, the extent to
   which these factors contribute to premature death resulting from CRC
   nationwide and by state is unknown.
   Patients and Methods
   We calculated age-standardized CRC death rates for three broad
   educational categories as a marker of socioeconomic status by
   race/ethnicity and state among individuals age 25 to 64 years from 2008
   through 2010. We also calculated the proportion of premature death
   resulting from CRC that could potentially be averted in each state by
   applying the average death rate for the five states with the lowest
   rates among the most educated whites (Connecticut, North Dakota, Utah,
   Vermont, and Wisconsin) to all populations.
   Results
   Compared with those with the most education, those with the least
   education had significantly higher CRC death rates in virtually all
   states for each racial/ethnic group. For example, rate ratios ranged
   from 1.15 (95\% CI, 0.66 to 2.01) in Delaware to 3.18 (95\% CI, 2.01 to
   5.05) in New Mexico among whites. Overall, half the premature deaths
   resulting from CRC that occurred nationwide from 2008 through 2010, or
   7,690 deaths annually, would have been avoided if everyone had
   experienced the lowest death rates of the most educated whites. More
   premature deaths could be averted in southern states (60\% to 70\%) than
   in northern and western states (30\% to 40\%). Restricting the analyses
   to persons age 50 to 64 years, for whom CRC screening is recommended,
   resulted in similar findings.
   Conclusion
   The majority of premature deaths from CRC in southern states and half
   these deaths nationwide are due to racial/ethnic, socioeconomic, and
   geographic inequalities. (C) 2014 by American Society of Clinical
   Oncology},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Jemal, A (Corresponding Author), Amer Canc Soc, Surveillance \& Hlth Serv Res, 250 Williams St NW, Atlanta, GA 30303 USA.
   Jemal, Ahmedin; Siegel, Rebecca L.; Ma, Jiemin; Islami, Farhad; DeSantis, Carol; Sauer, Ann Goding; Simard, Edgar P.; Ward, Elizabeth M., Amer Canc Soc, Surveillance \& Hlth Serv Res, Atlanta, GA 30303 USA.},
DOI = {10.1200/JCO.2014.58.7519},
ISSN = {0732-183X},
EISSN = {1527-7755},
Keywords-Plus = {UNITED-STATES; RACIAL DISPARITIES; PHYSICAL-ACTIVITY; RISK-FACTORS;
   MORTALITY; STATISTICS; PATTERNS; RATES; DIAGNOSIS; INSURANCE},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {ahmedin.jemal@cancer.org},
ORCID-Numbers = {Islami, Farhad/0000-0002-7357-5994},
Cited-References = {Ahmed NU, 2013, AM J PUBLIC HEALTH, V103, pE91, DOI 10.2105/AJPH.2012.301034.
   Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Bazargan M, 2009, PATIENT EDUC COUNS, V76, P240, DOI 10.1016/j.pec.2008.12.005.
   Blumenthal D, 2014, NEW ENGL J MED, V371, P275, DOI 10.1056/NEJMhpr1405667.
   Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437.
   Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S.
   Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122.
   Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411.
   Cutler David M, 2010, J Health Econ, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003.
   Doubeni CA, 2012, JNCI-J NATL CANCER I, V104, P1353, DOI 10.1093/jnci/djs346.
   German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005.
   Grubbs SS, 2013, J CLIN ONCOL, V31, P1928, DOI 10.1200/JCO.2012.47.8412.
   Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9.
   Hao Y, 2011, J EPIDEMIOL COMMUN H, V65, P211, DOI 10.1136/jech.2009.096008.
   Hao YP, 2009, CANCER CAUSE CONTROL, V20, P1855, DOI 10.1007/s10552-009-9379-y.
   Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343.
   Irby K, 2006, CANCER EPIDEM BIOMAR, V15, P792, DOI 10.1158/1055-9965.EPI-05-0879.
   Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207.
   Lansdorp-Vogelaar I, 2012, CANCER EPIDEM BIOMAR, V21, P728, DOI 10.1158/1055-9965.EPI-12-0023.
   Le H, 2008, CANCER EPIDEM BIOMAR, V17, P1950, DOI 10.1158/1055-9965.EPI-07-2774.
   Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678.
   Naishadham D, 2011, CANCER EPIDEM BIOMAR, V20, P1296, DOI 10.1158/1055-9965.EPI-11-0250.
   National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE.
   Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29.
   Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629.
   Roetzheim RG, 2000, AM J PUBLIC HEALTH, V90, P1746, DOI 10.2105/AJPH.90.11.1746.
   Rostron BL, 2010, VITAL HLTH STAT, V2.
   Rothman K, 2008, MODERN EPIDEMIOLOGY.
   Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838.
   Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334.
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220.
   Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153.
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI {[}10.3322/caac.21208, 10.1001/jamaoto.2014.2530, 10.3322/caac.21254, 10.1136/bmj.g1502].
   Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916.
   SINGH GK, 2003, NATL CANC I CANC SUR, V4.
   Smedley B. D., 2003, UNEQUAL TREATMENT CO.
   Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017.
   Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199.
   Tropman SE, 1999, CANCER DETECT PREV, V23, P428, DOI 10.1046/j.1525-1500.1999.99042.x.
   Wang A, 2012, MILBANK Q, V90, P592, DOI 10.1111/j.1468-0009.2012.00675.x.
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2.},
Number-of-Cited-References = {42},
Times-Cited = {33},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {J. Clin. Oncol.},
Doc-Delivery-Number = {CK2QI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000356055600008},
DA = {2022-03-29},
}

@article{ WOS:A1990DL74100002,
Author = {TOWNSEND, P},
Title = {INDIVIDUAL OR SOCIAL-RESPONSIBILITY FOR PREMATURE DEATH - CURRENT
   CONTROVERSIES IN THE BRITISH DEBATE ABOUT HEALTH},
Journal = {INTERNATIONAL JOURNAL OF HEALTH SERVICES},
Year = {1990},
Volume = {20},
Number = {3},
Pages = {373-392},
Publisher = {BAYWOOD PUBL CO INC},
Address = {26 AUSTIN AVE, AMITYVILLE, NY 11701},
Type = {Article},
Language = {English},
Affiliation = {TOWNSEND, P (Corresponding Author), UNIV BRISTOL,DEPT SOCIAL POLICY \& SOCIAL PLANNING,40 BERKELEY SQ,BRISTOL BS8 1HY,ENGLAND.},
DOI = {10.2190/9Q6H-2KE7-X6FN-3DK8},
ISSN = {0020-7314},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Cited-References = {Abel-Smith B., 1964, HOSPITALS 1800 1948.
   ARO S, 1986, SCAND J SOC MED, V14, P39, DOI 10.1177/140349488601400107.
   ASHTON J, 1984, HLTH MERSEY REV.
   Berkman L, 1983, HLTH WAYS LIVING ALA.
   BLACK N, 1985, HLTH DISEASE READER.
   {*}BLACK RES WORK GR, 1980, IN HLTH.
   Boyd Orr J., 1936, FOOD HLTH INCOME.
   {*}BRIT MED ASS, 1981, DEPRI ILL HLTH.
   Chadwick E, 1842, REPORT SANITARY COND.
   Cole-Hamilton I., 1986, TIGHTENING BELTS REP.
   CONGDON P, 1988, J ROY STAT SOC D-STA, V37, P451, DOI 10.2307/2348772.
   CORVISART JN, 1908, NOUVELLE METHODE REC.
   Dubos, 1968, MAN MED ENV.
   DUBOS R, 1965, HLTH DISEASE.
   Dubos R., 1960, MIRAGE HLTH.
   Ehrenreich J., 1978, CULTURAL CRISIS MODE.
   EYER J, 1977, REV RADICAL POLIT EC, V9.
   FARR W, 1860, J I ACTUARIES, V9.
   FLANAGAN B, 1985, FACTORS AFFECTING GR.
   FOUCAULT M, 1963, BIRTH CLINIC.
   FOX A, 1989, INEQUALITIES HLTH EU.
   FOX AJ, 1982, SERIES LS, V1.
   FOX AJ, 1986, CLASS HLTH RES LONGI.
   Goldblatt P., 1989, Population Trends, P6.
   GRAY A, 1981, BLACK REPORT INEQUAL.
   HART N, 1986, J ROY STAT SOC A STA, V149, P228, DOI 10.2307/2981554.
   HASAN J, 1989, INEQUALITIES HLTH EU.
   HASAN J, 1989, SOCIAL CLASS DISEASE.
   ILLICH I, 1977, LIMITS MED MED NEMES.
   ILLSLEY R, 1986, Q J SOC AFF, V2, P151.
   ILLSLEY R, 1987, Q J SOC AFF, V3, P213.
   ILLSLEY R, 1987, POVERTY, V67, P16.
   ILLSLEY R, 1987, EC HLTH.
   Jacob J., 1988, DOCTORS RULES SOCIOL.
   JARMAN B, 1984, BRIT MED J, V289, P1587, DOI 10.1136/bmj.289.6458.1587.
   JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705.
   KAASJAGER DC, 1989, WHO HLTH CITIES PAPE, V4.
   KAPLAN GA, 1985, NOV SOC PROSP MED AN.
   Kennedy I., 1983, UNMASKING MED.
   KLEIN R, 1988, ACCEPTABLE INEQUALIT.
   KOSKINEN S, 1985, JUN INT UN SCI STUD.
   LAMBERT R, 1963, J SIMON 1816 1904 EN.
   Le Grand J., 1986, PUBLIC PRIVATE HLTH.
   LEGRAND J, 1987, EUR ECON REV, V31, P182, DOI 10.1016/0014-2921(87)90030-4.
   LYNCH P, 1981, BRIT MED J, V283, P405, DOI 10.1136/bmj.283.6288.405.
   MARMOT M, 1988, INT J HEALTH SERV, V18, P659, DOI 10.2190/KTC1-N5LK-J1PM-9GRQ.
   MARMOT M, 1989, INEQUALITIES HLTH EU.
   MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551.
   MARMOT MG, 1984, LANCET, V1, P1003.
   MARMOT MG, 1986, LANCET, V2, P274.
   MARMOT MG, 1986, CLASS HLTH RES LONGI.
   MARSSDEN J, 1989, HLTH DEPRIVATION INE.
   MARTIN CJ, 1986, 1986 ANN SOC SOC MED.
   MARTIN J, 1988, 2 OFF POP CENS SURV.
   MCCARTHY P, 1985, J EPIDEMIOL COMMUN H, V39, P15, DOI 10.1136/jech.39.1.15.
   MCKEOWN T, 1976, ROLE MED.
   MGONIGLE GCM, 1936, POVERTY PUBLIC HLTH.
   NAVARRO V, 1986, CRISIS HLTH MED SOCI.
   Oakley A., 1980, WOMEN CONFINED SOCIO.
   {*}OFF POP CENS SURV, 1986, REG GEN DEC SUPPL GC.
   {*}OFF POP CENS SURV, 1978, REG GEN DEC SUPPL GC.
   PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256.
   Powles J, 1973, Sci Med Man, V1, P1.
   Preston SH, 1981, SOLICITED PAPERS, V2, P233.
   {*}RES UNIT HLTH BEH, 1989, CHANG PUBL HLTH.
   SHELDON TA, 1989, THESIS U LEICESTER L.
   Smith A., 1988, NATIONS HLTH STRATEG.
   SODERFELDT B, 1988, INEQUALITY HLTH COMP.
   STARK E, 1982, INT J HEALTH SERV, V12, P419, DOI 10.2190/4UA4-PLVK-46JY-677G.
   Szasz T.S., 1979, THEOLOGY MED POLITIC.
   Titmuss Richard M., 1950, PROBLEMS SOCIAL POLI.
   TITMUSS RM, 1938, POVERTY POPULATION.
   TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341.
   TOWNSEND P, 1988, INNER CITY DEPRIVATI.
   Townsend P., 1987, HLTH DEPRIVATION INE.
   TOWNSEND P, 1990, TACKLING INNER CITIE.
   Townsend P, 1982, INEQUALITIES HLTH BL.
   TOWNSEND P, 1988, INEQUALITIES HLTH BL.
   Townsend P., 1987, POVERTY LABOUR LONDO.
   {*}TRAD UN C, 1981, UN HLTH NAT.
   VALKONEN T, 1981, EUROPEAN POPULATION.
   VALKONEN T, 1989, INEQUALITIES HLTH EU.
   VIRCHOW R, 1958, DISEASE LIFE MEN.
   WALKER Alan, 1987, GROWING DIVIDE SOCIA.
   WANNOP UA, 1987, TARGETTING URBAN EMP.
   Whitehead M., 1987, HLTH DIVIDE INEQUALI.
   WHO, 1978, HLTH ALL SER, V1.
   WILKINSON RG, 1987, Q J SOC AFF, V3, P225.
   WILKINSON RG, 1989, J SOC POLICY, V18, P307, DOI 10.1017/S0047279400017591.
   WILKINSON RG, 1986, Q J SOC AFF, V2, P415.
   WILKINSON RG, 1986, CALSS HLTH RES LONGI.
   WINTER JM, 1980, POPULATION SOC BRITA.
   World Health Organisation, 1985, TARG HLTH ALL 2000.},
Number-of-Cited-References = {93},
Times-Cited = {17},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Int. J. Health Serv.},
Doc-Delivery-Number = {DL741},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1990DL74100002},
DA = {2022-03-29},
}

@article{ WOS:000348044800028,
Author = {Norheim, Ole F. and Jha, Prabhat and Admasu, Kesetebirhan and Godal,
   Tore and Hum, Ryan J. and Kruk, Margaret E. and Gomez-Dantes, Octavio
   and Mathers, Colin D. and Pan, Hongchao and Sepulveda, Jaime and
   Suraweera, Wilson and Verguet, Stephane and Woldemariam, Addis T. and
   Yamey, Gavin and Jamison, Dean T. and Peto, Richard},
Title = {Avoiding 40\% of the premature deaths in each country, 2010-30: review
   of national mortality trends to help quantify the UN Sustainable
   Development Goal for health},
Journal = {LANCET},
Year = {2015},
Volume = {385},
Number = {9964},
Pages = {239-252},
Month = {JAN 17},
Abstract = {Background The UN will formulate ambitious Sustainable Development Goals
   for 2030, including one for health. Feasible goals with some
   quantifiable, measurable targets can influence governments. We propose,
   as a quatitative health target, ``Avoid in each country 40\% of
   premature deaths (under-70 deaths that would be seen in the 2030
   population at 2010 death rates), and improve health care at all
   ages{''}. Targeting overall mortality and improved health care ignores
   no modifiable cause of death, nor any cause of disability that is
   treatable (or also causes many deaths). 40\% fewer premature deaths
   would be important in all countries, but implies very different
   priorities in different populations. Reinforcing this target for overall
   mortality in each country are four global subtargets for 2030: avoid
   two-thirds of child and maternal deaths; two-thirds of tuberculosis,
   HIV, and malaria deaths; a third of premature deaths from
   non-communicable diseases (NCDs); and a third of those from other causes
   (other communicable diseases, undernutrition, and injuries). These
   challenging subtargets would halve under-50 deaths, avoid a third of the
   (mainly NCD) deaths at ages 50-69 years, and so avoid 40\% of under-70
   deaths. To help assess feasibility, we review mortality rates and trends
   in the 25 most populous countries, in four country income groupings, and
   worldwide.
   Methods UN sources yielded overall 1970-2010 mortality trends. WHO
   sources yielded cause-specific 2000-10 trends, standardised to
   country-specific 2030 populations; decreases per decade of 42\% or 18\%
   would yield 20-year reductions of two-thirds or a third.
   Results Throughout the world, except in countries where the effects of
   HIV or political disturbances predominated, mortality decreased
   substantially from 1970-2010, particularly in childhood. From 2000-10,
   under-70 age-standardised mortality rates decreased 19\% (with the
   low-income and lower-middle-income countries having the greatest
   absolute gains). The proportional decreases per decade (2000-10) were:
   34\% at ages 0-4 years; 17\% at ages 5-49 years; 15\% at ages 50-69
   years; 30\% for communicable, perinatal, maternal, or nutritional
   causes; 14\% for NCDs; and 13\% for injuries (accident, suicide, or
   homicide).
   Interpretation Moderate acceleration of the 2000-10 proportional
   decreases in mortality could be feasible, achieving the targeted 2030
   disease-specific reductions of two-thirds or a third. If achieved, these
   reductions avoid about 10 million of the 20 million deaths at ages 0-49
   years that would be seen in 2030 at 2010 death rates, and about 17
   million of the 41 million such deaths at ages 0-69 years. Such changes
   could be achievable by 2030, or soon afterwards, at least in areas free
   of war, other major effects of political disruption, or a major new
   epidemic.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Norheim, OF (Corresponding Author), Univ Bergen, Dept Global Publ Hlth \& Primary Care, PB 7800, N-5020 Bergen, Norway.
   Norheim, Ole F., Univ Bergen, Dept Global Publ Hlth \& Primary Care, N-5020 Bergen, Norway.
   Jha, Prabhat; Suraweera, Wilson, Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5S 1A1, Canada.
   Admasu, Kesetebirhan; Woldemariam, Addis T., Minist Hlth, Addis Ababa, Ethiopia.
   Godal, Tore, Minist Foreign Affairs, Oslo, Norway.
   Hum, Ryan J., Univ Toronto, Ctr Global Engn, Toronto, ON M5S 1A1, Canada.
   Kruk, Margaret E., Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
   Gomez-Dantes, Octavio, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   Mathers, Colin D., WHO Mortal \& Burden Dis Unit, Geneva, Switzerland.
   Pan, Hongchao; Peto, Richard, Univ Oxford, Nuffield Dept Populat Hlth Clin Trial Serv Unit, Oxford, England.
   Pan, Hongchao; Peto, Richard, Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England.
   Sepulveda, Jaime; Yamey, Gavin; Jamison, Dean T., Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Verguet, Stephane, Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.},
DOI = {10.1016/S0140-6736(14)61591-9},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; MEXICO; SURVIVAL; COVERAGE;
   MIDDLE; RISK},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {Ole.norheim@igs.uib.no
   RPeto@ctsu.ox.ac.uk},
ResearcherID-Numbers = {Norheim, Ole Frithjof/AAC-8771-2020
   Kruk, Margaret E/E-3058-2010
   Suraweera, Wilson MG/O-8962-2014
   },
ORCID-Numbers = {Norheim, Ole Frithjof/0000-0002-5748-5956
   Kruk, Margaret E/0000-0002-9549-8432
   Mathers, Colin/0000-0002-0617-6731
   Suraweera, Wilson/0000-0001-9673-5746
   Jha, Prabhat/0000-0001-7067-8341},
Funding-Acknowledgement = {UK Medical Research CouncilUK Research \& Innovation (UKRI)Medical
   Research Council UK (MRC); Norwegian Agency for Development Cooperation;
   Centre for Global Health Research; Bill \& Melinda Gates FoundationBill
   \& Melinda Gates FoundationCGIAR},
Funding-Text = {UK Medical Research Council, Norwegian Agency for Development
   Cooperation, Centre for Global Health Research, and Bill \& Melinda
   Gates Foundation.},
Cited-References = {Acosta-Cazares B, 2010, AM HEART J, V160, P230, DOI 10.1016/j.ahj.2010.05.016.
   Astudillo O, 2014, LANCET DIABETES ENDO, V2, P15, DOI 10.1016/S2213-8587(13)70160-8.
   Barquera S, 2010, SALUD PUBLICA MEXICO, V52, pS63.
   Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3.
   Boyle CF, ACHIEVING GRAND CONV.
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0.
   Doll R, 1994, MORTALITY SMOKING DE.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1.
   Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383.
   Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19.
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6.
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5.
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1.
   Lopez A, 2013, LANCET, V381, P1275, DOI 10.1016/S0140-6736(13)60838-7.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X.
   Murray C., 2014, LANCET.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Open Working Group, 2014, OUTC DOC OP WORK GRO.
   Peto R, 2014, SCIENCE, V345, P1272, DOI 10.1126/science.1259971.
   Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14.
   Requejo J, 2014, COUNTDOWN 2015 MATER.
   Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947.
   Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0.
   Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X.
   Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099.
   Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X.
   Thornicroft G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5189.
   UN, 2010, RES AD GEN ASS.
   UN Inter-agency Group for Child Mortality Estimation, 2013, LEV TRENDS CHILD MOR.
   UNICEF, 2014, MON SIT CHILDR WOM.
   UNICEF, 2013, POST 2015 WORLD FIT.
   United Nations, 2014, ACT AG SUST DEV.
   United Nations, 2014, REP SECR GEN HIGH LE.
   United Nations Global Compact, POST 2015 AG REL SUS.
   United Nations Sustainable Development Knowledge Platform, 2014, SUST DEV GOALS.
   UNPD, 2012, WORLD POP PROSP 2012.
   Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128.
   Victora CG, 2012, POSITION PAPER INT E.
   Wamala S, 2014, HDB GLOBAL HLTH POLI, P425.
   Wang H, 2014, LANCET.
   Waters H, 2010, EC TOBACCO TOBACCO T.
   WHO U., 2010, PROGR SAN DRINK WAT.
   WHO. World Health Organisation, 2014, GLOB HLTH EST 2013.
   World Bank, 1993, INV IN HLTH.
   World Bank Group, 2012, WORLD BANK LIST EC.
   World Health Organization, 2011, GLOB STAT REP NONCOM.
   World Health Organization, 2014, TRENDS MAT MORT 1990.
   Yamey G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5295.
   Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890.
   Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3.},
Number-of-Cited-References = {53},
Times-Cited = {160},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {51},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {AZ2DL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000348044800028},
OA = {Green Submitted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000468070200001,
Author = {Fridell, Mats and Backstrom, Martin and Hesse, Morten and Krantz, Peter
   and Perrin, Sean and Nyhlen, Anna},
Title = {Prediction of psychiatric comorbidity on premature death in a cohort of
   patients with substance use disorders: a 42-year follow-up},
Journal = {BMC PSYCHIATRY},
Year = {2019},
Volume = {19},
Month = {MAY 15},
Abstract = {BackgroundWe need to better understand how the use of different
   substances and psychiatric comorbidity influence premature death
   generally and cause-specific death by overdose, intoxication and somatic
   disorders in people with substance use disorders.MethodA cohort of 1405
   patients consecutively admitted to a Swedish detoxification unit for
   substance use disorders in 1970-1995 was followed-up for 42years.
   Substances were identified by toxicological analyses. Mortality figures
   were obtained from a national registry. Causes of death were diagnosed
   by forensic autopsy in 594 patients deceased by 2012. Predictions were
   calculated by competing risks analysis.ResultsForty-two per cent of the
   cohort died during follow-up; more men than women (46.3\% vs 30.4\%).
   The standardised mortality ratio (SMR) was calculated as the ratio of
   observed deaths in males and females in specific age groups in the
   cohort versus expected deaths in corresponding groups in the general
   population. SMR was 5.68 for men (CI 95\%; 5.04-6.11) and 4.98 (CI 95\%;
   4.08-5.88) for women. The crude mortality rate (number of deaths divided
   by number of person observation years) was 2.28\% for men and 1.87\% for
   women.Opiates predicted increased risk of premature death while
   amphetamine and cannabis predicted lower risk. Comorbid psychiatric
   disorders were identified in 378 cases and personality disorders in 763
   cases. Primary psychoses or mood/depression and anxiety disorders
   predicted a higher risk of premature mortality.Death by overdose was
   predicted by male gender, younger age at admission to substance
   treatment, opiate use, and comorbid depression and anxiety syndromes.
   Cannabis and amphetamine use predicted a lower risk of overdose. Death
   by intoxication was predicted by male gender, use of sedatives/hypnotics
   or alcohol/mixed substances, primary psychoses and depression/anxiety
   syndromes. Premature death by somatic disorder was predicted by male
   gender and alcohol/mixed abuse.ConclusionPsychiatric comorbid disorders
   were important risk factors for premature drug-related death. Early
   identification of these factors may be life-saving in the treatment of
   patients with substance use disorders.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Fridell, M (Corresponding Author), Lund Univ, Dept Psychol, SE-22100 Lund, Sweden.
   Fridell, Mats; Backstrom, Martin; Perrin, Sean, Lund Univ, Dept Psychol, SE-22100 Lund, Sweden.
   Hesse, Morten, Univ Aarhus, Ctr Alcohol \& Drug Res, Bartholins Alle, DK-8000 Aarhus C, Denmark.
   Krantz, Peter, Lund Univ Hosp, Dept Forens Med, SE-22185 Lund, Sweden.
   Nyhlen, Anna, Malmo Univ Hosp, Dept Psychiat, SE-20502 Malmo, Sweden.},
DOI = {10.1186/s12888-019-2098-3},
Article-Number = {150},
ISSN = {1471-244X},
Keywords = {Cohort study; Premature death; 42-year follow-up; Drug abuse;
   Psychiatric comorbidity; Personality disorder; Somatic comorbidity},
Keywords-Plus = {NATIONAL EPIDEMIOLOGIC SURVEY; PERSONALITY-DISORDERS; OVERDOSE
   MORTALITY; SCID-II; CANNABIS; AMPHETAMINE; PSYCHOSIS; ALCOHOL; PEOPLE;
   COOCCURRENCE},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {Mats.Fridell@psy.lu.se},
ResearcherID-Numbers = {Perrin, Sean G/F-7723-2010
   Hesse, Morten/AAX-6198-2020
   Perrin, Sean/W-8413-2019},
ORCID-Numbers = {Perrin, Sean G/0000-0002-5468-4706
   Hesse, Morten/0000-0002-6849-6554
   Perrin, Sean/0000-0002-5468-4706},
Funding-Acknowledgement = {Commission for Social Research, Stockholm {[}SFR 92-0244: 1b]; Swedish
   Prison and Probation Service {[}Dnr. 52-2007-28104]},
Funding-Text = {This research was supported by the Commission for Social Research,
   Stockholm (Grant \# SFR 92-0244: 1b), and the Swedish Prison and
   Probation Service (Grant \# Dnr. 52-2007-28104).},
Cited-References = {Andersson B, SJUTTIOTALETS NARKOM.
   ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1.
   ANDREASSON S, 1990, SCAND J SOC MED, V18, P9.
   {[}Anonymous], 1980, 19805 DSS SWED NAT I.
   {[}Anonymous], 2014, ANN REPORT.
   Arendt M, 2007, J SUBST ABUSE TREAT, V32, P113, DOI 10.1016/j.jsat.2006.07.005.
   Arendt M, 2013, J SUBST ABUSE TREAT, V44, P400, DOI 10.1016/j.jsat.2012.09.007.
   Bartu A, 2004, ADDICTION, V99, P53, DOI 10.1111/j.1360-0443.2004.00602.x.
   BERGLUND GW, 1991, J SUBST ABUSE TREAT, V8, P161, DOI 10.1016/0740-5472(91)90008-X.
   Buster MCA, 2002, ADDICTION, V97, P993, DOI 10.1046/j.1360-0443.2002.00179.x.
   Dalmau A, 1999, EUR PSYCHIAT, V14, P366, DOI 10.1016/S0924-9338(99)00234-5.
   Darke S, 2014, ADDICTION, V109, P1237, DOI 10.1111/add.12456.
   Dawe S, 2011, J SUBST ABUSE TREAT, V40, P95, DOI 10.1016/j.jsat.2010.08.002.
   Degenhardt Louisa, 2005, J Clin Forensic Med, V12, P187, DOI 10.1016/j.jcfm.2004.11.003.
   Drake RE, 1996, NEW DIRECTIONS MENTA.
   European Monitoring Centre for Drugs and Drug Addiction, 2015, MORT DRUG US EUR NEW.
   FIRST MB, 1995, J PERS DISORD, V9, P83, DOI 10.1521/pedi.1995.9.2.83.
   FRIDELL M, 1991, PERSONLIGHET DROGMIS.
   Fridell M, 2015, FORSKNING UTVARDERIN, P9.
   Fridell M, 2008, ADDICT BEHAV, V33, P799, DOI 10.1016/j.addbeh.2008.01.001.
   Fridell M, 2006, EUR J PSYCHOL ASSESS, V22, P104, DOI 10.1027/1015-5759.22.2.104.
   Fugelstad A, 1997, ACTA PSYCHIAT SCAND, V96, P169, DOI 10.1111/j.1600-0447.1997.tb10147.x.
   Fugelstad A, 2007, ADDICTION, V102, P406, DOI 10.1111/j.1360-0443.2006.01714.x.
   Fugelstad A, 2012, AKUTA NARKOTIKARELAT.
   Fugelstad A, 2014, SCAND J PUBLIC HEALT, V42, P364, DOI 10.1177/1403494814525006.
   Gossop M, 2002, ADDICTION, V97, P39, DOI 10.1046/j.1360-0443.2002.00079.x.
   Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807.
   Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P361, DOI 10.1001/archpsyc.61.4.361.
   Hansen SS, 2000, ACTA PSYCHIAT SCAND, V102, P432, DOI 10.1034/j.1600-0447.2000.102006432.x.
   Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x.
   IBM Corporation, 2017, IBM SPSS STAT WINDOW.
   Jansson I, 2009, EUR ADDICT RES, V15, P25, DOI 10.1159/000173006.
   Kittirattanapaiboon P, 2010, DRUG ALCOHOL REV, V29, P456, DOI 10.1111/j.1465-3362.2010.00196.x.
   Leifman H, 2016, 158 CAN.
   Manrique-Garcia E, 2016, AM J PSYCHIAT, V173, P790, DOI 10.1176/appi.ajp.2016.14050637.
   Markkula N, 2012, BRIT J PSYCHIAT, V200, P143, DOI 10.1192/bjp.bp.111.094904.
   Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282.
   Muld BB, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-336.
   Nilsson M, 2006, EUROPEAN COLLABORATI, V4, P351.
   Nyhlen A, 2011, J FORENSIC LEG MED, V18, P66, DOI 10.1016/j.jflm.2011.01.003.
   Olsson B, 2001, 3 CAN SWED COUNC INF.
   Pintilie M, 2007, STAT MED, V26, P1360, DOI 10.1002/sim.2655.
   Ruggeri M, 2000, BRIT J PSYCHIAT, V177, P149, DOI 10.1192/bjp.177.2.149.
   Schifano F, 2010, NEUROPSYCHOBIOLOGY, V61, P122, DOI 10.1159/000279302.
   Sorensen HJ, 2005, ACTA PSYCHIAT SCAND, V111, P244, DOI 10.1111/j.1600-0447.2004.00445.x.
   Stenbacka M, 2010, DRUG ALCOHOL REV, V29, P21, DOI 10.1111/j.1465-3362.2009.00075.x.
   Uchtenhagen U, 2000, SUCHTMEDIZIN KONZEPT.
   Verheul R, 2001, EUR PSYCHIAT, V16, P274, DOI 10.1016/S0924-9338(01)00578-8.
   Waal H, 2014, EUR ADDICT RES, V20, P8, DOI 10.1159/000346781.
   World Health Organization, 1993, WHO ICD 10 CLASS MEN.},
Number-of-Cited-References = {50},
Times-Cited = {13},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {BMC Psychiatry},
Doc-Delivery-Number = {HY4AV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000468070200001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000188703600012,
Author = {Fiore, MC and Croyle, RT and Curry, SJ and Cutler, CM and Davis, RM and
   Gordon, C and Healton, C and Koh, HK and Orleans, CT and Richling, D and
   Satcher, D and Seffrin, J and Williams, C and Williams, LN and Keller,
   PA and Baker, TB},
Title = {Preventing 3 million premature deaths and helping 5 million smokers
   quit: A national action plan for tobacco cessation},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2004},
Volume = {94},
Number = {2},
Pages = {205-210},
Month = {FEB},
Abstract = {In August 2002, the Subcommittee on Cessation of the Interagency
   Committee on Smoking and Health (ICSH) was charged with developing
   recommendations to substantially increase rates of tobacco cessation in
   the United States.
   The subcommittee's report, A National Action Plan for Tobacco Cessation,
   outlines 10 recommendations for reducing premature morbidity and
   mortality by helping millions of Americans stop using tobacco. The plan
   includes both evidence-based, population-wide strategies designed to
   promote cessation (e.g., a national quitline network) and a Smokers'
   Health Fund to finance the programs (through a \$2 per pack excise tax
   increase).
   The subcommittee report was presented to the ICSH (February 11, 2003),
   which unanimously endorsed sending it to Secretary Thompson for his
   consideration. In this article, we summarize the national action plan.},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {Fiore, MC (Corresponding Author), Univ Wisconsin, Sch Med, Ctr Tobacco Res \& Intervent, 1930 Monroe St,Suite 200, Madison, WI 53711 USA.
   Univ Wisconsin, Sch Med, Ctr Tobacco Res \& Intervent, Madison, WI 53711 USA.
   NCI, Div Canc Control \& Populat Sci, Bethesda, MD 20892 USA.
   Univ Illinois, Hlth Res Ctr, Chicago, IL 60680 USA.
   Univ Illinois, Policy Ctr, Chicago, IL 60680 USA.
   Amer Assoc Hlth Plans, Washington, DC USA.
   Henry Ford Hlth Syst, Ctr Hlth Promot \& Dis Prevent, Detroit, MI USA.
   Ctr Med \& Medicaid Serv, Baltimore, MD USA.
   Amer Legacy Fdn, Washington, DC USA.
   Harvard Univ, Sch Publ Hlth, Dept Hlth Policy \& Management, Boston, MA 02115 USA.
   Robert Wood Johnson Fdn, Princeton, NJ 08540 USA.
   Midw Business Grp Hlth, Chicago, IL USA.
   Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA.
   Amer Canc Soc, Atlanta, GA 30329 USA.
   Agcy Healthcare Res \& Qual, Off Hlth Care Informat, Rockville, MD USA.
   USN, Dent Corps, Grayslake, IL USA.},
DOI = {10.2105/AJPH.94.2.205},
ISSN = {0090-0036},
EISSN = {1541-0048},
Keywords-Plus = {SMOKING-CESSATION; CIGARETTE CONSUMPTION; CONTROL PROGRAM; HEALTH-CARE;
   INTERVENTIONS; CALIFORNIA; CAMPAIGN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mcf@ctri.medicine.wisc.edu},
Funding-Acknowledgement = {National Institute on Minority Health and Health DisparitiesUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Minority Health \& Health
   Disparities (NIMHD) {[}U54MD008173] Funding Source: NIH RePORTER; NIMHD
   NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Minority
   Health \& Health Disparities (NIMHD) {[}U54 MD008173] Funding Source:
   Medline},
Cited-References = {{*}AM LEG FDN, 2002, SAV LIV SAV MON WHY.
   {[}Anonymous], 2000, MMWR Recomm Rep, V49, P1.
   {[}Anonymous], 2001, WOMEN SMOKING REPORT.
   {[}Anonymous], 2000, REDUCING TOBACCO USE.
   BARKER D, 2002, REIMBURSEMENT SMOKIN.
   Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351.
   Bobak M, 2000, TOBACCO CONTROL DEV, V1, P41.
   Boyd NR, 1998, PREV MED, V27, pS50, DOI 10.1006/pmed.1998.0383.
   Centers for Disease Control and Prevention Office of Smoking and Health, 1999, MMWR-MORBID MORTAL W, V48, P986.
   Chaloupka F., 2000, TAXATION TOBACCO PRO, P237.
   Chaloupka FJ, 1999, TOB CONTROL, V8, P373, DOI 10.1136/tc.8.4.373.
   CHALOUPKA FJ, 1996, NATL BUREAU EC RESS, V5740.
   CHALOUPKA FJ, 2000, HDB HLTH EC, P539.
   Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7.
   Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759.
   {*}CTR DIS CONTR PRE, 2002, MMWR-MORBID MORTAL W, V51, P300.
   {*}CTR DIS CONTR PRE, 1998, TOB US US RAC ETHN M.
   {*}CTR DIS CONTR PRE, 2001, MMWR-MORBID MORTAL W, V50, P979.
   {*}CTR DIS CONTR PRE, 1996, MORT MORB WEEKL REP, V45, P971.
   DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295.
   Farrelly MC, 2001, SOUTH ECON J, V68, P156, DOI 10.2307/1061518.
   Ferry LH, 1999, JAMA-J AM MED ASSOC, V282, P825, DOI 10.1001/jama.282.9.825.
   FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P624, DOI 10.1001/jama.271.8.624.
   Fiore MC, 2000, TREATING TOBACCO USE.
   GLYNN T J, 1988, Cancer Bulletin (Houston), V40, P359.
   Goldstein MG, 1997, ARCH INTERN MED, V157, P1313, DOI 10.1001/archinte.157.12.1313.
   Gross CP, 2002, NEW ENGL J MED, V347, P1080, DOI 10.1056/NEJMsa012743.
   GRUBER J, 2000, RISKY BEHAV YOUTHS E, P69.
   HODGSON TA, 1992, MILBANK Q, V70, P81, DOI 10.2307/3350086.
   Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X.
   HU TW, 1995, AM ECON REV, V85, P85.
   HU TW, 1995, AM J PUBLIC HEALTH, V85, P1218, DOI 10.2105/AJPH.85.9.1218.
   {*}I MED, 2003, FULF POT CANC PREV E.
   {*}I MED, 2003, PRIOR AR NAT ACT TRA.
   King G, 2003, AM J PUBLIC HEALTH, V93, P828, DOI 10.2105/AJPH.93.5.828.
   LANCASTER T, 2002, TRAINING HLTH PROFES.
   McAfee T, 1998, AM J PREV MED, V14, P46, DOI 10.1016/S0749-3797(97)00051-2.
   McPhillips-Tangum C, 1998, TOB CONTROL, V7, pS11, DOI 10.1136/tc.7.2008.S11.
   MCPHILLIPSTANGU.C, 2002, PREV MED MANAG CARE, V3, P85.
   MEYER G, 2003, SMOKERS ARE QUITTING.
   Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893.
   SCHOENBORN CA, 2003, ADV DATA VITAL HLTH, P331.
   Schroeder SA, 2002, NEW ENGL J MED, V347, P1106, DOI 10.1056/NEJMe020099.
   Siegel M, 2002, ANNU REV PUBL HEALTH, V23, P45, DOI 10.1146/annurev.publhealth.23.092601.095916.
   Spangler JG, 2002, JAMA-J AM MED ASSOC, V288, P1102, DOI 10.1001/jama.288.9.1102.
   TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x.
   Warner KE, 1997, PHARMACOECONOMICS, V11, P538, DOI 10.2165/00019053-199711060-00003.
   Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979.
   Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0.
   Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660.
   1999, NIH PUBLICATION.
   {[}No title captured].},
Number-of-Cited-References = {52},
Times-Cited = {180},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {770BP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000188703600012},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000253260700004,
Author = {Farragher, Tracey M. and Goodson, Nicola J. and Naseem, Haris and
   Silman, Alan J. and Thomson, Wendy and Symmons, Deborah and Barton, Anne},
Title = {Association of the HLA-DRB1 gene with premature death, particularly from
   cardiovascular disease, in patients with rheumatoid arthritis and
   inflammatory polyarthritis},
Journal = {ARTHRITIS AND RHEUMATISM},
Year = {2008},
Volume = {58},
Number = {2},
Pages = {359-369},
Month = {FEB},
Abstract = {Objective. To examine the role of the variants of the PTPN22 and
   HLA-DRB1 genes as predictors of mortality in inflammatory polyarthritis
   (IP) and rheumatoid arthritis (RA).
   Methods. Patients were recruited from a primary care-based inception
   cohort of, patients with IP and were followed up prospectively. For
   patients who died, the cause and date of death was obtained. Cox
   proportional hazards regression models were used to assess the
   association of the HLA-DRB1 (including the shared epitope {[}SE]) and
   PTPN22 genes with the risk of death from all causes and from
   cardiovascular disease (CVD) and to assess the interactions between SE,
   smoking, and anti-cyclic citrullinated peptide (anti-CCP) status,
   adjusted by age at symptom onset and sex.
   Results. DNA samples were available from 1,022 IP patients. During
   followup, 751 of them (74\%) satisfied the American College of
   Rheumatology 1987 criteria for RA, and 242 of them (24\%) died. Carriage
   of 2 copies of SE alleles predicted death from all causes (hazard ratio
   {[}HR] 1.57 {[}95\% confidence interval (95\% Cl) 1.1-2.2]) and from CVD
   (HR 1.68 {[}95\% CI 1.12.7]). This effect was most marked for
   individuals with the HLA-DRB1{*}01/{*}04 combination. An interaction of
   smoking, SE alleles, and anti-CCP antibodies was observed and was
   associated with the greatest risk of death from CVD (HR 7.81 {[}95\% CI
   2.6-23.2]). No association of the PTPN22 gene with mortality was
   detected.
   Conclusion. SE alleles, particularly compound heterozygotes, are
   associated with death from all causes and from CVD, independently of
   autoantibody status. However, the combination of SE, smoking, and
   anti-CCP antibodies is associated with a high risk of premature death in
   patients with IP and RA, which raises the possibility of a targeted
   strategy to prevent CVD in these patients.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Farragher, TM (Corresponding Author), Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
   Farragher, Tracey M.; Naseem, Haris; Silman, Alan J.; Thomson, Wendy; Symmons, Deborah; Barton, Anne, Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England.
   Goodson, Nicola J., Univ Liverpool, Univ Hosp Aintree, Liverpool L69 3BX, Merseyside, England.},
DOI = {10.1002/art.23149},
ISSN = {0004-3591},
EISSN = {1529-0131},
Keywords-Plus = {CITRULLINATED PEPTIDE ANTIBODIES; CORONARY-ARTERY-DISEASE; SHARED
   EPITOPE; CIGARETTE-SMOKING; FUTURE ONSET; RISK-FACTORS; PTPN22;
   POPULATION; MORTALITY; GENOTYPE},
Research-Areas = {Rheumatology},
Web-of-Science-Categories  = {Rheumatology},
Author-Email = {Tracey.Farragher@manchester.ac.uk},
ResearcherID-Numbers = {Farragher, Tracey/P-5847-2019
   Goodson, Nicola/L-7880-2019
   Goodson, Nicola j/A-7854-2012
   Barton, Anne/N-2053-2014
   },
ORCID-Numbers = {Goodson, Nicola j/0000-0003-0714-3568
   Farragher, Tracey/0000-0002-1968-6378
   Symmons, Deborah/0000-0002-8625-1200
   Barton, Anne/0000-0003-3316-2527
   Thomson, Wendy/0000-0002-9022-5179},
Funding-Acknowledgement = {Arthritis Research UKVersus Arthritis {[}17552] Funding Source: Medline;
   Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline},
Cited-References = {ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302.
   Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187.
   Cheung NT, 2000, J RHEUMATOL, V27, P882.
   DAHLEN GH, 1995, ATHEROSCLEROSIS, V114, P165, DOI 10.1016/0021-9150(94)05480-7.
   Gerli R, 2005, ANN NY ACAD SCI, V1051, P281, DOI 10.1196/annals.1361.069.
   Gonzalez-Juanatey C, 2003, AM J MED, V114, P647, DOI 10.1016/S0002-9343(03)00133-5.
   Goodson N, 2002, CURR OPIN RHEUMATOL, V14, P115, DOI 10.1097/00002281-200203000-00007.
   Goodson NJ, 2004, RHEUMATOLOGY, V43, P731, DOI 10.1093/rheumatology/keh161.
   Goodson NJ, 2005, ARTHRITIS RHEUM-US, V52, P2293, DOI 10.1002/art.21204.
   Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P400, DOI 10.1002/art.20006.
   Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P3476, DOI 10.1002/art.20588.
   Harrison B, 1999, ARTHRITIS RHEUM, V42, P2174, DOI 10.1002/1529-0131(199910)42:10<2174::AID-ANR19>3.0.CO;2-G.
   Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900.
   HAZES JMW, 1990, ANN RHEUM DIS, V49, P980, DOI 10.1136/ard.49.12.980.
   Hedger SC, 1999, AUST NZ J MED, V29, P234, DOI 10.1111/j.1445-5994.1999.tb00689.x.
   HELIOVAARA M, 1995, ANN RHEUM DIS, V54, P811, DOI 10.1136/ard.54.10.811.
   Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538.
   Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049.
   Johansson M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1868.
   Jonasson L, 1997, ATHEROSCLEROSIS, V133, P111, DOI 10.1016/S0021-9150(97)00101-9.
   Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736.
   Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808.
   KIRWAN JR, 1986, BRIT J RHEUMATOL, V25, P206.
   Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575.
   Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883.
   MACGREGOR A, 1995, J RHEUMATOL, V22, P1032.
   Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853.
   Mattey DL, 2002, ARTHRIT RHEUM-ARTHR, V47, P403, DOI 10.1002/art.10514.
   Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401.
   Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571.
   Samani NJ, 2005, AM J HUM GENET, V77, P1011.
   Sihvonen S, 2005, J RHEUMATOL, V32, P2089.
   Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504.
   Soderlin MK, 2004, SCAND J RHEUMATOL, V33, P185, DOI 10.1080/03009740310004856.
   Stata Corporation, 2003, STAT STAT SOFTW REL.
   Symmons DPM, 2003, J RHEUMATOL, V30, P902.
   Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106.
   SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735.
   Thomson W, 1999, ARTHRITIS RHEUM, V42, P757, DOI 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X.
   Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837.
   van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739.
   Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562.
   WallbergJonsson S, 1997, J RHEUMATOL, V24, P445.
   Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294.
   WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814.
   WHO, 1977, INT CLASS DIS 9 REV.
   WORDSWORTH P, 1992, AM J HUM GENET, V51, P585.
   World Health Organization, 1994, INT STAT CLASS DIS R.},
Number-of-Cited-References = {48},
Times-Cited = {136},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Arthritis Rheum.},
Doc-Delivery-Number = {264BR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000253260700004},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000324789100020,
Author = {Kim, Yeonju and Wilkens, Lynne R. and Schembre, Susan M. and Henderson,
   Brian E. and Kolonel, Laurence N. and Goodman, Marc T.},
Title = {Insufficient and excessive amounts of sleep increase the risk of
   premature death from cardiovascular and other diseases: The Multiethnic
   Cohort Study},
Journal = {PREVENTIVE MEDICINE},
Year = {2013},
Volume = {57},
Number = {4},
Pages = {377-385},
Month = {OCT},
Abstract = {Objective. To explore an independent association between self-reported
   sleep duration and cause-specific mortality.
   Methods. Data were obtained from the Multiethnic Cohort Study conducted
   in Los Angeles and Hawaii.
   Results. Among 61,936 men and 73,749 women with no history of cancer,
   heart attack or stroke, 19,335 deaths occurred during an average 12.9
   year follow-up. Shorter (<= 5 h/day) and longer (>= 9 h/day) sleepers of
   both sexes (vs. 7 h/day) had an increased risk of all-cause and
   cardiovascular disease (CVD) mortality, but not of cancer mortality.
   Multivariable hazard ratios for CVD mortality were 1.13 (95\% CI
   1.00-1.28) for <= 5 h/day and 1.22 (95\% CI 1.09-135) for >= 9 h/day
   among men; and 1.20 (95\% CI 1.05-136) for <= 5 h/day and 1.29 (95\% CI
   1.13-1.47) for >= 9 h/day among women. This risk pattern was not
   heterogeneous across specific causes of CVD death among men (P-hetero
   0.53) or among women (P-hetero 0.72). The U-shape association for
   all-cause and CVD mortality was observed in all five ethnic groups
   included in the study and by subgroups of age, smoking status, and body
   mass index.
   Conclusion. Insufficient or excessive amounts of sleep were associated
   with increased risk of mortality from CVD and other diseases in a
   multiethnic population. (c) 2013 Elsevier Inc. All rights reserved.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Kim, Y (Corresponding Author), Univ Hawaii Canc Ctr, Canc Epidemiol Program, 701 Ilalo St, Honolulu, HI 96813 USA.
   Kim, Yeonju; Wilkens, Lynne R.; Kolonel, Laurence N.; Goodman, Marc T., Univ Hawaii Canc Ctr, Canc Epidemiol Program, Honolulu, HI 96813 USA.
   Schembre, Susan M., Univ Hawaii Canc Ctr, Honolulu, HI 96813 USA.
   Henderson, Brian E., Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.},
DOI = {10.1016/j.ypmed.2013.06.017},
ISSN = {0091-7435},
EISSN = {1096-0260},
Keywords = {Sleep; Mortality; Cardiovascular disease; Ethnic groups; Prospective
   studies},
Keywords-Plus = {ALL-CAUSE MORTALITY; SELF-REPORTED SLEEP; BODY-MASS INDEX;
   RACIAL-DIFFERENCES; UNITED-STATES; WHITEHALL-II; LONG-SLEEP; DURATION;
   POPULATION; ADULTS},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {yeonju.kim5@gmail.com},
ResearcherID-Numbers = {Kim, Yeonju/D-8948-2013
   },
ORCID-Numbers = {Kim, Yeonju/0000-0002-2570-750X
   Schembre, Susan/0000-0002-9945-7136},
Funding-Acknowledgement = {NCI NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}R37 CA054281] Funding Source: Medline; NATIONAL CANCER
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}R37CA054281] Funding Source: NIH RePORTER},
Cited-References = {Amagai Y, 2004, J EPIDEMIOL, V14, P124, DOI 10.2188/jea.14.124.
   Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085.
   Burazeri G, 2003, CROAT MED J, V44, P193.
   Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471.
   Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007.
   Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585.
   Chaput JP, 2008, SLEEP, V31, P517, DOI 10.1093/sleep/31.4.517.
   Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177.
   CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754.
   Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C.
   Mesas AE, 2010, J AM GERIATR SOC, V58, P1870, DOI 10.1111/j.1532-5415.2010.03071.x.
   Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659.
   Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x.
   Gangwisch JE, 2008, SLEEP, V31, P1087.
   Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007.
   Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250.
   Hairston KG, 2010, SLEEP, V33, P289, DOI 10.1093/sleep/33.3.289.
   Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096.
   HAMMOND EC, 1964, AM J PUBLIC HEALTH N, V54, P11, DOI 10.2105/AJPH.54.1.11.
   Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661.
   Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3.
   Horne J, 2008, BIOL PSYCHOL, V77, P266, DOI 10.1016/j.biopsycho.2007.12.003.
   Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245.
   Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295.
   Institute of Medicine, 2005, DIET REF INT EN CARB.
   Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701.
   Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213.
   KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103.
   Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131.
   Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023.
   Lan TY, 2007, SLEEP, V30, P1105, DOI 10.1093/sleep/30.9.1105.
   Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0.
   Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199.
   Lopez-Garcia E, 2008, AM J CLIN NUTR, V87, P310, DOI 10.1093/ajcn/87.2.310.
   Magee CA, 2009, PREV MED, V49, P461, DOI 10.1016/j.ypmed.2009.10.006.
   Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x.
   Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001.
   Nishiura C, 2010, J EPIDEMIOL, V20, P385, DOI 10.2188/jea.JE20100019.
   Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822.
   Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440.
   Pesonen AK, 2012, PSYCHONEUROENDOCRINO, V37, P238, DOI 10.1016/j.psyneuen.2011.06.008.
   Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316.
   Ramires-Exposito MJ, 2008, HEART FAIL REV, V13, P355, DOI 10.1007/s10741-008-9082-1.
   Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371.
   Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281.
   Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07.096.
   Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x.
   Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337.
   Suzuki E, 2009, PREV MED, V49, P135, DOI 10.1016/j.ypmed.2009.06.016.
   Tamakoshi A, 2004, SLEEP, V27, P51.
   Therneau T. M., 2000, STAT BIOL HEALTH.
   Tu XD, 2012, SLEEP MED, V13, P1138, DOI 10.1016/j.sleep.2012.06.014.
   WINGARD DL, 1983, SLEEP, V6, P102, DOI 10.1093/sleep/6.2.102.
   Yanes LL, 2011, AM J HYPERTENS, V24, P740, DOI 10.1038/ajh.2011.71.
   Yanes LL, 2005, AM J PHYSIOL-REG I, V288, pR229, DOI 10.1152/ajpregu.00697.2003.},
Number-of-Cited-References = {55},
Times-Cited = {53},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Prev. Med.},
Doc-Delivery-Number = {223FC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000324789100020},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000406256100012,
Author = {Quitian-Reyes, Hoover and Gomez-Restrepo, Carlos and Juliana Gomez,
   Maria and Naranjo, Salome and Heredia, Patricia and Villegas, John},
Title = {Latin American Clinical Epidemiology Network Series - Paper 5: Years of
   life lost due to premature death in traffic accidents in Bogota,
   Colombia},
Journal = {JOURNAL OF CLINICAL EPIDEMIOLOGY},
Year = {2017},
Volume = {86},
Pages = {101-105},
Month = {JUN},
Abstract = {Objective: This study aimed to quantify the number of years of life lost
   in traffic accidents in Bogota, Colombia.
   Study Design and Setting: The years of life lost were calculated using
   the `age-standardized expected years of life lost' method, the table of
   Japanese adjusted life expectancy and the database of the Institute of
   Legal Medicine and Forensic Science between September 2012 and August
   2013.
   Results: During a period of 1 year, 430 people died and 10,056.3 years
   of life were lost in Bogota due to traffic accidents.
   Conclusion: The mortality burden of traffic accidents in Bogota is high.
   Further studies are required in order to characterize the accidents and
   develop effective policy decisions. (C) 2016 Elsevier Inc. All rights
   reserved.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Quitian-Reyes, H (Corresponding Author), Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol \& Biostat, Cra 7,40-62, Bogota 110231, Colombia.
   Quitian-Reyes, Hoover; Juliana Gomez, Maria, Pontificia Univ Javeriana, Fac Med, Dept Clin Epidemiol \& Biostat, Cra 7,40-62, Bogota 110231, Colombia.
   Gomez-Restrepo, Carlos, Pontificia Univ Javeriana, Hosp Univ San Ignacio, Fac Med, Dept Clin Epidemiol \& Biostat, Cra 7,40-62, Bogota 110231, Colombia.
   Naranjo, Salome, Corp Fondo Prevenc Vial, Barranquilla, Colombia.
   Heredia, Patricia; Villegas, John, Natl Inst Legal Med \& Forens Sci, Cll 7A,12A-51, Bogota 110321, Colombia.},
DOI = {10.1016/j.jclinepi.2016.04.017},
ISSN = {0895-4356},
EISSN = {1878-5921},
Keywords = {Traffic accidents; Years of potential life lost; Premature death;
   Premature mortality; Life extension; Death cause},
Keywords-Plus = {MORTALITY BURDEN; MOTOR-VEHICLE; RISK-FACTORS; INJURIES; ISLAND},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Author-Email = {quitianh@javeriana.edu.co},
ORCID-Numbers = {Gomez-Restrepo, Carlos/0000-0002-9013-5384
   Quitian-Reyes, Hoover/0000-0001-8286-4977},
Funding-Acknowledgement = {Road Prevention Fund Corporation Administrative Department of Science
   {[}501 253 730 902]; National Institute of Legal Medicine and Forensic
   Sciences; Directorate of Traffic and Transportation of the National
   Police},
Funding-Text = {This study was made possible by funding from the Road Prevention Fund
   Corporation and the Administrative Department of Science, Technology and
   Innovation COLCIENCIAS (as part of the project Health Interventions
   targeted PHC Program and reducing the burden of mental disorders
   generators greater chronicity and disability (UT/PUJ and HUSI),
   Colciencias no. 501 253 730 902), and the collaboration of the National
   Institute of Legal Medicine and Forensic Sciences, the Directorate of
   Traffic and Transportation of the National Police, and six participating
   hospitals.},
Cited-References = {{[}Anonymous], 2013, SECR MOV 2013 REC PA.
   Bachani AM, 2012, TRAFFIC INJ PREV, V13, P24, DOI 10.1080/15389588.2011.633136.
   Banerjee A, 2013, INT J CRIT ILLN INJ, V3, P8.
   Echeverry JC, 2005, ECONOMIA, V5, P151, DOI 10.1353/eco.2005.0014.
   Fernandez FJ, 2003, INJ CONTROL SAF PROM, V10, P29.
   Harvard School of Public Health World Health Organization World Bank, 1996, GLOBAL BURDEN DIS CO.
   Herman J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-479.
   Hijar M, 2012, TRAFFIC INJ PREV, V13, P5, DOI 10.1080/15389588.2011.631065.
   Holtslag HR, 2008, B WORLD HEALTH ORGAN, V86, P111, DOI 10.2471/BLT.06.033803.
   Jiang YW, 2012, PUBLIC HEALTH REP, V127, P293, DOI 10.1177/003335491212700309.
   Jiaying Z, 2012, B WORLD HEALTH ORGAN, V90, P461.
   Kudebong M, 2011, Ghana Med J, V45, P135.
   Lai CH, 2008, PUBLIC HEALTH NURS, V25, P28, DOI 10.1111/j.1525-1446.2008.00677.x.
   Mamady K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-733.
   Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184.
   Organizacion Mundial de la salud OMS, INF SIT MUND SEG VIA.
   Penalosa R, 2010, ESTIMACION CARGA ENF.
   Posada J, 2000, Rev Panam Salud Publica, V7, P88, DOI 10.1590/S1020-49892000000200003.
   Puvanachandra P, 2012, TRAFFIC INJ PREV, V13, P64, DOI 10.1080/15389588.2011.633135.
   Rodriguez Garcia J, 2008, ASS150208.
   Rothman L, 2010, TRAFFIC INJ PREV, V11, P43, DOI 10.1080/15389580903452340.
   Thirunaaukarasu D, 2013, INDIAN J MED SPEC, V4, P229, DOI 10.7713/ijms.2013.0028.
   Ubeda C, 2012, INT J INJ CONTROL SA, V19, P9, DOI 10.1080/17457300.2011.581377.
   Valdivia A. Velasquez, 2006, GUIA METODOLOGICA PA.
   Velásquez Aníbal, 2009, Rev. perú. med. exp. salud publica, V26, P222.
   World Health Organization, 2015, GLOB STAT REP ROAD S.
   World Health Organization (WHO), 2013, TOP 10 CAUS DEATH.},
Number-of-Cited-References = {27},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Clin. Epidemiol.},
Doc-Delivery-Number = {FB6MC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000406256100012},
DA = {2022-03-29},
}

@article{ WOS:000481563700004,
Author = {Lewis, Matthew T. and Lujan, Heidi L. and Wiseman, Robert W. and
   DiCarlo, Stephen E.},
Title = {The hypertension advantage and natural selection: Since type 2 diabetes
   associates with co-morbidities and premature death, why have the genetic
   variants remained in the human genome?},
Journal = {MEDICAL HYPOTHESES},
Year = {2019},
Volume = {129},
Month = {AUG},
Abstract = {Type 2 diabetes is a major public health crisis around the world. It is
   estimated that more than 300 million people worldwide have type 2
   diabetes. Furthermore, the World Health Organization estimates that
   deaths from the complications of diabetes will increase by two thirds
   between 2008 and 2030. Since type 2 diabetes is a major public health
   crisis, why have the genetic variants for diabetes not been removed from
   the genome by natural selection? We hypothesize that insulin resistance,
   a predisposition to type 2 diabetes, and the associated elevation in
   sympathetic nervous system activity and arterial blood pressure provided
   an advantage to humans who lived as hunter-gatherers. Specifically,
   sympathetic hyperactivity stimulates the renin-angiotensin aldosterone
   system, promotes sodium reabsorption, and increases blood volume, heart
   rate, stroke volume and peripheral vascular resistance, thus inducing
   hypertension. The hypertension in turn provides a hemodynamic advantage
   for hunter-gatherers. Specifically, sympathetic hyperactivity and
   increased blood pressure increases blood flow delivery to working
   muscles by increasing cardiac output and shunting blood from non-active
   tissue. This natural selection for hypertension occurred during the time
   in human evolutionary history when the life span of most individuals was
   probably 30-40 years, and morbidity and mortality from cardiovascular
   disorders was limited. Thus, the selection pressure for elevation in
   sympathetic nervous system activity and blood pressure provided an
   advantage for hunting and gathering that would be greater than the
   selection pressure exerted by the manifestations of cardiovascular
   disease in aged individuals.},
Publisher = {CHURCHILL LIVINGSTONE},
Address = {JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND},
Type = {Article},
Language = {English},
Affiliation = {DiCarlo, SE (Corresponding Author), Michigan State Univ, Dept Physiol, Biomed Phys Sci, 567 Wilson Rd,Room 2201, E Lansing, MI 48824 USA.
   Lewis, Matthew T.; Lujan, Heidi L.; Wiseman, Robert W.; DiCarlo, Stephen E., Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.},
DOI = {10.1016/j.mehy.2019.109237},
ISSN = {0306-9877},
EISSN = {1532-2777},
Keywords = {Obesity; A sedentary lifestyle; Goto-Kakizaki (GK) rat; Hyperglycemia;
   Perfusion pressure},
Keywords-Plus = {ARTERIAL-BLOOD PRESSURE; PULSE-WAVE VELOCITY; HEART-RATE RECOVERY;
   MENTAL STRESS; CARDIOVASCULAR REACTIVITY; CARNIVORE CONNECTION;
   ENDURANCE EXERCISE; PERFUSION-PRESSURE; AUTONOMIC FUNCTION; COLON
   DISTENSION},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {dicarlos@msu.edu},
ResearcherID-Numbers = {Lewis, Matthew/AAY-5520-2021},
ORCID-Numbers = {Lewis, Matthew/0000-0003-0580-6866},
Funding-Acknowledgement = {National Institute of Diabetes and Digestive and Kidney DiseasesUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes \& Digestive \&
   Kidney Diseases (NIDDK) {[}RO1DK095210]; National Heart, Lung, and Blood
   InstituteUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}RO1HL-122223]},
Funding-Text = {This work was supported in part by National Institute of Diabetes and
   Digestive and Kidney Diseases Grant RO1DK095210 awarded to RWW and
   National Heart, Lung, and Blood Institute Grant RO1HL-122223 awarded to
   SED.},
Cited-References = {ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794.
   BALLER D, 1981, BASIC RES CARDIOL, V76, P163, DOI 10.1007/BF01907955.
   Barbato JC, 1985, J APPL PHYSL BETHESD, V1998, P530, DOI {[}10.1152/jappl.1970.28.6.867, DOI 10.1152/JAPPL.1970.28.6.867].
   Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x.
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012.
   Bhambhani Y, 2010, DISABIL REHABIL, V32, P2172, DOI 10.3109/09638288.2010.505678.
   Bhati P, 2018, DIABETES METAB SYND, V12, P69, DOI 10.1016/j.dsx.2017.08.015.
   Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x.
   BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182.
   Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111.
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a.
   Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003.
   CDC, 2018, NAT DIAB STAT REP.
   Chandler MP, 1998, AM J PHYSIOL-REG I, V274, pR510, DOI 10.1152/ajpregu.1998.274.2.R510.
   Chen YC, 2016, AM J PHYSIOL-REG I, V311, pR426, DOI 10.1152/ajpregu.00112.2016.
   Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621.
   CHRISTENSEN NJ, 1983, ANNU REV PHYSIOL, V45, P139, DOI 10.1146/annurev.ph.45.030183.001035.
   Colagiuri S, 2002, EUR J CLIN NUTR, V56, pS30, DOI 10.1038/sj.ejcn.1601351.
   Collins HL, 2002, AM J PHYSIOL-HEART C, V283, pH1734, DOI 10.1152/ajpheart.00253.2002.
   Collins HL, 2002, AM J PHYSIOL-HEART C, V282, pH1566, DOI 10.1152/ajpheart.00733.2001.
   CONVERTINO VA, 1980, J APPL PHYSIOL, V48, P665, DOI 10.1152/jappl.1980.48.4.665.
   CONVERTINO VA, 1981, J APPL PHYSIOL, V50, P123, DOI 10.1152/jappl.1981.50.1.123.
   Coote JH, 2010, EXP PHYSIOL, V95, P431, DOI 10.1113/expphysiol.2009.047548.
   COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857.
   Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7.
   Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251.
   DEMEERSMAN RE, 1992, EUR J APPL PHYSIOL O, V64, P434, DOI 10.1007/BF00625063.
   Dinenno FA, 2001, J PHYSIOL-LONDON, V534, P287, DOI 10.1111/j.1469-7793.2001.00287.x.
   EKBLOM B, 1968, J APPL PHYSIOL, V25, P619, DOI 10.1152/jappl.1968.25.5.619.
   EKBLOM B, 1973, SCAND J CLIN LAB INV, V32, P249.
   Ferguson SK, 2013, J PHYSIOL-LONDON, V591, P547, DOI 10.1113/jphysiol.2012.243121.
   Fernandes AA, 2015, BRAZ J MED BIOL RES, V48, P813, DOI 10.1590/1414-431X20154355.
   Fitzpatrick R, 1996, J PHYSIOL-LONDON, V495, P885, DOI 10.1113/jphysiol.1996.sp021640.
   Franklin SS, 2013, HYPERTENSION, V62, P982, DOI 10.1161/HYPERTENSIONAHA.113.01275.
   Frisbee JC, 2019, J APPL PHYSIOL, V126, P626, DOI 10.1152/japplphysiol.00751.2018.
   Fu Qi, 2013, Handb Clin Neurol, V117, P147, DOI 10.1016/B978-0-444-53491-0.00013-4.
   Gavin JR, 1999, DIABETES CARE, V22, pS5.
   Gee CM, 2015, SPORTS MED, V45, P1133, DOI 10.1007/s40279-015-0340-9.
   GLEDHILL N, 1982, MED SCI SPORT EXER, V14, P183.
   GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549.
   GOLDSMITH RL, 1992, J AM COLL CARDIOL, V20, P552, DOI 10.1016/0735-1097(92)90007-A.
   Gourine AV, 2019, PHYSIOLOGY, V34, P71, DOI 10.1152/physiol.00041.2018.
   Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010.
   Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013.
   Hellsten Y, 2016, COMPR PHYSIOL, V6, P1, DOI 10.1002/cphy.c140080.
   HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0.
   Hopman MTE, 1998, INT J SPORTS MED, V19, P98, DOI 10.1055/s-2007-971889.
   Huang YL, 2017, J HYPERTENS, V35, P677, DOI 10.1097/HJH.0000000000001226.
   Huonker M, 2003, J APPL PHYSIOL, V95, P685, DOI 10.1152/japplphysiol.00710.2001.
   Johnson AK, 2018, NAT REV NEPHROL, V14, P750, DOI 10.1038/s41581-018-0068-5.
   KNIGHT DR, 1992, J APPL PHYSIOL, V73, P1114, DOI 10.1152/jappl.1992.73.3.1114.
   KNIGHT DR, 1993, J APPL PHYSIOL, V75, P2586, DOI 10.1152/jappl.1993.75.6.2586.
   Koch LG, 1999, PHYSIOL GENOMICS, V1, P63, DOI 10.1152/physiolgenomics.1999.1.2.63.
   Krantz DS, 1999, AM J CARDIOL, V84, P1292, DOI 10.1016/S0002-9149(99)00560-3.
   Krassioukov A, 2012, CLIN J SPORT MED, V22, P39, DOI 10.1097/JSM.0b013e3182420699.
   Kupper N, 2015, JACC-HEART FAIL, V3, P373, DOI 10.1016/j.jchf.2014.12.016.
   Laakso M, 2001, J INTERN MED, V249, P225, DOI 10.1046/j.1365-2796.2001.00789.x.
   Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749.
   Lewis MT, 2019, MED HYPOTHESES, V123, P110, DOI 10.1016/j.mehy.2019.01.013.
   Lujan HL, 2018, J APPL PHYSIOL, V124, P1471, DOI 10.1152/japplphysiol.01104.2017.
   Lujan HL, 2016, AUTON NEUROSCI-BASIC, V201, P24, DOI 10.1016/j.autneu.2016.08.017.
   MacGregor G, 1998, SALT DIET HLTH.
   Machhada A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15097.
   Machhada A, 2016, J PHYSIOL-LONDON, V594, P4017, DOI 10.1113/JP270984.
   MANUCK SB, 1992, PSYCHOSOM MED, V54, P102, DOI 10.1097/00006842-199201000-00003.
   Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165.
   Mazzeo F, 2015, FUNCT NEUROL, V30, P91.
   MILLER JCB, 1994, DIABETOLOGIA, V37, P1280, DOI 10.1007/s001250050246.
   Mitchell GF, 1997, J APPL PHYSIOL, V82, P203, DOI 10.1152/jappl.1997.82.1.203.
   Nederend I, 2016, EUR J APPL PHYSIOL, V116, P2167, DOI 10.1007/s00421-016-3459-y.
   NEEL JV, 1962, AM J HUM GENET, V14, P353.
   Neel JV, 1998, PERSPECT BIOL MED, V42, P44.
   Pearson MJ, 2018, HEART FAIL REV, V23, P91, DOI 10.1007/s10741-017-9662-z.
   PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504.
   Phillips WT, 1998, CURR PROB CARDIOLOGY, V23, P649.
   Ramirez J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04148-1.
   RICHARDSON RS, 1993, J APPL PHYSIOL, V75, P1911, DOI 10.1152/jappl.1993.75.4.1911.
   ROESKE WR, 1976, CIRCULATION, V53, P286, DOI 10.1161/01.CIR.53.2.286.
   ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75.
   SACKNOFF DM, 1994, AM HEART J, V127, P1275, DOI 10.1016/0002-8703(94)90046-9.
   Schwartz AR, 2003, PSYCHOSOM MED, V65, P22, DOI 10.1097/01.PSY.0000046075.79922.61.
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382.
   Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007.
   Tan I, 1979, HYPERTENS DALLAS TEX, V2012, P528, DOI {[}10.1161/HYPERTENSIONAHA.112, DOI 10.1161/HYPERTENSIONAHA.112].
   Treiber FA, 2003, PSYCHOSOM MED, V65, P46, DOI 10.1097/00006842-200301000-00007.
   Verweij N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03395-6.
   Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.ph.58.030196.000321.
   Webborn ADJ, 1999, BRIT J SPORT MED, V33, P74.
   Wright JR, 1999, J APPL PHYSIOL, V86, P845, DOI 10.1152/jappl.1999.86.3.845.
   Wright JR, 2000, J APPL PHYSIOL, V88, P1390, DOI 10.1152/jappl.2000.88.4.1390.},
Number-of-Cited-References = {90},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Med. Hypotheses},
Doc-Delivery-Number = {IR6QL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000481563700004},
DA = {2022-03-29},
}

@article{ WOS:000575412700001,
Author = {Saxena, Nitya and Sethia, Deepak},
Title = {Decomposition of years of life lost due to premature death (YLL): a
   method for spatial and temporal comparative assessment},
Journal = {ARCHIVES OF PUBLIC HEALTH},
Year = {2020},
Volume = {78},
Number = {1},
Month = {OCT 6},
Abstract = {Background Acceptance of Disability-Adjusted Life Year (DALY) as a
   measure of health summary and progression has increased over the years,
   which in turn has instigated comparative analysis studies of DALY across
   time and geography. Thus, it is important to explore methodological
   underpinnings of comparative analysis. Results A crude comparison of
   disease burden across time or space may mislead the interpretation of
   the health system's performance because the quantum and pattern of DALY
   can be influenced by the age structure of the society. A significant
   proportion of this burden is due to the Years of Life Lost (YLL)
   component. The paper proposes a mathematical exposition to decompose the
   change in YLL over time or region into burden attributed to a)
   population age structure, b) death rate, and c) age at death gradient.
   Conclusion We reasoned that the death rate and age at death burden
   gradient signify the real contribution of the health systems. Hence, the
   method of decomposition can be utilized to measure the health service
   progression of a region in real terms.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Saxena, N (Corresponding Author), Indian Inst Management, Dept Econ, Indore, India.
   Saxena, Nitya; Sethia, Deepak, Indian Inst Management, Dept Econ, Indore, India.},
DOI = {10.1186/s13690-020-00472-5},
Article-Number = {91},
ISSN = {0778-7367},
EISSN = {2049-3258},
Keywords = {Disease burden; DALY; YLL; Decomposition; Methodology; Health},
Keywords-Plus = {GLOBAL BURDEN; SYSTEMATIC ANALYSIS; DISEASE; DALYS; INJURIES; QALYS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {f13nityas@iimidr.ac.in},
Funding-Acknowledgement = {Indian Institute of Management Indore, India},
Funding-Text = {The manuscript is a part of the thesis work, which is funded by the
   Indian Institute of Management Indore, India.},
Cited-References = {AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015.
   Ahmad OB, 2001, GENEVA WORLD HLTH OR, V9, P10.
   Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5.
   Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2.
   {[}Anonymous], 2019, POPULATION PYRAMIDS.
   Bandyopadhyay A, 2009, SECOND INTERNATIONAL CONFERENCE ON SOFTWARE TESTING, VERIFICATION, AND VALIDATION, PROCEEDINGS, P121, DOI 10.1109/ICST.2009.23.
   BROWN AJ, 1969, ECON J, V79, P759, DOI 10.2307/2229791.
   Budke CM, 2004, AM J TROP MED HYG, V71, P56, DOI 10.4269/ajtmh.2004.71.56.
   Charlson FJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-47.
   Dholakia RH, 1986, REV REG STUD, V16, P44.
   Global Burden of Disease Collaborative Network, 2018, GLOBAL BURDEN DIS ST.
   Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513.
   ICMR PHFI and IHME (Indian Council of Medical Research Public Health Foundation of India \& Institute for Health Metrics and Evaluation), 2017, GBD IND COMP DAT VIS.
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4.
   Kearns K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-143.
   McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009.
   Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241.
   Molla M T, 2001, Healthy People 2010 Stat Notes, P1.
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9.
   Organization WH, 2017, GLOB TUB REP 2017, P157.
   REINSDORF M. B., 2002, J ECON SOC MEAS, V28, P51.
   Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018.
   Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2.},
Number-of-Cited-References = {27},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Arch. PUblic Health},
Doc-Delivery-Number = {NX0MG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000575412700001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1990DX86700010,
Author = {HALLBERG, H and MATTSSON, B},
Title = {PREMATURE DEATHS AMONG MEN IN A SWEDISH MUNICIPALITY - CIVIL STATUS AND
   PRIMARY HEALTH-CARE UTILIZATION PRIOR TO DEATH},
Journal = {SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE},
Year = {1990},
Volume = {18},
Number = {3},
Pages = {213-219},
Publisher = {SCANDINAVIAN UNIVERSITY PRESS},
Address = {PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY},
Type = {Article},
Language = {English},
Affiliation = {HALLBERG, H (Corresponding Author), KOPPARBERG CTY COUNCIL, DEV UNIT, KOPPARVAGEN 29F, S-79142 FALUN, SWEDEN.
   UMEA UNIV, MARIEHEMS PRIMARY HLTH CARE CTR, S-90185 UMEA, SWEDEN.},
DOI = {10.1177/140349489001800310},
ISSN = {0300-8037},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {Agren G, 1986, Lakartidningen, V83, P3984.
   BERKSON J, 1962, AM J PUBLIC HEALTH N, V52, P1318, DOI 10.2105/AJPH.52.8.1318.
   BLOTH B, 1976, ACTA MED SCAND, V200, P281.
   BOLANDER AM, 1980, HLTH SOC DIFFERENT A.
   BOLANDER AM, 1981, MED ASPECTS MORTALIT, P236.
   BRITTON M, 1974, ACTA MED SCAND, V196, P203.
   DAY N, 1979, THESIS U CALIFORNIA.
   GOVE WR, 1973, AM J SOCIOL, V79, P45, DOI 10.1086/225505.
   HACKL H, 1980, DEUT MED WOCHENSCHR, V105, P1743, DOI 10.1055/s-2008-1070948.
   HOLZMAN NA, 1979, INT SERV HLTH, V9, P25.
   MELLSTROM D, 1986, SOCIAL SUPPORT HLTH, P47.
   {*}NAT CENT BUR STAT, 1981, STAT B, V3, P10.
   NICHOLLS P, 1974, Q J STUD ALCOHOL, V35, P841.
   PETERSSON B, 1982, LANCET, V2, P1088.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   ROSENGREN A, 1988, THESIS U GOTHENBURG.
   SAINSBERRY P, 1980, SUICIDE SYNDROME, P938.
   SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171.
   SUNDBY P, 1967, PUBLICATION NATIONAL, V6.
   WALL S, 1985, INT J EPIDEMIOL, V14, P285, DOI 10.1093/ije/14.2.285.
   WELIN L, 1985, LANCET, V1, P915.
   1983, SPRI122 RAPP.
   1987, 15 NAT BOARD HLTH WE.},
Number-of-Cited-References = {23},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Soc. Med.},
Doc-Delivery-Number = {DX867},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1990DX86700010},
DA = {2022-03-29},
}

@article{ WOS:000230112400017,
Author = {Zhang, SW and Picard, MH and Vasile, E and Zhu, Y and Raffai, RL and
   Weisgraber, KH and Krieger, M},
Title = {Diet-induced occlusive coronary atherosclerosis, myocardial infarction,
   cardiac dysfunction, and premature death in scavenger receptor class B
   type I-deficient, hypomorphic apolipoprotein ER61 mice},
Journal = {CIRCULATION},
Year = {2005},
Volume = {111},
Number = {25},
Pages = {3457-3464},
Month = {JUN 28},
Abstract = {Background - Normal chow ( low fat) - fed mice deficient in both the HDL
   receptor SR- BI and apolipoprotein E ( SR- BI/ apoE dKO) provide a
   distinctive model of coronary heart disease ( CHD). They exhibit early-
   onset hypercholesterolemia characterized by unesterified cholesterol -
   rich abnormal lipoproteins ( lamellar/ vesicular and stacked discoidal
   particles), occlusive coronary atherosclerosis, spontaneous myocardial
   infarction, cardiac dysfunction, and premature death ( approximate to 6
   weeks of age). Mice in which similar features of CHD could be induced
   with a lipid- rich diet would represent a powerful tool to study CHD.
   Methods and Results - To generate a diet- inducible model of CHD, we
   bred SR- BI - deficient ( SR- BI KO) mice with hypomorphic
   apolipoprotein E mice ( ApoeR61(h/h)) that express reduced levels of an
   apoE4- like murine apoE isoform and exhibit diet- induced
   hypercholesterolemia. When fed a normal chow diet, SR- BI KO/
   ApoeR61(h/h) h mice did not exhibit early- onset atherosclerosis or CHD;
   the low expression level of the apoE4- like murine apoE was
   atheroprotective and cardioprotective. However, when fed an atherogenic
   diet rich in fat, cholesterol, and cholate, they rapidly developed
   hypercholesterolemia, atherosclerosis, and CHD, a response strikingly
   similar to that of SR- BI/ apoE dKO mice fed a chow diet, and they died
   32 +/- 6 days ( 50\% mortality) after initiation of the high- fat
   feeding.
   Conclusions - The SR- BI KO/ ApoeR61(h/h) mouse is a new model of diet-
   induced occlusive coronary atherosclerosis and CHD ( myocardial
   infarction, cardiac dysfunction and premature death), allowing control
   of the age of onset, duration, severity, and possibly regression of
   disease. Thus, SR- BI KO/ ApoeR61(h/h) mice have the potential to
   contribute to our understanding of CHD and its prevention and treatment.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Krieger, M (Corresponding Author), MIT, Dept Biol, Room 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.
   MIT, Dept Biol, Cambridge, MA 02139 USA.
   Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA.
   Univ Calif San Francisco, Dept Surg, Div Vasc Surg, San Francisco, CA 94143 USA.
   San Francisco Vet Adm Med Res Ctr, San Francisco, CA USA.
   Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pathol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Pathol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Gladstone Inst Neurol Dis, Cardiovasc Res Inst, San Francisco, CA 94143 USA.},
DOI = {10.1161/CIRCULATIONAHA.104.523563},
ISSN = {0009-7322},
EISSN = {1524-4539},
Keywords = {apolipoproteins; atherosclerosis; diet; myocardial infarction; receptors},
Keywords-Plus = {HIGH-DENSITY-LIPOPROTEIN; SR-BI; HDL RECEPTOR; LIPID-METABOLISM; E
   POLYMORPHISM; HEART-DISEASE; HYPERCHOLESTEROLEMIA; OVEREXPRESSION;
   EXPRESSION; CLEARANCE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {krieger@mit.edu},
ResearcherID-Numbers = {Picard, Michael/F-1567-2013},
ORCID-Numbers = {Picard, Michael/0000-0002-9264-3243},
Funding-Acknowledgement = {NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung \& Blood Institute (NHLBI) {[}P01HL047660,
   P01HL066105, R01HL064737] Funding Source: NIH RePORTER; NHLBI NIH
   HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}HL-66105, HL-64737, HL-47660] Funding Source:
   Medline},
Cited-References = {Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518.
   Bergeron N, 1998, P NATL ACAD SCI USA, V95, P15647, DOI 10.1073/pnas.95.26.15647.
   Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100.
   Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462.
   Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920.
   Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008.
   Cozen AE, 2004, CIRCULATION, V109, P2129, DOI 10.1161/01.CIR.0000127369.24127.03.
   Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004.
   DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1.
   Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487.
   GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435.
   Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993.
   Hopkins PCR, 2002, J LIPID RES, V43, P1881, DOI 10.1194/jlr.M200172-JLR200.
   Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982.
   Karackattu SL, 2005, ARTERIOSCL THROM VAS, V25, P803, DOI 10.1161/01.ATV.0000158310.64498.ac.
   Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172.
   Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI14011.
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935.
   Malloy SI, 2004, ARTERIOSCL THROM VAS, V24, P91, DOI 10.1161/01.ATV.0000094963.07902.FB.
   Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4.
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G.
   Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200.
   Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298.
   Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037.
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610.
   Scherrer-Crosbie M, 1999, AM J PHYSIOL-HEART C, V277, pH986, DOI 10.1152/ajpheart.1999.277.3.H986.
   Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322.
   Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84.
   Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200.
   WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243.
   Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294.
   WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249.
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543.},
Number-of-Cited-References = {33},
Times-Cited = {103},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Circulation},
Doc-Delivery-Number = {939ZJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000230112400017},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1996UD37700008,
Author = {Moechars, D and Lorent, K and DeStrooper, B and Dewachter, I and
   VanLeuven, F},
Title = {Expression in brain of amyloid precursor protein mutated in the
   alpha-secretase site causes disturbed behavior, neuronal degeneration
   and premature death in transgenic mice},
Journal = {EMBO JOURNAL},
Year = {1996},
Volume = {15},
Number = {6},
Pages = {1265-1274},
Month = {MAR 15},
Abstract = {A double mutation in the alpha-secretase site in the beta A4 region of
   mouse amyloid precursor protein (APP) reduced its secretion from COS
   cells, polarized MDCK cells and rat primary neurons, Expression of this
   mutant in the brain of mice, using the neuron-specific elements of the
   mouse Thy-1 gene promoter, resulted in transgenic mice that became
   progressively hyperactive, displayed seizures and died prematurely, In
   three different transgenic lines the severity of the phenotype was
   related directly to the expression levels of the transgene, estimated by
   both mRNA and protein levels, In addition, homozygous mice derived from
   each transgenic strain showed more severe symptoms which also occurred
   earlier in life than in heterozygotes, The observed symptoms were,
   however, not essentially different in the different lines, Increased
   aggressiveness, disturbed responses to kainic acid and
   N-methyl-D-aspartate, neophobia and deficiency in exploratory behavior
   were demonstrated in these mice, In the brain, the observed
   neuropathological changes included necrosis, apoptosis and astrogliosis
   in the hippocampus, cortex and other areas, The data demonstrate that
   incomplete or incorrect alpha-secretase processing of APP results in
   severe neurotoxicity and that this effect is expressed in a dominant
   manner.},
Publisher = {JOHN WILEY \& SONS LTD},
Address = {THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {CATHOLIC UNIV LEUVEN, CTR HUMAN GENET, EXPT GENET GRP, B-3000 LOUVAIN, BELGIUM.},
DOI = {10.1002/j.1460-2075.1996.tb00468.x},
ISSN = {0261-4189},
EISSN = {1460-2075},
Keywords = {amyloid precursor protein; apoptosis; neurodegeneration; transgenic mice},
Keywords-Plus = {FAMILIAL ALZHEIMERS-DISEASE; CEREBRAL-HEMORRHAGE; DOWNS-SYNDROME; GENE;
   CODON-717; CDNA},
Research-Areas = {Biochemistry \& Molecular Biology; Cell Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Cell Biology},
ResearcherID-Numbers = {de+Strooper, Bart/Z-1638-2019
   De Strooper, Bart/F-6507-2012
   },
ORCID-Numbers = {De Strooper, Bart/0000-0001-5455-5819
   , Ilse Dewachter/0000-0001-7202-515X},
Cited-References = {CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0.
   CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0.
   COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X.
   DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x.
   DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295.
   DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058.
   GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0.
   GANESAN L, 1995, BIOCHIM BIOPHYS ACTA, V1261, P134.
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9.
   GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0.
   GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169.
   HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537.
   HAASS C, 1994, J BIOL CHEM, V269, P1.
   HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218.
   HILBICH C, 1993, J BIOL CHEM, V268, P26571.
   IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8.
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0.
   LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21.
   LAMPE TH, 1994, ANN NEUROL, V36, P368, DOI 10.1002/ana.410360308.
   LEANDER JD, 1988, BRAIN RES, V448, P115, DOI 10.1016/0006-8993(88)91107-9.
   LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584.
   LO ACY, 1994, J BIOL CHEM, V269, P30966.
   LORENT K, 1995, NEUROSCIENCE, V65, P1009, DOI 10.1016/0306-4522(94)00555-J.
   MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7.
   MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245.
   MULLAN M, 1993, NEUROBIOL AGING, V14, P407, DOI 10.1016/0197-4580(93)90099-W.
   MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564.
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0.
   Rothman Steven M., 1995, Trends in Neurosciences, V18, P57, DOI 10.1016/0166-2236(95)93869-Y.
   RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203.
   SANDBRINK R, 1994, J BIOL CHEM, V269, P1510.
   SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214.
   SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cellbio.10.1.373.
   SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031.
   TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367.
   UMANS L, 1994, GENOMICS, V22, P519, DOI 10.1006/geno.1994.1425.
   VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x.
   WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482.
   ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X.},
Number-of-Cited-References = {39},
Times-Cited = {159},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Embo J.},
Doc-Delivery-Number = {UD377},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1996UD37700008},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000408655700006,
Author = {Kondo, Shinsuke and Kumakura, Yousuke and Kanehara, Akiko and Nagato,
   Daisuke and Ueda, Taro and Matsuoka, Tsuneo and Tao, Yukiko and Kasai,
   Kiyoto},
Title = {Premature deaths among individuals with severe mental illness after
   discharge from long-term hospitalisation in Japan: a naturalistic
   observation during a 24-year period},
Journal = {BJPSYCH OPEN},
Year = {2017},
Volume = {3},
Number = {4},
Pages = {193-195},
Month = {JUL},
Abstract = {Background
   Premature death in individuals with severe mental illness (SMI) in
   countries without nationally collected data, including Japan, is
   structurally underreported.
   Aims
   To elucidate excess mortality among individuals with SMI in Japan.
   Method
   We retrospectively investigated all deaths among users of a non-clinical
   community-based mental health service provider in suburban Tokyo from
   1992 to 2015.
   Results
   During the study period, 45 individuals died among 254 qualified
   registrants. Deaths were by natural causes in 33 cases (73.3\%). The
   mean years of life lost was 22.2 years and the overall standard
   mortality ratio (SMR) was 3.28 (95\% CI 2.40-4.39). The cause-specific
   SMR was 5.09 (95\% CI 2.33-9.66) for cardiovascular disease and 7.38
   (95\% CI 2.40-17.22) for suicide.
   Conclusions
   Although Japan leads the world in longevity, individuals with SMI suffer
   premature death and excess mortality due to physical conditions as well
   as suicide. Revealing this underreported disparity of life is the first
   step to improving physical care for individuals with SMI.
   Copyright and usage
   (C) The Royal College of Psychiatrists 2017.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Kondo, S (Corresponding Author), Univ Tokyo Hosp, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.
   Kondo, Shinsuke; Kasai, Kiyoto, Univ Tokyo Hosp, Dept Neuropsychiat, Tokyo, Japan.
   Kumakura, Yousuke, Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan.
   Kanehara, Akiko, Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.
   Nagato, Daisuke; Ueda, Taro; Matsuoka, Tsuneo; Tao, Yukiko, Sudachi Kai, Tokyo, Japan.},
DOI = {10.1192/bjpo.bp.117.004937},
ISSN = {2056-4724},
Keywords-Plus = {MORTALITY; SCHIZOPHRENIA; DISORDERS},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {kondo-psy@umin.ac.jp},
ORCID-Numbers = {Kasai, Kiyoto/0000-0002-4443-4535
   Kondo, Shinsuke/0000-0001-5849-3889},
Funding-Acknowledgement = {JSPS-KAKENHI grantMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) {[}JP16H06395,
   16H06399, 16K21720]; Research and Development Grants for Comprehensive
   Research for Persons with Disabilities from the Japan Agency for Medical
   Research and Development (AMED)Japan Agency for Medical Research and
   Development (AMED) {[}16dk0307066, 16dk0307059]; Japan Foundation for
   Neuroscience and Mental HealthJapan Foundation for Neuroscience and
   Mental Health; Grants-in-Aid for Scientific ResearchMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) {[}16K21720, 16H06399] Funding Source: KAKEN},
Funding-Text = {This study was supported in part by JSPS-KAKENHI grant numbers
   JP16H06395, 16H06399 and 16K21720 to K.K., by Research and Development
   Grants for Comprehensive Research for Persons with Disabilities from the
   Japan Agency for Medical Research and Development (AMED) grant numbers
   16dk0307066 and 16dk0307059 to K.K., and by Japan Foundation for
   Neuroscience and Mental Health to Y.K.},
Cited-References = {Laursen TM, 2014, ANNU REV CLIN PSYCHO, V10, P425, DOI 10.1146/annurev-clinpsy-032813-153657.
   Liu NH, 2017, WORLD PSYCHIATRY, V16, P30, DOI 10.1002/wps.20384.
   Ministry of Health Labour and Welfare, 1992, NAT LIF TABL.
   Ministry of Health Labour and Welfare, 2015, VIT STAT JAP.
   Ng C, 2010, AUSTRALAS PSYCHIATRY, V18, P57, DOI 10.3109/10398560903274381.
   OECD, 2014, OECD REV HLTH CAR QU.
   SAKU M, 1995, INT J EPIDEMIOL, V24, P366, DOI 10.1093/ije/24.2.366.
   SHINOZAKI H, 1976, COMPR PSYCHIAT, V17, P425, DOI 10.1016/0010-440X(76)90045-6.
   Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718.
   Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502.},
Number-of-Cited-References = {10},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {BJPsych Open},
Doc-Delivery-Number = {FF1JL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000408655700006},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000410859200036,
Author = {Leiva, Andrea and Contreras-Duarte, Susana and Amigo, Ludwig and
   Sepulveda, Esteban and Boric, Mauricio and Quinones, Veronica and Busso,
   Dolores and Rigotti, Attilio},
Title = {Gugulipid causes hypercholesterolemia leading to endothelial
   dysfunction, increased atherosclerosis, and premature death by ischemic
   heart disease in male mice},
Journal = {PLOS ONE},
Year = {2017},
Volume = {12},
Number = {9},
Month = {SEP 14},
Abstract = {For proper cholesterol metabolism, normal expression and function of
   scavenger receptor class B type I (SR-BI), a high-density lipoprotein
   (HDL) receptor, is required. Among the factors that regulate overall
   cholesterol homeostasis and HDL metabolism, the nuclear farnesoid X
   receptor plays an important role. Guggulsterone, a bioactive compound
   present in the natural product gugulipid, is an antagonist of this
   receptor. This natural product is widely used globally as a natural
   lipid-lowering agent, although its anti-atherogenic cardiovascular
   benefit in animal models or humans is unknown. The aim of this study was
   to determine the effects of gugulipid on cholesterol homeostasis and
   development of mild and severe atherosclerosis in male mice. For this
   purpose, we evaluated the impact of gugulipid treatment on liver
   histology, plasma lipoprotein cholesterol, endothelial function, and
   development of atherosclerosis and/or ischemic heart disease in
   wild-type mice; apolipoprotein E knockout mice, a model of
   atherosclerosis without ischemic complications; and SR-B1 knockout and
   atherogenic-diet-fed apolipoprotein E hypomorphic (SR-BI KO/ApoER61 h/h)
   mice, a model of lethal ischemic heart disease due to severe
   atherosclerosis. Gugulipid administration was associated with
   histological abnormalities in liver, increased alanine aminotransferase
   levels, lower hepatic SR-BI content, hypercholesterolemia due to
   increased HDL cholesterol levels, endothelial dysfunction, enhanced
   atherosclerosis, and accelerated death in animals with severe ischemic
   heart disease. In conclusion, our data show important adverse effects of
   gugulipid intake on HDL metabolism and atherosclerosis in male mice,
   suggesting potential and unknown deleterious effects on cardiovascular
   health in humans. In addition, these findings reemphasize the need for
   rigorous preclinical and clinical studies to provide guidance on the
   consumption of natural products and regulation of their use in the
   general population.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Leiva, A (Corresponding Author), Pontificia Univ Catolica Chile, Sch Med, Div Obstet \& Gynaecol, CMPL, Santiago, Chile.
   Rigotti, A (Corresponding Author), Pontificia Univ Catolica Chile, Dept Nutr Diabet \& Metab, Santiago, Chile.
   Rigotti, A (Corresponding Author), Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr \& Chron Dis, Santiago, Chile.
   Leiva, Andrea; Contreras-Duarte, Susana, Pontificia Univ Catolica Chile, Sch Med, Div Obstet \& Gynaecol, CMPL, Santiago, Chile.
   Amigo, Ludwig, Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile.
   Sepulveda, Esteban; Boric, Mauricio, Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile.
   Quinones, Veronica; Busso, Dolores; Rigotti, Attilio, Pontificia Univ Catolica Chile, Dept Nutr Diabet \& Metab, Santiago, Chile.
   Rigotti, Attilio, Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr \& Chron Dis, Santiago, Chile.},
DOI = {10.1371/journal.pone.0184280},
Article-Number = {e0184280},
ISSN = {1932-6203},
Keywords-Plus = {HIGH-DENSITY-LIPOPROTEIN; RECEPTOR SR-BI; FARNESOID-X-RECEPTOR;
   E-DEFICIENT MICE; SCAVENGER RECEPTOR; APOLIPOPROTEIN-E;
   MYOCARDIAL-INFARCTION; CARDIAC DYSFUNCTION; HDL METABOLISM; CHOLESTEROL},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {aaleiva@uc.cl
   arigotti@med.puc.cl},
ResearcherID-Numbers = {Busso, Dolores/AAF-2568-2020
   Boric, Mauricio P/G-1574-2013
   Busso, Dolores/K-7375-2012},
ORCID-Numbers = {Boric, Mauricio P/0000-0001-6735-6675
   Busso, Dolores/0000-0003-2113-1926},
Funding-Acknowledgement = {Chilean National Research and Technology Commission (Comision Nacional
   de Investigacion Cientifica y Tecnologica, CONICYT); Fondo Nacional de
   Desarrollo Cientifico y TecnologicoComision Nacional de Investigacion
   Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT {[}1070634, 1150399,
   1150344]; CONICYT Ph.D. fellowships},
Funding-Text = {This work was funded by the Chilean National Research and Technology
   Commission (Comision Nacional de Investigacion Cientifica y Tecnologica,
   CONICYT), Fondo Nacional de Desarrollo Cientifico y Tecnologico grant
   \#1070634 (A. Rigotti), \#1150399 (A. Rigotti), \# 1150344 (A. Leiva)
   and CONICYT Ph.D. fellowships (A. Leiva, E. Sepulveda). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.},
Cited-References = {Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518.
   ALLAIN CC, 1974, CLIN CHEM, V20, P470.
   Amigo L, 2000, GASTROENTEROLOGY, V118, P772, DOI 10.1016/S0016-5085(00)70147-8.
   Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242.
   Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2.
   Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462.
   Braun A, 2008, CURR DRUG TARGETS, V9, P217.
   BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311.
   Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011.
   Chander Ramesh, 2003, Indian J Clin Biochem, V18, P71, DOI 10.1007/BF02867370.
   Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7.
   Das Gupta R, 1990, J Indian Med Assoc, V88, P346.
   Morales MG, 2010, LIVER INT, V30, P887, DOI 10.1111/j.1478-3231.2010.02230.x.
   Ghorai M, 2000, PHYTOTHER RES, V14, P200, DOI 10.1002/(SICI)1099-1573(200005)14:3\&lt;200::AID-PTR548\&gt;3.0.CO;2-T.
   Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036.
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9.
   Grieco A, 2009, J HEPATOL, V50, P1273, DOI 10.1016/j.jhep.2009.02.021.
   Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993.
   Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191.
   Hag AMF, 2008, BIOCHEM BIOPH RES CO, V377, P689, DOI 10.1016/j.bbrc.2008.10.037.
   Hasani-Ranjbar S, 2010, CURR PHARM DESIGN, V16, P2935, DOI 10.2174/138161210793176464.
   Jain S, 2014, WORLD J PHARM RES, V3, P1616.
   Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0.
   Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523.
   Lata S, 1991, J Postgrad Med, V37, P132.
   Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036.
   Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200.
   Mardones P, 2001, J LIPID RES, V42, P170.
   Masten SA, 2005, GUM GUGGUL SOME STER, V2, P1.
   Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399.
   Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019.
   Nityanand S, 1989, J Assoc Physicians India, V37, P323.
   Nohr LA, 2009, COMPLEMENT THER MED, V17, P16, DOI 10.1016/j.ctim.2008.07.001.
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G.
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610.
   Russell A, 2000, J PHARMACOL EXP THER, V294, P598.
   Sairkar PK, 2017, J PHARM BIOALLIED SC, V9, P1, DOI 10.4103/0975-7406.206225.
   Sane RT, 1990, INDIAN DRUGS, V28, P86.
   Sarup P, 2015, SCIENTIFICA, V2015, DOI 10.1155/2015/138039.
   SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3.
   Shah R, 2012, PHYTOTHER RES, V26, P1594, DOI 10.1002/ptr.4647.
   SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420.
   SINGH V, 1990, PHARMACOL RES, V22, P37, DOI 10.1016/1043-6618(90)90741-U.
   Szapary PO, 2003, JAMA-J AM MED ASSOC, V290, P765, DOI 10.1001/jama.290.6.765.
   Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322.
   Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84.
   Ulbricht C, 2005, COMPLEMENT THER MED, V13, P279, DOI 10.1016/j.ctim.2005.08.003.
   Urizar NL, 2003, ANNU REV NUTR, V23, P303, DOI 10.1146/annurev.nutr.23.011702.073102.
   Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891.
   Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956.
   Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001.
   Yang DF, 2012, J LIPID RES, V53, P529, DOI 10.1194/jlr.M014688.
   Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286.
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543.
   Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563.},
Number-of-Cited-References = {55},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {FH0VR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000410859200036},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000702465300007,
Author = {Villarreal-Riosl, Enrique and Montoya-Cruz, Griselda and Vargas-Daza,
   Emma R. and Galicia-Rodriguez, Liliana and Escorcia-Reyes, VerOnica and
   Cu-Flores, Laura A.},
Title = {Disability adjusted life years lost due to acute, chronic disability and
   premature death in arterial hypertension},
Journal = {ARCHIVOS DE CARDIOLOGIA DE MEXICO},
Year = {2021},
Volume = {91},
Number = {2},
Pages = {171-176},
Month = {APR-JUN},
Abstract = {Objective: To determine the disability adjusted life years in arterial
   hypertension without diabetes mellitus. Method: Disability adjusted life
   years was determined from chronic disability (chronic kidney disease,
   heart disease and cerebral vascular event), acute disability
   (hypertensive crisis and hypertensive emergency) and premature death.
   Age of diagnosis, age of the complication, prevalence of the
   complication, duration of the acute event, number of acute events, time
   lived with hypertension, age of death and life expectancy were
   identified. In all cases a 3\% discount rate was applied, the estimate
   was made per 100,000. Results: When the total of women was used as a
   reference, the disability adjusted life years in women is 198,498.28. In
   men, using the total number of men as a reference, the value is
   204,232.13. If the referent is the total population, in women the
   disability adjusted life years is 102,028.11 and in men 99,256.98.
   Conclusions: The disability adjusted life years in arterial hypertension
   without diabetes is different for men and women; the topic has many
   edges that must be studied.},
Publisher = {INST NACIONAL CARDIOLOGIA IGNACIO CHAVEZ},
Address = {DEPT PUBLICACIONES, JUAN BADIANO NO 1, COL. SECCION XVI, DELEGACION
   TLALPAN, MEXICO CITY, D F 00000, MEXICO},
Type = {Article},
Language = {English},
Affiliation = {Villarreal-Riosl, E (Corresponding Author), Inst Mexicano Seguro Social IMSS, Unidad Invest Epidemiol, Queretaro, Mexico.
   Villarreal-Riosl, E (Corresponding Author), Inst Mexicano Seguro Social IMSS, Serv Salud Queretaro, Queretaro, Mexico.
   Villarreal-Riosl, Enrique; Montoya-Cruz, Griselda; Vargas-Daza, Emma R.; Galicia-Rodriguez, Liliana, Inst Mexicano Seguro Social IMSS, Unidad Invest Epidemiol, Queretaro, Mexico.
   Villarreal-Riosl, Enrique; Montoya-Cruz, Griselda; Vargas-Daza, Emma R.; Galicia-Rodriguez, Liliana, Inst Mexicano Seguro Social IMSS, Serv Salud Queretaro, Queretaro, Mexico.
   Montoya-Cruz, Griselda, Inst Mexicano Seguro Social IMSS, Dept Family Med, Family Med Unit 9, Queretaro, Mexico.
   Escorcia-Reyes, VerOnica, Inst Mexicano Seguro Social IMSS, Family Med Unit 6, Queretaro, Mexico.
   Cu-Flores, Laura A., Inst Mexicano Seguro Social IMSS, Family Med Unit 16, Queretaro, Mexico.},
DOI = {10.24875/ACME.M21000197},
ISSN = {1405-9940},
Keywords = {Disability adjusted life; Disability; Life expectancy; Arterial
   hypertension; Mortality},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Author-Email = {enriquevillarrealrios@gmail.com},
Cited-References = {Araya-Orozco M., 2004, MED, V25, P65.
   Campos Novato I, 2018, SALUD PUBLICA MEXICO, V60, P233.
   Frenk J, 1994, INFORME FINAL.
   Institut Mexicans del Segura Social, 2017, DIAGN TRAT HIP ART A.
   Institut Nacional de Estadistica y Geografia, 2018, MUJ HOMBR MEX 2018.
   Institute Nacional de Geografia y Estadistica, ESP VID MEX.
   Instituto Nacional de Salud Publica, 2016, ENCUESTA NACL SALUD.
   Lozano R, 2007, SALUD PUBLICA MEXICO, V49, pE283.
   Lozano R, 2013, SALUD PUBLICA MEXICO, V55, P580.
   Martinez A, 2018, HIPERTENSION ARTERIA.
   Murray C. J. L., 1995, Boletin de la Oficina Sanitaria Panamericana, V118, P221.
   Murray C.J.L., 1996, GLOBAL BURDEN DIS CO.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481.
   Organizacion Mundial de la Salud, 2011, INF MUND DISC.
   Pompa SG, 2018, REVISTA, V57, P80.
   Ramos MV, 2019, REV URUG CARDIOL, V34, P53.
   Rios Blancas MJ, 2017, SALUD PUBLICA MEXICO, V59, P154.
   Santeiro Perez L, 2018, REV FINLAY, V8.
   Secretaria de Integracion y Desarrollo del Sector Salud, 2015, INF SAL MEX 2015 DIA.
   Serra Valdes M, 2018, REV FINLAY, V8.
   Soto Estrada G., 2016, REV FACULTAD MED UNA, V59, P8.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Arch. Cardiol. Mex.},
Doc-Delivery-Number = {UZ8RA},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000702465300007},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000437109600001,
Author = {Tamura, Akihiro and Uemura, Suguru and Matsubara, Kousaku and Kozuki,
   Eru and Tanaka, Toshikatsu and Nino, Nanako and Yokoi, Takehito and
   Saito, Atsuro and Ishida, Toshiaki and Hasegawa, Daiichiro and Umeki,
   Ikumi and Niihori, Tetsuya and Nakazawa, Yozo and Koike, Kenichi and
   Aoki, Yoko and Kosaka, Yoshiyuki},
Title = {Co-occurrence of hypertrophic cardiomyopathy and juvenile myelomonocytic
   leukemia in a neonate with Noonan syndrome, leading to premature death},
Journal = {CLINICAL CASE REPORTS},
Year = {2018},
Volume = {6},
Number = {7},
Pages = {1202-1207},
Month = {JUL},
Abstract = {We report a case of a neonate with Noonan syndrome presenting with
   concurrent hypertrophic cardiomyopathy and juvenile myelomonocytic
   leukemia, which resulted in premature death. Cases with Noonan syndrome
   diagnosed during the neonatal period might not necessarily show mild
   clinical course, and premature death is a possible outcome to be
   considered.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Tamura, A (Corresponding Author), Kobe Childrens Hosp, Dept Hematol \& Oncol, Kobe, Hyogo, Japan.
   Tamura, Akihiro; Uemura, Suguru; Nino, Nanako; Yokoi, Takehito; Saito, Atsuro; Ishida, Toshiaki; Hasegawa, Daiichiro; Kosaka, Yoshiyuki, Kobe Childrens Hosp, Dept Hematol \& Oncol, Kobe, Hyogo, Japan.
   Uemura, Suguru; Nino, Nanako, Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo, Japan.
   Matsubara, Kousaku; Kozuki, Eru, Kobe City Nishi Kobe Med Ctr, Dept Pediat, Kobe, Hyogo, Japan.
   Tanaka, Toshikatsu, Kobe Childrens Hosp, Dept Cardiol, Kobe, Hyogo, Japan.
   Yokoi, Takehito, Osaka Univ Hosp, Dept Pediat, Suita, Osaka, Japan.
   Umeki, Ikumi; Niihori, Tetsuya; Aoki, Yoko, Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan.
   Nakazawa, Yozo, Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan.
   Koike, Kenichi, Shinonoi Gen Hosp, Minami Nagano Med Ctr, Dept Pediat, Nagano, Japan.},
DOI = {10.1002/ccr3.1568},
ISSN = {2050-0904},
Keywords = {hypertrophic cardiomyopathy; juvenile myelomonocytic leukemia; Noonan
   syndrome; p.Thr42Ala; premature death},
Keywords-Plus = {PROTEIN-TYROSINE-PHOSPHATASE; MUTATION ANALYSIS; MYELOPROLIFERATIVE
   DISORDER; ACTIVATING MUTATIONS; CLINICAL-ASSESSMENT; RAS/MAPK SYNDROMES;
   LEOPARD SYNDROMES; PTPN11 MUTATIONS; SHP2 MUTATIONS; GENE-MUTATIONS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {tamura\_kch@hp.pref.hyogo.jp},
ResearcherID-Numbers = {Niihori, Tetsuya/ABE-2350-2021
   },
ORCID-Numbers = {Niihori, Tetsuya/0000-0002-2118-9776
   Hasegawa, Daiichiro/0000-0003-2245-6554},
Cited-References = {Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748.
   Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021.
   Aoki Y, 2013, INT J HEMATOL, V97, P30, DOI 10.1007/s12185-012-1239-y.
   BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7.
   Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6.
   Cordeddu V, 2015, HUM MUTAT, V36, P1080, DOI 10.1002/humu.22834.
   Digilio MC, 2010, MOL SYNDROMOL, V1, P282, DOI 10.1159/000331266.
   Digilio MC, 2013, EUR J HUM GENET, V21, P200, DOI 10.1038/ejhg.2012.145.
   Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528.
   Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148.
   Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1.
   Jhang WK, 2016, PEDIATR CARDIOL, V37, P1539, DOI 10.1007/s00246-016-1468-6.
   Kleefstra T, 2011, EUR J HUM GENET, V19, P138, DOI 10.1038/ejhg.2010.171.
   Kratz CP, 2006, EUR J PEDIATR, V165, P182, DOI 10.1007/s00431-005-0031-x.
   Lee ST, 2007, CLIN GENET, V72, P150, DOI 10.1111/j.1399-0004.2007.00839.x.
   Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972.
   Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099.
   Martinelli S, 2018, AM J HUM GENET, V102, P309, DOI 10.1016/j.ajhg.2017.12.015.
   Muller PJ, 2013, J PROTEOMICS, V84, P132, DOI 10.1016/j.jprot.2013.04.005.
   Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4.
   Niihori T, 2005, J HUM GENET, V50, P192, DOI 10.1007/s10038-005-0239-7.
   Papadopoulou A, 2012, EUR J PEDIATR, V171, P51, DOI 10.1007/s00431-011-1487-5.
   Prendiville TW, 2014, ARCH DIS CHILD, V99, P629, DOI 10.1136/archdischild-2013-305047.
   Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X.
   Sarkozy A, 2003, J MED GENET, V40, P704, DOI 10.1136/jmg.40.9.704.
   Shaw AC, 2007, ARCH DIS CHILD, V92, P128, DOI 10.1136/adc.2006.104547.
   Strullu M, 2014, J MED GENET, V51, P689, DOI 10.1136/jmedgenet-2014-102611.
   Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925.
   Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766.
   Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156.
   Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847.
   van Trier DC, 2015, INT J PEDIATR OTORHI, V79, P874, DOI 10.1016/j.ijporl.2015.03.021.
   Wilkinson JD, 2012, AM HEART J, V164, P442, DOI 10.1016/j.ahj.2012.04.018.
   Yagasaki H, 2015, AM J MED GENET A, V167, P3144, DOI 10.1002/ajmg.a.37295.
   Yamamoto GL, 2015, J MED GENET, V52, P413, DOI 10.1136/jmedgenet-2015-103018.
   Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091.
   Yu ZH, 2014, BIOCHEMISTRY-US, V53, P4136, DOI 10.1021/bi5002695.
   Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023.
   Zhen L, 2016, EUR J OBSTET GYN R B, V201, P229, DOI 10.1016/j.ejogrb.2016.04.018.},
Number-of-Cited-References = {39},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Clin. Case Rep.},
Doc-Delivery-Number = {GL4HB},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000437109600001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000538111300001,
Author = {Rodriguez, Cesar che},
Title = {``The Whole Damn System Is Guilty{''}: Urban Violence, the Principal
   Contradiction of Racial Capitalism, and the Production of Premature
   Death in Oakland, California},
Journal = {CRITICAL SOCIOLOGY},
Year = {2020},
Volume = {46},
Number = {7-8},
Pages = {1057-1074},
Month = {NOV},
Abstract = {Discourses of ``urban violence{''} are deployed in reaction to the
   mobilizations advanced by working-class communities of color following
   extrajudicial police murders. This discourse delegitimates these
   mobilizations while pathologizing said communities by insisting that
   ``urban violence,{''} not police murders, is a more pertinent issue.
   This article takes seriously the claims made during the Oscar Grant
   ``moment{''}- a period of popular struggle - that ``the whole damn
   system is guilty.{''} This article uses Gramscian conceptualizations of
   socio-historical activity, organic and conjunctural, along with public
   health and socio-economic measures, to counter the obfuscating discourse
   of ``urban violence{''} by illustrating the structural violence that
   communities in Oakland endure and contest. The sum of this structural
   violence constitutes the principle contradiction of racial capitalism,
   which produces premature death for working-class communities of color in
   Oakland. The extrajudicial police murder of Grant in Oakland catalyzed
   the blossoming open of this contradiction into an intensified moment of
   struggle.},
Publisher = {SAGE PUBLICATIONS INC},
Address = {2455 TELLER RD, THOUSAND OAKS, CA 91320 USA},
Type = {Article},
Language = {English},
Affiliation = {Rodriguez, C (Corresponding Author), San Francisco State Univ, Criminal Justice Studies, 1600 Holloway Ave,HSS 261, San Francisco, CA 94132 USA.
   Rodriguez, Cesar che, San Francisco State Univ, San Francisco, CA 94132 USA.},
DOI = {10.1177/0896920520923429},
EarlyAccessDate = {JUN 2020},
Article-Number = {0896920520923429},
ISSN = {0896-9205},
EISSN = {1569-1632},
Keywords = {racial capitalism; political economy; premature death},
Keywords-Plus = {NEW-ORLEANS},
Research-Areas = {Sociology},
Web-of-Science-Categories  = {Sociology},
Author-Email = {crodrig@sfsu.edu},
ResearcherID-Numbers = {Rodríguez, César/AAI-5423-2021},
ORCID-Numbers = {Rodríguez, César/0000-0002-7016-9667},
Cited-References = {ACORN, 2007, FOR EXP STUD RAC INC.
   Alameda County Community Food Bank, 2010, HUNG FAC FACTS 2010.
   Allen-Taylor JD, 2003, E BAY EXPRESS   0312.
   Almaguer, 1994, RACIAL FAULT LINES H.
   American Public Health Association, 2018, 201811 AM PUBL HLTH.
   {[}Anonymous], 2009, BART MANAGEMENT AUDI.
   {[}Anonymous], 2009, PUBLIC REPORT REV PO.
   {[}Anonymous], 2009, FY 2007 2009 ADOPTED.
   {[}Anonymous], 2014, BOSTON GLOBE.
   ARNOLD E, 2011, RACE POVERTY ENV, V18, P70.
   Artz M, 2012, OAKLAND TRIBUNE.
   Bacon D., 2013, RIGHT STAY HOME US P.
   Baker YK, 2020, ARAB STUD Q, V42, P46, DOI 10.13169/arabstudquar.42.1-2.0046.
   Balko R., 2012, HUFFINGTON POST.
   BART, 2010, BPD YEST TOD TOM.
   BART, 2010, BART CHRON.
   Beatty Phillip, 2007, VORTEX CONCENTRATED.
   Beyers M., 2008, LIFE DEATH UNNATURAL.
   Bond-Graham D, 2016, E BAY EXPRESS   1207.
   Bond-Graham D, 2018, E BAY EXPRESS   0214.
   Bulwa D, 2010, SAN FRANCISCO CHRONI.
   Bulwa D, 2018, SAN FRANCISCO CHRONI.
   Bulwa D, 2009, SAN FRANCISCO CHRONI.
   Bulwa D, 2010, BART FIRES COP WHO H.
   Carson L, 2005, STREET SPIRIT JUSTIC.
   Causa Justa::Just Cause, 2013, HOUS HLTH HAB OAKL 2.
   Chimurenga T, 2014, DOUBT MURDERS OSCAR.
   Chimurenga T, 2012, HIP HOP POLITIC 0323.
   Communities for a Better Environment Urban Habitat and Public Advocates Inc, 2006, MTC AR OUR BUS CHALL.
   Cook D, 2010, DAVEY DS HIP HO 1106.
   Coup T, 1994, FAT CATS BIGGA FISH.
   East Bay Alliance for a Sustainable Economy, 2012, STAT WORK E BAY OAK.
   East Bay Alliance for a Sustainable Economy, TAK LOW ROAD IND CON.
   Eisen Arlene, 2013, OPERATION GHETTO STO.
   Environment C for a B, 2008, CUMULATIVE IMPACTS E.
   Escobar Edward J., 1999, RACE POLICE MAKING P.
   Esteva G., 2010, Development (London), V53, P64, DOI 10.1057/dev.2009.80.
   FAGAN K, 2000, SAN FRANCISCO CHRONI.
   Federici S., 2004, CALIBAN WITCH WOMEN.
   Gilmore R.W., 2007, GOLDEN GULAG PRISONS.
   Gray-Garcia L, 2009, MORE STOLEN LIVES IN.
   Grosfoguel R, 2016, J WORLD SYST RES, V22, P9, DOI 10.5195/jwsr.2016.609.
   Gutierrez E, 2006, DAILY CALIFORNI 0307.
   Haley A., 2012, NEIGHBORHOOD LEVEL D.
   Hall S., 1996, BLACK BRIT CULTURAL, P16.
   Hall Stuart., 1986, J COMMUNICATION INQU, V10, P5.
   Hall Stuart., 1978, POLICING CRISIS MUGG.
   Hall Stuart, 2010, SOUNDINGS, V44, P57.
   Harvey D., 1978, URBAN PROCESS CAPITA.
   Heredia C, 2006, SAN FRANCISCO CHRONI.
   Heredia C, 2008, SAN FRANCISCO CHRONI.
   Holloway J, 1998, ZAPATISTA REINVENTIN, P159.
   HOPE Collaborative, 2009, PLAC SIDEWALKS ASSE.
   Id D, 2009, OSCAR GRANT RALLY.
   Id D, 2009, RALLY RAGE BART POLI.
   Id D, 2009, NOTES CITIZENS POLIC.
   IndyBay, 2009, NOBLE PRESENT DISTUR.
   Kagan S, 2011, MEASURE VIOLENCE PRE.
   Kauanui JK, 2017, AM QUART, V69, P257, DOI 10.1353/aq.2017.0019.
   Kelley R.D.G., 2000, BLACK MARXISM MAKING.
   Kelley R, 2017, MON LABOR REV.
   Lee Henry, 2009, SAN FRANCISCO CHRONI.
   Lee HK, 2011, SAN FRANCISCO CHRONI.
   Lee HK, 2008, SAN FRANCISCO CHRONI.
   Lee HK, 2005, SAN FRANCISCO CHRONI.
   Lee HK, 2007, SAN FRANCISCO CHRONI.
   Lefebvre Henri., 1992, PRODUCTION SPACE.
   Lindorff D, 2014, COUNTERPUNCH.
   Lipsitz, 2006, POSSESSIVE INVESTMEN.
   Lipsitz G., 2011, RACISM TAKES PLACE.
   Lipsitz G, 2006, CULT ANTHROPOL, V21, P451, DOI 10.1525/can.2006.21.3.451.
   Lipsitz G, 2012, J AM FOLKLORE, V125, P111.
   Lobo S, 1990, OAKLANDS AM INNDIAN.
   Ma EA, 2014, HOMETOWN CHINATOWN H.
   Mac Donald, 2016, WAR COPS NEW ATTACK.
   Mac Donald H, 2007, OAKLAND TRIBUNE.
   Mac Donald H, 1999, CITY J.
   Maldari P, 2009, MORNING SHOW    0108.
   Manyak T, 2010, CALIFORNIA BEAT 0621.
   Mao Z, 1966, CORRECT HANDLING CON.
   Mao Z, 1952, MAO TSE TUNG CONTRAD.
   Marx K., 1992, CAPITAL, V1-3.
   McClintock N, 2008, IND GARDEN FOOD DESE.
   National Low Income Housing Coalition, 2013, OUT REACH 2013.
   Nguyen L-H, 2003, CHRONOLOGY CALIFORNI.
   O'Connor A, 2008, J URBAN HIST, V34, P333, DOI 10.1177/0096144207308672.
   Oakland Fund for Children and Youth, 2012, OAKL YOUTH IND REP.
   Olmos D, 2019, SOCIOL COMPASS, V13, DOI 10.1111/soc4.12729.
   Osuna S, 2020, RACE CLASS, V61, P3, DOI 10.1177/0306396820904304.
   Peele T, 2013, OAKLAND TRIBUNE.
   Peraino N, 2008, E BAY IMMIGRANT WORK.
   Phillips D, 2014, REBUILDING NEIGHBORH.
   Prashad V, 2018, RUINS PRESENT TRICON.
   Prashad Vijay, 2005, SOCIAL ANAL, V49, P191, DOI DOI 10.3167/015597705780886194.
   Redmonde R, 2009, OAKLAND REPORT HEARI.
   Robinson Cedric J., 2001, SOCIAL IDENTITIES, V7, P329, DOI DOI 10.1080/13504630120087208.
   Robinson Cedric J., 2007, FORGERIES MEMORY MEA.
   Robinson Cedric J., 2000, BLACK MARXISM MAKING.
   Sacchetti M, 2014, BOSTON GLOBE.
   Shapiro TM, 2004, HIDDEN COST BEING AF.
   Smith, 1989, SELECTIONS PRISON NO.
   Smith N., 1996, NEW URBAN FRONTIER G.
   Tepperman J, 2013, E BAY EXPRESS.
   Thanawala S, 2009, SAN MATEO DAILY 0102.
   Tina KN, 2009, COUNTERPUNCH.
   Tucker J, 2009, SAN FRANCISCO CHRONI.
   U.S. Census Bureau, 2010, AM FACT SHEET T.
   United States and Federal Bureau of Investigation, 2004, UN CRIM REP HDB.
   Winston A, 2011, COLORLINES.
   Woodall A, 2011, OAKLAND TRIBUNE.
   Woods C., 2007, BLACK GEOGRAPHIES PO, P46.
   Woods C.A., 1998, DEV ARRESTED BLUES P.
   Woods C, 2009, AM QUART, V61, P769.
   X M, 1965, MALCOLM X SPEAKS SEL.
   Zamora JH, 2006, SAN FRANCISCO CHRONI.},
Number-of-Cited-References = {115},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Crit. Sociol.},
Doc-Delivery-Number = {NY7QQ},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000538111300001},
DA = {2022-03-29},
}

@article{ WOS:000354374200026,
Author = {White, Mary C. and Wong, Faye L.},
Title = {Preventing premature deaths from breast and cervical cancer among
   underserved women in the United States: insights gained from a national
   cancer screening program},
Journal = {CANCER CAUSES \& CONTROL},
Year = {2015},
Volume = {26},
Number = {5, SI},
Pages = {805-809},
Month = {MAY},
Abstract = {This commentary highlights some of the valuable insights gained from a
   special collection of papers that utilized data from the National Breast
   and Cervical Cancer Early Detection Program (NBCCEDP) and appear in this
   special issue. The data and experiences of the NBCCEDP can inform the
   identification of new opportunities and directions for meeting the
   cancer screening needs of underserved women in a complex and changing
   health care environment.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {White, MC (Corresponding Author), Ctr Dis Control \& Prevent, Div Canc Prevent \& Control, Natl Ctr Chron Dis Prevent \& Hlth Promot, 4770 Buford Hwy NE,Mailstop F-76, Atlanta, GA 30341 USA.
   White, Mary C.; Wong, Faye L., Ctr Dis Control \& Prevent, Div Canc Prevent \& Control, Natl Ctr Chron Dis Prevent \& Hlth Promot, Atlanta, GA 30341 USA.},
DOI = {10.1007/s10552-015-0541-4},
ISSN = {0957-5243},
EISSN = {1573-7225},
Keywords = {Early detection of cancer; Healthcare disparities; Vulnerable
   populations; Mammography; Papanicolaou test; Medically uninsured},
Keywords-Plus = {MORTALITY; US},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Author-Email = {mxw5@cdc.gov},
ResearcherID-Numbers = {White, Mary C./Q-6572-2019},
ORCID-Numbers = {White, Mary C./0000-0002-9826-3962},
Funding-Acknowledgement = {Intramural CDC HHS {[}CC999999] Funding Source: Medline},
Cited-References = {Adams EK, 2015, CANCER CAUSE CONTROL, V26, P795, DOI 10.1007/s10552-015-0560-1.
   Benard VB, 2015, CANCER CAUSE CONTROL, V26, P713, DOI 10.1007/s10552-015-0542-3.
   Benard VB, 2011, J WOMENS HEALTH, V20, P1479, DOI 10.1089/jwh.2010.2530.
   Bhuyan SS, 2014, BREAST CANCER RES TR, V146, P221, DOI 10.1007/s10549-014-2992-9.
   Brown ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130174.
   Byrd TL, 2013, CANCER-AM CANCER SOC, V119, P1365, DOI 10.1002/cncr.27926.
   DeGroff A, 2015, CANCER CAUSE CONTROL, V26, P767, DOI 10.1007/s10552-015-0538-z.
   Ekwueme DU, 2014, AM J PREV MED, V47, P300, DOI 10.1016/j.amepre.2014.05.016.
   Escoffery C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-274.
   Frieden TR, 2014, AM J PUBLIC HEALTH, V104, P17, DOI 10.2105/AJPH.2013.301608.
   Hall IJ, 2015, CANCER CAUSE CONTROL, V26, P787, DOI 10.1007/s10552-015-0540-5.
   Hoerger TJ, 2011, AM J PREV MED, V40, P397, DOI 10.1016/j.amepre.2010.12.017.
   Howard DH, 2015, CANCER CAUSE CONTROL, V26, P657, DOI 10.1007/s10552-015-0553-0.
   Miller JW, 2015, CANCER CAUSE CONTROL, V26, P741, DOI 10.1007/s10552-015-0543-2.
   Miller JW, 2014, CANCER-AM CANCER SOC, V120, P2549, DOI 10.1002/cncr.28823.
   Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009.
   Peipins LA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-520.
   Plescia M, 2014, CANCER-AM CANCER SOC, V120, P2620, DOI 10.1002/cncr.28826.
   Plescia M, 2013, AM J PUBLIC HEALTH, V103, P1545, DOI 10.2105/AJPH.2013.301305.
   Ryerson AB, 2015, CANCER CAUSE CONTROL, V26, P733, DOI 10.1007/s10552-015-0544-1.
   Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009.
   Subramanian S, 2015, CANC CAUSES CO UNPUB.
   Subramanian S, 2009, AM J PREV MED, V37, P242, DOI 10.1016/j.amepre.2009.06.002.
   Tangka FKL, 2015, CANCER CAUSE CONTROL, V26, P671, DOI 10.1007/s10552-015-0524-5.
   Trogdon JG, 2014, HEALTH CARE MANAG SC, V17, P321, DOI 10.1007/s10729-013-9261-z.
   U.S. Cancer Statistics Working Group, 2013, US CANC STAT 1999 20.
   Watson M, 2015, CANCER CAUSE CONTROL, V26, P759, DOI 10.1007/s10552-015-0549-9.
   White A, 2015, CANC CAUSES CO UNPUB.
   Wu MX, 2015, CANCER CAUSE CONTROL, V26, P751, DOI 10.1007/s10552-015-0548-x.
   Yancy B, 2014, CANCER-AM CANCER SOC, V120, P2575, DOI 10.1002/cncr.28821.},
Number-of-Cited-References = {30},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Cancer Causes Control},
Doc-Delivery-Number = {CH9RP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000354374200026},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000449493300015,
Author = {Harper, Shavonn C. and Johnson, Jaslyn and Borghetti, Giulia and Zhao,
   Huaqing and Wang, Tao and Wallner, Markus and Kubo, Hajime and Feldsott,
   Eric A. and Yang, Yijun and Joo, Yunichel and Gou, Xinji and Sabri,
   Abdel Karim and Gupta, Priyanka and Myzithras, Maria and Khalil, Ashraf
   and Franti, Michael and Houser, Steven R.},
Title = {GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause
   Severe Cachexia and Premature Death},
Journal = {CIRCULATION RESEARCH},
Year = {2018},
Volume = {123},
Number = {11},
Pages = {1220-1231},
Month = {NOV 9},
Abstract = {Rationale: Possible beneficial effects of GDF11 (growth differentiation
   factor 11) on the normal, diseased, and aging heart have been reported,
   including reversing aging-induced hypertrophy. These effects have not
   been well validated. High levels of GDF11 have also been shown to cause
   cardiac and skeletal muscle wasting. These controversies could be
   resolved if dose-dependent effects of GDF11 were defined in normal and
   aged animals as well as in pressure overload-induced pathological
   hypertrophy.
   Objective: To determine dose-dependent effects of GDF11 on normal hearts
   and those with pressure overload-induced cardiac hypertrophy.
   Methods and Results: Twelve- to 13-week-old C57BL/6 mice underwent
   transverse aortic constriction (TAC) surgery. One-week post-TAC, these
   mice received rGDF11 (recombinant GDF11) at 1 of 3 doses: 0.5, 1.0, or
   5.0 mg/kg for up to 14 days. Treatment with GDF11 increased plasma
   concentrations of GDF11 and p-SMAD2 in the heart. There were no
   significant differences in the peak pressure gradients across the aortic
   constriction between treatment groups at 1 week post-TAC. Two weeks of
   GDF11 treatment caused dose-dependent decreases in cardiac hypertrophy
   as measured by heart weight/tibia length ratio, myocyte cross-sectional
   area, and left ventricular mass. GDF11 improved cardiac pump function
   while preventing TAC-induced ventricular dilation and caused a
   dose-dependent decrease in interstitial fibrosis (in vivo), despite
   increasing markers of fibroblast activation and myofibroblast
   transdifferentiation (in vitro). Treatment with the highest dose (5.0
   mg/kg) of GDF11 caused severe body weight loss, with significant
   decreases in both muscle and organ weights and death in both sham and
   TAC mice.
   Conclusions: Although GDF11 treatment can reduce pathological cardiac
   hypertrophy and associated fibrosis while improving cardiac pump
   function in pressure overload, high doses of GDF11 cause severe cachexia
   and death. Use of GDF11 as a therapy could have potentially devastating
   actions on the heart and other tissues.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Houser, SR (Corresponding Author), Temple Univ, Cardiovasc Res Ctr, Lewis Katz Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA.
   Harper, Shavonn C.; Johnson, Jaslyn; Borghetti, Giulia; Wang, Tao; Wallner, Markus; Kubo, Hajime; Feldsott, Eric A.; Yang, Yijun; Joo, Yunichel; Gou, Xinji; Sabri, Abdel Karim; Houser, Steven R., Temple Univ, Cardiovasc Res Ctr, Lewis Katz Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA.
   Zhao, Huaqing, Temple Univ, Dept Clin Sci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
   Wallner, Markus, Med Univ Graz, Div Cardiol, Graz, Austria.
   Gupta, Priyanka; Myzithras, Maria, Boehringer Ingelheim Pharmaceut, Biotherapeut Discovery Res, Ridgefield, CT USA.
   Khalil, Ashraf; Franti, Michael, Boehringer Ingelheim Pharmaceut, Res Borders, Ridgefield, CT USA.},
DOI = {10.1161/CIRCRESAHA.118.312955},
ISSN = {0009-7330},
EISSN = {1524-4571},
Keywords = {cachexia; cardiomegaly; fibrosis; growth differentiation factors;
   hypertrophy},
Keywords-Plus = {LEFT-VENTRICULAR HYPERTROPHY; DIFFERENTIATION FACTOR 11; CARDIAC
   FIBROSIS; SKELETAL-MUSCLE; HEART-FAILURE; CARDIOVASCULAR-DISEASE;
   MYOSTATIN; AGE; DYSFUNCTION; MODEL},
Research-Areas = {Cardiovascular System \& Cardiology; Hematology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease},
Author-Email = {srhouser@temple.edu},
ResearcherID-Numbers = {Wallner, Markus/AAD-7357-2019
   },
ORCID-Numbers = {Wallner, Markus/0000-0001-7692-892X
   Gupta, Priyanka/0000-0001-6483-3069},
Funding-Acknowledgement = {Boehringer IngelheimBoehringer Ingelheim; National Institutes of
   HealthUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USA; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI) {[}R01HL061495, P01HL108806] Funding Source: NIH
   RePORTER},
Funding-Text = {This study was supported by Boehringer Ingelheim and National Institutes
   of Health grants to S. R. Houser.},
Cited-References = {Angelov SN, 2017, ARTERIOSCL THROM VAS, V37, P2102, DOI 10.1161/ATVBAHA.117.309401.
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485.
   Biesemann N, 2015, CELL TISSUE RES, V361, P779, DOI 10.1007/s00441-015-2139-2.
   Biesemann N, 2014, CIRC RES, V115, P296, DOI 10.1161/CIRCRESAHA.115.304185.
   Cates C, 2018, BIOCHEM BIOPH RES CO, V495, P2584, DOI 10.1016/j.bbrc.2017.12.125.
   Cingolani OH, 2004, HYPERTENSION, V43, P1067, DOI 10.1161/01.HYP.0000125013.22494.c5.
   Du GQ, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0593-y.
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010.
   Furihata T, 2016, IJC HEART VASC, V11, P24, DOI 10.1016/j.ijcha.2016.03.007.
   Goldspink DF, 2003, EXP PHYSIOL, V88, P447, DOI 10.1113/eph8802549.
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231.
   Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963.
   Hirose M, 2017, J PHARMACOL SCI, V135, P164, DOI 10.1016/j.jphs.2017.11.006.
   Ho YL, 1998, CARDIOLOGY, V89, P52, DOI 10.1159/000006743.
   Jamaiyar A, 2017, PHARMACOL THERAPEUT, V175, P28, DOI 10.1016/j.pharmthera.2017.02.032.
   Jones JE, 2018, CELL REP, V22, P1522, DOI 10.1016/j.celrep.2018.01.044.
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141.
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3.
   Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824.
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58.
   Li GN, 2017, CARDIOVASC PATHOL, V28, P74, DOI 10.1016/j.carpath.2017.03.008.
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015.
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0.
   Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079.
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560.
   Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385.
   Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI {[}10.7150/ijbs.8.195, 10.7150/ijbs.3805].
   Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316.
   Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521.
   RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187.
   Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023.
   Schipke J, 2016, J ANAT, V229, P75, DOI 10.1111/joa.12463.
   Shimano M, 2011, J BIOL CHEM, V286, P9840, DOI 10.1074/jbc.M110.197079.
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152.
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527.
   Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220.
   Talbert EE, 2018, J CACHEXIA SARCOPENI, V9, P358, DOI 10.1002/jcsm.12251.
   Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009.
   Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003.
   Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1.
   Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5.
   Xing F, 2007, DEV GENES EVOL, V217, P549, DOI 10.1007/s00427-007-0162-3.
   Yamagishi S, 2016, BIORESEARCH OPEN ACC, V5, P155, DOI 10.1089/biores.2016.0015.
   Zhao RR, 2018, CIRCULATION, V137, P2497, DOI 10.1161/CIRCULATIONAHA.117.030353.
   Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9.},
Number-of-Cited-References = {45},
Times-Cited = {23},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Circ.Res.},
Doc-Delivery-Number = {GZ5TY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000449493300015},
OA = {Green Accepted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000521124400042,
Author = {Atchison, Kayla Marie and Pham, Truong-Minh and Sikdar, Khokan C. and
   Weeks, Lee-Anne and Karosas, Anthony Paul Vytautas and Sinnarajah,
   Aynharan and Dort, Joseph C. and Cheung, Winson Y. and Shack, Lorraine},
Title = {Premature deaths due to head and neck cancers in canada: A nationwide
   analysis from 1980 to 2010},
Journal = {LARYNGOSCOPE},
Year = {2020},
Volume = {130},
Number = {4},
Pages = {911-917},
Month = {APR},
Abstract = {Objectives/Hypothesis To examine if there has been a reduction in
   premature mortality due to head and neck cancers and their subtypes in
   the Canadian population between 1980 and 2010.
   Study Design Retrospective database review.
   Methods Mortality data for head and neck cancers were obtained from the
   World Health Organization's mortality database. Years of life lost (YLL)
   was calculated according to Canadian life tables. A new measure, average
   lifespan shortened (ALSS), was calculated as a ratio of YLL over the
   expected lifespan.
   Results During the period of interest, decreases in age standardized
   rates of death adjusted to the World Standard Population were observed
   mainly among men. The adjusted YLL rates remained unchanged with respect
   to oral cancers in women, but slightly decreased for oral cancers in men
   and for laryngeal cancers in both sexes. Our new measure of ALSS showed
   that in 1980, patients with oral cancers lost an average of 20\% of
   their lifespan, whereas in 2010, men and women still lost approximately
   20\% and 18\%, respectively. Patients with laryngeal cancers lost 18\%
   of their lifespan in both sexes in 1980 and 17\% in 2010. The ALSS
   subanalysis showed that the largest gain of lifespan was observed for
   cancers of the hypopharynx in men and for cancers of the floor of mouth
   and nasopharynx in women.
   Conclusions There appears to be modest improvements in premature
   mortality due to head and neck cancers in Canada over a 30-year period,
   with the exception of oral cancers in men. Changes in premature
   mortality varied slightly by cancer subtypes.
   Level of Evidence NA Laryngoscope, 130:911-917, 2020},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Pham, TM (Corresponding Author), Alberta Hlth Serv, Canc Control Alberta, Surveillance \& Reporting, Canc Res \& Analyt, Suite 1400,Sun Life Bldg,10123-99 St, Edmonton, AB T5J 3H1, Canada.
   Atchison, Kayla Marie, Univ Calgary, Dept Med, Calgary, AB, Canada.
   Pham, Truong-Minh; Weeks, Lee-Anne; Karosas, Anthony Paul Vytautas; Shack, Lorraine, Alberta Hlth Serv, Canc Control Alberta, Surveillance \& Reporting, Calgary, AB, Canada.
   Sikdar, Khokan C., Publ \& Indigenous Alberta Hlth Serv, Publ Hlth Surveillance \& Infrastruct Populat, Surveillance \& Reporting, Calgary, AB, Canada.
   Sikdar, Khokan C.; Sinnarajah, Aynharan; Shack, Lorraine, Univ Calgary, Cumming Sch Med, Community Hlth Sci, Calgary, AB, Canada.
   Sinnarajah, Aynharan, Univ Calgary, Dept Family Med, Calgary, AB, Canada.
   Dort, Joseph C., Univ Calgary, Dept Surg, Sect Otolaryngol Head \& Neck Surg, Calgary, AB, Canada.
   Sinnarajah, Aynharan; Cheung, Winson Y.; Shack, Lorraine, Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada.},
DOI = {10.1002/lary.28024},
ISSN = {0023-852X},
EISSN = {1531-4995},
Keywords = {Head and neck cancer; premature mortality; years of life lost; average
   years of life lost; average lifespan shortened},
Keywords-Plus = {INTERNATIONAL HEAD; POOLED ANALYSIS; ORAL-CANCER; LIFE LOST; MORTALITY;
   RISK; TOBACCO; BURDEN; JAPAN},
Research-Areas = {Research \& Experimental Medicine; Otorhinolaryngology},
Web-of-Science-Categories  = {Medicine, Research \& Experimental; Otorhinolaryngology},
Author-Email = {truongminh.pham@ahs.ca},
ResearcherID-Numbers = {Sinnarajah, Aynharan/AAN-4524-2020},
ORCID-Numbers = {Sinnarajah, Aynharan/0000-0002-7967-159X},
Cited-References = {Andrade RS, 2006, INT J RADIAT ONCOL, V65, P1315, DOI 10.1016/j.ijrobp.2006.03.015.
   Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X.
   Blitz AM, 2008, OTOLARYNG CLIN N AM, V41, P697, DOI 10.1016/j.otc.2008.01.015.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Canadian Cancer Society, 2015, CAN CANC STAT 2015.
   Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646.
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4.
   Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975.
   Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179.
   Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347.
   Huang CC, 2015, ORAL ONCOL, V51, P349, DOI 10.1016/j.oraloncology.2015.01.001.
   Ibayashi H, 2011, CANCER EPIDEMIOL, V35, P342, DOI 10.1016/j.canep.2011.01.010.
   Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6.
   Mukherji SK, 2002, EUR J RADIOL, V44, P108, DOI 10.1016/S0720-048X(02)00068-2.
   Murray C, 1996, GLOBAL HLTH STAT COM.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Pham TM, 2010, INT J CANCER, V127, P190, DOI 10.1002/ijc.25021.
   Statistics Canada, LIF TABL CAN PROV TE.
   Pham TM, 2019, J EPIDEMIOL, V29, P464, DOI 10.2188/jea.JE20180140.
   Pham TM, 2018, NEUROEPIDEMIOLOGY, V50, P195, DOI 10.1159/000488145.
   Pham TM, 2018, EUR J PUBLIC HEALTH, V28, P348, DOI 10.1093/eurpub/ckx195.},
Number-of-Cited-References = {21},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Laryngoscope},
Doc-Delivery-Number = {KW4GO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000521124400042},
DA = {2022-03-29},
}

@article{ WOS:000369536100032,
Author = {Flemmen, Grete and Wang, Eivind},
Title = {Impaired Aerobic Endurance and Muscular Strength in Substance Use
   Disorder Patients Implications for Health and Premature Death},
Journal = {MEDICINE},
Year = {2015},
Volume = {94},
Number = {44},
Month = {NOV},
Abstract = {Although substance use disorder ( SUD) patients are documented to have
   an inactive lifestyle, which is associated with cardiovascular disease,
   other lifestyle-related diseases and premature death, evidence regarding
   their aerobic endurance and muscular strength is limited. Therefore, the
   authors aimed to evaluate directly assessed maximal oxygen consumption,
   walking efficiency, as well as maximal strength in a group of SUD
   patients. A total of 44 SUD patients in residential treatment, 31 men (
   31 +/- 8 years) and 13 women ( 34 +/- 10 years), were included and
   completed the physical testing. The patients were compared with an age-
   and sex-matched reference group. Male and female SUD patients exhibited
   a maximal oxygen consumption of 44.6 +/- 6.2 and 33.8 +/- 6.6mL center
   dot min(-1) kg - 1, respectively. This was significantly lower than the
   reference group, 15\% ( P = 0.03) for men and 25\% ( P = 0.001) for
   women. In addition, the SUD patients had a 13\% significantly reduced
   walking efficiency ( P = 0.02), compared with healthy controls. The
   impairments in aerobic endurance were accompanied by significant
   reductions in maximal strength of 30\% ( P = 0.001) and 33\% ( P = 0.01)
   for men and women, respectively. In combination, these results imply
   that SUD patients have impaired endurance and muscular strength compared
   with what is typically observed in the population, and consequently
   suffer a higher risk of developing cardiovascular and other lifestyle-
   related diseases and early death. Effective physical exercise should be
   advocated as an essential part of the clinical practice of SUD treatment
   to improve the patient's health and consequently reduce the costs
   because of the high use of emergency departments, hospital, and medical
   care.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Flemmen, G (Corresponding Author), Norwegian Univ Sci \& Technol, Fac Med, Dept Circulat \& Med Imaging, Prinsesse Kristinas Gt 3, N-7006 Trondheim, Norway.
   Flemmen, Grete; Wang, Eivind, Norwegian Univ Sci \& Technol, Fac Med, Dept Circulat \& Med Imaging, Prinsesse Kristinas Gt 3, N-7006 Trondheim, Norway.
   Flemmen, Grete, St Olavs Univ Hosp, Clin Subst Use \& Addict Med, Dept Res \& Dev, Trondheim, Norway.
   Wang, Eivind, Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.},
DOI = {10.1097/MD.0000000000001914},
Article-Number = {e1914},
ISSN = {0025-7974},
EISSN = {1536-5964},
Keywords-Plus = {MAXIMAL STRENGTH; CARDIORESPIRATORY FITNESS; CIGARETTE-SMOKING;
   MORTALITY; EXERCISE; MEN; CAPACITY; DISEASE; WORK; ADOLESCENTS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {Grete.Flemmen@ntnu.no},
Funding-Acknowledgement = {Liaison Committee},
Funding-Text = {Role of funding Source: This project was funded by the Liaison Committee
   between the Central Norway Regional Health Authority and the Norwegian
   University of Science and Technology.},
Cited-References = {Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002.
   Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688.
   Barrett-O'Keefe Z, 2012, J APPL PHYSIOL, V113, P1846, DOI 10.1152/japplphysiol.00761.2012.
   Brown RA, 2009, BEHAV MODIF, V33, P220, DOI 10.1177/0145445508329112.
   CHATTERJEE S, 1987, JPN J PHYSIOL, V37, P837, DOI 10.2170/jjphysiol.37.837.
   COOPER KH, 1968, J AMER MED ASSOC, V203, P189, DOI 10.1001/jama.203.3.189.
   Cussler EC, 2003, MED SCI SPORT EXER, V35, P10, DOI 10.1097/00005768-200301000-00003.
   Dolezal BA, 2013, J ADDICT MED, V7, P122, DOI 10.1097/ADM.0b013e318282475e.
   Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458.
   Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459.
   Flemmen G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616935.
   Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28.
   Heggelund J, 2013, EUR J APPL PHYSIOL, V113, P1565, DOI 10.1007/s00421-013-2586-y.
   Heggelund J, 2011, NORD J PSYCHIAT, V65, P269, DOI 10.3109/08039488.2011.560278.
   Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570.
   Hoff J, 2007, MED SCI SPORT EXER, V39, P220, DOI 10.1249/01.mss.0000246989.48729.39.
   Hoydal KL, 2007, SCAND CARDIOVASC J, V41, P405, DOI 10.1080/14017430701601636.
   Kim EY, 2009, FORENSIC SCI INT, V188, P75, DOI 10.1016/j.forsciint.2009.03.016.
   Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681.
   Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717.
   Koivukangas J, 2010, SCHIZOPHR RES, V116, P152, DOI 10.1016/j.schres.2009.10.022.
   Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581.
   Mamen A, 2009, J SPORT MED PHYS FIT, V49, P187.
   Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x.
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858.
   NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334.
   Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176.
   Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243.
   Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279.
   Osteras H, 2002, EUR J APPL PHYSIOL, V88, P255, DOI 10.1007/s00421-002-0717-y.
   Roessler KK, 2010, SCAND J PUBLIC HEALT, V38, P664, DOI 10.1177/1403494810371249.
   Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439.
   Ruiz JR, 2009, CANCER EPIDEM BIOMAR, V18, P1468, DOI 10.1158/1055-9965.EPI-08-1075.
   Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005.
   Saltin B, 1968, CIRCULATION       S7, V38, P1, DOI DOI 10.1161/01.CIR.38.6.1104.
   Stenbacka M, 2010, DRUG ALCOHOL REV, V29, P21, DOI 10.1111/j.1465-3362.2009.00075.x.
   Wang E, 2012, INT J SPORTS MED, V33, P734, DOI 10.1055/s-0031-1301315.
   Wang E, 2010, SCAND J MED SCI SPOR, V20, P764, DOI 10.1111/j.1600-0838.2009.01014.x.
   Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547.},
Number-of-Cited-References = {39},
Times-Cited = {8},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Medicine (Baltimore)},
Doc-Delivery-Number = {DC9IX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000369536100032},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000306644600087,
Author = {Ma, Jiemin and Xu, Jiaquan and Anderson, Robert N. and Jemal, Ahmedin},
Title = {Widening Educational Disparities in Premature Death Rates in Twenty Six
   States in the United States, 1993-2007},
Journal = {PLOS ONE},
Year = {2012},
Volume = {7},
Number = {7},
Month = {JUL 20},
Abstract = {Background: Eliminating socioeconomic disparities in health is an
   overarching goal of the U.S. Healthy People decennial initiatives. We
   present recent trends in mortality by education among working-aged
   populations.
   Methods and Findings: Age-standardized death rates and their average
   annual percent change for all-cause and five major causes (cancer, heart
   disease, stroke, diabetes, and accidents) were calculated from 1993
   through 2007 for individuals aged 25-64 years by educational attainment
   as a marker of socioeconomic status, using national vital registration
   data for 26 states with consistent educational information on the death
   certificates. Rate ratios and rate differences were used to assess
   disparities (<= 12 versus >= 16 years of education) for 1993 through
   2007. From 1993 through 2007, relative educational disparities in
   all-cause mortality continued to increase among working-aged men and
   women in the U. S., due to larger decreases of mortality rates among the
   most educated coupled with smaller decreases or even worsening trends in
   the less educated. For example, the rate ratios of all-cause mortality
   increased from 2.5 (95\% confidence interval (CI), 2.4-2.6) in 1993 to
   3.6 (95\% CI, 3.5-3.7) in 2007 in men and from 1.9 (95\% CI, 1.8-2.0) to
   3.0 (95\% CI, 2.9-3.1) in women. Generally, the rate differences (per
   100,000 persons) of all-cause mortality increased from 415.5 (95\% CI,
   399.1-431.9) in 1993 to 472.7 (95\% CI, 460.2-485.2) in 2007 in men and
   from 165.4 (95\% CI, 154.5-176.2) to 256.2 (95\% CI, 248.3-264.2) in
   women. Disparity patterns varied largely across the five specific causes
   considered in this study, with the largest increases of relative
   disparities for accidents, especially in women.
   Conclusions: Relative educational differentials in mortality continued
   to widen among men and women despite emphasis on reducing disparities in
   the U. S. Healthy People decennial initiatives.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Ma, JM (Corresponding Author), Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA.
   Ma, Jiemin; Jemal, Ahmedin, Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA.
   Xu, Jiaquan; Anderson, Robert N., Ctr Dis Control \& Prevent, Mortal Stat Branch, Natl Ctr Hlth Stat, Hyattsville, MD USA.},
DOI = {10.1371/journal.pone.0041560},
Article-Number = {e41560},
ISSN = {1932-6203},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC-STATUS; ALL-CAUSE; INEQUALITIES;
   ADULTS; TRENDS; NORWAY; GAP},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {jiemin.ma@cancer.org},
ResearcherID-Numbers = {shen, Guanxin/F-7441-2011
   },
ORCID-Numbers = {Liu, Hongbo/0000-0002-7187-8115},
Funding-Acknowledgement = {American Cancer Society and the Centers for Disease Control and
   Prevention},
Funding-Text = {The American Cancer Society and the Centers for Disease Control and
   Prevention funded the analysis, interpretation, and compilation of
   surveillance data. No staff at either agency, other than the authors,
   was involved in the conduct of the study; collection, management,
   analysis, and interpretation of the data; or preparation of the
   manuscript.},
Cited-References = {{[}Agency for Healthcare Research and Quality Services USDoHaH], 2011, 2010 NAT HEALTHC DIS.
   Ahluwalia IB, 2008, J COMMUN HEALTH, V33, P293, DOI 10.1007/s10900-008-9106-8.
   Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127.
   Anderson R N, 2001, Natl Vital Stat Rep, V49, P1.
   Berkman L F, 1997, IARC Sci Publ, P51.
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879.
   FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225.
   Hadden WC, 2008, INT J HEALTH SERV, V38, P47, DOI 10.2190/HS.38.1.c.
   Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584.
   Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181.
   Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Kominski R., 1994, ED ATTAINMENT US MAR, P20.
   Korhonen N, 2011, INJURY, V42, P885, DOI 10.1016/j.injury.2010.08.033.
   Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046.
   Lash TL., 2008, MODERN EPIDEMIOLOGY.
   Mackenbach JP, 2010, SOC SCI MED, V71, P1249, DOI 10.1016/j.socscimed.2010.07.014.
   Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209.
   Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350.
   Minino AM, 2007, NATL VITAL STAT REP, V55, P1.
   PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207.
   Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93.
   Rim Sun Hee, 2011, Morbidity and Mortality Weekly Report, V60, P42.
   Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701.
   Rostron BL, 2010, ED REP CLASS DEATH C, Viii.
   Schalick LM, 2000, INT J HEALTH SERV, V30, P13, DOI 10.2190/8QMH-4FAB-XAWP-VU95.
   Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036.
   Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786.
   Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017.
   Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037.
   Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001.
   Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654.
   U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020.
   U.S. Department of Health and Human Services, 2007, HLTH PEOPL 2010 MIDC.
   U. S. Department of Health \& Human Services, 2000, HLTH PEOPL 2010 UND.
   {*}WHO, 1977, INT STAT CLASS DIS R.
   World Health Organization, 1992, INT STAT CLASS DIS R.},
Number-of-Cited-References = {37},
Times-Cited = {76},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {15},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {977GL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000306644600087},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000239051400002,
Author = {van Dam, Rob M. and Willett, Walter C. and Manson, JoAnn E. and Hu,
   Frank B.},
Title = {The relationship between overweight in adolescence and premature death
   in women},
Journal = {ANNALS OF INTERNAL MEDICINE},
Year = {2006},
Volume = {145},
Number = {2},
Pages = {91-97},
Month = {JUL 18},
Abstract = {Background: The impact of adiposity in adolescence on death during
   adulthood is uncertain.
   Objective: To examine the relation between adiposity in adolescence and
   premature death in women.
   Design: Prospective cohort study.
   Setting: United States.
   Participants: 102400 women from the Nurses' Health Study II who were 24
   to 44 years of age and free of cancer at baseline. Ninety percent were
   of non-Hispanic white ethnicity.
   Measurements: In 1989, current weight and height and recalled weight at
   age 18 years were assessed by using validated questionnaires, and body
   mass index (BMI) was calculated. Hazard ratios for death and 95\% Cls
   were adjusted for potential confounders, including cigarette smoking,
   alcohol use, and physical activity during adolescence.
   Results: During 12 years of follow-up, 710 participants died. Compared
   with a BMI of 18.5 to 21.9 kg/m(2) at age 18 years, the hazard ratio for
   premature death was 0.98 (95\% Cl, 0.78 to 1.23) for a BMI less than
   18.5 kg/m(2), 1.18 (Cl, 0.97 to 1.43) for a BMI of 22.0 to 24.9 kg/m(2),
   1.66 (Cl, 1.31 to 2.10) for a BMI of 25.0 to 29.9 kg/m(2), and 2.79 (Cl,
   2.04 to 3.81) for a BMI of 30 kg/m(2) or greater. Among participants who
   never smoked, a BMI of 22.0 to 24.9 kg/m2 at age 18 years was also
   associated with increased premature death (hazard ratio, 1.50 {[}Cl,
   1.16 to 1.94]). Associations between BMI at age 18 years and death could
   only partly be explained by adult BMI measured in 1989.
   Limitations: Because of the observational study design, residual
   confounding by imperfectly measured or unknown confounders may still be
   present.
   Conclusion: Moderately higher adiposity at age 18 years is associated
   with increased premature death in younger and middle-aged U.S. women.},
Publisher = {AMER COLL PHYSICIANS},
Address = {INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA},
Type = {Article},
Language = {English},
Affiliation = {van Dam, RM (Corresponding Author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bodg 2, Boston, MA 02115 USA.
   Harvard Univ, Brigham \& Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands.},
DOI = {10.7326/0003-4819-145-2-200607180-00006},
ISSN = {0003-4819},
EISSN = {1539-3704},
Keywords-Plus = {BODY-MASS INDEX; CORONARY-HEART-DISEASE; FOLLOW-UP; PHYSICAL-ACTIVITY;
   ADULT MORTALITY; WEIGHT CHANGE; MIDDLE-AGE; OBESITY; COHORT; RISK},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {rvandam@hsph.harvard.edu},
ResearcherID-Numbers = {Hu, Frank/C-1919-2013
   van Dam, Rob M/F-9674-2010},
ORCID-Numbers = {van Dam, Rob M/0000-0002-7354-8734},
Funding-Acknowledgement = {NCI NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   {[}CA50385] Funding Source: Medline; NIDDK NIH HHSUnited States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute of Diabetes \& Digestive \& Kidney
   Diseases (NIDDK) {[}P30 DK040561, P30 DK040561-11] Funding Source:
   Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) {[}R01CA050385] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes \& Digestive \&
   Kidney Diseases (NIDDK) {[}P30DK040561] Funding Source: NIH RePORTER},
Cited-References = {ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6.
   DIPIETRO L, 1994, INT J OBESITY, V18, P585.
   Eaton DK, 2005, ARCH PEDIAT ADOL MED, V159, P513, DOI 10.1001/archpedi.159.6.513.
   Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219.
   Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59.
   Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5.
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861.
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723.
   Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a.
   Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111.
   HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8.
   HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9.
   Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135.
   Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407.
   Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8.
   Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002.
   MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353.
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101.
   MUELLER WH, 1982, SOC SCI MED, V16, P191, DOI 10.1016/0277-9536(82)90022-3.
   MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904.
   Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852.
   NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486.
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728.
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI {[}10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557].
   RHOADS GG, 1983, LANCET, V1, P492.
   RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191.
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009.
   Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235.
   Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018.
   SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795.
   TROY LM, 1995, INT J OBESITY, V19, P570.
   WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461.
   Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607.
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991.
   World Health Organization, 1997, WHONUTNCD981.
   Yarnell JWG, 2000, J EPIDEMIOL COMMUN H, V54, P344, DOI 10.1136/jech.54.5.344.},
Number-of-Cited-References = {36},
Times-Cited = {130},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Ann. Intern. Med.},
Doc-Delivery-Number = {063WU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000239051400002},
DA = {2022-03-29},
}

@article{ WOS:000270354300009,
Author = {Freude, Susanna and Hettich, Moritz M. and Schumann, Christina and
   Stoehr, Oliver and Koch, Linda and Koehler, Christoph and Udelhoven,
   Michael and Leeser, Uschi and Mueller, Marita and Kubota, Naoto and
   Kadowaki, Takashi and Krone, Wilhelm and Schroeder, Hannsjoerg and
   Bruening, Jens C. and Schubert, Markus},
Title = {Neuronal IGF-1 resistance reduces A beta accumulation and protects
   against premature death in a model of Alzheimer's disease},
Journal = {FASEB JOURNAL},
Year = {2009},
Volume = {23},
Number = {10},
Pages = {3315-3324},
Month = {OCT},
Abstract = {Alzheimer's disease ( AD) is characterized by progressive
   neurodegeneration leading to loss of cognitive abilities and ultimately
   to death. Postmortem investigations revealed decreased expression of
   cerebral insulin-like growth factor (IGF)-1 receptor (IGF-1R) and
   insulin receptor substrate (IRS) proteins in patients with AD. To
   elucidate the role of insulin/IGF-1 signaling in AD, we crossed mice
   expressing the Swedish mutation of amyloid precursor protein (APP(SW),
   Tg2576 mice) as a model for AD with mice deficient for either IRS-2,
   neuronal IGF-1R (nIGF-1R(-/-)), or neuronal insulin receptor (nIR(-/-)),
   and analyzed survival, glucose, and APP metabolism. In the present
   study, we show that IRS-2 deficiency in Tg2576 mice completely reverses
   premature mortality in Tg2576 females and delays beta-amyloid (A beta)
   accumulation. Analysis of APP metabolism suggested that delayed A beta
   accumulation resulted from decreased APP processing. To delineate the
   upstream signal responsible for IRS-2-mediated disease protection, we
   analyzed mice with nIGF-1R or nIR deficiency predominantly in the
   hippocampus. Interestingly, both male and female nIGF1R(-/-) Tg2576 mice
   were protected from premature death in the presence of decreased A beta
   accumulation specifically in the hippocampus formation. However,
   neuronal IR deletion had no influence on lethality of Tg2576 mice. Thus,
   impaired IGF-1/IRS-2 signaling prevents premature death and delays
   amyloid accumulation in amodel of AD.-Freude, S., Hettich, M. M.,
   Schumann, C., Stohr, O., Koch, L., Kohler, C., Udelhoven, M., Leeser,
   U., Muller, M., Kubota, N., Kadowaki, T., Krone, W., Schroder, H.,
   Bruning, J. C., Schubert, M. Neuronal IGF-1 resistance reduces A beta
   accumulation and protects against premature death in a model of
   Alzheimer's disease. FASEB J. 23, 3315-3324 ( 2009). www.fasebj.org},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Schubert, M (Corresponding Author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62,LFI 4-061, D-50937 Cologne, Germany.
   Freude, Susanna; Hettich, Moritz M.; Schumann, Christina; Stoehr, Oliver; Udelhoven, Michael; Leeser, Uschi; Mueller, Marita; Krone, Wilhelm; Bruening, Jens C.; Schubert, Markus, Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany.
   Freude, Susanna; Hettich, Moritz M.; Schumann, Christina; Stoehr, Oliver; Koch, Linda; Udelhoven, Michael; Leeser, Uschi; Mueller, Marita; Krone, Wilhelm; Bruening, Jens C.; Schubert, Markus, Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany.
   Freude, Susanna; Hettich, Moritz M.; Stoehr, Oliver; Koch, Linda; Udelhoven, Michael; Leeser, Uschi; Mueller, Marita; Krone, Wilhelm; Bruening, Jens C.; Schubert, Markus, Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany.
   Koch, Linda; Bruening, Jens C., Univ Cologne, Inst Genet, Dept Mouse Genet \& Metab, D-50937 Cologne, Germany.
   Koehler, Christoph; Schroeder, Hannsjoerg, Univ Cologne, Dept Anat 2, D-50937 Cologne, Germany.
   Kubota, Naoto; Kadowaki, Takashi, Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo, Japan.
   Bruening, Jens C., Max Planck Inst Biol Ageing, Cologne, Germany.},
DOI = {10.1096/fj.09-132043},
ISSN = {0892-6638},
EISSN = {1530-6860},
Keywords = {beta-amyloid; longevity; insulin receptor substrate; brain; Tg2576 mice},
Keywords-Plus = {AMYLOID PRECURSOR PROTEIN; TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR
   EXPRESSION; INSULIN-RECEPTOR; LIFE-SPAN; SECRETASE CLEAVAGE; IMPAIRED
   INSULIN; PLAQUE-FORMATION; BRAIN INSULIN; RAT-BRAIN},
Research-Areas = {Biochemistry \& Molecular Biology; Life Sciences \& Biomedicine - Other
   Topics; Cell Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Biology; Cell Biology},
Author-Email = {markus.schubert@uni-koeln.de},
ResearcherID-Numbers = {Kubota, Naoto/N-7892-2015
   Schubert, Markus/F-5150-2010
   },
ORCID-Numbers = {Koch, Linda/0000-0002-2943-1993},
Funding-Acknowledgement = {Fritz-Thyssen Foundation {[}10.06.2.209]; Alzheimer
   Forschungs-Initiative {[}08813]; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) {[}Br-1492-7]; Fritz-Thyssen Foundation},
Funding-Text = {This work was supported by the Fritz-Thyssen Foundation (AZ 10.06.2.209)
   and Alzheimer Forschungs-Initiative e. V. ( 08813) to M. S. and by funds
   to J.C.B. by the Deutsche Forschungsgemeinschaft (Br-1492-7) and the
   Fritz-Thyssen Foundation. We gratefully thank Prof. R. Wiesner and Prof.
   C. Niessen for helpful discussions on the data and the manuscript.},
Cited-References = {Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200.
   BASKIN DG, 1986, J NEUROSCI METH, V16, P119, DOI 10.1016/0165-0270(86)90044-0.
   Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122.
   Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105.
   Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951.
   Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646.
   Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004.
   Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062.
   Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153.
   de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89.
   Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006.
   El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555.
   Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435.
   Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x.
   Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068.
   Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124.
   HILL JM, 1986, NEUROSCIENCE, V17, P1127, DOI 10.1016/0306-4522(86)90082-5.
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298.
   Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99.
   KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0.
   Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254.
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0.
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942.
   Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880.
   Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922.
   Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6.
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243.
   Lovestone S, 1999, NEUROLOGY, V53, P1907, DOI 10.1212/WNL.53.9.1907.
   Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87.
   Matsubara E, 2003, J NEUROCHEM, V85, P1101, DOI 10.1046/j.1471-4159.2003.01654.x.
   McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200.
   Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009.
   Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002.
   Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529.
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456.
   Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937.
   Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3.
   Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200.
   Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010.
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36.
   Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247.
   Ronnemaa E, 2008, NEUROLOGY, V71, P1065, DOI 10.1212/01.wnl.0000310646.32212.3a.
   Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3.
   Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012.
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com.
   Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141.
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107.
   Stein TD, 2002, J NEUROSCI, V22, P7380.
   Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x.
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179.
   Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2.
   UNGER J, 1989, NEUROSCIENCE, V31, P143, DOI 10.1016/0306-4522(89)90036-5.
   Van Houten M, 1983, Adv Metab Disord, V10, P269.
   VANHOUTEN M, 1979, NATURE, V282, P623, DOI 10.1038/282623a0.
   Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285.
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735.
   WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5.
   WERTHER GA, 1987, ENDOCRINOLOGY, V121, P1562, DOI 10.1210/endo-121-4-1562.
   WHITMER RA, 2006, ALZHEIMERS DEMENT, V2, pS149.
   Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147.
   Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004.},
Number-of-Cited-References = {61},
Times-Cited = {150},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {16},
Journal-ISO = {Faseb J.},
Doc-Delivery-Number = {501BQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000270354300009},
DA = {2022-03-29},
}

@article{ WOS:000174030100007,
Author = {Braun, A and Trigatti, BL and Post, MJ and Sato, K and Simons, M and
   Edelberg, JM and Rosenberg, RD and Schrenzel, M and Krieger, M},
Title = {Loss of SR-BI expression leads to the early onset of occlusive
   atherosclerotic coronary artery disease, spontaneous myocardial
   infarctions, severe cardiac dysfunction, and premature death in
   apolipoprotein E-deficient mice},
Journal = {CIRCULATION RESEARCH},
Year = {2002},
Volume = {90},
Number = {3},
Pages = {270-276},
Month = {FEB 22},
Abstract = {Murine models of atherosclerosis, such as the apolipoprotein E (apoE) or
   the LDL receptor knockout mice, usually do not exhibit many of the
   cardinal features of human coronary heart disease (CHD), eg, spontaneous
   myocardial infarction, severe cardiac dysfunction, and premature death.
   Here we show that mice with homozygous null mutations in the genes for
   both the high density lipoprotein receptor SR-BI and apoE (SR-BI/apoE
   double knockout {[}dKO] mice) exhibit morphological and functional
   defects with similarities to those seen in human CHD. When fed a
   standard chow diet, these hypercholesterolemic animals developed
   significant atherosclerotic lesions in the aortic sinus as early as 4 to
   5 weeks after birth. We now show that they also exhibited extensive
   lipid-rich coronary artery occlusions and spontaneously developed
   multiple myocardial infarctions and cardiac dysfunction (eg, enlarged
   hearts, reduced ejection fraction and contractility, and ECG
   abnormalities). Their coronary arterial lesions, which were strikingly
   similar to human atherosclerotic plaques, exhibited evidence of
   cholesterol clefts and extensive fibrin deposition, indicating
   hemorrhage and clotting. All of the dKO mice died by 8 weeks of age
   (50\% mortality at 6 weeks). Thus, SR-BI/apoE dKO mice provide a new
   murine model for CHD and may help better define the role of lipoprotein
   metabolism and atherosclerosis in the pathogenesis of myocardial
   infarction and cardiac dysfunction. Furthermore, these animals may be
   useful for preclinical testing of potential genetic and/or
   pharmacological therapies for CHD.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Krieger, M (Corresponding Author), MIT, Dept Biol, 77 Massachusetts Ave Rm 68-483, Cambridge, MA 02139 USA.
   MIT, Dept Biol, Cambridge, MA 02139 USA.
   MIT, Div Comparat Med, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Angiogenesis Res Ctr, Dept Med, Cambridge, MA 02138 USA.
   Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.},
DOI = {10.1161/hh0302.104462},
ISSN = {0009-7330},
EISSN = {1524-4571},
Keywords = {SR-BI/apolipoprotein E knockout mice atherosclerosis; myocardial
   infarction; coronary artery disease; lipoprotein metabolism},
Keywords-Plus = {SCAVENGER RECEPTOR-BI; VITAMIN-E; CARDIOVASCULAR-DISEASE; CHOLESTEROL;
   MUTATION; LESIONS; HDL; HYPERCHOLESTEROLEMIA; IDENTIFICATION;
   PROGRESSION},
Research-Areas = {Cardiovascular System \& Cardiology; Hematology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease},
Author-Email = {krieger@mit.edu},
ResearcherID-Numbers = {Eckhardt, Erik/G-1567-2010
   Simons, Michael/G-8553-2014
   },
ORCID-Numbers = {Simons, Michael/0000-0003-0348-7734
   Trigatti, Bernardo (Dino) L./0000-0002-4556-119X},
Funding-Acknowledgement = {NHLBI NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}HL41484, HL52212, HL53793, HL63609,
   HL64737, HL66105] Funding Source: Medline; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   \& Blood Institute (NHLBI) {[}R01HL064737, P01HL041484, P50HL063609,
   R01HL053793, P01HL066105, R01HL052212] Funding Source: NIH RePORTER},
Cited-References = {Atlee J L 3rd, 1985, Eur J Anaesthesiol, V2, P215.
   BACHMAIER K, 1995, CIRCULATION, V92, P1927, DOI 10.1161/01.CIR.92.7.1927.
   Calara F, 2001, J PATHOL, V195, P257, DOI 10.1002/path.915.
   Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920.
   Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196.
   Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6.
   Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004.
   Edelberg JM, 1998, J CLIN INVEST, V101, P337, DOI 10.1172/JCI1330.
   Eitzman DT, 2000, BLOOD, V96, P4212.
   Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x.
   Gussak I, 2000, J ELECTROCARDIOL, V33, P159, DOI 10.1016/S0022-0736(00)80072-2.
   Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2.
   Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956.
   HOLM TM, IN PRESS BLOOD.
   ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179.
   Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982.
   Keller RS, 2001, AM J PATHOL, V158, P1079, DOI 10.1016/S0002-9440(10)64055-2.
   Kim HE, 2000, J CLIN INVEST, V106, P857, DOI 10.1172/JCI8040.
   Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0.
   Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523.
   KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5.
   Mardones P, 2001, J LIPID RES, V42, P170.
   MARDONES P, IN PRESS J NUTR.
   MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775.
   NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133.
   Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730.
   Penninger JM, 2000, J INFECT DIS, V181, pS498, DOI 10.1086/315613.
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G.
   Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685.
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610.
   Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587.
   Russell JC, 1998, MOL CELL BIOCHEM, V188, P113, DOI 10.1023/A:1006828724405.
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2.
   Seo HS, 1997, ARTERIOSCL THROM VAS, V17, P3593, DOI 10.1161/01.ATV.17.12.3593.
   SHARPE MD, 1994, ANESTHESIOLOGY, V80, P63, DOI 10.1097/00000542-199401000-00013.
   Sjoland H, 2000, ARTERIOSCL THROM VAS, V20, P846, DOI 10.1161/01.ATV.20.3.846.
   STARY HC, 1993, EVOLUTION HUMAN ATHE.
   Swertfeger DK, 2001, FRONT BIOSCI-LANDMRK, V6, pD526, DOI 10.2741/Swertfeg.
   Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697.
   Thomas SR, 2001, ARTERIOSCL THROM VAS, V21, P585, DOI 10.1161/01.ATV.21.4.585.
   Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004.
   Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322.
   Vargas SO, 1999, MODERN PATHOL, V12, P635.
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262.
   Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006.
   Witt W, 2000, J LIPID RES, V41, P2009.
   Xiao Q, 1998, J CLIN INVEST, V101, P1184, DOI 10.1172/JCI1461.
   YOSHIDA H, 1987, AM J PATHOL, V129, P477.
   Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986.
   ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543.
   ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460.},
Number-of-Cited-References = {51},
Times-Cited = {387},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Circ.Res.},
Doc-Delivery-Number = {524TZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000174030100007},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000302913200001,
Author = {Ringmets, Inge and Tuusov, Jana and Lang, Katrin and Vaeli, Marika and
   Paerna, Kersti and Tonisson, Mailis and Helander, Anders and McKee,
   Martin and Leon, David A.},
Title = {Alcohol and premature death in Estonian men: a study of forensic
   autopsies using novel biomarkers and proxy informants},
Journal = {BMC PUBLIC HEALTH},
Year = {2012},
Volume = {12},
Month = {FEB 27},
Abstract = {Background: Alcohol makes an important contribution to premature
   mortality in many countries in Eastern Europe, including Estonia.
   However, the full extent of its impact, and the mechanisms underlying
   it, are challenging issues to research. We describe the design and
   initial findings of a study aimed at investigating the association of
   alcohol with mortality in a large series of forensic autopsies of
   working-age men in Estonia.
   Methods: 1299 male deaths aged 25-54 years were subject to forensic
   autopsy in 2008-2009. The routine autopsy protocol was augmented by a
   more systematic inspection of organs, drug testing, assay of liver
   enzymes and novel biomarkers of alcohol consumption (EtG, EtS and PEth),
   together with proxy interviews with next of kin for deaths among men who
   lived in or close to a major town.
   Results: 595 augmented autopsies were performed. Of these, 66\% were
   from external causes (26\% suicide, 25\% poisoning). 17\% were
   attributed to circulatory system diseases and 7\% to alcoholic liver
   disease. Blood alcohol concentrations (BAC) of >= 0.2 mg/g were found
   for 55\% of deaths. Interviews were conducted with proxy informants for
   61\% of the subjects who had resided in towns. Of these, 28\% were
   reported in the previous year to have been daily or almost daily
   drinkers and 10\% had drunk non-beverage alcohols. Blood ethanol and the
   liver enzyme GGT were only associated with daily drinking. However, the
   novel biomarkers showed a more graded response with recent consumption.
   In contrast, the liver enzymes AST and ALT were largely uninformative
   because of post-mortem changes. The presence of extremely high PEth
   concentrations in some samples also suggested post-mortem formation.
   Conclusion: We have shown the feasibility of deploying an extended
   research protocol within the setting of routine forensic autopsies that
   offer scope to deepen our understanding of the alcohol-related burden of
   premature mortality. The most unique feature of the study is the
   information on a wide range of informative alcohol biomarkers, several
   of which have not been used previously in this sort of post-mortem
   research study. We have demonstrated, for the first time, the
   epidemiological value and validity of these novel alcohol biomarkers in
   post-mortem samples.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Ringmets, I (Corresponding Author), Univ Tartu, Dept Publ Hlth, Ravila 19, EE-50411 Tartu, Estonia.
   Ringmets, Inge; Lang, Katrin; Paerna, Kersti, Univ Tartu, Dept Publ Hlth, EE-50411 Tartu, Estonia.
   Tuusov, Jana; Vaeli, Marika; Tonisson, Mailis, Univ Tartu, Inst Pathol Anat \& Forens Med, EE-50411 Tartu, Estonia.
   Tuusov, Jana; Vaeli, Marika; Tonisson, Mailis, Estonian Forens Sci Inst, Tallinn, Estonia.
   Helander, Anders, Karolinska Univ Lab Huddinge, Karolinska Inst, Dept Lab Med, Alcohol Lab, S-14186 Stockholm, Sweden.
   McKee, Martin, Univ London, London Sch Hyg \& Trop Med, ECOHOST, London WC1H 9SH, England.
   Leon, David A., Univ London, London Sch Hyg \& Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.},
DOI = {10.1186/1471-2458-12-146},
Article-Number = {146},
EISSN = {1471-2458},
Keywords-Plus = {URINARY ETHYL GLUCURONIDE; LIVER-CIRRHOSIS; EASTERN-EUROPE;
   HEART-DISEASE; RISK-FACTOR; MORTALITY; SULFATE; RUSSIA;
   PHOSPHATIDYLETHANOL; CONSUMPTION},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {inge.ringmets@ut.ee},
ResearcherID-Numbers = {Leon, David A/G-2195-2010
   McKee, Marc D/E-2187-2011
   Lang, Katrin/J-9611-2012
   Mckee, Martin/E-6673-2018
   },
ORCID-Numbers = {Leon, David A/0000-0001-9747-1762
   McKee, Marc D/0000-0001-8349-965X
   Mckee, Martin/0000-0002-0121-9683
   Helander, Anders/0000-0001-7480-8078},
Funding-Acknowledgement = {Estonian Science Foundation {[}8847]; Wellcome TrustWellcome
   TrustEuropean Commission {[}078557]},
Funding-Text = {This study was funded by the Estonian Science Foundation (grant number
   8847) and the Wellcome Trust (grant number 078557). We thank all
   forensic doctors of the Estonian Forensic Science Institute who
   participated in the study.},
Cited-References = {Estonian Institute of Economic Research, 2010, ALC MARK CONS HARMS.
   Helander A, 2005, CLIN CHEM, V51, P1728, DOI 10.1373/clinchem.2005.051565.
   Helander A, 2005, J ANAL TOXICOL, V29, P270, DOI 10.1093/jat/29.5.270.
   Helander A, 2003, CLIN CHEM, V49, P1881, DOI 10.1373/clinchem.2003.023341.
   Helander A, 2007, CLIN CHEM, V53, P1855, DOI 10.1373/clinchem.2007.089482.
   Helander A, 2009, FORENSIC SCI INT, V189, pE45, DOI 10.1016/j.forsciint.2009.04.022.
   Helander A, 2009, ALCOHOL ALCOHOLISM, V44, P55, DOI 10.1093/alcalc/agn084.
   Helander A, 2009, CLIN CHEM, V55, P1395, DOI 10.1373/clinchem.2008.120923.
   Leinsalu M, 2004, J EPIDEMIOL COMMUN H, V58, P583, DOI 10.1136/jech.2003.013755.
   Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6.
   Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102.
   Makela P, 2010, ADDICTION, V105, P1935, DOI 10.1111/j.1360-0443.2010.03069.x.
   McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802.
   Nordrum I, 2000, FORENSIC SCI INT, V110, P127, DOI 10.1016/S0379-0738(00)00163-8.
   Parna K, 2011, ALCOHOL CLIN EXP RES, V35, P1454, DOI 10.1111/j.1530-0277.2011.01481.x.
   Parna K, 2010, ALCOHOL ALCOHOLISM, V45, P548, DOI 10.1093/alcalc/agq050.
   Parna K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-261.
   Parna K, 2007, INT J PUBLIC HEALTH, V52, P402, DOI 10.1007/s00038-007-6112-z.
   Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124.
   Rahu K, 2009, ALCOHOL ALCOHOLISM, V44, P517, DOI 10.1093/alcalc/agp035.
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x.
   Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451.
   Siigur U, 2006, HDB UNITED LAB UHEND.
   StataCorp, 2007, STAT STAT SOFTW REL.
   Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274.
   Tomkins S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-343.
   Torvik FA, 2012, SOC PSYCH PSYCH EPID, V47, P805, DOI 10.1007/s00127-011-0387-3.
   WHO, EUR HLTH ALL DAT.
   Zheng YF, 2011, CLIN CHIM ACTA, V412, P1428, DOI 10.1016/j.cca.2011.04.022.},
Number-of-Cited-References = {29},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {927MY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000302913200001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1995TE85900017,
Author = {ZUREIK, M and DUCIMETIERE, P and WARNET, JM and ORSSAUD, G},
Title = {FATTY-ACID PROPORTIONS IN CHOLESTEROL ESTERS AND RISK OF PREMATURE DEATH
   FROM CANCER IN MIDDLE-AGED FRENCH MEN},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {1995},
Volume = {311},
Number = {7015},
Pages = {1251-1254},
Month = {NOV 11},
Abstract = {Objective-To assess the association of proportions of fatty acids in
   cholesterol esters with the risk of premature death ti om cancer in
   middle aged men.
   Design-Prospective cohort study.
   Setting-Paris, France.
   Subjects-3277 working men aged 36-52 in 1981-5.
   Main outcome measures-Cancer mortality during an average of 9.3 years of
   follow up.
   Results-59 men died of cancer during follow up. The age adjusted
   relative risks for men in the highest thirds of the distribution of the
   proportions of linoleic, palmitoleic, and oleic acid in cholesterol
   esters as compared with those in the corresponding lowest thirds were
   0.16 (95\% confidence interval 0.05 to 0.51), 3.39 (1.63 to 7.05), and
   4.22 (1.95 to 9.12), respectively. Adjustment for and stratification by
   smoking, alcohol consumption, serum cholesterol concentration, and body
   mass index did not alter the results. At the time of examination
   subjects with cancer had a lower intake of polyunsaturated fats,
   assessed by 24 hour recall, than those without cancer (13.2 v 17.4
   g/day, P< 0.01).
   Conclusions-Monounsaturated and polyunsaturated fatty acids of
   cholesterol esters are strong biological markers that predict premature
   death from cancer in French men. Consistently, intake of polyunsaturated
   fats did not seem to increase the risk of death from cancer. The
   association of biological markers of dietary fat intake with incidence
   of and mortality from cancer should be investigated prospectively in
   other populations.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {ZUREIK, M (Corresponding Author), HOP BROUSSAIS, INSERM, U258, F-75014 PARIS, FRANCE.
   CTR MEDICOSOCIAL, DIRECT ACT SOCIALE ENFANCE \& SANTE LAB, F-75013 PARIS, FRANCE.},
DOI = {10.1136/bmj.311.7015.1251},
ISSN = {1756-1833},
Keywords-Plus = {CORONARY HEART-DISEASE; ESTERIFYING SERUM-CHOLESTEROL; LUNG-CANCER;
   DIETARY-CHOLESTEROL; ASSOCIATION; MORTALITY; CONSUMPTION; PREVENTION;
   LIPIDS; PLASMA},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ResearcherID-Numbers = {Zureik, Mahmoud/F-7855-2018},
ORCID-Numbers = {Zureik, Mahmoud/0000-0002-8393-4217},
Cited-References = {AITCHISON J, 1986, MONOGRAPHS STATISTIC.
   AUSTOKER J, 1994, BRIT MED J, V308, P1610, DOI 10.1136/bmj.308.6944.1610.
   BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331.
   BYERS TE, 1987, AM J EPIDEMIOL, V125, P351, DOI 10.1093/oxfordjournals.aje.a114542.
   CAMBIEN F, 1988, AM J EPIDEMIOL, V127, P75, DOI 10.1093/oxfordjournals.aje.a114793.
   CAMBIEN F, 1980, AM J EPIDEMIOL, V112, P388, DOI 10.1093/oxfordjournals.aje.a113004.
   CAROLL KK, 1986, PROG CLIN BIOL RES, V206, P237.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   CRIQUI MH, 1994, LANCET, V344, P1719, DOI 10.1016/S0140-6736(94)92883-5.
   DEBACKER G, 1989, ATHEROSCLEROSIS, V78, P237, DOI 10.1016/0021-9150(89)90229-3.
   Ducimetiere P., 1992, Nutrition Metabolism and Cardiovascular Diseases, V2, P195.
   ETIENNE G, 1963, ANN BIOL CLIN, V21, P851.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   FREUDENHEIM JL, 1989, EPIDEMIOL REV, V11, P229, DOI 10.1093/oxfordjournals.epirev.a036039.
   GOODMAN MT, 1988, AM J EPIDEMIOL, V128, P1241, DOI 10.1093/oxfordjournals.aje.a115078.
   ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920.
   ISO H, 1994, J CLIN EPIDEMIOL, V47, P961, DOI 10.1016/0895-4356(94)90110-4.
   Karmali R A, 1986, Prog Clin Biol Res, V222, P687.
   KNEKT P, 1991, NUTR CANCER, V16, P267, DOI 10.1080/01635589109514165.
   KOLONEL LN, 1988, AM J EPIDEMIOL, V127, P999, DOI 10.1093/oxfordjournals.aje.a114903.
   KRITCHEVSKY SB, 1992, AM J EPIDEMIOL, V135, P509, DOI 10.1093/oxfordjournals.aje.a116318.
   LAW MR, 1991, CANCER CAUSE CONTROL, V2, P253, DOI 10.1007/BF00052142.
   LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373.
   MCGEE D, 1985, INT J EPIDEMIOL, V14, P97, DOI 10.1093/ije/14.1.97.
   MOILANEN T, 1985, AM J CLIN NUTR, V42, P708, DOI 10.1093/ajcn/42.4.708.
   NIKKARI T, 1983, AM J CLIN NUTR, V37, P848, DOI 10.1093/ajcn/37.5.848.
   PRENTICE RL, 1990, CANCER CAUSE CONTROL, V1, P81, DOI 10.1007/BF00053187.
   RENAUD S, 1979, TABLE COMPOSITION AL, P63.
   RICHARD JL, 1981, NOUV PRESSE MED, V10, P1111.
   ROSSENEU M, 1994, ATHEROSCLEROSIS, V108, P127, DOI 10.1016/0021-9150(94)90107-4.
   SANTOS MT, 1984, ATHEROSCLEROSIS, V50, P53, DOI 10.1016/0021-9150(84)90007-8.
   SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364.
   SCHUIT AJ, 1993, AM J EPIDEMIOL, V137, P966, DOI 10.1093/oxfordjournals.aje.a116769.
   SHEKELLE RB, 1981, LANCET, V2, P1185.
   SHEPHERD J, 1987, BRIT MED J, V295, P1245, DOI 10.1136/bmj.295.6608.1245.
   TUCKEY RC, 1979, ANAL BIOCHEM, V94, P402, DOI 10.1016/0003-2697(79)90381-6.
   TUYNS AJ, 1988, NUTR CANCER, V11, P189, DOI 10.1080/01635588809513986.
   ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M.
   URSIN G, 1993, AM J EPIDEMIOL, V137, P916, DOI 10.1093/oxfordjournals.aje.a116753.
   WARNET JM, 1985, BRIT MED J, V290, P1859, DOI 10.1136/bmj.290.6485.1859.
   WILLETT W, 1989, NATURE, V338, P389, DOI 10.1038/338389a0.},
Number-of-Cited-References = {41},
Times-Cited = {28},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {BMJ-British Medical Journal},
Doc-Delivery-Number = {TE859},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1995TE85900017},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1990EP54000001,
Author = {GRAVESON, AC and ARMSTRONG, JB},
Title = {THE PREMATURE DEATH (P) MUTATION OF AMBYSTOMA-MEXICANUM AFFECTS A
   SUBPOPULATION OF NEURAL CREST CELLS},
Journal = {DIFFERENTIATION},
Year = {1990},
Volume = {45},
Number = {2},
Pages = {71-75},
Month = {NOV},
Abstract = {The premature death (p) mutation of Ambystoma mexicanum causes
   abnormalities in a variety of organs, including the gills, liver, and
   heart.  In vitro culture techniques were used to test the hypothesis
   that mutant anterior endoderm is defective for several functions.  We
   find that the endoderm is normal in its ability to induce cartilage
   formation in cranial neural crest, and cardiomyogenesis in mesoderm. 
   Mutant neural crest, however, was found to be incapable of
   chondrogenesis, although other subpopulations of the neural crest were
   apparently normal.  We therefore propose that the p gene does not affect
   the endoderm, as previously suspected, but rather affects an
   intermediate step between the initial specification of the neural crest
   and its final segregation.},
Publisher = {SPRINGER VERLAG},
Address = {175 FIFTH AVE, NEW YORK, NY 10010},
Type = {Article},
Language = {English},
Affiliation = {UNIV OTTAWA,DEPT BIOL,OTTAWA K1N 6N5,ONTARIO,CANADA.
   DALHOUSIE UNIV,CTR LIFE SCI,DEPT BIOL,HALIFAX B3H 4J1,NS,CANADA.},
DOI = {10.1111/j.1432-0436.1990.tb00459.x},
ISSN = {0301-4681},
Research-Areas = {Cell Biology; Developmental Biology},
Web-of-Science-Categories  = {Cell Biology; Developmental Biology},
Cited-References = {Armstrong J. B., 1989, DEV BIOL AXOLOTL, P220.
   Armstrong J.B., 1989, DEV BIOL AXOLOTL, P228.
   ARMSTRONG JB, 1985, DEV GENET, V6, P1, DOI 10.1002/dvg.1020060102.
   Asashima M., 1989, DEV BIOL AXOLOTL, P255.
   BESSON WT, 1986, CIRCULATION, V73, P360, DOI 10.1161/01.CIR.73.2.360.
   Bordzilovskaya NP, 1989, DEV BIOL AXOLOTL, P201.
   BRUN RB, 1987, J NEUROGENET, V4, P29, DOI 10.3109/01677068709102331.
   CHIBON P, 1966, MEMOIRES SOC ZOOLOGI, V34.
   GRAVESON AC, 1987, DIFFERENTIATION, V35, P16, DOI 10.1111/j.1432-0436.1987.tb00146.x.
   Hall BK, 1988, NEURAL CREST.
   JACOBSON AG, 1968, J EXP ZOOL, V167, P79, DOI 10.1002/jez.1401670106.
   KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102.
   KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926.
   MESHARTREE M, 1980, J EMBRYOL EXP MORPH, V60, P295.
   Moser F, 1940, J MORPHOL, V66, P261, DOI 10.1002/jmor.1050660205.
   SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5.
   SMITH SC, 1990, J EXP ZOOL, V254, P48, DOI 10.1002/jez.1402540108.
   TROTTIER TM, 1977, J EMBRYOL EXP MORPH, V39, P139.},
Number-of-Cited-References = {18},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Differentiation},
Doc-Delivery-Number = {EP540},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1990EP54000001},
DA = {2022-03-29},
}

@article{ WOS:000352342500001,
Author = {Martinez, David and Giraldez-Garcia, Carolina and Miqueleiz, Estrella
   and Calle, Maria E. and Santos, Juana M. and Regidor, Enrique},
Title = {The role of population change in the increased economic differences in
   mortality: a study of premature death from all causes and major groups
   of causes of death in Spain, 1980-2010},
Journal = {BMC PUBLIC HEALTH},
Year = {2015},
Volume = {15},
Month = {APR 2},
Abstract = {Background: An increase has been observed in differences in mortality
   between the richest and poorest areas of rich countries. This study
   assesses whether one of the proposed explanations, i.e., population
   change, might be responsible for this increase in Spain.
   Methods: Observational study based on average income, population change
   and mortality at provincial level. The premature mortality rate (ages
   0-74 years) was estimated for all causes and for cancer, cardiovascular
   disease and external causes across the period 1980-2010. In the years
   analysed, provinces were grouped into tertiles based on provincial
   income, with the mortality rate ratio (MMR) being estimated by taking
   the tertile of highest-income provinces as reference. Population change
   was then controlled for to ascertain whether it would modify the rate
   ratio.
   Results: In all-cause mortality, the magnitude of the MRR for provinces
   in the poorest versus the richest tertile was 1.01 in 1980 and 1.12 in
   2010; in cardiovascular mortality, the MMRs for these same years were
   1.08 and 1.31 respectively; and in the case of cancer and external-cause
   mortality, MMR magnitude was similar in 1980 and 2010. The magnitude of
   the MMR remained unchanged in response to adjustment for population
   change, with the single exception of 1980, when it increased in
   all-cause and cardiovascular mortality.
   Conclusion: The increase in the difference in premature mortality
   between the richest and poorest areas in Spain is due to the increased
   difference in cardiovascular mortality. This increase is not accounted
   for by population change. In rich countries, more empirical evidence is
   thus needed to test other alternative explanations for the increase in
   economic differences in mortality.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Regidor, E (Corresponding Author), Univ Complutense Madrid, Fac Med, Dept Prevent Med \& Publ Hlth, Madrid, Spain.
   Martinez, David; Giraldez-Garcia, Carolina; Calle, Maria E.; Santos, Juana M.; Regidor, Enrique, Univ Complutense Madrid, Fac Med, Dept Prevent Med \& Publ Hlth, Madrid, Spain.
   Martinez, David; Giraldez-Garcia, Carolina; Calle, Maria E.; Santos, Juana M.; Regidor, Enrique, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain.
   Miqueleiz, Estrella, Univ Publ Navarra, Dept Sociol, Pamplona, Spain.
   Regidor, Enrique, CIBER Epidemiol Salud Publ CIBERESP, Madrid, Spain.},
DOI = {10.1186/s12889-015-1678-5},
Article-Number = {321},
EISSN = {1471-2458},
Keywords = {Population change; Per capita income; Mortality; Causes of death; Spain},
Keywords-Plus = {SHRINKING AREAS; GEOGRAPHICAL INEQUALITIES; HEALTH; ARTIFACT; MEN;
   MIGRATION; DENSITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {enriqueregidor@hotmail.com},
ORCID-Numbers = {Regidor, Enrique/0000-0002-2374-9861
   Giraldez-Garcia, Carolina/0000-0002-1938-0280},
Funding-Acknowledgement = {Ministry of Science and InnovationSpanish Government {[}PI12/01459]},
Funding-Text = {This study was conducted thanks to support from the Research Project
   PI12/01459 ``Population change and geographical inequalities in
   mortality{''} financed by the Ministry of Science and Innovation.},
Cited-References = {Boyle P, 2004, AREA, V36, P164, DOI 10.1111/j.0004-0894.2004.00212.x.
   Brimblecombe N, 2000, SOC SCI MED, V50, P861, DOI 10.1016/S0277-9536(99)00371-8.
   Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009.
   Connolly S, 2007, SOC SCI MED, V65, P1004, DOI 10.1016/j.socscimed.2007.04.035.
   Connolly S, 2007, SOC SCI MED, V64, P2008, DOI 10.1016/j.socscimed.2007.02.021.
   {*}EUR, 2005, EUR YB 2005.
   Exeter DJ, 2009, HEALTH PLACE, V15, P399, DOI 10.1016/j.healthplace.2008.04.001.
   Exeter DJ, 2005, J EPIDEMIOL COMMUN H, V59, P924, DOI 10.1136/jech.2004.032151.
   Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066.
   Fundacion BBV, 1999, SER HOM AN 1955 1993.
   Grau M, 2011, REV ESP CARDIOL, V64, P295, DOI {[}10.1016/j.rec.2010.11.005, 10.1016/j.recesp.2010.11.005].
   Harper S, 2006, INT J EPIDEMIOL, V35, P604, DOI 10.1093/ije/dyl099.
   Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046.
   Leyland AH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-172.
   MAHONEY MC, 1990, INT J EPIDEMIOL, V19, P483, DOI 10.1093/ije/19.3.483.
   Molarius A, 2000, J EPIDEMIOL COMMUN H, V54, P772, DOI 10.1136/jech.54.10.772.
   Pearce J, 2006, INT J EPIDEMIOL, V35, P597, DOI 10.1093/ije/dyl013.
   Regidor E, 2002, J EPIDEMIOL COMMUN H, V56, P919, DOI 10.1136/jech.56.12.919.
   Regidor E, 2008, ANN EPIDEMIOL, V18, P605, DOI 10.1016/j.annepidem.2008.04.007.
   Regidor E, 2014, HEALTH PLACE, V27, P30, DOI 10.1016/j.healthplace.2014.01.010.
   Reques L, 2014, J EPIDEMIOL COMMUN H, V68, P1151, DOI 10.1136/jech-2014-204186.
   Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016.
   Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600.
   Smith GD, 1998, LANCET, V352, P1439, DOI 10.1016/S0140-6736(05)61261-5.
   Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P9, DOI 10.1136/jech.55.1.9.
   Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639.
   Valencian Institute of Economic Research, 2014, HUMAN CAPITAL.
   WING S, 1988, AM J PUBLIC HEALTH, V78, P923, DOI 10.2105/AJPH.78.8.923.},
Number-of-Cited-References = {28},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {CF1XY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000352342500001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@incollection{ WOS:000372088600010,
Author = {Jacques, Roy},
Editor = {Prasad, A and Prasad, P and Mills, AJ and Mills, JH},
Title = {Power failure The short life and premature death of critical
   ``diversity{''} research},
Booktitle = {ROUTLEDGE COMPANION TO CRITICAL MANAGEMENT STUDIES},
Series = {Routledge Companions in Business Management and Accounting},
Year = {2016},
Pages = {140-158},
Publisher = {ROUTLEDGE},
Address = {2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND},
Type = {Article; Book Chapter},
Language = {English},
Affiliation = {Jacques, Roy, Acad Management, Gender \& Divers Div, London, England.},
ISBN = {978-1-315-88981-8; 978-0-415-50188-0},
Keywords-Plus = {WORK},
Research-Areas = {Business \& Economics},
Web-of-Science-Categories  = {Business; Management},
Cited-References = {BLACKFORD KMH, 1914, JOB MAN BOSS.
   Burrell G., 1979, SOCIOLOGICAL PARADIG.
   Calas M. B., 1988, 7 ANN C WOM ORG LONG.
   Clothier R., 1923, PERSONNEL MANAGEMENT.
   Fairclough N.L., 2010, CRITICAL DISCOURSE A.
   FERGUSON KE, 1984, FEMINIST CASE BUREAU.
   Foucault M., 1970, ARCHAEOLOGY KNOWLEDG, P215.
   Harrison DA, 1998, ACAD MANAGE J, V41, P96, DOI 10.2307/256901.
   Jacobson S. W., 1990, AC MAN M SAN FRANC A.
   Jacques R., 1992, MANUFACTURING EMPLOY.
   Jones D, 2004, J ORGAN CHANGE MANAG, V17, P281, DOI 10.1108/09534810410538333.
   Likert R., 1967, HUMAN ORG ITS MANAGE.
   Marcus, 1986, WRITING CULTURE POET, P234.
   Meyerson D. E., 2001, TEMPERED RADICALS PE.
   Miller J.B., 1976, NEW PSYCHOL WOMEN.
   MINTZBERG H, 1971, MANAGE SCI B-APPL, V18, pB97.
   Nkomo S., 1996, HDB ORG STUDIES, P329.
   Parsons T., 1967, GEN THEORY ACTION.
   Prasad P., 2005, CRAFTING QUALITATIVE.
   Prasad P., 1997, MANAGING ORG MELTING.
   Pringle, 2006, HDB WORKPLACE DIVERS.
   Putnam L., 2004, SAGE HDB ORG DISCOUR.
   Shipman P, 2002, EVOLUTION RACISM HUM.},
Number-of-Cited-References = {23},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {BE4QL},
Web-of-Science-Index = {Book Citation Index – Social Sciences & Humanities (BKCI-SSH)},
Unique-ID = {WOS:000372088600010},
DA = {2022-03-29},
}

@article{ WOS:000272207700025,
Author = {He, Jiang and Gu, Dongfeng and Chen, Jing and Wu, Xigui and Kelly,
   Tanika N. and Huang, Jian-feng and Chen, Ji-chun and Chen, Chung-Shiuan
   and Bazzano, Lydia A. and Reynolds, Kristi and Whelton, Paul K. and
   Klag, Michael J.},
Title = {Premature deaths attributable to blood pressure in China: a prospective
   cohort study},
Journal = {LANCET},
Year = {2009},
Volume = {374},
Number = {9703},
Pages = {1765-1772},
Month = {NOV 21},
Abstract = {Background Hypertension is a major global-health challenge because of
   its high prevalence and concomitant risks of cardiovascular disease. We
   estimated premature deaths attributable to increased blood pressure in
   China.
   Methods We did a prospective cohort study in a nationally representative
   sample of 169871 Chinese adults aged 40 years and older. Blood pressure
   and other risk factors were measured at a baseline examination in 1991
   and follow-up assessment was done in 1999-2000. Premature death was
   defined as mortality before age 72 years in men and 75 years in women,
   which were the average life expectancies in China in 2005. We calculated
   the numbers of total and premature deaths attributable to blood pressure
   using population-attributable risk, mortality; and the population size
   of China in 2005.
   Findings Hypertension and prehypertension were significantly associated
   with increased all-cause and cardiovascular mortality (p<0.0001). We
   estimated that in 2005, 2.33 million (95\% CI 2.21-2.45) cardiovascular
   deaths were attributable to increased blood pressure in China: 2.11
   million (2.03-2.20) in adults with hypertension and 0.22 million
   (0.19-0.25) in adults with prehypertension. Additionally, 1.27 million
   (1.18-1.36) premature cardiovascular deaths were attributable to raised
   blood pressure in China: 1.15 million (1.08-1.22) in adults with
   hypertension and 0.12 million (0.10-0.14) in adults with
   prehypertension. Most blood pressure-related deaths were caused by
   cerebrovascular diseases: 1.86 million (1.76-1.96) total deaths and 1.08
   million (1.00-1.15) premature deaths.
   Interpretation Increased blood pressure is the leading preventable risk
   factor for premature mortality in the Chinese general population.
   Prevention and control of this condition should receive top
   public-health priority in China.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {He, J (Corresponding Author), Tulane Univ, Sch Publ Hlth \& Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
   He, Jiang; Kelly, Tanika N.; Chen, Chung-Shiuan; Bazzano, Lydia A., Tulane Univ, Sch Publ Hlth \& Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
   He, Jiang; Chen, Jing; Bazzano, Lydia A., Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA.
   He, Jiang; Chen, Jing; Bazzano, Lydia A., Tulane Univ, Sch Med, Tulane Hypertens \& Renal Ctr Excellence, New Orleans, LA 70112 USA.
   Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun, Cardiovasc Inst, Dept Evidence Based Med, Beijing, Peoples R China.
   Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun, Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China.
   Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun, Peking Union Med Coll, Beijing 100021, Peoples R China.
   Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun, Natl Cardiovasc Ctr, Beijing, Peoples R China.
   Reynolds, Kristi, Kaiser Permanente So Calif, Dept Res \& Evaluat, Pasadena, CA USA.
   Whelton, Paul K., Loyola Univ Med Ctr, Maywood, IL 60153 USA.
   Klag, Michael J., Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.},
DOI = {10.1016/S0140-6736(09)61199-5},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {JOINT NATIONAL COMMITTEE; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN;
   HYPERTENSION; HEALTH; PREVALENCE; RISK; ADULTS; PREHYPERTENSION;
   POPULATION},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {jhe@tulane.edu},
ResearcherID-Numbers = {Reynolds, Kristi/AAN-1434-2021
   He, Jiang/AAF-5303-2020},
ORCID-Numbers = {Reynolds, Kristi/0000-0001-7619-1649
   He, Jiang/0000-0002-8286-9652},
Funding-Acknowledgement = {American Heart Association (USA)American Heart Association; National
   Heart, Lung, and Blood Institute, National institutes of Health
   (USA)United States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung \& Blood
   Institute (NHLBI); Ministry of Health (China); Ministry of Science and
   Technology (China)Ministry of Science and Technology, China; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung \& Blood Institute (NHLBI) {[}U01HL072507] Funding Source:
   NIH RePORTER},
Funding-Text = {American Heart Association (USA); National Heart, Lung, and Blood
   Institute, National institutes of Health (USA); Ministry of Health
   (China); and Ministry of Science and Technology (China).},
Cited-References = {{*}ATH RISK COMM STU, 1997, MAN 3 SURV COMP PROC.
   CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2.
   Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f.
   COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z.
   Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249.
   FROHLICH ED, 1988, CIRCULATION, V77, pA502.
   Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5.
   Gu DF, 2008, AM J HYPERTENS, V21, P265, DOI 10.1038/ajh.2007.59.
   He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467.
   Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850.
   INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1.
   Kahn HA., 1989, STAT METHODS EPIDEMI, P73.
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3.
   Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593.
   Korn EL, 1997, AM J EPIDEMIOL, V145, P72.
   Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8.
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8.
   Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2.
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9.
   Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f.
   {*}MIN HLTH PEOPL RE, 2001, HLTH STAT INF CHIN 2.
   Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497.
   Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003.
   Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027.
   United Nations General Assembly, 2000, UN MILL DECL.
   Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417.
   Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126.
   Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882.
   WHELTON PK, 2004, CLIN TRIALS CARDIOVA, P282.
   {*}WHO, 2006, LIF TABL CHIN.
   Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z.
   Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499.
   Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166.},
Number-of-Cited-References = {33},
Times-Cited = {169},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {34},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {525ID},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000272207700025},
DA = {2022-03-29},
}

@article{ WOS:000399036600006,
Author = {Chelo, David and Nguefack, Felicitee and Awa, Hubert D. Mbassi and
   Dongmo, Roger and Mafotso, Josiane Nkwonkam and Um, Suzanne Ngo and
   Ambomatei, Calson and Ndombo, Paul O. Koki},
Title = {Premature death of children aged 2 months to 5 years: the case of the
   Mother and Child Center of the Chantal Biya Foundation, Yaounde,
   Cameroon},
Journal = {TRANSLATIONAL PEDIATRICS},
Year = {2016},
Volume = {5},
Number = {1},
Pages = {23-30},
Month = {JAN},
Abstract = {Background: In hospital premature deaths of children less than 5 years
   of age admitted for different reasons still remains very high in our
   context warranting study in order to reverse the tendency (using
   appropriate means). Our study was aimed at describing and analyzing
   cases of those children aged from 2 months to 5 years who died within
   the first 48 hours of their admission at the Mother and Child Center of
   the Chantal Biya Foundation (MCC/CBF).
   Methods: It was a retrospective descriptive study. Data were extracted
   from the clinical records of the patients admitted from 2008 to 2012.
   Cases of accidental trauma were excluded from the study. Level of
   statistical significance was set at P<0.05. The approval of the ethical
   committee of the Universite des Montagnes was also obtained.
   Results: During the period of our study, out of the 14,200 patients aged
   2 months and 5 years who were hospitalized 522 premature deaths were
   registered. This gives an incidence of 4.9\%, representing 74.3\% of all
   hospitalized deaths in this age group. Considering the fact that some of
   the files had very little information, only 373 files were studied. The
   sex ratio was 1.2. More astonishing was that a majority of the deaths
   occurred between midnight and 8 am. The most frequent registered cases
   were patients with severe malaria (42.6\%), severe sepsis (20.6\%), and
   acute lower respiratory tract infections (RTI) (16.1\%) cases. One third
   of the patients had a poor nutritional status.
   Conclusions: The reinforcement of preventive measures and programs
   targeting the health of children such as the Integrated Management of
   Childhood Diseases (IMCD) would be a major priority in proffering a
   solution to this phenomenon.},
Publisher = {AME PUBL CO},
Address = {FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA},
Type = {Article},
Language = {English},
Affiliation = {Chelo, D (Corresponding Author), Chantal Biya Fdn, Mother \& Child Ctr, Pediat Cardiol Unit, POB 1936, Yaounde, Cameroon.
   Chelo, David; Nguefack, Felicitee; Awa, Hubert D. Mbassi; Mafotso, Josiane Nkwonkam; Um, Suzanne Ngo; Ndombo, Paul O. Koki, Chantal Biya Fdn, Mother \& Child Ctr, Yaounde, Cameroon.
   Chelo, David; Awa, Hubert D. Mbassi; Um, Suzanne Ngo; Ambomatei, Calson; Ndombo, Paul O. Koki, Univ Yaounde I, Fac Med \& Biomed Sci, Dept Pediat, Yaounde, Cameroon.
   Nguefack, Felicitee, Gyneco Obstetr \& Pediat Hosp, Yaounde, Cameroon.
   Dongmo, Roger, Dist Hosp Efoulan, Yaounde, Cameroon.},
DOI = {10.3978/j.issn.2224-4336.2016.01.02},
ISSN = {2224-4344},
Keywords = {Hospital deaths; 48 hours; children; Integrated Management of Childhood
   Diseases (IMCD)},
Keywords-Plus = {CARE-SEEKING; MALARIA; INTERVENTIONS; PNEUMONIA; MORTALITY; IMPACT},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Author-Email = {chelodad6@yahoo.fr},
ORCID-Numbers = {Calson Aba-andou, Ambomatei/0000-0002-1594-4405},
Cited-References = {Azoumah K. D., 2007, Medecine d'Afrique Noire, V54, P5.
   Azoumah KD, 2007, MORTALITE HOSPITALIE.
   Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309.
   Christopher JB, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-27.
   Commeyras C, 2005, CAH SANTE, V16, P5.
   Coulibaly I, 2008, ACT C AIDELF, P223.
   de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27.
   de Souza ACT, 2000, SOC SCI MED, V51, P1675, DOI 10.1016/S0277-9536(00)00100-3.
   Dongre AR, 2008, INDIAN J PEDIATR, V75, P325, DOI 10.1007/s12098-008-0032-7.
   Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x.
   Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1.
   Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353.
   Koffi AK, 2015, J GLOB HEALTH, V5, P172, DOI 10.7189/jogh.05.010413.
   Libite PR, 2011, REPUBLIC CAMEROON DE.
   Miakoundoba RC, MORBIDITY MORTALITY.
   Mockenhaupt FP, 2003, TROP MED INT HEALTH, V8, P857, DOI 10.1046/j.1365-3156.2003.01117.x.
   NGUEFACK F, 2012, PAN AFR MED J, V12, P46.
   Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33.
   Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151.
   World Health Organization, SER CHILDH PROBL COU.
   World Health Organization, 2009, STAT SAN MOND 2009.},
Number-of-Cited-References = {21},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Transl. Pediatr.},
Doc-Delivery-Number = {ER8AF},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000399036600006},
DA = {2022-03-29},
}

@article{ WOS:A1986C034100030,
Author = {KRISTAL, AR},
Title = {THE IMPACT OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME ON PATTERNS OF
   PREMATURE DEATH IN NEW-YORK-CITY},
Journal = {JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
Year = {1986},
Volume = {255},
Number = {17},
Pages = {2306-2310},
Month = {MAY 2},
Publisher = {AMER MEDICAL ASSOC},
Address = {515 N STATE ST, CHICAGO, IL 60610},
Type = {Article},
Language = {English},
Affiliation = {KRISTAL, AR (Corresponding Author), NEW YORK CITY DEPT HLTH,OFF EPIDEMIOL SURVEILLANCE \& STAT,125 WORTH ST,NEW YORK,NY 10013, USA.},
DOI = {10.1001/jama.255.17.2306},
ISSN = {0098-7484},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ResearcherID-Numbers = {Kristal, Alan/A-8779-2008
   },
ORCID-Numbers = {Kristal, Alan/0000-0002-7329-1617},
Cited-References = {CHAMBERLAND ME, 1985, JAMA-J AM MED ASSOC, V254, P383, DOI 10.1001/jama.254.3.383.
   HARDY AM, 1985, APR INT C ACQ IMM SY.
   KRISTAL AR, 1985, DHHS861214 NAT CTR H, P261.
   MARTIN JM, 1985, 93RD ANN CONV AM PSY.
   PETERMAN TA, 1985, EPIDEMIOL REV, V7, P1.
   STONEBURNER RL, 1984, 33RD ANN C EP INT SE.
   1985, MMWR, V34, P17.
   AM J EPIDEMIOL.},
Number-of-Cited-References = {8},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {JAMA-J. Am. Med. Assoc.},
Doc-Delivery-Number = {C0341},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1986C034100030},
DA = {2022-03-29},
}

@article{ WOS:000748796000003,
Author = {Lastra, Elizabeth},
Title = {Confronting premature death: Cluny, Arthur Kingsley Porter, and the tomb
   of Alfonso Ansurez},
Journal = {WORD \& IMAGE},
Year = {2021},
Volume = {37},
Number = {4},
Pages = {323-336},
Month = {OCT 2},
Abstract = {Since the early twentieth century, the carved sarcophagus of Alfonso
   Ansurez has been considered a central work of Spanish medieval art.
   Nonetheless, its singular imagery remains enigmatic and its contentious
   modern history largely unexplored. The late eleventh-century sarcophagus
   of the young noble Alfonso Ansurez is both exceptionally clear and
   frustratingly enigmatic. Inscriptions label every detail, down to a cup
   labeled calix, and large carved figures signal the viewer through
   pronounced gestures, but the tomb's details diverge from developing
   norms in funerary iconography. Unlike the common medieval representation
   of the deceased as a nude androgynous soul, the young Alfonso, while
   plainly identified by the inscription ``deceased Alfonso,{''} is shown
   fully dressed and animate. This article argues that the tomb depicts
   Alfonso's reception of last rites, which may not have been observed
   before the young noble's untimely death. The carefully marked details
   actualize a ritual indispensable for the salvation of his soul. The
   article also elucidates the little-known role played by Arthur Kingsley
   Porter - probable victim of another premature death - in the Spanish
   monument's clandestine and controversial appearance in the United
   States.},
Publisher = {ROUTLEDGE JOURNALS, TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
DOI = {10.1080/02666286.2021.1884822},
ISSN = {0266-6286},
EISSN = {1943-2178},
Keywords = {Alfonso Ansurez; Arthur Kingsley Porter; Romanesque; Cluny; sculpture;
   funerary art},
Research-Areas = {Arts \& Humanities - Other Topics},
Web-of-Science-Categories  = {Humanities, Multidisciplinary},
Cited-References = {Academia das Ciencias de Lisboa, 1873, PORT MON HIST DIPL C, V4, P475.
   Alonso Julio Puyol y, 1920, CRONICAS ANONIMAS SA, P68.
   Alvarez Moralejo, 1973, ACTAS 23 C INT HIST, V1, P65.
   Alvarez Serafin Moralejo, 2004, PATRIMONIO ARTISTICO, V3, P261.
   Alvarez Serafin Moralejo, 1985, SANTIAGO SAINT DENIS, P63.
   AMARAL Paulo, 2010, SUENO GUNZO SAHAGUN.
   {[}Anonymous], 1993, ART MEDIEVAL SPAIN, P214.
   {[}Anonymous], 1935, HARVARD CRIMSON 1212.
   Barasch Moshe., 2005, ARTIBUS HIST ART ANT, V52, P13, DOI {[}10.2307/20067095, DOI 10.2307/20067095].
   BARTON S, 1997, ARISTOCRACY 12 CENTU, P275.
   Baruque Julio Valdeon, 1983, CONDE ANSUREZ VALLIS.
   Baruque Valdeon Julio, 1983, CONDE ANSUREZ VALLIS.
   BASCHET J, 2000, SEIN PERE ABRAHAM PA.
   Binski Paul, 1996, MEDIEVAL DEATH RITUA, P36.
   BISHKO C. J., 1961, STUD MONASTICA, V3, P53.
   BISHKO Charles Julian, 1980, STUDIES MEDIEVAL SPA, VII, P1.
   Bruce Scott G., 2016, PENGUIN BOOK UNDEAD, P111.
   Bruce SG, 2007, CAMB STUD MED LIFE, V68, P1.
   BRUEL A, 1876, RECUEIL CHARTES ABBA, V1, P124.
   Caro Paz Cabello, 2013, MUSEOSES REV SUBDIRE, P156.
   CASSAGNESBROUQU.S, 1997, CAHIERS SAINT MICHEL, V28, P21.
   Cavero Alicia Miguelez, 2012, IMPAGINATIO INSCRIPC, P73.
   Cosmen Alonso Concepcion, 2006, DE ARTE, V5, P29, DOI {[}10.18002/da.v0i5.1544, DOI 10.18002/DA.V0I5.1544].
   Costigan Lucy, 2012, GLENVEAGH MYSTERY LI.
   de Leon Margarita Torres Sevilla-Quinones, 1999, LINAJES NOBILIARIOS, P142.
   de Morales Ambrosio, 1765, VIAGE AMBROSIO MORAL, P37.
   DEmilio James, 1992, ACT S INT PORT GLOR, P83.
   DESANDOVAL P, 1601, PRIMERA PARTE FUNDAC.
   Encinas J. M. Vidal, 2012, ALFONSO 4 LEGADO, P2.
   Escalona Romualdo, 1782, HIST REAL MONASTERIO, P236.
   Faraldo Andres Baron, 2013, CONDE PEDRO ANSUREZ.
   Fernandez Justiniano Rodriguez, 1961, B SEMINARIO ESTUDIOS, V27, P337.
   Forbes, 1932, COMMUNICATION 0709.
   Forbes, 1931, COMMUNICATION 0114.
   Forbes, 1932, COMMUNICATION 0423.
   Forbes Edward, 1926, COMMUNICATION 0405.
   Forbes Edward W., 1925, ANN REPORT FOGG ART, P269.
   Fozi S, 2015, SPECULUM, V90, P158, DOI 10.1017/S0038713414002413.
   Galan JLSGY, 2008, ARCH ESPAN ART, V81, P139.
   Ghislain Baury, 2011, ANUARIO ESTUDIOS MED, V41, P151.
   Gil Javier Perez, 2002, MONARQUIA MONACATO E, P88.
   Glaber Rodulfus, 2002, 5 BOOKS HIST, P234.
   Gomez-Moreno M., 1925, CATALOGO MONUMENTAL, P348.
   Harris J., 1991, B MUSEO ARQUEOLOG NA, V9, P69.
   HASSIG D, 1991, GESTA, V30, P140, DOI 10.2307/767056.
   Herrero de la Fuente Marta, 1988, COLECCION DIPLOMATIC.
   Kahsnitz Rainer, 1993, BERNWARD HILDESHEIM, P383.
   Lastra Elizabeth, 2017, THESIS U PENNSYLVANI, P91.
   LeGoff Jacques., 1990, BIRTH PURGATORY.
   Lopez Maria Encarnacion Martin, 2016, DOCUMENTA INSTRUMENT, V14, P122.
   Mann J, 1997, GESTA, V36, P156, DOI 10.2307/767235.
   Moralejo S., 1979, CAHIERS SAINT MICHEL, V10, P79.
   Odo of Cluny, 1900, ODONIS ABBATIS CLUNI, P447.
   Ortega Maria Victoria Herraez, 2000, PATRIMONIO ARTISTICO.
   Otero Alexandra Cabana, 1995, B DO MUSEO PROVINCIA, V1, P251.
   Patronato del Museo Arqueologico Nacional, 1932, LAUD CUB MARM SEP AL, P4.
   Paxton Frederick S., 2013, DEATH RITUAL CLUNY C, P96.
   Perez Mariel, 2015, B CTR ETUDES MEDIEVA, V19, P1.
   Peter the Venerable, 1988, PETRUS CLUNIACENSIS.
   Porter A. K., 1928, SPANISH ROMANESQUE S, VI, P59.
   Porter A. K., 1926, ART B, V8, P235.
   Porter Lucy, 1937, AES LETT MINANLABAIN, P17.
   Prado-Vilar F, 2019, CODEX AQUILAR, V35, P223.
   Reglero de la Fuente Carlos, 2008, CLUNY ESPANA PRIORAT.
   Reglero de la Fuente Carlos M., 2007, MONARQUIA SOC REINO, VII, P689.
   Reilly B. F., 2008, CROSS CRESCENT CONVE, P109.
   Richardson Hilary, 1993, DONEGAL ANN, V45, P83.
   Romo F. Garcia, 1966, MELANGES OFFERTS REN, V1, P359.
   Ruiz Maria Jose Martinez, 2011, B MUSEO ARQUEOLOGICO, V29, P117.
   Sazama Kristin M., 2002, AV NEFS ESP ACC EGL, P440.
   Senra Jose Luis, 1994, ARCH ESPAN ART, V67, P67.
   SENRA Jose Luis, 2017, J MEDIEV IBER STUD, V9.
   Senra Jose Luis, 2011, CONSTRUCCION MEDIEVA, P243.
   Senra Jose Luis, 2006, QUINTANA REV ESTUDIO, V5, P240.
   Sheingorn P., 1995, ART LIFE COLLECTED P, P155.
   Simon David, 1979, THESIS COURTAULD I A.
   SIMON David, 1979, CAHIERS SAINT MICHEL, P107.
   Sola Juan A. Estevez, 1995, CHRONICA NAIERENSIS, VII, P77.
   ValdezdelAlamo E, 1996, ART BULL, V78, P311.
   Villalobos Manuel Manueco, 1917, DOCUMENTOS IGLESIA C, V1, P24.
   Werckmeister O. K., 1972, J WARBURG COURTAULD, V35, P1.
   WILLIAMS J, 1988, GESTA, V27, P93, DOI 10.2307/766997.
   WILLIAMS J, 1973, ART B, V55, P171.},
Number-of-Cited-References = {85},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Word Image},
Doc-Delivery-Number = {YP7IU},
Web-of-Science-Index = {Arts &amp; Humanities Citation Index (A&amp;HCI)},
Unique-ID = {WOS:000748796000003},
DA = {2022-03-29},
}

@article{ WOS:000377439900001,
Author = {Sacco, Ralph L. and Roth, Gregory A. and Reddy, K. Srinath and Arnett,
   Donna K. and Bonita, Ruth and Gaziano, Thomas A. and Heidenreich, Paul
   A. and Huffman, Mark D. and Mayosi, Bongani M. and Mendis, Shanthi and
   Murray, Christopher J. L. and Perel, Pablo and Pineiro, Daniel J. and
   Smith, Jr., Sidney C. and Taubert, Kathryn A. and Wood, David A. and
   Zhao, Dong and Zoghbi, William A.},
Title = {The Heart of 25 by 25: Achieving the Goal of Reducing Global and
   Regional Premature Deaths From Cardiovascular Diseases and Stroke A
   Modeling Study From the American Heart Association and World Heart
   Federation},
Journal = {CIRCULATION},
Year = {2016},
Volume = {133},
Number = {23},
Pages = {E674-E690},
Month = {JUN 7},
Abstract = {In 2011, the United Nations set key targets to reach by 2025 to reduce
   the risk of premature noncommunicable disease death by 25\% by 2025.
   With cardiovascular disease being the largest contributor to global
   mortality, accounting for nearly half of the 36 million annual
   noncommunicable disease deaths, achieving the 2025 goal requires that
   cardiovascular disease and its risk factors be aggressively addressed.
   The Global Cardiovascular Disease Taskforce, comprising the World Heart
   Federation, American Heart Association, American College of Cardiology
   Foundation, European Heart Network, and European Society of Cardiology,
   with expanded representation from Asia, Africa, and Latin America, along
   with global cardiovascular disease experts, disseminates information and
   approaches to reach the United Nations 2025 targets. The writing
   committee, which reflects Global Cardiovascular Disease Taskforce
   membership, engaged the Institute for Health Metrics and Evaluation,
   University of Washington, to develop region-specific estimates of
   premature cardiovascular mortality in 2025 based on various scenarios.
   Results show that > 5 million premature CVD deaths among men and 2.8
   million among women are projected worldwide by 2025, which can be
   reduced to 3.5 million and 2.2 million, respectively, if risk factor
   targets for blood pressure, tobacco use, diabetes mellitus, and obesity
   are achieved. However, global risk factor targets have various effects,
   depending on region. For most regions, United Nations targets for
   reducing systolic blood pressure and tobacco use have more substantial
   effects on future scenarios compared with maintaining current levels of
   body mass index and fasting plasma glucose. However, preventing
   increases in body mass index has the largest effect in some high-income
   countries. An approach achieving reductions in multiple risk factors has
   the largest impact for almost all regions. Achieving these goals can be
   accomplished only if countries set priorities, implement cost-effective
   population wide strategies, and collaborate in public-private
   partnerships across multiple sectors.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
DOI = {10.1161/CIR.0000000000000395},
ISSN = {0009-7322},
EISSN = {1524-4539},
Keywords = {AHA Scientific Statements; cardiovascular diseases; forecasting; global
   health; premature mortality; prevention and control},
Keywords-Plus = {SYSTEMATIC ANALYSIS; SCIENTIFIC STATEMENT; RISK-FACTORS; ALL-CAUSE;
   HEALTH; MORTALITY; BURDEN; TRENDS; PREVALENCE; CARE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
ResearcherID-Numbers = {Heidenreich, Paul/AAU-6864-2021
   Sacco, Ralph/Y-9278-2019
   },
ORCID-Numbers = {Heidenreich, Paul/0000-0001-7730-8490
   Reddy, K Srinath/0000-0003-3416-3548},
Cited-References = {Asaria P, 2007, LANCET, V370, P2004.
   Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0.
   Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0.
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X.
   Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3.
   Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82.
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692.
   Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94.
   Roth GA, 2015, CIRCULATION, V132, P1270, DOI 10.1161/CIRCULATIONAHA.115.016021.
   Smith SC, 2013, CIRCULATION, V128, P2546, DOI 10.1161/CIR.0b013e3182a93504.
   Smith SC, 2012, CIRCULATION, V126, P2769, DOI 10.1161/CIR.0b013e318267e99f.
   University of Washington, GLOB BURD DIS INJ RI.
   WHO, DRAFT COMPR GLOB MON.
   World Health Organisation, PACK ESS NCD INT PRI.
   World Health Organization, GLOB HLTH OBS DAT RE.
   World Health Organization, GLOB ACT PLAN PREV C.
   World Health Organization, NCD GLOB MON FRAM.
   World Health Organization and World Economic Forum, BURD BEST BUYS RED E.
   World Health Organization (WHO), GLOB STAT REP NONC D.
   Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339.
   Zoghbi WA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000504.},
Number-of-Cited-References = {26},
Times-Cited = {64},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {19},
Journal-ISO = {Circulation},
Doc-Delivery-Number = {DN9ZT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000377439900001},
OA = {Green Accepted, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000534443100002,
Author = {Wang, Yujin and Ding, Zan and Deng, Changyu and Guo, Pi and You, Yingbin
   and Li, Liujiu and Wang, Yanfang and Zhang, Qingying},
Title = {Years of life lost with premature death due to ambient temperatures in a
   southwest plateau region of China: a cause-specific and individual
   characteristics stratified mortality study},
Journal = {INTERNATIONAL JOURNAL OF BIOMETEOROLOGY},
Year = {2020},
Volume = {64},
Number = {8},
Pages = {1333-1341},
Month = {AUG},
Abstract = {We aimed to explore whether there were cold and heat temperature adverse
   effects on years of life lost (YLL) for non-accidental mortality in
   Yuxi, a southwest plateau region of China. From data for 89,467
   non-accidental deaths over an 8-year study period, we used a general
   linear regression model combined with a distributed lag non-linear model
   to assess the burden of disease non-accidental mortality due to ambient
   temperature with the YLL indicator. We estimated the mean YLL change per
   1 degrees C decrease from the 25th to 1st percentile mean temperature as
   the cold effect and per 1 degrees C increase from the 75th to 99th
   percentile as the heat effect. The 95\% empirical confidence intervals
   (eCIs) were calculated by using a bootstrap simulation method. The
   exposure-response curve between average temperature and YLL was
   U-shaped. The cold effect peaked at the first day after exposure and
   disappeared at 2 weeks, and the heat effect only lasted for the first 3
   days. A per 1 degrees C decrease from the 25th to 1st mean temperature
   percentile was associated with an increase of 15.6 (95\% eCI: 2.4, 22.9)
   in YLL for non-accidental diseases, and the cumulative effects due to
   cold were stronger in contrast to that attributed by heat. Cold
   temperature had a significant impact on YLL among the subgroups, with
   higher YLL in cardiovascular disease, stroke, males, Han nationality,
   married, and those engaged in agriculture than their corresponding
   categories. An increasing death burden of non-accidental in Yuxi of
   China due to cold temperature was demonstrated, and the association was
   also modified by specific disease causes and individual features.},
Publisher = {SPRINGER},
Address = {ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES},
Type = {Article},
Language = {English},
Affiliation = {Zhang, QY (Corresponding Author), Shantou Univ, Med Coll, Dept Prevent Med, Shantou 515041, Guangdong, Peoples R China.
   Wang, Yujin; Deng, Changyu; Guo, Pi; You, Yingbin; Zhang, Qingying, Shantou Univ, Med Coll, Dept Prevent Med, Shantou 515041, Guangdong, Peoples R China.
   Ding, Zan, Baoan Cent Hosp Shenzhen, Dept Sci \& Educ, Shenzhen 518102, Guangdong, Peoples R China.
   Li, Liujiu; Wang, Yanfang, Yuxi Ctr Dis Control \& Prevent, Yuxi 653000, Yunnan, Peoples R China.},
DOI = {10.1007/s00484-020-01912-1},
EarlyAccessDate = {MAY 2020},
ISSN = {0020-7128},
EISSN = {1432-1254},
Keywords = {Cold temperature; Heat temperature; Years of life lost; Disease burden;
   Non-accidental mortality; Effect modification},
Keywords-Plus = {AIR-POLLUTION; CARDIOVASCULAR-DISEASE; HEAT-WAVE; MYOCARDIAL-INFARCTION;
   TIME-SERIES; BURDEN; ASSOCIATION; IMPACT; MORBIDITY; RESPONSES},
Research-Areas = {Biophysics; Environmental Sciences \& Ecology; Meteorology \&
   Atmospheric Sciences; Physiology},
Web-of-Science-Categories  = {Biophysics; Environmental Sciences; Meteorology \& Atmospheric Sciences;
   Physiology},
Author-Email = {qyzhang@stu.edu.cn},
Funding-Acknowledgement = {National key R\&D program of China {[}2016YFC1304000]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) {[}81703323]},
Funding-Text = {This study was supported by the National key R\&D program of China
   (2016YFC1304000) and the National Natural Science Foundation of China
   (No. 81703323).},
Cited-References = {Aboubakri O, 2019, INT J BIOMETEOROL, V63, P1139, DOI 10.1007/s00484-019-01726-w.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Baccini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069638.
   Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170.
   Breitner S, 2014, HEART, V100, P1272, DOI 10.1136/heartjnl-2014-305578.
   Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034.
   Castellani JW, 2016, AUTON NEUROSCI-BASIC, V196, P63, DOI 10.1016/j.autneu.2016.02.009.
   Ding Z, 2016, ENVIRON RES, V150, P431, DOI 10.1016/j.envres.2016.06.029.
   Ding Z, 2016, SCI TOTAL ENVIRON, V544, P627, DOI 10.1016/j.scitotenv.2015.12.016.
   Ding Z, 2015, SCI TOTAL ENVIRON, V526, P358, DOI 10.1016/j.scitotenv.2015.05.012.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   Fink R, 2017, CENT EUR J PUBL HEAL, V25, P293, DOI {[}10.21101/cejph.a4469, 10.21101/cejph.a4496].
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   Guo P, 2017, SCI TOTAL ENVIRON, V595, P1, DOI 10.1016/j.scitotenv.2017.03.193.
   Guo YM, 2016, ENVIRON HEALTH PERSP, V124, P1554, DOI 10.1289/EHP149.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405.
   Kim SE, 2015, SCI TOTAL ENVIRON, V524, P376, DOI 10.1016/j.scitotenv.2015.03.137.
   Liu JT, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193529.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Luan GJ, 2019, INT J ENVIRON HEAL R, V29, P246, DOI 10.1080/09603123.2018.1533533.
   Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007.
   Onozuka D, 2017, SCI REP-UK, V7, DOI 10.1038/srep39538.
   Ravallion M, 2007, J DEV ECON, V82, P1, DOI 10.1016/j.jdeveco.2005.07.003.
   Roosli M, 2005, INT J EPIDEMIOL, V34, P1029, DOI 10.1093/ije/dyi106.
   Schneider A, 2008, EPIDEMIOLOGY, V19, P391, DOI 10.1097/EDE.0b013e31816a4325.
   Seposo XT, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31500.
   Seposo XT, 2015, INT J ENV RES PUB HE, V12, P6842, DOI 10.3390/ijerph120606842.
   Song XP, 2017, SCI TOTAL ENVIRON, V586, P241, DOI 10.1016/j.scitotenv.2017.01.212.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.
   Yang J, 2017, ENVIRON POLLUT, V224, P400, DOI 10.1016/j.envpol.2017.02.020.
   Yang J, 2015, HEART, V101, P1966, DOI 10.1136/heartjnl-2015-308062.
   Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12250.
   Yang J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-63.
   Yin Q, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4129-7.
   Zhan ZY, 2017, SCI TOTAL ENVIRON, V584, P1152, DOI 10.1016/j.scitotenv.2017.01.177.
   Zhang YQ, 2018, SCI TOTAL ENVIRON, V621, P1491, DOI 10.1016/j.scitotenv.2017.10.079.
   Zhao L, 2017, ONCOTARGET, V8, P66438, DOI 10.18632/oncotarget.20090.
   Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188.},
Number-of-Cited-References = {44},
Times-Cited = {1},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Int. J. Biometeorol.},
Doc-Delivery-Number = {MN3UZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000534443100002},
DA = {2022-03-29},
}

@article{ WOS:000583838700015,
Author = {Luciano-Mateo, Fedra and Cabre, Noemi and Baiges-Gaya, Gerard and
   Fernandez-Arroyo, Salvador and Hernandez-Aguilera, Anna and Elisabet
   Rodriguez-Tomas, Elisabet and Arenas, Meritxell and Camps, Jordi and
   Menendez, Javier A. and Joven, Jorge},
Title = {Systemic overexpression of C-C motif chemokine ligand 2 promotes
   metabolic dysregulation and premature death in mice with accelerated
   aging},
Journal = {AGING-US},
Year = {2020},
Volume = {12},
Number = {20},
Pages = {20001-20023},
Month = {OCT 31},
Abstract = {Injection of tissues with senescent cells induces changes that mimic
   aging, and this process is delayed in mice engineered to eliminate
   senescent cells, which secrete proinflammatory cytokines, including C-C
   motif chemokine ligand 2 (Ccl2). Circulating levels of Ccl2 correlate
   with age, but the impact of Ccl2 on tissue homeostasis has not been
   established. We generated an experimental model by crossbreeding mice
   overexpressing Ccl2 with progeroid mice bearing a mutation in the lamin
   A (Lmna) gene. Wild-type animals and progeroid mice that do not
   overexpress Ccl2 were used as controls. Ccl2 overexpression decreased
   the lifespan of the progeroid mice and induced the dysregulation of
   glycolysis, the citric acid cycle and one-carbon metabolism in skeletal
   muscle, driving dynamic changes in energy metabolism and DNA
   methylation. This impact on cellular bioenergetics was associated with
   mitochondrial alterations and affected cellular metabolism, autophagy
   and protein synthesis through AMPK/mTOR pathways. The data revealed the
   ability of Ccl2 to promote death in mice with accelerated aging, which
   supports its putative use as a biomarker of an increased senescent cell
   burden and for the assessment of the efficacy of interventions aimed at
   extending healthy aging.},
Publisher = {IMPACT JOURNALS LLC},
Address = {6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA},
Type = {Article},
Language = {English},
Affiliation = {Camps, J; Joven, J (Corresponding Author), Univ Rovira \& Virgili, Dept Med \& Surg, Reus 43201, Spain.
   Camps, J; Joven, J (Corresponding Author), Univ Rovira \& Virgili, Inst Invest Sanitaria Pere Virgili, Unitat Recerca Biomed, Hosp Univ St Joan, Reus 43201, Spain.
   Joven, J (Corresponding Author), Campus Int Excellence Southern Catalonia, Tarragona 43003, Spain.
   Luciano-Mateo, Fedra; Cabre, Noemi; Baiges-Gaya, Gerard; Fernandez-Arroyo, Salvador; Camps, Jordi; Joven, Jorge, Univ Rovira \& Virgili, Dept Med \& Surg, Reus 43201, Spain.
   Luciano-Mateo, Fedra; Cabre, Noemi; Baiges-Gaya, Gerard; Fernandez-Arroyo, Salvador; Hernandez-Aguilera, Anna; Elisabet Rodriguez-Tomas, Elisabet; Camps, Jordi; Joven, Jorge, Univ Rovira \& Virgili, Inst Invest Sanitaria Pere Virgili, Unitat Recerca Biomed, Hosp Univ St Joan, Reus 43201, Spain.
   Arenas, Meritxell, Univ Rovira \& Virgili, Inst Invest Sanitaria Pere Virgili, Dept Radiat Oncol, Hosp Univ St Joan, Reus 43204, Spain.
   Menendez, Javier A., Catalan Inst Oncol, Metab \& Canc Grp, Program Canc Therapeut Resistance ProCURE, Girona 17007, Spain.
   Menendez, Javier A., Girona Biomed Res Inst IDIBGI, Girona 17190, Spain.
   Joven, Jorge, Campus Int Excellence Southern Catalonia, Tarragona 43003, Spain.},
DOI = {10.18632/aging.104154},
ISSN = {1945-4589},
Keywords = {C-C motif chemokine ligand 2; energy metabolism; one-carbon metabolism;
   progeria},
Keywords-Plus = {AUTOPHAGY; METFORMIN; SENESCENCE; PHENOTYPE; HALLMARKS; PROGRAM; STRESS},
Research-Areas = {Cell Biology; Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Cell Biology; Geriatrics \& Gerontology},
Author-Email = {Jcamps@grupsagessa.com
   Jorge.joven@urv.cat},
ResearcherID-Numbers = {MENENDEZ, JAVIER A/C-6148-2016},
ORCID-Numbers = {MENENDEZ, JAVIER A/0000-0001-8733-4561},
Funding-Acknowledgement = {Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos
   III {[}PI15/00285]; Fondo Europeo de Desarrollo Regional (FEDER)European
   Commission; Fundacio La Marato de TV3 (Barcelona, Spain) {[}60/U/2016];
   Associacio Oncologica Dr. Amedeu Pelegri (Salou, Spain) {[}AODAP/2017];
   Agencia de Gestio d'Ajuts Universitaris i de RecercaAgencia de Gestio
   D'Ajuts Universitaris de Recerca Agaur (AGAUR) {[}2016FI\_B 00352];
   Universitat Rovira i Virgili {[}URVPFRB21545]},
Funding-Text = {This study was funded by grant PI15/00285 from the Instituto de Salud
   Carlos III (Madrid, Spain), co-funded by the Fondo Europeo de Desarrollo
   Regional (FEDER), grant 60/U/2016 from the Fundacio La Marato de TV3
   (Barcelona, Spain), and grant AODAP/2017 from the Associacio Oncologica
   Dr. Amedeu Pelegri (Salou, Spain). We also acknowledge the support
   provided by the Agencia de Gestio d'Ajuts Universitaris i de Recerca
   (Grant 2016FI\_B 00352) and the Universitat Rovira i Virgili (Grant
   URVPFRB21545). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.},
Cited-References = {Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784.
   BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3.
   Barcena C, 2018, CELL REP, V24, P2392, DOI 10.1016/j.celrep.2018.07.089.
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011.
   Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002.
   Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711.
   Chamberlin ME, 2000, AM J HUM GENET, V66, P347, DOI 10.1086/302752.
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310.
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144.
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009.
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4.
   Fulop T, 2018, SEMIN IMMUNOL, V40, P17, DOI 10.1016/j.smim.2018.09.003.
   Gordaliza-Alaguero I, 2019, EMBO REP, V20, DOI 10.15252/embr.201947928.
   Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y.
   Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912.
   Hernandez-Aguilera A, 2020, CYTOKINE, V126, DOI 10.1016/j.cyto.2019.154923.
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3.
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115.
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034.
   Irvin MR, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0481-4.
   Janin A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0698-x.
   Justice JN, 2018, CARDIOVASC ENDOCR ME, V7, P80, DOI 10.1097/XCE.0000000000000159.
   Jylhava J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046.
   Lee JY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0092-3.
   Lopez-Mejia IC, 2014, EMBO REP, V15, P529, DOI 10.1002/embr.201338126.
   Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031.
   Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039.
   Luciano-Mateo F, 2019, BBA-MOL BASIS DIS, V1865, P1555, DOI 10.1016/j.bbadis.2019.03.006.
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042.
   Marino G, 2008, AUTOPHAGY, V4, P807, DOI 10.4161/auto.6478.
   Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120.
   Menendez JA, 2012, AGING-US, V4, P894.
   Menendez JA, 2011, AGING-US, V3, P1063, DOI 10.18632/aging.100407.
   Menendez JA, 2011, AGING-US, V3, P348, DOI 10.18632/aging.100316.
   Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898.
   Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x.
   Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847.
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950.
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586.
   Ren RT, 2017, CELL METAB, V26, P460, DOI 10.1016/j.cmet.2017.07.019.
   Riera-Borrull M, 2016, J AM SOC MASS SPECTR, V27, P168, DOI 10.1007/s13361-015-1262-3.
   Rodriguez-Gallego E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/953841.
   Rossella F, 2009, RAPID COMMUN MASS SP, V23, P2637, DOI 10.1002/rcm.4166.
   Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003.
   Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821.
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1.
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193.
   Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659.
   Wang WP, 2020, AGING CELL, V19, DOI 10.1111/acel.13090.
   Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706.},
Number-of-Cited-References = {50},
Times-Cited = {1},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Aging-US},
Doc-Delivery-Number = {OJ3AX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000583838700015},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000228985000007,
Author = {Lee, J and Park, CS and Chung, MY and Cho, DH and Watson, RR},
Title = {Reduced micronutrient intake accentuates premature death caused by
   immune dysfunction in leukemia retrovirus-infected C57BL/6 mice},
Journal = {NUTRITION RESEARCH},
Year = {2005},
Volume = {25},
Number = {4},
Pages = {401-412},
Month = {APR},
Abstract = {We investigated the effect of micronutrient deficiency on the survival
   and immune dysfunction of C57BL/6 mice during progression to murine
   AIDS. Survival of retrovirus-infected mice has been influenced by
   micronutrient deficiency although it alone could significantly reduce
   the median survival time. The premature death could be explained by
   dysregulation of the immune system and generation of free radicals.
   Dysfunction of T-cell and B-cell mitogenesis from primary cultured
   splenocytes has been observed with retrovirus infection and
   micronutrient deficiency in synergism. There was an abnormal shift of
   cytokine pattern that was designated by the decreased secretion of Th1
   cytokines and increased secretion of Th2 cytokines. The hepatic vitamin
   E level was significantly decreased by retrovirus infection and
   micronutrient deficiency, in accordance with the increased hepatic lipid
   peroxidation level. This study suggests that micronutrient deficiency
   may accelerate premature death during progression to murine AIDS,
   implying that nutritional application would be the first line to
   consider for retarding the progression from HIV infection to AIDS. (c)
   2005 Elsevier Inc. All rights reserved.},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Watson, RR (Corresponding Author), Univ Arizona, Div Hlth Promot Sci, Mel \& Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA.
   Univ Arizona, Div Hlth Promot Sci, Mel \& Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA.
   Nambu Univ, Dept Food \& Life Sci, Kwangju 506824, South Korea.
   Chonnam Natl Univ, Dept Internal Med, Sch Med, Kwangju 501746, South Korea.
   Chonnam Natl Univ, Dept Pathol, Sch Med, Kwangju 501746, South Korea.},
DOI = {10.1016/j.nutres.2004.12.010},
ISSN = {0271-5317},
Keywords = {micronutrients; murine AIDS; cytokine; oxidative stress; mice},
Keywords-Plus = {OXIDATIVE STRESS; MURINE AIDS; DEFICIENT},
Research-Areas = {Nutrition \& Dietetics},
Web-of-Science-Categories  = {Nutrition \& Dietetics},
Author-Email = {rwatson@u.arizona.edu},
Cited-References = {Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143.
   AMARAKOON AMT, 1995, INFLAMM RES, V44, P301, DOI 10.1007/BF02032573.
   BURTON GW, 1985, LIPIDS, V20, P29, DOI 10.1007/BF02534359.
   Campa A, 1999, J ACQ IMMUN DEF SYND, V20, P508, DOI 10.1097/00042560-199904150-00015.
   Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492.
   CHOUAIB S, 1985, J IMMUNOL, V135, P1172.
   Crapo JD, 2003, EUR RESPIR J, V22, p4S, DOI 10.1183/09031936.03.00000203a.
   Duffy PH, 2002, J NUTR, V132, P101, DOI 10.1093/jn/132.1.101.
   Gasparis AP, 2001, NUTRITION, V17, P981, DOI 10.1016/S0899-9007(01)00707-9.
   KAMINSKA T, 2003, MED SCI MONITOR, V9, P71.
   KANAGAWA O, 1993, SCIENCE, V262, P240, DOI 10.1126/science.8211142.
   Kelly P, 2002, ACTA TROP, V83, P151, DOI 10.1016/S0001-706X(02)00095-5.
   Lee J, 1998, NUTR RES, V18, P327, DOI 10.1016/S0271-5317(98)00025-6.
   Lee JM, 1999, ALCOHOL CLIN EXP RES, V23, P856.
   Liang BL, 2001, IMMUNOPHARM IMMUNOT, V23, P307, DOI 10.1081/IPH-100107332.
   OHISHI N, 1985, BIOCHEM INT, V10, P205.
   Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916.
   Sepulveda R Tomas, 2002, Cardiovasc Toxicol, V2, P53, DOI 10.1385/CT:2:1:53.
   ShorPosner G, 1996, NUTRITION, V12, P555, DOI 10.1016/S0899-9007(97)85095-2.
   Thurnham DI, 1997, J CLIN PATHOL, V50, P887, DOI 10.1136/jcp.50.11.887.
   WANG Y, 1994, IMMUNOLOGY, V83, P384.
   Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Nutr. Res.},
Doc-Delivery-Number = {924NH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000228985000007},
DA = {2022-03-29},
}

@article{ WOS:A1991FR74600023,
Author = {BOISSY, RE and BEATO, KE and NORDLUND, JJ},
Title = {DILATED ROUGH ENDOPLASMIC-RETICULUM AND PREMATURE DEATH IN MELANOCYTES
   CULTURED FROM THE VITILIGO MOUSE},
Journal = {AMERICAN JOURNAL OF PATHOLOGY},
Year = {1991},
Volume = {138},
Number = {6},
Pages = {1511-1525},
Month = {JUN},
Abstract = {It has been proposed that the selective melanocyte destruction in hair
   bulbs of the murine model for vitiligo (VIT) is instigated by either the
   local cutaneous environment or an innate melanocyte defect.  To address
   this problem, the authors have isolated the melanocyte population from
   environmental influences by using cell culture technology and have
   observed reduced proliferation, specific cytologic abnormalities, and
   premature cell death in cultures of pure VIT melanocytes established
   from neonatal skin.  Cultured VIT melanocytes manifest abnormal
   compartmentalization of melanosomes and some aberrant
   dibydroxyphenylalanine-positive structures.  The most prominent
   abnormality observed in cultured VIT melanocytes when compared with the
   control C57BL/6J cells is a development in dilation of the rough
   endoplasmic reticulum (RER) that morphologically resembles the in vivo
   condition.  Dilation of the RER can be exaggerated in VIT or induced in
   C57BL/6J melanocytes by the addition of Brefeldin A to cultures. 
   Conversely the dilated RER cisternae characteristic of the VIT
   melanocyte can be reversed by inhibition of protein synthesis with
   cycloheximide.  Melanocyte cultures developed from heterozygote
   neonates, resulting from cross-breedings between the VIT and the
   C57BL/6J lines, also demonstrated extensive RER dilation along with only
   slightly reduced proliferation.  The results in this report verify that
   the murine vitiligo melanocyte expresses an innate defect that affects
   the structure and presumably the function of the rough endoplasmic
   reticulum.},
Publisher = {AMER SOC INVESTIGATIVE PATHOLOGY, INC},
Address = {428 EAST PRESTON ST, BALTIMORE, MD 21202-3993},
Type = {Article},
Language = {English},
Affiliation = {BOISSY, RE (Corresponding Author), UNIV CINCINNATI,COLL MED,DEPT DERMATOL,ML 592,231 BETHESDA AVE,CINCINNATI,OH 45267, USA.},
ISSN = {0002-9440},
Keywords-Plus = {EHLERS-DANLOS SYNDROME; SYNDROME TYPE-IV; III PROCOLLAGEN;
   ULTRASTRUCTURAL CHARACTERISTICS; PIGMENT EPITHELIUM;
   ALPHA-1-ANTITRYPSIN; INVITRO; VARIANT; CELLS; FORM},
Research-Areas = {Pathology},
Web-of-Science-Categories  = {Pathology},
Funding-Acknowledgement = {NIADDK NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}1 R29 AM38954]
   Funding Source: Medline},
Cited-References = {ASA SL, 1988, LAB INVEST, V58, P403.
   BHAN AK, 1976, PEDIATR RES, V10, P35, DOI 10.1203/00006450-197601000-00007.
   BOISSY RE, 1987, AM J PATHOL, V127, P380.
   BOISSY RE, 1986, J INVEST DERMATOL, V86, P149, DOI 10.1111/1523-1747.ep12284190.
   BOISSY RE, 1983, PIGMENT CELL, V7, P731.
   BOMIRSKI A, 1987, J INVEST DERMATOL, V89, P469, DOI 10.1111/1523-1747.ep12460928.
   BOWERS RR, 1985, BIOL MOL CLIN ASPECT, P347.
   BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702.
   BYERS PH, 1981, LAB INVEST, V44, P336.
   BYERS PH, 1985, ANN NY ACAD SCI, V460, P298, DOI 10.1111/j.1749-6632.1985.tb51177.x.
   DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919.
   FEENEYBURNS L, 1979, DEV BIOL, V72, P73, DOI 10.1016/0012-1606(79)90099-X.
   HALABAN R, 1984, IN VITRO CELL DEV B, V20, P447.
   HARB JM, 1990, EMSA B, V20, P64.
   HARRI E, 1963, HELV CHIM ACTA, V46, P1235, DOI 10.1002/hlca.19630460419.
   HERCZ A, 1978, SCIENCE, V201, P1229, DOI 10.1126/science.308696.
   HOLBROOK KA, 1981, LAB INVEST, V44, P342.
   HUNTER JAA, 1978, BRIT J DERMATOL, V98, P255, DOI 10.1111/j.1365-2133.1978.tb06152.x.
   JIMBOW K, 1974, DEV BIOL, V36, P8, DOI 10.1016/0012-1606(74)90187-0.
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137.
   Karnovsky MJ, 1971, 11TH ANN M AM SOC CE, P146.
   LAURENT R, 1974, DERMATOLOGICA, V148, P28, DOI 10.1159/000251597.
   LERNER AB, 1971, AM J MED, V51, P141, DOI 10.1016/0002-9343(71)90232-4.
   LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353.
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W.
   MCKEEVER PE, 1987, AM J PATHOL, V127, P358.
   MISHIMA Y, 1969, CANCER-AM CANCER SOC, V24, P185, DOI 10.1002/1097-0142(196907)24:1<185::AID-CNCR2820240123>3.0.CO;2-Q.
   NAUGHTON GK, 1986, P SOC EXP BIOL MED, V181, P423.
   NORDLUND JJ, 1982, ARCH DERMATOL, V118, P5, DOI 10.1001/archderm.118.1.5.
   NOVIKOFF AB, 1968, J HISTOCHEM CYTOCHEM, V16, P299, DOI 10.1177/16.5.299.
   QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177.
   SMYTH J R JR, 1989, Critical Reviews in Poultry Biology, V2, P1.
   SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038.
   SZAMIER RB, 1979, INVEST OPHTH VIS SCI, V18, P145.
   TAMURA A, 1987, IN VITRO CELL DEV B, V23, P519.
   TROMP G, 1989, J BIOL CHEM, V264, P19313.
   ULMER J, 1989, P NATL ACAD SCI USA, V80, P6992.
   WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501.},
Number-of-Cited-References = {38},
Times-Cited = {35},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Am. J. Pathol.},
Doc-Delivery-Number = {FR746},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991FR74600023},
DA = {2022-03-29},
}

@article{ WOS:A1977DL79100011,
Author = {TROTTIER, TM and ARMSTRONG, JB},
Title = {EXPERIMENTAL STUDIES ON A MUTANT-GENE (P) CAUSING PREMATURE DEATH OF
   AMBYSTOMA-MEXICANUM EMBRYOS},
Journal = {JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY},
Year = {1977},
Volume = {39},
Number = {JUN},
Pages = {139-149},
Publisher = {COMPANY OF BIOLOGISTS LTD},
Address = {BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS,
   ENGLAND CB4 4DL},
Type = {Article},
Language = {English},
Affiliation = {UNIV OTTAWA,DEPT BIOL,OTTAWA K1N 6N5,ONTARIO,CANADA.},
ISSN = {0022-0752},
Research-Areas = {Anatomy \& Morphology; Developmental Biology},
Web-of-Science-Categories  = {Anatomy \& Morphology; Developmental Biology},
Cited-References = {Balinsky B. I., 1970, INTRO EMBRYOLOGY.
   BRIGGS R, 1973, S SOC DEVELOP BIOL, V31, P169.
   Copenhaver WM, 1943, AM J ANAT, V73, P81, DOI 10.1002/aja.1000730105.
   COPENHAVER WM, 1955, ANAL DEV, P440.
   Elias H., 1955, Anatomischer Anzeiger, V101, P153.
   Humphrey R.R., 1975, HDB GENETICS, P3, DOI 10.1007/978-1-4613-4470-4\_1.
   HUMPHREY RR, 1972, DEV BIOL, V27, P365, DOI 10.1016/0012-1606(72)90175-3.
   HUMPHREY RR, 1960, DEV BIOL, V2, P105, DOI 10.1016/0012-1606(60)90001-4.
   JACOBSON AG, 1961, J EXP ZOOL, V146, P139, DOI 10.1002/jez.1401460204.
   LEMANSKI LF, 1973, DEV BIOL, V33, P312, DOI 10.1016/0012-1606(73)90140-1.
   LEMANSKI LF, 1973, J MORPHOL, V139, P301, DOI 10.1002/jmor.1051390303.
   MALACINSKI GM, 1974, SCIENCE, V184, P1142, DOI 10.1126/science.184.4142.1142.
   MUCHMORE WB, 1951, J EXP ZOOL, V118, P137, DOI 10.1002/jez.1401180107.
   Nieuwkoop P D, 1973, Adv Morphog, V10, P1.
   SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7.
   Severinghaus AE, 1930, J EXP ZOOL, V56, P1, DOI 10.1002/jez.1400560102.},
Number-of-Cited-References = {16},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {DL791},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1977DL79100011},
DA = {2022-03-29},
}

@article{ WOS:A1981LC20300006,
Author = {PINTER, L and KALMAN, L},
Title = {EFFECT OF LEAF-AREA REDUCTION ON STANDABILITY AND PREMATURE DEATH OF
   LEAVES IN MAIZE (ZEA-MAYS-L) HYBRIDS WITH DIFFERENT GENOTYPES},
Journal = {ACTA AGRONOMICA ACADEMIAE SCIENTIARUM HUNGARICAE},
Year = {1981},
Volume = {30},
Number = {1-2},
Pages = {61-67},
Publisher = {AKADEMIAI KIADO},
Address = {PO BOX 245, H-1519 BUDAPEST, HUNGARY},
Type = {Article},
Language = {English},
Affiliation = {PINTER, L (Corresponding Author), CEREAL RES INST,SZEGED,HUNGARY.},
ISSN = {0001-513X},
Research-Areas = {Agriculture},
Web-of-Science-Categories  = {Agronomy},
Cited-References = {Aldrich S., 1975, MODERN CORN PRODUCTI.
   ALDRICH SR, 1972, MODERN CORN PRODUCTI.
   DETURK EE, 1937, AGR EXP STA ANN RPT, V49, P43.
   HOADLEY AD, 1942, THESIS U MARYLAND.
   Holbert JR, 1935, PHYTOPATHOLOGY, V25, P1113.
   JUGENHEIMER RW, 1940, THESIS IOWA STATE CO, P94.
   KALMAN L, 1974, Novenytermeles, V23, P313.
   KOEHLER B, 1960, 658 ILL AGR EXP STN, P90.
   KOEHLER B, 1925, FACTORS INFLUENCING.
   KOROM A, 1975, NOVENYVEDELEM, V11, P3.
   LITTLEFIELD LJ, 1962, AM J BOT, V49, P1072, DOI 10.2307/2439154.
   LOESCH PETER J., 1963, CROP SCIL, V3, P173.
   MICHAELSON ME, 1957, PHYTOPATHOLOGY, V47, P499.
   NELSON CE, 1958, LODGING FIELD CORN A.
   THOMPSON D. L., 1963, CROP SCI, V3, P323, DOI 10.2135/cropsci1963.0011183X000300040013x.
   ZUBER M. S., 1961, CROP SCI, V1, P378, DOI 10.2135/cropsci1961.0011183X000100050028x.
   ZUBER MS, 1966, AGRON J, V58, P173, DOI 10.2134/agronj1966.00021962005800020016x.},
Number-of-Cited-References = {17},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {LC203},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1981LC20300006},
DA = {2022-03-29},
}

@article{ WOS:000265453700016,
Author = {Venge, Per and Arnlov, Johan and Zethelius, Bjorn},
Title = {Seemingly healthy 71-year-old men with minor elevations of cardiac
   troponin I and at risk of premature death in CVD have elevated levels of
   NT-proBNP: Report from the ULSAM study},
Journal = {SCANDINAVIAN JOURNAL OF CLINICAL \& LABORATORY INVESTIGATION},
Year = {2009},
Volume = {69},
Number = {3},
Pages = {418-424},
Abstract = {Background. Hypersensitive cardiac troponin I (cTnI) assays detect even
   minor elevations of cTnI. Previous findings identifying a group of
   seemingly healthy elderly men with very minor elevations of cTnI have
   shown that these men were at risk of premature cardiovascular death.
   Objectives. To study the association between cTnI concentrations and
   cardiovascular risk factors and subclinical cardiac and renal target
   organ damage in a community-based sample of elderly men. Methods.
   Biomarkers reflecting glucose and lipid metabolism, renal function,
   cardiac function and inflammation were measured in the ULSAM study
   (n=1205, mean age 71 years). The participants were placed in three
   subgroups based on the cTnI concentrations: a low group with cTnI 0.02
   g/L, an intermediate group with cTnI between 0.02 and 0.039 g/L and a
   high group with cTnI 0.039 g/L. Results. In the entire cohort of
   71-year-old men, most markers of glucose and lipid metabolism, renal
   function, inflammation and NT-proBNP were significantly related to the
   concentrations of cTnI, and most obviously in the high-cTnI group. In
   subjects with no signs of CVD (cardiovascular disease), only levels of
   NT-proBNP related to cTnI, and with the highest NT-proBNP levels in the
   high-cTnI group (p0.01). A multiple regression analysis showed that
   NT-proBNP was independently related to cTnI (p0.001). Conclusions.
   Measurement of cardiac troponins with highly sensitive assays identifies
   those at risk of premature CVD death who have hitherto remained
   unrecognized. The associated elevations of NT-proBNP in these
   participants support the fact that these elevations reflect ongoing
   pathological processes in the myocardium.},
Publisher = {TAYLOR \& FRANCIS AS},
Address = {KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY},
Type = {Article},
Language = {English},
Affiliation = {Venge, P (Corresponding Author), Univ Hosp, Dept Clin Chem \& Pharmacol, SE-75185 Uppsala, Sweden.
   Venge, Per, Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   Arnlov, Johan; Zethelius, Bjorn, Uppsala Univ, Dept Clin Chem \& Publ Hlth \& Caring Sci Geriatr, Uppsala, Sweden.},
DOI = {10.1080/00365510802635463},
Article-Number = {PII 910665052},
ISSN = {0036-5513},
Keywords = {Biomarker; cardiovascular disease; glucose metabolism; lipid metabolism;
   population-based},
Keywords-Plus = {CORONARY-ARTERY-DISEASE; NATRIURETIC PEPTIDES; REFERENCE LIMITS;
   GUSTO-IV; MORTALITY; ASSAY},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {per.venge@akademiska.se},
ResearcherID-Numbers = {Ärnlöv, Johan/AAF-2746-2019},
ORCID-Numbers = {Ärnlöv, Johan/0000-0002-6933-4637},
Funding-Acknowledgement = {Erik, Karin och Gosta Selanders Foundation; Thuring Foundation; Ernfors
   Foundation; Uppsala University (BZ); Swedish Research CouncilSwedish
   Research CouncilEuropean Commission {[}2006-6555]; Swedish Heart-Lung
   FoundationSwedish Heart-Lung Foundation},
Funding-Text = {This study was supported through the Erik, Karin och Gosta Selanders
   Foundation, Thuring Foundation and the Ernfors Foundation, Uppsala
   University (BZ). The Swedish Research Council (2006-6555), Swedish
   Heart-Lung Foundation (Swedish Heart Lung Foundation, La Fondation
   Suedoise du Coeur et du Poumon, Schwedische Herzund Lungenstiftung), Loo
   och Hans Ostermans Foundation, Stiftelsen Sigurd och Elsa Goljes Minne
   (JA). The reagents and the instrument used for the AccuTnI assay were
   supplied by Beckman Coulter Inc. (Chaska, Mn., USA). Otherwise, there
   was no external sponsor of the study. The technical expertise of Martin
   Venge in the performance of troponin assays was greatly appreciated.},
Cited-References = {Apple Fred S, 2007, Circulation, V115, pe352.
   Apple FS, 2003, CLIN CHEM, V49, P1331, DOI 10.1373/49.8.1331.
   Braunwald E, 2001, ATHEROSCLEROSIS SUPP, V2, P27, DOI 10.1016/S1567-5688(00)00007-6.
   Byberg L, 2000, DIABETOLOGIA, V43, P54, DOI 10.1007/s001250050007.
   Chatha K, 2006, J CLIN PATHOL, V59, P1216, DOI 10.1136/jcp.2005.034702.
   Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529.
   Goetze JP, 2004, FASEB J, V18, P1928, DOI 10.1096/fj.03-1336fje.
   Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1.
   Heeschen Christopher, 2005, Diab Vasc Dis Res, V2, P122, DOI 10.3132/dvdr.2005.019.
   James SK, 2006, J AM COLL CARDIOL, V48, P1146, DOI 10.1016/j.jacc.2006.05.056.
   Jernberg T, 2004, EUR J HEART FAIL, V6, P319, DOI 10.1016/j.ejheart.2004.01.007.
   Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038.
   Poirier Paul, 2002, Curr Atheroscler Rep, V4, P448, DOI 10.1007/s11883-002-0049-8.
   Riezebos Robert K, 2006, Acute Card Care, V8, P51, DOI 10.1080/14628840600627972.
   Topol EJ, 2003, J AM COLL CARDIOL, V41, p123S, DOI 10.1016/S0735-1097(02)02689-X.
   Uettwiller-Geiger D, 2002, CLIN CHEM, V48, P869.
   Venge P, 2003, CLIN CHEM, V49, P880, DOI 10.1373/49.6.880.
   Venge P, 2001, CLIN CHEM, V47, P959.
   Wagner JA, 2007, EUR J CLIN INVEST, V37, P463, DOI 10.1111/j.1365-2362.2007.01810.x.
   Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762.
   Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064.},
Number-of-Cited-References = {21},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Clin. Lab. Invest.},
Doc-Delivery-Number = {436ZC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000265453700016},
DA = {2022-03-29},
}

@article{ WOS:000253761300006,
Author = {Makinen, Ville-Petteri and Soininen, Pasi and Forsblom, Carol and
   Parkkonen, Maija and Ingman, Petri and Kaski, Kimmo and Groop,
   Per-Henrik and Ala-Korpela, Mika and FinnDiane Study Grp},
Title = {H-1 NMR metabonomics approach to the disease continuum of diabetic
   complications and premature death},
Journal = {MOLECULAR SYSTEMS BIOLOGY},
Year = {2008},
Volume = {4},
Month = {FEB},
Abstract = {Subtle metabolic changes precede and accompany chronic vascular
   complications, which are the primary causes of premature death in
   diabetes. To obtain a multimetabolite characterization of these
   high-risk individuals, we measured proton nuclear magnetic resonance
   (H-1 NMR) data from the serum of 613 patients with type I diabetes and a
   diverse spread of complications. We developed a new metabonomics
   framework to visualize and interpret the data and to link the metabolic
   profiles to the underlying diagnostic and biochemical variables. Our
   results indicate complex interactions between diabetic kidney disease,
   insulin resistance and the metabolic syndrome. We illustrate how a
   single H-1 NMR protocol is able to identify the polydiagnostic
   metabolite manifold of type I diabetes and how its alterations translate
   to clinical phenotypes, clustering of micro- and macrovascular
   complications, and mortality during several years of follow-up. This
   work demonstrates the diffuse nature of complex vascular diseases and
   the limitations of single diagnostic biomarkers. However, it also
   promises cost-effective solutions through high-throughput analytics and
   advanced computational methods, as applied here in a case that is
   representative of the real clinical situation.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Groop, PH (Corresponding Author), Univ Helsinki, Biomedicum, Folkhalsan Inst Genet, Folkhalsan Res Ctr,FinnDiane Study Grp, POB 63, FI-00014 Helsinki, Finland.
   Makinen, Ville-Petteri; Forsblom, Carol; Parkkonen, Maija; Groop, Per-Henrik, Univ Helsinki, Biomedicum, Folkhalsan Inst Genet, Folkhalsan Res Ctr,FinnDiane Study Grp, POB 63, FI-00014 Helsinki, Finland.
   Makinen, Ville-Petteri; Kaski, Kimmo; Ala-Korpela, Mika, Aalto Univ, Lab Computat Engn Syst Biol \& Bioinformat Technol, Computat Med Res Grp, FI-02015 Helsinki, Finland.
   Makinen, Ville-Petteri; Forsblom, Carol; Parkkonen, Maija; Groop, Per-Henrik, Helsinki Univ Hosp, Dept Med, Div Nephrol, Helsinki, Finland.
   Ingman, Petri, Univ Turku, Dept Chem, Instrument Ctr, Turku, Finland.
   Soininen, Pasi, Univ Kuopio, Dept Biosci, Chem Lab, FIN-70211 Kuopio, Finland.},
DOI = {10.1038/msb4100205},
Article-Number = {167},
ISSN = {1744-4292},
Keywords = {H-1 NMR spectroscopy; biomarkers; metabonomics; serum; type I diabetes},
Keywords-Plus = {GENOME-WIDE ASSOCIATION; NUCLEAR-MAGNETIC-RESONANCE; GLOBAL SYSTEMS
   BIOLOGY; CORONARY-HEART-DISEASE; SELF-ORGANIZING MAPS; METABOLIC
   SYNDROME; INSULIN-RESISTANCE; MICROVASCULAR COMPLICATIONS; PITTSBURGH
   EPIDEMIOLOGY; LIPOPROTEIN SUBCLASSES},
Research-Areas = {Biochemistry \& Molecular Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology},
Author-Email = {per-henrik.groop@helsinki.fi
   mika.ala-korpela@hut.fi},
ResearcherID-Numbers = {Kaski, Kimmo/AAO-4320-2021
   Soininen, Pasi/B-9716-2008
   Kaski, Kimmo K K/G-8067-2012
   },
ORCID-Numbers = {Kaski, Kimmo/0000-0002-3805-9687
   Makinen, Ville-Petteri/0000-0002-7262-2656
   Ala-Korpela, Mika/0000-0001-5905-1206},
Cited-References = {Ala-Korpela M, 2008, CLIN CHEM LAB MED, V46, P27, DOI 10.1515/CCLM.2008.006.
   Ala-Korpela M, 2007, EXPERT REV MOL DIAGN, V7, P761, DOI 10.1586/14737159.7.6.761.
   Ala-Korpela M, 2006, ANN MED, V38, P322, DOI 10.1080/07853890600862418.
   AlaKorpela M, 1995, PROG NUCL MAG RES SP, V27, P475, DOI 10.1016/0079-6565(95)01013-0.
   Astel A, 2007, WATER RES, V41, P4566, DOI 10.1016/j.watres.2007.06.030.
   Avogaro A, 1996, J ENDOCRINOL INVEST, V19, P99, DOI 10.1007/BF03349844.
   Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797.
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376.
   Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802.
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911.
   Caramori ML, 2006, J AM SOC NEPHROL, V17, P339, DOI 10.1681/ASN.2005101075.
   Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399.
   Chaturvedi N, 2001, DIABETES CARE, V24, P2071, DOI 10.2337/diacare.24.12.2071.
   Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001.
   Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648.
   Cutri BA, 2006, CELL RES, V16, P799, DOI 10.1038/sj.cr.7310097.
   Davis TME, 2007, DIABETES RES CLIN PR, V78, P412, DOI 10.1016/j.diabres.2007.06.007.
   Dieterle F, 2006, ANAL CHEM, V78, P3551, DOI 10.1021/ac0518351.
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7.
   Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451.
   Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782.
   Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178.
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421.
   Giraudel JL, 2001, ECOL MODEL, V146, P329, DOI 10.1016/S0304-3800(01)00324-6.
   Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S.
   Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095.
   Groop PH, 2005, NAT CLIN PRACT ENDOC, V1, P100, DOI 10.1038/ncpendmet0046.
   Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164.
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143.
   Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010.
   Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101.
   Hyvonen MT, 2001, J AM CHEM SOC, V123, P810, DOI 10.1021/ja0025853.
   Jenkins AJ, 2003, DIABETES CARE, V26, P810, DOI 10.2337/diacare.26.3.810.
   Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004.
   Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432.
   Kohonen T., 2000, SELF ORGANIZING MAPS.
   KRENTZ AJ, 1991, DIABETIC MED, V8, P848, DOI 10.1111/j.1464-5491.1991.tb02123.x.
   LAMPINEN J, 1999, NEURAL NETWORKS, V3, P1911.
   Lavine BK, 2004, J CHEM INF COMP SCI, V44, P1056, DOI 10.1021/ci030039y.
   Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651.
   Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z.
   Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163.
   LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D.
   Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648.
   Makinen VP, 2006, MAGN RESON MATER PHY, V19, P281, DOI 10.1007/s10334-006-0054-y.
   Mangiameli P, 1996, EUR J OPER RES, V93, P402, DOI 10.1016/0377-2217(96)00038-0.
   Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153.
   Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934.
   Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095.
   Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157.
   NICHOLSON JK, 1984, BIOCHEM J, V217, P365, DOI 10.1042/bj2170365.
   Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423.
   Pambianco G, 2007, DIABETES CARE, V30, P1248, DOI 10.2337/dc06-2053.
   Reunanen A, 2000, DIABETES CARE, V23, P1265, DOI 10.2337/diacare.23.9.1265.
   Ronnback M, 2004, CIRCULATION, V110, P1076, DOI 10.1161/01.CIR.0000139903.29522.8D.
   Roy MS, 2004, ARCH OPHTHALMOL-CHIC, V122, P546, DOI 10.1001/archopht.122.4.546.
   Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006.
   Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1.
   Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6.
   Sierra-Johnson J, 2006, DIABETES CARE, V29, P668, DOI 10.2337/diacare.29.03.06.dc05-0970.
   Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530.
   Stadler M, 2006, J CLIN ENDOCR METAB, V91, P3814, DOI 10.1210/jc.2006-1058.
   Suna T, 2007, NMR BIOMED, V20, P658, DOI 10.1002/nbm.1123.
   Tang HR, 2004, ANAL BIOCHEM, V325, P260, DOI 10.1016/j.ab.2003.10.033.
   Tenenbaum A, 2004, INT J CARDIOL, V97, P167, DOI 10.1016/j.ijcard.2003.07.033.
   Thomas MC, 2006, DIABETES CARE, V29, P317, DOI 10.2337/diacare.29.02.06.dc05-0809.
   Thomas MC, 2006, DRUGS, V66, P2213, DOI 10.2165/00003495-200666170-00005.
   Thorn LM, 2005, DIABETES CARE, V28, P2019, DOI 10.2337/diacare.28.8.2019.
   Torffvit O, 2005, DIABETIC MED, V22, P723, DOI 10.1111/j.1464-5491.2005.01476.x.
   Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q.
   Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373.
   Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3.
   Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b.
   Yang J, 2004, J CHROMATOGR B, V813, P53, DOI 10.1016/j.jchromb.2004.09.023.
   Zenker S, 2007, PLOS COMPUT BIOL, V3, P2072, DOI 10.1371/journal.pcbi.0030204.},
Number-of-Cited-References = {75},
Times-Cited = {143},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {28},
Journal-ISO = {Mol. Syst. Biol.},
Doc-Delivery-Number = {271AM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000253761300006},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000224757500019,
Author = {Krestel, HE and Mihaljevic, ALA and Hoffman, DA and Schneider, A},
Title = {Neuronal co-expression of EGFP and beta-galactosidase in mice causes
   neuropathology and premature death},
Journal = {NEUROBIOLOGY OF DISEASE},
Year = {2004},
Volume = {17},
Number = {2},
Pages = {310-318},
Month = {NOV},
Abstract = {Dose-dependent co-expression of enhanced green fluorescent protein
   (EGFP) and beta-galactosidase (beta-gal) in the cytoplasm of forebrain
   neurons of two independent mouse lines resulted in growth retardation,
   weakness, and premature lethality. In primary motor cortex and striatum,
   apoptosis, glial fibrillary acidic protein proliferation, and cell loss
   were found. In addition, we observed aggregations of EGFP and beta-gal
   that colocalized with ubiquitin. GFP is unlikely to be toxic per se, as
   a third mouse line that expressed twice as much GFP in the cytoplasm of
   forebrain neurons as the two affected lines was normal. Cytoplasmic
   aggregations of EGFP and beta-gal occurred in affected and
   phenotypically normal mice suggesting a storage function rather than
   being detrimental. We successfully prolonged survival of affected mice
   with granulocyte colony-stimulating factor (GCSF) and the antibiotic
   minocycline. These compounds could protect neurons from EGFP and
   beta-gal-induced dysfunction, as demise of mice started after treatment
   was discontinued. (C) 2004 Elsevier Inc. All rights reserved.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Krestel, HE (Corresponding Author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.
   Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany.
   NICHD, Lab Cellular \& Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.
   Axaron Biosci AG, D-69120 Heidelberg, Germany.},
DOI = {10.1016/j.nbd.2004.05.012},
ISSN = {0969-9961},
Keywords = {cytoplasmic GFP and beta-gal; GCSF and minocycline; neurogenic paresis;
   protein aggregates; ubiquitin},
Keywords-Plus = {GREEN FLUORESCENT PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS;
   MAMMALIAN-CELLS; IN-VIVO; EXPRESSION; GENE; TETRACYCLINE; LOCALIZATION;
   MUTATIONS; PROMOTER},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Author-Email = {krestel@mpimf-heidelberg.mpg.de},
ResearcherID-Numbers = {Hoffman, Dax A/E-5155-2011
   },
ORCID-Numbers = {Hoffman, Dax A/0000-0001-6999-2157
   Schneider, Armin/0000-0003-0296-0059
   Mihaljevic, Andre/0000-0003-1902-657X
   Krestel, Heinz Eric/0000-0001-8742-0232},
Funding-Acknowledgement = {EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH \& HUMAN
   DEVELOPMENTUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health \& Human Development (NICHD) {[}ZIAHD008755]
   Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE
   OF CHILD HEALTH \&HUMAN DEVELOPMENTUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health \& Human Development
   (NICHD) {[}Z01HD008755] Funding Source: NIH RePORTER},
Cited-References = {ALBERTS B, 2002, MOL BIOL CELL, P740.
   BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605.
   Chtarto A, 2003, NEUROSCI LETT, V352, P155, DOI 10.1016/j.neulet.2003.08.067.
   Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8.
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565.
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315.
   Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8.
   DeGiorgi F, 1996, GENE, V173, P113, DOI 10.1016/0378-1119(95)00687-7.
   Detrait ER, 2002, MOL THER, V5, P723, DOI 10.1006/mthe.2002.0609.
   Felts K, 2000, STRATEGIES NEWSLETTE, V13, P85.
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493.
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547.
   Hanazono Y, 1997, HUM GENE THER, V8, P1313, DOI 10.1089/hum.1997.8.11-1313.
   HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501.
   Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914.
   Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2.
   Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X.
   Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39.
   Lamhonwah AM, 1999, BIOCHEM BIOPH RES CO, V264, P909, DOI 10.1006/bbrc.1999.1560.
   Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954.
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678.
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X.
   Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065.
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0.
   Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17.
   Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134.
   Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246.
   Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9.
   Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a.
   Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996.},
Number-of-Cited-References = {30},
Times-Cited = {29},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Neurobiol. Dis.},
Doc-Delivery-Number = {866EV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000224757500019},
DA = {2022-03-29},
}

@article{ WOS:000461072800004,
Author = {Debiasi, Marcio and Reinert, Tomas and Kaliks, Rafael and Amorim,
   Gilberto and Caleffi, Maira and Sampaio, Carlos and Fernandes, Gustavo
   dos Santos and Barrios, Carlos H.},
Title = {Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy
   for Advanced Breast Cancer in the Brazilian Public Health System},
Journal = {JOURNAL OF GLOBAL ONCOLOGY},
Year = {2017},
Volume = {3},
Number = {3},
Pages = {201-207},
Month = {JUN},
Abstract = {Purpose Patients with human epidermal growth factor receptor 2 (HER2)
   -positive metastatic tumors treated in the public health system in
   Brazil do not have access to trastuzumab. This study aimed to estimate
   the impact of the lack of access to anti-HER2 therapies on the mortality
   of these patients.
   Methods On the basis of published data, the number of patients with
   HER2-positive advanced breast cancer in 2016 who should receive
   anti-HER2 targeted therapy was estimated. Three different treatment
   groups were considered for this hypothetical cohort: chemotherapy alone,
   chemotherapy plus trastuzumab, and chemotherapy plus trastuzumab and
   pertuzumab. The number of patients alive after 2 years of follow-up was
   estimated on the basis of the efficacy results of the pivotal trials
   considering these interventions.
   Results It was calculated that 2,008 women will be diagnosed with
   advanced HER2-positive breast cancer in Brazil in 2016. It was estimated
   that only 808 women would be alive in 2018 if they receive only
   chemotherapy (which is the treatment offered by the public health
   system). On the other hand, the bar rises to 1,408 women alive in 2018
   if they receive chemotherapy plus trastuzumab and 1,576 women alive in
   2018 if they receive the gold standard of chemotherapy plus trastuzumab
   and pertuzumab.
   Conclusion Trastuzumab is included in the WHO's list of essential
   medications, but the Brazilian public health system does not yet provide
   this treatment to its population with advanced disease. The introduction
   of trastuzumab and pertuzumab would have a positive effect, preventing
   premature deaths in women with metastatic HER2-positive breast cancer in
   Brazil. (C) 2016 by American Society of Clinical Oncology Licensed under
   the Creative Commons Attribution 4.0 License},
Publisher = {AMER SOC CLINICAL ONCOLOGY},
Address = {2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA},
Type = {Article},
Language = {English},
Affiliation = {Barrios, CH (Corresponding Author), Latin Amer Cooperat Oncol Grp, Padre Chagas 66-203, BR-90570080 Porto Alegre, RS, Brazil.
   Debiasi, Marcio; Barrios, Carlos H., Latin Amer Cooperat Oncol Grp, Padre Chagas 66-203, BR-90570080 Porto Alegre, RS, Brazil.
   Debiasi, Marcio, Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil.
   Debiasi, Marcio; Reinert, Tomas, Hosp Canc Mae de Deus, Porto Alegre, RS, Brazil.
   Caleffi, Maira, Federacao Brasileira Inst Filantrop Apoio Saude M, Porto Alegre, RS, Brazil.
   Barrios, Carlos H., Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.
   Kaliks, Rafael, Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.
   Fernandes, Gustavo dos Santos, Hosp Sirio Libanes, Sao Paulo, Brazil.
   Amorim, Gilberto, Ctr Oncol DOr, Sao Cristovao, Brazil.
   Sampaio, Carlos, Clin Assistencia Multidisciplinar Oncol, Salvador, BA, Brazil.
   Fernandes, Gustavo dos Santos, Soc Brasileira Oncol, Belo Horizonte, MG, Brazil.},
DOI = {10.1200/JGO.2016.005678},
ISSN = {2378-9506},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {chbe@via-rs.net},
ResearcherID-Numbers = {Reinert, Tomas/E-8981-2017
   },
ORCID-Numbers = {Reinert, Tomas/0000-0003-4715-1415
   Caleffi, Maira/0000-0002-9494-9457},
Cited-References = {Azenha G, 2011, BREAST, V20, pS81, DOI 10.1016/j.breast.2011.02.005.
   Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7.
   Contreras-Hernandez IPF, 2012, RESEARCH, V9, P117.
   Drakaki A, 2015, AM J HEMATOL-ONCOL, V11, P17.
   Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6.
   Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2.
   Instituto Brasileiro de Geografia e Estatistica, AN OF RES.
   Instituto Nacional de Cancer, ONL MORT ATL.
   Instituto Nacional de Cancer, 2016, BRAZ CANC IND 2016.
   Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820.
   Lee BL, 2012, LANCET ONCOL, V13, pE95, DOI 10.1016/S1470-2045(11)70323-0.
   Liedke PER, 2014, CANCER EPIDEM BIOMAR, V23, P126, DOI 10.1158/1055-9965.EPI-13-0693.
   Lobbezoo DJA, 2013, BREAST CANCER RES TR, V141, P507, DOI 10.1007/s10549-013-2711-y.
   Ministerio da Saude SdC Tecnologia e Insumos Estrategicos, REL REC COM NAC INC.
   Moreira RB, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2\_suppl.73.
   Pan American Health Organization/ WHO, BRAZ HLTH SYST SERV.
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093.
   Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306.
   Simon SD, 2009, SAN ANT BREAST CANC.
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101.
   SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106.
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098.
   Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X.
   World Health Organiazation, 2015, 19 MOD LIST ESS MED.},
Number-of-Cited-References = {24},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Glob. Oncol.},
Doc-Delivery-Number = {VI1IN},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000461072800004},
OA = {gold, Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000444852200001,
Author = {Vergara-Duarte, Montse and Borrell, Carme and Perez, Gloria and Carlos
   Martin-Sanchez, Juan and Cleries, Ramon and Buxo, Maria and
   Martinez-Solanas, Erica and Yasui, Yutaka and Muntaner, Carles and
   Benach, Joan},
Title = {Sentinel Amenable Mortality: A New Way to Assess the Quality of
   Healthcare by Examining Causes of Premature Death for Which Highly
   Efficacious Medical Interventions Are Available},
Journal = {BIOMED RESEARCH INTERNATIONAL},
Year = {2018},
Volume = {2018},
Abstract = {Background. Amenable mortality, or premature deaths that could be
   prevented with medical care, is a proven indicator for assessing
   healthcare quality when adapted to a country or region's specific
   healthcare context. This concept is currently used to evaluate the
   performance of national and international healthcare systems. However,
   the levels of efficacy and effectiveness determined using this indicator
   can vary greatly depending on the causes of death that are included. We
   introduce a new approach by identifying a subgroup of causes for which
   there are available treatments with a high level of efficacy. These
   causes should be considered sentinel events to help identify limitations
   in the effectiveness and quality of health provision. Methods. We
   conducted an extensive literature review using a list of amenable causes
   of death compiled by Spanish researchers. We complemented this approach
   by assessing the time trends of amenable mortality in two high-income
   countries that have a similar quality of healthcare but very different
   systems of provision, namely, Spain and the United States. This enabled
   us to identify different levels of efficacy of medical interventions (
   high, medium, and low). We consulted a group of medical experts and
   combined this information to help make the final classification of
   sentinel amenable causes of death. Results. Sentinel amenable mortality
   includes causes such as surgical conditions, thyroid diseases, and
   asthma. The remaining amenable causes of death either have a higher
   complexity in terms of the disease or need more effective medical
   interventions or preventative measures to guarantee early detection and
   adherence to treatment. These included cardiovascular diseases,
   diabetes, hypertension, all amenable cancers, and some infectious
   diseases such as pneumonia, influenza, and tuberculosis. Conclusions.
   Sentinel amenable mortality could act as a good sentinel indicator to
   identify major deficiencies in healthcare quality and provision and
   detect inequalities across populations.},
Publisher = {HINDAWI LTD},
Address = {ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Vergara-Duarte, M (Corresponding Author), Generalitat Catalunya, Inst Catala Salut, Gerencia Terr Barcelona, CAP El Clot,Dept Salut, Barcelona, Spain.
   Vergara-Duarte, M (Corresponding Author), Generalitat Catalunya, Inst Catala Salut, Gerencia Terr Barcelona,Dept Salut, Unitat Avaluacio Sistemes Informacio \& Qualitat A, Barcelona, Spain.
   Vergara-Duarte, Montse, Generalitat Catalunya, Inst Catala Salut, Gerencia Terr Barcelona, CAP El Clot,Dept Salut, Barcelona, Spain.
   Vergara-Duarte, Montse, Generalitat Catalunya, Inst Catala Salut, Gerencia Terr Barcelona,Dept Salut, Unitat Avaluacio Sistemes Informacio \& Qualitat A, Barcelona, Spain.
   Borrell, Carme; Perez, Gloria, Agencia Salut Publ Barcelona, Barcelona, Spain.
   Borrell, Carme; Martinez-Solanas, Erica, CIBER Epidemiol \& Publ Hlth CIBERESP, Barcelona, Spain.
   Borrell, Carme; Perez, Gloria; Martinez-Solanas, Erica, Univ Pompeu Fabra, Barcelona, Spain.
   Borrell, Carme; Perez, Gloria, St Pau Biomed Res Inst IIB St Pau, Barcelona, Spain.
   Carlos Martin-Sanchez, Juan, Univ Int Catalunya, Dept Basic Sci, Biostat Unit, Sant Cugat Del Valles, Spain.
   Cleries, Ramon, IDIBELL, Oncol, Barcelona, Spain.
   Cleries, Ramon, Univ Barcelona, Dept Ciencies Clin, Barcelona, Spain.
   Buxo, Maria, Girona Biomed Res Inst IDIBGI, Salt, Spain.
   Martinez-Solanas, Erica, ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.
   Yasui, Yutaka, St Jude Childrens Res Hosp, Dept Epidemiol \& Canc Control S6050, 332 N Lauderdale St, Memphis, TN 38105 USA.
   Yasui, Yutaka, Univ Alberta, Edmonton Clin Hlth Acad, Sch Publ Hlth, Edmonton, AB, Canada.
   Muntaner, Carles, Univ Toronto, Bloomberg Fac Nursing, Toronto, ON, Canada.
   Muntaner, Carles, Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Benach, Joan, Univ Pompeu Fabra, Dept Polit \& Social Sci, Hlth Inequal Res Grp Employment Condit Network GR, Barcelona, Spain.
   Benach, Joan, Johns Hopkins Univ, Publ Policy Ctr, Barcelona, Spain.
   Benach, Joan, Univ Autonoma Madrid, Grp Invest Transdisciplinar Transic Socioecol Gin, Madrid, Spain.},
DOI = {10.1155/2018/5456074},
Article-Number = {5456074},
ISSN = {2314-6133},
EISSN = {2314-6141},
Keywords-Plus = {MULTIDRUG-RESISTANT TUBERCULOSIS; AVOIDABLE MORTALITY;
   PERINATAL-MORTALITY; MATERNAL MORTALITY; DISEASE MORTALITY; TESTICULAR
   CANCER; HEART-DISEASE; NEW-ZEALAND; SURVIVAL; STRATEGIES},
Research-Areas = {Biotechnology \& Applied Microbiology; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Biotechnology \& Applied Microbiology; Medicine, Research \&
   Experimental},
Author-Email = {mvergara.bcn.ics@gencat.cat},
ResearcherID-Numbers = {Benach, Joan/H-2519-2013
   Yasui, Yutaka/E-2564-2015
   Perez, Gloria/F-7588-2015
   Sanchez, Juan Carlos Martin/G-5650-2019
   Martín, JuanCarlos/AAB-5440-2019},
ORCID-Numbers = {Benach, Joan/0000-0003-2285-742X
   Yasui, Yutaka/0000-0002-7717-8638
   Perez, Gloria/0000-0001-6653-3393
   Sanchez, Juan Carlos Martin/0000-0002-1045-4802
   Martín, JuanCarlos/0000-0002-1045-4802},
Funding-Acknowledgement = {CIBER Epidemiologia y Salud Publica (Spain); Fondo de Investigaciones
   SanitariasInstituto de Salud Carlos III {[}FIS 07/0285]},
Funding-Text = {This work was supported by the CIBER Epidemiologia y Salud Publica
   (Spain) and the Fondo de Investigaciones Sanitarias {[}Grant no. FIS
   07/0285]. The authors would like to thank the group of medical experts
   from the Hospital del Mar in Barcelona (Spain) for their contributions,
   comments, and recommendations in this study: Pilar Arino, Isabel
   Campodarve, Ana Guelar, Francisca Sanchez, Pilar Torre, Adolfo Diez,
   Josep M. Garces, Luis Grande, Juan Pablo Horcajada, Andreu Llado, Xavier
   Nogues, and Oriol Vall. Particular thanks are due to Oriol Vall, Andreu
   Llado, Esther Guimera, and the administrative assistants in the Internal
   Medicine Department for providing the needed access to medical
   professionals; to Deborah Rose and Arialdi Minino of the CDC, for their
   clarifications regarding US mortality data; and to Jose Miguel Martinez,
   Javier Campos, Alejandra Vives, Lidia Casas, and Veronica Moldon for
   their valuable advice in dealing with the study of amenable causes of
   death in the classification process; and to Dave MacFarlane, Luke
   Stobart, and the Paper Mill for the critical reading and language
   review.},
Cited-References = {AMIEHS, AV MORT EUR UN BETT.
   {[}Anonymous], 2007, LANCET, V369, P1492, DOI 10.1016/S0140-6736(07)60683-7.
   {[}Anonymous], 1989, MMWR-MORBID MORTAL W, V38, P25.
   Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61.
   Azpitarte J, 2000, REV ESP CARDIOL, V53, P1209, DOI 10.1016/S0300-8932(00)75227-4.
   Bellido J B, 1997, Gac Sanit, V11, P171.
   Bonadonna G, 2005, EUR J CANCER, V41, P998, DOI 10.1016/j.ejca.2005.01.006.
   Bray F, 2006, INT J CANCER, V118, P3099, DOI 10.1002/ijc.21747.
   Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x.
   Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1.
   Census.gov, INT DAT.
   Centers for Disease Control and Prevention, COMPR MORT FIL UND C.
   Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6.
   Chen F, 2004, DIABETES RES CLIN PR, V63, P113, DOI 10.1016/j.diabres.2003.09.002.
   Chiu PWY, 2009, CLIN GASTROENTEROL H, V7, P311, DOI 10.1016/j.cgh.2008.08.044.
   Chung JI, 2008, J KOREAN MED SCI, V23, P975, DOI 10.3346/jkms.2008.23.6.975.
   Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756.
   Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6.
   Donabedian A, 1992, Qual Health Care, V1, P247, DOI 10.1136/qshc.1.4.247.
   Duarte MAT, 2009, THESIS.
   Duarte MV, 2009, GAC SANIT, V23, P16, DOI 10.1016/j.gaceta.2007.10.002.
   Farreras Valenti P, 2009, MED INTERNA, V1.
   fundaciondelcorazon.com, VALV.
   Geerligs WA, 2000, INT J TUBERC LUNG D, V4, P758.
   Gispert R, 2008, J EPIDEMIOL COMMUN H, V62, P783, DOI 10.1136/jech.2007.066027.
   Gispert Rosa, 2006, Gac Sanit, V20, P184, DOI 10.1157/13088849.
   Graafmans WC, 2001, BRIT J OBSTET GYNAEC, V108, P1237, DOI 10.1111/j.1471-0528.2001.00291.x.
   Hoffmann R, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-8.
   Hoffmann R, 2013, GAC SANIT, V27, P199, DOI 10.1016/j.gaceta.2012.08.004.
   Holland W. W., 1991, COMMISSION EUROPEAN, V3.
   Holland WW, 2003, INT J EPIDEMIOL, V32, P447, DOI 10.1093/ije/dyg157.
   Ine.es, DEF SEG CAUS MUERT.
   James PD, 2007, J EPIDEMIOL COMMUN H, V61, P287, DOI 10.1136/jech.2006.047092.
   Jatoi I, 2003, LANCET ONCOL, V4, P251, DOI 10.1016/S1470-2045(03)01037-4.
   Josting A, 2000, CURR OPIN ONCOL, V12, P403, DOI 10.1097/00001622-200009000-00004.
   Kasper D., 2008, HARRISONS PRINCIPLES, V17th.
   Kawai K, 2006, JPN J CLIN ONCOL, V36, P723, DOI 10.1093/jjco/hyl102.
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9.
   Korda RJ, 2007, INT J EPIDEMIOL, V36, P157, DOI {[}10.1093/ijc/dyl282, 10.1093/ije/dyl282].
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9.
   Lu TH, 2005, J CLIN EPIDEMIOL, V58, P1150, DOI 10.1016/j.jclinepi.2005.03.009.
   Macinko J, 2009, J EPIDEMIOL COMMUN H, V63, P715, DOI 10.1136/jech.2008.081141.
   Makela JT, 2002, EUR J SURG, V168, P446, DOI 10.1080/110241502321116424.
   Martin U., 2009, P 13 C SOC ESP SAL P.
   Martin Zurro A, 2003, ATENCION PRIMARIA CO.
   McDaid D, 2003, HEALTH POLICY, V63, P133, DOI 10.1016/S0168-8510(02)00060-X.
   McKee M., 2004, DOES HEALTHCARE SAVE.
   Menard J, 2004, PRESSE MED, V33, P721, DOI 10.1016/S0755-4982(04)98729-5.
   Menendez R, 2005, ARCH BRONCONEUMOL, V41, P475.
   Migliori GB, 2008, CAN J INFECT DIS MED, V19, P169, DOI 10.1155/2008/857901.
   Ministry of Health, 1996, SAV LIV AM MORT NZ 1.
   Monk BJ, 2009, GYNECOL ONCOL, V113, P1, DOI 10.1016/j.ygyno.2009.02.015.
   Mustard CA, 2010, CAN J PUBLIC HEALTH, V101, P500, DOI 10.1007/BF03403973.
   Myles PR, 2009, EUR J PUBLIC HEALTH, V19, P521, DOI 10.1093/eurpub/ckp081.
   Nolasco A, 2009, HEALTH PLACE, V15, P732, DOI 10.1016/j.healthplace.2008.12.003.
   Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047.
   Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520.
   Perez G, 2014, J PUBLIC HEALTH POL, V35, P171, DOI 10.1057/jphp.2014.8.
   Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889.
   REGIDOR E, 1992, MED CLIN-BARCELONA, V99, P183.
   Richardus JH, 2003, BJOG-INT J OBSTET GY, V110, P97.
   Riley R, 1991, Health Rep, V3, P245.
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104.
   Shah A, 2008, BRIT J CANCER, V99, P219, DOI 10.1038/sj.bjc.6604466.
   Sheiham A, 2009, COMMUNITY DENT HLTH, V26, P2, DOI 10.1922/CDH\_2500Sheiham02.
   Stevens G, 2010, EUR J PUBLIC HEALTH, V20, P241, DOI 10.1093/eurpub/ckq051.
   Tobias M, 2001, AUST NZ J PUBL HEAL, V25, P12, DOI 10.1111/j.1467-842X.2001.tb00543.x.
   Tromp M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-102.
   Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4.
   Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291.
   Warner DP, 1998, ARCH DIS CHILD, V78, P435, DOI 10.1136/adc.78.5.435.
   World Health Organisation, 2008, GE STAND MORT RAT CA.},
Number-of-Cited-References = {72},
Times-Cited = {4},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Biomed Res. Int.},
Doc-Delivery-Number = {GT9HS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000444852200001},
OA = {gold, Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000383550200015,
Author = {Sacco, Ralph L. and Roth, Gregory A. and Reddy, K. Srinath and Arnett,
   Donna K. and Bonita, Ruth and Gaziano, Thomas A. and Heidenreich, Paul
   A. and Huffman, Mark D. and Mayosi, Bongani M. and Mendis, Shanthi and
   Murray, Christopher J. L. and Perel, Pablo and Pineiro, Daniel J. and
   Smith, Jr., Sidney C. and Taubert, Kathryn A. and Wood, David A. and
   Zhao, Dong and Zoghbi, William A.},
Title = {The Heart of 25 by 25: Achieving the Goal of Reducing Global and
   Regional Premature Deaths From Cardiovascular Diseases and Stroke A
   Modeling Study From the American Heart Association and World Heart
   Federation},
Journal = {GLOBAL HEART},
Year = {2016},
Volume = {11},
Number = {2},
Pages = {251-264},
Month = {JUN},
Abstract = {In 2011, the United Nations set key targets to reach by 2025 to reduce
   the risk of premature noncommunicable disease death by 25\% by 2025.
   With cardiovascular disease being the largest contributor to global
   mortality, accounting for nearly half of the 36 million annual
   noncommunicable disease deaths, achieving the 2025 goal requires that
   cardiovascular disease and its risk factors be aggressively addressed.
   The Global Cardiovascular Disease Taskforce, comprising the World Heart
   Federation, American Heart Association, American College of Cardiology
   Foundation, European Heart Network, and European Society of Cardiology,
   with expanded representation from Asia, Africa, and Latin America, along
   with global cardiovascular disease experts, disseminates information and
   approaches to reach the United Nations 2025 targets. The writing
   committee, which reflects Global Cardiovascular Disease Taskforce
   membership, engaged the Institute for Health Metrics and Evaluation,
   University of Washington, to develop region-specific estimates of
   premature cardiovascular mortality in 2025 based on various scenarios.
   Results show that >5 million premature CVD deaths among men and 2.8
   million among women are projected worldwide by 2025, which can be
   reduced to 3.5 million and 2.2 million, respectively, if risk factor
   targets for blood pressure, tobacco use, diabetes mellitus, and obesity
   are achieved. However, global risk factor targets have various effects,
   depending on region. For most regions, United Nations targets for
   reducing systolic blood pressure and tobacco use have more substantial
   effects on future scenarios compared with maintaining current levels of
   body mass index and fasting plasma glucose. However, preventing
   increases in body mass index has the largest effect in some high-income
   countries. An approach achieving reductions in multiple risk factors has
   the largest impact for almost all regions. Achieving these goals can be
   accomplished only if countries set priorities, implement cost-effective
   population wide strategies, and collaborate in public-private
   partnerships across multiple sectors.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
DOI = {10.1016/j.gheart.2016.04.002},
ISSN = {2211-8160},
EISSN = {2211-8179},
Keywords = {AHA Scientific Statements; cardiovascular diseases; forecasting; global
   health; premature mortality; prevention and control!5\#},
Keywords-Plus = {SCIENTIFIC STATEMENT; SYSTEMATIC ANALYSIS; RISK-FACTORS; HEALTH;
   MORTALITY; TRENDS; PREVALENCE; BURDEN; CARE},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
ResearcherID-Numbers = {Zhao, D/AAX-5040-2021
   Sacco, Ralph/Y-9278-2019
   Heidenreich, Paul/AAU-6864-2021
   },
ORCID-Numbers = {Heidenreich, Paul/0000-0001-7730-8490
   /0000-0002-2342-301X
   Reddy, K Srinath/0000-0003-3416-3548
   Huffman, Mark/0000-0001-7412-2519},
Cited-References = {Asaria P, 2007, LANCET, V370, P2004.
   Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0.
   Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0.
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X.
   Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3.
   Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82.
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692.
   Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94.
   Roth GA, 2015, CIRCULATION, V132, P1270, DOI 10.1161/CIRCULATIONAHA.115.016021.
   Smith SC, 2013, CIRCULATION, V128, P2546, DOI 10.1161/CIR.0b013e3182a93504.
   Smith SC, 2012, CIRCULATION, V126, P2769, DOI 10.1161/CIR.0b013e318267e99f.
   University of Washington. Institute of Health Metrics and Evaluation, 2015, GLOB BURD DIS INJ RI.
   World Health Organisation, PACK ESS NCD INT PRI.
   World Health Organization, GLOB STAT REP NONC M.
   World Health Organization, GLOB HLTH OBS DAT RE.
   World Health Organization, COMPR GLOB IN PRESS.
   World Health Organization, GLOB ACT PLAN PREV C.
   World Health Organization, NCD GLOB MON FRAM.
   World Health Organization and World Economic Forum, BURD BEST BUYS RED E.
   Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339.
   Zoghbi WA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000504.},
Number-of-Cited-References = {26},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Glob. Heart},
Doc-Delivery-Number = {DW3OF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000383550200015},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000367677600011,
Author = {Patzig, Julia and Kusch, Kathrin and Fledrich, Robert and Eichel, Maria
   A. and Lueders, Katja A. and Moebius, Wiebke and Sereda, Michael W. and
   Nave, Klaus-Armin and Martini, Rudolf and Werner, Hauke B.},
Title = {Proteolipid Protein Modulates Preservation of Peripheral Axons and
   Premature Death when Myelin Protein Zero is Lacking},
Journal = {GLIA},
Year = {2016},
Volume = {64},
Number = {1},
Pages = {155-174},
Month = {JAN},
Abstract = {Protein zero (P0) is the major structural component of peripheral
   myelin. Lack of this adhesion protein from Schwann cells causes a severe
   dysmyelinating neuropathy with secondary axonal degeneration in humans
   with the neuropathy Dejerine-Sottas syndrome (DSS) and in the
   corresponding mouse model (P0(null)-mice). In the mammalian CNS, the
   tetraspan-membrane protein PLP is the major structural myelin
   constituent and required for the long-term preservation of myelinated
   axons, which fails in hereditary spastic paraplegia (SPG type-2) and the
   relevant mouse model (Plp(null)-mice). The Plp-gene is also expressed in
   Schwann cells but PLP is of very low abundance in normal peripheral
   myelin; its function has thus remained enigmatic. Here we show that the
   abundance of PLP but not of other tetraspan myelin proteins is strongly
   increased in compact peripheral myelin of P0(null)-mice. To determine
   the functional relevance of PLP expression in the absence of P0, we
   generated P0(null star) Plp(null)-double-mutant mice. Compared with
   either single-mutant, P0(null star) Plp(null)-mice display impaired
   nerve conduction, reduced motor functions, and premature death. At the
   morphological level, axonal segments were frequently non-myelinated but
   in a one-to-one relationship with a hypertrophic Schwann cell.
   Importantly, axonal numbers were reduced in the vital phrenic nerve of
   P0(null star) Plp(null)-mice. In the absence of P0, thus, PLP also
   contributes to myelination by Schwann cells and to the preservation of
   peripheral axons. These data provide a link between the Schwann
   cell-dependent support of peripheral axons and the
   oligodendrocyte-dependent support of central axons.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Nave, KA (Corresponding Author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.
   Patzig, Julia; Kusch, Kathrin; Fledrich, Robert; Eichel, Maria A.; Lueders, Katja A.; Moebius, Wiebke; Sereda, Michael W.; Nave, Klaus-Armin; Werner, Hauke B., Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.
   Moebius, Wiebke, Ctr Nanoscale Microscopy \& Mol Physiol Brain, Gottingen, Germany.
   Sereda, Michael W., Univ Med Ctr, Dept Clin Neurophysiol, Gottingen, Germany.
   Martini, Rudolf, Univ Hosp, Dept Neurol, Dev Neurobiol, Wurzburg, Germany.},
DOI = {10.1002/glia.22922},
ISSN = {0894-1491},
EISSN = {1098-1136},
Keywords = {Schwann cell; neuropathy; Charcot-Marie-tooth disease; Dejerine-Sottas
   syndrome; oligodendrocyte; hereditary spastic paraplegia (SPG-2);
   glia-axonal support; myelin; neurodegeneration},
Keywords-Plus = {CENTRAL-NERVOUS-SYSTEM; MARIE-TOOTH-DISEASE;
   PELIZAEUS-MERZBACHER-DISEASE; INHERITED DEMYELINATING NEUROPATHIES; MICE
   HETEROZYGOUSLY DEFICIENT; COLONY-STIMULATING FACTOR; MAJOR STRUCTURAL
   PROTEIN; SCHWANN-CELL DEVELOPMENT; MOUSE MODEL; BASIC-PROTEIN},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Neurosciences},
Author-Email = {Nave@em.mpg.de
   Hauke@em.mpg.de},
ResearcherID-Numbers = {Fledrich, Robert/AAF-1590-2020
   Fledrich, Robert/M-1911-2019
   },
ORCID-Numbers = {Werner, Hauke/0000-0002-7710-5738
   Kusch, Kathrin/0000-0002-5079-502X
   /0000-0002-2902-7165
   Martini, Rudolf/0000-0002-5463-5592
   Eichel-Vogel, Maria/0000-0002-9925-7249},
Funding-Acknowledgement = {Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) {[}DFG
   WE2720/2-1, MA1053/6-1, 1944/1-1]; European Research CouncilEuropean
   Research Council (ERC)European Commission},
Funding-Text = {Grant sponsor: Deutsche Forschungsgemeinschaft; Grant numbers: DFG
   WE2720/2-1 to H.B.W.; MA1053/6-1 to R.M.; 1944/1-1 to M.W.S.; Grant
   sponsor: European Research Council, Advanced Grand to K.-A.N.},
Cited-References = {Aboussouan LS, 2007, LUNG, V185, P1, DOI 10.1007/s00408-006-0053-9.
   Anderson TJ, 1997, J NEUROSCI RES, V50, P13, DOI 10.1002/(SICI)1097-4547(19971001)50:1<13::AID-JNR2>3.0.CO;2-O.
   Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5.
   ARCHELOS JJ, 1993, J NEUROSCI RES, V35, P46, DOI 10.1002/jnr.490350107.
   Beirowski B, 2014, NAT NEUROSCI, V17, P1351, DOI 10.1038/nn.3809.
   Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386.
   Berghoff M, 2005, MOL CELL NEUROSCI, V28, P118, DOI 10.1016/j.mcn.2004.09.001.
   Bosse F, 2003, J NEUROCHEM, V86, P508, DOI 10.1046/j.1471-4159.2003.01870.x.
   Boucher SEM, 2002, J NEUROSCI, V22, P1772, DOI 10.1523/JNEUROSCI.22-05-01772.2002.
   Bradl M, 1999, ACTA NEUROPATHOL, V97, P595, DOI 10.1007/s004010051035.
   Carenini S, 1999, GLIA, V28, P256, DOI 10.1002/(SICI)1098-1136(199912)28:3<256::AID-GLIA9>3.3.CO;2-F.
   Carenini S, 1999, GLIA, V27, P203, DOI 10.1002/(SICI)1098-1136(199909)27:3<203::AID-GLIA2>3.3.CO;2-Z.
   Carenini S, 2001, J CELL BIOL, V152, P301, DOI 10.1083/jcb.152.2.301.
   Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248.
   De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281.
   de Monasterio-Schrader P, 2013, GLIA, V61, P1832, DOI 10.1002/glia.22561.
   de Monasterio-Schrader P, 2012, CELL MOL LIFE SCI, V69, P2879, DOI 10.1007/s00018-012-0958-9.
   DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D.
   Dobretsova A, 2008, J NEUROCHEM, V105, P1979, DOI 10.1111/j.1471-4159.2008.05288.x.
   Duncan ID, 2005, J NEUROL SCI, V228, P204, DOI 10.1016/j.jns.2004.10.011.
   DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M.
   Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012.
   Edgar JM, 2002, J CELL BIOL, V158, P719, DOI 10.1083/jcb.200202124.
   Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003.
   FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0.
   Fischer S, 2008, MOL CELL NEUROSCI, V37, P359, DOI 10.1016/j.mcn.2007.10.012.
   Frei R, 1999, J NEUROSCI, V19, P6058, DOI 10.1523/JNEUROSCI.19-14-06058.1999.
   FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x.
   Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8.
   Garbern JY, 1997, NEURON, V19, P205, DOI 10.1016/S0896-6273(00)80360-8.
   Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043.
   Garbern JY, 1999, ANN NY ACAD SCI, V883, P351, DOI 10.1111/j.1749-6632.1999.tb08597.x.
   Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475.
   GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y.
   Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019.
   Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007.
   Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610.
   Groh J, 2015, GLIA, V63, P977, DOI 10.1002/glia.22796.
   Groh J, 2012, BRAIN, V135, P88, DOI 10.1093/brain/awr283.
   Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269.
   Hahn JS, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e95.
   HAMMER JA, 1993, J NEUROSCI RES, V35, P546, DOI 10.1002/jnr.490350511.
   Horste GMZ, 2011, NEUROBIOL DIS, V42, P1, DOI 10.1016/j.nbd.2010.12.006.
   Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507.
   Jahn O., 2013, CYTOSKELETON NEUROME, V79, DOI {[}10.1007/978-1-62703-266-7\_15, DOI 10.1007/978-1-62703-266-7\_15].
   Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2.
   Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487.
   Jung M, 1996, J NEUROSCI, V16, P7920.
   KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1.
   Klein D, 2015, BRAIN, V138, DOI 10.1093/brain/awv240.
   Klein D, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0267-y.
   Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5.
   Kobsar I, 2003, BRAIN, V126, P804, DOI 10.1093/brain/awg072.
   Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998.
   LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9.
   LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0.
   Li J, 2006, J COMP NEUROL, V498, P252, DOI 10.1002/cne.21051.
   Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273.
   Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002.
   Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x.
   Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385.
   Martini R, 1997, GLIA, V19, P298.
   MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281.
   Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027.
   MARTINI R, 1995, J NEUROSCI, V15, P4488.
   Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766.
   Martini R, 2013, AM J PATHOL, V183, P655, DOI 10.1016/j.ajpath.2013.06.002.
   Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132.
   Mayer JA, 2011, NEUROBIOL DIS, V44, P231, DOI 10.1016/j.nbd.2011.07.007.
   Mobius W, 2010, METHOD CELL BIOL, V96, P475, DOI 10.1016/S0091-679X(10)96020-2.
   Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X.
   Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852.
   MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3.
   Muller M, 2007, EXP NEUROL, V203, P55, DOI 10.1016/j.expneurol.2006.07.018.
   Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b.
   Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101.
   Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008.
   Nawaz S, 2013, GLIA, V61, P1364, DOI 10.1002/glia.22520.
   Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009.
   Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009.
   Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011.
   Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7.
   Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000.
   Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021.
   PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218.
   Petit B, 2014, NEUROBIOL DIS, V65, P55, DOI 10.1016/j.nbd.2014.01.005.
   Previtali SC, 2000, J CELL BIOL, V151, P1035, DOI 10.1083/jcb.151.5.1035.
   Prukop T, 2014, AM J HUM GENET, V94, P533, DOI 10.1016/j.ajhg.2014.03.001.
   Quintes S, 2010, J PERIPHER NERV SYST, V15, P10, DOI 10.1111/j.1529-8027.2010.00247.x.
   READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3.
   Runker AE, 2004, J CELL BIOL, V165, P565, DOI 10.1083/jcb.200402087.
   Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750.
   Samsam M, 2003, J NEUROSCI, V23, P2833.
   Sanmaneechai O, 2015, BRAIN, V138, DOI 10.1093/brain/awv241.
   Saporta MAC, 2012, BRAIN, V135, P2032, DOI 10.1093/brain/aws140.
   SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257.
   Schaeren-Wiemers N, 2004, J CELL BIOL, V166, P731, DOI 10.1083/jcb.200406092.
   Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751.
   Schmid CD, 2000, J NEUROSCI, V20, P729, DOI 10.1523/JNEUROSCI.20-02-00729.2000.
   Shy ME, 2006, J NEUROL SCI, V242, P55, DOI 10.1016/j.jns.2005.11.015.
   Shy ME, 2003, ANN NEUROL, V53, P354, DOI 10.1002/ana.10466.
   Sima AAF, 2009, ACTA NEUROPATHOL, V118, P531, DOI 10.1007/s00401-009-0562-8.
   Skoff RP, 2004, CELL DEATH DIFFER, V11, P1247, DOI 10.1038/sj.cdd.4401498.
   Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915.
   Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014.
   Stecca B, 2000, J NEUROSCI, V20, P4002.
   Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014.
   Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767.
   Tanaka H, 2009, J NEUROSCI, V29, P8363, DOI 10.1523/JNEUROSCI.3216-08.2009.
   Tatar CL, 2010, ASN NEURO, V2, DOI 10.1042/AN20100016.
   Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37.
   TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0.
   Tzvetanova ID, 2014, NAT NEUROSCI, V17, P1293, DOI 10.1038/nn.3825.
   Vaurs-Barriere C, 2003, ANN NEUROL, V54, P769, DOI 10.1002/ana.10762.
   Vavlitou N, 2010, J NEUROPATH EXP NEUR, V69, P945, DOI 10.1097/NEN.0b013e3181efa658.
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012.
   Werner H, 1998, BRAIN PATHOL, V8, P771, DOI 10.1111/j.1750-3639.1998.tb00200.x.
   Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007.
   Werner HB, 2013, GLIA, V61, P567, DOI 10.1002/glia.22456.
   Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006.
   Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021.
   Xu WB, 2000, J NEUROSCI RES, V60, P714, DOI 10.1002/1097-4547(20000615)60:6<714::AID-JNR3>3.0.CO;2-1.
   Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009.
   Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998.
   Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174.
   Yin XH, 2015, GLIA, V63, P66, DOI 10.1002/glia.22733.
   Yool DA, 2001, J NEUROSCI RES, V63, P151.
   Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5.},
Number-of-Cited-References = {128},
Times-Cited = {21},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Glia},
Doc-Delivery-Number = {DA3DU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000367677600011},
DA = {2022-03-29},
}

@article{ WOS:000295679700008,
Author = {Ma, Jiemin and Flanders, W. Dana and Ward, Elizabeth M. and Jemal,
   Ahmedin},
Title = {Body Mass Index in Young Adulthood and Premature Death: Analyses of the
   US National Health Interview Survey Linked Mortality Files},
Journal = {AMERICAN JOURNAL OF EPIDEMIOLOGY},
Year = {2011},
Volume = {174},
Number = {8},
Pages = {934-944},
Month = {OCT 15},
Abstract = {Knowledge of the association between body mass index (weight (kg)/height
   (m)(2)) and premature death in young adulthood is very limited,
   especially for specific causes of death. Using the US National Health
   Interview Survey linked mortality files, the authors examined the
   relation between body mass index and premature death from all causes,
   cardiovascular disease (CVD), and cancer among 112,328 persons aged
   18-39 years who participated in the National Health Interview Survey in
   the years 1987, 1988, and 1990-1995. During an average of 16 years of
   follow-up (ending on December 31, 2006), there were 3,178 deaths: 573
   from CVD and 733 from cancer. Hazard ratios and 95\% confidence
   intervals were estimated using multivariate proportional hazards models
   adjusting for age, gender, race/ethnicity, education, and smoking
   status. In analyses restricted to participants who had never smoked, the
   hazard ratios for death from all causes were 1.07 (95\% confidence
   interval (CI): 0.91, 1.26) for overweight participants, 1.41 (95\% CI:
   1.16, 1.73) for obese participants, and 2.46 (95\% CI: 1.91, 3.16) for
   extremely obese participants, compared with those of normal weight.
   Monotonically increasing risks for excess body weight were also observed
   for deaths from cancer and CVD. The associations found in this young
   cohort were much stronger than those in middle-aged or older
   populations.},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA},
Type = {Article},
Language = {English},
Affiliation = {Ma, JM (Corresponding Author), Amer Canc Soc, Surveillance Res Program, Dept Intramural Res, 250 Williams St,6D204, Atlanta, GA 30303 USA.
   Ma, Jiemin, Amer Canc Soc, Surveillance Res Program, Dept Intramural Res, Atlanta, GA 30303 USA.
   Flanders, W. Dana, Emory Univ, Dept Epidemiol \& Biostat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.},
DOI = {10.1093/aje/kwr169},
ISSN = {0002-9262},
Keywords = {body mass index; cardiovascular diseases; mortality; neoplasms},
Keywords-Plus = {ALCOHOL-CONSUMPTION; VASCULAR MORTALITY; INDIVIDUAL DATA;
   BLOOD-PRESSURE; KOREAN MEN; OBESITY; CANCER; RISK; OVERWEIGHT; WOMEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {jiemin.ma@cancer.org},
Funding-Acknowledgement = {American Cancer SocietyAmerican Cancer Society},
Funding-Text = {This work was supported by the American Cancer Society.},
Cited-References = {Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643.
   ANDERSON R, 2001, COMPARABILITY CAUSE, V49.
   Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498.
   Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096.
   Burke V, 2006, CLIN EXP PHARMACOL P, V33, P831, DOI 10.1111/j.1440-1681.2006.04449.x.
   Burton A, 2010, CANCER CAUSE CONTROL, V21, P2069, DOI 10.1007/s10552-010-9625-3.
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423.
   Carmichael AR, 2006, OBES REV, V7, P333, DOI 10.1111/j.1467-789X.2006.00261.x.
   {*}CDCP, 2010, NHANES WEB TUT FREQ.
   Centers for Disease Control and Prevention, 2011, NAT HLTH INT SURV.
   Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20.
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367.
   Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84.
   Flanders W D, 1990, Epidemiology, V1, P239, DOI 10.1097/00001648-199005000-00010.
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028.
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014.
   Gill T, 2005, P NUTR SOC, V64, P255, DOI 10.1079/PNS2005425.
   Gittelsohn A, 1982, Vital Health Stat 2, P1.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Hernan MA, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.82.
   Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135.
   Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719.
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017.
   Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x.
   Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148.
   Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8.
   Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4.
   Lloyd-Jones DM, 2007, CIRCULATION, V115, P1004, DOI 10.1161/CIRCULATIONAHA.106.648642.
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101.
   Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012.
   MICOZZI MS, 1990, AM J PHYS ANTHROPOL, V81, P375, DOI 10.1002/ajpa.1330810307.
   {*}NAT CTR HLTH STAT, 2009, NHANES I EP FOLL UP.
   National Center for Health Statistics, 2009, NAT HLTH INT SURV 19.
   Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496.
   Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536.
   Pajari M, 2010, ALCOHOL ALCOHOLISM, V45, P173, DOI 10.1093/alcalc/agp090.
   Park HS, 2006, INT J EPIDEMIOL, V35, P181, DOI 10.1093/ije/dyi213.
   Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8.
   Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699.
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891.
   Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976.
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI {[}10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557].
   REEVES GK, 2007, CANCER, V335, P7630, DOI DOI 10.1136/BMJ.39367.495995.AE).
   Reither EN, 2009, POPUL HEALTH METR, V7, P2, DOI DOI 10.1186/1478-7954-7-2.
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X.
   Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542.
   van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006.
   Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.
   WHO Expert Committee on Physical Status: the use and interpretation of anthropometry (1993: Geneva Switzerland) \& World Health Organization, 1995, PHYS STAT US INT ANT.
   Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190.},
Number-of-Cited-References = {51},
Times-Cited = {35},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Am. J. Epidemiol.},
Doc-Delivery-Number = {830TI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000295679700008},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000354640600010,
Author = {Heslop, Pauline and Marriott, Anna},
Title = {Making a difference - the impact of the Confidential Inquiry into
   premature deaths of people with learning disabilities},
Journal = {BRITISH JOURNAL OF LEARNING DISABILITIES},
Year = {2015},
Volume = {43},
Number = {2, SI},
Pages = {142-149},
Month = {JUN},
Abstract = {Accessible summary In our research, we looked at why people with
   learning disabilities sometimes live shorter lives than other people. We
   were told about the deaths of 247 people with learning disabilities. We
   looked at what happened to these people before they died. We found that
   the professionals who were supporting these people learnt a lot from our
   research. This led to some changes in how they support people with
   learning disabilities. We have also seen that people are using the
   findings to improve the care and services for people with learning
   disabilities in the places they live. The Department of Health and NHS
   England are some of the organisations working to make sure doctors and
   nurses listen to what our research said.
   SummaryThe Confidential Inquiry into premature deaths of people with
   learning disabilities (CIPOLD) was commissioned by the Department of
   Health in England in 2010 to investigate the avoidable or premature
   deaths of people with learning disabilities through retrospective
   reviews of deaths. Both the process of conducting CIPOLD and the
   findings of the study itself made an impact on the way in which
   professionals thought about issues relating to people with learning
   disabilities and led to changes in policy and practice. Much of the
   impact of CIPOLD came from arming practitioners, family carers, people
   with learning disabilities and policy makers with the research findings
   and encouraging them to take on the mantle of change from there, for
   example, by increasing the provision of training or reviewing their
   current practice. There were a number of challenges that the research
   team faced. First, they needed to ensure the assiduous recording of any
   impact that took place throughout the duration of the research and
   beyond. Secondly, they were careful to make sure that as far as
   possible, professionals were involved and that it was a learning
   experience for them from which they had something to gain. Thirdly,
   self-reflexivity on the part of the research team was required in order
   for them to understand where their own strengths and limitations lay.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Heslop, P (Corresponding Author), Univ Bristol, Sch Policy Studies, Norah Fry Res Ctr, 8 Priory Rd, Bristol BS8 1TZ, Avon, England.
   Heslop, Pauline; Marriott, Anna, Univ Bristol, Sch Policy Studies, Norah Fry Res Ctr, Bristol BS8 1TZ, Avon, England.},
DOI = {10.1111/bld.12114},
ISSN = {1354-4187},
EISSN = {1468-3156},
Keywords = {Health care; health inequalities; learning disability; policy; research
   impact; service provision},
Research-Areas = {Education \& Educational Research},
Web-of-Science-Categories  = {Education, Special},
Author-Email = {Pauline.Heslop@bristol.ac.uk},
ResearcherID-Numbers = {Heslop, Pauline/AAW-9538-2021},
Cited-References = {Angelow A, 2011, BMJ QUAL SAF, V20, P38, DOI 10.1136/bmjqs.2010.040477.
   BMA, 2014, GEN PRACT CONTR CHAN.
   Clarke V, 2013, PSYCHOLOGIST, V26, P120.
   Department of Health, 2013, GOV RESP CONF INQ PR.
   Department of Health, 2011, NHS OUTC FRAM 2012 1.
   Department of Health, 2014, PREM DEATHS PEOPL LE.
   Heslop P, 2013, CONFIDENTIAL INQUIRY.
   Heslop P, 2014, LANCET, V383, P889, DOI 10.1016/S0140-6736(13)62026-7.
   Heslop P, 2011, TIZARD LEARN DISABIL, V16, P18, DOI 10.1108/13595471111185729.
   Jayatilleke N., 2012, J PUB HLTH, V35, P308.
   Joint Committee on Vaccination and Immunisation, 2013, M WEDN 12 JUN 2013.
   Mann K, 2009, ADV HEALTH SCI EDUC, V14, P595, DOI 10.1007/s10459-007-9090-2.
   Mencap, 2007, DEATH IND.
   Michael J, 2008, HEALTHCARE ALL REPOR.
   NHS England, 2014, NHS ENGL BUS PLAN 20.
   Parliamentary and Health Service Ombudsman, 2009, 6 LIV PROV PUBL SERV.
   PEARSON GAE, 2008, WHY CHILDREN DIE PIL.
   Rankin J, 2006, BJOG-INT J OBSTET GY, V113, P387, DOI 10.1111/j.1471-0528.2006.00883.x.
   Russell Pioneering Research Group, 2012, RUSS GROUP PAP, V3.
   Sen G., 2004, RELATIONSHIP RES ACT.
   Sidebotham P, 2010, ARCH DIS CHILD, V95, P291, DOI 10.1136/adc.2009.167619.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Brit. J. Learn. Disabil.},
Doc-Delivery-Number = {CI3IF},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000354640600010},
DA = {2022-03-29},
}

@article{ WOS:000253078400011,
Author = {Shelley, Piran and Tarry-Adkins, Jane and Martin-Gronert, Malgorzata and
   Poston, Lucilla and Heales, Simon and Clark, John and Ozanne, Susan and
   McConnell, Josie},
Title = {Rapid neonatal weight gain in rats results in a renal ubiquinone (CoQ)
   deficiency associated with premature death},
Journal = {MECHANISMS OF AGEING AND DEVELOPMENT},
Year = {2007},
Volume = {128},
Number = {11-12},
Pages = {681-687},
Month = {NOV-DEC},
Abstract = {We have recently reported that maternal dietary imbalance during
   pregnancy and lactation can reduce the lifespan of offspring. Rats that
   were growth restricted in utero by maternal protein restriction and
   underwent rapid weight gain when suckled by control fed dams died
   earlier than animals whose mothers were fed a control diet throughout
   pregnancy and lactation. We demonstrate here that mitochondrial
   abnormalities and DNA damage occur in the kidney of offspring who die
   prematurely. We have established by direct measurement and by in vitro
   supplementation that mitochondrial abnormalities occur because of a
   functional deficit of the mitochondrial cofactor coenzyme Q9 (CoQ9).
   These data provide molecular insight into the association between
   maternal nutrition and determination of offspring lifespan, and
   identify, a potential dietary intervention to prevent detrimental
   consequences of imbalanced maternal nutrition. (c) 2007 Elsevier Ireland
   Ltd. All rights reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {McConnell, J (Corresponding Author), Kings Coll London, Div Reprod \& Endocrinol, Maternal \& Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England.
   Shelley, Piran; Poston, Lucilla; McConnell, Josie, Kings Coll London, Div Reprod \& Endocrinol, Maternal \& Fetal Res Unit, St Thomas Hosp, London SE1 7EH, England.
   Shelley, Piran; Heales, Simon; Clark, John, UCL, Inst Neurol, Div Neurochem, London WC1N 3BG, England.
   Tarry-Adkins, Jane; Martin-Gronert, Malgorzata; Ozanne, Susan, Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England.},
DOI = {10.1016/j.mad.2007.10.002},
ISSN = {0047-6374},
Keywords = {aging; developmental programming; mitochondria; ROS; telomeres; CoQ},
Keywords-Plus = {COENZYME Q(10) IMPROVES; SENESCENT MYOCARDIUM; ANTIOXIDANT CAPACITY;
   LIFE-SPAN; MITOCHONDRIAL; GROWTH; METABOLISM; LONGEVITY; STRESS; KIDNEY},
Research-Areas = {Cell Biology; Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Cell Biology; Geriatrics \& Gerontology},
Author-Email = {josie.mcconnell@kcl.ac.uk},
ORCID-Numbers = {Ozanne, Susan/0000-0001-8753-5144},
Cited-References = {Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com.
   CAMBONIE G, 2006, AM J PHYSL REGUL INT.
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208.
   Cote HCF, 2006, ANTIVIR THER, V11, P79.
   Eriksson JG, 2002, ANN MED, V34, P157, DOI 10.1080/713782141.
   ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J.
   Gegg ME, 2003, J NEUROCHEM, V86, P228, DOI 10.1046/j.1471-4159.2003.01821.x.
   Hall AM, 2007, NEPHRON PHYSIOL, V105, P1, DOI 10.1159/000096860.
   Hodgson JM, 2002, EUR J CLIN NUTR, V56, P1137, DOI 10.1038/sj.ejcn.1601464.
   Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006.
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1.
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027.
   Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016.
   Linnane AW, 2002, ANN NY ACAD SCI, V959, P396, DOI 10.1111/j.1749-6632.2002.tb02110.x.
   LINNANE AW, 2002, ANN NY ACAD SCI, V959, P463.
   Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066.
   Lucas Alan, 2005, J Perinatol, V25 Suppl 2, pS2, DOI 10.1038/sj.jp.7211308.
   Martin-Hernandez E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z.
   McConnell J. M. L., 2003, J SOC GYNAECOLOGIC I, V10, P732.
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003.
   OKAMOTO T, 1985, J CHROMATOGR, V342, P35, DOI 10.1016/S0378-4347(00)84487-4.
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b.
   Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021.
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110.
   Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966.
   Quiles JL, 2006, FREE RADICAL RES, V40, P199, DOI 10.1080/10715760500404805.
   Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575.
   Rodriguez-Aguilera JC, 2005, AGEING RES REV, V4, P41, DOI 10.1016/j.arr.2004.09.001.
   Rosenfeldt FL, 1999, BIOFACTORS, V9, P291, DOI 10.1002/biof.5520090226.
   Rowland MA, 1998, CARDIOVASC RES, V40, P165, DOI 10.1016/S0008-6363(98)00132-1.
   Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x.
   SIMMONS RA, 2005, J BIOL CHEM.
   Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005.
   Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004.
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517.
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478.
   Turunen M, 2002, FREE RADICAL RES, V36, P437, DOI 10.1080/10715760290021298.},
Number-of-Cited-References = {37},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Mech. Ageing Dev.},
Doc-Delivery-Number = {261KV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000253078400011},
DA = {2022-03-29},
}

@article{ WOS:000257165600062,
Author = {Iijima-Ando, Kanae and Hearn, Stephen A. and Granger, Linda and Shenton,
   Christopher and Gatt, Anthony and Chiang, Hsueh-Cheng and Hakker, Inessa
   and Zhong, Yi and Iijima, Koichi},
Title = {Overexpression of neprilysin reduces Alzheimer amyloid-beta 42 (A beta
   42)-induced neuron loss and intraneuronal A beta 42 deposits but causes
   a reduction in cAMP-responsive element-binding protein-mediated
   transcription, age-dependent axon pathology, and premature death in
   Drosophila},
Journal = {JOURNAL OF BIOLOGICAL CHEMISTRY},
Year = {2008},
Volume = {283},
Number = {27},
Pages = {19066-19076},
Month = {JUL 4},
Abstract = {The amyloid-beta 42 (A beta 42) peptide has been suggested to play a
   causative role in Alzheimer disease (AD). Neprilysin (NEP) is one of the
   rate-limiting A beta-degrading enzymes, and its enhancement ameliorates
   extracellular amyloid pathology, synaptic dysfunction, and memory
   defects in mouse models of A beta amyloidosis. In addition to the
   extracellular A beta, intraneuronal A beta 42 may contribute to AD
   pathogenesis. However, the protective effects of neuronal NEP expression
   on intraneuronal A beta 42 accumulation and neurodegeneration remain
   elusive. In contrast, sustained NEP activation may be detrimental
   because NEP can degrade many physiological peptides, but its
   consequences in the brain are not fully understood. Using transgenic
   Drosophila expressing human NEP and A beta 42, we demonstrated that NEP
   efficiently suppressed the formation of intraneuronal A beta 42 deposits
   and A beta 42-induced neuron loss. However, neuronal NEP overexpression
   reduced cAMP-responsive element-binding protein-mediated transcription,
   caused age-dependent axon degeneration, and shortened the life span of
   the flies. Interestingly, the mRNA levels of endogenous fly NEP genes
   and phosphoramidon-sensitive NEP activity declined during aging in fly
   brains, as observed in mammals. Taken together, these data suggest both
   the protective and detrimental effects of chronically high NEP activity
   in the brain. Down-regulation of NEP activity in aging brains may be an
   evolutionarily conserved phenomenon, which could predispose humans to
   developing late-onset AD.},
Publisher = {AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC},
Address = {9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA},
Type = {Article},
Language = {English},
Affiliation = {Iijima-Ando, K (Corresponding Author), 900 Walnut St JHN410, Philadelphia, PA 19107 USA.
   Iijima-Ando, Kanae; Granger, Linda; Shenton, Christopher, Thomas Jefferson Univ, Lab Neurogenet \& Pathobiol, Farber Inst Neurosciences, Philadelphia, PA 19107 USA.
   Granger, Linda; Gatt, Anthony; Iijima, Koichi, Thomas Jefferson Univ, Lab Neurodegenerat Dis \& Gene Discovery, Farber Inst Neurosciences, Philadelphia, PA 19107 USA.
   Iijima-Ando, Kanae; Iijima, Koichi, Thomas Jefferson Univ, Dept Biochem \& Mol Biol, Philadelphia, PA 19107 USA.
   Hearn, Stephen A.; Chiang, Hsueh-Cheng; Hakker, Inessa; Zhong, Yi, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.
   Chiang, Hsueh-Cheng, SUNY Stony Brook, Dept Neurobiol \& Behav, Stony Brook, NY 11794 USA.},
DOI = {10.1074/jbc.M710509200},
ISSN = {0021-9258},
EISSN = {1083-351X},
Keywords-Plus = {AMYLOID-BETA-PEPTIDE; A-BETA; PLAQUE-FORMATION; TRANSGENIC MICE;
   DEGRADING ENDOPEPTIDASE; PRECURSOR PROTEIN; DISEASE; BRAIN;
   ACCUMULATION; NEURODEGENERATION},
Research-Areas = {Biochemistry \& Molecular Biology},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology},
Author-Email = {Kanae.Iijima-Ando@jefferson.edu
   Koichi.Iijima@jefferson.edu},
ORCID-Numbers = {Zhong, Yi/0000-0002-7927-5976
   Zhong, Yi/0000-0001-7810-9899},
Cited-References = {BARNES K, 1992, J NEUROCHEM, V58, P2088, DOI 10.1111/j.1471-4159.1992.tb10950.x.
   Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9.
   Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040.
   BRAND AH, 1993, DEVELOPMENT, V118, P401.
   BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092.
   Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013.
   CARREL S, 1982, ACTA NEUROPATHOL, V57, P158, DOI 10.1007/BF00685384.
   Carter TL, 2006, NEUROSCI LETT, V392, P235, DOI 10.1016/j.neulet.2005.09.022.
   Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3.
   Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027.
   Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438.
   Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070.
   Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021.
   Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006.
   Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200.
   Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101.
   Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105.
   Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001.
   Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9.
   Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100.
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1.
   Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040.
   Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200.
   Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074.
   HELLSTROMLINDAH.E, 2006, NEUROBIOL AGING.
   Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262.
   Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200.
   Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101.
   Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703.
   Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004.
   Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237.
   Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390.
   Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946.
   Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019.
   LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168.
   Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730.
   Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6.
   LI CW, 1995, METHOD ENZYMOL, V248, P253.
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0.
   Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007.
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230.
   Marr RA, 2003, J NEUROSCI, V23, P1992.
   Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5.
   Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113.
   Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006.
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3.
   Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje.
   Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050.
   Poirier R, 2006, NEUROBIOL DIS, V24, P475, DOI 10.1016/j.nbd.2006.08.003.
   Rodrigo J, 2004, NEUROSCIENCE, V128, P73, DOI 10.1016/j.neuroscience.2004.06.030.
   Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083.
   Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481.
   Russo R, 2005, FEBS LETT, V579, P6027, DOI 10.1016/j.febslet.2005.09.054.
   SAITO T, 2003, SCI AGING KNOWLEDGE, pPE1.
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741.
   Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200.
   Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031.
   Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001.
   Sudoh S, 2002, BIOCHEMISTRY-US, V41, P1091, DOI 10.1021/bi011193l.
   Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X.
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008.
   Thomas JE, 2005, BIOCHEM J, V386, P357, DOI 10.1042/BJ20041753.
   Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6.
   Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X.
   Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K.
   Wang DS, 2003, BIOCHEM BIOPH RES CO, V310, P236, DOI 10.1016/j.bbrc.2003.09.003.
   WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085.
   Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6.
   Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X.
   YIN JCP, 1995, MOL CELL BIOL, V15, P5123.
   YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9.
   Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119.},
Number-of-Cited-References = {72},
Times-Cited = {65},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Biol. Chem.},
Doc-Delivery-Number = {319LR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000257165600062},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000338919600025,
Author = {Bauer, Ursula E. and Briss, Peter A. and Goodman, Richard A. and Bowman,
   Barbara A.},
Title = {Prevention of chronic disease in the 21st century: elimination of the
   leading preventable causes of premature death and disability in the USA},
Journal = {LANCET},
Year = {2014},
Volume = {384},
Number = {9937},
Pages = {45-52},
Month = {JUL 5},
Abstract = {With non-communicable conditions accounting for nearly two-thirds of
   deaths worldwide, the emergence of chronic diseases as the predominant
   challenge to global health is undisputed. In the USA, chronic diseases
   are the main causes of poor health, disability, and death, and account
   for most of health-care expenditures. The chronic disease burden in the
   USA largely results from a short list of risk factors-including tobacco
   use, poor diet and physical inactivity (both strongly associated with
   obesity), excessive alcohol consumption, uncontrolled high blood
   pressure, and hyperlipidaemia-that can be effectively addressed for
   individuals and populations. Increases in the burden of chronic diseases
   are attributable to incidence and prevalence of leading chronic
   conditions and risk factors (which occur individually and in
   combination), and population demographics, including ageing and health
   disparities. To effectively and equitably address the chronic disease
   burden, public health and health-care systems need to deploy integrated
   approaches that bundle strategies and interventions, address many risk
   factors and conditions simultaneously, create population-wide changes,
   help the population subgroups most affected, and rely on implementation
   by many sectors, including public-private partnerships and involvement
   from all stakeholders. To help to meet the chronic disease burden, the
   US Centers for Disease Control and Prevention (CDC) uses four
   cross-cutting strategies: (1) epidemiology and surveillance to monitor
   trends and inform programmes; (2) environmental approaches that promote
   health and support healthy behaviours; (3) health system interventions
   to improve the effective use of clinical and other preventive services;
   and (4) community resources linked to clinical services that sustain
   improved management of chronic conditions. Establishment of community
   conditions to support healthy behaviours and promote effective
   management of chronic conditions will deliver healthier students to
   schools, healthier workers to employers and businesses, and a healthier
   population to the health-care system. Collectively, these four
   strategies will prevent the occurrence of chronic diseases, foster early
   detection and slow disease progression in people with chronic
   conditions, reduce complications, support an improved quality of life,
   and reduce demand on the health-care system. Of crucial importance, with
   strengthened collaboration between the public health and health-care
   sectors, the health-care system better uses prevention and early
   detection services, and population health is improved and sustained by
   solidifying collaborations between communities and health-care
   providers. This collaborative approach will improve health equity by
   building communities that promote health rather than disease, have more
   accessible and direct care, and focus the health-care system on
   improving population health.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Goodman, RA (Corresponding Author), Ctr Dis Control \& Prevent, Atlanta, GA 30341 USA.
   Bauer, Ursula E.; Briss, Peter A.; Goodman, Richard A.; Bowman, Barbara A., Ctr Dis Control \& Prevent, Natl Ctr Chron Dis Prevent \& Hlth Promot, Atlanta, GA 30341 USA.},
DOI = {10.1016/S0140-6736(14)60648-6},
ISSN = {0140-6736},
EISSN = {1474-547X},
Keywords-Plus = {UNITED-STATES; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; RISK-FACTORS; 21
   REGIONS; HEALTH; IMPROVEMENTS; PREVALENCE; PROGRAM; OBESITY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {rag4@cdc.gov},
Cited-References = {Adams Patricia F, 2012, Vital Health Stat 10, P1.
   Administration on Aging, AM REC REINV ACT COM.
   Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009.
   Anderson G., 2010, CHRONIC CARE MAKING.
   {[}Anonymous], CDCRFADP131305 GRANT.
   Ashman JJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120308.
   Assembly U., 2011, POLITICAL DECLARATIO.
   Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062.
   Brownson RC, 2004, PUBLIC HEALTH REP, V119, P230, DOI 10.1016/j.phr.2004.04.001.
   Bunnell R, 2012, J COMMUN HEALTH, V37, P1081, DOI 10.1007/s10900-012-9542-3.
   Buntin MB, 2010, HEALTH AFFAIR, V29, P1214, DOI 10.1377/hlthaff.2010.0503.
   Center for Disease Control and Prevention, 2000, RED TOB US REP SURG.
   Centers for Disease Control and Prevention, NAT BREAST CERV CANC.
   Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR.
   Centers for Disease Control and Prevention, MEAN US EL REC.
   Centers for Disease Control and Prevention, THIS EARL REL EARL R.
   Centers for Disease Control and Prevention, BEH RISK FACT SURV S.
   Centers for Disease Control and Prevention (CDC), 2013, PROGR CHILDH OB.
   Centers for Medicare and Medicaid Services, STAT INN MOD GEN INF.
   Centers for Medicare and Medicaid Services, HLTH CAR INN AW PROJ.
   Centers for Medicare and Medicaid Services, NAT HLTH EXP DAT NAT.
   Centers for Medicare and Medicaid Services, 2012, CHRON COND MED BEN C.
   Committee on Population at the National Research Council, 2013, US HLTH INT PERSP SH.
   Community Preventive Services Task Force, GUID COMM PREV SERV.
   Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1.
   Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002.
   DeVol R, 2007, UNHEALTHY AM EC BURD.
   Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016.
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935.
   Frieden TR, 2011, NEW ENGL J MED, V365, DOI {[}10.1056/NEJMp1110421, 10.1056/NEJMP1110421].
   Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652.
   Frieden TR, 2013, CDC HLTH DISPARITIES.
   Healthy People.gov, 2010, 2020 TOP OBJ.
   Hoyert DL, 2012, NATL VITAL STAT REPO, V61.
   Institute of Medicine, 2012, ACC PROGR OB PREV SO.
   Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560.
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9.
   Li Chaoyang, 2011, Morbidity and Mortality Weekly Report, V60, P1.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lorig K R, 2001, Eff Clin Pract, V4, P256.
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008.
   Machlin SR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120172.
   McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78.
   Milstein B, 2011, HEALTH AFFAIR, V30, P823, DOI 10.1377/hlthaff.2010.1116.
   Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519.
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   National Center for Health Statistics, 2013, 2012 SPEC FEAT EM CA.
   National Heart Lung and Blood Institute, MORB MORT 2012 CHART.
   National Prevention Council, 2012, NAT PREV COUNC ACT P.
   Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099.
   Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94.
   Robert Wood Johnson Foundation, COUNT HLTH RANK ROAD.
   Rudegeair P., 2012, REUTERS         1211.
   Schiller JS, 2013, EARLY RELEASE SELECT.
   Steiner CA, 2013, PREV CHRONIC DIS, V10, DOI {[}10.5888/pcd10.120292e, 10.5888/pcd10.120292].
   U.S. Department of Health and Human Services, 2010, MULT CHRON COND STRA.
   U.S. Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE.
   United Health Foundation, 2012, AM HLTH RANK CALL AC.
   United States Department of Agriculture Economic Research Service, FOOD ACC RES ATL.
   Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248.
   Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203.
   Wegner M.V., 2010, CHRONIC DIS EPIDEMIO.
   Woolf SH, 2013, US HLTH INT PERSPECT, P1.
   Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P771, DOI 10.1001/jama.2013.91.
   World Health Organization, 2010, GLOBAL STATUS REPORT.
   World Health Organization, UN HIGH LEV M NONC D.
   Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616.},
Number-of-Cited-References = {68},
Times-Cited = {659},
Usage-Count-Last-180-days = {14},
Usage-Count-Since-2013 = {252},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {AL1XL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000338919600025},
DA = {2022-03-29},
}

@article{ WOS:000554498100001,
Author = {Reinert, Tomas and Pellegrini, Rodrigo and Barrios, Carlos Henrique},
Title = {Lack of access to CDK4/6 inhibitors for premenopausal patients with
   metastatic breast cancer in Brazil: estimation of the number of
   premature deaths},
Journal = {ECANCERMEDICALSCIENCE},
Year = {2020},
Volume = {14},
Month = {JUL 30},
Abstract = {Purpose: A CDK4/6 inhibitor (CDK4/6i) combined with endocrine therapy is
   the standard of care for patients with hormone receptor-positive (HR+)
   and HER2-negative (HER2-) metastatic breast cancer (MBC). However, the
   incorporation of these agents into clinical practice remains
   challenging. This study aims to estimate the impact of the lack of
   access to ribociclib on mortality of premenopausal patients with MBC in
   Brazil.
   Methods: Based on published epidemiological studies and national cancer
   registries, we estimated the number of premenopausal patients with
   potential indication of ribociclib as first-line treatment for MBC.
   Efficacy estimates were based on results from the Monaleesa-7 trial. Our
   analysis is made under the unrealistic assumption that all premenopausal
   MBC patients would be candidates for the treatment. To estimate the
   number of yearly premature deaths that could be prevented, we considered
   the largest absolute effect on mortality when sequentially applying the
   observed hazard ratio.
   Results: We estimated an annual incidence of 4,294 premenopausal HR+,
   HER2- MBC patients in Brazil. Considering these patients, at 12, 24 and
   60 months, the number of surviving subjects would be 3,504, 2,859 and
   1,553 for endocrine therapy (ET) alone; and 3,717, 3,217 and 2,086 for
   ET plus ribociclib. The largest difference between both groups was
   observed at the end of the sixth year when the use of ribociclib would
   prevent 538 premature deaths (survival of 1,805 versus 1,267 patients by
   the 72nd month).
   Conclusion: We estimate that lack of access to CDK4/6i for patients with
   HR+, HER2-, MBC will cause the premature death of a significant number
   of premenopausal women with MBC. The unavailability of effective
   therapies has measurable consequences. Progress in this area demands a
   concerted effort to prevent further loss of lives.},
Publisher = {CANCER INTELLIGENCE LTD},
Address = {11 ALMA VALE RD,, BRISTOL, BS8 2HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Barrios, CH (Corresponding Author), Latin Amer Cooperat Oncol Grp LACOG, BR-90619900 Porto Alegre, RS, Brazil.
   Barrios, CH (Corresponding Author), Oncoclin, BR-90570020 Porto Alegre, RS, Brazil.
   Reinert, Tomas; Barrios, Carlos Henrique, Latin Amer Cooperat Oncol Grp LACOG, BR-90619900 Porto Alegre, RS, Brazil.
   Reinert, Tomas; Barrios, Carlos Henrique, Oncoclin, BR-90570020 Porto Alegre, RS, Brazil.
   Pellegrini, Rodrigo, Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, BR-90619900 Porto Alegre, RS, Brazil.},
DOI = {10.3332/ecancer.2020.1081},
Article-Number = {1081},
ISSN = {1754-6605},
Keywords = {breast cancer; drug therapy; health care disparities; drug access},
Keywords-Plus = {SURVIVAL},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {barrios@tummi.org},
ResearcherID-Numbers = {Reinert, Tomas/E-8981-2017},
ORCID-Numbers = {Reinert, Tomas/0000-0003-4715-1415},
Cited-References = {Addison CL, 2017, BREAST, V15, P199, DOI {[}10.1158/0008-5472.CAN-15-2357, DOI 10.1158/0008-5472.CAN-15-2357].
   Agrawal A, 2017, J CLIN ONCOL, V18, P114, DOI {[}10.1038/onc.2016.382, DOI 10.1038/ONC.2016.382].
   Barrios CH, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.SABCS16-P6-16-04.
   Barrios Carlos H, 2018, Am Soc Clin Oncol Educ Book, V38, P441, DOI 10.1200/EDBK\_209183.
   Barrios CH, 2019, ECANCERMEDICALSCIENC, V13, DOI 10.3332/ecancer.2019.898.
   Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216.
   Cardoso F, 2018, ANN ONCOL, V29, P1634, DOI 10.1093/annonc/mdy192.
   Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118.
   Cortes J, 2020, CA-CANCER J CLIN, V70, P105, DOI 10.3322/caac.21597.
   Cruz M, 2018, CLIN PHARMACOL THER, V103, P1009, DOI 10.1002/cpt.965.
   Debiasi M, 2017, J GLOB ONCOL, V3, P201, DOI 10.1200/JGO.2016.005678.
   Ekwueme DU, 2014, AM J PREV MED, V46, P71, DOI 10.1016/j.amepre.2013.08.016.
   Franzoi MA, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00263.
   Goetz MP, 2019, J NATL COMPR CANC NE, V17, P119, DOI 10.6004/jnccn.2019.0009.
   Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2.
   Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI {[}10.1038/s41572-019-0122-z, 10.1038/s41572-019-0111-2].
   Im SA, 2019, NEW ENGL J MED, V381, P307, DOI 10.1056/NEJMoa1903765.
   Lopes GD, 2013, NAT REV CLIN ONCOL, V10, P314, DOI 10.1038/nrclinonc.2013.55.
   Modigliani F, 2014, SOC RES NEW YORK, V33, P160.
   Olah LiviaS., 2018, DEMOGRAPHIC PERSPECT, P41, DOI {[}10.1007/978-3-319-72356-3\_4, DOI 10.1007/978-3-319-72356-3\_4].
   Reinert T, 2020, JCO GLOB ONCOL, V6, P307, DOI 10.1200/JGO.19.00404.
   Reinert T, 2017, THER ADV MED ONCOL, V9, P693, DOI 10.1177/1758834017728928.
   Sashegyi A, 2017, ONCOLOGIST, V22, P484, DOI 10.1634/theoncologist.2016-0198.
   Schmid P, 2020, LANCET ONCOL, V21, P44, DOI 10.1016/S1470-2045(19)30689-8.
   Simon SD, 2019, BREAST, V44, P113, DOI 10.1016/j.breast.2019.01.008.
   Sledge GW, 2020, JAMA ONCOL, V6, P116, DOI 10.1001/jamaoncol.2019.4782.
   Snapinn S, 2011, STAT MED, V30, P2341, DOI 10.1002/sim.4256.
   Tripathy D, 2018, LANCET ONCOL, V19, P904, DOI 10.1016/S1470-2045(18)30292-4.
   Werutsky G, 2019, BRAZ J ONCOL S1, V15, P1.},
Number-of-Cited-References = {29},
Times-Cited = {0},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {eCancerMedicalScience},
Doc-Delivery-Number = {MS8BC},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000554498100001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1986E920000017,
Author = {STAMLER, J and WENTWORTH, D and NEATON, JD},
Title = {IS RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND RISK OF PREMATURE DEATH
   FROM CORONARY HEART-DISEASE CONTINUOUS AND GRADED - FINDINGS IN 356 222
   PRIMARY SCREENEES OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT)},
Journal = {JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
Year = {1986},
Volume = {256},
Number = {20},
Pages = {2823-2828},
Month = {NOV 28},
Publisher = {AMER MEDICAL ASSOC},
Address = {515 N STATE ST, CHICAGO, IL 60610},
Type = {Article},
Language = {English},
Affiliation = {UNIV MINNESOTA,MRFIT COORDINATING CTR,2829 UNIV AVE SE,SUITE 508,MINNEAPOLIS,MN 55414.},
DOI = {10.1001/jama.256.20.2823},
ISSN = {0098-7484},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {{[}Anonymous], 1984, JAMA, V251, P365.
   ARMITAGE P, 1973, STATISTICAL METHODS, P387.
   CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5.
   Consensus Conference, 1985, JAMA, V253, P2080.
   CORNFIELD J, 1962, FED PROC, V21, P58.
   GOTTO AM, 1983, PREVENTION CORONARY, P33.
   GRUNDY S M, 1982, Circulation, V65, p839A.
   Inter-Society Commission for Heart Disease Resources Atherosclerosis Study Group and Epidemiology Study Group, 1970, CIRCULATION, V42, pA55.
   LENFANT C, 1986, CIRCULATION, V73, P855, DOI 10.1161/01.CIR.73.5.855.
   OLIVER MF, 1981, LANCET, V2, P1090.
   PYORALA K, 1985, CARDIOLOGY, V72, P4.
   ROSE G, 1984, CORONARY HEART DISEA.
   STAMLER J, 1981, AM J CARDIOL, V47, P722.
   STAMLER J, 1985, NEW ENGL J MED, V312, P1053, DOI 10.1056/NEJM198504183121609.
   STAMLER J, 1985, CARDIOLOGY, V72, P11, DOI 10.1159/000173836.
   STAMLER J, CARDIOLOGY.
   STAMLER J, 1983, PREVENTION CORONARY, P188.
   1981, NIH812035 US DEP HLT, V2.
   {[}No title captured].
   1984, 28 DEP HLTH SOC SEC.
   1980, CIRCULATION, V62, pA449.
   1984, 1984 EUR C PRIM PREV.
   1984, AM HEART J, V108, P759.
   1983, PHS841232 US DEP HLT.
   {[}No title captured].
   1981, NIH812034 US DEP HLT.
   1982, WHO TECHNICAL REPORT, V678.
   1984, CIRCULATION, V70, pA153.
   1961, EM180 AM HEART ASS C.},
Number-of-Cited-References = {29},
Times-Cited = {1657},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {31},
Journal-ISO = {JAMA-J. Am. Med. Assoc.},
Doc-Delivery-Number = {E9200},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1986E920000017},
DA = {2022-03-29},
}

@article{ WOS:000300242000007,
Author = {Bertrand, Anne T. and Renou, Laure and Papadopoulos, Aurelie and Beuvin,
   Maud and Lacene, Emmanuelle and Massart, Catherine and Ottolenghi, Chris
   and Decostre, Valerie and Maron, Sophia and Schlossarek, Saskia and
   Cattin, Marie-Elodie and Carrier, Lucie and Malissen, Marie and Arimura,
   Takuro and Bonne, Gisele},
Title = {DelK32-lamin A/C has abnormal location and induces incomplete tissue
   maturation and severe metabolic defects leading to premature death},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2012},
Volume = {21},
Number = {5},
Pages = {1037-1048},
Month = {MAR 1},
Abstract = {The LMNA gene encodes lamin A/C intermediate filaments that polymerize
   beneath the nuclear membrane, and are also found in the nucleoplasm in
   an uncharacterized assembly state. They are thought to have structural
   functions and regulatory roles in signaling pathways via interaction
   with transcription factors. Mutations in LMNA have been involved in
   numerous inherited human diseases, including severe congenital muscular
   dystrophy (L-CMD). We created the Lmna(K32) knock-in mouse harboring a
   L-CMD mutation. Lmna(K32/K32) mice exhibited striated muscle maturation
   delay and metabolic defects, including reduced adipose tissue and
   hypoglycemia leading to premature death. The level of mutant proteins
   was markedly lower in Lmna(K32/K32), and while wild-type lamin A/C
   proteins were progressively relocated from nucleoplasmic foci to the
   nuclear rim during embryonic development, mutant proteins were
   maintained in nucleoplasmic foci. In the liver and during adipocyte
   differentiation, expression of K32-lamin A/C altered sterol regulatory
   element binding protein 1 (SREBP-1) transcriptional activities. Taken
   together, our results suggest that lamin A/C relocation at the nuclear
   lamina seems important for tissue maturation potentially by releasing
   its inhibitory function on transcriptional factors, including but not
   restricted to SREBP-1. And importantly, L-CMD patients should be
   investigated for putative metabolic disorders.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Bonne, G (Corresponding Author), GH Pitie Salpetriere, UPMC UM76, CNRS UMR7215, Therapie Malad Muscle Strie Inserm U974,Inst Myco, 47 Blvd Hop, F-75651 Paris 13, France.
   Bertrand, Anne T.; Renou, Laure; Papadopoulos, Aurelie; Beuvin, Maud; Lacene, Emmanuelle; Massart, Catherine; Decostre, Valerie; Cattin, Marie-Elodie; Carrier, Lucie; Arimura, Takuro; Bonne, Gisele, Univ Paris 06, INSERM, UMRS 974, F-75013 Paris, France.
   Bertrand, Anne T.; Renou, Laure; Papadopoulos, Aurelie; Beuvin, Maud; Lacene, Emmanuelle; Massart, Catherine; Decostre, Valerie; Cattin, Marie-Elodie; Carrier, Lucie; Arimura, Takuro; Bonne, Gisele, Univ Paris 06, CNRS, Inst Myol, UM 76,UMR 7215,IFR14, F-75013 Paris, France.
   Ottolenghi, Chris, Hop Necker Enfants Malad, AP HP, Serv Biochim Metab, F-75015 Paris, France.
   Maron, Sophia; Schlossarek, Saskia; Carrier, Lucie, Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol \& Toxicol, Hamburg, Germany.
   Malissen, Marie, Univ Mediterranee UM 631, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.
   Malissen, Marie, INSERM, UMR S 631, F-13288 Marseille, France.
   Malissen, Marie, CNRS, UMR6102, F-13288 Marseille, France.
   Bonne, Gisele, Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet \& Myogenet, Serv Biochim Metab, F-75013 Paris, France.},
DOI = {10.1093/hmg/ddr534},
ISSN = {0964-6906},
EISSN = {1460-2083},
Keywords-Plus = {RETINOBLASTOMA GENE-PRODUCT; ELEMENT-BINDING PROTEIN-1; ADIPOCYTE
   DIFFERENTIATION; LAMIN-A/C; NUCLEAR LAMINS; EXPRESSION; LMNA; MUTATIONS;
   IDENTIFICATION; LAMINOPATHIES},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {g.bonne@institut-myologie.org},
ResearcherID-Numbers = {Bonne, Gisèle/G-3121-2013
   Arimura, Takuro/AAA-2745-2022
   Bertrand, Anne/AAR-6751-2020
   Ottolenghi, Chris/H-3745-2017
   },
ORCID-Numbers = {Bonne, Gisèle/0000-0002-2516-3258
   Arimura, Takuro/0000-0002-0929-3140
   Ottolenghi, Chris/0000-0002-0734-344X
   Papadopoulos, Aurelie/0000-0003-0060-7040
   Malissen, Marie/0000-0003-2331-1445
   Bertrand, Anne/0000-0001-7153-848X},
Funding-Acknowledgement = {Institut National de la Sante et de la Recherche MedicaleInstitut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Pierre et Marie Curie Paris; Universite de la Mediterranee, Centre
   National de la Recherche Scientifique; Association Francaise contre les
   MyopathiesAssociation Francaise contre les Myopathies {[}11034, 11057,
   15261]; European UnionEuropean Commission {[}018690]},
Funding-Text = {This work was financially supported by the Institut National de la Sante
   et de la Recherche Medicale; the Universite Pierre et Marie Curie Paris
   06; the Universite de la Mediterranee, the Centre National de la
   Recherche Scientifique; the Association Francaise contre les Myopathies
   (\#11034, \#11057 to G. B. and \#15261 to T. A.); and the European Union
   Sixth Framework Programmes (Euro-laminopathies \#018690 to A.T.B.).},
Cited-References = {Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X.
   Bank EM, 2011, MOL BIOL CELL, V22, P2716, DOI 10.1091/mbc.E11-01-0064.
   Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024.
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799.
   Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005.
   Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295.
   Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524.
   Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794.
   Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124.
   Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466.
   D'Amico A, 2005, NEUROMUSCULAR DISORD, V15, P521, DOI 10.1016/j.nmd.2005.03.006.
   Fajas L, 1999, MOL CELL BIOL, V19, P5495.
   Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426.
   Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906.
   Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736.
   Hansen JB, 2004, CELL CYCLE, V3, P774.
   HOPPEL CL, 1982, AM J PHYSIOL, V243, pE168, DOI 10.1152/ajpendo.1982.243.2.E168.
   Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096.
   Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004.
   Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731.
   Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150.
   Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09.
   Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x.
   Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769.
   Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14.
   Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049.
   MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418.
   Maraldi NM, 2008, ADV ENZYME REGUL, V48, P209, DOI 10.1016/j.advenzreg.2007.11.003.
   Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.e04-02-0154.
   Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630.
   Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343.
   Naetar N, 2009, CELL CYCLE, V8, P1488, DOI 10.4161/cc.8.10.8499.
   OZAKI T, 1994, ONCOGENE, V9, P2649.
   Pegorier JP, 2004, J NUTR, V134, p2444S, DOI 10.1093/jn/134.9.2444S.
   Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003.
   Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417.
   Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951.
   Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x.
   Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047.
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093.
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913.
   TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33.
   Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4.
   Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745.
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028.},
Number-of-Cited-References = {45},
Times-Cited = {49},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Hum. Mol. Genet.},
Doc-Delivery-Number = {891UL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000300242000007},
DA = {2022-03-29},
}

@article{ WOS:000334543600006,
Author = {Kurtak, Karen A.},
Title = {Dietary and Nutritional Manipulation of the Nuclear Transcription
   Factors Peroxisome Proliferator-Activated Receptor and Sterol Regulatory
   Element-Binding Proteins As a Tool for Reversing the Primary Diseases of
   Premature Death and Delaying Aging},
Journal = {REJUVENATION RESEARCH},
Year = {2014},
Volume = {17},
Number = {2},
Pages = {140-144},
Month = {APR 1},
Abstract = {Evolution over 2.1 billion years has equipped us with a biochemical
   pathway that has the power to literally reverse the primary disease
   etiologies that have become the leading causes of death and aging in the
   developed world. Activation of the peroxisome proliferator-activated
   receptor (PPAR) pathway arrests inflammatory signaling throughout the
   body, reverses damage to tissues, reverses insulin resistance, and can
   even dissolve beta-amyloid plaque in the brain. It has played a critical
   role in the evolution of the metazoans and the successful migration of
   humans to all corners of the Earth. For two decades, various
   pharmaceuticals have been designed to activate the PPAR pathway but have
   consistently fallen short of expectations. There is nothing wrong with
   these drugs. The problem has been the standard ``healthy{''} diet
   creating mixed signals that render the drugs ineffective. This article
   explores the ongoing dance between the two primary nuclear receptors
   that mediate gene regulation of fatty acids. It discusses their
   interaction with sirtuins and telomerase, optimization of their obligate
   heterodimers, and why manipulation of dietary and nutritional factors,
   like the ketogenic diet, is the most effective means of activation.
   These are effective tools that we can start implementing now to slow,
   and in some cases reverse, the diseases of aging.},
Publisher = {MARY ANN LIEBERT, INC},
Address = {140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA},
Type = {Article},
Language = {English},
Affiliation = {Kurtak, KA (Corresponding Author), POB 185, Idledale, CO 80453 USA.},
DOI = {10.1089/rej.2013.1485},
ISSN = {1549-1684},
EISSN = {1557-8577},
Keywords-Plus = {PPAR-GAMMA AGONIST; GROWTH-FACTOR 21; NF-KAPPA-B; GENE-EXPRESSION;
   INSULIN-RESISTANCE; OXIDATIVE STRESS; ACID OXIDATION; FATTY-ACIDS;
   ALPHA; METABOLISM},
Research-Areas = {Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Geriatrics \& Gerontology},
Author-Email = {karen@karenkurtak.com},
Cited-References = {Bettoun DJ, 2003, MOL ENDOCRINOL, V17, P2320, DOI 10.1210/me.2003-0148.
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816.
   Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43.
   Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200.
   Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005.
   Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI {[}10.1089/ars.2008.2280, 10.1089/ARS.2008.2280].
   Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001.
   Jeong EA, 2011, EXP NEUROL, V232, P195, DOI 10.1016/j.expneurol.2011.09.001.
   Karasawa T, 2011, ARTERIOSCL THROM VAS, V31, P1788, DOI 10.1161/ATVBAHA.110.219659.
   Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006.
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606.
   Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051.
   Landrier JF, 2004, J BIOL CHEM, V279, P45512, DOI 10.1074/jbc.M407461200.
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012.
   Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017.
   Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0.
   Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309.
   Pershadsingh HA, 2007, EXPERT OPIN INV DRUG, V16, P291, DOI 10.1517/13543784.16.3.291.
   Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107.
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006.
   Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008.
   Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318.
   Schoonjans K, 1996, J LIPID RES, V37, P907.
   Sharabi Y, 2007, AM J HYPERTENS, V20, P206, DOI 10.1016/j.amjhyper.2006.08.002.
   Shen P, 2006, J NUTR, V136, P899, DOI 10.1093/jn/136.4.899.
   Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x.
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182.
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014.
   Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879.
   Van Cleemput M, 2009, MOL NUTR FOOD RES, V53, P1143, DOI 10.1002/mnfr.200800493.
   Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044.
   Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336.
   Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010.
   Wang ZJ, 2006, CHEM-BIOL INTERACT, V163, P207, DOI 10.1016/j.cbi.2006.08.005.
   Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898.
   Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200.
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984.
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143.
   Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003.},
Number-of-Cited-References = {39},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Rejuv. Res.},
Doc-Delivery-Number = {AF2LM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000334543600006},
DA = {2022-03-29},
}

@article{ WOS:000365312600001,
Author = {Rasky, Eva and Stolz, Erwin and Burkert, Nathalie Tatjana and
   Grossschaedl, Franziska},
Title = {Potentially preventable premature deaths in women and men from the two
   leading causes of death in Austria, mortality statistics of the nine
   federal states 2010-2012},
Journal = {BMC PUBLIC HEALTH},
Year = {2015},
Volume = {15},
Month = {NOV 25},
Abstract = {Background: In Austria, mortality from diseases of the circulatory
   system and malignant neoplasms is high and varies among the federal
   states. Lower mortality in some states indicates a preventive potential
   in those states with higher mortality.
   Methods: We computed the number of premature deaths, for women and men
   separately, from the two leading causes of death, diseases of the
   circulatory system (ICD-10: I00-I09) and cancer (ICD-10: C00-C97), in
   the nine Austrian federal states between 2010-2012. The potentially
   preventable deaths per federal state and sex were calculated by
   subtracting expected deaths from observed deaths.
   Results: The western federal states had the lowest death rates, and thus
   the smallest preventive potential. In death from circulatory diseases
   and from cancer the differences between women and men varied remarkably
   between the federal states. For circulatory diseases among all federal
   states the highest difference in percent was given in Vorarlberg (6.2
   \%) with more potentially preventable deaths for men. For cancer,
   Burgenland had the highest difference (8.6 \%) in comparison with the
   other federal states, again with the higher preventive potential for
   men.
   Conclusions: Intervention programs as lifestyle modification
   interventions as well as improvements in health care services provision,
   should focus on the characteristics of the specific federal state, which
   are setting-oriented and account for social determinants including
   sex/gender differences and economic factors. Relevant data gathering is
   therefore, urgently needed.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Rasky, E (Corresponding Author), Med Univ Graz, Inst Social Med \& Epidemiol, A-8010 Graz, Austria.
   Rasky, Eva; Stolz, Erwin; Burkert, Nathalie Tatjana; Grossschaedl, Franziska, Med Univ Graz, Inst Social Med \& Epidemiol, A-8010 Graz, Austria.},
DOI = {10.1186/s12889-015-2502-y},
Article-Number = {1177},
EISSN = {1471-2458},
Keywords = {Mortality statistics; Preventable death; Regional differences;
   Sex-specifity; Diseases of the circulatory system; Cancer; Austria},
Keywords-Plus = {HEART-DISEASE MORTALITY; PHYSICAL-ACTIVITY; EAST; OBESITY; DECLINE;
   TRENDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {eva.rasky@medunigraz.at},
ORCID-Numbers = {Stolz, Erwin/0000-0001-7393-1568
   Grossschadl, Franziska/0000-0002-6726-0443},
Cited-References = {{[}Anonymous], CARD DIS RISK FACT.
   {[}Anonymous], 2003, 916 WHO.
   Austria S, 2013, JB GES, P23.
   Bobak M, 1996, BRIT MED J, V312, P421.
   Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002.
   Burkert N, 2012, HERZ KREISLAUF REPOR.
   Camacho-Minano MJ, 2011, HEALTH EDUC RES, V26, P1025, DOI 10.1093/her/cyr040.
   Casey MM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-649.
   DIMDI/Deutsches Institut fur Medizinische Dokumentation und Information, 2014, INT CLASS DIS ICD 10.
   Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021.
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935.
   Grossschadl F, 2012, WIEN KLIN WOCHENSCHR, V124, P363, DOI 10.1007/s00508-012-0175-4.
   Klimont J., 2007, OSTERREICHISCHE GESU.
   Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274.
   Muller-Nordhorn J, 2004, J EPIDEMIOL COMMUN H, V58, P481, DOI 10.1136/jech.2003.013367.
   Rasky E, 2012, OKZ, V53, P31.
   Regidor E, 2014, HEALTH PLACE, V27, P30, DOI 10.1016/j.healthplace.2014.01.010.
   Siatisiik Austria, 2013, REG BIP HAUPT NACH W.
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI {[}10.3322/caac.21208, 10.1001/jamaoto.2014.2530, 10.3322/caac.21254, 10.1136/bmj.g1502].
   {[}Stanford University National Science Foundation European Commission], GEND INN SCI HLTH ME.
   Stein KV, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-59.
   Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2.
   WHO, 2008, COMM SOC DET HLTH CL.
   WHO, WHO GEND ASS TOOL.
   WHO/World Health Organization, 2007, FIGHT CANC STRAT PRE.
   World Health Organization, 1986, OTT CHART HLTH PROM.
   Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369.},
Number-of-Cited-References = {27},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {CW9IO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000365312600001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000432475300140,
Author = {Solazzo, Efisio and Riccio, Angelo and Van Dingenen, Rita and Valentini,
   Luana and Galmarini, Stefano},
Title = {Evaluation and uncertainty estimation of the impact of air quality
   modelling on crop yields and premature deaths using a multi-model
   ensemble},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2018},
Volume = {633},
Pages = {1437-1452},
Month = {AUG 15},
Abstract = {This study promotes the critical use of air pollution modelling results
   for health and agriculture impacts, with the primary goal of providing
   more reliable estimates to decision makers. To date, the accuracy of air
   quality (AQ) models and the effects of model-to-model result variability
   (which we will refer to as model uncertainty) on impact assessment
   studies have been often ignored, thus undermining the robustness of the
   information used in the decision making process and the confidence in
   the results obtained.
   A suite of twelve PM2.5 and ozone concentration fields produced by
   regional-scale chemistry transport Air Quality (AQ) models during the
   third phase of the Air Quality Model Evaluation International Initiative
   (AQMEII) has been used to calculate the impact of air pollution on
   premature deaths and crop yields. An innovative technique is applied to
   bias-adjust the models to available observations.
   The model results for ozone and PM2.5 are combined in a multi-model (MM)
   ensemble, which is used to estimate the damage and economic cost to
   human health and crop yields, as well as the associated uncertainties.
   The MM ensemble quantifies directly the uncertainty introduced by AQ
   models into the air pollution impact assessment chain, while the
   indirect use of experimental information through a bias adjustment,
   reduces the uncertainty in the ozone and PM2.5 fields and subsequently
   the uncertainty of the final impact assessment and cost valuation. The
   analysis over the European countries analysed in this study shows a mean
   number of premature deaths due to exposure to PM2.5 and ozone of
   approximately 370,000 (inter-quantile range between 260,000 and 415,000)
   and a relative yield loss of approximately 7\% to 9\% (depending on the
   exposure metrics used, for wheat and maize together). Furthermore, the
   results indicate that a reduction in the uncertainty of the modelled
   ozone by 61\% and by 80\% (depending on the aggregation metric used) and
   by 46\% for PM2.5, produces a reduction in the uncertainty in premature
   mortality and crop loss of >60\%, and of an equivalent percentage in the
   final uncertainty of cost valuation, providing decision makers with more
   accurate estimations for more targeted interventions. (c) 2018 The
   Authors. Published by Elsevier B.V.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Solazzo, E (Corresponding Author), European Commiss, Joint Res Ctr, Ispra, VA, Italy.
   Solazzo, Efisio; Van Dingenen, Rita; Galmarini, Stefano, European Commiss, Joint Res Ctr, Ispra, VA, Italy.
   Riccio, Angelo, Parthenope Univ, Dept Sci \& Technol, Isola C4, I-80143 Naples, Italy.
   Valentini, Luana, GFT Italia Srl, Via Sile 18, I-20139 Milan, Italy.},
DOI = {10.1016/j.scitotenv.2018.03.317},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Impact assessment; Multi-model ensemble; Bias-adjustment; Premature
   mortality; Uncertainty cascade},
Keywords-Plus = {GLOBAL BURDEN; OZONE; MORTALITY; PREDICTIONS; SCIENCE; AQMEII},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {efisio.solazzo@ec.europa.eu},
ResearcherID-Numbers = {Van Dingenen, Rita/AAI-3197-2021
   Riccio, Angelo/F-7795-2012
   SOLAZZO, EFISIO/AAE-7070-2020
   },
ORCID-Numbers = {Van Dingenen, Rita/0000-0003-2521-4972
   Riccio, Angelo/0000-0001-7775-5565
   solazzo, efisio/0000-0002-6333-1101
   galmarini, stefano/0000-0002-0321-152X},
Cited-References = {Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220.
   Annan JD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041994.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045.
   Beven K, 2016, HYDROLOG SCI J, V61, P1652, DOI 10.1080/02626667.2015.1031761.
   Bishop C.M., 2006, PATTERN RECOGN.
   Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2.
   Burnett, 2014, INTEGRATED RISK FUNC, V2014.
   Crippa M., 2017, ATMOS CHEM PHYS DISC, DOI {[}10.5194/acp-2017-779, DOI 10.5194/ACP-2017-779].
   Eckhardt S, 2008, ATMOS CHEM PHYS, V8, P3881, DOI 10.5194/acp-8-3881-2008.
   Galmarini S, 2004, ATMOS ENVIRON, V38, P4607, DOI 10.1016/j.atmosenv.2004.05.030.
   Galmarini S, 2013, ATMOS CHEM PHYS, V13, P7153, DOI 10.5194/acp-13-7153-2013.
   Gelman A, 2014, BAYESIAN DATA ANAL.
   Global Energy Assessment, 2012, GLOBAL ENERGY ASSESS.
   Henneman, 2017, J AIR WASTE MANAGE A, V67.
   Henneman LRF, 2017, ATMOS ENVIRON, V166, P551, DOI 10.1016/j.atmosenv.2017.07.049.
   Holland M., 2014, COST BENEFIT ANAL FI.
   Horalek J., 2016, EUROPEAN AIR QUALITY.
   IHME, 2011, GLOB BURD DIS STUD 2.
   IIASA and FAO, 2012, GLOB AGR ZON V3 0.
   Im U., 2017, ATMOS CHEM PHYS DISC, DOI {[}10.5194/acp-2017-751, DOI 10.5194/ACP-2017-751].
   Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894.
   Kioutsioukis I, 2016, ATMOS CHEM PHYS, V16, P15629, DOI 10.5194/acp-16-15629-2016.
   Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1.
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5.
   KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694.
   Kundzewicz ZW, 2018, ENVIRON SCI POLICY, V79, P1, DOI 10.1016/j.envsci.2017.10.008.
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383.
   Mills G, 2007, ATMOS ENVIRON, V41, P2630, DOI 10.1016/j.atmosenv.2006.11.016.
   Morgan RK, 2012, IMPACT ASSESS PROJ A, V30, P5, DOI 10.1080/14615517.2012.661557.
   Parker WS, 2013, WIRES CLIM CHANGE, V4, P213, DOI 10.1002/wcc.220.
   Pennell C, 2011, J CLIMATE, V24, P2358, DOI 10.1175/2010JCLI3814.1.
   Potempski S, 2009, ATMOS CHEM PHYS, V9, P9471, DOI 10.5194/acp-9-9471-2009.
   Rao ST, 2011, B AM METEOROL SOC, V92, P23, DOI 10.1175/2010BAMS3069.1.
   Rao S, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124013.
   Riccio A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016503.
   Silva RA, 2016, ENVIRON HEALTH PERSP, V124, P1776, DOI 10.1289/EHP177.
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005.
   Solazzo E, 2015, ATMOS CHEM PHYS, V15, P2535, DOI 10.5194/acp-15-2535-2015.
   Solazzo E, 2013, ATMOS CHEM PHYS, V13, P8315, DOI 10.5194/acp-13-8315-2013.
   Solazzo E., 2017, ATMOSPHERIC CHEM PHY.
   Solazzo E, 2016, ATMOS CHEM PHYS, V16, P6263, DOI 10.5194/acp-16-6263-2016.
   Solazzo E, 2012, ATMOS ENVIRON, V53, P60, DOI 10.1016/j.atmosenv.2012.01.003.
   Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005.
   van der Sluijs JP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024008.
   van Dingenen R., 2018, ATMOS CHEM PHYS DISC, DOI {[}10.5194/acp-2018-112., DOI 10.5194/ACP-2018-112].
   Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033.
   Vrugt JA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004838.
   WHO, 2015, EC COST HLTH IMP AIR.},
Number-of-Cited-References = {51},
Times-Cited = {17},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {38},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {GG1VK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000432475300140},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000171327700007,
Author = {Machler, H and Rose, C and Zeibig, C and McGauran, N and Robra, BP},
Title = {Workplace conditions predict the risk of premature death and functional
   dependence after retirement - results of a gerontological follow-up
   study in Germany},
Journal = {PUBLIC HEALTH},
Year = {2001},
Volume = {115},
Number = {5},
Pages = {345-349},
Month = {SEP},
Abstract = {Between 1983 and 1985, 595 employees who were entering retirement in
   East Germany were given a medical examination and asked to assess their
   workplace conditions. Ten years later, we examined whether occupational
   predictors were associated with death and functional dependence among
   the study participants and assessed how the surviving pensioners coped
   with activities and instrumental activities of daily living. We assigned
   the occupational factors reported between 1983 and 1985 to two scales:
   demands and resources. Multiple logistic regression analyses were
   carried out to examine the association of occupational and medical
   predictors with the outcome variables death and functional dependence.
   Workplace resources but not demands were significantly associated with a
   reduced chance of death in women, independent of medical diagnoses. For
   men neither of these associations were verified. Concerning functional
   dependence individual items such as `control over work content' (for
   both sexes) significantly reduced the risk of developing ADL-dependence.
   The associations remained stable after medical diagnoses were
   additionally taken into consideration. The results of our study
   highlight the influence of occupational factors beyond working life and
   support the importance of starting geriatric health promotion before
   retirement age.},
Publisher = {W B SAUNDERS CO LTD},
Address = {32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {McGauran, N (Corresponding Author), Univ Klinikum Magdeburg, Inst Sozialmed, Leipziger Str 44, D-39120 Magdeburg, Germany.
   Univ Klinikum Magdeburg, Inst Sozialmed, D-39120 Magdeburg, Germany.},
ISSN = {0033-3506},
EISSN = {1476-5616},
Keywords = {occupational health; geriatrics; functional dependence; activities of
   daily living (ADL); prospective studies},
Keywords-Plus = {WORKING LIFE; MORTALITY; HEALTH; DISABILITY; IMPAIRMENT; ILLNESS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {natalie.mcgauran@medizin.uni-magdeburg.de},
Cited-References = {Alonso J, 1997, AM J PUBLIC HEALTH, V87, P365, DOI 10.2105/AJPH.87.3.365.
   BALLWEG JA, 1989, PUBLIC HEALTH REP, V104, P498.
   Baltes MM, 1997, PSYCHOL AGING, V12, P433, DOI 10.1037/0882-7974.12.3.433.
   BALTES PB, 1996, BERLINER ALTERSSTUDI.
   Brenner H, 1996, Gesundheitswesen, V58, P272.
   Calmels P, 1998, J EPIDEMIOL COMMUN H, V52, P283, DOI 10.1136/jech.52.5.283.
   CASSOU B, 1992, J EPIDEMIOL COMMUN H, V46, P506, DOI 10.1136/jech.46.5.506.
   KARASEK RA, 1988, AM J PUBLIC HEALTH, V78, P910, DOI 10.2105/AJPH.78.8.910.
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016.
   KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1\_Part\_1.20.
   KELLER BK, 1994, J GERONTOL, V49, pM246, DOI 10.1093/geronj/49.6.M246.
   KUHNE HD, 1991, BEURTEILUNG ALTERSAB.
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3\_Part\_1.179.
   LEIGH JP, 1994, B NEW YORK ACAD MED, V71, P69.
   Leveille SG, 2000, AGING-CLIN EXP RES, V12, P106, DOI 10.1007/BF03339897.
   MACHLER H, 1998, Z GESUNDHEITSWISS, V2, P137.
   Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593.
   {*}MIN GES DEUTSCH D, 1978, INT STAT KLASS KRANK.
   OSTLIN P, 1990, J EPIDEMIOL COMMUN H, V44, P12, DOI 10.1136/jech.44.1.12.
   {*}STAT ZENTR STAT, 1984, STAT JAHRB DEUTSCH D.
   THOMAE H, 1993, Z GERONTOL, V26, P142.
   THOMPSON JR, 1989, AGE AGEING, V18, P83, DOI 10.1093/ageing/18.2.83.
   TINETTI ME, 1988, JAMA-J AM MED ASSOC, V259, P1190, DOI 10.1001/jama.259.8.1190.},
Number-of-Cited-References = {23},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Public Health},
Doc-Delivery-Number = {478DM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000171327700007},
DA = {2022-03-29},
}

@article{ WOS:000173548400002,
Author = {Hara, M and Sobue, T and Sasaki, S and Tsugane, S and JPHC Study Grp},
Title = {Smoking and risk of premature death among middle-aged Japanese: Ten-year
   follow-up of the Japan Public Health Center-based prospective study on
   cancer and cardiovascular diseases (JPHC study) Cohort I},
Journal = {JAPANESE JOURNAL OF CANCER RESEARCH},
Year = {2002},
Volume = {93},
Number = {1},
Pages = {6-14},
Month = {JAN},
Abstract = {To update the evidence on the association between smoking and mortality,
   we analyzed data from a population-based prospective study in Japan. In
   total, 19 950 men and 21534 women aged 40-59 who reported their smoking
   history and had no serious disease at baseline survey were followed.
   During 1990-1999, 1014 men and 500 women died. Smokers were associated
   with an unhealthy lifestyle. Relative risks (RRs) for selected cause of
   death due to smoking were slightly attenuated by adjusting for possible
   confounding factors. Age- and area-adjusted RRs of male current smokers
   compared with never smokers were 1.66 (95\% confidence intervals (CI):
   1.40, 1.95) for all causes, 1.69 (1.31, 2.18) for all cancers, 1.67
   (1.20, 2.34) for all circulatory system disease, and 1.63 (1.24, 2.15)
   for other causes, while those of females were 2.03 (1.52, 2.73), 2.06
   (1.35, 3.15), 2.99 (1.75, 5.11), 1.31 (0.69, 2.51), respectively. After
   adjusting for multivariate variables, the corresponding RRs of male
   smokers were 1.55 (1.29, 1.86), 1.61 (1.20, 2.15), 1.41 (0.97, 2.03),
   and 1.61 (1.17, 2.19), against 1.89 (1.36, 2.62), 1.83 (1.14, 2.95),
   2.72 (1.45, 5.07), and 1.39 (0.71, 2.73) for females. Twenty-two percent
   of death from all causes, 25\% of all cancer, and 17\% of all
   circulatory system disease deaths, could be attributed to cigarette
   smoking in males, and 5\%, 4\%, and 11\% in females, respectively.
   Cumulative dose as indicated by pack-years was clearly associated with
   cancer death. These findings provided information as to the quantitative
   risk for premature death due to smoking among middle-aged Japanese men
   and women, and showed that the elevated risk was not explained by the
   unhealthy lifestyle of smokers.},
Publisher = {JAPANESE CANCER ASSOC},
Address = {C/O JAPANESE FOUNDATION CANCER RESEARCH,1-37-1, KAMI-IKEBUKURO,
   TOSHIMA-KU, TOKYO, 170-0012, JAPAN},
Type = {Article},
Language = {English},
Affiliation = {Tsugane, S (Corresponding Author), Natl Canc Ctr, Res Inst E, Epidemiol \& Biostat Div, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.
   Natl Canc Ctr, Res Inst E, Epidemiol \& Biostat Div, Kashiwa, Chiba 2778577, Japan.
   Saga Med Sch, Dept Community \& Hlth Sci, Saga 8498501, Japan.
   Natl Canc Ctr, Res Inst, Canc Informat \& Epidemiol Div, Chuo Ku, Tokyo 10400345, Japan.},
DOI = {10.1111/j.1349-7006.2002.tb01194.x},
ISSN = {0910-5050},
Keywords = {smoking; mortality; prospective study},
Keywords-Plus = {CIGARETTE-SMOKING; UNITED-STATES; ALCOHOL-CONSUMPTION; MORTALITY;
   SMOKERS; MEN; NONSMOKERS; INTERVAL; VETERANS; TRENDS},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {stsugane@east.ncc.go.jp},
ResearcherID-Numbers = {Hara, Masayuki/AAH-4361-2019
   Tsugane, Shoichiro/A-2424-2015
   Sobue, Tomotaka/ABE-4739-2021
   },
ORCID-Numbers = {Tsugane, Shoichiro/0000-0003-4105-2774
   Hara, Megumi/0000-0002-8708-3237},
Cited-References = {AKIBA S, 1990, ENVIRON HEALTH PERSP, V87, P19, DOI 10.2307/3431001.
   AKIBA S, 1994, ENVIRON HEALTH PERSP, V102, P15, DOI 10.1289/ehp.94102s815.
   BURNS DM, 1997, NATL CANCER I MONOGR, V8, P113.
   Chyou PH, 1997, ANN EPIDEMIOL, V7, P311, DOI 10.1016/S1047-2797(97)00019-7.
   CHYOU PH, 1992, AM J PUBLIC HEALTH, V82, P37, DOI 10.2105/AJPH.82.1.37.
   COULTAS DB, 1989, AM J EPIDEMIOL, V130, P338, DOI 10.1093/oxfordjournals.aje.a115340.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865.
   FLODERUS B, 1988, INT J EPIDEMIOL, V17, P332, DOI 10.1093/ije/17.2.332.
   Greenland S, 1999, AM J EPIDEMIOL, V149, P884.
   Hirayama Takeshi, 1990, LIFE STYLE MORTALITY, P1.
   KLESGES RC, 1995, J CLIN EPIDEMIOL, V48, P1225, DOI 10.1016/0895-4356(95)00020-5.
   KONO S, 1987, JPN J CANCER RES, V78, P1323.
   LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303.
   Malarcher AM, 2000, AM J EPIDEMIOL, V152, P573, DOI 10.1093/aje/152.6.573.
   MCLAUGHLIN JK, 1995, INT J CANCER, V60, P190, DOI 10.1002/ijc.2910600211.
   {*}MHW, 1993, SMOK HLTH, P3.
   Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423.
   Nordlund LA, 1997, INT J CANCER, V73, P625, DOI 10.1002/(SICI)1097-0215(19971127)73:5<625::AID-IJC2>3.0.CO;2-Z.
   Phillips ELR, 2000, ANN EPIDEMIOL, V10, P417, DOI 10.1016/S1047-2797(00)00064-8.
   PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61.
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15.
   ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213.
   ROGOT E, 1980, JNCI-J NATL CANCER I, V65, P1163.
   {*}SAS I INC, 1996, SAS STAT SOFTW CHANG.
   Scheidt S, 1997, PREV MED, V26, P441, DOI 10.1006/pmed.1997.0185.
   SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323.
   Thun M, 1997, NCI SMOKING TOBACCO, P383.
   Thun M., 1997, NATL CANCER I MONOGR, P305.
   Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706.
   Tsubono Y, 1996, JPN J CANCER RES, V87, P563, DOI 10.1111/j.1349-7006.1996.tb00260.x.
   Tsugane S, 1999, AM J EPIDEMIOL, V150, P1201, DOI 10.1093/oxfordjournals.aje.a009946.
   Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646.
   Zhu BP, 1996, AM J PUBLIC HEALTH, V86, P1582, DOI 10.2105/AJPH.86.11.1582.},
Number-of-Cited-References = {35},
Times-Cited = {27},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Jpn. J. Cancer Res.},
Doc-Delivery-Number = {516HT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000173548400002},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000323106000002,
Author = {Diandini, Rachmania and Takahashi, Ken and Park, Eun-Kee and Jiang, Ying
   and Movahed, Mehrnoosh and Giang Vinh Le and Lee, Lukas Jyuhn-Hsiarn and
   Delgermaa, Vanya and Kim, Rokho},
Title = {Potential years of life lost (PYLL) caused by asbestos-related diseases
   in the world},
Journal = {AMERICAN JOURNAL OF INDUSTRIAL MEDICINE},
Year = {2013},
Volume = {56},
Number = {9},
Pages = {993-1000},
Month = {SEP},
Abstract = {Background We applied the well-established, but rather under-utilized,
   indicator of Potential Years of Life Lost (PYLL) to estimate the global
   burden of mesothelioma and asbestosis.
   Methods We analyzed all deaths caused by mesothelioma and asbestosis
   that were reported by 82 and 55 countries, respectively, to the World
   Health Organization (WHO) from 1994 to 2010.
   Results The 128,015 and 13,885 persons who died of mesothelioma and
   asbestosis, potentially lost a total of 2.18 million and 180,000 years
   of life (PYLL), or, an annual average PYLL of 201,000 years and 17,000
   years, respectively. The average PYLL per decedent were 17.0 and 13.0
   years for mesothelioma and asbestosis, respectively.
   Conclusions The current burden of asbestos-related diseases (ARDs) in
   terms of PYLL is substantial. The future burden of ARDs can be
   eliminated by stopping the use of asbestos. Am. J. Ind. Med.
   56:993-1000, 2013. (c) 2013 Wiley Periodicals, Inc.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Takahashi, K (Corresponding Author), Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Yahatanishi Ku, Iseigaoka 1-1, Kitakyushu, Fukuoka 8078555, Japan.
   Diandini, Rachmania; Takahashi, Ken; Park, Eun-Kee; Jiang, Ying; Movahed, Mehrnoosh, Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka 8078555, Japan.
   Diandini, Rachmania, Syarif Hidayatullah State Islamic Univ Jakarta, Fac Med \& Hlth Sci, Jakarta, Indonesia.
   Park, Eun-Kee, Kosin Univ, Coll Med, Dept Med Humanities \& Social Med, Pusan, South Korea.
   Giang Vinh Le, Hanoi Med Univ, Dept Epidemiol, Inst Prevent Med \& Publ Hlth, Hanoi, Vietnam.
   Lee, Lukas Jyuhn-Hsiarn, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli, Taiwan.
   Lee, Lukas Jyuhn-Hsiarn, Natl Taiwan Univ Hosp, Dept Environm \& Occupat Med, Taipei, Taiwan.
   Delgermaa, Vanya, Hlth Sci Univ Mongolia, Dept Prevent Med, Ulaanbaatar, Mongolia.
   Kim, Rokho, WHO, European Ctr Environm \& Hlth, Reg Off Europe, Bonn, Germany.},
DOI = {10.1002/ajim.22206},
ISSN = {0271-3586},
EISSN = {1097-0274},
Keywords = {asbestos; mesothelioma; asbestosis; asbestos-related diseases; potential
   years of life lost; disability adjusted life years (DALY); age adjusted
   mortality rate; burden of disease; global},
Keywords-Plus = {GLOBAL BURDEN; MESOTHELIOMA; MORTALITY; CANCER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ktaka@med.uoeh-u.ac.jp},
ResearcherID-Numbers = {Lee, Lukas Jyuhn-Hsiarn/AAB-6424-2021
   Lee, Lukas Jyuhn-Hsiarn/G-9641-2011
   Takahashi, Ken/AAX-7705-2020
   },
ORCID-Numbers = {Lee, Lukas Jyuhn-Hsiarn/0000-0003-1095-6877
   Takahashi, Ken/0000-0002-7310-2257
   Movahed, Mehrnoosh/0000-0001-5154-4700},
Funding-Acknowledgement = {Japan Society for the Promotion of SciencesMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science},
Funding-Text = {This work was supp orted in part by the Core-to-Core Program
   (Asia-Africa Science Platform) of the Japan Society for the Promotion of
   Sciences.},
Cited-References = {{[}Anonymous], 1997, SCAND J WORK ENV HEA, V23, P211.
   Center of Disease Control and Prevention (US), 1982, MMWR-MORBID MORTAL W, V31, P109.
   Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1321.
   Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678.
   Driscoll T, 2005, AM J IND MED, V48, P419, DOI 10.1002/ajim.20209.
   Driscoll T, 2005, AM J IND MED, V48, P432, DOI 10.1002/ajim.20210.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Harding AH, 2010, AM J IND MED, V53, P1070, DOI 10.1002/ajim.20844.
   HORM JW, 1989, AM J PUBLIC HEALTH, V79, P1490, DOI 10.2105/AJPH.79.11.1490.
   International Labour Organization, 2006, 95 INT LAB C.
   International Labour Organization/World Health Organization, 2003, REP COMM JCOH 2003 D.
   Leigh J, 2002, AM J IND MED, V41, P188, DOI 10.1002/ajim.10047.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45.
   McDonald JC, 1996, EUR RESPIR J, V9, P1932, DOI 10.1183/09031936.96.09091932.
   Moore AJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-34.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Nishikawa K, 2008, ENVIRON HEALTH PERSP, V116, P1675, DOI 10.1289/ehp.11272.
   Park EK, 2011, ENVIRON HEALTH PERSP, V119, P514, DOI 10.1289/ehp.1002845.
   PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X.
   pruss-ustun a, 2003, WHO ENV BURDEN DIS S, V1.
   Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152.
   Rushton L, 2012, BRIT J CANCER, V107, pS3, DOI 10.1038/bjc.2012.112.
   United Nations Statistics Division, 2011, COMP MACR CONT REG G.
   WHO, 2012, HLTH STAT HLTH INF S.
   World Bank, 2012, WORLD BANK LIST EC.
   World Health Organization, 2012, WHO MORT DAT WHO STA.
   World Health Organization, 2010, INT CLASS DIS ICD.
   World Health Organization (WHO), 2010, ASB EL ASB REL DIS.
   World Health Organization (WHO), 2006, EL ASB REL DIS.
   Yoshida K, 1997, Environ Health Prev Med, V2, P40, DOI 10.1007/BF02931228.},
Number-of-Cited-References = {31},
Times-Cited = {20},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Am. J. Ind. Med.},
Doc-Delivery-Number = {200XX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000323106000002},
DA = {2022-03-29},
}

@article{ WOS:000363978000007,
Author = {Onyeka, Ifeoma N. and Beynon, Caryl M. and Vohlonen, Ilkka and Tiihonen,
   Jari and Fohr, Jaana and Ronkainen, Kimmo and Kauhanen, Jussi},
Title = {Potential Years of Life Lost Due to Premature Mortality Among
   Treatment-Seeking Illicit Drug Users in Finland},
Journal = {JOURNAL OF COMMUNITY HEALTH},
Year = {2015},
Volume = {40},
Number = {6},
Pages = {1099-1106},
Month = {DEC},
Abstract = {Premature death is a serious public health concern. The primary
   objective of this study was to examine premature deaths in terms of
   potential years of life lost (PYLL) in a cohort of 4817
   treatment-seeking illicit drug users. Clients' data were linked to the
   Finnish national cause-of-death register and the follow-up period ranged
   from 31 January 1997 to 31 December 2010. PYLL before 70 years was
   calculated for all deaths and cause-specific deaths by gender. We
   observed 496 deaths (417 males and 79 females) at the end of 2010. The
   mean age at death was 33.8 years, 34.3 years for males (range 18-68) and
   31.4 years for females (range 16-53). Overall, 17,951 life years were
   lost; 14,898 among males and 3053 among females. The overall PYLL rate
   for males was more than twice that of females (513.0/1000 vs. 243.7/1000
   person-years) but the mean PYLL was higher in females than males (38.6
   vs. 35.7 years). Of the total PYLL, 34.8 \% was due to accidental
   overdose, and 24.0 \% to suicide. In both genders, accidental overdose
   and suicide were the two top-ranking causes of PYLL. Premature deaths
   among drug users are a potential loss to the society. Our findings
   suggest that measures targeting accidental overdose and suicide are top
   priorities for reducing preventable loss of life.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {Onyeka, IN (Corresponding Author), Univ Eastern Finland, Fac Hlth Sci, Inst Publ Hlth \& Clin Nutr, POB 1627, Kuopio 70211, Finland.
   Onyeka, Ifeoma N.; Ronkainen, Kimmo; Kauhanen, Jussi, Univ Eastern Finland, Fac Hlth Sci, Inst Publ Hlth \& Clin Nutr, Kuopio 70211, Finland.
   Vohlonen, Ilkka, Univ Eastern Finland, Fac Social Sci \& Business Studies, Dept Hlth \& Social Management, Kuopio 70211, Finland.
   Vohlonen, Ilkka, FCG Finnish Consulting Grp, Helsinki, Finland.
   Tiihonen, Jari, Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio 70211, Finland.
   Tiihonen, Jari, Natl Inst Hlth \& Welf, Helsinki, Finland.
   Tiihonen, Jari, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   Fohr, Jaana, Helsinki Deaconess Inst, Helsinki, Finland.},
DOI = {10.1007/s10900-015-0035-z},
ISSN = {0094-5145},
EISSN = {1573-3610},
Keywords = {Substance abuse; Potential years of life lost (PYLL); Treatment-seeking;
   Mortality; Premature deaths},
Keywords-Plus = {GLOBAL BURDEN; OPIATE USERS; COHORT; DISEASE; IMPACT; DEATH; DEPENDENCE;
   PATTERNS; ABUSERS; HEROIN},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Policy \& Services; Public, Environmental \& Occupational Health},
Author-Email = {ifeoma.onyeka@uef.fi},
ResearcherID-Numbers = {Tiihonen, Jari/G-3078-2012
   Kauhanen, Jussi/ABC-4064-2021},
ORCID-Numbers = {Tiihonen, Jari/0000-0002-0400-6798
   },
Funding-Acknowledgement = {Academy of FinlandAcademy of Finland {[}118584]; Finnish Cultural
   FoundationFinnish Cultural FoundationFinnish IT center for science},
Funding-Text = {The Academy of Finland (Grant Number 118584), and the Finnish Cultural
   Foundation (Central Fund) provided funding support for this study. We
   thank Veli Koistinen for his invaluable comments at the beginning of
   this study. We also thank the staff of Helsinki Deaconess Institute for
   their collaboration.},
Cited-References = {Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Association of Public Health Epidemiologists in Ontario, CALC POT YEARS LIF L.
   Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168.
   Bohnert ASB, 2010, DRUG ALCOHOL DEPEN, V110, P183, DOI 10.1016/j.drugalcdep.2010.03.010.
   Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x.
   Clausen T, 2009, ADDICTION, V104, P1356, DOI 10.1111/j.1360-0443.2009.02570.x.
   Degenhardt L, 2014, ADDICTION, V109, P90, DOI 10.1111/add.12337.
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5.
   Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x.
   Degenhardt L, 2009, ADDICTION, V104, P1466, DOI 10.1111/j.1360-0443.2009.02715.x.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x.
   Giraudon I, 2012, ADICCIONES, V24, P3, DOI 10.20882/adicciones.111.
   Greenfield SF, 2009, PSYCHIAT SERV, V60, P880, DOI 10.1176/appi.ps.60.7.880.
   Haukka J., 2004, NORSK EPIDEMIOLOGI, V14, P113.
   Knapp W. P., 2007, COCHRANE DB SYST REV, V3.
   Lankenau SE, 2013, J COMMUN HEALTH, V38, P133, DOI 10.1007/s10900-012-9591-7.
   Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92.
   Merrall ELC, 2012, INT J DRUG POLICY, V23, P24, DOI 10.1016/j.drugpo.2011.05.010.
   Milloy MJ, 2010, ADDICTION, V105, P1962, DOI 10.1111/j.1360-0443.2010.03077.x.
   Minnesota Department of Health, CTR HLTH STAT MINN V.
   Neale J, 2005, INT J DRUG POLICY, V16, P393, DOI 10.1016/j.drugpo.2005.10.001.
   Nyhlen A, 2011, J FORENSIC LEG MED, V18, P66, DOI 10.1016/j.jflm.2011.01.003.
   Odegard E, 2007, DRUG ALCOHOL DEPEN, V89, P176, DOI 10.1016/j.drugalcdep.2006.12.016.
   Onyeka IN, 2015, J SUBST ABUSE TREAT, V53, P64, DOI 10.1016/j.jsat.2014.12.009.
   Onyeka IN, 2014, INT J DRUG POLICY, V25, P1047, DOI 10.1016/j.drugpo.2014.07.008.
   Onyeka IN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-380.
   Onyeka IN, 2012, J ADDICT DIS, V31, P350, DOI 10.1080/10550887.2012.735563.
   Organisation for Economic Co-operation and Development (OECD), STATISTICS.
   Page A., 2006, PUBLIC HLTH INFORM D.
   Ravndal E, 2010, DRUG ALCOHOL DEPEN, V108, P65, DOI 10.1016/j.drugalcdep.2009.11.008.
   Rehm J., 2006, CONTEMP DRUG PROBL, V33, P343.
   Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453.
   Semerl JS, 2002, CROAT MED J, V43, P439.
   Singleton J, 2009, DRUG ALCOHOL DEPEN, V105, P1, DOI 10.1016/j.drugalcdep.2009.05.028.
   Smyth B, 2007, PREV MED, V44, P369, DOI 10.1016/j.ypmed.2006.10.003.
   Stenbacka M, 2010, DRUG ALCOHOL REV, V29, P21, DOI 10.1111/j.1465-3362.2009.00075.x.
   Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x.
   Vohlonen I., 2007, SUOM LAAKARILEHTI, V62, P305.
   World Health Organization (WHO), MAN SUBST AB OTH PSY.},
Number-of-Cited-References = {40},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Community Health},
Doc-Delivery-Number = {CV0XU},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000363978000007},
DA = {2022-03-29},
}

@article{ WOS:A1977DP48200008,
Author = {ROMEDER, JM and MCWHINNIE, JR},
Title = {POTENTIAL YEARS OF LIFE LOST BETWEEN AGES 1 AND 70 - INDICATOR OF
   PREMATURE MORTALITY FOR HEALTH-PLANNING},
Journal = {INTERNATIONAL JOURNAL OF EPIDEMIOLOGY},
Year = {1977},
Volume = {6},
Number = {2},
Pages = {143-151},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {DEPT NATL HLTH \& WELF, LONG RANGE HLTH PLANNING BRANCH, OTTAWA K1A 0K9, ONTARIO, CANADA.},
DOI = {10.1093/ije/6.2.143},
ISSN = {0300-5771},
EISSN = {1464-3685},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {BENJAMIN B, 1970, ANALYSIS MORTALITY A.
   BROWNLEE J, 1922, 60 MED RES COUNC SPE.
   CHIANG CL, 1968, INTRO STOCHASTIC PRO, pCH9.
   CHIANG CL, 1961, US DEP HEW VITAL STA, V47, P275.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   DICKINSON GF, 1948, 64 AM MED ASS BUR ME.
   DOUGHTY J H, 1951, Can J Public Health, V42, P134.
   Dublin LI, 1937, AM J PUBLIC HEALTH N, V27, P481, DOI 10.2105/AJPH.27.5.481.
   Elveback L., 1966, HUM BIOL, V38, P322.
   GNANASEKARAN KS, UNPUBLISHED DOCUMENT.
   Greenwood M, 1922, J R STAT SOC, V85, P537, DOI 10.2307/2341122.
   GREVILLE TNE, 1948, AM REV TUBERC PULM, V57, P417.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   HILL GB, 1971, METHODS HLTH CARE EV, pCH2.
   KILPATRICK SJ, 1962, POPULATION STUDIES, P175.
   KILPATRICK SJ, 1963, APPL STAT, V12, P65.
   KITAGAWA EM, 1966, HUM BIOL, V38, P293.
   KOHN R, 1951, Can J Public Health, V42, P375.
   LERY A, 1975, I NATIONAL STATISTIQ, V63, P27.
   LIDDELL F D, 1960, Br J Ind Med, V17, P228.
   LOGAN W P, 1953, Mon Bull Minist Health Public Health Lab Serv, V12, P244.
   MARTIN WJ, 1951, MED OFFICER, P151.
   ROMEDER JM, 1974, HLTH FIELD INDICAT 1.
   ROMEDER JM, UNPUBLISHED NOTE.
   STOCKS P, 1953, BRIT MED J, V2, P847, DOI 10.1136/bmj.2.4841.847.
   WOOLSEY TD, 1943, TECHNIQUES VITAL STA, pCH4.
   YERUSHALMY J, 1951, AM J PUBLIC HEALTH, V41, P907.
   Yule GU, 1934, J R STAT SOC, V97, P1, DOI 10.2307/2342014.},
Number-of-Cited-References = {28},
Times-Cited = {214},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Int. J. Epidemiol.},
Doc-Delivery-Number = {DP482},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1977DP48200008},
DA = {2022-03-29},
}

@article{ WOS:A1995RB15500020,
Author = {MARLOW, AK},
Title = {POTENTIAL YEARS OF LIFE LOST - WHAT IS THE DENOMINATOR},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {1995},
Volume = {49},
Number = {3},
Pages = {320-322},
Month = {JUN},
Abstract = {Objective - To suggest an appropriate denominator for use with the
   statistic `'potential years of life lost'', in order to facilitate valid
   comparisons between. health authorities.
   Design - Analysis of OPCS population and. mortality data for the period
   1987-91.
   Setting - Data for Wales were analysed. to provide comparisons between
   the nine: district health authorities.
   Subjects - There were 46 139 males and, 30 258 females - that is, all
   deaths of Welsh. residents, aged under 75 years, during the: period
   1987-91.
   Main results - The use of age sensitive denominators with the potential
   years of life lost statistic alters the rank position. of Welsh district
   health authorities.
   Conclusion - It is suggested that potential. years of Life lost should
   be expressed as a rate per 100 000 potential years of life in. public
   health common data sets, and elsewhere, to facilitate valid comparisons
   between health authorities.},
Publisher = {BRITISH MED JOURNAL PUBL GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR},
Type = {Article},
Language = {English},
Affiliation = {MARLOW, AK (Corresponding Author), DEPT PUBL HLTH MED,PUBL HLTH INFORMAT,POWYS HLTH,THE LAURELS,POWYS LD3 0HS,ENGLAND.},
DOI = {10.1136/jech.49.3.320},
ISSN = {0143-005X},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {ORTEGA A, 1992, EUR J EPIDEMIOL, V8, P875, DOI 10.1007/BF00145336.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   1992, WELSH PUBLIC HLTH CO.
   1991, PUBLIC HLTH COMMON D.},
Number-of-Cited-References = {4},
Times-Cited = {13},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {RB155},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1995RB15500020},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:A1980KH95200002,
Author = {MEADE, MS},
Title = {POTENTIAL YEARS OF LIFE LOST IN COUNTRIES OF SOUTHEAST-ASIA},
Journal = {SOCIAL SCIENCE \& MEDICINE PART D-MEDICAL GEOGRAPHY},
Year = {1980},
Volume = {14},
Number = {3D},
Pages = {277-281},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {MEADE, MS (Corresponding Author), UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA.},
DOI = {10.1016/0160-8002(80)90039-8},
ISSN = {0162-8002},
Research-Areas = {Health Care Sciences \& Services; Biomedical Social Sciences},
Web-of-Science-Categories  = {Health Policy \& Services; Social Sciences, Biomedical},
Cited-References = {OMAN AR, 1977, POP B, V32.
   OMAN AR, 1979, NO CAR MED J, V36, P23.
   OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.},
Number-of-Cited-References = {4},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {KH952},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1980KH95200002},
DA = {2022-03-29},
}

@article{ WOS:000740583900001,
Author = {Ugarte, Maider Pagola and Achilleos, Souzana and Quattrocchi, Annalisa
   and Gabel, John and Kolokotroni, Ourania and Constantinou, Constantina
   and Nicolaou, Nicoletta and Rodriguez-Llanes, Jose Manuel and Huang,
   Qian and Verstiuk, Olesia and Pidmurniak, Nataliia and Tao, Jennifer
   Wenjing and Burstrom, Bo and Klepac, Petra and Erzen, Ivan and Chong,
   Mario and Barron, Manuel and Hagen, Terje P. and Kalmatayeva, Zhanna and
   Davletov, Kairat and Zucker, Inbar and Kaufman, Zalman and Kereselidze,
   Maia and Kandelaki, Levan and Le Meur, Nolwenn and Goldsmith, Lucy and
   Critchley, Julia A. and Pinilla, Maria Angelica and Jaramillo, Gloria
   Isabel and Teixeira, Domingos and Gomez, Lara Ferrero and Lobato,
   Jackeline and Araujo, Carolina and Cuthbertson, Joseph and Bennett,
   Catherine M. and Polemitis, Antonis and Charalambous, Andreas and
   Demetriou, Christiana A. and C-MOR Consortium},
Title = {Premature mortality attributable to COVID-19: potential years of life
   lost in 17 countries around the world, January-August 2020},
Journal = {BMC PUBLIC HEALTH},
Year = {2022},
Volume = {22},
Number = {1},
Month = {JAN 9},
Abstract = {Background Understanding the impact of the burden of COVID-19 is key to
   successfully navigating the COVID-19 pandemic. As part of a larger
   investigation on COVID-19 mortality impact, this study aims to estimate
   the Potential Years of Life Lost (PYLL) in 17 countries and territories
   across the world (Australia, Brazil, Cape Verde, Colombia, Cyprus,
   France, Georgia, Israel, Kazakhstan, Peru, Norway, England \& Wales,
   Scotland, Slovenia, Sweden, Ukraine, and the United States {[}USA]).
   Methods Age- and sex-specific COVID-19 death numbers from primary
   national sources were collected by an international research consortium.
   The study period was established based on the availability of data from
   the inception of the pandemic to the end of August 2020. The PYLL for
   each country were computed using 80 years as the maximum life
   expectancy. Results As of August 2020, 442,677 (range: 18-185,083)
   deaths attributed to COVID-19 were recorded in 17 countries which
   translated to 4,210,654 (range: 112-1,554,225) PYLL. The average PYLL
   per death was 8.7 years, with substantial variation ranging from 2.7
   years in Australia to 19.3 PYLL in Ukraine. North and South American
   countries as well as England \& Wales, Scotland and Sweden experienced
   the highest PYLL per 100,000 population; whereas Australia, Slovenia and
   Georgia experienced the lowest. Overall, males experienced higher PYLL
   rate and higher PYLL per death than females. In most countries, most of
   the PYLL were observed for people aged over 60 or 65 years, irrespective
   of sex. Yet, Brazil, Cape Verde, Colombia, Israel, Peru, Scotland,
   Ukraine, and the USA concentrated most PYLL in younger age groups.
   Conclusions Our results highlight the role of PYLL as a tool to
   understand the impact of COVID-19 on demographic groups within and
   across countries, guiding preventive measures to protect these groups
   under the ongoing pandemic. Continuous monitoring of PYLL is therefore
   needed to better understand the burden of COVID-19 in terms of premature
   mortality.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Achilleos, S (Corresponding Author), Univ Nicosia, Dept Primary Care \& Populat Hlth, Med Sch, Nicosia, Cyprus.
   Ugarte, Maider Pagola; Gabel, John; Charalambous, Andreas, Univ Nicosia, Med Sch, Nicosia, Cyprus.
   Achilleos, Souzana; Quattrocchi, Annalisa; Kolokotroni, Ourania; Demetriou, Christiana A., Univ Nicosia, Dept Primary Care \& Populat Hlth, Med Sch, Nicosia, Cyprus.
   Constantinou, Constantina; Nicolaou, Nicoletta, Univ Nicosia, Dept Basic \& Clin Sci, Med Sch, Nicosia, Cyprus.
   Rodriguez-Llanes, Jose Manuel, European Commiss Joint Res Ctr, Ispra, Italy.
   Huang, Qian, Univ South Carolina, Dept Geog, South Carolina Ctr Rural \& Primary Healthcare, Columbia, SC 29208 USA.
   Verstiuk, Olesia; Pidmurniak, Nataliia, Bogomolets Natl Med Univ, Fac Med 2, Kiev, Ukraine.
   Tao, Jennifer Wenjing, Karolinska Inst, Dept Mol Med \& Surg, Stockholm, Sweden.
   Burstrom, Bo, Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.
   Klepac, Petra, Natl Inst Publ Hlth, Dept Communicable Dis, Ljubljana, Slovenia.
   Erzen, Ivan, Natl Inst Publ Hlth, Publ Hlth Sch, Ljubljana, Slovenia.
   Chong, Mario, Univ Pacifico, Fac Ingn, Lima, Peru.
   Barron, Manuel, Univ Pacifico, Dept Econ, Lima, Peru.
   Hagen, Terje P., Univ Oslo, Dept Hlth Management \& Econ, Oslo, Norway.
   Kalmatayeva, Zhanna, Al Farabi Kazakh Natl Univ, Fac Med, Alma Ata, Kazakhstan.
   Davletov, Kairat, Al Farabi Kazakh Natl Univ, Hlth Res Inst, Alma Ata, Kazakhstan.
   Zucker, Inbar; Kaufman, Zalman, Minist Hlth, Israel Ctr Dis Control, Ramat Gan, Israel.
   Kereselidze, Maia; Kandelaki, Levan, Natl Ctr Dis Control \& Publ Hlth, Tbilisi, Georgia.
   Le Meur, Nolwenn, Univ Rennes, EHESP, REPERES EA 7449, F-35000 Rennes, France.
   Goldsmith, Lucy; Critchley, Julia A., St Georges Univ London, Populat Hlth Res Inst, London, England.
   Goldsmith, Lucy, St Georges Univ London, Inst Infect \& Immun, London, England.
   Pinilla, Maria Angelica; Jaramillo, Gloria Isabel, Univ Cooperat Colombia, Fac Med, Villavicencio, Colombia.
   Teixeira, Domingos, Minist Hlth \& Social Secur, Praia, Cape Verde.
   Gomez, Lara Ferrero, Jean Piaget Univ Cape Verde, Dept Nat Life \& Environm Sci, Praia, Cape Verde.
   Lobato, Jackeline, Fluminense Fed Univ, Inst Collect Hlth ISC, Dept Epidemiol \& Biostat, Niteroi, RJ, Brazil.
   Araujo, Carolina, Univ Fed Rio de Janeiro, Inst Studies Collect Hlth IESC, Grad Publ Hlth Program, Rio De Janeiro, Brazil.
   Cuthbertson, Joseph, Monash Univ, Monash Univ Disaster Resilience Initiat, Melbourne, Vic, Australia.
   Bennett, Catherine M., Deakin Univ, Inst Hlth Transformat, Burwood, Australia.
   Polemitis, Antonis, Univ Nicosia, Nicosia, Cyprus.},
DOI = {10.1186/s12889-021-12377-1},
Article-Number = {54},
EISSN = {1471-2458},
Keywords = {COVID-19; SARS-CoV-2; Disease burden; Potential years of life lost;
   PYLL; Pandemic},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {achilleos.s@unicac.cy},
ResearcherID-Numbers = {Nicolaou, Nicoletta/AFQ-7836-2022
   },
ORCID-Numbers = {Nicolaou, Nicoletta/0000-0002-9570-5112
   Chong Chong, Mario Gustavo/0000-0002-1231-0992
   Goldsmith, Lucy/0000-0002-6934-1925
   Demetriou, Christiana A./0000-0003-4002-2880
   Achilleos, Souzana/0000-0002-1688-9225},
Funding-Acknowledgement = {University of Nicosia Medical School},
Funding-Text = {This work was supported by the University of Nicosia Medical School
   (internal funding). The funding supported researchers' salaries to work
   on the study design, data analysis and interpretation, and production of
   this manuscript. The funding body played no role in the design of the
   study and collection, analysis, and interpretation of data and in
   writing the manuscript.},
Cited-References = {Achilleos S, 2021, INT J EPIDEMIOL, DOI 10.1093/ije/dyab123.
   Ahmad OB, 2001, AGE STANDARDIZATION.
   Benitez MA, 2020, HEALTH POLICY TECHN, V9, P525, DOI 10.1016/j.hlpt.2020.08.014.
   {[}Anonymous], 2021, AUSTR WHO CORONAVIRU.
   {[}Anonymous], 2020, ECON.
   {[}Anonymous], 2021, COVID 19 SIT UPD WOR.
   {[}Anonymous], 2020, ESTIMATES POPULATION.
   {[}Anonymous], 2020, WORLD BANK OPEN DATA.
   Arolas HP i, 2020, GLOBAL YEARS LIFE LO.
   Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w.
   Capuano A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00131.
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896.
   Commission E. Statistics | Eurostat {[}Internet], 2020, POP 1 JAN AG SEX.
   Cruz-Correia, 2020, EXCESS MORTALITY COV, DOI 10.1101/2020.04.28.20083147.
   de la Vega R, 2020, GLOB PUBLIC HEALTH, V15, P1278, DOI 10.1080/17441692.2020.1791212.
   Department of Information E and R WHO, 2018, WHO METHODS DATA SOU.
   Devleesschauwer B, 2020, INT J PUBLIC HEALTH, V65, P719, DOI 10.1007/s00038-020-01430-2.
   Ellege StephenJ., 2020, 2 5 MILLION PERSON Y, DOI {[}10.1101/2020.10.18.20214783, DOI 10.1101/2020.10.18.20214783].
   Eurostat, 2020, WEEKL DEATHS SPEC DA.
   Gagliardi MC, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0276-1.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9.
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032.
   Gupta R, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108267.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1.
   Jo MW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e199.
   Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0.
   Madsen W., 2020, CORONAVIRUS TRACKER.
   Marois G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238678.
   Medina-Enriquez MM, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00519-8.
   Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392.
   Modig K, 2021, EUR J PUBLIC HEALTH, V31, P17, DOI 10.1093/eurpub/ckaa218.
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z.
   Njenga MK, 2020, AM J TROP MED HYG, V103, P564, DOI 10.4269/ajtmh.20-0474.
   Nurchis MC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124233.
   O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0.
   Office for National Statistics, 2020, DEATHS REG WEEKL ENG.
   Oh IH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e300.
   Organisation for Economic Co-operation and Development (OECD), 2021, HLTH STAT 2020 OECD.
   PopulationPyramid.net, 2019, POPULATION PYRAMIDS.
   Quast T, 2020, J PUBLIC HEALTH-UK, V42, P717, DOI 10.1093/pubmed/fdaa159.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Roser M, 2020, CAPE VERDE CORONAVIR.
   Rutayisire E, 2020, INT J INFECT DIS, V97, P267, DOI 10.1016/j.ijid.2020.06.024.
   Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031.
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7.
   Vestergaard LS, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.26.2001214.
   Wong ACP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020174.
   World Health Organization, COR DIS COVID 19 DAS.
   World Health Organization (WHO), 2020, INT GUID CERT CLASS.
   Yamamoto N, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110160.
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017.
   Zhao S, 2020, INFECT CONT HOSP EP, V41, P750, DOI {[}10.4018/IJSSOE.2020010101, 10.1017/ice.2020.64].},
Number-of-Cited-References = {54},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {YD6XX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000740583900001},
OA = {Green Published, Green Accepted, gold},
DA = {2022-03-29},
}

@article{ WOS:000355146400020,
Author = {Sun, L. and Zhang, J.},
Title = {Potential years of life lost due to suicide in China, 2006-2010},
Journal = {PUBLIC HEALTH},
Year = {2015},
Volume = {129},
Number = {5},
Pages = {555-560},
Month = {MAY},
Abstract = {Objectives: To calculate the potential years of life lost (PYLL) due to
   suicide in China, and analyse the distribution of PYLL by age, sex and
   region.
   Study design: The recent Chinese national mortality data (2006-2010)
   published by the Chinese Ministry of Health and the census data provided
   by the Chinese National Population Census were used to calculate PYLL
   due to suicide. Methods: Age-, sex-and region-specific PYLL due to
   suicide in China were determined for victims aged between 1 and 74
   years.
   Results: Suicide was found to be the 10th leading cause of death in
   terms of PYLL, and accounted for 3.06\% of all PYLL in China. There were
   three age peaks for PYLL due to suicide in rural areas (20-24, 35-44 and
   50-59 years), and two peaks for PYLL due to suicide in urban areas
   (20-24 and 35-44 years). PYLL due to suicide in rural areas was
   approximately two-fold higher than PYLL due to suicide in urban areas.
   Conclusions: Suicide is a major public health problem in China. This
   needs to be controlled, especially in rural areas. (C) 2015 The Royal
   Society for Public Health. Published by Elsevier Ltd. All rights
   reserved.},
Publisher = {W B SAUNDERS CO LTD},
Address = {32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Zhang, J (Corresponding Author), SUNY Coll Buffalo, Dept Sociol, 1300 Elmwood Ave, Buffalo, NY 14222 USA.
   Sun, L., Shandong Univ, Sch Publ Hlth, Ctr Suicide Prevent Res, Jinan, Shandong, Peoples R China.
   Zhang, J., SUNY Coll Buffalo, Dept Sociol, Buffalo, NY 14222 USA.},
DOI = {10.1016/j.puhe.2015.02.012},
ISSN = {0033-3506},
EISSN = {1476-5616},
Keywords = {Potential years of life lost; Suicide; Sex; Region; China},
Keywords-Plus = {PREMATURE MORTALITY; RATES; INDICATOR; HEALTH; MEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {zhangj@buffalostate.edu},
ResearcherID-Numbers = {Zhang, Jie/A-3489-2008
   },
ORCID-Numbers = {Sun, Long/0000-0002-3070-8427},
Funding-Acknowledgement = {NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) {[}R01MH068560] Funding Source: NIH
   RePORTER; NIMH NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Mental Health (NIMH) {[}R01 MH068560] Funding Source: Medline},
Cited-References = {Bose A, 2006, TROP MED INT HEALTH, V11, P1553, DOI 10.1111/j.1365-3156.2006.01707.x.
   Center for Health Statistics and information MOH, 2008, RES HLTH SERV PRIM H.
   Doessel DP, 2009, ARCH SUICIDE RES, V13, P87, DOI 10.1080/13811110802572197.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Government of Canada, 2014, POT YEARS LIF LOST S.
   Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X.
   Hvistendahl M, 2012, SCIENCE, V338, P1025, DOI 10.1126/science.338.6110.1025.
   Kamel MH, 2012, J UROLOGY, V187, P868, DOI 10.1016/j.juro.2011.10.142.
   Law CK, 2011, CRISIS, V32, P152, DOI 10.1027/0227-5910/a000070.
   MARLOW AK, 1995, J EPIDEMIOL COMMUN H, V49, P320, DOI 10.1136/jech.49.3.320.
   Ministry of Health of the People's Republic of China, 2008, CHIN HLTH STAT YB 20.
   Ministry of Health of the People's Republic of China, 2010, CHIN HLTH STAT YB 20.
   Ministry of Health of the People's Republic of China, 2009, CHIN HLTH STAT YB 20.
   Ministry of Health of the People's Republic of China, 2012, CHIN HLTH STAT YB 20.
   Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152.
   People's Republic of China National Statistics Bureau, 2012, TAB 2010 POP CENS PE.
   Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0.
   Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4.
   Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Tan Xu-hui, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1075.
   The Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB 20.
   Tjepkema Michael, 2011, Health Rep, V22, P25.
   Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100.
   Unite State Centers for Disease Control and Prevention, 2014, YEARS POT LIF LOST Y.
   Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5.
   World Health Organization, 2007, SUIC PREV SUPRE.
   World Health Organization, 2014, PREVENTING SUICIDE G.
   Yip PSF, 2008, CRISIS, V29, P131, DOI 10.1027/0227-5910.29.3.131.
   Yip PSF, 2005, SOC PSYCH PSYCH EPID, V40, P792, DOI 10.1007/s00127-005-0952-8.
   Zhang J, 2010, EUR PSYCHIAT, V25, P159, DOI 10.1016/j.eurpsy.2009.07.013.
   Zhang J., 2011, J SOC SCI CHIN, V32, P97.
   Zhang J, 2014, SUICIDE LIFE-THREAT, V44, P560, DOI 10.1111/sltb.12090.
   Zhao S, 1994, Crisis, V15, P44.},
Number-of-Cited-References = {34},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Public Health},
Doc-Delivery-Number = {CJ0EF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000355146400020},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000530038500003,
Author = {Orlewska, Katarzyna and Stepien, Renata and Orlewska, Ewa},
Title = {Burden of cancer in Poland analysed using potential years of life lost},
Journal = {WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY},
Year = {2020},
Volume = {24},
Number = {1},
Pages = {13-16},
Abstract = {Aim of the study: The aim was to assess the impact of the most frequent
   cancer-related causes of death in Poland by estimating the years of
   potential life lost (YPLL) and to compare different measures of the
   burden of cancer deaths on the population.
   Material and methods: Mortality rate, YPLL and mean YPLL were calculated
   for the 11 most frequently recorded cancer-related causes of death in
   Poland. YPLL were measured applying the up-to-date reference life tables
   proposed by the Institute for Health Metrics and Evaluation and used in
   the Global Burden of Disease study (GBD 2015). Absolute numbers of
   cancer deaths by site, gender and five-year age groups were obtained
   from the Polish National Cancer Registry (2015).
   Results: In 2015 the total YPLL amounted to 1,990,457, with 23.6\% from
   lung and bronchial cancer. Mean YPLL was 19.79 years and varied
   considerably according to tumour site (26.12 {[}brain] - 14.3
   {[}prostate]). Three tumour sites (brain, ovarian and kidney) are
   positioned higher according to mean YPLL than according to YPLL
   percentage and mortality percentage.
   Conclusions: Our results draw attention to the impact of cancer on
   society and individual patients. Addressing research efforts to
   prevention and/or treatment of major YPLL causes could result in a
   substantial impact on general life expectancy.},
Publisher = {TERMEDIA PUBLISHING HOUSE LTD},
Address = {KLEEBERGA ST 2, POZNAN, 61-615, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Orlewska, K (Corresponding Author), Med Univ Warsaw, Fac Med 1, 61 Zwirki \& Wigury St, PL-02091 Warsaw, Poland.
   Orlewska, Katarzyna; Stepien, Renata, Med Univ Warsaw, Fac Med 1, 61 Zwirki \& Wigury St, PL-02091 Warsaw, Poland.
   Stepien, Renata; Orlewska, Ewa, Jan Kochanowski Univ Humanities \& Sci, Fac Med \& Hlth Sci, Kielce, Poland.},
DOI = {10.5114/wo.2020.93680},
ISSN = {1428-2526},
EISSN = {1897-4309},
Keywords = {cancer; burden of disease; mortality; potential years of life lost},
Keywords-Plus = {GLOBAL BURDEN; UNITED-STATES; DISEASE},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {korlewskag@mail.com},
Funding-Acknowledgement = { {[}024/RID/2018/19]},
Funding-Text = {This work was supported under the program of the Minister of Science and
   Higher Education under the name ``Regional Initiative of Excellence in
   2019-2022{''}, project number: 024/RID/2018/19, financing amount:
   11,999,000.00 PLN.},
Cited-References = {Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Carter AJR, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0050-7.
   Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526.
   de Blank PM, 2015, CANCER MED-US, V4, P608, DOI 10.1002/cam4.410.
   Didkowska J, 2017, CANC POLAND 2015.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.
   Rouse C, 2016, NEURO-ONCOLOGY, V18, P70, DOI 10.1093/neuonc/nov249.
   Santric Milicevic Milena, 2009, Popul Health Metr, V7, P12, DOI 10.1186/1478-7954-7-12.
   Schiff D, 2016, NEURO-ONCOLOGY, V18, P5, DOI 10.1093/neuonc/nov287.
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   World Health Organization, 1992, ICD 10 CLASSIFICATIO.},
Number-of-Cited-References = {14},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Wspolczesna Onkol.},
Doc-Delivery-Number = {LJ2ZT},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000530038500003},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000736568700002,
Author = {Liu, Xiang and Wang, Dan and Fan, Ruoxin and Wang, Rongke and Xiang, Hu
   and Yang, Xianmei and Liu, Yuanyuan},
Title = {Life expectancy and potential years of life lost for schizophrenia in
   western China},
Journal = {PSYCHIATRY RESEARCH},
Year = {2022},
Volume = {308},
Month = {FEB},
Abstract = {Excess mortality in people with schizophrenia has been extensively
   reported. However, little is known about the life expectancy and
   potential years of life lost (PYLL) in western China. This study aimed
   to estimated life ex-pectancy and PYLL for people with schizophrenia in
   western China. A total of 228,572 people with schizophrenia were
   included from National Information System for Psychosis in one province
   of western China. Life-expectancy was calculated by using Chiang's
   method. One-way ANOVA was used to compare the age-sex standardized PYLL
   for different causes of death among different demographic
   characteristics groups. Life expectancy for men and women with
   schizophrenia was 52.8 years and 59.0 years respectively. The overall
   PYLL of people with schizophrenia was 18.4 years, and suicide had the
   largest PYLL (31.2 years) among all causes of mortality. The PYLL due to
   suicide was significantly higher among men, high school and above,
   non-poverty, non-farmer and divorced people with schizophrenia. The PYLL
   due to diseases and medical conditions was higher among men, illiteracy,
   farmer and unmarried people with schizophrenia. Strategies to prevent
   causes of premature death in schizophrenia are urgently required in
   western China, particularly in the promotion of physical health and
   prevention of suicide.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Liu, YY (Corresponding Author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.
   Yang, XM (Corresponding Author), Sichuan Mental Hlth Ctr, Hosp Mianyang 3, Mianyang, Sichuan, Peoples R China.
   Liu, YY (Corresponding Author), Sichuan Univ, Dept Epidemiol \& Biostat, West China Sch Publ Hlth, Chengdu, Peoples R China.
   Liu, Xiang, Sichuan Univ, Dept Hlth Behav \& Social Med, West China Sch Publ Hlth, Chengdu, Peoples R China.
   Liu, Xiang; Liu, Yuanyuan, Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.
   Wang, Dan; Fan, Ruoxin; Wang, Rongke; Xiang, Hu; Yang, Xianmei, Sichuan Mental Hlth Ctr, Hosp Mianyang 3, Mianyang, Sichuan, Peoples R China.
   Liu, Yuanyuan, Sichuan Univ, Dept Epidemiol \& Biostat, West China Sch Publ Hlth, Chengdu, Peoples R China.},
DOI = {10.1016/j.psychres.2021.114330},
EarlyAccessDate = {DEC 2021},
Article-Number = {114330},
ISSN = {0165-1781},
EISSN = {1872-7123},
Keywords = {Schizophrenia; Mortality; Life expectancy; Potential years of life lost},
Keywords-Plus = {PREMATURE MORTALITY; EXCESS MORTALITY; MENTAL-HEALTH; DISORDERS;
   SUICIDE; SYSTEM; INCOME},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {yangxianmei85@163.com
   y\_multi@126.com},
Funding-Acknowledgement = {Key research and development project of the Science and Technology of
   Sichuan Province {[}2020YFS0216]; Natural Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) {[}81903414]},
Funding-Text = {This research was funded by Key research and development project of the
   Science and Technology of Sichuan Province (Grant NO. 2020YFS0216) and
   Natural Science Foundation of China (Grant NO. 81903414) .},
Cited-References = {Agerbo E, 2007, ARCH GEN PSYCHIAT, V64, P1377, DOI 10.1001/archpsyc.64.12.1377.
   Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212.
   Centers for Disease Control, 1986, MMWR S, V35, p1S.
   Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590.
   Chiang C.L., 1984, LIFE TABLE ITS APPL.
   Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349.
   Fazel S, 2014, LANCET PSYCHIAT, V1, P44, DOI 10.1016/S2215-0366(14)70223-8.
   Galletly CA, 2017, LANCET PSYCHIAT, V4, P263, DOI 10.1016/S2215-0366(17)30079-2.
   Hannerz H, 2001, PUBLIC HEALTH, V115, P328.
   Health Commission of Sichuan Province, 2018, SICH HLTH STAT YB 20.
   Hjorthoj C, 2017, LANCET PSYCHIAT, V4, P295, DOI 10.1016/S2215-0366(17)30078-0.
   Hu X.Y., 2021, MOD PREV MED, V48, P930.
   Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X.
   Ko YS, 2018, PSYCHIAT RES, V270, P531, DOI 10.1016/j.psychres.2018.09.038.
   Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539.
   Lee EE, 2018, SCHIZOPHR RES, V196, P9, DOI 10.1016/j.schres.2017.09.005.
   Leng CH, 2016, SCHIZOPHR RES, V171, P97, DOI 10.1016/j.schres.2016.01.033.
   Lesage A, 2015, CAN J PSYCHIAT, V60, P571, DOI 10.1177/070674371506001208.
   Liu J, 2011, WORLD PSYCHIATRY, V10, P210.
   Liu YY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1709-8.
   McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476.
   Ministry of Health of the People's Republic of China, 2012, CHIN MAN TREATM REG.
   National Health Commission, 2019, CHIN HLTH STAT YB 20.
   Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737.
   Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123.
   Stavrova O, 2019, PSYCHOL SCI, V30, P798, DOI 10.1177/0956797619835147.
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297.
   Tanskanen A, 2018, ACTA PSYCHIAT SCAND, V138, P492, DOI 10.1111/acps.12913.
   Zhou W, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/1752-4458-9-3.},
Number-of-Cited-References = {29},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Psychiatry Res.},
Doc-Delivery-Number = {XX8WO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000736568700002},
DA = {2022-03-29},
}

@article{ WOS:000417858800006,
Author = {Silversmit, Geert and Vaes, Evelien and van Eycken, Liesbet},
Title = {Estimation of population-based cancer-specific potential years of life
   lost in Belgium},
Journal = {EUROPEAN JOURNAL OF CANCER PREVENTION},
Year = {2017},
Volume = {26},
Number = {2},
Pages = {S157-S163},
Month = {SEP},
Abstract = {The potential years of life lost (PYLL) observed in a cohort of cancer
   patients cannot be fully assigned to the cancer as both cancer-related
   and non-cancer-related deaths contribute. A method is presented to
   decompose the observed all-cause PYLL into cancer mortality and
   population background mortality fractions when cause of death
   information is not available. Furthermore, the association of
   cancer-specific PYLL with cancer-specific mortality and mean age at
   diagnosis is explored and the impact of the follow-up window length is
   examined. The framework of the actuarial relative survival and the
   Ederer II method is applied to estimate the population background
   mortality contribution, PYLL{*}. The fraction (PYLL-PYLL{*})/PYLL is
   then attributed to the cancer. The method is applied to cancer incidence
   in Belgium 2004-2014, about 631 300 cancer patients. The cancer-specific
   PYLL divided by the number of cancer patients, mean PYLL, in the Belgian
   cancer population ranges from 0.4 years for prostate cancer to 15 years
   for tumours of the central nervous system. The cancer-specific mean PYLL
   increases with both increasing cancer-specific mortality and decreasing
   age at diagnosis. Longer follow-up periods yield larger cancer-specific
   mean PYLL until statistical cure of cancer is achieved. The mean PYLL
   results, obtained by dividing the PYLL by the number of cancer patients,
   are visualized in combination with cancer incidence and mean age and
   mean life expectancy at diagnosis, providing an elegant summary to rank
   and compare cancer sites in terms of incidence, relative survival and
   PYLL. Copyright (c) 2017 Wolters Kluwer Health, Inc. All rights
   reserved.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Silversmit, G (Corresponding Author), Belgian Canc Registry, Rue Royale 215 B7, B-1210 Brussels, Belgium.
   Silversmit, Geert; Vaes, Evelien; van Eycken, Liesbet, Belgian Canc Registry, Rue Royale, Brussels, Belgium.},
DOI = {10.1097/CEJ.0000000000000385},
ISSN = {0959-8278},
EISSN = {1473-5709},
Keywords = {cancer; expected potential years of life lost; life expectancy;
   population-based; potential years of life lost},
Keywords-Plus = {DEATHS},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {geert.silversmit@kankerregister.org},
ORCID-Numbers = {Silversmit, Geert/0000-0003-1104-1839},
Cited-References = {Begg CB, 2002, JNCI-J NATL CANCER I, V94, P1044.
   Carstensen B, 2004, LEXIS MACRO SPLITTIN.
   Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597.
   Dickman PW, 2004, ESTIMATING MODELLING.
   Ederer F, 1962, NATL CANC I MONOGR, V6, P101.
   Esteve J, 1994, IARC Sci Publ, P1.
   Francisci S, 2009, EUR J CANCER, V45, P1067, DOI 10.1016/j.ejca.2008.11.034.
   HORM JW, 1989, AM J PUBLIC HEALTH, V79, P1490, DOI 10.2105/AJPH.79.11.1490.
   PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242.
   Pukkala E, 2013, CANC FINLAND.
   R Core Team,, 2014, R LANG ENV STAT COMP.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Silversmit G, 2017, INT J CANCER, V140, P1102, DOI 10.1002/ijc.30532.
   Welch HG, 2002, J NATL CANCER I, V94, P1066.},
Number-of-Cited-References = {14},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Eur. J. Cancer Prev.},
Doc-Delivery-Number = {FP7ZM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000417858800006},
DA = {2022-03-29},
}

@article{ WOS:000484262500001,
Author = {Estrada Perea, Lillia Magali and Boing, Alexandra Crispim and Peres,
   Marco Aurelio and Boing, Antonio Fernando},
Title = {Potential years of life lost due to oropharyngeal cancer in Brazil: 1979
   to 2013},
Journal = {REVISTA DE SAUDE PUBLICA},
Year = {2019},
Volume = {53},
Abstract = {OBJECTIVE: To estimate the years of life lost by the Brazilian
   population due to mouth and pharynx cancer from 1979 to 2013, and
   analyze the temporal trends in the studied period, according to the
   country's region, sex and anatomical site.
   METHODS: The death records were obtained from the Mortality Information
   System and the data referring to the population, from the censuses of
   the Brazilian Institute of Geography and Statistics of 1980, 1991, 2000,
   2010, and from intercensal estimates for the other years. The rates of
   potential years of life lost were calculated by applying the method
   suggested by Romeder and McWhinnie, and their trends were calculated
   using the Prais-Winsten method with first-order autocorrelation. The
   historical series were smoothed with the centered moving average
   technique of third order for white noise reduction.
   RESULTS: In the period from 1979 to 2013 in Brazil, there were a total
   of 107,506 premature deaths due to mouth and pharynx cancer, which
   generated a total of 1,589,501 potential years of life lost, the
   equivalent to a rate of 3.6 per 10,000 inhabitants. Males, whose rate
   was six times higher than for females, contributed with 85\% of the
   years lost. The trends in the rates of years of life lost showed an
   annual 0.72\% increase for men, 1.13\% for women and 1.05\% for pharynx
   cancer.
   CONCLUSIONS: The rate of potential years of life lost due to mouth and
   pharynx cancer in the country showed an upward trend within the studied
   period for both sexes, as well as for pharynx cancer and for the North,
   Northeast and Midwest regions.},
Publisher = {REVISTA DE SAUDE PUBLICA},
Address = {FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Perea, LME (Corresponding Author), Univ Fed Santa Catarina, Campus Reitor Joao David Ferreira Lima, BR-88040900 Florianopolis, SC, Brazil.
   Estrada Perea, Lillia Magali, Univ Fed Santa Catarina, Programa Posgrad Saude Colet, Florianopolis, SC, Brazil.
   Boing, Alexandra Crispim; Boing, Antonio Fernando, Univ Fed Santa Catarina, Dept Saude Publ, Florianopolis, SC, Brazil.
   Peres, Marco Aurelio, Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.
   Peres, Marco Aurelio, Sch Dent \& Oral Hlth, Gold Coast, Australia.},
DOI = {10.11606/s1518-8787.2019053001054},
Article-Number = {67},
ISSN = {0034-8910},
EISSN = {1518-8787},
Keywords = {Mouth Neoplasms, mortality; Pharyngeal Neoplasms, mortality; Potential
   Years of Life Lost; Time Series Studies},
Keywords-Plus = {MORTALITY INFORMATION-SYSTEM; PREMATURE MORTALITY; TRENDS; DISEASES;
   STATE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {estradaperea.magali@gmail.com},
ResearcherID-Numbers = {BOING, ALEXANDRA/AAT-8673-2021
   Boing, Antonio F/G-3010-2012
   Peres, Marco Aurelio/D-1623-2013
   },
ORCID-Numbers = {BOING, ALEXANDRA/0000-0001-7792-4824
   Boing, Antonio F/0000-0001-9331-1550
   Estrada Perea, Lillia Magali/0000-0003-4156-9108
   Peres, Marco Aurelio/0000-0002-8329-2808
   Reis, AlessanRSS/0000-0001-8486-7469},
Cited-References = {Adhikari R, 2013, INTRO STUDY TIME SER, DOI {[}10.13140/2.1.2771.8084, DOI 10.13140/2.1.2771.8084].
   Alves CG, 2015, CIENC SAUDE COLETIVA, V20, P641, DOI 10.1590/1413-81232015203.15342014.
   Antunes JLF, 2002, B WORLD HEALTH ORGAN, V80, P391.
   Boing AF, 2006, REV PANAM SALUD PUBL, V20, P1, DOI 10.1590/S1020-49892006000700001.
   Fajardo S, 2009, CAD SAUDE PUBLICA, V25, P2218, DOI 10.1590/S0102-311X2009001000012.
   Figueiredo VC, 2016, VER SAUDE PUBLICA S1, V50, P12, DOI DOI 10.1590/S01518-8787.2016050006741.
   Figueiroa BD, 2013, CAD SAUDE PUBLICA, V29, P475, DOI 10.1590/S0102-311X2013000300006.
   França Elisabeth Barboza, 2014, Rev. bras. epidemiol., V17, P119, DOI 10.1590/1415-790X201400010010ENG.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Globocan, 2012, HOME.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Ibayashi H, 2011, CANCER EPIDEMIOL, V35, P342, DOI 10.1016/j.canep.2011.01.010.
   Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2016, EST 2016 INC CANC BR.
   Instituto Nacional do Cancer; Instituto Brasileiro de Geografia e Estatistica, 2008, PESQ NAC AM DOM TAB.
   Jacobson Jed J, 2012, Head Neck Oncol, V4, P15, DOI 10.1186/1758-3284-4-15.
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X.
   Khorasani Soheila, 2015, Asian Pac J Cancer Prev, V16, P1845.
   Machado LP, 2012, REV SAUDE PUBL, V46, P526, DOI 10.1590/S0034-89102012000300015.
   Martins Junior Davi Félix, 2011, Rev. Assoc. Med. Bras., V57, P338, DOI 10.1590/S0104-42302011000300019.
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude Coordenacao Geral de Informacoes e Analises Epidemiologicas, SIST INF MORT SIM CO.
   Paes NL, 2016, CIENC SAUDE COLETIVA, V21, P53, DOI 10.1590/1413-81232015211.00162015.
   REDE Interagencial de Informacao para a Saude, 2008, IND BAS SAUD BRAS CO.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.},
Number-of-Cited-References = {23},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Rev. Saude Publica},
Doc-Delivery-Number = {IV4SJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000484262500001},
OA = {Green Published, gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000266143500003,
Author = {de Araujo, Edna Maria and Costa, Maria da Conceicao N. and Hogan, Vijaya
   K. and Andrade Mota, Eduardo Luiz and Oliveira, Nelson Fernandes and de
   Araujo, Tania Maria},
Title = {Race/skin color differentials in potential years of life lost due to
   external causes},
Journal = {REVISTA DE SAUDE PUBLICA},
Year = {2009},
Volume = {43},
Number = {3},
Month = {JUN},
Abstract = {OBJECTIVE: Deaths by external causes represent one of the most important
   challenges for public health and are the second cause of death in
   Brazil. The aim of this study was to analyze differentials in mortality
   by external causes according to race/skin color.
   METHODS: A descriptive study was carried out in Salvador, Northeastern
   Brazil, using 9,626 cases of deaths by external causes between 1998 and
   2003. Data were obtained from the Forensic Medicine Institute and from
   Instituto Brasileiro de Geografia e Estatistica (Brazilian Institute of
   Geography and Statistics). The indicator ``potential years of life
   lost{''} was utilized to identify the existence of differences among age
   groups, sex groups and race/skin color groups.
   RESULTS: Deaths by external causes provoked the loss of 339,220
   potential years of life, of which 210,000 were due to homicides.
   Nonwhite individuals died at earlier ages and lost 12.2 times as much
   potential years of life due to deaths by homicidies than white
   individuals. Although the nonwhite (black and mixed) population was
   three times larger than the white population, its number of potential
   years of life lost was 30 times higher. The population of blacks was
   11.4\% smaller than the white population, but its loss of potential
   years of life was almost three times higher. Even after the adjustment
   for age, the differences observed in the indicator potential years of
   life lost/100,000 inhabitants and in the ratios between strata according
   to race/skin color were maintained.
   CONCLUSIONS: The results showed differentials in mortality by external
   causes according to race/skin color in Salvador. The nonwhite population
   had greater loss of potential years of life, higher average number of
   years not lived and, on average, they died at an earlier age due to
   homicides, traffic accidents an all other external causes.},
Publisher = {REVISTA DE SAUDE PUBLICA},
Address = {FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {de Araujo, EM (Corresponding Author), Av Transnordestina S-N,Km 03 BR 116 Campus Univ, BR-44031460 Feira De Santana, BA, Brazil.
   de Araujo, Edna Maria; Oliveira, Nelson Fernandes; de Araujo, Tania Maria, Univ Estadual Feira de Santana, Nucleo Epidemiol, Feira De Santana, BA, Brazil.
   Costa, Maria da Conceicao N.; Andrade Mota, Eduardo Luiz, Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   Hogan, Vijaya K., Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA.},
ISSN = {0034-8910},
EISSN = {1518-8787},
Keywords = {External Causes; Mortality; Potential Years of Life Lost; Ethnic Group
   and Health; Health Inequalities; Social Inequity; Brazil; Race/Skin
   color},
Keywords-Plus = {MORTALITY; RACE; HOMICIDE; IMPACT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ednakam@gmail.com},
ResearcherID-Numbers = {de Araújo, Tânia Maria/AAE-3048-2019},
Cited-References = {Arnold MW, 2002, J TROP PEDIATRICS, V48, P67, DOI 10.1093/tropej/48.2.67.
   Batista LE, 2004, REV SAUDE PUBL, V38, P630, DOI 10.1590/S0034-89102004000500003.
   CARVALHO JJ, 2005, INCLUSAO ETNICA RACI.
   CUNHA EMG, 2001, EQUIDADE SAUDE CONTR, P219.
   Dever GEA, 1988, EPIDEMIOLOGIA ADM SE.
   Gavrilova NS, 2000, POPUL RES POLICY REV, V19, P397, DOI 10.1023/A:1010621601409.
   Ikeda R. M., 2004, Morbidity and Mortality Weekly Report, V53, P478.
   Johansen JD, 2005, SCAND J PUBLIC HEALT, V33, P222, DOI 10.1080/14034940510005671.
   Jorge MHPD, 1997, REV SAUDE PUBL, V31, P5, DOI 10.1590/S0034-89101997000500002.
   Lam LT, 2004, AUST NZ J PUBL HEAL, V28, P555, DOI 10.1111/j.1467-842X.2004.tb00046.x.
   LAURENTI R, 1987, ESTATISTICAS SAUDE.
   Liu Jing-Tao, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P246.
   {*}ORG MUND SAUD, 2002, REL MUND VIOL SAUD.
   {*}ORG PAN SAUD, 1996, CID 10A REV CLASS ES, P1012.
   PEIXOTO HCG, 1999, INF EPIDEMIOL SUS, V8, P17, DOI {[}10.5123/ S0104-16731999000100003, DOI 10.5123/S0104-16731999000100003].
   Reichenheim ME, 1994, CAD SAUDE PUBLICA S1, V10, P188.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   STARK E, 1990, INT J HEALTH SERV, V20, P3, DOI 10.2190/2TN0-DAFW-8CPG-8VE5.
   Telles EE, 1998, DEMOGRAPHY, V35, P465, DOI 10.2307/3004014.
   Waiselfisz Julio Jacobo, 2007, Estud. av., V21, P119, DOI 10.1590/S0103-40142007000300009.
   Wong MD, 2005, MED CARE, V43, P1058, DOI 10.1097/01.mlr.0000178196.14532.40.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Rev. Saude Publica},
Doc-Delivery-Number = {446TG},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000266143500003},
DA = {2022-03-29},
}

@article{ WOS:000292594400006,
Author = {Law, Chi-Kin and Yip, Paul S. F. and Chen, Ying-Yeh},
Title = {The Economic and Potential Years of Life Lost from Suicide in Taiwan,
   1997-2007},
Journal = {CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION},
Year = {2011},
Volume = {32},
Number = {3},
Pages = {152-159},
Abstract = {Background: Taiwan has experienced a marked increase in the suicide rate
   in the last decade. However, the socioeconomic burden and impact to the
   community has not been adequately assessed. Aims: This study aimed to
   estimate the social and economic burden of premature mortality from
   suicide in Taiwan in 1997-2007. Methods: The suicide rate, potential
   years of life lost (PYLL), and present value of lifetime earnings (PVLE)
   by sex and age groups in 1997-2007 were calculated. The contribution of
   each suicide method to PYLL for each age group was also assessed.
   Results: Using the PYLL calculations, suicide had become the third
   leading cause of death in Taiwan in 2007, compared to its ninth position
   in terms of absolute numbers. Furthermore, the PYLL was associated with
   an estimated NTD (New Taiwan Dollars) 32.5 billion of lost earnings in
   2007. The increase in PYLL and PVLE from suicide was highest in
   middle-aged men (aged 25-59 years). Charcoal burning suicide accounted
   for most of the increase in PYLL in the middle-aged group in the past
   decade. Conclusions: The loss of life in middle-aged males contributes
   disproportionately to the social and economic burden of suicide in
   Taiwan. Suicide intervention effort should target this high-risk
   population.},
Publisher = {HOGREFE \& HUBER PUBLISHERS},
Address = {MERKELSTR 3, D-37085 GOTTINGEN, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Chen, YY (Corresponding Author), Taipei City Hosp, Taipei City Psychiat Ctr, Taiwan 309 Songde Rd, Taipei, Taiwan.
   Chen, Ying-Yeh, Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan.
   Law, Chi-Kin, Chinese Univ Hong Kong, Hong Kong Inst Asia Pacific Studies, Hong Kong, Hong Kong, Peoples R China.
   Yip, Paul S. F., Univ Hong Kong, Dept Social Work \& Social Adm, Hong Kong, Hong Kong, Peoples R China.
   Yip, Paul S. F., Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res \& Prevent, Hong Kong, Hong Kong, Peoples R China.
   Chen, Ying-Yeh, Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan.
   Chen, Ying-Yeh, Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.},
DOI = {10.1027/0227-5910/a000070},
ISSN = {0227-5910},
EISSN = {2151-2396},
Keywords = {Taiwan; potential years of life lost; present value of lifetime
   earnings; economic burden},
Keywords-Plus = {CHARCOAL-BURNING SUICIDES; HONG-KONG; TRENDS; MORTALITY; COSTS; AGE},
Research-Areas = {Psychiatry; Psychology},
Web-of-Science-Categories  = {Psychiatry; Psychology, Multidisciplinary},
Author-Email = {dai73@tpech.gov.tw},
ResearcherID-Numbers = {Chen, Ying-Yeh/AAY-1478-2021
   },
ORCID-Numbers = {Chen, Ying-Yeh/0000-0001-5543-5704},
Cited-References = {{[}Anonymous], 2005, APPLE DAILY, pA15.
   Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P413, DOI 10.1080/j.1440-1614.2000.00690.x.
   Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x.
   Chen YY, 2010, SOC PSYCH PSYCH EPID, V45, P363, DOI 10.1007/s00127-009-0075-8.
   Clayton D, 1999, Chronic Dis Can, V20, P89.
   Coggan C.A., 1995, 4 PUBL HLTH COMM.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   {*}DEP HLTH, 2008, HLTH NAT HLTH INS AN.
   Doessel DP, 2009, ARCH SUICIDE RES, V13, P87, DOI 10.1080/13811110802572197.
   Gold MR., 1996, COST EFFECTIVENESS H.
   Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X.
   HADDIX A, 1996, PREVENTION EFFECTIVE.
   HANVELT RA, 1994, AIDS, V8, pF7, DOI 10.1097/00002030-199410000-00001.
   Knox KL, 2005, AM J PUBLIC HEALTH, V95, P1898, DOI 10.2105/AJPH.2004.047217.
   Kuo CJ, 2008, SOC PSYCH PSYCH EPID, V43, P286, DOI 10.1007/s00127-007-0300-2.
   Lin JJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-6.
   Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553.
   MILLER TR, 1995, CAN MED ASSOC J, V153, P1261.
   ODEA M, 2005, COST SUICIDE SOC.
   Palmer CS, 1995, CLIN NEUROPHARMACOL, V18, pS25, DOI 10.1097/00002826-199518003-00004.
   Rice DP, 1998, BRIT J PSYCHIAT, V173, P4, DOI 10.1192/S0007125000293458.
   Stark C, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-49.
   Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514.
   Watson W., 1997, COST INJURY VICTORIA.
   Watt JR, 2008, KAOHSIUNG J MED SCI, V24, P563, DOI 10.1016/S1607-551X(09)70017-8.
   World Health Organization, 1977, MAN INT STAT CLASS D.
   Yip P, 2009, OXFORD TXB SUICIDOLO, P595.
   Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21.
   Yip PSF, 2010, BRIT J PSYCHIAT, V196, P241, DOI 10.1192/bjp.bp.109.065185.
   Yip PSF, 2005, CRISIS, V26, P156, DOI 10.1027/0227-5910.26.4.156.},
Number-of-Cited-References = {30},
Times-Cited = {27},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Crisis},
Doc-Delivery-Number = {790NG},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000292594400006},
DA = {2022-03-29},
}

@article{ WOS:000428567400002,
Author = {Pavanitto, Drielle Rezende and de Moura Menezes, Renata Armani and Costa
   Nascimento, Luiz Fernando},
Title = {Accidents involving motorcycles and potential years of life lost. An
   ecological and exploratory study},
Journal = {SAO PAULO MEDICAL JOURNAL},
Year = {2018},
Volume = {136},
Number = {1},
Pages = {4-9},
Month = {JAN-FEB},
Abstract = {CONTEXT AND OBJECTIVE: Traffic accidents have gained prominence as one
   of the modern epidemics that plague the world. The objective of this
   study was to identify the spatial distribution of potential years of
   life lost (PYLL) due to accidents involving motorcycles in the state of
   Sao Paulo, Brazil.
   DESIGN AND SETTING: Ecological and exploratory study conducted in Sao
   Paulo.
   METHODS: Data on deaths among individuals aged 20-39 years due to
   motorcycle accidents (V20-V29 in the International Classification of
   Diseases, 10th revision) in the state of Sao Paulo in the years 20072011
   were obtained from DATASUS. These data were stratified into a database
   for the 63 microregions of this state, according to where the
   motorcyclist lived. PYLL rates per 100,000 inhabitants were calculated.
   Spatial autocorrelations were estimated using the Global Moran index
   (IM). Thematic, Moran and Kernel maps were constructed using PYLL rates
   for the age groups of 20-29 and 30-39 years. The Terraview 4.2.2
   software was used for the analysis.
   RESULTS: The PYLL rates were 486.9 for the ages of 20-29 years and 199.5
   for 30-39 years. Seventeen microregions with high PYLL rates for the age
   group of 20-29 years were identified. There was higher density of these
   rates on the Kernel map of the southeastern region (covering the
   metropolitan region of Sao Paulo). There were no spatial
   autocorrelations between rates.
   CONCLUSIONS: The data presented in this study identified microregions
   with high accident rates involving motorcycles and microregions that
   deserve special attention from regional managers and traffic experts.},
Publisher = {ASSOCIACAO PAULISTA MEDICINA},
Address = {AV BRIG LUIS ANTONIO, 278-7 ANDAR, SAO PAULO, CEP01318-901, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Nascimento, LFC (Corresponding Author), Univ Estadual Paulista UNESP, Dept Energia, Av Ariberto Pereira Cunha 333, BR-12516410 Guaratingueta, SP, Brazil.
   Pavanitto, Drielle Rezende; de Moura Menezes, Renata Armani; Costa Nascimento, Luiz Fernando, Univ Taubate UNITAU, Dept Med, Taubate, SP, Brazil.
   Costa Nascimento, Luiz Fernando, Univ Estadual Paulista UNESP, Dept Energy, Guaratingueta, SP, Brazil.},
DOI = {10.1590/1516-3180.2017.0098070817},
ISSN = {1516-3180},
Keywords = {Life expectancy; Geographic information systems; Motorcycles; Accidents,
   traffic},
Keywords-Plus = {ROAD TRAFFIC ACCIDENTS; SPATIAL-DISTRIBUTION; SAO-PAULO; BRAZIL; STATE;
   HOSPITALIZATION; MUNICIPALITY; MORTALITY; TRENDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {luiz.nascimento@pq.cnpq.br},
ResearcherID-Numbers = {Nascimento, Luiz Fernando/O-2400-2018
   NASCIMENTO, LUIZ FERNANDO C/B-5007-2015},
ORCID-Numbers = {Nascimento, Luiz Fernando/0000-0001-9793-750X
   },
Cited-References = {Almeida APB, 2013, EPIDEMIOL SERV SAUDE, V22, P235, DOI DOI 10.5123/S1679-49742013000200005.
   Vieira RDA, 2011, REV ESC ENFERM USP, V45, P1356.
   Andrade SSCD, 2017, EPIDEMIOL SERV SAUDE, V26, P31, DOI {[}10.5123/S1679-49742017000100004, 10.5123/s1679-49742017000100004].
   Andrade SSCD, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006465.
   Almeida MCD, 2014, SAO PAULO MED J, V132, P199, DOI 10.1590/1516-3180.2014.1324610.
   Campi SFD, 2014, REV ASSOC MED BRAS, V60, P419, DOI 10.1590/1806-9282.60.05.008.
   Neto OLD, 2012, CIENC SAUDE COLETIVA, V17, P2223.
   Oliveira Nelson Luiz Batista de, 2012, Rev. esc. enferm. USP, V46, P1379.
   GANNE N, 2013, REV PAN-AMAZ SAUDE, V4, P15, DOI DOI 10.5123/S2176-62232013000100003.
   Lucena RM, 2009, DST J BRAS DOENCAS S, V21, P136.
   Martins ET, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004227.
   Mascarenhas MDM, 2016, CIENC SAUDE COLETIVA, V21, P3661, DOI 10.1590/1413-812320152112.24332016.
   Neves MC, ANALISE EXPLORATORIA.
   Silva PHND, 2011, REV SAUDE PUBL, V45, P409, DOI 10.1590/S0034-89102011005000010.
   Nunes MN, 2010, REV ASSOC MED BRAS, V56, P684, DOI 10.1590/S0104-42302010000600018.
   Rocha GD, 2013, CIENC SAUDE COLETIVA, V18, P721, DOI 10.1590/S1413-81232013000300018.
   Romeder J. M., 1988, DESAFIO EPIDEMIOLOGI, P254.
   Schneider Ione Jayce Ceola, 2017, Cad. saúde colet., V25, P233, DOI 10.1590/1414-462x2017000200025.
   Venancio TS, 2015, CIENC SAUDE COLETIVA, V20, P1540, DOI 10.1590/1413-81232015205.14672014.},
Number-of-Cited-References = {19},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Sao Paulo Med. J.},
Doc-Delivery-Number = {GA8DD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000428567400002},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000430606100006,
Author = {Panis, Carolina and Bufalo Kawasaki, Aedra Carla and Pascotto,
   Claudiceia Risso and Della Justina, Eglea Yamamoto and Vicentini,
   Geraldo Emilio and Lucio, Leia Carolina and Cunha Prates, Rosebel
   Trindade},
Title = {Critical review of cancer mortality using hospital records and potential
   years of life lost},
Journal = {EINSTEIN-SAO PAULO},
Year = {2018},
Volume = {16},
Number = {1},
Month = {JAN-MAR},
Abstract = {Objective: To determine and discuss cancer mortality rates in southern
   Brazil between 1988 and 2012. Methods: This was a critical review of
   literature based on analysis of data concerning incidence and mortality
   of prostate cancer, breast cancer, bronchial and lung cancer, and
   uterine and ovarian cancer. Data were collected from the online database
   of the Brazil Instituto Nacional de Cancer Jose Alencar Gomes da Silva.
   Results: The southern Brazil is the leading region of cancer incidence
   and mortality. Data on the cancer profile of this population are scarce
   especially in the States of Santa Catarina and Parana. We observed
   inconsistency between data from hospital registers and death recorded.
   Conclusion: Both cancer incidence and the mortality are high in Brazil.
   In addition, Brazil has great numbers of registers and deaths for cancer
   compared to worldwide rates. Regional risk factors might explain the
   high cancer rates.},
Publisher = {INST ISRAELITA ENSINO \& PESQUISA ALBERT EINSTEIN},
Address = {AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Panis, C (Corresponding Author), Univ Estadual Oeste Parana, Ctr Ciencias Saude, Rodovia PR 180,Km 02 Agua Branca, BR-85601970 Francisco Beltrao, PR, Brazil.
   Panis, Carolina; Bufalo Kawasaki, Aedra Carla; Pascotto, Claudiceia Risso; Della Justina, Eglea Yamamoto; Vicentini, Geraldo Emilio; Lucio, Leia Carolina; Cunha Prates, Rosebel Trindade, Univ Estadual Oeste Parana, Grp Adv Studies Hlth Appl Sci, Francisco Beltrao, PR, Brazil.},
DOI = {10.1590/S1679-45082018AO4018},
Article-Number = {UNSP eAO4018},
ISSN = {1679-4508},
EISSN = {2317-6385},
Keywords = {Neoplasms/mortality; Hospital records; Potential years of life lost;
   Brazil},
Keywords-Plus = {BREAST-CANCER; RISK-FACTORS; BRAZIL; PREVALENCE; TRENDS; STATE; AGE},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {carolpanis@hotmail.com},
ResearcherID-Numbers = {Lucio, Léia Carolina/AAW-3037-2020
   Pascotto, Claudicéia Risso/AAE-2657-2021
   PANIS, CAROLINA/AAM-7214-2021},
ORCID-Numbers = {Lucio, Léia Carolina/0000-0002-8094-4188
   PANIS, CAROLINA/0000-0002-0104-4369},
Cited-References = {Almeida J.R.C., 2007, REV BRAS CANCEROL, V53, P305.
   Alvarenga Marcelo, 2003, J. Bras. Patol. Med. Lab., V39, P167, DOI 10.1590/S1676-24442003000200013.
   Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001.
   Barros Sergio Gabriel Silva de, 2000, Arquivos de Gastroenterologia, V37, P25.
   Brasil. Ministerio da Saude, DATASUS IND DEM MORT.
   Brasil. Secretaria Nacional de Assistencia a Saude. Instituto Nacional de Cancer. Coordenacao Nacional de Controle do Tabagismo Prevencao e Vigilancia do Cancer, 2000, REG HOSP CANC ROT PR.
   de Matos JC, 2010, REV LAT-AM ENFERM, V18, P352, DOI 10.1590/S0104-11692010000300009.
   de Paiva EP, 2010, ACTA PAUL ENFERM, V23, P88, DOI 10.1590/S0103-21002010000100014.
   DEROSSI AS, 2001, REV BRAS CANCEROL, V47, P163.
   Ewald IP., 2012, THESIS U FEDERAL RIO.
   FACINA T., 2014, REV BRASILEIRA CANCE, V60, P63.
   Garicochea B, 2009, REV SAUDE PUBL, V43, P311, DOI 10.1590/S0034-89102009005000009.
   Girianelli VR, 2014, REV SAUDE PUBL, V48, P459, DOI 10.1590/S0034-8910.2014048005214.
   Goncalves ATC, 2007, CAD SAUDE PUBLICA, V23, P1785, DOI 10.1590/S0102-311X2007000800005.
   INSTITUTO NACIONAL DO CANCER-INCA, OBS POL NAC CONTR TA.
   Koifman S., 2003, VENENO REMEDIO, P75.
   Kolling FL, 2009, SCI MED, V19, P115.
   Pereira MSLC, 2011, EPIDEMIOL SERV SAUDE, V20, P161, DOI 10.5123/S1679-49742011000200005.
   Malta Deborah Carvalho, 2007, J. bras. pneumol., V33, P536, DOI 10.1590/S1806-37132007000500008.
   Fonseca LAM, 2010, REV ASSOC MED BRAS, V56, P309, DOI 10.1590/S0104-42302010000300015.
   McLean RC, 2015, CURR NUTR REP, V4, P22.
   Melo WA, 2003, REV GESTAO SAUDE, P2087.
   Oliveira Junior FJM, 2005, REV BRAS CANCEROL, V51, P201.
   Paiva CJK, 2015, REV BRAS CANCEROL, V61, P23, DOI DOI 10.32635/2176-9745.RBC.2015V61N1.374.
   Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x.
   Stewart B.W., 2014, WORLD CANC REPORT 20.
   Tauil PL, 1996, REV BIOET, V4, P1.
   WHO, CANCER.
   Wünsch Filho Victor, 2010, Rev. bras. epidemiol., V13, P175, DOI 10.1590/S1415-790X2010000200001.
   WÜNSCH FILHO VICTOR, 2002, Rev. Assoc. Med. Bras., V48, P250.},
Number-of-Cited-References = {30},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Einstein},
Doc-Delivery-Number = {GD6GC},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000430606100006},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000386112600014,
Author = {Caribe de Araujo Andrade, Silvania Suely and Prado de Mello-Jorge, Maria
   Helena},
Title = {Mortality and potential years of life lost by road traffic injuries in
   Brazil, 2013},
Journal = {REVISTA DE SAUDE PUBLICA},
Year = {2016},
Volume = {50},
Abstract = {OBJECTIVE: To estimate the potential years of life lost by road traffic
   injuries three years after the beginning of the Decade of Action for
   Traffic Safety.
   METHODS: We analyzed the data of the Sistema de Informacoes sobre
   Mortalidade (SIM - Mortality Information System) related to road traffic
   injuries, in 2013. We estimated the crude and standardized mortality
   rates for Brazil and geographic regions. We calculated, for the Country,
   the proportional mortality according to age groups, education level,
   race/skin color, and type or quality of the victim while user of the
   public highway. We estimated the potential years of life lost according
   to sex.
   RESULTS: The mortality rate in 2013 was of 21.0 deaths per 100,000
   inhabitants for the Country. The Midwest region presented the highest
   rate (29.9 deaths per 100,000 inhabitants). Most of the deaths by road
   traffic injuries took place with males (34.9 deaths per 100,000 males).
   More than half of the people who have died because of road traffic
   injuries were of black race/skin color, young adults (24.2\%),
   individuals with low schooling (24.0\%), and motorcyclists (28.5\%). The
   mortality rate in the triennium 2011-2013 decreased 4.1\%, but increased
   among motorcyclists. Across the Country, more than a million of
   potential years of life were lost, in 2013, because of road traffic
   injuries, especially in the age group of 20 to 29 years.
   CONCLUSIONS: The impact of the high mortality rate is of over a million
   of potential years of life lost by road traffic injuries, especially
   among adults in productive age (early mortality), in only one year,
   representing extreme social cost arising from a cause of death that
   could be prevented. Despite the reduction of mortality by road traffic
   injuries from 2011 to 2013, the mortality rates increased among
   motorcyclists.},
Publisher = {REVISTA DE SAUDE PUBLICA},
Address = {FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Andrade, SSCD (Corresponding Author), Minist Saude, Secretaria Vigilancia Saude, Dept Vigilancia Doencas \& Agravos Nao Transmissiv, Edificio Premium SAF Quadra 2,Torre 1, BR-70070600 Brasilia, DF, Brazil.
   Caribe de Araujo Andrade, Silvania Suely, Univ Sao Paulo, Fac Saude Publ, Programa Posgrad Saude Publ, Sao Paulo, SP, Brazil.
   Prado de Mello-Jorge, Maria Helena, Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil.},
DOI = {10.1590/S1518-8787.2016050006465},
Article-Number = {59},
ISSN = {0034-8910},
EISSN = {1518-8787},
Keywords = {Accidents,Traffic, mortality; Potential Years of Life Lost;
   Transportation; Hospital Information Systems; Mortality Registries},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {silvaniasuely@yahoo.com.br},
Cited-References = {Adura F. E., 2013, REV USP, P23, DOI {[}10.11606/issn.2316-9036.v0i96p23-36, DOI 10.11606/ISSN.2316-9036.V0I96P23-36].
   Almeida APB, 2013, EPIDEMIOL SERV SAUDE, V22, P235, DOI DOI 10.5123/S1679-49742013000200005.
   Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069.
   Neto OLD, 2013, EPIDEMIOL SERV SAUDE, V22, P373, DOI 10.5123/S1679-49742013000300002.
   Neto OLD, 2012, CIENC SAUDE COLETIVA, V17, P2223.
   Duarte EC, 2008, EPIDEMIOL SERV SAUDE, V17, P7.
   Jorge Maria Helena Prado de Mello, 2007, Ciênc. saúde coletiva, V12, P643, DOI 10.1590/S1413-81232007000300014.
   Malta DC, 2014, REV SAUDE PUBL, V48, P692, DOI 10.1590/S0034-8910.2014048005633.
   de Souza MDM, 2007, EPIDEMIOL SERV SAUDE, V16, P33.
   Martins ET, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004227.
   Mascarenhas MDM, 2009, CIENC SAUDE COLETIVA, V14, P1789, DOI 10.1590/S1413-81232009000500020.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Reichenheim ME, 2011, LANCET, DOI {[}10.1016/S0140-6736(11)60053-6, DOI 10.1016/S0140-6736(11)60053-6].
   Reichenheim ME, 1994, CAD SAUDE PUBLICA S1, V10, pS188, DOI {[}10.1590/S0102-311X1994000500014, DOI 10.1590/S0102-311X1994000500014].
   Romeder J. M., 1988, DESAFIO EPIDEMIOLOGI, P254.
   Silva MGC, 1984, REV SAUDE PUBL, V18, P108, DOI {[}10.1590/S0034-89101984000200004, DOI 10.1590/S0034-89101984000200004].
   Montenegro MDS, 2011, REV SAUDE PUBL, V45, P529.
   Souza ER, 2005, IMPACTO VIOLENCIA SA, P279.
   Souza Verena Maria Mendes de, 2011, Rev. Saúde Pública, V45, P1001, DOI 10.1590/S0034-89102011005000070.
   Tauil MD, 2012, CAD SAUDE PUBLICA, V28, P472, DOI 10.1590/S0102-311X2012000300007.
   World Health Organization, 1994, 10 WHO CID ED.},
Number-of-Cited-References = {21},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Rev. Saude Publica},
Doc-Delivery-Number = {DZ8HX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000386112600014},
OA = {gold, Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000301527500001,
Author = {Shield, Kevin D. and Taylor, Benjamin and Kehoe, Tara and Patra,
   Jayadeep and Rehm, Juergen},
Title = {Mortality and potential years of life lost attributable to alcohol
   consumption in Canada in 2005},
Journal = {BMC PUBLIC HEALTH},
Year = {2012},
Volume = {12},
Month = {JAN 31},
Abstract = {Background: Alcohol is a substantial risk factor for mortality according
   to the recent 2010 World Health Assembly strategy to reduce the harmful
   use of alcohol which outlined the need to characterize and monitor this
   burden. Accordingly, using new methodology we estimated 1) the number of
   deaths caused and prevented by alcohol consumption, and 2) the potential
   years of life lost (PYLLs) attributable to alcohol consumption in Canada
   in 2005.
   Methods: Mortality attributable to alcohol consumption was estimated by
   calculating Alcohol-Attributable Fractions (AAFs) (defined as the
   proportion of mortality that would be eliminated if the exposure was
   eliminated) using data from various sources. Indicators for alcohol
   consumption were obtained from the Canadian Alcohol and Drug Use
   Monitoring Survey 2008 and corrected for adult per capita recorded and
   unrecorded alcohol consumption. Risk relations were taken from the
   Comparative Risk Assessment within the current Global Burden of Disease
   (GBD) study. Due to concerns about the reliability of information
   specifying causes of death for people aged 65 or older, our analysis was
   limited to individuals aged 0 to 64 years. Calculation of the 95\%
   confidence intervals (CIs) for the AAFs was performed using Monte Carlo
   random sampling. Information on mortality was obtained from Statistics
   Canada. A sensitivity analysis was performed comparing the mortality
   results obtained using our study methods to results obtained using
   previous methodologies.
   Results: In 2005, 3,970 (95\% CI: 810 to 7,170) deaths (4,390 caused and
   420 prevented) and 134,555 (95\% CI: 36,690 to 236,376) PYLLs were
   attributable to alcohol consumption for individuals aged 0 to 64 years.
   These figures represent 7.7\% (95\% CI: 1.6\% to 13.9\%) of all deaths
   and 8.0\% (95\% CI: 2.2\% to 14.1\%) of all PYLLs for individuals aged 0
   to 64 years. The sensitivity analysis showed that the number of deaths
   as measured by this new methodology is greater than that if mortality
   was estimated using previous methodologies.
   Conclusions: The mortality burden attributable to alcohol consumption
   for Canada is large, unnecessary, and could be substantially reduced in
   a short period of time if effective public health policies were
   implemented. A monitoring system on alcohol consumption is imperative
   and would greatly assist in planning and evaluating future Canadian
   public health policies related to alcohol consumption.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Shield, KD (Corresponding Author), CAMH, Toronto, ON, Canada.
   Shield, Kevin D.; Taylor, Benjamin; Kehoe, Tara; Patra, Jayadeep; Rehm, Juergen, CAMH, Toronto, ON, Canada.
   Shield, Kevin D.; Taylor, Benjamin; Patra, Jayadeep; Rehm, Juergen, Univ Toronto, DLSPH, Toronto, ON, Canada.
   Kehoe, Tara, Univ Toronto, Dept Stat, Toronto, ON, Canada.
   Rehm, Juergen, Tech Univ Dresden, Inst Clin Psychol \& Psychotherapy, Dresden, Germany.},
DOI = {10.1186/1471-2458-12-91},
Article-Number = {91},
EISSN = {1471-2458},
Keywords = {Alcohol consumption; Mortality; Potential years of life lost; Relative
   risk; Canada},
Keywords-Plus = {RISK-FACTOR; GLOBAL BURDEN; LIVER-CIRRHOSIS; DISEASE; DRINKING;
   MORBIDITY; INJURY; VOLUME; COST; TUBERCULOSIS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {shield@utoronto.ca},
ResearcherID-Numbers = {Shield, Kevin/AAR-8220-2020
   },
ORCID-Numbers = {Shield, Kevin/0000-0003-1871-8849},
Funding-Acknowledgement = {National Institute for Alcohol Abuse and Alcoholism (NIAAA)United States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}HHSN267200700041C]; Ontario Ministry of Health and Long-Term
   CareMinistry of Health and Long-Term Care, Ontario},
Funding-Text = {Financial support for this study was provided to the last author listed
   above by the National Institute for Alcohol Abuse and Alcoholism (NIAAA)
   with contract \# HHSN267200700041C to conduct the study titled
   ``Alcohol- and Drug-attributable Burden of Disease and Injury in the
   US{''}. In addition, the last author received a salary and
   infrastructure support from the Ontario Ministry of Health and Long-Term
   Care.},
Cited-References = {Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2.
   Babor TF, 2010, ALCOHOL NO ORDINARY, V2nd.
   Baliunas D, 2005, THESIS U TORONTO.
   Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227.
   Canadian Centre on Substance Abuse, 2004, CAN ADD SURV 2004 MI.
   Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782.
   Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027.
   English D., 1995, QUANTIFICATION DRUG.
   Flegal KM, 2006, AM J PUBLIC HEALTH, V96, P398, DOI 10.2105/AJPH.2005.079731.
   Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI {[}10.1177/009145090403100304, DOI 10.1177/009145090403100304].
   Gmel G, 2010, AM J EPIDEMIOL, V171, P93, DOI 10.1093/aje/kwp331.
   Health Canada, CAN ALC DRUG US MON.
   Irving HM, 2009, J PANCREAS, V10, P387.
   Kehoe T, POPUL HLTH METR.
   Korn E.L., 1999, ANAL HLTH SURVEYS.
   Laslett A-M, 2010, RANGE MAGNITUDE ALCO.
   Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6.
   Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289.
   Macdonald S, 1999, DRUG ALCOHOL REV, V18, P21, DOI 10.1080/09595239996725.
   Mathers CD, 2002, GLOBAL BURDEN DIS 20.
   Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2.
   Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242.
   {*}NAT I ALC AB ALC, 2006, NAT EP SURV ALC REL.
   Organization World Health, 2002, WORLD HLTH REPORT 20.
   Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x.
   Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258.
   {*}PUBL HLTH AG CAN, 2007, ALC US PREGN IMP CAN.
   Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x.
   Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x.
   Rehm J, 2009, CONT DRUG PROBS, V36, P575, DOI DOI 10.1177/009145090903600313.
   Rehm J, 2010, ESTIMATING UNCERTAIN.
   Rehm J, 2008, AVOIDABLE COST ALCOH.
   Rehm J, 2008, INT J METH PSYCH RES, V17, P141, DOI 10.1002/mpr.259.
   Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204.
   Rehm J, 2011, EUR ADDICT RES, V17, P72, DOI 10.1159/000321463.
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x.
   Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3.
   Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x.
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450.
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7.
   Rehm J, 2007, INT J CANCER, V121, P1132, DOI 10.1002/ijc.22798.
   Rehn J, 2006, ADDICTION, V101, P1086, DOI 10.1111/j.1360-0443.2006.01491.x.
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15.
   Roerecke M, 2010, ALCOHOL CONSUMPTION.
   Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451.
   Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2.
   Samokhvalov AV, 2010, EPIDEMIOL INFECT, V138, P1789, DOI 10.1017/S0950268810000774.
   Samokhvalov AV, 2010, EUR J CARDIOV PREV R, V17, P706, DOI 10.1097/HJR.0b013e32833a1947.
   Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x.
   Shield K, INT J METHODS PSYCHI.
   Single E, 1999, AM J PUBLIC HEALTH, V89, P385, DOI 10.2105/AJPH.89.3.385.
   Statistics Canada, 2011, VIT STAT DEATH DAT.
   Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011.
   Taylor B, 2008, AM J EPIDEMIOL, V168, P1119, DOI 10.1093/aje/kwn215.
   Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x.
   Wagenaar AC, 2009, AM J PUBLIC HEALTH, V99, P1464, DOI 10.2105/AJPH.2007.131326.
   World Health Organization, 2009, GLOB HLTH RISKS MORT.
   World Health Organization, 2010, WHO GLOB STRAT RED H.
   Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248.},
Number-of-Cited-References = {59},
Times-Cited = {26},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {14},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {908XX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000301527500001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000276400200008,
Author = {Doessel, D. P. and Williams, Ruth F. G. and Whiteford, Harvey},
Title = {Policy-Appropriate Measurement of Suicide: Headcount vs. Potential Years
   of Life Lost, Australia, 1907-2005},
Journal = {ARCHIVES OF SUICIDE RESEARCH},
Year = {2009},
Volume = {13},
Number = {1},
Pages = {87-99},
Abstract = {We reconsider conventional suicide measurement. First, a headcount of
   suicide is examined relative to some other causes of death (circulatory
   diseases, cancer, and motor vehicle accidents). We then construct a
   time-series data set of an alternative measure of suicide, the potential
   years of life lost (PYLL) for males and females. Suicide PYLLs average
   4.57\% of all male PYLLs and 2.44\% of female PYLLs for 1907-2005. The
   comparable ``count'' percentages are 1.85 and 0.65, respectively. These
   differences are widening through time. In 2005, suicide represented
   3.25\% of all male deaths and 0.90\% of female deaths using the count
   measure and, using PYLLs, 11.0\% and 4.96\%, respectively. The two
   measures produce quite different indications of suicide.},
Publisher = {ROUTLEDGE JOURNALS, TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Williams, RFG (Corresponding Author), Victoria Univ, Sch Econ \& Finance, Melbourne, Vic 8001, Australia.
   Williams, Ruth F. G., Victoria Univ, Sch Econ \& Finance, Melbourne, Vic 8001, Australia.
   Williams, Ruth F. G., Victoria Univ, Ctr Strateg Econ Studies, Melbourne, Vic 8001, Australia.
   Doessel, D. P.; Whiteford, Harvey, Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.
   Doessel, D. P.; Williams, Ruth F. G.; Whiteford, Harvey, Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.},
DOI = {10.1080/13811110802572197},
ISSN = {1381-1118},
EISSN = {1543-6136},
Keywords = {Australia; potential years of life lost; PYLL; suicide; suicide
   prevention strategies},
Keywords-Plus = {TRENDS},
Research-Areas = {Psychiatry; Psychology},
Web-of-Science-Categories  = {Psychiatry; Psychology; Psychology, Multidisciplinary},
Author-Email = {ruth.williams@vu.edu.au},
ResearcherID-Numbers = {Whiteford, Harvey A/A-4840-2009},
ORCID-Numbers = {Whiteford, Harvey A/0000-0003-4667-6623},
Cited-References = {Associate Minister of Health, 2006, NZ SUIC PREV STRAT 2.
   {*}AUSTR BUR STAT, 2000, SUIC AUSTR 1921 1998.
   {*}AUSTR DEP HLTH AG, 2008, LIFE FRAM PREV SUIC.
   {*}AUSTR I HLTH WELF, 2007, STAT TERR GRIM GEN R.
   BHATTACHARYYA MN, 1979, J AM STAT ASSOC, V74, P596, DOI 10.2307/2286976.
   Caldwell TM, 2004, MED J AUSTRALIA, V181, pS10.
   Cantor C, 2000, AUST NZ J PSYCHIAT, V34, P370, DOI 10.1080/j.1440-1614.2000.00756.x.
   Cantor CH, 1999, MED J AUSTRALIA, V171, P137, DOI 10.5694/j.1326-5377.1999.tb123565.x.
   {*}COMM DEP HLTH AG, 2000, AR ACT LIF FRAM PREV.
   Commonwealth Department of Human Services and Health. Better Health Outcomes for Australians, 1994, BETT HLTH OUTC AUSTR.
   Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   Department of Health, 2002, NAT SUIC PREV STRAT.
   Easterlin R., 2004, RELUCTANT EC PERSPEC, P101.
   FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304.
   GOLDBERGER AS, 1971, PSYCHOMETRIKA, V36, P83, DOI 10.1007/BF02291392.
   GOLDBERGER AS, 1973, STRUCTURAL EQUATION, P1.
   Goldney Robert D, 2004, Crisis, V25, P86, DOI 10.1027/0227-5910.25.2.86.
   Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X.
   JORESKOG KG, 1972, PSYCHOMETRIKA, V37, P243, DOI 10.1007/BF02306782.
   Mills C.W., 1970, SOCIOLOGICAL IMAGINA.
   Okun A.M., 1962, P BUS EC STAT SECT, P98, DOI DOI 10.1016/0167-2231(79)90009-5.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   {*}US PHS, 1999, SURG GEN CALL ACT PR.
   Wilkinson D, 2000, AUST NZ J PSYCHIAT, V34, P822.
   Yip PSF, 2005, CRISIS, V26, P156, DOI 10.1027/0227-5910.26.4.156.},
Number-of-Cited-References = {26},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Arch. Suicide Res.},
Doc-Delivery-Number = {579UF},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000276400200008},
DA = {2022-03-29},
}

@article{ WOS:000342467100001,
Author = {Allin, Sara and Graves, Erin and Grignon, Michel and Ridgeway, Diana and
   Wang, Li},
Title = {Health-adjusted potential years of life lost due to treatable causes of
   death and illness},
Journal = {HEALTH REPORTS},
Year = {2014},
Volume = {25},
Number = {8},
Pages = {3-9},
Month = {AUG},
Abstract = {Background Summary measures based on potential years of life lost (PYLL)
   to death and to illness would complement population health measures such
   as health-adjusted life expectancy. These measures can be applied to
   deaths and to conditions that are considered amenable to treatment by
   the health care system.
   Data and methods Life tables for 2007 to 2009 were used to calculate
   health-adjusted potential years of life lost (HAPYLL) for males and
   females from birth to age 75 for Canada and the provinces. Mortality
   rates for all causes were adjusted using the Health Utility Index 3
   (HUI3) as a measure of the average value of a year in ill health.
   Average HUI3 was calculated for each age group for selected health
   conditions self-reported in the 2009/2010 Canadian Community Health
   Survey. HAPYLL was estimated by adding the average number of years lost
   due to treatable causes of death (treatable PYLL) to the average number
   of years lost because of ill health (HUI3 gap).
   Results More years of life are lost because of ill health than are lost
   because of premature death. During the 2007-to-2009 period,
   age-/sex-standardized PYLL due to treatable causes of death was 1,257
   years lost per 100,000 person-years, while the age-/sex-standardized
   HUI3 gap was 6,477 years. Provincial rankings change when information on
   deaths is combined with information on ill health.
   Interpretation The impact of treatable conditions is greater in terms of
   quality of life lost than in life-years lost.},
Publisher = {STATISTICS CANADA},
Address = {100 TUNNEYS PASTURE DRIVEWAY, OTTAWA, ONTARIO K1A 0T6, CANADA},
Type = {Article},
Language = {English},
Affiliation = {Allin, S (Corresponding Author), Canadian Inst Hlth Informat, Toronto, ON M2P 2B7, Canada.
   Allin, Sara; Graves, Erin; Ridgeway, Diana; Wang, Li, Canadian Inst Hlth Informat, Toronto, ON M2P 2B7, Canada.
   Grignon, Michel, McMaster Univ, Hamilton, ON, Canada.},
ISSN = {0840-6529},
EISSN = {1209-1367},
Keywords = {Health Utility Index; summary measures of health; treatable mortality},
Keywords-Plus = {MORTALITY; DISEASE; CANADA},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {sallin@cihi.ca},
ORCID-Numbers = {Allin, Sara/0000-0002-0579-8985},
Cited-References = {{[}Anonymous], 2012, HLTH IND 2012.
   BERTHELOT JM, 1993, COLLOQ INSE, V226, P161.
   Furlong W, 1998, 9811 MCMASTER U CTR.
   James PD, 2007, J EPIDEMIOL COMMUN H, V61, P287, DOI 10.1136/jech.2006.047092.
   Manuel DG, 2003, CAN J CARDIOL, V19, P997.
   Mullahy J, 2001, HEALTH ECON, V10, P429, DOI 10.1002/hec.633.
   Murray CJL, 2002, HLTH GAPS OVERVIEW C, P233.
   Nelson MR, 2005, BMJ-BRIT MED J, V330, P1306, DOI 10.1136/bmj.38456.676806.8F.
   Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129.
   Orpana Heather M, 2009, Health Rep, V20, P29.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   ROMIEU I, 1994, ADV HLTH EXPECTANCIE.
   Statistics Canada, OCC CANSIM DAT.
   Wolfson M C, 1996, Health Rep, V8, P41.},
Number-of-Cited-References = {14},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Health Rep.},
Doc-Delivery-Number = {AQ0IQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000342467100001},
DA = {2022-03-29},
}

@article{ WOS:000295505700002,
Author = {Tjepkema, Michael and Wilkins, Russell and Pennock, Jennifer and
   Goedhuis, Neil},
Title = {Potential years of life lost at ages 25 to 74 among Status Indians, 1991
   to 2001},
Journal = {HEALTH REPORTS},
Year = {2011},
Volume = {22},
Number = {1},
Month = {MAR},
Abstract = {Background
   Compared with other Canadians, First Nations peoples experience a
   disproportionate burden of illness and disease. Potential years of life
   lost (PYLL) before age 75 highlights the impact of youthful or early
   deaths.
   Data and methods
   The 1991 to 2001 Canadian census mortality follow-up study tracked a
   15\% sample of adults aged 25 or older over more than a decade. This
   study examined mortality among people aged 25 to 74-55,600 Status
   Indians (39,200 on reserve and 16,500 off reserve) and 2,475,700
   non-Aboriginal adults-all of whom were enumerated by the 1991 census
   long-form questionnaire. Age-standardized PYLL rates were calculated,
   based on the number of person-years at risk before age 75.
   Results
   Status Indian adults had 2.5 times the risk of dying before age 75,
   compared with non-Aboriginal adults. Results did not differ greatly by
   residence on or off reserve. Relative and absolute inequalities were
   greatest for unintentional and intentional injuries. Socio-economic
   factors such as income, education, housing and employment explained a
   substantial share of the disparities in premature death.
   Interpretation
   Status Indian adults had higher rates of premature mortality.
   Socio-economic factors played an important role in those disparities.
   Injuries were important contributors to both relative and absolute
   inequalities.},
Publisher = {STATISTICS CANADA},
Address = {100 TUNNEYS PASTURE DRIVEWAY, OTTAWA, ONTARIO K1A 0T6, CANADA},
Type = {Article},
Language = {English},
Affiliation = {Tjepkema, M (Corresponding Author), STAT Canada, Hlth Anal Div, Ottawa, ON K1A 0T6, Canada.
   Tjepkema, Michael; Wilkins, Russell, STAT Canada, Hlth Anal Div, Ottawa, ON K1A 0T6, Canada.
   Pennock, Jennifer; Goedhuis, Neil, Hlth Canada, Nations \& Inuit Hlth Branch 1, Ottawa, ON K1A 0L2, Canada.},
ISSN = {0840-6529},
EISSN = {1209-1367},
Keywords = {Aboriginal; cause of death; death rate; First Nations; indigenous; life
   expectancy; longevity; mortality},
Keywords-Plus = {CANCER INCIDENCE; CERVICAL-CANCER; 1ST NATIONS; HEALTH; DISEASE;
   INEQUALITIES; POPULATION; MORTALITY; ONTARIO},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {tjepkema@statcan.gc.ca
   russell.wilkins@statcan.gc.ca},
Funding-Acknowledgement = {First Nations and Inuit Health Branch at Health Canada; Canadian
   Population Health Initiative, part of the Canadian Institute for Health
   Information},
Funding-Text = {Funding for this study was provided by the First Nations and Inuit
   Health Branch at Health Canada. The 1991 to 2001 Canadian census
   mortality follow-up study was developed with funding from the Canadian
   Population Health Initiative, part of the Canadian Institute for Health
   Information.},
Cited-References = {Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702.
   Allard Yvon E, 2004, Health Rep, V15, P51.
   {[}Anonymous], 2005, Health Stat Q, P52.
   BAND PR, 1992, CAN MED ASSOC J, V147, P1802.
   {*}BRIT COL PROV HLT, 2009, 2 MIN HLTH LIV BRIT.
   {*}CAN HEART HLTH ST, 2009, BUILD HEART HLTH CAN.
   Canadian Revenue Agency, INF STAT IND.
   Dyck R, 2010, CAN MED ASSOC J, V182, P249, DOI 10.1503/cmaj.090846.
   Fair M, 2004, AUST J STAT, V33, P37.
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4.
   Health Canada, 2001, UN INT INJ PROF AB P.
   Health Council of Canada, 2005, HLTH STAT CAN 1 NAT HLTH STAT CAN 1 NAT.
   Indian and Northern Affairs of Canada, 2005, BAS DEP DAT 2004.
   Last, 1995, DICT EPIDEMIOLOGY.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Loppie Reading C, 2009, HLTH INEQUALITIES SO.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   MAHONEY MC, 1991, INT J EPIDEMIOL, V20, P323, DOI 10.1093/ije/20.2.323.
   Marrett LD, 2003, CANCER CAUSE CONTROL, V14, P259, DOI 10.1023/A:1023632518568.
   Martens PJ, 2005, CAN J PUBLIC HEALTH, V96, pS33, DOI 10.1007/BF03405314.
   Reading J, 2009, LIFE COURSE APPROACH.
   Shah BR, 2000, ARCH INTERN MED, V160, P1862, DOI 10.1001/archinte.160.12.1862.
   Spiegelman M, 1968, INTRO DEMOGRAPHY.
   Statistics Canada, 1995, 1991 AB PEOPL SURV M.
   Statistics Canada, 2008, AB PEOPL CAN 2006 IN.
   Statistics Canada, 1994, COV CENS TECHN REP R.
   TJEPKEMA M, 2002, HLTH REP S, V13, P73.
   Tjepkema Michael, 2009, Health Rep, V20, P31.
   Waldram J., 2006, ABORIGINAL HLTH CANA, V2nd ed..
   Wilkins Russell, 2008, Health Rep, V19, P25.
   World Health Organization, 1977, MAN INT STAT CLASS D.
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2.
   World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U.
   Young TK, 2000, AM J PUBLIC HEALTH, V90, P1466, DOI 10.2105/AJPH.90.9.1466.},
Number-of-Cited-References = {34},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Health Rep.},
Doc-Delivery-Number = {828MQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000295505700002},
DA = {2022-03-29},
}

@article{ WOS:A1995TV35900024,
Author = {Zhong, YN and Li, DH},
Title = {Potential years of life lost and work tenure lost when silicosis is
   compared with other pneumoconioses},
Journal = {SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT \& HEALTH},
Year = {1995},
Volume = {21},
Number = {2},
Pages = {91-94},
Note = {2nd International Symposium on Silica, Silicosis, and Cancer, SAN
   FRANCISCO, CA, OCT 27-30, 1993},
Abstract = {Potential years of life lost (PYLL) and potential years of work lost
   (PYWL) because of pneumoconiosis were studied using the data from the
   Nationwide Epidemiological Study on Pneumoconioses in China. The cases
   were patients diagnosed with pneumoconiosis between 1949 and 1956. The
   subjects studied for PYLL included 74 741 cases ranging in age from 15
   to 75 years, while for PYWL there were 74 224 cases with 1 to 35 years
   of remaining employment experience. Overall there were 1 489 692
   potential years of life lost, and there was an average of 19.9 years for
   all pneumoconioses. Silicosis had the greatest mean PYLL with an average
   of 22.1 years. Coal workers' pneumoconiosis was the second leading cause
   of PYLL with an average of 17.0 years. The mean PYWL for all
   pneumoconioses was 19.7 years, and the mean PYWL from silicosis was 21.5
   years. The conclusion was reached that silicosis is the most serious
   pneumoconiosis in China with regard to years of life lost, and chronic
   respiratory diseases such as chronic pulmonary disease and tuberculosis
   are the main causes of death for patients with pneumoconiosis.},
Publisher = {SCAND J WORK ENV HEALTH},
Address = {TOPELIUKSENKATU 41A, SF-00250 HELSINKI, FINLAND},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Zhong, YN (Corresponding Author), CHINESE ACAD PREVENT MED,INST OCCUPAT MED,29 NANWEI RD,BEIJING 100050,PEOPLES R CHINA.},
ISSN = {0355-3140},
Keywords = {China; cohort follow-up; potential years of life lost; potential years
   of work lost; pneumoconioses; silicosis},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {FU Z, 1992, CHINESE J IND MED, V5, P144.
   FU Z, 1991, J HYG RES, V20, P47.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   ZOU C, 1991, CHINA SAFETY SCI, V1, P16.},
Number-of-Cited-References = {4},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Scand. J. Work Environ. Health},
Doc-Delivery-Number = {TV359},
Web-of-Science-Index = {Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1995TV35900024},
DA = {2022-03-29},
}

@article{ WOS:000274443000008,
Author = {Jiang, Jingmei and Liu, Boqi and Sitas, Freddy and Li, Junyao and Zeng,
   Xianjia and Han, Wei and Zou, Xiaonong and Wu, Yanping and Zhao, Ping},
Title = {Smoking-attributable deaths and potential years of life lost from a
   large, representative study in China},
Journal = {TOBACCO CONTROL},
Year = {2010},
Volume = {19},
Number = {1},
Pages = {7-12},
Month = {FEB},
Abstract = {Objectives To provide a more accurate estimate of early
   smoking-attributable mortality and potential years of life lost using
   data from a representative study of 103 study areas in China.
   Methods Two datasets were employed as follows. Firstly, retrospective
   national mortality survey data, which included a population of 67
   million in 103 study areas, and about 1 million adults who died in
   1986-1988; secondly, nationally representative case-control comparative
   data was extracted from the survey data to measure the effect of smoking
   on age trends in smoking-attributable mortality. Potential years of life
   lost, and sex differences in life expectancy in smokers and non-smokers
   in the total population aged 35 and over were also estimated.
   Results Tobacco caused 11.2\% (16.0\% of men and 3.7\% of women) of
   total deaths in 1987, and more than two-thirds of these excess deaths
   occurred between the ages of 50 and 74 years, but only less than 5\%
   excess deaths occurred at ages under 50. Although life expectancies
   varied with region or sex differences, the years of life lost
   attributable to smoking was almost the same. Smokers at age 35 lost
   about 3 years of life expectancy in comparison with never smokers. The
   study also confirmed that more than 50\% of the sex difference in life
   expectancy was accounted for by smoking.
   Conclusion Fully understanding the consequences of smoking in relation
   to mortality can clarify its effects on the health and longevity of the
   entire population.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Liu, BQ (Corresponding Author), Chinese Acad Med Sci, Natl Canc Inst, 17 Pan Jia Yuan Nan Li, Beijing 100021, Peoples R China.
   Jiang, Jingmei; Zeng, Xianjia; Han, Wei, Chinese Acad Med Sci, Dept Epidemiol \& Biostat, Inst Basic Med Sci, Beijing 100021, Peoples R China.
   Liu, Boqi; Li, Junyao; Zou, Xiaonong; Wu, Yanping; Zhao, Ping, Chinese Acad Med Sci, Canc Inst Hosp, Beijing 100021, Peoples R China.
   Sitas, Freddy, NSW Canc Council, Canc Epidemiol Res Unit, Sydney, NSW, Australia.},
DOI = {10.1136/tc.2009.031245},
ISSN = {0964-4563},
EISSN = {1468-3318},
Keywords-Plus = {UNITED-STATES; CIGARETTE-SMOKING; MORTALITY; TOBACCO; POPULATION;
   EXPECTANCY; COUNTRIES; DISEASE; SMOKERS; HEALTH},
Research-Areas = {Substance Abuse; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Substance Abuse; Public, Environmental \& Occupational Health},
Author-Email = {wangjbo@263.net},
ORCID-Numbers = {Sitas, Freddy/0000-0001-9679-1481},
Funding-Acknowledgement = {Cancer Research UKCancer Research UK; UK Medical Research CouncilUK
   Research \& Innovation (UKRI)Medical Research Council UK (MRC); US
   National Institutes of HealthUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USA; Chinese Ministry of
   Health; Chinese Academy of Medical Sciences},
Funding-Text = {The project was funded by Cancer Research UK, the UK Medical Research
   Council, the US National Institutes of Health, the Chinese Ministry of
   Health and the Chinese Academy of Medical Sciences.},
Cited-References = {ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15.
   Bronnum-Hansen H, 2001, TOB CONTROL, V10, P273, DOI 10.1136/tc.10.3.273.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215.
   Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8.
   Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972.
   Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902.
   Hunt D, 2005, INT J EPIDEMIOL, V34, P1020, DOI 10.1093/ije/dyi139.
   Jiang JM, 2008, ANN EPIDEMIOL, V18, P484, DOI 10.1016/j.annepidem.2008.01.004.
   Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361.
   Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411.
   Lu L, 1994, POPULATION RES, V18, P52.
   Malarcher AM, 2000, AM J EPIDEMIOL, V152, P573, DOI 10.1093/aje/152.6.573.
   Nam CB, 1996, SOC BIOL, V43, P155.
   PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D.
   Rivara FP, 2004, AM J PREV MED, V27, P118, DOI 10.1016/j.amepre.2004.04.014.
   ROGERS RG, 1991, SOC SCI MED, V32, P1151, DOI 10.1016/0277-9536(91)90092-Q.
   Rogers RG, 2005, POPUL DEV REV, V31, P259, DOI 10.1111/j.1728-4457.2005.00065.x.
   ROGERS RG, 1992, DEMOGRAPHY, V29, P287, DOI 10.2307/2061732.
   Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682.
   STERLING TD, 1993, AM J EPIDEMIOL, V138, P128, DOI 10.1093/oxfordjournals.aje.a116835.
   Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706.
   Valkonen T, 1997, EUR J PUBLIC HEALTH, V7, P302, DOI 10.1093/eurpub/7.3.302.
   WENG XZ, 1988, REPORT 1984 CHINESE.
   Yang G, 1997, REPORT 1996 NATIONWI.},
Number-of-Cited-References = {25},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Tob. Control},
Doc-Delivery-Number = {554NZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000274443000008},
DA = {2022-03-29},
}

@article{ WOS:000178083900007,
Author = {Trombetti, A and Herrmann, F and Hoffmeyer, P and Schurch, MA and
   Bonjour, JP and Rizzoli, R},
Title = {Survival and potential years of life lost after hip fracture in men and
   age-matched women},
Journal = {OSTEOPOROSIS INTERNATIONAL},
Year = {2002},
Volume = {13},
Number = {9},
Pages = {731-737},
Abstract = {Hip fracture is associated with a higher mortality rate in men than in
   women. However, mean age of men and women with hip fracture differs
   markedly. Thus, some of the differences in the clinical pattern and
   outcome between genders could be related to different ages. To avoid the
   influence of age on gender-specific outcome, we analyzed prefracture
   conditions and hip fracture outcome in a cohort of men and of
   age-matched women. Risk factors for low bone mass were recorded in 106
   men (mean age +/- SD, 80.3 +/- 9.3 years) and 264 age-matched women
   (mean age 81.4 +/- 8.0) with hip fracture. We compared mortality rate,
   survival, years of potential life lost and modification of housing
   conditions. These outcomes were prospectively assessed during an average
   3.6 years follow-up (up to 7 years). Men with hip fracture differed from
   age-matched hip-fractured women by a higher alcohol and tobacco
   consumption, a greater frequency of living in couple, and by less
   prevalent fractures. Mortality rate after hip fracture was significantly
   higher in men (RR = 1.74, 95\% CI 1.34-2.24). Since mortality is higher
   in the general male population, we compared reduction in life expectancy
   taking into account the gender-specific mortality rate. The excess
   mortality in each age-group of hip-fractured patients, which was
   measured during the whole follow-up period, and is an estimate of death
   attributable to fracture, did not differ between genders. Reduction in
   life expectancy due to hip fracture was similar in both genders (5.9 +/-
   4.5 and 5.8 +/- 4.8 years, in men and women, respectively; NS), but the
   proportion of the years of life lost was higher in men (70 +/- 33\%)
   than in women (59 +/- 42\%, p < 0.01). It was concluded that for the
   same age, mortality rate after hip fracture was higher in men than in
   women. Although the reduction in life expectancy was similar in both
   genders, the proportion of the years of life lost was higher in men,
   suggesting a worse impact of hip fracture on survival in men, even after
   consideration of the higher mortality rate in the general male
   population.},
Publisher = {SPRINGER LONDON LTD},
Address = {236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Rizzoli, R (Corresponding Author), Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, WHO Collaborating Ctr Osteoporosis \& Bone Dis, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, WHO Collaborating Ctr Osteoporosis \& Bone Dis, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Dept Surg, Orthoped Clin, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Dept Geriatr, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Dept Internal Med, CH-1211 Geneva 4, Switzerland.},
DOI = {10.1007/s001980200100},
ISSN = {0937-941X},
EISSN = {1433-2965},
Keywords = {epidemiology; mortality; osteoporosis},
Keywords-Plus = {RISK-FACTORS; PROXIMAL FEMUR; ELDERLY MEN; MORTALITY; EPIDEMIOLOGY; SEX},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {Rene.Rizzoli@medecine.unige.ch},
ResearcherID-Numbers = {hoffmeyer, pierre/AAY-1392-2021
   Trombetti, Andrea/J-9965-2013
   HERRMANN, Francois/M-7390-2019
   Hoffmeyer, Pierre/X-4491-2019
   },
ORCID-Numbers = {HERRMANN, Francois/0000-0003-1312-1517
   Hoffmeyer, Pierre/0000-0001-9736-828X},
Cited-References = {BORGQUIST L, 1990, ACTA ORTHOP SCAND, V61, P404, DOI 10.3109/17453679008993550.
   BORGQUIST L, 1991, ACTA ORTHOP SCAND, V62, P39, DOI 10.3109/17453679108993089.
   Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8.
   COLLETT D, 1995, TESTS STAT SCI, P40.
   COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756.
   COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184.
   COX DR, 1972, J R STAT SOC B, V34, P187.
   CUMMING RG, 1994, AM J EPIDEMIOL, V139, P493, DOI 10.1093/oxfordjournals.aje.a117032.
   Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956.
   DAHL E, 1980, ACTA ORTHOP SCAND, V51, P163, DOI 10.3109/17453678008990781.
   Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x.
   FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102.
   Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197.
   FORSEN L, 1994, J BONE MINER RES, V9, P1671.
   Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171.
   HEMENWAY D, 1994, AM J PUBLIC HEALTH, V84, P1843, DOI 10.2105/AJPH.84.11.1843.
   HOLMBERG S, 1987, CLIN ORTHOP RELAT R, V218, P32.
   JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147, DOI 10.2105/AJPH.82.8.1147.
   JACOBSEN SJ, 1990, AM J PUBLIC HEALTH, V80, P871, DOI 10.2105/AJPH.80.7.871.
   Johnell O, 2001, CALCIFIED TISSUE INT, V69, P182, DOI 10.1007/s00223-001-1045-7.
   Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115.
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868.
   LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287.
   MELTON LJ, 1993, BONE, V14, pS1.
   MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622.
   MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010.
   NYDEGGER V, 1991, OSTEOPOROSIS INT, V2, P42, DOI 10.1007/BF01627078.
   POOR G, 1995, J BONE MINER RES, V10, P1900.
   SCHRODER HM, 1993, J ORTHOP TRAUMA, V7, P525, DOI 10.1097/00005131-199312000-00007.
   Schurch MA, 1996, J BONE MINER RES, V11, P1935.
   van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8.},
Number-of-Cited-References = {31},
Times-Cited = {155},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Osteoporosis Int.},
Doc-Delivery-Number = {595AD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000178083900007},
DA = {2022-03-29},
}

@article{ WOS:000701020600036,
Author = {Yang, Jia and Zhao, Li and Zhang, Nan and Du, Zhenhua and Li, Yanyan and
   Li, Xia and Zhao, Deli and Wang, Jialin},
Title = {Cancer death and potential years of life lost in Feicheng City, China
   Trends from 2013 to 2018},
Journal = {MEDICINE},
Year = {2021},
Volume = {100},
Number = {39},
Month = {OCT 1},
Abstract = {This study aimed to evaluate the impact of cancer-related mortality on
   life expectancy in Feicheng City. We extracted the death records and
   population data of Feicheng City from 2013 to 2018 through the Feicheng
   Center for Disease Control and Prevention. The mortality, premature
   mortality, cause-eliminated life expectancy, potential years of life
   lost (PYLL), average potential years of life lost (APYLL), annual change
   percentage (APC), and other indicators of cancer were calculated. The
   age-standardized rates were calculated using the sixth national census
   (2010). From 2013 to 2018, the mortality rate of cancer in Feicheng City
   was 221.55/100,000, and the standardized mortality rate was
   166.37/100,000. The standardized mortality rate increased from 2013 to
   2014 and then decreased annually. The premature mortality of cancer was
   8.98\% and showed a downward trend (APC = -2.47\%, t = -3.10, P = .04).
   From 2013 to 2018, the average life expectancy of residents in Feicheng
   City was 78.63 years. Eliminating the impact of cancer, life expectancy
   could increase by 3.72 years. The rate of life loss caused by cancer in
   men was higher than that in women. The total life loss caused by cancer
   deaths was 126,870.50 person-years, the potential life loss rate was
   22.51 parts per thousand, and the average potential life loss was 13.30
   years. The standardized potential years of life lost rate showed a
   downward trend (APC = -2.96\%, t = -3.72, P = .02), and APYLL decreased
   by 1.98\% annually (t = -5.44, P = .01). The top 5 malignant tumors in
   APYLL were leukemia, breast cancer, brain tumor, liver cancer, and
   ovarian cancer. Lung cancer, esophageal cancer, female breast cancer,
   and childhood leukemia have a great impact on the life expectancy of
   residents in Feicheng City. Effective measures need to be taken to
   reduce the disease burden of malignant tumors.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Wang, JL (Corresponding Author), Shandong First Med Univ, Shandong Canc Hosp \& Inst, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.
   Wang, JL (Corresponding Author), Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.
   Yang, Jia, Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China.
   Zhao, Li; Li, Yanyan; Zhao, Deli, Feicheng Peoples Hosp, Canc Prevent \& Trentment Ctr, Feicheng, Shandong, Peoples R China.
   Zhang, Nan; Wang, Jialin, Shandong First Med Univ, Shandong Canc Hosp \& Inst, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.
   Zhang, Nan; Wang, Jialin, Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.
   Du, Zhenhua, Feicheng Ctr Dis Control \& Prevent, Feicheng, Shandong, Peoples R China.
   Li, Xia, Shandong Univ, Sch Publ Hlth, Dept Biostat, Jinan, Shandong, Peoples R China.},
DOI = {10.1097/MD.0000000000027370},
Article-Number = {e27370},
ISSN = {0025-7974},
EISSN = {1536-5964},
Keywords = {cancer; cause eliminated life expectancy; potential years of life lost;
   premature mortality},
Keywords-Plus = {GASTRIC-CANCER; UNITED-STATES; MORTALITY; PREVALENCE; STATISTICS;
   EXPECTANCY; WORLDWIDE; SMOKING; DISEASE; BURDEN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {wangjialin6681@163.com},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}71904109]; Natural Science Foundation of
   Shandong ProvinceNatural Science Foundation of Shandong Province
   {[}ZR2019PG006]},
Funding-Text = {This study was supported by National Natural Science Foundation of China
   (71904109) and Natural Science Foundation of Shandong Province
   (ZR2019PG006).},
Cited-References = {Alattas M, 2020, CHEM-BIOL INTERACT, V315, DOI 10.1016/j.cbi.2019.108885.
   Andersson TML, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1427-2.
   Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6.
   Bin L., 2021, TUTORIAL OUTLINE HLT, P1.
   Brownlee J, 1919, J R STAT SOC, V82, P34, DOI 10.2307/2340732.
   Chen R, 2021, GUT, V70, P251, DOI 10.1136/gutjnl-2019-320200.
   Chen WQ, 2017, CANCER LETT, V401, P63, DOI 10.1016/j.canlet.2017.04.024.
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338.
   Chen WY, 2013, CLIN GASTROENTEROL H, V11, P1595, DOI 10.1016/j.cgh.2013.05.036.
   Chen ZM, 2015, CANCER-AM CANCER SOC, V121, P3097, DOI 10.1002/cncr.29560.
   Cho YA, 2019, CANCER RES TREAT, V51, P1033, DOI 10.4143/crt.2018.447.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   de Blank PM, 2015, CANCER MED-US, V4, P608, DOI 10.1002/cam4.410.
   de Vries E, 2016, BIOMEDICA, V36, P547, DOI 10.7705/biomedica.v36i4.3207.
   Dunford A, 2017, NAT GENET, V49, P10, DOI 10.1038/ng.3726.
   Ediriweera DS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5503-9.
   Fei FR, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/1074286.
   FORSTER DP, 1992, BRIT MED J, V304, P715, DOI 10.1136/bmj.304.6828.715-c.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gu XY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0308-x.
   Ilic M, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0282-3.
   Islami F, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2019.1460.
   Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402.
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI 10.3322/caac.20073.
   Jiang J, 2018, PUBLIC HEALTH, V163, P95, DOI 10.1016/j.puhe.2018.06.003.
   Jin M, 2013, ANN ONCOL, V24, P807, DOI 10.1093/annonc/mds508.
   Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459.
   Li T, 2016, BREAST CANCER RES TR, V159, P395, DOI 10.1007/s10549-016-3947-0.
   Li YY, 2018, CANCER CONTROL, V25, DOI 10.1177/1073274818799306.
   Liang D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18715-x.
   Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048.
   Lin X, 2019, CANCER EPIDEMIOL, V63, DOI 10.1016/j.canep.2019.101586.
   Liu PC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1193.
   McGuinn LA, 2012, ENVIRON RES, V112, P230, DOI 10.1016/j.envres.2011.10.009.
   Morais S, 2016, EUR J CANCER PREV, V25, P275, DOI 10.1097/CEJ.0000000000000183.
   Pearce A, 2018, CANCER EPIDEMIOL, V53, P27, DOI 10.1016/j.canep.2017.12.013.
   Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6.
   Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483.
   Rocha-Brischiliari SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168950.
   Rosso T, 2015, TUMORI J, V101, P664, DOI 10.5301/tj.5000352.
   Sede PI, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-014-0037-z.
   Su MZ, 2019, CANCER MED-US, V8, P7859, DOI 10.1002/cam4.2627.
   Sun XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173211.
   Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943.
   Tian K., 2011, CHIN INSUR, V7, P24.
   Pham TM, 2018, EUR J PUBLIC HEALTH, V28, P348, DOI 10.1093/eurpub/ckx195.
   Wang JB, 2012, ANN ONCOL, V23, P2983, DOI 10.1093/annonc/mds139.
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1.
   Xu Z L, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P231, DOI 10.3760/cma.j.issn.0254-6450.2017.02.019.
   Xu ZS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204221.
   Yu Shun-Zhang, 1998, Journal of Toxicological Sciences, V23, P143.
   Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x.},
Number-of-Cited-References = {52},
Times-Cited = {1},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Medicine (Baltimore)},
Doc-Delivery-Number = {UX7KX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000701020600036},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1984TL07200002,
Author = {HASLETT, D},
Title = {SMOKING-RELATED CANCERS AND POTENTIAL YEARS OF LIFE LOST ATTRIBUTABLE TO
   CIGARETTE-SMOKING, IRELAND, 1968 TO 1978},
Journal = {IRISH JOURNAL OF MEDICAL SCIENCE},
Year = {1984},
Volume = {153},
Number = {9},
Pages = {302-309},
Publisher = {SPRINGER LONDON LTD},
Address = {236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {HASLETT, D (Corresponding Author), UNIV DUBLIN TRINITY COLL, DEPT COMMUNITY HLTH, DUBLIN, IRELAND.},
DOI = {10.1007/BF02939890},
ISSN = {0021-1265},
EISSN = {1863-4362},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {BEST EW, 1966, CANADIAN STUDY SMOKI, P65.
   CEDERLOF R, 1975, RELATIONSHIP SMOKI 1, P1.
   COLE P, 1971, BRIT J PREV SOC MED, V25, P242.
   DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525.
   DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967.
   DORN HF, 1959, P SOC STAT, P34.
   HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127.
   HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007.
   HIRAYAMA T, 1972, 14TH AM CANC SOC SCI.
   KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1.
   LILIENFELD AM, 1980, F EPIDEMIOLOGY.
   MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617.
   MORGAN RGH, 1977, GUT, V18, P580, DOI 10.1136/gut.18.7.580.
   Pugh, 1970, EPIDEMIOLOGY PRINCIP.
   ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   WALTER SD, 1978, INT J EPIDEMIOL, V7, P175, DOI 10.1093/ije/7.2.175.
   WEIR JM, 1970, CANCER, V25, P105, DOI 10.1002/1097-0142(197001)25:1<105::AID-CNCR2820250115>3.0.CO;2-Z.
   WYNDER EL, 1974, JNCI-J NATL CANCER I, V53, P1619.
   1972, CIGARETTE SMOKERS IR.
   1968, REPORTS VITAL STATIS.
   1982, HLTH CONSEQUENCES SM.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Irish J. Med. Sci.},
Doc-Delivery-Number = {TL072},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1984TL07200002},
DA = {2022-03-29},
}

@article{ WOS:000258040700009,
Author = {Ivey, M. A. and Legall, G. and Boisson, E. V. and Hinds, A.},
Title = {Mortality trends and potential years of life lost in the English and
   Dutch-speaking Caribbean, 1985-2000},
Journal = {WEST INDIAN MEDICAL JOURNAL},
Year = {2008},
Volume = {57},
Number = {2},
Pages = {122-131},
Month = {MAR},
Abstract = {Objective: To describe mortality trends andpotential years of life lost
   (PYLL) due to leading causes of death in 21 Caribbean countries during
   1985, 1990, 1995 and 2000.
   Methods: Mortality data for 1985, 1990, 1995 and 2000 were analyzed to
   identify regional mortality trends using crude, age-specific and
   age-adjusted death rates and potential years of life lost. The variables
   used were age, gender and underlying cause of death.
   Results: During 1985-2000, there was an overall 5\% decrease in
   age-adjusted mortality rates and male mortality exceededfemale
   mortality. Heart disease was the leading cause ofdeath, with cancers,
   cerebrovascular diseases, diabetes mellitus and hypertensive disease
   also among the topfive causes in mostyears. Prostate cancer and cancer
   of the uterus and breast were the leading causes of death due tocancers.
   HIV disease (AIDS) featured in the ten leading causes of death for
   thefirst time in 1995 and was the 51h leading cause in 2000.
   Conclusion
   During the period 1985-2000, countries experienced an increase in
   mortality due to noncommunicable diseases, AIDS and assaults
   (homicides); the latter two causes were most common among the 15-44 year
   age group. In 2000, AIDS, heart disease and assault (homicide) were the
   largest contributors to PYLL.},
Publisher = {UNIV WEST INDIES FACULTY MEDICAL SCIENCES},
Address = {MONA CAMPUS, KINGSTON 7, JAMAICA},
Type = {Article},
Language = {English},
Affiliation = {Ivey, MA (Corresponding Author), CAREC PAHO WHO, 16-18 Jamaica Blvd,Federat Pk, Port Of Spain, Trinidad Tobago.
   Ivey, M. A.; Boisson, E. V.; Hinds, A., CAREC PAHO WHO, Port Of Spain, Trinidad Tobago.
   Legall, G., Univ W Indies, Dept Math \& Comp Sci, St Augustine, Trinidad Tobago.},
ISSN = {0043-3144},
EISSN = {2309-5830},
Keywords-Plus = {CHRONIC DISEASES; BODY-WEIGHT; POPULATIONS; PREVALENCE; CHINA},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {marsha\_ivey@yahoo.com},
ResearcherID-Numbers = {Ivey, Marsha A/AAL-3096-2020},
ORCID-Numbers = {Ivey, Marsha A/0000-0002-3205-1748},
Cited-References = {Alleyne S I, 1989, Bull Pan Am Health Organ, V23, P306.
   BEAGLEHOLE R, 1997, PUBLIC HLTH CROSSROA, P6.
   {*}CAR TOUR ORG, 2002, CAR TOUR STAT REP 20.
   {[}Anonymous], 1997, MMWR Recomm Rep, V46, P1.
   Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160.
   Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343.
   Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290.
   Eldemire D, 1996, W INDIAN MED J, V45, P82.
   FEACHEM RGA, 1992, HLTH ADULTS DEV WORL, P1.
   Figueroa JP, 1999, W INDIAN MED J, V48, P9.
   Figueroa JP, 2001, W INDIAN MED J, V50, P15.
   FRIIS RH, 2004, EPIDEMIOLOGY PUBLIC, P45.
   Gulliford MC, 1996, INT J EPIDEMIOL, V25, P357, DOI 10.1093/ije/25.2.357.
   HOLDER Y, 1997, PAN AM HLTH ORG SCI, V561, P22.
   KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349.
   Maskarinec G, 1998, EPIDEMIOLOGY, V9, P654, DOI 10.1097/00001648-199811000-00016.
   McGlashan N D, 1982, Bull Pan Am Health Organ, V16, P212.
   Meng LX, 1999, PREV MED, V29, P296, DOI 10.1006/pmed.1999.0538.
   MURRAY CJL, 1992, HLTH ADULTS DEV WORL, V23, P51.
   OGUNNAIKECOOKE S, 2005, THESIS LONDON SCH HY.
   {*}PAHO, 2006, HLTH SIT AM BAS IND.
   Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x.
   Reddy KS, 2005, LANCET, V366, P1744, DOI {[}10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6].
   Sargeant LA, 2001, W INDIAN MED J, V50, P27.
   Torun B., 2000, Obesity and poverty: a new public health challenge., P29.
   Troiano RP, 1996, INT J OBESITY, V20, P63.
   {*}USDHHS, 2001, SURG GEN CALL ACT PR.
   Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354.
   Wilks R, 1998, W INDIAN MED J, V47, P40.
   World Health Organization, 2000, OB PREV MAN GLOB EP.
   2004, CARIBBEAN EPIDEMIOLO.
   1993, WORLD BANK WORLD HLT.
   2005, SUSTAINABLE IMPACT A, P80.
   1998, EPIDEMIOLOGICAL B, V20.},
Number-of-Cited-References = {34},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {West Ind. Med. J.},
Doc-Delivery-Number = {331VM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000258040700009},
DA = {2022-03-29},
}

@article{ WOS:000235593600010,
Author = {Rehm, J and Patra, J and Popova, S},
Title = {Alcohol-attributable mortality and potential years of life lost in
   Canada 2001: implications for prevention and policy},
Journal = {ADDICTION},
Year = {2006},
Volume = {101},
Number = {3},
Pages = {373-384},
Month = {MAR},
Abstract = {Alcohol is one of the most important risk factors for burden of disease.
   To estimate the number of deaths and the years of life lost attributable
   to alcohol for Canada 2001 using different ways to measure alcohol
   exposure.
   Distribution of exposure was taken from a major national survey of
   Canada, the Canadian Addiction Survey, and corrected for per capita
   consumption from production and sales. For chronic disease, risk
   relations were taken from the published literature and combined with
   exposure to calculate age- and sex-specific alcohol-attributable
   fractions (AAFs). For injury, AAFs were taken directly from available
   statistics. Information on mortality, with cause of death coded
   according to the International Classification of Diseases version 10
   (ICD-10) was obtained from Statistics Canada.
   For Canada in 2001, 4010 of all deaths in the group below 70 years of
   age were attributable to alcohol, 3132 in men and 877 in women. This
   constituted 6.0\% of all deaths in Canada in this age group, 7.6\% for
   men, and 3.5\% for women. The 4010 deaths are a net figure, already
   taking into account the deaths prevented by moderate consumption of
   alcohol. Main causes of alcohol-attributable death were unintentional
   injuries, malignant neoplasms and digestive diseases. Ischaemic heart
   disease (IHD) was the biggest cause of death prevented by alcohol, with
   78.7\% of all alcohol-attributable prevented deaths in the age groups of
   70 years and above. A total of 144 143 years of life were lost
   prematurely in Canada in that year, 113 079 years in men and 31 063
   years in women.
   Regardless of the assumptions made, alcohol is a major contributor to
   mortality in Canada. The impact of alcohol on social life is not
   confined to mortality, as other studies indicated that alcohol is linked
   even more strongly to disability and social harm. Alcohol-attributable
   harm could be substantially reduced, however, if known effective
   policies were introduced.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Rehm, J (Corresponding Author), 33 Russell St,Room 2035B, Toronto, ON M5S 2S1, Canada.
   Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada.
   Addict Res Inst, Zurich, Switzerland.
   Ctr Addict \& Mental Hlth, Toronto, ON, Canada.
   Univ Toronto, Dept Human Dev \& Appl Psychol, Toronto, ON, Canada.
   Univ Toronto, Fac Social Work, Toronto, ON, Canada.},
DOI = {10.1111/j.1360-0443.2005.01338.x},
ISSN = {0965-2140},
EISSN = {1360-0443},
Keywords = {alcohol-attributable fraction (AAF); alcohol consumption; Canada;
   mortality; potential years of life lost (PYLL); relative risk (RR)},
Keywords-Plus = {CORONARY-HEART-DISEASE; AVERAGE VOLUME; CARDIOVASCULAR-DISEASE;
   CONSUMPTION; DRINKING; RISK; PATTERNS; BURDEN; HEALTH; MORBIDITY},
Research-Areas = {Substance Abuse; Psychiatry},
Web-of-Science-Categories  = {Substance Abuse; Psychiatry},
Author-Email = {jtrehm@aol.com},
ResearcherID-Numbers = {Rem, Jürgen/H-1309-2011
   Rehm, Jürgen/K-2147-2012},
ORCID-Numbers = {Rehm, Jürgen/0000-0001-5665-0385},
Cited-References = {Abrams J, 1995, Curr Probl Cardiol, V20, P533.
   ASHLEY MJ, 2000, CONTEMP DRUG PROBL, V27, P735.
   Babor T., 2003, ALCOHOL NO ORDINARY.
   BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P207, DOI 10.1016/0376-8716(85)90001-8.
   Britton A, 2003, EUR J EPIDEMIOL, V18, P643, DOI 10.1023/A:1024834608689.
   Canadian Centre on Substance Abuse, 2004, CAN ADD SURV 2004 MI.
   Castaneda R, 1996, J CLIN PSYCHIAT, V57, P207.
   CASTANEDA R, 1998, RECENT DEV ALCOHOLIS, P197.
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866.
   Chick J, 1998, ALCOHOL ALCOHOLISM, V33, P576, DOI 10.1093/alcalc/33.6.576.
   Chick J, 1999, EUR ADDICT RES, V5, P74, DOI 10.1159/000018969.
   Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782.
   Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x.
   Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x.
   {*}COUNC CAN FIR MAR, 2003, FIR LOSS CAN ANN REP.
   DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911.
   Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x.
   English D., 1995, QUANTIFICATION DRUG.
   Gmel G, 2003, EUR J EPIDEMIOL, V18, P631, DOI 10.1023/A:1024805021504.
   Gmel G., 2003, SUCHT, V49, P95.
   Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI {[}10.1177/009145090403100304, DOI 10.1177/009145090403100304].
   Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729.
   HAUGE R, 1990, BRIT J ADDICT, V85, P645.
   KLATSKY AL, 1994, ALCOHOL CLIN EXP RES, V18, P88, DOI 10.1111/j.1530-0277.1994.tb00886.x.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   MIDANIK LT, 1988, BRIT J ADDICT, V83, P1019.
   Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1.
   Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242.
   {*}NAT HLTH MED RES, 1992, THER SAF LEV DAIL CO.
   Organization World Health, 2002, WORLD HLTH REPORT 20.
   POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x.
   Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x.
   Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x.
   Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39.
   Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221.
   Rehm J, 2003, J CARDIOVASC RISK, V10, P15, DOI 10.1097/00043798-200302000-00004.
   Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731.
   Rehm J, 1998, NOVART FDN SYMP, V216, P223.
   Rehm J., 2001, CONTEMP DRUG PROBL, V28, P337, DOI DOI 10.1177/009145090102800302.
   Rehm J., 2004, COMP QUANTIFICATION, P959.
   Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579.
   Ridolfo B, 2001, QUANTIFICATION DRUG.
   Room R, 2003, EUR ADDICT RES, V9, P165, DOI 10.1159/000072223.
   Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2.
   SCHULTZ JM, 1990, MMWR-MORBID MORTAL W, V39, P173.
   SEMPOS CT, 2002, CONTEMP DRUG PROBL, V29, P805.
   SHULTZ JM, 1991, PUBLIC HEALTH REP, V106, P443.
   Single E, 2000, CAN MED ASSOC J, V162, P1669.
   SINGLE E, 1996, COSTS SUBSTANCE ABUS.
   Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2.
   {*}TRAFF INJ RES FDN, 2004, ALC CRASH PROBL CAN.
   {*}TRANSP CAN, 2004, ROAD SAF CAN 2001.
   WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007.
   WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268.
   White IR, 2004, ADDICTION, V99, P749, DOI 10.1111/j.1360-0443.2004.00710.x.
   {*}WHO, 2000, STAT INF SYST.},
Number-of-Cited-References = {56},
Times-Cited = {89},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Addiction},
Doc-Delivery-Number = {016AT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000235593600010},
OA = {Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:A1990DW47600008,
Author = {KUROISHI, T and HIROSE, K and TOMINAGA, S},
Title = {EVALUATION OF THE EFFECTIVENESS OF MASS-SCREENING FOR UTERINE-CANCER IN
   JAPAN - THE POTENTIAL YEARS OF LIFE LOST},
Journal = {ENVIRONMENTAL HEALTH PERSPECTIVES},
Year = {1990},
Volume = {87},
Pages = {51-56},
Month = {JUL},
Publisher = {NATL INST ENVIRON HEALTH SCI},
Address = {PO BOX 12233, RES TRIANGLE PK, NC 27709},
Type = {Article},
Language = {English},
Affiliation = {KUROISHI, T (Corresponding Author), AICHI CANC CTR,RES INST,DIV EPIDEMIOL,TASHIRO CHO,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN.},
DOI = {10.2307/3431005},
ISSN = {0091-6765},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology},
Cited-References = {ARISUE T, 1986, J GASTROENTEROL MASS, V73, P26.
   FONTANA RS, 1985, SCREENING CANCER, P377.
   HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317.
   HIRAOKA T, 1981, J JPN SOC GASTRIC MA, V51, P9.
   HISAMICHI S, 1988, CANCER DETECT PREV, V11, P323.
   HOWE GR, 1983, BIOMETRICS, V39, P325, DOI 10.2307/2531005.
   KUROISHI T, 1986, JPN J CANCER RES, V77, P399.
   KUROISHI T, 1985, J GASTROENTEROL MASS, V69, P51.
   KUROISHI T, 1983, J GASTROENTEROL MASS, V58, P45.
   MURRAY JL, 1974, J NATL CANCER I, V52, P3, DOI 10.1093/jnci/52.1.3.
   OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K.
   SHAPIRO S, 1988, SCREENING BREAST CAN, P3.
   TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4.
   1980, REPORT 4TH NATIONWID, P67.},
Number-of-Cited-References = {16},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Environ. Health Perspect.},
Doc-Delivery-Number = {DW476},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1990DW47600008},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000183904700007,
Author = {Mariotti, S and D'Errigo, P and Mastroeni, S and Freeman, K},
Title = {Years of life lost due to premature mortality in Italy},
Journal = {EUROPEAN JOURNAL OF EPIDEMIOLOGY},
Year = {2003},
Volume = {18},
Number = {6},
Pages = {513-521},
Abstract = {Background: The assessment of the burden of disease (BOD) is necessary
   for sensibly allocating limited health-related resources. No such
   assessment is available currently for Italy. Methods: Global burden of
   disease (GBD) methods were used to analyse in detail the years of life
   lost (YLLs) component of BOD for the most important diseases
   contributing to premature mortality in Italy in 1998. YLLs were computed
   with and without age-weighting and discounting. YLLs were also analysed
   by gender, for Italy vs. the Euro-A region (a group of 26 European
   countries) defined in the 2000 update of the GBD Study, and for
   northern, central and southern Italy, the three traditionally demarcated
   regions of the country. Results: The use of YLLs yields a ranking of
   diseases by their relative contribution to mortality burden which
   differs from a ranking based purely on death counts. Although males
   contributed 58.5\% and females 41.5\% of the total mortality burden in
   terms of YLLs, using death counts the percentages for males and females
   were similar (50.6\% M, 49.4\% F). The leading cause of mortality
   burden, both in terms of YLLs and death counts, was ischaemic heart
   disease, followed by stroke and lung cancer. Several other conditions,
   however, had rankings that varied depending on the measure used. While
   cardiovascular diseases accounted for 31.7\% and `all cancers' for
   34.1\% of YLLs, they were responsible, respectively, for 44.7 and 27.9\%
   of death counts. The results for Italy generally corresponded with those
   obtained in GBD 2000 for EURO-A, but the proportion of the total
   mortality burden explained by the four leading causes is higher in
   Italy. For within Italy comparisons, there was a decreasing trend from
   north to south for `all cancers' and for several specific cancers.
   Conversely, a consistent increase in YLL rates from north to south was
   observed for stroke and hypertensive disease. Conclusions: This analysis
   of Italy's mortality burden represents the first phase in identifying
   Italy's total BOD. Simply establishing death counts and rates is no
   longer sufficient for a full understanding of a country's health status.},
Publisher = {KLUWER ACADEMIC PUBL},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Mariotti, S (Corresponding Author), Ist Super Sanita, Epidemiol \& Biostat Lab, Viale Regina Elena 299, I-00161 Rome, Italy.
   Ist Super Sanita, Lab Epidemiol, I-00161 Rome, Italy.},
ISSN = {0393-2990},
Keywords = {burden of disease; Italy; mortality; years of life lost},
Keywords-Plus = {BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
ResearcherID-Numbers = {Mastroeni, Simona/AAG-7878-2020
   },
ORCID-Numbers = {Mariotti, Sergio/0000-0003-4123-6514
   D'Errigo, Paola/0000-0002-3174-4278},
Cited-References = {COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Conti S, 1997, INT J EPIDEMIOL, V26, P873, DOI 10.1093/ije/26.4.873.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Mathers C., 1999, BURDEN DIS INJURY AU.
   Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241.
   Murray C. J. L., 1996, GLOBAL BURDEN DIS, VII.
   MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1.
   Murray CJL, 2001, GLOBAL BURDEN DIS 20.
   {*}US DEP HHS, 1997, INT CLASS DIS.
   WHO, 2000, WORLD HLTH REP 2000.
   {*}WHO GLOB PROGR EV, 2001, NAT BURD DIS STUD PR.
   World Health Organization, 1996, INV HLTH RES DEV REP.
   Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487.},
Number-of-Cited-References = {13},
Times-Cited = {27},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Eur. J. Epidemiol.},
Doc-Delivery-Number = {696TY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000183904700007},
DA = {2022-03-29},
}

@article{ WOS:000229546800012,
Author = {Johansen, JD and Smith, E and Juel, K and Rosdahl, N},
Title = {The AIDS epidemic in the city of Copenhagen, Denmark: Potential years of
   life lost and impact on life expectancy},
Journal = {SCANDINAVIAN JOURNAL OF PUBLIC HEALTH},
Year = {2005},
Volume = {33},
Number = {3},
Pages = {222-227},
Month = {JUN},
Abstract = {Aims: This study seeks to describe the impact of AIDS on the city of
   Copenhagen by estimating potential years of life lost (PYLL) before the
   age of 65 years and to estimate the impact of AIDS deaths on life
   expectancy for males and females. Methods: All AIDS cases reported to
   the national AIDS surveillance register for residents in the city of
   Copenhagen in the period 1983 - 98 were included. For comparative
   purposes data were obtained on six other causes of death: accidents,
   suicide, lung cancer, ischaemic heart disease, testicular cancer, and
   breast cancer. Results: Overall, deaths from AIDS accounted for 8\% of
   all PYLL in men and showed an increasing tendency from 1983 to 1991,
   when it became the leading cause of PYLL. AIDS had most impact in men in
   the age group 25 - 44 years and accounted for 29\% of all PYLL in this
   group at the peak in 1993, decreasing significantly after the
   introduction of anti-retroviral treatments to 5\% of PYLL in 1998. Other
   leading causes of PYLL, accidents and suicide, also showed a decreasing
   tendency over the years, but of a much smaller magnitude than AIDS. The
   impact of AIDS in women was more modest. In the entire study period
   suicide, accidents, and breast cancer were the leading causes of PYLL in
   women. It was shown that AIDS deaths at the top of the epidemic in 1991
   - 95 were responsible for a loss of 0.76 years in life expectancy for
   men and 0.08 years for women. Conclusions: AIDS has had a considerable
   impact on potential years of life lost. A significant decline in AIDS
   deaths has been seen since 1995 with an effect on life expectancy for
   men in the city of Copenhagen.},
Publisher = {SAGE PUBLICATIONS LTD},
Address = {1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Smith, E (Corresponding Author), Natl Board Hlth, Brygge 67, DK-2300 Copenhagen, Denmark.
   Natl Board Hlth, DK-2300 Copenhagen, Denmark.
   Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark.
   Natl Inst Publ Hlth, Copenhagen, Denmark.
   City Copenhagen, Med Off Hlth, Copenhagen, Denmark.},
DOI = {10.1080/14034940510005671},
ISSN = {1403-4948},
EISSN = {1651-1905},
Keywords = {AIDS; PYLL; life expectancy; prevention},
Keywords-Plus = {PREMATURE MORTALITY; HIV-INFECTION; DEATH; MEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {esm@sst.dk},
ResearcherID-Numbers = {Juel, Knud/C-8916-2013
   },
ORCID-Numbers = {Johansen, Jeanne Duus/0000-0002-3537-8463
   Juel, Knud/0000-0002-4134-1173},
Cited-References = {Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61.
   BARBARA JC, 1993, AIDS, V7, P1099, DOI 10.1097/00002030-199308000-00012.
   BINDELS PJE, 1994, AIDS, V8, P233, DOI 10.1097/00002030-199402000-00011.
   Castilla J, 1997, INT J EPIDEMIOL, V26, P1346, DOI 10.1093/ije/26.6.1346.
   {*}CIT COP MED OFF H, DEV LIF EXP COP 5 1.
   CONTI S, 1994, EUR J EPIDEMIOL, V10, P669, DOI 10.1007/BF01719279.
   {*}EUR CTR EP MON AI, 63 EUR CTR EP MON AI.
   HESSOL NA, 1992, AM J PUBLIC HEALTH, V82, P561, DOI 10.2105/AJPH.82.4.561.
   HOGG RS, 1994, CAN MED ASSOC J, V150, P711.
   KRISTAL AR, 1986, JAMA-J AM MED ASSOC, V255, P2306, DOI 10.1001/jama.255.17.2306.
   Nylen G, 1999, AIDS, V13, P1535, DOI 10.1097/00002030-199908200-00014.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   SCHMIDT KW, 1992, SOC SCI MED, V34, P1119, DOI 10.1016/0277-9536(92)90285-X.
   SMITH E, 1999, UGESKRIFT LAEGER, V22, P3281.
   SMITH E, 2001, EPINEWS, P10.
   {*}STAT DENM, LIF EXP COUNT DENM 1.},
Number-of-Cited-References = {16},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Scand. J. Public Health},
Doc-Delivery-Number = {932IG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000229546800012},
DA = {2022-03-29},
}

@article{ WOS:000295505700001,
Author = {Tjepkema, Michael and Wilkins, Russell and Senecal, Sacha and Guimond,
   Eric and Penney, Christopher},
Title = {Potential years of life lost at ages 25 to 74 among Metis and non-Status
   Indians, 1991 to 2001},
Journal = {HEALTH REPORTS},
Year = {2011},
Volume = {22},
Number = {1},
Month = {MAR},
Abstract = {Background
   Aboriginal peoples experience a disproportionate burden of disease,
   compared with other Canadians. However, relatively little information is
   available about mortality among Metis and non-Status Indians.
   Methods
   This study calculates potential years of life lost before age 75 (PYLL)
   for people aged 25 to 74 by all-cause and cause-specific mortality, and
   examines the effect of socio-economic factors on premature mortality.
   Age-specific and age-standardized PYLL rates were calculated for 11,600
   Metis, 5,400 non-Status Indians, and 2,475,700 non-Aboriginal adults
   based on the number of person-years at risk up to age 75.
   Results
   Metis and non-Status Indian adults had about twice the risk of dying
   before age 75, compared with non-Aboriginal adults. While the largest
   percentage of PYLL was due to non-communicable diseases such as
   cardiovascular disease and cancer, relative and absolute inequalities
   were greatest for injuries. Socioeconomic indicators such as income,
   education and employment explained a large share of the disparities in
   premature mortality.
   Interpretation
   The results highlight the losses of potential years of life due to
   chronic diseases, as well as the possible importance of injury
   prevention programs for Metis and non-Status Indians.},
Publisher = {STATISTICS CANADA},
Address = {100 TUNNEYS PASTURE DRIVEWAY, OTTAWA, ONTARIO K1A 0T6, CANADA},
Type = {Article},
Language = {English},
Affiliation = {Tjepkema, M (Corresponding Author), STAT Canada, Hlth Anal Div, Ottawa, ON K1A 0T6, Canada.
   Tjepkema, Michael; Wilkins, Russell, STAT Canada, Hlth Anal Div, Ottawa, ON K1A 0T6, Canada.
   Senecal, Sacha; Guimond, Eric; Penney, Christopher, Indian \& No Affairs Canada, Strateg Res \& Anal Directorate, Quebec City, PQ, Canada.},
ISSN = {0840-6529},
EISSN = {1209-1367},
Keywords = {Aboriginal; cause of death; death rate; First Nations; indigenous; life
   expectancy; longevity; mortality},
Keywords-Plus = {1ST NATIONS; METABOLIC SYNDROME; CANCER INCIDENCE; CERVICAL-CANCER;
   HEALTH; DISEASE; INEQUALITIES; DETERMINANTS; POPULATION; PREVALENCE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {tjepkema@statcan.gc.ca
   russell.wilkins@statcan.gc.ca},
Funding-Acknowledgement = {Canadian Population Health Initiative, part of the Canadian Institute
   for Health Information; Strategic Research and Analysis Directorate of
   Indian and Northern Affairs Canada},
Funding-Text = {Funding for this study was provided by the Strategic Research and
   Analysis Directorate of Indian and Northern Affairs Canada. The 1991 to
   2001 census mortality follow-up study was developed with funding from
   the Canadian Population Health Initiative, part of the Canadian
   Institute for Health Information.},
Cited-References = {Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702.
   Allard Yvon E, 2004, Health Rep, V15, P51.
   {[}Anonymous], 2005, Health Stat Q, P52.
   BAND PR, 1992, CAN MED ASSOC J, V147, P1802.
   British Columbia Provincial Health Officer, 2009, 2 MIN HLTH LIV SPORT.
   {*}CAN HEART HLTH ST, 2009, BUILD HEART HLTH CAN.
   Canadian Institute for Health Information, 2004, IMPR HLTH CAN.
   Dyck R, 2010, CAN MED ASSOC J, V182, P249, DOI 10.1503/cmaj.090846.
   Fair M, 2004, AUST J STAT, V33, P37.
   Fines P, 2008, HLTH REPORTS, V19, P47.
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4.
   Guimond E, 2003, NOT STRANGERS THESE, P35.
   Health Canada, 2001, UN INT INJ PROF AB P.
   Health Council of Canada, 2005, HLTH STAT CAN 1 NAT HLTH STAT CAN 1 NAT.
   Indian and Northern Affairs of Canada, 2005, BAS DEP DAT 2004.
   Kaler SN, 2006, INT J CIRCUMPOL HEAL, V65, P389, DOI 10.3402/ijch.v65i5.18139.
   Katzmarzyk PT, 2008, OBESITY, V16, P184, DOI 10.1038/oby.2007.51.
   Last, 1995, DICT EPIDEMIOLOGY.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Lix Lisa M, 2009, Health Rep, V20, P21.
   Loppie Reading C, 2009, HLTH INEQUALITIES SO.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   MAHONEY MC, 1991, INT J EPIDEMIOL, V20, P323, DOI 10.1093/ije/20.2.323.
   Marrett LD, 2003, CANCER CAUSE CONTROL, V14, P259, DOI 10.1023/A:1023632518568.
   Martens PJ, 2005, CAN J PUBLIC HEALTH, V96, pS33, DOI 10.1007/BF03405314.
   Pollex RL, 2006, ATHEROSCLEROSIS, V184, P121, DOI 10.1016/j.atherosclerosis.2005.03.024.
   Reading J, 2009, LIFE COURSE APPROACH.
   Shah BR, 2000, ARCH INTERN MED, V160, P1862, DOI 10.1001/archinte.160.12.1862.
   Spiegelman M., 1968, INTRO DEMOGRAPHY REV.
   {*}STAT CAN, 1994, COV.
   Statistics Canada, 1991, 1991 CENS DICT.
   Statistics Canada, 1995, 1991 AB PEOPL SURV M.
   Statistics Canada, 2008, AB PEOPL CAN 2006 IN.
   TJEPKEMA M, 2002, HLTH REP S, V13, P73.
   Tjepkema Michael, 2009, Health Rep, V20, P31.
   Waldram J., 2006, ABORIGINAL HLTH CANA, V2nd ed..
   Wilkins Russell, 2008, Health Rep, V19, P25.
   Wilkins Russell, 2008, Health Rep, V19, P7.
   Wilson K, 2008, INT J CIRCUMPOL HEAL, V67, P179, DOI 10.3402/ijch.v67i2-3.18260.
   World Health Organization, 1977, MAN INT STAT CLASS D.
   World Health Organization, 2004, ICD 10 INT STAT CLAS, V2.
   World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U.
   Young TK, 2000, AM J PUBLIC HEALTH, V90, P1466, DOI 10.2105/AJPH.90.9.1466.
   Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419.},
Number-of-Cited-References = {44},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Health Rep.},
Doc-Delivery-Number = {828MQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000295505700001},
DA = {2022-03-29},
}

@article{ WOS:000246187800002,
Author = {O'Lorcain, Plaras and Walsh, Paul M. and Comber, Harry},
Title = {Cumulative cancer mortality risk and potential years of life lost to 64
   years of age in Ireland, 1953-2002},
Journal = {EUROPEAN JOURNAL OF CANCER PREVENTION},
Year = {2007},
Volume = {16},
Number = {3},
Pages = {167-177},
Month = {JUN},
Abstract = {Premature cancer mortality trends were examined by reviewing cumulative
   mortality risk ('cumulative risk' hereafter) and potential years of life
   lost (PYLL) up to and including 64 years of age between 1953 and 2002 in
   Ireland. Trends were assessed quantitatively by Joinpoint analysis of
   both measures (with PYLL expressed as an age-standardized rate). The age
   of 64 years was used for these summary measures to reflect the focus of
   the Irish Government's cancer strategy on cancer in the under-65
   population. Some differences emerged when ranking the significant types
   of cancer using cumulative risk and PYLL values. In general, however,
   the two methods generated similar overall trends, although PYLL rates
   tended to show steeper or longer-term declines, presumably reflecting
   the greater weight given to deaths at younger ages. Most cancers have,
   in recent years, shown a downward, or levelling-off of, trend for both
   sexes. The only exceptions were significant increases for oesophageal
   cancer in men (both measures), and prostate cancer (cumulative risk),
   cervical cancer (PYLL rate) and lymphoma in both sexes (cumulative
   risk). Rankings based on both cumulative risk and PYLL showed that male
   lung cancer is still the leading cause of premature death from cancer in
   Ireland, despite recent falls in mortality rates. Breast cancer has
   consistently been the leading cause of premature cancer death in women
   since the 1950s. Stomach cancer was once the second leading cause of
   premature cancer death in women, but since the 1960s it has been
   replaced by lung cancer. Ovarian cancer, having had a middle ranking for
   many years has, since the early 1990s, become the third leading cause of
   premature cancer death for women. European Journal of Cancer Prevention
   16:167-177 (C) 2007 Lippincott Williams \& Wilkins.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Comber, H (Corresponding Author), Natl Canc Registry, Boreenmanna Rd,Elm Court, Cork, Ireland.
   Natl Canc Registry, Cork, Ireland.},
DOI = {10.1097/01.cej.0000228408.68353.ba},
ISSN = {0959-8278},
EISSN = {1473-5709},
Keywords = {cancer; cumulative mortality risk; Ireland; mortality; potential years
   of life lost; premature},
Keywords-Plus = {DEATH CERTIFICATES; TRENDS; STATISTICS},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {h.comber@ncri.ie},
ORCID-Numbers = {Comber, Harry/0000-0003-1475-7883},
Cited-References = {{[}Anonymous], 2005, SEXUALLY TRANSMITTED.
   ASHWORTH TG, 1991, J CLIN PATHOL, V44, P265, DOI 10.1136/jcp.44.4.265.
   Balanda K., 2001, INEQUALITIES MORTALI.
   {*}CENTR STAT OFF, 1952, ANN REP VIT STAT YEA.
   COLEMAN M, 2000, DEATH CERTIFICATION.
   COLEMAN MP, 1993, IARC SCI PUBL, V121, P1.
   dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Garne JP, 1996, ACTA ONCOL, V35, P671, DOI 10.3109/02841869609083997.
   GRULICH AE, 1995, INT J CANCER, V63, P164, DOI 10.1002/ijc.2910630203.
   HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Koutsky Laura, 1997, American Journal of Medicine, V102, P3.
   Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894.
   LINDAHL BIB, 1994, SCAND J SOC MED, V22, P145, DOI 10.1177/140349489402200211.
   PERCY C, 1989, AM J EPIDEMIOL, V129, P934, DOI 10.1093/oxfordjournals.aje.a115226.
   PERCY C, 1978, PUBLIC HEALTH REP, V93, P335.
   PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242.
   PERCY CL, 1990, ANN NY ACAD SCI, V609, P87, DOI 10.1111/j.1749-6632.1990.tb32059.x.
   Skeet, 1991, CANC REGISTRATION PR.
   Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012.
   {*}WHO, 1977, INT STAT CLASS DIS R.
   World Cancer Research Fund, 1997, FOOD NUTR PREV CANC.
   1996, CANC SERVICES IRELAN.
   {[}No title captured].},
Number-of-Cited-References = {25},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Eur. J. Cancer Prev.},
Doc-Delivery-Number = {163UD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000246187800002},
DA = {2022-03-29},
}

@article{ WOS:000620633200048,
Author = {Graham, Laurie M. and Ranapurwala, I, Shabbar and Zimmer, Catherine and
   Macy, Rebecca J. and Rizo, Cynthia F. and Lanier, Paul and Martin,
   Sandra L.},
Title = {Disparities in potential years of life lost due to intimate partner
   violence: Data from 16 states for 2006-2015},
Journal = {PLOS ONE},
Year = {2021},
Volume = {16},
Number = {2},
Month = {FEB 17},
Abstract = {Background
   Intimate partner violence can lead to deaths of one or both partners and
   others (i.e., corollary victims). Prior studies do not enumerate the
   societal cost of intimate partner violence-related fatalities, exclude
   corollary victims from most analyses, and do not describe groups who
   bear the highest societal costs from intimate partner violence.
   Objective
   We examine racial/ethnic and gender-based disparities in potential years
   of life lost (PYLL) among intimate partners and corollary victims of
   intimate partner violence-related mortality.
   Methods
   We used 16 US states' 2006-2015 National Violent Death Reporting System
   data to estimate PYLL among intimate partners (n = 6,282) and corollary
   victims (n = 1,634) by victims' race/ethnicity and sex. We describe
   fatalities by sex, race/ethnicity, age, and victim-suspect relationships
   and used hierarchical linear models to examine PYLL per death
   differences by victims' sex and race/ethnicity.
   Results
   Nearly 290,000 years of potential life were lost by partner and
   corollary victims as a result of IPV in 16 states during the decade of
   study. Most partner victims were female (59\%); most corollary victims
   were male (76\%). Female intimate partners died 5.1 years earlier (95\%
   CI: 4.4., 5.9) than males, and female corollary victims died 3.6 years
   (1.9, 5.5) earlier than males. Racial/ethnic minorities died nine or
   more years earlier than their White counterparts. White males had the
   lowest PYLL per death of all sex/race groups.
   Implications
   Intimate partner violence-related fatalities exact a high societal cost,
   and the burden of that cost is disproportionately high among
   racial/ethnic minorities. Future interventions targeting specific sex
   and race/ethnic groups might help reduce disparities in intimate partner
   violence burden.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Graham, LM (Corresponding Author), Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA.
   Graham, Laurie M., Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA.
   Ranapurwala, Shabbar, I; Macy, Rebecca J.; Lanier, Paul; Martin, Sandra L., Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA.
   Ranapurwala, Shabbar, I, Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   Zimmer, Catherine, Univ North Carolina Chapel Hill, Odum Inst, Chapel Hill, NC USA.
   Macy, Rebecca J.; Rizo, Cynthia F.; Lanier, Paul, Univ North Carolina Chapel Hill, Sch Social Work, Chapel Hill, NC USA.
   Martin, Sandra L., Univ North Carolina Chapel Hill, Dept Maternal \& Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.},
DOI = {10.1371/journal.pone.0246477},
Article-Number = {e0246477},
ISSN = {1932-6203},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {laurie.graham@ssw.umaryland.edu},
ORCID-Numbers = {Graham, Laurie/0000-0003-3318-8591},
Funding-Acknowledgement = {University of North Carolina at Chapel Hill Graduate School; UNC Injury
   Prevention Research Center; University of Maryland-Baltimore},
Funding-Text = {The Caroline H. and Thomas S. Royster Fellowship awarded by the
   University of North Carolina at Chapel Hill Graduate School and the
   Injury and Violence Prevention Fellowship awarded by the UNC Injury
   Prevention Research Center supported, in part, LMG's time and effort on
   this research by supporting her pursuit of a doctoral degree. Funds from
   both the University of Maryland-Baltimore Open Access Publishing Fund
   and UNC Injury Prevention Research Center paid for the open access
   publication fee.},
Cited-References = {Adhia A, 2019, AM J PREV MED, V56, P38, DOI 10.1016/j.amepre.2018.08.028.
   Arias Esther, 2013, Psychosocial Intervention, V22, P153, DOI 10.5093/in2013a18.
   Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131.
   Beckett K, 2015, LAW SOC REV, V49, P241, DOI 10.1111/lasr.12120.
   Black MC, 2011, NATL INTIMATE PARTNE.
   Breiding MJ, 2015, AM J PUBLIC HEALTH, V105, pE11, DOI 10.2105/AJPH.2014.302321.
   Brown Sabrina, 2019, J Inj Violence Res, V11, P53, DOI 10.5249/jivr.v11i1.997.
   Campbell JC, 2007, TRAUMA VIOLENCE ABUS, V8, P246, DOI 10.1177/1524838007303505.
   Centers for Disease Control and Prevention, 2018, NATL VIOLENT DEATH R.
   Centers for Disease Control Prevention, 2019, INTIMATE PARTNER VIO.
   De Koker P, 2014, J ADOLESCENT HEALTH, V54, P3, DOI 10.1016/j.jadohealth.2013.08.008.
   Eckhardt CI, 2013, PARTN ABUSE, V4, P196, DOI 10.1891/1946-6560.4.2.196.
   Fridel EE, 2019, VIOLENCE GEND, V6, P27, DOI 10.1089/vio.2019.0005.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Graham L.M, 2019, TRAUMA VIOLENCE ABUS.
   Ho CK., 1990, DIVERSITY COMPLEXITY, P129.
   Jack SPD, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6711a1.
   Kafka JM, 2021, INJURY PREV, V27, P137, DOI 10.1136/injuryprev-2020-043704.
   Lee RK, 2002, AM J PUBLIC HEALTH, V92, P530, DOI 10.2105/AJPH.92.4.530.
   Messing JT, 2015, AFFILIA J WOM SOC WO, V30, P328, DOI 10.1177/0886109915576520.
   Mortality Surveillance Team, 2018, NATL VIOLENT DEATH R.
   Morton E, 1998, Violence Vict, V13, P91.
   National Center for Health Statistics, 2018, LIFE EXPECTANCY BIRT.
   Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1.
   Rand M., 2009, FEMALE VICTIMS VIOLE.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Rosenberg M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185957.
   Sabina C., 2015, SUMMARY REPORT LATIN.
   Salari S, 2007, CLIN INTERV AGING, V2, P441.
   Smith SG, 2014, AM J PUBLIC HEALTH, V104, P461, DOI 10.2105/AJPH.2013.301582.
   Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2.
   Trabold N, 2020, TRAUMA VIOLENCE ABUS, V21, P311, DOI 10.1177/1524838018767934.
   US Census Bureau, POPULATION DIVISION.
   Wyatt GE, 1994, J SOC DISTRESS HOMEL, V3, P7, DOI {[}10.1007/BF02087356, DOI 10.1007/BF02087356].},
Number-of-Cited-References = {34},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {QK8ME},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000620633200048},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000740227600006,
Author = {Liu, Jianwei and Cao, Hongbin and Zhang, Yali and Chen, Hui},
Title = {Potential years of life lost due to PM2.5-bound toxic metal exposure:
   Spatial patterns across 60 cities in China},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2022},
Volume = {812},
Month = {MAR 15},
Abstract = {To clarify the spatial patterns of disease burden caused by toxic metals
   in line particulate matter (PM2.5) across China, annual concentration
   levels of typical toxic metals in PM2.5 over 60 cities of China were
   retrieved. Then, potential years of life lost (PYLL) attributable to
   toxic metal (As, Cd, Cr (VI), Mn, and Ni) exposure was calculated from
   health risk assessments and lifetable estimates. The results show that
   Cr(VI) and As were the most polluted metals and greatly exceeded the
   recommended annual values in the National Ambient Air Quality Standard
   of China. PYLL for each death (mean +/- standard deviation) of 19.8 +/-
   4.5 years was observed for lung cancer, followed closely by COPD and
   pneumonia. Furthermore, the PYLL rate (years per 100,000 people)
   attributable to exposure to these toxic metals was 457 (male: 505,
   female: 402) years for different cities; therein, Cr(VO contributed the
   highest PYLL among these toxic metals, with a proportion of 72.7\%
   (male: 75.3\%, female: 69.5\%), followed by As of 16.4\% (male: 13.8\%,
   female: 19.8\%). The concentration level and PYLL both showed large
   spatial variability, of which the top-ranking cities were observed to be
   affected by well-developed metal-related industries and coal-powered
   industrial sectors.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Liu, JW (Corresponding Author), Henan Agr Univ, Coll Resources \& Environm Sci, Zhengzhou 450002, Peoples R China.
   Liu, Jianwei; Zhang, Yali; Chen, Hui, Henan Agr Univ, Coll Resources \& Environm Sci, Zhengzhou 450002, Peoples R China.
   Cao, Hongbin, Beijing Normal Univ, Fac Geog Sci, Beijing 100875, Peoples R China.},
DOI = {10.1016/j.scitotenv.2021.152593},
EarlyAccessDate = {DEC 2021},
Article-Number = {152593},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Toxic metals; PYLL; Lifetable; Spatial variability; Cities},
Keywords-Plus = {POLYCYCLIC AROMATIC-HYDROCARBONS; AIR-POLLUTION COMPONENTS; LUNG-CANCER
   RISK; PARTICULATE MATTER; AMBIENT AIR; PM2.5; COHORTS; ASSOCIATIONS;
   IMPACTS; BURDEN},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {liujianwei@henau.edu.cn},
ResearcherID-Numbers = {Liu, Jianwei/AFT-0717-2022},
Funding-Acknowledgement = {Natural Science Foundation of Henan Province, China {[}212300410165];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}42077392]; Scientific Research Foundation
   for the PhD of Henan Agricultural University, China {[}30602115]},
Funding-Text = {Natural Science Foundation of Henan Province, China (212300410165),
   National Natural Science Foundation of China (42077392), and Scientific
   Research Foundation for the PhD of Henan Agricultural University, China
   (30602115) funded the research.},
Cited-References = {Bu X, 2021, ENVIRON RES, V197, DOI 10.1016/j.envres.2021.111123.
   Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671.
   Chen X, 2020, SCI TOTAL ENVIRON, V717, DOI 10.1016/j.scitotenv.2020.137285.
   Chen YJ, 2021, ATMOS ENVIRON, V248, DOI 10.1016/j.atmosenv.2021.118202.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Dai QL, 2015, AEROSOL AIR QUAL RES, V15, P875, DOI 10.4209/aaqr.2014.09.0226.
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127.
   Duan JC, 2013, ATMOS ENVIRON, V74, P93, DOI 10.1016/j.atmosenv.2013.03.031.
   Duan JC, 2012, ATMOS RES, V114, P17, DOI 10.1016/j.atmosres.2012.05.010.
   Etchie TO, 2018, CHEMOSPHERE, V204, P277, DOI 10.1016/j.chemosphere.2018.04.054.
   Ferguson JM, 2020, ENVIRON RES, V180, DOI 10.1016/j.envres.2019.108876.
   Fuertes E, 2014, INT J HYG ENVIR HEAL, V217, P819, DOI 10.1016/j.ijheh.2014.05.004.
   Garshick E, 2012, ENVIRON HEALTH PERSP, V120, P1301, DOI 10.1289/ehp.1204989.
   {*}GBD 2019 RISK FAC, 2019, LANCET, V0396.
   Ge C, 2020, AM J RESP CRIT CARE, V202, P402, DOI 10.1164/rccm.201911-2101OC.
   Geng GN, 2021, NAT GEOSCI, V14, P645, DOI 10.1038/s41561-021-00792-3.
   Goldewijk KK, 2017, EARTH SYST SCI DATA, V9, P927, DOI 10.5194/essd-9-927-2017.
   Hao YF, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114910.
   Hieu NT, 2010, ATMOS RES, V98, P526, DOI 10.1016/j.atmosres.2010.08.019.
   Hsu CY, 2019, ENVIRON POLLUT, V250, P934, DOI 10.1016/j.envpol.2019.04.038.
   Huang J, 2021, CHEMOSPHERE, V275, DOI 10.1016/j.chemosphere.2021.130041.
   Jakovljevic M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su131911038.
   Jakovljevic M, 2020, RISK MANAG HEALTHC P, V13, P2261, DOI 10.2147/RMHP.S266386.
   Jakovljevic M, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00590-3.
   Jakovljevic M, 2019, J MED ECON, V22, P722, DOI 10.1080/13696998.2019.1600523.
   Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005.
   Lelieveld J, 2020, CARDIOVASC RES, V116, P1910, DOI 10.1093/cvr/cvaa025.
   Li F, 2021, J CLEAN PROD, V286, DOI 10.1016/j.jclepro.2020.124967.
   Li J, 2021, ENVIRON RES, V194, DOI 10.1016/j.envres.2020.110503.
   Lin X, 2018, CHEMOSPHERE, V212, P705, DOI 10.1016/j.chemosphere.2018.08.129.
   Liu JW, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.105041.
   Liu ZY, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118597.
   Luan GJ, 2021, ATMOS POLLUT RES, V12, P200, DOI 10.1016/j.apr.2020.11.002.
   Petit P, 2019, ENVIRON INT, V124, P109, DOI 10.1016/j.envint.2018.12.058.
   Raaschou-Nielsen O, 2016, ENVIRON INT, V87, P66, DOI 10.1016/j.envint.2015.11.007.
   Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1.
   Ran JJ, 2019, SCI TOTAL ENVIRON, V657, P28, DOI 10.1016/j.scitotenv.2018.12.015.
   Rovira J, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135538.
   Shamsipour M, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113173.
   Sun Y, 2014, INT J ENV RES PUB HE, V11, P1312, DOI 10.3390/ijerph110201312.
   Tsai PJ, 2020, ATMOS POLLUT RES, V11, P851, DOI 10.1016/j.apr.2020.01.013.
   US EPA, 1994, EPA600890066F US EPA.
   Wang YY, 2021, RESOUR CONSERV RECY, V173, DOI 10.1016/j.resconrec.2021.105731.
   Weinmayr G, 2018, ENVIRON INT, V120, P163, DOI 10.1016/j.envint.2018.07.030.
   Wignall JA, 2014, ENVIRON HEALTH PERSP, V122, P499, DOI 10.1289/ehp.1307539.
   WINNEKE G, 1992, TOXICOL LETT, V64-5, P239, DOI 10.1016/0378-4274(92)90195-P.
   Xie R, 2016, ENVIRON INT, V97, P180, DOI 10.1016/j.envint.2016.09.003.
   Yue HB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15319-4.
   Zhang XG, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114575.
   Zhang YX, 2009, P NATL ACAD SCI USA, V106, P21063, DOI 10.1073/pnas.0905756106.},
Number-of-Cited-References = {50},
Times-Cited = {0},
Usage-Count-Last-180-days = {11},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {YD2SX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000740227600006},
DA = {2022-03-29},
}

@article{ WOS:000354549100012,
Author = {Etzersdorfer, Elmar and Klein, Jakob and Baus, Nicole and Sonneck,
   Gernot and Kapusta, Nestor D.},
Title = {Epidemiology of suicide in Austria during 2000-2010: potential years of
   life lost: time for the national suicide prevention program},
Journal = {WIENER KLINISCHE WOCHENSCHRIFT},
Year = {2015},
Volume = {127},
Number = {7-8},
Pages = {308-313},
Month = {APR},
Abstract = {Background This article investigates suicide rates from 2000 to 2010 in
   Austria, a country with now average rates that had started to decline in
   the mid-80s.
   Results Rates declined in the observed period, to an average of 26.1 per
   100,000 persons for men, 8.2 for women, and 16.9 in the general
   population. The decrease was found in all age-groups, but more marked in
   women, with a reduction by 26.3 \% compared with the previous decade
   than in men (20.0 \% reduction). Hanging still is the most common
   method, 49.1 \% for men and 35.0 \% for women, although also on the
   decline. Furthermore, person years of lost life were calculated, also
   reflecting a decrease from 40,702 years in 2000 to 29,883 in 2010.
   Altogether, 372,551 years of life were lost by suicide in Austria in the
   period 2000-2010, 277,998 years among men and 94,553 years among women.
   Conclusions Concerning the still observed increase in old age-groups and
   the huge amount of lost life years, it is argued that implementation of
   the National Suicide Prevention Programme for Austria is strongly
   needed.},
Publisher = {SPRINGER WIEN},
Address = {SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA},
Type = {Article},
Language = {English},
Affiliation = {Etzersdorfer, E (Corresponding Author), Furtbachkrankenhaus, Klin Psychiat \& Psychotherapie, Furtbachstr 6, D-70178 Stuttgart, Germany.
   Etzersdorfer, Elmar, Furtbachkrankenhaus, Klin Psychiat \& Psychotherapie, D-70178 Stuttgart, Germany.
   Klein, Jakob; Baus, Nicole; Kapusta, Nestor D., Med Univ Vienna, Dept Psychoanal \& Psychotherapy, Suicide Res Grp, Vienna, Austria.
   Sonneck, Gernot, Krisenintervent Zentrum Wien, Vienna, Austria.},
DOI = {10.1007/s00508-015-0729-3},
ISSN = {0043-5325},
EISSN = {1613-7671},
Keywords = {Suicide; Austria; Epidemiology; Years of potential life lost},
Keywords-Plus = {MORTALITY; PATTERNS; IMPACT; RATES; HOMICIDE},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {etzersdorfer@fbkh.org},
ResearcherID-Numbers = {Kapusta, Nestor D/C-9368-2009},
ORCID-Numbers = {Kapusta, Nestor D/0000-0002-0970-4341},
Cited-References = {Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489.
   AUSENDA G, 1991, EUR ARCH PSY CLIN N, V240, P301, DOI 10.1007/BF02189544.
   BMG, 2012, SUPRA SUIZ AUSTR.
   Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6.
   Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108.
   Clark Sheila E., 2000, INT HDB SUICIDE ATTE, P467, DOI DOI 10.1002/9780470698976.CH26.
   Doessel DP, 2009, ARCH SUICIDE RES, V13, P87, DOI 10.1080/13811110802572197.
   Doessel DP, 2010, AUST NZ HLTH POLICY, V7, P1.
   Doll R, 1976, INT J CANCER, V2, P269.
   Etzersdorfer E, 2005, WIEN KLIN WOCHENSCHR, V117, P31, DOI 10.1007/s00508-004-0263-1.
   ETZERSDORFER E, 1992, WIEN KLIN WOCHENSCHR, V104, P594.
   Gunnell D, 2003, BRIT J PSYCHIAT, V182, P164, DOI 10.1192/bjp.182.2.164.
   Gusmao R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066455.
   Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205.
   Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x.
   Kapusta ND, 2008, SOC PSYCH PSYCH EPID, V43, P311, DOI 10.1007/s00127-008-0317-1.
   Kapusta ND, 2007, BRIT J PSYCHIAT, V191, P253, DOI 10.1192/bjp.bp.106.032862.
   Kapusta ND, 2011, ARCH GEN PSYCHIAT, V68, P1050, DOI 10.1001/archgenpsychiatry.2011.66.
   Kennelly B, 2007, CRISIS, V28, P89, DOI 10.1027/0227-5910.28.2.89.
   Koger R, 2013, THESIS WIEN.
   Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064.
   Niederkrotenthaler T, 2007, AUST NZ J PSYCHIAT, V41, P419, DOI 10.1080/00048670701266680.
   OECD, 2008, OECD GLOSS STAT TERM.
   Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8.
   Rockett IR, 2012, AM J PUBLIC HEALTH, V102, P84.
   SAKR L, 1989, WIEN KLIN WOCHENSCHR, V101, P511.
   Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550.
   Savidan A, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13077.
   Schmidtke A, 1997, SUICIDE LIFE-THREAT, V27, P127.
   Sonneck G, 2000, WIEN KLIN WOCHENSCHR, V112, P943.
   Statistik Austria, 2007, LEB GEM STERB 1970 7.
   Strauss F, 1975, MITT OSTERR SAN VERW, V76, P169.
   Tucker, 2005, COST SUICIDE SOC.
   Vyssoki B, 2011, J AFFECT DISORDERS, V133, P93, DOI 10.1016/j.jad.2011.03.031.
   Wolfersdof M, 2002, WIEN KLIN WOCHENSCHR, V114, P657.
   World Healh Organization, 2012, PUBL HLTH ACT PREV S.
   Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2.},
Number-of-Cited-References = {37},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Wien. Klin. Wochen.},
Doc-Delivery-Number = {CI2BI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000354549100012},
DA = {2022-03-29},
}

@article{ WOS:000369498500005,
Author = {Perez-Perez, Eduardo and Cruz-Lopez, Leonardo and Francisco
   Hernandez-Llanes, Norberto and Gallegos-Cari, Andrea and Edgardo
   Camacho-Solis, Rafael and Angel Mendoza-Melendez, Miguel},
Title = {Years of Life Lost (YLL) attributable to alcohol consumption in Mexico
   City},
Journal = {CIENCIA \& SAUDE COLETIVA},
Year = {2016},
Volume = {21},
Number = {1},
Pages = {37-44},
Month = {JAN},
Abstract = {The aim of this study was to estimate the YLL attributable to alcohol
   consumption in Mexico City from 2006 - 2012. Vital statistics on
   mortality attributable to alcohol consumption from the INEGI (Instituto
   Nacional de Estadistica y Geografia) were used to determine YLL as well
   as the average age of death in relation to different age ranges by sex.
   A total estimate of 168,607 YLL was obtained, with an average loss of
   18.32 years being observed for men and 17.54 years for women. Men
   accounted for a higher proportion of the YLL than women. According to
   the ICD10 (Tenth Revision of International Classification of Diseases),
   liver disease attributable to alcohol consumption was found to be
   responsible for more than 80\% of the total YLL. There was a cyclical
   trend in YLL from 2006 to 2012. The YLL attributable to alcohol suggest
   that alcohol consumption is a public health problem that involves losses
   in productivity and economic costs, and the decline in YLL could be
   explained by the decrease in income caused by the economic crisis of
   2008, just as the increase could be explained by economic improvement in
   2012.},
Publisher = {ABRASCO},
Address = {RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Mendoza-Melendez, MA (Corresponding Author), Inst Atenc \& Prevenc Adicc Ciudad de Mexico, Direcc Invest \& Evaluac, Ave Rio Mixcoac 234, Ciudad De Mexico 03240, DF, Mexico.
   Perez-Perez, Eduardo; Cruz-Lopez, Leonardo; Francisco Hernandez-Llanes, Norberto; Gallegos-Cari, Andrea; Edgardo Camacho-Solis, Rafael; Angel Mendoza-Melendez, Miguel, Inst Atenc \& Prevenc Adicc Ciudad de Mexico, Direcc Invest \& Evaluac, Ave Rio Mixcoac 234, Ciudad De Mexico 03240, DF, Mexico.},
DOI = {10.1590/1413-81232015211.09472015},
ISSN = {1413-8123},
EISSN = {1678-4561},
Keywords = {Years of life lost; Alcohol consumption; Cost of illness; Mortality},
Keywords-Plus = {DISEASE; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mmendozam@df.gob.mx},
ResearcherID-Numbers = {Hernández-Llanes, Norberto F/AAR-7268-2021},
Cited-References = {Arriaga EE, 2000, ANOS VIDA PERDIDOS U.
   Babor T, 2010, ALCOHOL PRODUCTO CON.
   Bajaj JS, 2013, CLIN GASTROENTEROL H, V11, P1511, DOI 10.1016/j.cgh.2013.05.010.
   CONADIC, 2009, ENC NAC AD 2008.
   Dávila´Cervantes Claudio A, 2011, Rev. salud pública, V13, P560.
   del Valle Gomez M O, 1993, Rev Sanid Hig Publica (Madr), V67, P129.
   Medina-Mora ME, 2010, SALUD MENT, V33, P373.
   Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x.
   INEGI, 2011, CENS POBL VIV 2010.
   Instituto Nacional de Estadistica y Geografia, 2014, ENC NAC INGR GAST HO.
   Instituto Nacional de Estadistica y Geografia (INEGI), 2014, EST MORT GEN.
   Jones L, 2014, UPDATING ENGLAND SPE.
   Medina-Mora M. E., 2012, ENCUESTA NACL ADICCI.
   Medina-Mora ME, 2012, ALCOHOL POLITICA PUB, P3.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   National Services Scotland, 2009, ALC ATTR MORT MORB A.
   NU CEPAL CELADE Fondo de Poblacion de las Naciones Unidas, 2014, NU SER MAN.
   OPS, 2012, SIT SAL AM IND BAS 2.
   Organizacion Internacional del Trabajo (OIT), 1996, TRAT CUEST REL CON A.
   Organizacion Mundial de la Salud, 2011, GLOB STAT REP ALC HL.
   Organizacion Mundial de la Salud, 1992, CIE 10 DEC REV CLAS.
   Organizacion Mundial de la Salud (OMS), 2010, ESTR MUND RED US NOC.
   Pontificia Universidad Catolica de Chile, 2008, EST CARG ENF CARG AT.
   pruss-ustun a, 2003, WHO ENV BURDEN DIS S, V1.
   Rehm J, 2005, REV PANAM SALUD PUBL, V18, P241, DOI 10.1590/S1020-49892005000900003.
   SEUC AH, 2000, REV CUB HIG EPIDEMIO, V38, P92.
   Seuc Armando H, 2005, Rev Cubana Hig Epidemiol, V43, P0.
   Tocque K., 2008, ALCOHOL ATTRIBUTABLE.
   Valdez-Huarcaya W, 2010, CARGA ENFERMEDAD MAR.
   Velazquez-Valdivia A, 2006, GUIA METODOLOGICA ES.
   WHO, HLTH STAT INF SYST M.},
Number-of-Cited-References = {31},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Cienc. Saude Coletiva},
Doc-Delivery-Number = {DC8VT},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000369498500005},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000313320900013,
Author = {Shield, Kevin D. and Gmel, Gerrit and Kehoe-Chan, Tara and Dawson,
   Deborah A. and Grant, Bridget F. and Rehm, Juergen},
Title = {Mortality and Potential Years of Life Lost Attributable to Alcohol
   Consumption by Race and Sex in the United States in 2005},
Journal = {PLOS ONE},
Year = {2013},
Volume = {8},
Number = {1},
Month = {JAN 2},
Abstract = {Background: Alcohol has been linked to health disparities between races
   in the US; however, race-specific alcohol-attributable mortality has
   never been estimated. The objective of this article is to estimate
   premature mortality attributable to alcohol in the US in 2005,
   differentiated by race, age and sex for people 15 to 64 years of age.
   Methods and Findings: Mortality attributable to alcohol was estimated
   based on alcohol-attributable fractions using indicators of exposure
   from the National Epidemiologic Survey on Alcohol and Related Conditions
   and risk relations from the Comparative Risk Assessment study.
   Consumption data were corrected for undercoverage (the observed
   underreporting of alcohol consumption when using survey as compared to
   sales data) using adult per capita consumption from WHO databases.
   Mortality data by cause of death were obtained from the US Department of
   Health and Human Services. For people 15 to 64 years of age in the US in
   2005, alcohol was responsible for 55,974 deaths (46,461 for men; 9,513
   for women) representing 9.0\% of all deaths, and 1,288,700 PYLL
   (1,087,280 for men; 201,420 for women) representing 10.7\% of all PYLL.
   Per 100,000 people, this represents 29 deaths (29 for White; 40 for
   Black; 82 for Native Americans; 6 for Asian/Pacific Islander) and 670
   PYLL (673 for White; 808 for Black; 1,808 for Native American; 158 for
   Asian/Pacific Islander). Sensitivity analyses showed a lower but still
   substantial burden without adjusting for undercoverage.
   Conclusions: The burden of mortality attributable to alcohol in the US
   is unequal among people of different races and between men and women.
   Racial differences in alcohol consumption and the resulting harms
   explain in part the observed disparities in the premature mortality
   burden between races, suggesting the need for interventions for specific
   subgroups of the population such as Native Americans.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Shield, KD (Corresponding Author), Ctr Addict \& Mental Hlth, Toronto, ON, Canada.
   Shield, Kevin D.; Gmel, Gerrit; Kehoe-Chan, Tara; Rehm, Juergen, Ctr Addict \& Mental Hlth, Toronto, ON, Canada.
   Shield, Kevin D.; Rehm, Juergen, Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
   Kehoe-Chan, Tara, Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada.
   Rehm, Juergen, Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   Rehm, Juergen, Tech Univ Dresden, Inst Clin Psychol \& Psychotherapy, D-01062 Dresden, Saxony, Germany.
   Rehm, Juergen, Univ Toronto, Dept Psychiat, Toronto, ON, Canada.
   Dawson, Deborah A.; Grant, Bridget F., NIAAA, Lab Epidemiol \& Biometry, NIH, Bethesda, MD USA.
   Dawson, Deborah A., Kelly Govt Serv, Bethesda, MD USA.},
DOI = {10.1371/journal.pone.0051923},
Article-Number = {e51923},
ISSN = {1932-6203},
Keywords-Plus = {ISCHEMIC-HEART-DISEASE; GLOBAL BURDEN; RISK; HEALTH; DEATH; INJURY;
   DISPARITIES; CALCULATE; DRINKING; ACCURACY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {Kevin.shield@utoronto.ca},
ResearcherID-Numbers = {Rehm, Jürgen/K-2147-2012
   Shield, Kevin/AAR-8220-2020
   },
ORCID-Numbers = {Rehm, Jürgen/0000-0001-5665-0385
   Shield, Kevin/0000-0003-1871-8849},
Funding-Acknowledgement = {National Institute for Alcohol Abuse and Alcoholism (NIAAA)United States
   Department of Health \& Human ServicesNational Institutes of Health
   (NIH) - USANIH National Institute on Alcohol Abuse \& Alcoholism (NIAAA)
   {[}HHSN267200700041C]; Ontario Ministry of Health and Long-Term
   CareMinistry of Health and Long-Term Care, Ontario; NATIONAL INSTITUTE
   ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health \&
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Alcohol Abuse \& Alcoholism (NIAAA) {[}ZIAAA000449] Funding
   Source: NIH RePORTER},
Funding-Text = {Financial support for this study was provided to Jurgen Rehm by the
   National Institute for Alcohol Abuse and Alcoholism (NIAAA) with
   contract \# HHSN267200700041C to conduct the study titled ``Alcohol- and
   Drug-attributable Burden of Disease and Injury in the US{''}. In
   addition, Jurgen Rehm received a salary and infrastructure support from
   the Ontario Ministry of Health and Long-Term Care. Kevin Shield had full
   access to all the data in the study and takes responsibility for the
   integrity of the data and the accuracy of the data analysis. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.},
Cited-References = {Alfsen G Cecilie, 2012, Tidsskr Nor Laegeforen, V132, P147, DOI 10.4045/tidsskr.11.0427.
   {[}Anonymous], 2011, GLOBAL STATUS REPORT.
   Arias E, 2010, NATL VITAL STAT REPO.
   Babor TF, 2010, ALCOHOL NO ORDINARY, V2nd.
   Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263.
   Centers for Disease Control, 2012, INT CLASS DIS 10 REV.
   Chartier K, 2010, ALCOHOL RES HEALTH, V33, P152.
   Cunningham M, 2006, HOMELESSNESS COUNTS.
   Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058.
   Ezzati Majid, 2004, COMP QUANTIFICATION.
   Flegal KM, 2006, AM J PUBLIC HEALTH, V96, P398, DOI 10.2105/AJPH.2005.079731.
   Gmel G, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-5.
   Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X.
   Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78.
   Hollingworth W, 2006, J STUD ALCOHOL, V67, P300, DOI 10.15288/jsa.2006.67.300.
   James G, 1955, PUBLIC HEALTH REP, V70, P39.
   Kehoe T, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-6.
   Korn E.L., 1999, ANAL HLTH SURVEYS.
   Laslett A-M, 2010, RANGE MAGNITUDE ALCO.
   Mackenbach JP, 2003, LANCET, V362, P1409, DOI 10.1016/S0140-6736(03)14639-9.
   Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399.
   MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207.
   MIDANIK L, 1982, BRIT J ADDICT, V77, P357.
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238.
   Moore, 2003, SOURCE ACCURACY STAT.
   Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260.
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8.
   Nashelsky MB, 2003, AM J FOREN MED PATH, V24, P313, DOI 10.1097/01.paf.0000097857.50734.c3.
   OTTEN MW, 1990, JAMA-J AM MED ASSOC, V263, P845, DOI 10.1001/jama.263.6.845.
   R Development Core Team, 2011, R LANG ENV STAT COMP.
   Rehm J, 2012, ALCOHOL CONSUMPTION.
   Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204.
   Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3.
   Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x.
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15.
   Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x.
   Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451.
   Rothman K, 2008, MODERN EPIDEMIOLOGY.
   Samokhvalov AV, 2012, ALCOHOL SCI POLICY P.
   Shield KD, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-9.
   Shield KD, 2012, INT J PUBLIC HEALTH, V57, P391, DOI 10.1007/s00038-011-0247-7.
   Shield KD, 2012, INT J METH PSYCH RES, V21, P17, DOI 10.1002/mpr.1345.
   Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849.
   StataCorp, 2007, STAT STAT SOFTW REL.
   Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011.
   Taylor B., 2007, ALCOHOL GENDER CULTU.
   Taylor BJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-265.
   US Department of Health and Human Services, 2011, NAT EP SURV ALC REL.
   World Health Organization, 2010, GLOB STRAT RED HARMF.
   World Health Organization, 2011, GLOB INF SYST ALC HL.
   World Health Organization, 2009, GLOB HLTH RISKS MORT.
   Zatonski WA, 2011, ANN AGR ENV MED, V18, P194.},
Number-of-Cited-References = {52},
Times-Cited = {53},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {19},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {067UP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000313320900013},
OA = {gold, Green Submitted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000529348100001,
Author = {Samohyl, Martin and Argalasova, Lubica and Hirosova, Katarina and
   Jurkovicova, Jana},
Title = {Long-term trends of potential years of life lost due to main causes of
   death in the Slovak population, 2004-2013},
Journal = {CADERNOS DE SAUDE PUBLICA},
Year = {2020},
Volume = {36},
Number = {4},
Abstract = {The aim of this study was to evaluate trends of potential years of life
   lost (PYLL) rates in the Slovak population and analyze the average
   annual percent change (AAPC) of PYLL rates regarding the most common
   causes of death between 2004 and 2013. National mortality and
   demographic data were obtained from the Statistical Office of the Slovak
   Republic, and 378,535 causes of death within the period were analyzed.
   The PYLL values in both genders and each disease category were added up
   across all age groups to form annual values. For the trend analysis, the
   AAPC indicator was proposed. The PYLL rate is age-standardized and
   expressed as a sum of all deaths per 100,000. In the period 2004-2013,
   the highest mean PYLL rates were observed in neoplasms in the whole
   population (2103 per 10(1000), as well as in females (2088 per 100,000),
   with a permanent high significant increase of AAPC of PYLL in both
   genders. The second highest mean PYLL rate in the ten-year period was
   related to circulatory system diseases in total (1,922 per 100,000) as
   well as in females (1,449 per 100,000). In males, circulatory system
   diseases had the highest PYLL rate (2,397 per 100,000). The PYLL rates
   trend regarding external causes of morbidity and mortality showed the
   most notable decrease in the assessed period and the AAPC of PYLL showed
   significant negative values both in males (-2.5\% p < 0.001) and females
   (-4\%; p < 0.001). Our results should contribute in developing
   intervention programs aimed at reducing the burden of premature
   mortality since the main causes of premature death are associated to
   well-known and preventable risk factors.},
Publisher = {CADERNOS SAUDE PUBLICA},
Address = {RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Samohyl, M (Corresponding Author), Comenius Univ, Fac Med, Inst Hyg, 24 Spitalska, Bratislava 81372, Slovakia.
   Samohyl, Martin; Argalasova, Lubica; Hirosova, Katarina; Jurkovicova, Jana, Comenius Univ, Fac Med, Bratislava, Slovakia.},
DOI = {10.1590/0102-311X00052218},
Article-Number = {e00052218},
ISSN = {0102-311X},
EISSN = {1678-4464},
Keywords = {Potential Years of Lost Life; Trends; Premature Mortality; Causes of
   Death},
Keywords-Plus = {MORTALITY; EXPECTANCY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {martin.samohyl@fmed.uniba.sk},
ORCID-Numbers = {Jurkovicova, Jana/0000-0002-0892-5572
   Samohyl, Martin/0000-0001-6581-2294
   Argalasova, Lubica/0000-0002-8908-3441},
Cited-References = {Pou SA, 2017, CAD SAUDE PUBLICA, V33, DOI {[}10.1590/0102-311x00016616, 10.1590/0102-311X00016616].
   Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516.
   Bryla M, 2016, CENT EUR J PUBL HEAL, V24, P156, DOI 10.21101/cejph.a4289.
   Bucholz EM, 2015, J AM COLL CARDIOL, V66, P645, DOI 10.1016/j.jacc.2015.06.022.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   del Valle Gomez M O, 1993, Rev Sanid Hig Publica (Madr), V67, P129.
   European Health Information Gateway, SDR DIS CIRC SYST AL.
   Fleiss JL., 1973, STAT METHODS RATES P.
   Joel GR, 2017, HLTH PROMOT CHRONIC, V37, P27.
   Kalakun Luciane, 2005, Cad. Saúde Pública, V21, P299, DOI 10.1590/S0102-311X2005000100033.
   Kamensky G, 2015, COUNTRY REPORT SLOVA.
   Krzyzak M, 2015, ANN AGR ENV MED, V22, P564, DOI 10.5604/12321966.1168657.
   Mackenbach JP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-840.
   Markovic-Denic L, 2008, CROAT MED J, V49, P792, DOI 10.3325/cmj.2008.49.792.
   Marshall DC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0781-4.
   McKenzie K, 2012, EPIDEMIOL REV, V34, P4, DOI 10.1093/epirev/mxr014.
   Nalini M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021479.
   Organisation for Economic Co-operation and Development, 2015, HLTH AT A GLANC.
   Organisation for Economic Co-operation and Development, POT YEARS LIF LOST.
   Organisation for Economic Cooperation and Development, OECD HLTH STAT 2015.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Sebekova K, 2016, BRATISL MED J, V117, P702, DOI 10.4149/BLL\_2016\_135.
   SEN PK, 1968, J AM STAT ASSOC, V63, P1379.
   Stanciak J, 2017, ZDOROVJA NACII, V42, P46.
   Svihrova V, 2015, PUBLIC HLTH, V130, P43.
   The Institute of National Health Information Center, 2016, HLTH STAT YB SLOV RE.
   The Institute of National Health Information Center, 2015, HLTH STAT YB SLOV RE.
   Vohlonen I, POTENTIAL YEARS LIFE.
   Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0.
   World Health Organization, 2006, NEUR DIS PUBL HLTH C.},
Number-of-Cited-References = {30},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Cad. Saude Publica},
Doc-Delivery-Number = {LI2XY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000529348100001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000549563400001,
Author = {Mitra, Amal K. and Payton, Marinelle and Kabir, Nusrat and Whitehead,
   April and Ragland, Kimberly N. and Brown, Alexis},
Title = {Potential Years of Life Lost Due to COVID-19 in the United States,
   Italy, and Germany: An Old Formula with Newer Ideas},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2020},
Volume = {17},
Number = {12},
Month = {JUN},
Abstract = {Today, the world is facing the challenge of a major pandemic due to
   COVID-19, which has caused more than 6.1 million cases of infection and
   nearly 370,000 deaths so far. Most of the deaths from the disease are
   clustered in the older population, but the young and children are not
   spared. In this context, there is a critical need to revisit the formula
   for calculating potential years of life lost (PYLL). Data on
   age-specific deaths due to COVID-19 in three countries, including the
   United States (US), Italy, and Germany, were evaluated. New York State,
   as a significant outlier within the US, was also included. PYLLs in the
   US were five times as high as those of Italy. Compared with Germany,
   PYLLs in Italy were 4 times higher, and the rates in the US were 23, 25,
   and 18 times higher when using upper age limits of 70, 75, and 80,
   respectively. Standardized PYLLs in New York were 2 times as high as the
   rates in Italy, and 7 to 9 times as high as PYLLs in Germany. The
   revised formula of PYLL, using an upper limit of age 80, is recommended
   to accurately measure premature deaths due to a major disastrous disease
   such as COVID-19.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Mitra, AK (Corresponding Author), Jackson State Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Jackson, MS 39213 USA.
   Mitra, Amal K.; Payton, Marinelle; Kabir, Nusrat; Whitehead, April; Ragland, Kimberly N.; Brown, Alexis, Jackson State Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Jackson, MS 39213 USA.},
DOI = {10.3390/ijerph17124392},
Article-Number = {4392},
EISSN = {1660-4601},
Keywords = {COVID-19; PYLL; disease burden; United States; Italy; Germany; New York
   State},
Keywords-Plus = {PREMATURE MORTALITY},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {amal.k.mitra@jsums.edu
   marinelle.payton@jsums.edu
   nusratkabir14@gmail.com
   aprilwhitehead96@gmail.com
   kimberly.raglandjones@gmail.com
   J00889135@students.jsums.edu},
ORCID-Numbers = {Mitra, Amal/0000-0003-4238-7322},
Cited-References = {Association of Public Health Epidemiologists in Ontario, CALC POT YEARS LIF L.
   Canadian Institute for Health Information, POT YEARS LIF LOST I.
   Centers for Disease Control and Prevention, PROV DEATH COUNTS CO.
   Egunsola O, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027825.
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003.
   Grandjean P, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0340-3.
   Kirigia JM, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05044-y.
   Maximova K, 2016, CAN J PUBLIC HEALTH, V107, pE202, DOI {[}10.17269/cjph.107.5261, 10.17269/CJPH.107.5261].
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683.
   Organization for Economic Co-Operation and Development (OECD), OECD HLTH STAT 2019.
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033.
   Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600.
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   United Nations Population Division Estimates, 2020, EST COUNTR WORLD POP.
   Vienonen MA, 2019, EUR J PUBLIC HEALTH, V29, P626, DOI 10.1093/eurpub/cky278.
   WHO, METR DIS ADJ LIF YEA.
   (WHO) WHO, ROLL UPD COR DIS COV.
   World Bank, LIF EXP BIRTH.
   World Population Review, NEW YORK POP 2020 DE.
   Worldometer, COVID 19 COR PAND.
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648.
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5.},
Number-of-Cited-References = {23},
Times-Cited = {20},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {ML6GZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000549563400001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000364164500035,
Author = {Krzyzak, Michalina and Maslach, Dominik and Szpak, Andrzej and
   Piotrowska, Katarzyna and Florczyk, Katarzyna and Skrodzka, Martyna and
   Owoc, Alfred and Bojar, Iwona},
Title = {Trends of potential years of life lost due to main causes of deaths in
   urban and rural population in Poland, 2002-2011},
Journal = {ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE},
Year = {2015},
Volume = {22},
Number = {3},
Pages = {564-571},
Abstract = {The aim of the study was to analyse the level and the trends of
   Potential Years of Life Lost due to main causes of deaths in Poland in
   2002-2011, with consideration of place of residence, urban-rural. The
   material for the study was the number of deaths due to main causes in
   Poland in years 2002-2011, based on data from the Central Statistical
   Office. Premature mortality analysis was conducted with the use of PYLL
   indicator (PYLL-Potential Years of Life Lost). PYLL rate was calculated
   according to the method proposed by J.Romeder, according to which the
   premature mortality was defined as death before the age of 70. Time
   trends of PYLL rate and the annual percent change (APC) were assessed
   using the Joinpoint Regression Programme. Rural/urban ratio was used to
   presented the differences in premature mortality between rural and urban
   areas. In years2002-2011, the PYLL rate for all-cause deaths decreased
   by 13.2\% among men and 16.0\% among women in rural areas, whereas in
   urban decreased it decreased by 15.7\% among men and 14.9\% among women.
   In 2011, the main causes of PYLL among men in rural areas were: external
   causes (32.3\%), cardiovascular diseases (23.5\%) and cancers (19.4\%);
   in urban areas: cardiovascular diseases (24.7\%), external causes
   (24.3\%) and cancers (20.9\%). Among women in rural areas, the leading
   causes were: cancers (39.9\%), cardiovascular diseases (20.1\%) and
   external causes (15.1\%). The main causes of premature mortality among
   women in urban areas were: cancers (41.7\%), cardiovascular diseases
   (19.6\%) and external causes (11.1\%). Premature mortality among men in
   rural areas was significantly higher than in urban for all analysed
   causes of death, with the exception of ischaemic heart diseases and
   colorectal cancer. Premature mortality among women in rural areas was
   significantly lower than in urban for all analysed cause of deaths,
   except of cerebrovascular diseases, external causes, suicides and
   traffic accidents. The presented epidemiological situation for premature
   mortality indicate differences in the state of health of the inhabitants
   in urban and rural areas in Poland. The leading causes of premature
   mortality are caused by preventable deaths, which leads to a need to
   intensify measures in primary and secondary prevention.},
Publisher = {INST AGRICULTURAL MEDICINE},
Address = {JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Krzyzak, M (Corresponding Author), Med Univ, Fac Hlth Sci, Dept Publ Hlth, Szpitalna 37, PL-15295 Bialystok, Poland.
   Krzyzak, Michalina; Maslach, Dominik; Szpak, Andrzej, Med Univ, Fac Hlth Sci, Dept Publ Hlth, PL-15295 Bialystok, Poland.
   Piotrowska, Katarzyna, Med Univ, Fac Hlth Sci, Dept Hyg \& Epidemiol, PL-15295 Bialystok, Poland.
   Florczyk, Katarzyna; Skrodzka, Martyna, Med Univ, Dept Publ Hlth, Students Sci Grp Publ Hlth, PL-15295 Bialystok, Poland.
   Owoc, Alfred, Coll Publ Hlth, Zielona Gora, Poland.
   Owoc, Alfred, Ctr Publ Hlth \& Hlth Promot, Inst Rural Hlth, Lublin, Poland.
   Bojar, Iwona, Inst Rural Hlth, Lublin, Poland.},
DOI = {10.5604/12321966.1168657},
ISSN = {1232-1966},
EISSN = {1898-2263},
Keywords = {health inequalities; Potential Years of Life Lost; premature mortality;
   preventable deaths; urban-rural population},
Keywords-Plus = {LUNG-CANCER MORTALITY; BREAST-CANCER; PODLASKIE VOIVODSHIP;
   FEMALE-POPULATION; HEALTH-STATUS; INEQUALITIES; DISPARITIES; TRANSITION;
   SURVIVAL; PATTERNS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {michalina.krzyzak@umb.edu.pl},
ResearcherID-Numbers = {Bojar, Iwona/S-6029-2018
   Szpak, Andrzej/U-7753-2018
   },
ORCID-Numbers = {Bojar, Iwona/0000-0002-3171-225X
   Szpak, Andrzej/0000-0002-0006-8721
   Maslach, Dominik/0000-0002-5044-9995},
Cited-References = {Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018.
   Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136.
   Bobak M, 2006, BRIT J PSYCHIAT, V188, P359, DOI 10.1192/bjp.188.4.359.
   Bosetti C, 2012, LUNG CANCER, V78, P171, DOI 10.1016/j.lungcan.2012.08.008.
   Bosetti C, 2012, BREAST, V21, P77, DOI 10.1016/j.breast.2011.08.001.
   Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653.
   Boyle P., 2008, WORLD CANC REPORT.
   Colin M, 2004, GLOBAL BURDEN DIS UP.
   Curado MP, 2007, CANC INCIDENCE 5 CON, VIx, p{[}160, 961].
   Didkowska J, 2000, NOWOTWORY ZLOSLIWE P.
   FRIIS S, 1993, EUR J CANCER, V29A, P538, DOI 10.1016/S0959-8049(05)80147-9.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009.
   Gromulska Lucyna, 2008, Przegl Epidemiol, V62, P811.
   Health Disparities Calculator Version 1. 2. 4. 2013, 2013, HLTH DISP CALC VERS.
   HOWE HL, 1993, AM J EPIDEMIOL, V138, P29, DOI 10.1093/oxfordjournals.aje.a116774.
   Joinpoint Regression Program. Version 4. 0. 4, 2013, JOINP REGR PROGR VER.
   Kalediene R, 2004, ECON HUM BIOL, V2, P87, DOI 10.1016/j.ehb.2003.12.001.
   Kim HJ, 2001, STAT MED, V20, P655, DOI 10.1002/sim.811.
   Krzyzak M, 2013, ZDR PUBL, V123, P273.
   Krzyzak M, 2010, ANN AGR ENV MED, V17, P277.
   Krzyzak M, 2010, ANN AGR ENV MED, V17, P159.
   Kulaga Z, 2010, MED OGOL, V16, P63.
   Leinsalu M, 2009, INT J EPIDEMIOL, V38, P512, DOI 10.1093/ije/dyn248.
   Lipowicz A, 2015, ANTHROPOL ANZ, V72, P13, DOI 10.1127/anthranz/2014/0438.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   MAINOUS AG, 1995, J COMMUN HEALTH, V20, P423, DOI 10.1007/BF02260438.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Maslach D, 2013, ANN AGR ENV MED, V20, P161.
   Organisation for Economic Co-operation and Development (OECD), HLTH GLANC 2011 OECD.
   Rachtan J, 2008, WSPOLCZESNA ONKOL, V9, P425.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Savidan A, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13077.
   Senior M, 2000, SOC SCI MED, V51, P289, DOI 10.1016/S0277-9536(99)00454-2.
   Singh GK, 2014, J URBAN HEALTH, V91, P272, DOI 10.1007/s11524-013-9847-2.
   Smailyte G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-56.
   Spaczynski M, 2010, GINEKOL POL, V81, P655.
   Topor-Madry R, 2002, SZACOWANIE POTRZEB Z, P37.
   Tyczynski JE, 2004, INT J CANCER, V109, P598, DOI 10.1002/ijc.20019.
   Whitehead M, 2007, CONCEPTS PRINCIPLE 1.
   Wojtyniak B, 2012, SYTUACJA ZDROWOTNA L, P58.
   World Health Organization, 2004, INT STAT CLASS DIS H.
   Xavier A., 2009, Eurohealth, V15, P1.
   Yu XQ, 2008, CANCER CAUSE CONTROL, V19, P1383, DOI 10.1007/s10552-008-9210-1.
   Zatonski W., 1996, EVALUATION HLTH POLA, P13.
   Zdrowia Ministerstwo, GLOB SOND DOT UZ TYT.},
Number-of-Cited-References = {46},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Ann. Agr. Env. Med.},
Doc-Delivery-Number = {CV3MY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000364164500035},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000316742800002,
Author = {Congdon, Peter},
Title = {Modelling small-area inequality in premature mortality using years of
   life lost rates},
Journal = {JOURNAL OF GEOGRAPHICAL SYSTEMS},
Year = {2013},
Volume = {15},
Number = {2},
Pages = {149-167},
Month = {APR},
Abstract = {Analysis of premature mortality variations via standardized expected
   years of life lost (SEYLL) measures raises questions about suitable
   modelling for mortality data, especially when developing SEYLL profiles
   for areas with small populations. Existing fixed effects estimation
   methods take no account of correlations in mortality levels over ages,
   causes, socio-ethnic groups or areas. They also do not specify an
   underlying data generating process, or a likelihood model that can
   include trends or correlations, and are likely to produce unstable
   estimates for small-areas. An alternative strategy involves a fully
   specified data generation process, and a random effects model which
   ``borrows strength{''} to produce stable SEYLL estimates, allowing for
   correlations between ages, areas and socio-ethnic groups. The resulting
   modelling strategy is applied to gender-specific differences in SEYLL
   rates in small-areas in NE London, and to cause-specific mortality for
   leading causes of premature mortality in these areas.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Congdon, P (Corresponding Author), Queen Mary Univ London, Dept Geog, Ctr Stat, Mile End Rd, London E1 4NS, England.
   Queen Mary Univ London, Dept Geog, Ctr Stat, London E1 4NS, England.},
DOI = {10.1007/s10109-012-0167-y},
ISSN = {1435-5930},
EISSN = {1435-5949},
Keywords = {Premature mortality; Small-area mortality; Standardized expected years
   of life lost; Spatial; Bayesian},
Keywords-Plus = {STANDARD EXPECTED YEARS; DISEASE; BURDEN; HEALTH},
Research-Areas = {Geography},
Web-of-Science-Categories  = {Geography},
Author-Email = {p.congdon@qmul.ac.uk},
ResearcherID-Numbers = {Congdon, Peter/P-3639-2018
   },
ORCID-Numbers = {Congdon, Peter/0000-0003-1934-9205},
Cited-References = {Alho J. M., 2005, STAT DEMOGRAPHY FORE.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123.
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466.
   Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675.
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P121.
   Chib S, 2001, J BUS ECON STAT, V19, P428, DOI 10.1198/07350010152596673.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   GILKS WR, 1996, MARKOV CHAIN MONTE C.
   Graham H, 2006, BENEFITS, V14, P77.
   Higdon D, 2007, MONOGR STAT APPL PRO, V107, P217.
   James PD, 2007, J EPIDEMIOL COMMUN H, V61, P287, DOI 10.1136/jech.2006.047092.
   Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-\#.
   Knorr-Held L, 2001, Biostatistics, V2, P109, DOI 10.1093/biostatistics/2.1.109.
   Lee WC, 1999, STAT MED, V18, P2645, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2645::AID-SIM184>3.0.CO;2-Q.
   Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Marshall EC, 2007, BAYESIAN ANAL, V2, P409, DOI 10.1214/07-BA218.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   McCullagh P., 1989, GEN LINEAR MODELS 2, V37.
   McLaughlin D. K., 2007, SOCIOLOGY SPATIAL IN, P141.
   Mollie A, 2000, SPATIAL EPIDEMIOLOGY, P267.
   Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   PERLOFF J D, 1984, Journal of Public Health Policy, V5, P167, DOI 10.2307/3342337.
   Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049.
   Rees P., 2008, 0804 U LEEDS SCH GEO.
   Riches Samantha, 2000, ST GEORGE HERO MARTY, P104.
   RIGGAN WB, 1991, ENVIRON HEALTH PERSP, V96, P223, DOI 10.2307/3431235.
   Rue H., 2005, GAUSSIAN MARKOV RAND.
   Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871.
   SISA, 2011, DISC MORT ADJ YEARS.
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353.
   Torgerson DJ, 1999, BRIT MED J, V319, P914, DOI 10.1136/bmj.319.7214.914.
   Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271.
   White AK, 2010, EUR UROL SUPPL, V9, P467, DOI 10.1016/j.eursup.2010.03.003.
   Zhu Li, 2006, Int J Health Geogr, V5, P54, DOI 10.1186/1476-072X-5-54.
   {[}No title captured].},
Number-of-Cited-References = {39},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Geogr. Syst.},
Doc-Delivery-Number = {114LM},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000316742800002},
DA = {2022-03-29},
}

@article{ WOS:000333487400011,
Author = {Jang, Sung-In and Nam, Jung-Mo and Choi, Jongwon and Park, Eun-Cheol},
Title = {Disease management index of potential years of life lost as a tool for
   setting priorities in national disease control using OECD health data},
Journal = {HEALTH POLICY},
Year = {2014},
Volume = {115},
Number = {1},
Pages = {92-99},
Month = {MAR},
Abstract = {Limited healthcare resources make it necessary to maximize efficiency in
   disease management at the country level by priority-setting according to
   disease burden. To make the best priority settings, it is necessary to
   measure health status and have standards for its judgment, as well as
   consider disease management trends among nations.
   We used 17 International Classification of Diseases (ICD) categories of
   potential years of life lost (YPLL) from Organization for Economic
   Co-operation and Development (OECD) health data for 2012, 37 disease
   diagnoses YPLL from OECD health data for 2009 across 22 countries and
   disability-adjusted life years (DALY) from the World Health Organization
   (WHO). We set a range of 1-1 for each YPLL per disease in a nation
   (position value for relative comparison, PARC). Changes over 5 years
   were also accounted for in this disease management index (disease
   management index, DMI).
   In terms of ICD categories, the DMI indicated specific areas for
   priority setting for different countries with regard to managing disease
   treatment and diagnosis.
   Our study suggests that DMI is a realistic index that reflects trend
   changes over the past 5 years to the present state, and PARC is an easy
   index for identifying relative status. Moreover, unlike existing
   indices, DMI and PARC make it easy to conduct multiple comparisons among
   countries and diseases. DMI and PARC are therefore useful tools for
   policy implications and for future studies incorporating them and other
   existing indexes. (C) 2013 Elsevier Ireland Ltd. All rights reserved.},
Publisher = {ELSEVIER IRELAND LTD},
Address = {ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND},
Type = {Article},
Language = {English},
Affiliation = {Park, EC (Corresponding Author), Yonsei Univ, Coll Med, Severance Hosp, Dept Prevent Med, 50 Yonsei Ro, Seoul 120752, South Korea.
   Park, Eun-Cheol, Yonsei Univ, Coll Med, Severance Hosp, Dept Prevent Med, Seoul 120752, South Korea.
   Yonsei Univ, Coll Med, Severance Hosp, Inst Hlth Serv Res, Seoul 120752, South Korea.},
DOI = {10.1016/j.healthpol.2013.11.007},
ISSN = {0168-8510},
EISSN = {1872-6054},
Keywords = {Setting priorities; Disease burden; Disease management index; DMI;
   Position value for relative comparison; PARC; Potential years of life
   lost},
Keywords-Plus = {UNITED-STATES; BURDEN; CANCER; DALYS},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Author-Email = {jangsi@yuhs.ac
   ecpark@yuhs.ac},
ResearcherID-Numbers = {Park, Eun-Cheol/O-5644-2019
   },
ORCID-Numbers = {Park, Eun-Cheol/0000-0002-2306-5398
   Nam, Chung Mo/0000-0003-0985-0928
   Jang, Sung-in/0000-0002-0760-2878},
Cited-References = {Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29.
   ASVALL JE, 1986, HEALTH POLICY, V6, P239, DOI 10.1016/0168-8510(86)90034-5.
   Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439.
   Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Calltorp J, 1999, HEALTH POLICY, V50, P1, DOI 10.1016/S0168-8510(99)00061-5.
   France FHR, 2000, INT J MED INFORM, V58, P11, DOI 10.1016/S1386-5056(00)00071-X.
   Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X.
   Jones DS, 2012, NEW ENGL J MED, V366, P2333, DOI 10.1056/NEJMp1113569.
   Kapiriri L, 2007, HEALTH POLICY, V82, P78, DOI 10.1016/j.healthpol.2006.09.001.
   Lansang MA, 2000, HEALTH POLICY PLANN, V15, P130, DOI 10.1093/heapol/15.2.130.
   Lopez, 2002, SUMMARY MEASURES POP.
   Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8.
   Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4.
   Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495.
   Nelson DE, 2013, AM J PUBLIC HEALTH, V103, P641, DOI 10.2105/AJPH.2012.301199.
   Organization for Economic Cooperation and Development, 2012, OECD HLTH DAT 2012 D.
   Park EC, 2010, CANC CONTROL POLICY.
   Park JH, 2013, CANCER EPIDEMIOL, V37, P353, DOI 10.1016/j.canep.2013.03.015.
   Waldau S, 2010, HEALTH POLICY, V96, P245, DOI 10.1016/j.healthpol.2010.02.007.
   Werber D, 2013, EPIDEMIOL INFECT, V141, P961, DOI 10.1017/S0950268812001550.
   Woolf SH, 2006, AM J PREV MED, V31, P99, DOI 10.1016/j.amepre.2006.03.010.},
Number-of-Cited-References = {23},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Health Policy},
Doc-Delivery-Number = {AD7ZX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000333487400011},
DA = {2022-03-29},
}

@article{ WOS:000523453000004,
Author = {Phung, Dung and Nguyen, Ha Trong and Chu, Cordia and Sadler, Ross and
   Luong, Anh Mai and Nguyen, Huyen Thi and Pham, Tuan Cong and Huang,
   Cunrui},
Title = {Impacts of helmet law on the changes in potential years of life lost due
   to traffic injury: a multiple-province evaluation in Vietnam},
Journal = {INJURY PREVENTION},
Year = {2020},
Volume = {26},
Number = {2},
Pages = {109-115},
Month = {APR},
Abstract = {Introduction
   This study aimed to evaluate the impact of the helmet law on the changes
   in potential years of life lost (PYLL) due to traffic mortality and to
   examine modification effects of socioeconomic factors on the impacts in
   Vietnam.
   Methods
   We applied an interrupted time series design using the Bayesian
   framework to estimate the impact of the law at the provincial level.
   Then, we used random effects meta-analysis to estimate the impact of the
   law at the country level and to examine the modification effects of
   socioeconomic factors.
   Results
   The results indicate that the impacts varied among the provinces. These
   impacts could be classified by four main groups comprising positive
   impact, and positive impact without sustainability, possible positive
   impact, negative or inconsistent impact. For the country-level impact,
   the results reveal a significantly consistent change in monthly PYLLs at
   the level of 18 per 100 000 persons, and the post-trend was stable
   without significant change. The results of meta-regression show that 1
   unit increase in the population density (persons/km(2)), migration rate
   (\%) and income (x1000 dong) are non-significantly associated with
   increases of PYLLs at 1.3, 27 and 27 per 100 000 person-months,
   respectively, whereas 1\% increase in literacy associated with a
   decrease of PYLL at 44 per 100 000 person-months.
   Discussion
   Further studies should be warranted to provide a comprehensive
   evaluation of the law implementation, including its acceptability,
   adoption, appropriateness, feasibility, cost-effectiveness and
   sustainability.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Phung, D (Corresponding Author), Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld 4215, Australia.
   Huang, CR (Corresponding Author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.
   Phung, Dung; Huang, Cunrui, Sun Yat Sen Univ, Sch Publ Hlth, Hlth Management \& Policy, Guangzhou, Peoples R China.
   Phung, Dung; Chu, Cordia; Sadler, Ross; Pham, Tuan Cong, Griffith Univ, Sch Med, Brisbane, Qld, Australia.
   Nguyen, Ha Trong, George Inst Global Hlth, Injury Div, Sydney, NSW, Australia.
   Luong, Anh Mai; Nguyen, Huyen Thi, Minist Hlth, Vietnam Hlth Environm Management Agcy, Hanoi, Vietnam.},
DOI = {10.1136/injuryprev-2018-043088},
ISSN = {1353-8047},
EISSN = {1475-5785},
Keywords = {helmet; regulation; traumatic brain injury; burden of disease; process;
   impact evaluation},
Keywords-Plus = {MOTORCYCLE INJURIES; A6 MORTALITY; UNIVERSAL; BURDEN; RIDERS; GUIDE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {d.phung@griffith.edu.au
   huangcr@mail.sysu.edu.cn},
ResearcherID-Numbers = {Phung, Dung/ABC-9218-2021
   Huang, Cunrui/ABI-3312-2020
   },
ORCID-Numbers = {Phung, Dung/0000-0002-1615-3234
   Pham, Cong Tuan/0000-0002-1662-2483
   Chu, Cordia/0000-0002-3683-5638},
Funding-Acknowledgement = {Sun Yat-Sen University, China},
Funding-Text = {DP was supported by the research fellowship from Sun Yat-Sen University,
   China.},
Cited-References = {Araujo M, 2017, INT J INJ CONTROL SA, V24, P406, DOI 10.1080/17457300.2016.1224901.
   Bernstein J, 2016, IOP EXPAND PHYS, P1, DOI 10.1088/978-0-7503-1308-7.
   Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793.
   Chliaoutakis JE, 2000, ACCIDENT ANAL PREV, V32, P815, DOI 10.1016/S0001-4575(00)00006-3.
   Craft G, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121486.
   Dalal Koustuv, 2013, Int J Prev Med, V4, P1442.
   Enserink M, 2014, SCIENCE, V345, P1261, DOI 10.1126/science.345.6202.1261.
   General Statistics Office of Vietnam, 2009 VIETN POP HOUS.
   Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290.
   Nguyen H, 2013, INJURY PREV, V19, P79, DOI 10.1136/injuryprev-2011-040293.
   Haqverdi MQ, 2015, ACCIDENT ANAL PREV, V85, P102, DOI 10.1016/j.aap.2015.09.007.
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557.
   Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6.
   Ivers RQ, 2014, J ORTHOP TRAUMA, V28, pS50, DOI 10.1097/BOT.0000000000000098.
   LC L, 2009, GLOBAL HLTH ACTION, V6.
   Lee JM, 2018, ACCIDENT ANAL PREV, V111, P173, DOI 10.1016/j.aap.2017.11.042.
   Ministry of Transport, 2013, NUMB TRANSP REG.
   Ngo AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-561.
   Ha NT, 2018, TRAFFIC INJ PREV, V19, P75, DOI 10.1080/15389588.2017.1322203.
   Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650.
   Papadakaki M, 2013, TRANSPORT RES F-TRAF, V18, P189, DOI 10.1016/j.trf.2013.01.002.
   Peng YA, 2017, AM J PREV MED, V52, P820, DOI 10.1016/j.amepre.2016.11.030.
   Pervin A, 2009, B WORLD HEALTH ORGAN, V87, P369, DOI 10.2471/BLT.08.057109.
   Russo BJ, 2017, TRAFFIC INJ PREV, V18, P95, DOI 10.1080/15389588.2016.1168925.
   Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221.
   Stevenson M, 2015, ASIA-PAC J PUBLIC HE, V27, P733, DOI 10.1177/1010539515602742.
   Stevenson MR, 2012, INJURY PREV, V18, P360, DOI 10.1136/injuryprev-2011-040261.
   Urie Y, 2016, TRAFFIC INJ PREV, V17, P686, DOI 10.1080/15389588.2016.1146823.
   Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x.
   WHO, 2013, GLOB STAT REP ROAD S.
   World Health Organization, 2004, WORLD REPORT ROAD TR.},
Number-of-Cited-References = {31},
Times-Cited = {2},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Inj. Prev.},
Doc-Delivery-Number = {KZ7QD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000523453000004},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000764869100001,
Author = {Yousefi, Mehdi and Fazaeli, Somayeh and Mohammad-Pour, Saeed},
Title = {Years of life lost (YLL) associated with COVID-19 deaths in
   Khorasan-RAZAVI province, Iran},
Journal = {JOURNAL OF PUBLIC HEALTH},
Abstract = {Background The number of deaths among people with coronavirus disease
   2019 (COVID-19) does not show the true impact of the disease on
   communities. Therefore, this study aimed to calculate years of life lost
   (YLL) due to premature death in patients with COVID-19. Methods We
   performed a descriptive cross-sectional study based on data from one of
   the largest provinces of Iran, in the period 13 February 2020 to 17 May
   2021. We used WHO proposed guidelines for the calculation of the burden
   of diseases to calculate the YLL among patients with COVID-19, taking
   into consideration gender in different age groups. Results Findings
   showed that 13 628 deaths were due to COVID-19 with associated 249 309
   YLL. The study reported higher mortality among men (1222 cases) in the
   age group over 85 years than in women (840) of the same age group. The
   minimum number of YLL for men was 1749 in the 5-9 years age group and
   that for women was 1551 years in the 14-10 years age group. Conclusion
   The high number of deaths due to COVID-19 has led to high YLL due to
   premature death. The provision of adequate health care and appropriate
   policies will bring about a decrease in YLL due to COVID-19.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Mohammad-Pour, S (Corresponding Author), Iran Univ Med Sci, Sch Management \& Med Informat, Tehran 1996713883, Iran.
   Yousefi, Mehdi, Mashhad Univ Med Sci, Social Determinants Hlth Res Ctr, Mashhad 9137673119, Razavi Khorasan, Iran.
   Fazaeli, Somayeh, Mashhad Univ Med Sci, Sch Paramed Sci, Mashhad 9177648964, Razavi Khorasan, Iran.
   Mohammad-Pour, Saeed, Iran Univ Med Sci, Sch Management \& Med Informat, Tehran 1996713883, Iran.},
DOI = {10.1093/pubmed/fdab392},
EarlyAccessDate = {DEC 2021},
ISSN = {1741-3842},
EISSN = {1741-3850},
Keywords = {burden of disease; COVID-19; Iran; YLL},
Keywords-Plus = {MORTALITY; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Saeed\_Moahammadpur@yahoo.com},
Cited-References = {{[}Anonymous], 2021, MED CAR DAT MON SYST.
   Arolas HP., 2021, SCI REP-UK, V11, P1.
   Baloch S, 2020, TOHOKU J EXP MED, V250, P271, DOI 10.1620/tjem.250.271.
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896.
   Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644.
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397.
   Darab MG, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06126-8.
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4.
   Devleesschauwer B, 2020, INT J PUBLIC HEALTH, V65, P719, DOI 10.1007/s00038-020-01430-2.
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394.
   Green K., 2020, CTR EVIDENCE BASED M.
   Harper S, 2021, J POPUL AGEING, V14, P137, DOI 10.1007/s12062-021-09330-w.
   Helleringer Stephane, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.01a99f8342b42a58d806d7d1749574ea.
   Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1.
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5.
   Jo MW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e199.
   Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154.
   Lu L., 2020, J INFECT, V34, P18.
   Marois G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238678.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   McDonald SA, 2018, AM J EPIDEMIOL, V187, P1791, DOI 10.1093/aje/kwy021.
   Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392.
   Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x.
   Nurchis MC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124233.
   Oh IH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e300.
   Pradhan A, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00330-7.
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686.
   Quast T., 2021, J PUBLIC HLTH OXFORD, V43, P1.
   Quast T, 2020, J PUBLIC HEALTH-UK, V42, P717, DOI 10.1093/pubmed/fdaa159.
   Rommel A, 2021, DTSCH ARZTEBL INT, V118, P145, DOI 10.3238/arztebl.m2021.0147.
   Salamatbakhsh M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7899-2.
   Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215.
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2.
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648.
   Zhou Y, 2013, AM J EPIDEMIOL, V178, P1313, DOI 10.1093/aje/kwt120.},
Number-of-Cited-References = {35},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Public Health},
Doc-Delivery-Number = {ZN2KI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000764869100001},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000300265500022,
Author = {Kamel, Mohamed H. and Moore, Page C. and Bissada, Nabil K. and Heshmat,
   Samy M.},
Title = {Potential Years of Life Lost Due to Urogenital Cancer in the United
   States: Trends From 1972 to 2006 Based on Data From the SEER Database},
Journal = {JOURNAL OF UROLOGY},
Year = {2012},
Volume = {187},
Number = {3},
Pages = {868-871},
Month = {MAR},
Abstract = {Purpose: Urogenital cancer is a major health problem in the United
   States. We assessed potential years of life lost secondary to
   genitourinary cancer in the United States from 1972 to 2006 using the
   SEER (Surveillance, Epidemiology and End Results) database. We report
   trends in potential years of life lost during the same period.
   Materials and Methods: Potential years of life lost were calculated to
   assess premature mortality trends for ureter, bladder, kidney and renal
   pelvis, penis, testis and prostate cancers. Calculations were based on
   SEER cancer mortality data. Potential years of life lost up to and
   including age 75 years were calculated by and across genders in 5-year
   increments between 1972 and 2006.
   Results: A total of 7,733,235 potential years of life were lost in men
   and women. In each gender the greatest potential loss was for kidney and
   renal pelvis cancer related mortality. In each gender no improvement in
   the potential loss due to ureteral and bladder cancer related mortality
   was observed during 3 decades. In males the greatest decrease in
   potential years of life lost was for testicular cancer, followed by
   prostate cancer.
   Conclusions: There has been an increasing trend in potential years of
   life lost related to urogenital cancer during the last 35 years for
   males and females. This trend is mainly due to an increase in kidney
   cancer. The continued increase in potential years of life lost due to
   renal cancer and the lack of a decrease in the loss in those with
   bladder cancer should alert urologists and health care policy makers to
   deficient areas that most need to be addressed.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA},
Type = {Article},
Language = {English},
Affiliation = {Bissada, NK (Corresponding Author), Univ Arkansas Med Sci, Dept Urol, 4301 W Markham,540, Little Rock, AR 72205 USA.
   Bissada, Nabil K., Univ Arkansas Med Sci, Dept Urol, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA.},
DOI = {10.1016/j.juro.2011.10.142},
ISSN = {0022-5347},
EISSN = {1527-3792},
Keywords = {kidney; urogenital system; neoplasms; mortality; SEER program},
Keywords-Plus = {RENAL-CELL CARCINOMA; PROSTATE-CANCER; MORTALITY; OUTCOMES},
Research-Areas = {Urology \& Nephrology},
Web-of-Science-Categories  = {Urology \& Nephrology},
Author-Email = {bissadanabilk@uams.edu},
Cited-References = {Abouassaly R, 2010, UROLOGY, V76, P895, DOI 10.1016/j.urology.2010.04.020.
   Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696.
   Centers for Disease Control and Prevention, NAT VIT STAT REP.
   Gori S, 2005, CRIT REV ONCOL HEMAT, V53, P141, DOI 10.1016/j.critrevonc.2004.05.006.
   Gudbjartsson T, 2005, UROLOGY, V66, P1186, DOI 10.1016/j.urology.2005.07.009.
   HERNANDEZ BY, 2008, CANCER S, V15, P2883, DOI DOI 10.1111/J.1464-410X.2010.10032.X.
   HORM JW, 1989, AM J PUBLIC HEALTH, V79, P1490, DOI 10.2105/AJPH.79.11.1490.
   Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x.
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006.
   Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685.
   Kochanek KD, NATL VITAL STAT REPO, V59.
   O'Lorcain P, 2007, EUR J CANCER PREV, V16, P167, DOI 10.1097/01.cej.0000228408.68353.ba.
   Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6.
   SAGOLOWSKI AI, 2011, CAMPBELLWALSH UROLOG, V2, P1516, DOI DOI 10.1002/CNCR.24685.
   Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084.
   Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004.
   Yabroff KR, 2008, J NATL CANCER I, V100, P1755, DOI 10.1093/jnci/djn383.},
Number-of-Cited-References = {17},
Times-Cited = {21},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Urol.},
Doc-Delivery-Number = {892CY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000300265500022},
DA = {2022-03-29},
}

@article{ WOS:000494598100001,
Author = {Salazar, Alejandro and Moreno, Soledad and De Sola, Helena and Antonio
   Moral-Munoz, Jose and Duenas, Maria and Failde, Inmaculada},
Title = {The evolution of opioid-related mortality and potential years of life
   lost in Spain from 2008 to 2017: differences between Spain and the
   United States},
Journal = {CURRENT MEDICAL RESEARCH AND OPINION},
Year = {2020},
Volume = {36},
Number = {2},
Pages = {285-291},
Month = {FEB 1},
Abstract = {Objective: To investigate the evolution of opioid-related mortality and
   potential years of life lost in Spanish general population from 2008 to
   2017. To evaluate the differences between Spain and the US. Methods: A
   descriptive study using retrospective annual data from 2008 to 2017 in
   Spanish and US general population. Information on the population and
   opioid-related deaths stratified by age and sex was obtained from
   Spanish National Statistics Institute and the Centers for Disease
   Control and Prevention (CDC) WONDER Multiple Cause of Death Database,
   according to the ICD-10 codes. Years of life lost, crude and
   standardized mortality rates are reported and compared with the results
   in US. Results: Crude rate of opioid-related deaths per 10(6)
   inhabitants has changed from 1.68 in 2008 to 2.25 in 2017 in Spain, with
   around 30,000 years of life lost per year. The most affected groups were
   middle-aged men and women over 65, and the main cause of death was
   accidental poisoning. The standardized rates per 10 inhabitants across
   the years were between 1.19 and 1.62 in Spain and between 11.17 and
   20.68 in the US population. Conclusions: An opioid overuse crisis does
   not seem a likely scenario in Spain. However, it is a social problem
   that requires special health surveillance, particularly in middle-aged
   men and women over 65.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {De Sola, H (Corresponding Author), Univ Cadiz, Prevent Med \& Publ Hlth Area, Ave Ana de Viya 52, Cadiz 11009, Spain.
   Salazar, Alejandro; De Sola, Helena; Antonio Moral-Munoz, Jose; Duenas, Maria; Failde, Inmaculada, Biomed Res \& Innovat Inst Cadiz INiBICA, Cadiz, Spain.
   Salazar, Alejandro; De Sola, Helena; Antonio Moral-Munoz, Jose; Duenas, Maria; Failde, Inmaculada, Univ Cadiz, Observ Pain Dept, Cadiz, Spain.
   Salazar, Alejandro; Duenas, Maria, Univ Cadiz, Dept Stat \& Operat Res, Cadiz, Spain.
   Moreno, Soledad, Univ Cadiz, Dept Math, Cadiz, Spain.
   De Sola, Helena; Failde, Inmaculada, Univ Cadiz, Prevent Med \& Publ Hlth Area, Ave Ana de Viya 52, Cadiz 11009, Spain.
   Antonio Moral-Munoz, Jose, Univ Cadiz, Dept Nursing \& Physiotherapy, Cadiz, Spain.},
DOI = {10.1080/03007995.2019.1684251},
EarlyAccessDate = {NOV 2019},
ISSN = {0300-7995},
EISSN = {1473-4877},
Keywords = {Opioid; mortality; years of life lost; Spanish population; US population},
Keywords-Plus = {CHRONIC PAIN; ECONOMIC BURDEN; OVERDOSE DEATHS; OLDER-ADULTS; ABUSE;
   DEPENDENCE; ANALGESICS; SUBGROUPS; INCREASES; TRENDS},
Research-Areas = {General \& Internal Medicine; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal; Medicine, Research \& Experimental},
Author-Email = {helena.desolaperea@alum.uca.es},
ResearcherID-Numbers = {FCADIZ, INIBICA/AFS-0591-2022
   De Sola, Helena/AAM-7072-2020
   Dueñas, María/AAT-1354-2020
   Failde, Immaculada/AAL-8563-2020
   Moral-Munoz, Jose A./A-5893-2014
   Salazar, Alejandro/K-9183-2014
   },
ORCID-Numbers = {De Sola, Helena/0000-0003-0196-4875
   Failde, Immaculada/0000-0002-6603-3054
   Moral-Munoz, Jose A./0000-0002-6465-982X
   Salazar, Alejandro/0000-0001-9567-462X
   Duenas, Maria/0000-0003-4822-7258
   Moreno Pulido, Soledad/0000-0002-4537-9929},
Funding-Acknowledgement = {Grunenthal Foundation},
Funding-Text = {This work was supported by The Grunenthal Foundation, a private
   non-profit making organization that promotes the dissemination of
   scientific knowledge and supports research. This organization did not
   have any involvement in the design of the study and collection, analysis
   and interpretation of data or writing the manuscript.},
Cited-References = {Agencia Espanola de Medicamentos y Productos Sanitarios, 2017, UT MED OP ESP DUR PE.
   Ahmad O.B, 2001, GPE DISCUSSION PAPER, V31.
   {[}Anonymous], 2004, ICD 10 INT STAT CLAS.
   Ballantyne JC, 2017, ANESTH ANALG, V125, P1769, DOI 10.1213/ANE.0000000000002500.
   Becker JB, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-018-0215-5.
   Bosetti C, 2019, EUR J PAIN, V23, P697, DOI 10.1002/ejp.1337.
   Buse DC, 2012, HEADACHE, V52, P18, DOI 10.1111/j.1526-4610.2011.02050.x.
   Carew AM, 2018, DRUG ALCOHOL DEPEN, V182, P48, DOI 10.1016/j.drugalcdep.2017.10.007.
   Chartoff EH, 2016, NEUROPSYCHOPHARMACOL, V41, P383, DOI 10.1038/npp.2015.272.
   Chen YX, 2019, ANN INTERN MED, V170, P352, DOI 10.7326/M18-2415.
   Cicero TJ, 2009, PAIN, V144, P20, DOI 10.1016/j.pain.2009.01.026.
   de Sola H, 2018, J PAIN SYMPTOM MANAG, V55, P1095, DOI 10.1016/j.jpainsymman.2017.12.474.
   Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551.
   del Pozo JG, 2008, EUR J CLIN PHARMACOL, V64, P411, DOI 10.1007/s00228-007-0419-9.
   Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142.
   Duenas M, 2015, PAIN MED, V16, P811, DOI 10.1111/pme.12640.
   Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006.
   Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625.
   Fontanella AT, 2019, EUR J PAIN, V23, P639, DOI 10.1002/ejp.1359.
   Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217.
   Gomes T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002396.
   Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598.
   Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802.
   Jacobs AA, 2018, PRIMARY CARE, V45, P731, DOI 10.1016/j.pop.2018.08.002.
   Kaplovitch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134550.
   McAdam-Marx Carrie, 2010, J Pain Palliat Care Pharmacother, V24, P5, DOI 10.3109/15360280903544877.
   Meyer R, 2014, POPUL HEALTH MANAG, V17, P372, DOI 10.1089/pop.2013.0098.
   Niesters M, 2010, PAIN, V151, P61, DOI 10.1016/j.pain.2010.06.012.
   Observatorio Espanol de las Drogas y las Adicciones, 2017, INF 2017 ALC TAB DRO.
   Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487.
   Roxburgh A, 2017, DRUG ALCOHOL DEPEN, V179, P291, DOI 10.1016/j.drugalcdep.2017.07.018.
   Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1.
   Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391.
   Spanish National Statistics Institute, 2017, STAT DEATHS ACC CAUS.
   Spanish National Statistics Institute. Official website of the Spanish National Statistics Institute {[}Internet], 2018, OFF WEBS SPAN NAT ST.
   United Nations Office on Drugs and Crime, 2017, WORLD DRUG REP 2017.
   United States Department of Health and Human Services (Us Dhhs) CFDCaPC National Center for Health Statistics (Nchs), 2018, MULT CAUS DEATH 1999.
   Webster F, 2017, PAIN MED, V18, P1467, DOI 10.1093/pm/pnw352.
   White Alan G, 2005, J Manag Care Pharm, V11, P469.},
Number-of-Cited-References = {39},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Curr. Med. Res. Opin.},
Doc-Delivery-Number = {KK6HM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000494598100001},
DA = {2022-03-29},
}

@article{ WOS:000353943400038,
Author = {Castillo-Rodriguez, Liliana and Diaz-Jimenez, Diana and
   Castaneda-Orjuela, Carlos and De la Hoz-Restrepo, Fernando},
Title = {Years of Life Lost (YLL) in Colombia 1998-2011: Overall and Avoidable
   Causes of Death Analysis},
Journal = {PLOS ONE},
Year = {2015},
Volume = {10},
Number = {5},
Month = {MAY 5},
Abstract = {Objective
   Estimate the Years of Life Lost (YLL) for overall and avoidable causes
   of death (CoD) in Colombia for the period 1998-2011.
   Methods
   From the reported deaths to the Colombian mortality database during
   1998-2011, we classified deaths from avoidable causes. With the
   reference life table of the Global Burden of Disease (GBD) 2010 study,
   we estimated the overall YLL and YLL due to avoidable causes.
   Calculations were performed with the difference between life expectancy
   and the age of death. Results are reported by group of cause of death,
   events, sex, year and department. Comparative analysis between number of
   deaths and YLL was carried out.
   Results
   A total of 83,856,080 YLL were calculated in Colombia during period
   1998-2011, 75.9\% of them due to avoidable CoD. The year 2000 reported
   the highest number of missed YLL by both overall and avoidable CoD. The
   departments with the highest YLL rates were Caqueta, Guaviare, Arauca,
   Meta, and Risaralda. In men, intentional injuries and cardiovascular and
   circulatory diseases had the higher losses, while in women YLL were
   mainly due to cardiovascular and circulatory diseases.
   Conclusions
   The public health priorities should focus on preventing the loss of YLL
   due to premature death and differentiated interventions by sex.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Castillo-Rodriguez, L (Corresponding Author), Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.
   Castillo-Rodriguez, Liliana; Diaz-Jimenez, Diana; Castaneda-Orjuela, Carlos, Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.
   De la Hoz-Restrepo, Fernando, Inst Nacl Salud, Bogota, Colombia.},
DOI = {10.1371/journal.pone.0125456},
Article-Number = {e0125456},
ISSN = {1932-6203},
Keywords-Plus = {STANDARD EXPECTED YEARS; PREMATURE MORTALITY; BURDEN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {liliana.casro@gmail.com},
ResearcherID-Numbers = {Castañeda-Orjuela, Carlos/N-2601-2017
   },
ORCID-Numbers = {Castañeda-Orjuela, Carlos/0000-0002-8735-6223
   CASTILLO RODRIGUEZ, LILIANA/0000-0001-9251-6423},
Cited-References = {Arriaga EE, 2014, ANOS VIDA PERDIDOS U.
   Bonita R, 2008, BASIC EPIDEMIOLOGY.
   Cajka James C, 2010, Methods Rep RTI Press, V19, P1.
   Centers for Disease Control, 1986, MMWR S, V35, p1S.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Alvis Guzmán Nelson Rafael, 2004, Rev. salud pública, V6, P235.
   Londono JF, 1999, FACULTAD NACL SALUD, V16.
   Londono JL, 1995, METODOLOGIA INVESTIG.
   Lopez, 2002, SUMMARY MEASURES POP.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Minerba L, 1999, J PREVENTIVE MED HYG, V40, P99.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   National Health Observatory Colombia, 2014, 3 NAT HLTH OBS COL, P11.
   Organizacion Panamericana de la Salud, 2003, B EPIDEMIOL, V24, P1.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Toro MA, 2007, ANOS VIDA POTENCIALM.
   Vanegas Y, 2011, CES SALUD PUBLICA, V2, P159.
   World Health Organization, 2012, UND 5 MORT RAT GLOB.
   World Health Organization, 2012, HLTH STAT STAT MORT.
   Zuluaga AC, 2013, SEMESTRE EC, V16.},
Number-of-Cited-References = {23},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {CH3PT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000353943400038},
OA = {gold, Green Published, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000380974300013,
Author = {Bryla, Marek and Pikala, Malgorzata and Maniecka-Bryla, Irena},
Title = {YEARS OF LIFE LOST DUE TO PREMATURE MORTALITY IN A PROVINCE WITH THE
   SHORTEST LIFE EXPECTANCY IN POLAND},
Journal = {CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH},
Year = {2016},
Volume = {24},
Number = {2},
Pages = {156-162},
Month = {JUN},
Abstract = {Aim: The aim of the study was to evaluate years of life lost for
   citizens of the Lodz Province, which is characterized by the lowest life
   expectancy in Poland, and to identify current trends in this area
   according to the most common causes of death.
   Methods: The study material included a database containing information
   gathered from 470,000 death certificates of Lodz Province inhabitants,
   who died between 1999 and 2011. In order to calculate years of life
   lost, the authors applied the SEYLLp (Standard Expected Years of Life
   Lost per living person) and SEYLLd (per death) indices. The analysis of
   time trends was carried out with the application of joinpoint models.
   Results: The SEYLLp measure was 2,300 years per 10,000 males and 1,500
   years per 10,000 females in 2011. Cardiovascular diseases contributed to
   the highest number of years of life lost (SEYLLp = 682 years per 10,000
   males and 559 years per 10,000 females). Next were malignant neoplasms
   (SEYLLp = 505 years per 10,000 males and 437 years per 10,000 females),
   external causes of death (SEYLLp = 361 years per 10,000 males and 83
   years per 10,000 females). The number of years of life lost due to acute
   myocardial infarction decreased most rapidly, the Annual Percent Change
   (APC) was -10.1\% in males and -3.7\% in females. However, heart failure
   contributed to the highest increase in the number of years of life lost
   (APC = 10.8\% in males and 10.9\% in females).
   Conclusions: A further decrease in the mortality rate due to
   cardiovascular diseases might contribute to the highest reduction of
   years of life lost. The most effective preventive activities are those
   aimed at reducing productive years of life lost due to a particular
   cause of death, i.e. road traffic accidents, suicides, cirrhosis of the
   liver, alcoholic liver disease, and malignant neoplasms of the trachea,
   bronchi and lungs.},
Publisher = {NATL INST PUBLIC HEALTH},
Address = {DEPT SCIENTIFIC INFORMATION, SROBAROVA 48, PRAGUE 10, 100 42, CZECH
   REPUBLIC},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Dept Epidemiol \& Biostat, Zeligowskiego Str 7-9, PL-90742 Lodz, Poland.
   Bryla, Marek, Med Univ Lodz, Dept Social Med, Lodz, Poland.
   Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ Lodz, Dept Epidemiol \& Biostat, Zeligowskiego Str 7-9, PL-90742 Lodz, Poland.},
DOI = {10.21101/cejph.a4289},
ISSN = {1210-7778},
EISSN = {1803-1048},
Keywords = {standard expected years of life lost; premature mortality; burden of
   disease; Lodz province; Poland},
Keywords-Plus = {LUNG-CANCER MORTALITY; EUROPEAN-UNION; DEPRESSION; COUNTRIES; TOBACCO;
   8-YEAR; TRENDS; DEATH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Pikala, Malgorzata/S-9898-2016
   Maniecka-Bryla, Irena/AAW-5779-2021
   Bryla, Marek/AAW-5787-2021},
ORCID-Numbers = {Pikala, Malgorzata/0000-0003-4426-4908
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Bryla, Marek/0000-0001-6757-9211},
Funding-Acknowledgement = {National Science CentreNational Science Centre, Poland
   {[}DEC-2013/11/B/HS4/00465]},
Funding-Text = {The project was financed by the National Science Centre (Decision no.
   DEC-2013/11/B/HS4/00465).},
Cited-References = {Amiri M, 2011, J EPIDEMIOL COMMUN H, V65, P676, DOI 10.1136/jech.2010.109058.
   Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136.
   Bray F, 2004, EUR J CANCER, V40, P96, DOI 10.1016/j.ejca.2003.08.005.
   Didkowska J, 2005, BMJ-BRIT MED J, V331, P189, DOI 10.1136/bmj.331.7510.189.
   Didkowska J, 2009, PREDICTION CANC INCI.
   Didkowska J, 2009, CANC POLAND 2007.
   Dziankowska-Zaborszczyk E, 2014, MED PR, V65, P251.
   Eurostat, 2009, HLTH STAT ATL MORT E.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463.
   Jasinski B., 2008, ZDR PUBL, V118, P36.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Levi F, 2004, CANCER-AM CANCER SOC, V101, P2843, DOI 10.1002/cncr.20666.
   Malvezzi M, 2012, ANN ONCOL, V23, P1044, DOI 10.1093/annonc/mds024.
   Maniecka-Bryla I, 2013, INT J OCCUP MED ENV, V26, P724, DOI 10.2478/s13382-013-0154-7.
   Maniecka-Bryla I, 2013, ANN AGR ENV MED, V20, P794.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Murray CJL, 2000, GLOBAL BURDEN DIS CO, VI.
   Oquendo MA, 2007, AM J PSYCHIAT, V164, P134, DOI 10.1176/appi.ajp.164.1.134.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Rywik Stefan L, 2003, Kardiol Pol, V58, P344.
   Sapinski W, 1999, KARDIOLPOL, V50, P111.
   Tyczynski JE, 2004, INT J CANCER, V109, P598, DOI 10.1002/ijc.20019.
   United Nations Economic Commission for Europe, STAT DAT.
   Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010.
   Walinder J, 2001, INT CLIN PSYCHOPHARM, V16, pS21.
   World Health Organization, EUR HLTH ALL DAT HFA.},
Number-of-Cited-References = {33},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Cent. Eur. J. Public Health},
Doc-Delivery-Number = {DS7PB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000380974300013},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000350319600001,
Author = {Maniecka-Bryla, Irena and Bryla, Marek and Bryla, Pawel and Pikala,
   Malgorzata},
Title = {The burden of premature mortality in Poland analysed with the use of
   standard expected years of life lost},
Journal = {BMC PUBLIC HEALTH},
Year = {2015},
Volume = {15},
Month = {FEB 7},
Abstract = {Background: Despite positive changes in the health of the population of
   Poland, compared to the EU average, the average life expectancy in 2011
   was 5 years shorter for males and 2.2 years shorter for females. The
   immediate cause is the great number of premature deaths, which results
   in years of life lost in the population. The aim of the study was to
   identify the major causes of years of life lost in Poland.
   Methods: The analysis was based on a database of the Central Statistical
   Office of Poland, containing information gathered from 375,501 death
   certificates of inhabitants of Poland who died in 2011. The SEYLLp
   (Standard Expected Years of Life Lost per living person) and the SEYLLd
   (SEYLL per death) measures were calculated to determine years of life
   lost.
   Results: In 2011, the total number of years of life lost by in Polish
   residents due to premature mortality was 2,249,213 (1,415,672 for males
   and 833,541 for females). The greatest number of years of life lost in
   males were due to ischemic heart disease (7.8 per 1,000), lung cancer
   (6.0), suicides (6.6), cerebrovascular disease (4.6) and road traffic
   accidents (5.4). In females, the factors contributing to the greatest
   number of deaths were cerebrovascular disease (3.8 per 1,000), ischemic
   heart disease (3.7), heart failure (2.7), lung cancer (2.5) and breast
   cancer (2.3). Regarding the individual scores per person in both males
   and females, the greatest death factors were road traffic accidents
   (20.2 years in males and 17.1 in females), suicides (17.4 years in males
   and 15.4 in females) and liver cirrhosis (12.1 years in males and 11.3
   in females).
   Conclusions: It would be most beneficial to further reduce the number of
   deaths due to cardiovascular diseases, because they contribute to the
   greatest number of years of life lost. Moreover, from the economic point
   of view, the most effective preventative activities are those which
   target causes which result in a large number of years of life lost at
   productive age for each death due to a particular reason, i.e. road
   traffic accidents, suicides and liver cirrhosis.},
Publisher = {BIOMED CENTRAL LTD},
Address = {236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Zeligowskiego 7-9, Lodz, Poland.
   Maniecka-Bryla, Irena; Pikala, Malgorzata, Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Lodz, Poland.
   Maniecka-Bryla, Irena; Bryla, Marek, Med Univ Lodz, Chair Social \& Prevent Med, Dept Social Med, Lodz, Poland.
   Bryla, Pawel, Univ Lodz, Dept Int Mkt \& Retailing, PL-90131 Lodz, Poland.},
DOI = {10.1186/s12889-015-1487-x},
Article-Number = {101},
ISSN = {1471-2458},
Keywords = {Standard expected years of life lost; Premature mortality; Burden of
   disease; Poland},
Keywords-Plus = {EUROPEAN-UNION; COUNTRIES; POPULATION; DISEASE; 8-YEAR},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Bryla, Marek/AAW-5787-2021
   Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016
   Bryła, Paweł/B-8262-2013},
ORCID-Numbers = {Bryla, Marek/0000-0001-6757-9211
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Pikala, Malgorzata/0000-0003-4426-4908
   Bryła, Paweł/0000-0003-1535-5659},
Funding-Acknowledgement = {National Science CentreNational Science Centre, Poland
   {[}DEC-2013/11/B/HS4/00465]},
Funding-Text = {The study was conducted with financial help from the National Science
   Centre, no. DEC-2013/11/B/HS4/00465.},
Cited-References = {Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136.
   Bray F, 2004, EUR J CANCER, V40, P96, DOI 10.1016/j.ejca.2003.08.005.
   Didkowska J, 2009, PROGNOZY ZACHOROWALN.
   Dziankowska-Zaborszczyk E, 2014, MED PR, V65, P251.
   Eurostat, 2009, HLTH STAT ATL MORT E.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Levi F, 2004, CANCER-AM CANCER SOC, V101, P2843, DOI 10.1002/cncr.20666.
   Levi F, 2003, ANN ONCOL, V14, P490, DOI 10.1093/annonc/mdg110.
   Malvezzi M, 2012, ANN ONCOL, V23, P1044, DOI 10.1093/annonc/mds024.
   Maniecka-Bryla I, 2013, INT J OCCUP MED ENV, V26, P724, DOI 10.2478/s13382-013-0154-7.
   Maniecka-Bryla I, 2013, ANN AGR ENV MED, V20, P794.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Murray CJ, WHO SYSTEM MODEL LIF.
   Murray CJL, 2000, GLOBAL BURDEN DIS, V1.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Rywik S, 2003, KARDIOL POL, V58, P350.
   Tyczynski JE, 2004, INT J CANCER, V109, P598, DOI 10.1002/ijc.20019.
   Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010.
   Wojtyniak B., 2012, SYTUACJA ZDROWOTNA L.},
Number-of-Cited-References = {27},
Times-Cited = {41},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {CC4JL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000350319600001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000296654200001,
Author = {Genova-Maleras, Ricard and Catala-Lopez, Ferran and Fernandez de
   Larrea-Baz, Nerea and Alvarez-Martin, Elena and Morant-Ginestar,
   Consuelo},
Title = {The burden of premature mortality in Spain using standard expected years
   of life lost: a population-based study},
Journal = {BMC PUBLIC HEALTH},
Year = {2011},
Volume = {11},
Month = {OCT 11},
Abstract = {Background: Measures of premature mortality have been used to guide
   debates on future health priorities and to monitor the population health
   status. Standard expected years of life lost (SEYLL) is one of the
   methods used to assess the time lost due to premature death. This
   article affords an overview of premature mortality in Spain for the year
   2008.
   Methods: A population-based study was conducted estimating SEYLL by sex
   and age groups. SEYLL, a key component of the disability-adjusted life
   years measure of disease burden, was calculated using Princeton West
   standard life tables with life expectancy at birth fixed at 80 years for
   males and 82.5 years for females. Population data and specific death
   records were obtained from the official registers of the National
   Institute of Statistics. All data were analysed and prepared in GesMor
   and Epidat software packages.
   Results: The burden of premature mortality was estimated at 2.1 million
   SEYLL when age at death is taken into account. Males lost 60.9\% and
   females lost 39.1\% of total SEYLL. Malignant tumors (34.5\%) and
   cardiovascular diseases (24.0\%) were the leading categories in terms of
   SEYLL. Ischaemic heart disease (8.5\%) and lung cancers (8.0\%) were the
   most common specific causes of SEYLL followed by cerebrovascular
   diseases (5.9\%), colorectal cancer (4.1\%), road traffic accidents
   (3.5\%), Alzheimer and other dementias (2.9\%), chronic obstructive
   pulmonary disease (2.8\%), breast cancer (2.8\%) and suicides (2.6\%).
   Conclusions: In Spain, premature mortality was essentially due to
   chronic non-communicable diseases. Data provided in this study are
   relevant for a more balanced health agenda aimed at reducing the burden
   of premature mortality. This study also represents a first step in
   estimating the overall burden of disease in terms of premature death and
   disability.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Genova-Maleras, R (Corresponding Author), Reg Hlth Council, Primary Care Gen Directorate, Madrid, Spain.
   Genova-Maleras, Ricard, Reg Hlth Council, Primary Care Gen Directorate, Madrid, Spain.
   Catala-Lopez, Ferran, CSISP, Valencia, Spain.
   Catala-Lopez, Ferran, Fdn Inst Invest Serv Salud, Valencia, Spain.
   Fernandez de Larrea-Baz, Nerea, Reg Hlth Council, Lain Entralgo Agcy, Hlth Technol Assessment Unit, Madrid, Spain.
   Alvarez-Martin, Elena, Rey Juan Carlos Univ, Dept Prevent Med \& Publ Hlth, Madrid, Spain.
   Alvarez-Martin, Elena, Spanish Minist Hlth Social Policy \& Equal, Madrid, Spain.
   Morant-Ginestar, Consuelo, Reg Hlth Council, Dept Hlth Informat Syst, Madrid, Spain.},
DOI = {10.1186/1471-2458-11-787},
Article-Number = {787},
EISSN = {1471-2458},
Keywords-Plus = {PUBLIC-HEALTH UTILITY; DEATH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ricard.genova@salud.madrid.org},
ResearcherID-Numbers = {Catalá-López, Ferrán/N-6018-2018},
ORCID-Numbers = {Catalá-López, Ferrán/0000-0002-3833-9312},
Funding-Acknowledgement = {Instituto de Salud Carlos III, Spanish Ministry of Health and Social
   PolicyInstituto de Salud Carlos III {[}PS09/00086)]; Spanish Ministry of
   Science and InnovationSpanish Government},
Funding-Text = {All authors are supported by the Instituto de Salud Carlos III (Grant
   PS09/00086) from the Spanish Ministry of Health and Social Policy and
   the Spanish Ministry of Science and Innovation. The views expressed are
   those of the authors and should not be understood or quoted as being
   made on behalf of or reflecting the position of any academic or public
   health institution.},
Cited-References = {Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8.
   BENAVIDES FG, 1989, AM J PUBLIC HEALTH, V79, P1352, DOI 10.2105/AJPH.79.10.1352.
   Bonita R., 2006, BASIC EPIDEMIOLOGY.
   Bonneux L, 2002, J EPIDEMIOL COMMUN H, V56, P128, DOI 10.1136/jech.56.2.128.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI 10.1590/s1135-57272009000100011.
   Catala-Lopez F, 2011, J HYPERTENS.
   Centers for Disease Control, 1986, MMWR S, V35, p1S.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Conselleria de Sanidade Xunta de Galicia and Pan American Health Organization (PAHO), 2011, EP VERS 4 0 AN EP DA.
   Departamento de Salud Internacional, 2001, GESMOR SOFTW VERS 1.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Instituto Nacional de Estadistica (INE), 2011, PROJ CURR POP YEAR 2.
   Instituto Nacional de Fstadistica (INF, 2011, AN DEATH REC MICR YE.
   Lopez, 2002, SUMMARY MEASURES POP.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Perez-Gomez Beatriz, 2006, Gac Sanit, V20 Suppl 3, P42, DOI 10.1157/13101089.
   Spanish Ministry of Health, 2007, DIAB STRAT SPAN NAT.
   Spanish Ministry of Health, 2009, COPD STRAT SPAN NAT.
   Spanish Ministry of Health, 2011, PALL CAR STRAT SPAN.
   Spanish Ministry of Health, 2009, STROK STRAT SPAN NAT.
   Spanish Ministry of Health and Social Policy, 2010, CANC STRAT SPAN NAT.
   Spanish Ministry of Health Social Policy and Equality, 2011, MENT HLTH STRAT SPAN.
   Spanish Ministry of Health Social Policy and Equality, 2009, ISCH HEART DIS STRAT.
   Spanish Ministry of Health Social Policy and Equality, 2009, QUAL PLAN NAT HLTH S.
   Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010.
   WHO, 2001, NAT BURD DIS STUD PR.
   World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U.},
Number-of-Cited-References = {31},
Times-Cited = {35},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {843ED},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000296654200001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000497787600424,
Author = {Al-Shamsi, Saif and Govender, Romona Devi and Soteriades, Elpidoforos S.},
Title = {Mortality and potential years of life lost attributable to non-optimal
   glycaemic control in men and women with diabetes in the United Arab
   Emirates: a population-based retrospective cohort study},
Journal = {BMJ OPEN},
Year = {2019},
Volume = {9},
Number = {9},
Month = {SEP},
Abstract = {Objectives Numerous studies reported that achieving near-normal glycated
   haemoglobin (HbA1c) levels in patients with diabetes may delay or even
   prevent vascular complications. However, information regarding the
   impact of non-optimal HbA1c control on adverse health outcomes in an
   Arab population is unknown. The aim of this study was to estimate the
   fraction of deaths and potential years of life lost (PYLL) attributable
   to non-optimal HbA1c control among Emirati men and women with diabetes
   in the United Arab Emirates (UAE).
   Design A retrospective cohort study.
   Setting This study was conducted in outpatient clinics at a tertiary
   care centre in Al Ain, UAE, between April 2008 and September 2018.
   Participants The sample comprised of 583 adult UAE nationals, aged >= 18
   years, with diabetes. Overall, 57\% (n=332) of the study participants
   were men and 43\% (n=251) were women.
   Exposure Non-optimal HbA1c control, defined as HbA1c >= 6.5\%.
   Primary outcome measure All-cause mortality, defined as death from any
   cause.
   Results At the end of the 9-year follow-up period, 86 (14.8\%)
   participants died. Overall, up to 33\% (95\% CI 2\% to 63\%) of deaths
   were attributable to non-optimal HbA1c control among patients with
   diabetes mellitus (DM). Stratified by sex, the adjusted fraction of
   avoidable mortality was 17\% (95\% CI -23\% to 57\%) for men and 50\%
   (95\% CI 3\% to 98\%) for women. Both deaths and PYLL attributable to
   non-optimal HbA1c control were higher in women compared with men.
   Conclusions Up to one-third of all deaths in adult UAE nationals with DM
   could be attributed to non-optimal HbA1c control. Effective sex-specific
   interventions and healthcare quality-improvement programmes should
   urgently be implemented.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Al-Shamsi, S (Corresponding Author), United Arab Emirates Univ, Coll Med \& Hlth Sci, Internal Med, Al Ain, U Arab Emirates.
   Al-Shamsi, Saif, United Arab Emirates Univ, Coll Med \& Hlth Sci, Internal Med, Al Ain, U Arab Emirates.
   Govender, Romona Devi, United Arab Emirates Univ, Coll Med \& Hlth Sci, Family Med, Al Ain, U Arab Emirates.
   Soteriades, Elpidoforos S., United Arab Emirates Univ, Coll Med \& Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.},
DOI = {10.1136/bmjopen-2019-032654},
Article-Number = {e032654},
ISSN = {2044-6055},
Keywords = {diabetes; glycated haemoglobin; mortality; population-attributable
   fraction; potential years of life lost; United Arab Emirates},
Keywords-Plus = {CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; SEX-DIFFERENCES;
   ALL-CAUSE; TYPE-2; CARE; HYPERGLYCEMIA; METAANALYSIS; MANAGEMENT;
   MELLITUS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {salshamsi@uaeu.ac.ae},
ResearcherID-Numbers = {Shamsi, Saif Al/AAR-3410-2020
   Govender, Romona/AAR-9829-2020},
ORCID-Numbers = {Shamsi, Saif Al/0000-0001-9755-3493
   Govender, Romona/0000-0003-3393-9594},
Funding-Acknowledgement = {College of Medicine and Health Sciences, UAE University {[}31M325]},
Funding-Text = {This work was supported by the College of Medicine and Health Sciences,
   UAE University (grant number 31M325).},
Cited-References = {Al-Hussein FA, 2008, ANN SAUDI MED, V28, P267.
   Ali Malik A, 2015, J DIABETES METAB DIS, V2, DOI {[}10.15406/jdmdc.2015.02.00026, DOI 10.15406/JDMDC.2015.02.00026].
   {[}Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001.
   {[}Anonymous], 2018, STAT YB AB DHAB.
   Barnett KN, 2010, DIABETIC MED, V27, P1124, DOI 10.1111/j.1464-5491.2010.03075.x.
   Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X.
   Cefalu WT, 2019, DIABETES CARE, V42, pS61, DOI 10.2337/dc19-S006.
   Charpentier G, 2003, DIABETES METAB, V29, P152, DOI 10.1016/S1262-3636(07)70022-8.
   Choe SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196719.
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486.
   Dahlqwist E, 2016, EUR J EPIDEMIOL, V31, P575, DOI 10.1007/s10654-016-0137-7.
   Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194.
   Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337.
   Guisasola FA, 2008, DIABETES OBES METAB, V10, P8, DOI 10.1111/j.1463-1326.2008.00881.x.
   Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258.
   Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C.
   International Diabetes Federation, 2017, IDF DIABETES ATLAS.
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441.
   Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898.
   Karter AJ, 2014, DIABETES CARE, V37, P3188, DOI 10.2337/dc14-0874.
   Khunti K, 2018, DIABETES OBES METAB, V20, P427, DOI 10.1111/dom.13088.
   Koornneef E, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2597-1.
   Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91.
   Magnan EM, 2015, BMJ OPEN DIAB RES CA, V3, DOI {[}10.1136/bmjdrc-2015-000080, 10.1136/bmjdrc-2015000080].
   Natarajan S, 2003, ARCH INTERN MED, V163, P1735, DOI 10.1001/archinte.163.14.1735.
   National High Blood Pressure Education Program, 2004, 7 REP JOINT NAT COMM.
   Navarro-Perez J, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0914-1.
   Ratsep A, 2010, EUR J GEN PRACT, V16, P85, DOI 10.3109/13814788.2010.481017.
   Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256.
   Roche MM, 2013, DIABETES CARE, V36, P2582, DOI 10.2337/dc12-1272.
   Roglic G, 2016, INT J NONCOMMUNICABL, V1, P3, DOI 10.4103/2468-8827.184853.
   Saran R, 2015, AM J KIDNEY DIS, V66, P545, DOI 10.1053/j.ajkd.2015.05.001.
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9.
   Saydah SH, 2002, AM J EPIDEMIOL, V156, P714, DOI 10.1093/aje/kwf111.
   Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y.},
Number-of-Cited-References = {35},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {BMJ Open},
Doc-Delivery-Number = {JO7XE},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000497787600424},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000324728300001,
Author = {Plass, Dietrich and Chau, Patsy Yuen Kwan and Thuan Quoc Thach and Jahn,
   Heiko J. and Lai, Poh Chin and Wong, Chit Ming and Kraemer, Alexander},
Title = {Quantifying the burden of disease due to premature mortality in Hong
   Kong using standard expected years of life lost},
Journal = {BMC PUBLIC HEALTH},
Year = {2013},
Volume = {13},
Month = {SEP 18},
Abstract = {Background: To complement available information on mortality in a
   population Standard Expected Years of Life Lost (SEYLL), an indicator of
   premature mortality, is increasingly used to calculate the
   mortality-associated disease burden. SEYLL consider the age at death and
   therefore allow a more accurate view on mortality patterns as compared
   to routinely used measures (e. g. death counts). This study provides a
   comprehensive assessment of disease and injury SEYLL for Hong Kong in
   2010.
   Methods: To estimate the SEYLL, life-expectancy at birth was set
   according to the 2004 Global Burden of Disease study at 82.5 and 80
   years for females and males, respectively. Cause of death data for 2010
   were corrected for misclassification of cardiovascular and cancer
   causes. In addition to the baseline estimates, scenario analyses were
   performed using alternative assumptions on life-expectancy (Hong Kong
   standard life-expectancy), time-discounting and age-weighting. To
   estimate a trend of premature mortality a time-series analysis from 2001
   to 2010 was conducted.
   Results: In 2010 524,706.5 years were lost due to premature death in
   Hong Kong with 58.3\% of the SEYLL attributable to male deaths. The
   three overall leading single causes of SEYLL were ``trachea, bronchus
   and lung cancers{''}, ``ischaemic heart disease{''} and ``lower
   respiratory infections{''} together accounting for about 29\% of the
   overall SEYLL. Further, self-inflicted injuries (5.6\%; ranked 5) and
   liver cancer (4.9\%; ranked 7) were identified as important causes not
   adequately captured by classical mortality measures. Scenario analyses
   highlighted that by using a 3\% time-discount rate and non-uniform
   age-weights the SEYLL dropped by 51.6\%. Using Hong Kong's standard
   life-expectancy values resulted in an overall increase of SEYLL by
   10.8\% as compared to the baseline SEYLL. Time-series analysis indicates
   an overall increase of SEYLL by 6.4\%. In particular, group I
   (communicable, maternal, perinatal and nutritional) conditions showed
   highest increases with SEYLL-rates per 100,000 in 2010 being 1.4 times
   higher than 2001.
   Conclusions: The study stresses the mortality impact of diseases and
   injuries that occur in earlier stages of life and thus presents the
   SEYLL measure as a more sensitive indicator compared to classical
   mortality indicators. SEYLL provide useful additional information and
   supplement available death statistics.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Plass, D (Corresponding Author), Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany.
   Plass, Dietrich; Jahn, Heiko J.; Kraemer, Alexander, Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany.
   Chau, Patsy Yuen Kwan; Thuan Quoc Thach; Wong, Chit Ming, Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.
   Lai, Poh Chin, Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China.},
DOI = {10.1186/1471-2458-13-863},
Article-Number = {863},
ISSN = {1471-2458},
Keywords = {Burden of disease; Hong Kong; Standard expected years of life lost;
   SEYLL},
Keywords-Plus = {HEALTH; CANCER; TRENDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {dietrich.plass@uni-bielefeld.de},
ResearcherID-Numbers = {Kraemer, Alexander/F-8832-2016
   },
ORCID-Numbers = {Kraemer, Alexander/0000-0003-2774-7860
   Thach, Thuan quoc/0000-0003-3404-3888
   Lai, PC/0000-0003-2458-5405},
Funding-Acknowledgement = {Hong Kong Research Grants Council (RGC)Hong Kong Research Grants
   Council; German Academic Exchange Service (DAAD) under the Germany/Hong
   Kong Joint Research Scheme (HK) {[}G\_HK032/10, 50751245]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG); Bielefeld
   University},
Funding-Text = {This study was supported by the Hong Kong Research Grants Council (RGC)
   and the German Academic Exchange Service (DAAD) under the Germany/Hong
   Kong Joint Research Scheme (HK Grant no: G\_HK032/10; GER Project-ID
   50751245).r We acknowledge support of the publication fee by Deutsche
   Forschungsgemeinschaft and the Open Access Publication Funds of
   Bielefeld University.},
Cited-References = {Allard Yvon E, 2004, Health Rep, V15, P51.
   Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2.
   Anand S, 1998, WORLD DEV.
   Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004.
   Au JSK, 2004, LUNG CANCER, V45, P143, DOI 10.1016/j.lungcan.2004.01.012.
   Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Census and Statistics Department, 2018, HONG KONG ANN DIG ST.
   Cheung KSL, 2010, EUR J AGEING, V7, P257, DOI 10.1007/s10433-010-0171-3.
   Chuang YC, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.126961.
   Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015.
   Field MJ, 1998, SUMMARIZING POPULATI, P85.
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   HK SAR Census and Statistics Department, 2011, 48 SOC SURV SECT CEN.
   HK SAR Government Department, 2010, HONG KONG YB 2010.
   Hong Kong Census and Statistics Department, 2011, HONG KONG SAR 2001 2.
   Horton R, 2009, LANCET, V373, P355, DOI 10.1016/S0140-6736(09)60116-1.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9.
   Lozano R, 2001, MISCODING MISCLASSIF.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Marmot M., 2009, BMJ-BRIT MED J, V338, P858.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Murray CJL, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P233.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   OECD, 2011, HLTH GLANC 2011 OECD, DOI DOI 10.1787/HEALTH\_.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Shah A, 2007, INT PSYCHOGERIATR, V19, P1141, DOI 10.1017/S1041610207005285.
   Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010.
   Werber D, 2012, EPIDEMIOL INFECT, V338, P1.
   World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U.
   Zhou Shang-Cheng, 2011, Environmental Health and Preventive Medicine, V16, P148, DOI 10.1007/s12199-010-0176-8.},
Number-of-Cited-References = {37},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {11},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {222JY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000324728300001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000587725900019,
Author = {Shahbazi, Fatemeh and Mirtorabi, Davood and Ghadirzadeh, Mohammad Reza
   and Shojaei, Ahmad and Nazari, Seyed Saeed Hashemi},
Title = {Years of Life Lost (YLL) Due to Substance Abuse in Iran, in 2014-2017:
   Global Burden of Disease 2010 Method},
Journal = {IRANIAN JOURNAL OF PUBLIC HEALTH},
Year = {2020},
Volume = {49},
Number = {11},
Pages = {2170-2178},
Month = {NOV},
Abstract = {Background: Using dexmedetomidine (Dex) as a sedative agent may benefit
   the clinical outcomes of post-surgery patients. We reviewed randomized
   controlled trials (RCTs) to assess whether use of a Dex could improve
   the outcomes in post-surgery critically ill adults.
   Methods: We searched Medline, Embase, PubMed, and the Cochrane databases
   for RCTs comparing Dex with propofol or a placebo in post-operative
   patients, all included RCTs should be published in English before Jul
   2016. Citations meeting inclusion criteria were full screened, and trial
   available data were abstracted independently and the Cochrane risk of
   bias tool was used for quality assessment.
   Results: Sixteen RCTs involving 2568 patients were subjected to this
   meta-analysis. The use of a Dex sedative regimen was associated with a
   reduce delirium prevalence {[}odd ratio (OR):0.33, 95\% confidence
   intervals (CI): 0.24-0.45, I-2= 5\%, P<0.0011, a shorter the length of
   ICU stay {[}mean difference (MD): -0.60, 95\%CI: -0.69 to -0.50,
   I-2=40\%, P<0.0011 and the length of hospital stay {[}MD: -0.68, 95\%CI:
   -1.21 to -0.16, I-2=0\%, P=0.011. However, using of Dex could not
   shorter the duration of mechanical ventilation {[}MD: -10.18. 95\%CI:
   -31.08-10.72, I-2=99\%, P=0.34], but could shorter the time to
   extubation in post-surgery patients {[}MD: -47.46, 95\%CI: -84.63-10.67,
   I-2=98\%, P=0.011.
   Conclusion: The use of a Dex sedative regimen was associated with a
   reduce delirium prevalence, a shorter the length of ICU and hospital
   stay, and a shorter time to extubation in post-surgery critical ill
   patients.},
Publisher = {IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY},
Address = {SCHOOL PUBLIC HEALTH \& INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN},
Type = {Article},
Language = {English},
Affiliation = {Nazari, SSH (Corresponding Author), Shahid Beheshti Univ Med Sci, Sch Publ Hlth \& Safety, Dept Epidemiol, Safety Promot \& Injury Prevent Res Ctr, Tehran, Iran.
   Shahbazi, Fatemeh, Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Hamadan, Iran.
   Mirtorabi, Davood, Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci \& Addict Studies, Tehran, Iran.
   Ghadirzadeh, Mohammad Reza; Shojaei, Ahmad, Legal Med Org, Legal Med Res Ctr, Tehran, Iran.
   Nazari, Seyed Saeed Hashemi, Shahid Beheshti Univ Med Sci, Sch Publ Hlth \& Safety, Dept Epidemiol, Safety Promot \& Injury Prevent Res Ctr, Tehran, Iran.},
ISSN = {2251-6085},
EISSN = {2251-6093},
Keywords = {Dexmedetomidine; Sedation; Mechanical ventilation; Delirium},
Keywords-Plus = {DRUG-USE; ALCOHOL-USE; MORTALITY; CANADA; USERS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Saeedh\_1999@yahoo.com},
Funding-Acknowledgement = {Vice -Chancellor of Research and Technology of Shahid Beheshti
   University of Medical Sciences {[}IR.SBMU.PHNS.REC.1397.078]},
Funding-Text = {This study (ID: IR.SBMU.PHNS.REC.1397.078) was funded by the Vice
   -Chancellor of Research and Technology of Shahid Beheshti University of
   Medical Sciences. The funders had no role in study design, data
   collection, and analysis, decision to publish, or preparation of the
   manuscript.},
Cited-References = {Azhdar F, 2017, J RES HEALTH SCI, V17.
   Baheiraei A, 2013, IRAN RED CRESCENT ME, V15, P212, DOI 10.5812/ircmj.4022.
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5.
   Fischer B, 2005, J URBAN HEALTH, V82, P250, DOI 10.1093/jurban/jti049.
   Ghoreishi SMS, 2017, J RES HEALTH SCI, V17.
   Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217.
   Green P, 2009, IEEE INT CONF AUTOM, P52, DOI 10.1109/ASE.2009.93.
   Hayden A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1153.
   Moazen B, 2015, ARCH IRAN MED, V18, P480, DOI 015188/AIM.004.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x.
   Rehm J., 2006, CONTEMP DRUG PROBL, V33, P343.
   Scherbaum N, 2008, INT J METH PSYCH RES, V17, pS39, DOI 10.1002/mpr.244.
   Scott KM, 2010, PSYCHOL MED, V40, P1495, DOI 10.1017/S0033291709991942.
   Shahbazi F, 2018, IRAN J EPIDEMIOL, V14, P9.
   Shahbazi Fatemeh, 2018, Addict Health, V10, P260, DOI 10.22122/ahj.v10i4.602.
   Shahbazi Fatemeh, 2017, Addict Health, V9, P166.
   Statistical Center of Iran, 2018, POP COUNTR TERMS GEN.},
Number-of-Cited-References = {18},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Iran J. Public Health},
Doc-Delivery-Number = {OO9WH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000587725900019},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000226543800008,
Author = {Burnet, NG and Jefferies, SJ and Benson, RJ and Hunt, DP and Treasure,
   FP},
Title = {Years of life lost (YLL) from cancer is an important measure of
   population burden - and should be considered when allocating research
   funds},
Journal = {BRITISH JOURNAL OF CANCER},
Year = {2005},
Volume = {92},
Number = {2},
Pages = {241-245},
Month = {JAN 31},
Abstract = {Recently, cancer mortality has been compared to research spending by the
   National Cancer Research Institute ( NCRI), whose research budget is
   approximately pound250 million. The analysis shows a mis- match between
   mortality and research spending. As well as crude mortality rates, other
   measures of cancer burden should be considered because they contribute
   additional information. ` Years of life lost' ( YLL) summed over each
   individual dying after a diagnosis of cancer represents a population-
   based mortality indicator of the impact of that disease on society.
   Years of life lost divided by the number of deaths for each cancer site
   produces an additional statistic, the average years of life lost (
   AYLL), which is a measure of the burden of cancer to the individual
   patient. For 17 cancer sites where data are available, four tumour sites
   have a rather large difference in mortality, comparing YLL to crude
   mortality. Years of life lost shows the population burden from cancers
   of the ovary, cervix, and CNS to be rather larger than suggested by
   crude mortality, despite screening programmes for cervix cancer. Using
   YLL, the underprovision of funding for lung cancer research is similar
   to that reported using percentage mortality. Breast cancer and leukaemia
   receive a relatively higher research spend than the population burden of
   these cancers, and the spending on leukaemia is quite extreme. Prostate
   cancer has a low per cent YLL but attracts a moderate amount of research
   spending. The use of AYLL as an indicator of individual cancer burden
   considerably changes the ranking of the mortality from different
   tumours. The mean AYLL is 12.5 years. Prostate cancer has the lowest
   AYLL, only 6.1 years; brain tumour patients have the highest, at just
   over 20 years. Comparing AYLL to research spending suggests four `
   Cinderella' cancer sites with high individual cancer burden but low
   research spending: CNS tumours, cervix and kidney cancers, and melanoma.
   Breast cancer and leukaemia have roughly average AYLL but a considerable
   excess of research spending. YLL emphasises the discrepancy between
   research spending and mortality, and may be helpful for decisions
   concerning research support. Avearage years of life lost measures the
   burden to individual patients and may be helpful where individuals'
   needs are relevant, such as palliative care. As well as crude mortality,
   more subtle and comprehensive calculations of mortality statistics would
   be useful in debates on research funding and public health issues.},
Publisher = {NATURE PUBLISHING GROUP},
Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Burnet, NG (Corresponding Author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Box 193,Hills Rd, Cambridge CB2 2QQ, England.
   Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England.
   Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England.
   Addenbrookes Hosp, Sch Clin, E Anglian Canc Intelligence Unit, Cambridge CB2 2SP, England.},
DOI = {10.1038/sj.bjc.6602321},
ISSN = {0007-0920},
Keywords = {years of life lost; mortality; research spending},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {ngb21@cam.ac.uk},
ResearcherID-Numbers = {Burnet, Neil/L-1025-2019},
Cited-References = {{*}BMJ NEWS, 2002, BRIT MED J, V325, P920.
   {*}CRUK, 2004, MORT STAT.
   {*}NCRI, 2002, NAT CANC RES I STRAT.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.},
Number-of-Cited-References = {4},
Times-Cited = {228},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {20},
Journal-ISO = {Br. J. Cancer},
Doc-Delivery-Number = {890XF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000226543800008},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000726464800001,
Author = {Ni, Yang and Song, Wang and Bai, Yu and Liu, Tao and Li, Guoxing and
   Bian, Ying and Zeng, Qiang},
Title = {Years of Life Lost (YLL) Due to Short-Term Exposure to Ambient Air
   Pollution in China: A Systematic Review and Meta-Analysis},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2021},
Volume = {18},
Number = {21},
Month = {NOV},
Abstract = {(1) Background: Years of life lost (YLL) as a surrogate of health is
   important for supporting ambient air pollution related policy decisions.
   However, there has been little comprehensive evaluation of the
   short-term impact of air pollution on cause-specific YLL, especially in
   China. Hence in this study, we selected China as sentinel region in
   order to conduct a meta-analysis to evaluate disease-specific YLL due to
   all the main ambient air pollutants. (2) Methods: A meta-analysis was
   conducted to evaluate disease-specific YLL due to the main ambient air
   pollutants in China, and 19 studies were included. We conducted
   methodological quality and risk of bias assessment for each included
   study as well as for heterogeneity and publication bias. Subgroup
   analysis and sensitivity analysis were also performed. (3) Results:
   Meta-analysis indicated that increases in PM2.5, PM10, SO2 and NO2 were
   associated with 1.99-5.84 years increase in YLL from non-accidental
   diseases. The increase in YLL to cardiovascular disease (CVD) was
   associated with PM10 and NO2, and the increase in YLL to respiratory
   diseases (RD) was associated with PM10. (4) Conclusions: Ambient air
   pollution was observed to be associated with several cause-specific YLL,
   increasing especially for elderly people and females.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Review},
Language = {English},
Affiliation = {Zeng, Q (Corresponding Author), Tianjin Ctr Dis Control \& Prevent, Tianjin 300011, Peoples R China.
   Zeng, Q (Corresponding Author), Tianjin Med Univ, Sch Publ Hlth, Tianjin 300070, Peoples R China.
   Ni, Yang; Song, Wang; Zeng, Qiang, Tianjin Ctr Dis Control \& Prevent, Tianjin 300011, Peoples R China.
   Song, Wang; Bian, Ying, Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa 999078, Macao, Peoples R China.
   Bai, Yu; Liu, Tao; Zeng, Qiang, Tianjin Med Univ, Sch Publ Hlth, Tianjin 300070, Peoples R China.
   Li, Guoxing, Peking Univ, Sch Publ Hlth, Dept Occupat \& Environm Hlth, Beijing 100191, Peoples R China.},
DOI = {10.3390/ijerph182111467},
Article-Number = {11467},
EISSN = {1660-4601},
Keywords = {ambient air pollution; years of life lost; meta-analysis; short-term
   exposure; disease burden; health effects},
Keywords-Plus = {FINE PARTICULATE MATTER; DAILY MORTALITY; TIME-SERIES; PM10 POLLUTION;
   HEALTH IMPACT; GLOBAL BURDEN; DISEASE; ASSOCIATION; RISK; CITY},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {ni1989yang@163.com
   wang.song@connect.um.edu.mo
   berrypei1996@126.com
   gwyxstt@163.com
   liguoxing@bjmu.edu.cn
   bianyingumac@126.com
   zengqianghaiyan@126.com},
ORCID-Numbers = {ceng, qiang/0000-0002-9288-7387},
Funding-Acknowledgement = {National Natural Science Foundation Project of ChinaNational Natural
   Science Foundation of China (NSFC) {[}81872590]},
Funding-Text = {The study was funded by the National Natural Science Foundation Project
   of China {[}grant numbers:81872590].},
Cited-References = {Achilleos S, 2017, ENVIRON INT, V109, P89, DOI 10.1016/j.envint.2017.09.010.
   Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29.
   Al-Hemoud A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112609.
   Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090.
   Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615.
   Booth A, 2008, HEALTH INFO LIBR J, V25, P313, DOI 10.1111/j.1471-1842.2008.00825.x.
   Castillo-Rodriguez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125456.
   Chen DY, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134909.
   Chen F, 2017, SCI TOTAL ENVIRON, V581, P426, DOI 10.1016/j.scitotenv.2016.12.151.
   Chen F, 2017, SCI TOTAL ENVIRON, V576, P775, DOI 10.1016/j.scitotenv.2016.10.161.
   Chen Z, 2013, LANCET, V382, P1959, DOI 10.1016/S0140-6736(13)62064-4.
   DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002.
   Dhaini HR, 2017, ENVIRON SCI POLLUT R, V24, P14151, DOI 10.1007/s11356-017-9000-y.
   Doi SAR, 2017, INT J EVID-BASED HEA, V15, P152, DOI 10.1097/XEB.0000000000000125.
   Doi SAR, 2015, CONTEMP CLIN TRIALS, V45, P130, DOI 10.1016/j.cct.2015.05.009.
   Dzhambov AM, 2018, ENVIRON POLLUT, V240, P306, DOI 10.1016/j.envpol.2018.04.122.
   Fan SJ, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134721.
   Faridi S, 2018, ENVIRON INT, V114, P37, DOI 10.1016/j.envint.2018.02.026.
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   Furuya-Kanamori L, 2018, INT J EVID-BASED HEA, V16, P195, DOI 10.1097/XEB.0000000000000141.
   Gao TT, 2015, SCI TOTAL ENVIRON, V511, P268, DOI 10.1016/j.scitotenv.2014.11.048.
   Goldberg MS, 2013, SCI TOTAL ENVIRON, V463, P931, DOI 10.1016/j.scitotenv.2013.06.095.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Huang J, 2018, ENVIRON POLLUT, V242, P1266, DOI 10.1016/j.envpol.2018.08.021.
   Huang J, 2018, LANCET PLANET HEALTH, V2, pE313, DOI 10.1016/S2542-5196(18)30141-4.
   Huang J, 2018, ENVIRON RES, V164, P255, DOI 10.1016/j.envres.2018.02.033.
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012.
   Kan Haidong, 2010, Res Rep Health Eff Inst, P17.
   Lai HK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-360.
   Lam J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161851.
   Li GX, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0253-1.
   Li J, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P331, DOI 10.3760/cma.j.issn.0254-6450.2019.03.014.
   Li X, 2019, SCI TOTAL ENVIRON, V691, P549, DOI 10.1016/j.scitotenv.2019.06.382.
   Liang HQ, 2018, SCI TOTAL ENVIRON, V615, P558, DOI 10.1016/j.scitotenv.2017.09.266.
   Lin HL, 2017, ADV EXP MED BIOL, V1017, P103, DOI 10.1007/978-981-10-5657-4\_5.
   Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364.
   Liu Shiwei, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P327.
   Lopez, 2002, SUMMARY MEASURES POP.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029.
   MANTEL N, 1959, J NATL CANCER I, V22, P719.
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI {[}10.1016/j.ijsu.2010.02.007, 10.1136/bmj.g7647, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086].
   Morgan RL, 2018, ENVIRON INT, V121, P1027, DOI 10.1016/j.envint.2018.07.015.
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126.
   Ni Y., 2017, J PUBL HLTH PREV MED, V28, P8.
   Ni Y., 2017, J ENVIRON HEALTH, V34, P408.
   Office of Health Assessment and Translation (OHAT), 2019, HDB COND LIT BAS HLT.
   Ohlwein S, 2019, INT J PUBLIC HEALTH, V64, P547, DOI 10.1007/s00038-019-01202-7.
   Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010.
   Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37.
   Sun MQ, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134985.
   Szyszkowicz M, 2016, ENVIRON HEALTH INSIG, V10, P155, DOI {[}10.4137/EHI.S40493, 10.4137/ehi.s40493].
   Thurston GD, 2001, J EXPO ANAL ENV EPID, V11, P286, DOI 10.1038/sj.jea.7500169.
   van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623.
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2.
   Wuthrich B, 2013, INT ARCH ALLERGY IMM, V162, P45, DOI 10.1159/000351416.
   Yang BY, 2018, ENVIRON POLLUT, V235, P576, DOI 10.1016/j.envpol.2018.01.001.
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1.
   Yang J, 2020, ENVIRON INT, V143, DOI 10.1016/j.envint.2020.105927.
   Yang J, 2016, SCI TOTAL ENVIRON, V573, P1566, DOI 10.1016/j.scitotenv.2016.09.014.
   Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076759.
   Yin P, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1849.
   Yoon SJ, 2015, INT J ENV RES PUB HE, V12, P7938, DOI 10.3390/ijerph120707938.
   Yu YQ, 2019, ENVIRON RES, V170, P7, DOI 10.1016/j.envres.2018.11.041.
   Zeng Q, 2018, Zhonghua Xin Xue Guan Bing Za Zhi, V46, P50, DOI 10.3760/cma.j.issn.0253-3758.2018.01.009.
   Zeng Q, 2019, ENVIRON SCI POLLUT R, V26, P6931, DOI 10.1007/s11356-019-04123-3.
   Zeng Q, 2018, ATMOS ENVIRON, V172, P26, DOI 10.1016/j.atmosenv.2017.10.046.
   Zeng Q, 2017, ENVIRON RES, V157, P71, DOI 10.1016/j.envres.2017.05.004.
   Zeng Q, 2017, ENVIRON POLLUT, V220, P713, DOI 10.1016/j.envpol.2016.10.036.
   Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1.
   Zhang YQ, 2017, ENVIRON POLLUT, V230, P1073, DOI 10.1016/j.envpol.2017.07.053.
   Zheng XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138146.
   Zhu JY, 2017, ENVIRON POLLUT, V224, P689, DOI 10.1016/j.envpol.2017.02.053.},
Number-of-Cited-References = {76},
Times-Cited = {0},
Usage-Count-Last-180-days = {11},
Usage-Count-Since-2013 = {11},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {XJ0BK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000726464800001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000484383300041,
Author = {Martinez, Ramon and Soliz, Patricia and Caixeta, Roberta and Ordunez,
   Pedro},
Title = {Reflection on modern methods: years of life lost due to premature
   mortality-a versatile and comprehensive measure for monitoring
   non-communicable disease mortality},
Journal = {INTERNATIONAL JOURNAL OF EPIDEMIOLOGY},
Year = {2019},
Volume = {48},
Number = {4},
Pages = {1367-1376},
Month = {AUG},
Abstract = {The analysis of causes impacting on premature mortality is an essential
   function of public health surveillance. Diverse methods have been used
   for accurately assessing and reporting the level and trends of premature
   mortality; however, many have important limitations, particularly in
   capturing actual early deaths. We argue that the framework of years of
   life lost (YLL), as conceptualized in disability-adjusted life-years
   (DALYs), is a robust and comprehensive measure of premature mortality.
   Global Burden of Disease study is systematically providing estimates of
   YLL; however, it is not widely adopted at country level, among other
   reasons because its conceptual and methodological bases seem to be not
   sufficiently known and understood. In this paper, we provide the
   concepts and the methodology of the YLL framework, including the
   selection of the loss of function that defines the time lost due to
   premature deaths, and detailed methods for calculating YLL metrics. We
   also illustrate how to use YLL to quantify the level and trends of
   premature non-communicable disease (NCD) mortality in the Americas. The
   tutorial style of the illustrative example is intended to educate the
   public health community and stimulate the use of YLL in disease
   prevention and control programmes at different levels.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Martinez, R (Corresponding Author), Pan Amer Hlth Org, Dept Noncommunicable Dis \& Mental Hlth, 525 23rd St NW, Washington, DC 20037 USA.
   Martinez, Ramon; Caixeta, Roberta; Ordunez, Pedro, Pan Amer Hlth Org, Dept Noncommunicable Dis \& Mental Hlth, 525 23rd St NW, Washington, DC 20037 USA.
   Soliz, Patricia, Pan Amer Hlth Org, Dept Evidence \& Intelligence Act Hlth, Washington, DC 20037 USA.},
DOI = {10.1093/ije/dyy254},
ISSN = {0300-5771},
EISSN = {1464-3685},
Keywords = {Mortality; premature; epidemiological method; non-communicable diseases;
   public health surveillance},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {martiner@paho.org},
ORCID-Numbers = {Martinez-Piedra, Ramon/0000-0003-0641-0206},
Cited-References = {{[}Anonymous], 2017, JOINP REGR PROGR VER.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Coale AJ, 1983, REGIONAL MODEL LIFE.
   Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930.
   Fleiss JL., 1973, STAT METHODS RATES P.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Global burden of disease study 2015, 2016, GLOB BURD DIS STUD 2.
   Lopez A.D., 2001, GPE DISCUSSION PAPER.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   United Nations, 2017, WORLD POP PROSP 2017.
   United Nations, 2013, WORLD POP PROSP 2017.
   United Nations, 2015, TRANSF OUR WORLD 203.
   WHO, 2015, GLOB ACT PLAN ANT RE.
   WHO, 2016, GLOB HLTH EST 2015 D.
   World Health Organization, 2014, NONC DIS GLOB MON FR.
   World Health Organization, 2017, WHOHISIERGHE20163.
   World Health Organization, 2012, GLOB MON FRAM PREV C.},
Number-of-Cited-References = {18},
Times-Cited = {26},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Int. J. Epidemiol.},
Doc-Delivery-Number = {IV6MU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000484383300041},
OA = {Green Published, hybrid},
DA = {2022-03-29},
}

@article{ WOS:000648782500002,
Author = {Wengler, Annelene and Rommel, Alexander and Plass, Dietrich and Gruhl,
   Heike and Leddin, Janko and Ziese, Thomas and von der Lippe, Elena and
   Burden 2020 Study Grp},
Title = {Years of Life Lost to Death},
Journal = {DEUTSCHES ARZTEBLATT INTERNATIONAL},
Year = {2021},
Volume = {118},
Number = {9},
Pages = {137+},
Month = {MAR 5},
Abstract = {Background: Knowing which diseases and causes of death account for most
   of the years of life lost (YLL) can help to better target appropriate
   prevention and intervention measures. The YLL in Germany for specific
   causes of death were estimated as part of the BURDEN 2020 project at the
   Robert Koch Institute.
   Methods: Data from cause-of-death statistics were used for the analysis.
   ICD codes were grouped into causes of death categories at different
   levels of disaggregation. The YLL were estimated by combining each cause
   of death with the remaining life expectancy at the age of death. Deaths
   and YLL were compared by sex, age category, and regional distribution.
   Results: Approximately 11.6 million years were estimated to be lost in
   Germany in 2017, of which 42.8\% were lost by women and 57.2\% by men.
   The largest number of YLL were due to (malignant) neoplasms (35.2\%),
   followed by cardiovascular diseases (27.6\%), gastrointestinal diseases
   (5.8\%), and neurological diseases (5.7\%). Deaths at younger ages had a
   greater impact on population health if expressed in YLL: the death share
   of persons under age 65 was 14.7\%, but the years of life lost in this
   age group amounted to 38.3\% of all YLL. The most common causes of death
   in this group include accidents, self-injury and violence, malignant
   neoplasms, and alcohol-related diseases.
   Conclusion: A large proportion of YLL is borne by young and middle-aged
   persons. These findings emphasize the need to introduce preventive
   strategies early in life to reduce the YLL at younger ages, as well as
   to prevent risk factors for diseases in older ages.},
Publisher = {DEUTSCHER AERZTE-VERLAG GMBH},
Address = {DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {von der Lippe, E (Corresponding Author), Robert Koch Inst, Abt Epidemiol \& Gesundheitsmonitoring 2, Nordufer 20, D-13353 Berlin, Germany.
   Wengler, Annelene; Rommel, Alexander; Leddin, Janko; Ziese, Thomas; von der Lippe, Elena, Robert Koch Inst, Dept Epidemiol \& Hlth Monitoring 2, Berlin, Germany.
   Plass, Dietrich; Gruhl, Heike, German Environm Agcy, Dept Environm Hyg 2 1, Berlin, Germany.},
DOI = {10.3238/arztebl.m2021.0148},
ISSN = {1866-0452},
Keywords-Plus = {GLOBAL BURDEN; DISEASE; MORTALITY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Funding-Acknowledgement = {Federal Joint Committee {[}01VSF17007]},
Funding-Text = {The study ``BURDEN 2020: Burden of disease in Germany at the national
   and regional level{''} is supported by the innovation fund of the
   Federal Joint Committee (project number 01VSF17007).},
Cited-References = {American Public Health Association, 2019, PUBL HLTH COD ETH.
   Belgian National Burden of Disease Study (BeBOD), BELGIAN NATL BURDEN.
   Bundesinstitut fur BauStadtund Raumforschung, IND KART RAUM STADT.
   Cornez A., 2020, BELGIAN NATL BURDEN.
   Devleesschauwer B, 2020, INT J PUBLIC HEALTH, V65, P719, DOI 10.1007/s00038-020-01430-2.
   GBD 2017 Causes of Death Collaborators, 2018, LANCET, V392, P1736, DOI DOI 10.1016/S0140-6736(18)32203-7.
   Global Burden of Disease Collaborative Network, 2018, GLOBAL BURDEN DIS ST.
   Kyu HH, 2018, LANCET, V392, P1859, DOI {[}10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3].
   Lee K, 2009, GLOB INST, P1.
   Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7.
   Luy M, 2003, POPUL DEV REV, V29, P647, DOI 10.1111/j.1728-4457.2003.00647.x.
   Martinez R, 2019, INT J EPIDEMIOL, V48, P1367, DOI 10.1093/ije/dyy254.
   Mesalles-Naranjo O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196906.
   Murray CJL, 2017, LANCET, V390, P1460, DOI 10.1016/S0140-6736(17)32367-X.
   Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Naghavi M., MASTER CAUSE LIST GB.
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9.
   National Institute for Public Health and the Environment (RIVM), 2018, INT MEAS PUBL HLTH F.
   Plass D, 2014, DTSCH ARZTEBL INT, V111, P629, DOI 10.3238/arztebl.2014.0629.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Rau R, 2020, DTSCH ARZTEBL INT, V117, P493, DOI 10.3238/arztebl.2020.0493.
   Robert Koch-Institut, DIAB SURV VERL LEB.
   Robert Koch-Institut: BURDEN, 2020, POT NUTZ.
   Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119.
   Rommel A, 2018, BUNDESGESUNDHEITSBLA, V61, P1159, DOI 10.1007/s00103-018-2793-0.
   Scotland NH., 2015, SCOTT BURD DIS STUD.
   Statistisches Bundesamt, Sterbetafeln 2016/2018, nach Bundeslandern. Durchschnittliche Lebenserwartung (Periodensterbetafel).
   Taksler GB, 2017, AM J PUBLIC HEALTH, V107, P1653, DOI {[}10.2105/AJPH.2017.303986, 10.2105/ajph.2017.303986].
   Verschuuren M, 2020, EUR J PUBLIC HEALTH, V30, P30, DOI 10.1093/eurpub/ckz200.
   Wengler A, 2020, ARCH PUBLIC HEALTH, V79.
   Wengler A, 2019, BUNDESGESUNDHEITSBLA, V62, P1485, DOI 10.1007/s00103-019-03054-1.},
Number-of-Cited-References = {33},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Dtsch. Arztebl. Int.},
Doc-Delivery-Number = {RZ7LG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000648782500002},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000397102200013,
Author = {Bryla, Marek and Maniecka-Bryla, Irena and Burzynska, Monika and Pikala,
   Malgorzata},
Title = {Years of life lost of inhabitants of rural areas in Poland due to
   premature mortality caused by external reasons of death 1999-2012},
Journal = {ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE},
Year = {2016},
Volume = {23},
Number = {4},
Pages = {598-603},
Abstract = {Introduction. External causes of death are the third most common causes
   of death, after cardiovascular diseases and malignant neoplasms, in
   inhabitants of Poland. External causes of death pose the greatest threat
   to people aged 5-44, which results in a great number of years of life
   lost.
   Objective. The aim of the study is the analysis of years of life lost
   due to external causes of death among rural inhabitants in Poland,
   particularly due to traffic accidents and suicides.
   Material and methods. The study material included a database created on
   the basis of 2,100,785 certificates of rural inhabitants in Poland in
   the period 1999-2012. The SEYLLp (Standard Expected Years of Life Lost
   per living person) and the SEYLLd (per death) indices were used to
   determine years of life lost due to external causes of death. Joinpoint
   models were used to analyze time trends.
   Results. In the period 1999-2012, 151,037 rural inhabitants died due to
   external causes, including 27.2\% due to traffic accidents and 25.2\%
   due to suicides. In 2012, the SEYLLp was 1,817 per 100,000 males and 298
   per 100,000 females. Among males, suicides (SEYLLp = 633 years per
   100,000) and traffic accidents (SEYLLp = 473 years per 100,000)
   contributed to the largest number of years of life lost. Among females,
   SEYLLp values were: 109 years due to traffic accidents and 69 years due
   to suicides (per 100,000). Among males, SEYLLp values started to
   decrease in 2008 at the average annual rate of 3.2\%. In the group of
   females in the period 1999-2012, SEYLLp values were decreasing by 2.4\%
   per year.
   Conclusions. The decreasing trend of the number of lost years of life
   due to external causes among rural inhabitants does not apply to
   suicides among men. The SEYLLp due to this group of causes has been
   steadily increasing since 1999. Analysis of the years of life lost
   focuses on the social and economic aspects of premature mortality due to
   external causes.},
Publisher = {INST AGRICULTURAL MEDICINE},
Address = {JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ, Dept Epidemiol \& Biostat, Chair Social \& Prevent Med, Zeligowskiego 7-9, PL-90752 Lodz, Poland.
   Bryla, Marek, Med Univ, Dept Social Med, Chair Social \& Prevent Med, Lodz, Poland.
   Maniecka-Bryla, Irena; Burzynska, Monika; Pikala, Malgorzata, Med Univ, Dept Epidemiol \& Biostat, Chair Social \& Prevent Med, Zeligowskiego 7-9, PL-90752 Lodz, Poland.},
DOI = {10.5604/12321966.1226853},
ISSN = {1232-1966},
EISSN = {1898-2263},
Keywords = {external reasons of death; suicides; traffic accidents; years of life
   lost; Poland},
Keywords-Plus = {SUICIDE MORTALITY; HEALTH; URBAN; INEQUALITIES; DEPRIVATION; TRENDS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Bryla, Marek/AAW-5787-2021
   Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Bryla, Marek/0000-0001-6757-9211
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Burzynska, Monika/0000-0001-9875-7383
   Pikala, Malgorzata/0000-0003-4426-4908},
Funding-Acknowledgement = {National Science CentreNational Science Centre, Poland
   {[}DEC-2013/11/B/HS4/00465]},
Funding-Text = {The study was financed by the National Science Centre
   (DEC-2013/11/B/HS4/00465).},
Cited-References = {Fogelholm M, 2006, SCAND J PUBLIC HEALT, V34, P632, DOI 10.1080/14034940600616039.
   Gilmore ABC, 2002, SOC SCI MED, V55, P2177, DOI 10.1016/S0277-9536(01)00361-6.
   Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X.
   Hofer P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-644.
   Kalediene R, 2004, ECON HUM BIOL, V2, P87, DOI 10.1016/j.ehb.2003.12.001.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Krzyzak M, 2015, ANN AGR ENV MED, V22, P564, DOI 10.5604/12321966.1168657.
   Leinsalu M, 2002, SOC SCI MED, V55, P847, DOI 10.1016/S0277-9536(01)00221-0.
   MAINOUS AG, 1995, J COMMUN HEALTH, V20, P423, DOI 10.1007/BF02260438.
   Makinen IH, 2006, SOC SCI MED, V63, P307, DOI 10.1016/j.socscimed.2006.01.002.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6.
   Murray CJ, WHO SYSTEM MODEL LIF.
   Murray CJL, 2000, GLOBAL BURDEN DIS, V1.
   Oquendo MA, 2007, AM J PSYCHIAT, V164, P134, DOI 10.1176/appi.ajp.164.1.134.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Powles J, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-24.
   Rockett IRH, 2011, SUICIDOL ONLINE-SOL, V2, P48.
   Senior M, 2000, SOC SCI MED, V51, P289, DOI 10.1016/S0277-9536(99)00454-2.
   Skog OJ, 2001, ADDICTION, V96, pS49.
   Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084.
   Twisk DAM, 2007, J SAFETY RES, V38, P245, DOI 10.1016/j.jsr.2007.03.006.
   Verheij RA, 1996, SOC SCI MED, V42, P923, DOI 10.1016/0277-9536(95)00190-5.
   Walinder J, 2001, INT CLIN PSYCHOPHARM, V16, pS21.
   Wojtyniak B., 2012, SYTUACJA ZDROWOTNA L.},
Number-of-Cited-References = {29},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Ann. Agr. Env. Med.},
Doc-Delivery-Number = {EP0UM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000397102200013},
OA = {gold, Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000497732000001,
Author = {Salamatbakhsh, Maryam and Mobaraki, Kazhal and Sadeghimohammadi, Sara
   and Ahmadzadeh, Jamal},
Title = {The global burden of premature mortality due to the Middle East
   respiratory syndrome (MERS) using standard expected years of life lost,
   2012 to 2019},
Journal = {BMC PUBLIC HEALTH},
Year = {2019},
Volume = {19},
Number = {1},
Month = {NOV 14},
Abstract = {Background It has been 8 years since the first case of Middle East
   respiratory syndrome coronavirus (MERS-CoV) was reported in Saudi Arabia
   and the disease is still being reported in 27 countries; however, there
   is no international study to estimate the overall burden related of this
   emerging infectious disease. The present study was conducted to assess
   the burden of premature mortality due to Middle East respiratory
   syndrome (MERS) worldwide. Methods In this retrospective analysis, we
   have utilized publicly available data from the WHO website related to
   1789 MERS patients reported between September 23, 2012 and May 17, 2019.
   To calculate the standard expected years of life lost (SEYLL), life
   expectancy at birth was set according to the 2000 global burden of
   disease study on levels 25 and 26 of West model life tables from
   Coale-Demeny at 82.5 and 80 years for females and males, respectively.
   Results Overall, the total SEYLL in males and females was 10,702 and
   3817.5 years, respectively. The MERS patients within the age range of
   30-59 year-olds had the highest SEYLL (8305.5 years) in comparison to
   the patients within the age groups 0-29 (SEYLL = 3744.5 years) and >= 60
   years (SEYLL = 2466.5 years). The total SEYLL in all age groups in 2012,
   2013, 2014, 2015, 2016, 2017, 2018, and 2019 were 71.5, 2006.5, 3162,
   4425.5, 1809.5, 878, 1257.5 and 909 years, respectively. The most SEYLL
   related to MERS-CoV infection was in the early four years of the onset
   of the pandemic (2012 to 2015) and in the last four years of the
   MERS-CoV pandemic (216 to 2019), a significant reduction was observed in
   the SEYLL related to MERS-CoV infection in the MERS patients. Conclusion
   We believe that the findings of this study will shed light about the
   burden of premature mortality due to MERS infection in the world and the
   results may provide necessary information for policy-makers to prevent,
   control, and make a quick response to the outbreak of MERS-CoV disease.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Ahmadzadeh, J (Corresponding Author), Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Orumiyeh, Iran.
   Salamatbakhsh, Maryam, Urmia Univ Med Sci, Crit Care Nursing, Orumiyeh, Iran.
   Mobaraki, Kazhal; Ahmadzadeh, Jamal, Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Orumiyeh, Iran.
   Sadeghimohammadi, Sara, Zanjan Univ Med Sci, Sch Nursing \& Midwifery, Crit Care Nursing, Zanjan, Iran.},
DOI = {10.1186/s12889-019-7899-2},
Article-Number = {1523},
EISSN = {1471-2458},
Keywords = {Standard expected years of life; Premature mortality; Burden of disease;
   Worldwide},
Keywords-Plus = {SYNDROME CORONAVIRUS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Ahmadzadeh.j@umsu.ac.ir},
Cited-References = {Aghazadeh-Attari J, 2019, CRISIS, V40, P407, DOI 10.1027/0227-5910/a000581.
   Aghazadeh-Attari J, 2018, INT J GEN MED, V11, P121, DOI 10.2147/IJGM.S160741.
   Ahmadzadeh J, 2019, INT J GEN MED, V12, P305, DOI 10.2147/IJGM.S215396.
   Ahmed AE, 2018, EPIDEMIOL INFECT, V146, P489, DOI {[}10.1017/S095026881700293X, 10.1017/s095026881700293x].
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686.
   Dziankowska-Zaborszczyk E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213581.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230.
   Gordis L, 2008, EPIDEMIOLOGY, P42.
   Maniecka-Bryla I, 2018, ADV CLIN EXP MED, V27, P743, DOI 10.17219/acem/69227.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Marshall R., 2010, HDB DIS BURDENS QUAL, P401, DOI {[}10.1007/978-0-387-78665-0\_22, DOI 10.1007/978-0-387-78665-0\_22].
   Mobaraki K, 2019, J URMIA U MED SCI, V30, P41.
   Mobaraki K, 2019, HEALTH SECUR, V17, P407, DOI 10.1089/hs.2019.0074.
   Mobaraki K, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3987-2.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Poorolajal J, 2012, EPIDEMIOL HEALTH, V34, DOI 10.4178/epih/e2012005.
   Rabaan AA, 2017, EXPERT REV RESP MED, V11, P901, DOI 10.1080/17476348.2017.1367288.
   Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI {[}10.1080/22221751.2019.1597644, 10.6084/m9.figshare.7937462.v3].
   Yang YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10402-1.
   Yen EY, 2018, ARCH DIS CHILD.},
Number-of-Cited-References = {24},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {JO7BX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000497732000001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000180226400029,
Author = {Fontaine, KR and Redden, DT and Wang, CX and Westfall, AO and Allison,
   DB},
Title = {Years of life lost due to obesity},
Journal = {JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
Year = {2003},
Volume = {289},
Number = {2},
Pages = {187-193},
Month = {JAN 8},
Abstract = {Context Public health officials and organizations have disseminated
   health messages regarding the dangers of obesity, but these have not
   produced the desired effect.
   Objective To estimate the expected number of years of life lost (YLL)
   due to overweight and obesity across the life span of an adult.
   Design, Setting, and Subjects Data from the (1) US Life Tables (1999);
   (2) Third National Health and Nutrition Examination Survey (NHANES III;
   1988-1994); and (3) First National Health and Nutrition Epidemiologic
   Follow-up Study (NHANES I and II; 1971-1992) and NHANES II, Mortality
   Study (1976-1992) were used to derive YLL estimates for adults aged 18
   to 85 years. Body mass index (BMI) integer-defined categories were used
   (ie, <17; 17 to <18; 18 to <19; 20 to <21; 21 to 45; or greater than or
   equal to45). A BMI of 24 was used as the reference category.
   Main Outcome Measure The difference between the number of years of life
   expected if an individual were obese vs not obese, which was designated
   YLL.
   Results Marked race and sex differences were observed in estimated YLL.
   Among whites, a J- or U-shaped association was found between overweight
   or obesity and YLL. The optimal BMI (associated with the least YLL or
   greatest longevity) is approximately 23 to 25 for whites and -23 to 30
   for blacks. For any given degree of overweight, younger adults generally
   had greater YLL than did older adults. The maximum YLL for white men
   aged 20 to 30 years with a severe level of obesity (BMI >45) is 13 and
   is 8 for white women. For men, this could represent a 22\% reduction in
   expected remaining life span. Among black men and black women older than
   60 years, overweight and moderate obesity were generally not associated
   with an increased YLL and only severe obesity resulted in YLL. However,
   blacks at younger ages with severe levels of obesity had a maximum YLL
   of 20 for men and 5 for women.
   Conclusion Obesity appears to lessen life expectancy markedly,
   especially among younger adults.},
Publisher = {AMER MEDICAL ASSOC},
Address = {330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA},
Type = {Article},
Language = {English},
Affiliation = {Allison, DB (Corresponding Author), Univ Alabama Birmingham, Dept Biostat, 327 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.
   Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.
   Univ Alabama Birmingham, Clin Nutr Res Ctr, Sect Stat Genet, Birmingham, AL 35294 USA.
   Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA.},
DOI = {10.1001/jama.289.2.187},
ISSN = {0098-7484},
EISSN = {1538-3598},
Keywords-Plus = {BODY-MASS INDEX; ALL-CAUSE MORTALITY; WHITE; DISEASE; COHORT; HEALTH;
   MEN},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {dallison@ms.soph.uab.edu},
ResearcherID-Numbers = {Kohn, Geoffrey P/A-9056-2009
   },
ORCID-Numbers = {Westfall, Andrew/0000-0002-0468-4695
   Allison, David/0000-0003-3566-9399},
Funding-Acknowledgement = {NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health \& Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes \& Digestive \&
   Kidney Diseases (NIDDK) {[}P30DK056336] Funding Source: NIH RePORTER;
   NIDDK NIH HHSUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes \& Digestive \& Kidney Diseases (NIDDK) {[}P30DK56336]
   Funding Source: Medline},
Cited-References = {Allison D. B., 2001, International textbook of obesity, P31, DOI 10.1002/0470846739.ch3.
   Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875.
   Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530.
   Allison DB, 1997, AM J EPIDEMIOL, V146, P672.
   Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275.
   Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194.
   Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925.
   ANDRES R, 1985, PRINCIPLES GERIATRIC, P311.
   Berman DM, 2001, J CLIN ENDOCR METAB, V86, P97, DOI 10.1210/jc.86.1.97.
   Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898.
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501.
   {*}CDCP, 1988, MMWR-MORBID MORTAL W, V37, P543.
   CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765.
   Cox C S, 1997, Vital Health Stat 1, P1.
   DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443.
   Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401.
   Ezzati T M, 1992, Vital Health Stat 2, P1.
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723.
   FLEGAL KM, 1997, OBES RES, V5, pS93.
   Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1.
   Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x.
   Green L.W., 1999, HLTH PROMOTION PLANN, V3rd.
   HEO M, IN PRESS STAT MED.
   JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230.
   Moeschberger, 1978, THEORY COMPETING RIS.
   National Center for Health Statistics, 1994, VITAL HLTH STAT, V32, P1.
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S.
   Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24.
   Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018.
   Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x.
   Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019.
   Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x.
   US Department of Health and Human Services Office of the Surgeon General, 2001, SURG GEN CALL ACT PR.
   WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4.},
Number-of-Cited-References = {34},
Times-Cited = {1495},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {95},
Journal-ISO = {JAMA-J. Am. Med. Assoc.},
Doc-Delivery-Number = {632ME},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000180226400029},
DA = {2022-03-29},
}

@article{ WOS:A1979HR67800011,
Author = {JONES, MB},
Title = {YEARS OF LIFE LOST THROUGH DOWNS-SYNDROME},
Journal = {JOURNAL OF MEDICAL GENETICS},
Year = {1979},
Volume = {16},
Number = {5},
Pages = {379-383},
Publisher = {BRITISH MED JOURNAL PUBL GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR},
Type = {Article},
Language = {English},
Affiliation = {JONES, MB (Corresponding Author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT BEHAV SCI,HERSHEY,PA 17033, USA.},
DOI = {10.1136/jmg.16.5.379},
ISSN = {0022-2593},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Cited-References = {BENDA CE, 1969, DOWNS SYNDROME MONGO, P45.
   BROTHERS CRD, 1954, J MENT SCI, V100, P580, DOI 10.1192/bjp.100.419.580.
   CARR DH, 1977, POPULATION CYTOGENET.
   Carter C, 1951, BR J SOC MED, V5, P83.
   CARTER CO, 1958, J MENT DEFIC RES, V2, P64, DOI 10.1111/j.1365-2788.1958.tb00388.x.
   COLLMANN RD, 1963, J MENT DEFIC RES, V7, P60.
   CORNFIELD J, 1957, AM J PUBLIC HEALTH N, V47, P601, DOI 10.2105/AJPH.47.5.601.
   DEATON JG, 1973, J MENT DEFIC RES, V17, P117.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   FABIA J, 1970, J MENT DEFIC RES, V14, P235.
   FIELDING JE, 1976, NEW ENGL J MED, V294, P841, DOI 10.1056/NEJM197604082941515.
   FORSSMAN H, 1965, J MENT DEFIC RES, V9, P146.
   GAIL M, 1975, BIOMETRICS, V31, P209, DOI 10.2307/2529721.
   GREVILLE TNE, 1948, AM REV TUBERC PULM, V57, P417.
   HEMMINKI E, 1976, SCAND J SOC MED, V4, P1.
   JORDAN CW, 1952, LIFE CONTINGENCIES.
   NORA JJ, 1974, MED GENETICS PRINCIP, P29.
   OMENN GS, 1978, SCIENCE, V200, P952, DOI 10.1126/science.77042.
   OSTER J, 1975, ACTA PAEDIATR SCAND, V64, P322, DOI 10.1111/j.1651-2227.1975.tb03842.x.
   Preston SamuelH., 1972, CAUSES DEATH LIFE TA.
   Record RG, 1955, BRIT J PREV SOC MED, V9, P10.
   WETZLER HP, 1976, NEW ENGL J MED, V294, P1348.
   1974, 1970 VIT STAT US   5, V2.
   1977, MANUAL INT CLASSIFIC.},
Number-of-Cited-References = {24},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Med. Genet.},
Doc-Delivery-Number = {HR678},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1979HR67800011},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1979HZ74200007,
Author = {JONES, MB},
Title = {YEARS OF LIFE LOST DUE TO HUNTINGTON DISEASE},
Journal = {AMERICAN JOURNAL OF HUMAN GENETICS},
Year = {1979},
Volume = {31},
Number = {6},
Pages = {711-717},
Publisher = {UNIV CHICAGO PRESS},
Address = {5720 S WOODLAWN AVE, CHICAGO, IL 60637},
Type = {Article},
Language = {English},
Affiliation = {JONES, MB (Corresponding Author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT BEHAV SCI,HERSHEY,PA 17033, USA.},
ISSN = {0002-9297},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Cited-References = {CORNFIELD J, 1957, AM J PUBLIC HEALTH N, V47, P601, DOI 10.2105/AJPH.47.5.601.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   FIELDING JE, 1976, NEW ENGL J MED, V294, P841, DOI 10.1056/NEJM197604082941515.
   GAIL M, 1975, BIOMETRICS, V31, P209, DOI 10.2307/2529721.
   GREVILLE TNE, 1948, AM REV TUBERC PULM, V57, P417.
   HEMMINKI E, 1976, SCAND J SOC MED, V4, P1.
   JONES MB, J MED GENET.
   KURLAND L T, 1958, J Chronic Dis, V8, P378, DOI 10.1016/0021-9681(58)90002-X.
   MORGAN WKC, 1976, AM REV RESPIR DIS, V113, P531.
   MYRIANTHOPOULOS NTINOS C., 1966, J MED GENET, V3, P298, DOI 10.1136/jmg.3.4.298.
   PEARSON JS, 1955, P STAFF M MAYO CLIN, V30, P349.
   REED TE, 1958, AM J HUM GENET, V10, P201.
   SHOULSON I, 1975, ANNU REV MED, V26, P419, DOI 10.1146/annurev.me.26.020175.002223.
   STEVENS PL, 1973, ADV NEUROLOGY, V1, P191.
   WETZLER HP, 1976, NEW ENGL J MED, V294, P1348.
   1974, VITAL STATISTICS US, V2.
   1977, MANUAL INT CLASSIFIC.},
Number-of-Cited-References = {17},
Times-Cited = {7},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Am. J. Hum. Genet.},
Doc-Delivery-Number = {HZ742},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1979HZ74200007},
DA = {2022-03-29},
}

@article{ WOS:A1981LL39100005,
Author = {JONES, MB},
Title = {YEARS OF LIFE LOST DUE TO GENETIC-DISEASE},
Journal = {SOCIAL INDICATORS RESEARCH},
Year = {1981},
Volume = {9},
Number = {2},
Pages = {225-242},
Publisher = {KLUWER ACADEMIC PUBL},
Address = {SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {JONES, MB (Corresponding Author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,HERSHEY,PA 17033, USA.},
DOI = {10.1007/BF00286198},
ISSN = {0303-8300},
Research-Areas = {Social Sciences - Other Topics; Sociology},
Web-of-Science-Categories  = {Social Sciences, Interdisciplinary; Sociology},
Cited-References = {Carter C, 1951, BR J SOC MED, V5, P83.
   CORNFIELD J, 1957, AM J PUBLIC HEALTH N, V47, P601, DOI 10.2105/AJPH.47.5.601.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   DICKINSON FG, 1948, WHAT LEADING CAUSE D.
   DOUGHTY J H, 1951, Can J Public Health, V42, P134.
   Dublin LI, 1937, AM J PUBLIC HEALTH N, V27, P481, DOI 10.2105/AJPH.27.5.481.
   FIELDING JE, 1976, NEW ENGL J MED, V294, P841, DOI 10.1056/NEJM197604082941515.
   GAIL M, 1975, BIOMETRICS, V31, P209, DOI 10.2307/2529721.
   GREVILLE TNE, 1948, AM REV TUBERC PULM, V57, P417.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Harsanyi JC, 1955, J POLIT ECON, V63, P309, DOI 10.1086/257678.
   HOWELL RR, 1971, SOC BIOL, V18, P519.
   JONES MB, 1977, SOCIO ECON PLAN SCI, V11, P301, DOI 10.1016/0038-0121(77)90015-5.
   JONES MB, 1979, J MED GENET, V16, P379, DOI 10.1136/jmg.16.5.379.
   JONES MB, 1979, AM J HUM GENET, V31, P711.
   JONES MB, J CHRONIC DISEASES.
   JONES MB, 1975, Q J STUDIES ALCOHOL, V36, P62.
   MACMAHON B, 1970, EPIDEMIOLOGY PRINCIP, P125.
   MARTIN WJ, 1951, MED OFFICER, P151.
   MEEHL PE, 1970, STUDIES PHILOS SCI.
   MORGAN WKC, 1976, AM REV RESPIRATORY D, V113, P513.
   MULLER HJ, 1950, AM J HUM GENET, V2, P111.
   MURPHY EA, 1969, AM ACADEMY GENERAL P, V40, P102.
   MURPHY EA, 1973, BIRTH DEFECTS OAS, V9.
   MURPHY GE, 1967, J AMER MED ASSOC, V199, P303, DOI 10.1001/jama.199.5.303.
   {*}NAT CTR HLTH STA, 1963, PHS1000 PUBL       1.
   NORA JJ, 1974, MED GENETICS PRINCIP, P29.
   {*}ORG EC COOP DEV, 1977, 1976 PROGR REP PHAS.
   OUELLET BL, 1979, AM J EPIDEMIOL, V109, P451, DOI 10.1093/oxfordjournals.aje.a112703.
   Rawls J., 1971, THEORY JUSTICE.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Smart J. J. C., 1961, OUTLINE SYSTEM UTILI.
   TORRANCE GW, 1976, MANAGE SCI, V22, P990, DOI 10.1287/mnsc.22.9.990.
   {*}WHO, 1977, MAN INT CLASS DIS.},
Number-of-Cited-References = {34},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Soc. Indic. Res.},
Doc-Delivery-Number = {LL391},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1981LL39100005},
DA = {2022-03-29},
}

@article{ WOS:A1980KU55800003,
Author = {JONES, MB},
Title = {YEARS OF LIFE LOST DUE TO CYSTIC-FIBROSIS},
Journal = {JOURNAL OF CHRONIC DISEASES},
Year = {1980},
Volume = {33},
Number = {11-1},
Pages = {697-701},
Publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB},
Type = {Article},
Language = {English},
Affiliation = {JONES, MB (Corresponding Author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT BEHAV SCI,HERSHEY,PA 17033, USA.},
DOI = {10.1016/0021-9681(80)90056-9},
ISSN = {0021-9681},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Cited-References = {CHIANG CL, 1978, INTRO STOCHASTIC PRO.
   CORNFIELD J, 1957, AM J PUBLIC HEALTH N, V47, P601, DOI 10.2105/AJPH.47.5.601.
   GAIL M, 1975, BIOMETRICS, V31, P209, DOI 10.2307/2529721.
   Harsanyi JC, 1955, J POLIT ECON, V63, P309, DOI 10.1086/257678.
   JONES MB, 1977, SOCIO ECON PLAN SCI, V11, P301, DOI 10.1016/0038-0121(77)90015-5.
   JONES MB, 1979, J MED GENET, V16, P379, DOI 10.1136/jmg.16.5.379.
   JONES MB, 1979, AM J HUM GENET, V31, P711.
   Rawls J., 1971, THEORY JUSTICE.
   Smart J. J. C., 1961, OUTLINE SYSTEM UTILI.
   TORRANCE GW, 1976, MANAGE SCI, V22, P990, DOI 10.1287/mnsc.22.9.990.
   WARWICK WJ, 1975, J CHRON DIS, V28, P609, DOI 10.1016/0021-9681(75)90074-0.
   WARWICK WJ, 1978, HELV PAEDIATR ACTA, V33, P117.
   1970, VITAL STATISTICS US, V2.
   1977, MANUAL INT CLASSIFIC.},
Number-of-Cited-References = {14},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {KU558},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1980KU55800003},
DA = {2022-03-29},
}

@article{ WOS:000661467600006,
Author = {da Silva, Jaime A. Teixeira and Tsigaris, Panagiotis},
Title = {Estimating worldwide costs of premature mortalities caused by COVID-19},
Journal = {JOURNAL OF HEALTH RESEARCH},
Year = {2021},
Volume = {35},
Number = {4},
Pages = {353-358},
Abstract = {Purpose - The purpose of this paper is to provide an estimate of the
   costs of premature mortality caused by the COVID-19 pandemic.
   Design/methodology/approach - Using COVID-19 pandemic-derived mortality
   data for November 9, 2020 (globally 1,303,215 deaths) and applying a
   country-based value of statistical life (VSL), the worldwide cost of
   premature mortality was assessed. The cost was assessed based on income
   groups until November 9, 2020 and projected into the future until March
   1, 2021 using three scenarios from the Institute for Health Metrics and
   Evaluation (IHME).
   Findings - The global cost of premature mortality is currently estimated
   at Int\$5.9 trillion. For the high-income group, the current estimated
   cost is Int\$ \$4.4 trillion or \$3,700 per person. Using IHME
   projections until March 1, 2021, global premature mortality costs will
   increase to Int\$13.7 trillion and reach Int\$22.1 trillion if policies
   are relaxed, while the cost with 95\% universal masks is Int\$10.9
   trillion. The richest nations will bear the largest burden of these
   costs, reaching \$15,500 per person by March 1, 2021 if policies are
   relaxed.
   Originality/value - The cost of human lives lost due to the pandemic is
   unprecedented. Preparedness in the future is the best policy to avoid
   many premature deaths and severe recessions in order to combat
   pandemics.},
Publisher = {EMERALD GROUP PUBLISHING LTD},
Address = {HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Tsigaris, Panagiotis, Thompson Rivers Univ, Kamloops, BC, Canada.},
DOI = {10.1108/JHR-09-2020-0406},
ISSN = {0857-4421},
EISSN = {2586-940X},
Keywords = {COVID-19; Premature mortality; Preparedness; Transfer method approach;
   Value of statistical life (VSL)},
Keywords-Plus = {EPIDEMIC},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services},
Author-Email = {jaimetex@yahoo.com
   ptsigaris@tru.ca},
Cited-References = {Barbier EB, 2017, ENVIRON RESOUR ECON, V68, P663, DOI 10.1007/s10640-016-0040-4.
   Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759.
   da Silva JAT, 2020, PUBLIC HEALTH, V187, P140, DOI 10.1016/j.puhe.2020.08.008.
   Fan VY, 2018, B WORLD HEALTH ORGAN, V96, P129, DOI 10.2471/BLT.17.199588.
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762.
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918.
   IHME, COVID 19 PROJ.
   International Monetary Fund, WORLD EC OUTL LONG D.
   International Monetary Fund, WORLD EC OUTL TENT S.
   Khubchandani J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093171.
   Kniesner TJ, 1915 OXF RES ENC EC.
   Lau H, 2021, PULMONOLOGY, V27, P110, DOI 10.1016/j.pulmoe.2020.05.015.
   Murray EJ, 2020, J ECON PERSPECT, V34, P105, DOI 10.1257/jep.34.4.105.
   Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068.
   Park J, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105198.
   Reiner RC, 2021, NAT MED, V27, P94, DOI 10.1038/s41591-020-1132-9.
   RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P1954, DOI 10.2105/AJPH.57.11.1954.
   Robinson LA, 2021, RISK ANAL, V41, P761, DOI 10.1111/risa.13561.
   Schelling T.C., 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015.
   Viscusi WK, 2017, J BENEFIT-COST ANAL, V8, P226, DOI 10.1017/bca.2017.12.
   Witvorapong N, 2020, J CONSUM POLICY, V43, P491, DOI 10.1007/s10603-019-09431-2.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {J. Health Res.},
Doc-Delivery-Number = {SS0YB},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000661467600006},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000399102200094,
Author = {Bryla, Marek and Dziankowska-Zaborszczyk, Elzbieta and Bryla, Pawel and
   Pikala, Malgorzata and Maniecka-Bryla, Irena},
Title = {Years of life lost due to infectious diseases in Poland},
Journal = {PLOS ONE},
Year = {2017},
Volume = {12},
Number = {3},
Month = {MAR 23},
Abstract = {Purpose
   An evaluation of mortality due to infectious diseases in Poland in
   1999-2012 and an analysis of standard expected years of life lost due to
   the above diseases.
   Methods
   The study material included a database created on the basis of 5,219,205
   death certificates of Polish inhabitants, gathered between 1999 and 2012
   and provided by the Central Statistical Office. Crude Death Rates (CDR),
   Standardized Death Rates (SDR) and Standard Expected Years of Life Lost
   (SEYLL) due to infectious and parasitic diseases were also evaluated in
   the study period as well as Standard Expected Years of Life Lost per
   living person (SEYLLp) and Standard Expected Years of Life Lost per dead
   person (SEYLLd). Time trends were evaluated with the application of
   joinpoint models and an annual percentage change in their values.
   Results
   Death certificates report that 38,261 people died due to infectious
   diseases in Poland in the period 1999-2012, which made up 0.73\% of the
   total number of deaths. SDR caused by these diseases decreased,
   particularly in the male group: Annual Percentage Change (APC = -1.05;
   95\% CI:-2.0 to -0.2; p<0.05). The most positive trends were observed in
   mortality caused by tuberculosis (A15-A19) (APC = -5.40; 95\% CI:-6.3 to
   -4.5; p<0.05) and also meningitis, encephalitis, myelitis and
   encephalomyelitis (G03-G04) (APC = -3.42; 95\% CI:4.7 to -2.1; p<0.05).
   The most negative mortality trends were observed for intestinal
   infectious diseases (A00-A09) Annual Average Percentage Change (AAPC =
   7.3; 95\% CI: 3.1 to 11.7; p<0.05). SDR substantially decreased in the
   first half of the study period, but then significantly increased in the
   second half. Infectious and parasitic diseases contributed to a loss of
   around 37,000 standard expected years of life in 1999 and more than
   28,000 in 2012. During the study period, the SEYLLp index decreased from
   9.59 to 7.39 per 10,000 population and the SEYLLd index decreased from
   14.26 to 10.34 years (AAPC = 2.3; 95\% CI:-2,9 to -1.7; p<0.05).
   Conclusions
   Despite smaller numbers of deaths reported from infectious causes these
   diseases still represent a serious problem for Poland compared to
   countries in Western Europe.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Dept Epidemiol \& Biostat, Chair Social \& Prevent Med, Lodz, Poland.
   Bryla, Marek, Med Univ Lodz, Dept Social Med, Chair Social \& Prevent Med, Lodz, Poland.
   Dziankowska-Zaborszczyk, Elzbieta; Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ Lodz, Dept Epidemiol \& Biostat, Chair Social \& Prevent Med, Lodz, Poland.
   Bryla, Pawel, Univ Lodz, Dept Int Mkt \& Retailing, Lodz, Poland.},
DOI = {10.1371/journal.pone.0174391},
Article-Number = {e0174391},
ISSN = {1932-6203},
Keywords-Plus = {STANDARD EXPECTED YEARS; AVOIDABLE MORTALITY; PREMATURE MORTALITY;
   BURDEN; TUBERCULOSIS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Bryła, Paweł/B-8262-2013
   Maniecka-Bryla, Irena/AAW-5779-2021
   Bryla, Marek/AAW-5787-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Bryła, Paweł/0000-0003-1535-5659
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Bryla, Marek/0000-0001-6757-9211
   Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606
   Pikala, Malgorzata/0000-0003-4426-4908},
Funding-Acknowledgement = {National Science CentreNational Science Centre, Poland
   {[}DEC-2013/11/B/HS4/00465]; Medical University of Lodz
   {[}503/6-029-07/503-61-001]},
Funding-Text = {This study was funded by the National Science Centre no.
   DEC-2013/11/B/HS4/00465 and by the Medical University of Lodz (project
   no. 503/6-029-07/503-61-001).The funders had no role in study design,
   data col lection and analysis, decision to publish, or preparation of
   the manuscript},
Cited-References = {Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085.
   {[}Anonymous], 2003, GLOWRIY INSPEKTORAT.
   {[}Anonymous], EST APC SURV RES PRO.
   {[}Anonymous], WHO MEMB STAT 2012 X.
   {[}Anonymous], 2016, DEMOGRAPHIC YB POLAN.
   {[}Anonymous], 2015, JOINT REGR PROGR VER.
   {[}Anonymous], 2015, GLOBAL BURDEN DIS ST.
   Bryla M, 2017, INT J TUBERC LUNG D, V21, P202, DOI 10.5588/ijtld.16.0268.
   Castillo-Rodriguez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125456.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   European Centre for Disease Prevention and Control/WHO Regional Office for Europe, TUB SURV MON EUR 201.
   Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167.
   Gawryszewski A., 2006, PAN.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Gonzalez-Gonzalez C, 2015, SALUD PUBLICA MEX S1, V57, P39.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103.
   Leowski J, 2008, HLTH POLICY PUBLIC H, P44.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Malta Deborah Carvalho, 2007, Ciênc. saúde coletiva, V12, P765, DOI 10.1590/S1413-81232007000300027.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Moore P, 2006, NEW KILLER GERMS WHA.
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8.
   Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537.
   Murray CJL, 2000, VESALIUS, V1.
   Ollandezos M, 2011, HIPPOKRATIA, V15, P330.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Rosinska M., 2016, PRZEGL EPIDEMIOLOG, V70.
   Stevens G, 2010, EUR J PUBLIC HEALTH, V20, P241, DOI 10.1093/eurpub/ckq051.
   Tobias M, 2009, AUST NZ J PUBL HEAL, V33, P70, DOI 10.1111/j.1753-6405.2009.00342.x.
   Treurniet HF, 2004, J EPIDEMIOL COMMUN H, V58, P290, DOI 10.1136/jech.2002.006452.
   World Health Organization, 2004, ANN C AN CAT MORT DA.
   Wroblewska W, 2012, STUDIA DEMOGR, V1, P129.
   Zielinski Andrzej, 2006, Przegl Epidemiol, V60, P857.},
Number-of-Cited-References = {39},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {ER8VS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000399102200094},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000621413800001,
Author = {Pifarre i Arolas, Hector and Acosta, Enrique and Lopez-Casasnovas,
   Guillem and Lo, Adeline and Nicodemo, Catia and Riffe, Tim and
   Myrskylae, Mikko},
Title = {Years of life lost to COVID-19 in 81 countries},
Journal = {SCIENTIFIC REPORTS},
Year = {2021},
Volume = {11},
Number = {1},
Month = {FEB 18},
Abstract = {Understanding the mortality impact of COVID-19 requires not only
   counting the dead, but analyzing how premature the deaths are. We
   calculate years of life lost (YLL) across 81 countries due to COVID-19
   attributable deaths, and also conduct an analysis based on estimated
   excess deaths. We find that over 20.5 million years of life have been
   lost to COVID-19 globally. As of January 6, 2021, YLL in heavily
   affected countries are 2-9 times the average seasonal influenza; three
   quarters of the YLL result from deaths in ages below 75 and almost a
   third from deaths below 55; and men have lost 45\% more life years than
   women. The results confirm the large mortality impact of COVID-19 among
   the elderly. They also call for heightened awareness in devising
   policies that protect vulnerable demographics losing the largest number
   of life-years.},
Publisher = {NATURE PORTFOLIO},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Arolas, HPI (Corresponding Author), Univ Pompeu Fabra, Ctr Res Hlth Econ, Barcelona 08002, Spain.
   Pifarre i Arolas, Hector; Lopez-Casasnovas, Guillem, Univ Pompeu Fabra, Ctr Res Hlth Econ, Barcelona 08002, Spain.
   Acosta, Enrique; Riffe, Tim; Myrskylae, Mikko, Max Planck Inst Demog Res, D-18057 Rostock, Germany.
   Lo, Adeline, Univ Wisconsin, Dept Polit Sci, Madison, WI 53706 USA.
   Nicodemo, Catia, Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.
   Myrskylae, Mikko, Univ Helsinki, Ctr Social Data Sci, Helsinki 00014, Finland.},
DOI = {10.1038/s41598-021-83040-3},
Article-Number = {3504},
ISSN = {2045-2322},
Keywords-Plus = {MORTALITY; AGE},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {hector.pifarre@upf.edu},
ResearcherID-Numbers = {Lopez-Casasnovas, Guillem/A-9342-2013
   },
ORCID-Numbers = {Lopez-Casasnovas, Guillem/0000-0001-8020-9987
   Acosta, Enrique/0000-0001-6250-4018
   Nicodemo, Catia/0000-0001-5490-9576},
Funding-Acknowledgement = {La Caixa Foundation for Hector Pifarre i Arolas
   {[}LCF/PR/GN12/50250002]; Social Sciences and Humanities Research
   CouncilSocial Sciences and Humanities Research Council of Canada
   (SSHRC); Fonds de recherche du Quebec - Societe et culture;  {[}0009139]},
Funding-Text = {The research funding included grant LCF/PR/GN12/50250002 from La Caixa
   Foundation for Hector Pifarre i Arolas and Guillem Lopez Casasnovas.
   Enrique Acosta is supported by the Social Sciences and Humanities
   Research Council and the Fonds de recherche du Quebec - Societe et
   culture. Catia Nicodemo is supported by the University of Oxford's
   COVID-19 Research Response Fund, Number 0009139. The views expressed are
   those of the author and not necessarily those of the University of
   Oxford.},
Cited-References = {{[}Anonymous], 2020, HUMAN MORTALITY DATA.
   {[}Anonymous], 2013, WHOHISHSIGHE20134.
   {[}Anonymous], 2020, GLOBAL HLTH DATA EXC.
   Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0.
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7.
   Dicker D, 2018, LANCET, V392, P1684, DOI 10.1016/s0140-6736(18)31891-9.
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7.
   GEMES K, 2020, EUR, DOI DOI 10.1007/S10654-020-00646-Z.
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8.
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152.
   Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8.
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683.
   Riffe T., 2020, COVerAGE-DB: COVID-19 cases and deaths by age database, DOI {[}10.17605/OSF.IO/MPWJQ, DOI 10.17605/OSF.IO/MPWJQ].
   Robilotti EV, 2020, NAT MED, V26, P1218, DOI 10.1038/s41591-020-0979-0.
   Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517.
   Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533.
   United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD POPULATION PRO.
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5.
   Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035.
   Wu J., NEW YORK TIMES.
   Xiong QT, 2021, CLIN MICROBIOL INFEC, V27, P89, DOI 10.1016/j.cmi.2020.09.023.},
Number-of-Cited-References = {21},
Times-Cited = {40},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {QL9PW},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000621413800001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000257831700004,
Author = {Yip, Paul S. F. and Liu, Ka Y. and Law, C. K.},
Title = {Years of life lost from suicide in China, 1990-2000},
Journal = {CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION},
Year = {2008},
Volume = {29},
Number = {3},
Pages = {131-136},
Abstract = {Suicide is an important public health problem in China: It is the fifth
   leading cause of death in China, and suicide in China accounts for over
   30\% of the world's overall suicide deaths. The substantial burden due
   to suicide has not been well recognized. This study aims to provide an
   estimate of the socioeconomic burden of the suicide problem in China in
   terms of years of life lost (YLL) and to discuss its implications.
   Suicide rates and the related YLL by age, gender, and region
   (urban/rural) from 1990 to 2000 were estimated using the most recent
   data from the Ministry of Health of China. The suicide rate in rural
   China was three times higher than that in urban areas. Suicide
   completers in rural areas shared 90\% of total YLL. Rural women aged
   25-39 years contributed the largest share of YLL. Our results show that
   some population subgroups contributed a disproportionate share to the
   disease burden of suicide. National strategies for suicide prevention
   should include targeted programs in catering the need of these specified
   subgroups in China.},
Publisher = {HOGREFE \& HUBER PUBLISHERS},
Address = {MERKELSTR 3, D-37085 GOTTINGEN, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Yip, PSF (Corresponding Author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res \& Prevent, Hong Kong, Hong Kong, Peoples R China.
   Yip, Paul S. F.; Liu, Ka Y.; Law, C. K., Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res \& Prevent, Hong Kong, Hong Kong, Peoples R China.
   Yip, Paul S. F., Univ Hong Kong, Dept Social Work \& Social Adm, Hong Kong, Hong Kong, Peoples R China.
   Liu, Ka Y., Columbia Univ, Inst Social \& Econ Res \& Policy, New York, NY 10027 USA.
   Yip, Paul S. F., Int Assoc Suicide Prevent, Hong Kong, Hong Kong, Peoples R China.},
DOI = {10.1027/0227-5910.29.3.131},
ISSN = {0227-5910},
EISSN = {2151-2396},
Keywords = {China; socioeconomic burden; suicide; urbanization; years of life lost
   (YLL)},
Keywords-Plus = {PREMATURE MORTALITY; PREVENTION; RATES; INDICATOR},
Research-Areas = {Psychiatry; Psychology},
Web-of-Science-Categories  = {Psychiatry; Psychology, Multidisciplinary},
Author-Email = {sfpyip@hku.hk},
Cited-References = {{*}CDC, 1986, MORBIDITY MORTALI S2, V35, P15.
   {*}CHIN MIN HLTH, 1991, CHIN HLTH STAT YB.
   DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157.
   Dickinson F. G., 1948, AMA B, V64, P1.
   Feachem RGA, 1992, HLTH ADULTS DEV WORL.
   Goldney RD, 1998, ARCH SUICIDE RES, V4, P329, DOI 10.1080/13811119808258307.
   GRECILLE TNE, 1948, AM REV TUBERCULOSIS, V57, P417.
   GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227.
   Gunnell D, 2003, LANCET, V362, P961, DOI 10.1016/S0140-6736(03)14367-X.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Knox KL, 2003, BMJ-BRIT MED J, V327, P1376, DOI 10.1136/bmj.327.7428.1376.
   KOHN R, 1951, Can J Public Health, V42, P375.
   LIU M, 2002, INT J SOC WELF, V11, P300.
   MURRAY CJL, 1987, SOC SCI MED, V25, P773, DOI 10.1016/0277-9536(87)90035-9.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   {*}NAT BUR STAT CHIN, 2002, CHIN POP STAT YB 199.
   Pearson V, 2002, SUICIDE LIFE-THREAT, V32, P347, DOI 10.1521/suli.32.4.347.22338.
   Pearson V, 2002, SUICIDE LIFE-THREAT, V32, P359, DOI 10.1521/suli.32.4.359.22345.
   Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0.
   Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x.
   ROBINSON HL, 1984, CANADIAN J PUBLIC HL, V39, P60.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   {*}WHO, 1999, INJ LEAD CAUS GLOB.
   {*}WHO, 1998, GUID PRIM PREV MENT.
   {*}WHO, 1996, NAT BURD DIS MAN.
   WHO-World Health Organisation, 2001, WORLD HLTH REPORT 20.
   Yip PSF, 2005, SOC PSYCH PSYCH EPID, V40, P792, DOI 10.1007/s00127-005-0952-8.
   Yip PSF, 2001, SUICIDE LIFE-THREAT, V31, P62, DOI 10.1521/suli.31.1.62.21311.
   Yip PSF, 1998, INT J SOC PSYCHIATR, V44, P267, DOI 10.1177/002076409804400403.},
Number-of-Cited-References = {29},
Times-Cited = {24},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Crisis},
Doc-Delivery-Number = {328XO},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000257831700004},
DA = {2022-03-29},
}

@article{ WOS:000451640500283,
Author = {Al-Hemoud, Ali and Gasana, Janvier and Al-Dabbous, Abdullah N. and
   Al-Shatti, Ahmad and Al-Khayat, Ahmad},
Title = {Disability Adjusted Life Years (DALYs) in Terms of Years of Life Lost
   (YLL) Due to Premature Adult Mortalities and Postneonatal Infant
   Mortalities Attributed to PM2.5 and PM10 Exposures in Kuwait},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2018},
Volume = {15},
Number = {11},
Month = {NOV},
Abstract = {Ambient air pollution in terms of fine and coarse particulate matter
   (PM2.5 and PM10) has been shown to increase adult and infant
   mortalities. Most studies have estimated the risk of mortalities through
   attributable proportions and number of excess cases with no reference to
   the time lost due to premature mortalities. Disability adjusted life
   years (DALYs) are necessary to measure the health impact of Ambient
   particulate matter (PM) over time. In this study, we used life-tables
   for three years (2014-2016) to estimate the years of life lost (YLL), a
   main component of DALYs, for adult mortalities (age 30+ years) and
   postneonatal infant mortalities (age 28+ days-1 year) associated with
   PM2.5 exposure and PM10 exposure, respectively. The annual average of
   PM2.5 and PM10 concentrations were recorded as 87.9 mu g/m(3) and 167.5
   mu g/m(3), which are 8 times greater than the World Health Organization
   (WHO) air quality guidelines of 10 mu g/m(3) and 20 mu g/m(3),
   respectively. Results indicated a total of 252.18 (95\% CI:
   170.69-322.92) YLL for all ages with an increase of 27,474.61 (95\% CI:
   18,483.02-35,370.58) YLL over 10 years. The expected life remaining
   (ELR) calculations showed that 30- and 65-year-old persons would gain
   2.34 years and 1.93 years, respectively if the current PM2.5 exposure
   levels were reduced to the WHO interim targets (IT-1 = 35 mu g/m(3)).
   Newborns and 1-year old children may live 79.81 and 78.94 years,
   respectively with an increase in average life expectancy of 2.65 years
   if the WHO PM10 interim targets were met (IT-1 = 70 mu g/m(3)).
   Sensitivity analyses for YLL were carried out for the years 2015, 2025,
   and 2045 and showed that the years of life would increase significantly
   for age groups between 30 and 85. Life expectancy, especially for the
   elderly (>= 60 years), would increase at higher rates if PM2.5 levels
   were reduced further. This study can be helpful for the assessment of
   poor air quality represented by PM2.5 and PM10 exposures in causing
   premature adult mortalities and postneonatal infant mortalities in
   developing countries with high ambient air pollution. Information in
   this article adds insights to the sustainable development goals (SDG
   3.9.1 and 11.6.2) related to the reduction of mortality rates attributed
   to ambient air levels of coarse and fine particulate matter.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Al-Hemoud, A (Corresponding Author), Kuwait Inst Sci Res, Environm \& Life Sci Res Ctr, Crisis Decis Support Program, POB 24885, Safat 13109, Kuwait.
   Al-Hemoud, Ali; Al-Dabbous, Abdullah N., Kuwait Inst Sci Res, Environm \& Life Sci Res Ctr, Crisis Decis Support Program, POB 24885, Safat 13109, Kuwait.
   Gasana, Janvier, Kuwait Univ, Fac Publ Hlth, Hlth Sci Ctr, POB 24923, Hawalli 13110, Kuwait.
   Al-Shatti, Ahmad, Kuwait Minist Hlth, Occupat Hlth Dept, POB 51360, Riqqa 53454, Kuwait.
   Al-Khayat, Ahmad, Kuwait Inst Sci Res, Technoecon Div, POB 24885, Safat 13109, Kuwait.},
DOI = {10.3390/ijerph15112609},
Article-Number = {2609},
ISSN = {1661-7827},
EISSN = {1660-4601},
Keywords = {AirQ; burden of disease (BOD); DALYs; PM2.5; postneonatal mortality;
   YLD; YLL},
Keywords-Plus = {HEALTH IMPACT ASSESSMENT; FINE PARTICULATE MATTER; AIR-POLLUTION; GLOBAL
   BURDEN; RISK-ASSESSMENT; DUST STORMS; TIME-SERIES; FOLLOW-UP; DISEASE;
   QUALITY},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {ahomood@kisr.edu.kw
   janvier.gasana@HSC.EDU.KW
   adabbous@kisr.edu.kw
   ahmad.alshatti2011@yahoo.com
   akhayat@kisr.edu.kw},
ResearcherID-Numbers = {Gasana, Janvier/K-8904-2015},
ORCID-Numbers = {Al-Hemoud, Ali/0000-0002-4936-0176
   Gasana, Janvier/0000-0003-3345-2065},
Funding-Acknowledgement = {Kuwait Foundation for the Advancement of Sciences (KFAS)Kuwait
   Foundation for the Advancement of Sciences (KFAS) {[}PR17-12SL-05,
   EC101C]},
Funding-Text = {This research was funded by the Kuwait Foundation for the Advancement of
   Sciences (KFAS), grant number {[}PR17-12SL-05], project number
   {[}EC101C].},
Cited-References = {Al-Dabbous AN, 2014, ENVIRON SCI TECHNOL, V48, P13634, DOI 10.1021/es505175u.
   Al-Hemoud A., 2018, ENV RES.
   Al-Hemoud A, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9010006.
   Al-Hemoud A, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-016-2816-9.
   Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2.
   Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236.
   Ashbolt Nicholas J, 2015, Curr Environ Health Rep, V2, P95, DOI 10.1007/s40572-014-0037-5.
   Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492.
   Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3.
   Boldo E, 2006, EUR J EPIDEMIOL, V21, P449, DOI 10.1007/s10654-006-9014-0.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Cambra K, 2006, EPIDEMIOLOGY, V17, pS106, DOI 10.1097/00001648-200611001-00257.
   Chen A, 2015, SOCIO-ECON PLAN SCI, V49, P10, DOI 10.1016/j.seps.2014.12.002.
   Chen CJ, 2008, SCI TOTAL ENVIRON, V391, P76, DOI 10.1016/j.scitotenv.2007.11.011.
   Cohen AJ, 2017, LANCET, V389, P1907, DOI {[}10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6].
   Collier SA, 2012, EPIDEMIOL INFECT, V140, P2003, DOI 10.1017/S0950268811002858.
   Conti GO, 2017, ENVIRON SCI POLLUT R, V24, P6426, DOI 10.1007/s11356-016-8180-1.
   Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237.
   Crouse DL, 2015, ENVIRON HEALTH PERSP, V123, P1180, DOI 10.1289/ehp.1409276.
   Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401.
   Dwyer-Lindgren L, 2017, LANCET PUBLIC HEALTH, V2, pE400, DOI 10.1016/S2468-2667(17)30165-2.
   Faridi S, 2018, ENVIRON INT, V114, P37, DOI 10.1016/j.envint.2018.02.026.
   Fattore E, 2011, ENVIRON RES, V111, P1321, DOI 10.1016/j.envres.2011.06.012.
   Fewtrell L., 2003, ASS ENV BURD DIS NAT.
   Gao TT, 2015, SCI TOTAL ENVIRON, V511, P268, DOI 10.1016/j.scitotenv.2014.11.048.
   Geelen LMJ, 2009, ATMOS ENVIRON, V43, P1613, DOI 10.1016/j.atmosenv.2008.12.002.
   Ghozikali MG, 2016, ENVIRON RES, V144, P99, DOI 10.1016/j.envres.2015.10.030.
   Goudarzi G, 2017, PUBLIC HEALTH, V148, P109, DOI 10.1016/j.puhe.2017.03.009.
   Ha EH, 2003, PEDIATRICS, V111, P284, DOI 10.1542/peds.111.2.284.
   Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029.
   Habeebullah, 2013, J BASIC APPL SCI, V9, P259, DOI DOI 10.6000/1927-5129.2013.09.34.
   Hadei M., 2018, J AIR POLLUT HLTH, V2, P129.
   Heroux ME, 2015, INT J PUBLIC HEALTH, V60, P619, DOI 10.1007/s00038-015-0690-y.
   Homedes N., 1996, DISABILITY ADJUSTED.
   Hopke PK, 2018, AEROSOL AIR QUAL RES, V18, P497, DOI 10.4209/aaqr.2017.09.0325.
   JIN JEONG SANG, 2013, Asian Journal of Atmospheric Environment, V7, P227, DOI 10.5572/ajae.2013.7.4.227.
   Kaiser Reinhard, 2004, Environ Health, V3, P4, DOI 10.1186/1476-069X-3-4.
   Khaniabadi YO, 2018, ENVIRON SCI POLLUT R, V25, P17726, DOI 10.1007/s11356-018-1902-9.
   Kobayashi Y, 2015, SCI TOTAL ENVIRON, V530, P120, DOI 10.1016/j.scitotenv.2015.05.017.
   Krewski D, 2009, EXTENDED FOLLOW UP S.
   Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050.
   Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Liu J, 2016, SCI TOTAL ENVIRON, V568, P1253, DOI 10.1016/j.scitotenv.2016.05.165.
   Lopez, 2002, SUMMARY MEASURES POP.
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442.
   Miri M, 2017, ENVIRON SCI POLLUT R, V24, P16513, DOI 10.1007/s11356-017-9189-9.
   Moustris KP, 2017, URBAN SCI, V1, DOI 10.3390/urbansci1010006.
   Murray CJL, 2017, LANCET, V390, P1460, DOI 10.1016/S0140-6736(17)32367-X.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752.
   Orru H, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-7.
   Ostro B, 2015, ENVIRON HEALTH PERSP, V123, P549, DOI 10.1289/ehp.1408565.
   Ostro B, 2010, ENVIRON HEALTH PERSP, V118, P363, DOI 10.1289/ehp.0901181.
   Ostro BD, 1999, ENVIRON RES, V81, P231, DOI 10.1006/enrs.1999.3978.
   Ostro BD, 2004, OUTDOOR AIR POLLUTIO.
   Paldy A, 2006, EPIDEMIOLOGY, V17, pS131, DOI 10.1097/00001648-200611001-00324.
   Pascal M, 2011, IMPROVING KNOWLEDGE.
   Pharoah P O, 1979, Epidemiol Rev, V1, P170.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Popoola LT, 2018, INT J ENVIRON SCI TE, V15, P935, DOI 10.1007/s13762-017-1454-4.
   Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9.
   Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537.
   Pruss-Ustun A., 2003, INTRO METHODS ASSESS.
   Ragas AMJ, 2011, ENVIRON INT, V37, P872, DOI 10.1016/j.envint.2011.02.015.
   Salomon, 2014, ENCY HLTH EC, P200, DOI DOI 10.1016/B978-0-12-375678-7.00511-3.
   Skotak Krzysztof, 2008, Przegl Lek, V65 Suppl 2, P18.
   Son JY, 2017, AM J EPIDEMIOL, V186, P1268, DOI 10.1093/aje/kwx015.
   Tominz Riccardo, 2005, Epidemiol Prev, V29, P149.
   Tsuchiya A., 2002, SUMMARY MEASURES POP.
   USEPA, 1996, REV NAT AMB AIR QUAL.
   Valent F, 2004, LANCET, V363, P2032, DOI 10.1016/S0140-6736(04)16452-0.
   van Zelm R, 2008, ATMOS ENVIRON, V42, P441, DOI 10.1016/j.atmosenv.2007.09.072.
   Wheida A, 2018, ENVIRON RES, V160, P223, DOI 10.1016/j.envres.2017.09.028.
   WHO, 2013, REV EVIDENCE HLTH AS.
   Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608, DOI 10.1289/ehp.97105608.
   Woodruff TJ, 2008, ENVIRON HEALTH PERSP, V116, P110, DOI 10.1289/ehp.10370.
   World Health Organisation, 2016, AMB AIR POLL GLOB AS.
   World Health Organization, 2016, AIR QUAL GUID GLOB U.
   Yassin MF, 2018, ATMOS RES, V212, P158, DOI 10.1016/j.atmosres.2018.05.020.
   Yorifuji T, 2016, SCI TOTAL ENVIRON, V551, P66, DOI 10.1016/j.scitotenv.2016.01.211.},
Number-of-Cited-References = {82},
Times-Cited = {24},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {9},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {HC2OB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000451640500283},
OA = {gold, Green Submitted, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000465463100011,
Author = {Arai, Hidenori and Mortaki, Kalliopi and Rane, Pratik and Quinn, Casey
   and Zhao, Zhongyun and Qian, Yi},
Title = {Estimating Years of Life Lost Due to Cardiovascular Disease in Japan},
Journal = {CIRCULATION JOURNAL},
Year = {2019},
Volume = {83},
Number = {5},
Pages = {1006-1010},
Month = {MAY},
Abstract = {Background: In Japan, the burden associated with myocardial infarction
   (MI) and ischemic stroke as well as atherosclerotic cardiovascular
   disease (ASCVD) generally is high. One key element in measuring disease
   burden is years of life lost (YLL). The aim of this study was to
   understand the burden of these diseases by estimating YLL at an overall
   disease level and average person-YLL (PYLL), a measure of disease burden
   also used in prior studies.
   Methods and Results: Because calculation of YLL and PYLL involves inputs
   such as disease prevalence, disease-related mortality by age, and
   general population mortality by age and sex, we searched public
   databases of disease surveillance to identify comprehensive
   Japanese-specific inputs. For our reference analysis, disease-specific
   prevalence and mortality were taken from the Institute for Health
   Metrics and Evaluation Global Disease Burden study, and background
   mortality data were from the Japanese life tables published by the
   Ministry of Health, Labour and Welfare. The average age of patients with
   MI or stroke was 74 and 70 years, respectively. On average, men
   comprised 59\% and 54\% of the MI and stroke population, respectively.
   The disease-level burden of ASCVD (inclusive of MI, stroke, and
   peripheral artery disease) was 2,703,711 YLL in 2017. The patient-level
   burden was 11.99 PYLL for MI and 9.39 PYLL for stroke.
   Conclusions: The burden of ASCVD, MI, and stroke in terms of premature
   mortality is substantial in Japan, both on a population disease level
   and an individual patient level.},
Publisher = {JAPANESE CIRCULATION SOC},
Address = {18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO,
   100-0011, JAPAN},
Type = {Article},
Language = {English},
Affiliation = {Arai, H (Corresponding Author), Natl Ctr Geriatr \& Gerontol, 7-430 Morioka Cho, Obu 4740038, Japan.
   Arai, Hidenori, Natl Ctr Geriatr \& Gerontol, 7-430 Morioka Cho, Obu 4740038, Japan.
   Mortaki, Kalliopi; Quinn, Casey, PRMA Consulting, Fleet, England.
   Rane, Pratik; Zhao, Zhongyun; Qian, Yi, Amgen Inc, Thousand Oaks, CA 91320 USA.},
DOI = {10.1253/circj.CJ-18-1216},
ISSN = {1346-9843},
EISSN = {1347-4820},
Keywords = {Atherosclerotic cardiovascular disease; Disease burden; Ischemic stroke;
   Myocardial infarction},
Keywords-Plus = {CANCER; BURDEN},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {harai@kuhp.kyoto-u.ac.jp},
ResearcherID-Numbers = {Arai, Hidenori/P-9816-2017},
ORCID-Numbers = {Arai, Hidenori/0000-0002-9000-6849},
Funding-Acknowledgement = {Amgen Inc., Thousand Oaks, CA, USAAmgen},
Funding-Text = {This study was funded by Amgen Inc., Thousand Oaks, CA, USA.},
Cited-References = {Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Davis KL, 2015, J ATHEROSCLER THROMB, V22, P1287, DOI 10.5551/jat.28852.
   Gilmour Stuart, 2014, J Prev Med Public Health, V47, P136, DOI 10.3961/jpmph.2014.47.3.136.
   Institute for Health Metrics and Evaluation, GLOB BURD DIS STUD 2.
   Kaufman JE, 2019, INT J AGING HUM DEV, V88, P127, DOI 10.1177/0091415018754310.
   Ministry of Health Labour and Welfare, 2015, THE 22 LIF TABL.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Nomura S, 2017, LANCET, V390, P1521, DOI 10.1016/S0140-6736(17)31544-1.
   Park EO, 2016, REHABIL NURS, V41, P260, DOI 10.1002/rnj.252.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.},
Number-of-Cited-References = {11},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Circ. J.},
Doc-Delivery-Number = {HU7LP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000465463100011},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:A1989T260600004,
Author = {METTLIN, C},
Title = {TRENDS IN YEARS OF LIFE LOST TO CANCER - 1970 TO 1985},
Journal = {CA-A CANCER JOURNAL FOR CLINICIANS},
Year = {1989},
Volume = {39},
Number = {1},
Pages = {33-39},
Month = {JAN-FEB},
Publisher = {AMER CANCER SOC},
Address = {C/O JB LIPPINCOTT CO 1180 AVE OF THE AMERICAS 6TH FLOOR, NEW YORK, NY
   10036},
Type = {Article},
Language = {English},
Affiliation = {METTLIN, C (Corresponding Author), CANC CONTROL ROSWELL PK MEM INST,EPIDEMIOL RES,BUFFALO,NY, USA.},
DOI = {10.3322/canjclin.39.1.33},
ISSN = {0007-9235},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Number-of-Cited-References = {0},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {CA-Cancer J. Clin.},
Doc-Delivery-Number = {T2606},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1989T260600004},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:A1993KY75600002,
Author = {MAILLIE, HD and SIMON, W and WATTS, RJ and QUINN, BR},
Title = {DETERMINING PERSON-YEARS OF LIFE LOST USING THE BEIR-V METHOD},
Journal = {HEALTH PHYSICS},
Year = {1993},
Volume = {64},
Number = {5},
Pages = {461-466},
Month = {MAY},
Abstract = {A method is given that permits the calculation of the estimated
   person-years of life lost when groups of males or females are exposed to
   low linear energy transfer (LET) ionizing radiation. It is felt that
   this determination is informative in rating risks to populations from
   radiation exposures. For example, when 1,000,000 females have received
   an acute 10 mSv, the total number of radiation-induced fatal cancers is
   835. The total number of person-years of life lost is 1.4 x 10(4) or an
   average of about 5 d. However, the 22 who die of leukemia suffer an
   average of about 34 y. Those who die of other forms of cancer lose an
   average of 16 y. Some examples have been reported by the U.S. National
   Academy of Sciences (1990) report. In those cases where the Committee
   presented results, the method given here is in good agreement.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA},
Type = {Article},
Language = {English},
Affiliation = {MAILLIE, HD (Corresponding Author), UNIV ROCHESTER, DEPT BIOPHYS, ROCHESTER, NY 14642 USA.
   ROCHESTER GAS \& ELECT CORP, ROCHESTER, NY 14649 USA.},
DOI = {10.1097/00004032-199305000-00001},
ISSN = {0017-9078},
EISSN = {1538-5159},
Keywords = {CANCER; CARCINOGENESIS; RADIATION RISK; RADIATION, IONIZING},
Keywords-Plus = {TABLE FACTORS; RISK},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Nuclear Science \& Technology; Radiology, Nuclear Medicine \&
   Medical Imaging},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health;
   Nuclear Science \& Technology; Radiology, Nuclear Medicine \& Medical
   Imaging},
Cited-References = {{[}Anonymous], 1990, HLTH EFFECTS EXPOSUR.
   BERGER ES, 1989, ARCH INTERN MED, V149, P1507, DOI 10.1001/archinte.149.7.1507.
   BUNGER BM, 1981, HEALTH PHYS, V40, P439, DOI 10.1097/00004032-198104000-00002.
   COHEN BL, 1991, HEALTH PHYS, V61, P317, DOI 10.1097/00004032-199109000-00002.
   MAILLIE HD, 1984, HEALTH PHYS, V47, P47, DOI 10.1097/00004032-198407000-00004.
   MAILLIE HD, 1983, HEALTH PHYS, V44, P317.
   MAILLIE HD, 1992, HEALTH PHYS, V63, P273, DOI 10.1097/00004032-199209000-00002.
   MERWIN SE, 1991, HEALTH PHYS, V61, P305, DOI 10.1097/00004032-199109000-00001.
   THOMAS D, 1992, HEALTH PHYS, V63, P259, DOI 10.1097/00004032-199209000-00001.
   1990, VITAL STATISTICS U A, V2.
   {[}No title captured].
   {[}No title captured].
   1985, VITAL STATISTICS U A, V1.},
Number-of-Cited-References = {13},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Health Phys.},
Doc-Delivery-Number = {KY756},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1993KY75600002},
DA = {2022-03-29},
}

@article{ WOS:000371716600006,
Author = {Thiam, Aminata and Zhao, Zhongyun and Quinn, Casey and Barber, Beth},
Title = {Years of life lost due to metastatic melanoma in 12 countries},
Journal = {JOURNAL OF MEDICAL ECONOMICS},
Year = {2016},
Volume = {19},
Number = {3},
Pages = {259-264},
Month = {MAR 3},
Abstract = {Background:
   Regionally or distantly metastatic melanoma (stages IIIB/C and IV) place
   a high burden on society. To quantify this burden, this study estimated
   years of life lost (YLL) per patient for adults with metastatic melanoma
   in 12 countries in 2014.
   Methods:
   General population growth and life expectancy were estimated from the
   Organization for Economic Co-operation and Development data and life
   tables for each country. Incidence of melanoma and mortality rates for
   the disease were based on GLOBOCAN and US registry data. The prevalence
   of metastatic melanoma was calculated using mortality rates and survival
   data from patients with melanoma. YLL per patient was estimated by the
   difference between the disease-free life expectancy and the life
   expectancy with metastatic melanoma.
   Results:
   YLL per patient were as follows: Australia, men = 19.9 years, women =
   22.7 years; Brazil, 16.3, 19.8; Canada, 19.4, 22.3; France, 18.8, 23.1;
   Germany, 18.3, 20.8; Italy, 19.3, 22.7; Mexico, 17.2, 19.0; the
   Netherlands, 18.5, 21.5; Spain, 19.2, 23.1; Sweden 19.4, 22.0; the UK,
   18.7, 21.2; and the US, 17.9, 20.6.
   Conclusions:
   The burden of metastatic melanoma as measured by YLL is substantial in
   all 12 countries; although there is variation across countries and
   between men and women.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Quinn, C (Corresponding Author), PRMA Consulting Ltd, Cygnus House,1 Waterfront Business Pk, Fleet GU51 3QT, Hants, England.
   Thiam, Aminata; Quinn, Casey, PRMA Consulting Ltd, Cygnus House,1 Waterfront Business Pk, Fleet GU51 3QT, Hants, England.
   Zhao, Zhongyun; Barber, Beth, Amgen Inc, Global Hlth Econ, Thousand Oaks, CA USA.},
DOI = {10.3111/13696998.2015.1115764},
ISSN = {1369-6998},
EISSN = {1941-837X},
Keywords = {YLL; Mortality; Life expectancy; Metastatic melanoma; Disease burden},
Keywords-Plus = {CUTANEOUS MELANOMA; BURDEN; CANCER; MORTALITY},
Research-Areas = {Health Care Sciences \& Services; General \& Internal Medicine},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medicine, General \& Internal},
Author-Email = {cquinn@prmaconsulting.com},
Funding-Acknowledgement = {Amgen Inc.Amgen},
Funding-Text = {This study was funded by Amgen Inc.},
Cited-References = {American Cancer Society, 2014, MEL SKIN CANC.
   {[}Anonymous], 2011, SEER STAT FACT SHEET.
   Arnold M, 2014, J EUR ACAD DERMATOL, V28, P1170, DOI 10.1111/jdv.12236.
   Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635.
   Bristow BN, 2013, MELANOMA RES, V23, P331, DOI 10.1097/CMR.0b013e328361926c.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Central Intelligence Agency, 2014, WORLD FACTBOOK.
   Ekwueme DU, 2011, J AM ACAD DERMATOL, V65, pS133, DOI 10.1016/j.jaad.2011.04.036.
   Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616.
   Ferlay J, 2014, GLOBOCAN 2012 V1 2 C.
   Holterhues C, 2013, BRIT J DERMATOL, V169, P389, DOI 10.1111/bjd.12346.
   Joshua AM, 2012, CURR ONCOL, V19, pE462, DOI 10.3747/co.19.1222.
   Salama AKS, 2012, CANCER INVEST, V30, P637, DOI 10.3109/07357907.2012.726387.
   Shkolnikov VM., 2014, METHODOLOGY NOTE HUM.
   Song X, 2015, CURR MED RES OPIN, V31, P987, DOI 10.1185/03007995.2015.1021904.
   The Department of Demography at the University of California, 2007, BUAATMPIFDRIR HUM LI.},
Number-of-Cited-References = {17},
Times-Cited = {8},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Med. Econ.},
Doc-Delivery-Number = {DF9XT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000371716600006},
DA = {2022-03-29},
}

@article{ WOS:000467019900016,
Author = {Wang, Yueh and Chiang, Chun-Ju and Lee, Wen-Chung},
Title = {Age-standardized expected years of life lost: quantification of cancer
   severity},
Journal = {BMC PUBLIC HEALTH},
Year = {2019},
Volume = {19},
Month = {MAY 2},
Abstract = {BackgroundThe critical implications of the expected years of life lost
   (EYLL) index of cancer for health policy assessments have been largely
   overlooked. We advocate to standardize life lost indices.MethodsUsing
   the Taiwan Cancer Registry database as an example, we calculated the
   EYLL and the age-standardized EYLL to facilitate comparisons among
   cancer types (a total of 903,935 patients from the database). The
   International Cancer Survival Standard was used for calculating
   age-standardized EYLL.ResultsPancreatic cancer is the most severe cancer
   in Taiwan, with the greatest age-standardized EYLL for the men
   (15.6years) and women (18.0years) as well as for the men and women
   combined (16.6years). Negative correlations were observed between
   unstandardized EYLL of cancer and mean age at diagnosis.ConclusionsThe
   unstandardized EYLL represents an overall assessment of disease burden,
   whereas the age-standardized EYLL is a suitable measure of disease
   severity. We suggest that both measures be incorporated into routine
   annual reports of cancer statistics alongside the usual incidence and
   mortality rates and their age-standardized counterparts.},
Publisher = {BMC},
Address = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Lee, WC (Corresponding Author), Taiwan Canc Registry, Rm 506,17 Xuzhou Rd, Taipei 100, Taiwan.
   Lee, WC (Corresponding Author), Natl Taiwan Univ, Inst Epidemiol \& Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
   Wang, Yueh; Chiang, Chun-Ju; Lee, Wen-Chung, Taiwan Canc Registry, Rm 506,17 Xuzhou Rd, Taipei 100, Taiwan.
   Wang, Yueh; Chiang, Chun-Ju; Lee, Wen-Chung, Natl Taiwan Univ, Inst Epidemiol \& Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
   Lee, Wen-Chung, Natl Taiwan Univ, Coll Publ Hlth, Innovat \& Policy Ctr Populat Hlth \& Sustainable E, Taipei, Taiwan.},
DOI = {10.1186/s12889-019-6843-9},
Article-Number = {486},
ISSN = {1471-2458},
Keywords = {Expected years of life lost; Age-standardization; Cancer; Burden of
   disease},
Keywords-Plus = {HEALTH PROFILE; SURVIVAL; POPULATION; MORTALITY; STATISTICS; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {wenchung@ntu.edu.tw},
ORCID-Numbers = {Lee, Wen-Chung/0000-0003-3171-7672},
Funding-Acknowledgement = {Health Promotion Administration; Ministry of Health and Welfare in
   Taiwan {[}A1061011]; Ministry of Science and Technology in
   TaiwanMinistry of Science and Technology, Taiwan {[}MOST
   105-2314-B-002-049-MY3, MOST 104-2314-B-002-118-MY3, MOST
   107-3017-F-002-003]; Public Health Research Center from the Featured
   Areas Research Center Program within the Ministry of Education (MOE) in
   Taiwan {[}NTU-107 L9003]},
Funding-Text = {This paper is supported by grants from the Health Promotion
   Administration, the Ministry of Health and Welfare in Taiwan (A1061011;
   the tobacco control and health care funds), the Ministry of Science and
   Technology in Taiwan (MOST 105-2314-B-002-049-MY3, MOST
   104-2314-B-002-118-MY3 and MOST 107-3017-F-002-003), and the Public
   Health Research Center from the Featured Areas Research Center Program
   within the framework of the Higher Education Sprout Project by the
   Ministry of Education (MOE) in Taiwan (NTU-107 L9003). No additional
   external funding was received for this study. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.},
Cited-References = {Ahmad OB, 2001, AGE STANDARDIZATION.
   Andersson TML, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-96.
   Angelis R.D., 1999, STAT MED, V18, P441, DOI DOI 10.1002/(SICI)1097-0258(19990228)18:4.
   Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91.
   Chen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134694.
   Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x.
   Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7.
   Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002.
   Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141.
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210.
   Fidler MM, 2018, SCAND J PUBLIC HEALT, V46, P27, DOI 10.1177/1403494817715400.
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Ho JJ, 2006, SCAND J WORK ENV HEA, V32, P91, DOI 10.5271/sjweh.984.
   Hsu C, 2003, QUAL LIFE RES, V12, P503, DOI 10.1023/A:1025043113819.
   HWANG J, 1959, STAT MED, V18, P1627, DOI DOI 10.1002/(SICI)1097-0258(19990715)18:13.
   Hwang JS, 2004, QUAL LIFE RES, V13, P1, DOI 10.1023/B:QURE.0000015299.45623.38.
   International Agency for Research on Cancer, 2014, WORLD CANC REP, V16.
   Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002.
   Lambert PC, 2007, BIOSTATISTICS, V8, P576, DOI 10.1093/biostatistics/kxl030.
   LEE W, 1984, STAT MED, V18, P2645, DOI DOI 10.1002/(SICI)1097-0258(19991015)18:19.
   Lee WC, 1997, AM J PUBLIC HEALTH, V87, P1456, DOI 10.2105/AJPH.87.9.1456.
   Lee WC, 2002, STAT MED, V21, P247, DOI 10.1002/sim.1000.
   Lee WC, 1998, INT J EPIDEMIOL, V27, P1053, DOI 10.1093/ije/27.6.1053.
   Liu PH, 2013, PREV MED, V56, P309, DOI 10.1016/j.ypmed.2013.02.003.
   Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089.
   Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x.
   Rossi S, 2015, EUR J CANCER, V51, P2104, DOI 10.1016/j.ejca.2015.08.001.
   Sim X, 2006, BMC CANCER, V6, P1.
   Taiwan Cancer Registry, 2017, TAIW CANC REG ANN RE.
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262.
   Wu TY, 2018, CLIN EPIDEMIOL, V10, P581, DOI 10.2147/CLEP.S155601.
   Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb.
   Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005.},
Number-of-Cited-References = {35},
Times-Cited = {1},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {3},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {HW9OH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000467019900016},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000403412500061,
Author = {Freundlich, Robert E. and Maile, Michael D. and Hajjar, Mark M. and
   Habib, Joseph R. and Jewell, Elizabeth S. and Schwann, Thomas and Habib,
   Robert H. and Engoren, Milo},
Title = {Years of Life Lost After Complications of Coronary Artery Bypass
   Operations},
Journal = {ANNALS OF THORACIC SURGERY},
Year = {2017},
Volume = {103},
Number = {6},
Pages = {1893-1899},
Month = {JUN},
Note = {Annual Meeting of the American-Society-of-Anesthesiologists, San Diego,
   CA, OCT 24-28, 2015},
Organization = {Amer Soc Anesthesiologists},
Abstract = {Background. We currently have an incomplete understanding of which
   postoperative complications after coronary artery bypass grafting (CABG)
   are associated with long-term death. The purpose of this study was to
   find the associations between complications and attributable death.
   Methods. Prospectively collected data on patient characteristics, risk
   factors, and complications of patients undergoing isolated CABG with
   20-year follow-up were analyzed with a Cox regression model to calculate
   the overall hazard of dying associated with each postoperative
   complication. An individual's age and hazard of dying from each
   complication were then used to calculate years of life lost to each
   complication.
   Results. The postoperative mortality rate was 0.79\% (69 of 8,773) at 30
   days, 2.85\% (250 of 8,773) at 180 days, and 6.38\% (560 of 8,773) at 2
   years. At a median follow-up of 9.8 years, 1,891 patients (21.6\%) had
   died. Postoperative complications occurred in 3,438 patients (39.2\%).
   Cardiac arrest (hazard ratio, 2.153), reoperation (hazard ratio, 1.679),
   and new dialysis (hazard ratio, 1.64) were the complications with the
   greatest hazard of death. After adjusting for complication incidence and
   patient age, cardiac arrest (703 years), reoperation (544 years), atrial
   fibrillation (470 years), and prolonged mechanical ventilation (371
   years) were associated with the greatest number of years of life lost.
   Conclusions. Acute cardiac arrest, reoperation for other cardiac
   reasons, new dialysis, atrial fibrillation, and prolonged mechanical
   ventilation are associated with the largest increase in attributable
   deaths. Prevention and treatment of these complications may improve
   mortality rates after cardiac operations. (C) 2017 by The Society of
   Thoracic Surgeons},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Freundlich, RE (Corresponding Author), Vanderbilt Univ, Dept Anesthesiol, 1211 21st St S,Ste 526, Nashville, TN 37212 USA.
   Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN USA.
   Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
   Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.
   Amer Univ Beirut, Outcomes Res Unit, Beirut, Lebanon.
   Univ Toledo, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA.
   Mercy St Vincent Med Ctr, Dept Anesthesiol, Toledo, OH USA.},
DOI = {10.1016/j.athoracsur.2016.09.048},
ISSN = {0003-4975},
EISSN = {1552-6259},
Keywords-Plus = {AKAIKE INFORMATION CRITERION; LONG-TERM SURVIVAL; CARDIAC-SURGERY;
   GRAFT-SURGERY; NATIONAL DATABASE; MODEL SELECTION; F-TEST; SOCIETY;
   MORTALITY; ANGIOPLASTY},
Research-Areas = {Cardiovascular System \& Cardiology; Respiratory System; Surgery},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Respiratory System; Surgery},
Author-Email = {robert.e.freundlich@vanderbilt.edu},
ResearcherID-Numbers = {Maile, Michael David/C-6277-2011
   },
ORCID-Numbers = {Maile, Michael David/0000-0001-8236-3371
   Freundlich, Robert/0000-0002-0343-9823},
Cited-References = {Blackstone EH, 2012, J THORAC CARDIOV SUR, V143, P37, DOI 10.1016/j.jtcvs.2011.11.028.
   Buratto E, 2014, HEART LUNG CIRC, V23, P711, DOI 10.1016/j.hlc.2014.03.005.
   Chalmers J, 2013, EUR J CARDIO-THORAC, V43, P555, DOI 10.1093/ejcts/ezs329.
   Chikwe J, 2010, J CARDIOTHOR VASC AN, V24, P574, DOI 10.1053/j.jvca.2009.10.017.
   De Somer F, 2013, MINERVA ANESTESIOL, V79, P285.
   Dover M, 2016, VASCULAR, V24, P390, DOI 10.1177/1708538115604089.
   Engoren M, 2000, CRIT CARE MED, V28, P2742, DOI 10.1097/00003246-200008000-00010.
   Engoren M, 2013, J CLIN MONIT COMPUT, V27, P455, DOI 10.1007/s10877-013-9444-7.
   Frost L, 2007, NEUROEPIDEMIOLOGY, V29, P59, DOI 10.1159/000109497.
   Gallagher S, 2014, EUR J CARDIO-THORAC, V45, P1075, DOI 10.1093/ejcts/ezt630.
   Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176.
   Grover FL, 2014, ANN THORAC SURG, V97, pS48, DOI 10.1016/j.athoracsur.2013.10.015.
   Hannan EL, 1999, J AM COLL CARDIOL, V33, P63, DOI 10.1016/S0735-1097(98)00540-3.
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602.
   Lapar DJ, 2014, ANN THORAC SURG, V98, P534, DOI 10.1016/j.athoracsur.2014.03.030.
   LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864.
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304.
   Shahian DM, 2014, ANN THORAC SURG, V97, P1604, DOI 10.1016/j.athoracsur.2013.10.114.
   Shahian DM, 2013, HEART, V99, P1494, DOI 10.1136/heartjnl-2012-303456.
   Shahian DM, 2012, CIRCULATION, V125, P1491, DOI 10.1161/CIRCULATIONAHA.111.066902.
   Shahian DM, 2010, J THORAC CARDIOV SUR, V140, P955, DOI 10.1016/j.jtcvs.2010.09.004.
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053.
   Vogt A, 2000, EUR HEART J, V21, P28, DOI 10.1053/euhj.1999.1634.
   Wahl GW, 1996, CHEST, V110, P1394, DOI 10.1378/chest.110.6.1394.
   Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108.
   Weintraub WS, 2003, CIRCULATION, V107, P1271, DOI 10.1161/01.CIR.0000053642.34528.D9.
   Yamaoka H, 2016, J CARDIOL, V68, P135, DOI 10.1016/j.jjcc.2015.08.017.
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1.},
Number-of-Cited-References = {28},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Ann. Thorac. Surg.},
Doc-Delivery-Number = {EX7FB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000403412500061},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000377893600002,
Author = {Nevalainen, Olli and Simola, Mikko and Ansakorpi, Hanna and Raitanen,
   Jani and Artama, Miia and Isojarvi, Jouko and Auvinen, Anssi},
Title = {Epilepsy, excess deaths and years of life lost from external causes},
Journal = {EUROPEAN JOURNAL OF EPIDEMIOLOGY},
Year = {2016},
Volume = {31},
Number = {5},
Pages = {445-453},
Month = {MAY},
Abstract = {We systematically quantified excess mortality in epilepsy patients by
   cause of death using the population-attributable fraction and
   epilepsy-attributable years of potential life lost (YPLL) by age 75
   years at ages 15 and over. We updated and undertook a re-review of
   mortality studies from our previous systematic review following PRISMA
   guidelines to identify cohort studies of general epilepsy populations
   reporting a relative risk (RR) of death by cause relative to the
   background rates in the population. Studies on epilepsy prevalence were
   identified through published reviews. Country-specific mortality figures
   were obtained from the WHO World Mortality Database. We performed a
   pooled analysis with the DerSimonian-Laird random effects method. In
   countries with very high Human Development Indices, epilepsy contributed
   to 0.5-1.1 \% of all deaths in the total population. Among external
   causes, suicides (RR 2.9, 95 \% confidence interval 2.2-3.8; I-2 52 \%)
   were the major contributor to YPLL, corresponding to 6.7 \% and 4.2 \%
   of excess YPLL due to epilepsy in the United States (US) and in the
   United Kingdom (UK) in 2010, with 541 (346-792) and 44 (28-65) excess
   suicide cases, respectively. Fatal accidental falls were more common,
   with 813 (610-1064) and 95 (71-125) excess deaths in the US and in the
   UK, but these caused only 2.0 \% of excess YPLL as they occurred in
   older age groups. Suicides were the most important external cause of
   death in epilepsy patients in terms of excess YPLL, whereas other
   external causes were either more common in older ages or caused less
   excess deaths.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Review},
Language = {English},
Affiliation = {Nevalainen, O (Corresponding Author), Hatanpaa Hlth Ctr, Tampere, Finland.
   Nevalainen, O (Corresponding Author), Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
   Nevalainen, Olli, Hatanpaa Hlth Ctr, Tampere, Finland.
   Nevalainen, Olli; Raitanen, Jani; Auvinen, Anssi, Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
   Simola, Mikko; Ansakorpi, Hanna; Isojarvi, Jouko, Univ Oulu, Res Unit Clin Neurosci, Oulu, Finland.
   Raitanen, Jani, UKK Inst Hlth Promot, Tampere, Finland.
   Artama, Miia, Finnish Canc Registry, FIN-00170 Helsinki, Finland.
   Isojarvi, Jouko, Lundbeck, Deerfield, IL USA.
   Auvinen, Anssi, Tampere Univ Hosp, Pediat Res Ctr, Tampere, Finland.
   Auvinen, Anssi, Univ Tampere, FIN-33101 Tampere, Finland.},
DOI = {10.1007/s10654-015-0095-5},
ISSN = {0393-2990},
EISSN = {1573-7284},
Keywords = {Epilepsy; Mortality; Meta-analysis; Epidemiology},
Keywords-Plus = {CAUSE-SPECIFIC MORTALITY; SUDDEN UNEXPECTED DEATH; LONG-TERM MORTALITY;
   PREMATURE MORTALITY; CLINICAL CHARACTERISTICS; CONVULSIVE EPILEPSY;
   ALZHEIMERS-DISEASE; FOLLOW-UP; RISK; SUICIDE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {olli.neval@gmail.com
   mikko.simola@student.oulu.fi},
ResearcherID-Numbers = {Auvinen, Anssi/AAD-9311-2020
   Auvinen, Anssi/AAL-2111-2020
   Raitanen, Jani/AAW-9233-2021
   },
ORCID-Numbers = {Auvinen, Anssi/0000-0003-1125-4818
   Raitanen, Jani/0000-0001-7674-0978},
Funding-Acknowledgement = {Vaajasalo foundation; Eka-apuraha from the Finnish Medical Foundation;
   Finnish Epilepsy Research Foundation; Maire Taponen Research Foundation;
   Eisai ABEisai Co Ltd; UCBUCB Pharma SA; Ratiopharm TevaTeva
   Pharmaceutical Industries},
Funding-Text = {Olli Nevalainen: O.N. reports grants from the Vaajasalo foundation,
   Eka-apuraha from the Finnish Medical Foundation, Finnish Epilepsy
   Research Foundation and Maire Taponen Research Foundation, a travel
   bursary to the 11th European Congress on Epileptology with assistance in
   travel expenses and accommodation (ILAE 2014), travel expenses and
   accommodation to an epilepsy-related teaching course organized in
   Finland in 2013 and 2014 (UCB Pharma). Mikko Simola:Disclosure: M.S.
   reports no disclosures. Hanna Ansakorpi: H.A. is a board member of the
   Finnish Epilepsy Association since 2010 and reports personal fees from
   lectures (Eisai AB, UCB, Ratiopharm Teva), travel expenses to European
   Congress of Epileptology 2011, Rome (Eisai AB), World Congress of
   Neurology 2013, Wien (Novartis Oy), and expert opinion on epilepsy
   treatment to the Finnish Medicines Agency in 2012. Jani Raitanen: J.R.
   reports no disclosures. Jouko lsojarvi: J.I. is an employee of Lundbeck,
   LLC. Miia Artama: M.A. reports no disclosures. Anssi Auvinen: A.A.
   reports no disclosures.},
Cited-References = {ANNEGERS JF, 1984, EPILEPSIA, V25, P699, DOI 10.1111/j.1528-1157.1984.tb03480.x.
   Arana A, 2010, NEW ENGL J MED, V363, P542, DOI 10.1056/NEJMoa0909801.
   Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003.
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104.
   Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2.
   Bell GS, 2008, NEUROLOGY, V71, P578, DOI 10.1212/01.wnl.0000323813.36193.4d.
   Bell GS, 2014, EPILEPSIA, V55, P958, DOI 10.1111/epi.12605.
   Bell GS, 2009, EPILEPSIA, V50, P1933, DOI 10.1111/j.1528-1167.2009.02106.x.
   Chang YH, 2012, SEIZURE-EUR J EPILEP, V21, P254, DOI 10.1016/j.seizure.2012.01.006.
   Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8.
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104.
   Craven Rebecca, 2010, Lancet Neurol, V9, P568, DOI 10.1016/S1474-4422(10)70126-5.
   Ding D, 2013, EPILEPSIA, V54, P512, DOI 10.1111/epi.12048.
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629.
   Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5.
   Ferrer P, 2014, NEUROEPIDEMIOLOGY, V42, P107, DOI 10.1159/000356807.
   Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x.
   Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x.
   HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x.
   Higgins JP., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186.
   Kaiboriboon K, 2014, EPILEPSIA, V55, P1781, DOI 10.1111/epi.12789.
   Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482.
   LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531.
   Lhatoo SD, 2001, ANN NEUROL, V49, P336.
   Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Lu TH, 2007, INJURY PREV, V13, P276, DOI 10.1136/ip.2006.012930.
   Lunetta P, 2007, INJURY PREV, V13, P282, DOI 10.1136/ip.2006.012922.
   Mohanraj R, 2006, LANCET NEUROL, V5, P481, DOI 10.1016/S1474-4422(06)70448-3.
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI {[}10.1016/j.ijsu.2010.02.007, 10.1136/bmj.g7647, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086].
   Morgan CL, 2002, EPILEPSIA, V43, P1251, DOI 10.1046/j.1528-1157.2002.38701.x.
   Mu J, 2011, NEUROLOGY, V77, P132, DOI 10.1212/WNL.0b013e318223c784.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Neligan A, 2011, BRAIN, V134, P388, DOI 10.1093/brain/awq378.
   Nevalainen O, 2014, NEUROLOGY, V83, P1968, DOI 10.1212/WNL.0000000000001005.
   Nevalainen O, 2013, EUR J EPIDEMIOL, V28, P981, DOI 10.1007/s10654-013-9848-1.
   Nevalainen O, 2012, EPILEPSIA, V53, pe212, DOI 10.1111/epi.12006.
   Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x.
   Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x.
   Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X.
   Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P964, DOI 10.1002/pds.2186.
   Pugh MJV, 2013, NEUROLOGY, V81, P1900, DOI 10.1212/01.wnl.0000436614.51081.2e.
   Rafnsson V, 2001, NEUROEPIDEMIOLOGY, V20, P232, DOI 10.1159/000054795.
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15.
   Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x.
   Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d.
   Shackleton DP, 1999, J NEUROL NEUROSUR PS, V66, P636, DOI 10.1136/jnnp.66.5.636.
   Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1.
   Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610.
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   Thurman DJ, 2014, EPILEPSIA, V55, P1479, DOI 10.1111/epi.12666.
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x.
   Trinka E, 2013, EPILEPSIA, V54, P495, DOI 10.1111/epi.12014.
   United Nations Development Program, 2010, HUM DEV REP 2010 20.
   Wang WZ, 2003, NEUROLOGY, V60, P1544, DOI 10.1212/01.WNL.0000059867.35547.DE.
   Wells GA, NEWCASTLE OTTAWA SCA.
   WHO, 2013, MORT DAT DOC.
   WHO, 2014, PREV SUIC GLOB IMP.},
Number-of-Cited-References = {59},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {21},
Journal-ISO = {Eur. J. Epidemiol.},
Doc-Delivery-Number = {DO6KZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000377893600002},
DA = {2022-03-29},
}

@article{ WOS:000407953100001,
Author = {Murillo-Zamora, Efren and Mendoza-Cano, Oliver and Trujillo-Hernandez,
   Benjamin and Guzman-Esquivel, Jose and Medina-Gonzalez, Alfredo and
   Huerta, Miguel and Alberto Sanchez-Pina, Ramon and Lugo-Radillo, Agustin},
Title = {Expected years of life lost through road traffic injuries in Mexico},
Journal = {GLOBAL HEALTH ACTION},
Year = {2017},
Volume = {10},
Number = {1},
Month = {AUG 18},
Abstract = {Background: Road traffic injuries (RTIs) are a leading cause of
   premature mortality, mainly in low-and middle-income countries
   Objective: To estimate the 2014 burden of RTIs in Mexico calculating
   years of life lost (YLL) and age-standardized YLL rates (ASYLL), and to
   evaluate sex, age, and region-related differences in premature
   mortality.
   Methods: Mortality data were obtained from the National Institute of
   Statistics and Geography and 14,637 deaths of individuals 15 years of
   age and older were analyzed. The YLL and ASYLL were computed.
   Results: The overall burden of RTIs was 332,922 YLL and 82.4\% of the
   deaths occurred in males. Males from 25 to 34 years of age and females
   from 15 to 24 years of age showed the highest age-adjusted YLL rates
   (933 and 158 YLL per 100,000 inhabitants, respectively). The national
   ASYLL rate was 416 per 100,000 inhabitants and the highest
   state-stratified mortality rates were observed in Tabasco (851), Sinaloa
   (709), Durango (656), Zacatecas (642), and Baja California Sur (570).
   Conclusions: RTIs contributed to the premature mortality rate in the
   study population. Our findings may be useful from a health policy
   perspective for designing and prioritizing interventions focused on the
   prevention of premature loss of life.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Lugo-Radillo, A (Corresponding Author), Univ Autonoma Benito Juarez Oaxaca, Fac Med \& Cirugia, Ex Hacienda de Aguilera S-N, Oaxaca 68020, Oax, Mexico.
   Murillo-Zamora, Efren, Inst Mexicano Seguro Social, Jefatura Serv Prestac Med, Coordinac Vigilancia Epidemiol, Colima, Mexico.
   Mendoza-Cano, Oliver; Alberto Sanchez-Pina, Ramon, Harvard TH Chan Sch Publ Hlth, Ctr Hlth \& Global Environm, Boston, MA USA.
   Mendoza-Cano, Oliver, Univ Colima, Fac Ingn Civil, Colima, Mexico.
   Lugo-Radillo, Agustin, Univ Autonoma Benito Juarez Oaxaca, Fac Med \& Cirugia, CONACYT, Oaxaca, Mexico.
   Trujillo-Hernandez, Benjamin, Univ Colima, Fac Med, Colima, Mexico.
   Guzman-Esquivel, Jose, Inst Mexicano Seguro Social, Unidad Invest Epidemiol Clin, Colima, Mexico.
   Medina-Gonzalez, Alfredo, Inst Mexicano Seguro Social, Jefatura Serv Prestac Med, Coordinac Planeac \& Enlace Inst, Colima, Mexico.
   Huerta, Miguel, Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico.},
DOI = {10.1080/16549716.2017.1360629},
Article-Number = {1360629},
ISSN = {1654-9880},
Keywords = {Traffic accidents; premature mortality; burden of illness; Mexico;
   health Policy},
Keywords-Plus = {SUSTAINABLE DEVELOPMENT GOAL; MORTALITY; HEALTH; GUADALAJARA;
   40-PERCENT; DEATHS; TRENDS; IMPACT; LEON},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {alugora@conacyt.mx},
ResearcherID-Numbers = {Mendoza-Cano, Oliver/C-9317-2018
   Guzman-Esquivel, Jose/N-2853-2015
   Sanchez, Ramon/AAW-8839-2021
   Murillo, Efrén/AAF-7236-2021
   },
ORCID-Numbers = {Mendoza-Cano, Oliver/0000-0001-9614-4946
   Guzman-Esquivel, Jose/0000-0002-6727-0051
   Sanchez, Ramon/0000-0002-8810-9777
   Huerta, Miguel/0000-0001-8515-0777
   Medina-Gonzalez, Alfredo/0000-0002-2401-4592
   LUGO-RADILLO, AGUSTIN/0000-0001-6689-2783
   Murillo-Zamora, Efren/0000-0002-1118-498X
   Trujillo-Hernandez, Benjamin/0000-0001-8306-0137},
Cited-References = {Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Arreola-Rissa C, 2008, SALUD PUBLICA MEXICO, V50, pS48.
   Bhatti Junaid A, 2013, Int J Crit Illn Inj Sci, V3, P25, DOI 10.4103/2229-5151.109415.
   Trejo AC, 2014, GAC MED MEX, V150, P552.
   Consejo Nacional para la Prevencion de Accidentes, 2016, PERF NAC EST SEG VIA.
   Dalal Koustuv, 2013, Int J Prev Med, V4, P1442.
   Dibben C, 2013, EUR J PUBLIC HEALTH, V23, P39, DOI 10.1093/eurpub/cks019.
   Direccion General de Epidemiologia, 2013, MAN PROC EST SIST ES.
   Espitia-Hardeman V, 2008, SALUD PUBLICA MEXICO, V50, pS69, DOI 10.1590/S0036-36342008000700011.
   Global Health Observatory World Health Organization, 2015, LIF TABL COUNTR MEX.
   Gomez-Garcia L, 2014, CAD SAUDE PUBLICA, V30, P1281, DOI 10.1590/0102-311X00121813.
   Gonzalez-Pier E, 2016, LANCET GLOB HEALTH, V4, pE714, DOI 10.1016/S2214-109X(16)30181-4.
   Granie MA, 2011, TRANSPORT RES F-TRAF, V14, P341, DOI 10.1016/j.trf.2011.04.002.
   Hijar M, 2012, TRAFFIC INJ PREV, V13, P5, DOI 10.1080/15389588.2011.631065.
   Instituto Nacional de Estadistia y Geografia, 2015, CENS NAC POBL VIV 20.
   Instituto Nacional de Estadistica y Geografia, 2016, PRINC CAUS MORT LUG.
   Instituto Nacional de Estadistica y Geografia, 2013, LIST MEX CAUS MUERT.
   Instituto Nacional de Geografia y Estadistica, 2016, VEH MOT REG CIRC 198.
   Ishigami Y, 2009, J SAFETY RES, V40, P157, DOI 10.1016/j.jsr.2009.02.006.
   Katcher BS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-682.
   La Torre G, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-49.
   LaGrone L, 2016, B WORLD HEALTH ORGAN, V94, P585, DOI 10.2471/BLT.15.162214.
   Leenen I., 2015, GAC MED MEX, V151, P54.
   Lukaschek K, 2012, INT J ENV RES PUB HE, V9, P924, DOI 10.3390/ijerph9030924.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442.
   Murillo-Zamora E, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31642.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   ORGANIZACION PANAMERICANA DE LA SALUD, 2009, INF EST SEG VIAL REG.
   Perez-Nunez R, 2014, CAD SAUDE PUBLICA, V30, P911, DOI 10.1590/0102-311X00026113.
   Prieto Luis, 2003, Health Qual Life Outcomes, V1, P80, DOI 10.1186/1477-7525-1-80.
   Rodrigues EMS, 2014, INT J INJ CONTROL SA, V21, P170, DOI 10.1080/17457300.2013.792289.
   Shahraz S, 2013, INJURY PREV, V19, P1, DOI 10.1136/injuryprev-2011-040178.
   STATON C, 2016, PLOS ONE, V11.
   Thacker SB, 2006, PUBLIC HEALTH REP, V121, P14, DOI 10.1177/003335490612100107.
   World Health Organization, 2015, GLOB STAT REP ROAD S.},
Number-of-Cited-References = {38},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Glob. Health Action},
Doc-Delivery-Number = {FE1BJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000407953100001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000659878000002,
Author = {Ferenci, Tamas},
Title = {Different approaches to quantify years of life lost from COVID-19},
Journal = {EUROPEAN JOURNAL OF EPIDEMIOLOGY},
Year = {2021},
Volume = {36},
Number = {6},
Pages = {589-597},
Month = {JUN},
Abstract = {The burden of an epidemic is often characterized by death counts, but
   this can be misleading as it fails to acknowledge the age of the
   deceased patients. Years of life lost is therefore widely used as a more
   relevant metric, however, such calculations in the context of COVID-19
   are all biased upwards: patients dying from COVID-19 are typically
   multimorbid, having far worse life expectation than the general
   population. These questions are quantitatively investigated using a
   unique Hungarian dataset that contains individual patient level data on
   comorbidities for all COVID-19 deaths in the country. To account for the
   comorbidities of the patients, a parametric survival model using 11
   important long-term conditions was used to estimate a more realistic
   years of life lost. As of 12 May, 2021, Hungary reported a total of
   27,837 deaths from COVID-19 in patients above 50 years of age. The usual
   calculation indicates 10.5 years of life lost for each death, which
   decreases to 9.2 years per death after adjusting for 11 comorbidities.
   The expected number of years lost implied by the life table, reflecting
   the mortality of a developed country just before the pandemic is 11.1
   years. The years of life lost due to COVID-19 in Hungary is therefore
   12\% or 1.3 years per death lower when accounting for the comorbidities
   and is below its expected value, but how this should be interpreted is
   still a matter of debate. Further research is warranted on how to
   optimally integrate this information into epidemiologic risk assessments
   during a pandemic.},
Publisher = {SPRINGER},
Address = {VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Ferenci, T (Corresponding Author), Obuda Univ, Physiol Controls Res Ctr, Becsi Ut 96-b, H-1034 Budapest, Hungary.
   Ferenci, T (Corresponding Author), Corvinus Univ Budapest, Dept Stat, Budapest, Hungary.
   Ferenci, Tamas, Obuda Univ, Physiol Controls Res Ctr, Becsi Ut 96-b, H-1034 Budapest, Hungary.
   Ferenci, Tamas, Corvinus Univ Budapest, Dept Stat, Budapest, Hungary.},
DOI = {10.1007/s10654-021-00774-0},
EarlyAccessDate = {JUN 2021},
ISSN = {0393-2990},
EISSN = {1573-7284},
Keywords = {COVID-19; Years of life lost; PYLL; Disease burden; Mortality;
   Multimorbidity},
Keywords-Plus = {UNITED-STATES; MORTALITY; BURDEN; NATIONWIDE; DISEASE; TRENDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ferenci.tamas@nik.uni-obuda.hu},
ResearcherID-Numbers = {Ferenci, Tamas/H-4682-2012},
ORCID-Numbers = {Ferenci, Tamas/0000-0001-6791-3080},
Funding-Acknowledgement = {Obuda University},
Funding-Text = {Open access funding provided by Obuda University. No funding was
   received for conducting this study.},
Cited-References = {{[}Anonymous], HUM MORT DAT.
   Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61.
   Bonneux L, 2002, J EPIDEMIOL COMMUN H, V56, P128, DOI 10.1136/jech.56.2.128.
   Briggs AH, 2021, HEALTH ECON, V30, P699, DOI 10.1002/hec.4208.
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404.
   Devleesschauwer B, 2020, INT J PUBLIC HEALTH, V65, P719, DOI 10.1007/s00038-020-01430-2.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Goldstein JR, 2020, P NATL ACAD SCI USA, V117, P22035, DOI 10.1073/pnas.2006392117.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Hanlon P., 2021, WELLCOME OPEN RES, V5, P1, DOI {[}10.12688/wellcomeopenres.15849.3, DOI 10.12688/WELLCOMEOPENRES.15849.2, DOI 10.12688/WELLCOMEOPENRES.15849.3].
   Horvath A, 2016, CLIN EPIDEMIOL, V8, P211, DOI 10.2147/CLEP.S91439.
   Jackson CH, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i08.
   Kolossvary E, 2015, EUR J VASC ENDOVASC, V50, P78, DOI 10.1016/j.ejvs.2015.02.019.
   Kolossvary E, 2020, VASA, V49, P87, DOI 10.1024/0301-1526/a000823.
   Kozponti Statisztikai Hivatal (KSH), 22113 KSH STADT.
   Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205.
   Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103.
   Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8.
   Li S, 2007, RESP MED, V101, P1244, DOI 10.1016/j.rmed.2006.10.022.
   Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2815.
   Marshall R., 2010, HDB DIS BURDENS QUAL, P401, DOI {[}10.1007/978-0-387-78665-0\_22, DOI 10.1007/978-0-387-78665-0\_22].
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Martinez R, 2019, INT J EPIDEMIOL, V48, P1367, DOI 10.1093/ije/dyy254.
   Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392.
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534.
   Noordzij M, 2021, CLIN KIDNEY J, V14, P14, DOI 10.1093/ckj/sfab027.
   Arolas HPI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83040-3.
   Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0.
   Quast T, 2020, J PUBLIC HEALTH-UK, V42, P717, DOI 10.1093/pubmed/fdaa159.
   R Core Team, 2013, R LANG ENV STAT COMP.
   Rommel A, 2021, DTSCH ARZTEBL INT, V118, P145, DOI 10.3238/arztebl.m2021.0147.
   Rubo Marius, 2020, Wellcome Open Res, V5, P137, DOI 10.12688/wellcomeopenres.16015.1.
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a.
   Setel P, 2020, B WORLD HEALTH ORGAN, V98, P374, DOI 10.2471/BLT.20.263194.
   Sornette D, 2020, NONLINEAR DYNAM, V101, P1751, DOI 10.1007/s11071-020-05966-z.
   STICKLE G, 1965, AM J PUBLIC HEALTH N, V55, P1692, DOI 10.2105/AJPH.55.11.1692.
   van Lier E A, 2007, Euro Surveill, V12, pE3.
   Wood S., 2017, GEN ADDITIVE MODELS, V2, DOI {[}10.1201/9781315370279, DOI 10.1201/9781315370279].
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374.
   Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1.
   Yelin D, 2020, LANCET INFECT DIS, V20, P1115, DOI 10.1016/S1473-3099(20)30701-5.},
Number-of-Cited-References = {41},
Times-Cited = {4},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Eur. J. Epidemiol.},
Doc-Delivery-Number = {TU2VS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000659878000002},
OA = {Green Submitted, hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000397553800013,
Author = {Bryla, M. and Dziankowska-Zaborszczyk, E. and Maniecka-Bryla, I.},
Title = {Standard expected years of life lost due to tuberculosis in Poland},
Journal = {INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE},
Year = {2017},
Volume = {21},
Number = {2},
Pages = {202-207},
Month = {FEB},
Abstract = {SETTING: Central European countries such as Poland have higher
   tuberculosis (TB) morbidity and mortality than Western European Union
   countries.
   OBJECTIVE: To evaluate changes in mortality due to TB during the period
   1999-2012 in Poland and years of life lost due to the disease.
   DESIGN: Information obtained from 5 219 205 death certificates in Poland
   during the period 1999-2012 was used for the study. Crude (CDRs) and
   standardised (SDRs) death rates due to TB were analysed. Standard
   expected years of life lost per living person (SEYLLp) was also
   calculated.
   RESULTS: In Poland, TB and related complications contributed 0.23\% of
   total deaths from 1999 to 2012. The SEYLL was 3.46 per 10 000 population
   in 1999 and 1.88 in 2012. It was respectively 5.75 and 3.12 for males,
   and 1.31 and 0.72 for females. The SEYLL index decreased over the period
   (annual per cent change {[}APC]-4.27\%, P < 0.05); the decrease was
   greater in females than in males (APC-4.75 P < 0.05 vs. APC-4.15\%, P <
   0.05).
   CONCLUSION: Despite an improvement in the epidemiological situation, TB
   remains the most common single cause of death due to an infectious agent
   in Poland.},
Publisher = {INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)},
Address = {68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Dept Social \& Prevent Med, Epidemiol \& Biostatist Units, Zeligowskiego Str 7-9, PL-90752 Lodz, Poland.
   Bryla, M., Med Univ Lodz, Social Med, Lodz, Poland.
   Dziankowska-Zaborszczyk, E.; Maniecka-Bryla, I., Med Univ Lodz, Dept Social \& Prevent Med, Epidemiol \& Biostatist Units, Zeligowskiego Str 7-9, PL-90752 Lodz, Poland.},
DOI = {10.5588/ijtld.16.0268},
ISSN = {1027-3719},
EISSN = {1815-7920},
Keywords = {TB; mortality; trends},
Keywords-Plus = {PREMATURE MORTALITY; BURDEN},
Research-Areas = {Infectious Diseases; Respiratory System},
Web-of-Science-Categories  = {Infectious Diseases; Respiratory System},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Maniecka-Bryla, Irena/AAW-5779-2021
   Bryla, Marek/AAW-5787-2021
   },
ORCID-Numbers = {Maniecka-Bryla, Irena/0000-0002-6671-7456
   Bryla, Marek/0000-0001-6757-9211
   Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606},
Funding-Acknowledgement = {National Science Centre, Krakow, Poland {[}DEC-2013/11/B/HS4/00465]},
Funding-Text = {The study was funded by the National Science Centre, Krakow, Poland (no.
   DEC-2013/11/B/HS4/00465). The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.},
Cited-References = {{[}Anonymous], 1935, DZIENNIK USTAW, V27, P198.
   {[}Anonymous], 2014, ZACH ZGON NA GRUZL P.
   {[}Anonymous], 1959, DZIENNIK USTAW, V27, P170.
   Berner Wlodzimierz, 2009, Przegl Epidemiol, V63, P149.
   Blondal K, 2013, INT J TUBERC LUNG D, V17, P961, DOI 10.5588/ijtld.12.0946.
   Central Statistical Office, 1937, CONC YB.
   Central Statistical Office, 1939, CONC YB.
   Central Statistical Office, 1932, CONC YB.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2016, TUB SURV MON EUR 201.
   Gawryszewski A, 2006, POPULATION POLAND 20.
   Janicki J, 2010, MED NOW, V16, P32.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Korzeniewska-Kosela M, 2015, EPIDEMIOLOGIA GRUILI.
   Korzeniewska-Kosela Maria, 2015, Przegl Epidemiol, V69, P277.
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Marx F M, 2009, Pneumologie, V63, P253, DOI 10.1055/s-0028-1119571.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   National Cancer Institute, 2015, EST APC.
   Office for Official Publications of the European Communities, 2009, HLTH STAT ATL MORT E.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Toungoussova OS, 2006, TUBERCULOSIS, V86, P1, DOI 10.1016/j.tube.2005.04.001.
   United States National Cancer Institute Surveillance Research Program., 2015, JOINP REGR PROGR VER.
   World Health Organization, 2016, TUB COUNTR WORK SUMM.
   World Health Organization, 2015, GLOBAL TUBERCULOSIS.
   Wroblewska W, 2012, STUDIA DEMOGR, V161, P129.},
Number-of-Cited-References = {33},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Int. J. Tuberc. Lung Dis.},
Doc-Delivery-Number = {EP7JJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000397553800013},
DA = {2022-03-29},
}

@article{ WOS:000257658500003,
Author = {Miller, Mark A. and Viboud, Cecile and Olson, Donald R. and Grais,
   Rebecca F. and Rabaa, Maia A. and Simonsen, Lone},
Title = {Prioritization of influenza pandemic vaccination to minimize years of
   life lost},
Journal = {JOURNAL OF INFECTIOUS DISEASES},
Year = {2008},
Volume = {198},
Number = {3},
Pages = {305-311},
Month = {AUG 1},
Note = {9th Annual Conference on Vaccine Research, Baltimore, MD, MAY 08-10,
   2006},
Abstract = {Background. How to allocate limited vaccine supplies in the event of an
   influenza pandemic is currently under debate. Conventional vaccination
   strategies focus on those at highest risk for severe outcomes, including
   seniors, but do not consider (1) the signature pandemic pattern in which
   mortality risk is shifted to younger ages, (2) likely reduced vaccine
   response in seniors, and (3) differences in remaining years of life with
   age.
   Methods. We integrated these factors to project the age-specific years
   of life lost (YLL) and saved in a future pandemic, on the basis of
   mortality patterns from 3 historical pandemics, age-specific vaccine
   efficacy, and the 2000 US population structure.
   Results. For a 1918-like scenario, the absolute mortality risk is
   highest in people < 45 years old; in contrast, seniors (those >= 65
   years old) have the highest mortality risk in the 1957 and 1968
   scenarios. The greatest YLL savings would be achieved by targeting
   different age groups in each scenario; people < 45 years old in the 1918
   scenario, people 45-64 years old in the 1968 scenario, and people < 45
   years old in the 1957 scenario.
   Conclusions. Our findings shift the focus of pandemic vaccination
   strategies onto younger populations and illustrate the need for
   real-time surveillance of mortality patterns in a future pandemic.
   Flexible setting of vaccination priority is essential to minimize
   mortality.},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA},
Type = {Article; Proceedings Paper},
Language = {English},
Affiliation = {Miller, MA (Corresponding Author), NIH, Div Int Epidemiol \& Populat Studies, Fogarty Int Ctr, 16 Ctr Dr, Bethesda, MD 20892 USA.
   Miller, Mark A., NIH, Div Int Epidemiol \& Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   Olson, Donald R., New York City Dept Hlth \& Mental Hyg, New York, NY USA.
   Simonsen, Lone, George Washington Univ, Sch Publ Hlth \& Hlth Serv, Dept Global Hlth, Washington, DC USA.},
DOI = {10.1086/589716},
ISSN = {0022-1899},
EISSN = {1537-6613},
Keywords-Plus = {PUBLIC-HEALTH; UNITED-STATES; COST-EFFECTIVENESS; AGE DISTRIBUTION;
   MORTALITY; DISEASE; BURDEN; IMPACT; ETHICS; PATTERN},
Research-Areas = {Immunology; Infectious Diseases; Microbiology},
Web-of-Science-Categories  = {Immunology; Infectious Diseases; Microbiology},
Author-Email = {millemar@mail.nih.gov},
ResearcherID-Numbers = {Rabaa, Maia/AAL-5501-2021
   Simonsen, Lone/K-4531-2014
   Rabaa, Maia/W-2223-2019
   },
ORCID-Numbers = {Simonsen, Lone/0000-0003-1535-8526
   Rabaa, Maia/0000-0003-0529-2228
   Freeman Grais, Rebecca/0000-0002-5037-8218
   Olson, Donald/0000-0002-5980-229X},
Cited-References = {Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065.
   Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387.
   Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104.
   Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257.
   Cohen J, 2000, J PUBLIC HEALTH MED, V22, P518, DOI 10.1093/pubmed/22.4.518.
   Curson Peter, 2006, N S W Public Health Bull, V17, P103.
   DAUER CC, 1961, AM REV RESPIR DIS, V83, P15.
   Demicheli V, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001269.PUB2.
   Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820.
   Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174.
   Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5.
   Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347.
   Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980.
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795.
   Frey HS, 2006, SCIENCE, V313, P758.
   Galvani AP, 2006, SCIENCE, V313, P758.
   Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103.
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105.
   Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554.
   Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143.
   Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104.
   HOUSWORTH WJ, 1971, AM J EPIDEMIOL, V94, P348, DOI 10.1093/oxfordjournals.aje.a121329.
   Harper Scott A., 2004, Morbidity and Mortality Weekly Report, V53, P1.
   Langford C, 2002, MED HIST, V46, P1.
   Lieu TA, 2000, JAMA-J AM MED ASSOC, V283, P1460, DOI 10.1001/jama.283.11.1460.
   Mamelund SE, 2006, SOC SCI MED, V62, P923, DOI 10.1016/j.socscimed.2005.06.051.
   Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399.
   McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009.
   Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507.
   Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247.
   Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102.
   PAHO's Area of Health Analysis and Information Systems (AIS), 2003, Epidemiol Bull, V24, P1.
   Palese P, 2006, IMMUNITY, V24, P121, DOI 10.1016/j.immuni.2006.01.007.
   SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753.
   Silverstein RP, 2006, SCIENCE, V313, P758.
   Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616.
   SIMONSEN L, 2003, OPTIONS CONTROL INFL, V5.
   SIMONSEN L, 2004, FORUM MICROBIAL THRE.
   Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849.
   {*}US CDCP, EST INFL VACC TARG P.
   {*}US DEP HHS, DRAFT GUID ALL TARG.
   {*}US NAT CTR HLTH S, 1999, US LIF TABL.
   Uscher-Pines L, 2006, PLOS MED, V3, P1721, DOI 10.1371/journal.pmed.0030436.
   Vallejo AN, 2007, TRENDS MOL MED, V13, P94, DOI 10.1016/j.molmed.2007.01.005.
   Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150.
   Wynia MK, 2006, AM J BIOETHICS, V6, P4, DOI 10.1080/15265160601021256.
   Zimmerman RK, 2007, VACCINE, V25, P2019, DOI 10.1016/j.vaccine.2006.11.045.
   1986, MMWR MORB MORTAL WKL, V35, pS1.},
Number-of-Cited-References = {50},
Times-Cited = {48},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Infect. Dis.},
Doc-Delivery-Number = {326KU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)},
Unique-ID = {WOS:000257658500003},
OA = {Bronze, Green Published, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:000473525500025,
Author = {Mazzotti, Federico and Cucchetti, Alessandro and Claassen, Yvette H. M.
   and Bos, Amanda C. R. K. and Bastiaannet, Esther and Ercolani, Giorgio
   and Dekker, Jan Willem T.},
Title = {Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis},
Journal = {WORLD JOURNAL OF SURGERY},
Year = {2019},
Volume = {43},
Number = {8},
Pages = {2077-2085},
Month = {AUG},
Abstract = {BackgroundAn aging population combined with an increased colorectal
   cancer (CRC) incidence in the older population will increase its
   prevalence in the elderly, questioning how many years of life are lost
   (YLLs) in these patients.Patients and methodsData from 32,568 Dutch CRC
   patients80years were used to estimate the number of YLLs after
   diagnosis, using a reference age-, sex- and year-of-onset-matched cohort
   derived from national life tables. YLLs were additionally adjusted by
   comorbidities. Number needed to treat (NNT) was used as measure of
   surgical effect size.ResultsSurgery was applied in 74.9\% of patients
   leading to 1.3 YLLs, being superior in 86.1\% of cases with respect to
   alternative therapies (YLLs 4.8years) and resulting in a number of two
   patients needed to operate to achieve one positive outcome. YLLs and
   NNTs depended on CRC stage, patient' age and comorbidities. For Stage
   I-II patients in the best clinical conditions (80-85years without
   comorbidities), YLLs increased up to 4.1years after surgery and up to
   8.8years without surgery (NNT 3). For Stage III patients, the NNT of
   surgery varied between 2 when they were in the best clinical conditions
   and 4 when they were older with high comorbidities. In Stage IV
   patients, the NNT ranged between 6 and 31.ConclusionsYLLs represents a
   novel approach to evaluate CRC prognosis. Stage I-III surgical patients
   can have a life expectancy similar to that of general population, being
   the NNT of surgery reasonably small compared with alternatives.
   Personalized comorbidity data are needed to confirm present findings.},
Publisher = {SPRINGER},
Address = {233 SPRING ST, NEW YORK, NY 10013 USA},
Type = {Article},
Language = {English},
Affiliation = {Mazzotti, F (Corresponding Author), Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands.
   Mazzotti, F (Corresponding Author), Univ Bologna, Alma Mater Studiorum, Dept Med \& Surg Sci DIMEC, Bologna, Italy.
   Mazzotti, Federico; Dekker, Jan Willem T., Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands.
   Mazzotti, Federico; Cucchetti, Alessandro; Ercolani, Giorgio, Univ Bologna, Alma Mater Studiorum, Dept Med \& Surg Sci DIMEC, Bologna, Italy.
   Claassen, Yvette H. M.; Bastiaannet, Esther, Leiden Univ, Dept Surg Oncol, Med Ctr, Leiden, Netherlands.
   Bos, Amanda C. R. K., Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands.
   Bastiaannet, Esther, Leiden Univ, Dept Med Oncol, Med Ctr, Leiden, Netherlands.},
DOI = {10.1007/s00268-019-04978-0},
ISSN = {0364-2313},
EISSN = {1432-2323},
Keywords-Plus = {ELDERLY-PATIENTS; COLON-CANCER; SURVIVAL; MORTALITY; SURGERY;
   EXTRAPOLATION; NETHERLANDS; COMORBIDITY; EXPECTANCY; RESECTION},
Research-Areas = {Surgery},
Web-of-Science-Categories  = {Surgery},
Author-Email = {mazzottifederico@gmail.com},
ResearcherID-Numbers = {ercolani, giorgio/AAD-1462-2022
   },
ORCID-Numbers = {Ercolani, Giorgio/0000-0003-4334-5167
   Mazzotti, Federico/0000-0002-4590-3540},
Cited-References = {Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226.
   Altman DG, 1999, BRIT MED J, V318, P1209.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Chawla Neetu, 2013, Journal of the National Cancer Institute Monographs, P36, DOI 10.1093/jncimonographs/lgt009.
   Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005.
   Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x.
   Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587.
   Cucchetti A, 2016, BRIT J SURG, V103, pE93, DOI 10.1002/bjs.10056.
   Dekker JWT, 2014, EJSO-EUR J SURG ONC, V40, P1481, DOI 10.1016/j.ejso.2014.05.010.
   Dekker JWT, 2011, ANN SURG ONCOL, V18, P1533, DOI 10.1245/s10434-011-1671-x.
   Devon KM, 2009, DIS COLON RECTUM, V52, P1272, DOI 10.1007/DCR.0b013e3181a74d2e.
   Doat S, 2014, EUR J CANCER, V50, P1276, DOI 10.1016/j.ejca.2013.12.026.
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210.
   Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009.
   Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4.
   Jobsen JJ, 2012, CLIN ONCOL-UK, V24, pE1, DOI 10.1016/j.clon.2011.09.009.
   Karoui M, 2011, DIS COLON RECTUM, V54, P930, DOI 10.1097/DCR.0b013e31821cced0.
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014.
   Le Teuff G, 2005, STAT MED, V24, P3887, DOI 10.1002/sim.2392.
   Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181.
   Muss HB, 2007, J CLIN ONCOL, V25, P1870, DOI 10.1200/JCO.2006.10.3457.
   Othus M, 2012, CLIN CANCER RES, V18, P3731, DOI 10.1158/1078-0432.CCR-11-2859.
   Ouakrim DA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4970.
   Ruscio J, 2008, PSYCHOL METHODS, V13, P19, DOI 10.1037/1082-989X.13.1.19.
   Schurer W, 2010, EUR J HEALTH ECON, V10, P51, DOI 10.1007/s10198-009-0189-7.
   Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6.
   Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235.
   van Leersum NJ, 2013, INT J CANCER, V132, P2157, DOI 10.1002/ijc.27871.
   van Rooijen KL, 2018, EUR J CANCER, V91, P99, DOI 10.1016/j.ejca.2017.12.014.
   van Steenbergen LN, 2010, ANN ONCOL, V21, P1273, DOI 10.1093/annonc/mdp482.
   Verweij NM, 2016, ANN SURG ONCOL, V23, P1875, DOI 10.1245/s10434-015-5085-z.
   Wang J.D., 2002, BASIC PRINCIPLES PRA.},
Number-of-Cited-References = {32},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {World J.Surg.},
Doc-Delivery-Number = {IG1BQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000473525500025},
DA = {2022-03-29},
}

@article{ WOS:000371038400001,
Author = {He, Tianfeng and Yang, Zuyao and Liu, Tao and Shen, Yueping and Fu,
   Xiaohong and Qian, Xujun and Zhang, Yuelun and Wang, Yong and Xu, Zhiwei
   and Zhu, Shankuan and Mao, Chen and Xu, Guozhang and Tang, Jinling},
Title = {Ambient air pollution and years of life lost in Ningbo, China},
Journal = {SCIENTIFIC REPORTS},
Year = {2016},
Volume = {6},
Month = {MAR 1},
Abstract = {To evaluate the burden of air pollution on years of life lost (YLL) in
   addition to mortality, we conducted a time series analysis based on the
   data on air pollution, meteorological conditions and 163,704
   non-accidental deaths of Ningbo, China, 2009-2013. The mean
   concentrations of particulate matter with aerodynamic diameter <10 mu m,
   particulate matter with aerodynamic diameter <2.5 mu m, sulfur dioxide
   and nitrogen dioxide were 84.0 mu g/m(3), 60.1 mu g/m(3), 25.1 mu g/m(3)
   and 41.7 mu g/m(3), respectively. An increase of 10-mu g/m(3) in
   particulate matter with aerodynamic diameter <10 mu m, particulate
   matter with aerodynamic diameter <2.5 mu m, sulfur dioxide and nitrogen
   dioxide was associated with 4.27 (95\% confidence interval {[}CI]
   1.17-7.38), 2.97 (95\% CI - 2.01-7.95), 29.98 (95\% CI 19.21-40.76) and
   16.58 (95\% CI 8.19-24.97) YLL, respectively, and 0.53\% (95\% CI
   0.29-0.76\%), 0.57\% (95\% CI 0.20-0.95\%), 2.89\% (95\% CI
   2.04-3.76\%), and 1.65\% (95\% CI 1.01-2.30\%) increase of daily death
   counts, respectively. The impact of air pollution lasted for four days
   (lag 0-3), and were more significant in the elderly than in the young
   population for both outcomes. These findings clarify the burden of air
   pollution on YLL and highlight the importance and urgency of air
   pollution control in China.},
Publisher = {NATURE RESEARCH},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Xu, GZ (Corresponding Author), Ningbo Municipal Ctr Dis Control \& Prevent, Ningbo, Zhejiang, Peoples R China.
   Tang, JL (Corresponding Author), Chinese Univ Hong Kong, JC Sch Publ Hlth \& Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.
   Tang, JL (Corresponding Author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Key Lab Hlth Risk Anal, Shenzhen, Peoples R China.
   He, Tianfeng; Wang, Yong; Xu, Guozhang, Ningbo Municipal Ctr Dis Control \& Prevent, Ningbo, Zhejiang, Peoples R China.
   Yang, Zuyao; Fu, Xiaohong; Zhang, Yuelun; Mao, Chen; Tang, Jinling, Chinese Univ Hong Kong, JC Sch Publ Hlth \& Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.
   Liu, Tao, Guangdong Prov Ctr Dis Control \& Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   Shen, Yueping; Qian, Xujun, Soochow Univ, Sch Publ Hlth, Suzhou, Peoples R China.
   Xu, Zhiwei, Queensland Univ Technol, Sch Publ Hlth \& Social Work, Brisbane, Qld 4001, Australia.
   Zhu, Shankuan, Zhejiang Univ, Sch Publ Hlth, Injury Control Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.
   Mao, Chen; Tang, Jinling, Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Key Lab Hlth Risk Anal, Shenzhen, Peoples R China.},
DOI = {10.1038/srep22485},
Article-Number = {22485},
ISSN = {2045-2322},
Keywords-Plus = {FINE-PARTICLE DEPOSITION; TIME-SERIES ANALYSIS; SHORT-TERM EXPOSURE;
   DAILY MORTALITY; PARTICULATE MATTER; RESPIRATORY MORTALITY;
   NITROGEN-DIOXIDE; HEALTH; TEMPERATURE; IMPACT},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {xugz@nbcdc.org.cn
   jltang@cuhk.edu.hk},
ResearcherID-Numbers = {Mao, Chen/G-9805-2013
   Mao, Chen/AAW-2742-2020
   },
ORCID-Numbers = {Mao, Chen/0000-0001-7471-1516
   Mao, Chen/0000-0002-6537-6215
   Xu, Zhiwei/0000-0001-7903-2141
   Zhang, Yuelun/0000-0001-7990-9003},
Funding-Acknowledgement = {Health and Medical Science and Technology Scheme of Zhejiang Province
   {[}2014KYA202]; Science and Technology Scheme of Ningbo {[}2014C50027];
   Innovation Team of Science and Technology Bureau of Ningbo
   {[}2012B82018]},
Funding-Text = {This study was supported by the Health and Medical Science and
   Technology Scheme of Zhejiang Province (2014KYA202), the Science and
   Technology Scheme of Ningbo (2014C50027), and the Innovation Team of
   Science and Technology Bureau of Ningbo (2012B82018). The sponsors have
   had no role in the study design, the collection, analysis and
   interpretation of data, the writing of the report, or the decision to
   submit the paper for publication.},
Cited-References = {Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003.
   Chen RJ, 2012, ENVIRON RES, V118, P101, DOI 10.1016/j.envres.2012.07.003.
   Chen RJ, 2012, ENVIRON INT, V45, P32, DOI 10.1016/j.envint.2012.04.008.
   Cheng YX, 2012, J EPIDEMIOL, V22, P28, DOI 10.2188/jea.JE20110049.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598.
   Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851.
   Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA187, DOI 10.1289/ehp.12737.
   Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658.
   Kohlhaufl M, 1999, AM J RESP CRIT CARE, V159, P902, DOI 10.1164/ajrccm.159.3.9805036.
   Lai HK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-360.
   Li GX, 2011, SCI TOTAL ENVIRON, V409, P1811, DOI 10.1016/j.scitotenv.2011.02.005.
   Li P, 2013, ATMOS ENVIRON, V81, P253, DOI 10.1016/j.atmosenv.2013.09.004.
   Li P, 2013, ENVIRON SCI POLLUT R, V20, P6433, DOI 10.1007/s11356-013-1688-8.
   Liu T, 2014, ENVIRON POLLUT, V187, P116, DOI 10.1016/j.envpol.2013.12.027.
   Ministry of Environmental Protection of the People's Republic of China, 2012, 30952012 GB MIN ENV.
   National Bureau of Statistics of China, 2014, CHIN STAT YB 2014.
   Ningbo Municipal Government, 2013, SUMM STAT IND EC NIN.
   Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x.
   Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075.
   Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481.
   Qiu H, 2013, ATMOS ENVIRON, V76, P74, DOI 10.1016/j.atmosenv.2012.07.026.
   R Core Team,, 2014, R LANG ENV STAT COMP.
   Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1.
   Rabl A, 2003, J AIR WASTE MANAGE, V53, P41, DOI 10.1080/10473289.2003.10466118.
   Ren CZ, 2006, INT J BIOMETEOROL, V51, P87, DOI 10.1007/s00484-006-0054-7.
   Samoli E, 2006, EUR RESPIR J, V27, P1129, DOI 10.1183/09031936.06.00143905.
   Samoli E, 2001, ENVIRON HEALTH PERSP, V109, P349, DOI 10.2307/3454893.
   SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005.
   Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004.
   Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010.
   Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794.
   Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461.
   Wong CM, 2001, ENVIRON HEALTH PERSP, V109, P335, DOI 10.2307/3454891.
   World Health Organization, 2012, 10 REV INT STAT CLAS.
   World Health Organization, 2012, LIF TAB COUNTR CHIN.
   World Health Organization (WHO), 2006, AIR QUAL GUID GLOB U.
   Yi O, 2010, ENVIRON RES, V110, P89, DOI 10.1016/j.envres.2009.09.009.
   Zhang LW, 2014, ENVIRON INT, V62, P41, DOI 10.1016/j.envint.2013.09.012.
   Zhou BZ, 2011, B AM METEOROL SOC, V92, P47, DOI 10.1175/2010BAMS2857.1.
   Zmirou D, 1998, EPIDEMIOLOGY, V9, P495, DOI 10.1097/00001648-199809000-00005.},
Number-of-Cited-References = {46},
Times-Cited = {49},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {40},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {DF0OK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000371038400001},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000517746900001,
Author = {Zheng, Wenlong and Zhang, Hui and Shen, Chengfeng and Zhang, Shuang and
   Wang, Dezheng and Li, Wei and Jiang, Guohong},
Title = {Trend analysis of lung cancer mortality and years of life lost (YLL)
   rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in
   rural areas exceed that of urban areas?},
Journal = {THORACIC CANCER},
Year = {2020},
Volume = {11},
Number = {4},
Pages = {867-874},
Month = {APR},
Abstract = {Background The aim of this study was to examine the trends in the
   mortality rate and years of life lost (YLL) rate of lung cancer in
   Tianjin, China, during the period from 1999 to 2016.
   Methods Lung cancer death data were obtained from Tianjin residents'
   all-cause death monitoring system, which covers the whole population of
   Tianjin. Crude mortality rate, age-standardized mortality rate,
   truncated rate (35-64 years), YLL and age-standardized YLL rate data
   were calculated and trends examined.
   Results From 1999 to 2016, a total of 93 358 lung cancer deaths were
   reported in Tianjin, which accounted for 38.0\% of all cancer deaths (93
   358/245744). The crude mortality rate of lung cancer had increased
   58.5\% from 1999 (40.15/100000) to 2016 (63.64/100000), average annual
   percent change (AACP) = 2.9\%, P < 0.01. However, the age-standard YLL
   rate had decreased to 13.3\% in 2016 than in 1999, AACP = -0.8\%, P <
   0.01, with a stable trend in males (AACP = -0.2\%), and noticeable
   decreasing trend in females (AACP = -1.4\%). The lung cancer mortality
   rate (ASRW) in urban areas was higher than that in rural areas in 1999,
   with a ratio of 1.99:1. However, it was lower in 2016, with the ratio of
   0.98:1. For the truncated rate (35-64 years), it had decreased in urban
   areas compared with rural areas since the year 2013.
   Conclusion Lung cancer remains the most fatal cancer in Tianjin.
   However, the age-standard YLL rate of lung cancer has decreased
   considerably accompanied by a decline in smoking rate years ago,
   especially in women and people living in urban areas. Considerable
   attention is therefore needed in the rural areas where cases of lung
   cancer are still rapidly increasing.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Jiang, GH (Corresponding Author), Tianjin Ctr Dis Control \& Prevent, 6 Huayue Rd, Tianjin 300011, Peoples R China.
   Zheng, Wenlong; Zhang, Hui; Shen, Chengfeng; Zhang, Shuang; Wang, Dezheng; Li, Wei; Jiang, Guohong, Tianjin Ctr Dis Control \& Prevent, NCDs Prevent Dept, Tianjin, Peoples R China.
   Jiang, Guohong, Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China.},
DOI = {10.1111/1759-7714.13314},
EarlyAccessDate = {MAR 2020},
ISSN = {1759-7706},
EISSN = {1759-7714},
Keywords = {Lung cancer; mortality; risk factors; trend; YLL},
Keywords-Plus = {SMOKING; STATISTICS; TOBACCO},
Research-Areas = {Oncology; Respiratory System},
Web-of-Science-Categories  = {Oncology; Respiratory System},
Author-Email = {jghcdc@126.com},
ResearcherID-Numbers = {Li, Wei/AAG-2028-2022},
ORCID-Numbers = {Li, Wei/0000-0001-9199-4757},
Cited-References = {Agudo A, 2000, INT J CANCER, V88, P820, DOI 10.1002/1097-0215(20001201)88:5\&lt;820::AID-IJC21\&gt;3.0.CO;2-J.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Chen W Q, 2017, Zhonghua Zhong Liu Za Zhi, V39, P795, DOI 10.3760/cma.j.issn.0253-3766.2017.10.015.
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338.
   Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20.
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733.
   Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   Fang Jia-Ying, 2015, Asian Pac J Cancer Prev, V16, P5829.
   Ferlay J., 2013, IARC CANC BASE.
   Fu ZT, 2017, ONCOTARGET, V8, P88770, DOI 10.18632/oncotarget.21144.
   Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI {[}10.1289/ehp/1408092, 10.1289/ehp.1408092].
   He J, 2017, CHINESE CANC REGISTR, P139.
   He YT, 2016, THORAC CANCER, V7, P323, DOI 10.1111/1759-7714.12331.
   Institute for Health Metrics and Evaluation (IHME), GBD CAUS PATT.
   Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04.
   Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437.
   Jiang Guohong, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P381, DOI 10.3760/cma.j.issn.0254-6450.2016.03.018.
   Li W, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170577.
   Liang F, 2019, LUNG CANCER, V132, P114, DOI 10.1016/j.lungcan.2019.04.020.
   Loomis D, 2013, LANCET ONCOL, V14, P1262, DOI 10.1016/S1470-2045(13)70487-X.
   National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE.
   Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323.
   Ribassin-Majed L, 2015, EUR J PUBLIC HEALTH, V25, P824, DOI 10.1093/eurpub/ckv078.
   Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2.
   Sisti J, 2012, INT J CANCER, V131, P265, DOI 10.1002/ijc.27477.
   SVENSSON C, 1989, ACTA ONCOL, V28, P623, DOI 10.3109/02841868909092282.
   The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209.
   Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578.
   Torre LA, 2014, CANCER EPIDEM BIOMAR, V23, P1025, DOI 10.1158/1055-9965.EPI-13-1220.
   US National Institutes of Health. National Cancer Institute, 1975, SEER CANC STAT REV.
   Vos T, 2016, LANCET, V388, P1545, DOI {[}10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1].
   WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886.
   Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14513-7.
   Yang Juan, 2015, Asian Pac J Cancer Prev, V16, P7295.
   Yu Y W, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P268, DOI 10.3760/cma.j.issn.0254-6450.2016.02.024.
   Yuan Y N, 2018, Zhonghua Yu Fang Yi Xue Za Zhi, V52, P691, DOI 10.3760/cma.j.issn.0253-9624.2018.07.003.
   Zheng W, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001631.
   Zhong YJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00404.},
Number-of-Cited-References = {38},
Times-Cited = {3},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {7},
Journal-ISO = {Thorac. Cancer},
Doc-Delivery-Number = {KY5PD},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000517746900001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000432688700010,
Author = {Khoramdad, Maliheh and Izadi, Neda and Najafi, Farid},
Title = {Years of Life Lost Due to Road Traffic Injuries in Kermanshah Province},
Journal = {TRAUMA MONTHLY},
Year = {2017},
Volume = {22},
Number = {6},
Month = {NOV},
Abstract = {Background: Remarkably, one of the main causes of years of life lost due
   to premature death (YLL) is due to road traffic injuries (RTIs), which
   usually occurs at an earlier age in life.
   Objectives: This study aimed to determine the trend of YLL due to road
   traffic injuries in Kermanshah Province during the years 2009 - 2014.
   Methods: This study relied on census data from forensic medicine
   reports. YLL related to RTIs were calculated according to the global
   burden of disease (GBD) 2010 guidelines, and the age and sex
   demographics of the population were obtained from the Governor General's
   Office records for 2009 - 2014. The external causes of death were
   determined using the international classification of diseases (ICD-10)
   codes. To assess the YLL trend and its significance, negative binomial
   regression through the use of Stata 11 was implemented.
   Results: The mean age of the 3,231 subjects studied was 39.83 +/- 21.27
   years. A total of 78.4\% of the subjects were males. The average number
   of fatal RTIs in the six-year period was 27.8 per 100,000 persons. The
   YLL rate was 149,995 (76.5 per 1000) including both sexes. The YLL rates
   due to premature mortality were 118,393 (119.8 per 1000) for males, and
   31,602 for females (32.5 per 1000). The highest YLL rates for both sexes
   were in the age group of 15 - 44 years. The six-year trend of YLL due to
   premature mortality was therefore descending; with respect to the
   incremental period of one year, the YLL decreased by 7\% on average
   (beta = -0.07; CI: -0.09, -0.05).
   Conclusions: Despite the decrease in the mortality and YLL rates due to
   TRIs in recent years, these figures are higher global numbers;
   therefore, there needs to be more serious intervention.},
Publisher = {NATL CENTER TRAUMA RESEARCH},
Address = {NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN},
Type = {Article},
Language = {English},
Affiliation = {Najafi, F (Corresponding Author), Kermanshah Univ Med Sci, Fac Hlth, Kermanshah, Iran.
   Khoramdad, Maliheh, Kermanshah Univ Med Sci, Noncommunicable Dis Unit Hlth Deputy, Kermanshah, Iran.
   Izadi, Neda, Kermanshah Univ Med Sci, Fac Hlth, Kermanshah, Iran.
   Najafi, Farid, Kermanshah Univ Med Sci, Dept Epidemiol, RCEDH, Kermanshah, Iran.},
DOI = {10.5812/traumamon.39880},
Article-Number = {e39880},
ISSN = {2251-7464},
EISSN = {2251-7472},
Keywords = {Trend; YLL; Road Traffic Injuries},
Keywords-Plus = {MORTALITY; IRAN; ACCIDENTS},
Research-Areas = {Emergency Medicine},
Web-of-Science-Categories  = {Emergency Medicine},
Author-Email = {farid\_n32@yahoo.com},
ORCID-Numbers = {Izadi, Neda/0000-0002-6373-1113},
Funding-Acknowledgement = {Kermanshah University of Medical Sciences},
Funding-Text = {This work was supported by Kermanshah University of Medical Sciences.
   The funding agency did not play any role in the planning, execution, or
   reporting process, nor in the decision to submit the paper for
   publication.},
Cited-References = {Ayatollahi M., 2008, IRANIAN J EPIDEMIOLO, V4, P51.
   Bahadorimonfared A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065198.
   Bakhtiyari M, 2013, INT J INJ CONTROL SA, V1, P150.
   Farzandipour M, 2007, J INJ VIOLENCE RES, V11, P58.
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3.
   Hasanzadeh J, 2014, IRAN J PUBLIC HEALTH, V43, P1259.
   Hashemi Nazari S. S., 2011, LEGAL MED J, V17, P123.
   Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621.
   Izadi N, 2014, J MAZANDARAN U MED S, V24, P51.
   Izadi N, 2014, HAKIM HLTH SYS RES, V17, P177.
   Karkee R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010757.
   Khorasani-Zavareh D, 2009, INT J INJ CONTROL SA, V16, P119, DOI 10.1080/17457300903023980.
   Malekifar A, 2016, J KERMANSHAH U MED S, V19, P327.
   Moafian G, 2013, CHIN J TRAUMATOL, V16, P140, DOI 10.3760/cma.j.issn.1008-1275.2013.03.003.
   Monga S, 2015, IAIM, V2, P44.
   Montazeri A, 2004, PUBLIC HEALTH, V118, P110, DOI 10.1016/S0033-3506(03)00173-2.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9.
   Pakgouhar AR, 2009, TRAFFIC MANAGEMENT S, V4, P55.
   Rad Mahdieh, 2016, Glob J Health Sci, V8, P51677, DOI 10.5539/gjhs.v8n9p149.
   Rezazadeh J, 2013, INT J INJ CONTROL SA, V1, P19.
   Sadeghian F., 2008, PAYESH HLTH MONITOR, V7, P225.
   Sango HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149070.
   WHO, 2013, GLOB STAT REP ROAD S.
   World Health Organization, 2010, INJ VIOL FACTS.
   Xie SH, 2016, TRAFFIC INJ PREV, V17, P39, DOI {[}10.1080/15389588.2015.1035370, 10.1080/15389588.2015.103537].
   Yazdani J, 2012, J MAZAND U MED SCI, V22, P50.
   Ye P, 2013, ZHONGHUA LIU XING BI, V2015, P1.},
Number-of-Cited-References = {28},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Trauma Mon.},
Doc-Delivery-Number = {GG4TI},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000432688700010},
DA = {2022-03-29},
}

@article{ WOS:000302672800020,
Author = {Huang, Cunrui and Barnett, Adrian G. and Wang, Xiaoming and Tong, Shilu},
Title = {The impact of temperature on years of life lost in Brisbane, Australia},
Journal = {NATURE CLIMATE CHANGE},
Year = {2012},
Volume = {2},
Number = {4},
Pages = {265-270},
Month = {APR},
Abstract = {Temperature is an important determinant of health. A better knowledge of
   how temperature affects population health is important not only to the
   scientific community, but also to the decision-makers who develop and
   implement early warning systems and intervention strategies to mitigate
   the health effects of extreme temperatures(1,2). The temperature-health
   relationship is also of growing interest as climate change is projected
   to shift the overall temperature distribution higher(3,4). Previous
   studies have examined the relative risks of temperature-related
   mortality, but the absolute measure of years of life lost is also useful
   as it combines the number of deaths with life expectancy. Here we use
   years of life lost to provide a novel measure of the impact of
   temperature on mortality in Brisbane, Australia. We also project the
   future temperature-related years of life lost attributable to climate
   change. We show that the association between temperature and years of
   life lost is U-shaped, with increased years of life lost for cold and
   hot temperatures. The temperature-related years of life lost will worsen
   greatly if future climate change goes beyond a 2 degrees C increase and
   without any adaptation to higher temperatures. This study highlights
   that public health adaptation to climate change is necessary.},
Publisher = {NATURE PUBLISHING GROUP},
Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Huang, CR (Corresponding Author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4059, Australia.
   Huang, Cunrui; Barnett, Adrian G.; Tong, Shilu, Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4059, Australia.
   Huang, Cunrui; Barnett, Adrian G.; Tong, Shilu, Queensland Univ Technol, Inst Hlth \& Biomed Innovat, Brisbane, Qld 4059, Australia.
   Wang, Xiaoming, CSIRO, CSIRO Climate Adaptat Flagship, Melbourne, Vic 3190, Australia.
   Wang, Xiaoming, CSIRO, CSIRO Ecosyst Sci, Melbourne, Vic 3190, Australia.},
DOI = {10.1038/NCLIMATE1369},
ISSN = {1758-678X},
EISSN = {1758-6798},
Keywords-Plus = {HEAT-RELATED MORTALITY; CLIMATE-CHANGE; PUBLIC-HEALTH; EXTREMES;
   WEATHER; DEATHS; WAVES; COLD},
Research-Areas = {Environmental Sciences \& Ecology; Meteorology \& Atmospheric Sciences},
Web-of-Science-Categories  = {Environmental Sciences; Environmental Studies; Meteorology \&
   Atmospheric Sciences},
Author-Email = {huangcunrui@hotmail.com},
ResearcherID-Numbers = {Huang, Cunrui/ABI-3312-2020
   Barnett, Adrian/I-9850-2012
   Wang, Xiaoming/A-3804-2008
   Wang, Xiaoming/A-3804-2008},
ORCID-Numbers = {Barnett, Adrian/0000-0001-6339-0374
   Wang, Xiaoming/0000-0002-6648-0057
   Wang, Xiaoming/0000-0002-1088-8862},
Funding-Acknowledgement = {QUTPRA; CSIRO Climate Adaptation FlagshipCommonwealth Scientific \&
   Industrial Research Organisation (CSIRO); National Health and Medical
   Research CouncilNational Health and Medical Research Council of
   Australia},
Funding-Text = {C.H. was supported by a QUTPRA scholarship and CSIRO Climate Adaptation
   Flagship Collaboration Fund. S.T. was supported by a National Health and
   Medical Research Council Research Fellowship. Computational resources
   and services used in this work were provided by the High Performance
   Computer and Research Support Unit, Queensland University of Technology,
   Brisbane, Australia.},
Cited-References = {Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266.
   Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08.
   Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f.
   Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd.
   Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x.
   CONFALONIERI U, 2007, IPCC CLIMATE CHANGE, P391.
   Costello A, 2009, LANCET, V373, P1693, DOI {[}10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6].
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99.
   Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005.
   Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63.
   Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999.
   Hajat S, 2010, AM J PUBLIC HEALTH, V100, P1137, DOI 10.2105/AJPH.2009.169748.
   Hess JJ, 2009, ACAD EMERG MED, V16, P782, DOI 10.1111/j.1553-2712.2009.00469.x.
   Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456.
   Huang CR, 2011, AM J PREV MED, V40, P183, DOI 10.1016/j.amepre.2010.10.025.
   Kinney PL, 2008, ENVIRON SCI POLICY, V11, P87, DOI 10.1016/j.envsci.2007.08.001.
   Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594.
   Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843.
   Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021.
   McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086.
   Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175.
   Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074.
   O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122.
   SOLOMAN S., 2007, CLIMATE CHANGE 2007.
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   WHO, 2009, IMPR PUBL HLTH RESP.
   Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55.},
Number-of-Cited-References = {30},
Times-Cited = {100},
Usage-Count-Last-180-days = {5},
Usage-Count-Since-2013 = {61},
Journal-ISO = {Nat. Clim. Chang.},
Doc-Delivery-Number = {924EB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000302672800020},
DA = {2022-03-29},
}

@article{ WOS:000616712100005,
Author = {Luan, Guijie and Yin, Peng and Zhou, Maigeng},
Title = {Associations between ambient air pollution and years of life lost in
   Beijing},
Journal = {ATMOSPHERIC POLLUTION RESEARCH},
Year = {2021},
Volume = {12},
Number = {2},
Pages = {200-205},
Month = {FEB},
Abstract = {The severe economic and disease burden caused by air pollution have
   become a public health concern. A great number of studies have proved
   that air pollution had an impact on mortality, but the association
   between air pollution and years of life lost (YLL) remains indistinct.
   The mortality data between January 1, 2008 to December 31, 2012 was
   collected from the China National Mortality Surveillance system to
   estimate the burden of disease attribute to air pollution. We used
   Distributed Lag Non-linear Model (DLNM) to analyze it, adjusting for
   long-term trend and weather confounders. Total 386,695 death was
   included in the study. 185,360 death was cardiovascular disease and
   37,812 death was respiratory disease. The average value of air pollution
   index (API) was 84, average YLL for non-accidental death, cardiovascular
   disease, ischemic heart disease (IHD), stroke, respiratory disease, and
   chronic obstructive pulmonary disease (COPD) were 12.0, 9.8, 9.2, 9.7,
   7.3 and 6.5, and daily YLL for non-accidental death, cardiovascular
   disease, IHD, stroke, respiratory disease, and COPD were 2540, 994, 428,
   456, 150 and 60 respectively. The relative risk (RR) of API on YLL was
   1.04 (95\%CI, 1.00-1.07) at lag 0-2 days for non-accidental death, and
   1.44 (95\%CI, 1.02-2.02) at lag 0-7 days for cardiovascular disease. Air
   pollution had a more serious impact on the elderly and women. We found
   the positive association between API and YLL in Beijing. The study
   indicates that the government needs to develop public health policies to
   improve the quality of the air.},
Publisher = {TURKISH NATL COMMITTEE AIR POLLUTION RES \& CONTROL-TUNCAP},
Address = {DOKUZ EYLUL UNIV, DEPT ENVIRONMENTAL ENGINEERING, TINAZTEPE CAMPUS,
   BUCA, IZMIR 35160, TURKEY},
Type = {Article},
Language = {English},
Affiliation = {Zhou, MG (Corresponding Author), Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, 27 Nanwei Rd, Beijing 100050, Peoples R China.
   Luan, Guijie, Shandong Ctr Dis Control \& Prevent, 16992 Jingshi Rd, Jinan 250014, Peoples R China.
   Yin, Peng; Zhou, Maigeng, Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, 27 Nanwei Rd, Beijing 100050, Peoples R China.},
DOI = {10.1016/j.apr.2020.11.002},
EarlyAccessDate = {FEB 2021},
ISSN = {1309-1042},
Keywords = {Air pollution index; Years of life lost; Non-accidental death;
   Cardiovascular disease; Respiratory disease},
Keywords-Plus = {CARDIOVASCULAR MORTALITY; PARTICULATE MATTER; SULFUR-DIOXIDE;
   HEALTH-RISKS; COMMUNICATE; POLLUTANTS; EXPOSURES; IMPACT; OZONE; CHINA},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {luanguijie@sina.com},
ResearcherID-Numbers = {Yin, Peng/AFP-5157-2022
   },
ORCID-Numbers = {Luan, Guijie/0000-0001-8364-137X},
Cited-References = {Achilleos S, 2017, ENVIRON INT, V109, P89, DOI 10.1016/j.envint.2017.09.010.
   Aliyu AJ, 2016, ENVIRON SCI POLLUT R, V23, P21288, DOI 10.1007/s11356-016-7253-5.
   Borbet TC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5418-5.
   Chen F, 2017, SCI TOTAL ENVIRON, V576, P775, DOI 10.1016/j.scitotenv.2016.10.161.
   Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI {[}10.1164/rccm.201609-1862oc, 10.1164/rccm.201609-1862OC, 10.1164/rccm.201612-2427OC].
   Chen TM, 2007, AM J MED SCI, V333, P249, DOI 10.1097/MAJ.0b013e31803b900f.
   Crouse DL, 2015, ENVIRON HEALTH PERSP, V123, P1180, DOI 10.1289/ehp.1409276.
   Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663.
   Fiordelisi A, 2017, HEART FAIL REV, V22, P337, DOI 10.1007/s10741-017-9606-7.
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035.
   Greenberg N, 2016, J TOXICOL ENV HEAL A, V79, P342, DOI 10.1080/15287394.2016.1153548.
   Guan WJ, 2016, LANCET, V388, P1939, DOI 10.1016/S0140-6736(16)31597-5.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Huang CR, 2017, ADV EXP MED BIOL, V1017, P243, DOI 10.1007/978-981-10-5657-4\_11.
   Huang J, 2018, ENVIRON INT, V113, P42, DOI 10.1016/j.envint.2018.01.022.
   Jo EJ, 2017, RESP MED, V124, P79, DOI 10.1016/j.rmed.2017.02.010.
   Kim H, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00375.
   Li L, 2015, ENVIRON POLLUT, V205, P153, DOI 10.1016/j.envpol.2015.05.038.
   Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364.
   Luan GJ, 2019, INT J ENVIRON HEAL R, V29, P246, DOI 10.1080/09603123.2018.1533533.
   Luan GJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13225-2.
   Ministry of ecology and environment of the people's Republic of China, 1996, AMB AIR QUAL STAND.
   Monforte P, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-7006-7.
   Perlmutt L, 2017, J EXPO SCI ENV EPID, V27, P24, DOI 10.1038/jes.2015.43.
   Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1.
   Shi HD, 2018, INTEGR ENVIRON ASSES, V14, P710, DOI 10.1002/ieam.4067.
   Smargiassi A, 2014, ENVIRON RES, V132, P38, DOI 10.1016/j.envres.2014.03.030.
   Turner MC, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1249.
   Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC.
   UN Environment, 2019, REV 20 YEARS AIR POL.
   Wang XL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091917.
   WHO, 2012, WORLD MALARIA REPORT 2012, P1.
   WHO, 2018, AMB OUTD AIR POLL.
   Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19.
   Yang J, 2016, SCI TOTAL ENVIRON, V573, P1566, DOI 10.1016/j.scitotenv.2016.09.014.
   Zhang C, 2017, ENVIRON POLLUT, V229, P790, DOI 10.1016/j.envpol.2017.06.022.},
Number-of-Cited-References = {39},
Times-Cited = {3},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Atmos. Pollut. Res.},
Doc-Delivery-Number = {QF2EL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000616712100005},
DA = {2022-03-29},
}

@article{ WOS:000664478800017,
Author = {Paciej-Golebiowska, Paulina and Pikala, Malgorzata and Maniecka-Bryla,
   Irena},
Title = {Years of life lost due to viral hepatitis in Poland, 2000-2014},
Journal = {ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE},
Year = {2021},
Volume = {28},
Number = {2},
Pages = {300-305},
Abstract = {Introduction. Viral hepatitis often affects young people; it therefore
   seems reasonable to analyze the phenomenon of premature mortality due to
   this reason, using Years of Life Lost (YLLs) measurement.
   Objective. The aim of the study was to analyze YLLs due to viral
   hepatitis in Poland in 2000-2014. For the years 2002 and 2011,
   socio-economic variables (marital status, level of education, working
   status, place of residence) were included.
   Materials and method. The research material was a database containing
   information from 5,601,568 death certificates of Polish citizens from
   2000-2014. The data on deaths caused by viral hepatitis, i.e. coded as
   B15-B19 according to the ICD-10, was used for the analysis. The Standard
   Expected Years of Life Lost measure was used to calculate YLLs. Analysis
   of time trends was performed with the linear regression method using the
   joinpoint model.
   Results. In the studied period, 3.628 deaths of Polish citizens were
   caused by viral hepatitis (0.06\% of all deaths), which translated to
   92,845.70 YLLs (16.17 years per 100,000 inhabitants). The number of YLLs
   increased over time (p<0.05), reaching its highest value in the last
   analyzed year - 22.14 years per 100,000. The YLLs average per one death
   was 25.59 years. Among the risk group there were individuals living in
   urban areas, divorced/separated, with lower than secondary education,
   and economically inactive.
   Conclusions. Despite the fact that Poland belongs to a group of
   countries with low mortality due to viral hepatitis, this disease is a
   serious social problem as measured with YLLs. The study provides the
   basis for policymakers to implement more effective methods to prevent
   premature deaths caused by this disease.},
Publisher = {INST AGRICULTURAL MEDICINE},
Address = {JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Paciej-Golebiowska, P (Corresponding Author), Med Univ, Dept Epidemiol \& Biostat, Lodz, Poland.
   Paciej-Golebiowska, Paulina; Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ, Dept Epidemiol \& Biostat, Lodz, Poland.},
DOI = {10.26444/aaem/122301},
ISSN = {1232-1966},
EISSN = {1898-2263},
Keywords = {standard expected years of life lost; premature mortality; viral
   hepatitis; health inequalities; SEYLL},
Keywords-Plus = {SOCIOECONOMIC INEQUALITIES; MALIGNANT NEOPLASMS; MORTALITY;
   EPIDEMIOLOGY; INHABITANTS; INFECTION; HEALTH; VIRUS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {paulina.paciej@gmail.com},
ResearcherID-Numbers = {Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Maniecka-Bryla, Irena/0000-0002-6671-7456
   Paciej-Golebiowska, Paulina/0000-0002-4494-9299
   Pikala, Malgorzata/0000-0003-4426-4908},
Cited-References = {{[}Anonymous], 2012, INT STANDARD CLASSIF.
   Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633.
   Bryla M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174391.
   Bryla M, 2016, ANN AGR ENV MED, V23, P598, DOI 10.5604/12321966.1226853.
   Central Statistical Office in Poland, LOC DAT BANK.
   Central Statistical Office in Poland, NAT CENS 2002.
   Chlabicz S, 2006, WORLD J GASTROENTERO, V12, P141, DOI 10.3748/wjg.v12.i1.141.
   European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001.
   European Centre for Disease Prevention and Control, 2014, HEP B C SURV EUR 201.
   Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2.
   Jobczyk M, 2017, CENT EUR J UROL, V70, P338, DOI 10.5173/ceju.2017.1521.
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519.
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Murray Christopher J. L., 1996, GLOBAL BURDEN DIS CO.
   National Cancer Institute, 2015, SURV RES PROGR STAT.
   Paciej-Golebiowska P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030304.
   Paciej-Golebiowska P, 2018, UNITED EUR GASTROENT, V6, P943, DOI 10.1177/2050640618764714.
   Pikala M, 2017, KARDIOL POL, V75, P1033, DOI 10.5603/KP.a2017.0124.
   Pikala M, 2017, MED PR, V68, P771, DOI 10.13075/mp.5893.00543.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009.
   Stepien Malgorzata, 2015, Przegl Epidemiol, V69, P465.
   Vos T, 2016, LANCET, V388, P1545, DOI {[}10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1].
   Whitehead M., 2007, CONCEPTS PRINCIPLES.
   World Health Organization, 2017, GLOB HEP REP.
   World Health Organization (WHO), 2016, GLOB HLTH SECT STRAT.
   Zielinski Andrzej, 2017, Przegl Epidemiol, V71, P3.},
Number-of-Cited-References = {29},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Ann. Agr. Env. Med.},
Doc-Delivery-Number = {SW4IH},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000664478800017},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:A1982PV61500006,
Author = {DEEB, LC and WILLIAMS, PE},
Title = {PREMATURE MORTALITY FROM DIABETES},
Journal = {JOURNAL OF THE FLORIDA MEDICAL ASSOCIATION},
Year = {1982},
Volume = {69},
Number = {12},
Pages = {1004-1008},
Publisher = {J FLORIDA MED ASSN INC},
Address = {PO BOX 2411 760 RIVERSIDE AVENUE, JACKSONVILLE, FL 32203},
Type = {Article},
Language = {English},
Affiliation = {DEEB, LC (Corresponding Author), DEPT HLTH \& REHABIL SERV,1317 WINEWOOD BLVD,TALLAHASSEE,FL 32301, USA.},
ISSN = {0015-4148},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Number-of-Cited-References = {0},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Doc-Delivery-Number = {PV615},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1982PV61500006},
DA = {2022-03-29},
}

@article{ WOS:000747235100003,
Author = {Liu, Tao and Zhou, Chunliang and Zhang, Haoming and Huang, Biao and Xu,
   Yanjun and Lin, Lifeng and Wang, Lijun and Hu, Ruying and Hou, Zhulin
   and Xiao, Yize and Li, Junhua and Xu, Xiaojun and Jin, Donghui and Qin,
   Mingfang and Zhao, Qinglong and Gong, Weiwei and Yin, Peng and Xu,
   Yiqing and Hu, Jianxiong and Xiao, Jianpeng and Zeng, Weilin and Li,
   Xing and Chen, Siqi and Guo, Lingchuan and Rong, Zuhua and Zhang,
   Yonghui and Huang, Cunrui and Du, Yaodong and Guo, Yuming and
   Rutherford, Shannon and Yu, Min and Zhou, Maigeng and Ma, Wenjun},
Title = {Ambient Temperature and Years of Life Lost: A National Study in China},
Journal = {THE INNOVATION},
Year = {2021},
Volume = {2},
Number = {1},
Month = {FEB 28},
Abstract = {Although numerous studies have investigated premature deaths
   attributable to temperature, effects of temperature on years of life
   lost (YLL) remain unclear. We estimated the relationship between
   temperatures and YLL, and quantified the YLL per death caused by
   temperature in China. We collected daily meteorological and mortality
   data, and calculated the daily YLL values for 364 locations (2013-2017
   in Yunnan, Guangdong, Hunan, Zhejiang, and Jilin provinces, and
   2006-2011 in other locations) in China. A time-series design with a
   distributed lag nonlinear model was first employed to estimate the
   location-specific associations between temperature and YLL rates
   (YLL/100,000 population), and a multivariate meta-analysis model was
   used to pool location-specific associations. Then, YLL per death caused
   by temperatures was calculated. The temperature and YLL rates
   consistently showed U-shaped associations. A mean of 1.02 (95\%
   confidence interval: 0.67, 1.37) YLL per death was attributable to
   temperature. Cold temperature caused 0.98 YLL per death with most from
   moderate cold (0.84). The mean YLL per death was higher in those with
   cardiovascular diseases (1.14), males (1.15), younger age categories
   (1.31 in people aged 65-74 years), and in central China (1.34) than in
   those with respiratory diseases (0.47), females (0.87), older people
   (0.85 in people >= 75 years old), and northern China (0.64) or southern
   China (1.19). The mortality burden was modified by annual temperature
   and temperature variability, relative humidity, latitude, longitude,
   altitude, education attainment, and central heating use. Temperatures
   caused substantial YLL per death in China, which was modified by
   demographic and regional characteristics.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA},
Type = {Article},
Language = {English},
Affiliation = {Ma, WJ (Corresponding Author), Guangdong Prov Ctr Dis Control \& Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Peoples R China.
   Zhou, MG (Corresponding Author), Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing 100050, Peoples R China.
   Yu, M (Corresponding Author), Zhejiang Ctr Dis Control \& Prevent, Hangzhou 310051, Peoples R China.
   Liu, Tao; Hu, Jianxiong; Xiao, Jianpeng; Zeng, Weilin; Li, Xing; Chen, Siqi; Guo, Lingchuan; Rong, Zuhua; Ma, Wenjun, Guangdong Prov Ctr Dis Control \& Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Peoples R China.
   Zhou, Chunliang; Li, Junhua; Jin, Donghui; Xu, Yiqing, Hunan Prov Ctr Dis Control \& Prevent, Changsha 410005, Peoples R China.
   Zhang, Haoming; Xiao, Yize; Qin, Mingfang, Yunnan Ctr Dis Control \& Prevent, Kunming 650022, Yunnan, Peoples R China.
   Huang, Biao; Hou, Zhulin; Zhao, Qinglong, Jilin Prov Ctr Dis Control \& Prevent, Hlth Hazard Factors Control Dept, Changchun 130062, Peoples R China.
   Xu, Yanjun; Lin, Lifeng; Xu, Xiaojun; Zhang, Yonghui, Guangdong Prov Ctr Dis Control \& Prevent, Guangzhou 511430, Peoples R China.
   Wang, Lijun; Yin, Peng; Zhou, Maigeng, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing 100050, Peoples R China.
   Hu, Ruying; Gong, Weiwei; Yu, Min, Zhejiang Ctr Dis Control \& Prevent, Hangzhou 310051, Peoples R China.
   Huang, Cunrui, Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.
   Du, Yaodong, Guangdong Prov Climate Ctr, Guangzhou 510080, Peoples R China.
   Guo, Yuming, Monash Univ, Sch Publ Hlth \& Prevent Med, Dept Epidemiol \& Prevent Med, Melbourne, Vic 3800, Australia.
   Rutherford, Shannon, Griffith Univ, Sch Med, Gold Coast 4214, Australia.},
DOI = {10.1016/j.xinn.2020.100072},
EarlyAccessDate = {JAN 2021},
Article-Number = {100072},
ISSN = {2666-6758},
Keywords = {TEMPERATURE; YEARS OF LIFE LOST; MORTALITY BURDEN; DISTRIBUTED LAG
   NONLINEAR MODEL; MULTIVARIATE META-ANALYSIS; CHINA},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; AFFECT MORTALITY; HEAT; COLD; BURDEN;
   METAANALYSIS; POPULATION; IMPACTS; RISK},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {myu@cdc.zj.cn
   maigengzhou@126.com
   mawj@gdiph.org.cn},
ResearcherID-Numbers = {Yin, Peng/AFP-5157-2022
   },
ORCID-Numbers = {, Tao/0000-0003-1451-5251},
Funding-Acknowledgement = {National Key Research and Development Program of China
   {[}2018YFA0606200]; Guangzhou Science and Technology Project
   {[}201704020194]},
Funding-Text = {We thank Professor Antonio Gasparrini for providing assistance during
   statistical analysis. This work was supported by the National Key
   Research and Development Program of China (2018YFA0606200), Guangzhou
   Science and Technology Project (201704020194), and theGuangdongHealth
   Innovation Platform. The funders were not involved in the research and
   preparation of the article, including study design; collection,
   analysis, and interpretation of data; writing of the article; and the
   decision to submit it for publication.},
Cited-References = {Achebak H, 2019, LANCET PLANET HEALTH, V3, pE297, DOI 10.1016/S2542-5196(19)30090-7.
   Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08.
   {[}Anonymous], 2016, LANCET, V388, P2323, DOI 10.1016/S0140-6736(16)32170-5.
   Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133.
   Benmarhnia T, 2015, EPIDEMIOLOGY, V26, P781, DOI 10.1097/EDE.0000000000000375.
   Chen RJ, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4306.
   Chen S., 2020, DEV NOVEL INDICATOR, DOI {[}10.1088/1748-9326/abb10c, DOI 10.1088/1748-9326/ABB10C].
   Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110.
   Cheng J, 2019, SCI TOTAL ENVIRON, V651, P2558, DOI 10.1016/j.scitotenv.2018.10.186.
   Du HD, 2016, NEW ENGL J MED, V374, P1332, DOI 10.1056/NEJMoa1501451.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996.
   Fu SH, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002619.
   Gal-Oz ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12348-6.
   Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471.
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2015, ENVIRON HEALTH PERSP, V123, P1200, DOI 10.1289/ehp.1409070.
   Giorgini P, 2017, CURR PHARM DESIGN, V23, P3247, DOI 10.2174/1381612823666170317143248.
   Guo YM, 2016, ENVIRON HEALTH PERSP, V124, P1554, DOI 10.1289/EHP149.
   Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518.
   He Y., 2019, PUBLIC HLTH ADAPTATI.
   Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707.
   Huang ZJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009172.
   Li GX, 2018, STROKE, V49, P828, DOI {[}10.1161/STROKEAHA.117.020042, 10.1161/strokeaha.117.020042].
   Li YH, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-65.
   Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148.
   Liu T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030376.
   Luan GJ, 2019, INT J ENVIRON HEAL R, V29, P246, DOI 10.1080/09603123.2018.1533533.
   Luan GJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13225-2.
   Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007.
   Ma WJ, 2015, ENVIRON RES, V137, P72, DOI 10.1016/j.envres.2014.11.016.
   Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175.
   Sewe MO, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP1745.
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324.
   Sun RJ, 2015, PROTEIN CELL, V6, P314, DOI 10.1007/s13238-015-0145-5.
   Wang C., 2019, OVERVIEW CLIMATE CHA.
   Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6.
   Watts N, 2017, LANCET, V389, P1151, DOI 10.1016/S0140-6736(16)32124-9.
   World Health Organization, 2013, GLOB HLTH OBS DAT RE.
   Xiao J., 2014, INT J BIOMETEOROL, V59, P1.
   Xu T., 2013, ANUSPLIN VERSION 4 4.
   Xu X, 2019, INT J BIOMETEOROL, V63, P1319, DOI 10.1007/s00484-019-01746-6.
   Yang CY, 2015, SCI TOTAL ENVIRON, V538, P524, DOI 10.1016/j.scitotenv.2015.08.097.
   Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12250.
   Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI {[}10.1289/ehp.120-a19, 10.1289/ehp.1003198].
   Zhang BY, 2018, ENVIRON RES, V162, P152, DOI 10.1016/j.envres.2017.12.027.
   Zhang YQ, 2019, ENVIRON RES, V179, DOI 10.1016/j.envres.2019.108771.
   Zhang YQ, 2018, SCI TOTAL ENVIRON, V621, P1491, DOI 10.1016/j.scitotenv.2017.10.079.
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6.},
Number-of-Cited-References = {51},
Times-Cited = {12},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Innovation-Amsterdam},
Doc-Delivery-Number = {YN4MS},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000747235100003},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000172758500005,
Author = {Leksell, I and Rabl, A},
Title = {Air pollution and mortality: Quantification and valuation of years of
   life lost},
Journal = {RISK ANALYSIS},
Year = {2001},
Volume = {21},
Number = {5},
Pages = {843-857},
Month = {OCT},
Abstract = {To analyze the loss of life expectancy (LLE) due to air pollution and
   the associated social cost, a dynamic model was developed that took into
   account the decrease of risk after the termination of an exposure to
   pollution. A key parameter was the time constant for the decrease of
   risk, for which estimates from studies of smoking were used. A
   sensitivity analysis showed that the precise value of the time
   constant(s) was not critical for the resulting LLE. An interesting
   aspect of the model was that the relation between population total LLE
   and PM2.5 concentration was numerically almost indistinguishable from a
   straight line, even though the functional dependence was nonlinear. This
   essentially linear behavior implies that the detailed history of a
   change in concentration does not matter, except for the effects of
   discounting. This model was used to correct the data of the largest
   study of chronic mortality for variations in past exposure, performed by
   Pope et al in 1995; the correction factor was shown to depend on
   assumptions about the relative toxicity of the components of PM2.5. In
   the European Union, an increment of 1 mug/m(3) Of PM2.5 for 1 year
   implies an average LLE of 0.22 days per person. With regard to the
   social cost of an air pollution pulse, it was found that for typical
   discount rates (3\% to 8\% real) the cost was reduced by a factor of
   about 0.4 to 0.6 relative to the case with zero discount rate, if the
   value of a life year was taken as given; if the value of a life year was
   calculated from the ``value of statistical life{''} by assuming the
   latter as a series of discounted annual values, the cost varied by at
   most :+/- 20\% relative to the case with zero discount rate. To assess
   the uncertainties, this study also examined how the LLE depended on the
   demographics (mortality, and age pyramid) of a population, and how it
   would change if the relative risk varied with age, in the manner
   suggested by smoking studies. These points were found to have a
   relatively small effect (compared to the epidemiological uncertainties)
   on the calculated LLE.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Rabl, A (Corresponding Author), Ecole Mines Paris, Ctr Energet, 60 Boul St Michel, F-75272 Paris, France.
   Ecole Mines Paris, Ctr Energet, F-75272 Paris, France.
   Univ Gothenburg, Dept Appl Environm Sci, Gothenburg, Sweden.},
DOI = {10.1111/0272-4332.215156},
ISSN = {0272-4332},
EISSN = {1539-6924},
Keywords = {air pollution mortality; monetary valuation; value of life; discounting;
   particulate matter; life expectancy; years of life lost},
Keywords-Plus = {INFANT-MORTALITY; EXPECTANCY; EXPOSURE; SMOKING},
Research-Areas = {Public, Environmental \& Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods},
Author-Email = {rabl@cenerg.ensmp.fr},
Cited-References = {Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020.
   BELLANDER T, 1999, PUBLICATION NATL ROA.
   BOBAK M, 1992, LANCET, V340, P1010, DOI 10.1016/0140-6736(92)93017-H.
   Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   DOCKERY DW, 1981, JAPCA J AIR WASTE MA, V31, P153, DOI 10.1080/00022470.1981.10465205.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   {*}EUR, 1999, DEM STAT DAT 1960 19.
   {*}EXT, 1995, 16525 EUR OFF OFF PU.
   {*}EXT, 1995, 16521 EUR OFF OFF PU.
   {*}EXT, 1995, 16523 EUR OFF OFF PU.
   {*}EXT, 1995, 16522 EUR OFF OFF PU.
   {*}EXT, 1995, 16524 EUR OFF OFF PU.
   {*}EXT, 1998, 18836 EUR OFF OFF PU.
   {*}EXT, 1998, 19083 EUR OFF OFF PU.
   {*}EXT, 1995, 16520 EUR OFF OFF PU.
   {*}EXT, 1998, 18528 EUR OFF OFF PU.
   {*}EXT, 1998, 18887 EUR OFF OFF PU.
   Johannesson M, 1996, J RISK UNCERTAINTY, V13, P163, DOI 10.1007/BF00057866.
   LEE R, 1994, EXTERNAL COSTS BENEF.
   LEKSELL I, 2000, THESIS CHALMERS U TE.
   Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089.
   {*}NAT CTR HLTH STAT, 1998, VIT STAT US 1995 A, V2.
   NIZICH SV, 1997, EPA454R97011.
   Peters K D, 1998, Natl Vital Stat Rep, V47, P1.
   POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3\_Pt\_1.669.
   Rabl A, 1998, J HAZARD MATER, V61, P91, DOI 10.1016/S0304-3894(98)00112-5.
   Rabl A, 2000, ANNU REV ENERG ENV, V25, P601, DOI 10.1146/annurev.energy.25.1.601.
   Rowe R. D., 1995, NEW YORK ELECT EXTER.
   Seinfeld J.H., 1998, ATMOSPHERIC CHEM PHY, Vxxvii, P1326.
   {*}USDHHS, 1990, DHHS PUBL CDC.
   {*}USDOC, 1997, STAT ABSTR US.
   {*}USEPA, 1997, NAT AIR QUAL EM TREN.
   Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608, DOI 10.1289/ehp.97105608.},
Number-of-Cited-References = {34},
Times-Cited = {39},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {Risk Anal.},
Doc-Delivery-Number = {502TH},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000172758500005},
DA = {2022-03-29},
}

@article{ WOS:000274208600019,
Author = {Finkelstein, Eric A. and Brown, Derek S. and Wrage, Lisa A. and Allaire,
   Benjamin T. and Hoerger, Thomas J.},
Title = {Individual and Aggregate Years-of-life-lost Associated With Overweight
   and Obesity},
Journal = {OBESITY},
Year = {2010},
Volume = {18},
Number = {2},
Pages = {333-339},
Month = {FEB 10},
Abstract = {This study presents nationally representative estimates of individual
   and aggregate years-of-life-lost (YLLs) associated with overweight and
   three categories of obesity separately by age, race, smoking status, and
   gender strata. Using proportional hazards analysis and data from the
   National Health Interview Survey (NHIS) Linked Mortality Files, we
   estimated life expectancies for each BMI strata and quantified YLLs by
   comparing differences between each strata and the normal BMI reference
   group. Our results provide further evidence that overweight and mild
   obesity are not associated with a reduction in life expectancy. However,
   higher BMI categories are associated with lower expected survival. In
   aggregate, excess BMI is responsible for similar to 95 million YLLs.
   White females account for more than two-thirds of the aggregate YLLs.
   Unless something is done to reduce the rising prevalence of those with
   BMIs >35, or to mitigate the impact of obesity or its correlates on
   YLLs, expected life expectancy for US adults may decrease in the future.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Brown, DS (Corresponding Author), RTI Int, Res Triangle Pk, NC USA.
   Finkelstein, Eric A.; Brown, Derek S.; Wrage, Lisa A.; Allaire, Benjamin T.; Hoerger, Thomas J., RTI Int, Res Triangle Pk, NC USA.},
DOI = {10.1038/oby.2009.253},
ISSN = {1930-7381},
EISSN = {1930-739X},
Keywords-Plus = {BODY-MASS INDEX; TABLE ANALYSIS; US ADULTS; MORTALITY; BURDEN; RISK;
   CONSEQUENCES; UNDERWEIGHT; TRENDS; IMPACT},
Research-Areas = {Endocrinology \& Metabolism; Nutrition \& Dietetics},
Web-of-Science-Categories  = {Endocrinology \& Metabolism; Nutrition \& Dietetics},
Author-Email = {dsbrown@rti.org},
ResearcherID-Numbers = {Brown, Derek/J-3035-2013
   Sriwisit, Sukhumaphorn/G-1405-2011
   },
ORCID-Numbers = {Brown, Derek/0000-0001-9908-9882
   Hoerger, Thomas/0000-0003-4154-7806
   Allaire, Benjamin/0000-0002-7033-2129},
Funding-Acknowledgement = {Centers for Disease Control and PreventionUnited States Department of
   Health \& Human ServicesCenters for Disease Control \& Prevention - USA
   {[}1 P30 CD000138-01]; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE
   CONTROL \&PREVENTIONUnited States Department of Health \& Human
   ServicesCenters for Disease Control \& Prevention - USA {[}P30CD000138]
   Funding Source: NIH RePORTER},
Funding-Text = {This research was supported by grant number 1 P30 CD000138-01 from the
   Centers for Disease Control and Prevention to the RTI-UNC Center of
   Excellence in Health Promotion Economics. The views expressed in this
   paper are solely those of the authors. an institutional review board
   exemption was obtained.},
Cited-References = {Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643.
   Anderson R N, 2000, Vital Health Stat 2, P1.
   Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8.
   Beasley JW, 2003, JAMA-J AM MED ASSOC, V289, P1777, DOI 10.1001/jama.289.14.1777-a.
   Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855.
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581.
   FINKELSTEIN EA, 2008, FATTENING AM.
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028.
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861.
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723.
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187.
   Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868.
   Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218.
   Judge GG., 1985, THEORY PRACTICE ECON.
   Lochner K, 2007, COMP ANAL PUBLIC USE.
   Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801.
   Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874.
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523.
   {*}NAT CTR HLTH STAT, 2007, 1986 2000 NHIS LINK.
   Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008.
   Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699.
   Rao JNK, 1999, BIOMETRIKA, V86, P403, DOI 10.1093/biomet/86.2.403.
   Reuser M, 2008, EUR J EPIDEMIOL, V23, P601, DOI 10.1007/s10654-008-9269-8.
   Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019.
   Westat, 2002, WESVAR 4 2 US GUID.},
Number-of-Cited-References = {25},
Times-Cited = {98},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {12},
Journal-ISO = {Obesity},
Doc-Delivery-Number = {551KX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000274208600019},
DA = {2022-03-29},
}

@article{ WOS:000232141000014,
Author = {Krishnamoorthy, K and Harichandrakumar, KT and Kumari, AK and Das, PK},
Title = {Years of life lost and productivity loss due to tsunami in India},
Journal = {CURRENT SCIENCE},
Year = {2005},
Volume = {89},
Number = {5},
Pages = {739-740},
Month = {SEP 10},
Publisher = {INDIAN ACAD SCIENCES},
Address = {C V RAMAN AVENUE, SADASHIVANAGAR, P B \#8005, BANGALORE 560 080, INDIA},
Type = {Article},
Language = {English},
Affiliation = {Krishnamoorthy, K (Corresponding Author), Vector Control Res Ctr, Pondicherry 605006, India.
   Vector Control Res Ctr, Pondicherry 605006, India.},
ISSN = {0011-3891},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {kkrish\_3@yahoo.com},
Cited-References = {Chandrasekharan H, 2005, CURR SCI INDIA, V89, P30.
   LOPEZ AD, 2002, WORLD MORTAL 2000 LI.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   {*}WHO, 1999, WHO REP 1999.},
Number-of-Cited-References = {4},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Curr. Sci.},
Doc-Delivery-Number = {968DB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000232141000014},
DA = {2022-03-29},
}

@article{ WOS:000562023300002,
Author = {Oh, In-Hwan and Ock, Minsu and Jang, Su Yeon and Go, Dun-Sol and Kim,
   Young-Eun and Jung, Yoon-Sun and Kim, Ki Beom and Park, Hyesook and Jo,
   Min-Woo and Yoon, Seok-Jun},
Title = {Years of Life Lost Attributable to COVID-19 in High-incidence Countries},
Journal = {JOURNAL OF KOREAN MEDICAL SCIENCE},
Year = {2020},
Volume = {35},
Number = {32},
Month = {AUG 17},
Abstract = {Background: The coronavirus disease 2019 (COVID-19) pandemic is a major
   public health problem of international concern. It is important to
   estimate its impact of COVID-19 for health policy decision-making. We
   estimated the years of life lost (YLLs) due to COVID-19 in
   high-incidence countries.
   Methods: We collected the YLLs due to COVID-19 in 30 high-incidence
   countries as of April 13, 2020 and followed up as of July 14, 2020.
   Incidence and mortality were collected using each country's formal
   reports, articles, and other electronic sources. The life expectancy of
   Japanese females by age and the UN population data were used to
   calculate YLLs in total and per 100,000.
   Results: As of April 22, 2020, there were 1,699,574 YLLs due to COVID-19
   in 30 high-incidence countries. On July 14, 2020, this increased to
   4,072,325. Both on April 22 and July14, the total YLLs due to COVID-19
   was highest in the USA (April 22, 534,481 YLLs; July 14,1,199,510 YLLs),
   and the YLLs per 100,000 population was highest in Belgium (April 22,
   868.12 YLLs/100,000; July14, 1,593.72 YLLs/100,000). YLLs due to
   COVID-19 were higher among males than among females and higher in those
   aged >= 60 years than in younger individuals. Belgium had the highest
   proportion ofYLLs attributable to COVID-19 as a proportion of the total
   YLLs and the highest disability-adjusted life years per 100,000
   population.
   Conclusion: This study estimated YLLs due to COVID-19 in 30 countries.
   COVID-19 is a high burden in the USA and Belgium, among males and the
   elderly. The YLLs are very closely related with the incidence as well as
   the mortality. This highlights the importance of the early detection of
   incident case that minimizes severe acute respiratory syndrome
   coronavirus-2 fatality.},
Publisher = {KOREAN ACAD MEDICAL SCIENCES},
Address = {302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA},
Type = {Article},
Language = {English},
Affiliation = {Jo, MW (Corresponding Author), Univ Ulsan, Dept Prevent Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   Yoon, SJ (Corresponding Author), Korea Univ, Dept Prevent Med, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea.
   Oh, In-Hwan; Jang, Su Yeon, Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.
   Ock, Minsu; Jo, Min-Woo, Univ Ulsan, Dept Prevent Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   Ock, Minsu, Ulsan Univ Hosp, Dept Prevent Med, Ulsan, South Korea.
   Go, Dun-Sol, Korea Inst Hlth \& Social Affairs, Dept Hlth Care Policy Res, Sejong, South Korea.
   Kim, Young-Eun, Natl Hlth Insurance Serv, Big Data Dept, Wonju, South Korea.
   Jung, Yoon-Sun; Kim, Ki Beom, Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.
   Park, Hyesook, Ewha Womans Univ, Dept Prevent Med, Sch Med, Seoul, South Korea.
   Yoon, Seok-Jun, Korea Univ, Dept Prevent Med, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea.},
DOI = {10.3346/jkms.2020.35.e300},
Article-Number = {e300},
ISSN = {1011-8934},
EISSN = {1598-6357},
Keywords = {COVID-19; SARS-CoV-2; Burden of Disease; Years of Life Lost;
   Disability-Adjusted Life Years},
Keywords-Plus = {SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISABILITY; DISEASES; INJURIES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {mdjominwoo@gmail.com
   yoonsj02@korea.ac.kr},
ORCID-Numbers = {Kim, Ki Beom/0000-0001-7613-0125
   Kim, Young-Eun/0000-0003-0694-6844
   Ock, Minsu/0000-0001-9949-9224
   Jang, Su Yeon/0000-0001-7545-3168
   Yoon, Seok-Jun/0000-0003-3297-0071
   Park, Hyesook/0000-0002-9359-6522},
Funding-Acknowledgement = {Korean Health Technology R\&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health and Welfare, Republic
   of Korea {[}HI18C0446]},
Funding-Text = {This study was supported by a grant from the Korean Health Technology
   R\&D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea
   (No. HI18C0446).},
Cited-References = {Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076.
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X.
   Director-General for Statistics and Information Policy Ministry of Health Labour and Welfare, 2015, 22 LIF TABL.
   Global Health 5050. Global Health 5050, COVID 19 SEX DIS DAT.
   Her M, 2020, DISASTER MED PUBLIC, V14, P684, DOI 10.1017/dmp.2020.69.
   James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7.
   Kang Yun-Jung, 2020, Disaster Med Public Health Prep, V14, P384, DOI 10.1017/dmp.2020.60.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Ogden N H, 2017, Can Commun Dis Rep, V43, P206, DOI 10.14745/ccdr.v43i10a03.
   United Nations: Department of Economic and Social Affairs, WORLD POP PROSP 2019.
   Walker PGT, GLOBAL IMPACT COVID.
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9.
   WHO, COR DIS COVID 19 PAN.
   World Health Organization, COR DIS COVID 19 SIT.
   World Health Organization (WHO), NAM COR DIS COVID 19.
   World Health Organization (WHO), WHO DIR GEN OP REM M.},
Number-of-Cited-References = {16},
Times-Cited = {17},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Korean Med. Sci.},
Doc-Delivery-Number = {ND6OO},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000562023300002},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1992JF51400007,
Author = {RENNERT, G},
Title = {PREMATURE MORTALITY, ISRAEL 1986},
Journal = {ISRAEL JOURNAL OF MEDICAL SCIENCES},
Year = {1992},
Volume = {28},
Number = {7},
Pages = {442-446},
Month = {JUL},
Abstract = {Mortality statistics serve as the most common tool for health policy
   planning.  However, this method suffers from several shortcomings.  The
   mortality patterns in Israel in 1986 are presented in this article using
   the measure of years of potential life lost (YPLL), which better
   expresses premature mortality and the burden of diseases on society. 
   Ischemic heart disease, cancer, and accidents of all types are
   responsible equally for most premature deaths in males in Israel,
   whereas cancer is the leading cause of premature mortality in women in
   Israel.  Planning future health policy should rely more heavily on
   measures such as YPLL.},
Publisher = {ISRAEL JOURNAL MED SCIENCES},
Address = {2 ETZEL ST, FRENCH HILL, JERUSALEM 97853, ISRAEL},
Type = {Article},
Language = {English},
Affiliation = {RENNERT, G (Corresponding Author), LADY DAVIES CARMEL HOSP,DEPT COMMUNITY MED \& EPIDEMIOL,IL-34362 HAIFA,ISRAEL.
   TECHNION ISRAEL INST TECHNOL,FAC MED,HAIFA,ISRAEL.},
ISSN = {0021-2180},
Keywords = {PREMATURE MORTALITY; YPLL (YEARS OF POTENTIAL LIFE LOST); ACCIDENTS;
   ISCHEMIC HEART DISEASE; CANCER},
Keywords-Plus = {PROGRESS; CANCER},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {BAILAR JC, 1986, NEW ENGL J MED, V314, P1226, DOI 10.1056/NEJM198605083141905.
   DOLL R, 1989, ACTA ONCOL, V28, P611.
   GOODMAN RA, 1987, JAMA-J AM MED ASSOC, V258, P379.
   KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349.
   RICHTER E D, 1979, International Journal of Epidemiology, V8, P383, DOI 10.1093/ije/8.4.383.
   1988, STATISTICAL ABSTRACT, P133.
   1986, MMWR S2S, V35, pS1.
   1988, JAMA-J AM MED ASSOC, V259, P1148.
   1988, WORLD HLTH STATISTIC.},
Number-of-Cited-References = {9},
Times-Cited = {2},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Isr. J. Med. Sci.},
Doc-Delivery-Number = {JF514},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1992JF51400007},
DA = {2022-03-29},
}

@article{ WOS:000448977500014,
Author = {Izadi, Neda and Mirtorabi, Seyed Davood and Najafi, Farid and Nazparvar,
   Bashir and Nazari Kangavari, Hajar and Nazari, Seyed Saeed Hashemi},
Title = {Trend of years of life lost due to suicide in Iran (2006-2015)},
Journal = {INTERNATIONAL JOURNAL OF PUBLIC HEALTH},
Year = {2018},
Volume = {63},
Number = {8, SI},
Pages = {993-1000},
Month = {NOV},
Abstract = {ObjectivesSuicide is a major global public health problem and much
   burden in the societies. This study aims to calculate the years of life
   lost (YLL) due to suicide and investigate its trend in
   Iran.MethodsInformation on deaths due to suicide in Iran was extracted
   from Iran Legal Medicine Organization. The years of life lost was
   calculated in each year according to gender and age-groups. To examine
   the trend for different years, joinpoint regression was used.ResultsThe
   35,297 deaths due to suicide were recorded in 2006-2015. The total YLL
   in the 10-year period was 34.52 per 1000 persons in males, 13.61 per
   1000 persons in females and 23.35 per 1000 persons in both sexes.
   Hanging comprised the largest YLL of suicide. The annual percent change
   of YLL rate was 3.3\%.ConclusionsThe results revealed that male shows an
   increasing trend in YLL specifically among youth and adult, while there
   is no improvement in females. There is a national need to implement an
   effective health policy intervention in Iran.},
Publisher = {SPRINGER BASEL AG},
Address = {PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Nazari, SSH (Corresponding Author), Shahid Beheshti Univ Med Sci, Dept Epidemiol, Safety Promot \& Injury Prevent Res Ctr, Sch Publ Hlth, Tehran, Iran.
   Izadi, Neda, Kermanshah Univ Med Sci, Student Res Comm, Sch Publ Hlth, Kermanshah, Iran.
   Mirtorabi, Seyed Davood, Univ Tehran Med Sci, Sch Adv Technol Med, Dept Addict Studies, Tehran, Iran.
   Najafi, Farid, Kermanshah Univ Med Sci, Dept Epidemiol, RCEDH, Kermanshah, Iran.
   Nazparvar, Bashir; Nazari Kangavari, Hajar, Legal Med Org, Legal Med Res Ctr, Tehran, Iran.
   Nazari, Seyed Saeed Hashemi, Shahid Beheshti Univ Med Sci, Dept Epidemiol, Safety Promot \& Injury Prevent Res Ctr, Sch Publ Hlth, Tehran, Iran.},
DOI = {10.1007/s00038-018-1151-1},
ISSN = {1661-8556},
EISSN = {1661-8564},
Keywords = {Trend; Years of life lost; Suicide; Iran},
Keywords-Plus = {UNITED-STATES; POTENTIAL YEARS; GLOBAL BURDEN; MORTALITY; DISEASES;
   HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {saeedh\_1999@yahoo.com},
ORCID-Numbers = {Izadi, Neda/0000-0002-6373-1113},
Funding-Acknowledgement = {Kermanshah University of Medical Sciences {[}96271]},
Funding-Text = {This study was supported by Kermanshah University of Medical Sciences
   Grant Number 96271. The funding agency did not play any role in the
   planning, conduct, and reporting or in the decision to submit the paper
   for publication.},
Cited-References = {Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37.
   Brazinova A, 2017, INT J SOC PSYCHIATR, V63, P161, DOI 10.1177/0020764016688715.
   Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE.
   Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171.
   Etzersdorfer E, 2015, WIEN KLIN WOCHENSCHR, V127, P308, DOI 10.1007/s00508-015-0729-3.
   Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936.
   Fond G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20256.
   Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004.
   Fountoulakis KN, 2014, BRIT J PSYCHIAT, V205, P486, DOI 10.1192/bjp.bp.114.147454.
   Gould MS, 2004, J AM ACAD CHILD PSY, V43, P1124, DOI 10.1097/01.chi.0000132811.06547.31.
   Hamilton E, 2015, INT J ENV RES PUB HE, V12, P2359, DOI 10.3390/ijerph120302359.
   Hempstead KA, 2015, AM J PREV MED, V48, P491, DOI 10.1016/j.amepre.2014.11.006.
   Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP DAT VIS.
   Kamel MH, 2012, J UROLOGY, V187, P868, DOI 10.1016/j.juro.2011.10.142.
   Kiadaliri AA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005227.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005.
   Nakanishi M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010104.
   National Survey on Drug Use and Health Substance Abuse and Mental Health Services Administration, 2014, NSDUH SER H.
   Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0.
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0.
   Puzo Q, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2919-y.
   Shepherd G, 1998, ARCH PEDIAT ADOL MED, V152, P1181.
   Skinner R, 2016, HEALTH PROMOT CHRON, V36, P243, DOI 10.24095/hpcdp.36.11.02.
   Tollefsen IM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-9.
   Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2.
   World Health Organization, 2007, SUIC PREV SUPRE.
   World Health Organization, 2014, PREVENTING SUICIDE G.
   World Health Organization, 2015, GLOB HLTH OBS GHO DA.
   World Health Organization (WHO), 2015, KEY FACTS.},
Number-of-Cited-References = {31},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Int. J. Public Health},
Doc-Delivery-Number = {GY9OP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000448977500014},
DA = {2022-03-29},
}

@article{ WOS:000377555600024,
Author = {Cucchetti, Alessandro and Ercolani, Giorgio and Taffurelli, Giovanni and
   Serenari, Matteo and Maroni, Lorenzo and Pezzilli, Raffaele and Del
   Gaudio, Massimo and Ravaioli, Matteo and Cescon, Matteo and Pinna,
   Antonio D.},
Title = {A comprehensive analysis on expected years of life lost due to
   pancreatic cancer},
Journal = {PANCREATOLOGY},
Year = {2016},
Volume = {16},
Number = {3},
Pages = {449-453},
Month = {MAY-JUN},
Abstract = {Background: Pancreatic cancer represents a fatal malignancy leading to
   premature death and loss of life expectancy. The aim of the present
   study was to assess how many years of life are lost due to this cancer,
   in relationship with surgery and ageing.
   Methods: Data from 716 consecutive patients discharged from a tertiary
   referral hospital (2002-2012) with a diagnosis of pancreatic cancer and
   with complete clinical and follow-up data were used to estimate the
   number of years of life-lost (YLL) through a semi-parametric
   extrapolation having an age-, sex- and year-of-onset-matched population
   derived from national life tables as reference.
   Results: The mean entire lifespan estimated for the 716 patients was 1.4
   years (95\% C.I.:0.8-1.9) resulting in a number of YLL after diagnosis
   of 12 years (95\% C.I.:11.5-12.6) per person. Surgical patients (147
   cases; 20.5\%) were younger and experienced higher post-diagnostic
   lifespan (3.5 years) than nonsurgical older individuals (0.8 years; p <
   0.001). These figures were reflected on the number of expected YLL
   (EYLL) that remained substantially unaffected by surgery (p = 0.821).
   Patients aged <= 68 years experienced the highest number of EYLL
   (20.8.years); whereas elderly patients had a loss of life that
   corresponded to only 6\% of the entire life they had already lived.
   Conclusions: In a typical pancreatic cancer cohort, surgery was not able
   to modify population-based statistics because of a different age at
   tumor onset which nullifies any benefit from a ``lifespan from birth{''}
   perspective. Pancreatic cancer in younger individuals must be ranked
   within the very first causes of EYLL due to malignancy. (C) 2016 IAP and
   EPC. Published by Elsevier B.V. All rights reserved.},
Publisher = {KARGER},
Address = {ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Cucchetti, A (Corresponding Author), Univ Bologna, Alma Mater Studiorum, Dept Med \& Surg Sci DIMEC, Via Massarenti 9, I-40138 Bologna, Italy.
   Cucchetti, Alessandro; Ercolani, Giorgio; Taffurelli, Giovanni; Serenari, Matteo; Maroni, Lorenzo; Pezzilli, Raffaele; Del Gaudio, Massimo; Ravaioli, Matteo; Cescon, Matteo; Pinna, Antonio D., Univ Bologna, Alma Mater Studiorum, Dept Med \& Surg Sci DIMEC, S Orsola Malpighi Hosp, Bologna, Italy.},
DOI = {10.1016/j.pan.2016.02.005},
ISSN = {1424-3903},
EISSN = {1424-3911},
Keywords = {Pancreatic cancer; Surgery; Survival; Relative survival; Years-of-life
   lost; Ageing},
Keywords-Plus = {UNITED-STATES; SURVIVAL; AGE; EXTRAPOLATION; HEALTH},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {aleqko@libero.it},
ResearcherID-Numbers = {Cucchetti, Alessandro/B-5194-2014
   Pezzilli, Raffaele/H-8280-2019
   Pinna, Antonio/AAC-6685-2019
   ercolani, giorgio/AAD-1462-2022
   Ravaioli, Matteo/D-6314-2016
   },
ORCID-Numbers = {Cucchetti, Alessandro/0000-0001-5269-1964
   Pezzilli, Raffaele/0000-0001-9827-7451
   Ravaioli, Matteo/0000-0001-5862-6151
   serenari, matteo/0000-0003-1471-8585
   Maroni, Lorenzo/0000-0003-4195-3580
   Ercolani, Giorgio/0000-0003-4334-5167},
Cited-References = {American Cancer Society, 2014, CANC FACTS FIG.
   {[}Anonymous], STAT METH APPL BRANC.
   Bilimoria KY, 2007, CANCER-AM CANCER SOC, V110, P738, DOI 10.1002/cncr.22852.
   Brauer S, 2009, J MED ETHICS, V35, P27, DOI 10.1136/jme.2008.024398.
   Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x.
   Churchill LR, 2005, HEALTH CARE ANAL, V13, P137, DOI 10.1007/s10728-005-4477-9.
   Cucchetti A, 2016, BRIT J SURG, V103, pE93, DOI 10.1002/bjs.10056.
   Cucchetti A, 2016, PANCREAS.
   Daniels Norman, 1996, JUSTICE JUSTIFICATIO, P257.
   Edge SBCC, 2010, AJCC CANC STAGING MA.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4.
   Liu PH, 2013, PREV MED, V56, P309, DOI 10.1016/j.ypmed.2013.02.003.
   Mayo SC, 2012, J AM COLL SURGEONS, V214, P33, DOI 10.1016/j.jamcollsurg.2011.09.022.
   National Cancer Institute, 2012, PERS YEARS LIF LOST.
   Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078.
   Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x.
   US Department of Health and Human Services, GLOB HLTH AG.
   Wang J.D., 2002, BASIC PRINCIPLES PRA.},
Number-of-Cited-References = {19},
Times-Cited = {9},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Pancreatology},
Doc-Delivery-Number = {DO1RB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000377555600024},
DA = {2022-03-29},
}

@article{ WOS:000338966400004,
Author = {Owusu-Bempah, Akwasi and Kanters, Steve and Druyts, Eric and Toor,
   Kabirraaj and Muldoon, Katherine A. and Farquhar, John W. and Mills,
   Edward J.},
Title = {Years of life lost to incarceration: inequities between Aboriginal and
   non-Aboriginal Canadians},
Journal = {BMC PUBLIC HEALTH},
Year = {2014},
Volume = {14},
Month = {JUN 11},
Abstract = {Background: Aboriginal representation in Canadian correctional
   institutions has increased rapidly over the past decade. We calculated
   ``years of life lost to incarceration{''} for Aboriginal and
   non-Aboriginal Canadians.
   Methods: Incarceration data from provincial databases were used
   conjointly with demographic data to estimate rates of incarceration and
   years of life lost to provincial incarceration in (BC) and federal
   incarceration, by Aboriginal status. We used the Sullivan method to
   estimate the years of life lost to incarceration.
   Results: Aboriginal males can expect to spend approximately 3.6 months
   in federal prison and within BC spend an average of 3.2 months in
   custody in the provincial penal system. Aboriginal Canadians on average
   spend more time in custody than their non-Aboriginal counterparts. The
   ratio of the Aboriginal incarceration rate to the non-Aboriginal
   incarceration rate ranged from a low of 4.28 in Newfoundland and
   Labrador to a high of 25.93 in Saskatchewan. Rates of incarceration at
   the provincial level were highest among Aboriginals in Manitoba with an
   estimated rate of 1377.6 individuals in prison per 100,000 population
   (95\% confidence interval {[}CI]: 1311.8 - 1443.4).
   Conclusions: The results indicate substantial differences in life years
   lost to incarceration for Aboriginal versus non-Aboriginal Canadians. In
   light of on-going prison expansion in Canada, future research and policy
   attention should be paid to the public health consequences of
   incarceration, particularly among Aboriginal Canadians.},
Publisher = {BIOMED CENTRAL LTD},
Address = {236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Mills, EJ (Corresponding Author), Univ Ottawa, Fac Hlth Sci, 25 Univ Private, Ottawa, ON K1N 6N5, Canada.
   Owusu-Bempah, Akwasi, Univ Toronto, Ctr Criminol \& Sociolegal Studies, Toronto, ON M5S 3K9, Canada.
   Kanters, Steve; Toor, Kabirraaj; Muldoon, Katherine A., Univ British Columbia, Sch Populat \& Publ Hlth, Vancouver, BC V6T 1Z3, Canada.
   Druyts, Eric; Mills, Edward J., Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.
   Farquhar, John W.; Mills, Edward J., Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.},
DOI = {10.1186/1471-2458-14-585},
Article-Number = {585},
ISSN = {1471-2458},
Keywords = {Prison; Incarceration; Aboriginal; Public health},
Keywords-Plus = {PARENTAL INCARCERATION; PRISONS; HEALTH; HIV},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {edward.mills@uottawa.ca},
ResearcherID-Numbers = {Muldoon, Katherine/AAC-4703-2021
   },
ORCID-Numbers = {Owusu-Bempah, Akwasi/0000-0003-4237-3422
   Muldoon, Katherine/0000-0002-0766-4294},
Funding-Acknowledgement = {Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) {[}FRN 116392]},
Funding-Text = {This work was supported by a catalyst grant from the Canadian Institutes
   of Health Research (FRN 116392). We would like to acknowledge the
   expertise and insights provided to us by Robert Hogg and Larry
   Nicholson.},
Cited-References = {Canada S., 2013, 2011 NAT HOUS SURV.
   Canada S, 2011, PROB SURV VAR AG POP.
   Canadian Broadcasting Corporation (CBC), 2013, AB CORR REP FINDS SY.
   Clear Todd, 2002, INVISIBLE PUNISHMENT, P181.
   Dauvergne M, 2012, STAT CANADA CATALOGU.
   Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7.
   Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214.
   Geller A, 2012, DEMOGRAPHY, V49, P49, DOI 10.1007/s13524-011-0081-9.
   Geller A, 2009, SOC SCI QUART, V90, P1186, DOI 10.1111/j.1540-6237.2009.00653.x.
   Hogg RS, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-4.
   Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102.
   JusticeBC, 2012, JUSTICEBC DASHB CORR.
   Kaplan AH, 2006, AIDS READ, V16, p{[}247, 257].
   Krebs CP, 2002, AIDS EDUC PREV, V14, P53, DOI 10.1521/aeap.14.7.53.23865.
   Lau J, 2012, HLTH IMPACTS SAFE ST.
   Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218.
   Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105.
   Murray J, 2012, PSYCHOL BULL, V138, P175, DOI 10.1037/a0026407.
   Office of the Correctional Investigator, 2012, ANN REP OFF CORR INV.
   Perreault Samuel, 2009, JURISTAT, V29, P9.
   Public Safety Canada, 2012, CORR COND REL STAT O.
   Statistics Canada, 2005, PROJ AB POP CAN PROV.
   Statistics Canada, 2011, ANN DEM EST CAN PROV.
   SULLIVAN DF, 1971, HEALTH SERV REP, V86, P347, DOI 10.2307/4594169.
   Wortley S, 2012, RACE, ETHNICITY, CRIME AND CRIMINAL JUSTICE IN THE AMERICAS, P11.},
Number-of-Cited-References = {25},
Times-Cited = {12},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {9},
Journal-ISO = {BMC Public Health},
Doc-Delivery-Number = {AL2PB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000338966400004},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000606028600036,
Author = {Quast, Troy and Andel, Ross and Gregory, Sean and Storch, Eric A.},
Title = {Years of life lost associated with COVID-19 deaths in the United States},
Journal = {JOURNAL OF PUBLIC HEALTH},
Year = {2020},
Volume = {42},
Number = {4},
Pages = {717-722},
Month = {DEC},
Abstract = {Background The mortality effects of COVID-19 are a critical aspect of
   the disease's impact. Years of life lost (YLLs) can provide greater
   insight than the number of deaths by conveying the shortfall in life
   expectancy and thus the age profile of the decedents.
   Methods We employed data regarding COVID-19 deaths in the USA by
   jurisdiction, gender and age group for the period 1 February 2020
   through 11 July 2020. We used actuarial life expectancy tables by gender
   and age to estimate YLLs.
   Results We estimated roughly 1.2 million YLLs due to COVID-19 deaths.
   The YLLs for the top six jurisdictions exceeded those for the remaining
   43. On a per-capita basis, female YLLs were generally higher than male
   YLLs throughout the country.
   Conclusions Our estimates offer new insight into the effects of
   COVID-19. Our findings of heterogenous rates of YLLs by geography and
   gender highlight variation in the magnitude of the pandemic's effects
   that may inform effective policy responses.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Quast, T (Corresponding Author), Univ S Florida, Coll Publ Hlth, Tampa, FL 33612 USA.
   Quast, Troy, Univ S Florida, Coll Publ Hlth, Tampa, FL 33612 USA.
   Andel, Ross, Univ S Florida, Coll Behav \& Community Sci, Tampa, FL 33620 USA.
   Andel, Ross, Charles Univ Prague, Dept Neurol, Prague 15006, Czech Republic.
   Andel, Ross, Motol Univ Hosp, Prague 15006, Czech Republic.
   Andel, Ross, St Annes Univ Hosp, Int Clin Res Ctr, Brno 65691, Czech Republic.
   Gregory, Sean, No Arizona Univ, Dept Polit \& Int Affairs, Flagstaff, AZ 86011 USA.
   Storch, Eric A., Baylor Coll Med, Menninger Dept Psychiat \& Behav Sci, Houston, TX 77030 USA.},
DOI = {10.1093/pubmed/fdaa159},
ISSN = {1741-3842},
EISSN = {1741-3850},
Keywords = {COVID-19; years of lost life; mortality},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {troyquast@usf.edu},
ORCID-Numbers = {Quast, Troy/0000-0001-8564-3379
   Andel, Ross/0000-0003-4083-4790},
Cited-References = {Alva ML, 2018, ANN EPIDEMIOL, V28, P790, DOI 10.1016/j.annepidem.2018.08.015.
   {[}Anonymous], STAT POP CHAR 2010 2.
   Basset M, UNEQUAL TOLL COVID 1.
   Council of State \& Territorial Epidemiologists, POS STAT STAND SURV.
   de Vries E, 2016, BIOMEDICA, V36, P547, DOI 10.7705/biomedica.v36i4.3207.
   Goh KJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02916-4.
   Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1.
   Imtiaz S, 2016, ADDICTION, V111, P653, DOI 10.1111/add.13237.
   Izadi N, 2018, INT J PUBLIC HEALTH, V63, P993, DOI 10.1007/s00038-018-1151-1.
   Jung YS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144961.
   Krieger N, 2020, LANCET, V395, P1829, DOI 10.1016/S0140-6736(20)31234-4.
   Martinez R, 2019, INT J EPIDEMIOL, V48, P1367, DOI 10.1093/ije/dyy254.
   Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392.
   Regitz-Zagrosek V, 2012, EMBO REP, V13, P596, DOI 10.1038/embor.2012.87.
   Resnick Brian, VOX.
   Salazar A, 2020, CURR MED RES OPIN, V36, P285, DOI 10.1080/03007995.2019.1684251.
   Shavelle Robert M, 2009, Int J Chron Obstruct Pulmon Dis, V4, P137.
   U.S. Census Bureau, QUICKFACTS NEW YORK.
   U.S. Centers for Disease Control and Prevention, PROV COVID 19 DEATH.
   US Social Security Administration, ACT LIF TABL.
   Vienonen MA, 2019, EUR J PUBLIC HEALTH, V29, P626, DOI 10.1093/eurpub/cky278.
   Weinberger DM, 2020, JAMA INTERN MED, V180, P1336, DOI 10.1001/jamainternmed.2020.3391.
   Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787.
   Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1.},
Number-of-Cited-References = {24},
Times-Cited = {12},
Usage-Count-Last-180-days = {3},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Public Health},
Doc-Delivery-Number = {PP7HG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000606028600036},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000264653300016,
Author = {Pham, Truong-Minh and Fujino, Yoshihisa and Ide, Reiko and Tokui,
   Noritaka and Kubo, Tatsuhiko and Mizoue, Tetsuya and Ogimoto, Itsuro and
   Matsuda, Shinya and Yoshimura, Takesumi},
Title = {Years of life lost due to cancer in a cohort study in Japan},
Journal = {EUROPEAN JOURNAL OF PUBLIC HEALTH},
Year = {2009},
Volume = {19},
Number = {2},
Pages = {189-192},
Month = {APR},
Abstract = {Background: We estimated the burden of cancer using mortality and years
   of life lost according to life tables in a cohort study in Japan.
   Methods: A cohort of 13 270 subjects established in the late 1980s in
   Japan was followed annually for the vital status of all subjects until
   2003. For subjects who died, the underlying cause of death was
   ascertained from the death certificate. Crude mortality rate from cancer
   per 100 000 person-years was calculated, and years of life lost (YLL) as
   well as the average years of life lost (AYLL) were computed using the
   1995 life tables in Japan. Results: During the follow-up period, we
   recorded a total 839 cancer deaths (517 men and 322 women), representing
   35.5 of deaths from all causes. Overall crude cancer mortality was 654.9
   per 100 000 person-years in men and 312.6 in women. Total YLL due to
   cancer was 7035.3 years in men and 5627.0 years in women. Overall AYLL
   due to all cancers was 13.6 years less than life expectancy in men and
   17.5 years in women. Conclusion: These results showed that cancer was
   the leading cause of death in this cohort; with stomach, liver and lung
   cancer the three most frequent cancers in both sexes. YLL and AYLL
   reflect the cost of dying from cancer in terms of years of life
   expectancy lost. The different mortality statistics used here may be
   useful in public health considerations of cancer burden.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Pham, TM (Corresponding Author), Univ Occupat \& Environm Hlth, Sch Med, Dept Prevent Med \& Community Hlth, Kitakyushu, Fukuoka 807, Japan.
   Pham, Truong-Minh; Fujino, Yoshihisa; Matsuda, Shinya, Univ Occupat \& Environm Hlth, Sch Med, Dept Prevent Med \& Community Hlth, Kitakyushu, Fukuoka 807, Japan.
   Pham, Truong-Minh, Thai Nguyen Univ, Thai Nguyen Med Coll, Thai Nguyen, Vietnam.
   Ide, Reiko, Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Dept Work Syst \& Hlth, Kitakyushu, Fukuoka 807, Japan.
   Tokui, Noritaka, Univ Occupat \& Environm Hlth, Inst Ind Ecol Sci, Dept Prevent Med \& Dietet, Kitakyushu, Fukuoka 807, Japan.
   Kubo, Tatsuhiko, Asahi Kasei Nobeoka Off Hlth Care Ctr, Miyazaki, Japan.
   Mizoue, Tetsuya, Int Med Ctr Japan, Res Inst, Dept Epidemiol, Tokyo, Japan.
   Ogimoto, Itsuro, Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka 830, Japan.
   Yoshimura, Takesumi, Fukuoka Inst Hlth \& Environm Sci, Fukuoka, Japan.},
DOI = {10.1093/eurpub/ckp020},
ISSN = {1101-1262},
EISSN = {1464-360X},
Keywords = {cancer; cohort study; mortality; years of life lost},
Keywords-Plus = {PREMATURE MORTALITY; BREAST-CANCER; BURDEN; LIVER},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ptrminh@med.uoeh-u.ac.jp},
ResearcherID-Numbers = {Fujino, Yoshihisa/F-3054-2010
   },
ORCID-Numbers = {Fujino, Yoshihisa/0000-0002-9126-206X
   Kubo, Tatsuhiko/0000-0001-8822-9181
   Matsuda, Shinya/0000-0002-8472-8909},
Funding-Acknowledgement = {Ministry of Education, Science and Culture of JapanMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)
   {[}12218216, 12218237]},
Funding-Text = {The Ministry of Education, Science and Culture of Japan {[}Grant-in-Aid
   for Scientific Research on Priority Areas C-1 (12218216, partial) and
   C-2 (12218237, partial)].},
Cited-References = {Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   {*}HLTH WELF STAT AS, 2007, J HLTH WELFARE STAT, V54, P10.
   HORM JW, 1989, AM J PUBLIC HEALTH, V79, P1490, DOI 10.2105/AJPH.79.11.1490.
   Ide R, 2008, J DENT RES, V87, P485, DOI 10.1177/154405910808700510.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   {*}MIN HLTH WELF JAP, 1995 COMPL LIF TABL.
   Mizoue T, 2000, INT J EPIDEMIOL, V29, P232, DOI 10.1093/ije/29.2.232.
   Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7.
   Pham TM, 2006, INT J CANCER, V119, P2408, DOI 10.1002/ijc.22122.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Semerl JS, 2002, CROAT MED J, V43, P439.
   StataCorp, 2005, STAT STAT SOFTW REL.
   TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4.
   Vlajinac H, 2006, CROAT MED J, V47, P134.},
Number-of-Cited-References = {15},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Eur. J. Public Health},
Doc-Delivery-Number = {425QX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000264653300016},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000462304300012,
Author = {Go, Dun-Sol and Kim, Young-Eun and Radnaabaatar, Munkhzul and Jung,
   Yunsun and Jung, Jaehun and Yoon, Seok-Jun},
Title = {Regional Differences in Years of Life Lost in Korea from 1997 to 2015},
Journal = {JOURNAL OF KOREAN MEDICAL SCIENCE},
Year = {2019},
Volume = {34},
Number = {1},
Month = {MAR 26},
Abstract = {Background: Reducing the gaps in health inequality at a regional level
   and improving health equity have been emphasized in Korea, it is
   essential to accurately measure the burden of disease by region. This
   study aimed to estimate years of life lost (YLLs) in 17 Si and Do of
   Korea from 1997 to 2015 and determine the trends of regional differences
   in health status and disease structure.
   Methods: YLL was calculated by subtracting the age at death from the
   life expectancy. Data on the region, gender, and age-stratified
   cause-specific death were obtained from the Korean Statistical
   Information Service of Statistics Korea.
   Results: Age-standardized YLLs per 100,000 population decreased by year
   in all regions from 1997 to 2015 by 27.4\% (27.5\% for men; 27.2\% for
   women). Despite the decline in YLLs, the regions with the highest and
   lowest YLLs did not change between 1997 and 2015. The diseases showing
   regional differences were caused by injury, often classified as
   avoidable mortality. We also confirmed that YLLs were higher in the
   regions with a higher deprivation index.
   Conclusion: The present study identified that YLLs differed by regions
   in Korea with specific causes. The findings of this study can be used by
   decision-makers to prioritize the reduction of regional gaps in
   premature deaths.},
Publisher = {KOREAN ACAD MEDICAL SCIENCES},
Address = {302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA},
Type = {Article},
Language = {English},
Affiliation = {Yoon, SJ (Corresponding Author), Korea Univ, Dept Prevent Med, Coll Med, 73 Inchon Ro, Seoul 02841, South Korea.
   Go, Dun-Sol; Radnaabaatar, Munkhzul; Jung, Yunsun, Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.
   Kim, Young-Eun; Yoon, Seok-Jun, Korea Univ, Dept Prevent Med, Coll Med, 73 Inchon Ro, Seoul 02841, South Korea.
   Jung, Jaehun, Gachon Univ, Dept Prevent Med, Coll Med, Incheon, South Korea.},
DOI = {10.3346/jkms.2019.34.e91},
Article-Number = {e91},
ISSN = {1011-8934},
EISSN = {1598-6357},
Keywords = {Mortality, Premature; Population Health; Health Status; Epidemiologic
   Measurements},
Keywords-Plus = {INEQUALITIES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {yoonsj02@korea.ac.kr},
ORCID-Numbers = {Yoon, Seok-Jun/0000-0003-3297-0071
   Kim, Young-Eun/0000-0003-0694-6844
   Go, Dun-Sol/0000-0002-9025-7760
   Jung, Jaehun/0000-0002-4856-3668},
Funding-Acknowledgement = {Korea Health Industry Development Institute (KHIDI) - Ministry of Health
   \& Welfare, Republic of Korea {[}HI18C0446]},
Funding-Text = {This study was supported by a grant for the Korea Health Technology R\&D
   Project provided by the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health \& Welfare, Republic of Korea
   (Grant No.: HI18C0446).},
Cited-References = {Cheong Kyu-Seok, 2012, J Prev Med Public Health, V45, P70, DOI 10.3961/jpmph.2012.45.2.70.
   Choi Min Hyeok, 2011, J Prev Med Public Health, V44, P242, DOI 10.3961/jpmph.2011.44.6.242.
   Choi Minhyeok, 2015, {[}Journal of Critical Social Welfare, 비판사회정책], V49, P404.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Hong E, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-41.
   Jeong Baek-Geun, 2006, J Prev Med Public Health, V39, P46.
   Kim Agnus M, 2016, J Prev Med Public Health, V49, P230, DOI 10.3961/jpmph.16.034.
   Kim I, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e3.
   Kim Y, 2019, KOREAN J INTERN MED, V34, P1, DOI 10.3904/kjim.2018.381.
   Lee YR, 2016, J KOREAN MED SCI, V31, pS121, DOI 10.3346/jkms.2016.31.S2.S121.
   Lim D, 2014, J KOREAN MED SCI, V29, P1597, DOI 10.3346/jkms.2014.29.12.1597.
   Moon S, 2016, J KOREAN MED SCI, V31, P67, DOI 10.3346/jkms.2016.31.1.67.
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104.
   Shin Hosung, 2009, J Prev Med Public Health, V42, P392, DOI 10.3961/jpmph.2009.42.6.392.
   Shin Y.J., 2009, HLTH PROMOTION STRAT.
   Singh-Manoux A, 2005, INT J EPIDEMIOL, V34, P638, DOI 10.1093/ije/dyi074.
   Song HN, 2016, CANCER RES TREAT, V48, P789, DOI 10.4143/crt.2015.062.
   Yun JW, 2016, J KOREAN MED SCI, V31, P568, DOI 10.3346/jkms.2016.31.4.568.},
Number-of-Cited-References = {18},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {J. Korean Med. Sci.},
Doc-Delivery-Number = {HQ3IJ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000462304300012},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000180584700005,
Author = {Rabl, A},
Title = {Interpretation of air pollution mortality: Number of deaths or years of
   life lost?},
Journal = {JOURNAL OF THE AIR \& WASTE MANAGEMENT ASSOCIATION},
Year = {2003},
Volume = {53},
Number = {1},
Pages = {41-50},
Month = {JAN},
Abstract = {This paper examines the relation between the results of epidemiologic
   studies of air pollution mortality and impact indicators that can be
   informative for environmental policy decisions. Using models that are
   simple and transparent, yet contain the essential features, it is shown
   that (1) number of deaths is not meaningful for air pollution, whereas
   loss of life expectancy (LLE) is an appropriate impact indicator; (2)
   the usual short term (time series) studies yield a change in daily
   number of deaths attributable to acute effects of pollution, without any
   information on the associated LLE (although some information on this has
   recently become available by extending the observation window of time
   series); and (3) long-term studies yield a change in age-specific
   mortality, which makes it possible to calculate the total population
   averaged LLE (acute and chronic effects) but not the total number of
   premature deaths attributable to air pollution. The latter is
   unobservable because one cannot distinguish whether few individuals
   suffer a large or many suffer a small LLE. The paper calculates the LLE
   from exposure to PM10, as implied by the long-term mortality studies of
   adults and infants; population LLE for infants turns out to be an order
   of magnitude smaller than for adults. The LLE implied by short-term
   studies is a small fraction of the total loss implied by long-term
   studies, even if one assumes a very high loss per death. Applied to
   environmental policy, taking a permanent 50-70\% reduction of PM10 as a
   reasonable goal, one finds a corresponding increase of average life
   expectancy in urban areas of the European Union (EU) and the United
   States of approximately four months.},
Publisher = {TAYLOR \& FRANCIS INC},
Address = {530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA},
Type = {Article},
Language = {English},
Affiliation = {Rabl, A (Corresponding Author), Ecole Mines Paris, Ctr Energet, 60 Boul St Michel, F-75272 Paris, France.
   Ecole Mines Paris, Ctr Energet, F-75272 Paris, France.},
DOI = {10.1080/10473289.2003.10466118},
ISSN = {1096-2247},
EISSN = {2162-2906},
Keywords-Plus = {PARTICULATE MATTER; INFANT-MORTALITY; EXPECTANCY; EXPOSURE; CITIES},
Research-Areas = {Engineering; Environmental Sciences \& Ecology; Meteorology \&
   Atmospheric Sciences},
Web-of-Science-Categories  = {Engineering, Environmental; Environmental Sciences; Meteorology \&
   Atmospheric Sciences},
Author-Email = {rabl@cenerg.ensmp.fr},
Cited-References = {Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020.
   {*}ABT ASS INC, 2000, PART REL HLTH BEN RE.
   Bobak M, 1999, EPIDEMIOLOGY, V10, P666, DOI 10.1097/00001648-199911000-00004.
   Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781.
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Evans J, 1996, PARTICLES OUR AIR CO, P189.
   FRIEDRICH R, 2001, JOS3CT970015.
   {*}HLTH EFF I, 2001, HEI PERSP.
   Johannesson M, 1996, J RISK UNCERTAINTY, V13, P163, DOI 10.1007/BF00057866.
   Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658.
   KREWSKI D, 2000, PARTICLE EPIDEMIOLOG.
   KRUPNICK A, 2000, AERE SESS ASSA M BOS.
   Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2.
   Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050.
   LEE R, 1994, EXTERNAL COSTS BENEF.
   Leksell I, 2001, RISK ANAL, V21, P843, DOI 10.1111/0272-4332.215156.
   Levy JI, 2000, ENVIRON HEALTH PERSP, V108, P109, DOI 10.2307/3454508.
   Levy JI, 1999, ENVIRON SCI TECHNOL, V33, P4364, DOI 10.1021/es990634+.
   McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450.
   {*}NAT CTR HLTH STAT, 1999, 19 NAT CTR HLTH STAT, V47.
   POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3\_Pt\_1.669.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Rabl A, 1998, J HAZARD MATER, V61, P91, DOI 10.1016/S0304-3894(98)00112-5.
   ROBINS J, 1991, STAT MED, V10, P79, DOI 10.1002/sim.4780100113.
   Rowe R. D., 1995, NEW YORK ELECT EXTER.
   Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401.
   SAMET JM, 2000, NATL MORBIDITY MOR 1.
   SCHWARTZ J, 2000, NATL MORBIDITY MOR 2.
   THOMAS D, 1992, HEALTH PHYS, V63, P259, DOI 10.1097/00004032-199209000-00001.
   {*}US EPA, 1997, NAT AIR QUAL EM TREN.
   Wilson R., 2001, RISK BENEFIT ANAL.
   Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608, DOI 10.1289/ehp.97105608.
   Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015.
   1998, EXTERNE EXTERNALITIE, V7.
   18887 EUR, V9.
   18528 EUR, V10.
   18836 EUR, V8.},
Number-of-Cited-References = {38},
Times-Cited = {76},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {12},
Journal-ISO = {J. Air Waste Manage. Assoc.},
Doc-Delivery-Number = {638RU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000180584700005},
DA = {2022-03-29},
}

@article{ WOS:000359122600001,
Author = {Yang, Jun and Ou, Chun-Quan and Guo, Yuming and Li, Li and Guo, Cui and
   Chen, Ping-Yan and Lin, Hua-Liang and Liu, Qi-Yong},
Title = {The burden of ambient temperature on years of life lost in Guangzhou,
   China},
Journal = {SCIENTIFIC REPORTS},
Year = {2015},
Volume = {5},
Month = {AUG 6},
Abstract = {Limited evidence is available on the association between temperature and
   years of life lost (YLL). We applied distributed lag non-linear model to
   assess the nonlinear and delayed effects of temperature on YLL due to
   cause-/age-/education-specific mortality in Guangzhou, China. We found
   that hot effects appeared immediately, while cold effects were more
   delayed and lasted for 14 days. On average, 1 degrees C decrease from
   25th to 1st percentile of temperature was associated with an increase of
   31.15 (95\% CI: 20.57, 41.74), 12.86 (8.05, 17.68) and 6.64 (3.68, 9.61)
   YLL along lag 0-14 days for non-accidental, cardiovascular and
   respiratory diseases, respectively. The corresponding estimate of
   cumulative hot effects (1 degrees C increase from 75th to 99th
   percentile of temperature) was 12.71 (-2.80, 28.23), 4.81 (-2.25, 11.88)
   and 2.81 (-1.54, 7.16). Effect estimates of cold and hot
   temperatures-related YLL were higher in people aged up to 75 years and
   persons with low education level than the elderly and those with high
   education level, respectively. The mortality risks associated with cold
   and hot temperatures were greater on the elderly and persons with low
   education level. This study highlights that YLL provides a complementary
   method for assessing the death burden of temperature.},
Publisher = {NATURE PUBLISHING GROUP},
Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Liu, QY (Corresponding Author), Chinese Ctr Dis Control \& Prevent, Natl Inst Communicable Dis Control \& Prevent, Collaborat Innovat Ctr Diag \& Treatment Infect Di, State Key Lab Infect Dis Prevent \& Control, Beijing 102206, Peoples R China.
   Yang, Jun; Liu, Qi-Yong, Chinese Ctr Dis Control \& Prevent, Natl Inst Communicable Dis Control \& Prevent, Collaborat Innovat Ctr Diag \& Treatment Infect Di, State Key Lab Infect Dis Prevent \& Control, Beijing 102206, Peoples R China.
   Ou, Chun-Quan; Li, Li; Guo, Cui; Chen, Ping-Yan, Southern Med Univ, Sch Publ Hlth \& Trop Med, State Key Lab Organ Failure Res, Dept Biostat,Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
   Guo, Yuming, Univ Queensland, Sch Publ Hlth, Div Epidemiol \& Biostat, Brisbane, Qld 4006, Australia.
   Lin, Hua-Liang, Guangdong Prov Ctr Dis Control \& Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Guangdong, Peoples R China.
   Yang, Jun; Liu, Qi-Yong, Shandong Univ, Climate Change \& Hlth Ctr, Jinan 250012, Peoples R China.},
DOI = {10.1038/srep12250},
Article-Number = {12250},
ISSN = {2045-2322},
Keywords-Plus = {LAG NONLINEAR MODEL; 15 EUROPEAN CITIES; AIR-POLLUTION; UNITED-STATES;
   TIME-SERIES; HEAT-WAVE; AFFECT MORTALITY; COLD; IMPACT; POPULATION},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {liuqiyong@icdc.cn},
ResearcherID-Numbers = {Guo, Yuming/I-8353-2018
   Yang, Jun/Q-3037-2019
   guo, cui/AAR-5300-2020
   },
ORCID-Numbers = {Guo, Yuming/0000-0002-1766-6592
   guo, cui/0000-0003-0816-6534
   Ou, Chun-Quan/0000-0001-6866-7213
   Li, Li/0000-0003-4802-8689
   Yang, Jun/0000-0002-8049-4746},
Funding-Acknowledgement = {National Basic Research Program of China (973 Program)National Basic
   Research Program of China {[}2012CB955504]; National Nature Science
   Foundation of ChinaNational Natural Science Foundation of China (NSFC)
   {[}81102207]},
Funding-Text = {This study were supported by the National Basic Research Program of
   China (973 Program) (Grant No. 2012CB955504) and National Nature Science
   Foundation of China (81102207).},
Cited-References = {Almeida SP, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-12.
   Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266.
   Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd.
   Baccini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069638.
   Bai L, 2014, SCI TOTAL ENVIRON, V485, P41, DOI 10.1016/j.scitotenv.2014.02.094.
   Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010.
   Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   Group TE, 1997, LANCET, V349, P1341.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598.
   Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63.
   Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Li L, 2014, ENVIRON POLLUT, V190, P75, DOI 10.1016/j.envpol.2014.03.020.
   Lin YK, 2013, SCI TOTAL ENVIRON, V461, P627, DOI 10.1016/j.scitotenv.2013.05.030.
   Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007.
   Ma WJ, 2012, INT J BIOMETEOROL, V56, P205, DOI 10.1007/s00484-011-0406-9.
   O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122.
   Ou CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077150.
   Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.
   Wong CM, 2001, ENVIRON HEALTH PERSP, V109, P335, DOI 10.2307/3454891.
   World Health Organization, 2010, LIF TABL WHO MEMB ST.
   Wu W, 2013, SCI TOTAL ENVIRON, V449, P355, DOI 10.1016/j.scitotenv.2013.01.090.
   Yang J, 2013, BIOMED ENVIRON SCI, V26, P647, DOI 10.3967/0895-3988.2013.08.003.
   Yang J, 2013, ENVIRON POLLUT, V175, P131, DOI 10.1016/j.envpol.2012.12.021.
   Yang J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-63.},
Number-of-Cited-References = {30},
Times-Cited = {40},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {24},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {CO4HU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000359122600001},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000479315000001,
Author = {Feigelman, William and Rosen, Zohn and Cerel, Julie},
Title = {Unraveling the Complex Web of Associations Between Easy Access to
   Firearms and Premature Mortalities},
Journal = {SUICIDE AND LIFE-THREATENING BEHAVIOR},
Year = {2020},
Volume = {50},
Number = {1},
Pages = {277-291},
Month = {FEB},
Abstract = {Objective We investigated whether high school students reporting easy
   access to guns were more likely to die prematurely from either suicide,
   homicide, or an accidental death. Method Based upon the National
   Longitudinal Study of Adolescent to Adult Health, we contrasted those
   reporting easy access to guns, n = 5,185, 25\%, with the remaining 75\%
   (n = 15,589) on various sociodemographic characteristics, behaviors, and
   premature mortalities. Results We found higher rates of suicides,
   homicides, and accidental deaths among those reporting easy access to
   guns at Wave 1 or Wave 2. This was only true for males. Those with easy
   access to guns were more likely to share common sociodemographic
   characteristics, came from two-parent homes where children had strong
   and close relationships with parents, where children were more likely to
   get into fights, do delinquent misdeeds, and engage in other risk-taking
   behaviors such as increased drinking, drug use, and riding motorcycles.
   Logistic regression analysis showed easy access to guns remained a
   significant predictor of premature mortalities when sex, family income
   differences, risk-taking, and delinquency were used as covariates.
   Conclusions This study supports previous research and carves out new
   ground showing easy access to guns acts synergistically with other
   lifestyle differences to diminish youth life chances.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Feigelman, W (Corresponding Author), Nassau Community Coll, Sociol, Jamaica, NY USA.
   Feigelman, William, Nassau Community Coll, Sociol, Jamaica, NY USA.
   Rosen, Zohn, Columbia Univ, Sch Publ Hlth, New York, NY USA.
   Cerel, Julie, Univ Kentucky, Coll Social Work, Lexington, KY USA.},
DOI = {10.1111/sltb.12580},
EarlyAccessDate = {AUG 2019},
ISSN = {0363-0234},
EISSN = {1943-278X},
Keywords-Plus = {GUN OWNERSHIP; UNITED-STATES; ADOLESCENTS; PREDICTORS; HOMICIDE; RATES},
Research-Areas = {Psychiatry; Psychology},
Web-of-Science-Categories  = {Psychiatry; Psychology, Multidisciplinary},
Author-Email = {feigelw@ncc.edu},
ResearcherID-Numbers = {Feigelman, William/R-9736-2019
   Cerel, Julie/H-5925-2019},
ORCID-Numbers = {Cerel, Julie/0000-0002-4534-5526},
Funding-Acknowledgement = {Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health \& Human Development (NICHD) {[}P01-HD31921]},
Funding-Text = {This research uses data from Add Health, a program project directed by
   Kathleen Mullan Harris and designed by J. Richard Udry, Peter S.
   Bearman, and Kathleen Mullan Harris at the University of North Carolina
   at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development, with
   cooperative funding from 23 other federal agencies and foundations.
   Special acknowledgment is due to Ronald R. Rindfuss and Barbara Entwisle
   for assistance in the original design. Information on how to obtain the
   Add Health data files is available on the Add Health website
   http://www.cpc.unc.edu/addhealth No direct support was received from
   grant P01-HD31921 for this analysis.},
Cited-References = {Add Health, 2014, RESTR US DAT DESCR C.
   Cretacci MA, 2017, INT J CRIM JUSTICE S, V12, P285, DOI 10.5281/zenodo.1034676.
   Feigelman W, 2010, J PSYCHOACTIVE DRUGS, V42, P353, DOI 10.1080/02791072.2010.10400698.
   KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506.
   Kim J, 2018, SOC SCI MED, V203, P51, DOI 10.1016/j.socscimed.2017.11.044.
   Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076.
   Mann JJ, 2016, AM J PSYCHIAT, V173, P969, DOI 10.1176/appi.ajp.2016.16010069.
   Matza, 1964, DELINQUENCY DRIFT.
   Miller M, 2005, ACCIDENT ANAL PREV, V37, P661, DOI 10.1016/j.aap.2005.02.003.
   Miller M, 2001, ACCIDENT ANAL PREV, V33, P477, DOI 10.1016/S0001-4575(00)00061-0.
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306.
   Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823.
   Ruback RB, 2011, J INTERPERS VIOLENCE, V26, P2111, DOI 10.1177/0886260510372948.
   Siegel M, 2013, AM J PUBLIC HEALTH, V103, P2098, DOI 10.2105/AJPH.2013.301409.
   Simonetti JA, 2015, JAMA PSYCHIAT, V72, P152, DOI 10.1001/jamapsychiatry.2014.1760.
   Stroope S, 2017, SOC SCI RES, V67, P147, DOI 10.1016/j.ssresearch.2017.06.001.
   Swahn MH, 2002, INJURY PREV, V8, P227, DOI 10.1136/ip.8.3.227.},
Number-of-Cited-References = {17},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Suicide Life-Threat. Behav.},
Doc-Delivery-Number = {KK8XP},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000479315000001},
DA = {2022-03-29},
}

@article{ WOS:000388638000008,
Author = {de Vries, Esther and Meneses, Maria Ximena and Pineros, Marion},
Title = {Years of life lost as a measure of cancer burden in Colombia, 1997-2012},
Journal = {BIOMEDICA},
Year = {2016},
Volume = {36},
Number = {4},
Pages = {547+},
Month = {DEC},
Abstract = {Introduction: There is hardly any information regarding years of life
   lost due to cancer in Colombia.
   Objective: To quantify total and average years of life lost due to
   cancer in Colombia, and to investigate changes in this burden between
   1997 and 2012.
   Materials and methods: We obtained sex-specific data on age
   distribution, remaining life expectancy, deaths due to specific cancers
   and total number of deaths from the Colombian Departamento
   Administrativo Nacional de Estadisticas. We calculated years of life
   lost based on each individual's age at death and the remaining life
   expectancy at that age; as for average years of life, we divided these
   by the number of deaths due to specific cancers.
   Results: The total number of cancer deaths increased by 33\% between
   1997 and 2012, comprising 15\% of male and 20\% of female deaths in the
   period 2010-2012. Total years of life lost due to cancer increased by
   25.1\% for males and 31.1\% for females over the study period. The
   highest increases (>40\%) were observed for colorectal, pancreas and
   kidney cancers in both sexes, for melanomas and bladder cancer in men,
   and for breast and ovarian cancer in women. Trends in average years of
   life lost were stable. Almost half (48-50\%) of the years of life lost
   due to childhood cancers were due to leukemia.
   Conclusion: Cancer is an increasing health burden in Colombia. The high
   average years of life lost illustrate the poor prognosis of the disease
   compared to other countries. Primary prevention, early detection, and
   adequate and timely treatments are needed to change this situation.},
Publisher = {INST NACIONAL SALUD},
Address = {AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C,
   00000, COLOMBIA},
Type = {Article},
Language = {English},
Affiliation = {de Vries, E (Corresponding Author), Carrera 21 106B-82, Bogota, DC, Colombia.
   de Vries, Esther; Meneses, Maria Ximena, Inst Nacl Cancerol, Subdirecc Invest Vigilancia Epidemiol Promoc \& Pr, Bogota, DC, Colombia.
   de Vries, Esther, Pontificia Univ Javeriana, Dept Epidemiol Clin \& Bioestadist, Bogota, DC, Colombia.
   Pineros, Marion, Int Agcy Res Canc, Sect Canc Surveillance, Lyon, France.},
DOI = {10.7705/biomedica.v36i4.3207},
ISSN = {0120-4157},
EISSN = {2590-7379},
Keywords = {Neoplasms; potential years of life lost/trends; cost of illness;
   Colombia},
Keywords-Plus = {MORTALITY; TRENDS; DELAY; CALI},
Research-Areas = {Tropical Medicine},
Web-of-Science-Categories  = {Tropical Medicine},
Author-Email = {estherdevries77@gmail.com},
ResearcherID-Numbers = {Piñeros, Marion/K-3255-2019
   de Vries, Esther/A-6603-2009},
ORCID-Numbers = {Piñeros, Marion/0000-0002-4249-7276
   de Vries, Esther/0000-0002-5560-2258},
Funding-Acknowledgement = {DANE},
Funding-Text = {This project did not receive any external funding. Salaries of the
   authors were paid for by their respective employers and data was
   provided free of charge by DANE.},
Cited-References = {Agudelo-Botero Marcela, 2011, Rev. Gerenc. Polit. Salud, V10, P138.
   Davila-Cervantes CA, 2014, REV PANAM SALUD PUBL, V36, P10.
   Restrepo JA, 2014, SALUD PUBLICA MEXICO, V56, P440.
   Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9.
   Asi vamos en salud, 2015, GRAF AS GEORR 2012.
   Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364.
   Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526.
   Castillo-Rodriguez L, 2015, PLOS ONE, V10, P1.
   de Blank PM, 2015, CANCER MED-US, V4, P608, DOI 10.1002/cam4.410.
   Departamento Administrativo Nacional de Estadistica DANE, 1985, PROYECC POBL 2005 20.
   Bravo LE, 2013, COLOMB MEDICA, V44, P155.
   Esquiaqui-Felipe Rafael, 2012, Rev. salud pública, V14, P213, DOI 10.1590/S0124-00642012000200003.
   Instituto Nacional de Salud Observatorio Nacional de Salud, 2015, PRIM INF ONS ASP REL.
   Loos AH, 2004, EUR J CANCER, V40, P2794, DOI 10.1016/j.ejca.2004.09.007.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Ministerio de Salud y Proteccion Social, 2007, SOC INF FIN EV NEC A.
   Ministerio de Salud y Proteccion Social Instituto Nacional de Salud, 2015, PROT VIG SAL PUBL LE.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Pineros M, 2004, CANCER-AM CANCER SOC, V101, P2285, DOI 10.1002/cncr.20607.
   Pineros M, 2007, REV COLOMB CANCEROL, V11, P219.
   Pineros M., 2010, ATLAS MORTALIDAD CAN.
   Pineros M, 2013, CANCER EPIDEMIOL, V37, P233, DOI 10.1016/j.canep.2013.02.003.
   Pineros M, 2011, SALUD PUBLICA MEXICO, V53, P478.
   Pineros M, 2011, REV PANAM SALUD PUBL, V30, P15.
   Pineros M, 2009, SALUD PUBLICA MEXICO, V51, P372.
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263.
   World Health Organization Global Health Observatory data repository, 2016, CENS CIV REG COV.
   Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719.},
Number-of-Cited-References = {28},
Times-Cited = {5},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {13},
Journal-ISO = {Biomedica},
Doc-Delivery-Number = {ED1XK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000388638000008},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000652870000001,
Author = {Askari-Nodoushan, Abbas and Sabbaghchi, Maryam and Mohammadi, Masoud and
   Askari, Maryam},
Title = {Years of Life Lost Due to Main Causes of Deaths in Yazd Province, Iran},
Journal = {OMEGA-JOURNAL OF DEATH AND DYING},
Abstract = {Aim
   One approach to measure the demographic impacts of death is to examine
   the number of lost years of life. The present paper aims to estimate the
   ``Years of Lost Life{''} (YLL) due to the main causes of death in Yazd
   province of Iran.
   Method
   The present study is an epidemiological examination for which the
   statistical population included all the death incidents in Yazd province
   (excluding stillbirth cases) over two time periods of 2011 and 2016 with
   a 5-year distance. The required data were obtained based on the
   Comprehensive System of Mortality Registration maintained by the
   Ministry of Health and Medical Education; while the standard life
   expectancy data were based on the World Health Organization standards
   using standard life table, level 26 of the West model (Coale and Demeny)
   for Japanese men and women. The standard YLL was calculated according to
   the WHO standard using a 0.03 relaxation rate for the future time and
   weighting coefficient for various ages and life years through the
   formula using the Microsoft Excel software.
   Results
   The findings of the present study suggest that two main causes of YLL in
   Yazd province during the year of 2011 were cardiovascular difficulties
   with the rates of 31.6 per 1000 persons for women and 27.1 per 1000
   persons for men, and cancers with the rates of 14.9 per 1000 persons for
   women and 16.2 per 1000 persons for men. While the above numbers in 2016
   were, respectively 22.5 per 1000 persons for women and 25.5 per 1000
   persons for men due to cardiovascular difficulties; and 18 per 1000
   persons for women and 15.5/1000 for men due to various types of cancers.
   Conclusions
   Our findings suggest that cardiovascular diseases and cancers are the
   main factors leading to Years of Lost Lifetime for the residents of Yazd
   province in Iran.},
Publisher = {SAGE PUBLICATIONS INC},
Address = {2455 TELLER RD, THOUSAND OAKS, CA 91320 USA},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Mohammadi, M (Corresponding Author), Kermanshah Univ Med Sci, Sch Nursing \& Midwifery, Dept Nursing, Kermanshah, Iran.
   Askari-Nodoushan, Abbas; Sabbaghchi, Maryam, Yazd Univ, Fac Social Sci, Yazd, Iran.
   Mohammadi, Masoud, Kermanshah Univ Med Sci, Sch Nursing \& Midwifery, Dept Nursing, Kermanshah, Iran.
   Askari, Maryam, Shahid Sadoughi Univ Med Sci, Diabet Res Ctr, Yazd, Iran.},
DOI = {10.1177/00302228211018107},
EarlyAccessDate = {MAY 2021},
Article-Number = {00302228211018107},
ISSN = {0030-2228},
EISSN = {1541-3764},
Keywords = {years of lost lifetime; mortality; life expectancy; epidemiology},
Keywords-Plus = {COUNTRIES; DISEASES; CANCER; TRENDS},
Research-Areas = {Psychology; Biomedical Social Sciences},
Web-of-Science-Categories  = {Psychology, Multidisciplinary; Social Sciences, Biomedical},
Author-Email = {masoud.mohammadi1989@yahoo.com},
ResearcherID-Numbers = {Mohammadi, Masoud/N-5971-2017
   Askari-Nodoushan, Abbas/I-9368-2018},
ORCID-Numbers = {Mohammadi, Masoud/0000-0002-5722-8300
   Askari-Nodoushan, Abbas/0000-0001-9815-7476},
Funding-Acknowledgement = {deputy of research and technology of the Yazd University {[}38542]},
Funding-Text = {The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Funding
   for this research was provided by the deputy of research and technology
   of the Yazd University, number 38542.},
Cited-References = {Abbasi Shawazi A.N.A., 2008, SOCIAL SCI LETT, V16, P49.
   Adair T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197047.
   Akbarpour S., 2012, Iranian Journal of Epidemiology, V7, P29.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567.
   Dehghan H, 2010, IRAN J ARTHROPOD-BOR, V4, P42.
   Faghihi F, 2015, IJFM, V21, P35.
   Faraji Obeidollah, 2015, Glob J Health Sci, V7, P187, DOI 10.5539/gjhs.v7n6p187.
   Ghashlaghi F., 2005, IRANIAN J FORENSIC M, V11, P77.
   Hajivandi A., 2011, J HLTH SYSTEM RES, V7, P1029.
   Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9.
   Kamel MH, 2012, J UROLOGY, V187, P868, DOI 10.1016/j.juro.2011.10.142.
   Khazaei S., 2014, PAJOUHAN SCI J, V12, P39.
   Khosravi Ardeshir, 2007, Popul Health Metr, V5, P7, DOI 10.1186/1478-7954-5-7.
   Koohi F, 2015, J SABZEVAR U MED SCI, V22, P630.
   Leonard JC, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3221.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   Mirzaei M., 2012, J POPULATION ASS IRA, V7, P7.
   Mohammadi M., 2017, IRANIAN J EPIDEMIOLO, V13, P299.
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X.
   Naghavi M, 2008, IRANIAN J EPIDEMIOLO, V4, P1.
   Tjepkema Michael, 2011, Health Rep, V22, P25.
   Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.},
Number-of-Cited-References = {24},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Omega-J. Death Dying},
Doc-Delivery-Number = {SF6NN},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000652870000001},
DA = {2022-03-29},
}

@article{ WOS:000341527100026,
Author = {Brustugun, O. T. and Moller, B. and Helland, A.},
Title = {Years of life lost as a measure of cancer burden on a national level},
Journal = {BRITISH JOURNAL OF CANCER},
Year = {2014},
Volume = {111},
Number = {5},
Pages = {1014-1020},
Month = {AUG 26},
Abstract = {Background: The severity of cancers is often measured in number of
   deaths. However, number of years of life lost (YLL) may be a more
   appropriate indicator of impact on society. Here we have calculated the
   YLL of adult cancers in Norway for the year 2012, as well as for the
   previous 15-year period.
   Methods: Data on age composition, expected remaining years of life,
   total numbers of deaths and deaths due to cancer were retrieved from the
   National Census Agency Statistics Norway. YLL were calculated for both
   sexes aged 25-99 years based on each individual's age at death, and the
   expected remaining years of life at that age.
   Results: Cancer deaths represented 25.8\% of all adult deaths in 2012,
   with a lower fraction of females (28.7\% in men and 23.1\% in women),
   whereas cancer represented 35.2\% of all YLL, with a higher fraction of
   females (32.8\% in men and 37.8\% in women). Females loose on average
   more life years to cancer than men (14.9 vs 12.7 years). Average YLL
   varied from 23.7 (cervical cancer) to 7.9 (prostate cancer). Lung cancer
   caused almost as many YLL alone (22.1\% of cancer-caused YLL) as colon,
   prostate and breast cancer combined (23.1\%). From 1997 to 2012,
   cancer-caused YLL as a fraction of all YLL increased from 32.5\% to
   35.2\%, but with major differences among diagnoses.
   Conclusions: Cancer is a major and increasing cause of premature deaths,
   and YLL may be a more accurate measure than number of deaths. Public
   health efforts and research funding should be explicitly directed at
   preventing premature deaths.},
Publisher = {NATURE PUBLISHING GROUP},
Address = {MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Brustugun, OT (Corresponding Author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway.
   Brustugun, O. T.; Helland, A., Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway.
   Brustugun, O. T.; Helland, A., Univ Oslo, Inst Clin Med, Oslo, Norway.
   Moller, B., Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway.},
DOI = {10.1038/bjc.2014.364},
ISSN = {0007-0920},
EISSN = {1532-1827},
Keywords = {life expectancy; neoplasms; epidemiology; mortality; cause of death},
Keywords-Plus = {PREMATURE MORTALITY; EXPECTED YEARS; GLOBAL BURDEN; SMOKING; QUALITY;
   DISEASE},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {otr@ous-hf.no},
ResearcherID-Numbers = {Helland, Åslaug/H-3910-2015
   Møller, Bjørn/K-7152-2012},
ORCID-Numbers = {Helland, Åslaug/0000-0002-5520-0275
   },
Funding-Acknowledgement = {South-Eastern Norway Regional Health Authority},
Funding-Text = {Help in data retrieval from Statistics Norway by Oystein Kramer-Johansen
   is highly appreciated. This work was supported by the South-Eastern
   Norway Regional Health Authority to OTB and AH.},
Cited-References = {{[}Anonymous], 2001, J Natl Cancer Inst, V93, P341.
   Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526.
   CRN, 2014, CANC NORW 2012.
   Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017.
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516.
   Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128.
   Kowalczyk JR, 2014, EUR J CANCER, V50, P481, DOI 10.1016/j.ejca.2013.11.004.
   Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037.
   Liu PH, 2013, PREV MED, V56, P309, DOI 10.1016/j.ypmed.2013.02.003.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.
   Santric Milicevic Milena, 2009, Popul Health Metr, V7, P12, DOI 10.1186/1478-7954-7-12.
   Schroeder SA, 2013, NEW ENGL J MED, V368, P389, DOI 10.1056/NEJMe1213751.
   Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2.
   Soneji S, 2014, J CLIN ONCOL, V32, P444, DOI 10.1200/JCO.2013.50.8952.
   Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127.
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263.},
Number-of-Cited-References = {22},
Times-Cited = {54},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {18},
Journal-ISO = {Br. J. Cancer},
Doc-Delivery-Number = {AO7IR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000341527100026},
OA = {hybrid, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000344199700019,
Author = {Pikala, Malgorzata and Maniecka-Bryla, Irena},
Title = {Years of life lost due to malignant neoplasms characterized by the
   highest mortality rate},
Journal = {ARCHIVES OF MEDICAL SCIENCE},
Year = {2014},
Volume = {10},
Number = {5},
Pages = {999-1006},
Month = {OCT},
Abstract = {Introduction: The analysis of premature deaths measured with years of
   life lost between the studied and referential populations helps to
   emphasize the social and economic aspect of a loss caused by deaths due
   to malignant neoplasms. The aim of the study was to analyze years of
   life lost by inhabitants of the Lodz province due to malignant
   neoplasms.
   Material and methods: The study material included a database which
   contained information gathered from 313,144 death certificates
   (including 66,899 people who died of malignant neoplasms) of inhabitants
   of the Lodz province who died between 1999 and 2008. The SEYLLp
   (Standard Expected Years of Life Lost per living person) method was used
   to determine years of life lost. Jointpoint models were used to analyze
   time trends.
   Results: In males the diseases which mostly contributed to death were
   tracheal, bronchial and lung malignant neoplasms (SEYLLp = 170.7) and
   cancer of the large intestine, rectum and anus (SEYLLp = 47.5). In
   females the principal diseases were tracheal, bronchial and lung
   malignant neoplasms (SEYLLp = 61.6), breast cancer (SEYLLp = 60.4) and
   cancer of the large intestine, rectum and anus (SEYLLp = 42.3). The
   years of life lost were growing in the period under study.
   Conclusions: The number of years lost due to malignant neoplasms in the
   Lodz province between 1999 and 2008 was growing. The main reasons for
   deaths in females were tracheal, bronchial and lung malignant neoplasms
   as well as breast cancer and in males cancer of the large intestine,
   rectum and anus as well as prostate cancer.},
Publisher = {TERMEDIA PUBLISHING HOUSE LTD},
Address = {WENEDOW ST 9-1, POZNAN, 61-614, POLAND},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Dept Epidemiol \& Biostat, 7-9 Zeligowskiego St, PL-90742 Lodz, Poland.
   Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ Lodz, Dept Epidemiol \& Biostat, PL-90742 Lodz, Poland.},
DOI = {10.5114/aoms.2013.36237},
ISSN = {1734-1922},
EISSN = {1896-9151},
Keywords = {malignant neoplasms; years of life lost; trends; the Lodz province},
Keywords-Plus = {LUNG-CANCER MORTALITY; EUROPEAN-UNION; COLORECTAL-CANCER; COUNTRIES;
   TRENDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Pikala, Malgorzata/S-9898-2016
   Maniecka-Bryla, Irena/AAW-5779-2021},
ORCID-Numbers = {Pikala, Malgorzata/0000-0003-4426-4908
   Maniecka-Bryla, Irena/0000-0002-6671-7456},
Funding-Acknowledgement = {Medical University of Lodz {[}503/6-029-07/503-01]},
Funding-Text = {This project was supported by the Medical University of Lodz grant
   number 503/6-029-07/503-01.},
Cited-References = {{[}Anonymous], 2009, HLTH STAT ATL MORT E.
   Arbyn M, 2011, INT J CANCER, V128, P1899, DOI 10.1002/ijc.25525.
   Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018.
   Bosetti C, 2008, ANN ONCOL, V19, P631, DOI 10.1093/annonc/mdm597.
   Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653.
   Bray F, 2004, EUR J CANCER, V40, P96, DOI 10.1016/j.ejca.2003.08.005.
   Central Statistical Office, LOC DAT BANK.
   Didkowska J, 2005, BMJ-BRIT MED J, V331, P189, DOI 10.1136/bmj.331.7510.189.
   Didkowska J., 2009, NOWOTWORY ZLOSLIWE P.
   Didkowska J, 2009, PROGNOZY ZACHOROWALN.
   Didkowska Joanna, 2006, Ginekol Pol, V77, P660.
   Godlewski D, 2012, WSPOLCZESNA ONKOL, V16, P38, DOI 10.5114/wo.2012.27335.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Klimczak A, 2011, ARCH MED SCI, V7, P673, DOI 10.5114/aoms.2011.24138.
   Kozlowska E, 2011, ARCH MED SCI, V7, P304, DOI 10.5114/aoms.2011.22082.
   Levi F, 2004, CANCER-AM CANCER SOC, V101, P2843, DOI 10.1002/cncr.20666.
   Levi F, 2003, ANN ONCOL, V14, P490, DOI 10.1093/annonc/mdg110.
   Malvezzi M, 2012, ANN ONCOL, V23, P1044, DOI 10.1093/annonc/mds024.
   Maniecka-Bryta I, 2006, THESIS UNIWERSYTET M.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Murray CJL, 2000, GLOBALNE OBCIAZENIE.
   Tyczynski JE, 2004, INT J CANCER, V109, P598, DOI 10.1002/ijc.20019.
   Wojtyniak B., 2008, SYTUACJA ZDROWOTNA L.
   Zatonski W, 2009, POL PRZEGL CHIR, V81, P808.},
Number-of-Cited-References = {25},
Times-Cited = {25},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Arch. Med. Sci.},
Doc-Delivery-Number = {AS3SZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000344199700019},
OA = {Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000469517300070,
Author = {Pikala, Malgorzata and Burzynska, Monika and Maniecka-Bryla, Irena},
Title = {Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2019},
Volume = {16},
Number = {9},
Month = {MAY 1},
Abstract = {The aim of the study was an analysis of years of life lost due to
   cervical cancer in Poland in the period 2000 to 2015 with consideration
   given to differences related to education and place of residence. The
   study material was 28,274 death certificates of all female inhabitants
   of Poland, who died in 2000 to 2015 due to cervical cancer. In order to
   calculate years of life lost, the authors used indices: SEYLLp (Standard
   Expected Years of Life Lost per living person), SEYLLd (per deaths) and
   AAPC (Average Annual Percentage Change). The SEYLLp index (per 100,000)
   due to cervical cancer in Poland decreased from 394.3 in 2000 to 220.9
   years of life in 2015 (AAPC = -3.6\%). Women with university education
   lost the smallest number of years of life (SEYLLp = 139.0 in 2000 and
   53.7 in 2015; AAPC = -5.4\%), whereas those with elementary education
   had the greatest number of years of life lost (524.2 and 312.8; AAPC =
   -3.4\%). Women living in rural areas lost on average 329.5 years in 2000
   and 177.0 in 2015 (AAPC = -3.8\%). In city areas, the values were 428.6
   and 247.1 (AAPC = -3.4\%). Many of the years of life lost could have
   been avoided by including more women, particularly those with elementary
   education, in screening examinations.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Pikala, M (Corresponding Author), Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, PL-90136 Lodz, Poland.
   Pikala, Malgorzata; Burzynska, Monika; Maniecka-Bryla, Irena, Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, PL-90136 Lodz, Poland.},
DOI = {10.3390/ijerph16091545},
Article-Number = {1545},
ISSN = {1661-7827},
EISSN = {1660-4601},
Keywords = {cervical cancer; neoplasms; years of life lost; mortality; epidemiology;
   trends; socioeconomic factors; Poland},
Keywords-Plus = {MORTALITY; PREVENTION; BURDEN; IMPACT; RISK; HEALTH; WOMEN},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {malgorzata.pikala@umed.lodz.pl
   monika.burzynska@umed.lodz.pl
   irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Maniecka-Bryla, Irena/0000-0002-6671-7456
   Burzynska, Monika/0000-0001-9875-7383
   Pikala, Malgorzata/0000-0003-4426-4908},
Funding-Acknowledgement = {Medical University of Lodz {[}503/6-029-07/503-61-002-18]},
Funding-Text = {The work was supported by Medical University of Lodz (project no
   503/6-029-07/503-61-002-18).},
Cited-References = {Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Campos NG, 2017, INT J GYNECOL OBSTET, V138, P47, DOI 10.1002/ijgo.12184.
   Castillo-Rodriguez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125456.
   Chelimo C, 2013, J INFECTION, V66, P207, DOI 10.1016/j.jinf.2012.10.024.
   Cierniak M., NA CO UMAR PACJENT C.
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688.
   Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735.
   Franceschi S, 2009, BRIT J CANCER, V101, P865, DOI 10.1038/sj.bjc.6605224.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Goodman A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2372.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Lam JUH, 2014, J MED SCREEN, V21, P38, DOI 10.1177/0969141314522454.
   Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Marshall R., 2010, HDB DIS BURDENS QUAL, P401, DOI {[}10.1007/978-0-387-78665-0\_22, DOI 10.1007/978-0-387-78665-0\_22].
   Murray C.J., 2000, GLOBAL BURDEN DIS.
   Nowakowski A, 2017, EUR J EPIDEMIOL, V32, P529, DOI 10.1007/s10654-017-0291-6.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Pikala M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09441-5.
   Pikala M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011501.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Ponti A, 2017, CANC SCREENING EUROP.
   Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666.
   Sant M, 2015, EUR J CANCER, V51, P2191, DOI 10.1016/j.ejca.2015.07.022.
   Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121.
   Singh Gopal K, 2012, Int J MCH AIDS, V1, P17.
   Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858.
   WHO/ICO Information Center of HPV and Cervical Cancer (HPV Information Center), HUM PAP REL DIS REP.
   Wojciechowska U., 2017, NOWOTW J ONCOL, V67, P349, DOI {[}10.5603/NJO.2017.0057, DOI 10.5603/NJO.2017.0057].
   World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069.},
Number-of-Cited-References = {33},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {IA4ER},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000469517300070},
OA = {Green Published, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000507312700020,
Author = {Pikala, Malgorzata and Burzynska, Monika and Maniecka-Bryla, Irena},
Title = {Standard Expected Years of Life Lost Due to Malignant Neoplasms in
   Poland, 2000-2014},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2019},
Volume = {16},
Number = {24},
Month = {DEC 2},
Abstract = {The aim of the study was an analysis of mortality trends due to
   malignant neoplasms in Poland. The study material was a database,
   consisting of 1,367,364 death certificates of inhabitants of Poland who
   died during the period 2000-2014 due to malignant cancer. To calculate
   years of life lost, the SEYLLp index (Standard Expected Years of Life
   Lost per living person) was applied. We also calculated AAPC (Average
   Annual Percentage Change). The SEYLLp index (per 10,000 population) due
   to malignant neoplasms in Poland in males decreased from 586.3 in 2000
   to 575.5 in 2014, whereas in females it increased from 398.6 in 2000 to
   418.3 in 2014. The greatest number of lost years of life in 2014 was
   attributed to lung cancer (174.7 per 10,000 males and 77.3 per 10,000
   females), breast cancer in females (64.5) and colorectal cancer in males
   (39.0). The most negative trends were observed for lung cancer in
   females (AAPC = 3.5\%) and for colorectal cancer (AAPC = 1.8\%) and
   prostate cancer (AAPC = 1.6\%) in males. Many lost years could have been
   prevented by including a greater number of Polish inhabitants in
   screening examinations, mostly targeted at malignant neoplasm, whose
   incidence is closely connected with modifiable risk factors.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Pikala, M (Corresponding Author), Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Zeligowskiego 7-9, PL-90752 Lodz, Poland.
   Pikala, Malgorzata; Burzynska, Monika; Maniecka-Bryla, Irena, Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Zeligowskiego 7-9, PL-90752 Lodz, Poland.},
DOI = {10.3390/ijerph16244898},
Article-Number = {4898},
EISSN = {1660-4601},
Keywords = {standard expected years of life lost; premature mortality; malignant
   tumours; trends; Poland},
Keywords-Plus = {CANCER-MORTALITY; GASTRIC-CANCER; LUNG-CANCER; TRENDS; PREDICTIONS;
   STATISTICS; IMPROVEMENT; INFECTION; WORLDWIDE; PATTERNS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {malgorzata.pikala@umed.lodz.pl
   monika.burzynska@umed.lodz.pl
   irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Maniecka-Bryla, Irena/0000-0002-6671-7456
   Burzynska, Monika/0000-0001-9875-7383
   Pikala, Malgorzata/0000-0003-4426-4908},
Funding-Acknowledgement = {Medical University of Lodz {[}503/6-029-07/503-61-002-18]},
Funding-Text = {The work was supported by Medical University of Lodz (project No.
   503/6-029-07/503-61-002-18).},
Cited-References = {{[}Anonymous], INCIDENCE MORTALITY.
   Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912.
   Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518.
   Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301.
   Boyle P, 2008, WORLD CANC REPORT 20.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Carioli G, 2017, BREAST, V36, P89, DOI 10.1016/j.breast.2017.06.003.
   Castillo-Rodriguez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125456.
   Chatenoud L, 2014, ANN ONCOL, V25, P1843, DOI 10.1093/annonc/mdu206.
   Choi KS, 2014, CLIN ENDOSC, V47, P490, DOI 10.5946/ce.2014.47.6.490.
   Cierniak M., NA CO UMAR PACJENT C.
   DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134.
   DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192.
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210.
   Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029.
   Freimanis Rita I, 2014, N C Med J, V75, P117.
   Hashim D, 2016, ANN ONCOL, V27, P926, DOI 10.1093/annonc/mdw027.
   Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43.
   Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   La Vecchia C, 2015, ONCOLOGIST, V20, P495, DOI 10.1634/theoncologist.2015-0011.
   Leppo K., 2006, HLTH ALL POLICIES PR.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Malvezzi M, 2015, ANN ONCOL, V26, P779, DOI 10.1093/annonc/mdv001.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Marmot M, 2013, REV SOCIAL DETERMINA.
   Marshall R., 2010, HDB DIS BURDENS QUAL, P401, DOI {[}10.1007/978-0-387-78665-0\_22, DOI 10.1007/978-0-387-78665-0\_22].
   Mesl? F., 2004, SPECIAL COLLECTION, V2, P11, DOI {[}DOI 10.4054/DEMRES.2004.S2.2, 10.4054/DemRes.2004.S2.2].
   Murphy S.L., 2015, NATL VITAL STAT REP, V63, P100.
   Murray C.J., 2000, GLOBAL BURDEN DIS.
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74.
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731.
   Peleteiro B, 2012, EUR J CANCER PREV, V21, P118, DOI 10.1097/CEJ.0b013e32834a7f66.
   Pikala M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09441-5.
   Pikala M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011501.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pimenta JM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-553.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Ponti A, 2017, CANC SCREENING EUROP.
   Popat K, 2013, BEST PRACT RES-CLIN, V27, P399, DOI 10.1016/j.bpa.2013.10.010.
   Powles JW, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-116.
   Rachtan J, 2002, LUNG CANCER-J IASLC, V35, P129, DOI 10.1016/S0169-5002(01)00330-0.
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI {[}10.3322/caac.21208, 10.1001/jamaoto.2014.2530, 10.3322/caac.21254, 10.1136/bmj.g1502].
   Waskiewicz A, 2016, KARDIOL POL, V74, P969, DOI 10.5603/KP.a2016.0003.
   White A., STATE MENS EUROPE.
   Wojtys P, 2013, CENT EUR J MED, V8, P185, DOI 10.2478/s11536-012-0103-z.
   Wong MCS, 2016, EUR UROL, V70, P862, DOI 10.1016/j.eururo.2016.05.043.
   World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069.
   Zatonski WA, 2012, PUBLIC HEALTH, V126, P248, DOI 10.1016/j.puhe.2011.11.017.
   Zatonski W, 2013, ANN AGR ENV MED, V20, P405.
   Zatonski W, 2012, ANN AGR ENV MED, V19, P181.
   Zatoski W., 1993, POL POPUL REV, V3, P103.
   Zhou CK, 2016, INT J CANCER, V138, P1388, DOI 10.1002/ijc.29894.},
Number-of-Cited-References = {54},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {KC6VK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000507312700020},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:A1991ET13100012,
Author = {ROBINS, J and GREENLAND, S},
Title = {ESTIMABILITY AND ESTIMATION OF EXPECTED YEARS OF LIFE LOST DUE TO A
   HAZARDOUS EXPOSURE},
Journal = {STATISTICS IN MEDICINE},
Year = {1991},
Volume = {10},
Number = {1},
Pages = {79-93},
Month = {JAN},
Abstract = {Expected years of life lost is an important concept in public-health and
   legal issues.  We describe conditions under which the expected years of
   life lost due to hazardous exposure is estimable (identifiable) from
   epidemiologic data.  We show that, in general, the average years of life
   lost among exposed subjects dying at a given age (the age-specific
   expected years of life lost) is not identifiable, although the average
   years of life lost among all exposed subjects (the unconditional
   expected years of life lost) is identifiable from an unbiased
   epidemiologic study.  We also show that the average years of life lost
   among all exposed subjects dying of a specific cause (the cause-specific
   expected years of life lost) is not identifiable.  We discuss the
   implications of these results for compensation schemes based on years of
   life lost, and compare such schemes with those based on the probability
   of causation.},
Publisher = {JOHN WILEY \& SONS LTD},
Address = {BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD},
Type = {Article},
Language = {English},
Affiliation = {ROBINS, J (Corresponding Author), HARVARD UNIV,SCH PUBL HLTH,OCCUPAT HEALTH PROGRAM,665 HUNTINGTON AVE,BOSTON,MA 02115, USA.},
DOI = {10.1002/sim.4780100113},
ISSN = {0277-6715},
Research-Areas = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Research \& Experimental
   Medicine; Mathematics},
Web-of-Science-Categories  = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Medicine, Research \&
   Experimental; Statistics \& Probability},
Number-of-Cited-References = {0},
Times-Cited = {47},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Stat. Med.},
Doc-Delivery-Number = {ET131},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1991ET13100012},
DA = {2022-03-29},
}

@article{ WOS:000318751300011,
Author = {Liu, Pang-Hsiang and Wang, Jung-Der and Keating, Nancy L.},
Title = {Expected years of life lost for six potentially preventable cancers in
   the United States},
Journal = {PREVENTIVE MEDICINE},
Year = {2013},
Volume = {56},
Number = {5},
Pages = {309-313},
Month = {MAY},
Abstract = {Objective. This study aimed to quantify the reduced life expectancy for
   six types of potentially preventable cancer in the United States.
   Methods. A total of 1,579,310 patients diagnosed with cancers of the
   lung, colon and rectum, liver, breast, cervix, or prostate in 1992-2005
   were identified from the Surveillance, Epidemiology, and End Results
   registries. The lifetime survival functions for the cancer cohort and
   age-/sex-matched reference population were generated using a
   semiparametric extrapolation method with annual life tables. The average
   expected years of life lost (EYLL) for cancers were calculated by
   subtracting the estimated life expectancy of the cancer cohorts from
   that of the reference population.
   Results. Liver cancer and lung cancer had an average EYLL of over 13
   years, while the EYLL for prostate cancer was below 2 years. When
   considering the annual incidence in 2012, lung cancer would cause the
   greatest subtotal of EYLL (3,116,000 years) followed by female breast
   cancer (1,420,000 years) and colorectal cancer (932,000 years).
   Conclusion. The potential life years saved by successful prevention, in
   terms of EYLL since diagnosis, would be substantial for lung cancer,
   breast cancer, and colorectal cancer. This work will inform
   prioritization of strategies for cancer control to minimize the life
   expectancy loss. (C) 2013 Elsevier Inc. All rights reserved.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Keating, NL (Corresponding Author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.
   Liu, Pang-Hsiang; Keating, Nancy L., Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.
   Wang, Jung-Der, Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.
   Keating, Nancy L., Brigham \& Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA.},
DOI = {10.1016/j.ypmed.2013.02.003},
ISSN = {0091-7435},
EISSN = {1096-0260},
Keywords = {Cancer prevention; Resource allocation; Modeling; Survival; Burden of
   disease},
Keywords-Plus = {COMPETING-RISKS; SURVIVAL; TRENDS; EXTRAPOLATION; BURDEN; IMPACT},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {phliu@hcp.med.harvard.edu
   jdwang121@gmail.com
   keating@hcp.med.harvard.edu},
ResearcherID-Numbers = {Keating, Nancy L/I-9968-2019
   Liu, Pang-Hsiang/B-9903-2015},
ORCID-Numbers = {Keating, Nancy L/0000-0002-8274-4681
   Liu, Pang-Hsiang/0000-0001-8842-2264},
Funding-Acknowledgement = {National Science Council of TaiwanMinistry of Science and Technology,
   Taiwan {[}NSC98-2917-I-564-171]},
Funding-Text = {One of the authors (P.-H. Liu) was supported in part by the National
   Science Council of Taiwan (NSC98-2917-I-564-171). The funder did not
   have a role in the study design, in the collection, analysis and
   interpretation of data, in the writing of the report, or in the decision
   to submit the article for publication.},
Cited-References = {Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753.
   {[}Anonymous], 2012, CANC TRENDS PROGR RE.
   Arias Elizabeth, 2011, Natl Vital Stat Rep, V59, P1.
   Baliunas Dolly, 2007, Chronic Dis Can, V27, P154.
   Briganti A, 2013, EUR UROL, V63, P693, DOI 10.1016/j.eururo.2012.08.054.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x.
   Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760.
   Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141.
   Ho JJ, 2006, ACCIDENT ANAL PREV, V38, P961, DOI 10.1016/j.aap.2006.03.007.
   Horner M., 2009, SEER CANC STAT REV 1.
   Hwang JS, 2004, QUAL LIFE RES, V13, P1, DOI 10.1023/B:QURE.0000015299.45623.38.
   Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4.
   Kao TW, 2010, J NEPHROL, V23, P677.
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868.
   Kutikova L, 2005, LUNG CANCER, V50, P143, DOI 10.1016/j.lungcan.2005.06.005.
   Lee LJH, 2012, OCCUP ENVIRON MED, V69, P582, DOI 10.1136/oemed-2011-100462.
   METTLIN C, 1989, CA-CANCER J CLIN, V39, P33, DOI 10.3322/canjclin.39.1.33.
   Nelson CL, 2008, STAT MED, V27, P5525, DOI 10.1002/sim.3355.
   Nieburg HE, 2005, CANCER DETECT PREV, V29, P403, DOI 10.1016/j.cdp.2005.09.001.
   Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4.
   Pham TM, 2009, EUR J PUBLIC HEALTH, V19, P189, DOI 10.1093/eurpub/ckp020.
   ROBINS J, 1991, STAT MED, V10, P79, DOI 10.1002/sim.4780100113.
   Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102.
   Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954.
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138.
   Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103.
   Yabroff KR, 2008, J NATL CANCER I, V100, P1755, DOI 10.1093/jnci/djn383.},
Number-of-Cited-References = {28},
Times-Cited = {43},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {10},
Journal-ISO = {Prev. Med.},
Doc-Delivery-Number = {141UF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000318751300011},
DA = {2022-03-29},
}

@article{ WOS:000432467700093,
Author = {Li, Guoxing and Li, Yixue and Tian, Lin and Guo, Qun and Pan, Xiaochuan},
Title = {Future temperature-related years of life lost projections for
   cardiovascular disease in Tianjin, China},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2018},
Volume = {630},
Pages = {943-950},
Month = {JUL 15},
Abstract = {It is widely accepted that temperatures is associated with
   cardiovascular mortality, however, few studies have explored the effects
   of temperature on years of life lost (YLL) from cardiovascular mortality
   in China under future global warming scenarios. Therefore, there is an
   urgent need to obtain projections of YLL from cardiovascular diseases.
   Here we applied nineteen global-scale climate models (GCMs) and three
   Representative Concentration Pathway emission scenarios (RCPs) in the
   2050s and 2070s for temperature-related YLL projection in Tianjin,
   China. We found the relationships between daily maximum temperatures
   with YLL from cardiovascular mortality were basically U-shaped. We
   observed increasing net annual YLL across a range of multiple models
   under different climate scenarios, suggesting that increasing
   heat-related YLL from cardiovascular mortality could offset decreasing
   cold-related YLL from cardiovascular mortality. The largest
   temperature-related YLL from cardiovascular mortality were observed
   under the RCP8.5 scenario and increased more rapidly in the 20705 versus
   the 2050s, Monthly analyses of percent changes in YLL from
   cardiovascular mortality showed that the largest percent increases
   occurred from May to September. If warm adaptation occurs, only the
   adverse effects under RCP2.6 could be fully offset in both 2050 and
   2070. Our exploration provided further evidence for the potential health
   impacts of global warming and highlighted that government should develop
   environmental policies for future health risks. (C) 2018 Published by
   Elsevier B.V.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Pan, XC (Corresponding Author), Peking Univ, Sch Publ Hlth, Dept Occupat \& Environm Hlth Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
   Li, Guoxing; Li, Yixue; Tian, Lin; Guo, Qun; Pan, Xiaochuan, Peking Univ, Sch Publ Hlth, Dept Occupat \& Environm Hlth Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.},
DOI = {10.1016/j.scitotenv.2018.02.261},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Projection; Temperature; Years of life lost (YLL); Cardiovascular
   disease; Adaptation},
Keywords-Plus = {DIFFERENT CLIMATE-CHANGE; HEAT-WAVE; EXTREME TEMPERATURES; CAUSE
   MORTALITY; TIME-SERIES; DEATHS; BURDEN; IMPACT; ACCLIMATIZATION;
   POPULATION},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {xcpan@bjmu.edu.cn},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}81372950]},
Funding-Text = {This study is funded by the National Natural Science Foundation of China
   {[}grant numbers 81372950]. We also thank the China Centers for Disease
   Control and Prevention (CDC) for providing health data.},
Cited-References = {Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266.
   Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313.
   Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f.
   Aring;strom DO, 2016, ENVIRON HEALTH PERSP, V124, P740, DOI 10.1289/ehp.1509692.
   Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd.
   Baccini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069638.
   Ballester J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1360.
   Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006.
   Benmarhnia T, 2014, ENVIRON HEALTH PERSP, V122, P1293, DOI 10.1289/ehp.1306954.
   Cheng XS, 2010, EUR J INTERN MED, V21, P164, DOI 10.1016/j.ejim.2010.03.001.
   Christidis N, 2010, CLIMATIC CHANGE, V102, P539, DOI 10.1007/s10584-009-9774-0.
   Chung Y, 2017, AM J EPIDEMIOL, V185, P907, DOI 10.1093/aje/kww199.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005.
   Gosling SN, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP634.
   Guo YM, 2016, ENVIRON POLLUT, V208, P66, DOI 10.1016/j.envpol.2015.09.041.
   Guo YM, 2013, ENVIRON RES, V120, P55, DOI 10.1016/j.envres.2012.09.001.
   Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017.
   Halonen JI, 2011, ENVIRON RES, V111, P281, DOI 10.1016/j.envres.2010.12.001.
   Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Kendrovski V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070729.
   Kettaneh A, 2010, EUR J EPIDEMIOL, V25, P517, DOI 10.1007/s10654-010-9478-9.
   Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947.
   Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f.
   Li Jing, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P375, DOI 10.3760/cma.j.issn.0254-6450.2016.03.017.
   Li TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28161.
   Li TT, 2013, NAT CLIM CHANGE, V3, P717, DOI {[}10.1038/nclimate1902, 10.1038/NCLIMATE1902].
   Li YX, 2018, ENVIRON POLLUT, V233, P1068, DOI 10.1016/j.envpol.2017.10.008.
   Li Zhihao, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P720.
   {[}刘方 LIU Fang], 2005, {[}环境与健康杂志, Journal of Environment and Health], V22, P252.
   McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x.
   McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086.
   Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175.
   Orru H, 2017, INT J BIOMETEOROL, V61, P963, DOI 10.1007/s00484-016-1270-4.
   Pachauri R. K., 2014, IPCC CLIMATE CHANGE.
   Roldan E, 2016, STOCH ENV RES RISK A, V30, P831, DOI 10.1007/s00477-015-1068-7.
   Sanderson M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180369.
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   Tawatsupa B, 2014, INT J BIOMETEOROL, V58, P203, DOI 10.1007/s00484-012-0597-8.
   Thornes JE, 2014, EMERG MED J, V31, P220, DOI 10.1136/emermed-2012-201817.
   Varum CA, 2010, FUTURES, V42, P355, DOI 10.1016/j.futures.2009.11.021.
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1.
   Yang J, 2017, ENVIRON POLLUT, V224, P400, DOI 10.1016/j.envpol.2017.02.020.
   Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12250.
   Zeng N, 2008, SCIENCE, V319, P730, DOI 10.1126/science.1153368.
   Zhang BY, 2018, ENVIRON RES, V162, P152, DOI 10.1016/j.envres.2017.12.027.
   Zhou MG, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-60.},
Number-of-Cited-References = {50},
Times-Cited = {12},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {18},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {GG1SQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000432467700093},
DA = {2022-03-29},
}

@article{ WOS:000413190900010,
Author = {Luan, Guijie and Yin, Peng and Li, Tiantian and Wang, Lijun and Zhou,
   Maigeng},
Title = {The years of life lost on cardiovascular disease attributable to ambient
   temperature in China},
Journal = {SCIENTIFIC REPORTS},
Year = {2017},
Volume = {7},
Month = {OCT 19},
Abstract = {Few studies have examined the association between ambient temperature
   and years of life lost (YLL). We aim to explore the burden of
   cardiovascular disease attributed to non-optimum temperature in China.
   YLL provides a complementary measure for examining the burden of disease
   due to ambient temperature. Non-optimal temperature leads to the
   increase of YLL. The mortality of fourteen cities in China during
   2008-2013 was included in this study. We used the Distributed Lag
   Non-linear Model (DLNM) to estimate the association between daily mean
   temperature and YLL, controlling for long term trends, day of the week,
   seasonality and relative humidity. The daily YLL varied from 807 in
   Changchun to 2751 in Chengdu, with males higher than females. Extreme
   high and low temperatures were associated with higher YLL. The
   attributable fraction (AF) to cold effect is from 2.67 (95\% CI: -1.63,
   6.70) to 8.55 (95\% CI: 5.05, 11.90), while the AF to heat effect is
   from 0.16 (95\% CI: 0.06, 0.26) to 2.29 (95\% CI: 1.29, 3.19). Cold
   effect was significantly higher than heat effect on cardiovascular
   disease in both men and women and for different age groups.},
Publisher = {NATURE PORTFOLIO},
Address = {HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Zhou, MG (Corresponding Author), Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing, Peoples R China.
   Luan, Guijie, Shandong Ctr Dis Control \& Prevent, Jinan, Shandong, Peoples R China.
   Yin, Peng; Wang, Lijun; Zhou, Maigeng, Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing, Peoples R China.
   Li, Tiantian, Chinese Ctr Dis Control \& Prevent, Natl Inst Environm Hlth, Beijing, Peoples R China.},
DOI = {10.1038/s41598-017-13225-2},
Article-Number = {13531},
ISSN = {2045-2322},
Keywords-Plus = {ISCHEMIC-HEART-DISEASE; EXTREME TEMPERATURES; DAILY MORTALITY;
   AIR-POLLUTION; TIME-SERIES; COLD; IMPACT; WAVES; WEATHER; DEATHS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {maigengzhou@126.com},
ORCID-Numbers = {Luan, Guijie/0000-0001-8364-137X},
Cited-References = {Almeida SP, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-12.
   Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08.
   Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161.
   Aring;strom DO, 2016, ENVIRON HEALTH PERSP, V124, P740, DOI 10.1289/ehp.1509692.
   Baccini M., 2008, J EPIDEMIOL COMMUNIT, V65, P64.
   Bao JZ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3031-z.
   Barnett A. G., 2011, ENVIRON RES, V112, P218.
   Braga ALF, 2001, EPIDEMIOLOGY, V12, P662.
   Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859.
   Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394.
   Carmona R, 2016, ENVIRON INT, V91, P22, DOI 10.1016/j.envint.2016.02.018.
   Chen W., 2016, CHINA MED NEWS, V12, P11.
   Cheng YX, 2012, J EPIDEMIOL, V22, P28, DOI 10.2188/jea.JE20110049.
   Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009.
   Donaldson GC, 2003, INT J HYPERTHER, V19, P225, DOI 10.1080/0265673021000058357.
   Donev D, 2014, MEASURING BURDEN DIS.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253.
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55.
   Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518.
   Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598.
   Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a.
   Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704.
   Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2.
   Li YP, 2016, J AM COLL CARDIOL, V68, P818, DOI 10.1016/j.jacc.2016.06.011.
   Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148.
   Maessen MFH, 2016, MAYO CLIN PROC, V91, P745, DOI 10.1016/j.mayocp.2016.02.028.
   Montero JC, 2010, SCI TOTAL ENVIRON, V408, P5768, DOI 10.1016/j.scitotenv.2010.07.086.
   Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803.
   Pope CA, 2015, CIRC RES, V116, P108, DOI 10.1161/CIRCRESAHA.116.305060.
   Sun Zhongjie, 2010, Front Biosci (Elite Ed), V2, P495, DOI 10.2741/e108.
   Wang CC, 2014, SCI TOTAL ENVIRON, V466, P985, DOI 10.1016/j.scitotenv.2013.08.011.
   Wang LJ, 2007, J EPIDEMIOL COMMUN H, V61, P519, DOI 10.1136/jech.2005.043927.
   Yang J, 2015, HEART, V101, P1966, DOI 10.1136/heartjnl-2015-308062.
   Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12250.
   Yu WW, 2010, SCI TOTAL ENVIRON, V408, P3513, DOI 10.1016/j.scitotenv.2010.04.058.},
Number-of-Cited-References = {40},
Times-Cited = {25},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Sci Rep},
Doc-Delivery-Number = {FK0SR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000413190900010},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000232594600017,
Author = {Roosli, M and Kunzli, N and Braun-Fahrlander, C and Egger, M},
Title = {Years of life lost attributable to air pollution in Switzerland: dynamic
   exposure-response model},
Journal = {INTERNATIONAL JOURNAL OF EPIDEMIOLOGY},
Year = {2005},
Volume = {34},
Number = {5},
Pages = {1029-1035},
Month = {OCT},
Abstract = {Background There is debate on how the effect of air pollution should be
   assessed. We propose an approach to estimate its impact on adult and
   infant mortality that integrates data from long-term epidemiological
   studies and studies of interventions to reduce pollution. We use the
   method to estimate the number of years of life lost (YLLs) attributable
   to air pollution during 1 year in Switzerland.
   Methods A dynamic exposure-response model was implemented, which uses an
   exponential function (exp(-kt)) to model the change in mortality after
   cessation of air pollution. The model was populated with relative risk
   estimates and estimates of time constant k from the literature. Air
   pollution exposure in Switzerland was modelled using data from emission
   inventories. YLLs attributable to air pollution were calculated by
   taking the difference between observed survival probabilities in
   Switzerland in 2000 and modified survival probabilities, assuming no air
   pollution during the year 2000.
   Results Meta-analyses of three studies of adult mortality and five
   studies of infant mortality gave relative risks of 1.059 (95\%
   confidence interval (CI) 1.031-1.088) and 1.056 (95\% CI 1.026-1.088)
   per 10 mu g/m(3) increase in PM10 concentration. Time constants k
   derived from two studies of the effects of the closing down of a steel
   mill in the Utah Valley and of the coal ban in Dublin were 0.88 and
   0.11. Assuming a time constant k of 0.5 resulted in 42 400 (95\% CI 22
   600-63 600) YLLs, with 4.0\% being ascribed to infant deaths. A total of
   39\% of the effect occurred in the same year and 80\% within 5 years.
   The estimated number of YLLs was little affected by the choice of the
   time constant.
   Conclusions In contrast to traditional steady-state models the dynamic
   model allows changes in mortality following short-term increases or
   decreases in air pollution levels to be quantified. This type of
   information is of obvious interest to policy makers.},
Publisher = {OXFORD UNIV PRESS},
Address = {GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Roosli, M (Corresponding Author), Univ Bern, Dept Social \& Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.
   Univ Bern, Dept Social \& Prevent Med, CH-3012 Bern, Switzerland.
   Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA.
   Univ Basel, Inst Social \& Prevent Med, CH-4003 Basel, Switzerland.},
DOI = {10.1093/ije/dyi106},
ISSN = {0300-5771},
Keywords = {air pollution; impact assessment; cohort studies; meta-analysis; years
   of life lost},
Keywords-Plus = {PUBLIC-HEALTH IMPACT; LONG-TERM EXPOSURE; INFANT-MORTALITY;
   UNITED-STATES; PM10; INTERVENTION; METAANALYSIS; EXPECTANCY; SMOKING;
   OUTDOOR},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Roeoesli@ispm.unibe.ch},
ResearcherID-Numbers = {Kuenzli, Nino/F-7195-2014
   Röösli, Martin/A-2658-2008
   },
ORCID-Numbers = {Kuenzli, Nino/0000-0001-8360-080X
   Röösli, Martin/0000-0002-7475-1531
   Egger, Matthias/0000-0001-7462-5132},
Cited-References = {Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020.
   Bobak M, 1999, EPIDEMIOLOGY, V10, P666, DOI 10.1097/00001648-199911000-00004.
   Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5.
   Coyle D, 2003, J TOXICOL ENV HEAL A, V66, P1847, DOI 10.1080/15287390306447.
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2.
   Fellows JL, 2002, JAMA-J AM MED ASSOC, V287, P2355.
   FILLIGER P, 1999, HLTH COSTS DUE ROAD.
   Gehrig R, 2003, ATMOS ENVIRON, V37, P2571, DOI 10.1016/S1352-2310(03)00221-8.
   Ha EH, 2003, PEDIATRICS, V111, P284, DOI 10.1542/peds.111.2.284.
   Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6.
   HEI Accountability Working Group, 2003, ASS HLTH IMP AIR QUA.
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186.
   Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3.
   Kan HD, 2002, BIOMED ENVIRON SCI, V15, P209.
   Krewski D, 2000, REANALYSIS HARVARD 6.
   Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2.
   Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050.
   Leksell I, 2001, RISK ANAL, V21, P843, DOI 10.1111/0272-4332.215156.
   Lipfert FW, 2000, J AIR WASTE MANAGE, V50, P1350, DOI 10.1080/10473289.2000.10464168.
   Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006.
   Max W, 2004, TOB CONTROL, V13, P264, DOI 10.1136/tc.2003.006023.
   Miller BG, 2003, J EPIDEMIOL COMMUN H, V57, P200, DOI 10.1136/jech.57.3.200.
   Ostro B, 1994, 1301 WORLD BANK.
   POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351.
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132.
   Powe NA, 2004, J ENVIRON MANAGE, V70, P119, DOI 10.1016/j.jenvman.2003.11.003.
   Rabl A, 2003, J AIR WASTE MANAGE, V53, P41, DOI 10.1080/10473289.2003.10466118.
   Reshetin VP, 2004, ENVIRON MODEL ASSESS, V9, P43, DOI 10.1023/B:ENMO.0000020889.41526.66.
   Roemer WH, 2001, ENVIRON HEALTH PERSP, V109, P151, DOI 10.2307/3434768.
   SOMMER H, 2004, EXTERNAL COST DUE TR.
   SOMMER R, 1996, MONETARISIERUNG VERK.
   Woodruff TJ, 1997, ENVIRON HEALTH PERSP, V105, P608, DOI 10.1289/ehp.97105608.},
Number-of-Cited-References = {32},
Times-Cited = {26},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {14},
Journal-ISO = {Int. J. Epidemiol.},
Doc-Delivery-Number = {974MB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000232594600017},
OA = {Green Published, Bronze},
DA = {2022-03-29},
}

@article{ WOS:000450020400007,
Author = {Alva, Maria L. and Hoerger, Thomas J. and Zhang, Ping and Cheng, Yiling
   J.},
Title = {State-level diabetes-attributable mortality and years of life lost in
   the United States},
Journal = {ANNALS OF EPIDEMIOLOGY},
Year = {2018},
Volume = {28},
Number = {11},
Pages = {790-795},
Month = {NOV},
Abstract = {Purpose: To estimate state-level diabetes-attributable deaths and years
   of life lost (YLL) in the Unites States.
   Methods: We estimated diabetes-attributable all-cause and cardiovascular
   disease (CVD) deaths by age, sex, and state, using the attributable
   fraction approach. Data on diabetes prevalence were collected from
   Behavioral Risk Factor Surveillance System. Relative risks for people
   with and without diabetes were estimated using the National Health
   Interview Survey. State-sex-age-specific deaths were obtained from CDC
   WONDER. YLL were calculated by multiplying the number of people with
   diabetes by the difference in life expectancy between people with and
   without diabetes using the life table approach.
   Results: Nationally, estimated diabetes-attributable all-cause deaths
   and CVD deaths were 293,224 and 90,953, respectively. Diabetes resulted
   in a total of 109,707,000 YLL with an average 4.4 years of life lost per
   person with diabetes. Most state variation in total deaths was explained
   by state population size and diabetes prevalence. All-cause deaths
   ranged from 415 in Alaska to 28,538 in California, and CVD deaths ranged
   from 113 in Alaska to 8908 in California. Across all states, the average
   diabetes-attributable death rate per 100,000 was 125 for males and 105
   for females for all-cause deaths and 40 for males and 31 for females for
   CVD deaths.
   Conclusions: Mortality attributable to diabetes is greatly
   underestimated when looking only at diabetes listed as an underlying
   cause of death. These results can be used to track state differences in
   deaths due to diabetes and to monitor the success of public health
   activities. (C) 2018 Elsevier Inc. All rights reserved.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Alva, ML (Corresponding Author), IMPAQ Int, 1325 G St,NW Suite 900, Washington, DC 20005 USA.
   Alva, Maria L., IMPAQ Int, 1325 G St,NW Suite 900, Washington, DC 20005 USA.
   Hoerger, Thomas J., RTI Int, Res Triangle Pk, Durham, NC USA.
   Zhang, Ping; Cheng, Yiling J., Ctr Dis Control \& Prevent, Atlanta, GA USA.},
DOI = {10.1016/j.annepidem.2018.08.015},
ISSN = {1047-2797},
EISSN = {1873-2585},
Keywords = {Mortality; Diabetes; Years of life lost; CVD; Attributable fractions},
Keywords-Plus = {STYLE INTERVENTION; COST-EFFECTIVENESS; POPULATION},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {malva@impaqint.com},
ResearcherID-Numbers = {Alva, Maria/J-6080-2019
   },
ORCID-Numbers = {Alva, Maria/0000-0003-0989-2730
   Hoerger, Thomas/0000-0003-4154-7806},
Funding-Acknowledgement = {Centers for Disease Control and PreventionUnited States Department of
   Health \& Human ServicesCenters for Disease Control \& Prevention - USA
   {[}200-2013-M-53964B]},
Funding-Text = {This research was supported under contract number 200-2013-M-53964B from
   the Centers for Disease Control and Prevention.},
Cited-References = {Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1.
   Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295.
   Centers for Disease Control and Prevention (CDC), INSTR COMPL CAUS OF.
   Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET.
   FLEISS JL, 1979, AM J EPIDEMIOL, V110, P103, DOI 10.1093/oxfordjournals.aje.a112794.
   Geiss L, DIABETES AM.
   IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037.
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512.
   Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1.
   Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9.
   Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843.
   MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617.
   Pharoah PDP, 1996, BMJ-BRIT MED J, V312, P1443, DOI 10.1136/bmj.312.7044.1443.},
Number-of-Cited-References = {13},
Times-Cited = {7},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Ann. Epidemiol.},
Doc-Delivery-Number = {HA1XA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000450020400007},
DA = {2022-03-29},
}

@article{ WOS:000432549300011,
Author = {Paciej, Paulina and Dziankowska-Zaborszczyk, Elzbieta and Ciabiada,
   Beata and Bryla, Marek and Maniecka-Bryla, Irena},
Title = {Years of life lost due to bronchial asthma in Poland between 1999 and
   2013},
Journal = {JOURNAL OF ASTHMA},
Year = {2018},
Volume = {55},
Number = {6},
Pages = {668-674},
Abstract = {Objective: The aim of this study was to analyze the years of life lost
   due to asthma in Poland between 1999 and 2013, with the use of the SEYLL
   measure (Standard Expected Years of Life Lost). Methods: The study was
   based on a dataset of 5,606,516 records gathered from death certificates
   of Polish residents from 1999 to 2013. The data on the deaths due to
   bronchial asthma and status asthmaticus (J45 and J46 according to
   ICD-10) were used for the analysis. The SEYLL, SEYLLp (SEYLL per person)
   and SEYLLd (SEYLL per death) were implemented to assess lost life years,
   The analysis of time trends was performed with the use of the join point
   model. Results: In 1999-2013, asthma and status asthmaticus were the
   cause of 11,380 deaths of Poles (0.20\% of all deaths), resulting in
   4.23 prematurely lost life years per 10,000 males and 3.22 years per
   10,000 females. Over the analyzed years, the value of SEYLL decreased
   both for men and women, Every man who died due to bronchial asthma in
   Poland in the studied period, lost on average 19.12 years of life, and
   every woman 18.20 years. Conclusions: The analysis of SEYLL indicated
   that premature mortality due to asthma is still a meaningful problem in
   the Polish population and a constant challenge for public health
   activities.},
Publisher = {TAYLOR \& FRANCIS LTD},
Address = {2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Paciej, P (Corresponding Author), Uniwersytet Med Lodz, Zaklad Epidemiol \& Biostat, Zeligowskiego 7-9, PL-90742 Lodz, Poland.
   Paciej, Paulina; Dziankowska-Zaborszczyk, Elzbieta; Ciabiada, Beata; Maniecka-Bryla, Irena, Med Univ Lodz, Dept Epidemiol \& Biostat, Lodz, Poland.
   Bryla, Marek, Med Univ Lodz, Dept Social Med, Lodz, Poland.},
DOI = {10.1080/02770903.2017.1355382},
ISSN = {0277-0903},
EISSN = {1532-4303},
Keywords = {Bronchial asthma; diseases of the respiratory system; lost life years
   premature mortality; Poland; potential measures; SEYLL},
Keywords-Plus = {PREMATURE MORTALITY; NATURAL-HISTORY; BURDEN; PREVALENCE; DISABILITY;
   DISEASES},
Research-Areas = {Allergy; Respiratory System},
Web-of-Science-Categories  = {Allergy; Respiratory System},
Author-Email = {paulina.paciej@stud.umed.lodz.pl},
ResearcherID-Numbers = {Ciabiada-Bryła, Beata/S-9641-2016
   Bryla, Marek/AAW-5787-2021
   Maniecka-Bryla, Irena/AAW-5779-2021
   Ciabiada-Bryła, Beata/AAL-6309-2021
   },
ORCID-Numbers = {Ciabiada-Bryła, Beata/0000-0003-0744-1610
   Bryla, Marek/0000-0001-6757-9211
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Ciabiada-Bryła, Beata/0000-0003-0744-1610
   Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606
   Paciej-Golebiowska, Paulina/0000-0002-4494-9299},
Cited-References = {{[}Anonymous], 2015, JOINP REGR PROGR VER.
   {[}Anonymous], 2016, GLOBAL INITIATIVE AS.
   {[}Anonymous], 2017, EST APC.
   Bisgaard H, 2010, J ALLERGY CLIN IMMUN, V126, P187, DOI 10.1016/j.jaci.2010.07.011.
   Bochenek G, 1998, PRINCIPLES MANAGEMEN.
   Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548.
   Breborowicz A, 2007, ALERG ASTMA IMMUNOL, V12, P129.
   Central Statistical Office of Poland, 2017, LOC DAT BANK.
   Dmochowska H, 2015, STAT YB REPUBLIC POL.
   Doniec Z, 2016, FAM MED PRIM CARE RE, V18, P181, DOI 10.5114/fmpcr/63211.
   Genova-Maleras R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-787.
   Hansell A, 2003, EUR RESPIR J, V21, P279, DOI 10.1183/09031936.03.00006102.
   Hitchman SC, 2011, B WORLD HEALTH ORGAN, V89, P195, DOI 10.2471/BLT.10.079905.
   Liebhart J, 2007, J INVEST ALLERG CLIN, V17, P367.
   Maniecka-Bryla I, ADV CLIN EXP MED.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020.
   Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   Paciej Paulina, 2016, Przegl Epidemiol, V70, P500.
   Penner D, 2010, J PUBLIC HEALTH-HEID, V18, P319, DOI 10.1007/s10389-010-0322-1.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Plass D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-863.
   Rodrigo Gustavo Javier, 2008, J. bras. pneumol., V34, P546, DOI 10.1590/S1806-37132008000800002.
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143.
   Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612.
   The International Study of Asthma and Allergies in Childhood, 2012, INT STUDY ASTHMA ALL.
   Vos T, 2016, LANCET, V388, P1545, DOI {[}10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1].
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   Watson L, 2007, RESP MED, V101, P1659, DOI 10.1016/j.rmed.2007.03.006.
   World Health Organization, WORLD HLTH STAT REP.
   World Health Organization, 2015, WHO REP GLOB TOB EP.
   World Health Organization, 2016, EUR HLTH ALL DAT.
   World Health Organization (WHO), 2012, WORLD HLTH SURV 2002.},
Number-of-Cited-References = {39},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Asthma},
Doc-Delivery-Number = {GG2UV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000432549300011},
DA = {2022-03-29},
}

@article{ WOS:000386784600010,
Author = {Jiang, Yongwen and Ranney, Megan L. and Perez, Beatriz and Viner-Brown,
   Samara},
Title = {Burden of Violent Death on Years of Life Lost in Rhode Island, 2006-2013},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {2016},
Volume = {51},
Number = {5, 3},
Pages = {S251-S259},
Month = {NOV},
Abstract = {Introduction: Mortality from injuries, particularly violent injuries, is
   more common among the young. Although traditional epidemiologic measures
   describe burden of death using rate-related mortalities, this method may
   not accurately represent burden of premature death. Years of life lost
   (YLLs) incorporate time discounting and age weighting to more accurately
   estimate the burden of death. To the authors' knowledge, there has been
   no examination of YLLs using the Rhode Island Violent Death Reporting
   System data. This study's objective was to assess the burden of violent
   death in Rhode Island in terms of YLLs.
   Methods: This study used 2006-2013 Rhode Island Violent Death Reporting
   System data. YLLs as a result of premature violent deaths were assessed
   overall and by age, sex, race/ethnicity, and manner of death. Data were
   analyzed in 2015.
   Results: Suicide made the largest contribution to the overall YLLs
   (61.3\%), followed by homicide (24.0\%), whereas undetermined intent
   deaths captured by the system accounted for 14.8\% of YLLs. In Rhode
   Island, people aged 25-44 years had the highest YLLs due to suicide, and
   Hispanics had the highest YLLs due to homicide/legal intervention. By
   comparison, using crude mortality rate calculations, people aged 45-64
   years had the highest suicide mortality rate and non-Hispanic blacks had
   the highest homicide mortality rate.
   Conclusions: YLL calculations provide a different picture than crude
   mortality-based assessments of the population at highest risk for
   violent death. This study demonstrates the strengths of using YLL to
   assess the burden of violent death at the state level. Published by
   Elsevier Inc. on behalf of American Journal of Preventive Medicine.},
Publisher = {ELSEVIER SCIENCE INC},
Address = {360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA},
Type = {Article},
Language = {English},
Affiliation = {Jiang, YW (Corresponding Author), Rhode Isl Dept Hlth, Ctr Hlth Data \& Anal, 3 Capitol Hill, Providence, RI 02908 USA.
   Jiang, Yongwen; Viner-Brown, Samara, Rhode Isl Dept Hlth, Ctr Hlth Data \& Anal, 3 Capitol Hill, Providence, RI 02908 USA.
   Jiang, Yongwen, Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA.
   Ranney, Megan L., Rhode Isl Hosp, Injury Prevent Ctr, Providence, RI USA.
   Ranney, Megan L., Brown Univ, Alpert Sch Med, Dept Emergency Med, Emergency Digital Hlth Innovat Program, Providence, RI 02912 USA.
   Ranney, Megan L., Brown Univ, Alpert Sch Med, Dept Hlth Serv Policy \& Practice, Providence, RI 02912 USA.
   Perez, Beatriz, Rhode Isl Dept Hlth, Ctr Hlth Promot, Violence \& Injury Prevent Program, Providence, RI 02908 USA.},
DOI = {10.1016/j.amepre.2016.08.004},
ISSN = {0749-3797},
EISSN = {1873-2607},
Keywords-Plus = {REPORTING SYSTEM; 16 STATES; MORTALITY; SUICIDE; DISEASE; SURVEILLANCE;
   INJURY},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {yongwen.jiang@health.ri.gov},
Funding-Acknowledgement = {Centers for Disease Control and PreventionUnited States Department of
   Health \& Human ServicesCenters for Disease Control \& Prevention - USA
   {[}1U17CE002615-01]; NATIONAL CENTER FOR INJURY PREVENTION AND
   CONTROLUnited States Department of Health \& Human ServicesCenters for
   Disease Control \& Prevention - USA {[}U17CE002615] Funding Source: NIH
   RePORTER},
Funding-Text = {Publication of this article was supported by the Centers for Disease
   Control and Prevention. The findings and conclusions in this article are
   those of the author(s) and do not necessarily represent the official
   position of the Centers for Disease Control and Prevention.; The IRB
   number for this study is IRB 2014-07-{''}Rhode Island Violent Death
   Reporting System (RIVDRS).{''} This brief was funded by a Centers for
   Disease Control and Prevention grant (1U17CE002615-01 Revised) awarded
   to the Rhode Island Department of Health, Office of State Medical
   Examiners. The authors would like to thank the Office of Vital Records,
   the Office of State Medical Examiners, the Rhode Island State Police and
   local law enforcement agencies, and the crime laboratory who provided
   data in a timely manner and without whom RIVDRS would be non-existent.
   The authors would like to express the special thanks to data abstractors
   Karen Foss and Shannon Young who spend hours compiling the data and
   constructing sound narratives to make Rhode Island's program one of the
   best. Without their daily efforts throughout the years, the data and
   reports would not be as accurate or complete. The authors gratefully
   appreciate Edward F. Donnelly, the previous RIVDRS epidemiologist, Rhode
   Island Department of Health, for his generous help. The authors thank
   the staff of the Division of Violence Prevention, National Center for
   Injury Prevention and Control, Centers for Disease Control and
   Prevention for reviewing and commenting on the final draft.},
Cited-References = {Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021.
   Center for Disease Control and Prevention (CDC), 2015, NAT VIOL DEATH REP S.
   Dahlberg Linda L, 2009, Virtual Mentor, V11, P167, DOI 10.1001/virtualmentor.2009.11.2.mhst1-0902.
   Fekadu A, 2015, BRIT J PSYCHIAT, V206, P289, DOI 10.1192/bjp.bp.114.149112.
   Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033.
   Injury Prevention and Control: Data and Statistics (WISQARSTM), 2015, YEARS POTENTIAL LIFE.
   Jiang YW, 2012, PUBLIC HEALTH REP, V127, P293, DOI 10.1177/003335491212700309.
   Karch Debra L., 2011, Morbidity and Mortality Weekly Report, V60, P1.
   Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5.
   Law CK, 2010, ARCH SUICIDE RES, V14, P284, DOI 10.1080/13811118.2010.494148.
   Lim JY, 2016, J SOC WORK PRACT ADD, V16, P72, DOI 10.1080/1533256X.2016.1162166.
   Lukaschek K, 2012, INT J ENV RES PUB HE, V9, P924, DOI 10.3390/ijerph9030924.
   McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO, V10.
   National Center for Health Statistics, 2016, NVSR, V65.
   National Center for Injury Prevention and Control, 2015, NAT VIOL DEATH REP S, P194.
   Parker RN, 2004, J PSYCHOACTIVE DRUGS, P157.
   Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1.
   Paulozzi LJ, 2004, INJURY PREV, V10, P47, DOI 10.1136/ip.2003.003434.
   Webster DW, 2013, J URBAN HEALTH, V90, P27, DOI 10.1007/s11524-012-9731-5.
   Wyoming Department of Health, 2014, PREV SUIC WYOM 2014.
   Yip PSF, 2008, CRISIS, V29, P131, DOI 10.1027/0227-5910.29.3.131.
   Yip PSF, 2005, CRISIS, V26, P156, DOI 10.1027/0227-5910.26.4.156.},
Number-of-Cited-References = {24},
Times-Cited = {1},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {Am. J. Prev. Med.},
Doc-Delivery-Number = {EA7CB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000386784600010},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000430802400010,
Author = {Buchanich, Jeanine M. and Doerfler, Shannon M. and Lann, Michael F. and
   Marsh, Gary M. and Burke, Donald S.},
Title = {Improvement in racial disparities in years of life lost in the USA since
   1990},
Journal = {PLOS ONE},
Year = {2018},
Volume = {13},
Number = {4},
Month = {APR 25},
Abstract = {Objective
   To examine changes in cause-specific Years of Life Lost (YLL) by age,
   race, and sex group in the USA from 1990 to 2014.
   Methods
   60 million death reports from the National Center for Health Statistics
   (NCHS) were categorized by age group, sex, race, and cause of death. YLL
   were calculated using age-specific life expectancies. Age groups were:
   infants < 1, children 1-19, adults 20-64, and older adults 65+.
   Results
   Blacks have historically experienced more years of life lost than whites
   or other racial groups in the USA. In the year 1990 the YLL per 100,000
   population was 21,103 for blacks, 14,160 for whites, and 7,417 for
   others. Between 1990 and 2014 overall YLL in the USA improved by 10\%,
   but with marked variations in the rate of change across age, race, and
   sex groups. Blacks (all ages, both sexes) showed substantial improvement
   with a 28\% reduction in YLL, compared to whites (all ages, both sexes)
   who showed a 4\% reduction. Among blacks, improvements were seen in all
   age groups: reductions of 43\%, 48\%, 28\%, and 25\% among infants,
   children, adults, and older adults, respectively. Among whites,
   reductions of 33\%, 44\%, and 18\% were seen in infants, children, and
   older adults, but there was a 6\% increase in YLL among white adults.
   YLL increased by 18\% in white adult females and declined 1\% in white
   adult males. American Indian/Alaska Native women also had worsening in
   YLL, with an 8\% increase. Asian Pacific Islanders consistently had the
   lowest YLL across all ages. Whites had a higher proportion of YLL due to
   overdose; blacks had a higher proportion due to homicide at younger ages
   and to heart disease at older ages.
   Conclusions
   Race-based disparities in YLL in the USA since 1990 have narrowed
   considerably, largely as a result of improvements among blacks compared
   to whites. Adult white and American Indian / Alaskan Native females have
   experienced worsening YLL, while white males have experienced
   essentially no change. If recent trajectories continue, adult
   black/white disparities in YLL will continue to narrow.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Buchanich, JM (Corresponding Author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.
   Buchanich, Jeanine M.; Doerfler, Shannon M.; Lann, Michael F.; Marsh, Gary M., Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.
   Burke, Donald S., Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   Doerfler, Shannon M., Duke Univ, Duke Clin Res Inst, Durham, NC USA.},
DOI = {10.1371/journal.pone.0194308},
Article-Number = {e0194308},
ISSN = {1932-6203},
Keywords-Plus = {UNITED-STATES; RACIAL/ETHNIC DISPARITIES; HEALTH DISPARITIES; MORTALITY;
   TRENDS; DEATH; EXPECTANCY; RACE; ASSOCIATION; ETHNICITY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {Jeanine@pitt.edu},
ORCID-Numbers = {Woolley, Shannon/0000-0001-8616-7255},
Funding-Acknowledgement = {Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF);
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health \& Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) {[}U54GM088491]
   Funding Source: NIH RePORTER},
Funding-Text = {This work was sponsored in part by the Robert Wood Johnson Foundation.
   There was no additional external funding received for this study. The
   sponsors had no role in the design, conduct, analysis, interpretation of
   the data, or preparation of the manuscript.; The authors declare no
   conflicts of interest. This work was sponsored in part by the Robert
   Wood Johnson Foundation. There was no additional external funding
   received for this study. The sponsors had no role in the design,
   conduct, analysis, interpretation of the data, or preparation of the
   manuscript.},
Cited-References = {Acciai F, 2015, J EPIDEMIOLOGY COMMU.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Beckles GL, 2013, MMWR-MORBID MORTAL W, V62, P9.
   Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293.
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Cohen, 2004, CRITICAL PERSPECTIVE.
   Dranger E, 2004, WISCONSIN PUBLIC HLT, V5.
   Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066.
   HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P259, DOI 10.1001/jama.267.2.259.
   Institute for Health Metrics and Evaluation (IHME), 2014, GLOB BURD DIS STUD 2.
   Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255.
   Johns LE, 2013, AM J PUBLIC HEALTH, V103, P733, DOI 10.2105/AJPH.2012.300683.
   Kitagawa Evelyn M., 1973, DIFFERENTIAL MORTALI.
   KOCHANEK KD, 1994, AM J PUBLIC HEALTH, V84, P938, DOI 10.2105/AJPH.84.6.938.
   Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319.
   Marsh GM, 1998, J OCCUP ENVIRON MED, V40, P351, DOI 10.1097/00043764-199804000-00010.
   McDonnell S, 1998, PUBLIC HEALTH REP, V113, P55.
   Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350.
   Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P3.
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805.
   Noymer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015812.
   Shiels MS, 2017, LANCET, V389, P1043, DOI {[}10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3].
   Statistics NCfH, 2016, Q PROV EST SEL CAUS.
   Thorpe RJ, 2013, AM J MENS HEALTH, V7, P220, DOI 10.1177/1557988312466910.
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4.
   Woghiren-Akinnifesi EL, 2013, CDC HLTH DISPARITIES, V62, P46.
   Zuvekas SH, 2003, HEALTH AFFAIR, V22, P139, DOI 10.1377/hlthaff.22.2.139.},
Number-of-Cited-References = {28},
Times-Cited = {4},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {5},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {GD8ZI},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000430802400010},
OA = {Green Submitted, gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000308863600004,
Author = {Rizzuto, Debora and Bellocco, Rino and Kivipelto, Miia and Clerici,
   Francesca and Wimo, Anders and Fratiglioni, Laura},
Title = {Dementia After Age 75: Survival in Different Severity Stages and Years
   of Life Lost},
Journal = {CURRENT ALZHEIMER RESEARCH},
Year = {2012},
Volume = {9},
Number = {7},
Pages = {795-800},
Month = {SEP},
Abstract = {Dementia is a known predictor of mortality, but little is known about
   disease duration. We therefore aimed to investigate the impact of
   dementia on survival by estimating years lived with the disease, in
   total and in different severity stages, and by comparing dementia to
   other major chronic disorders such as cancer and cardiovascular disease
   (CVD). During a 7.4-year follow-up of the Kungsholmen project, 371
   incident dementia cases of the 1,307 dementia-free persons, aged 75+ at
   baseline, were clinically diagnosed (DSM-III-R criteria). Diagnoses of
   cancer and CVD were obtained from the national Stockholm Inpatient
   Registry System, active since 1969. Disease duration, hazard ratio (HR),
   and potential years of life lost (PYLL) were derived from Kaplan-Meier
   survival estimation, the Cox model, and standard life-table analysis,
   respectively. Dementia was a significant predictor of mortality (HR=1.7;
   95\% CI: 1.47-1.92) after adjustment for several covariates including
   comorbidity, accounting for 16\% of all deaths. The mean (+/- SD)
   survival time after dementia diagnosis was 4.1 (+/- 2.6) years, and more
   than 2 years were spent in moderate (14-month) and severe (12-month)
   stages. Women with dementia lived longer than men, as they survived
   longer in the severe stage (2.1 vs. 0.5 years among 75-84-year-old women
   compared to coetaneous men). The PYLL were 3.4 for dementia, 3.6 for
   CVD, and 4.4 for cancer. We found a similar impact of dementia and CVD
   on survival, but following diagnosis, persons with dementia, and
   especially women, spent half of their remaining lives in the severe
   disabling stages of the disease.},
Publisher = {BENTHAM SCIENCE PUBL LTD},
Address = {EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES},
Type = {Article},
Language = {English},
Affiliation = {Rizzuto, D (Corresponding Author), Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci \& Soc, Gavlegatan 16, S-11330 Stockholm, Sweden.
   Rizzuto, Debora; Kivipelto, Miia; Wimo, Anders; Fratiglioni, Laura, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci \& Soc, S-11330 Stockholm, Sweden.
   Rizzuto, Debora; Kivipelto, Miia; Wimo, Anders; Fratiglioni, Laura, Stockholm Univ, S-10691 Stockholm, Sweden.
   Bellocco, Rino, Karolinska Inst, Dept Med Epidemiol \& Biostat, S-11330 Stockholm, Sweden.
   Bellocco, Rino, Univ Milano Bicocca, Dept Stat, Milan, Italy.
   Kivipelto, Miia, Univ Kuopio, Dept Neurosci \& Neurol, FIN-70211 Kuopio, Finland.
   Clerici, Francesca, Univ Milan, Inst Clin Neurol, Ctr Res \& Treatment Cognit Dysfunct, L Sacco Hosp, I-20122 Milan, Italy.
   Wimo, Anders, Karolinska Inst, KI Alzheimer Dis Res Ctr, Dept Neurobiol Hlth Care Sci \& Soc, S-11330 Stockholm, Sweden.
   Fratiglioni, Laura, Stockholm Gerontol Res Ctr, Stockholm, Sweden.},
DOI = {10.2174/156720512802455421},
ISSN = {1567-2050},
EISSN = {1875-5828},
Keywords = {Cancer; cardiovascular diseases; mortality; dementia; survival; PYLL},
Keywords-Plus = {CLINICALLY DIAGNOSED DEMENTIA; ALZHEIMERS-DISEASE; POPULATION SURVEY;
   MORTALITY; PREVALENCE; RISK},
Research-Areas = {Neurosciences \& Neurology},
Web-of-Science-Categories  = {Clinical Neurology; Neurosciences},
Author-Email = {debora.rizzuto@ki.se},
ResearcherID-Numbers = {Rizzuto, Debora/X-7065-2019
   Kivipelto, Miia/AAS-3557-2021
   Wimo, Anders/ABA-2678-2021
   Bellocco, Rino/E-7674-2018
   Rizzuto, Debora/V-1890-2018
   },
ORCID-Numbers = {Rizzuto, Debora/0000-0001-6199-9629
   Wimo, Anders/0000-0003-0963-5750
   Kivipelto, Miia/0000-0003-0992-3875},
Funding-Acknowledgement = {Swedish Council for Working Life and Social ResearchSwedish Research
   CouncilSwedish Research Council for Health Working Life \& Welfare
   (Forte); Swedish Brain Power; Solstickan Foundation; Karolinska
   Institutet's FacultyKarolinska Institutet; Novo Nordisk FondenNovo
   Nordisk Foundation {[}NNF11OC1014884, NNF12OC1016402] Funding Source:
   researchfish},
Funding-Text = {The authors would like to express their gratitude to members of the
   Kungsholmen Project study group for the data collection. The project was
   supported by Swedish Council for Working Life and Social Research, the
   Swedish Brain Power, Solstickan Foundation, and Karolinska Institutet's
   Faculty funding for postgraduate students.},
Cited-References = {Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452.
   Aguero-Torres H, 1999, J CLIN EPIDEMIOL, V52, P737, DOI 10.1016/S0895-4356(99)00067-0.
   Aguero-Torres H, 2002, ALZ DIS ASSOC DIS, V16, P221, DOI 10.1097/00002093-200210000-00003.
   ARONSON MK, 1991, ARCH INTERN MED, V151, P989, DOI 10.1001/archinte.151.5.989.
   Borjesson-Hanson A, 2007, NEUROLOGY, V69, P2069, DOI 10.1212/01.wnl.0000280464.59322.af.
   Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764.
   Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5.
   Conover W.J., 1999, PRACTICAL NONPARAMET, V3rd ed..
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0.
   Fitzpatrick AL, 2005, J NEUROL SCI, V229, P43, DOI 10.1016/j.jns.2004.11.022.
   FORSELL Y, 1992, ACTA PSYCHIAT SCAND, V86, P49, DOI 10.1111/j.1600-0447.1992.tb03225.x.
   Fratiglioni L, 2000, NEUROLOGY, V54, pS10.
   Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132.
   FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958.
   Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779.
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515.
   Guhne U, 2006, DEMENT GERIATR COGN, V22, P185, DOI 10.1159/000094786.
   Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642.
   KATZMAN R, 1994, ARCH NEUROL-CHICAGO, V51, P1220, DOI 10.1001/archneur.1994.00540240064017.
   Kinnunen PJ, 2010, NEUROLOGY, V75, P1215, DOI 10.1212/WNL.0b013e3181f001fb.
   Kinnunen PJ, NEUROLOGY, V75.
   Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P85, DOI 10.1001/archneur.60.1.85.
   Llinas-Regla J, 2008, NEUROEPIDEMIOLOGY, V31, P80, DOI 10.1159/000144088.
   Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137.
   Murray C.J.L., 1996, GLOBAL BURDEN DIS CO.
   Qiu C, J ALZHEIMERS DIS, V20, P293.
   Qiu CX, 2001, ARCH NEUROL-CHICAGO, V58, P2034, DOI 10.1001/archneur.58.12.2034.
   Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3.
   Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I.
   Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002.
   Wimo A., 2010, WORLD ALZHEIMER REPO.
   Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25.},
Number-of-Cited-References = {32},
Times-Cited = {26},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {8},
Journal-ISO = {Curr. Alzheimer Res.},
Doc-Delivery-Number = {007BK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000308863600004},
DA = {2022-03-29},
}

@article{ WOS:000473807000003,
Author = {Aghaali, Mohammad and Mirtorabi, Seyed Davood and Ghadirzadeh, Mohammad
   Reza and Hashemi-Nazari, Seyed Saeed},
Title = {Mortality and Years of Life Lost Due to Occupational Injury in Iran
   (2012-2016)},
Journal = {JOURNAL OF RESEARCH IN HEALTH SCIENCES},
Year = {2019},
Volume = {19},
Number = {2},
Month = {SPR},
Abstract = {Background: Occupational injury is a cause of premature mortality,
   mainly in low- and middle-income countries. Occupational injuries
   estimated to kill more than 300,000 workers worldwide every year. We
   estimated the years of life lost (YLL) of fatal unintentional
   occupational injuries in Iran for the five years of 2012-2016.
   Study design: A cross-sectional study.
   Methods: To estimate the YLL, registered deaths due to occupational
   unintentional injury were identified from the Iranian Legal Medicine
   Organization. Estimated YLL was calculated according to Global Burden of
   Disease 2010 guideline. Population life expectancy in each corresponding
   years was retrieved from the national health database. All data
   collected entered into Excel software for calculations.
   Results: In 2012-2016, fatal unintentional occupational injuries were
   the cause of 8,606 deaths in Iran, resulting in 4.6 prematurely lost
   life yr per 1000 males and 0.3 yr per 1000 females among workers, every
   year. 98.7\% of the deaths occurred in males. Males from 15 to 19 yr of
   age and females from 10 to 14 yr of age showed the highest YLL rates.
   The rate of YLLs per 1,000 workers per year was 3.99 overall, 4.6 in
   males, and 0.4 in females.
   Conclusion: Premature mortality due to occupational injury is still a
   serious problem in the Iranian population. Our findings may be useful
   from a health policy perspective for designing and prioritizing
   interventions focused on the prevention of premature loss of life. Known
   prevention strategies need to be implemented widely to diminish
   avoidable injuries in the workplace.},
Publisher = {HAMADAN UNIV MEDICAL SCIENCES},
Address = {PO BOX 65175 HAMEDAN, ISLAMIC, 4171, IRAN},
Type = {Article},
Language = {English},
Affiliation = {Hashemi-Nazari, SS (Corresponding Author), Shahid Beheshti Univ Med Sci, Safety Promot \& Injury Prevent Res Ctr, Dept Epidemiol, Sch Publ Hlth \& Safety, Tehran, Iran.
   Aghaali, Mohammad, Qom Univ Med Sci, Sch Med, Dept Epidemiol, Qom, Iran.
   Mirtorabi, Seyed Davood, Univ Tehran Med Sci, Sch Adv Technol Med, Dept Addict Studies, Tehran, Iran.
   Ghadirzadeh, Mohammad Reza, Legal Med Org, Legal Med Res Ctr, Tehran, Iran.
   Aghaali, Mohammad; Hashemi-Nazari, Seyed Saeed, Shahid Beheshti Univ Med Sci, Safety Promot \& Injury Prevent Res Ctr, Dept Epidemiol, Sch Publ Hlth \& Safety, Tehran, Iran.},
Article-Number = {e00444},
ISSN = {2228-7795},
EISSN = {2228-7809},
Keywords = {Occupational injuries; Occupational health; Accidents; Occupational;
   Iran},
Keywords-Plus = {WORK; ACCIDENTS; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {saeedh\_1999@yahoo.com},
ResearcherID-Numbers = {Aghaali, Mohammad/M-2225-2015},
ORCID-Numbers = {Aghaali, Mohammad/0000-0003-3417-1580},
Funding-Acknowledgement = {Legal Medicine Organization},
Funding-Text = {Legal Medicine Organization supported the study financially.},
Cited-References = {Alizadeh SS, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.18976.
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P317.
   Concha-Barrientos M, 2005, AM J IND MED, V48, P470, DOI 10.1002/ajim.20226.
   Dror DM, 2001, B WORLD HEALTH ORGAN, V79, P672.
   Ergor OA, 2003, J OCCUP HEALTH, V45, P74, DOI 10.1539/joh.45.74.
   Hamalainen P, 2009, SAFETY SCI, V47, P733, DOI 10.1016/j.ssci.2008.01.011.
   Kang SK, 2011, SAF HEALTH WORK, V2, P52, DOI 10.5491/SHAW.2011.2.1.52.
   Karimlou M, 2015, INT J OCCUP ENV HEAL, V21, P279, DOI 10.1179/2049396714Y.0000000108.
   Mandryk J., 2001, J OCCUP HEALTH, V17, P45.
   Marsh SM, 2013, MMWR-MORBID MORTAL W, V62, P41.
   Mehrdad R, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10359.
   Rabi AZ, 1998, SAFETY SCI, V28, P177, DOI 10.1016/S0925-7535(98)80007-6.
   Rivara FR, 2003, EPIDEMIOL REV, V25, P20, DOI 10.1093/epirev/mxg009.
   Rushton Lesley, 2017, Curr Environ Health Rep, V4, P340, DOI 10.1007/s40572-017-0151-2.
   Shouroki FK, 2018, J RES HEALTH SCI, V18.
   Statistical Center of Iran, 2013, YB IR STAT.
   Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131.
   Vahabi N, 2017, ARCH IRAN MED, V20, P302, DOI 0172005/AIM.008.
   Wu Y, 2018, INT J ENV RES PUBLIC, V15.},
Number-of-Cited-References = {19},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Res. Health Sci.},
Doc-Delivery-Number = {IG4XK},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000473807000003},
DA = {2022-03-29},
}

@article{ WOS:000258124200001,
Author = {Richmond, Therese S. and Lemaire, Jean},
Title = {Years of life lost because of gunshot injury to the brain and spinal
   cord},
Journal = {AMERICAN JOURNAL OF PHYSICAL MEDICINE \& REHABILITATION},
Year = {2008},
Volume = {87},
Number = {8},
Pages = {609-615},
Month = {AUG},
Abstract = {Objective: A recent study (Lemaire) estimated the life expectancy loss
   attributable to gun deaths at 103.6 days for the overall U.S.
   population: 150.7 days for white males and 361.5 days for black males.
   This study estimates the life expectancy loss attributable to the
   premature death of individuals who initially survived gun-related
   traumatic brain injury (TBI) and spinal cord injury (SCI) in the United
   States.
   Design: Interpersonal TBI data were drawn from a surveillance system,
   and self-inflicted TBI data were obtained from the Web-based Injury
   Statistics and Reporting System. SCI data were obtained from a national
   database. Multiple decrement analysis was used to calculate the days of
   life lost to gunshot wounds to the brain and spinal cord, by race and
   gender, in the United States.
   Results: On average, across age, gender, and race, life expectancy in
   the United States is reduced by 3.1 days because of the shorter lifespan
   for individuals who survive an initial gunshot wound to the brain or
   spinal cord. Black males bear a disproportionate burden, losing 9.5
   days, whereas white males lose 4.6 days. Black and white females lose
   1.5 and 1.0 days, respectively.
   Conclusions: We add these findings to the Lemaire study, resulting in a
   total of 106.7 days of life expectancy loss from gunshot wounds for the
   U.S. population, with 37 1.0 days of life lost for black males.},
Publisher = {LIPPINCOTT WILLIAMS \& WILKINS},
Address = {530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA},
Type = {Article},
Language = {English},
Affiliation = {Richmond, TS (Corresponding Author), Univ Penn, Sch Nursing, Fagin Hall,418 Curie Blvd, Philadelphia, PA 19104 USA.
   Richmond, Therese S., Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.
   Richmond, Therese S., Univ Penn, Firearm \& Injury Ctr Penn, Philadelphia, PA 19104 USA.
   Lemaire, Jean, Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA.},
DOI = {10.1097/PHM.0b013e31817fb496},
ISSN = {0894-9115},
Keywords = {life expectancy; brain injuries; spinal cord injuries; wounds; gunshot},
Keywords-Plus = {MORTALITY; SUICIDE; BURDEN; DEATH; FIREARMS; HEALTH; TRENDS; STATES},
Research-Areas = {Rehabilitation; Sport Sciences},
Web-of-Science-Categories  = {Rehabilitation; Sport Sciences},
Cited-References = {Bowers N. L., 1997, ACTUARIAL MATH, V2nd.
   {*}CDC, 2002, HLTH EXP PERC GROSS.
   {*}CENTR INT AG, 2006, FACTB.
   {*}CTR INJ PREV CONT, WISQARS.
   Cukier W. T. Sarkar, 2000, CANADIAN CRIMINAL LA, V6, P99.
   DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6.
   Fingerhut L A, 1998, Adv Data, P1.
   Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638.
   Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45.
   Hyder AA, 2006, HEALTH POLICY, V77, P129, DOI 10.1016/j.healthpol.2005.07.008.
   Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062.
   Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894.
   Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1.
   Lemaire J, 2005, J RISK INSUR, V72, P359, DOI 10.1111/j.1539-6975.2005.00128.x.
   Miller M, 2004, J TRAUMA, V57, P626, DOI 10.1097/01.TA.0000093367.07960.E4.
   {*}NAT SPIN CORD INJ, 2004, 2004 ANN STAT REP MO.
   National Spinal Cord Injury Statistical Center, SPIN CORD INJ FACTS.
   Perrott GSJ, 2005, MILBANK Q, V83, P569, DOI 10.1111/j.1468-0009.2005.00393.x.
   Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973.
   Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009.
   Shavelle RM., 2007, BRAIN INJURY MED PRI.
   Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120.
   Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885.
   {*}SPIN CORD INF NET, 2004, FACTS FIG GLANC.
   Stolzenberg L, 2000, SOC FORCES, V78, P1461, DOI 10.2307/3006181.
   Sutton L, 2005, SOC PSYCH PSYCH EPID, V40, P324, DOI 10.1007/s00127-005-0889-y.
   Thomas KE., 2004, TRAUMATIC BRAIN INJU.
   Wadman MC, 2003, ANN EMERG MED, V42, P468, DOI 10.1067/S0196-0644(03)00489-X.
   Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628.},
Number-of-Cited-References = {29},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Am. J. Phys. Med. Rehabil.},
Doc-Delivery-Number = {333AK},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000258124200001},
OA = {Green Submitted},
DA = {2022-03-29},
}

@article{ WOS:000601401800022,
Author = {Song, Minkyo and Hildesheim, Allan and Shiels, Meredith S.},
Title = {Premature Years of Life Lost Due to Cancer in the United States in 2017},
Journal = {CANCER EPIDEMIOLOGY BIOMARKERS \& PREVENTION},
Year = {2020},
Volume = {29},
Number = {12},
Pages = {2591-2598},
Month = {DEC},
Abstract = {Background: Burden of cancer mortality is often measured by death counts
   or mortality rates, but potential years of life lost (PYLL) and PYLL per
   death may be more useful to estimate the impact of cancer-related deaths
   occurring at younger ages.
   Methods: We used U.S. national death certificate data. A total of 45
   categories of common cancers were grouped for cancer-specific
   calculations of PYLL and PYLL per death. PYLL was defined as the sum of
   the total years of life lost prior to age 75 years.
   Results: The largest number of PYLL in 2017 was due to deaths from
   cancers of the lung/bronchus (891,313; 20.8\%), colon/rectum (409,538;
   9.6\%), and breast (400,643; 9.4\%). Cancers with the highest PYLLs
   generally also caused the largest number of deaths and had the highest
   mortality rates, with the exception of prostate cancer (5.1\% of deaths,
   2.0\% of PYLL). In contrast, PYLLs per death were greatest for deaths
   due to cancers of testis (mean = 34.0 years), bones/joints (26.4), and
   other endocrine sites including thymus (25.2).
   Conclusions: Although PYLLs generally reflect mortality rates, they more
   heavily weigh cancers that occur at younger ages. In contrast, PYLL per
   death, which is an average quantification of life years lost for
   individual patients with cancer, shows a different pattern. Impact:
   Mortality rates, PYLL, and PYLL per death are complementary measures of
   the burden of deaths due to cancer that should be considered in tandem
   to prioritize public health interventions focused on preventing
   premature mortality.},
Publisher = {AMER ASSOC CANCER RESEARCH},
Address = {615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA},
Type = {Article},
Language = {English},
Affiliation = {Song, M (Corresponding Author), NCI, 9609 Med Ctr Dr,6E204, Bethesda, MD 20892 USA.
   Song, Minkyo; Hildesheim, Allan; Shiels, Meredith S., NCI, Div Canc Epidemiol \& Genet, NIH, Bethesda, MD 20892 USA.},
DOI = {10.1158/1055-9965.EPI-20-0782},
ISSN = {1055-9965},
EISSN = {1538-7755},
Keywords-Plus = {ADULTS},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Author-Email = {minkyo.song@nih.gov},
ResearcherID-Numbers = {Song, Minkyo/AAE-9095-2020},
ORCID-Numbers = {Song, Minkyo/0000-0002-9412-2871},
Funding-Acknowledgement = {Intramural Research Program of the NCIUnited States Department of Health
   \& Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI)},
Funding-Text = {This work was supported by the Intramural Research Program of the NCI.},
Cited-References = {Anderson WF, 2018, JNCI-J NATL CANCER I, V110, P608, DOI 10.1093/jnci/djx262.
   Arias E, 2016, NATL VITAL STAT SYST, V68, P1.
   Arias E, 2016, VITAL HLTH STAT, V172, P1.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Howlader N., SEER CANC STAT REV 1.
   Jamal A, 2018, MMWR-MORBID MORTAL W, V67, P53, DOI 10.15585/mmwr.mm6702a1.
   Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933.
   Kish Jonathan K., 2014, Journal of the National Cancer Institute Monographs, P236, DOI 10.1093/jncimonographs/lgu020.
   Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015.
   Publication, 2020, PUBL PART COMP MORT.
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936.
   Siegel RL, 2017, JAMA-J AM MED ASSOC, V318, P572, DOI 10.1001/jama.2017.7630.
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332.
   Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372.
   Taksler GB, 2017, AM J PUBLIC HEALTH, V107, P1653, DOI {[}10.2105/AJPH.2017.303986, 10.2105/ajph.2017.303986].
   United States Centers for Disease Control and Prevention, 2017, YEARS POT LIF LOST A.},
Number-of-Cited-References = {17},
Times-Cited = {4},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Cancer Epidemiol. Biomarkers Prev.},
Doc-Delivery-Number = {PI9KY},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000601401800022},
OA = {Bronze, Green Accepted},
DA = {2022-03-29},
}

@article{ WOS:A1978EZ87800008,
Author = {SIMS, A},
Title = {HYPOTHESES LINKING NEUROSES WITH PREMATURE MORTALITY},
Journal = {PSYCHOLOGICAL MEDICINE},
Year = {1978},
Volume = {8},
Number = {2},
Pages = {255-263},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA},
Type = {Article},
Language = {English},
Affiliation = {SIMS, A (Corresponding Author), QUEEN ELIZABETH HOSP, DEPT PSYCHIAT, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND.},
DOI = {10.1017/S0033291700014306},
ISSN = {0033-2917},
EISSN = {1469-8978},
Research-Areas = {Psychology; Psychiatry},
Web-of-Science-Categories  = {Psychology, Clinical; Psychiatry; Psychology},
Cited-References = {ALDERSON M, 1975, BRIT J PREV SOC MED, V29, P151.
   {[}Anonymous], 1971, ANN INTERN MED, V74, P789, DOI 10.7326/0003-4819-74-5-789.
   APPLETON WS, 1975, AM J PSYCHOANAL, V35, P377, DOI 10.1007/BF01249472.
   BABIGIAN HM, 1969, AM J PSYCHIAT, V126, P470, DOI 10.1176/ajp.126.4.470.
   BARKER JC, 1968, SCARED DEATH EXAMINA.
   BARRACLOUGH B, 1976, BRIT J PSYCHIAT, V128, P471, DOI 10.1192/bjp.128.5.471.
   BARRACLOUGH B, 1974, BRIT J PSYCHIAT, V125, P355, DOI 10.1192/bjp.125.4.355.
   BENNET G, 1970, BRIT MED J, V3, P454, DOI 10.1136/bmj.3.5720.454.
   BERKSON J, 1962, B INT STATIST INST, V39, P425.
   BUNCH J, 1971, BRIT J PSYCHIAT, V118, P621, DOI 10.1192/bjp.118.547.621.
   BURNS BH, 1969, Q J MED, V38, P277.
   BURRELL RJW, 1963, H FORD HOSPITAL INT, P95.
   Cannon WB, 1942, AM ANTHROPOL, V44, P169, DOI 10.1525/aa.1942.44.2.02a00010.
   CANNON WB, 1957, PSYCHOSOM MED, V19, P182, DOI 10.1097/00006842-195705000-00003.
   CARRUTHERS ME, 1969, LANCET, V2, P1170.
   CHAPPLE PAL, 1972, BRIT MED J, V2, P680, DOI 10.1136/bmj.2.5815.680.
   COHEN SI, 1972, J PSYCHOSOM RES, V16, P335, DOI 10.1016/0022-3999(72)90086-4.
   COPPEN A, 1963, BMJ-BRIT MED J, P18, DOI 10.1136/bmj.2.5348.18.
   COX PR, 1964, LANCET, V1, P163.
   DAVIES M, 1970, J PSYCHOSOM RES, V14, P89, DOI 10.1016/0022-3999(70)90074-7.
   DAVISON K, 1964, ACTA PSYCHIAT SCAND, V40, P141, DOI 10.1111/j.1600-0447.1964.tb05742.x.
   EASTWOOD MR, 1971, J PSYCHOSOM RES, V15, P289, DOI 10.1016/0022-3999(71)90040-7.
   EKBLOM BENGT, 1961, ACTA PSYCHIAT ET NEUROL SCAND, V36, P300.
   ENGEL GL, 1968, ANN INTERN MED, V69, P293, DOI 10.7326/0003-4819-69-2-293.
   ENGEL GL, 1971, ANN INTERN MED, V74, P771, DOI 10.7326/0003-4819-74-5-771.
   Eysenck, 1959, MANUAL MAUDSLEY PERS.
   FARR W, 1841, J STAT SOC, V4, P17.
   FRIEDMAN M, 1975, METABOLISM, V24, P205, DOI 10.1016/0026-0495(75)90022-0.
   FRIEDMAN M, 1971, ANN CLIN RES, V3, P300.
   FRIEDMAN M, 1974, TYPE A BEHAVIOUR YOU.
   FRIESINGER, 1967, B J HOPKINS HOSPITAL, V120, P186.
   GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439.
   GREENWOOD M, 1919, REP IND FATIGUE RES, V4, P1.
   GUILFORD JS, 1973, J APPL PSYCHOL, V57, P306, DOI 10.1037/h0034725.
   HAGNELL O, 1966, ANN NY ACAD SCI, V125, P846, DOI 10.1111/j.1749-6632.1966.tb45435.x.
   HERMANN P, 1974, MED HYG, V32, P1323.
   HINKLE LE, 1957, ARCH INTERN MED, V99, P442, DOI 10.1001/archinte.1957.00260030124013.
   HOENIG J, 1966, ACTA PSYCHIAT SCAND, V42, P349, DOI 10.1111/j.1600-0447.1966.tb06175.x.
   Hofmann FG, 1975, HDB DRUG ALCOHOL ABU.
   HOLDING TA, 1975, BRIT J PSYCHIAT, V127, P133, DOI 10.1192/bjp.127.2.133.
   HOLDING TA, 1977, BRIT J PSYCHIAT, V130, P244, DOI 10.1192/bjp.130.3.244.
   Innes G, 1970, Scott Med J, V15, P143.
   KEEHN RJ, 1974, PSYCHOSOM MED, V36, P27, DOI 10.1097/00006842-197401000-00003.
   KEEHN RJ, 1977, ARMED FORCES SOC.
   Kerr T A, 1970, Proc R Soc Med, V63, P235.
   KESSEL N, 1961, BRIT MED J, V2, P1671, DOI 10.1136/bmj.2.5268.1671.
   KESSEL WIN, 1963, LANCET, V1, P1082.
   LEIGHTON DC, 1963, AM J PSYCHIAT, V119, P1021, DOI 10.1176/ajp.119.11.1021.
   MACDONALD JM, 1964, AM J PSYCHIAT, V121, P366, DOI 10.1176/ajp.121.4.366.
   MALZBERG B, 1934, MORTALITY PATIENTS M.
   MANN AH, 1977, PSYCHOL MED, V7, P431, DOI 10.1017/S0033291700004402.
   MILTON GW, 1973, LANCET, V1, P1435.
   Norris V., 1959, MENTAL ILLNESS LONDO.
   ODEGARD O, 1952, ACTA PSYCH NEUROL, V27, P353, DOI 10.1111/j.1600-0447.1952.tb04667.x.
   OVENSTONE IM, 1973, BRIT J PSYCHIAT, V123, P15, DOI 10.1192/bjp.123.1.15.
   PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740.
   PERLMAN LV, 1971, ANN INTERN MED, V75, P1, DOI 10.7326/0003-4819-75-1-1.
   RAHE RH, 1974, ARCH INTERN MED, V133, P221, DOI 10.1001/archinte.133.2.221.
   REES WD, 1967, BRIT MED J, V4, P13, DOI 10.1136/bmj.4.5570.13.
   RICHTER CP, 1957, PSYCHOSOM MED, V19, P191, DOI 10.1097/00006842-195705000-00004.
   RORSMAN B, 1974, ACTA PSYCHIAT SCAND, V50, P354, DOI 10.1111/j.1600-0447.1974.tb08221.x.
   RORSMAN B, 1973, SOC PSYCHIATR, V8, P55, DOI 10.1007/BF00589237.
   RORSMAN B, 1968, LAKARTIDNINGEN, V65, P149.
   SAINSBUR.P, 1968, NATURE, V220, P1252, DOI 10.1038/2201252a0.
   SAINSBURY P, 1968, RECENT DEVELOPMENTS, P1.
   SCHMALE AH, 1966, PSYCHOSOM MED, V28, P714, DOI 10.1097/00006842-196609000-00003.
   SCHMIDT CW, 1972, ARCH GEN PSYCHIAT, V27, P800.
   SCHMIDT W, 1969, Q J STUD ALCOHOL, V30, P112.
   SELTZER CC, 1963, JAMA-J AM MED ASSOC, V183, P639.
   SELZER ML, 1968, AM J PSYCHIAT, V124, P1028, DOI 10.1176/ajp.124.8.1028.
   SHAFFER JW, 1974, ARCH GEN PSYCHIAT, V30, P508.
   SHEPHERD M, 1957, MILBANK FUND Q, V35, P258, DOI 10.2307/3348499.
   SHEPHERD M, 1966, PSYCHIATRIC ILLNESS.
   SHEPHERD M, 1957, STUDY MAJOR PSYCHOSE.
   SIMS A, 1975, BRIT J ADDICT, V70, P33.
   SIMS A, 1973, LANCET, V2, P1072.
   SIMS AC, 1975, J PSYCHIAT RES, V12, P167, DOI 10.1016/0022-3956(75)90024-2.
   SIMS ACP, 1975, PSYCHOL MED, V5, P62, DOI 10.1017/S0033291700007224.
   SIMS AR, UNPUBLISHED.
   SJOBRING H, 1963, PERSONALITE STRUCTUR.
   Taylor Stephen, 1964, MENTAL HLTH ENV.
   TOKUHATA GK, 1958, PUBLIC HEALTH REP, V73, P750, DOI 10.2307/4590234.
   {*}UK REG GEN, 1968, 22 STUD MED POP SUBJ.
   {*}UK REG GEN, 1976, 1973 STAT REV ENG WA.
   WARDWELL WI, 1973, J CHRON DIS, V26, P447, DOI 10.1016/0021-9681(73)90096-9.
   WEISMAN AD, 1961, PSYCHOSOM MED, V23, P232, DOI 10.1097/00006842-196105000-00005.
   WHITELEY JS, 1970, BRIT J PSYCHIAT, V116, P517, DOI 10.1192/bjp.116.534.517.
   World Health Organization, 1965, INT STAT CLASS DIS I.},
Number-of-Cited-References = {88},
Times-Cited = {15},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Psychol. Med.},
Doc-Delivery-Number = {EZ878},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:A1978EZ87800008},
DA = {2022-03-29},
}

@article{ WOS:000166865600011,
Author = {Tomlinson, JW and Holden, N and Hills, RK and Wheatley, K and Clayton,
   RN and Bates, AS and Sheppard, MC and Stewart, PM and W Midlands
   Prospective Hypopituita},
Title = {Association between premature mortality and hypopituitarism},
Journal = {LANCET},
Year = {2001},
Volume = {357},
Number = {9254},
Pages = {425-431},
Month = {FEB 10},
Abstract = {Background Four retrospective studies have reported premature mortality
   in patients with hypopituitarism with standard mortality ratios (SMRs)
   varying between 1.20 and 2.17. Patients with hypopituitarism have
   complex endocrine deficiencies, and the mechanisms underpinning any
   excess mortality are unknown. Furthermore, the suggestion has emerged
   that endogenous growth-hormone deficiency might account for any excess
   mortality. We aimed to clarify these issues by doing a large prospective
   study of total, and specific-cause mortality in patients with
   hypopituitarism.
   Methods We followed up 1014 UK patients (514 men, 500 women) with
   hypopituitarism from January, 1992, to January, 2000, 573 (57\%)
   patients had non-functioning adenomas, 118 (12\%) craniopharyngiomas,
   and 93 (9\%) prolactinomas. SMRs were calculated as the ratio of
   observed deaths to the number of deaths in an age-matched and
   sex-matched UK population.
   Findings The number of observed deaths was 181 compared with the 96.7
   expected (SMR 1.87 {[}99\% CI 1.62-2.16], p<0.0001). Univariate analysis
   indicated that mortality was higher in women (2.29 {[}1.86-2.82]) than
   men (1.57 {[}1.28-1.93], p=0.002), in younger patients, in patients with
   an underlying diagnosis of craniopharyngioma (9.28 {[}5.84-14.75] vs
   1.61 {[}1.30-1.99], p<0.0001), and in the 353 patients treated with
   radiotherapy (2.32 {[}1.71-3.14] vs 1.66 {[}1.30-2.13], p=0.004). Excess
   mortality was attributed to cardiovascular (1.82 {[}1.30-2.54],
   p<0.0001), respiratory (2.66 {[}1.72-4.11], p<0.0001), and
   cerebrovascular (2.44 {[}1.58-4.18], p<0.0001) causes. There was no
   effect of hormonal deficiency on mortality, except for gonadotropin
   deficiency, which, if untreated was associated with excess mortality
   (untreated 2.97 {[}2.13-4.13] vs treated 1.42 {[}0.97-2.07], p<0.0001).
   Multiple regression analyses identified age at diagnosis, sex, a
   diagnosis of craniopharyngioma, and untreated gonadotropin deficiency as
   independent significant factors affecting mortality.
   Interpretation Patients with hypopituitarism have excess mortality,
   predominantly from vascular and respiratory disease. Age at diagnosis,
   female sex, and above all, craniopharyngioma were significant
   independent risk factors. Specific endocrine-axis deficiency, with the
   exception of untreated gonadotropin deficiency, does not seem to have a
   role.},
Publisher = {LANCET LTD},
Address = {84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Stewart, PM (Corresponding Author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.
   Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.
   Univ Birmingham, Clin Trials Unit, Birmingham, W Midlands, England.
   N Staffordshire Hosp, Postgrad Med Sch, Dept Med, Stoke On Trent, Staffs, England.
   Sollhill Hosp, Dept Med, Solihull, W Midlands, England.},
DOI = {10.1016/S0140-6736(00)04006-X},
ISSN = {0140-6736},
Keywords-Plus = {GROWTH-HORMONE DEFICIENCY; CARDIOVASCULAR RISK-FACTORS;
   PITUITARY-TUMORS; LIFE EXPECTANCY; ADULTS; DISEASE; REPLACEMENT;
   RADIATION; THERAPY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
ORCID-Numbers = {Hills, Robert/0000-0003-0166-0062
   Tomlinson, Jeremy/0000-0002-3170-8533},
Cited-References = {Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x.
   Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169.
   BATES AS, 1993, Q J MED, V86, P293.
   BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327.
   Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x.
   BITZER M, 1995, STROKE, V26, P131, DOI 10.1161/01.STR.26.1.131.
   BOWEN J, 1992, STROKE, V23, P908, DOI 10.1161/01.STR.23.6.908.
   Brada M, 1999, INT J RADIAT ONCOL, V45, P693, DOI 10.1016/S0360-3016(99)00159-5.
   Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x.
   Erfurth EM, 1999, GROWTH HORM IGF RES, V9, P21, DOI 10.1016/S1096-6374(99)80005-7.
   ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39.
   Evans LM, 1999, CLIN ENDOCRINOL, V50, P457.
   FLICKINGER JC, 1989, CANCER, V63, P2404, DOI 10.1002/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3.
   Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103.
   FREY H, 1987, ACATA MED SCAND, V272, P163.
   Gelding SV, 1998, CLIN ENDOCRINOL, V48, P153, DOI 10.1046/j.1365-2265.1998.3641180.x.
   Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331.
   Maison P, 1998, BRIT MED J, V316, P1132, DOI 10.1136/bmj.316.7138.1132.
   MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029.
   Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730.
   PARLE JV, 1993, BRIT J GEN PRACT, V43, P107.
   Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453.
   POLTZ CM, 1952, AM J MED, V13, P597.
   Rodriguez-Arnao J, 1999, CLIN ENDOCRINOL, V51, P53, DOI 10.1046/j.1365-2265.1999.00737.x.
   ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195.
   ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O.
   SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901.
   Stewart PM, 1999, GROWTH HORM IGF RES, V9, P15, DOI 10.1016/S1096-6374(99)80004-5.
   TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x.
   Vahl N, 1998, INT J OBESITY, V22, P529, DOI 10.1038/sj.ijo.0800618.},
Number-of-Cited-References = {30},
Times-Cited = {745},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {29},
Journal-ISO = {Lancet},
Doc-Delivery-Number = {400HF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000166865600011},
DA = {2022-03-29},
}

@article{ WOS:A1988Q434500005,
Author = {WISE, RP and LIVENGOOD, JR and BERKELMAN, RL and GOODMAN, RA},
Title = {METHODOLOGICAL ALTERNATIVES FOR MEASURING PREMATURE MORTALITY},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {1988},
Volume = {4},
Number = {5},
Pages = {268-273},
Month = {SEP-OCT},
Publisher = {OXFORD UNIV PRESS INC},
Address = {JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513},
Type = {Article},
Language = {English},
Affiliation = {CTR DIS CONTROL,EPIDEMIOL PROGRAM OFF,DIV SURVEILLANCE \& EPIDEMIOL STUDIES,ATLANTA,GA 30333.},
DOI = {10.1016/S0749-3797(18)31160-7},
ISSN = {0749-3797},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Number-of-Cited-References = {0},
Times-Cited = {22},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Am. J. Prev. Med.},
Doc-Delivery-Number = {Q4345},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1988Q434500005},
DA = {2022-03-29},
}

@article{ WOS:000371388600006,
Author = {Hirvikoski, Tatja and Mittendorfer-Rutz, Ellenor and Boman, Marcus and
   Larsson, Henrik and Lichtenstein, Paul and Bolte, Sven},
Title = {Premature mortality in autism spectrum disorder},
Journal = {BRITISH JOURNAL OF PSYCHIATRY},
Year = {2016},
Volume = {208},
Number = {3},
Pages = {232+},
Month = {MAR},
Abstract = {Background
   Mortality has been suggested to be increased in autism spectrum disorder
   (ASD).
   Aims
   To examine both all-cause and cause-specific mortality in ASD, as well
   as investigate moderating role of gender and intellectual ability.
   Method
   Odds ratios (ORs) were calculated for a population-based cohort of ASD
   probands (n = 27 122, diagnosed between 1987 and 2009) compared with
   gender-, age-and county of residence-matched controls (n = 2 672 185).
   Results
   During the observed period, 24 358 (0.91\%) individuals in the general
   population died, whereas the corresponding figure for individuals with
   ASD was 706 (2.60\%; OR = 2.56; 95\% CI 2.38-2.76). Cause-specific
   analyses showed elevated mortality in ASD for almost all analysed
   diagnostic categories. Mortality and patterns for cause-specific
   mortality were partly moderated by gender and general intellectual
   ability.
   Conclusions
   Premature mortality was markedly increased in ASD owing to a multitude
   of medical conditions.},
Publisher = {CAMBRIDGE UNIV PRESS},
Address = {EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hirvikoski, T (Corresponding Author), Karolinska Inst KIND, Ctr Neurodev Disorders, CAP Res Ctr, Gavlegatan 22B, SE-11330 Stockholm, Sweden.
   Hirvikoski, Tatja; Bolte, Sven, Karolinska Inst, Karolinska Inst KIND, Ctr Neurodev Disorders, Dept Womens \& Childrens Hlth,Pediat Neuropsychiat, Stockholm, Sweden.
   Hirvikoski, Tatja, Stockholm Cty Council, Habilitat \& Hlth, Stockholm, Sweden.
   Mittendorfer-Rutz, Ellenor, Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.
   Boman, Marcus; Larsson, Henrik; Lichtenstein, Paul, Karolinska Inst, Dept Med Epidemiol \& Biostat, Stockholm, Sweden.
   Bolte, Sven, Stockholm Cty Council, Div Child \& Adolescent Psychiat, Stockholm, Sweden.},
DOI = {10.1192/bjp.bp.114.160192},
ISSN = {0007-1250},
EISSN = {1472-1465},
Keywords-Plus = {PROTECTIVE FACTORS; SUICIDAL-BEHAVIOR; ASPERGER-SYNDROME; CHILDREN;
   COHORT; ADULTS; DEATH; RISK; INDIVIDUALS; CHILDHOOD},
Research-Areas = {Psychiatry},
Web-of-Science-Categories  = {Psychiatry},
Author-Email = {Tatja.Hirvikoski@ki.se},
ResearcherID-Numbers = {wang, edwin/G-5372-2010
   Bölte, Sven/AAH-8675-2019
   },
ORCID-Numbers = {Bölte, Sven/0000-0002-4579-4970
   Hirvikoski, Tatja/0000-0003-1824-3003},
Funding-Acknowledgement = {Stockholm County CouncilStockholm County Council {[}20120419, 20130630];
   Karolinska InstitutetKarolinska Institutet {[}20120419, 20130630];
   Karolinska Institutet in cooperation with the Stockholm County Council
   (KI/SLL) {[}2008:9]; Swedish Research CouncilSwedish Research
   CouncilEuropean Commission {[}523-2009-7054, 259-2012-24]},
Funding-Text = {The study was funded by the regional agreement on medical training and
   clinical research (ALF) between Stockholm County Council and Karolinska
   Institutet (grants no. 20120419 and 20130630, Tatja Hirvikoski),
   Karolinska Institutet in cooperation with the Stockholm County Council
   (KI/SLL, 2008:9, Sven Bolte), the Swedish Research Council (grant no.
   523-2009-7054, Sven Bolte) and the Swedish Research Council in
   cooperation with the Swedish Research Council for Health, Working Life
   and Welfare, Vinnova and FORMAS (cross-disciplinary research programme
   concerning children's and youth's mental health, grant no. 259-2012-24,
   Sven Bolte).},
Cited-References = {American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th Edn, DOI 10.1176/appi.books.9780890425596.dsm05.
   Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X.
   Bilder D, 2013, J AUTISM DEV DISORD, V43, P1196, DOI 10.1007/s10803-012-1664-z.
   Billstedt E, 2005, J AUTISM DEV DISORD, V35, P351, DOI 10.1007/s10803-005-3302-5.
   Bjorkenstam E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000778.
   Bolte S, 2014, AUTISM RES, V7, P167, DOI 10.1002/aur.1335.
   Caamano M, 2013, J AUTISM DEV DISORD, V43, P2442, DOI 10.1007/s10803-013-1792-0.
   Cassidy S, 2014, LANCET PSYCHIAT, V1, P142, DOI 10.1016/S2215-0366(14)70248-2.
   Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6.
   Chioqueta AP, 2007, CRISIS, V28, P67, DOI 10.1027/0227-5910.28.2.67.
   Fowler JC, 2012, PSYCHOTHERAPY, V49, P81, DOI 10.1037/a0026148.
   GILLBERG C, 1987, J AUTISM DEV DISORD, V17, P273, DOI 10.1007/BF01495061.
   Gillberg C, 2010, J AUTISM DEV DISORD, V40, P352, DOI 10.1007/s10803-009-0883-4.
   Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35.
   Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x.
   Howlin P, 2013, J AM ACAD CHILD PSY, V52, P572, DOI 10.1016/j.jaac.2013.02.017.
   Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280.
   Idring S, 2014, INT J EPIDEMIOL, V43, P107, DOI 10.1093/ije/dyt262.
   Isager T., 1999, AUTISM, V3, P7, DOI {[}10.1177/1362361399003001002, DOI 10.1177/1362361399003001002].
   Lager A, 2012, SCAND J PUBLIC HEALT, V40, P42, DOI 10.1177/1403494812459459.
   Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223.
   Lugnegard T, 2011, RES DEV DISABIL, V32, P1910, DOI 10.1016/j.ridd.2011.03.025.
   Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125.
   Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2.
   Mouridsen SE, 2008, AUTISM, V12, P403, DOI 10.1177/1362361308091653.
   Oquendo MA, 2005, J NERV MENT DIS, V193, P438, DOI 10.1097/01.nmd.0000168262.06163.31.
   Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012.
   Pickett JA, 2006, J AUTISM DEV DISORD, V36, P287, DOI 10.1007/s10803-005-0066-x.
   Pinborough-Zimmerman J, 2012, J AUTISM DEV DISORD, V42, P521.
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104.
   Shavelle RM, 2001, J AUTISM DEV DISORD, V31, P569, DOI 10.1023/A:1013247011483.
   Skokauskas N, 2010, PSYCHOPATHOLOGY, V43, P8, DOI 10.1159/000255958.
   Wazana A, 2007, J AM ACAD CHILD PSY, V46, P721, DOI 10.1097/chi.0b013e31804a7f3b.
   Woolfenden S, 2012, DEV MED CHILD NEUROL, V54, P306, DOI 10.1111/j.1469-8749.2012.04223.x.
   World Health Organization, 1992, ICD 10 ICD 10 CLASS.
   World Health Organization (WHO), 1978, ICD 9 INT STAT CLASS.},
Number-of-Cited-References = {36},
Times-Cited = {317},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {44},
Journal-ISO = {Br. J. Psychiatry},
Doc-Delivery-Number = {DF5JS},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000371388600006},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000771367800001,
Author = {Benjamin, David J. and Haslam, Alyson and Gill, Jenny and Prasad, Vinay},
Title = {Targeted therapy in lung cancer: Are we closing the gap in years of life
   lost?},
Journal = {CANCER MEDICINE},
Abstract = {Purpose Patients with non-small cell lung cancer (NSCLC) that harbor
   driver mutations are associated with a cancer diagnosis at a younger
   age. While targeted therapies provide deep remissions and durable
   benefit in a subset of patients, it is unclear whether targeted
   therapies bridge the gap in years of life lost (YLL) in these younger
   NSCLC patients with targetable mutations in comparison to generally
   older NSCLC patients without actionable driver mutations. Materials and
   Methods Retrospective cross-sectional study using landmark trials
   leading to the approval of targeted therapies in NSCLC with actionable
   mutations. We evaluated all targeted therapies as well as chemotherapy
   and IO regimens for the treatment of NSCLC through FDA Oncology
   Announcements and NCCN Guidelines for NSCLC (version 4.2021). Results We
   estimated the YLL for each driver mutation, cumulative median duration
   of response (DOR) with targeted therapies by mutation type, and
   percentage of estimated improvement in YLL from NSCLC targeted
   therapies. The median ages at diagnosis (in years) for patients whose
   tumors express targetable mutations were: 47.6 (NTRK); 52.0 (ALK); 62.0
   (HER2); 57.0 (ROS1); 61.4 (RET); 63.0 (BRAF); 69.0 (EGFR); and 72.0
   (MET). For comparison, the median age at diagnosis for patients without
   driver mutations, regardless of PD-L1 status was 71 years. The median
   DOR (in years) for patients whose tumors express the same mutations
   include: 0.9 (NTRK); 3.9 (ALK); 0.6 (HER2); 6.2 (ROS1); 2.2 (RET); 1.5
   (BRAF); 3.1 (EGFR); and 2.4 (MET). The median DOR for patients without
   driver mutations was 1.2 years. The cumulative estimated survival time
   (years; median age at diagnosis plus the median DOR or OS) for patients
   whose tumors express targetable mutations were: 48.5 (NTRK); 55.9 (ALK);
   62.6 (HER2); 63.2 (ROS1); 63.6 (RET); 64.5 (BRAF); 72.1 (EGFR); and 74.4
   (MET). The cumulative estimated survival time for patients without
   driver mutations, regardless of PD-L1 status, was 72.2 years of age. We
   calculated the number of years NSCLC is diagnosed earlier in patients
   with targetable mutations as follows: 23.4 (NTRK), 19 (ALK), 14 (ROS1),
   11 (EGFR), 9.6 (RET), 9 (HER2), and 8 (BRAF). The percent difference
   (\%) ameliorated in YLL by mutation type is as follows: 44.3 (ROS1),
   28.2 (EGFR), 22.9 (RET), 20.5 (ALK), 18.8 (BRAF), 6.4 (HER2), and 3.7
   (NTRK). Conclusion Although targeted therapies have paved the way for
   significant progress toward providing a survival benefit to many young
   patients with advanced NSCLC with actionable mutations, it is evident
   that these therapies still leave a wide gap in the YLL in these younger
   patients compared to generally older individuals with advanced NSCLC
   without targetable mutations.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article; Early Access},
Language = {English},
Affiliation = {Benjamin, DJ (Corresponding Author), Univ Calif Irvine, Div Hematol Oncol, Dept Med, 101 City Dr South,Bldg 200, Orange, CA 92868 USA.
   Benjamin, David J., Univ Calif Irvine, Div Hematol Oncol, Dept Med, 101 City Dr South,Bldg 200, Orange, CA 92868 USA.
   Haslam, Alyson; Gill, Jenny; Prasad, Vinay, Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA USA.},
DOI = {10.1002/cam4.4703},
EarlyAccessDate = {MAR 2022},
ISSN = {2045-7634},
Keywords = {driver mutation; non-small cell lung cancer; targeted therapy; years of
   life lost},
Keywords-Plus = {INTEGRATED ANALYSIS; SURVIVAL-DATA; OPEN-LABEL; CRIZOTINIB;
   CHEMOTHERAPY; ENTRECTINIB; MUTATIONS; EFFICACY; IMPACT; NSCLC},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {djbenjam@hs.uci.edu},
Funding-Acknowledgement = {Arnold Ventures},
Funding-Text = {This study was funded by a grant from Arnold Ventures.},
Cited-References = {{[}Anonymous], 2021, CANC LUNG BRONCH CAN.
   Awad MM, 2019, LUNG CANCER, V133, P96, DOI 10.1016/j.lungcan.2019.05.011.
   Camidge DR, 2020, J CLIN ONCOL, V38, P3592, DOI 10.1200/JCO.20.00505.
   Chia PL, 2014, CLIN EPIDEMIOL, V6, P423, DOI 10.2147/CLEP.S69718.
   Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385.
   Doebele RC, 2020, LANCET ONCOL, V21, P271, DOI 10.1016/S1470-2045(19)30691-6.
   Drilon A, 2020, ANN ONCOL, V31, pS834, DOI 10.1016/j.annonc.2020.08.1603.
   Drilon A, 2020, NEW ENGL J MED, V383, P813, DOI 10.1056/NEJMoa2005653.
   Drilon A, 2020, LANCET ONCOL, V21, P261, DOI 10.1016/S1470-2045(19)30690-4.
   Drilon A, 2020, NAT MED, V26, P47, DOI 10.1038/s41591-019-0716-8.
   Farago AF, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.18.00037.
   FDA, 2021, APPR PRALS MET RET F.
   Gadgeel S, 2020, J CLIN ONCOL, V38, P1505, DOI 10.1200/JCO.19.03136.
   Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005.
   Garon EB, 2019, J CLIN ONCOL, V37, P2518, DOI 10.1200/JCO.19.00934.
   Gautschi O, 2015, J THORAC ONCOL, V10, P1451, DOI 10.1097/JTO.0000000000000625.
   Li YL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209709.
   Lin C, 2015, CANCER BIOL THER, V16, P1019, DOI 10.1080/15384047.2015.1046649.
   Lu T, 2019, CANCER MANAG RES, V11, P943, DOI 10.2147/CMAR.S187317.
   Mok T, 2020, ANN ONCOL, V31, P1056, DOI 10.1016/j.annonc.2020.04.478.
   Mok TSK, 2019, ANN ONCOL, V30.
   Nishio M, 2020, J THORAC ONCOL, V15, P609, DOI 10.1016/j.jtho.2019.11.006.
   Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443.
   Paik PK, 2020, NEW ENGL J MED, V383, P931, DOI 10.1056/NEJMoa2004407.
   Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865.
   Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795.
   Pillai RN, 2017, CANCER-AM CANCER SOC, V123, P4099, DOI 10.1002/cncr.30869.
   Planchard D, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15\_suppl.9075.
   Ramalingam SS, 2020, NEW ENGL J MED, V382, P41, DOI 10.1056/NEJMoa1913662.
   Sacher AG, 2016, JAMA ONCOL, V2, P313, DOI 10.1001/jamaoncol.2015.4482.
   Shaw AT, 2019, ANN ONCOL, V30, P1121, DOI 10.1093/annonc/mdz131.
   Shaw AT, 2020, NEW ENGL J MED, V383, P2018, DOI 10.1056/NEJMoa2027187.
   Shaw AT, 2019, LANCET ONCOL, V20, P1691, DOI 10.1016/S1470-2045(19)30655-2.
   Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551.
   Smit EF, 2020, J CLIN ONCOL, V38.
   Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI {[}10.1056/NEJMx150034, 10.1056/NEJMoa1408440].
   Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X.
   Wolf J, 2020, J CLIN ONCOL, V38.
   Xu Jiaquan, 2020, NCHS Data Brief, P1.
   Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8.
   Zhou CC, 2020, J CLIN ONCOL, V38, P2753, DOI 10.1200/JCO.20.00297.
   Zinsky R., 2016, EUR RESPIR J, V48, P2867.},
Number-of-Cited-References = {42},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Cancer Med.},
Doc-Delivery-Number = {ZW7CX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000771367800001},
DA = {2022-03-29},
}

@article{ WOS:000442469800010,
Author = {Bui, Anthony L. and Coates, Matthew M. and Matthay, Ellicott C.},
Title = {Years of life lost due to encounters with law enforcement in the USA,
   2015-2016},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2018},
Volume = {72},
Number = {8},
Pages = {715-718},
Month = {AUG},
Abstract = {Background To inform discussions on rates, burden and priority-setting
   in relation to police violence, we quantified the number and rate of
   years of life lost (YLLs) due to police violence by race/ethnicity and
   age in the USA, 2015-2016.
   Methods We used data on the number of deaths due to police violence from
   `The Counted', a media-based source compiled by The Guardian. YLLs are
   the difference between an individual's age at death and their
   corresponding standard life expectancy at age of death.
   Results There were 57 375 and 54 754 YLLs due to police violence in 2015
   and 2016, respectively. People of colour comprised 38.5\% of the
   population, but 51.5\% of YLLs. YLLs were greatest among those aged
   25-34 years, and the number of YLLs at younger ages was greater among
   people of colour than whites.
   Conclusions The number of YLLs due to police violence is substantial.
   YLLs highlight that police violence disproportionately impacts young
   people, and the young people affected are disproportionately people of
   colour. Framing police violence as an important cause of deaths among
   young adults provides another valuable lens to motivate prevention
   efforts.},
Publisher = {BMJ PUBLISHING GROUP},
Address = {BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Bui, AL (Corresponding Author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90066 USA.
   Bui, Anthony L., Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90066 USA.
   Coates, Matthew M., Harvard Med Sch, Dept Global Hlth \& Social Med, Boston, MA USA.
   Matthay, Ellicott C., Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.},
DOI = {10.1136/jech-2017-210059},
ISSN = {0143-005X},
EISSN = {1470-2738},
Keywords-Plus = {BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ALBui@mednet.ucla.edu},
ORCID-Numbers = {Coates, Matthew/0000-0002-8474-4992},
Cited-References = {Alang S, 2017, AM J PUBLIC HEALTH, V107, P662, DOI 10.2105/AJPH.2017.303691.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Feldman JM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002399.
   Feldman JM, 2017, AM J PUBLIC HEALTH, V107, P1624, DOI 10.2105/AJPH.2017.303940.
   Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837.
   Kindig D, 2017, JAMA-J AM MED ASSOC, V317, P467, DOI 10.1001/jama.2016.19435.
   Krieger N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001915.
   Miller TR, 2017, INJURY PREV, V23, P27, DOI 10.1136/injuryprev-2016-042023.
   Swaine J, GUARDIAN.
   Taksler GB, 2017, AM J PUBLIC HEALTH, V107, P1653, DOI {[}10.2105/AJPH.2017.303986, 10.2105/ajph.2017.303986].
   US Census Bureau, 2014, NAT POP PROJ DAT.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.},
Number-of-Cited-References = {12},
Times-Cited = {24},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {J. Epidemiol. Community Health},
Doc-Delivery-Number = {GR3DP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000442469800010},
DA = {2022-03-29},
}

@article{ WOS:000240681100009,
Author = {Bose, Anuradha and Konradsen, Flemming and John, Jacob and Suganthy,
   Pearline and Muliyil, Jayaprakash and Abraham, Sulochana},
Title = {Mortality rate and years of life lost from unintentional injury and
   suicide in South India},
Journal = {TROPICAL MEDICINE \& INTERNATIONAL HEALTH},
Year = {2006},
Volume = {11},
Number = {10},
Pages = {1553-1556},
Month = {OCT},
Abstract = {We calculated mortality rates and years of life lost because of
   unintentional injuries and suicides using community based information
   obtained prospectively over a 7-year period, from 1998 to 2004, among a
   rural and peri-urban population of 108 000 in South India. Per 100 000
   population the total mortality rate for unintentional injuries and
   suicides combined was 137.1, with 54.9 for unintentional injuries and
   82.2 for suicides respectively. Hanging and self-poisoning with
   pesticides were the preferred means of suicide. Unintentional injuries
   and suicides resulted in 26.9\% of total life years lost over the study
   period while 18.9\% of all deaths in the population were attributable to
   unintentional injuries and suicides in the same period. The high burden
   is particularly notable in the 15-29 age group, where up to 70\% of
   years of life lost are due to injury. The burden of injuries reported in
   this study is significantly higher than the figures reflected in
   available reports for India and is likely due to the under reporting in
   routine mortality statistics, particularly of suicides.},
Publisher = {BLACKWELL PUBLISHING},
Address = {9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Bose, A (Corresponding Author), Christian Med Coll \& Hosp, Dept Community Hlth, Vellore 632002, Tamil Nadu, India.
   Christian Med Coll \& Hosp, Dept Community Hlth, Vellore 632002, Tamil Nadu, India.
   Univ Copenhagen, Inst Publ Hlth, Dept Int Hlth, Copenhagen, Denmark.},
DOI = {10.1111/j.1365-3156.2006.01707.x},
ISSN = {1360-2276},
Keywords = {unintentional injury; suicide; poisoning; hanging; road traffic injury;
   India},
Research-Areas = {Public, Environmental \& Occupational Health; Tropical Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Tropical Medicine},
Author-Email = {abose@cmcvellore.ac.in},
ResearcherID-Numbers = {John, Jacob/K-7093-2012
   John, Jacob/M-3563-2019
   },
ORCID-Numbers = {John, Jacob/0000-0003-3654-5099
   John, Jacob/0000-0003-3654-5099
   Konradsen, Flemming/0000-0003-1036-6949},
Cited-References = {Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0.
   Abraham VJ, 2005, INT J GERIATR PSYCH, V20, P953, DOI 10.1002/gps.1385.
   Joseph A, 2003, BRIT MED J, V326, P1121, DOI 10.1136/bmj.326.7399.1121.
   Krug EG, 2004, LANCET, V364, P1563, DOI 10.1016/S0140-6736(04)17328-5.
   Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0.
   Mohan D, 2004, NATL MED J INDIA, V17, P63.},
Number-of-Cited-References = {6},
Times-Cited = {39},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Trop. Med. Int. Health},
Doc-Delivery-Number = {086NU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000240681100009},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000284107400008,
Author = {Kao, Tze-Wah and Huang, Jenq-Wen and Hung, Kuan-Yu and Chang, Yu-Yin and
   Chen, Pau-Chung and Yen, Chung-Jen and Chen, Yung-Ming and Chu,
   Tzong-Shinn and Wu, Ming-Shiou and Tsai, Tun-Jun and Wu, Kwan-Dun and
   Wang, Jung-Der},
Title = {Life expectancy, expected years of life lost and survival of
   hemodialysis and peritoneal dialysis patients},
Journal = {JOURNAL OF NEPHROLOGY},
Year = {2010},
Volume = {23},
Number = {6},
Pages = {677-682},
Month = {NOV-DEC},
Abstract = {Background: Expected years of life lost (EYLL) in dialysis patients are
   rarely discussed. This study compared life expectancy, EYLL and survival
   between hemodialysis (HD) and peritoneal dialysis (PD) patients.
   Methods: Adults who underwent maintenance dialysis at National Taiwan
   University Hospital from 1995 to 2006 were followed up until December
   2007. Kaplan-Meier analysis and a constant excess hazard model were used
   to estimate and project long-term survival. EYLL was calculated by
   subtracting the life expectancy of patients from that of age-and
   sex-matched referents. HD patients were then matched with PD patients on
   age, sex and diabetes mellitus (DM). Life expectancy, EYLL and survival
   between the 2 groups were compared. Mortality risks were determined by
   the Cox model.
   Results: Before matching, the 305 HD patients were older than the 428 PD
   patients (62.4 +/- 13.7 vs. 53.1 +/- 16.7 years; p<0.0001). More HD
   patients had DM (HD vs. PD, 29.2\% vs. 20.6\%; p=0.0072). Life
   expectancy and EYLL of HD patients were 8.8 and 11.5 years, compared
   with those of PD patients (19.9 and 7.4 years). After matching, life
   expectancy (p=0.790) and EYLL (p=0.793) of both groups (236 patients
   each) were similar. Age (adjusted hazard ratio {[}AHR] =1.07; 95\%
   confidence interval {[}95\% CI], 1.05-1.09) and DM (AHR=3.81; 95\% CI,
   2.28-6.36) were independent mortality predictors. For diabetic patients
   who underwent HD, a better survival rate was observed (AHR=0.24; 95\%
   CI, 0.11-0.53).
   Conclusions: After matching, HD and PD patients had similar life
   expectancy and EYLL. Survival was better for diabetic patients if they
   received HD.},
Publisher = {SPRINGER HEIDELBERG},
Address = {TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY},
Type = {Article},
Language = {English},
Affiliation = {Wang, JD (Corresponding Author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med \& Ind Hyg, 17 Shiujou Rd, Taipei 100, Taiwan.
   Kao, Tze-Wah; Chang, Yu-Yin; Chen, Pau-Chung; Wang, Jung-Der, Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med \& Ind Hyg, Taipei 100, Taiwan.
   Kao, Tze-Wah; Huang, Jenq-Wen; Hung, Kuan-Yu; Yen, Chung-Jen; Chen, Yung-Ming; Chu, Tzong-Shinn; Wu, Ming-Shiou; Tsai, Tun-Jun; Wu, Kwan-Dun; Wang, Jung-Der, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.
   Kao, Tze-Wah; Huang, Jenq-Wen; Hung, Kuan-Yu; Yen, Chung-Jen; Chen, Yung-Ming; Chu, Tzong-Shinn; Wu, Ming-Shiou; Tsai, Tun-Jun; Wu, Kwan-Dun; Wang, Jung-Der, Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan.
   Chen, Pau-Chung; Wang, Jung-Der, Natl Taiwan Univ Hosp, Dept Environm \& Occupat Med, Taipei, Taiwan.},
ISSN = {1121-8428},
EISSN = {1724-6059},
Keywords = {Hemodialysis; Life expectancy; Peritoneal dialysis; Survival},
Keywords-Plus = {STAGE RENAL-DISEASE; QUALITY-OF-LIFE; REPLACEMENT THERAPY;
   SINGLE-CENTER; FOLLOW-UP; OUTCOMES; MORTALITY; FAILURE},
Research-Areas = {Urology \& Nephrology},
Web-of-Science-Categories  = {Urology \& Nephrology},
Author-Email = {jdwang@ntu.edu.tw},
ResearcherID-Numbers = {Chen, Pau-Chung/H-5686-2011
   },
ORCID-Numbers = {Chen, Pau-Chung/0000-0002-6242-5974
   HUNG, KUAN-YU/0000-0003-3472-5512
   TSAI, TUN-JUN/0000-0002-1666-8940
   CHU, TZONG-SHINN/0000-0002-5291-2509
   WU, KWAN-DUN/0000-0002-3339-1509
   WU, MING-SHIOU/0000-0002-1674-443X
   HUANG, JENQ-WEN/0000-0001-8011-2317
   CHEN, YUNG-MING/0000-0002-9241-1258
   YEN, CHUNG-JEN/0000-0001-5372-3657},
Funding-Acknowledgement = {Ta-Tung Kidney Research Foundation; Mrs. Hsiu-Chin Lee Kidney Research
   Fund},
Funding-Text = {Financial support for this study was received from the Ta-Tung Kidney
   Research Foundation and Mrs. Hsiu-Chin Lee Kidney Research Fund.},
Cited-References = {Berlanga JR, 2002, PERITON DIALYSIS INT, V22, P239.
   Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905.
   Chen SC, 2008, NEPHROLOGY, V13, P730, DOI 10.1111/j.1440-1797.2008.01023.x.
   Couchoud C, 2007, NEPHROL DIAL TRANSPL, V22, P3246, DOI 10.1093/ndt/gfm400.
   Enriquez Jaime, 2005, Adv Perit Dial, V21, P164.
   Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141.
   Garber Alan J, 2003, Clin Cornerstone, V5, P22, DOI 10.1016/S1098-3597(03)90016-0.
   Gokal R, 1999, NEPHROL DIAL TRANSPL, V14, P24, DOI 10.1093/ndt/14.suppl\_6.24.
   Harris SAC, 2002, PERITON DIALYSIS INT, V22, P463.
   Ho JJ, 2006, SCAND J WORK ENV HEA, V32, P91, DOI 10.5271/sjweh.984.
   Huang CC, 2007, PERITON DIALYSIS INT, V27, pS176.
   Huang CC, 2008, PERITON DIALYSIS INT, V28, pS15.
   Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4.
   HWANG JS, SOFTWARE ISQOL PACKA.
   Inrig JK, 2006, CLIN J AM SOC NEPHRO, V1, P774, DOI 10.2215/CJN.00580705.
   Kontodimopoulos N, 2008, HEALTH POLICY, V86, P85, DOI 10.1016/j.healthpol.2007.10.002.
   Lee ET, 1997, ANNU REV PUBL HEALTH, V18, P105, DOI 10.1146/annurev.publhealth.18.1.105.
   Lopez, 2002, SUMMARY MEASURES POP.
   Lorenzo V, 2006, J NEPHROL, V19, P97.
   Lysaght M J, 1991, ASAIO Trans, V37, P598.
   Mandayam S, 2008, J NEPHROL, V21, P166.
   Obama B, 2008, NEW ENGL J MED, V359, P1537, DOI 10.1056/NEJMp0807677.
   Schatz Sharon R, 2008, Nephrol Nurs J, V35, P403.
   Song YS, 2007, J KOREAN MED SCI, V22, P81, DOI 10.3346/jkms.2007.22.1.81.
   Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x.
   Tessari G, 2009, J NEPHROL, V22, P241.
   Uchida Kousuke, 2007, Adv Perit Dial, V23, P144.
   Van Biesen W, 2008, J NEPHROL, V21, P299.
   Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048.
   LIFE TABLE TAIWANESE.},
Number-of-Cited-References = {30},
Times-Cited = {19},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {4},
Journal-ISO = {J. Nephrol.},
Doc-Delivery-Number = {678UQ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000284107400008},
DA = {2022-03-29},
}

@article{ WOS:000519987300134,
Author = {Urban, Ales and Kysely, Jan and Plavcova, Eva and Hanzlikova, Hana and
   Stepanek, Petr},
Title = {Temporal changes in years of life lost associated with heat waves in the
   Czech Republic},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2020},
Volume = {716},
Month = {MAY 10},
Abstract = {Seniors constitute the population group generally most at risk of
   mortality due to heat stress. As life expectancy increases and health
   conditions of elderly people improve over time, vulnerability of the
   population to heat changes as well. We employed the years-of-life-lost
   (YLL) approach, considering life expectancy at the time of each death,
   to investigate how population ageing affects temporal changes in
   heat-related mortality in the Czech Republic. Using an updated gridded
   meteorological database, we identified heat waves during 1994-2017, and
   analysed temporal changes in their impacts on YLL and mortality. The
   mean impact of a heatwave day on relative excess mortality and YLL had
   declined by approximately 2-3\% per decade. That decline abated in the
   current decade, however, and the decreasing trend in mean excess
   mortality as well as NIL vanished when the short-term mortality
   displacement effect was considered. Moreover, the cumulative number of
   excess deaths and YLL during heat waves rose due to increasing frequency
   and intensity of heat waves during the examined period. The results show
   that in studies of temporal changes it is important to differentiate
   between mean effects of heat waves on mortality and the overall death
   burden associated with heat waves. Analysis of the average ratio of
   excess YLL/death per heat-wave day indicated that the major
   heat-vulnerable population group shifted towards older age (70+ years
   among males and 75+ years among females). Our findings highlight the
   importance of focusing heat-protection measures especially upon the
   elderly population, which is most heatvulnerable and whose numbers are
   rising. (C) 2020 Elsevier B.V. All rights reserved.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Urban, A (Corresponding Author), Czech Acad Sci, Inst Atmospher Phys, Prague, Czech Republic.
   Urban, Ales; Kysely, Jan; Plavcova, Eva; Hanzlikova, Hana, Czech Acad Sci, Inst Atmospher Phys, Prague, Czech Republic.
   Kysely, Jan, Czech Univ Life Sci, Fac Environm Sci, Prague, Czech Republic.
   Kysely, Jan; Stepanek, Petr, Czech Acad Sci, Global Change Res Inst, Brno, Czech Republic.
   Hanzlikova, Hana; Stepanek, Petr, Czech Acad Sci, Inst Geophys, Prague, Czech Republic.
   Stepanek, Petr, Czech Hydrometeorol Inst, Reg Off Brno, Brno, Czech Republic.},
DOI = {10.1016/j.scitotenv.2020.137093},
Article-Number = {137093},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Years-of-life-lost approach; Heat-related mortality; Heat wave;
   Population ageing; Central Europe},
Keywords-Plus = {TEMPERATURE-RELATED MORTALITY; CLIMATE-CHANGE SCENARIOS; CARDIOVASCULAR
   MORTALITY; EXTREME TEMPERATURES; SUMMER TEMPERATURE; NORTH-CAROLINA;
   RISK-FACTORS; HUMAN HEALTH; COLD SPELL; TRENDS},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {urban@ufa.cas.cz},
ResearcherID-Numbers = {Hanzlíková, Hana/H-6368-2014
   Urban, Aleš/H-6476-2014
   Stepanek, Petr/G-1614-2014
   Plavcova, Eva Pejchova/H-6308-2014
   Kysely, Jan/A-6982-2012
   },
ORCID-Numbers = {Hanzlíková, Hana/0000-0002-2460-0241
   Urban, Aleš/0000-0003-4608-3553
   Stepanek, Petr/0000-0001-8956-5590
   Kysely, Jan/0000-0002-6371-6597
   Plavcova, Eva/0000-0003-3922-6106},
Funding-Acknowledgement = {Czech Science FoundationGrant Agency of the Czech Republic
   {[}18-22125S]; Institute of Health Information and Statistics of the
   Czech Republic},
Funding-Text = {The study was supported by the Czech Science Foundation, project no.
   18-22125S. Mortality data were provided by the Institute of Health
   Information and Statistics of the Czech Republic. We thank B. Kriz and
   J. Kyncl, the National Institute of Public Health, for assistance with
   the data acquisition and preparation.},
Cited-References = {Akihiko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05655.
   {[}Anonymous], 2005, GRIDD POP WORLD 2005.
   {[}Anonymous], WORLD POP PROSP.
   {[}Anonymous], 2018, BBC.
   {[}Anonymous], 2019, BBC.
   Arbuthnott K, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0102-7.
   Astrom DO, 2013, EPIDEMIOLOGY, V24, P820, DOI 10.1097/01.ede.0000434530.62353.0b.
   Baccini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069638.
   Ballester J, 2010, CLIM DYNAM, V35, P1191, DOI 10.1007/s00382-009-0641-5.
   Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0.
   Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224.
   Bobak M, 1997, J EPIDEMIOL COMMUN H, V51, P272, DOI 10.1136/jech.51.3.272.
   Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392.
   Boeckmann M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1112.
   Burkart K, 2016, ENVIRON HEALTH PERSP, V124, P927, DOI 10.1289/ehp.1409529.
   Carson C, 2006, AM J EPIDEMIOL, V164, P77, DOI 10.1093/aje/kwj147.
   Christidis N, 2010, CLIMATIC CHANGE, V102, P539, DOI 10.1007/s10584-009-9774-0.
   Cifkova R, 2010, J HYPERTENS, V28, P2196, DOI 10.1097/HJH.0b013e32833d4451.
   Davidkovova H, 2013, HEART, V99, P409, DOI 10.1136/heartjnl-2012-303123.
   Davis RE, 2003, INT J BIOMETEOROL, V47, P166, DOI 10.1007/s00484-003-0160-8.
   de' Donato FK, 2015, INT J ENV RES PUB HE, V12, P15567, DOI 10.3390/ijerph121215006.
   Donaldson GC, 2003, ENVIRON RES, V91, P1, DOI 10.1016/S0013-9351(02)00002-6.
   DWD, 2018, UB VIEL HITZ SOMM 20.
   Egondi T, 2015, INT J ENV RES PUB HE, V12, P2735, DOI 10.3390/ijerph120302735.
   European Environment Agency, 2010, 132010 EUR ENV AG.
   Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0.
   Green HK, 2016, ENVIRON RES, V147, P343, DOI 10.1016/j.envres.2016.02.028.
   Gronlund CJ, 2015, ENVIRON RES, V136, P449, DOI 10.1016/j.envres.2014.08.042.
   Ha J, 2013, INT J BIOMETEOROL, V57, P535, DOI 10.1007/s00484-012-0580-4.
   Haas W, 2015, SPRINGER CLIMATE, P191, DOI 10.1007/978-3-319-12457-5\_11.
   Hanzlikova H, 2015, INT J BIOMETEOROL, V59, P1673, DOI 10.1007/s00484-015-0974-1.
   Hattis D, 2012, APPL GEOGR, V33, P45, DOI 10.1016/j.apgeog.2011.07.008.
   Hondula DM, 2015, CURR CLIM CHANGE REP, V1, P144, DOI 10.1007/s40641-015-0016-4.
   Hondula DM, 2014, SCI TOTAL ENVIRON, V490, P538, DOI 10.1016/j.scitotenv.2014.04.130.
   Hondula DM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-16.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456.
   Johnson MG, 2016, ENVIRON RES, V150, P30, DOI 10.1016/j.envres.2016.05.035.
   Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003.
   Kim H, 2015, SCI TOTAL ENVIRON, V512, P74, DOI 10.1016/j.scitotenv.2015.01.012.
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130.
   Kovach MM, 2015, APPL GEOGR, V60, P175, DOI 10.1016/j.apgeog.2015.03.012.
   Kysely J, 2004, INT J BIOMETEOROL, V49, P91, DOI 10.1007/s00484-004-0218-2.
   Kysely J, 2008, INT J BIOMETEOROL, V52, P733, DOI 10.1007/s00484-008-0166-3.
   Kysely J, 2012, CLIMATIC CHANGE, V113, P437, DOI 10.1007/s10584-011-0358-4.
   Kysely J, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014123.
   Lee JY, 2019, ENVIRON INT, V131, DOI 10.1016/j.envint.2019.105027.
   Lee W, 2018, ENVIRON INT, V116, P136, DOI 10.1016/j.envint.2018.04.017.
   Lee W, 2018, SCI TOTAL ENVIRON, V616, P703, DOI 10.1016/j.scitotenv.2017.10.258.
   Lhotka O, 2018, CLIM DYNAM, V50, P4249, DOI 10.1007/s00382-017-3873-9.
   Lhotka O, 2018, THEOR APPL CLIMATOL, V131, P1043, DOI 10.1007/s00704-016-2031-3.
   Lhotka O, 2015, INT J CLIMATOL, V35, P4399, DOI 10.1002/joc.4277.
   Li GX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04945-6.
   Li TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28161.
   Lorencova EK, 2019, CLIMATE, V7, DOI 10.3390/cli7050061.
   Lowe D, 2011, INT J ENV RES PUB HE, V8, P4623, DOI 10.3390/ijerph8124623.
   Mirabelli MC, 2005, AM J PUBLIC HEALTH, V95, P635, DOI 10.2105/AJPH.2004.042630.
   Ng CFS, 2016, GLOBAL ENVIRON CHANG, V39, P234, DOI 10.1016/j.gloenvcha.2016.05.006.
   O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043.
   OECD d, INC DISTR DAT IDD GI.
   Ourednicek M., 2016, ATLAS OBYVATELSTVA S.
   Pachauri R.K, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415416.
   Petkova EP, 2017, ENVIRON HEALTH PERSP, V125, P47, DOI 10.1289/EHP166.
   Petkova EP, 2014, EPIDEMIOLOGY, V25, P554, DOI 10.1097/EDE.0000000000000123.
   Putnam H, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aadb44.
   Qiao Z, 2015, ENVIRON HEALTH PERSP, V123, P766, DOI 10.1289/ehp.1307606.
   Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2.
   Rocklov J, 2011, OCCUP ENVIRON MED, V68, P531, DOI 10.1136/oem.2010.058818.
   Russo S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124003.
   Rychtarikova, 2004, DEMOGRAPHIC RES SPEC, V2, P105, DOI {[}10.4054/DemRes.2004.S2.5, 10.4054/DemRes.2004., DOI 10.4054/DemRes.2004.S2.5].
   Saha MV, 2014, AM J EPIDEMIOL, V179, P467, DOI 10.1093/aje/kwt264.
   SCHOENBERG B S, 1983, Neuroepidemiology, V2, P257, DOI 10.1159/000110529.
   Sewe MO, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP1745.
   Sheridan SC, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab214.
   Sheridan SC, 2017, ANTHROPOCENE, V20, P61, DOI 10.1016/j.ancene.2016.10.001.
   Sheridan SC, 2009, NAT HAZARDS, V50, P145, DOI 10.1007/s11069-008-9327-2.
   Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879.
   Taylor J, 2015, URBAN CLIM, V14, P517, DOI 10.1016/j.uclim.2015.08.001.
   Toloo G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-27.
   Uejio CK, 2011, HEALTH PLACE, V17, P498, DOI 10.1016/j.healthplace.2010.12.005.
   Urban A., 2019, 99 ANN M AM MET SOC.
   Urban A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121562.
   Urban A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030284.
   Vicedo-Cabrera AM, 2018, ENVIRON INT, V111, P239, DOI 10.1016/j.envint.2017.11.006.
   Vicedo-Cabrera AM, 2018, CLIMATIC CHANGE, V150, P391, DOI 10.1007/s10584-018-2274-3.
   Weisskopf MG, 2002, AM J PUBLIC HEALTH, V92, P830, DOI 10.2105/AJPH.92.5.830.
   World Bank, DEATH RAT CRUD PER 1.
   Yang J, 2015, CLIN PRACT, V5, P1, DOI DOI 10.1038/SREP12250.},
Number-of-Cited-References = {90},
Times-Cited = {6},
Usage-Count-Last-180-days = {6},
Usage-Count-Since-2013 = {28},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {KU8UM},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000519987300134},
DA = {2022-03-29},
}

@article{ WOS:000522163900001,
Author = {Assuncao, Ada Avila and Franca, Elisabeth Barboza},
Title = {Years of life lost by CNCD attributed to occupational hazards in Brazil:
   GBD 2016 study},
Journal = {REVISTA DE SAUDE PUBLICA},
Year = {2020},
Volume = {54},
Abstract = {OBJECTIVE: To assess the years of life lost due to premature death and
   disability-adjusted life years (DALY) as a result of chronic
   noncommunicable diseases attributable to occupational hazard factors,
   and to compare their position according to the risk ranking for chronic
   noncommunicable diseases in 1990 and 2016.
   METHODS: Data for the DALY indicator, estimated from the Global Burden
   of Disease 2016 (GBD 2016) study, were analyzed for noncommunicable
   chronic diseases attributable to occupational, and other risk factors,
   selected in Brazil. A descriptive analysis was performed comparing the
   proportion of DALY by sex and age group (15 to 49 and 50 to 69 years
   old), as well as the ranking of occupational hazard factors in 1990 and
   2016.
   RESULTS: In 2016, ergonomic risk factors, carcinogenic agents, and noise
   in the workplace were among the 25 largest contributors to DALY for
   chronic noncommunicable diseases affecting the age group between 15 and
   49 years. The contribution of all occupational hazard factors increased
   in 2016, except for occupational aerodispersoids affecting men.
   Concerning the age group between 50 and 69, occupational carcinogens
   stand out, with an increase of 26.0\% for men, and 17.1\% for women in
   2016. Risk factors evaluated according to their 1990 and 2016 ranking
   show that occupational hazards have all scored higher on the second
   evaluation (2016), especially when compared with other risks.
   CONCLUSIONS: The global burden of chronic noncommunicable diseases
   attributed to occupational hazard factors has become increasingly
   important. We suggest the strengthening of the approach of occupational
   hazard factors in the agendas for tackling these diseases in Brazil.},
Publisher = {REVISTA DE SAUDE PUBLICA},
Address = {FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Assuncao, AA (Corresponding Author), Av Alfredo Balena 190,Sala 705, BR-30130100 Belo Horizonte, MG, Brazil.
   Assuncao, Ada Avila; Franca, Elisabeth Barboza, Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Publ, Belo Horizonte, MG, Brazil.},
DOI = {10.11606/S1518-8787.2020054001257},
Article-Number = {28},
ISSN = {0034-8910},
EISSN = {1518-8787},
Keywords = {DALY; Occupational hazard factors; Brazil; Workers health},
Keywords-Plus = {GLOBAL BURDEN; RISK-FACTORS; DISEASE; HEALTH; PREVALENCE; NOISE; WORK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {avilaufmg@gmail.com},
ORCID-Numbers = {assuncao, ada/0000-0003-2123-0422
   Franca, Elisabeth Barboza/0000-0001-6984-0233},
Funding-Acknowledgement = {Ministerio da Saude - Fundo Nacional de Saude {[}TED-125/2017,
   25000.479.735/2017-40]},
Funding-Text = {Ministerio da Saude - Fundo Nacional de Saude (TED-125/2017) - Process:
   25000.479.735/2017-40.},
Cited-References = {Abtahi M, 2018, ENVIRON RES, V165, P158, DOI 10.1016/j.envres.2018.04.023.
   {[}Anonymous], GLOB HLTH DAT EXCH.
   Bambra C, 2011, J EPIDEMIOL COMMUN H, V65, P746, DOI 10.1136/jech.2009.102103.
   Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X.
   de Braga LC, 2010, CIENC SAUDE COLETIVA, V15, P1585, DOI 10.1590/S1413-81232010000700070.
   Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631.
   Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X.
   Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034799.
   Kalleberg AL, 2009, AM SOCIOL REV, V74, P1, DOI 10.1177/000312240907400101.
   Malta Deborah Carvalho, 2017, Rev. bras. epidemiol., V20, P217, DOI 10.1590/1980-5497201700050018.
   Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P609, DOI 10.5123/S1679-49742014000400003.
   de Castro TGM, 2019, CIENC SAUDE COLETIVA, V24, P2923, DOI 10.1590/1413-81232018248.18042017.
   Messing K, 2006, ENVIRON RES, V101, P149, DOI 10.1016/j.envres.2005.03.015.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223.
   Otero UB, 2016, REV BRAS CANC, V62, P43.
   Fernandes RDP, 2011, CAD SAUDE PUBLICA, V27, P78, DOI 10.1590/S0102-311X2011000100008.
   Pimenta AM, 2015, APPL ERGON, V47, P236, DOI 10.1016/j.apergo.2014.10.011.
   Ribeiro Fátima Sueli Neto, 2004, Cad. Saúde Pública, V20, P881, DOI 10.1590/S0102-311X2004000400002.
   Rushton Lesley, 2017, Curr Environ Health Rep, V4, P340, DOI 10.1007/s40572-017-0151-2.
   Rzewuska M, 2017, PLOS ONE, V12.
   Salvi S, 2018, LANCET GLOB HEALTH, V6, pE1363, DOI 10.1016/S2214-109X(18)30409-1.
   Schulte PA, 2017, AM J PUBLIC HEALTH, V107, P1051, DOI 10.2105/AJPH.2017.303765.
   Soriano JB, 2018, MED CLIN-BARCELONA, V151, P171, DOI 10.1016/j.medcli.2018.05.011.
   Souza Maria de Fatima Marinho de, 2017, Rev. bras. epidemiol., V20, P1, DOI 10.1590/1980-5497201700050001.},
Number-of-Cited-References = {27},
Times-Cited = {1},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {Rev. Saude Publica},
Doc-Delivery-Number = {KX8ZB},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000522163900001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000496924300006,
Author = {Butsing, Nipaporn and Tipayamongkholgul, Mathuros and Ratanakorn, Disya},
Title = {Estimation of expected years of life lost for patients with ischemic
   stroke and intracerebral hemorrhage},
Journal = {JOURNAL OF HEALTH RESEARCH},
Year = {2019},
Volume = {33},
Number = {5},
Pages = {408-415},
Abstract = {Purpose - The purpose of this paper is to estimate the mean life
   expectancy (LE) and the expected years of life lost (EYLL) for ischemic
   stroke and intracerebral hemorrhage.
   Design/methodology/approach - This retrospective cohort study included
   5,210 patients with a diagnosis of first ischemic stroke or
   intracerebral hemorrhage between 2005 and 2013 from Ramathibodi
   Hospital, Bangkok, Thailand. The survival of each case was followed
   until December 31, 2016. A semiparametric extrapolation method was
   applied to estimate the lifetime survival function relative to an age
   and sex-matched reference population.
   Findings - Of 5,210 patients, 74.2 percent experienced ischemic stroke.
   About 54.3 percent were men. Mean age at diagnosis was 64.3 years. The
   mean LE was 12.5 years for ischemic stroke and 12.0 years for
   intracerebral hemorrhage. The EYLL among patients with intracerebral
   hemorrhage was significantly higher than among those with ischemic
   stroke (10.1 vs 5.7). Women were expected to lose more LE than men for
   both types of stroke (p-value < 0.05), while younger aged patients were
   expected to lose more years of life than older ones.
   Originality/value - This study fulfilled an identified need to estimate
   LE and EYLL among patients with ischemic stroke and intracerebral
   hemorrhage.},
Publisher = {COLL PUBLIC HEALTH SCIENCES, CHULALONGKORN UNIV},
Address = {INST BUILDING 3 1011 FLR, CHULALONGKORN SOI 62, PHYATHAI RD, BANGKOK,
   10330, THAILAND},
Type = {Article},
Language = {English},
Affiliation = {Butsing, N (Corresponding Author), Mahidol Univ, Fac Med, Ramathibodi Hosp, Ramathibodi Sch Nursing, Bangkok, Thailand.
   Butsing, Nipaporn, Mahidol Univ, Fac Med, Ramathibodi Hosp, Ramathibodi Sch Nursing, Bangkok, Thailand.
   Tipayamongkholgul, Mathuros, Mahidol Univ, Fac Publ Hlth, Dept Epidemiol, Bangkok, Thailand.
   Ratanakorn, Disya, Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Med, Bangkok, Thailand.},
DOI = {10.1108/JHR-10-2018-0126},
ISSN = {0857-4421},
EISSN = {2586-940X},
Keywords = {Ischemic stroke; Intracerebral hemorrhage; Mean life expectancy;
   Expected years of life lost},
Keywords-Plus = {QUALITY-OF-LIFE; MORTALITY; SURVIVAL},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services},
Author-Email = {nipaporn.but@mahidol.ac.th},
Cited-References = {Aragon TJ, 2008, BMC PUBLIC HEALTH, V116, P1.
   Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263.
   Bundhamcharoen K, 2011, J BIOMED CENTRAL, V53, P1.
   Caplan L., 2009, CAPLANS STROKE, V4th.
   Chen YQ, 2006, BIOMETRIKA, V93, P303, DOI 10.1093/biomet/93.2.303.
   Chou CY, 2015, J STROKE CEREBROVASC, V24, P655, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.022.
   Fang MC, 2014, NEUROLOGY, V82, P1033, DOI 10.1212/WNL.0000000000000248.
   Hung MC, 2014, MED CARE, V52, P63, DOI 10.1097/MLR.0000000000000010.
   Hwang JS, 2004, QUAL LIFE RES, V13, P1, DOI 10.1023/B:QURE.0000015299.45623.38.
   Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543.
   Ma YY, 2010, CAN J STAT, V38, P665, DOI 10.1002/cjs.10076.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Meijering E, 2002, P IEEE, V90, P319, DOI 10.1109/5.993400.
   Rachpukdee S, 2013, J STROKE CEREBROVASC, V22, pE70, DOI 10.1016/j.jstrokecerebrovasdis.2012.05.005.
   Rutten-Jacobs LCA, 2013, JAMA-J AM MED ASSOC, V309, P1136, DOI 10.1001/jama.2013.842.
   Sun Y, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-133.
   Suwanwela NC, 2014, J STROKE, V16, P1, DOI 10.5853/jos.2014.16.1.1.
   Syriopoulou E, 2017, BRIT J CANCER, V117, P1419, DOI 10.1038/bjc.2017.300.
   Vibo R, 2012, STROKE RES TREAT, V1, P1.
   WHO, 2014, WORLD HLTH STAT.
   World Health Organization, 2018, TOP 10 CAUS DEATH 20.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {J. Health Res.},
Doc-Delivery-Number = {JN5FN},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000496924300006},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000419237700050,
Author = {Taksler, Glen B. and Rothberg, Michael B.},
Title = {Assessing Years of Life Lost Versus Number of Deaths in the United
   States, 1995-2015},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2017},
Volume = {107},
Number = {10},
Pages = {1653-1659},
Month = {OCT},
Abstract = {Objectives. To assess years of life lost to each cause of death in the
   United States between 1995 and 2015, and compare it with the number of
   deaths.
   Methods. We used Vital Statistics mortality data and defined
   ``life-years lost{''} as remaining life expectancy for each decedent's
   age, sex, and race. We calculated the share of life-years lost to each
   cause of death in each year, and examined reasons for changes.
   Results. In 2015, heart disease caused the most deaths, but cancer
   caused 23\% more life-years lost. Life-years lost to heart disease
   declined 6\% since 1995, whereas life-years lost to cancer increased
   16\%. The increase for cancer was entirely attributable to population
   growth and longer life expectancy; had these factors remained constant,
   life-years lost to heart disease and cancer would have fallen 56\% and
   38\%, respectively. Accidents (including overdoses), suicides, and
   homicides each caused twice the share of life-years lost as deaths.
   Measuring life-years lost highlighted racial disparities in heart
   disease, homicides, and perinatal conditions.
   Conclusions. Life-years lost may provide additional context for
   understanding long-term mortality trends.},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {800 I STREET, NW, WASHINGTON, DC 20001-3710 USA},
Type = {Article},
Language = {English},
Affiliation = {Taksler, GB (Corresponding Author), Cleveland Clin, Inst Med, 9500 Euclid Ave,G1-40F, Cleveland, OH 44195 USA.
   Taksler, Glen B.; Rothberg, Michael B., Cleveland Clin, Inst Med, 9500 Euclid Ave,G1-40F, Cleveland, OH 44195 USA.},
DOI = {10.2105/AJPH.2017.303986},
ISSN = {0090-0036},
EISSN = {1541-0048},
Keywords-Plus = {OVERDOSE DEATHS; ASSOCIATION; EXPECTANCY; INCREASES; DISEASE; HEALTH},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {taksleg@ccf.org},
ORCID-Numbers = {Taksler, Glen/0000-0002-7566-7104},
Funding-Acknowledgement = {Clinical and Translational Science Collaborative of Cleveland from the
   National Center for Advancing Translational Sciences, National
   Institutes of Health {[}KL2TR000440]; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health \& Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) {[}KL2TR000440] Funding Source:
   NIH RePORTER},
Funding-Text = {This study was supported in part by the Clinical and Translational
   Science Collaborative of Cleveland grant KL2TR000440, from the National
   Center for Advancing Translational Sciences, National Institutes of
   Health.},
Cited-References = {{[}Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1.
   Arias Elizabeth, 2016, Natl Vital Stat Rep, V65, P1.
   Arias Elizabeth, 2008, Vital Health Stat 2, P1.
   Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082.
   Brock D., 2002, MED SOCIAL JUSTICE, P362.
   Centers for Disease Control and Prevention, HIV AFR AM.
   Centers for Disease Control and Prevention, YEARS POT LIF LOST Y.
   Centers for Disease Control and Prevention, 2014, HIV SURV REP, V26.
   Centers for Disease Control and Prevention, 2017, CDC WOND.
   Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226.
   Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005.
   Egen O, 2017, AM J PUBLIC HEALTH, V107, P130, DOI 10.2105/AJPH.2016.303515.
   Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P157.
   Hinchliffe SR, 2013, CANCER EPIDEMIOL, V37, P11, DOI 10.1016/j.canep.2012.08.012.
   Institute for Health Metrics and Evaluation, GBD DAT TOOL GLOB BU.
   Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1.
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534.
   Murray CJL, 1996, GLOBAL BURDEN DIS CO.
   National Center for Health Statistics, VIT STAT US MORT 199.
   National Center for Health Statistics, VIT STAT DAT AV ONL.
   National Center for Health Statistics, VIT STAT US 1995 LIF, VII.
   Organization for Economic Co-operation and Development, INF MORT RAT IND.
   Perera G, 2016, AGE AGEING, V45, P667, DOI 10.1093/ageing/afw077.
   Peterson AB, 2016, MMWR-MORBID MORTAL W, V65, P844, DOI 10.15585/mmwr.mm6533a3.
   Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3.
   Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606.
   Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277.
   Taksler GB, 2013, ANN INTERN MED, V159, P161, DOI 10.7326/0003-4819-159-3-201308060-00005.
   The White House, FACT SHEET PRES OB P.
   US Census, QUICK FACTS.
   US Department of Health \& Human Services, OP EP NUMB.
   Weir HK, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160211.
   Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B.},
Number-of-Cited-References = {33},
Times-Cited = {12},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {FR7HF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000419237700050},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:A1989AW78300006,
Author = {HORM, JW and SONDIK, EJ},
Title = {PERSON-YEARS OF LIFE LOST DUE TO CANCER IN THE UNITED-STATES, 1970 AND
   1984},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {1989},
Volume = {79},
Number = {11},
Pages = {1490-1493},
Month = {NOV},
Publisher = {AMER PUBLIC HEALTH ASSOC INC},
Address = {1015 FIFTEENTH ST NW, WASHINGTON, DC 20005},
Type = {Article},
Language = {English},
Affiliation = {HORM, JW (Corresponding Author), NCI,DIV CANC PREVENT \& CONTROL,SPECIAL POPULAT STUDIES BRANCH,EPN-240,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.
   NCI,DIV CANC PREVENT \& CONTROL,CANC CONTROL SCI PROGRAM,BETHESDA,MD 20892.},
DOI = {10.2105/AJPH.79.11.1490},
ISSN = {0090-0036},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Cited-References = {EIHHORN LH, 1977, ANN INTERN MED, V87, P293.
   {*}NAT CANC I, 1988, NIH 882789 PUBL.
   {*}NAT CANC I, 1986, NIH862880 PUBL.
   {*}NAT CTR HLTH STAT, 1987, 1984 VIT STAT US A, V2.
   {*}NAT CTR HLTH STAT, 1988, OHHS PHS881232 PUBL.
   {*}NAT CTR HLTH STAT, 1974, 1970 VIT STAT US 5, V5.
   {*}NAT CTR HLTH STAT, 1987, 1984 VIT STAT US 6, V2.
   SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349.
   SONDIK E, 1987, NIH872789 PUB.
   STENKVIST B, 1984, JAMA-J AM MED ASSOC, V252, P1423, DOI 10.1001/jama.252.11.1423.
   STOCKWELL S, 1907, ONCOLOGY TIMES  0916.
   TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4.
   1984, MMWR, V35, P365.
   1987, MMWR, V36, P44.
   1986, MMWR S, V35, pS2.},
Number-of-Cited-References = {15},
Times-Cited = {58},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {1},
Journal-ISO = {Am. J. Public Health},
Doc-Delivery-Number = {AW783},
Web-of-Science-Index = {Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:A1989AW78300006},
OA = {Bronze, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000390071000151,
Author = {Yang, Jun and Ou, Chun-Quan and Song, Yu-Feng and Li, Li and Chen,
   Ping-Yan and Liu, Qi-Yong},
Title = {Estimating years of life lost from cardiovascular mortality related to
   air pollution in Guangzhou, China},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2016},
Volume = {573},
Pages = {1566-1572},
Month = {DEC 15},
Abstract = {Previous studies have mainly used mortality or morbidity as the health
   outcome to examine the air pollution health association. Little evidence
   is available on relationships between air pollutants and years of life
   lost (YLL). We aimed to estimate the YLL from cardiovascular mortality
   due to air pollution. Daily data on weather and air pollutants and
   individual data of all registered deaths for years 2004-2007 were
   obtained in Guangzhou, China. The generalized additive model was used to
   assess the YLL associated with 10 mu g/m(3) increases in NO2, SO2 and
   PM10. We found that the mean daily YLL was 248, 87.5 and 73.7 for deaths
   from cardiovascular disease (CVD), stroke and Ischemic heart disease
   (IHD), respectively. A significant linear correlation was observed
   between air pollution and YLL due to cardiovascular disease. The effects
   of air pollutants on YLL were immediate and lasted for two days. A 10 mu
   g/m(3) increase above the corresponding threshold of 55.6 mu g/m(3),
   40.4 mu g/m(3) and 0 mu g/m(3) in NO2, PM10 and SO2 was related to YLL
   increase of 1.8 (95\% CI: 0.8-2.9), 2.8 (1.7-3.8) and 2.6 (1.2-4.0)
   years at lag 0-1 days for CVD, respectively. The estimates of YLL
   associated with NO2 and PM10 were higher in men than women. The air
   pollutants-related YLL was higher among young people and those with low
   education level, compared to the elderly and those with high education
   level, respectively. These findings confirmed YLL provides a
   complementary strategy for assessing the health effect of air pollution.
   This study underscores the necessity of the reduction of air pollution
   benefiting public health. (C) 2016 Elsevier B.V. All rights reserved.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Ou, CQ (Corresponding Author), Southern Med Univ, Sch Publ Hlth, Guangzhou 510515, Guangdong, Peoples R China.
   Liu, QY (Corresponding Author), Chinese Ctr Dis Control \& Prevent, Natl Inst Communicable Dis Control \& Prevent, Beijing 102206, Peoples R China.
   Yang, Jun; Liu, Qi-Yong, Chinese Ctr Dis Control \& Prevent, State Key Lab Infect Dis Prevent \& Control, Collaborat Innovat Ctr Diag \& Treatment Infect Di, Natl Inst Communicable Dis Control \& Prevent, Beijing 102206, Peoples R China.
   Yang, Jun; Ou, Chun-Quan; Li, Li; Chen, Ping-Yan, Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res, Dept Biostat,Sch Publ Hlth, Guangzhou 510515, Guangdong, Peoples R China.
   Song, Yu-Feng, Guangdong 2 Prov Peoples Hosp, Intens Care Unit, Guangzhou 510317, Guangdong, Peoples R China.},
DOI = {10.1016/j.scitotenv.2016.09.014},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Air pollutants; Years of life lost; Cardiovascular disease; Mortality;
   China},
Keywords-Plus = {SHORT-TERM EXPOSURE; PARTICULATE MATTER; TEMPERATURE; HEALTH;
   ASSOCIATION; STATEMENT; DISEASE; BURDEN},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {smart\_yjun@163.com
   ouchunquan@hotmail.com
   yfsong126@126.com
   lylygdsg@163.com
   chenpy99@126.com
   liuqiyong@icdc.cn},
ResearcherID-Numbers = {Yang, Jun/Q-3037-2019
   },
ORCID-Numbers = {Ou, Chun-Quan/0000-0001-6866-7213
   Li, Li/0000-0003-4802-8689
   Yang, Jun/0000-0002-8049-4746},
Funding-Acknowledgement = {National Basic Research Program of China (973 Program)National Basic
   Research Program of China {[}2012CB955504]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China (NSFC)
   {[}81573249]; Natural Science Foundation of Guangdong ProvinceNational
   Natural Science Foundation of Guangdong Province {[}2016A030313530]},
Funding-Text = {This study was supported by the National Basic Research Program of China
   (973 Program) (Grant No. 2012CB955504), National Natural Science
   Foundation of China (81573249) and Natural Science Foundation of
   Guangdong Province {[}2016A030313530].},
Cited-References = {Beelen R, 2014, EPIDEMIOLOGY, V25, P368, DOI 10.1097/EDE.0000000000000076.
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8.
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1.
   Burkart K, 2013, ENVIRON POLLUT, V183, P54, DOI 10.1016/j.envpol.2013.06.002.
   Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b.
   Chen RJ, 2012, ENVIRON RES, V118, P101, DOI 10.1016/j.envres.2012.07.003.
   Chen RJ, 2012, ENVIRON INT, V45, P32, DOI 10.1016/j.envint.2012.04.008.
   Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425.
   Fang M, 2009, ATMOS ENVIRON, V43, P79, DOI 10.1016/j.atmosenv.2008.09.064.
   Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046.
   Guo YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05509.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Hu WB, 2008, INT J BIOMETEOROL, V52, P689, DOI 10.1007/s00484-008-0161-8.
   Jhun I, 2014, ENVIRON INT, V73, P128, DOI 10.1016/j.envint.2014.07.009.
   Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa.
   Li L., 2016, SCI REP, V6.
   Li S., 2016, ENV HLTH PERSPECT.
   Liu T, 2014, ENVIRON POLLUT, V187, P116, DOI 10.1016/j.envpol.2013.12.027.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Milojevic A, 2014, HEART, V100, P1093, DOI 10.1136/heartjnl-2013-304963.
   National Bureau of Statistics of China, 2011, CHIN STAT YB.
   Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010.
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003.
   Valdes A, 2012, ENV HLTH, V11, P11, DOI DOI 10.1186/1476-069X-11-82.
   Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257.
   Wong CM, 2007, EPIDEMIOLOGY, V18, P593, DOI 10.1097/EDE.0b013e318125713c.
   World Health Organization, 2009, WHO DIS INJ COUNTR E.
   World Health Organization, 2010, LIF TABL WHO MEMB ST.
   Yang CX, 2012, INT ARCH OCC ENV HEA, V85, P579, DOI 10.1007/s00420-011-0707-7.
   Yang J., 2015, SCI REP, V5.
   Yang J, 2016, ENVIRON INT, V92-93, P232, DOI 10.1016/j.envint.2016.04.001.
   Yang J, 2016, SCI TOTAL ENVIRON, V543, P75, DOI 10.1016/j.scitotenv.2015.11.014.
   Yang J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-63.
   YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888.
   Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108.
   Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116.},
Number-of-Cited-References = {37},
Times-Cited = {48},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {40},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {EF1FP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000390071000151},
DA = {2022-03-29},
}

@article{ WOS:000556978100001,
Author = {Jung, Yoon-Sun and Kim, Ki-Beom and Yoon, Seok-Jun},
Title = {Factors Associated with Regional Years of Life Lost (YLLs) due to
   Suicide in South Korea},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2020},
Volume = {17},
Number = {14},
Month = {JUL},
Abstract = {South Korea's suicide rate has remained among the highest in the world
   for some years, and there is also a gap in suicide rates among regions
   within the country. This study investigates the differences in years of
   life lost (YLLs) due to suicide in 250 districts and the factors
   associated with regional YLLs in South Korea in 2016. The relationships
   between YLLs due to suicide by region and factors such as population
   characteristics, health behaviors, socioeconomic factors, and mental
   health resources in the community were examined through multiple linear
   regression analysis. The gap between districts with the highest and
   lowest YLL due to suicide per 100,000 people was more than a 7-times
   difference. Factors related to YLLs due to suicide by region were
   physical activity rates and community mental healthcare centers, and
   there were differences in these factors according to gender. In
   conclusion, to prevent suicide at the community level, it is necessary
   to consider gender in establishing intervention strategies. The
   community needs to play an active role in promoting mental health and
   reducing suicide among local residents and to continue to invest in the
   support and management of those at high risk of suicide.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Yoon, SJ (Corresponding Author), Korea Univ, Coll Med, Dept Prevent Med, 73 Goryeodae Ro, Seoul 02841, South Korea.
   Jung, Yoon-Sun; Kim, Ki-Beom, Korea Univ, Dept Publ Hlth, 73 Goryeodae Ro, Seoul 02841, South Korea.
   Yoon, Seok-Jun, Korea Univ, Coll Med, Dept Prevent Med, 73 Goryeodae Ro, Seoul 02841, South Korea.},
DOI = {10.3390/ijerph17144961},
Article-Number = {4961},
EISSN = {1660-4601},
Keywords = {suicide; years of life lost; regional difference; South Korea},
Keywords-Plus = {GENDER DIFFERENCES; RISK-FACTORS; ADOLESCENTS; IDEATION; WALKING;
   ADULTS; SEX},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {sunnyaurora@nate.com
   socommat@korea.ac.kr
   yoonsj02@korea.ac.kr},
ORCID-Numbers = {Yoon, Seok-Jun/0000-0003-3297-0071},
Funding-Acknowledgement = {National Research Foundation of Korea (NRF) grant from the Korean
   government (Ministry of Science and ICT) {[}2017R1A2B4005876]},
Funding-Text = {This work was supported by a National Research Foundation of Korea (NRF)
   grant from the Korean government (Ministry of Science and ICT) (No.
   2017R1A2B4005876). The funding agency had no role in the study design,
   analysis and interpretation of the data, or the preparation of the
   manuscript.},
Cited-References = {{[}Anonymous], {*}{*}NON-TRADITIONAL{*}{*}.
   Chang SS, 2011, HEALTH PLACE, V17, P641, DOI 10.1016/j.healthplace.2011.01.003.
   Cheong Kyu-Seok, 2012, J Prev Med Public Health, V45, P70, DOI 10.3961/jpmph.2012.45.2.70.
   Chin YR, 2011, INT J PUBLIC HEALTH, V56, P429, DOI 10.1007/s00038-011-0245-9.
   Cho KO, 2014, J SPORT SCI MED, V13, P888.
   Ekkekakis P, 2008, PSYCHOL SPORT EXERC, V9, P246, DOI 10.1016/j.psychsport.2007.04.004.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gehlert S, 2011, SOC DISPAR H H CARE, P57, DOI 10.1007/978-1-4419-7482-2\_4.
   Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484.
   Hung PY, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02607-y.
   Jeong Jinyoung, 2017, {[}Korean Public Health Research, 대한보건연구], V43, P91.
   Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117929.
   Korea National Center for Mental Health, 2016, MENT HLTH STAT SURV.
   Korea National Statistical Office, 2018, CAUS DEATH DAT 2018.
   Korea National Statistical Office, 2016, CAUS DEATH DAT 2016.
   Korea National Statistical Office, 2016, FUT POP EST DAT 2016.
   Korean Ministry of Health and Welfare, 2016, NAT HLTH INS STAT 20.
   Korean Ministry of Health and Welfare, 2016, COMM HLTH SURV 2016.
   Korean Ministry of Interior and Safety, 2016, RES REG POP STAT DAT.
   Korean Ministry of Interior and Safety Korean Ministry of Interior and Safety, 2019, LOC AUT.
   Lee HY, 2013, PSYCHIAT RES, V210, P323, DOI 10.1016/j.psychres.2013.05.012.
   Lee SY., 2015, J KOREA ACAD IND COO, V16, P4777, DOI {[}10.5762/KAIS.2015.16.7.4777, DOI 10.5762/KAIS.2015.16.7.4777].
   Lee YR, 2016, J KOREAN MED SCI, V31, pS121, DOI 10.3346/jkms.2016.31.S2.S121.
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3.
   Marmot M., 2004, SOCIAL CAUSES SOCIAL, P37.
   Melanson, 2011, SELF DIRECTED VIOLEN.
   Murphy M, 2002, MED SCI SPORT EXER, V34, P1468, DOI 10.1097/00005768-200209000-00011.
   Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94.
   Park E, 2008, J KOREAN ACAD NURS, V38, P465, DOI 10.4040/jkan.2008.38.3.465.
   Park I.J., 2017, KOREA INS PUBLIC AFF, V55, P333.
   Park S, 2018, PSYCHIAT RES, V261, P143, DOI 10.1016/j.psychres.2017.12.055.
   Park S, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0277-1.
   Qin P, 2000, BRIT J PSYCHIAT, V177, P546, DOI 10.1192/bjp.177.6.546.
   Ro Junsoo, 2015, J Prev Med Public Health, V48, P28, DOI 10.3961/jpmph.14.030.
   Shin KM, 2013, AGING MENT HEALTH, V17, P109, DOI 10.1080/13607863.2012.702732.
   Song J, 2019, PSYCHIAT INVEST, V16, P800, DOI 10.30773/pi.2019.0025.
   The Office for Government Policy Coordination, 2019, NAT ACT PLAN SUIC PR.
   Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034.
   World Health Organization (WHO), 2013, COMPR MENT HLTH ACT.
   Yoon Myeong-Sook, 2012, {[}Journal of community welfare, 한국지역사회복지학], V40, P213.
   김효창, 2006, {[}Korean Psychological Journal of Culture and Social Issues, 한국심리학회지: 문화 및 사회문제], V12, P15.},
Number-of-Cited-References = {41},
Times-Cited = {4},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {MW3ZA},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000556978100001},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000338213300077,
Author = {Pikala, Malgorzata and Bryla, Marek and Bryla, Pawel and Maniecka-Bryla,
   Irena},
Title = {Years of Life Lost Due to External Causes of Death in the Lodz Province,
   Poland},
Journal = {PLOS ONE},
Year = {2014},
Volume = {9},
Number = {5},
Month = {MAY 8},
Abstract = {Background: The aim of the study is the analysis of years of life lost
   due to external causes of death, particularly due to traffic accidents
   and suicides.
   Materials and Methods: The study material includes a database containing
   information gathered from 376,281 death certificates of inhabitants of
   the Lodz province who died between 1999 and 2010. The Lodz province is
   characterized by the highest mortality rates in Poland. The SEYLLp
   (Standard Expected Years of Life Lost per living person) and the SEYLLd
   (per death) indices were used to determine years of life lost. Joinpoint
   models were used to analyze time trends.
   Results: In 2010, deaths due to external causes constituted 6.0\% of the
   total number of deaths. The standardized death rate (SDR) due to
   external causes was 110.0 per 100,000 males and was five times higher
   than for females (22.0 per 100,000 females). In 2010, the SEYLLp due to
   external causes was 3746 per 100,000 males and 721 per 100,000 females.
   Among males, suicides and traffic accidents were the most common causes
   of death (the values of the SEYLLp were: 1098 years and 887 years per
   100,000 people, respectively). Among females, the SEYLLp values were 183
   years due to traffic accidents and 143 years due to suicides (per
   100,000 people).
   Conclusions: A decrease in the number of years of life lost due to
   external causes is much higher among females. The authors observe that a
   growing number of suicides contribute to an increase in the value of the
   SEYLLp index. This directly contributes to over-mortality of males due
   to external causes. The analysis of the years of life lost focuses on
   the social and economic aspects of premature mortality due to external
   causes.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Maniecka-Bryla, I (Corresponding Author), Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Lodz, Poland.
   Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ Lodz, Chair Social \& Prevent Med, Dept Epidemiol \& Biostat, Lodz, Poland.
   Bryla, Marek, Med Univ Lodz, Chair Social \& Prevent Med, Dept Social Med, Lodz, Poland.
   Bryla, Pawel, Univ Lodz, Dept Int Mkt \& Retailing, PL-90131 Lodz, Poland.},
DOI = {10.1371/journal.pone.0096830},
Article-Number = {e96830},
ISSN = {1932-6203},
Keywords-Plus = {SELF-RATED HEALTH; SUICIDE MORTALITY; JOINPOINT REGRESSION; PREMATURE
   DEATH; RISK-FACTORS; TRENDS; DEPRESSION; DETERMINANTS; INEQUALITIES;
   COUNTRIES},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {irena.maniecka-bryla@umed.lodz.pl},
ResearcherID-Numbers = {Pikala, Malgorzata/S-9898-2016
   Bryla, Marek/AAW-5787-2021
   Maniecka-Bryla, Irena/AAW-5779-2021
   Bryła, Paweł/B-8262-2013},
ORCID-Numbers = {Pikala, Malgorzata/0000-0003-4426-4908
   Bryla, Marek/0000-0001-6757-9211
   Maniecka-Bryla, Irena/0000-0002-6671-7456
   Bryła, Paweł/0000-0003-1535-5659},
Funding-Acknowledgement = {Medical University of Lodz {[}503/6-029-07/503-01]},
Funding-Text = {The study was conducted on the basis of the Medical University of Lodz
   project no. 503/6-029-07/503-01. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.},
Cited-References = {{[}Anonymous], 2009, HLTH STAT ATLAS MORT.
   Bertolote JM, 2015, SUICIDOLOGI, V7, P6, DOI DOI 10.5617/SUICIDOLOGI.2330.
   Bryla M, 2013, MED PR, V64, P307.
   Bryla M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-181.
   Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108.
   Flavio M, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13759.
   Goniewicz M, 2010, BEZPIECZENSTWO PRACY, V9, P14.
   Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X.
   Hofer P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-644.
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q.
   Kolves K, 2013, SOCIOL HEALTH ILL, V35, P956, DOI 10.1111/1467-9566.12011.
   Kulaga Z., 2009, PROBL HIG EPIDEMIOL, V90, P332.
   Kuypers KPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043496.
   Maki NE, 2007, SCAND J PUBLIC HEALT, V35, P387.
   Makinen IH, 2006, SOC SCI MED, V63, P307, DOI 10.1016/j.socscimed.2006.01.002.
   Maniecka-Bryla I, 2013, INT J OCCUP MED ENV, V26, P724, DOI 10.2478/s13382-013-0154-7.
   Maniecka-Bryla I, 2013, ANN AGR ENV MED, V20, P794.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Maniecka-Bryla I, 2013, ARCH GERONTOL GERIAT, V57, P156, DOI 10.1016/j.archger.2013.03.006.
   Maniecka-Bryla I, 2012, ANN AGR ENV MED, V19, P723.
   Maniecka-Bryla I, 2011, MED LAV, V102, P523.
   Maniecka-Bryla I, 2011, POL J ENVIRON STUD, V20, P691.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Marshall RJ, 2004, AUST NZ J PUBL HEAL, V28, P452, DOI 10.1111/j.1467-842X.2004.tb00027.x.
   Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985.
   Martinez-Beneito MA, 2011, ANN APPL STAT, V5, P2150, DOI 10.1214/11-AOAS471.
   Mazur Joanna, 2007, Przegl Epidemiol, V61, P777.
   Mladovsky P., 2009, HLTH EUROPEAN UNION.
   Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6.
   Moniruzzaman S, 2004, PUBLIC HEALTH, V118, P346, DOI 10.1016/j.puhe.2003.10.004.
   Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537.
   Murray CJL, 2000, GLOBAL BURDEN DIS, V1.
   Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176.
   Oquendo MA, 2007, AM J PSYCHIAT, V164, P134, DOI 10.1176/appi.ajp.164.1.134.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2011, CENT EUR J PUBL HEAL, V19, P183, DOI 10.21101/cejph.a3675.
   Razvodovsky Y, 2009, PUBLIC HEALTH, V123, P27, DOI 10.1016/j.puhe.2008.10.003.
   Rockett IRH, 2011, SUICIDOL ONLINE-SOL, V2, P48.
   Salmeron D, 2013, J PUBLIC HEALTH-UK, V35, P237, DOI 10.1093/pubmed/fds103.
   Skog OJ, 2001, ADDICTION, V96, pS49.
   Titelman D, 2013, NORD J PSYCHIAT, V67, P414, DOI 10.3109/08039488.2012.752036.
   Twisk DAM, 2007, J SAFETY RES, V38, P245, DOI 10.1016/j.jsr.2007.03.006.
   Vlajinac H, 2008, PUBLIC HEALTH, V122, P277, DOI 10.1016/j.puhe.2007.06.010.
   Walinder J, 2001, INT CLIN PSYCHOPHARM, V16, pS21.
   Wojtyniak B., 2012, HLTH SITUATION POLIS.},
Number-of-Cited-References = {45},
Times-Cited = {18},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {7},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {AK1XT},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000338213300077},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000176513000001,
Author = {Park, RM and Bailer, AJ and Stayner, LT and Halperin, W and Gilbert, SJ},
Title = {An alternate characterization of hazard in occupational epidemiology:
   Years of life lost per years worked},
Journal = {AMERICAN JOURNAL OF INDUSTRIAL MEDICINE},
Year = {2002},
Volume = {42},
Number = {1},
Pages = {1-10},
Month = {JUL},
Abstract = {Background Standardized mortality ratios (SMRs) and other measures of
   relative risk by themselves may not suffice as descriptors of
   occupational hazards for many audiences including decision-makers and
   those at direct risk from hazardous work. To explore other approaches,
   we calculated excess years of potential life lost and excess lifetime
   risk for both lung diseases and fatal injuries in a cohort of uranium
   miners with historical records of exposure to radon gas.
   Methods We used relatively simple life table (SMR) methods and also
   analyzed lung cancer mortality with Poisson regression methods
   permitting control for smoking.
   Results Among uranium miners hired after 1950, whose all-cause SMR was
   1.5, 28 percent would experience premature death from lung diseases or
   injury in a lifetime of uranium mining. On average, each miner lost 1.5
   yr of potential life due to mining-related lung cancer or almost 3
   months of life for each year employed in uranium mining. As a
   consequence of all excess lung disease and injury risks combined, a year
   of mining was associated with 5.9 months loss of potential life. For
   each year actually working underground, miners lost more than 8 months
   of potential life. When controlled for smoking (and healthy worker
   effect) with Poisson regression, the estimates for radon-related lung
   cancer effects were slightly larger Although chronic disease deaths
   dominated in excess years of life lost (due to radon, silica and
   possibly other exposures), more years were lost on average per
   individual injury death (38 yr), than per excess lung cancer (20 yr) or
   other lung disease death (18 yr). Fatal-injury dominated the potential
   years of life lost up to about age 40.
   Conclusions Years of life lost per years employed provides another more
   intuitive summary of occupational mortality risk. Published 2002
   Wiley-Liss, Inc.(dagger).},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Park, RM (Corresponding Author), NIOSH, EID, Risk Evaluat Branch, 4676 Columbia Pkwy,MS C-15, Cincinnati, OH 45226 USA.
   NIOSH, EID, Risk Evaluat Branch, Cincinnati, OH 45226 USA.
   Miami Univ, Dept Math \& Stat, Oxford, OH 45056 USA.
   NIOSH, Div Surveillance Hazard Evaluat \& Field Studi, Cincinnati, OH 45226 USA.
   Univ Med \& Dent New Jersey, Dept Prevent Med \& Community Hlth, Newark, NJ 07103 USA.},
DOI = {10.1002/ajim.10082},
ISSN = {0271-3586},
EISSN = {1097-0274},
Keywords = {attributable risk; excess lifetime risk; fatal mining injury; radon;
   silicosis; uranium mining; worker notification; YPLL},
Keywords-Plus = {LUNG-CANCER MORTALITY; URANIUM MINERS; RISK; SILICA},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {rhp9@cdc.gov},
ORCID-Numbers = {Bailer, A. John/0000-0002-7233-1461},
Cited-References = {Archer VE, 1998, J OCCUP ENVIRON MED, V40, P460, DOI 10.1097/00043764-199805000-00009.
   ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009.
   {*}BEIR 4, 1988, BIOL EFF ION RAD, V4.
   Checkoway H, 1997, AM J EPIDEMIOL, V145, P680, DOI 10.1093/aje/145.8.680.
   FINGER R, 1990, MMWR-MORBID MORTAL W, V39, P680.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gilbert SJ, 1998, HUM ECOL RISK ASSESS, V4, P1321, DOI 10.1080/10807039891284695.
   Greenland S, 1999, AM J PUBLIC HEALTH, V89, P1166, DOI 10.2105/AJPH.89.8.1166.
   HAENSZEL W, 1950, AM J PUBLIC HEALTH, V40, P17, DOI 10.2105/AJPH.40.1.17.
   Hornung RW, 1998, HEALTH PHYS, V74, P12, DOI 10.1097/00004032-199801000-00002.
   Infante P F, 1995, New Solut, V5, P52, DOI 10.2190/NS5.2.j.
   Langholz B, 1999, AM J IND MED, V35, P246, DOI 10.1002/(SICI)1097-0274(199903)35:3<246::AID-AJIM4>3.3.CO;2-Y.
   Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219.
   Lundin F.E., 1971, NIOSH NIEHS JOINT MO, V1.
   MONSON R, 1997, USDR97 RATES DEP ENV.
   Park R M, 1991, Epidemiology, V2, P49, DOI 10.1097/00001648-199101000-00008.
   PEACOCK PB, 1971, BIOMETRICS, V27, P903, DOI 10.2307/2528827.
   Preston DL, 1993, EPICURE USERS GUIDE.
   Pugh, 1970, EPIDEMIOLOGY PRINCIP.
   Rice FL, 2001, OCCUP ENVIRON MED, V58, P38, DOI 10.1136/oem.58.1.38.
   ROSCOE RJ, 1989, JAMA-J AM MED ASSOC, V262, P629, DOI 10.1001/jama.262.5.629.
   ROSCOE RJ, 1995, AM J PUBLIC HEALTH, V85, P535, DOI 10.2105/AJPH.85.4.535.
   Roscoe RJ, 1997, AM J IND MED, V31, P211, DOI 10.1002/(SICI)1097-0274(199702)31:2<211::AID-AJIM11>3.0.CO;2-4.
   ROTHMAN K, 1986, MODERN EPIDEMIOLOGY.
   Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869.
   Steenland K, 1998, AM J IND MED, V34, P517, DOI 10.1002/(SICI)1097-0274(199811)34:5<517::AID-AJIM14>3.0.CO;2-4.
   Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606.},
Number-of-Cited-References = {27},
Times-Cited = {31},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {Am. J. Ind. Med.},
Doc-Delivery-Number = {567XV},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000176513000001},
DA = {2022-03-29},
}

@article{ WOS:000275824600025,
Author = {Ludwig, Heinz and Bolejack, Vanessa and Crowley, John and Blade, Joan
   and San Miguel, Jesus and Kyle, Robert A. and Rajkumar, S. Vincent and
   Shimizu, Kazuyuki and Turesson, Ingemar and Westin, Jan and Sonneveld,
   Pieter and Cavo, Michele and Boccadoro, Mario and Palumbo, Antonio and
   Tosi, Patrizia and Harousseau, Jean-Luc and Attal, Michel and Barlogie,
   Bart and Stewart, A. Keith and Durie, Brian},
Title = {Survival and Years of Life Lost in Different Age Cohorts of Patients
   With Multiple Myeloma},
Journal = {JOURNAL OF CLINICAL ONCOLOGY},
Year = {2010},
Volume = {28},
Number = {9},
Pages = {1599-1605},
Month = {MAR 20},
Abstract = {Purpose
   To assess the impact of age on outcome and to analyze the projected
   years of life lost in patients with multiple myeloma.
   Patients and Methods
   Ten thousand five hundred forty-nine patients were evaluated; 6,996
   patients were treated with conventional chemotherapy, and 3,553 patients
   were treated with high-dose therapy with autologous stem-cell
   transplantation.
   Results
   Mean observed and relative overall survival times in the entire cohort
   were 3.7 and 3.9 years, respectively. Observed survival decreased
   steadily from 6.4 years in patients younger than age 50 years to 2.5
   years in patients >= age 80 years. A similar decrease was noted for
   relative survival. Higher age correlated significantly with higher
   International Staging System (ISS) stage. Relative excess risk of death
   differed significantly between 10-year age cohorts beginning from age 40
   years (P < .001 for age 50 to 59 v age 40 to 49, P < .001 for age 60 to
   69 v age 50 to 59, P < .001 for age 70 to 79 v age 60 to 69, and P =
   .009 for age >= 80 v 70 to 79). The average years of life lost per
   patient was 16.8 years in the entire patient cohort and decreased
   steadily from 36.1 years in patients younger than 40 years old to 4.6
   years in patients >= age 80 years.
   Conclusion
   Age is associated with higher ISS stage and is an important risk factor
   for early mortality. Survival declined continuously by each decade from
   age 50 to age >= 80 from more than 6 to less than 3 years. The average
   of years of life lost in patients with myeloma is higher than in many
   other cancers and amounts to more than 30 years in patients younger than
   40 years old but decreases to less than 5 years in patients age 80 years
   or older.},
Publisher = {AMER SOC CLINICAL ONCOLOGY},
Address = {2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA},
Type = {Article},
Language = {English},
Affiliation = {Ludwig, H (Corresponding Author), Wilhelminenspital Stadt Wien, Ctr Oncol \& Hematol, Dept Med 1, Montleartstr 37, A-1160 Vienna, Austria.
   Ludwig, Heinz, Wilhelminenspital Stadt Wien, Ctr Oncol \& Hematol, Dept Med 1, A-1160 Vienna, Austria.
   Canc Res \& Biostat, Seattle, WA USA.
   Mayo Clin, Div Hematol, Rochester, MN USA.
   Univ Arkansas Med Sci, Myeloma Inst Res \& Therapy, Little Rock, AR 72205 USA.
   Mayo Clin, Scottsdale, AZ USA.
   Int Myeloma Fdn, SW Oncol Grp, Los Angeles, CA USA.
   Cedars Sinai Comprehens Canc Ctr, Los Angeles, CA USA.
   Hosp Clin Inst Invest Biomed August Pi \& Sunyer, Inst Hematol \& Oncol, Dept Hematol, Barcelona, Spain.
   USAL, Serv Hematol, Inst Biol Mol \& Celular Canc, Hosp Univ Salamanca,Ctr Invest Canc,CSIC, Salamanca, Spain.
   Nagoya City Midori Gen Hosp, Dept Med, Nagoya, Aichi, Japan.
   Univ Hosp, Dept Hematol, Malmo, Sweden.
   Univ Gothenburg, Dept Hematol, Sahlgrenska Univ Hosp, Gothenburg, Sweden.
   Erasmus MC, Dept Hematol, Rotterdam, Netherlands.
   Univ Bologna, Inst Hematol \& Med Oncol Seragnoli, Bologna, Italy.
   Osped Univ San Giovanni Battista Torino, Hosp Univ Torino, Serv Hematol, Turin, Italy.
   Hop Purpan, Serv Hematol, Toulouse, France.
   CHU Hotel Dieu, Div Hematol, F-44035 Nantes 01, France.},
DOI = {10.1200/JCO.2009.25.2114},
ISSN = {0732-183X},
EISSN = {1527-7755},
Keywords-Plus = {SERUM BETA-2-MICROGLOBULIN; CANCER; DISEASE; IMPACT;
   BETA2-MICROGLOBULIN; FEATURES},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {heinz.ludwig@wienkav.at},
ResearcherID-Numbers = {Rajkumar, S. Vincent/AAV-1834-2021
   CAVO, MICHELE/AAK-8274-2020
   IBSAL, Secretaría/H-3719-2011
   San-Miguel, Jesús F./V-8977-2018
   ATTAL, Michel M/G-5290-2017
   },
ORCID-Numbers = {Rajkumar, S. Vincent/0000-0002-5862-1833
   CAVO, MICHELE/0000-0003-4514-3227
   San-Miguel, Jesús F./0000-0002-9183-4857
   ATTAL, Michel M/0000-0002-0136-9665
   Boccadoro, Mario/0000-0001-8130-5209},
Cited-References = {Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098.
   Brown ML., 2006, CANC EPIDEMIOLOGY PR, P202.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   CUTLER DM, 2008, W7760 NBER.
   Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597.
   DIMOPOULOS MA, 1993, J CLIN ONCOL, V11, P1108, DOI 10.1200/JCO.1993.11.6.1108.
   GREY HM, 1973, J EXP MED, V138, P1608, DOI 10.1084/jem.138.6.1608.
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010.
   KANTARJIAN HM, 1992, AM J MED, V93, P599, DOI 10.1016/0002-9343(92)90191-D.
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868.
   Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100.
   Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129.
   Lenhoff S, 2006, BRIT J HAEMATOL, V133, P389, DOI 10.1111/j.1365-2141.2006.06042.x.
   LITAM P, 1991, ANN INTERN MED, V114, P855, DOI 10.7326/0003-4819-114-10-855.
   LUDWIG H, 1982, J NATL CANCER I, V68, P729.
   Ludwig H, 2008, BLOOD, V111, P4039, DOI 10.1182/blood-2007-03-081018.
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163.
   MINCER J, 1970, J ECON LIT, V8, P1.
   National Cancer Institute, SEER CANC STAT REV 1.
   Nilsson T, 2002, EUR J HAEMATOL, V68, P345, DOI 10.1034/j.1600-0609.2002.00724.x.
   Riccardi A, 1998, BRIT J CANCER, V77, P485, DOI 10.1038/bjc.1998.77.
   Sagaster V, 2007, EUR J HAEMATOL, V78, P227, DOI 10.1111/j.1600-0609.2006.00807.x.
   SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689.
   TEASDALE C, 1977, CLIN CHIM ACTA, V78, P135, DOI 10.1016/0009-8981(77)90346-1.
   {*}U CALF BERK M PLA, HUM MORT DAT.
   {*}US NAT CTR HLTH S, CANC TRENDS PROGR RE.
   WIBELL L, 1973, NEPHRON, V10, P320, DOI 10.1159/000180203.
   Yabroff KR, 2008, J NATL CANCER I, V100, P1755, DOI 10.1093/jnci/djn383.
   {[}No title captured].},
Number-of-Cited-References = {29},
Times-Cited = {98},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {5},
Journal-ISO = {J. Clin. Oncol.},
Doc-Delivery-Number = {572IR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000275824600025},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000748401300001,
Author = {Sahin, B. and Ilgun, G.},
Title = {MULTI-DIMENSIONAL DETERMINANTS OF CANCER INCIDENCE, CANCER DEATHS AND
   CANCER-RELATED YEARS OF LIFE LOST},
Journal = {WORLD CANCER RESEARCH JOURNAL},
Year = {2022},
Volume = {9},
Abstract = {Objective: The aim of this study is to reveal the effects of lifestyle,
   the environmental, health services, and demographic characteristics on
   cancer incidence, cancer deaths, and cancer-relat-ed years of life lost.
   Materials and Methods: The population of the study is composed of 36
   OECD countries. All variables used in the study were examined under four
   dimensions: lifestyle, environmental, health services, and demographics.
   The OECD database was used to obtain data on the variables used in the
   study over five-year periods (2000, 2005, 2010, and 2015). In order to
   reveal the variables af-fecting cancer incidence, cancer deaths, and
   cancer-related years of life lost, ordinary least squares regression
   analysis was used.
   Results: In consideration of research findings, the incidence of cancer
   is affected by variables re-lated to lifestyle, environmental, and
   health services; cancer deaths and lost life years were affected by
   variables related to lifestyle and health services. Also, while
   lifestyle variables were more effective on cancer in the 2000s, in the
   following years, both lifestyle variables and health service-related
   vari-ables were found to be effective.
   Conclusions: This finding shows that the effect of health services on
   individuals' health levels is increasing compared to the past.},
Publisher = {VERDUCI PUBLISHER},
Address = {VIA GREGORIO VII, ROME, 186-00165, ITALY},
Type = {Article},
Language = {English},
Affiliation = {Ilgun, G (Corresponding Author), Aksaray Univ, Dept Hlth Care Management, Fac Hlth Sci, Aksaray, Turkey.
   Sahin, B., Hacettepe Univ, Fac Econ \& Adm Sci, Dept Hlth Care Management, Ankara, Turkey.
   Ilgun, G., Aksaray Univ, Dept Hlth Care Management, Fac Hlth Sci, Aksaray, Turkey.},
Article-Number = {e2159},
ISSN = {2372-3416},
Keywords = {Cancer incidence; Cancer deaths; Cancer-related years of life lost; OECD
   countries},
Keywords-Plus = {PRIMARY-CARE; HEALTH EXPENDITURE; RISK-FACTORS; MORTALITY; STYLE; STATES},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {gulnurilgun@aksaray.edu.tr},
Cited-References = {Ades F, 2013, ANN ONCOL, V24, P2897, DOI 10.1093/annonc/mdt352.
   Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514.
   Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7.
   Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0.
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492.
   Chahoud J, 2016, J NATL COMPR CANC NE, V14, P972, DOI 10.6004/jnccn.2016.0104.
   Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103.
   Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2.
   Datzmann T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5615-2.
   Dunn JR, 2005, J EPIDEMIOL COMMUN H, V59, P768, DOI 10.1136/jech.2004.030361.
   Egi Y, 2007, JPN J CLIN ONCOL, V37, P365, DOI 10.1093/jjco/hym029.
   Grundy Anne, 2016, CMAJ Open, V4, pE507, DOI 10.9778/cmajo.20160070.
   Gulliford MC, 2002, J PUBLIC HEALTH MED, V24, P252, DOI 10.1093/pubmed/24.4.252.
   Guo Y, 2005, LANCET, V386, pS5.
   Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584.
   Jiang H, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0713.
   Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013.
   Kulhanova I, 2018, ENVIRON INT, V121, P1079, DOI 10.1016/j.envint.2018.09.055.
   Kunzmann AT, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002585.
   LeMarchand L, 1997, CANCER RES, V57, P4787.
   Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149.
   McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763.
   McDaniel JT, 2019, GLOB HEALTH PROMOT, V26, P41, DOI 10.1177/1757975916686913.
   Ministry of Health, 2017, HLTH STAT YB.
   National Cancer Institute, 2021, RISK FACT CANC.
   Nelson DE, 2013, AM J PUBLIC HEALTH, V103, P641, DOI 10.2105/AJPH.2012.301199.
   Parsa N, 2012, IRAN J PUBLIC HEALTH, V41, P1.
   Perez-Perez E, 2016, CIENC SAUDE COLETIVA, V21, P37, DOI 10.1590/1413-81232015211.09472015.
   Poirier Abbey E, 2017, CMAJ Open, V5, pE524, DOI 10.9778/cmajo.20160040.
   Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x.
   Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584.
   Sherr K, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2658-5.
   Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412.
   Sloan FA., 2007, CANC CONTROL OPPORTU.
   Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427.
   Stare SM, 2008, INT J APPL EC, V5, P95.
   Stefler D, 2018, INT J CANCER, V143, P1128, DOI 10.1002/ijc.31406.
   Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509.
   Stewart B, 2014, WORLD CANC REPORT 20.
   Turkish Statistical Institute, 2018, NEWSLETTER.
   Tyrovolas S, 2010, HLTH SCI J, V4, P149.
   WHO, 2017, GUID CANC EARL DIAGN.
   WHO (World Health Organization), 2021, CANCER.
   World Health Organisation (WHO), 2014, WORLD HLTH STAT 2014.
   World Health Organization, 2007, CANC CONTR KNOWL ACT.
   World Health Organization,, 2006, CANC CONTR KNOWL ACT.
   Xu ZS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204221.},
Number-of-Cited-References = {47},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {World Cancer Res. J.},
Doc-Delivery-Number = {YP1PY},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000748401300001},
DA = {2022-03-29},
}

@article{ WOS:000368066500007,
Author = {van Kruijsdijk, Rob C. M. and van der Graaf, Yolanda and Koffijberg,
   Hendrik and de Borst, Gert Jan and Nathoe, Hendrik M. and Kappelle, L.
   Jaap and Visseren, Frank L. J. and SMART Study Grp},
Title = {Cause-specific mortality and years of life lost in patients with
   different manifestations of vascular disease},
Journal = {EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY},
Year = {2016},
Volume = {23},
Number = {2},
Pages = {160-169},
Month = {JAN},
Abstract = {BackgroundPatients with cardiovascular disease might be at increased
   risk of non-vascular mortality due to shared risk factors. Our aim was
   to evaluate causes of death and years of life lost (YLL) in patients
   with different manifestations of vascular disease. DesignThe design was
   a prospective cohort study. MethodsA total of 5911 patients with stable
   coronary artery disease, cerebrovascular disease, peripheral artery
   disease (PAD), abdominal aortic aneurysm or polyvascular disease were
   followed-up for mortality. Cause-specific standardised mortality ratios
   (SMRs) and YLL, compared to the Dutch population, were estimated.
   Determinants for cause-specific mortality were evaluated using competing
   risks models. ResultsDuring a median follow-up of 6.0 years
   (interquartile range (IQR): 3.1-9.2), 958 (16.2\%) patients died.
   All-cause mortality was increased compared to the general population
   (SMR: 1.26, 95\% confidence interval (CI): 1.18-1.34). Patients with PAD
   and polyvascular disease were at highest risk, especially for ischaemic
   heart disease (SMR: 2.52, 95\% CI: 1.70-3.60 and SMR: 3.97, 95\% CI:
   3.18-4.90, respectively). Patients with PAD were at increased risk of
   dying from cancer (SMR: 1.67, 95\% CI: 1.25-2.17). On average, patients
   with vascular disease of 50 years died 7.8 years younger than the
   general population, with 80\% of the excess YLL attributable to
   cardiovascular disease. In middle-aged patients the excess YLL were
   about 10 years, of which 24\% were lost due to cancer. Important
   determinants for mortality were male gender, smoking, physical
   inactivity, renal insufficiency and polyvascular disease.
   ConclusionsPatients with manifest vascular disease are at increased risk
   of both cardiovascular and cancer mortality, particularly patients with
   PAD or polyvascular disease. On average, patients with vascular disease
   of 50 years die 7.8 years younger than the general population.},
Publisher = {SAGE PUBLICATIONS LTD},
Address = {1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Visseren, FLJ (Corresponding Author), Univ Med Ctr Utrecht, Dept Vasc Med, F 02-126,POB 85500, NL-3508 TA Utrecht, Netherlands.
   van Kruijsdijk, Rob C. M.; Visseren, Frank L. J., Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 TA Utrecht, Netherlands.
   van der Graaf, Yolanda; Koffijberg, Hendrik, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci \& Primary Care, NL-3508 GA Utrecht, Netherlands.
   de Borst, Gert Jan, Univ Med Ctr Utrecht, Dept Vasc Surg, NL-3508 GA Utrecht, Netherlands.
   Nathoe, Hendrik M., Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands.
   Kappelle, L. Jaap, Univ Med Ctr Utrecht, Dept Neurol, NL-3508 GA Utrecht, Netherlands.},
DOI = {10.1177/2047487314566998},
ISSN = {2047-4873},
EISSN = {2047-4881},
Keywords = {Cardiovascular disease; mortality; cause of death; years of life lost;
   competing risks},
Keywords-Plus = {LONG-TERM SURVIVAL; ARTERIAL-DISEASE; EVENT RATES; ATHEROTHROMBOSIS;
   SMOKING; OBESITY; CANCER; DEATH; RISK},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {f.l.j.visseren@umcutrecht.nl},
ResearcherID-Numbers = {van Kruijsdijk, Rob/AAW-5860-2020
   },
ORCID-Numbers = {Koffijberg, Hendrik/0000-0002-1753-0652
   Visseren, Frank/0000-0003-3951-5223},
Funding-Acknowledgement = {board of directors of the University Medical Center Utrecht},
Funding-Text = {The SMART study was supported by a grant of the board of directors of
   the University Medical Center Utrecht. The funder had no role in the
   design and conduct of the study, collection, management, analysis, and
   interpretation of the data, nor in preparation, review, and approval of
   the manuscript.},
Cited-References = {Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355.
   {[}Anonymous], 1993, WHO INT STAT CLASS D, V2.
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116.
   Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322.
   BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395.
   Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X.
   Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253.
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501.
   Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   El Sakka K, 2005, BRIT J SURG, V92, P1498, DOI 10.1002/bjs.5125.
   Erdem G, 2013, INT J CARDIOL, V168, P490, DOI 10.1016/j.ijcard.2012.09.160.
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170.
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404.
   Lafeber M, 2013, EUR J PREV CARDIOL, V20, P771, DOI 10.1177/2047487312449587.
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0.
   Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356.
   Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712.
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046.
   Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757.
   Statistics Netherlands website, CAUS DEATH MAIN PRIM.
   Vaartjes I, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-43.
   van Kruijsdijk RCM, 2013, CANCER EPIDEM BIOMAR, V22, P1267, DOI 10.1158/1055-9965.EPI-13-0090.
   van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372.
   Viles-Gonzalez JF, 2004, EUR HEART J, V25, P1197, DOI 10.1016/j.ehj.2004.03.011.},
Number-of-Cited-References = {24},
Times-Cited = {14},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Eur. J. Prev. Cardiol.},
Doc-Delivery-Number = {DA8PC},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000368066500007},
DA = {2022-03-29},
}

@article{ WOS:000760474600035,
Author = {Bracco, Paula A. and Gregg, Edward W. and Rolka, Deborah B. and Schmidt,
   Maria Ines and Barreto, Sandhi M. and Lotufo, Paulo A. and Bensenor,
   Isabela and Duncan, Bruce B.},
Title = {Lifetime risk of developing diabetes and years of life lost among those
   with diabetes in Brazil},
Journal = {JOURNAL OF GLOBAL HEALTH},
Year = {2021},
Volume = {11},
Abstract = {Background Given the paucity of studies for low- or middle-income
   countries, we aim to provide the first ever estimations of lifetime risk
   of diabetes, years of life spent and lost among those with diabetes for
   Brazilians. Estimates of Brazil's diabetes burden consist essentially of
   reports of diabetes prevalence from national surveys and mortality data.
   However, these additional metrics are at times more meaningful ways to
   characterize this burden.
   Methods We joined data on incidence of physician-diagnosed diabetes from
   the Brazilian risk factor surveillance system, all-cause mortality from
   national statistics, and diabetes mortality rate ratios from
   ELSA-Brasil, an ongoing cohort study. To calculate lifetime risk of
   developing diabetes, we applied an illness-death state model. To
   calculate years of life lost for those with diabetes and years lived
   with the disease, we additionally calculated the mortality rates for
   those with diabetes.
   Results A 35-year-old white adult had a 23.4\% (95\% CI = 22.5\%-25.5\%)
   lifetime risk of developing diabetes by age 80 while a same-aged
   black/brown adult had a 30.8\% risk (95\% confidence interval (CI) =
   29.6\%-33.2\%). Men diagnosed with diabetes at age 35 would live 32.9
   (95\% CI = 32.4-33.2) years with diabetes and lose 5.5 (95\% CI =
   5.1-6.1) years of life. Similarly-aged women would live 38.8 (95\% CI =
   38.3-38.9) years with diabetes and lose 2.1 (95\% CI = 1.9-2.6) years of
   life.
   Conclusions Assuming maintenance of current rates, one-quarter of young
   Brazilians will develop diabetes over their lifetimes, with this number
   reaching almost one-third among young, black/brown women. Those
   developing diabetes will suffer a decrease in life expectancy and will
   generate a considerable cost in terms of medical care.},
Publisher = {INT SOC GLOBAL HEALTH},
Address = {CALEDONIAN EXCHANGE, 19A CANNING ST, EDINBURGH, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Bracco, PA (Corresponding Author), R Ramiro Barcelos 2600-518, BR-90035003 Porto Alegre, RS, Brazil.
   Bracco, Paula A.; Schmidt, Maria Ines; Duncan, Bruce B., Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil.
   Bracco, Paula A.; Schmidt, Maria Ines; Duncan, Bruce B., Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   Gregg, Edward W., Imperial Coll London, Sch Publ Hlth, Dept Diabet \& Cardiovasc Dis Epidemiol, London, England.
   Rolka, Deborah B., Ctr Dis Control \& Prevent, Div Diabet Translat, Atlanta, GA USA.
   Barreto, Sandhi M., Univ Fed Minas Gerais, Sch Med, Dept Prevent \& Social Med, Belo Horizonte, MG, Brazil.
   Lotufo, Paulo A.; Bensenor, Isabela, Univ Sao Paulo, Sch Med, Dept Internal Med, Sao Paulo, Brazil.},
DOI = {10.7189/jgh.11.04041},
Article-Number = {04041},
ISSN = {2047-2978},
EISSN = {2047-2986},
Keywords-Plus = {PREVALENCE; BURDEN; PEOPLE; TRENDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {paula.abracco@gmail.com},
ResearcherID-Numbers = {Barreto, Sandhi/D-2855-2014},
ORCID-Numbers = {Barreto, Sandhi/0000-0001-7383-7811},
Funding-Acknowledgement = {Brazilian Ministry of Health (Department of Science and Technology);
   Ministry of Science, Technology and Innovation (FINEP, Financiadora de
   Estudos e Projetos)Financiadora de Inovacao e Pesquisa (Finep) {[}01 06
   0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00, 01
   06 0071.00]; CNPq (the National Council for Scientific and Technological
   Development)Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPQ); CAPES (Coordination for the Improvement of Higher
   Education Personnel)Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)},
Funding-Text = {The study is supported by the Brazilian Ministry of Health (Department
   of Science and Technology) and Ministry of Science, Technology and
   Innovation (FINEP, Financiadora de Estudos e Projetos), grants No. 01 06
   0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00 and
   01 06 0071.00 and CNPq (the National Council for Scientific and
   Technological Development). PAB received a fellowship from CAPES
   (Coordination for the Improvement of Higher Education Personnel).
   Funders had no role in the study design; the collection, analysis, and
   interpretation of data; the writing of the report; or the decision to
   submit the article for publication. The corresponding author affirms
   that she had full access to all the data in the study and had final
   responsibility for the decision to submit for publication.},
Cited-References = {Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294.
   Arredondo A, 2018, GLOB PUBLIC HEALTH, V13, P780, DOI 10.1080/17441692.2017.1316414.
   Aviles-Santa ML, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01341-9.
   Bahia LR, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0448-4.
   Barry E, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6538.
   Bloom DE., 2011, GLOBAL EC BURDEN NON.
   Bracco PA, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010401.
   Brinks R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122145.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Camara Interministerial de Seguranca Alimentar e Nutricional Ministerio do Desenvolvimento Social e Agrario, PLAN NAC SEG AL NUTR.
   Capewell S, 2018, J PUBLIC HEALTH-UK, V40, P350, DOI 10.1093/pubmed/fdx055.
   Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z.
   Carstensen B., 2017, EPI YEARS LIFE LOST.
   Damacena GN, 2015, EPIDEMIOL SERV SAUDE, V24, P197, DOI 10.5123/S1679-49742015000200002.
   de Almeida-Pititto B, 2015, DIABETES METAB SYNDR, V8, P17, DOI 10.2147/DMSO.S72542.
   Duncan BB, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0216-2.
   Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827.
   Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757.
   Felisbino-Mendes MS, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00219-y.
   FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892.
   Gregg EW, 2018, LANCET, V391, P2430, DOI {[}10.1016/S0140-6736(18)30314-3, 10.1016/s0140-6736(18)30314-3].
   Gregg EW, 2014, LANCET DIABETES ENDO, V2, P867, DOI 10.1016/S2213-8587(14)70161-5.
   Haire-Joshu D, 2019, ANNU REV PUBL HEALTH, V40, P391, DOI 10.1146/annurev-publhealth-040218-044158.
   Harding JL, 2014, DIABETES CARE, V37, P2579, DOI 10.2337/dc14-0096.
   Heisler M, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0778-7.
   IBGE, I BRAS GEOGR EST.
   Institute for Health Metrics and Evaluation (IHME), GBD COMPARE.
   Instituto Brasileiro de Geografia E Estatistica (IBGE), 2020, PESQ NAC SAUD 2019 A.
   Iser Betine Pinto Moehlecke, 2015, Epidemiol. Serv. Saúde, V24, P305, DOI 10.5123/S1679-49742015000200013.
   Bernal RTI, 2017, EPIDEMIOL SERV SAUDE, V26, P701, DOI {[}10.5123/S1679-49742017000400003, 10.5123/s1679-49742017000400003].
   Bernal RTI, 2017, REV SAUDE PUBL, V51, DOI {[}10.1590/S1518-8787.2017051000171, 10.1590/s1518-8787.2017051000171].
   Jacobs E, 2017, DIABETES CARE, V40, P1703, DOI 10.2337/dc17-0954.
   Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5.
   Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015.
   Ministerio da Saude, 2011, PLANO ACOES ESTRATEG.
   Ministerio da Saude, 2020, SURV RISK PROT FACT.
   Ministerio da Saude, 2019, SURV RISK PROT FACT.
   Ministerio da Saude, 2017, SURV RISK PROT FACT.
   Ministerio da Saude, 2018, SURV RISK PROT FACT.
   Ministerio do Desenvolvimento Social e Combate a Fome, BAL AC PLAN NAC SEG.
   Murray CJL, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P233.
   Nascimento BR, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00218-z.
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024.
   Roberts S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017184.
   Silva DAS, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00214-3.
   Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027.
   Schmidt MI, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0105-5.
   Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123.
   World Health Organization, DIABETES.
   World Health Organization. (WHO), 2013, GLOB ACT PLAN PREV C.
   World Health Organization (WHO), 2017, BEST BUYS OTH REC IN.
   Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8.},
Number-of-Cited-References = {52},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Glob. Health},
Doc-Delivery-Number = {ZG7ZZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000760474600035},
OA = {Green Published},
DA = {2022-03-29},
}

@article{ WOS:000408684300061,
Author = {Zhang, Yunquan and Yu, Chuanhua and Yang, Jin and Zhang, Lan and Cui,
   Fangfang},
Title = {Diurnal Temperature Range in Relation to Daily Mortality and Years of
   Life Lost in Wuhan, China},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2017},
Volume = {14},
Number = {8},
Month = {AUG},
Abstract = {Diurnal temperature range (DTR) is an important meteorological indicator
   associated with global climate change, and has been linked with
   mortality and morbidity in previous studies. To date, however, little
   evidence has been available regarding the association of DTR with years
   of life lost (YLL). This study aimed to evaluate the DTR-related burden
   on both YLL and mortality. We collected individual records of all
   registered deaths and daily meteorological data in Wuhan, central China,
   between 2009 and 2012. For the whole population, every 1 degrees C
   increase in DTR at a lag of 0-1 days was associated with an increase of
   0.65\% (95\% CI: 0.08-1.23) and 1.42 years (0.88-3.72) for mortality and
   YLL due to non-accidental deaths, respectively. Relatively stronger
   DTR-mortality/YLL associations were found for cardiovascular deaths.
   Subgroup analyses (stratified by gender, age, and education level)
   showed that females, the elderly (75+ years old), and those with higher
   education attainment (7+ years) suffered more significantly from both
   increased YLL and mortality due to large DTR. Our study added additional
   evidence that short-term exposure to large DTR was associated with
   increased burden of premature death using both mortality incidence and
   YLL.},
Publisher = {MDPI},
Address = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {Yu, CH (Corresponding Author), Wuhan Univ, Sch Hlth Sci, Dept Prevent Med, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.
   Yu, CH (Corresponding Author), Wuhan Univ, Global Hlth Inst, 8 Donghunan Rd, Wuhan 430072, Hubei, Peoples R China.
   Zhang, Yunquan; Yu, Chuanhua; Yang, Jin; Cui, Fangfang, Wuhan Univ, Sch Hlth Sci, Dept Prevent Med, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.
   Yu, Chuanhua, Wuhan Univ, Global Hlth Inst, 8 Donghunan Rd, Wuhan 430072, Hubei, Peoples R China.
   Zhang, Lan, Hubei Prov Ctr Dis Control \& Prevent, Off Chron Dis, 6 Zhuodaoquan Rd, Wuhan 430079, Hubei, Peoples R China.},
DOI = {10.3390/ijerph14080891},
Article-Number = {891},
ISSN = {1661-7827},
EISSN = {1660-4601},
Keywords = {climate change; diurnal temperature range; mortality; years of life
   lost; China},
Keywords-Plus = {AMBIENT-TEMPERATURE; TIME-SERIES; AIR-POLLUTION; GLOBAL BURDEN;
   RISK-FACTOR; SYSTEMATIC ANALYSIS; IMPACT; DISEASE; MORBIDITY; GUANGZHOU},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {Yun-quanZhang@whu.edu.cn
   YuCHua@whu.edu.cn
   jinan0218@163.com
   hbcdczl@163.com
   cuifangfang@whu.edu.cn},
ResearcherID-Numbers = {Zhang, Yunquan/M-9828-2017
   Yu, chuanhua/I-6711-2016},
ORCID-Numbers = {Zhang, Yunquan/0000-0002-2618-5088
   Yu, chuanhua/0000-0002-5467-2481},
Funding-Acknowledgement = {NSFCNational Natural Science Foundation of China (NSFC) {[}71661167007];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}81273179]},
Funding-Text = {We appreciated the anonymous reviewers very much, whose insightful
   comments contributed greatly to improving the quality of our manuscript.
   The study was partly supported by the Chinese NSFC International
   Cooperation and Exchange Program (Grant No. 71661167007) and the
   National Natural Science Foundation of China (Grant No. 81273179).},
Cited-References = {Amegah AK, 2016, ENVIRON INT, V91, P133, DOI 10.1016/j.envint.2016.02.027.
   Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08.
   Ban J, 2017, ENVIRON INT, V106, P19, DOI 10.1016/j.envint.2017.05.019.
   Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170.
   Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40.
   Benmarhnia T, 2015, EPIDEMIOLOGY, V26, P781, DOI 10.1097/EDE.0000000000000375.
   Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034.
   Cao JY, 2009, J EPIDEMIOL, V19, P328, DOI 10.2188/jea.JE20080074.
   Chen K, 2016, ENVIRON HEALTH PERSP, V124, P1863, DOI 10.1289/EHP204.
   Cheng J, 2014, INT J BIOMETEOROL, V58, P2011, DOI 10.1007/s00484-014-0797-5.
   Ding Z, 2016, SCI TOTAL ENVIRON, V544, P627, DOI 10.1016/j.scitotenv.2015.12.016.
   Ding Z, 2015, SCI TOTAL ENVIRON, V526, P358, DOI 10.1016/j.scitotenv.2015.05.012.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2015, LANCET, DOI DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI {[}10.1038/nclimate1369, 10.1038/NCLIMATE1369].
   Kan HD, 2007, ENVIRON RES, V103, P424, DOI 10.1016/j.envres.2006.11.009.
   Kim J, 2016, SCI TOTAL ENVIRON, V539, P313, DOI 10.1016/j.scitotenv.2015.08.134.
   Lee M, 2016, ENVIRON RES, V151, P610, DOI 10.1016/j.envres.2016.08.029.
   Li TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28161.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Lim YH, 2015, INT J BIOMETEOROL, V59, P1311, DOI 10.1007/s00484-014-0941-2.
   Lim YH, 2012, INT J BIOMETEOROL, V56, P33, DOI 10.1007/s00484-010-0395-0.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Magalhaes R, 2011, CEREBROVASC DIS, V32, P542, DOI 10.1159/000331473.
   Makowski K, 2008, ATMOS CHEM PHYS, V8, P6483, DOI 10.5194/acp-8-6483-2008.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Onozuka D, 2015, ENVIRON RES, V140, P177, DOI 10.1016/j.envres.2015.03.031.
   Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x.
   Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847.
   Seposo XT, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31500.
   Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x.
   Song XP, 2017, SCI TOTAL ENVIRON, V586, P241, DOI 10.1016/j.scitotenv.2017.01.212.
   Vicedo-Cabrera AM, 2016, AM J EPIDEMIOL, V183, P286, DOI 10.1093/aje/kwv205.
   Vutcovici M, 2014, INT J BIOMETEOROL, V58, P843, DOI 10.1007/s00484-013-0664-9.
   Yang J, 2016, SCI TOTAL ENVIRON, V573, P1566, DOI 10.1016/j.scitotenv.2016.09.014.
   Yang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12250.
   Yang J, 2013, ENVIRON POLLUT, V175, P131, DOI 10.1016/j.envpol.2012.12.021.
   Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3.
   Zhang Y., 2016, OXIDATIVE MED CELLUL, V2016, P13, DOI DOI 10.1155/2016/758981327069532.
   Zhang Yunquan, 2017, Glob Health Res Policy, V2, P10, DOI 10.1186/s41256-017-0030-2.
   Zhang YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45093.
   Zhang YQ, 2017, SCI TOTAL ENVIRON, V587, P196, DOI 10.1016/j.scitotenv.2017.02.117.
   Zhao Q, 2017, ENVIRON POLLUT, V224, P310, DOI 10.1016/j.envpol.2017.02.010.
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6.
   Zhou XD, 2014, SCI TOTAL ENVIRON, V493, P92, DOI 10.1016/j.scitotenv.2014.05.116.},
Number-of-Cited-References = {50},
Times-Cited = {21},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {25},
Journal-ISO = {Int. J. Environ. Res. Public Health},
Doc-Delivery-Number = {FF1UL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000408684300061},
OA = {Green Submitted, Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000681330200025,
Author = {Xu, Xin and Fiacco, Leah and Rostron, Brian and Homsi, Ghada and
   Salazar, Esther and Levine, Burton and Ren, Chunfeng and Nonnemaker,
   James},
Title = {Assessing quality-adjusted years of life lost associated with exclusive
   cigarette smoking and smokeless tobacco use},
Journal = {PREVENTIVE MEDICINE},
Year = {2021},
Volume = {150},
Month = {SEP},
Abstract = {The main purpose of this analysis is to quantify quality adjusted life
   years (QALYs) lost associated with lifetime exclusive cigarette or
   smokeless tobacco use among U.S. adults. Multiple waves of National
   Health Interview Survey (NHIS) data linked to death certificate records
   were used to define current exclusive cigarette and smokeless tobacco
   use and associated mortality risks. NHIS data were used to assess
   health-related quality of life (HRQOL). Regression and Cox proportional
   hazard modeling were used to adjust HRQOL and mortality risk associated
   with tobacco use for age, sex, race/ethnicity, body mass index,
   education, and household poverty level. QALYs were estimated based on
   adjusted HRQOL and mortality risks. All analyses were initiated in 2019
   and completed in 2020. Male current exclusive cigarette smokers, aged 25
   to 29 years would lose 8.1 QALYs (SE = 0.09), and male current exclusive
   smokeless tobacco users aged 25 to 34 would lose 4.1 QALYs (SE = 0.22),
   compared to never users of tobacco. Current exclusive cigarette or
   smokeless tobacco use is associated with QALY loss. QALYs lost can be
   lessened through preventing the initiation of tobacco product use or
   helping tobacco product users quit as early in life as possible.},
Publisher = {ACADEMIC PRESS INC ELSEVIER SCIENCE},
Address = {525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA},
Type = {Article},
Language = {English},
Affiliation = {Xu, X (Corresponding Author), Ctr Tobacco Prod Food \& Drug Adm, Silver Spring, MD 20993 USA.
   Xu, Xin; Rostron, Brian; Salazar, Esther; Ren, Chunfeng, Ctr Tobacco Prod Food \& Drug Adm, Silver Spring, MD 20993 USA.
   Fiacco, Leah; Homsi, Ghada; Levine, Burton; Nonnemaker, James, RTI Int, Res Triangle Pk, NC USA.},
DOI = {10.1016/j.ypmed.2021.106707},
EarlyAccessDate = {JUL 2021},
Article-Number = {106707},
ISSN = {0091-7435},
EISSN = {1096-0260},
Keywords = {Quality adjusted life years; Health related quality of life; Mortality;
   Cigarettes; Smokeless tobacco; National Health Interview Survey},
Keywords-Plus = {COST-EFFECTIVENESS ANALYSIS; CESSATION; RECOMMENDATIONS; MORTALITY;
   HEALTH; BENEFITS; BURDEN; PANEL},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {xin.xu@fda.hhs.gov},
ORCID-Numbers = {nonnemaker, james/0000-0003-1044-7482
   Levine, Burton/0000-0002-2337-9338
   Homsi, Ghada/0000-0002-8494-9760},
Funding-Acknowledgement = {Center for Tobacco Products (CTP), U.S. Food and Drug Administration
   (FDA)United States Department of Health \& Human Services
   {[}HHSF223201510002B]},
Funding-Text = {Funding for this study was provided by the Center for Tobacco Products
   (CTP), U.S. Food and Drug Administration (FDA) under contract
   HHSF223201510002B to RTI International.},
Cited-References = {Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226.
   Chaiton M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011045.
   Chiang C.L., 1984, LIFE TABLE ITS APPL.
   Christensen CH, 2018, JAMA INTERN MED, V178, P469, DOI 10.1001/jamainternmed.2017.8625.
   Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759.
   Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058.
   DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901.
   Erickson P, 1995, Healthy People 2000 Stat Notes, P1.
   Feirman SP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3319-z.
   Fenelon A, 2012, DEMOGRAPHY, V49, P797, DOI 10.1007/s13524-012-0108-x.
   Fiscella K, 1996, JAMA-J AM MED ASSOC, V275, P1247, DOI 10.1001/jama.275.16.1247.
   Fisher MT, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0294-6.
   Hatsukami D., 2014, NIH PUBLICATION, P36.
   Holtgrave DR, 2009, AM J PREV MED, V36, P385, DOI 10.1016/j.amepre.2009.01.020.
   Javitz HS, 2004, AM J MANAG CARE, V10, P217.
   Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128.
   Jia HM, 2013, QUAL LIFE RES, V22, P27, DOI 10.1007/s11136-012-0118-6.
   Jia HM, 2011, QUAL LIFE RES, V20, P853, DOI 10.1007/s11136-010-9826-y.
   Kaplan RM, 2007, SOC INDIC RES, V81, P51, DOI 10.1007/s11205-006-0014-y.
   Keeler TE, 2002, HEALTH ECON, V11, P389, DOI 10.1002/hec.677.
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4.
   Lortet-Tieulent J, 2017, CANCER CAUSE CONTROL, V28, P981, DOI 10.1007/s10552-017-0932-9.
   National Center for Health Statistics, 2018, SURV DESCR NAT HLTH.
   National Center for Health Statistics, 2018, NATL HLTH INTERVIEW.
   Nonnemaker J, 2014, AM J PUBLIC HEALTH, V104, pE86, DOI 10.2105/AJPH.2014.301991.
   Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X.
   Rostron B, 2011, EPIDEMIOLOGY, V22, P350, DOI 10.1097/EDE.0b013e3182126729.
   Rostron BL, 2014, JAMA INTERN MED, V174, P1922, DOI 10.1001/jamainternmed.2014.5219.
   Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172.
   Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195.
   Scherbov S, 2011, DEMOGR RES, V24, P527, DOI 10.4054/DemRes.2011.24.22.
   Siddiqi K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01677-9.
   Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339.
   Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459.
   U.S. Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE.
   Villanti AC, 2012, HEALTH AFFAIR, V31, P2708, DOI 10.1377/hlthaff.2012.0277.
   Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253.
   Xu X, 2015, AM J PREV MED, V48, P318, DOI 10.1016/j.amepre.2014.10.011.},
Number-of-Cited-References = {38},
Times-Cited = {1},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {2},
Journal-ISO = {Prev. Med.},
Doc-Delivery-Number = {TU9DR},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000681330200025},
DA = {2022-03-29},
}

@article{ WOS:000659427500002,
Author = {Qi, Jinlei and Tian, Fei and Ai, Siqi and Yin, Peng and Zhou, Maigeng
   and Wang, Lijun and Lin, Hualiang},
Title = {Association Between Ambient Temperature and Years of Life Lost from
   Stroke-30 PLADs, China, 2013-2016},
Journal = {CHINA CDC WEEKLY},
Year = {2021},
Volume = {3},
Number = {23},
Pages = {485+},
Month = {JUN 4},
Abstract = {What is already known about this topic?
   Previous studies have mainly focused on the relationship between
   temperature and mortality from stroke, but analysis on the effects on
   years of life lost (YLL) is limited.
   What is added by this report?
   YLLs were used as the health outcome, and cold and hot weather were
   found to be significantly associated with an increase in YLLs from
   stroke and for different groups, with a stronger effect found to be
   associated with low temperature.
   What are the implications for public health practice?
   These findings could help identify vulnerable regions and populations
   that have a more serious temperaturerelated burden and to guide the
   practical and effective measures for stroke control from a YLL
   perspective.},
Publisher = {Chinese Center for Disease Control and Prevention},
Address = {No.155 Changbai Road, Changping District, Beijing, PEOPLES R CHINA},
Type = {Article},
Language = {English},
Affiliation = {Wang, LJ (Corresponding Author), Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing, Peoples R China.
   Lin, HL (Corresponding Author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.
   Qi, Jinlei; Yin, Peng; Zhou, Maigeng; Wang, Lijun, Chinese Ctr Dis Control \& Prevent, Natl Ctr Chron \& Noncommunicable Dis Control \& Pr, Beijing, Peoples R China.
   Tian, Fei; Ai, Siqi; Lin, Hualiang, Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.},
DOI = {10.46234/ccdcw2021.125},
EISSN = {2096-7071},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {wanglijun@ncncd.chinacdc.cn
   linhualiang@mail.sysu.edu.cn},
ResearcherID-Numbers = {Yin, Peng/AFP-5157-2022},
Funding-Acknowledgement = {National Key R\&D Program of China {[}2018YFA0606200]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   (NSFC) {[}82041021]; Bill \& Melinda Gates FoundationBill \& Melinda
   Gates FoundationCGIAR {[}INV-006371]},
Funding-Text = {The National Key R\&D Program of China (2018YFA0606200), the National
   Natural Science Foundation of China (82041021), and Bill \& Melinda
   Gates Foundation (INV-006371).},
Cited-References = {Arbuthnott K, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.105966.
   Cai J, 2016, SCI TOTAL ENVIRON, V568, P271, DOI 10.1016/j.scitotenv.2016.06.030.
   CROUGHWELL N, 1992, J THORAC CARDIOV SUR, V103, P549.
   Epstein Y, 2019, NEW ENGL J MED, V380, P2449, DOI 10.1056/NEJMra1810762.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165.
   Li GX, 2018, STROKE, V49, P828, DOI {[}10.1161/STROKEAHA.117.020042, 10.1161/strokeaha.117.020042].
   Luan GJ, 2018, INT J ENVIRON HEAL R, V28, P192, DOI 10.1080/09603123.2018.1453056.
   Luan GJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13225-2.
   Qi JL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003027.},
Number-of-Cited-References = {10},
Times-Cited = {2},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {2},
Journal-ISO = {China CDC Weekly},
Doc-Delivery-Number = {SP1JG},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000659427500002},
OA = {gold, Green Published},
DA = {2022-03-29},
}

@article{ WOS:000452961300012,
Author = {Paciej-Golebiowska, Paulina and Pikala, Malgorzata and Maniecka-Bryla,
   Irena},
Title = {Years of Life Lost due to Diseases of the Digestive System in Poland in
   2000-2014},
Journal = {JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES},
Year = {2018},
Volume = {27},
Number = {4},
Pages = {419+},
Month = {DEC},
Abstract = {Background \& Aims: Diseases of the digestive system substantially
   contribute to premature mortality of the Polish population. Years of
   Life Lost (YLLs) are more and more commonly used in order to evaluate
   social and economic aspects of these deaths. The aim of the study was to
   analyse YLLs due to diseases of the digestive system in Poland between
   2000-2014.
   Methods: The study material included a database which contained
   information gathered from 5,601,568 death certificates of Poles who died
   between 2000-2014. Data on deaths due to diseases of the digestive
   system were used for the analysis (i.e. coded as K00-K93 according to
   International Statistical Classification of Diseases and Related Health
   Problems, 10th Revision). Standard Expected Years of Life Lost (SEYLL)
   was used to calculate YLLs.
   Results: In 2000-2014 diseases of the digestive system contributed to
   239,176 deaths of Poles (4.3\% of all deaths), which corresponded to
   5,470,096.8 YLLs (95.2 years per 10,000 population). Each death due to
   the above cause was responsible for the average loss of 22.9 years.
   Diseases of the liver, including alcoholic liver disease and fibrosis
   and cirrhosis of the liver, contributed to the highest number of YLLs
   (54.1\%).
   Conclusions: Of all digestive diseases, the dominant causes of YLLs are
   alcohol-related liver diseases. In order to minimize this phenomenon, it
   is important to intensify public health activities, aimed at combating
   alcohol addiction in Poland.},
Publisher = {MEDICAL UNIV PRESS},
Address = {3RD MEDICAL CLINIC, STR CROITORILOR NO 19-21, CLUJ-NAPOCA, 400162,
   ROMANIA},
Type = {Article},
Language = {English},
Affiliation = {Paciej-Golebiowska, P (Corresponding Author), Med Univ Lodz, Lodz, Poland.
   Paciej-Golebiowska, Paulina; Pikala, Malgorzata; Maniecka-Bryla, Irena, Med Univ Lodz, Lodz, Poland.},
DOI = {10.15403/jgld.2014.1121.274.yrs},
ISSN = {1841-8724},
EISSN = {1842-1121},
Keywords = {premature mortality; years of life lost; SEYLL; alcohol-related diseases},
Keywords-Plus = {PREMATURE MORTALITY; GLOBAL BURDEN; ALCOHOL},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {paulina.paciej@stud.umed.lodz.pl},
ResearcherID-Numbers = {Maniecka-Bryla, Irena/AAW-5779-2021
   Pikala, Malgorzata/S-9898-2016},
ORCID-Numbers = {Maniecka-Bryla, Irena/0000-0002-6671-7456
   Paciej-Golebiowska, Paulina/0000-0002-4494-9299
   Pikala, Malgorzata/0000-0003-4426-4908},
Funding-Acknowledgement = {Medical University of Lodz {[}503/6-029-07/503-61-001]},
Funding-Text = {The study was financed by the Medical University of Lodz from the grant
   number 503/6-029-07/503-61-001.},
Cited-References = {Anderson P, 2006, DRUG-EDUC PREV POLIC, V13, P483, DOI 10.1080/09687630600902477.
   {[}Anonymous], 2015, JOINP REGR PROGR VER.
   Central Statistical Office in Poland, DEM YB POL 2015.
   Central Statistical Office in Poland, LIF EXP TABL POL 201.
   Eurostat, 2012, REP EUR TASK FORC, DOI {[}10.2785/11470, DOI 10.2785/11470].
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Global Burden of Diseases, GBD RESULTS TOOL.
   Katcher BS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-682.
   Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x.
   Maniecka-Bryla I, 2013, ANN AGR ENV MED, V20, P794.
   Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262.
   Marshall R., 2009, HDB DIS BURDENS QUAL, P3421.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Murray CJ, WHO SYSTEM MODEL LIF.
   Murray CJ, GLOBAL BURDEN DIS CO.
   Paciej P, 2017, FAM MED PRIM CARE RE, V19, P251, DOI 10.5114/fmpcr.2017.69287.
   Paciej Paulina, 2016, Przegl Epidemiol, V70, P500.
   Perez-Perez E, 2016, CIENC SAUDE COLETIVA, V21, P37, DOI 10.1590/1413-81232015211.09472015.
   Pikala M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09441-5.
   Pikala M, 2014, ARCH MED SCI, V10, P999, DOI 10.5114/aoms.2013.36237.
   Pikala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096830.
   Polish Ministry of Health, NAT HLTH PROGR 2016.
   Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222.
   Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294.
   Shield KD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-91.
   WHO, GLOB STAT REP ALC HL.
   World Health Organization, GLOB STRAT RED HARMF.},
Number-of-Cited-References = {27},
Times-Cited = {3},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {J. Gastrointest. Liver Dis.},
Doc-Delivery-Number = {HE0MP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000452961300012},
OA = {Bronze},
DA = {2022-03-29},
}

@article{ WOS:000394635300040,
Author = {Chen, Fei and Deng, Zibing and Deng, Ying and Qiao, Zhijiao and Lan, Lan
   and Meng, Qiong and Luo, Bin and Zhang, Wei and Ji, Kui and Qiao, Xue
   and Fan, Zhiwei and Zhang, Meixia and Cui, Yan and Zhao, Xing and Li,
   Xiaosong},
Title = {Attributable risk of ambient PM10 on daily mortality and years of life
   lost in Chengdu, China},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2017},
Volume = {581},
Pages = {426-433},
Month = {MAR 1},
Abstract = {Attributable risk is an important indicator for planning and evaluating
   public health interventions. However, most current measures of the
   attributable risk of air pollutants have not considered temporal
   relationships between exposure and risk More importantly, limited
   information is available regarding the attributable risk due to ambient
   air pollutants in basin regions like the Sichuan Basin, China. To
   quantify the association between PM10 and deaths in the Basin region, we
   used a measure proposed recently within the framework of the distributed
   lag non-linear model to estimate the attributable risk in Chengdu,
   China. Meanwhile, we examined the association between PM10 and years of
   life lost (YLL). Our analysis showed that population-attributable
   fractions for non-accidental, respiratory, and cardiovascular mortality
   were 0.569\% (95\% CI: -3.474\%, 4374\%), 0.695\%
   (95\%CI:-5.260\%,6.457\%), and 0.631\% (95\% CI: -6.973\%, 7390\%),
   respectively. On average, a 1 mu g/m(3) increase in PM10 was associated
   With cumulative increases of 026893, 030437, and 0.21924 YLL for
   non-accidental, respiratory, and cardiovascular mortality, respectively,
   rdferring to 20 mu g/m(3). In addition, we found an inverse U-shaped
   pattern for the cumulative risk with 350 mu g/m(3) as the reverse point.
   With a 1 mu g/m(3) increase in PM10, YLL changed more significantly than
   mortality. Moreover, PM10 demonstrated remarkable effects on YLL among
   men and the elderly. (C) 2016 Elsevier B.V. All rights reserved.},
Publisher = {ELSEVIER},
Address = {RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS},
Type = {Article},
Language = {English},
Affiliation = {Zhao, X; Li, XS (Corresponding Author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol \& Hlth Stat, Chengdu 610041, Sichuan, Peoples R China.
   Chen, Fei; Deng, Zibing; Qiao, Zhijiao; Lan, Lan; Fan, Zhiwei; Cui, Yan; Zhao, Xing; Li, Xiaosong, Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol \& Hlth Stat, Chengdu 610041, Sichuan, Peoples R China.
   Deng, Ying; Ji, Kui, Sichuan Ctr Dis Control \& Prevent, Chengdu 610041, Sichuan, Peoples R China.
   Meng, Qiong, Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Yunnan, Peoples R China.
   Luo, Bin; Zhang, Wei, Sichuan Environm Monitoring Ctr, Chengdu 610041, Sichuan, Peoples R China.
   Qiao, Xue, Sichuan Univ, Inst New Energy \& Low Carbon Technol, Chengdu, Sichuan, Peoples R China.},
DOI = {10.1016/j.scitotenv.2016.12.151},
ISSN = {0048-9697},
EISSN = {1879-1026},
Keywords = {Mortality; PM10; Disease burden; YLL; China},
Keywords-Plus = {AIR-POLLUTION; BURDEN; DISEASE; PARTICLES; TABLES; OZONE; AGE},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {zhaoxing731@gmail.com
   lixiaosong1101@126.com},
ORCID-Numbers = {Qiao, Xue/0000-0001-7412-5090},
Funding-Acknowledgement = {Natural Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) {[}81502894]; Sichuan Applying Basic Research Project
   {[}2016JY0073]},
Funding-Text = {This study was supported by the Natural Science Foundation of China (No.
   81502894) and Sichuan Applying Basic Research Project (No. 2016JY0073).},
Cited-References = {{[}Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1.
   {[}Anonymous], 2006, R LANG ENV STAT COMP.
   Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615.
   Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709.
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049.
   Chen Qingsha, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P627.
   Chen RJ, 2014, AM J EPIDEMIOL, V180, P729, DOI 10.1093/aje/kwu183.
   Chen RJ, 2012, ENVIRON RES, V118, P101, DOI 10.1016/j.envres.2012.07.003.
   Cheng Z, 2013, ATMOS ENVIRON, V65, P186, DOI 10.1016/j.atmosenv.2012.10.022.
   Davis MC, 1999, ANN BEHAV MED, V21, P83, DOI 10.1007/BF02895038.
   DEVALIA JL, 1994, LANCET, V344, P1668, DOI 10.1016/S0140-6736(94)90458-8.
   Donev D, 2010, METHODS TOOLS PUBLIC, V30, P715.
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6.
   Forastiere F, 2013, LANCET, V382, P1008, DOI 10.1016/S0140-6736(13)61167-8.
   Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55.
   Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963.
   Gouveia Nelson, 2006, Cad. Saúde Pública, V22, P2669, DOI 10.1590/S0102-311X2006001200016.
   Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276.
   Guillois-Becel Y, 2007, ENVIRON RISQUE SANTE, V6, P189, DOI 10.1684/ers.2007.0085.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   Hastie M. T., 2015, PACKAGE MDA.
   He GJ, 2016, J ENVIRON ECON MANAG, V79, P18, DOI 10.1016/j.jeem.2016.04.004.
   Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1.
   HSIEH JJ, 1991, BIOMETRICAL J, V33, P143, DOI 10.1002/bimj.4710330204.
   Ibrahim RI, 2011, SAINS MALAYS, V40, P1449.
   Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1.
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851.
   Kassomenos PA, 2013, ENVIRON MONIT ASSESS, V185, P6933, DOI 10.1007/s10661-013-3076-8.
   Liao CM, 2015, ENVIRON SCI POLLUT R, V22, P15067, DOI 10.1007/s11356-015-4701-6.
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1.
   Mathers CD, 2001, NATL BURDEN DIS STUD.
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429.
   Noubiap JJN, 2015, J CLIN HYPERTENS, V17, P825, DOI 10.1111/jch.12610.
   Organization WH UNAIDS, 2006, AIR QUAL GUID GLOB U.
   Peng RD, 2008, USE R, P1.
   Poursafa P, 2015, ENVIRON SCI POLLUT R, V22, P18645, DOI 10.1007/s11356-015-5545-9.
   Pruss-ustun A., 2003, ENV BURDEN DIS SERIE, V1.
   Qiao Z, 2015, ENVIRON HEALTH PERSP, V123, P766, DOI 10.1289/ehp.1307606.
   Rom WN, 2006, AM J RESP CRIT CARE, V173, P365, DOI 10.1164/rccm.2601003.
   Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326.
   Schwartz J, 2005, AM J RESP CRIT CARE, V172, P1529, DOI 10.1164/rccm.200412-1698OC.
   Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004.
   Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI {[}10.1136/bmj.h1295, 10.1136/bmj.i4851].
   Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43.
   Tobollik M, 2015, INT J ENV RES PUB HE, V12, P10602, DOI 10.3390/ijerph120910602.
   Vander Hoorn S., 2004, ESTIMATING ATTRIBUTA, P2129.
   Wang SX, 2012, J ENVIRON SCI, V24, P2, DOI 10.1016/S1001-0742(11)60724-9.
   Wen M, 2007, J GEN INTERN MED, V22, P1674, DOI 10.1007/s11606-007-0400-4.
   WHO (World Health Organization), 2014, BURD DIS AMB AIR POL.
   Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30.
   Wood S.N., 2006, GEN ADDITIVE MODELS.
   Yang JH, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/294589.
   Yearbook C. S., 2013, CHIN STAT YB.
   Yoon SJ, 2015, INT J ENV RES PUB HE, V12, P7938, DOI 10.3390/ijerph120707938.
   YUSUF F, 1985, J BIOSOC SCI, V17, P91, DOI 10.1017/S0021932000015492.
   Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712.
   Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279.
   Zhou MG, 2015, ENVIRON RES, V137, P278, DOI 10.1016/j.envres.2014.12.016.},
Number-of-Cited-References = {60},
Times-Cited = {28},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {30},
Journal-ISO = {Sci. Total Environ.},
Doc-Delivery-Number = {EL5AZ},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000394635300040},
DA = {2022-03-29},
}

@article{ WOS:000519531200001,
Author = {de Oliveira Santos, Emelynne Gabrielly and Giacchero Vedana, Kelly
   Graziani and Barbosa, Isabelle Ribeiro},
Title = {Mortality and years of life lost to suicide in Rio Grande do Norte,
   Brazil, 2000-2015},
Journal = {ACTA SCIENTIARUM-HEALTH SCIENCES},
Year = {2019},
Volume = {41},
Abstract = {Analyze the epidemiological profile of and years of life lost to suicide
   in Rio Grande do Norte, Brazil, from 2000 to 2015. This is an ecological
   study in which data on death were sourced from the Mortality Information
   System. Years of Potential Life Lost were calculated over the historical
   series. A total of 2,266 deaths by suicide were analyzed, identified
   during the period, with the most frequent cases being those occurring at
   home, by hanging, among men, black people, single people and the
   elderly. More Years of Potential Life Lost were counted in the
   economically active age group (30-39 years old). Thus, recognizing the
   epidemiological characteristics of suicide in Rio Grande do Norte may
   guide more effective actions and strategies targeting risk populations
   and reinforces the need for further studies focusing on regions with the
   highest rates in the state. Moreover, mental health care must be adapted
   to age and gender, besides approaching social support needs and feeling
   of belonging.},
Publisher = {UNIV ESTADUAL MARINGA, PRO-REITORIA PESQUISA POS-GRADUACAO},
Address = {AV. COLOMBO, 5790, DIVISAO DE DIVULGACAO CIENTIFICA, MARINGA, PR
   87020-900, BRAZIL},
Type = {Article},
Language = {English},
Affiliation = {Santos, EGD (Corresponding Author), Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Ave Rio Branco, BR-59200000 Santa Cruz, CA, Brazil.
   de Oliveira Santos, Emelynne Gabrielly; Barbosa, Isabelle Ribeiro, Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Ave Rio Branco, BR-59200000 Santa Cruz, CA, Brazil.
   Giacchero Vedana, Kelly Graziani, Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, Ribeirao Preto, SP, Brazil.},
DOI = {10.4025/actascihealthsci.v41i1.45972},
Article-Number = {e5972},
ISSN = {1679-9291},
EISSN = {1807-8648},
Keywords = {suicide; epidemiology; years of potential life lost; mental health},
Keywords-Plus = {ADULTS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {emeoliveirasantos@hotmail.com},
ResearcherID-Numbers = {Giacchero Vedana, Kelly Graziani/H-6982-2013},
ORCID-Numbers = {Giacchero Vedana, Kelly Graziani/0000-0001-7363-2429},
Cited-References = {Associacao Brasileira de Psiquiatria {[}abp], 2014, SUIC INF PREV.
   Bernardes SS, 2010, CAD SAUDE PUBLICA, V26, P1366, DOI 10.1590/S0102-311X2010000700015.
   Botega N., 2010, DEBATES PSIQUIATRIA.
   Camargo FC, 2011, TEXTO CONTEXTO ENFER, V20, P100, DOI 10.1590/S0104-07072011000500013.
   Chen IM, 2016, J FORMOS MED ASSOC, V115, P364, DOI 10.1016/j.jfma.2015.07.009.
   Conte M, 2012, CIENC SAUDE COLETIVA, V17, P2017, DOI 10.1590/S1413-81232012000800013.
   Minayo MCD, 2015, CIENC SAUDE COLETIVA, V20, P1751, DOI 10.1590/1413-81232015206.10962014.
   Minayo MCD, 2012, REV SAUDE PUBL, V46, P300, DOI 10.1590/S0034-89102012000200012.
   Departamento de Informatica do SUS, 2016, SIST INF MORT.
   Durkheim E., 1897, SUICIDIO ESTUDO SOCI.
   Gonçalves Ludmilla R. C., 2011, Nova econ., V21, P281, DOI 10.1590/S0103-63512011000200005.
   Lapierre S, 2011, CRISIS, V32, P88, DOI 10.1027/0227-5910/a000076.
   Lovisi GM, 2006, REV BRAS PSIQUIAT S2, V31, P86.
   Lutz J, 2018, J AFFECT DISORDERS, V227, P260, DOI 10.1016/j.jad.2017.10.043.
   Machado Daiane Borges, 2015, J. bras. psiquiatr., V64, P45, DOI 10.1590/0047-2085000000056.
   Perry Brea L, 2013, Race Soc Probl, V5, P1.
   Pinto LW, 2012, CIENC SAUDE COLETIVA, V17, P2003, DOI 10.1590/S1413-81232012000800011.
   Romeder J. M., 1988, DESAFIO EPIDEMIOLOGI, P254.
   Sachs-Ericsson NJ, 2016, AGING MENT HEALTH, V20, P139, DOI 10.1080/13607863.2015.1063107.
   Santos E. G. O, 2018, CADERNOS SAUDE COLET.
   Santos Emelynne Gabrielly de Oliveira, 2017, Cad. saúde colet., V25, P371, DOI 10.1590/1414-462x201700030015.
   Sistema de Informacao sobre Mortalidade, 2018, BANC DAD SIST UN SAU.
   Souza Maximiliano Loiola Ponte de, 2013, J. bras. psiquiatr., V62, P245.
   Stenbacka M, 2018, ARCH SUICIDE RES, V22, P254, DOI 10.1080/13811118.2017.1319311.
   WHO, 2017, DEPRESSION OTHER COM.
   World Health Organization, 2014, PREVENTING SUICIDE G.},
Number-of-Cited-References = {26},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Acta Sci.-Health Sci.},
Doc-Delivery-Number = {KU2IE},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000519531200001},
OA = {gold},
DA = {2022-03-29},
}

@article{ WOS:000341304700004,
Author = {Ashwell, Margaret and Mayhew, Les and Richardson, Jon and Rickayzen, Ben},
Title = {Waist-to-Height Ratio Is More Predictive of Years of Life Lost than Body
   Mass Index},
Journal = {PLOS ONE},
Year = {2014},
Volume = {9},
Number = {9},
Month = {SEP 8},
Abstract = {Objective: Our aim was to compare the effect of central obesity
   (measured by waist-to-height ratio, WHtR) and total obesity (measured by
   body mass index, BMI) on life expectancy expressed as years of life lost
   (YLL), using data on British adults.
   Methods: A Cox proportional hazards model was applied to data from the
   prospective Health and Lifestyle Survey (HALS) and the cross sectional
   Health Survey for England (HSE). The number of years of life lost (YLL)
   at three ages (30, 50, 70 years) was found by comparing the life
   expectancies of obese lives with those of lives at optimum levels of BMI
   and WHtR.
   Results: Mortality risk associated with BMI in the British HALS survey
   was similar to that found in US studies. However, WHtR was a better
   predictor of mortality risk. For the first time, YLL have been
   quantified for different values of WHtR. This has been done for both
   sexes separately and for three representative ages.
   Conclusion: This study supports the simple message ``Keep your waist
   circumference to less than half your height{''}. The use of WHtR in
   public health screening, with appropriate action, could help add years
   to life.},
Publisher = {PUBLIC LIBRARY SCIENCE},
Address = {1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA},
Type = {Article},
Language = {English},
Affiliation = {Ashwell, M (Corresponding Author), Ashwell Associates, Ashwell, Herts, England.
   Ashwell, Margaret, Ashwell Associates, Ashwell, Herts, England.
   Ashwell, Margaret, Oxford Brookes Univ, Oxford OX3 0BP, England.
   Mayhew, Les; Richardson, Jon; Rickayzen, Ben, City Univ London, Fac Actuarial Sci \& Insurance, Cass Business Sch, London EC1V 0HB, England.},
DOI = {10.1371/journal.pone.0103483},
Article-Number = {e103483},
ISSN = {1932-6203},
Keywords-Plus = {SCREENING TOOL; RISK-FACTORS; MORTALITY; OBESITY; CIRCUMFERENCE;
   ASSOCIATION; DISEASE},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {margaret@ashwell.uk.com},
Funding-Acknowledgement = {Institute and Faculty of Actuaries in the UK},
Funding-Text = {The initial work on this project was funded by a research grant from the
   Institute and Faculty of Actuaries in the UK. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.},
Cited-References = {{[}Anonymous], 2000, WHO TECHN REP SER.
   Ashwell M, 2012, CLIN OBES, V2, P3, DOI 10.1111/j.1758-8111.2012.00037.x.
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x.
   Ashwell M, 1996, BRIT MED J, V312, P377.
   Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI DOI 10.2174/1876823701103010078.
   Bender R, 1998, AM J EPIDEMIOL, V147, P42.
   Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099.
   Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144.
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501.
   Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487.
   Cox BD, 1988, HLTH LIFESTYLE SURVE.
   Department of Health, 2011, HLTH LIV HLTH PEOPL.
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905.
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187.
   Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218.
   HSIEH SD, 1995, INT J OBESITY, V19, P585.
   Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793.
   Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504.
   Lee J S, 1995, Sangyo Eiseigaku Zasshi, V37, P9.
   McPherson K, 2007, LANCET, V370, P1755, DOI 10.1016/S0140-6736(07)61740-1.
   National Centre for Social Research and University College London. Department of Epidemiology and Public Health, 2008, HLTH SURV ENGL 2006.
   National Institute for Health and Clinical Excellence, 2012, NICE DRAFT SCOP ASS.
   National Institute for Health and Clinical Excellence, 2006, NICE CLIN GUID 43 OB.
   Peeters A, 2003, JAMA-J AM MED ASSOC, V289, P2941, DOI 10.1001/jama.289.22.2941-a.
   Preston S. H., 2014, WILL MORE OBESITY LE.
   Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584.
   Song X, 2013, EUR J CLIN NUTR, V67, P1298, DOI 10.1038/ejcn.2013.203.
   Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101.
   Stevens J, 2001, AM J EPIDEMIOL, V153, P946, DOI 10.1093/aje/153.10.946.
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1.
   The NHS Information Centre for Health and Social Care, 2011, HLTH SURV ENGL 2010.
   The NHS Information Centre Lifestyle Statistics, 2011, STAT OB PHYS ACT DIE.
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3.
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4.
   Zamboni M, 1998, INT J OBESITY, V22, P655, DOI 10.1038/sj.ijo.0800643.
   Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692.},
Number-of-Cited-References = {36},
Times-Cited = {76},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {21},
Journal-ISO = {PLoS One},
Doc-Delivery-Number = {AO4JX},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000341304700004},
OA = {Green Published, Green Accepted, Green Submitted, gold},
DA = {2022-03-29},
}

@article{ WOS:000363014300002,
Author = {Mirzadeh, M. and Mirzaei, M. and Mirzaei, M. and ShogaeiFar, H.},
Title = {Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd
   Province, Iran (2004-2009)},
Journal = {IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY},
Year = {2015},
Volume = {5},
Number = {3},
Pages = {125-130},
Abstract = {Background
   The Years of Life Lost (YLL) due to cancer can be a more illustrative
   index to promote preventive and therapeutic services, this study aimed
   to investigate the childhood cancer mortality and its trend over the
   past few years in Yazd to provide planners with baseline data.
   Material and Method
   Data obtained from death registration system of the healthcare center
   were used to calculate the age-specific standardized mortality for
   5-year age groups. To calculate the YLL, the standardized expected YLL
   method was used with a discount rate of 0.03 for health gain in the
   future, the age weight of 0.04 for different years of age, and a
   constant age weight correction factor of 0.165. The collected data were
   analyzed using the Epi 6 and Excel 2007.
   Results
   28 patients in Yazd aged 0-19 die annually due Leukemia and CNS tumors
   were the most common causes of death. The crude cancer death rate is
   8.48 in boys and 6.72 in girls per 100000. Premature cancer deaths have
   caused 3,436 YLL in boys and 2,561 YLL in girls (4.92\% of total YLL in
   both sex). The average death age did not have a significant relationship
   with sex or location of residence.
   Conclusion
   Childhood cancer mortality has had a decreasing trend. This study can
   help in the assessment of healthcare needs and improvement of the
   quality of healthcare services. It can also help in the design and
   prioritization of interventions to identify cancer risk factors which
   can facilitate early diagnosis.},
Publisher = {SHAHID SADOUGHI UNIV MEDICAL SCIENCES},
Address = {BOUALI AVE, SAFAEYEH, YAZD, SAFAIEEH 8915887857, IRAN},
Type = {Article},
Language = {English},
Affiliation = {Mirzaei, M (Corresponding Author), Shahid Sadoughi Univ Med Sci \& Hlth Serv, Sch Med, Dept Community Med, Yazd, Iran.
   Mirzadeh, M., Shahid Sadoughi Univ Med Sci \& Hlth Serv, Sch Med, Dept Internal Med, Yazd, Iran.
   Mirzaei, M., Shahid Sadoughi Univ Med Sci \& Hlth Serv, Sch Med, Dept Community Med, Yazd, Iran.
   Mirzaei, M., Tehran Univ Med Sci \& Hlth Serv, Tehran, Iran.
   ShogaeiFar, H., Shahid Sadoughi Univ Med Sci \& Hlth Serv, Hlth Ctr Yazd Prov, Yazd, Iran.},
ISSN = {2008-8892},
EISSN = {2228-6993},
Keywords = {Years of Life Lost; Cancer; Mortality; Childhood; Iran},
Keywords-Plus = {STATISTICS; BURDEN},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Author-Email = {drmmirzaei@ssu.ac.ir},
ResearcherID-Numbers = {Mirzadeh, Mahboobahsadat/F-8266-2017
   Mirzaei, Mohsen/F-8176-2017},
ORCID-Numbers = {Mirzadeh, Mahboobahsadat/0000-0001-9508-7003
   Mirzaei, Mohsen/0000-0002-4153-5023},
Cited-References = {Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1257.
   {[}Anonymous], 2007, STRAT CANC CONTR N A.
   Bosetti C, 2010, EUR J CANCER, V46, P384, DOI 10.1016/j.ejca.2009.09.011.
   Buka I, 2007, PEDIATR CLIN N AM, V54, P177, DOI 10.1016/j.pcl.2006.11.010.
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321.
   Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526.
   Chatenoud L, 2010, CANCER-AM CANCER SOC, V116, P5063, DOI 10.1002/cncr.25406.
   Etemadi Arash, 2008, Arch Iran Med, V11, P577.
   Farahmand M, 2011, KOOMESH, V13, P8.
   Gurney JG, 2006, PRINCIPLES PRACTICE, P2.
   Hashemi A, 2009, JSSU, V16, P14.
   Hashemi A, 2009, JSSU, V16, P26.
   Henderson TO, 2010, PEDIATRICS, V126, P129, DOI 10.1542/peds.2009-2802.
   Howlader N., 2013, SEER CANC STAT REV 1.
   Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106.
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006.
   Mathers Colin D., 2003, GLOBAL BURDEN DIS 20.
   Mgaya EM, 2000, E AFR MED J, V77, P435.
   Moradi A, 2010, IRAN J PEDIATR, V20, P335.
   Mousavi SM, 2010, J PEDIAT HEMATOL ONC, V32, P376, DOI 10.1097/MPH.0b013e3181e003f7.
   Murphy SL, 2013, NATL VITAL STAT REP, V61, P4.
   Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9.
   Ries LA, SEER CANC STAT REV 1.
   Smith MA, 2014, CANCER          0815.
   Tettey Y., 2007, GHANA MED J, V41.
   Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219.
   Wayne AS, 2008, JNCI-J NATL CANCER I, V100, P1271, DOI 10.1093/jnci/djn306.
   Yang L, 2009, ANN ONCOL, V20, P166, DOI 10.1093/annonc/mdn562.
   Youlden DR, 2012, CANCER EPIDEMIOL, V36, P476, DOI 10.1016/j.canep.2012.06.001.
   Zareifar S, 2012, KOOMESH, V14, P13.},
Number-of-Cited-References = {30},
Times-Cited = {6},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Iran. J. Pediatr. Hematol. Oncol.},
Doc-Delivery-Number = {CT7SH},
Web-of-Science-Index = {Emerging Sources Citation Index (ESCI)},
Unique-ID = {WOS:000363014300002},
DA = {2022-03-29},
}

@article{ WOS:000435566000002,
Author = {van de Weijer, Steve G. A. and Smallbone, Holly S. and Bouwman, Valery},
Title = {Parental Imprisonment and Premature Mortality in Adulthood},
Journal = {JOURNAL OF DEVELOPMENTAL AND LIFE-COURSE CRIMINOLOGY},
Year = {2018},
Volume = {4},
Number = {2},
Pages = {148-161},
Month = {JUN},
Abstract = {Purpose Rising prison populations worldwide have led to an increasing
   body of research about the well-being of children of prisoners. Research
   to date has demonstrated that the consequences of parental imprisonment
   for children are significant and long lasting, often extending beyond
   the imprisonment period and into adulthood. However, research examining
   the association between parental imprisonment and offspring health
   problems and mortality is lacking. Moreover, no research to date has
   examined the association between parental imprisonment and premature
   mortality among adults.
   Methods Using a Dutch multigenerational sample, this study aimed to
   extend existing literature by examining the link between parental
   imprisonment and offspring mortality up to age 65, while controlling for
   parental criminality.
   Results Results indicated that children of imprisoned parents were
   significantly more likely to die prematurely than children of both
   non-criminal and criminal but non-imprisoned parents.
   Conclusions These findings implicate that the mortality risk is not the
   consequence of the parental criminal behavior but is specifically
   related to the incarceration of the parent. Further research is required
   to examine the mechanisms at play for the increased risk of premature
   mortality for children of prisoners. This research has important
   implications for health-related early interventions and criminal justice
   policy.},
Publisher = {SPRINGER INTERNATIONAL PUBLISHING AG},
Address = {GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND},
Type = {Article},
Language = {English},
Affiliation = {van de Weijer, SGA (Corresponding Author), Netherlands Inst Study Crime \& Law Enforcement NS, Amsterdam, Netherlands.
   van de Weijer, Steve G. A.; Smallbone, Holly S.; Bouwman, Valery, Netherlands Inst Study Crime \& Law Enforcement NS, Amsterdam, Netherlands.
   Smallbone, Holly S., Griffith Univ, Griffith Criminol Inst, Mt Gravatt, Qld, Australia.
   Smallbone, Holly S., Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld, Australia.},
DOI = {10.1007/s40865-017-0078-1},
ISSN = {2199-4641},
EISSN = {2199-465X},
Keywords = {Parental imprisonment; Parental incarceration; Premature mortality;
   Children of prisoners; Health; Criminal justice},
Keywords-Plus = {MENTAL-HEALTH; INCARCERATION; INVOLVEMENT; PERFORMANCE; BEHAVIOR; DEATH;
   RISK},
Research-Areas = {Criminology \& Penology},
Web-of-Science-Categories  = {Criminology \& Penology},
Author-Email = {SvandeWeijer@nscr.nl},
Cited-References = {Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115.
   Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064.
   D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252.
   Dennison S. M., 2017, ROUTLEDGE INT HDB LI, P450.
   Dirkzwager A, 2012, J RES CRIME DELINQ, V49, P383, DOI 10.1177/0022427811415534.
   Geller A, 2012, DEMOGRAPHY, V49, P49, DOI 10.1007/s13524-011-0081-9.
   Glaze L., 2008, PARENTS PRISON THEIR.
   Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385.
   Kjelsberg E, 2010, EUR J EPIDEMIOL, V25, P237, DOI 10.1007/s10654-010-9436-6.
   Lee RD, 2013, PEDIATRICS, V131, pE1188, DOI 10.1542/peds.2012-0627.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Link BG, 2002, AM J PUBLIC HEALTH, V92, P730, DOI 10.2105/AJPH.92.5.730.
   Murray J., 2007, CRIMINOL CRIM JUSTIC, V7, P55, DOI DOI 10.1177/1748895807072476.
   Murray J., 2014, EFFECTS PARENTAL INC.
   Murray J, 2008, CRIME JUSTICE, V37, P133, DOI 10.1086/520070.
   Murray J, 2012, PSYCHOL BULL, V138, P175, DOI 10.1037/a0026407.
   Murray J, 2012, CRIMINOLOGY, V50, P255, DOI 10.1111/j.1745-9125.2011.00257.x.
   Phillips SD, 2002, J CHILD FAM STUD, V11, P385, DOI DOI 10.1023/A:1020975106679.
   Piquero AR, 2014, JUSTICE Q, V31, P445, DOI 10.1080/07418825.2011.641027.
   Roettger ME, 2012, AM J EPIDEMIOL, V175, P636, DOI 10.1093/aje/kwr409.
   THORNBERRY TP, 1982, AM SOCIOL REV, V47, P505, DOI 10.2307/2095195.
   van de Weijer S, 2016, ADV LIFE COURSE RES, V28, P91, DOI 10.1016/j.alcr.2015.11.004.
   Wakefield S, 2011, CRIMINOL PUBLIC POL, V10, P793, DOI 10.1111/j.1745-9133.2011.00740.x.
   WHO, 2015, EUR HLTH REP 2015 TA.
   Wildeman C, 2014, AM J PUBLIC HEALTH, V104, P428, DOI 10.2105/AJPH.2013.301590.
   Wildeman C, 2012, SOC PROBL, V59, P228, DOI 10.1525/sp.2012.59.2.228.},
Number-of-Cited-References = {26},
Times-Cited = {14},
Usage-Count-Last-180-days = {4},
Usage-Count-Since-2013 = {9},
Journal-ISO = {J. Dev. Life-Course Criminol.},
Doc-Delivery-Number = {GJ7KO},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000435566000002},
DA = {2022-03-29},
}

@article{ WOS:000207448600004,
Author = {Hogg, Robert S. and Druyts, Eric F. and Burris, Scott and Drucker,
   Ernest and Strathdee, Steffanie A.},
Title = {Years of life lost to prison: racial and gender gradients in the United
   States of America},
Journal = {HARM REDUCTION JOURNAL},
Year = {2008},
Volume = {5},
Abstract = {Background: The United States has the highest rate of imprisonment of
   any country in the world. African Americans and Hispanics comprise a
   disproportionately large share of the prison population. We applied a
   ``prison life expectancy{''} to specify differences in exposure to
   imprisonment by gender and race at the population level.
   Methods: The impact of imprisonment on life expectancy in the United
   States was measured for each year from 2000 to 2004, and then averaged.
   Using the Sullivan method, prison and prison-free life expectancies were
   estimated by dividing the years lived in each age range of the life
   table into these two states using prevalence of imprisonment by gender
   and race.
   Results: African American males can expect to spend on average 3.09
   years in prison or jail over their lifetime and Hispanic and Caucasian
   males can spend on average 1.06 and 0.50 years, respectively. African
   American females, on the other hand, can expect to spend on average 0.23
   years in these institutions and Hispanic and Caucasian females can
   expect to spend on average 0.09 and 0.05 years, respectively. Overall,
   African American males, the highest risk group, can expect to spend on
   average 61.80 times longer in prison or jail as compared to Caucasian
   women, the lowest risk group.
   Conclusion: There are clear gender and racial gradients in life
   expectancy spent in prison in the United States. Future research needs
   to examine how current imprisonment practice in the United States may
   influence population health and health disparities.},
Publisher = {BIOMED CENTRAL LTD},
Address = {236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Hogg, RS (Corresponding Author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.
   Hogg, Robert S., Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.
   Hogg, Robert S.; Druyts, Eric F.; Strathdee, Steffanie A., St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.
   Hogg, Robert S.; Strathdee, Steffanie A., Univ Calif, San Diego Sch Med, Div Int Hlth \& Cross Cultural Med, San Diego, CA USA.
   Drucker, Ernest, Montefiore Med Ctr, New York, NY USA.
   Burris, Scott, Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA.},
DOI = {10.1186/1477-7517-5-4},
Article-Number = {4},
ISSN = {1477-7517},
Research-Areas = {Substance Abuse},
Web-of-Science-Categories  = {Substance Abuse},
Author-Email = {rhogg@sfu.ca
   edruyts@cfenet.ubc.ca
   scott.burris@temple.edu
   drucker@aecom.yu.edu
   sstrathdee@ucsd.edu},
ResearcherID-Numbers = {Strathdee, Steffanie A/B-9042-2009
   Hogg, Robert S/B-2783-2012
   },
ORCID-Numbers = {Hogg, Robert S/0000-0003-3463-5488
   Strathdee, Steffanie/0000-0002-7724-691X
   Burris, Scott/0000-0002-6013-5842},
Funding-Acknowledgement = {NIDA NIH HHSUnited States Department of Health \& Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) {[}R01 DA009225, R01 DA014499, R01 DA012568, R56 DA012568]
   Funding Source: Medline},
Cited-References = {Beck A, 2001, PRISON JAIL INMATES.
   BECK AJ, 2003, PRISON JAIL INMATES.
   BECK AJ, 2004, PRISON JAIL INMATES.
   BECK AJ, 2002, PRISON JAIL INMATES.
   BECK AJ, 2005, PRISON JAIL INMATES.
   Bonczar T., 2003, PREVALENCE IMPRISONM.
   Bonczar T.P., 1997, LIFETIME LIKELIHOOD.
   BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005.
   Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012.
   {*}DEP JUST OFF JUST, 2002, CORR POP US STAT TAB.
   Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214.
   Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789.
   Iguchi MY, 2002, PUBLIC HEALTH REP, V117, pS146.
   KREBS CP, 2002, AIDS EDUC PREV, V2, P363.
   Mahon N, 1996, AM J PUBLIC HEALTH, V86, P1211, DOI 10.2105/AJPH.86.9.1211.
   MUTTER RC, 1994, ARCH INTERN MED, V154, P793, DOI 10.1001/archinte.154.7.793.
   Robertson JE, 2003, AIDS PATIENT CARE ST, V17, P423, DOI 10.1089/108729103322277448.
   Struckman-Johnson C, 2002, J SEX RES, V39, P217, DOI 10.1080/00224490209552144.
   SULLIVAN DF, 1971, HEALTH SERV REP, V86, P347, DOI 10.2307/4594169.
   {*}US BUR CENS, NAT POP EST APR 1 20.
   US Census Bureau, NAT POP PROJ.
   {*}WHO REG OFF EUR, 2001, WHO GUID HIV INF AID.
   {*}WHO REG OFF EUR, 2001, HLTH PRIS PROJ POMP.},
Number-of-Cited-References = {23},
Times-Cited = {10},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {6},
Journal-ISO = {Harm Reduct. J.},
Doc-Delivery-Number = {V10EZ},
Web-of-Science-Index = {Social Science Citation Index (SSCI)},
Unique-ID = {WOS:000207448600004},
OA = {Green Published, gold},
DA = {2022-03-29},
}

@article{ WOS:000765485400004,
Author = {Mirahmadizadeh, Alireza and Rezaei, Fariba and Moftakhar, Leila and
   Heiran, Neda and Azarbakhsh, Habibollah},
Title = {Years of Life Lost due to Suicide in Southern Iran 2011-18 A
   Population-Based Study},
Journal = {ARCHIVES OF IRANIAN MEDICINE},
Year = {2022},
Volume = {25},
Number = {1},
Pages = {12-16},
Month = {JAN},
Abstract = {Background: Suicide is a major public health concern with diversity in
   epidemiological aspects and applied methods. In this study, we estimate
   years of life lost (YLLs) related to completed suicidal in the Fars
   province, southern Iran.
   Methods: Our study included data of all mortality events during
   2011-2018 from Fars Suicide Surveillance System (FSSS). The validity of
   qualitative and quantitative variables was assessed through contrasting
   data between different sources and phone call justification.
   Case-fatality rates, age-specific and gender-specific mortality rates,
   ASR (age standardized rate), and YLLs through WHO's 2015 ``YLL
   template{''} were calculated.
   Results: During the study period, 2384 mortalities with a mean age of
   32.73 +/- 15.65 had been registered. Most of them were males (male:
   70.05\% vs. female: 29.95\%; male-female ratio: 2.33), hanging was the
   most frequent method (29.94\%), and an increasing pattern in successful
   suicidal attempts was observed. The total YLLs were calculated to be
   58669 years (14.71 per 1000 persons). Regardless of year or gender,
   suicide had the largest YLLs amongst those aged 15-29 years.
   Conclusion: Regarding the increasing trend in YLLs and observing the
   highest rate of successful suicidal attempts amongst active and
   productive members of community, a comprehensive inter organizational
   reaction is demanded.},
Publisher = {ACAD MEDICAL SCIENCES I R IRAN},
Address = {PO BOX 19395-5655, TEHRAN, 00000, IRAN},
Type = {Article},
Language = {English},
Affiliation = {Azarbakhsh, H (Corresponding Author), Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   Mirahmadizadeh, Alireza, Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran.
   Rezaei, Fariba, Shiraz Univ Med Sci, Mental Hlth, Shiraz, Iran.
   Moftakhar, Leila; Azarbakhsh, Habibollah, Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   Heiran, Neda, Zahedan Univ Med Sci, Sch Nursing \& Midwifery, Zahedan, Iran.},
DOI = {10.34172/aim.2022.03},
ISSN = {1029-2977},
EISSN = {1735-3947},
Keywords = {Burden; Premature death; Suicide; YLL},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {azarbakhshhabibollah@gmail.com},
ResearcherID-Numbers = {Mirahmadizadeh, Alireza/I-9178-2016},
ORCID-Numbers = {Mirahmadizadeh, Alireza/0000-0002-2259-4984},
Cited-References = {Bachmann S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071425.
   Hajebi A, 2016, IRAN J PSYCHIATRY BE, V10, DOI 10.17795/ijpbs-4398.
   Izadi N, 2018, INT J PUBLIC HEALTH, V63, P993, DOI 10.1007/s00038-018-1151-1.
   Mirahmadizadeh A, 2020, J PUBLIC HEALTH-UK, V42, pE1, DOI 10.1093/pubmed/fdy218.
   Mokhtari AM, 2019, ASIAN J PSYCHIATR, V44, P90, DOI 10.1016/j.ajp.2019.07.027.
   Mokhtari AM, 2019, J FORENSIC LEG MED, V66, P129, DOI 10.1016/j.jflm.2019.06.018.
   Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6.
   Orlewska K, 2018, EUR J HEALTH ECON, V19, P409, DOI 10.1007/s10198-017-0892-8.
   Ortiz-Prado E, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1502-0.
   Poorolajal Jalal, 2012, Epidemiol Health, V34, pe2012005, DOI 10.4178/epih/e2012005.
   Sankoh O, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23286.
   Skinner R, 2016, HEALTH PROMOT CHRON, V36, P243, DOI 10.24095/hpcdp.36.11.02.
   Sun L, 2015, PUBLIC HEALTH, V129, P555, DOI 10.1016/j.puhe.2015.02.012.
   van Spijker BAJ, 2011, J AFFECT DISORDERS, V134, P341, DOI 10.1016/j.jad.2011.05.020.
   Veisani Yousef, 2018, Bull Emerg Trauma, V6, P245, DOI 10.29252/beat-0603010.
   World Health Organization (WHO), 2001, NATL BURDEN DIS STUD, V2nd.},
Number-of-Cited-References = {16},
Times-Cited = {0},
Usage-Count-Last-180-days = {0},
Usage-Count-Since-2013 = {0},
Journal-ISO = {Arch. Iran. Med.},
Doc-Delivery-Number = {ZO1KF},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000765485400004},
OA = {hybrid},
DA = {2022-03-29},
}

@article{ WOS:000298063000012,
Author = {Scosyrev, Emil and Golijanin, Dragan and Wu, Guan and Messing, Edward},
Title = {The burden of bladder cancer in men and women: analysis of the years of
   life lost},
Journal = {BJU INTERNATIONAL},
Year = {2012},
Volume = {109},
Number = {1},
Pages = {57-62},
Month = {JAN},
Abstract = {OBJECTIVE To estimate the average loss in life expectancy (LE) due to
   bladder cancer (BC) in men and women in the USA. PATIENTS AND METHODS
   Cancer records for 51 528 patients diagnosed with BC during 1988- 1997
   were obtained from the Surveillance, Epidemiology, and End Results
   database. Potential follow- up ranged from 10 to 20 years (median 14
   years). Loss in median LE at BC diagnosis was computed as the difference
   between expected median survival and observed median survival. Expected
   survival was calculated using two methods: method 1 used age, sex, and
   race- specific LE in the general population, method 2 used the hazard of
   death from non- BC causes in patients with BC (to account for past
   exposures and treatmentrelated toxicities not present in the general
   population). RESULTS During the study period, BC death occurred in 17\%
   of men and 23\% of women and non- BC death occurred in 53\% of men and
   47\% of women. Using LE in the general population as the reference
   (method 1), loss in median LE at BC diagnosis was 3.9 years for men
   (33\% of their potential remaining years of life) and 6.5 years for
   women (47\% of their potential remaining years of life). Using non- BC-
   specific hazard as the reference (method 2), loss in median LE was 2.7
   years for men (26\% of their potential remaining years of life) and 4.1
   years for women (36\% of their potential remaining years of life).
   CONCLUSION Compared with men, women loose more years of life and a
   greater fraction of their life expectancy to BC.},
Publisher = {WILEY},
Address = {111 RIVER ST, HOBOKEN 07030-5774, NJ USA},
Type = {Article},
Language = {English},
Affiliation = {Messing, E (Corresponding Author), 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.
   Scosyrev, Emil; Golijanin, Dragan; Wu, Guan; Messing, Edward, Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA.},
DOI = {10.1111/j.1464-410X.2011.10318.x},
ISSN = {1464-4096},
EISSN = {1464-410X},
Keywords = {bladder cancer; survival; years of potential life lost},
Keywords-Plus = {CIGARETTE-SMOKING; STAGE},
Research-Areas = {Urology \& Nephrology},
Web-of-Science-Categories  = {Urology \& Nephrology},
Author-Email = {Edward\_Messing@urmc.rochester.edu},
Funding-Acknowledgement = {Ashley Family Foundation},
Funding-Text = {Funding for this work was provided by the Ashley Family Foundation.},
Cited-References = {Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M.
   Brennan P, 2001, CANCER CAUSE CONTROL, V12, P411, DOI 10.1023/A:1011214222810.
   Dawson B, 2004, BASIC CLIN BIOSTATIS, P28.
   Edge SBCC, 2010, AJCC CANC STAGING MA.
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006.
   Li CY, 2010, UROLOGY, V76, P528, DOI 10.1016/j.urology.2010.04.030.
   Marubini E, 1995, ANAL SURVIVAL DATA C, P335.
   Messing EM, 2009, J CLIN ONCOL, V27, P2443, DOI 10.1200/JCO.2008.16.5951.
   Mungan NA, 2000, UROLOGY, V55, P876, DOI 10.1016/S0090-4295(00)00523-9.
   National Center for Health Statistics, 1988, VIT STAT US LIF TABL.
   Pipe AL, 2010, CURR ATHEROSCLER REP, V12, P145, DOI 10.1007/s11883-010-0105-8.
   PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374.
   Scosyrev E, 2012, UROL ONCOL-SEMIN ORI, V30, P126, DOI 10.1016/j.urolonc.2009.11.005.
   Scosyrev E, 2010, CURR OPIN UROL, V20, P404, DOI 10.1097/MOU.0b013e32833c7a9b.},
Number-of-Cited-References = {14},
Times-Cited = {22},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {3},
Journal-ISO = {BJU Int.},
Doc-Delivery-Number = {862AU},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000298063000012},
DA = {2022-03-29},
}

@article{ WOS:000412250900111,
Author = {Zhang, Yunquan and Peng, Minjin and Yu, Chuanhua and Zhang, Lan},
Title = {Burden of mortality and years of life lost due to ambient PM10 pollution
   in Wuhan, China},
Journal = {ENVIRONMENTAL POLLUTION},
Year = {2017},
Volume = {230},
Pages = {1073-1080},
Month = {NOV},
Abstract = {Ambient particulate matter (PM) has been mainly linked with mortality
   and morbidity when assessing PM-associated health effects. Up-to-date
   epidemiologic evidence is very sparse regarding the relation between PM
   and years of life lost (YLL). The present study aimed to estimate the
   burden of YLL and mortality due to ambient PM pollution. Individual
   records of all registered deaths and daily data on PM10 and meteorology
   during 2009-2012 were obtained in Wuhan, central China. Using a
   time-series study design, we applied generalized additive model to
   assess the short-term association of 10-mu g/m(3) increase in PM10 with
   daily YLL and mortality, adjusting for long-term trend and seasonality,
   mean temperature, relative humidity, public holiday, and day of the
   week. A linear-no-threshold dose-response association was observed
   between daily ambient PM10 and mortality outcomes. PM10 pollution along
   lag 0-1 days was found to be mostly strongly associated with mortality
   and YLL. The effects of PM10 on cause-specific mortality and YLL showed
   generally similar seasonal patterns, with stronger associations
   consistently occurring in winter and/or autumn. Compared with males and
   younger persons, females and the elderly suffered more significantly
   from both increased YLL and mortality due to ambient PM10 pollution.
   Stratified analyses by education level (0-6 and 7 + years) demonstrated
   great mortality impact on both subgroups, whereas only low-educated
   persons were strongly affected by PM10-associated burden of YLL. Our
   study confirmed that short-term PIA exposure was linearly associated
   with significant increases in both mortality incidence and years of life
   lost. Given the non-threshold adverse effects on mortality burden, the
   on-going efforts to reduce particulate air pollution would substantially
   benefit public health in China. (C) 2017 Elsevier Ltd. All rights
   reserved.},
Publisher = {ELSEVIER SCI LTD},
Address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND},
Type = {Article},
Language = {English},
Affiliation = {Yu, CH (Corresponding Author), Wuhan Univ, Sch Hlth Sci, Dept Prevent Med, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.
   Zhang, Yunquan; Yu, Chuanhua, Wuhan Univ, Sch Hlth Sci, Dept Prevent Med, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.
   Peng, Minjin, Hubei Univ Med, Taihe Hosp, Dept Infect Control, Shiyan 442000, Peoples R China.
   Yu, Chuanhua, Wuhan Univ, Global Hlth Inst, 8 Donghunan Rd, Wuhan 430072, Hubei, Peoples R China.
   Zhang, Lan, Hubei Prov Ctr Dis Control \& Prevent, Off Chron Dis, 6 Zhuodaoquan Rd, Wuhan 430079, Hubei, Peoples R China.},
DOI = {10.1016/j.envpol.2017.07.053},
ISSN = {0269-7491},
EISSN = {1873-6424},
Keywords = {Air pollution; Particulate matter; Mortality; Years of life lost; China},
Keywords-Plus = {PARTICULATE AIR-POLLUTION; SHORT-TERM EXPOSURE; TIME-SERIES; HOSPITAL
   ADMISSIONS; SYSTEMATIC ANALYSIS; FINE PARTICLES; PUBLIC-HEALTH; GLOBAL
   BURDEN; MATTER; TEMPERATURE},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {Yun-quanZhang@whu.edu.cn
   whupeng@whu.edu.cn
   YuChua@whu.edu.cn
   hbcdczl@163.com},
ResearcherID-Numbers = {Zhang, Yunquan/M-9828-2017
   Peng, Minijin/K-8377-2019
   Peng, Minjin/A-2254-2019},
ORCID-Numbers = {Zhang, Yunquan/0000-0002-2618-5088
   Peng, Minijin/0000-0002-1350-4780
   Peng, Minjin/0000-0002-1350-4780},
Funding-Acknowledgement = {National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) {[}81273179]; Chinese NSFC International
   Cooperation and Exchange Program {[}71661167007]; National Basic
   Research Program (973 Program) of ChinaNational Basic Research Program
   of China {[}2012CB955504]},
Funding-Text = {The study was supported by the National Natural Science Foundation of
   China (Grant No. 81273179), the Chinese NSFC International Cooperation
   and Exchange Program (Grant No. 71661167007), and the National Basic
   Research Program (973 Program) of China (Grant No. 2012CB955504). We
   appreciated the anonymous reviewers very much, whose comments and
   suggestions contributed a lot to improving the quality of the
   manuscript.},
Cited-References = {Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1.
   Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492.
   Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090.
   Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252.
   Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85.
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8.
   Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485.
   Chen F, 2017, SCI TOTAL ENVIRON, V581, P426, DOI 10.1016/j.scitotenv.2016.12.151.
   Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI {[}10.1164/rccm.201609-1862oc, 10.1164/rccm.201609-1862OC, 10.1164/rccm.201612-2427OC].
   Chen RJ, 2014, AM J EPIDEMIOL, V180, P729, DOI 10.1093/aje/kwu183.
   Chen RJ, 2013, SCI TOTAL ENVIRON, V450, P259, DOI 10.1016/j.scitotenv.2013.02.040.
   Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2.
   Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994.
   Cohen A.J., 2017, LANCET.
   Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237.
   Deng ZB, 2016, ENVIRON POLLUT, V208, P663, DOI 10.1016/j.envpol.2015.10.044.
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012.
   Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139.
   Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598.
   He TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22485.
   Hoek G, 2014, CHIN J CANCER, V33, P197, DOI 10.5732/cjc.014.10039.
   Huang ZJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009172.
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851.
   Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658.
   Krewski D, 2009, NEW ENGL J MED, V360, P413, DOI 10.1056/NEJMe0809178.
   Li P, 2013, ATMOS ENVIRON, V81, P253, DOI 10.1016/j.atmosenv.2013.09.004.
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8.
   Liu MM, 2017, ENVIRON INT, V98, P75, DOI 10.1016/j.envint.2016.10.003.
   Liu T, 2014, ENVIRON POLLUT, V187, P116, DOI 10.1016/j.envpol.2013.12.027.
   Loomis D, 2013, LANCET ONCOL, V14, P1262, DOI 10.1016/S1470-2045(13)70487-X.
   Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048.
   Ma YJ, 2011, SCI TOTAL ENVIRON, V409, P2473, DOI 10.1016/j.scitotenv.2011.03.017.
   Marzouni M. B., 2017, INT J BIOMETEOROL.
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2.
   Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x.
   Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075.
   Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481.
   Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401.
   Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345.
   Shah PS, 2011, ENVIRON INT, V37, P498, DOI 10.1016/j.envint.2010.10.009.
   Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010.
   Stafoggia M, 2008, AM J EPIDEMIOL, V167, P1476, DOI 10.1093/aje/kwn074.
   Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794.
   Watts J, 2005, LANCET, V366, P1761, DOI 10.1016/S0140-6736(05)67711-2.
   Wong CM, 2008, ENVIRON HEALTH PERSP, V116, P1195, DOI 10.1289/ehp.11257.
   Xu P, 2013, LANCET, V382, P2067, DOI 10.1016/S0140-6736(13)62693-8.
   Yang J, 2016, SCI TOTAL ENVIRON, V573, P1566, DOI 10.1016/j.scitotenv.2016.09.014.
   Yin P, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j667.
   Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382.
   Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116.
   Zeng Q, 2017, ENVIRON POLLUT, V220, P713, DOI 10.1016/j.envpol.2016.10.036.
   Zhang Y., 2016, OXIDATIVE MED CELLUL, V2016, P13, DOI DOI 10.1155/2016/758981327069532.
   Zhang Yunquan, 2017, Glob Health Res Policy, V2, P10, DOI 10.1186/s41256-017-0030-2.
   Zhang YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45093.
   Zhang YQ, 2017, SCI TOTAL ENVIRON, V587, P196, DOI 10.1016/j.scitotenv.2017.02.117.
   Zhu JY, 2017, ENVIRON POLLUT, V224, P689, DOI 10.1016/j.envpol.2017.02.053.},
Number-of-Cited-References = {56},
Times-Cited = {40},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {48},
Journal-ISO = {Environ. Pollut.},
Doc-Delivery-Number = {FI8KG},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000412250900111},
DA = {2022-03-29},
}
